primaryid,indi_drug_seq,indi_pt,caseversion,i_f_code,rept_cod,drug_name,drug_seq,role_cod,pt,dsg_drug_seq,sex,outc_cod,Days
102035193,6,Product used for unknown indication,3,F,EXP,thalidomide,6,SS,Myelodysplastic syndrome,6,F,OT,457
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Atrioventricular block,1,M,OT,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Atrioventricular block,1,M,LT,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Atrioventricular block,1,M,HO,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Atrioventricular block,1,M,DE,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Dehydration,1,M,LT,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Dehydration,1,M,DE,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,LT,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,DE,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,LT,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,HO,6
104036308,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,DE,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Atrioventricular block,2,M,OT,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Atrioventricular block,2,M,LT,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Atrioventricular block,2,M,HO,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Atrioventricular block,2,M,DE,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Dehydration,2,M,OT,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Dehydration,2,M,LT,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Dehydration,2,M,HO,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Dehydration,2,M,DE,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,LT,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,HO,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DE,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,OT,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,LT,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,HO,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,DE,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Respiratory failure,2,M,OT,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Respiratory failure,2,M,LT,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Respiratory failure,2,M,HO,6
104036308,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Respiratory failure,2,M,DE,6
1074665814,1,Inflammatory myofibroblastic tumour,14,F,EXP,ceritinib,1,PS,Acute hepatic failure,1,M,LT,83
1074665814,1,Inflammatory myofibroblastic tumour,14,F,EXP,ceritinib,1,PS,Acute hepatic failure,1,M,HO,83
1074665814,1,Inflammatory myofibroblastic tumour,14,F,EXP,ceritinib,1,PS,Acute kidney injury,1,M,LT,83
1074665814,1,Inflammatory myofibroblastic tumour,14,F,EXP,ceritinib,1,PS,Acute kidney injury,1,M,HO,83
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Alanine aminotransferase increased,1,M,OT,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Alanine aminotransferase increased,1,M,HO,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Aspartate aminotransferase increased,1,M,OT,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Aspartate aminotransferase increased,1,M,HO,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Blood lactate dehydrogenase increased,1,M,OT,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Blood lactate dehydrogenase increased,1,M,HO,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,C-reactive protein increased,1,M,OT,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,C-reactive protein increased,1,M,HO,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Diarrhoea,1,M,OT,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Diarrhoea,1,M,HO,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Hepatitis E,1,M,OT,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Hepatitis E,1,M,HO,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Leukocytosis,1,M,OT,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Leukocytosis,1,M,HO,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Leukopenia,1,M,OT,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Leukopenia,1,M,HO,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Lymphopenia,1,M,OT,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Lymphopenia,1,M,HO,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Polycythaemia,1,M,OT,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Polycythaemia,1,M,HO,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Thrombocytopenia,1,M,OT,1
1080382915,1,Relapsing multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Thrombocytopenia,1,M,HO,1
108618773,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Depressed mood,1,M,OT,2458
108618773,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Oral disorder,1,M,OT,2458
108618773,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Palpitations,1,M,OT,2458
108618773,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Product dose omission,1,M,OT,2458
108838816,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,31
108838816,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,31
108838816,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,31
108838816,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Pericardial effusion,1,F,OT,31
108838816,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Pericardial effusion,1,F,HO,31
108838816,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Pericardial effusion,1,F,DE,31
108838816,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Transaminases increased,1,F,OT,31
108838816,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Transaminases increased,1,F,HO,31
108838816,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Transaminases increased,1,F,DE,31
108838816,2,Non-small cell lung cancer,6,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,OT,31
108838816,2,Non-small cell lung cancer,6,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,HO,31
108838816,2,Non-small cell lung cancer,6,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,DE,31
108838816,2,Non-small cell lung cancer,6,F,EXP,ipilimumab,2,SS,Pericardial effusion,2,F,OT,31
108838816,2,Non-small cell lung cancer,6,F,EXP,ipilimumab,2,SS,Pericardial effusion,2,F,HO,31
108838816,2,Non-small cell lung cancer,6,F,EXP,ipilimumab,2,SS,Pericardial effusion,2,F,DE,31
108838816,2,Non-small cell lung cancer,6,F,EXP,ipilimumab,2,SS,Transaminases increased,2,F,OT,31
108838816,2,Non-small cell lung cancer,6,F,EXP,ipilimumab,2,SS,Transaminases increased,2,F,HO,31
108838816,2,Non-small cell lung cancer,6,F,EXP,ipilimumab,2,SS,Transaminases increased,2,F,DE,31
1096311910,1,Bladder cancer,10,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,DE,26
1096311910,1,Bladder cancer,10,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,26
1096311910,2,Bladder cancer,10,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,DE,26
1096311910,2,Bladder cancer,10,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,HO,26
109836422,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Hypophysitis,1,M,HO,56
109836422,3,Metastatic malignant melanoma,2,F,EXP,ipilimumab,3,SS,Hypophysitis,3,M,HO,56
110816728,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Abdominal pain upper,1,M,OT,53
110816728,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Feeling abnormal,1,M,OT,53
110816728,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Headache,1,M,OT,53
110816728,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Immune system disorder,1,M,OT,53
110816728,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Malaise,1,M,OT,53
110816728,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Paraesthesia,1,M,OT,53
110816728,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Peripheral swelling,1,M,OT,53
110816728,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Product odour abnormal,1,M,OT,53
110816728,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Pruritus,1,M,OT,53
110816728,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Rash macular,1,M,OT,53
110816728,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Tooth fracture,1,M,OT,53
110816728,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Tremor,1,M,OT,53
1132870312,1,Chronic myeloid leukaemia,12,F,EXP,bosutinib,1,PS,Necrotising oesophagitis,1,M,HO,20
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Anxiety,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Arthralgia,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Axillary pain,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Back pain,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Blood calcium decreased,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Chest pain,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Cough,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Decreased appetite,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Epistaxis,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Gingivitis,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Headache,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Musculoskeletal discomfort,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Musculoskeletal pain,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Nausea,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Neck pain,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Neuropathy peripheral,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Pain in extremity,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Palpitations,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Retching,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Spinal pain,13,F,HO,84
1144560313,13,Vitamin D decreased,13,F,EXP,zoledronic acid,13,C,Tachycardia,13,F,HO,84
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Blood creatinine increased,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Blood creatinine increased,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Blood creatinine increased,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Blood creatinine increased,1,M,OT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Cardiac failure congestive,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Cardiac failure congestive,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Cardiac failure congestive,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Cardiac failure congestive,1,M,OT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Dyspnoea,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Dyspnoea,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Dyspnoea,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Dyspnoea,1,M,OT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Hypertension,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Hypertension,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Hypertension,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Hypertension,1,M,OT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Lymphocyte count decreased,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Lymphocyte count decreased,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Lymphocyte count decreased,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Lymphocyte count decreased,1,M,OT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Nausea,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Nausea,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Nausea,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Nausea,1,M,OT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Pulmonary hypertension,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Pulmonary hypertension,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Pulmonary hypertension,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Pulmonary hypertension,1,M,OT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Pyrexia,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Pyrexia,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Pyrexia,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Pyrexia,1,M,OT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Renal failure,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Renal failure,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Renal failure,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Renal failure,1,M,OT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Respiratory failure,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Respiratory failure,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Respiratory failure,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Respiratory failure,1,M,OT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Sinus bradycardia,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Sinus bradycardia,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Sinus bradycardia,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Sinus bradycardia,1,M,OT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Tachycardia,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Tachycardia,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Tachycardia,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Tachycardia,1,M,OT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Tachypnoea,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Tachypnoea,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Tachypnoea,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Tachypnoea,1,M,OT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Troponin increased,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Troponin increased,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Troponin increased,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Troponin increased,1,M,OT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Vomiting,1,M,DE,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Vomiting,1,M,HO,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Vomiting,1,M,LT,2
115110285,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Vomiting,1,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Blood creatinine increased,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Blood creatinine increased,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Blood creatinine increased,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Blood creatinine increased,3,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Cardiac failure congestive,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Cardiac failure congestive,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Cardiac failure congestive,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Cardiac failure congestive,3,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Dyspnoea,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Dyspnoea,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Dyspnoea,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Dyspnoea,3,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Hypertension,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Hypertension,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Hypertension,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Hypertension,3,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Lymphocyte count decreased,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Lymphocyte count decreased,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Lymphocyte count decreased,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Lymphocyte count decreased,3,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Nausea,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Nausea,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Nausea,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Nausea,3,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Pulmonary hypertension,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Pulmonary hypertension,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Pulmonary hypertension,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Pulmonary hypertension,3,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Pyrexia,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Pyrexia,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Pyrexia,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Pyrexia,3,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Renal failure,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Renal failure,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Renal failure,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Renal failure,3,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Respiratory failure,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Respiratory failure,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Respiratory failure,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Respiratory failure,3,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Sinus bradycardia,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Sinus bradycardia,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Sinus bradycardia,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Sinus bradycardia,3,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Tachycardia,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Tachycardia,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Tachycardia,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Tachycardia,3,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Tachypnoea,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Tachypnoea,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Tachypnoea,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Tachypnoea,3,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Troponin increased,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Troponin increased,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Troponin increased,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Troponin increased,3,M,OT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Vomiting,3,M,DE,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Vomiting,3,M,HO,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Vomiting,3,M,LT,2
115110285,3,Plasma cell myeloma,5,F,PER,lenalidomide,3,SS,Vomiting,3,M,OT,2
115192034,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Hepatitis viral,1,M,HO,293
116988703,1,Metastatic malignant melanoma,3,F,EXP,nivolumab,1,PS,Scleroderma,1,F,HO,616
116988703,1,Metastatic malignant melanoma,3,F,EXP,nivolumab,1,PS,Scleroderma,1,F,OT,616
116988703,2,Metastatic malignant melanoma,3,F,EXP,ipilimumab,2,SS,Scleroderma,2,F,HO,616
116988703,2,Metastatic malignant melanoma,3,F,EXP,ipilimumab,2,SS,Scleroderma,2,F,OT,616
117001625,3,Bone cancer metastatic,5,F,EXP,zoledronic acid,3,C,Syncope,3,F,HO,18
117206778,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Cervicobrachial syndrome,1,M,HO,108
117698032,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Sarcoidosis,1,M,OT,98
117698032,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Sarcoidosis,1,M,HO,98
117698032,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Sarcoidosis,2,M,OT,98
117698032,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Sarcoidosis,2,M,HO,98
1178803111,2,Colorectal cancer,11,F,EXP,trametinib,2,SS,Acute kidney injury,2,M,HO,56
1178803111,3,Colorectal cancer,11,F,EXP,panitumumab,3,SS,Acute kidney injury,3,M,HO,56
118229395,2,Breast cancer,5,F,EXP,lapatinib ditosylate,2,PS,Cardiac failure congestive,2,F,HO,1578
118229395,2,Breast cancer,5,F,EXP,lapatinib ditosylate,2,PS,Cardiac failure congestive,2,F,OT,1578
118229395,2,Breast cancer,5,F,EXP,lapatinib ditosylate,2,PS,Cardiac failure congestive,2,F,DE,1578
118229395,2,Breast cancer,5,F,EXP,lapatinib ditosylate,2,PS,Pneumonia,2,F,HO,1578
118229395,2,Breast cancer,5,F,EXP,lapatinib ditosylate,2,PS,Pneumonia,2,F,OT,1578
118229395,2,Breast cancer,5,F,EXP,lapatinib ditosylate,2,PS,Pneumonia,2,F,DE,1578
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Brain hypoxia,1,M,LT,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Brain hypoxia,1,M,HO,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Brain hypoxia,1,M,DE,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Brain hypoxia,1,M,OT,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Dyspnoea,1,M,LT,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Dyspnoea,1,M,HO,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Dyspnoea,1,M,DE,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Dyspnoea,1,M,OT,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Enterocolitis,1,M,LT,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Enterocolitis,1,M,HO,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Enterocolitis,1,M,DE,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Enterocolitis,1,M,OT,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Escherichia sepsis,1,M,LT,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Escherichia sepsis,1,M,HO,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Escherichia sepsis,1,M,DE,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Escherichia sepsis,1,M,OT,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Pneumonitis,1,M,LT,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Pneumonitis,1,M,HO,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Pneumonitis,1,M,DE,63
118593733,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Pneumonitis,1,M,OT,63
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,OT,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,LT,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,DE,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,HO,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Myocarditis,1,F,OT,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Myocarditis,1,F,LT,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Myocarditis,1,F,DE,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Myocarditis,1,F,HO,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Myositis,1,F,OT,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Myositis,1,F,LT,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Myositis,1,F,DE,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Myositis,1,F,HO,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,F,OT,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,F,LT,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,F,DE,12
118644763,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,F,HO,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,OT,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,LT,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,DE,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,HO,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Myocarditis,2,F,OT,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Myocarditis,2,F,LT,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Myocarditis,2,F,DE,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Myocarditis,2,F,HO,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Myositis,2,F,OT,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Myositis,2,F,LT,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Myositis,2,F,DE,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Myositis,2,F,HO,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,F,OT,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,F,LT,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,F,DE,12
118644763,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,F,HO,12
118696568,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Cardiac pacemaker insertion,1,M,DE,15
118696568,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Cardiac pacemaker insertion,1,M,OT,15
118696568,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Cardiac pacemaker insertion,1,M,HO,15
118696568,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Myocarditis,1,M,DE,15
118696568,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Myocarditis,1,M,OT,15
118696568,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Myocarditis,1,M,HO,15
118696568,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Myositis,1,M,DE,15
118696568,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Myositis,1,M,OT,15
118696568,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Myositis,1,M,HO,15
118696568,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,DE,15
118696568,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,OT,15
118696568,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,HO,15
118696568,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Cardiac pacemaker insertion,2,M,DE,15
118696568,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Cardiac pacemaker insertion,2,M,OT,15
118696568,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Cardiac pacemaker insertion,2,M,HO,15
118696568,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Myocarditis,2,M,DE,15
118696568,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Myocarditis,2,M,OT,15
118696568,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Myocarditis,2,M,HO,15
118696568,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Myositis,2,M,DE,15
118696568,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Myositis,2,M,OT,15
118696568,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Myositis,2,M,HO,15
118696568,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Rhabdomyolysis,2,M,DE,15
118696568,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Rhabdomyolysis,2,M,OT,15
118696568,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Rhabdomyolysis,2,M,HO,15
118696568,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Cardiac pacemaker insertion,3,M,DE,15
118696568,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Cardiac pacemaker insertion,3,M,OT,15
118696568,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Cardiac pacemaker insertion,3,M,HO,15
118696568,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Myocarditis,3,M,DE,15
118696568,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Myocarditis,3,M,OT,15
118696568,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Myocarditis,3,M,HO,15
118696568,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Myositis,3,M,DE,15
118696568,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Myositis,3,M,OT,15
118696568,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Myositis,3,M,HO,15
118696568,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Rhabdomyolysis,3,M,DE,15
118696568,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Rhabdomyolysis,3,M,OT,15
118696568,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Rhabdomyolysis,3,M,HO,15
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Alopecia,7,F,HO,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Alopecia,7,F,OT,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Constipation,7,F,HO,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Constipation,7,F,OT,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Febrile neutropenia,7,F,HO,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Febrile neutropenia,7,F,OT,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Headache,7,F,HO,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Headache,7,F,OT,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Nausea,7,F,HO,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Nausea,7,F,OT,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Neurotoxicity,7,F,HO,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Neurotoxicity,7,F,OT,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Oropharyngeal pain,7,F,HO,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Oropharyngeal pain,7,F,OT,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Rectal haemorrhage,7,F,HO,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Rectal haemorrhage,7,F,OT,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Stomatitis,7,F,HO,132
119974704,7,Breast cancer,4,F,EXP,denosumab,7,SS,Stomatitis,7,F,OT,132
121543026,1,Non-small cell lung cancer recurrent,6,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,OT,12
122207443,1,Non-small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Disseminated intravascular coagulation,1,M,DE,7
122207443,1,Non-small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Disseminated intravascular coagulation,1,M,OT,7
122207443,1,Non-small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,DE,7
122207443,1,Non-small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,OT,7
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute respiratory failure,1,F,OT,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute respiratory failure,1,F,HO,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,F,OT,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,F,HO,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Muscular weakness,1,F,OT,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Muscular weakness,1,F,HO,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pneumonia,1,F,OT,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pneumonia,1,F,HO,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pneumonitis,1,F,OT,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pneumonitis,1,F,HO,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,OT,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,HO,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Urine output decreased,1,F,OT,5
122247083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Urine output decreased,1,F,HO,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Acute respiratory failure,2,F,OT,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Acute respiratory failure,2,F,HO,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Blood creatinine increased,2,F,OT,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Blood creatinine increased,2,F,HO,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,F,OT,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,F,HO,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Muscular weakness,2,F,OT,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Muscular weakness,2,F,HO,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Pneumonia,2,F,OT,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Pneumonia,2,F,HO,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Pneumonitis,2,F,OT,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Pneumonitis,2,F,HO,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Urinary tract infection,2,F,OT,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Urinary tract infection,2,F,HO,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Urine output decreased,2,F,OT,5
122247083,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Urine output decreased,2,F,HO,5
122715719,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Peroneal nerve palsy,1,M,OT,57
122763445,6,B-cell lymphoma,5,F,EXP,pegfilgrastim,6,SS,Febrile neutropenia,6,F,HO,35
122763445,6,B-cell lymphoma,5,F,EXP,pegfilgrastim,6,SS,Hypotension,6,F,HO,35
122763445,6,B-cell lymphoma,5,F,EXP,pegfilgrastim,6,SS,Interstitial lung disease,6,F,HO,35
122763445,6,B-cell lymphoma,5,F,EXP,pegfilgrastim,6,SS,Malaise,6,F,HO,35
122763445,6,B-cell lymphoma,5,F,EXP,pegfilgrastim,6,SS,Pneumonia aspiration,6,F,HO,35
122763445,6,B-cell lymphoma,5,F,EXP,pegfilgrastim,6,SS,Pyrexia,6,F,HO,35
122763445,6,B-cell lymphoma,5,F,EXP,pegfilgrastim,6,SS,Stomatitis,6,F,HO,35
122934425,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,SS,Confusional state,1,M,HO,4
122934425,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,SS,Lower respiratory tract infection,1,M,HO,4
122934425,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,SS,Malaise,1,M,HO,4
122934425,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,SS,Nausea,1,M,HO,4
122934425,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,SS,Sepsis,1,M,HO,4
1232631114,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,68
1232631114,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,68
1232631114,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Polymyositis,1,M,OT,68
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Basal cell carcinoma,1,F,DS,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Basal cell carcinoma,1,F,OT,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Basal cell carcinoma,1,F,LT,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Basal cell carcinoma,1,F,HO,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Ischaemic stroke,1,F,DS,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Ischaemic stroke,1,F,OT,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Ischaemic stroke,1,F,LT,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Ischaemic stroke,1,F,HO,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Plasmacytoma,1,F,DS,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Plasmacytoma,1,F,OT,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Plasmacytoma,1,F,LT,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Plasmacytoma,1,F,HO,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Pulmonary oedema,1,F,DS,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Pulmonary oedema,1,F,OT,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Pulmonary oedema,1,F,LT,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Pulmonary oedema,1,F,HO,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Rash vesicular,1,F,DS,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Rash vesicular,1,F,OT,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Rash vesicular,1,F,LT,259
1233179416,1,Plasma cell myeloma recurrent,16,F,EXP,pomalidomide,1,PS,Rash vesicular,1,F,HO,259
123547578,14,Prophylaxis,8,F,EXP,rasburicase,14,C,Bronchiectasis,14,M,HO,974
123547578,14,Prophylaxis,8,F,EXP,rasburicase,14,C,Bronchiectasis,14,M,DE,974
123547578,14,Prophylaxis,8,F,EXP,rasburicase,14,C,Death,14,M,HO,974
123547578,14,Prophylaxis,8,F,EXP,rasburicase,14,C,Death,14,M,DE,974
123547578,14,Prophylaxis,8,F,EXP,rasburicase,14,C,Infective exacerbation of bronchiectasis,14,M,HO,974
123547578,14,Prophylaxis,8,F,EXP,rasburicase,14,C,Infective exacerbation of bronchiectasis,14,M,DE,974
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Achromotrichia acquired,1,M,HO,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Achromotrichia acquired,1,M,OT,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Facial paralysis,1,M,HO,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Facial paralysis,1,M,OT,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Headache,1,M,HO,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Headache,1,M,OT,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Hyperthyroidism,1,M,HO,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Hyperthyroidism,1,M,OT,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Leukoderma,1,M,HO,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Leukoderma,1,M,OT,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Liver disorder,1,M,HO,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Liver disorder,1,M,OT,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Off label use,1,M,HO,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Off label use,1,M,OT,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Otitis media,1,M,HO,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Otitis media,1,M,OT,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Pyrexia,1,M,HO,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Pyrexia,1,M,OT,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Skin depigmentation,1,M,HO,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Skin depigmentation,1,M,OT,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Tinnitus,1,M,HO,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Tinnitus,1,M,OT,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Urticaria,1,M,HO,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Urticaria,1,M,OT,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Uveitis,1,M,HO,7
1238207616,1,Malignant melanoma stage IV,16,F,EXP,ipilimumab,1,PS,Uveitis,1,M,OT,7
123824605,1,Metastatic renal cell carcinoma,5,F,EXP,avelumab,1,SS,Neutropenia,1,F,HO,44
123824605,1,Metastatic renal cell carcinoma,5,F,EXP,avelumab,1,SS,Pyrexia,1,F,HO,44
123824605,1,Metastatic renal cell carcinoma,5,F,EXP,avelumab,1,SS,Transaminases increased,1,F,HO,44
123824605,2,Metastatic renal cell carcinoma,5,F,EXP,axitinib,2,PS,Neutropenia,2,F,HO,44
123824605,2,Metastatic renal cell carcinoma,5,F,EXP,axitinib,2,PS,Pyrexia,2,F,HO,44
123824605,2,Metastatic renal cell carcinoma,5,F,EXP,axitinib,2,PS,Transaminases increased,2,F,HO,44
124168726,1,Acute lymphocytic leukaemia,6,F,PER,carfilzomib,1,PS,Febrile neutropenia,1,F,HO,16
124168726,1,Acute lymphocytic leukaemia,6,F,PER,carfilzomib,1,PS,Febrile neutropenia,1,F,LT,16
124168726,1,Acute lymphocytic leukaemia,6,F,PER,carfilzomib,1,PS,Febrile neutropenia,1,F,OT,16
124485357,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Deafness neurosensory,1,M,OT,230
124485357,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Uveitis,1,M,OT,230
124485357,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Deafness neurosensory,2,M,OT,209
124485357,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Uveitis,2,M,OT,209
124485357,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Deafness neurosensory,3,M,OT,188
124485357,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Uveitis,3,M,OT,188
124485357,4,Product used for unknown indication,7,F,EXP,nivolumab,4,SS,Deafness neurosensory,4,M,OT,167
124485357,4,Product used for unknown indication,7,F,EXP,nivolumab,4,SS,Uveitis,4,M,OT,167
124485357,5,Product used for unknown indication,7,F,EXP,nivolumab,5,SS,Deafness neurosensory,5,M,OT,146
124485357,5,Product used for unknown indication,7,F,EXP,nivolumab,5,SS,Uveitis,5,M,OT,146
124485357,6,Product used for unknown indication,7,F,EXP,nivolumab,6,SS,Deafness neurosensory,6,M,OT,125
124485357,6,Product used for unknown indication,7,F,EXP,nivolumab,6,SS,Uveitis,6,M,OT,125
124485357,7,Product used for unknown indication,7,F,EXP,nivolumab,7,SS,Deafness neurosensory,7,M,OT,104
124485357,7,Product used for unknown indication,7,F,EXP,nivolumab,7,SS,Uveitis,7,M,OT,104
124485357,8,Product used for unknown indication,7,F,EXP,nivolumab,8,SS,Deafness neurosensory,8,M,OT,83
124485357,8,Product used for unknown indication,7,F,EXP,nivolumab,8,SS,Uveitis,8,M,OT,83
124485357,9,Product used for unknown indication,7,F,EXP,nivolumab,9,SS,Deafness neurosensory,9,M,OT,62
124485357,9,Product used for unknown indication,7,F,EXP,nivolumab,9,SS,Uveitis,9,M,OT,62
124485357,10,Product used for unknown indication,7,F,EXP,nivolumab,10,SS,Deafness neurosensory,10,M,OT,41
124485357,10,Product used for unknown indication,7,F,EXP,nivolumab,10,SS,Uveitis,10,M,OT,41
124485357,11,Product used for unknown indication,7,F,EXP,nivolumab,11,SS,Deafness neurosensory,11,M,OT,20
124485357,11,Product used for unknown indication,7,F,EXP,nivolumab,11,SS,Uveitis,11,M,OT,20
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Alanine aminotransferase decreased,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Alanine aminotransferase decreased,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Drug ineffective,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Drug ineffective,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Fibrin D dimer increased,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Fibrin D dimer increased,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Leukoderma,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Leukoderma,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Metastases to peritoneum,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Metastases to peritoneum,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Ocular sarcoidosis,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Ocular sarcoidosis,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Off label use,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pleurisy,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pleurisy,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pulmonary sarcoidosis,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pulmonary sarcoidosis,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pyrexia,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Uveitis,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Uveitis,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Vitiligo,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Vitiligo,1,M,OT,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,White blood cell count decreased,1,M,DE,5
124785396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,White blood cell count decreased,1,M,OT,5
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Ataxia,10,F,HO,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Ataxia,10,F,DE,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Ataxia,10,F,DS,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Balance disorder,10,F,HO,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Balance disorder,10,F,DE,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Balance disorder,10,F,DS,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Dyspnoea exertional,10,F,HO,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Dyspnoea exertional,10,F,DE,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Dyspnoea exertional,10,F,DS,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Fatigue,10,F,HO,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Fatigue,10,F,DE,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Fatigue,10,F,DS,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Hydrocephalus,10,F,HO,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Hydrocephalus,10,F,DE,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Hydrocephalus,10,F,DS,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Hypertension,10,F,HO,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Hypertension,10,F,DE,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Hypertension,10,F,DS,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Mobility decreased,10,F,HO,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Mobility decreased,10,F,DE,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Mobility decreased,10,F,DS,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Nausea,10,F,HO,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Nausea,10,F,DE,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Nausea,10,F,DS,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Pain,10,F,HO,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Pain,10,F,DE,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Pain,10,F,DS,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Urinary tract infection,10,F,HO,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Urinary tract infection,10,F,DE,13
1251682213,10,Metastases to bone,13,F,EXP,zoledronic acid,10,C,Urinary tract infection,10,F,DS,13
1253032310,2,Plasma cell myeloma,10,F,EXP,pomalidomide,2,SS,Invasive breast carcinoma,2,F,DE,19
1253032310,2,Plasma cell myeloma,10,F,EXP,pomalidomide,2,SS,Invasive breast carcinoma,2,F,HO,19
1253032310,2,Plasma cell myeloma,10,F,EXP,pomalidomide,2,SS,Invasive breast carcinoma,2,F,OT,19
1253032310,2,Plasma cell myeloma,10,F,EXP,pomalidomide,2,SS,Wound infection,2,F,DE,19
1253032310,2,Plasma cell myeloma,10,F,EXP,pomalidomide,2,SS,Wound infection,2,F,HO,19
1253032310,2,Plasma cell myeloma,10,F,EXP,pomalidomide,2,SS,Wound infection,2,F,OT,19
125319354,1,Chronic myeloid leukaemia,4,F,EXP,bosutinib,1,PS,Cardiac arrest,1,M,DE,2445
125319545,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Acute myocardial infarction,1,M,HO,346
125319545,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Acute myocardial infarction,1,M,OT,346
125319545,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Cardiac failure congestive,1,M,HO,346
125319545,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Cardiac failure congestive,1,M,OT,346
125319545,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Cardiomyopathy,1,M,HO,346
125319545,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Cardiomyopathy,1,M,OT,346
125464359,1,Non-small cell lung cancer,9,F,EXP,crizotinib,1,PS,Cardiac arrest,1,F,HO,320
125464359,1,Non-small cell lung cancer,9,F,EXP,crizotinib,1,PS,Cardiac arrest,1,F,DE,320
125464359,1,Non-small cell lung cancer,9,F,EXP,crizotinib,1,PS,Pneumonia,1,F,HO,320
125464359,1,Non-small cell lung cancer,9,F,EXP,crizotinib,1,PS,Pneumonia,1,F,DE,320
1259801411,6,Metastatic malignant melanoma,11,F,EXP,trametinib,6,SS,Autoimmune colitis,6,M,OT,6
1259801411,6,Metastatic malignant melanoma,11,F,EXP,trametinib,6,SS,Autoimmune colitis,6,M,HO,6
1259801411,6,Metastatic malignant melanoma,11,F,EXP,trametinib,6,SS,Diabetes mellitus,6,M,OT,6
1259801411,6,Metastatic malignant melanoma,11,F,EXP,trametinib,6,SS,Diabetes mellitus,6,M,HO,6
1259801411,6,Metastatic malignant melanoma,11,F,EXP,trametinib,6,SS,General physical health deterioration,6,M,OT,6
1259801411,6,Metastatic malignant melanoma,11,F,EXP,trametinib,6,SS,General physical health deterioration,6,M,HO,6
1259801411,6,Metastatic malignant melanoma,11,F,EXP,trametinib,6,SS,Pneumonia,6,M,OT,6
1259801411,6,Metastatic malignant melanoma,11,F,EXP,trametinib,6,SS,Pneumonia,6,M,HO,6
1259801411,6,Metastatic malignant melanoma,11,F,EXP,trametinib,6,SS,Pyrexia,6,M,OT,6
1259801411,6,Metastatic malignant melanoma,11,F,EXP,trametinib,6,SS,Pyrexia,6,M,HO,6
125996499,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,F,HO,47
125996499,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,F,OT,47
125996499,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,47
125996499,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,47
125996499,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,F,HO,47
125996499,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,F,OT,47
125996499,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Metastases to lung,1,F,HO,47
125996499,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Metastases to lung,1,F,OT,47
125996499,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Off label use,1,F,HO,47
125996499,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Off label use,1,F,OT,47
125996499,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Uveitis,1,F,HO,47
125996499,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Uveitis,1,F,OT,47
126078458,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Arrhythmia,1,M,DE,38
126078458,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Arrhythmia,1,M,HO,38
126078458,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Arrhythmia,1,M,OT,38
126078458,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Arrhythmia,2,M,DE,38
126078458,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Arrhythmia,2,M,HO,38
126078458,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Arrhythmia,2,M,OT,38
126446669,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Cytokine release syndrome,1,F,HO,2
126446669,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Fatigue,1,F,HO,2
126446669,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Hypertransaminasaemia,1,F,HO,2
126446669,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Lymphopenia,1,F,HO,2
126446669,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Pain in extremity,1,F,HO,2
126446669,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Pericarditis,1,F,HO,2
126446669,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Pneumonitis,1,F,HO,2
1267683017,1,Plasma cell myeloma,17,F,EXP,pomalidomide,1,SS,Neutropenia,1,F,HO,12
1267683017,1,Plasma cell myeloma,17,F,EXP,pomalidomide,1,SS,Neutropenia,1,F,DE,12
1267683017,1,Plasma cell myeloma,17,F,EXP,pomalidomide,1,SS,Neutropenia,1,F,OT,12
1267683017,1,Plasma cell myeloma,17,F,EXP,pomalidomide,1,SS,Neutropenic sepsis,1,F,HO,12
1267683017,1,Plasma cell myeloma,17,F,EXP,pomalidomide,1,SS,Neutropenic sepsis,1,F,DE,12
1267683017,1,Plasma cell myeloma,17,F,EXP,pomalidomide,1,SS,Neutropenic sepsis,1,F,OT,12
1267683017,1,Plasma cell myeloma,17,F,EXP,pomalidomide,1,SS,Plasma cell myeloma,1,F,HO,12
1267683017,1,Plasma cell myeloma,17,F,EXP,pomalidomide,1,SS,Plasma cell myeloma,1,F,DE,12
1267683017,1,Plasma cell myeloma,17,F,EXP,pomalidomide,1,SS,Plasma cell myeloma,1,F,OT,12
1267683017,1,Plasma cell myeloma,17,F,EXP,pomalidomide,1,SS,Thrombocytopenia,1,F,HO,12
1267683017,1,Plasma cell myeloma,17,F,EXP,pomalidomide,1,SS,Thrombocytopenia,1,F,DE,12
1267683017,1,Plasma cell myeloma,17,F,EXP,pomalidomide,1,SS,Thrombocytopenia,1,F,OT,12
126915242,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Multiple organ dysfunction syndrome,2,M,DE,43
126915242,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Multiple organ dysfunction syndrome,2,M,HO,43
127398629,1,Squamous cell carcinoma of head and neck,9,F,PER,talimogene laherparepvec,1,PS,Mucosal haemorrhage,1,F,HO,18
127501356,1,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,43
127501356,1,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,1,PS,Back injury,1,M,OT,43
127501356,1,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,1,PS,Back pain,1,M,OT,43
127501356,1,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,1,PS,Chest pain,1,M,OT,43
127501356,1,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,43
127501356,1,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,1,PS,Memory impairment,1,M,OT,43
127501356,1,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,1,PS,Prostatic specific antigen increased,1,M,OT,43
127501356,1,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,1,PS,Sinusitis,1,M,OT,43
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Diabetes mellitus inadequate control,1,M,OT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Diabetes mellitus inadequate control,1,M,HO,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Diabetes mellitus inadequate control,1,M,LT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Diabetes mellitus inadequate control,1,M,DE,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,LT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Lethargy,1,M,OT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Lethargy,1,M,HO,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Lethargy,1,M,LT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Lethargy,1,M,DE,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Metabolic acidosis,1,M,OT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Metabolic acidosis,1,M,HO,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Metabolic acidosis,1,M,LT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Metabolic acidosis,1,M,DE,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Neutropenia,1,M,OT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Neutropenia,1,M,HO,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Neutropenia,1,M,LT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Neutropenia,1,M,DE,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,HO,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,LT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,DE,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,OT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,HO,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,LT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,DE,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,OT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,HO,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,LT,26
127559617,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,DE,26
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Acute kidney injury,1,F,HO,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Acute kidney injury,1,F,OT,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Acute kidney injury,1,F,LT,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Anaemia,1,F,HO,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Anaemia,1,F,OT,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Anaemia,1,F,LT,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Hyperkalaemia,1,F,HO,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Hyperkalaemia,1,F,OT,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Hyperkalaemia,1,F,LT,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Neutropenia,1,F,HO,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Neutropenia,1,F,OT,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Neutropenia,1,F,LT,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Neutropenic sepsis,1,F,HO,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Neutropenic sepsis,1,F,OT,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Neutropenic sepsis,1,F,LT,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Urinary tract infection,1,F,HO,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Urinary tract infection,1,F,OT,16
1278836025,1,Plasma cell myeloma,25,F,EXP,pomalidomide,1,SS,Urinary tract infection,1,F,LT,16
1282134020,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,PS,Anaemia,1,M,LT,97
1282134020,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,PS,Anaemia,1,M,HO,97
1282134020,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,PS,Anaemia,1,M,DE,97
1282134020,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,PS,Pneumonia,1,M,LT,97
1282134020,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,PS,Pneumonia,1,M,HO,97
1282134020,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,PS,Pneumonia,1,M,DE,97
1282134020,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,PS,Thrombocytopenia,1,M,LT,97
1282134020,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,PS,Thrombocytopenia,1,M,HO,97
1282134020,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,PS,Thrombocytopenia,1,M,DE,97
128264192,1,Cutaneous T-cell lymphoma,2,F,EXP,nivolumab,1,PS,Cholecystitis,1,M,HO,183
128264192,1,Cutaneous T-cell lymphoma,2,F,EXP,nivolumab,1,PS,Cholecystitis,1,M,OT,183
128264192,2,Cutaneous T-cell lymphoma,2,F,EXP,brentuximab vedotin,2,SS,Cholecystitis,2,M,HO,192
128264192,2,Cutaneous T-cell lymphoma,2,F,EXP,brentuximab vedotin,2,SS,Cholecystitis,2,M,OT,192
128777267,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,SS,Neutropenia,1,F,LT,330
128777267,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,SS,Neutropenic sepsis,1,F,LT,330
1291733521,1,Multiple sclerosis,21,F,EXP,alemtuzumab,1,PS,Eosinophilia,1,F,OT,217
1291733521,1,Multiple sclerosis,21,F,EXP,alemtuzumab,1,PS,Haematocrit increased,1,F,OT,217
1291733521,1,Multiple sclerosis,21,F,EXP,alemtuzumab,1,PS,Haematuria,1,F,OT,217
1291733521,1,Multiple sclerosis,21,F,EXP,alemtuzumab,1,PS,Haemoglobin urine present,1,F,OT,217
1291733521,1,Multiple sclerosis,21,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,OT,217
1291733521,1,Multiple sclerosis,21,F,EXP,alemtuzumab,1,PS,Leukopenia,1,F,OT,217
1291733521,1,Multiple sclerosis,21,F,EXP,alemtuzumab,1,PS,Lymphopenia,1,F,OT,217
1291733521,1,Multiple sclerosis,21,F,EXP,alemtuzumab,1,PS,Red blood cells urine,1,F,OT,217
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Atrial fibrillation,1,M,OT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Atrial fibrillation,1,M,HO,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Atrial fibrillation,1,M,LT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Atrial fibrillation,1,M,DE,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Atrial fibrillation,1,M,DS,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Cardiac failure,1,M,OT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Cardiac failure,1,M,HO,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Cardiac failure,1,M,LT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Cardiac failure,1,M,DE,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Cardiac failure,1,M,DS,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Diarrhoea,1,M,OT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Diarrhoea,1,M,HO,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Diarrhoea,1,M,LT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Diarrhoea,1,M,DE,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Diarrhoea,1,M,DS,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Hypocalcaemia,1,M,OT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Hypocalcaemia,1,M,HO,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Hypocalcaemia,1,M,LT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Hypocalcaemia,1,M,DE,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Hypocalcaemia,1,M,DS,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Hypomagnesaemia,1,M,OT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Hypomagnesaemia,1,M,HO,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Hypomagnesaemia,1,M,LT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Hypomagnesaemia,1,M,DE,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Hypomagnesaemia,1,M,DS,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Pain in extremity,1,M,OT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Pain in extremity,1,M,HO,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Pain in extremity,1,M,LT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Pain in extremity,1,M,DE,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Pain in extremity,1,M,DS,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Renal failure,1,M,OT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Renal failure,1,M,HO,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Renal failure,1,M,LT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Renal failure,1,M,DE,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Renal failure,1,M,DS,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Urinary tract infection,1,M,OT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Urinary tract infection,1,M,HO,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Urinary tract infection,1,M,LT,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Urinary tract infection,1,M,DE,1
1291880818,1,Plasma cell myeloma,18,F,EXP,pomalidomide,1,SS,Urinary tract infection,1,M,DS,1
129620739,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Abdominal discomfort,1,F,HO,1
129620739,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Alanine aminotransferase increased,1,F,HO,1
129620739,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Dyspnoea,1,F,HO,1
129620739,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Pain,1,F,HO,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Acute respiratory failure,4,M,HO,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Acute respiratory failure,4,M,LT,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Fluid overload,4,M,HO,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Fluid overload,4,M,LT,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Haemoptysis,4,M,HO,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Haemoptysis,4,M,LT,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Hyperkalaemia,4,M,HO,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Hyperkalaemia,4,M,LT,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Iron deficiency anaemia,4,M,HO,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Iron deficiency anaemia,4,M,LT,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Pleural effusion,4,M,HO,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Pleural effusion,4,M,LT,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Pneumonia,4,M,HO,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Pneumonia,4,M,LT,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Pulmonary oedema,4,M,HO,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Pulmonary oedema,4,M,LT,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Sepsis,4,M,HO,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Sepsis,4,M,LT,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Tumour lysis syndrome,4,M,HO,1
1296291719,4,Chronic lymphocytic leukaemia,19,F,EXP,chlorambucil,4,SS,Tumour lysis syndrome,4,M,LT,1
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,OT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,LT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,DE,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,HO,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,OT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,LT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,DE,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,HO,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,M,OT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,M,LT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,M,DE,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,M,HO,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,OT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,LT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,DE,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,HO,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,M,OT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,M,LT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,M,DE,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,M,HO,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,OT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,LT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,DE,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,HO,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Pneumonia,1,M,LT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Stent placement,1,M,OT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Stent placement,1,M,LT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Stent placement,1,M,DE,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Stent placement,1,M,HO,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Tracheo-oesophageal fistula,1,M,OT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Tracheo-oesophageal fistula,1,M,LT,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Tracheo-oesophageal fistula,1,M,DE,12
1297379313,1,Non-small cell lung cancer recurrent,13,F,EXP,nivolumab,1,PS,Tracheo-oesophageal fistula,1,M,HO,12
129773647,1,Malignant melanoma,7,F,PER,talimogene laherparepvec,1,PS,Lymph gland infection,1,M,OT,77
129773647,1,Malignant melanoma,7,F,PER,talimogene laherparepvec,1,PS,Lymph gland infection,1,M,HO,77
129999573,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,1060
129999573,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,1060
129999573,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Diabetes mellitus,1,M,HO,1060
129999573,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Diabetes mellitus,1,M,OT,1060
129999573,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Gastrointestinal haemorrhage,1,M,HO,1060
129999573,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Gastrointestinal haemorrhage,1,M,OT,1060
129999573,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hepatitis,1,M,HO,1060
129999573,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hepatitis,1,M,OT,1060
129999573,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Lower respiratory tract infection,1,M,HO,1060
129999573,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Lower respiratory tract infection,1,M,OT,1060
129999573,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,M,HO,1060
129999573,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,M,OT,1060
130316723,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Malignant melanoma,2,M,OT,771
130765215,1,Malignant melanoma,5,F,PER,talimogene laherparepvec,1,PS,Tumour haemorrhage,1,M,HO,12
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,DE,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,HO,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,OT,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Fall,1,M,DE,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Fall,1,M,HO,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Fall,1,M,OT,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Malaise,1,M,DE,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Malaise,1,M,HO,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Malaise,1,M,OT,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Nausea,1,M,DE,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Renal impairment,1,M,DE,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Renal impairment,1,M,HO,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Renal impairment,1,M,OT,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Secondary adrenocortical insufficiency,1,M,DE,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Secondary adrenocortical insufficiency,1,M,HO,80
131056008,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Secondary adrenocortical insufficiency,1,M,OT,80
131155053,1,Cutaneous T-cell lymphoma,3,F,EXP,brentuximab vedotin,1,PS,Cholecystitis,1,M,OT,192
131155053,1,Cutaneous T-cell lymphoma,3,F,EXP,brentuximab vedotin,1,PS,Cholecystitis,1,M,HO,192
131155053,2,Cutaneous T-cell lymphoma,3,F,EXP,nivolumab,2,SS,Cholecystitis,2,M,OT,183
131155053,2,Cutaneous T-cell lymphoma,3,F,EXP,nivolumab,2,SS,Cholecystitis,2,M,HO,183
131213494,21,Product used for unknown indication,4,F,EXP,zoledronic acid,21,C,Colitis ulcerative,21,F,OT,1497
131213494,21,Product used for unknown indication,4,F,EXP,zoledronic acid,21,C,Colitis ulcerative,21,F,HO,1497
1313605427,1,Relapsing multiple sclerosis,27,F,EXP,alemtuzumab,1,PS,Haematoma,1,F,HO,2
1313605427,1,Relapsing multiple sclerosis,27,F,EXP,alemtuzumab,1,PS,Lung abscess,1,F,HO,2
1313605427,1,Relapsing multiple sclerosis,27,F,EXP,alemtuzumab,1,PS,Lymphopenia,1,F,HO,2
1313605427,1,Relapsing multiple sclerosis,27,F,EXP,alemtuzumab,1,PS,Pain in extremity,1,F,HO,2
1313605427,1,Relapsing multiple sclerosis,27,F,EXP,alemtuzumab,1,PS,Paraesthesia,1,F,HO,2
1313605427,1,Relapsing multiple sclerosis,27,F,EXP,alemtuzumab,1,PS,Pneumonia,1,F,HO,2
1313605427,1,Relapsing multiple sclerosis,27,F,EXP,alemtuzumab,1,PS,Scar pain,1,F,HO,2
1313605427,1,Relapsing multiple sclerosis,27,F,EXP,alemtuzumab,1,PS,Sinusitis,1,F,HO,2
1313605427,1,Relapsing multiple sclerosis,27,F,EXP,alemtuzumab,1,PS,Skin irritation,1,F,HO,2
1313605427,1,Relapsing multiple sclerosis,27,F,EXP,alemtuzumab,1,PS,Vision blurred,1,F,HO,2
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Circulatory collapse,1,F,OT,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Circulatory collapse,1,F,LT,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Circulatory collapse,1,F,HO,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Circulatory collapse,1,F,DE,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Colitis,1,F,OT,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Colitis,1,F,LT,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Colitis,1,F,HO,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Colitis,1,F,DE,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Dehydration,1,F,OT,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Dehydration,1,F,LT,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Dehydration,1,F,HO,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Dehydration,1,F,DE,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Diarrhoea,1,F,OT,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Diarrhoea,1,F,LT,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Diarrhoea,1,F,HO,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Diarrhoea,1,F,DE,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Sepsis,1,F,OT,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Sepsis,1,F,LT,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Sepsis,1,F,HO,92
1314335920,1,Plasma cell myeloma,20,F,EXP,pomalidomide,1,SS,Sepsis,1,F,DE,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Circulatory collapse,5,F,OT,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Circulatory collapse,5,F,LT,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Circulatory collapse,5,F,HO,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Circulatory collapse,5,F,DE,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Colitis,5,F,OT,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Colitis,5,F,LT,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Colitis,5,F,HO,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Colitis,5,F,DE,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Dehydration,5,F,OT,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Dehydration,5,F,LT,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Dehydration,5,F,HO,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Dehydration,5,F,DE,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Diarrhoea,5,F,OT,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Diarrhoea,5,F,LT,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Diarrhoea,5,F,HO,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Diarrhoea,5,F,DE,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Sepsis,5,F,OT,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Sepsis,5,F,LT,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Sepsis,5,F,HO,92
1314335920,5,Plasma cell myeloma,20,F,EXP,nivolumab,5,SS,Sepsis,5,F,DE,92
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Dizziness,1,M,HO,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Dyspepsia,1,M,OT,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Dyspepsia,1,M,HO,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Dyspnoea,1,M,OT,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Dyspnoea,1,M,HO,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Fatigue,1,M,HO,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Insomnia,1,M,OT,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Insomnia,1,M,HO,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Sluggishness,1,M,OT,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Sluggishness,1,M,HO,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Transient ischaemic attack,1,M,OT,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Transient ischaemic attack,1,M,HO,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Upper respiratory tract infection,1,M,OT,48
131493454,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Upper respiratory tract infection,1,M,HO,48
131519224,1,Malignant melanoma,4,F,PER,talimogene laherparepvec,1,PS,Lung infiltration,1,M,HO,414
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Emotional distress,1,M,LT,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Emotional distress,1,M,OT,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Emotional distress,1,M,DE,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Ileus,1,M,LT,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Ileus,1,M,OT,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Ileus,1,M,DE,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Infection,1,M,LT,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Infection,1,M,OT,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Infection,1,M,DE,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Liver disorder,1,M,LT,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Liver disorder,1,M,OT,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Liver disorder,1,M,DE,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Malignant neoplasm progression,1,M,LT,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Malignant neoplasm progression,1,M,OT,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Malignant neoplasm progression,1,M,DE,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Platelet count decreased,1,M,LT,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Platelet count decreased,1,M,OT,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Platelet count decreased,1,M,DE,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Renal failure,1,M,LT,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Renal failure,1,M,OT,12
131531403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Renal failure,1,M,DE,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Emotional distress,3,M,LT,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Emotional distress,3,M,OT,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Emotional distress,3,M,DE,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Ileus,3,M,LT,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Ileus,3,M,OT,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Ileus,3,M,DE,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Infection,3,M,LT,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Infection,3,M,OT,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Infection,3,M,DE,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Liver disorder,3,M,LT,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Liver disorder,3,M,OT,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Liver disorder,3,M,DE,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Malignant neoplasm progression,3,M,LT,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Malignant neoplasm progression,3,M,OT,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Malignant neoplasm progression,3,M,DE,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Platelet count decreased,3,M,LT,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Platelet count decreased,3,M,OT,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Platelet count decreased,3,M,DE,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Renal failure,3,M,LT,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Renal failure,3,M,OT,12
131531403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Renal failure,3,M,DE,12
131778105,1,Malignant melanoma,5,F,PER,talimogene laherparepvec,1,PS,Autoimmune hepatitis,1,F,OT,118
1317859310,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Brain oedema,1,M,DE,28
1317859310,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Brain oedema,1,M,OT,28
1317859310,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Haemolytic anaemia,1,M,DE,28
1317859310,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Haemolytic anaemia,1,M,OT,28
1317859310,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,28
1317859310,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,28
1317859310,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Packed red blood cell transfusion,1,M,DE,28
1317859310,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Packed red blood cell transfusion,1,M,OT,28
1317971710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,2
1317971710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,DS,2
1317971710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Radiation pneumonitis,1,F,OT,2
1317971710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Radiation pneumonitis,1,F,DS,2
131822026,1,Hodgkin's disease,6,F,EXP,brentuximab vedotin,1,PS,Dermatitis exfoliative generalised,1,M,OT,93
131822026,1,Hodgkin's disease,6,F,EXP,brentuximab vedotin,1,PS,Dermatitis exfoliative generalised,1,M,HO,93
131822026,3,Hodgkin's disease,6,F,EXP,nivolumab,3,SS,Dermatitis exfoliative generalised,3,M,OT,83
131822026,3,Hodgkin's disease,6,F,EXP,nivolumab,3,SS,Dermatitis exfoliative generalised,3,M,HO,83
131860206,1,Malignant melanoma,6,F,PER,talimogene laherparepvec,1,PS,Tumour haemorrhage,1,M,HO,65
132004976,1,Malignant melanoma,6,F,PER,talimogene laherparepvec,1,PS,Erysipelas,1,F,HO,84
132290144,1,Acute lymphocytic leukaemia,4,F,PER,carfilzomib,1,PS,Haemolytic uraemic syndrome,1,F,LT,2
132290144,1,Acute lymphocytic leukaemia,4,F,PER,carfilzomib,1,PS,Haemolytic uraemic syndrome,1,F,OT,2
132290144,1,Acute lymphocytic leukaemia,4,F,PER,carfilzomib,1,PS,Respiratory failure,1,F,LT,2
132290144,1,Acute lymphocytic leukaemia,4,F,PER,carfilzomib,1,PS,Respiratory failure,1,F,OT,2
132290144,1,Acute lymphocytic leukaemia,4,F,PER,carfilzomib,1,PS,Sepsis,1,F,LT,2
132290144,1,Acute lymphocytic leukaemia,4,F,PER,carfilzomib,1,PS,Sepsis,1,F,OT,2
1327844211,1,Chronic lymphocytic leukaemia,11,F,EXP,ofatumumab,1,PS,Fungal infection,1,F,HO,11
1327844211,1,Chronic lymphocytic leukaemia,11,F,EXP,ofatumumab,1,PS,Lower respiratory tract infection,1,F,HO,11
1327844211,1,Chronic lymphocytic leukaemia,11,F,EXP,ofatumumab,1,PS,Pneumocystis jirovecii pneumonia,1,F,HO,11
1327844211,1,Chronic lymphocytic leukaemia,11,F,EXP,ofatumumab,1,PS,Pneumonia,1,F,HO,11
132997123,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Cellulitis,1,F,HO,453
132997123,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,F,HO,453
132997123,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Staphylococcal abscess,1,F,HO,453
133229892,2,Malignant melanoma,2,F,EXP,trametinib,2,SS,Pyrexia,2,M,HO,35
133250283,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,70
133250283,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,HO,70
133439802,1,Pleural mesothelioma,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,OT,14
133439802,1,Pleural mesothelioma,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,HO,14
133439802,2,Pleural mesothelioma,2,F,EXP,ipilimumab,2,SS,Cerebrovascular accident,2,M,OT,14
133439802,2,Pleural mesothelioma,2,F,EXP,ipilimumab,2,SS,Cerebrovascular accident,2,M,HO,14
133447937,7,Prophylaxis,7,F,EXP,zoledronic acid,7,C,Circulatory collapse,7,M,DE,134
133447937,7,Prophylaxis,7,F,EXP,zoledronic acid,7,C,Circulatory collapse,7,M,HO,134
133447937,7,Prophylaxis,7,F,EXP,zoledronic acid,7,C,Dyspnoea,7,M,DE,134
133447937,7,Prophylaxis,7,F,EXP,zoledronic acid,7,C,Dyspnoea,7,M,HO,134
133447937,7,Prophylaxis,7,F,EXP,zoledronic acid,7,C,General physical health deterioration,7,M,DE,134
133447937,7,Prophylaxis,7,F,EXP,zoledronic acid,7,C,General physical health deterioration,7,M,HO,134
133447937,7,Prophylaxis,7,F,EXP,zoledronic acid,7,C,Leukopenia,7,M,DE,134
133447937,7,Prophylaxis,7,F,EXP,zoledronic acid,7,C,Leukopenia,7,M,HO,134
133447937,7,Prophylaxis,7,F,EXP,zoledronic acid,7,C,Pericardial effusion,7,M,DE,134
133447937,7,Prophylaxis,7,F,EXP,zoledronic acid,7,C,Pericardial effusion,7,M,HO,134
133447937,7,Prophylaxis,7,F,EXP,zoledronic acid,7,C,Thrombocytopenia,7,M,DE,134
133447937,7,Prophylaxis,7,F,EXP,zoledronic acid,7,C,Thrombocytopenia,7,M,HO,134
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Anaemia,1,F,OT,15
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Anaemia,1,F,LT,15
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Anaemia,1,F,HO,15
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Constipation,1,F,OT,15
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Constipation,1,F,LT,15
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Constipation,1,F,HO,15
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Dehydration,1,F,OT,15
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Dehydration,1,F,LT,15
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Dehydration,1,F,HO,15
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Neutropenia,1,F,OT,15
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Neutropenia,1,F,LT,15
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Neutropenia,1,F,HO,15
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Venous injury,1,F,OT,15
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Venous injury,1,F,LT,15
1335667719,1,Plasma cell myeloma,19,F,EXP,pomalidomide,1,SS,Venous injury,1,F,HO,15
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Arthralgia,1,M,OT,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Arthralgia,1,M,HO,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Headache,1,M,OT,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Headache,1,M,HO,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Liver disorder,1,M,OT,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Liver disorder,1,M,HO,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,M,OT,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,M,HO,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Myositis,1,M,OT,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Myositis,1,M,HO,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Pyrexia,1,M,OT,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Pyrexia,1,M,HO,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Uveitis,1,M,OT,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Uveitis,1,M,HO,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Visual acuity reduced,1,M,OT,5
133615264,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Visual acuity reduced,1,M,HO,5
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Abdominal pain,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Abdominal pain,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Abdominal pain,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Acute pulmonary oedema,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Acute pulmonary oedema,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Acute pulmonary oedema,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Anaemia,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Anaemia,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Anaemia,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Ankle fracture,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Ankle fracture,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Ankle fracture,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Asthenia,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Asthenia,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Asthenia,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Cardiac failure,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Cardiac failure,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Cardiac failure,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Chest pain,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Chest pain,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Chest pain,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Cholestasis,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Cholestasis,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Cholestasis,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Constipation,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Constipation,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Constipation,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Diabetic foot,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Diabetic foot,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Diabetic foot,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Gastric ulcer,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Gastric ulcer,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Gastric ulcer,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Melaena,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Melaena,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Melaena,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Metastases to nervous system,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Metastases to nervous system,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Metastases to nervous system,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Nephrotic syndrome,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Nephrotic syndrome,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Nephrotic syndrome,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Pneumonia,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Pneumonia,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Pneumonia,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Post thrombotic syndrome,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Post thrombotic syndrome,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Post thrombotic syndrome,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Prescribed underdose,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Prescribed underdose,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Prescribed underdose,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Rectal haemorrhage,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Rectal haemorrhage,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Rectal haemorrhage,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Renal failure,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Renal failure,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Renal failure,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Scleroderma,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Scleroderma,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Scleroderma,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Sinus node dysfunction,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Sinus node dysfunction,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Sinus node dysfunction,1,F,HO,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Vomiting,1,F,LT,28
1338733831,1,Lung neoplasm malignant,31,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,28
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Catheter site pain,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Catheter site pain,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Dermatitis acneiform,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Dermatitis acneiform,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Device related infection,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Device related infection,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Diarrhoea,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Diarrhoea,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Dry skin,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Dry skin,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Dyspnoea,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Dyspnoea,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Hypothyroidism,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Hypothyroidism,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Malaise,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Malaise,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Palmar-plantar erythrodysaesthesia syndrome,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Palmar-plantar erythrodysaesthesia syndrome,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Paronychia,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Paronychia,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Peripheral sensory neuropathy,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Peripheral sensory neuropathy,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Renal impairment,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Renal impairment,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Skin hyperpigmentation,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Skin hyperpigmentation,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Stomatitis,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Stomatitis,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Taste disorder,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Taste disorder,1,F,OT,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Thrombophlebitis,1,F,HO,56
1340736814,1,Colon cancer,14,F,PER,panitumumab,1,PS,Thrombophlebitis,1,F,OT,56
134181343,1,Gastric cancer,3,F,EXP,nivolumab,1,PS,Capillary leak syndrome,1,F,LT,11
134181343,1,Gastric cancer,3,F,EXP,nivolumab,1,PS,Capillary leak syndrome,1,F,HO,11
134181343,1,Gastric cancer,3,F,EXP,nivolumab,1,PS,Capillary leak syndrome,1,F,OT,11
134181343,2,Gastric cancer,3,F,EXP,ipilimumab,2,SS,Capillary leak syndrome,2,F,LT,11
134181343,2,Gastric cancer,3,F,EXP,ipilimumab,2,SS,Capillary leak syndrome,2,F,HO,11
134181343,2,Gastric cancer,3,F,EXP,ipilimumab,2,SS,Capillary leak syndrome,2,F,OT,11
134189049,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Bronchitis,1,F,OT,14
134189049,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Fall,1,F,OT,14
134189049,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,OT,14
134189049,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,OT,14
134189049,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,14
134189049,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Neutropenia,1,F,OT,14
134189049,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Skin laceration,1,F,OT,14
134189049,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Spinal fracture,1,F,OT,14
134189049,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Weight increased,1,F,OT,14
134189049,2,Product used for unknown indication,9,F,EXP,nivolumab,2,SS,Bronchitis,2,F,OT,14
134189049,2,Product used for unknown indication,9,F,EXP,nivolumab,2,SS,Fall,2,F,OT,14
134189049,2,Product used for unknown indication,9,F,EXP,nivolumab,2,SS,Hyperthyroidism,2,F,OT,14
134189049,2,Product used for unknown indication,9,F,EXP,nivolumab,2,SS,Hypothyroidism,2,F,OT,14
134189049,2,Product used for unknown indication,9,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,F,OT,14
134189049,2,Product used for unknown indication,9,F,EXP,nivolumab,2,SS,Neutropenia,2,F,OT,14
134189049,2,Product used for unknown indication,9,F,EXP,nivolumab,2,SS,Skin laceration,2,F,OT,14
134189049,2,Product used for unknown indication,9,F,EXP,nivolumab,2,SS,Spinal fracture,2,F,OT,14
134189049,2,Product used for unknown indication,9,F,EXP,nivolumab,2,SS,Weight increased,2,F,OT,14
134202908,1,Acute lymphocytic leukaemia,8,F,PER,blinatumomab,1,PS,Eye pain,1,M,HO,199
134202908,1,Acute lymphocytic leukaemia,8,F,PER,blinatumomab,1,PS,Vision blurred,1,M,HO,199
134332425,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Syncope,1,M,OT,16
134332425,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Syncope,1,M,HO,16
134866884,1,Renal cell carcinoma,4,F,EXP,avelumab,1,SS,Electrocardiogram T wave inversion,1,F,OT,84
134979957,1,Chronic lymphocytic leukaemia,7,F,EXP,idelalisib,1,PS,Cardiac failure acute,1,M,DE,44
135046035,10,Product used for unknown indication,5,F,EXP,gemtuzumab ozogamicin,10,C,Cardiotoxicity,10,F,HO,11
135046035,10,Product used for unknown indication,5,F,EXP,gemtuzumab ozogamicin,10,C,Ejection fraction decreased,10,F,HO,11
135054564,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,SS,Hyperglycaemia,1,M,HO,55
135054564,2,Non-small cell lung cancer,4,F,EXP,ipilimumab,2,PS,Hyperglycaemia,2,M,HO,55
135124778,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Dizziness,1,F,DE,49
135124778,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Dizziness,1,F,HO,49
135124778,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Dizziness,1,F,OT,49
135124778,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Dysphagia,1,F,DE,49
135124778,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Dysphagia,1,F,HO,49
135124778,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Dysphagia,1,F,OT,49
135124778,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Headache,1,F,DE,49
135124778,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Headache,1,F,HO,49
135124778,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Headache,1,F,OT,49
135124778,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,49
135124778,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,49
135124778,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,49
1351450112,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,58
1351450112,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,58
1351450112,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,LT,58
1351450112,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,58
1351450112,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,F,DE,58
1351450112,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,F,OT,58
1351450112,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,F,LT,58
1351450112,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,F,HO,58
1351450112,2,Malignant melanoma,12,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,DE,58
1351450112,2,Malignant melanoma,12,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,OT,58
1351450112,2,Malignant melanoma,12,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,LT,58
1351450112,2,Malignant melanoma,12,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,HO,58
1351450112,2,Malignant melanoma,12,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,F,DE,58
1351450112,2,Malignant melanoma,12,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,F,OT,58
1351450112,2,Malignant melanoma,12,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,F,LT,58
1351450112,2,Malignant melanoma,12,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,F,HO,58
135325574,1,Renal cell carcinoma,4,F,EXP,avelumab,1,PS,Electrocardiogram T wave inversion,1,F,OT,84
135446878,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,18
135446878,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Blood viscosity increased,1,M,OT,18
135446878,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Constipation,1,M,OT,18
135446878,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Drug ineffective,1,M,OT,18
135446878,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Dyspnoea,1,M,OT,18
135446878,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Haematochezia,1,M,OT,18
135446878,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Intentional product misuse,1,M,OT,18
135446878,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,International normalised ratio abnormal,1,M,OT,18
135446878,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,International normalised ratio decreased,1,M,OT,18
135446878,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Loss of consciousness,1,M,OT,18
135455614,5,Metastatic malignant melanoma,4,F,EXP,trametinib,5,SS,Malignant neoplasm progression,5,M,OT,45
135455614,5,Metastatic malignant melanoma,4,F,EXP,trametinib,5,SS,Malignant neoplasm progression,5,M,DE,45
135455614,5,Metastatic malignant melanoma,4,F,EXP,trametinib,5,SS,Metastatic malignant melanoma,5,M,OT,45
135455614,5,Metastatic malignant melanoma,4,F,EXP,trametinib,5,SS,Metastatic malignant melanoma,5,M,DE,45
135455614,5,Metastatic malignant melanoma,4,F,EXP,trametinib,5,SS,Pneumonia,5,M,OT,45
135455614,5,Metastatic malignant melanoma,4,F,EXP,trametinib,5,SS,Pneumonia,5,M,DE,45
1354950221,1,Metastatic renal cell carcinoma,21,F,EXP,nivolumab,1,PS,Hypertension,1,F,OT,28
1354950221,1,Metastatic renal cell carcinoma,21,F,EXP,nivolumab,1,PS,Inappropriate schedule of product administration,1,F,OT,28
1354950221,1,Metastatic renal cell carcinoma,21,F,EXP,nivolumab,1,PS,Uveitis,1,F,OT,28
135543705,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Sepsis,1,M,OT,24
135543705,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Sepsis,1,M,DE,24
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,OT,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Gastrointestinal haemorrhage,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Gastrointestinal haemorrhage,1,M,OT,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Herpes zoster,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Herpes zoster,1,M,OT,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,OT,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,OT,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Impaired gastric emptying,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Impaired gastric emptying,1,M,OT,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Ischaemic cardiomyopathy,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Ischaemic cardiomyopathy,1,M,OT,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Myocardial ischaemia,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Myocardial ischaemia,1,M,OT,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Myositis,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Myositis,1,M,OT,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Oesophageal motility disorder,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Oesophageal motility disorder,1,M,OT,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Packed red blood cell transfusion,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Packed red blood cell transfusion,1,M,OT,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Pancytopenia,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Pancytopenia,1,M,OT,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,M,HO,93
135704758,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Atrial fibrillation,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Atrial fibrillation,2,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Gastrointestinal haemorrhage,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Gastrointestinal haemorrhage,2,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Herpes zoster,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Herpes zoster,2,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Hypokalaemia,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Hypokalaemia,2,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Impaired gastric emptying,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Impaired gastric emptying,2,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Ischaemic cardiomyopathy,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Ischaemic cardiomyopathy,2,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Myocardial ischaemia,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Myocardial ischaemia,2,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Myositis,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Myositis,2,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Oesophageal motility disorder,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Oesophageal motility disorder,2,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Packed red blood cell transfusion,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Packed red blood cell transfusion,2,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Pancytopenia,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Pancytopenia,2,M,OT,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Thrombocytopenia,2,M,HO,93
135704758,2,Metastatic malignant melanoma,8,F,EXP,ipilimumab,2,SS,Thrombocytopenia,2,M,OT,93
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Acarodermatitis,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Acarodermatitis,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Acarodermatitis,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Accidental overdose,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Accidental overdose,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Accidental overdose,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Amyotrophy,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Amyotrophy,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Amyotrophy,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Clostridium difficile colitis,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Clostridium difficile colitis,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Clostridium difficile colitis,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Colitis,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Nerve compression,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Nerve compression,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Nerve compression,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Neuropathy peripheral,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Neuropathy peripheral,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Neuropathy peripheral,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Pemphigoid,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Pemphigoid,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Pemphigoid,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Systemic inflammatory response syndrome,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Systemic inflammatory response syndrome,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Systemic inflammatory response syndrome,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Thyroid function test abnormal,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Thyroid function test abnormal,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Thyroid function test abnormal,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Umbilical hernia,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Umbilical hernia,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Umbilical hernia,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Urinary retention,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Urinary retention,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Urinary retention,1,M,DE,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Urosepsis,1,M,HO,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Urosepsis,1,M,OT,9
1357168918,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Urosepsis,1,M,DE,9
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Blood creatine phosphokinase increased,4,F,OT,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Blood creatine phosphokinase increased,4,F,HO,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Blood creatine phosphokinase increased,4,F,DE,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Dermatomyositis,4,F,OT,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Dermatomyositis,4,F,HO,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Dermatomyositis,4,F,DE,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Erythema,4,F,OT,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Erythema,4,F,HO,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Erythema,4,F,DE,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Malignant neoplasm progression,4,F,OT,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Malignant neoplasm progression,4,F,HO,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Malignant neoplasm progression,4,F,DE,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Metastases to spine,4,F,OT,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Metastases to spine,4,F,HO,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Metastases to spine,4,F,DE,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Metastatic malignant melanoma,4,F,OT,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Metastatic malignant melanoma,4,F,HO,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Metastatic malignant melanoma,4,F,DE,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Paraparesis,4,F,OT,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Paraparesis,4,F,HO,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Paraparesis,4,F,DE,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Urinary retention,4,F,OT,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Urinary retention,4,F,HO,314
1357828810,4,Metastatic malignant melanoma,10,F,EXP,trametinib,4,SS,Urinary retention,4,F,DE,314
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Anaemia,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Anaemia,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Atrial fibrillation,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Atrial fibrillation,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Bone marrow failure,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Bone marrow failure,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Cardiac failure,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Cardiac failure,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Corneal bleeding,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Corneal bleeding,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Erythema,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Erythema,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Hypokalaemic syndrome,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Hypokalaemic syndrome,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Leukopenia,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Leukopenia,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Neurotoxicity,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Neurotoxicity,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Neutropenia,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Neutropenia,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Oedema,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Oedema,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Paronychia,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Paronychia,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Pruritus,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Pruritus,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Skin discolouration,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Skin discolouration,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Staphylococcal sepsis,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Staphylococcal sepsis,16,F,OT,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Thrombocytopenia,16,F,HO,78
135975654,16,Prophylaxis,4,F,EXP,filgrastim,16,C,Thrombocytopenia,16,F,OT,78
1360809418,1,Relapsing multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Autoimmune haemolytic anaemia,1,M,HO,310
1360809418,1,Relapsing multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Basedow's disease,1,M,HO,310
1360809418,1,Relapsing multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,M,HO,310
1360809418,1,Relapsing multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Neutropenia,1,M,HO,310
1360809418,1,Relapsing multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Thrombocytopenia,1,M,HO,310
136178136,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,F,HO,64
136178136,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,F,OT,64
136178136,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,F,HO,64
136178136,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,F,OT,64
136178136,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Leukoderma,1,F,HO,64
136178136,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Leukoderma,1,F,OT,64
136178136,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pneumonia bacterial,1,F,HO,64
136178136,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pneumonia bacterial,1,F,OT,64
136178136,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pruritus,1,F,HO,64
136178136,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pruritus,1,F,OT,64
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Adrenocorticotropic hormone deficiency,1,F,OT,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Adrenocorticotropic hormone deficiency,1,F,HO,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Adrenocorticotropic hormone deficiency,1,F,DE,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,F,OT,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,F,HO,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,F,DE,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Blood lactate dehydrogenase increased,1,F,OT,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Blood lactate dehydrogenase increased,1,F,HO,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Blood lactate dehydrogenase increased,1,F,DE,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Embolism venous,1,F,OT,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Embolism venous,1,F,HO,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Embolism venous,1,F,DE,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Fall,1,F,OT,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Fall,1,F,HO,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Fall,1,F,DE,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Hip fracture,1,F,OT,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Hip fracture,1,F,HO,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Hip fracture,1,F,DE,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Hip surgery,1,F,OT,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Hip surgery,1,F,HO,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Hip surgery,1,F,DE,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,OT,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,HO,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,DE,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Leukoderma,1,F,OT,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Leukoderma,1,F,HO,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Leukoderma,1,F,DE,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,1
136186919,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Autoimmune hypothyroidism,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Autoimmune hypothyroidism,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Bone pain,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Bone pain,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Bronchitis,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Bronchitis,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Cough,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Cough,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Dizziness,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Dizziness,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Dry eye,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Dry eye,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Dry mouth,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Dry mouth,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Fatigue,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Headache,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Headache,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Hypocalcaemia,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Hypocalcaemia,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Hypomagnesaemia,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Hypomagnesaemia,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Infection,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Infection,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Influenza like illness,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Influenza like illness,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Insomnia,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Insomnia,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Lichen planus,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Lichen planus,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Prurigo,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Prurigo,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Pruritus,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Pruritus,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Vision blurred,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Vision blurred,1,F,HO,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Weight decreased,1,F,OT,1
1366498835,1,Malignant melanoma,35,F,EXP,nivolumab,1,PS,Weight decreased,1,F,HO,1
136653629,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Atelectasis,1,M,DE,1
136653629,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Atelectasis,1,M,OT,1
136653629,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Back pain,1,M,DE,1
136653629,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Back pain,1,M,OT,1
136653629,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Chest pain,1,M,DE,1
136653629,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Chest pain,1,M,OT,1
136653629,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,1
136653629,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,1
136653629,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Haemoptysis,1,M,DE,1
136653629,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Haemoptysis,1,M,OT,1
136653629,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,1
136653629,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,1
136653629,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Sputum discoloured,1,M,DE,1
136653629,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Sputum discoloured,1,M,OT,1
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Anaemia,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Anaemia,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Anaemia,1,F,HO,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Atelectasis,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Atelectasis,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Atelectasis,1,F,HO,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Lymphangiosis carcinomatosa,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Lymphangiosis carcinomatosa,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Lymphangiosis carcinomatosa,1,F,HO,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Off label use,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Off label use,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Off label use,1,F,HO,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Packed red blood cell transfusion,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Packed red blood cell transfusion,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Packed red blood cell transfusion,1,F,HO,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Pleural effusion,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Pleural effusion,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Pleural effusion,1,F,HO,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Pneumonia,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Pneumonia,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Pneumonia,1,F,HO,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Pneumothorax,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Pneumothorax,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Pneumothorax,1,F,HO,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Respiratory distress,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Respiratory distress,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Respiratory distress,1,F,HO,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,HO,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Sepsis,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Sepsis,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Sepsis,1,F,HO,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Thoracic cavity drainage,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Thoracic cavity drainage,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Thoracic cavity drainage,1,F,HO,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Tumour associated fever,1,F,DE,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Tumour associated fever,1,F,OT,48
136676229,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Tumour associated fever,1,F,HO,48
136762474,1,Lymphocytic lymphoma,4,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,F,OT,12
136762474,1,Lymphocytic lymphoma,4,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,F,DE,12
136762474,1,Lymphocytic lymphoma,4,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,F,HO,12
136762474,1,Lymphocytic lymphoma,4,F,EXP,nivolumab,1,PS,Pneumonitis,1,F,OT,12
136762474,1,Lymphocytic lymphoma,4,F,EXP,nivolumab,1,PS,Pneumonitis,1,F,DE,12
136762474,1,Lymphocytic lymphoma,4,F,EXP,nivolumab,1,PS,Pneumonitis,1,F,HO,12
136762474,1,Lymphocytic lymphoma,4,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,OT,12
136762474,1,Lymphocytic lymphoma,4,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,DE,12
136762474,1,Lymphocytic lymphoma,4,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,HO,12
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Confusional state,1,M,OT,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Confusional state,1,M,DE,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Confusional state,1,M,HO,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Lung disorder,1,M,OT,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Lung disorder,1,M,DE,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Lung disorder,1,M,HO,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Off label use,1,M,DE,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Off label use,1,M,HO,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,OT,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,DE,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,HO,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Pleural infection,1,M,OT,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Pleural infection,1,M,DE,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Pleural infection,1,M,HO,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Respiratory disorder,1,M,OT,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Respiratory disorder,1,M,DE,28
1367691815,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Respiratory disorder,1,M,HO,28
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Cancer pain,1,M,HO,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Cancer pain,1,M,OT,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Confusional state,1,M,HO,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Confusional state,1,M,OT,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Disorientation,1,M,HO,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Disorientation,1,M,OT,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Drug tolerance decreased,1,M,HO,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Drug tolerance decreased,1,M,OT,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Encephalitis,1,M,HO,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Encephalitis,1,M,OT,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Myositis,1,M,HO,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Myositis,1,M,OT,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Oedema,1,M,HO,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Oedema,1,M,OT,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Pain,1,M,HO,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Pain,1,M,OT,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Phlebitis,1,M,HO,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Phlebitis,1,M,OT,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Subclavian vein thrombosis,1,M,HO,139
1368048219,1,Lung neoplasm malignant,19,F,EXP,nivolumab,1,PS,Subclavian vein thrombosis,1,M,OT,139
136898307,1,Relapsing multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Herpes zoster,1,M,HO,42
136898307,1,Relapsing multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Pustule,1,M,HO,42
136976285,1,Relapsing multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Infertility,1,F,OT,112
136976285,1,Relapsing multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Malignant melanoma in situ,1,F,OT,112
136976285,1,Relapsing multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Pregnancy,1,F,OT,112
137030075,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Lymphadenopathy mediastinal,1,M,HO,105
137030075,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Lymphadenopathy mediastinal,1,M,OT,105
137030075,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Lymphadenopathy mediastinal,1,M,DE,105
137030075,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,105
137030075,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,105
137030075,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,105
137030075,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Stent placement,1,M,HO,105
137030075,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Stent placement,1,M,OT,105
137030075,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Stent placement,1,M,DE,105
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,40
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,40
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,40
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,40
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,40
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,40
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pain,1,M,DE,40
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pain,1,M,HO,40
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pain,1,M,OT,40
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Superior vena cava syndrome,1,M,DE,40
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Superior vena cava syndrome,1,M,HO,40
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Superior vena cava syndrome,1,M,OT,40
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Tracheal obstruction,1,M,DE,40
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Tracheal obstruction,1,M,HO,40
137046785,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Tracheal obstruction,1,M,OT,40
137085514,1,Gastric cancer,4,F,EXP,nivolumab,1,PS,Death,1,M,DE,13
137085514,1,Gastric cancer,4,F,EXP,nivolumab,1,PS,Death,1,M,OT,13
137169472,1,Renal cell carcinoma,2,F,EXP,avelumab,1,PS,Gastrointestinal haemorrhage,1,F,HO,179
137248374,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,24
137248374,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,24
137283669,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Acute myeloid leukaemia,1,M,HO,29
137283669,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Acute myeloid leukaemia,1,M,DE,29
137283669,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Acute myeloid leukaemia,1,M,LT,29
137283669,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Acute myeloid leukaemia,1,M,OT,29
137283669,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Ascites,1,M,HO,29
137283669,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Ascites,1,M,DE,29
137283669,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Ascites,1,M,LT,29
137283669,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Ascites,1,M,OT,29
137283669,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Myelodysplastic syndrome,1,M,HO,29
137283669,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Myelodysplastic syndrome,1,M,DE,29
137283669,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Myelodysplastic syndrome,1,M,LT,29
137283669,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Myelodysplastic syndrome,1,M,OT,29
137314556,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Lung disorder,1,F,HO,378
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Aspergillus infection,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Aspergillus infection,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Aspergillus infection,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Bronchitis chronic,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Bronchitis chronic,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Bronchitis chronic,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Constipation,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Constipation,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Constipation,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Diabetes mellitus,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Diabetes mellitus,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Diabetes mellitus,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Disseminated intravascular coagulation,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Disseminated intravascular coagulation,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Disseminated intravascular coagulation,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Gastric perforation,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Gastric perforation,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Gastric perforation,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Gastric ulcer perforation,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Gastric ulcer perforation,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Gastric ulcer perforation,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Gastritis,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Gastritis,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Gastritis,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Gastrointestinal perforation,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Gastrointestinal perforation,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Gastrointestinal perforation,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Haemoglobin decreased,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Haemoglobin decreased,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Haemoglobin decreased,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Haemolytic anaemia,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Haemolytic anaemia,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Haemolytic anaemia,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Hepatic failure,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Hepatic failure,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Hepatic failure,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Hepatic steatosis,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Hepatic steatosis,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Hepatic steatosis,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Hyperlipidaemia,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Hyperlipidaemia,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Hyperlipidaemia,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Insomnia,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Insomnia,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Insomnia,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Large intestine perforation,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Large intestine perforation,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Large intestine perforation,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Oedema,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Oedema,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Oedema,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Peritonitis,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Peritonitis,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Peritonitis,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Pleurisy,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Pleurisy,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Pleurisy,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Pyoderma gangrenosum,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Pyoderma gangrenosum,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Pyoderma gangrenosum,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Red blood cell count decreased,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Red blood cell count decreased,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Red blood cell count decreased,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Respiratory failure,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Respiratory failure,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Respiratory failure,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Shock,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Shock,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Shock,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Skin infection,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Skin infection,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Skin infection,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Vasculitis,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Vasculitis,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,Vasculitis,1,F,DE,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,White blood cell count increased,1,F,LT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,White blood cell count increased,1,F,OT,6
137339669,1,Immune thrombocytopenic purpura,9,F,PER,romiplostim,1,PS,White blood cell count increased,1,F,DE,6
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Asthenia,1,M,DE,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Lung disorder,1,M,OT,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Lung disorder,1,M,DE,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Lung disorder,1,M,HO,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Sepsis,1,M,DE,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Weight decreased,1,M,DE,9
137348683,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Weight decreased,1,M,HO,9
137393482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Anaemia,1,F,DE,17
137393482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Anaemia,1,F,HO,17
137393482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Anaemia,1,F,OT,17
137393482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Bone pain,1,F,DE,17
137393482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Bone pain,1,F,HO,17
137393482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Bone pain,1,F,OT,17
137393482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,17
137393482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,17
137393482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,17
137393482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Anaemia,2,F,DE,17
137393482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Anaemia,2,F,HO,17
137393482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Anaemia,2,F,OT,17
137393482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Bone pain,2,F,DE,17
137393482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Bone pain,2,F,HO,17
137393482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Bone pain,2,F,OT,17
137393482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,DE,17
137393482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,HO,17
137393482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,OT,17
137423357,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,29
137423357,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,DE,29
137423357,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,29
137423357,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Arthralgia,1,M,DE,29
137423357,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,29
137423357,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,29
137423357,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Musculoskeletal pain,1,M,OT,29
137423357,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Musculoskeletal pain,1,M,DE,29
137423357,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Pneumonia aspiration,1,M,OT,29
137423357,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Pneumonia aspiration,1,M,DE,29
137423357,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Polyarthritis,1,M,OT,29
137423357,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Polyarthritis,1,M,DE,29
137423357,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,29
137423357,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Weight decreased,1,M,DE,29
1374508011,1,Plasma cell myeloma,11,F,PER,carfilzomib,1,PS,Anaemia,1,F,HO,28
1374508011,1,Plasma cell myeloma,11,F,PER,carfilzomib,1,PS,Back pain,1,F,HO,28
1374508011,1,Plasma cell myeloma,11,F,PER,carfilzomib,1,PS,Hypocalcaemia,1,F,HO,28
1374508011,1,Plasma cell myeloma,11,F,PER,carfilzomib,1,PS,Malaise,1,F,HO,28
1374508011,1,Plasma cell myeloma,11,F,PER,carfilzomib,1,PS,Nausea,1,F,HO,28
1374508011,1,Plasma cell myeloma,11,F,PER,carfilzomib,1,PS,Neutrophil count decreased,1,F,HO,28
1374508011,1,Plasma cell myeloma,11,F,PER,carfilzomib,1,PS,Oral pain,1,F,HO,28
1374508011,1,Plasma cell myeloma,11,F,PER,carfilzomib,1,PS,Platelet count decreased,1,F,HO,28
1374508011,1,Plasma cell myeloma,11,F,PER,carfilzomib,1,PS,Vomiting,1,F,HO,28
1374508011,5,Plasma cell myeloma,11,F,PER,lenalidomide,5,SS,Anaemia,5,F,HO,28
1374508011,5,Plasma cell myeloma,11,F,PER,lenalidomide,5,SS,Back pain,5,F,HO,28
1374508011,5,Plasma cell myeloma,11,F,PER,lenalidomide,5,SS,Hypocalcaemia,5,F,HO,28
1374508011,5,Plasma cell myeloma,11,F,PER,lenalidomide,5,SS,Malaise,5,F,HO,28
1374508011,5,Plasma cell myeloma,11,F,PER,lenalidomide,5,SS,Nausea,5,F,HO,28
1374508011,5,Plasma cell myeloma,11,F,PER,lenalidomide,5,SS,Neutrophil count decreased,5,F,HO,28
1374508011,5,Plasma cell myeloma,11,F,PER,lenalidomide,5,SS,Oral pain,5,F,HO,28
1374508011,5,Plasma cell myeloma,11,F,PER,lenalidomide,5,SS,Platelet count decreased,5,F,HO,28
1374508011,5,Plasma cell myeloma,11,F,PER,lenalidomide,5,SS,Vomiting,5,F,HO,28
1374844712,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,SS,Diabetic ketoacidosis,1,M,OT,120
1374844712,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,SS,Diabetic ketoacidosis,1,M,HO,120
1374844712,2,Non-small cell lung cancer,12,F,EXP,ipilimumab,2,PS,Diabetic ketoacidosis,2,M,OT,120
1374844712,2,Non-small cell lung cancer,12,F,EXP,ipilimumab,2,PS,Diabetic ketoacidosis,2,M,HO,120
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Anaemia,1,M,DE,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Normocytic anaemia,1,M,DE,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Normocytic anaemia,1,M,HO,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Normocytic anaemia,1,M,OT,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Packed red blood cell transfusion,1,M,DE,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Packed red blood cell transfusion,1,M,HO,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Packed red blood cell transfusion,1,M,OT,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Pneumonia pseudomonal,1,M,DE,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Pneumonia pseudomonal,1,M,HO,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Pneumonia pseudomonal,1,M,OT,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Postrenal failure,1,M,DE,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Postrenal failure,1,M,HO,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Postrenal failure,1,M,OT,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Thrombosis,1,M,DE,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Thrombosis,1,M,HO,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Thrombosis,1,M,OT,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Venous thrombosis,1,M,DE,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Venous thrombosis,1,M,HO,14
1376988710,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Venous thrombosis,1,M,OT,14
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,1
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Anaemia,1,M,DE,1
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,1
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Gallbladder disorder,1,M,HO,1
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Gallbladder disorder,1,M,DE,1
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Gallbladder disorder,1,M,OT,1
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Hyperleukocytosis,1,M,HO,1
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Hyperleukocytosis,1,M,DE,1
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Hyperleukocytosis,1,M,OT,1
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,1
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,1
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,1
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,1
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Renal failure,1,M,DE,1
1379418118,1,Lung neoplasm malignant,18,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,1
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,OT,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,HO,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,DE,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Anaemia,1,M,DE,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Balance disorder,1,M,OT,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Balance disorder,1,M,HO,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Balance disorder,1,M,DE,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Bone lesion,1,M,OT,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Bone lesion,1,M,HO,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Bone lesion,1,M,DE,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Chest pain,1,M,OT,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Chest pain,1,M,HO,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Chest pain,1,M,DE,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Dizziness,1,M,OT,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Dizziness,1,M,HO,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Dizziness,1,M,DE,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Herpes virus infection,1,M,OT,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Herpes virus infection,1,M,HO,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Herpes virus infection,1,M,DE,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Lung disorder,1,M,OT,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Lung disorder,1,M,HO,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Lung disorder,1,M,DE,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Musculoskeletal chest pain,1,M,OT,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Musculoskeletal chest pain,1,M,HO,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Musculoskeletal chest pain,1,M,DE,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,13
1379850415,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,13
138054823,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Central venous catheterisation,1,M,OT,100
138054823,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Central venous catheterisation,1,M,DE,100
138054823,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Central venous catheterisation,1,M,HO,100
138054823,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Hepatic artery occlusion,1,M,OT,100
138054823,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Hepatic artery occlusion,1,M,DE,100
138054823,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Hepatic artery occlusion,1,M,HO,100
138054823,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Intestinal ischaemia,1,M,OT,100
138054823,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Intestinal ischaemia,1,M,DE,100
138054823,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Intestinal ischaemia,1,M,HO,100
138060677,1,Chronic lymphocytic leukaemia,7,F,EXP,ofatumumab,1,PS,Richter's syndrome,1,F,DE,209
138060677,1,Chronic lymphocytic leukaemia,7,F,EXP,ofatumumab,1,PS,Richter's syndrome,1,F,OT,209
138060677,1,Chronic lymphocytic leukaemia,7,F,EXP,ofatumumab,1,PS,Richter's syndrome,1,F,HO,209
138060677,2,Chronic lymphocytic leukaemia,7,F,EXP,ibrutinib,2,SS,Richter's syndrome,2,F,DE,237
138060677,2,Chronic lymphocytic leukaemia,7,F,EXP,ibrutinib,2,SS,Richter's syndrome,2,F,OT,237
138060677,2,Chronic lymphocytic leukaemia,7,F,EXP,ibrutinib,2,SS,Richter's syndrome,2,F,HO,237
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Asthenia,1,F,OT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Asthenia,1,F,HO,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Asthenia,1,F,LT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Asthenia,1,F,DE,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Atelectasis,1,F,OT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Atelectasis,1,F,HO,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Atelectasis,1,F,LT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Atelectasis,1,F,DE,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Cystitis escherichia,1,F,OT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Cystitis escherichia,1,F,HO,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Cystitis escherichia,1,F,LT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Cystitis escherichia,1,F,DE,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,OT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,HO,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,LT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,DE,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,LT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,DE,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Dysphagia,1,F,OT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Dysphagia,1,F,HO,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Dysphagia,1,F,LT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Dysphagia,1,F,DE,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Dyspnoea exertional,1,F,OT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Dyspnoea exertional,1,F,HO,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Dyspnoea exertional,1,F,LT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Dyspnoea exertional,1,F,DE,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,LT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Nausea,1,F,LT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Nausea,1,F,DE,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Oesophageal stenosis,1,F,OT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Oesophageal stenosis,1,F,HO,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Oesophageal stenosis,1,F,LT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Oesophageal stenosis,1,F,DE,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Palpitations,1,F,OT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Palpitations,1,F,HO,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Palpitations,1,F,LT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Palpitations,1,F,DE,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Streptococcal sepsis,1,F,OT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Streptococcal sepsis,1,F,HO,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Streptococcal sepsis,1,F,LT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Streptococcal sepsis,1,F,DE,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Weight decreased,1,F,OT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Weight decreased,1,F,HO,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Weight decreased,1,F,LT,14
1381292413,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Weight decreased,1,F,DE,14
138172786,1,Plasma cell myeloma,6,F,PER,carfilzomib,1,PS,Localised infection,1,M,HO,32
138172786,1,Plasma cell myeloma,6,F,PER,carfilzomib,1,PS,Periodontitis,1,M,HO,32
138604406,1,Renal cell carcinoma,6,F,EXP,avelumab,1,SS,Troponin I increased,1,F,HO,56
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Anxiety,1,M,HO,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Anxiety,1,M,OT,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Anxiety,1,M,DE,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Blood potassium decreased,1,M,HO,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Blood potassium decreased,1,M,OT,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Blood potassium decreased,1,M,DE,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Constipation,1,M,HO,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Constipation,1,M,OT,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Constipation,1,M,DE,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Gastrooesophageal reflux disease,1,M,HO,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Gastrooesophageal reflux disease,1,M,OT,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Gastrooesophageal reflux disease,1,M,DE,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Haemoglobin decreased,1,M,HO,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Haemoglobin decreased,1,M,OT,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Haemoglobin decreased,1,M,DE,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Hypertension,1,M,HO,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Hypertension,1,M,OT,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Hypertension,1,M,DE,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Hypertensive crisis,1,M,HO,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Hypertensive crisis,1,M,OT,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Hypertensive crisis,1,M,DE,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Oedema,1,M,HO,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Oedema,1,M,OT,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Oedema,1,M,DE,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Oesophagitis,1,M,HO,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Oesophagitis,1,M,OT,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Oesophagitis,1,M,DE,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,4
1386150612,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Vomiting,1,M,DE,4
1387265310,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Neutropenia,1,M,HO,4
1387265310,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Oral fungal infection,1,M,HO,4
1387265310,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Pyrexia,1,M,HO,4
1387265310,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Skin exfoliation,1,M,HO,4
1387265310,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Viral infection,1,M,HO,4
1390614615,1,Multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Arthralgia,1,F,HO,290
1390614615,1,Multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Autoimmune haemolytic anaemia,1,F,HO,290
1390614615,1,Multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Gastrointestinal infection,1,F,HO,290
1390614615,1,Multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Gingival bleeding,1,F,HO,290
1390614615,1,Multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Hodgkin's disease mixed cellularity stage unspecified,1,F,HO,290
1390614615,1,Multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,F,HO,290
1390614615,1,Multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Leukopenia,1,F,HO,290
1390614615,1,Multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Nasopharyngitis,1,F,HO,290
1390614615,1,Multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Oral disorder,1,F,HO,290
1390614615,1,Multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Petechiae,1,F,HO,290
1390614615,1,Multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Skin mass,1,F,HO,290
1390614615,1,Multiple sclerosis,15,F,EXP,alemtuzumab,1,PS,Upper respiratory tract infection,1,F,HO,290
139224085,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Myocardial infarction,2,M,OT,20
139224085,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Myocardial infarction,2,M,HO,20
139224085,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Myocardial infarction,2,M,LT,20
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Asthenia,1,M,DE,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Cancer pain,1,M,OT,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Cancer pain,1,M,HO,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Cancer pain,1,M,DE,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Clostridium difficile colitis,1,M,OT,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Clostridium difficile colitis,1,M,HO,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Clostridium difficile colitis,1,M,DE,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Dehydration,1,M,DE,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Febrile bone marrow aplasia,1,M,OT,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Febrile bone marrow aplasia,1,M,HO,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Febrile bone marrow aplasia,1,M,DE,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Hypernatraemia,1,M,OT,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Hypernatraemia,1,M,HO,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Hypernatraemia,1,M,DE,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Medical device repositioning,1,M,OT,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Medical device repositioning,1,M,HO,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Medical device repositioning,1,M,DE,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Pyrexia,1,M,DE,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Renal failure,1,M,DE,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Respiratory tract congestion,1,M,OT,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Respiratory tract congestion,1,M,HO,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Respiratory tract congestion,1,M,DE,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Tachypnoea,1,M,OT,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Tachypnoea,1,M,HO,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Tachypnoea,1,M,DE,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,15
1392881712,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Vomiting,1,M,DE,15
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Anaemia,1,M,LT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Anaemia,1,M,HO,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Anaemia,1,M,OT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Atrial fibrillation,1,M,LT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Atrial fibrillation,1,M,HO,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Atrial fibrillation,1,M,OT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Atrial flutter,1,M,LT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Atrial flutter,1,M,HO,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Atrial flutter,1,M,OT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Cardiac failure congestive,1,M,LT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Cardiac failure congestive,1,M,HO,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Cardiac failure congestive,1,M,OT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Fatigue,1,M,LT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Fatigue,1,M,HO,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Fatigue,1,M,OT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Febrile neutropenia,1,M,LT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Febrile neutropenia,1,M,HO,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Febrile neutropenia,1,M,OT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Lymphocyte count decreased,1,M,LT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Lymphocyte count decreased,1,M,HO,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Lymphocyte count decreased,1,M,OT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Myocardial ischaemia,1,M,LT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Myocardial ischaemia,1,M,HO,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Myocardial ischaemia,1,M,OT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Platelet count decreased,1,M,LT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Platelet count decreased,1,M,HO,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Platelet count decreased,1,M,OT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Pleural effusion,1,M,LT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Pleural effusion,1,M,HO,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,Pleural effusion,1,M,OT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,White blood cell count decreased,1,M,LT,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,White blood cell count decreased,1,M,HO,29
1393496110,1,Plasma cell myeloma,10,F,PER,carfilzomib,1,PS,White blood cell count decreased,1,M,OT,29
139359598,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,SS,Acidosis,1,M,HO,36
139359598,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,SS,Hyperglycaemia,1,M,HO,36
139359598,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,PS,Acidosis,2,M,HO,36
139359598,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,PS,Hyperglycaemia,2,M,HO,36
1393745812,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Arrhythmia,1,M,OT,17
1393745812,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Arrhythmia,1,M,HO,17
1393745812,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Arrhythmia,1,M,DE,17
1393745812,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,OT,17
1393745812,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,HO,17
1393745812,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,DE,17
1393745812,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,17
1393745812,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,17
1393745812,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,17
1393745812,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,17
1393745812,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,17
1393745812,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,17
1393745812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Arrhythmia,2,M,OT,3
1393745812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Arrhythmia,2,M,HO,3
1393745812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Arrhythmia,2,M,DE,3
1393745812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Cerebrovascular accident,2,M,OT,3
1393745812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Cerebrovascular accident,2,M,HO,3
1393745812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Cerebrovascular accident,2,M,DE,3
1393745812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,OT,3
1393745812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,HO,3
1393745812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,DE,3
1393745812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,3
1393745812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,HO,3
1393745812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,DE,3
139439848,1,Plasma cell myeloma,8,F,EXP,pomalidomide,1,PS,Acute kidney injury,1,M,LT,7
139439848,1,Plasma cell myeloma,8,F,EXP,pomalidomide,1,PS,Acute kidney injury,1,M,HO,7
139439848,1,Plasma cell myeloma,8,F,EXP,pomalidomide,1,PS,Pulmonary sepsis,1,M,LT,7
139439848,1,Plasma cell myeloma,8,F,EXP,pomalidomide,1,PS,Pulmonary sepsis,1,M,HO,7
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Back pain,1,M,OT,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Back pain,1,M,DE,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Back pain,1,M,HO,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Bone pain,1,M,OT,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Bone pain,1,M,DE,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Bone pain,1,M,HO,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Constipation,1,M,OT,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Constipation,1,M,DE,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Constipation,1,M,HO,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Lumbar vertebral fracture,1,M,OT,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Lumbar vertebral fracture,1,M,DE,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Lumbar vertebral fracture,1,M,HO,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Rash,1,M,OT,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Rash,1,M,DE,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Rash,1,M,HO,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Sleep apnoea syndrome,1,M,OT,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Sleep apnoea syndrome,1,M,DE,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Sleep apnoea syndrome,1,M,HO,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Suicide threat,1,M,OT,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Suicide threat,1,M,DE,11
1394626213,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Suicide threat,1,M,HO,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Back pain,2,M,OT,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Back pain,2,M,DE,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Back pain,2,M,HO,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Bone pain,2,M,OT,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Bone pain,2,M,DE,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Bone pain,2,M,HO,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Constipation,2,M,OT,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Constipation,2,M,DE,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Constipation,2,M,HO,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,OT,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,DE,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,HO,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Lumbar vertebral fracture,2,M,OT,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Lumbar vertebral fracture,2,M,DE,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Lumbar vertebral fracture,2,M,HO,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,DE,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,HO,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Rash,2,M,OT,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Rash,2,M,DE,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Rash,2,M,HO,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Sleep apnoea syndrome,2,M,OT,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Sleep apnoea syndrome,2,M,DE,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Sleep apnoea syndrome,2,M,HO,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Suicide threat,2,M,OT,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Suicide threat,2,M,DE,11
1394626213,2,Product used for unknown indication,13,F,EXP,nivolumab,2,SS,Suicide threat,2,M,HO,11
139471792,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,78
139471792,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,HO,78
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Fall,1,M,HO,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Fall,1,M,OT,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Hypersensitivity,1,M,HO,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Hypersensitivity,1,M,OT,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,M,HO,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,M,OT,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Hypocalcaemia,1,M,HO,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Hypocalcaemia,1,M,OT,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Inappropriate antidiuretic hormone secretion,1,M,HO,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Inappropriate antidiuretic hormone secretion,1,M,OT,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Left ventricular dysfunction,1,M,HO,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Left ventricular dysfunction,1,M,OT,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Off label use,1,M,HO,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,HO,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,OT,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Urticaria,1,M,HO,4
1396008721,1,Malignant melanoma,21,F,EXP,nivolumab,1,PS,Urticaria,1,M,OT,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Colitis,2,M,HO,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Colitis,2,M,OT,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Dehydration,2,M,HO,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Dehydration,2,M,OT,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Diarrhoea,2,M,HO,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Diarrhoea,2,M,OT,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Fall,2,M,HO,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Fall,2,M,OT,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Fatigue,2,M,HO,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Fatigue,2,M,OT,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Hypersensitivity,2,M,HO,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Hypersensitivity,2,M,OT,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Hyperthyroidism,2,M,HO,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Hyperthyroidism,2,M,OT,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Hypocalcaemia,2,M,HO,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Hypocalcaemia,2,M,OT,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Inappropriate antidiuretic hormone secretion,2,M,HO,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Inappropriate antidiuretic hormone secretion,2,M,OT,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Left ventricular dysfunction,2,M,HO,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Left ventricular dysfunction,2,M,OT,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Off label use,2,M,HO,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Off label use,2,M,OT,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Rash maculo-papular,2,M,HO,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Rash maculo-papular,2,M,OT,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Urticaria,2,M,HO,4
1396008721,2,Product used for unknown indication,21,F,EXP,nivolumab,2,SS,Urticaria,2,M,OT,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Colitis,13,M,HO,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Colitis,13,M,OT,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Dehydration,13,M,HO,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Dehydration,13,M,OT,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Diarrhoea,13,M,HO,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Diarrhoea,13,M,OT,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Fall,13,M,HO,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Fall,13,M,OT,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Fatigue,13,M,HO,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Fatigue,13,M,OT,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Hypersensitivity,13,M,HO,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Hypersensitivity,13,M,OT,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Hyperthyroidism,13,M,HO,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Hyperthyroidism,13,M,OT,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Hypocalcaemia,13,M,HO,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Hypocalcaemia,13,M,OT,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Inappropriate antidiuretic hormone secretion,13,M,HO,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Inappropriate antidiuretic hormone secretion,13,M,OT,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Left ventricular dysfunction,13,M,HO,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Left ventricular dysfunction,13,M,OT,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Off label use,13,M,HO,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Off label use,13,M,OT,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Rash maculo-papular,13,M,HO,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Rash maculo-papular,13,M,OT,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Urticaria,13,M,HO,4
1396008721,13,Malignant melanoma,21,F,EXP,ipilimumab,13,SS,Urticaria,13,M,OT,4
139627278,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,164
139627278,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Arthralgia,1,M,HO,164
139627278,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Escherichia infection,1,M,OT,164
139627278,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Escherichia infection,1,M,HO,164
139627278,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Herpes zoster,1,M,OT,164
139627278,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Herpes zoster,1,M,HO,164
139627278,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,164
139627278,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,164
139627278,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,164
139627278,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,164
139675406,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,53
139675406,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,53
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Epistaxis,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Feeling abnormal,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Head discomfort,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Headache,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Hypoaesthesia,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Muscle tightness,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Nasopharyngitis,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Nausea,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Neuropathy peripheral,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Pain in extremity,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Peripheral swelling,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Product distribution issue,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Sinus disorder,1,M,OT,301
139721912,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Somnolence,1,M,OT,301
139749593,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Abdominal discomfort,1,M,OT,94
139749593,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,94
139749593,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Cough,1,M,OT,94
139749593,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Drug intolerance,1,M,OT,94
139749593,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Haematochezia,1,M,OT,94
139749593,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Nasopharyngitis,1,M,OT,94
1397621612,1,Adenocarcinoma of colon,12,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,DE,137
1397621612,1,Adenocarcinoma of colon,12,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,137
1397621612,1,Adenocarcinoma of colon,12,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,137
1397621612,1,Adenocarcinoma of colon,12,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,DE,137
1397621612,1,Adenocarcinoma of colon,12,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,OT,137
1397621612,1,Adenocarcinoma of colon,12,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,HO,137
1397621612,1,Adenocarcinoma of colon,12,F,EXP,nivolumab,1,PS,Septic shock,1,F,DE,137
1397621612,1,Adenocarcinoma of colon,12,F,EXP,nivolumab,1,PS,Septic shock,1,F,OT,137
1397621612,1,Adenocarcinoma of colon,12,F,EXP,nivolumab,1,PS,Septic shock,1,F,HO,137
1397621612,2,Adenocarcinoma of colon,12,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,F,DE,137
1397621612,2,Adenocarcinoma of colon,12,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,F,OT,137
1397621612,2,Adenocarcinoma of colon,12,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,F,HO,137
1397621612,2,Adenocarcinoma of colon,12,F,EXP,ipilimumab,2,SS,Respiratory failure,2,F,DE,137
1397621612,2,Adenocarcinoma of colon,12,F,EXP,ipilimumab,2,SS,Respiratory failure,2,F,OT,137
1397621612,2,Adenocarcinoma of colon,12,F,EXP,ipilimumab,2,SS,Respiratory failure,2,F,HO,137
1397621612,2,Adenocarcinoma of colon,12,F,EXP,ipilimumab,2,SS,Septic shock,2,F,DE,137
1397621612,2,Adenocarcinoma of colon,12,F,EXP,ipilimumab,2,SS,Septic shock,2,F,OT,137
1397621612,2,Adenocarcinoma of colon,12,F,EXP,ipilimumab,2,SS,Septic shock,2,F,HO,137
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Anaemia,2,F,LT,15
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Anaemia,2,F,OT,15
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Anaemia,2,F,HO,15
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Constipation,2,F,LT,15
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Constipation,2,F,OT,15
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Constipation,2,F,HO,15
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Dehydration,2,F,LT,15
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Dehydration,2,F,OT,15
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Dehydration,2,F,HO,15
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Neutropenia,2,F,LT,15
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Neutropenia,2,F,OT,15
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Neutropenia,2,F,HO,15
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Venous injury,2,F,LT,15
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Venous injury,2,F,OT,15
139782293,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Venous injury,2,F,HO,15
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Amnesia,1,M,HO,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Amnesia,1,M,OT,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Back injury,1,M,HO,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Back injury,1,M,OT,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Blood test abnormal,1,M,HO,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Blood test abnormal,1,M,OT,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Fall,1,M,HO,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Fall,1,M,OT,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Fatigue,1,M,HO,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Hypertension,1,M,HO,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Hypertension,1,M,OT,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Neuropathy peripheral,1,M,HO,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Neuropathy peripheral,1,M,OT,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Pain in extremity,1,M,HO,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Pain in extremity,1,M,OT,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,HO,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,OT,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Skin discolouration,1,M,HO,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Skin discolouration,1,M,OT,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Therapy cessation,1,M,HO,27
139790192,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Therapy cessation,1,M,OT,27
139792445,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Anaemia,3,F,OT,67
139792445,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Anaemia,3,F,HO,67
139792445,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Anaemia,3,F,DE,67
139792445,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Dehydration,3,F,OT,67
139792445,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Dehydration,3,F,HO,67
139792445,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Dehydration,3,F,DE,67
139792445,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Neutropenia,3,F,OT,67
139792445,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Neutropenia,3,F,HO,67
139792445,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Neutropenia,3,F,DE,67
139792445,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Thrombocytopenia,3,F,OT,67
139792445,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Thrombocytopenia,3,F,HO,67
139792445,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Thrombocytopenia,3,F,DE,67
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Asthenia,1,M,HO,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Buttock injury,1,M,OT,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Buttock injury,1,M,HO,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Constipation,1,M,OT,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Constipation,1,M,HO,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,OT,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,HO,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Diarrhoea,1,M,OT,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Diarrhoea,1,M,HO,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Fall,1,M,OT,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Fall,1,M,HO,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Functional gastrointestinal disorder,1,M,OT,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Functional gastrointestinal disorder,1,M,HO,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Hypertension,1,M,OT,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Hypertension,1,M,HO,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,International normalised ratio fluctuation,1,M,OT,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,International normalised ratio fluctuation,1,M,HO,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Nasopharyngitis,1,M,OT,172
139797807,1,Prostate cancer,7,F,EXP,enzalutamide,1,PS,Nasopharyngitis,1,M,HO,172
139798854,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Arthralgia,1,M,OT,9
139798854,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,9
139798854,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Musculoskeletal pain,1,M,OT,9
139798854,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Myalgia,1,M,OT,9
139798854,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Neuropathy peripheral,1,M,OT,9
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Bronchopneumopathy,1,M,OT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Bronchopneumopathy,1,M,HO,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Bronchopneumopathy,1,M,DE,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Bronchopneumopathy,1,M,LT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Hypercapnia,1,M,OT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Hypercapnia,1,M,HO,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Hypercapnia,1,M,DE,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Hypercapnia,1,M,LT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Hypoxia,1,M,OT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Hypoxia,1,M,HO,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Hypoxia,1,M,DE,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Hypoxia,1,M,LT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,International normalised ratio abnormal,1,M,OT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,International normalised ratio abnormal,1,M,HO,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,International normalised ratio abnormal,1,M,DE,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,International normalised ratio abnormal,1,M,LT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Paraneoplastic syndrome,1,M,OT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Paraneoplastic syndrome,1,M,HO,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Paraneoplastic syndrome,1,M,DE,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Paraneoplastic syndrome,1,M,LT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,HO,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,DE,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,LT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Pulmonary toxicity,1,M,OT,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Pulmonary toxicity,1,M,HO,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Pulmonary toxicity,1,M,DE,188
1400259616,1,Lung neoplasm malignant,16,F,EXP,nivolumab,1,PS,Pulmonary toxicity,1,M,LT,188
1400448612,12,Prophylaxis,12,F,EXP,pegfilgrastim,12,C,Febrile bone marrow aplasia,12,M,HO,125
1400448612,12,Prophylaxis,12,F,EXP,pegfilgrastim,12,C,Rash,12,M,HO,125
1400787010,1,Non-small cell lung cancer,10,F,EXP,nivolumab,1,PS,Blood gases abnormal,1,M,HO,98
1400787010,1,Non-small cell lung cancer,10,F,EXP,nivolumab,1,PS,Blood gases abnormal,1,M,OT,98
1400787010,1,Non-small cell lung cancer,10,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,98
1400787010,1,Non-small cell lung cancer,10,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,98
1400787010,1,Non-small cell lung cancer,10,F,EXP,nivolumab,1,PS,Musculoskeletal pain,1,M,HO,98
1400787010,1,Non-small cell lung cancer,10,F,EXP,nivolumab,1,PS,Musculoskeletal pain,1,M,OT,98
1400787010,1,Non-small cell lung cancer,10,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,98
1400787010,1,Non-small cell lung cancer,10,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,98
1400787010,2,Non-small cell lung cancer,10,F,EXP,ipilimumab,2,SS,Blood gases abnormal,2,M,HO,98
1400787010,2,Non-small cell lung cancer,10,F,EXP,ipilimumab,2,SS,Blood gases abnormal,2,M,OT,98
1400787010,2,Non-small cell lung cancer,10,F,EXP,ipilimumab,2,SS,Dyspnoea,2,M,HO,98
1400787010,2,Non-small cell lung cancer,10,F,EXP,ipilimumab,2,SS,Dyspnoea,2,M,OT,98
1400787010,2,Non-small cell lung cancer,10,F,EXP,ipilimumab,2,SS,Musculoskeletal pain,2,M,HO,98
1400787010,2,Non-small cell lung cancer,10,F,EXP,ipilimumab,2,SS,Musculoskeletal pain,2,M,OT,98
1400787010,2,Non-small cell lung cancer,10,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,HO,98
1400787010,2,Non-small cell lung cancer,10,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,OT,98
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,F,LT,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,F,HO,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,F,OT,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,F,DE,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Atrioventricular block complete,1,F,LT,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Atrioventricular block complete,1,F,HO,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Atrioventricular block complete,1,F,OT,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Atrioventricular block complete,1,F,DE,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,F,LT,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,F,HO,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,F,OT,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,F,DE,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Hypotension,1,F,LT,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Hypotension,1,F,HO,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Hypotension,1,F,OT,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Hypotension,1,F,DE,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Myasthenia gravis,1,F,LT,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Myasthenia gravis,1,F,HO,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Myasthenia gravis,1,F,OT,19
140098154,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Myasthenia gravis,1,F,DE,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Acute myocardial infarction,2,F,LT,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Acute myocardial infarction,2,F,HO,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Acute myocardial infarction,2,F,OT,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Acute myocardial infarction,2,F,DE,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Atrioventricular block complete,2,F,LT,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Atrioventricular block complete,2,F,HO,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Atrioventricular block complete,2,F,OT,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Atrioventricular block complete,2,F,DE,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,F,LT,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,F,HO,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,F,OT,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,F,DE,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Hypotension,2,F,LT,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Hypotension,2,F,HO,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Hypotension,2,F,OT,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Hypotension,2,F,DE,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Myasthenia gravis,2,F,LT,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Myasthenia gravis,2,F,HO,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Myasthenia gravis,2,F,OT,19
140098154,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Myasthenia gravis,2,F,DE,19
140108582,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Rheumatoid arthritis,1,F,OT,1365
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Angiopathy,1,F,DE,13
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Angiopathy,1,F,HO,13
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Angiopathy,1,F,OT,13
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Colitis,1,F,DE,13
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Colitis,1,F,HO,13
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Colitis,1,F,OT,13
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Hepatic pain,1,F,DE,13
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Hepatic pain,1,F,HO,13
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Hepatic pain,1,F,OT,13
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,13
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,13
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,13
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Nausea,1,F,DE,13
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,13
1401125516,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Angiopathy,3,F,DE,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Angiopathy,3,F,HO,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Angiopathy,3,F,OT,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Colitis,3,F,DE,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Colitis,3,F,HO,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Colitis,3,F,OT,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Hepatic pain,3,F,DE,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Hepatic pain,3,F,HO,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Hepatic pain,3,F,OT,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,F,DE,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,F,HO,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,F,OT,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Nausea,3,F,DE,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Nausea,3,F,HO,13
1401125516,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Nausea,3,F,OT,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Angiopathy,4,F,DE,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Angiopathy,4,F,HO,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Angiopathy,4,F,OT,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Colitis,4,F,DE,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Colitis,4,F,HO,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Colitis,4,F,OT,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Hepatic pain,4,F,DE,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Hepatic pain,4,F,HO,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Hepatic pain,4,F,OT,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,F,DE,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,F,HO,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,F,OT,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Nausea,4,F,DE,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Nausea,4,F,HO,13
1401125516,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Nausea,4,F,OT,13
140150273,8,Plasma cell myeloma,3,F,EXP,lenalidomide,8,SS,Malignant neoplasm progression,8,M,HO,35
140150273,8,Plasma cell myeloma,3,F,EXP,lenalidomide,8,SS,Malignant neoplasm progression,8,M,DE,35
140150273,8,Plasma cell myeloma,3,F,EXP,lenalidomide,8,SS,Malignant neoplasm progression,8,M,OT,35
140150273,8,Plasma cell myeloma,3,F,EXP,lenalidomide,8,SS,Oedema peripheral,8,M,HO,35
140150273,8,Plasma cell myeloma,3,F,EXP,lenalidomide,8,SS,Oedema peripheral,8,M,DE,35
140150273,8,Plasma cell myeloma,3,F,EXP,lenalidomide,8,SS,Oedema peripheral,8,M,OT,35
140150273,8,Plasma cell myeloma,3,F,EXP,lenalidomide,8,SS,Platelet count decreased,8,M,HO,35
140150273,8,Plasma cell myeloma,3,F,EXP,lenalidomide,8,SS,Platelet count decreased,8,M,DE,35
140150273,8,Plasma cell myeloma,3,F,EXP,lenalidomide,8,SS,Platelet count decreased,8,M,OT,35
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Anaemia,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Angioedema,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Autoimmune hypothyroidism,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Bacterial test positive,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,CD4 lymphocytes decreased,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Haematocrit decreased,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Haemoglobin decreased,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Heart rate increased,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Mean cell haemoglobin decreased,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Neutrophil count decreased,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Pachymeningitis,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Pneumonia,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Pyrexia,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Respiratory tract infection fungal,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Thyroid disorder,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Urine analysis abnormal,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Urine leukocyte esterase positive,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Urticaria,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,White blood cell count abnormal,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,OT,7
140159279,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,White blood cells urine positive,1,F,OT,7
140202567,1,Malignant melanoma,7,F,EXP,ipilimumab,1,PS,Diarrhoea,1,F,OT,128
140202567,1,Malignant melanoma,7,F,EXP,ipilimumab,1,PS,Diarrhoea,1,F,DE,128
140202567,1,Malignant melanoma,7,F,EXP,ipilimumab,1,PS,Diarrhoea,1,F,HO,128
140202567,1,Malignant melanoma,7,F,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,F,OT,128
140202567,1,Malignant melanoma,7,F,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,F,DE,128
140202567,1,Malignant melanoma,7,F,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,F,HO,128
140202567,1,Malignant melanoma,7,F,EXP,ipilimumab,1,PS,Tumour lysis syndrome,1,F,OT,128
140202567,1,Malignant melanoma,7,F,EXP,ipilimumab,1,PS,Tumour lysis syndrome,1,F,DE,128
140202567,1,Malignant melanoma,7,F,EXP,ipilimumab,1,PS,Tumour lysis syndrome,1,F,HO,128
140206487,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Pneumonia,1,M,OT,116
140206487,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Pneumonia,1,M,LT,116
140206487,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Pneumonia,1,M,HO,116
140366547,1,Gastrooesophageal cancer,7,F,EXP,nivolumab,1,PS,Acute hepatic failure,1,F,DE,122
140366547,1,Gastrooesophageal cancer,7,F,EXP,nivolumab,1,PS,Acute hepatic failure,1,F,HO,122
140366547,1,Gastrooesophageal cancer,7,F,EXP,nivolumab,1,PS,Acute hepatic failure,1,F,OT,122
140366547,1,Gastrooesophageal cancer,7,F,EXP,nivolumab,1,PS,Acute hepatic failure,1,F,LT,122
140366547,1,Gastrooesophageal cancer,7,F,EXP,nivolumab,1,PS,Subdural haematoma,1,F,DE,122
140366547,1,Gastrooesophageal cancer,7,F,EXP,nivolumab,1,PS,Subdural haematoma,1,F,HO,122
140366547,1,Gastrooesophageal cancer,7,F,EXP,nivolumab,1,PS,Subdural haematoma,1,F,OT,122
140366547,1,Gastrooesophageal cancer,7,F,EXP,nivolumab,1,PS,Subdural haematoma,1,F,LT,122
140366547,1,Gastrooesophageal cancer,7,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,DE,122
140366547,1,Gastrooesophageal cancer,7,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,HO,122
140366547,1,Gastrooesophageal cancer,7,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,OT,122
140366547,1,Gastrooesophageal cancer,7,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,LT,122
140366547,2,Gastrooesophageal cancer,7,F,EXP,ipilimumab,2,SS,Acute hepatic failure,2,F,DE,122
140366547,2,Gastrooesophageal cancer,7,F,EXP,ipilimumab,2,SS,Acute hepatic failure,2,F,HO,122
140366547,2,Gastrooesophageal cancer,7,F,EXP,ipilimumab,2,SS,Acute hepatic failure,2,F,OT,122
140366547,2,Gastrooesophageal cancer,7,F,EXP,ipilimumab,2,SS,Acute hepatic failure,2,F,LT,122
140366547,2,Gastrooesophageal cancer,7,F,EXP,ipilimumab,2,SS,Subdural haematoma,2,F,DE,122
140366547,2,Gastrooesophageal cancer,7,F,EXP,ipilimumab,2,SS,Subdural haematoma,2,F,HO,122
140366547,2,Gastrooesophageal cancer,7,F,EXP,ipilimumab,2,SS,Subdural haematoma,2,F,OT,122
140366547,2,Gastrooesophageal cancer,7,F,EXP,ipilimumab,2,SS,Subdural haematoma,2,F,LT,122
140366547,2,Gastrooesophageal cancer,7,F,EXP,ipilimumab,2,SS,Thrombocytopenia,2,F,DE,122
140366547,2,Gastrooesophageal cancer,7,F,EXP,ipilimumab,2,SS,Thrombocytopenia,2,F,HO,122
140366547,2,Gastrooesophageal cancer,7,F,EXP,ipilimumab,2,SS,Thrombocytopenia,2,F,OT,122
140366547,2,Gastrooesophageal cancer,7,F,EXP,ipilimumab,2,SS,Thrombocytopenia,2,F,LT,122
140375424,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,94
140375424,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Rheumatoid arthritis,1,M,OT,94
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Anorectal cellulitis,16,F,HO,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Anorectal cellulitis,16,F,OT,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Anorectal cellulitis,16,F,DS,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Bacterial infection,16,F,HO,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Bacterial infection,16,F,OT,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Bacterial infection,16,F,DS,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Encopresis,16,F,HO,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Encopresis,16,F,OT,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Encopresis,16,F,DS,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Febrile neutropenia,16,F,HO,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Febrile neutropenia,16,F,OT,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Febrile neutropenia,16,F,DS,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Perirectal abscess,16,F,HO,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Perirectal abscess,16,F,OT,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Perirectal abscess,16,F,DS,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Sepsis,16,F,HO,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Sepsis,16,F,OT,79
140441045,16,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,16,SS,Sepsis,16,F,DS,79
140442826,1,Neuroendocrine carcinoma of the skin,6,F,EXP,ipilimumab,1,PS,Autoimmune colitis,1,F,HO,69
140442826,1,Neuroendocrine carcinoma of the skin,6,F,EXP,ipilimumab,1,PS,Autoimmune colitis,1,F,OT,69
140442826,1,Neuroendocrine carcinoma of the skin,6,F,EXP,ipilimumab,1,PS,Autoimmune disorder,1,F,HO,69
140442826,1,Neuroendocrine carcinoma of the skin,6,F,EXP,ipilimumab,1,PS,Autoimmune disorder,1,F,OT,69
140442826,1,Neuroendocrine carcinoma of the skin,6,F,EXP,ipilimumab,1,PS,Pyrexia,1,F,HO,69
140442826,1,Neuroendocrine carcinoma of the skin,6,F,EXP,ipilimumab,1,PS,Pyrexia,1,F,OT,69
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Affective disorder,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Affective disorder,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Affective disorder,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Affective disorder,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Anxiety,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Anxiety,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Anxiety,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Anxiety,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Arthralgia,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Arthralgia,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Arthralgia,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Arthralgia,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Asthenia,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Asthenia,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Asthenia,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Asthenia,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Ataxia,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Ataxia,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Ataxia,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Ataxia,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Back pain,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Back pain,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Back pain,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Back pain,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Bedridden,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Bedridden,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Bedridden,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Bedridden,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Blister,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Blister,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Blister,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Blister,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Burning sensation,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Burning sensation,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Burning sensation,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Burning sensation,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,CD4 lymphocytes decreased,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,CD4 lymphocytes decreased,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,CD4 lymphocytes decreased,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,CD4 lymphocytes decreased,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Chills,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Chills,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Chills,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Chills,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Clonus,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Clonus,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Clonus,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Clonus,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Coccidioidomycosis,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Coccidioidomycosis,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Coccidioidomycosis,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Coccidioidomycosis,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Computerised tomogram abnormal,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Computerised tomogram abnormal,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Computerised tomogram abnormal,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Computerised tomogram abnormal,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Confusional state,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Confusional state,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Confusional state,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Confusional state,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Consciousness fluctuating,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Consciousness fluctuating,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Consciousness fluctuating,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Consciousness fluctuating,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Cough,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Cough,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Cough,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Cough,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dementia,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dementia,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dementia,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dementia,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Depression,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Depression,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Depression,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Depression,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dysaesthesia,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dysaesthesia,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dysaesthesia,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dysaesthesia,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dysarthria,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dysarthria,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dysarthria,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dysarthria,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dysphagia,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dysphagia,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dysphagia,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Dysphagia,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Ear infection,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Ear infection,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Ear infection,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Ear infection,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Facial pain,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Facial pain,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Facial pain,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Facial pain,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Facial spasm,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Facial spasm,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Facial spasm,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Facial spasm,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Fatigue,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Fatigue,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Fatigue,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Fatigue,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Fear,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Fear,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Fear,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Fear,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Feeling abnormal,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Feeling abnormal,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Feeling abnormal,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Feeling abnormal,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Feeling of body temperature change,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Feeling of body temperature change,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Feeling of body temperature change,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Feeling of body temperature change,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Full blood count decreased,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Full blood count decreased,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Full blood count decreased,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Full blood count decreased,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Hemiparesis,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Hemiparesis,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Hemiparesis,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Hemiparesis,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Herpes simplex,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Herpes simplex,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Herpes simplex,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Herpes simplex,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Herpes zoster,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Herpes zoster,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Herpes zoster,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Herpes zoster,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Hyperhidrosis,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Hyperhidrosis,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Hyperhidrosis,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Hyperhidrosis,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Hypoacusis,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Hypoacusis,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Hypoacusis,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Hypoacusis,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Immunodeficiency,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Immunodeficiency,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Immunodeficiency,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Immunodeficiency,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Increased tendency to bruise,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Increased tendency to bruise,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Increased tendency to bruise,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Increased tendency to bruise,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Influenza like illness,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Influenza like illness,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Influenza like illness,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Influenza like illness,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Lymphadenopathy,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Lymphadenopathy,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Lymphadenopathy,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Lymphadenopathy,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Malaise,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Malaise,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Malaise,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Malaise,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Memory impairment,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Memory impairment,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Memory impairment,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Memory impairment,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Mental disorder,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Mental disorder,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Mental disorder,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Mental disorder,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Mobility decreased,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Mobility decreased,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Mobility decreased,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Mobility decreased,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Multiple sclerosis,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Multiple sclerosis,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Multiple sclerosis,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Multiple sclerosis,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Muscle rigidity,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Muscle rigidity,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Muscle rigidity,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Muscle rigidity,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Muscle spasticity,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Muscle spasticity,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Muscle spasticity,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Muscle spasticity,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Nasopharyngitis,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Nasopharyngitis,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Nasopharyngitis,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Nasopharyngitis,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Neuralgia,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Neuralgia,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Neuralgia,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Neuralgia,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Oral herpes,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Oral herpes,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Oral herpes,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Oral herpes,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Oropharyngeal pain,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Oropharyngeal pain,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Oropharyngeal pain,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Oropharyngeal pain,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pain,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pain,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pain,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pain,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pruritus,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pruritus,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pruritus,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pruritus,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pulmonary congestion,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pulmonary congestion,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pulmonary congestion,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pulmonary congestion,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pyrexia,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pyrexia,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pyrexia,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pyrexia,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rash,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rash,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rash,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rash,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rash erythematous,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rash erythematous,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rash erythematous,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rash erythematous,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rash pustular,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rash pustular,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rash pustular,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rash pustular,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Respiratory tract congestion,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Respiratory tract congestion,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Respiratory tract congestion,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Respiratory tract congestion,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rocky mountain spotted fever,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rocky mountain spotted fever,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rocky mountain spotted fever,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Rocky mountain spotted fever,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Sinus congestion,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Sinus congestion,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Sinus congestion,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Sinus congestion,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Skin discolouration,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Skin discolouration,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Skin discolouration,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Skin discolouration,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Sleep disorder,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Sleep disorder,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Sleep disorder,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Sleep disorder,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Tonsillar hypertrophy,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Tonsillar hypertrophy,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Tonsillar hypertrophy,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Tonsillar hypertrophy,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Toxoplasmosis,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Toxoplasmosis,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Toxoplasmosis,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Toxoplasmosis,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Tremor,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Tremor,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Tremor,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Tremor,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Unevaluable event,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Unevaluable event,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Unevaluable event,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Unevaluable event,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Wheezing,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Wheezing,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Wheezing,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Wheezing,1,M,OT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,M,LT,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,M,HO,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,M,DS,17
1404855918,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,M,OT,17
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Dehydration,1,M,DE,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,OT,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,DE,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,HO,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Nausea,1,M,DE,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Pyrexia,1,M,DE,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,OT,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,DE,15
140572214,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,HO,15
140701532,3,Chronic lymphocytic leukaemia,2,F,EXP,chlorambucil,3,SS,Febrile neutropenia,3,M,HO,185
140701532,3,Chronic lymphocytic leukaemia,2,F,EXP,chlorambucil,3,SS,Febrile neutropenia,3,M,LT,185
140701532,4,Chronic lymphocytic leukaemia,2,F,EXP,chlorambucil,4,SS,Febrile neutropenia,4,M,HO,31
140701532,4,Chronic lymphocytic leukaemia,2,F,EXP,chlorambucil,4,SS,Febrile neutropenia,4,M,LT,31
140905235,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,35
140905235,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,35
140905235,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,35
141255012,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Apathy,1,M,OT,318
141255012,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Apathy,1,M,HO,318
141255012,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,318
141255012,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Dizziness,1,M,HO,318
141255012,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Feeling hot,1,M,OT,318
141255012,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Feeling hot,1,M,HO,318
141255012,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Pain,1,M,OT,318
141255012,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Pain,1,M,HO,318
141255012,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Rectal haemorrhage,1,M,OT,318
141255012,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Rectal haemorrhage,1,M,HO,318
141255012,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,"Sleep disorder due to general medical condition, insomnia type",1,M,OT,318
141255012,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,"Sleep disorder due to general medical condition, insomnia type",1,M,HO,318
141255012,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Tachycardia,1,M,OT,318
141255012,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Tachycardia,1,M,HO,318
141365447,1,Breast cancer,7,F,EXP,palbociclib,1,PS,Pulmonary embolism,1,F,HO,81
141501506,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,HO,15
141509819,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Back pain,1,F,HO,51
141509819,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Back pain,1,F,DE,51
141509819,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Back pain,1,F,OT,51
141509819,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,51
141509819,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,51
141509819,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,51
141509819,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Thrombosis,1,F,HO,51
141509819,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Thrombosis,1,F,DE,51
141509819,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Thrombosis,1,F,OT,51
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,OT,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,DE,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,HO,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,OT,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,DE,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,HO,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,OT,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,DE,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,HO,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Basedow's disease,1,M,OT,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Basedow's disease,1,M,DE,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Basedow's disease,1,M,HO,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Fatigue,1,M,DE,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Hypersensitivity,1,M,OT,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Hypersensitivity,1,M,DE,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Hypersensitivity,1,M,HO,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Oesophagitis,1,M,OT,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Oesophagitis,1,M,DE,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Oesophagitis,1,M,HO,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Vomiting,1,M,DE,17
1417327713,1,Metastatic malignant melanoma,13,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Atrial fibrillation,2,M,OT,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Atrial fibrillation,2,M,DE,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Atrial fibrillation,2,M,HO,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Autoimmune hepatitis,2,M,OT,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Autoimmune hepatitis,2,M,DE,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Autoimmune hepatitis,2,M,HO,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Autoimmune thyroiditis,2,M,OT,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Autoimmune thyroiditis,2,M,DE,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Autoimmune thyroiditis,2,M,HO,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Basedow's disease,2,M,OT,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Basedow's disease,2,M,DE,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Basedow's disease,2,M,HO,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Fatigue,2,M,OT,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Fatigue,2,M,DE,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Fatigue,2,M,HO,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Hypersensitivity,2,M,OT,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Hypersensitivity,2,M,DE,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Hypersensitivity,2,M,HO,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DE,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,HO,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Oesophagitis,2,M,OT,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Oesophagitis,2,M,DE,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Oesophagitis,2,M,HO,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Vomiting,2,M,OT,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Vomiting,2,M,DE,17
1417327713,2,Metastatic malignant melanoma,13,F,EXP,ipilimumab,2,SS,Vomiting,2,M,HO,17
141766093,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,OT,18
141766093,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,DE,18
141910697,1,Head and neck cancer,7,F,EXP,nivolumab,1,PS,Pemphigoid,1,F,HO,98
141910697,1,Head and neck cancer,7,F,EXP,nivolumab,1,PS,Pemphigoid,1,F,OT,98
141940214,1,Hepatocellular carcinoma,4,F,EXP,nivolumab,1,PS,Hemiparesis,1,F,HO,322
141940214,1,Hepatocellular carcinoma,4,F,EXP,nivolumab,1,PS,Hemiparesis,1,F,OT,322
141949514,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Gastric ulcer,1,M,OT,1007
141949514,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,OT,1007
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Connective tissue neoplasm,1,F,HO,7
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Connective tissue neoplasm,1,F,OT,7
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Connective tissue neoplasm,1,F,DE,7
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,7
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,OT,7
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,DE,7
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,F,HO,7
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,F,OT,7
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,F,DE,7
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,HO,7
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,OT,7
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,DE,7
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Pharyngeal disorder,1,F,HO,7
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Pharyngeal disorder,1,F,OT,7
1420317211,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Pharyngeal disorder,1,F,DE,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Connective tissue neoplasm,2,F,HO,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Connective tissue neoplasm,2,F,OT,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Connective tissue neoplasm,2,F,DE,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,F,HO,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,F,OT,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,F,DE,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,F,HO,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,F,OT,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,F,DE,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Hyperthyroidism,2,F,HO,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Hyperthyroidism,2,F,OT,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Hyperthyroidism,2,F,DE,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Pharyngeal disorder,2,F,HO,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Pharyngeal disorder,2,F,OT,7
1420317211,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Pharyngeal disorder,2,F,DE,7
142064053,1,Non-Hodgkin's lymphoma,3,F,EXP,brentuximab vedotin,1,PS,Acute respiratory failure,1,F,HO,212
142064053,1,Non-Hodgkin's lymphoma,3,F,EXP,brentuximab vedotin,1,PS,Acute respiratory failure,1,F,OT,212
142064053,2,Non-Hodgkin's lymphoma,3,F,EXP,nivolumab,2,SS,Acute respiratory failure,2,F,HO,204
142064053,2,Non-Hodgkin's lymphoma,3,F,EXP,nivolumab,2,SS,Acute respiratory failure,2,F,OT,204
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Bacterial test positive,1,F,HO,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Bacterial test positive,1,F,DE,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Bacterial test positive,1,F,OT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Bacterial test positive,1,F,LT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Bronchitis,1,F,HO,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Bronchitis,1,F,DE,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Bronchitis,1,F,OT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Bronchitis,1,F,LT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Dry skin,1,F,HO,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Dry skin,1,F,DE,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Dry skin,1,F,OT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Dry skin,1,F,LT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,DE,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,OT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,LT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Inflammation,1,F,HO,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Inflammation,1,F,DE,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Inflammation,1,F,OT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Inflammation,1,F,LT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,LT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Metastases to meninges,1,F,HO,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Metastases to meninges,1,F,DE,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Metastases to meninges,1,F,OT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Metastases to meninges,1,F,LT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Nervous system disorder,1,F,HO,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Nervous system disorder,1,F,DE,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Nervous system disorder,1,F,OT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Nervous system disorder,1,F,LT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Paraneoplastic encephalomyelitis,1,F,HO,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Paraneoplastic encephalomyelitis,1,F,DE,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Paraneoplastic encephalomyelitis,1,F,OT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Paraneoplastic encephalomyelitis,1,F,LT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Steroid diabetes,1,F,HO,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Steroid diabetes,1,F,DE,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Steroid diabetes,1,F,OT,46
142067718,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Steroid diabetes,1,F,LT,46
142163783,2,Plasma cell myeloma,3,F,EXP,thalidomide,2,SS,Acute myeloid leukaemia,2,M,DE,1662
142163783,2,Plasma cell myeloma,3,F,EXP,thalidomide,2,SS,Acute myeloid leukaemia,2,M,OT,1662
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Cachexia,1,F,DE,25
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Cachexia,1,F,HO,25
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Cachexia,1,F,OT,25
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Condition aggravated,1,F,DE,25
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Condition aggravated,1,F,HO,25
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Condition aggravated,1,F,OT,25
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,DE,25
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,25
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,25
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,25
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,25
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,25
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Pleurisy,1,F,DE,25
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Pleurisy,1,F,HO,25
1421690210,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Pleurisy,1,F,OT,25
142219606,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Infective exacerbation of chronic obstructive airways disease,1,M,OT,10
142219606,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Infective exacerbation of chronic obstructive airways disease,1,M,DE,10
142219606,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Infective exacerbation of chronic obstructive airways disease,1,M,HO,10
142219606,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,10
142219606,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,10
142219606,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,10
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Anaemia,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Anaemia,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Anxiety,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Anxiety,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Arthralgia,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Arthralgia,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Constipation,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Constipation,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Depression,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Depression,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Fatigue,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Fatigue,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Febrile neutropenia,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Febrile neutropenia,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Herpes zoster,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Herpes zoster,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Hyperglycaemia,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Hyperglycaemia,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Hypertension,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Hypertension,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Hyponatraemia,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Hyponatraemia,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Insomnia,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Insomnia,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Lymphocyte count decreased,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Lymphocyte count decreased,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Nausea,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Nausea,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Neutropenia,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Neutropenia,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Oral herpes,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Oral herpes,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Pain in extremity,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Pain in extremity,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Paranasal sinus hypersecretion,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Paranasal sinus hypersecretion,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Stomatitis,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Stomatitis,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Tachycardia,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Tachycardia,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Weight increased,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,Weight increased,2,M,HO,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,White blood cell count decreased,2,M,OT,14
1422211511,2,Hodgkin's disease,11,F,EXP,abvd,2,SS,White blood cell count decreased,2,M,HO,14
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Abdominal pain,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Abdominal pain,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Abdominal pain,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Abdominal pain upper,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Abdominal pain upper,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Abdominal pain upper,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Ageusia,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Ageusia,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Ageusia,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Alanine aminotransferase increased,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Alanine aminotransferase increased,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Alanine aminotransferase increased,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Alopecia,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Alopecia,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Alopecia,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Amylase increased,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Amylase increased,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Amylase increased,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Apathy,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Apathy,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Apathy,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Aspartate aminotransferase increased,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Aspartate aminotransferase increased,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Aspartate aminotransferase increased,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Asthenia,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Asthenia,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Asthenia,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Blood alkaline phosphatase increased,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Blood alkaline phosphatase increased,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Blood alkaline phosphatase increased,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Cholestasis,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Cholestasis,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Cholestasis,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Decreased appetite,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Decreased appetite,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Decreased appetite,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Diarrhoea,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Diarrhoea,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Diarrhoea,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Disorientation,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Disorientation,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Disorientation,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Dry skin,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Dry skin,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Dry skin,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Fatigue,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Fatigue,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Fatigue,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Gamma-glutamyltransferase increased,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Gamma-glutamyltransferase increased,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Gamma-glutamyltransferase increased,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Gastric ulcer,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Gastric ulcer,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Gastric ulcer,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Gastritis erosive,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Gastritis erosive,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Gastritis erosive,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Gout,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Gout,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Gout,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Insomnia,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Insomnia,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Insomnia,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Lipase increased,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Lipase increased,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Lipase increased,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Malaise,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Malaise,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Malaise,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Malignant melanoma,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Malignant melanoma,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Malignant melanoma,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Malignant neoplasm progression,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Malignant neoplasm progression,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Malignant neoplasm progression,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Metastases to liver,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Metastases to liver,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Metastases to liver,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Mood altered,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Mood altered,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Mood altered,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Multiple organ dysfunction syndrome,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Multiple organ dysfunction syndrome,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Multiple organ dysfunction syndrome,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Nausea,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Nausea,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Nausea,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Polyuria,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Polyuria,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Polyuria,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Pruritus,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Pruritus,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Pruritus,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Radiation skin injury,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Radiation skin injury,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Radiation skin injury,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Taste disorder,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Taste disorder,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Taste disorder,11,M,OT,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Vertigo,11,M,HO,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Vertigo,11,M,DE,13
1422521116,11,Metastatic malignant melanoma,16,F,EXP,trametinib,11,SS,Vertigo,11,M,OT,13
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Dry mouth,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Flank pain,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Hypophysitis,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Influenza like illness,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Infusion related reaction,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Insomnia,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Metastases to retroperitoneum,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Myalgia,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Palpitations,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Pneumothorax,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Radiation skin injury,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Respiratory tract procedural complication,1,F,OT,83
1423942217,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Alanine aminotransferase increased,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Aspartate aminotransferase increased,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Diarrhoea,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Dry mouth,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Fatigue,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Flank pain,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Hypophysitis,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Influenza like illness,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Infusion related reaction,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Insomnia,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Metastases to retroperitoneum,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Myalgia,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Palpitations,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Pneumothorax,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Radiation skin injury,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Respiratory tract procedural complication,6,F,OT,83
1423942217,6,Malignant melanoma,17,F,EXP,ipilimumab,6,SS,Vomiting,6,F,OT,83
142404242,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,42
142404242,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,42
142404242,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,OT,42
142404242,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,HO,42
142442245,1,Plasma cell myeloma,5,F,EXP,daratumumab,1,PS,Acute kidney injury,1,F,HO,14
142442245,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Acute kidney injury,3,F,HO,14
142449184,2,Hepatocellular carcinoma,4,F,EXP,nivolumab,2,PS,Stress cardiomyopathy,2,F,HO,51
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Back pain,1,F,DE,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Back pain,1,F,HO,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Back pain,1,F,OT,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Chest pain,1,F,DE,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Chest pain,1,F,HO,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Chest pain,1,F,OT,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Cholestasis,1,F,DE,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Cholestasis,1,F,HO,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Cholestasis,1,F,OT,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Cough,1,F,DE,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Cough,1,F,HO,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Cough,1,F,OT,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Gastrointestinal disorder,1,F,DE,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Gastrointestinal disorder,1,F,HO,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Gastrointestinal disorder,1,F,OT,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Headache,1,F,DE,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Headache,1,F,HO,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Headache,1,F,OT,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Neck pain,1,F,DE,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Neck pain,1,F,HO,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Neck pain,1,F,OT,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pain,1,F,DE,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pain,1,F,HO,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pain,1,F,OT,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Vomiting,1,F,DE,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,1
1424909911,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,1
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Acute disseminated encephalomyelitis,1,M,HO,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Acute disseminated encephalomyelitis,1,M,OT,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Aspergillus infection,1,M,HO,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Aspergillus infection,1,M,OT,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Blood lactate dehydrogenase increased,1,M,HO,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Blood lactate dehydrogenase increased,1,M,OT,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Bronchitis,1,M,HO,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Bronchitis,1,M,OT,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Depression,1,M,HO,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Depression,1,M,OT,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Eosinophil count increased,1,M,HO,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Eosinophil count increased,1,M,OT,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Herpes zoster,1,M,HO,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Herpes zoster,1,M,OT,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Hyperphosphatasaemia,1,M,HO,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Hyperphosphatasaemia,1,M,OT,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Hyperuricaemia,1,M,HO,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Hyperuricaemia,1,M,OT,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Hypoalbuminaemia,1,M,HO,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Hypoalbuminaemia,1,M,OT,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Lower gastrointestinal haemorrhage,1,M,HO,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Lower gastrointestinal haemorrhage,1,M,OT,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Pneumonia,1,M,HO,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Pneumonia,1,M,OT,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Renal impairment,1,M,HO,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Renal impairment,1,M,OT,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Staphylococcal infection,1,M,HO,70
142625857,1,Immune thrombocytopenic purpura,7,F,PER,romiplostim,1,PS,Staphylococcal infection,1,M,OT,70
142654017,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,F,DS,160
142654017,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,F,OT,160
142654017,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,F,HO,160
142654017,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Thrombophlebitis,1,F,DS,160
142654017,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Thrombophlebitis,1,F,OT,160
142654017,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Thrombophlebitis,1,F,HO,160
142654017,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,F,DS,160
142654017,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,F,OT,160
142654017,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,F,HO,160
143062586,1,Malignant melanoma,6,F,PER,talimogene laherparepvec,1,PS,Nervous system disorder,1,F,HO,298
143062586,1,Malignant melanoma,6,F,PER,talimogene laherparepvec,1,PS,Pulmonary embolism,1,F,HO,298
143070054,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Cellulitis,2,M,OT,41
143070054,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Cellulitis,2,M,HO,41
143070054,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Lower respiratory tract infection,2,M,OT,41
143070054,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Lower respiratory tract infection,2,M,HO,41
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Acute respiratory failure,1,M,HO,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Acute respiratory failure,1,M,OT,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Acute respiratory failure,1,M,DE,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Adenocarcinoma of colon,1,M,HO,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Adenocarcinoma of colon,1,M,OT,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Adenocarcinoma of colon,1,M,DE,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Bronchitis,1,M,HO,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Bronchitis,1,M,OT,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Bronchitis,1,M,DE,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Haemoptysis,1,M,HO,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Haemoptysis,1,M,OT,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Haemoptysis,1,M,DE,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Lower respiratory tract congestion,1,M,HO,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Lower respiratory tract congestion,1,M,OT,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Lower respiratory tract congestion,1,M,DE,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Off label use,1,M,HO,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Off label use,1,M,DE,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Prescribed underdose,1,M,HO,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Prescribed underdose,1,M,OT,164
143101397,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Prescribed underdose,1,M,DE,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Acute respiratory failure,2,M,HO,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Acute respiratory failure,2,M,OT,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Acute respiratory failure,2,M,DE,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Adenocarcinoma of colon,2,M,HO,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Adenocarcinoma of colon,2,M,OT,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Adenocarcinoma of colon,2,M,DE,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Bronchitis,2,M,HO,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Bronchitis,2,M,OT,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Bronchitis,2,M,DE,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,HO,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,OT,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,DE,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Haemoptysis,2,M,HO,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Haemoptysis,2,M,OT,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Haemoptysis,2,M,DE,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Lower respiratory tract congestion,2,M,HO,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Lower respiratory tract congestion,2,M,OT,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Lower respiratory tract congestion,2,M,DE,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,HO,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,DE,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Off label use,2,M,HO,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Off label use,2,M,OT,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Off label use,2,M,DE,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Prescribed underdose,2,M,HO,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Prescribed underdose,2,M,OT,164
143101397,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Prescribed underdose,2,M,DE,164
143122208,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,14
143122208,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,14
143122208,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Colitis,1,M,DE,14
143122208,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,14
143122208,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,14
143122208,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,14
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Acute kidney injury,4,F,OT,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Acute kidney injury,4,F,HO,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Acute kidney injury,4,F,LT,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Anaemia,4,F,OT,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Anaemia,4,F,HO,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Anaemia,4,F,LT,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Hyperkalaemia,4,F,OT,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Hyperkalaemia,4,F,HO,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Hyperkalaemia,4,F,LT,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Neutropenia,4,F,OT,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Neutropenia,4,F,HO,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Neutropenia,4,F,LT,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Neutropenic sepsis,4,F,OT,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Neutropenic sepsis,4,F,HO,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Neutropenic sepsis,4,F,LT,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Urinary tract infection,4,F,OT,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Urinary tract infection,4,F,HO,16
1431432913,4,Plasma cell myeloma,13,F,EXP,pomalidomide,4,SS,Urinary tract infection,4,F,LT,16
143195188,1,Relapsing multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Alopecia,1,F,OT,3
143195188,1,Relapsing multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Dizziness,1,F,OT,3
143195188,1,Relapsing multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Dysaesthesia,1,F,OT,3
143195188,1,Relapsing multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Gait disturbance,1,F,OT,3
143195188,1,Relapsing multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Lymphopenia,1,F,OT,3
143195188,1,Relapsing multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Rash,1,F,OT,3
143213344,3,Breast cancer,4,F,EXP,goserelin acetate,3,SS,Febrile neutropenia,3,F,HO,14
143213344,3,Breast cancer,4,F,EXP,goserelin acetate,3,SS,Influenza,3,F,HO,14
143283415,4,Plasma cell myeloma,5,F,EXP,pomalidomide,4,SS,Pneumonia,4,F,OT,28
143283415,4,Plasma cell myeloma,5,F,EXP,pomalidomide,4,SS,Pneumonia,4,F,HO,28
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Confusional state,6,M,OT,7
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Confusional state,6,M,HO,7
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Confusional state,6,M,DE,7
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Lower respiratory tract infection,6,M,OT,7
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Lower respiratory tract infection,6,M,HO,7
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Lower respiratory tract infection,6,M,DE,7
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Mobility decreased,6,M,OT,7
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Mobility decreased,6,M,HO,7
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Mobility decreased,6,M,DE,7
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Plasma cell myeloma,6,M,OT,7
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Plasma cell myeloma,6,M,HO,7
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Plasma cell myeloma,6,M,DE,7
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Pulmonary oedema,6,M,OT,7
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Pulmonary oedema,6,M,HO,7
1432910612,6,Plasma cell myeloma,12,F,EXP,pomalidomide,6,SS,Pulmonary oedema,6,M,DE,7
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Abdominal pain,7,F,OT,314
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Abdominal pain,7,F,DE,314
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Abdominal pain,7,F,HO,314
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Constipation,7,F,OT,314
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Constipation,7,F,DE,314
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Constipation,7,F,HO,314
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Intracranial pressure increased,7,F,OT,314
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Intracranial pressure increased,7,F,DE,314
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Intracranial pressure increased,7,F,HO,314
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Malignant neoplasm progression,7,F,OT,314
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Malignant neoplasm progression,7,F,DE,314
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Malignant neoplasm progression,7,F,HO,314
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Metastatic malignant melanoma,7,F,OT,314
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Metastatic malignant melanoma,7,F,DE,314
143320699,7,Metastatic malignant melanoma,9,F,EXP,trametinib,7,SS,Metastatic malignant melanoma,7,F,HO,314
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Analgesic therapy,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Analgesic therapy,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Analgesic therapy,3,M,OT,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Anxiety,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Anxiety,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Anxiety,3,M,OT,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Asthenia,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Asthenia,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Asthenia,3,M,OT,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Confusional state,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Confusional state,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Confusional state,3,M,OT,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,General physical health deterioration,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,General physical health deterioration,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,General physical health deterioration,3,M,OT,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Insomnia,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Insomnia,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Insomnia,3,M,OT,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Lung disorder,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Lung disorder,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Lung disorder,3,M,OT,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Neoplasm progression,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Neoplasm progression,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Neoplasm progression,3,M,OT,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Neuralgia,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Neuralgia,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Neuralgia,3,M,OT,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Off label use,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Off label use,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Off label use,3,M,OT,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Oral candidiasis,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Oral candidiasis,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Oral candidiasis,3,M,OT,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Pain,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Pain,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Pain,3,M,OT,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Pleural effusion,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Pleural effusion,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Pleural effusion,3,M,OT,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Pleural infection,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Pleural infection,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Pleural infection,3,M,OT,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Respiratory disorder,3,M,DE,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Respiratory disorder,3,M,HO,28
143476896,3,Lung neoplasm malignant,6,F,EXP,nivolumab,3,SS,Respiratory disorder,3,M,OT,28
143503714,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,SS,Multiple organ dysfunction syndrome,1,M,HO,17
143503714,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,SS,Multiple organ dysfunction syndrome,1,M,DE,17
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,OT,283
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,HO,283
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,LT,283
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Cardiac failure,1,M,OT,283
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Cardiac failure,1,M,HO,283
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Cardiac failure,1,M,LT,283
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Myocardial infarction,1,M,OT,283
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Myocardial infarction,1,M,HO,283
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Myocardial infarction,1,M,LT,283
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,OT,283
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,HO,283
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,LT,283
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Tachycardia,1,M,OT,283
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Tachycardia,1,M,HO,283
1435104910,1,Lung neoplasm malignant,10,F,EXP,nivolumab,1,PS,Tachycardia,1,M,LT,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Atrial fibrillation,3,M,OT,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Atrial fibrillation,3,M,HO,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Atrial fibrillation,3,M,LT,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Cardiac failure,3,M,OT,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Cardiac failure,3,M,HO,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Cardiac failure,3,M,LT,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Myocardial infarction,3,M,OT,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Myocardial infarction,3,M,HO,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Myocardial infarction,3,M,LT,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Oedema peripheral,3,M,OT,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Oedema peripheral,3,M,HO,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Oedema peripheral,3,M,LT,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Tachycardia,3,M,OT,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Tachycardia,3,M,HO,283
1435104910,3,Product used for unknown indication,10,F,EXP,nivolumab,3,SS,Tachycardia,3,M,LT,283
143558356,5,Plasma cell myeloma,6,F,EXP,pomalidomide,5,SS,Adrenal insufficiency,5,M,OT,118
143558356,5,Plasma cell myeloma,6,F,EXP,pomalidomide,5,SS,Adrenal insufficiency,5,M,HO,118
143558356,5,Plasma cell myeloma,6,F,EXP,pomalidomide,5,SS,Dehydration,5,M,OT,118
143558356,5,Plasma cell myeloma,6,F,EXP,pomalidomide,5,SS,Dehydration,5,M,HO,118
143558356,5,Plasma cell myeloma,6,F,EXP,pomalidomide,5,SS,Diabetes mellitus,5,M,OT,118
143558356,5,Plasma cell myeloma,6,F,EXP,pomalidomide,5,SS,Diabetes mellitus,5,M,HO,118
143558356,5,Plasma cell myeloma,6,F,EXP,pomalidomide,5,SS,Neutropenia,5,M,OT,118
143558356,5,Plasma cell myeloma,6,F,EXP,pomalidomide,5,SS,Neutropenia,5,M,HO,118
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Ataxia,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Ataxia,1,F,HO,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Cough,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Cough,1,F,HO,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Cystitis,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Cystitis,1,F,HO,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,HO,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Depression,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Depression,1,F,HO,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Electrolyte depletion,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Electrolyte depletion,1,F,HO,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,F,HO,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Immune-mediated hepatitis,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Immune-mediated hepatitis,1,F,HO,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,HO,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Pyrexia,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Weight decreased,1,F,OT,8
1436356312,1,Metastatic malignant melanoma,12,F,EXP,nivolumab,1,PS,Weight decreased,1,F,HO,8
143648822,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Pneumonia,2,M,HO,635
143648822,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Respiratory tract infection,2,M,HO,635
1436590810,9,Plasma cell myeloma,10,F,EXP,pomalidomide,9,SS,Anaemia,9,F,OT,12
1436590810,9,Plasma cell myeloma,10,F,EXP,pomalidomide,9,SS,Anaemia,9,F,HO,12
1436590810,9,Plasma cell myeloma,10,F,EXP,pomalidomide,9,SS,Leukopenia,9,F,OT,12
1436590810,9,Plasma cell myeloma,10,F,EXP,pomalidomide,9,SS,Leukopenia,9,F,HO,12
1436590810,9,Plasma cell myeloma,10,F,EXP,pomalidomide,9,SS,Lower respiratory tract infection,9,F,OT,12
1436590810,9,Plasma cell myeloma,10,F,EXP,pomalidomide,9,SS,Lower respiratory tract infection,9,F,HO,12
1436590810,9,Plasma cell myeloma,10,F,EXP,pomalidomide,9,SS,Neutropenia,9,F,OT,12
1436590810,9,Plasma cell myeloma,10,F,EXP,pomalidomide,9,SS,Neutropenia,9,F,HO,12
143665719,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Bronchitis,1,F,DE,9
143665719,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Bronchitis,1,F,OT,9
143665719,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Constipation,1,F,DE,9
143665719,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Constipation,1,F,OT,9
143665719,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Hepatitis A,1,F,DE,9
143665719,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Hepatitis A,1,F,OT,9
143665719,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,9
143665719,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,9
143665719,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Nausea,1,F,DE,9
143665719,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,9
143665719,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Off label use,1,F,DE,9
143665719,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Off label use,1,F,OT,9
143665719,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,DE,9
143665719,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,OT,9
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Anaemia,7,M,OT,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Anaemia,7,M,HO,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Confusional state,7,M,OT,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Confusional state,7,M,HO,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Decreased appetite,7,M,OT,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Decreased appetite,7,M,HO,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Hypercalcaemia,7,M,OT,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Hypercalcaemia,7,M,HO,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Hyperuricaemia,7,M,OT,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Hyperuricaemia,7,M,HO,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Lethargy,7,M,OT,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Lethargy,7,M,HO,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Lower respiratory tract infection,7,M,OT,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Lower respiratory tract infection,7,M,HO,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Neutropenia,7,M,OT,4
143776555,7,Plasma cell myeloma,5,F,EXP,pomalidomide,7,SS,Neutropenia,7,M,HO,4
1438123617,1,Relapsing multiple sclerosis,17,F,EXP,alemtuzumab,1,PS,Autoimmune haemolytic anaemia,1,F,HO,1
1438123617,1,Relapsing multiple sclerosis,17,F,EXP,alemtuzumab,1,PS,Basedow's disease,1,F,HO,1
1438123617,1,Relapsing multiple sclerosis,17,F,EXP,alemtuzumab,1,PS,Blood folate decreased,1,F,HO,1
1438123617,1,Relapsing multiple sclerosis,17,F,EXP,alemtuzumab,1,PS,Eczema,1,F,HO,1
1438123617,1,Relapsing multiple sclerosis,17,F,EXP,alemtuzumab,1,PS,Headache,1,F,HO,1
1438123617,1,Relapsing multiple sclerosis,17,F,EXP,alemtuzumab,1,PS,Limb injury,1,F,HO,1
1438123617,1,Relapsing multiple sclerosis,17,F,EXP,alemtuzumab,1,PS,Lymphopenia,1,F,HO,1
1438123617,1,Relapsing multiple sclerosis,17,F,EXP,alemtuzumab,1,PS,Menstruation delayed,1,F,HO,1
1438123617,1,Relapsing multiple sclerosis,17,F,EXP,alemtuzumab,1,PS,Menstruation irregular,1,F,HO,1
1438123617,1,Relapsing multiple sclerosis,17,F,EXP,alemtuzumab,1,PS,Nasopharyngitis,1,F,HO,1
1438123617,1,Relapsing multiple sclerosis,17,F,EXP,alemtuzumab,1,PS,Oedema peripheral,1,F,HO,1
143834908,1,Osteogenesis imperfecta,8,F,PER,denosumab,1,PS,Femur fracture,1,F,DS,12
143834908,1,Osteogenesis imperfecta,8,F,PER,denosumab,1,PS,Femur fracture,1,F,HO,12
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Asthenia,1,M,DE,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Bronchitis,1,M,HO,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Bronchitis,1,M,OT,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Bronchitis,1,M,DE,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Infection,1,M,HO,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Infection,1,M,OT,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Infection,1,M,DE,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Lymphadenopathy,1,M,HO,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Lymphadenopathy,1,M,OT,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Lymphadenopathy,1,M,DE,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Myalgia,1,M,HO,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Myalgia,1,M,OT,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Myalgia,1,M,DE,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Prescribed underdose,1,M,HO,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Prescribed underdose,1,M,OT,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Prescribed underdose,1,M,DE,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Productive cough,1,M,HO,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Productive cough,1,M,OT,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Productive cough,1,M,DE,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Pyrexia,1,M,DE,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Vocal cord paralysis,1,M,HO,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Vocal cord paralysis,1,M,OT,263
1439126512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Vocal cord paralysis,1,M,DE,263
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Asthenia,2,M,HO,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Asthenia,2,M,OT,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Asthenia,2,M,DE,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Bronchitis,2,M,HO,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Bronchitis,2,M,OT,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Bronchitis,2,M,DE,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,HO,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,OT,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,DE,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Infection,2,M,HO,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Infection,2,M,OT,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Infection,2,M,DE,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Lymphadenopathy,2,M,HO,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Lymphadenopathy,2,M,OT,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Lymphadenopathy,2,M,DE,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,HO,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,DE,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Myalgia,2,M,HO,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Myalgia,2,M,OT,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Myalgia,2,M,DE,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Prescribed underdose,2,M,HO,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Prescribed underdose,2,M,OT,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Prescribed underdose,2,M,DE,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Productive cough,2,M,HO,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Productive cough,2,M,OT,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Productive cough,2,M,DE,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Pyrexia,2,M,HO,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Pyrexia,2,M,OT,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Pyrexia,2,M,DE,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Vocal cord paralysis,2,M,HO,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Vocal cord paralysis,2,M,OT,157
1439126512,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Vocal cord paralysis,2,M,DE,157
144004394,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Polyneuropathy,1,F,OT,28
144004394,4,Plasma cell myeloma,4,F,PER,lenalidomide,4,SS,Polyneuropathy,4,F,OT,28
144024254,1,Plasma cell myeloma,4,F,EXP,daratumumab,1,PS,Alanine aminotransferase increased,1,F,HO,6
144024254,3,Plasma cell myeloma,4,F,EXP,carfilzomib,3,SS,Alanine aminotransferase increased,3,F,HO,6
1440358312,1,Plasma cell myeloma,12,F,EXP,daratumumab,1,PS,Acute kidney injury,1,F,HO,57
1440358312,1,Plasma cell myeloma,12,F,EXP,daratumumab,1,PS,Anaemia,1,F,HO,57
1440358312,2,Plasma cell myeloma,12,F,EXP,carfilzomib,2,SS,Acute kidney injury,2,F,HO,57
1440358312,2,Plasma cell myeloma,12,F,EXP,carfilzomib,2,SS,Anaemia,2,F,HO,57
1440358312,6,Product used for unknown indication,12,F,EXP,darbepoetin alfa,6,C,Acute kidney injury,6,F,HO,37
1440358312,6,Product used for unknown indication,12,F,EXP,darbepoetin alfa,6,C,Anaemia,6,F,HO,37
1440358312,11,Product used for unknown indication,12,F,EXP,zoledronic acid,11,C,Acute kidney injury,11,F,HO,57
1440358312,11,Product used for unknown indication,12,F,EXP,zoledronic acid,11,C,Anaemia,11,F,HO,57
1440358312,17,Product used for unknown indication,12,F,EXP,rasburicase,17,C,Acute kidney injury,17,F,HO,13
1440358312,17,Product used for unknown indication,12,F,EXP,rasburicase,17,C,Anaemia,17,F,HO,13
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Affective disorder,1,F,HO,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Affective disorder,1,F,OT,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Affective disorder,1,F,DE,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Cough,1,F,HO,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Cough,1,F,OT,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Cough,1,F,DE,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Cystitis,1,F,HO,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Cystitis,1,F,OT,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Cystitis,1,F,DE,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Depression,1,F,HO,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Depression,1,F,OT,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Depression,1,F,DE,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,DE,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Dyspnoea exertional,1,F,HO,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Dyspnoea exertional,1,F,OT,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Dyspnoea exertional,1,F,DE,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,OT,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,DE,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Micturition disorder,1,F,HO,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Micturition disorder,1,F,OT,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Micturition disorder,1,F,DE,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Nausea,1,F,DE,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Pelvic venous thrombosis,1,F,HO,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Pelvic venous thrombosis,1,F,OT,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Pelvic venous thrombosis,1,F,DE,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Polyneuropathy,1,F,HO,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Polyneuropathy,1,F,OT,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Polyneuropathy,1,F,DE,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,HO,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,OT,126
1440538614,1,Non-small cell lung cancer,14,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,DE,126
144067716,2,Plasma cell myeloma,6,F,EXP,pomalidomide,2,SS,Rectosigmoid cancer metastatic,2,F,LT,133
144067716,2,Plasma cell myeloma,6,F,EXP,pomalidomide,2,SS,Rectosigmoid cancer metastatic,2,F,OT,133
144067716,2,Plasma cell myeloma,6,F,EXP,pomalidomide,2,SS,Rectosigmoid cancer metastatic,2,F,DE,133
144116115,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Squamous cell carcinoma of skin,3,M,OT,384
144234664,7,Plasma cell myeloma recurrent,4,F,EXP,pomalidomide,7,SS,Anaemia,7,M,HO,14
144234664,7,Plasma cell myeloma recurrent,4,F,EXP,pomalidomide,7,SS,Atrial fibrillation,7,M,HO,14
144234664,7,Plasma cell myeloma recurrent,4,F,EXP,pomalidomide,7,SS,Pneumonia,7,M,HO,14
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Chest pain,1,M,OT,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Chest pain,1,M,HO,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Lung disorder,1,M,OT,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Lung disorder,1,M,HO,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pruritus,1,M,OT,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pruritus,1,M,HO,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Psoriasis,1,M,OT,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Psoriasis,1,M,HO,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Respiratory distress,1,M,OT,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Respiratory distress,1,M,HO,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Superior vena cava syndrome,1,M,OT,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Superior vena cava syndrome,1,M,HO,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Vena cava thrombosis,1,M,OT,173
1443163511,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Vena cava thrombosis,1,M,HO,173
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Asthenia,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Chest pain,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Chest pain,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Chest pain,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Cough,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Cough,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Cough,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dysphagia,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dysphagia,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dysphagia,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dysphonia,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dysphonia,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dysphonia,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Musculoskeletal pain,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Musculoskeletal pain,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Musculoskeletal pain,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Neck pain,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Neck pain,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Neck pain,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Oedema,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Oedema,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Oedema,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Productive cough,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Productive cough,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Productive cough,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Skin lesion,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Skin lesion,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Skin lesion,1,M,HO,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Weight decreased,1,M,DE,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,11
144318729,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Weight decreased,1,M,HO,11
144322113,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Deafness,1,M,OT,936
144322113,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Intentional product use issue,1,M,OT,936
144322113,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Visual impairment,1,M,OT,936
144445864,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Haemophilus infection,1,M,HO,5
144445864,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Haemophilus infection,1,M,OT,5
144445864,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Motor dysfunction,1,M,HO,5
144445864,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Motor dysfunction,1,M,OT,5
144445864,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Peroneal nerve palsy,1,M,HO,5
144445864,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Peroneal nerve palsy,1,M,OT,5
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Acidosis,1,F,HO,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Acidosis,1,F,OT,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Acidosis,1,F,DE,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,F,HO,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,F,OT,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,F,DE,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,F,HO,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,F,OT,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,F,DE,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,F,HO,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,F,OT,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,F,DE,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,F,HO,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,F,OT,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,F,DE,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Hepatic failure,1,F,HO,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Hepatic failure,1,F,OT,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Hepatic failure,1,F,DE,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,F,HO,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,F,OT,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,F,DE,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Platelet count decreased,1,F,HO,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Platelet count decreased,1,F,OT,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Platelet count decreased,1,F,DE,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,F,HO,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,F,OT,154
144488223,1,Ovarian granulosa cell tumour,3,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,F,DE,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Acidosis,2,F,HO,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Acidosis,2,F,OT,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Acidosis,2,F,DE,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Acute respiratory distress syndrome,2,F,HO,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Acute respiratory distress syndrome,2,F,OT,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Acute respiratory distress syndrome,2,F,DE,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Alanine aminotransferase increased,2,F,HO,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Alanine aminotransferase increased,2,F,OT,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Alanine aminotransferase increased,2,F,DE,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Aspartate aminotransferase increased,2,F,HO,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Aspartate aminotransferase increased,2,F,OT,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Aspartate aminotransferase increased,2,F,DE,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Deep vein thrombosis,2,F,HO,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Deep vein thrombosis,2,F,OT,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Deep vein thrombosis,2,F,DE,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Hepatic failure,2,F,HO,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Hepatic failure,2,F,OT,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Hepatic failure,2,F,DE,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,F,HO,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,F,OT,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,F,DE,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Platelet count decreased,2,F,HO,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Platelet count decreased,2,F,OT,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Platelet count decreased,2,F,DE,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Pulmonary embolism,2,F,HO,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Pulmonary embolism,2,F,OT,154
144488223,2,Ovarian granulosa cell tumour,3,F,EXP,ipilimumab,2,SS,Pulmonary embolism,2,F,DE,154
144495428,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Colitis,1,F,HO,5
144495428,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Colitis,1,F,OT,5
144495428,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Groin abscess,1,F,HO,5
144495428,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Groin abscess,1,F,OT,5
144495428,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,HO,5
144495428,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,OT,5
144495428,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,5
144495428,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,5
144495428,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,F,HO,5
144495428,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,F,OT,5
144500167,1,Acute lymphocytic leukaemia,7,F,PER,blinatumomab,1,PS,Hypoacusis,1,F,DS,4
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,DE,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,HO,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,LT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,OT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Back pain,1,M,DE,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Back pain,1,M,HO,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Back pain,1,M,LT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Back pain,1,M,OT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Embolism,1,M,DE,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Embolism,1,M,HO,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Embolism,1,M,LT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Embolism,1,M,OT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Generalised tonic-clonic seizure,1,M,DE,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Generalised tonic-clonic seizure,1,M,HO,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Generalised tonic-clonic seizure,1,M,LT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Generalised tonic-clonic seizure,1,M,OT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Haemorrhage intracranial,1,M,DE,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Haemorrhage intracranial,1,M,HO,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Haemorrhage intracranial,1,M,LT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Haemorrhage intracranial,1,M,OT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Metastases to central nervous system,1,M,DE,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Metastases to central nervous system,1,M,HO,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Metastases to central nervous system,1,M,LT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Metastases to central nervous system,1,M,OT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Nausea,1,M,DE,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Nausea,1,M,LT,31
1445705812,1,Malignant melanoma,12,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,31
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Atrial fibrillation,2,M,DE,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Atrial fibrillation,2,M,HO,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Atrial fibrillation,2,M,LT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Atrial fibrillation,2,M,OT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Back pain,2,M,DE,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Back pain,2,M,HO,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Back pain,2,M,LT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Back pain,2,M,OT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Embolism,2,M,DE,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Embolism,2,M,HO,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Embolism,2,M,LT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Embolism,2,M,OT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Generalised tonic-clonic seizure,2,M,DE,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Generalised tonic-clonic seizure,2,M,HO,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Generalised tonic-clonic seizure,2,M,LT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Generalised tonic-clonic seizure,2,M,OT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Haemorrhage intracranial,2,M,DE,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Haemorrhage intracranial,2,M,HO,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Haemorrhage intracranial,2,M,LT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Haemorrhage intracranial,2,M,OT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,DE,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,HO,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,LT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Metastases to central nervous system,2,M,DE,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Metastases to central nervous system,2,M,HO,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Metastases to central nervous system,2,M,LT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Metastases to central nervous system,2,M,OT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Nausea,2,M,DE,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Nausea,2,M,HO,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Nausea,2,M,LT,10
1445705812,2,Product used for unknown indication,12,F,EXP,nivolumab,2,SS,Nausea,2,M,OT,10
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Atrial fibrillation,5,M,DE,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Atrial fibrillation,5,M,HO,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Atrial fibrillation,5,M,LT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Atrial fibrillation,5,M,OT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Back pain,5,M,DE,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Back pain,5,M,HO,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Back pain,5,M,LT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Back pain,5,M,OT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Embolism,5,M,DE,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Embolism,5,M,HO,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Embolism,5,M,LT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Embolism,5,M,OT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Generalised tonic-clonic seizure,5,M,DE,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Generalised tonic-clonic seizure,5,M,HO,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Generalised tonic-clonic seizure,5,M,LT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Generalised tonic-clonic seizure,5,M,OT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Haemorrhage intracranial,5,M,DE,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Haemorrhage intracranial,5,M,HO,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Haemorrhage intracranial,5,M,LT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Haemorrhage intracranial,5,M,OT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Malignant neoplasm progression,5,M,DE,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Malignant neoplasm progression,5,M,HO,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Malignant neoplasm progression,5,M,LT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Malignant neoplasm progression,5,M,OT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Metastases to central nervous system,5,M,DE,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Metastases to central nervous system,5,M,HO,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Metastases to central nervous system,5,M,LT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Metastases to central nervous system,5,M,OT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Nausea,5,M,DE,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Nausea,5,M,HO,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Nausea,5,M,LT,31
1445705812,5,Malignant melanoma,12,F,EXP,ipilimumab,5,SS,Nausea,5,M,OT,31
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Atrial fibrillation,6,M,DE,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Atrial fibrillation,6,M,HO,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Atrial fibrillation,6,M,LT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Atrial fibrillation,6,M,OT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Back pain,6,M,DE,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Back pain,6,M,HO,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Back pain,6,M,LT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Back pain,6,M,OT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Embolism,6,M,DE,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Embolism,6,M,HO,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Embolism,6,M,LT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Embolism,6,M,OT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Generalised tonic-clonic seizure,6,M,DE,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Generalised tonic-clonic seizure,6,M,HO,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Generalised tonic-clonic seizure,6,M,LT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Generalised tonic-clonic seizure,6,M,OT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Haemorrhage intracranial,6,M,DE,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Haemorrhage intracranial,6,M,HO,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Haemorrhage intracranial,6,M,LT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Haemorrhage intracranial,6,M,OT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,M,DE,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,M,HO,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,M,LT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,M,OT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Metastases to central nervous system,6,M,DE,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Metastases to central nervous system,6,M,HO,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Metastases to central nervous system,6,M,LT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Metastases to central nervous system,6,M,OT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Nausea,6,M,DE,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Nausea,6,M,HO,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Nausea,6,M,LT,10
1445705812,6,Product used for unknown indication,12,F,EXP,ipilimumab,6,SS,Nausea,6,M,OT,10
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Gastrointestinal ulcer,1,F,OT,49
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Gastrointestinal ulcer,1,F,DE,49
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Gastrointestinal ulcer,1,F,HO,49
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,OT,49
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,DE,49
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,HO,49
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,49
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,49
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,49
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Melaena,1,F,OT,49
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Melaena,1,F,DE,49
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Melaena,1,F,HO,49
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Neutropenia,1,F,OT,49
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Neutropenia,1,F,DE,49
1446835113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Neutropenia,1,F,HO,49
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Back pain,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Back pain,1,M,OT,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Dental caries,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Dental caries,1,M,OT,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Gastrointestinal disorder,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Gastrointestinal disorder,1,M,OT,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Jugular vein thrombosis,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Jugular vein thrombosis,1,M,OT,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Musculoskeletal pain,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Musculoskeletal pain,1,M,OT,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Nasopharyngitis,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Nasopharyngitis,1,M,OT,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Oesophageal obstruction,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Oesophageal obstruction,1,M,OT,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Oesophagitis ulcerative,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Oesophagitis ulcerative,1,M,OT,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Off label use,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Rash,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Rash,1,M,OT,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Spinal compression fracture,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Spinal compression fracture,1,M,OT,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Tooth fracture,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Tooth fracture,1,M,OT,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Tooth loss,1,M,HO,1
1447240113,1,Lung neoplasm malignant,13,F,EXP,nivolumab,1,PS,Tooth loss,1,M,OT,1
144724145,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pericardial effusion,1,M,DE,165
144724145,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pericardial effusion,1,M,OT,165
144724145,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,DE,165
144724145,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,OT,165
144752784,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Confusional state,1,M,HO,7
144752784,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Confusional state,1,M,DE,7
144752784,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Confusional state,1,M,OT,7
144752784,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Lower respiratory tract infection,1,M,HO,7
144752784,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Lower respiratory tract infection,1,M,DE,7
144752784,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Lower respiratory tract infection,1,M,OT,7
144752784,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Mobility decreased,1,M,HO,7
144752784,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Mobility decreased,1,M,DE,7
144752784,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Mobility decreased,1,M,OT,7
144752784,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Pulmonary oedema,1,M,HO,7
144752784,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Pulmonary oedema,1,M,DE,7
144752784,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Pulmonary oedema,1,M,OT,7
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Abdominal pain,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Abdominal pain,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Blood uric acid decreased,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Blood uric acid decreased,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Constipation,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Constipation,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Dehydration,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Dehydration,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Fatigue,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Gastrooesophageal reflux disease,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Gastrooesophageal reflux disease,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Haemorrhoids,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Haemorrhoids,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Headache,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Headache,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Hypoglycaemia,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Hypoglycaemia,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Hypophysitis,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Hypophysitis,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Hypotension,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Hypotension,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Impaired gastric emptying,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Impaired gastric emptying,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Insomnia,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Insomnia,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Rash,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Rash,1,F,OT,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Vitamin D decreased,1,F,HO,18
1448295031,1,Malignant melanoma,31,F,EXP,nivolumab,1,PS,Vitamin D decreased,1,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Abdominal pain,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Abdominal pain,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Blood uric acid decreased,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Blood uric acid decreased,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Constipation,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Constipation,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Dehydration,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Dehydration,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Fatigue,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Fatigue,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Gastrooesophageal reflux disease,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Gastrooesophageal reflux disease,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Haemorrhoids,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Haemorrhoids,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Headache,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Headache,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Hyperglycaemia,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Hyperglycaemia,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Hypoglycaemia,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Hypoglycaemia,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Hypokalaemia,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Hypokalaemia,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Hyponatraemia,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Hyponatraemia,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Hypophysitis,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Hypophysitis,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Hypotension,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Hypotension,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Hypothyroidism,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Hypothyroidism,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Impaired gastric emptying,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Impaired gastric emptying,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Insomnia,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Insomnia,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Nausea,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Nausea,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Pain in extremity,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Pain in extremity,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Rash,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Rash,3,F,OT,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Vitamin D decreased,3,F,HO,18
1448295031,3,Malignant melanoma,31,F,EXP,ipilimumab,3,SS,Vitamin D decreased,3,F,OT,18
144853635,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Anaemia,3,M,LT,42
144853635,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Anaemia,3,M,OT,42
144853635,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Anaemia,3,M,HO,42
144853635,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Anaemia,3,M,DE,42
144853635,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Pneumonia,3,M,LT,42
144853635,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Pneumonia,3,M,OT,42
144853635,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Pneumonia,3,M,HO,42
144853635,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Pneumonia,3,M,DE,42
144853635,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Thrombocytopenia,3,M,LT,42
144853635,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Thrombocytopenia,3,M,OT,42
144853635,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Thrombocytopenia,3,M,HO,42
144853635,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Thrombocytopenia,3,M,DE,42
144989503,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Hepatitis,1,M,LT,21
144989503,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Hepatitis,1,M,OT,21
144989503,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,LT,21
144989503,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,21
144989503,2,Small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Hepatitis,2,M,LT,21
144989503,2,Small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Hepatitis,2,M,OT,21
144989503,2,Small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Intentional product use issue,2,M,LT,21
144989503,2,Small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Intentional product use issue,2,M,OT,21
145081194,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Hyperthermia,1,F,HO,2
145081194,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Hypokalaemia,1,F,HO,2
145081194,2,Plasma cell myeloma,4,F,PER,daratumumab,2,SS,Hyperthermia,2,F,HO,2
145081194,2,Plasma cell myeloma,4,F,PER,daratumumab,2,SS,Hypokalaemia,2,F,HO,2
145084367,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,101
145084367,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,101
145084367,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,101
145084367,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,101
145084367,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Sinus tachycardia,1,M,OT,101
145084367,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Sinus tachycardia,1,M,HO,101
145266939,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Hypertensive crisis,1,M,HO,3
145266939,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Listeriosis,1,M,HO,3
145267973,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Lower respiratory tract infection,2,M,OT,240
145278923,4,Plasma cell myeloma,3,F,EXP,pomalidomide,4,SS,Adenocarcinoma of colon,4,M,HO,49
145278923,4,Plasma cell myeloma,3,F,EXP,pomalidomide,4,SS,Adenocarcinoma of colon,4,M,OT,49
145278923,4,Plasma cell myeloma,3,F,EXP,pomalidomide,4,SS,Colon cancer,4,M,HO,49
145278923,4,Plasma cell myeloma,3,F,EXP,pomalidomide,4,SS,Colon cancer,4,M,OT,49
145310892,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Ageusia,1,M,OT,1
145310892,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Chronic obstructive pulmonary disease,1,M,OT,1
145310892,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,OT,1
145310892,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Drug interaction,1,M,OT,1
145310892,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,1
145313973,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Confusional state,3,M,HO,7
145313973,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Confusional state,3,M,OT,7
145313973,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Confusional state,3,M,DE,7
145313973,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Lower respiratory tract infection,3,M,HO,7
145313973,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Lower respiratory tract infection,3,M,OT,7
145313973,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Lower respiratory tract infection,3,M,DE,7
145313973,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Mobility decreased,3,M,HO,7
145313973,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Mobility decreased,3,M,OT,7
145313973,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Mobility decreased,3,M,DE,7
145313973,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Pulmonary oedema,3,M,HO,7
145313973,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Pulmonary oedema,3,M,OT,7
145313973,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Pulmonary oedema,3,M,DE,7
145367254,1,Plasma cell myeloma,4,F,EXP,daratumumab,1,PS,Hyperthermia,1,F,HO,2
145367254,1,Plasma cell myeloma,4,F,EXP,daratumumab,1,PS,Hypokalaemia,1,F,HO,2
145367254,2,Plasma cell myeloma,4,F,EXP,carfilzomib,2,SS,Hyperthermia,2,F,HO,2
145367254,2,Plasma cell myeloma,4,F,EXP,carfilzomib,2,SS,Hypokalaemia,2,F,HO,2
145397112,6,Bronchial carcinoma,2,F,EXP,crizotinib,6,SS,Interstitial lung disease,6,M,HO,23
145397112,6,Bronchial carcinoma,2,F,EXP,crizotinib,6,SS,Interstitial lung disease,6,M,OT,23
145417013,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Lower respiratory tract infection,3,M,OT,125
145417013,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Neutropenia,3,M,OT,125
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,LT,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,HO,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,DE,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,OT,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,LT,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,HO,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,DE,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,OT,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Cholecystitis,1,M,LT,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Cholecystitis,1,M,HO,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Cholecystitis,1,M,DE,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Cholecystitis,1,M,OT,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Circulatory collapse,1,M,LT,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Circulatory collapse,1,M,HO,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Circulatory collapse,1,M,DE,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Circulatory collapse,1,M,OT,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,14
145444289,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Autoimmune hepatitis,4,M,LT,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Autoimmune hepatitis,4,M,HO,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Autoimmune hepatitis,4,M,DE,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Autoimmune hepatitis,4,M,OT,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Autoimmune thyroiditis,4,M,LT,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Autoimmune thyroiditis,4,M,HO,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Autoimmune thyroiditis,4,M,DE,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Autoimmune thyroiditis,4,M,OT,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Cholecystitis,4,M,LT,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Cholecystitis,4,M,HO,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Cholecystitis,4,M,DE,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Cholecystitis,4,M,OT,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Circulatory collapse,4,M,LT,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Circulatory collapse,4,M,HO,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Circulatory collapse,4,M,DE,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Circulatory collapse,4,M,OT,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,M,LT,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,M,HO,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,M,DE,14
145444289,4,Malignant melanoma,9,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,M,OT,14
145547304,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Neutropenia,2,M,HO,41
145547304,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Neutropenia,2,M,OT,41
145547304,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Varicella,2,M,HO,41
145547304,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Varicella,2,M,OT,41
145547447,3,Plasma cell myeloma,7,F,EXP,pomalidomide,3,SS,Confusional state,3,M,HO,4
145547447,3,Plasma cell myeloma,7,F,EXP,pomalidomide,3,SS,Lower respiratory tract infection,3,M,HO,4
145547447,3,Plasma cell myeloma,7,F,EXP,pomalidomide,3,SS,Malaise,3,M,HO,4
145547447,3,Plasma cell myeloma,7,F,EXP,pomalidomide,3,SS,Nausea,3,M,HO,4
145547447,3,Plasma cell myeloma,7,F,EXP,pomalidomide,3,SS,Sepsis,3,M,HO,4
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,LT,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,DE,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,HO,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,LT,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,OT,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,DE,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,HO,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,LT,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,OT,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,DE,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,HO,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,LT,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,DE,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,HO,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,LT,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,OT,42
145586337,1,Testicular malignant teratoma,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,DE,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,HO,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,LT,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,OT,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,DE,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Cardiac arrest,3,M,HO,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Cardiac arrest,3,M,LT,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Cardiac arrest,3,M,OT,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Cardiac arrest,3,M,DE,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Encephalopathy,3,M,HO,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Encephalopathy,3,M,LT,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Encephalopathy,3,M,OT,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Encephalopathy,3,M,DE,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Respiratory failure,3,M,HO,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Respiratory failure,3,M,LT,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Respiratory failure,3,M,OT,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Respiratory failure,3,M,DE,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Septic shock,3,M,HO,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Septic shock,3,M,LT,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Septic shock,3,M,OT,42
145586337,3,Testicular malignant teratoma,7,F,EXP,ipilimumab,3,SS,Septic shock,3,M,DE,42
145626345,1,Metastases to lung,5,F,EXP,nivolumab,1,PS,Conjunctivitis,1,M,OT,326
145626345,1,Metastases to lung,5,F,EXP,nivolumab,1,PS,Conjunctivitis,1,M,DE,326
145626345,1,Metastases to lung,5,F,EXP,nivolumab,1,PS,Conjunctivitis,1,M,HO,326
145626345,1,Metastases to lung,5,F,EXP,nivolumab,1,PS,Hypophysitis,1,M,OT,326
145626345,1,Metastases to lung,5,F,EXP,nivolumab,1,PS,Hypophysitis,1,M,DE,326
145626345,1,Metastases to lung,5,F,EXP,nivolumab,1,PS,Hypophysitis,1,M,HO,326
145626345,1,Metastases to lung,5,F,EXP,nivolumab,1,PS,Leukopenia,1,M,OT,326
145626345,1,Metastases to lung,5,F,EXP,nivolumab,1,PS,Leukopenia,1,M,DE,326
145626345,1,Metastases to lung,5,F,EXP,nivolumab,1,PS,Leukopenia,1,M,HO,326
145626345,1,Metastases to lung,5,F,EXP,nivolumab,1,PS,Lung cancer metastatic,1,M,OT,326
145626345,1,Metastases to lung,5,F,EXP,nivolumab,1,PS,Lung cancer metastatic,1,M,DE,326
145626345,1,Metastases to lung,5,F,EXP,nivolumab,1,PS,Lung cancer metastatic,1,M,HO,326
145626345,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Conjunctivitis,2,M,OT,20
145626345,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Conjunctivitis,2,M,DE,20
145626345,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Conjunctivitis,2,M,HO,20
145626345,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Hypophysitis,2,M,OT,20
145626345,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Hypophysitis,2,M,DE,20
145626345,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Hypophysitis,2,M,HO,20
145626345,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Leukopenia,2,M,OT,20
145626345,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Leukopenia,2,M,DE,20
145626345,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Leukopenia,2,M,HO,20
145626345,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Lung cancer metastatic,2,M,OT,20
145626345,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Lung cancer metastatic,2,M,DE,20
145626345,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Lung cancer metastatic,2,M,HO,20
145626345,4,Metastases to lung,5,F,EXP,ipilimumab,4,SS,Conjunctivitis,4,M,OT,20
145626345,4,Metastases to lung,5,F,EXP,ipilimumab,4,SS,Conjunctivitis,4,M,DE,20
145626345,4,Metastases to lung,5,F,EXP,ipilimumab,4,SS,Conjunctivitis,4,M,HO,20
145626345,4,Metastases to lung,5,F,EXP,ipilimumab,4,SS,Hypophysitis,4,M,OT,20
145626345,4,Metastases to lung,5,F,EXP,ipilimumab,4,SS,Hypophysitis,4,M,DE,20
145626345,4,Metastases to lung,5,F,EXP,ipilimumab,4,SS,Hypophysitis,4,M,HO,20
145626345,4,Metastases to lung,5,F,EXP,ipilimumab,4,SS,Leukopenia,4,M,OT,20
145626345,4,Metastases to lung,5,F,EXP,ipilimumab,4,SS,Leukopenia,4,M,DE,20
145626345,4,Metastases to lung,5,F,EXP,ipilimumab,4,SS,Leukopenia,4,M,HO,20
145626345,4,Metastases to lung,5,F,EXP,ipilimumab,4,SS,Lung cancer metastatic,4,M,OT,20
145626345,4,Metastases to lung,5,F,EXP,ipilimumab,4,SS,Lung cancer metastatic,4,M,DE,20
145626345,4,Metastases to lung,5,F,EXP,ipilimumab,4,SS,Lung cancer metastatic,4,M,HO,20
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Anaemia,1,F,HO,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Anaemia,1,F,OT,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Colitis,1,F,HO,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Colitis,1,F,OT,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Gastrointestinal haemorrhage,1,F,HO,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Gastrointestinal haemorrhage,1,F,OT,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,OT,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Helicobacter gastritis,1,F,HO,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Helicobacter gastritis,1,F,OT,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,HO,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,OT,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Oedema,1,F,HO,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Oedema,1,F,OT,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Off label use,1,F,HO,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Off label use,1,F,OT,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Prerenal failure,1,F,HO,52
1456444116,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Prerenal failure,1,F,OT,52
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Anaemia,2,F,HO,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Anaemia,2,F,OT,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Colitis,2,F,HO,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Colitis,2,F,OT,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Gastrointestinal haemorrhage,2,F,HO,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Gastrointestinal haemorrhage,2,F,OT,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,General physical health deterioration,2,F,HO,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,General physical health deterioration,2,F,OT,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Helicobacter gastritis,2,F,HO,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Helicobacter gastritis,2,F,OT,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Hypokalaemia,2,F,HO,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Hypokalaemia,2,F,OT,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Hyponatraemia,2,F,HO,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Hyponatraemia,2,F,OT,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Oedema,2,F,HO,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Oedema,2,F,OT,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Off label use,2,F,HO,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Off label use,2,F,OT,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Prerenal failure,2,F,HO,31
1456444116,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Prerenal failure,2,F,OT,31
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Anaemia,3,F,HO,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Anaemia,3,F,OT,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Colitis,3,F,HO,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Colitis,3,F,OT,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Gastrointestinal haemorrhage,3,F,HO,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Gastrointestinal haemorrhage,3,F,OT,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,General physical health deterioration,3,F,HO,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,General physical health deterioration,3,F,OT,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Helicobacter gastritis,3,F,HO,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Helicobacter gastritis,3,F,OT,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Hypokalaemia,3,F,HO,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Hypokalaemia,3,F,OT,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Hyponatraemia,3,F,HO,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Hyponatraemia,3,F,OT,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Oedema,3,F,HO,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Oedema,3,F,OT,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Off label use,3,F,HO,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Off label use,3,F,OT,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Prerenal failure,3,F,HO,11
1456444116,3,Product used for unknown indication,16,F,EXP,nivolumab,3,SS,Prerenal failure,3,F,OT,11
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Anaemia,5,F,HO,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Anaemia,5,F,OT,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Colitis,5,F,HO,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Colitis,5,F,OT,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Gastrointestinal haemorrhage,5,F,HO,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Gastrointestinal haemorrhage,5,F,OT,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,General physical health deterioration,5,F,HO,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,General physical health deterioration,5,F,OT,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Helicobacter gastritis,5,F,HO,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Helicobacter gastritis,5,F,OT,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Hypokalaemia,5,F,HO,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Hypokalaemia,5,F,OT,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Hyponatraemia,5,F,HO,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Hyponatraemia,5,F,OT,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Oedema,5,F,HO,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Oedema,5,F,OT,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Off label use,5,F,HO,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Off label use,5,F,OT,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Prerenal failure,5,F,HO,52
1456444116,5,Malignant melanoma,16,F,EXP,ipilimumab,5,SS,Prerenal failure,5,F,OT,52
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Anaemia,6,F,HO,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Anaemia,6,F,OT,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Colitis,6,F,HO,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Colitis,6,F,OT,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Gastrointestinal haemorrhage,6,F,HO,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Gastrointestinal haemorrhage,6,F,OT,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,General physical health deterioration,6,F,HO,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,General physical health deterioration,6,F,OT,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Helicobacter gastritis,6,F,HO,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Helicobacter gastritis,6,F,OT,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Hypokalaemia,6,F,HO,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Hypokalaemia,6,F,OT,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Hyponatraemia,6,F,HO,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Hyponatraemia,6,F,OT,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Oedema,6,F,HO,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Oedema,6,F,OT,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Off label use,6,F,HO,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Off label use,6,F,OT,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Prerenal failure,6,F,HO,31
1456444116,6,Product used for unknown indication,16,F,EXP,ipilimumab,6,SS,Prerenal failure,6,F,OT,31
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Anaemia,7,F,HO,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Anaemia,7,F,OT,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Colitis,7,F,HO,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Colitis,7,F,OT,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Gastrointestinal haemorrhage,7,F,HO,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Gastrointestinal haemorrhage,7,F,OT,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,General physical health deterioration,7,F,HO,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,General physical health deterioration,7,F,OT,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Helicobacter gastritis,7,F,HO,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Helicobacter gastritis,7,F,OT,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Hypokalaemia,7,F,HO,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Hypokalaemia,7,F,OT,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Hyponatraemia,7,F,HO,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Hyponatraemia,7,F,OT,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Oedema,7,F,HO,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Oedema,7,F,OT,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Off label use,7,F,HO,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Off label use,7,F,OT,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Prerenal failure,7,F,HO,11
1456444116,7,Product used for unknown indication,16,F,EXP,ipilimumab,7,SS,Prerenal failure,7,F,OT,11
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Acne,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Acne,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Arthralgia,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Constipation,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Constipation,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Disease progression,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Disease progression,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Headache,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Headache,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Neurological symptom,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Neurological symptom,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Pneumonia legionella,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Pneumonia legionella,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Rash pustular,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Rash pustular,1,M,OT,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Sinusitis,1,M,HO,14
1456456917,1,Malignant melanoma,17,F,EXP,nivolumab,1,PS,Sinusitis,1,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Acne,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Acne,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Alanine aminotransferase increased,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Alanine aminotransferase increased,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Arthralgia,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Arthralgia,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Autoimmune hepatitis,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Autoimmune hepatitis,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Autoimmune thyroiditis,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Autoimmune thyroiditis,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Constipation,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Constipation,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Decreased appetite,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Decreased appetite,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Disease progression,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Disease progression,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Headache,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Headache,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Nausea,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Nausea,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Neurological symptom,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Neurological symptom,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Pneumonia,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Pneumonia,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Pneumonia legionella,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Pneumonia legionella,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Pyrexia,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Pyrexia,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Rash pustular,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Rash pustular,4,M,OT,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Sinusitis,4,M,HO,14
1456456917,4,Malignant melanoma,17,F,EXP,ipilimumab,4,SS,Sinusitis,4,M,OT,14
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Disease progression,25,M,OT,56
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Disease progression,25,M,DS,56
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Disease progression,25,M,HO,56
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Disease progression,25,M,LT,56
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Disease progression,25,M,DE,56
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Pyrexia,25,M,OT,56
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Pyrexia,25,M,DS,56
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Pyrexia,25,M,HO,56
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Pyrexia,25,M,LT,56
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Pyrexia,25,M,DE,56
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Thrombocytopenia,25,M,OT,56
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Thrombocytopenia,25,M,DS,56
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Thrombocytopenia,25,M,HO,56
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Thrombocytopenia,25,M,LT,56
145668944,25,Neutropenia,4,F,EXP,pegfilgrastim,25,C,Thrombocytopenia,25,M,DE,56
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone decreased,1,F,HO,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone decreased,1,F,OT,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Bradycardia,1,F,HO,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Bradycardia,1,F,OT,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Nasopharyngitis,1,F,HO,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Nasopharyngitis,1,F,OT,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Oedema,1,F,HO,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Oedema,1,F,OT,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Oral discomfort,1,F,HO,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Oral discomfort,1,F,OT,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Oral pain,1,F,HO,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Oral pain,1,F,OT,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Pain,1,F,HO,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Pain,1,F,OT,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Pleural effusion,1,F,HO,3
145679464,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Pleural effusion,1,F,OT,3
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Blood thyroid stimulating hormone decreased,2,F,HO,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Blood thyroid stimulating hormone decreased,2,F,OT,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Bradycardia,2,F,HO,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Bradycardia,2,F,OT,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Nasopharyngitis,2,F,HO,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Nasopharyngitis,2,F,OT,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Oedema,2,F,HO,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Oedema,2,F,OT,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Oral discomfort,2,F,HO,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Oral discomfort,2,F,OT,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Oral pain,2,F,HO,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Oral pain,2,F,OT,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Pain,2,F,HO,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Pain,2,F,OT,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Pleural effusion,2,F,HO,690
145679464,2,Multiple sclerosis,4,F,EXP,alemtuzumab,2,SS,Pleural effusion,2,F,OT,690
145690553,1,Gastrooesophageal cancer,3,F,EXP,nivolumab,1,PS,Bronchospasm,1,M,HO,9
145690553,1,Gastrooesophageal cancer,3,F,EXP,nivolumab,1,PS,Bronchospasm,1,M,OT,9
145690553,1,Gastrooesophageal cancer,3,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,HO,9
145690553,1,Gastrooesophageal cancer,3,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,OT,9
145690553,1,Gastrooesophageal cancer,3,F,EXP,nivolumab,1,PS,Pancreatitis,1,M,HO,9
145690553,1,Gastrooesophageal cancer,3,F,EXP,nivolumab,1,PS,Pancreatitis,1,M,OT,9
145690553,1,Gastrooesophageal cancer,3,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,9
145690553,1,Gastrooesophageal cancer,3,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,9
145690553,2,Gastrooesophageal cancer,3,F,EXP,ipilimumab,2,SS,Bronchospasm,2,M,HO,9
145690553,2,Gastrooesophageal cancer,3,F,EXP,ipilimumab,2,SS,Bronchospasm,2,M,OT,9
145690553,2,Gastrooesophageal cancer,3,F,EXP,ipilimumab,2,SS,Interstitial lung disease,2,M,HO,9
145690553,2,Gastrooesophageal cancer,3,F,EXP,ipilimumab,2,SS,Interstitial lung disease,2,M,OT,9
145690553,2,Gastrooesophageal cancer,3,F,EXP,ipilimumab,2,SS,Pancreatitis,2,M,HO,9
145690553,2,Gastrooesophageal cancer,3,F,EXP,ipilimumab,2,SS,Pancreatitis,2,M,OT,9
145690553,2,Gastrooesophageal cancer,3,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,HO,9
145690553,2,Gastrooesophageal cancer,3,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,OT,9
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Decreased appetite,1,F,OT,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Decreased appetite,1,F,HO,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Electrolyte imbalance,1,F,OT,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Electrolyte imbalance,1,F,HO,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Hypoaesthesia,1,F,OT,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Hypoaesthesia,1,F,HO,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Hypokalaemia,1,F,OT,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Hypokalaemia,1,F,HO,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Hypomagnesaemia,1,F,OT,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Hypomagnesaemia,1,F,HO,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Infection,1,F,OT,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Infection,1,F,HO,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Neuropathy peripheral,1,F,OT,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Neuropathy peripheral,1,F,HO,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Neutrophil count decreased,1,F,OT,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Neutrophil count decreased,1,F,HO,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Rash,1,F,OT,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,Rash,1,F,HO,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,White blood cell count decreased,1,F,OT,499
145715729,1,Rectal cancer,9,F,PER,panitumumab,1,PS,White blood cell count decreased,1,F,HO,499
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Arrhythmia supraventricular,1,M,OT,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Arrhythmia supraventricular,1,M,HO,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Arrhythmia supraventricular,1,M,DE,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Atrial flutter,1,M,OT,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Atrial flutter,1,M,HO,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Atrial flutter,1,M,DE,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dysgeusia,1,M,OT,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dysgeusia,1,M,HO,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dysgeusia,1,M,DE,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Loss of consciousness,1,M,OT,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Loss of consciousness,1,M,HO,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Loss of consciousness,1,M,DE,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malaise,1,M,OT,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malaise,1,M,HO,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malaise,1,M,DE,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Vertigo,1,M,OT,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Vertigo,1,M,HO,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Vertigo,1,M,DE,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Weight decreased,1,M,HO,28
145756969,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Weight decreased,1,M,DE,28
145762233,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Arthralgia,1,M,HO,23
145762233,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Arthralgia,2,M,HO,23
1457669015,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,OT,30
1457669015,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,HO,30
1457669015,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,OT,30
1457669015,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,HO,30
1457669015,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Lipase increased,1,F,OT,30
1457669015,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Lipase increased,1,F,HO,30
1457669015,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,30
1457669015,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,30
1457669015,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Metastases to pancreas,1,F,OT,30
1457669015,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Metastases to pancreas,1,F,HO,30
1457669015,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,30
1457669015,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,30
1457669015,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Vulvovaginal candidiasis,1,F,OT,30
1457669015,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Vulvovaginal candidiasis,1,F,HO,30
1457669015,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Hyperglycaemia,3,F,OT,30
1457669015,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Hyperglycaemia,3,F,HO,30
1457669015,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Hypothyroidism,3,F,OT,30
1457669015,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Hypothyroidism,3,F,HO,30
1457669015,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Lipase increased,3,F,OT,30
1457669015,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Lipase increased,3,F,HO,30
1457669015,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,F,OT,30
1457669015,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,F,HO,30
1457669015,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Metastases to pancreas,3,F,OT,30
1457669015,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Metastases to pancreas,3,F,HO,30
1457669015,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Nausea,3,F,OT,30
1457669015,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Nausea,3,F,HO,30
1457669015,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Vulvovaginal candidiasis,3,F,OT,30
1457669015,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Vulvovaginal candidiasis,3,F,HO,30
1457669015,4,Product used for unknown indication,15,F,EXP,nivolumab,4,SS,Hyperglycaemia,4,F,OT,30
1457669015,4,Product used for unknown indication,15,F,EXP,nivolumab,4,SS,Hyperglycaemia,4,F,HO,30
1457669015,4,Product used for unknown indication,15,F,EXP,nivolumab,4,SS,Hypothyroidism,4,F,OT,30
1457669015,4,Product used for unknown indication,15,F,EXP,nivolumab,4,SS,Hypothyroidism,4,F,HO,30
1457669015,4,Product used for unknown indication,15,F,EXP,nivolumab,4,SS,Lipase increased,4,F,OT,30
1457669015,4,Product used for unknown indication,15,F,EXP,nivolumab,4,SS,Lipase increased,4,F,HO,30
1457669015,4,Product used for unknown indication,15,F,EXP,nivolumab,4,SS,Malignant neoplasm progression,4,F,OT,30
1457669015,4,Product used for unknown indication,15,F,EXP,nivolumab,4,SS,Malignant neoplasm progression,4,F,HO,30
1457669015,4,Product used for unknown indication,15,F,EXP,nivolumab,4,SS,Metastases to pancreas,4,F,OT,30
1457669015,4,Product used for unknown indication,15,F,EXP,nivolumab,4,SS,Metastases to pancreas,4,F,HO,30
1457669015,4,Product used for unknown indication,15,F,EXP,nivolumab,4,SS,Nausea,4,F,OT,30
1457669015,4,Product used for unknown indication,15,F,EXP,nivolumab,4,SS,Nausea,4,F,HO,30
1457669015,4,Product used for unknown indication,15,F,EXP,nivolumab,4,SS,Vulvovaginal candidiasis,4,F,OT,30
1457669015,4,Product used for unknown indication,15,F,EXP,nivolumab,4,SS,Vulvovaginal candidiasis,4,F,HO,30
1457669015,5,Malignant melanoma,15,F,EXP,ipilimumab,5,SS,Hyperglycaemia,5,F,OT,30
1457669015,5,Malignant melanoma,15,F,EXP,ipilimumab,5,SS,Hyperglycaemia,5,F,HO,30
1457669015,5,Malignant melanoma,15,F,EXP,ipilimumab,5,SS,Hypothyroidism,5,F,OT,30
1457669015,5,Malignant melanoma,15,F,EXP,ipilimumab,5,SS,Hypothyroidism,5,F,HO,30
1457669015,5,Malignant melanoma,15,F,EXP,ipilimumab,5,SS,Lipase increased,5,F,OT,30
1457669015,5,Malignant melanoma,15,F,EXP,ipilimumab,5,SS,Lipase increased,5,F,HO,30
1457669015,5,Malignant melanoma,15,F,EXP,ipilimumab,5,SS,Malignant neoplasm progression,5,F,OT,30
1457669015,5,Malignant melanoma,15,F,EXP,ipilimumab,5,SS,Malignant neoplasm progression,5,F,HO,30
1457669015,5,Malignant melanoma,15,F,EXP,ipilimumab,5,SS,Metastases to pancreas,5,F,OT,30
1457669015,5,Malignant melanoma,15,F,EXP,ipilimumab,5,SS,Metastases to pancreas,5,F,HO,30
1457669015,5,Malignant melanoma,15,F,EXP,ipilimumab,5,SS,Nausea,5,F,OT,30
1457669015,5,Malignant melanoma,15,F,EXP,ipilimumab,5,SS,Nausea,5,F,HO,30
1457669015,5,Malignant melanoma,15,F,EXP,ipilimumab,5,SS,Vulvovaginal candidiasis,5,F,OT,30
1457669015,5,Malignant melanoma,15,F,EXP,ipilimumab,5,SS,Vulvovaginal candidiasis,5,F,HO,30
145793094,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,OT,140
145793094,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,DE,140
145793094,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,HO,140
145837089,3,Plasma cell myeloma,9,F,EXP,lenalidomide,3,SS,Drug reaction with eosinophilia and systemic symptoms,3,F,HO,13
145837089,3,Plasma cell myeloma,9,F,EXP,lenalidomide,3,SS,Drug reaction with eosinophilia and systemic symptoms,3,F,OT,13
145837089,3,Plasma cell myeloma,9,F,EXP,lenalidomide,3,SS,Hepatitis,3,F,HO,13
145837089,3,Plasma cell myeloma,9,F,EXP,lenalidomide,3,SS,Hepatitis,3,F,OT,13
145837089,3,Plasma cell myeloma,9,F,EXP,lenalidomide,3,SS,Renal failure,3,F,HO,13
145837089,3,Plasma cell myeloma,9,F,EXP,lenalidomide,3,SS,Renal failure,3,F,OT,13
145860597,2,Relapsing multiple sclerosis,7,F,EXP,ofatumumab,2,SS,Suicide attempt,2,F,HO,170
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Arthralgia,1,M,HO,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,OT,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,HO,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Basal cell carcinoma,1,M,OT,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Basal cell carcinoma,1,M,HO,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Infection,1,M,OT,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Infection,1,M,HO,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Mitral valve disease,1,M,OT,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Mitral valve disease,1,M,HO,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Neoplasm malignant,1,M,OT,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Neoplasm malignant,1,M,HO,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Pulmonary hypertension,1,M,OT,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Pulmonary hypertension,1,M,HO,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Solar dermatitis,1,M,OT,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Solar dermatitis,1,M,HO,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Tricuspid valve disease,1,M,OT,15
1459462815,1,Metastatic malignant melanoma,15,F,EXP,nivolumab,1,PS,Tricuspid valve disease,1,M,HO,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Arthralgia,4,M,OT,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Arthralgia,4,M,HO,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Atrial fibrillation,4,M,OT,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Atrial fibrillation,4,M,HO,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Basal cell carcinoma,4,M,OT,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Basal cell carcinoma,4,M,HO,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Infection,4,M,OT,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Infection,4,M,HO,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,M,OT,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,M,HO,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Mitral valve disease,4,M,OT,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Mitral valve disease,4,M,HO,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Neoplasm malignant,4,M,OT,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Neoplasm malignant,4,M,HO,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Pneumonitis,4,M,OT,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Pneumonitis,4,M,HO,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Pulmonary hypertension,4,M,OT,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Pulmonary hypertension,4,M,HO,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Solar dermatitis,4,M,OT,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Solar dermatitis,4,M,HO,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Tricuspid valve disease,4,M,OT,15
1459462815,4,Metastatic malignant melanoma,15,F,EXP,ipilimumab,4,SS,Tricuspid valve disease,4,M,HO,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Arthralgia,5,M,OT,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Arthralgia,5,M,HO,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Atrial fibrillation,5,M,OT,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Atrial fibrillation,5,M,HO,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Basal cell carcinoma,5,M,OT,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Basal cell carcinoma,5,M,HO,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Infection,5,M,OT,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Infection,5,M,HO,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Malignant neoplasm progression,5,M,OT,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Malignant neoplasm progression,5,M,HO,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Mitral valve disease,5,M,OT,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Mitral valve disease,5,M,HO,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Neoplasm malignant,5,M,OT,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Neoplasm malignant,5,M,HO,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Pneumonitis,5,M,OT,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Pneumonitis,5,M,HO,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Pulmonary hypertension,5,M,OT,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Pulmonary hypertension,5,M,HO,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Solar dermatitis,5,M,OT,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Solar dermatitis,5,M,HO,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Tricuspid valve disease,5,M,OT,15
1459462815,5,Product used for unknown indication,15,F,EXP,ipilimumab,5,SS,Tricuspid valve disease,5,M,HO,15
146011718,1,Prostate cancer,8,F,EXP,nivolumab,1,PS,Myocarditis,1,M,DE,16
146011718,1,Prostate cancer,8,F,EXP,nivolumab,1,PS,Myocarditis,1,M,HO,16
146011718,1,Prostate cancer,8,F,EXP,nivolumab,1,PS,Myocarditis,1,M,LT,16
146011718,1,Prostate cancer,8,F,EXP,nivolumab,1,PS,Myocarditis,1,M,OT,16
146011718,2,Prostate cancer,8,F,EXP,ipilimumab,2,SS,Myocarditis,2,M,DE,16
146011718,2,Prostate cancer,8,F,EXP,ipilimumab,2,SS,Myocarditis,2,M,HO,16
146011718,2,Prostate cancer,8,F,EXP,ipilimumab,2,SS,Myocarditis,2,M,LT,16
146011718,2,Prostate cancer,8,F,EXP,ipilimumab,2,SS,Myocarditis,2,M,OT,16
146054163,1,Gastrooesophageal cancer,3,F,EXP,nivolumab,1,PS,Transient ischaemic attack,1,F,HO,20
146054163,1,Gastrooesophageal cancer,3,F,EXP,nivolumab,1,PS,Transient ischaemic attack,1,F,OT,20
1460937210,2,Plasma cell myeloma,10,F,EXP,pomalidomide,2,SS,Pneumonia streptococcal,2,F,OT,112
1460937210,2,Plasma cell myeloma,10,F,EXP,pomalidomide,2,SS,Pneumonia streptococcal,2,F,DE,112
146189473,1,Chronic lymphocytic leukaemia,3,F,EXP,chlorambucil,1,PS,Constipation,1,M,OT,13
146189473,1,Chronic lymphocytic leukaemia,3,F,EXP,chlorambucil,1,PS,Constipation,1,M,HO,13
146189473,1,Chronic lymphocytic leukaemia,3,F,EXP,chlorambucil,1,PS,Urinary retention,1,M,OT,13
146189473,1,Chronic lymphocytic leukaemia,3,F,EXP,chlorambucil,1,PS,Urinary retention,1,M,HO,13
146189473,8,Chronic lymphocytic leukaemia,3,F,EXP,ofatumumab,8,SS,Constipation,8,M,OT,13
146189473,8,Chronic lymphocytic leukaemia,3,F,EXP,ofatumumab,8,SS,Constipation,8,M,HO,13
146189473,8,Chronic lymphocytic leukaemia,3,F,EXP,ofatumumab,8,SS,Urinary retention,8,M,OT,13
146189473,8,Chronic lymphocytic leukaemia,3,F,EXP,ofatumumab,8,SS,Urinary retention,8,M,HO,13
146268724,11,Plasma cell myeloma,4,F,EXP,lenalidomide,11,SS,Anaemia,11,F,HO,28
146268724,11,Plasma cell myeloma,4,F,EXP,lenalidomide,11,SS,Back pain,11,F,HO,28
146268724,11,Plasma cell myeloma,4,F,EXP,lenalidomide,11,SS,Hypocalcaemia,11,F,HO,28
146268724,11,Plasma cell myeloma,4,F,EXP,lenalidomide,11,SS,Malaise,11,F,HO,28
146268724,11,Plasma cell myeloma,4,F,EXP,lenalidomide,11,SS,Nausea,11,F,HO,28
146268724,11,Plasma cell myeloma,4,F,EXP,lenalidomide,11,SS,Neutrophil count decreased,11,F,HO,28
146268724,11,Plasma cell myeloma,4,F,EXP,lenalidomide,11,SS,Oral pain,11,F,HO,28
146268724,11,Plasma cell myeloma,4,F,EXP,lenalidomide,11,SS,Platelet count decreased,11,F,HO,28
146268724,11,Plasma cell myeloma,4,F,EXP,lenalidomide,11,SS,Vomiting,11,F,HO,28
146268724,16,Plasma cell myeloma,4,F,EXP,carfilzomib,16,SS,Anaemia,16,F,HO,28
146268724,16,Plasma cell myeloma,4,F,EXP,carfilzomib,16,SS,Back pain,16,F,HO,28
146268724,16,Plasma cell myeloma,4,F,EXP,carfilzomib,16,SS,Hypocalcaemia,16,F,HO,28
146268724,16,Plasma cell myeloma,4,F,EXP,carfilzomib,16,SS,Malaise,16,F,HO,28
146268724,16,Plasma cell myeloma,4,F,EXP,carfilzomib,16,SS,Nausea,16,F,HO,28
146268724,16,Plasma cell myeloma,4,F,EXP,carfilzomib,16,SS,Neutrophil count decreased,16,F,HO,28
146268724,16,Plasma cell myeloma,4,F,EXP,carfilzomib,16,SS,Oral pain,16,F,HO,28
146268724,16,Plasma cell myeloma,4,F,EXP,carfilzomib,16,SS,Platelet count decreased,16,F,HO,28
146268724,16,Plasma cell myeloma,4,F,EXP,carfilzomib,16,SS,Vomiting,16,F,HO,28
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Aspartate aminotransferase increased,10,F,OT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Aspartate aminotransferase increased,10,F,LT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Aspartate aminotransferase increased,10,F,HO,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Back pain,10,F,OT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Back pain,10,F,LT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Back pain,10,F,HO,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Basophil count increased,10,F,OT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Basophil count increased,10,F,LT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Basophil count increased,10,F,HO,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Blood creatinine increased,10,F,OT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Blood creatinine increased,10,F,LT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Blood creatinine increased,10,F,HO,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Bone marrow failure,10,F,OT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Bone marrow failure,10,F,LT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Bone marrow failure,10,F,HO,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Constipation,10,F,OT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Constipation,10,F,LT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Constipation,10,F,HO,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Hyperkalaemia,10,F,OT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Hyperkalaemia,10,F,LT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Hyperkalaemia,10,F,HO,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Hypertension,10,F,OT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Hypertension,10,F,LT,1
146363182,10,Prophylaxis,2,F,EXP,granisetron,10,SS,Hypertension,10,F,HO,1
146384943,4,Chronic lymphocytic leukaemia,3,F,EXP,ofatumumab,4,SS,Constipation,4,M,OT,13
146384943,4,Chronic lymphocytic leukaemia,3,F,EXP,ofatumumab,4,SS,Constipation,4,M,HO,13
146384943,4,Chronic lymphocytic leukaemia,3,F,EXP,ofatumumab,4,SS,Urinary retention,4,M,OT,13
146384943,4,Chronic lymphocytic leukaemia,3,F,EXP,ofatumumab,4,SS,Urinary retention,4,M,HO,13
146384943,8,Chronic lymphocytic leukaemia,3,F,EXP,chlorambucil,8,SS,Constipation,8,M,OT,13
146384943,8,Chronic lymphocytic leukaemia,3,F,EXP,chlorambucil,8,SS,Constipation,8,M,HO,13
146384943,8,Chronic lymphocytic leukaemia,3,F,EXP,chlorambucil,8,SS,Urinary retention,8,M,OT,13
146384943,8,Chronic lymphocytic leukaemia,3,F,EXP,chlorambucil,8,SS,Urinary retention,8,M,HO,13
146461369,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,F,OT,96
146461369,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,F,HO,96
146461369,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,96
146461369,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,96
146461369,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,F,OT,96
146461369,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,F,HO,96
146461369,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Nausea,2,F,OT,96
146461369,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Nausea,2,F,HO,96
146496063,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Atrial fibrillation,1,M,DE,42
146496063,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Atrial fibrillation,1,M,OT,42
146496063,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Blood urine present,1,M,DE,42
146496063,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Blood urine present,1,M,OT,42
146496063,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Cardiac flutter,1,M,DE,42
146496063,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Cardiac flutter,1,M,OT,42
146496063,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Death,1,M,DE,42
146496063,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Death,1,M,OT,42
146496063,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Nephrolithiasis,1,M,DE,42
146496063,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Nephrolithiasis,1,M,OT,42
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Influenza like illness,1,F,DE,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Influenza like illness,1,F,HO,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Influenza like illness,1,F,OT,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Meningitis listeria,1,F,DE,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Meningitis listeria,1,F,HO,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Meningitis listeria,1,F,OT,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Multiple sclerosis,1,F,DE,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Multiple sclerosis,1,F,HO,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Multiple sclerosis,1,F,OT,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Nausea,1,F,DE,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Nausea,1,F,HO,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Nausea,1,F,OT,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Pain,1,F,DE,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Pain,1,F,HO,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Pain,1,F,OT,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Pyrexia,1,F,DE,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Pyrexia,1,F,HO,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Pyrexia,1,F,OT,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Vomiting,1,F,DE,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Vomiting,1,F,HO,1057
146507333,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Vomiting,1,F,OT,1057
146615712,4,Osteoporosis,2,F,EXP,zoledronic acid,4,SS,Fanconi syndrome,4,F,OT,6
1467087810,1,Sarcoma,10,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,74
1467087810,1,Sarcoma,10,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,74
1467087810,1,Sarcoma,10,F,EXP,nivolumab,1,PS,Immune-mediated nephritis,1,M,HO,74
1467087810,1,Sarcoma,10,F,EXP,nivolumab,1,PS,Immune-mediated nephritis,1,M,OT,74
1467087810,1,Sarcoma,10,F,EXP,nivolumab,1,PS,Psoriatic arthropathy,1,M,HO,74
1467087810,1,Sarcoma,10,F,EXP,nivolumab,1,PS,Psoriatic arthropathy,1,M,OT,74
146711014,3,Renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Hepatitis,3,M,OT,23
146711014,3,Renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Hepatitis,3,M,HO,23
146711014,4,Renal cell carcinoma,4,F,EXP,ipilimumab,4,SS,Hepatitis,4,M,OT,23
146711014,4,Renal cell carcinoma,4,F,EXP,ipilimumab,4,SS,Hepatitis,4,M,HO,23
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Arthralgia,1,F,DE,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Arthralgia,1,F,HO,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Arthralgia,1,F,OT,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Back pain,1,F,DE,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Back pain,1,F,HO,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Back pain,1,F,OT,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Haemoptysis,1,F,DE,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Haemoptysis,1,F,HO,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Haemoptysis,1,F,OT,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,DE,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,HO,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,OT,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Sepsis,1,F,DE,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Sepsis,1,F,HO,42
146798486,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Sepsis,1,F,OT,42
146815344,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Encephalitis,1,M,DE,170
146815344,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Encephalitis,1,M,OT,170
146815344,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Encephalitis,1,M,HO,170
146815344,2,Pleural mesothelioma,4,F,EXP,ipilimumab,2,SS,Encephalitis,2,M,DE,170
146815344,2,Pleural mesothelioma,4,F,EXP,ipilimumab,2,SS,Encephalitis,2,M,OT,170
146815344,2,Pleural mesothelioma,4,F,EXP,ipilimumab,2,SS,Encephalitis,2,M,HO,170
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Anaemia,1,M,HO,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Anaemia,1,M,OT,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Contusion,1,M,HO,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Contusion,1,M,OT,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Dental caries,1,M,HO,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Dental caries,1,M,OT,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Dizziness,1,M,HO,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Fall,1,M,HO,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Fall,1,M,OT,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Fatigue,1,M,HO,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Gingivitis,1,M,HO,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Gingivitis,1,M,OT,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Hypertension,1,M,HO,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Hypertension,1,M,OT,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Infected dermal cyst,1,M,HO,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Infected dermal cyst,1,M,OT,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Pancytopenia,1,M,HO,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Pancytopenia,1,M,OT,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Pneumonia pneumococcal,1,M,HO,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Pneumonia pneumococcal,1,M,OT,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Seborrhoeic keratosis,1,M,HO,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Seborrhoeic keratosis,1,M,OT,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Weight decreased,1,M,HO,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,Weight decreased,1,M,OT,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,White blood cell count decreased,1,M,HO,53
1468451934,1,Hormone-refractory prostate cancer,34,F,EXP,enzalutamide,1,PS,White blood cell count decreased,1,M,OT,53
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Anaemia,12,M,HO,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Anaemia,12,M,OT,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Contusion,12,M,HO,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Contusion,12,M,OT,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Dental caries,12,M,HO,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Dental caries,12,M,OT,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Dizziness,12,M,HO,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Dizziness,12,M,OT,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Fall,12,M,HO,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Fall,12,M,OT,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Fatigue,12,M,HO,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Fatigue,12,M,OT,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Gingivitis,12,M,HO,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Gingivitis,12,M,OT,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Hypertension,12,M,HO,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Hypertension,12,M,OT,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Infected dermal cyst,12,M,HO,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Infected dermal cyst,12,M,OT,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Pancytopenia,12,M,HO,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Pancytopenia,12,M,OT,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Pneumonia pneumococcal,12,M,HO,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Pneumonia pneumococcal,12,M,OT,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Seborrhoeic keratosis,12,M,HO,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Seborrhoeic keratosis,12,M,OT,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Weight decreased,12,M,HO,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,Weight decreased,12,M,OT,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,White blood cell count decreased,12,M,HO,609
1468451934,12,Prophylaxis,34,F,EXP,zoledronic acid,12,C,White blood cell count decreased,12,M,OT,609
146901722,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Oesophageal obstruction,1,M,OT,7
146901722,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Oesophageal obstruction,1,M,HO,7
146901722,2,Gastric cancer,2,F,EXP,ipilimumab,2,SS,Oesophageal obstruction,2,M,OT,7
146901722,2,Gastric cancer,2,F,EXP,ipilimumab,2,SS,Oesophageal obstruction,2,M,HO,7
146956317,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Deafness,1,M,LT,57
146956317,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Deafness,1,M,DE,57
146956317,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Deafness,1,M,OT,57
146956317,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,57
146956317,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,57
146956317,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,57
146956317,3,Lung neoplasm malignant,7,F,EXP,ipilimumab,3,SS,Deafness,3,M,LT,57
146956317,3,Lung neoplasm malignant,7,F,EXP,ipilimumab,3,SS,Deafness,3,M,DE,57
146956317,3,Lung neoplasm malignant,7,F,EXP,ipilimumab,3,SS,Deafness,3,M,OT,57
146956317,3,Lung neoplasm malignant,7,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,LT,57
146956317,3,Lung neoplasm malignant,7,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,DE,57
146956317,3,Lung neoplasm malignant,7,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,OT,57
146991772,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Anaemia,4,F,HO,14
146991772,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Anaemia,4,F,OT,14
146991772,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Intentional product misuse,4,F,HO,14
146991772,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Intentional product misuse,4,F,OT,14
146991772,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Leukopenia,4,F,HO,14
146991772,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Leukopenia,4,F,OT,14
147025863,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Device related infection,1,F,HO,70
147025863,3,Plasma cell myeloma,3,F,PER,daratumumab,3,SS,Device related infection,3,F,HO,70
147052043,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Myocarditis,1,F,HO,113
147052043,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Myocarditis,1,F,LT,113
147052043,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Myocarditis,1,F,OT,113
147052043,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Myocarditis,2,F,HO,382
147052043,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Myocarditis,2,F,LT,382
147052043,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Myocarditis,2,F,OT,382
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Alanine aminotransferase increased,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Alanine aminotransferase increased,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Anaemia,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Anaemia,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Aphthous ulcer,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Aphthous ulcer,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Aspartate aminotransferase increased,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Aspartate aminotransferase increased,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,C-reactive protein increased,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,C-reactive protein increased,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Concomitant disease aggravated,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Concomitant disease aggravated,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Corona virus infection,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Corona virus infection,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Cough,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Cough,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Dental caries,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Dental caries,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Dermatitis,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Dermatitis,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Dyspnoea,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Dyspnoea,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Eczema,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Eczema,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Hair colour changes,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Hair colour changes,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Hyperpyrexia,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Hyperpyrexia,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Hypothyroidism,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Hypothyroidism,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Ingrowing nail,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Ingrowing nail,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Laryngitis,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Laryngitis,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Lower respiratory tract infection,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Lower respiratory tract infection,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Nail bed inflammation,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Nail bed inflammation,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Obesity,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Obesity,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Paronychia,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Paronychia,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Pneumonia viral,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Pneumonia viral,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Staphylococcal infection,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Staphylococcal infection,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Subclavian vein thrombosis,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Subclavian vein thrombosis,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Tonsillitis,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Tonsillitis,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Upper respiratory tract infection,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Upper respiratory tract infection,5,F,OT,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Urinary tract infection,5,F,HO,49
1470821713,5,Malignant melanoma,13,F,EXP,trametinib,5,SS,Urinary tract infection,5,F,OT,49
147111545,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Pneumocystis jirovecii pneumonia,1,M,HO,91
147111545,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Pneumocystis jirovecii pneumonia,1,M,LT,91
147111545,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Pneumocystis jirovecii pneumonia,1,M,DE,91
147111545,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Septic shock,1,M,HO,91
147111545,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Septic shock,1,M,LT,91
147111545,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Septic shock,1,M,DE,91
147111545,4,Plasma cell myeloma,5,F,PER,daratumumab,4,SS,Pneumocystis jirovecii pneumonia,4,M,HO,91
147111545,4,Plasma cell myeloma,5,F,PER,daratumumab,4,SS,Pneumocystis jirovecii pneumonia,4,M,LT,91
147111545,4,Plasma cell myeloma,5,F,PER,daratumumab,4,SS,Pneumocystis jirovecii pneumonia,4,M,DE,91
147111545,4,Plasma cell myeloma,5,F,PER,daratumumab,4,SS,Septic shock,4,M,HO,91
147111545,4,Plasma cell myeloma,5,F,PER,daratumumab,4,SS,Septic shock,4,M,LT,91
147111545,4,Plasma cell myeloma,5,F,PER,daratumumab,4,SS,Septic shock,4,M,DE,91
147127538,55,Neutropenia,8,F,EXP,filgrastim,55,C,Systemic inflammatory response syndrome,55,F,OT,11
147156495,4,Plasma cell myeloma,5,F,EXP,pomalidomide,4,SS,Pneumonia streptococcal,4,F,OT,112
147156495,4,Plasma cell myeloma,5,F,EXP,pomalidomide,4,SS,Pneumonia streptococcal,4,F,DE,112
147168706,1,Plasma cell myeloma,6,F,EXP,daratumumab,1,PS,Pneumocystis jirovecii pneumonia,1,M,LT,91
147168706,1,Plasma cell myeloma,6,F,EXP,daratumumab,1,PS,Pneumocystis jirovecii pneumonia,1,M,HO,91
147168706,1,Plasma cell myeloma,6,F,EXP,daratumumab,1,PS,Pneumocystis jirovecii pneumonia,1,M,DE,91
147168706,1,Plasma cell myeloma,6,F,EXP,daratumumab,1,PS,Septic shock,1,M,LT,91
147168706,1,Plasma cell myeloma,6,F,EXP,daratumumab,1,PS,Septic shock,1,M,HO,91
147168706,1,Plasma cell myeloma,6,F,EXP,daratumumab,1,PS,Septic shock,1,M,DE,91
147168706,3,Plasma cell myeloma,6,F,EXP,carfilzomib,3,SS,Pneumocystis jirovecii pneumonia,3,M,LT,91
147168706,3,Plasma cell myeloma,6,F,EXP,carfilzomib,3,SS,Pneumocystis jirovecii pneumonia,3,M,HO,91
147168706,3,Plasma cell myeloma,6,F,EXP,carfilzomib,3,SS,Pneumocystis jirovecii pneumonia,3,M,DE,91
147168706,3,Plasma cell myeloma,6,F,EXP,carfilzomib,3,SS,Septic shock,3,M,LT,91
147168706,3,Plasma cell myeloma,6,F,EXP,carfilzomib,3,SS,Septic shock,3,M,HO,91
147168706,3,Plasma cell myeloma,6,F,EXP,carfilzomib,3,SS,Septic shock,3,M,DE,91
147262399,1,Malignant melanoma,9,F,EXP,nivolumab,1,SS,Gastrooesophageal reflux disease,1,M,HO,84
147262399,1,Malignant melanoma,9,F,EXP,nivolumab,1,SS,Stomatitis,1,M,HO,84
147262399,3,Malignant melanoma,9,F,EXP,ipilimumab,3,PS,Gastrooesophageal reflux disease,3,M,HO,9
147262399,3,Malignant melanoma,9,F,EXP,ipilimumab,3,PS,Stomatitis,3,M,HO,9
147282542,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Cystitis,1,F,HO,8
147282542,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Listeriosis,1,F,HO,8
147285835,9,Plasma cell myeloma,5,F,EXP,pomalidomide,9,SS,Neuropathy peripheral,9,F,OT,122
147285835,9,Plasma cell myeloma,5,F,EXP,pomalidomide,9,SS,Neurotoxicity,9,F,OT,122
147300703,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Device related infection,1,F,HO,70
147300703,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Sepsis,1,F,HO,70
147300703,4,Plasma cell myeloma,3,F,EXP,carfilzomib,4,SS,Device related infection,4,F,HO,70
147300703,4,Plasma cell myeloma,3,F,EXP,carfilzomib,4,SS,Sepsis,4,F,HO,70
147305413,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Anaemia,3,F,HO,203
147305413,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Pneumonia,3,F,HO,203
147311213,1,Metastatic squamous cell carcinoma,3,F,EXP,nivolumab,1,SS,Pleural effusion,1,M,HO,12
147311213,2,Metastatic squamous cell carcinoma,3,F,EXP,ipilimumab,2,PS,Pleural effusion,2,M,HO,12
147317182,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Myocardial infarction,2,M,HO,164
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,DE,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,M,DE,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,M,HO,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,M,OT,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Anaemia,1,M,DE,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Bronchitis,1,M,DE,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Bronchitis,1,M,HO,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Bronchitis,1,M,OT,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Gout,1,M,DE,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Gout,1,M,HO,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Gout,1,M,OT,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Influenza like illness,1,M,DE,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Influenza like illness,1,M,HO,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Influenza like illness,1,M,OT,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Lung disorder,1,M,DE,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Lung disorder,1,M,HO,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Lung disorder,1,M,OT,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Red blood cell count decreased,1,M,DE,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Red blood cell count decreased,1,M,HO,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Red blood cell count decreased,1,M,OT,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Septic shock,1,M,DE,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Septic shock,1,M,HO,82
1474314612,1,Lung neoplasm malignant,12,F,EXP,nivolumab,1,PS,Septic shock,1,M,OT,82
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Anaemia,2,M,DE,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Anaemia,2,M,OT,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Anaemia,2,M,HO,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Hypoxia,2,M,DE,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Hypoxia,2,M,OT,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Hypoxia,2,M,HO,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Neutropenic sepsis,2,M,DE,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Neutropenic sepsis,2,M,OT,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Neutropenic sepsis,2,M,HO,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Pancytopenia,2,M,DE,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Pancytopenia,2,M,OT,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Pancytopenia,2,M,HO,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Pneumonia,2,M,DE,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Pneumonia,2,M,OT,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Pneumonia,2,M,HO,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Renal failure,2,M,DE,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Renal failure,2,M,OT,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Renal failure,2,M,HO,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Sepsis,2,M,DE,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Sepsis,2,M,OT,5
147455865,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Sepsis,2,M,HO,5
147474392,5,Plasma cell myeloma,2,F,EXP,pomalidomide,5,SS,Erythema,5,M,OT,9
147474392,5,Plasma cell myeloma,2,F,EXP,pomalidomide,5,SS,Leukopenia,5,M,OT,9
147474392,5,Plasma cell myeloma,2,F,EXP,pomalidomide,5,SS,Neutropenia,5,M,OT,9
147474392,5,Plasma cell myeloma,2,F,EXP,pomalidomide,5,SS,Thrombocytopenia,5,M,OT,9
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Alanine aminotransferase increased,1,F,OT,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Alanine aminotransferase increased,1,F,HO,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Alanine aminotransferase increased,1,F,DE,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Aspartate aminotransferase increased,1,F,OT,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Aspartate aminotransferase increased,1,F,HO,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Aspartate aminotransferase increased,1,F,DE,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Decreased appetite,1,F,OT,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Decreased appetite,1,F,HO,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Decreased appetite,1,F,DE,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Hypotension,1,F,OT,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Hypotension,1,F,HO,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Hypotension,1,F,DE,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,F,OT,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,F,HO,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,F,DE,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Rash,1,F,OT,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Rash,1,F,HO,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Rash,1,F,DE,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Systemic inflammatory response syndrome,1,F,OT,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Systemic inflammatory response syndrome,1,F,HO,63
1475568818,1,Malignant melanoma,18,F,EXP,nivolumab,1,SS,Systemic inflammatory response syndrome,1,F,DE,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Alanine aminotransferase increased,2,F,OT,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Alanine aminotransferase increased,2,F,HO,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Alanine aminotransferase increased,2,F,DE,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Aspartate aminotransferase increased,2,F,OT,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Aspartate aminotransferase increased,2,F,HO,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Aspartate aminotransferase increased,2,F,DE,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Decreased appetite,2,F,OT,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Decreased appetite,2,F,HO,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Decreased appetite,2,F,DE,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Hypotension,2,F,OT,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Hypotension,2,F,HO,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Hypotension,2,F,DE,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Malignant neoplasm progression,2,F,OT,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Malignant neoplasm progression,2,F,HO,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Malignant neoplasm progression,2,F,DE,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Rash,2,F,OT,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Rash,2,F,HO,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Rash,2,F,DE,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Systemic inflammatory response syndrome,2,F,OT,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Systemic inflammatory response syndrome,2,F,HO,63
1475568818,2,Malignant melanoma,18,F,EXP,ipilimumab,2,PS,Systemic inflammatory response syndrome,2,F,DE,63
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Diabetes mellitus,2,F,HO,9
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Diabetes mellitus,2,F,DS,9
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Diabetes mellitus,2,F,OT,9
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Hypothyroidism,2,F,HO,9
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Hypothyroidism,2,F,DS,9
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Hypothyroidism,2,F,OT,9
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Nausea,2,F,HO,9
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Nausea,2,F,DS,9
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Nausea,2,F,OT,9
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Uveitis,2,F,HO,9
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Uveitis,2,F,DS,9
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Uveitis,2,F,OT,9
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Vulvovaginal candidiasis,2,F,HO,9
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Vulvovaginal candidiasis,2,F,DS,9
147561007,2,Lung neoplasm malignant,7,F,EXP,nivolumab,2,SS,Vulvovaginal candidiasis,2,F,OT,9
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Diabetes mellitus,3,F,HO,30
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Diabetes mellitus,3,F,DS,30
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Diabetes mellitus,3,F,OT,30
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Hypothyroidism,3,F,HO,30
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Hypothyroidism,3,F,DS,30
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Hypothyroidism,3,F,OT,30
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Nausea,3,F,HO,30
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Nausea,3,F,DS,30
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Nausea,3,F,OT,30
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Uveitis,3,F,HO,30
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Uveitis,3,F,DS,30
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Uveitis,3,F,OT,30
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Vulvovaginal candidiasis,3,F,HO,30
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Vulvovaginal candidiasis,3,F,DS,30
147561007,3,Malignant melanoma,7,F,EXP,ipilimumab,3,PS,Vulvovaginal candidiasis,3,F,OT,30
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Diabetes mellitus,4,F,HO,9
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Diabetes mellitus,4,F,DS,9
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Diabetes mellitus,4,F,OT,9
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Hypothyroidism,4,F,HO,9
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Hypothyroidism,4,F,DS,9
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Hypothyroidism,4,F,OT,9
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Nausea,4,F,HO,9
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Nausea,4,F,DS,9
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Nausea,4,F,OT,9
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Uveitis,4,F,HO,9
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Uveitis,4,F,DS,9
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Uveitis,4,F,OT,9
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Vulvovaginal candidiasis,4,F,HO,9
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Vulvovaginal candidiasis,4,F,DS,9
147561007,4,Lung neoplasm malignant,7,F,EXP,ipilimumab,4,SS,Vulvovaginal candidiasis,4,F,OT,9
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Eye inflammation,1,M,OT,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Eye inflammation,1,M,HO,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Fall,1,M,OT,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Fall,1,M,HO,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Hip fracture,1,M,OT,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Hip fracture,1,M,HO,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Inflammation,1,M,OT,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Inflammation,1,M,HO,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Lacrimation increased,1,M,OT,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Lacrimation increased,1,M,HO,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Middle ear inflammation,1,M,OT,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Middle ear inflammation,1,M,HO,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Nasal inflammation,1,M,OT,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Nasal inflammation,1,M,HO,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,OT,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,HO,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Product dose omission,1,M,OT,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Product dose omission,1,M,HO,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Productive cough,1,M,OT,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Productive cough,1,M,HO,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Sinus disorder,1,M,OT,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Sinus disorder,1,M,HO,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Upper respiratory tract infection,1,M,OT,201
147571776,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Upper respiratory tract infection,1,M,HO,201
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Eye inflammation,2,M,OT,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Eye inflammation,2,M,HO,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Fall,2,M,OT,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Fall,2,M,HO,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Hip fracture,2,M,OT,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Hip fracture,2,M,HO,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Inflammation,2,M,OT,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Inflammation,2,M,HO,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Lacrimation increased,2,M,OT,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Lacrimation increased,2,M,HO,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Middle ear inflammation,2,M,OT,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Middle ear inflammation,2,M,HO,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Nasal inflammation,2,M,OT,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Nasal inflammation,2,M,HO,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Product availability issue,2,M,OT,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Product availability issue,2,M,HO,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Product dose omission,2,M,OT,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Product dose omission,2,M,HO,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Productive cough,2,M,OT,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Productive cough,2,M,HO,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Sinus disorder,2,M,OT,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Sinus disorder,2,M,HO,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Upper respiratory tract infection,2,M,OT,200
147571776,2,Bone cancer,6,F,EXP,enzalutamide,2,SS,Upper respiratory tract infection,2,M,HO,200
1476690410,1,Squamous cell carcinoma of head and neck,10,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,435
1476690410,2,Squamous cell carcinoma of head and neck,10,F,EXP,ipilimumab,2,SS,Dehydration,2,M,HO,435
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Bronchitis,1,M,DE,34
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Bronchitis,1,M,HO,34
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Bronchitis,1,M,OT,34
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Colitis,1,M,DE,34
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,34
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,34
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Coronary artery disease,1,M,DE,34
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Coronary artery disease,1,M,HO,34
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Coronary artery disease,1,M,OT,34
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Dehydration,1,M,DE,34
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,34
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,34
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Quadriplegia,1,M,DE,34
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Quadriplegia,1,M,HO,34
147729908,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Quadriplegia,1,M,OT,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Bronchitis,2,M,DE,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Bronchitis,2,M,HO,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Bronchitis,2,M,OT,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Colitis,2,M,DE,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Colitis,2,M,HO,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Colitis,2,M,OT,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Coronary artery disease,2,M,DE,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Coronary artery disease,2,M,HO,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Coronary artery disease,2,M,OT,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Dehydration,2,M,DE,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Dehydration,2,M,HO,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Dehydration,2,M,OT,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Quadriplegia,2,M,DE,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Quadriplegia,2,M,HO,34
147729908,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Quadriplegia,2,M,OT,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Bronchitis,5,M,DE,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Bronchitis,5,M,HO,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Bronchitis,5,M,OT,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Colitis,5,M,DE,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Colitis,5,M,HO,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Colitis,5,M,OT,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Coronary artery disease,5,M,DE,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Coronary artery disease,5,M,HO,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Coronary artery disease,5,M,OT,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Dehydration,5,M,DE,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Dehydration,5,M,HO,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Dehydration,5,M,OT,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Quadriplegia,5,M,DE,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Quadriplegia,5,M,HO,34
147729908,5,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,5,SS,Quadriplegia,5,M,OT,34
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Bronchitis,6,M,DE,13
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Bronchitis,6,M,HO,13
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Bronchitis,6,M,OT,13
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Colitis,6,M,DE,13
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Colitis,6,M,HO,13
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Colitis,6,M,OT,13
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Coronary artery disease,6,M,DE,13
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Coronary artery disease,6,M,HO,13
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Coronary artery disease,6,M,OT,13
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Dehydration,6,M,DE,13
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Dehydration,6,M,HO,13
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Dehydration,6,M,OT,13
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Quadriplegia,6,M,DE,13
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Quadriplegia,6,M,HO,13
147729908,6,Product used for unknown indication,8,F,EXP,pemetrexed disodium,6,SS,Quadriplegia,6,M,OT,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Bronchitis,10,M,DE,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Bronchitis,10,M,HO,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Bronchitis,10,M,OT,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Colitis,10,M,DE,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Colitis,10,M,HO,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Colitis,10,M,OT,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Coronary artery disease,10,M,DE,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Coronary artery disease,10,M,HO,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Coronary artery disease,10,M,OT,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Dehydration,10,M,DE,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Dehydration,10,M,HO,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Dehydration,10,M,OT,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Quadriplegia,10,M,DE,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Quadriplegia,10,M,HO,13
147729908,10,Product used for unknown indication,8,F,EXP,granisetron,10,C,Quadriplegia,10,M,OT,13
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Bronchitis,11,M,DE,12
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Bronchitis,11,M,HO,12
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Bronchitis,11,M,OT,12
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Colitis,11,M,DE,12
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Colitis,11,M,HO,12
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Colitis,11,M,OT,12
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Coronary artery disease,11,M,DE,12
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Coronary artery disease,11,M,HO,12
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Coronary artery disease,11,M,OT,12
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Dehydration,11,M,DE,12
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Dehydration,11,M,HO,12
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Dehydration,11,M,OT,12
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Quadriplegia,11,M,DE,12
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Quadriplegia,11,M,HO,12
147729908,11,Product used for unknown indication,8,F,EXP,granisetron,11,C,Quadriplegia,11,M,OT,12
147792644,1,Relapsing multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Fatigue,1,F,HO,9
147792644,1,Relapsing multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Fatigue,1,F,OT,9
147792644,1,Relapsing multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Haemolytic anaemia,1,F,HO,9
147792644,1,Relapsing multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Haemolytic anaemia,1,F,OT,9
147792644,1,Relapsing multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Influenza like illness,1,F,HO,9
147792644,1,Relapsing multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Influenza like illness,1,F,OT,9
147792644,1,Relapsing multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Pain,1,F,HO,9
147792644,1,Relapsing multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Pain,1,F,OT,9
147792644,1,Relapsing multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Thrombocytopenia,1,F,HO,9
147792644,1,Relapsing multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Thrombocytopenia,1,F,OT,9
147802294,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Soft tissue infection,1,F,HO,19
147830556,5,Metastatic malignant melanoma,6,F,EXP,trametinib,5,SS,General physical health deterioration,5,F,HO,16
147830556,5,Metastatic malignant melanoma,6,F,EXP,trametinib,5,SS,Headache,5,F,HO,16
147830556,5,Metastatic malignant melanoma,6,F,EXP,trametinib,5,SS,Infection,5,F,HO,16
147830556,5,Metastatic malignant melanoma,6,F,EXP,trametinib,5,SS,Pyrexia,5,F,HO,16
147981953,13,Plasma cell myeloma,3,F,EXP,pomalidomide,13,SS,Pneumonitis,13,F,HO,372
148028852,2,Transitional cell carcinoma,2,F,EXP,nivolumab,2,SS,Cardiac ventricular thrombosis,2,F,HO,51
148028852,2,Transitional cell carcinoma,2,F,EXP,nivolumab,2,SS,Cardiac ventricular thrombosis,2,F,OT,51
148028852,2,Transitional cell carcinoma,2,F,EXP,nivolumab,2,SS,Cardiomyopathy,2,F,HO,51
148028852,2,Transitional cell carcinoma,2,F,EXP,nivolumab,2,SS,Cardiomyopathy,2,F,OT,51
148054806,2,Ovarian cancer,6,F,EXP,avelumab,2,SS,Wound infection,2,F,HO,135
148248122,6,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,6,SS,Constipation,6,M,HO,13
148248122,6,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,6,SS,Urinary retention,6,M,HO,13
148248122,9,Chronic lymphocytic leukaemia,2,F,EXP,chlorambucil,9,SS,Constipation,9,M,HO,13
148248122,9,Chronic lymphocytic leukaemia,2,F,EXP,chlorambucil,9,SS,Urinary retention,9,M,HO,13
148310269,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,28
148310269,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,28
148310269,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,HO,28
148310269,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,OT,28
148310269,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,28
148310269,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,28
148310269,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,28
148310269,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,28
148310269,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Neutropenia,1,M,HO,28
148310269,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Neutropenia,1,M,OT,28
148310269,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Anaemia,2,M,HO,28
148310269,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Anaemia,2,M,OT,28
148310269,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,C-reactive protein increased,2,M,HO,28
148310269,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,C-reactive protein increased,2,M,OT,28
148310269,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,28
148310269,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,28
148310269,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,HO,28
148310269,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,OT,28
148310269,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Neutropenia,2,M,HO,28
148310269,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Neutropenia,2,M,OT,28
148310987,1,Colorectal cancer,7,F,PER,talimogene laherparepvec,1,PS,Platelet count decreased,1,F,HO,21
148380094,1,Gastric cancer recurrent,4,F,EXP,nivolumab,1,PS,Anaphylactic shock,1,M,OT,217
148380094,1,Gastric cancer recurrent,4,F,EXP,nivolumab,1,PS,Anaphylactic shock,1,M,LT,217
148380094,1,Gastric cancer recurrent,4,F,EXP,nivolumab,1,PS,Anaphylactic shock,1,M,HO,217
148380094,1,Gastric cancer recurrent,4,F,EXP,nivolumab,1,PS,Haemolytic anaemia,1,M,OT,217
148380094,1,Gastric cancer recurrent,4,F,EXP,nivolumab,1,PS,Haemolytic anaemia,1,M,LT,217
148380094,1,Gastric cancer recurrent,4,F,EXP,nivolumab,1,PS,Haemolytic anaemia,1,M,HO,217
148395438,1,Renal cell carcinoma,8,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,F,HO,196
148395438,1,Renal cell carcinoma,8,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,F,OT,196
148424689,7,Prophylaxis,9,F,EXP,zoledronic acid,7,C,Pneumonia,7,F,HO,23
148424689,7,Prophylaxis,9,F,EXP,zoledronic acid,7,C,Pneumonia,7,F,DE,23
148425365,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Haemorrhage intracranial,1,M,HO,64
148452714,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Pancytopenia,2,M,OT,14
148462114,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,6
148462114,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,6
148462114,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,6
148462114,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Respiratory distress,1,M,OT,6
148462114,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Respiratory distress,1,M,HO,6
148462114,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Respiratory distress,1,M,DE,6
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Cardiac failure,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Cardiac failure,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Cough,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Cough,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Deafness,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Deafness,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Fatigue,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Haemoptysis,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Haemoptysis,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Hypertension,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Hypertension,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Hypertensive heart disease,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Hypertensive heart disease,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Infection,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Infection,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Nasopharyngitis,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Nasopharyngitis,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Oedema,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Oedema,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Off label use,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Off label use,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Pain,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Pain,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Pneumonia,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Pneumonia,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Type 2 diabetes mellitus,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Type 2 diabetes mellitus,1,F,HO,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Ventricular extrasystoles,1,F,OT,32
1484800928,1,Non-small cell lung cancer,28,F,EXP,nivolumab,1,PS,Ventricular extrasystoles,1,F,HO,32
1484819422,2,Hormone-refractory prostate cancer,22,F,EXP,enzalutamide,2,SS,Cardiac failure,2,M,DE,9
1484819422,2,Hormone-refractory prostate cancer,22,F,EXP,enzalutamide,2,SS,Cardiac failure,2,M,HO,9
1484819422,2,Hormone-refractory prostate cancer,22,F,EXP,enzalutamide,2,SS,Pneumonitis,2,M,DE,9
1484819422,2,Hormone-refractory prostate cancer,22,F,EXP,enzalutamide,2,SS,Pneumonitis,2,M,HO,9
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Addison's disease,1,F,OT,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Addison's disease,1,F,HO,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Aphasia,1,F,OT,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Aphasia,1,F,HO,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Asthenia,1,F,OT,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Asthenia,1,F,HO,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Back pain,1,F,OT,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Back pain,1,F,HO,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Confusional state,1,F,OT,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Confusional state,1,F,HO,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Hallucination,1,F,OT,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Hallucination,1,F,HO,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Hospitalisation,1,F,OT,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Hospitalisation,1,F,HO,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Intentional product use issue,1,F,OT,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Intentional product use issue,1,F,HO,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,OT,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,HO,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Seizure,1,F,OT,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Seizure,1,F,HO,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Somnolence,1,F,OT,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Somnolence,1,F,HO,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,66
148512214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Addison's disease,3,F,OT,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Addison's disease,3,F,HO,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Aphasia,3,F,OT,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Aphasia,3,F,HO,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Asthenia,3,F,OT,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Asthenia,3,F,HO,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Back pain,3,F,OT,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Back pain,3,F,HO,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Confusional state,3,F,OT,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Confusional state,3,F,HO,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Hallucination,3,F,OT,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Hallucination,3,F,HO,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Hospitalisation,3,F,OT,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Hospitalisation,3,F,HO,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Intentional product use issue,3,F,OT,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Intentional product use issue,3,F,HO,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,F,OT,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,F,HO,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Pain in extremity,3,F,OT,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Pain in extremity,3,F,HO,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Seizure,3,F,OT,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Seizure,3,F,HO,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Somnolence,3,F,OT,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Somnolence,3,F,HO,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Vomiting,3,F,OT,66
148512214,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,SS,Vomiting,3,F,HO,66
148525403,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Cellulitis,1,M,HO,57
148525403,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Cellulitis,3,M,HO,57
148559359,1,Myeloid leukaemia,9,F,EXP,bosutinib,1,PS,Cellulitis orbital,1,M,HO,1166
148585744,4,Product used for unknown indication,4,F,EXP,trametinib,4,SS,Autoimmune colitis,4,M,HO,44
148585744,4,Product used for unknown indication,4,F,EXP,trametinib,4,SS,Autoimmune colitis,4,M,OT,44
148585744,4,Product used for unknown indication,4,F,EXP,trametinib,4,SS,Diabetes mellitus,4,M,HO,44
148585744,4,Product used for unknown indication,4,F,EXP,trametinib,4,SS,Diabetes mellitus,4,M,OT,44
148585744,4,Product used for unknown indication,4,F,EXP,trametinib,4,SS,General physical health deterioration,4,M,HO,44
148585744,4,Product used for unknown indication,4,F,EXP,trametinib,4,SS,General physical health deterioration,4,M,OT,44
148585744,4,Product used for unknown indication,4,F,EXP,trametinib,4,SS,Pneumonia,4,M,HO,44
148585744,4,Product used for unknown indication,4,F,EXP,trametinib,4,SS,Pneumonia,4,M,OT,44
148585744,4,Product used for unknown indication,4,F,EXP,trametinib,4,SS,Pyrexia,4,M,HO,44
148585744,4,Product used for unknown indication,4,F,EXP,trametinib,4,SS,Pyrexia,4,M,OT,44
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Bronchitis,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Bronchitis,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Cough,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Cough,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Dyspnoea,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Dyspnoea,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Epilepsy,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Epilepsy,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Fatigue,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Fatigue,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Hyperpyrexia,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Hyperpyrexia,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Hypersensitivity,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Hypersensitivity,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Laryngitis,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Laryngitis,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Lower respiratory tract infection,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Lower respiratory tract infection,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Nasopharyngitis,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Nasopharyngitis,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Neutropenia,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Neutropenia,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Pharyngitis,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Pharyngitis,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Pneumonia viral,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Pneumonia viral,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Pyrexia,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Pyrexia,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Rash,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Rash,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Respiratory distress,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Respiratory distress,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Respiratory syncytial virus bronchitis,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Respiratory syncytial virus bronchitis,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Stridor,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Stridor,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Tonsillitis,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Tonsillitis,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Tracheitis,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Tracheitis,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Urticaria,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Urticaria,6,M,OT,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Viral infection,6,M,HO,29
1485896012,6,Metastatic malignant melanoma,12,F,EXP,trametinib,6,SS,Viral infection,6,M,OT,29
148831677,2,Plasma cell myeloma,7,F,EXP,pomalidomide,2,SS,Lower respiratory tract infection,2,M,OT,240
148853015,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,SS,Hepatitis,2,M,OT,69
148853015,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,SS,Hepatitis,2,M,HO,69
148953572,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Eosinophilia,1,M,OT,52
148953572,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Lung disorder,1,M,OT,52
148973598,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,SS,Hyponatraemia,1,M,HO,62
148973598,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,SS,Hyponatraemia,1,M,OT,62
148973598,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,SS,Hyponatraemia,1,M,LT,62
148973598,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,SS,Hypophysitis,1,M,HO,62
148973598,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,SS,Hypophysitis,1,M,OT,62
148973598,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,SS,Hypophysitis,1,M,LT,62
148973598,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,PS,Hyponatraemia,2,M,HO,62
148973598,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,PS,Hyponatraemia,2,M,OT,62
148973598,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,PS,Hyponatraemia,2,M,LT,62
148973598,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,PS,Hypophysitis,2,M,HO,62
148973598,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,PS,Hypophysitis,2,M,OT,62
148973598,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,PS,Hypophysitis,2,M,LT,62
148973598,3,Product used for unknown indication,8,F,EXP,ipilimumab,3,SS,Hyponatraemia,3,M,HO,19
148973598,3,Product used for unknown indication,8,F,EXP,ipilimumab,3,SS,Hyponatraemia,3,M,OT,19
148973598,3,Product used for unknown indication,8,F,EXP,ipilimumab,3,SS,Hyponatraemia,3,M,LT,19
148973598,3,Product used for unknown indication,8,F,EXP,ipilimumab,3,SS,Hypophysitis,3,M,HO,19
148973598,3,Product used for unknown indication,8,F,EXP,ipilimumab,3,SS,Hypophysitis,3,M,OT,19
148973598,3,Product used for unknown indication,8,F,EXP,ipilimumab,3,SS,Hypophysitis,3,M,LT,19
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Abdominal tenderness,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Abdominal tenderness,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Abdominal tenderness,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Anaemia,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Ascites,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Ascites,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Ascites,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Bone pain,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Bone pain,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Bone pain,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Cachexia,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Cachexia,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Cachexia,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Chest pain,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Chest pain,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Chest pain,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Cholestasis,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Cholestasis,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Cholestasis,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Constipation,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Constipation,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Constipation,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Cough,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Cough,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Cough,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Fatigue,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Hepatic pain,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Hepatic pain,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Hepatic pain,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Jaundice,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Jaundice,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Jaundice,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Lymphoedema,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Lymphoedema,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Lymphoedema,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Melaena,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Melaena,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Melaena,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Metastases to bone,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Metastases to bone,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Metastases to bone,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Metastases to liver,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Metastases to liver,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Metastases to liver,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Metastases to pancreas,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Metastases to pancreas,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Metastases to pancreas,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Nausea,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Osteolysis,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Osteolysis,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Osteolysis,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pain,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pain,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pain,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pain in extremity,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pain in extremity,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pain in extremity,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pancreatic duct dilatation,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pancreatic duct dilatation,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pancreatic duct dilatation,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pancreatic mass,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pancreatic mass,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pancreatic mass,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Productive cough,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Productive cough,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Productive cough,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pyrexia,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Thrombocytosis,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Thrombocytosis,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Thrombocytosis,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Vomiting,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Weight decreased,1,M,DE,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Weight decreased,1,M,HO,40
1490804911,1,Non-small cell lung cancer,11,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,40
149093213,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Myocardial infarction,3,M,HO,89
149093213,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Myocardial infarction,3,M,OT,89
149093213,4,Renal cell carcinoma,3,F,EXP,ipilimumab,4,SS,Myocardial infarction,4,M,HO,89
149093213,4,Renal cell carcinoma,3,F,EXP,ipilimumab,4,SS,Myocardial infarction,4,M,OT,89
149101887,1,Malignant melanoma,7,F,PER,talimogene laherparepvec,1,PS,Tumour associated fever,1,M,HO,510
149105677,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,129
149105677,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,LT,129
149105677,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,129
149105677,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,DE,129
149105677,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,HO,129
149105677,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,LT,129
149105677,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,129
149105677,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,DE,129
149105677,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Weight decreased,1,M,HO,129
149105677,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Weight decreased,1,M,LT,129
149105677,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,129
149105677,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Weight decreased,1,M,DE,129
149105677,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Decreased appetite,2,M,HO,38
149105677,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Decreased appetite,2,M,LT,38
149105677,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Decreased appetite,2,M,OT,38
149105677,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Decreased appetite,2,M,DE,38
149105677,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Pulmonary embolism,2,M,HO,38
149105677,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Pulmonary embolism,2,M,LT,38
149105677,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Pulmonary embolism,2,M,OT,38
149105677,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Pulmonary embolism,2,M,DE,38
149105677,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Weight decreased,2,M,HO,38
149105677,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Weight decreased,2,M,LT,38
149105677,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Weight decreased,2,M,OT,38
149105677,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Weight decreased,2,M,DE,38
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Cough,6,F,HO,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Cough,6,F,OT,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Diarrhoea,6,F,HO,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Diarrhoea,6,F,OT,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Dysphonia,6,F,HO,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Dysphonia,6,F,OT,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Fatigue,6,F,HO,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Fatigue,6,F,OT,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Laryngeal inflammation,6,F,HO,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Laryngeal inflammation,6,F,OT,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Leukopenia,6,F,HO,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Leukopenia,6,F,OT,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Neutropenia,6,F,HO,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Neutropenia,6,F,OT,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Oral candidiasis,6,F,HO,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Oral candidiasis,6,F,OT,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Pyrexia,6,F,HO,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Pyrexia,6,F,OT,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Viral diarrhoea,6,F,HO,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Viral diarrhoea,6,F,OT,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Vomiting,6,F,HO,149
149118109,6,Plasma cell myeloma,9,F,EXP,pomalidomide,6,SS,Vomiting,6,F,OT,149
149150622,2,Renal cell carcinoma,2,F,EXP,avelumab,2,SS,Cellulitis,2,F,HO,6
149173545,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Haematemesis,1,M,OT,195
149173545,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Haematemesis,1,M,HO,195
149173545,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,195
149173545,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,HO,195
149173545,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,195
149173545,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,195
149173545,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,195
149173545,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,195
149173545,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,195
149173545,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,195
149173545,3,Head and neck cancer,5,F,EXP,ipilimumab,3,SS,Haematemesis,3,M,OT,195
149173545,3,Head and neck cancer,5,F,EXP,ipilimumab,3,SS,Haematemesis,3,M,HO,195
149173545,3,Head and neck cancer,5,F,EXP,ipilimumab,3,SS,Intentional product use issue,3,M,OT,195
149173545,3,Head and neck cancer,5,F,EXP,ipilimumab,3,SS,Intentional product use issue,3,M,HO,195
149173545,3,Head and neck cancer,5,F,EXP,ipilimumab,3,SS,Pneumonia,3,M,OT,195
149173545,3,Head and neck cancer,5,F,EXP,ipilimumab,3,SS,Pneumonia,3,M,HO,195
149173545,3,Head and neck cancer,5,F,EXP,ipilimumab,3,SS,Pneumonitis,3,M,OT,195
149173545,3,Head and neck cancer,5,F,EXP,ipilimumab,3,SS,Pneumonitis,3,M,HO,195
149173545,3,Head and neck cancer,5,F,EXP,ipilimumab,3,SS,Vomiting,3,M,OT,195
149173545,3,Head and neck cancer,5,F,EXP,ipilimumab,3,SS,Vomiting,3,M,HO,195
149260036,1,Acute lymphocytic leukaemia,6,F,PER,blinatumomab,1,PS,Fall,1,M,HO,80
149364034,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,F,HO,37
149364034,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,F,OT,37
149364034,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Troponin I increased,1,F,HO,37
149364034,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Troponin I increased,1,F,OT,37
149364034,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Urosepsis,1,F,HO,37
149364034,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Urosepsis,1,F,OT,37
149364034,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,F,HO,37
149364034,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,F,OT,37
149364034,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Troponin I increased,2,F,HO,37
149364034,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Troponin I increased,2,F,OT,37
149364034,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Urosepsis,2,F,HO,37
149364034,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Urosepsis,2,F,OT,37
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Asthenia,1,M,LT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Back pain,1,M,OT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Back pain,1,M,HO,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Back pain,1,M,LT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Diabetic metabolic decompensation,1,M,OT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Diabetic metabolic decompensation,1,M,HO,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Diabetic metabolic decompensation,1,M,LT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Duodenitis,1,M,OT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Duodenitis,1,M,HO,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Duodenitis,1,M,LT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Fatigue,1,M,LT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,M,OT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,M,HO,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,M,LT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Nausea,1,M,LT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Palmar-plantar erythrodysaesthesia syndrome,1,M,OT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Palmar-plantar erythrodysaesthesia syndrome,1,M,HO,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Palmar-plantar erythrodysaesthesia syndrome,1,M,LT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,OT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,HO,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,LT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Thrombosis,1,M,OT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Thrombosis,1,M,HO,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Thrombosis,1,M,LT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,28
149367457,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Vomiting,1,M,LT,28
149393012,1,Metastatic squamous cell carcinoma,2,F,EXP,ipilimumab,1,SS,Psoriasis,1,M,HO,41
149393012,2,Metastatic squamous cell carcinoma,2,F,EXP,nivolumab,2,PS,Psoriasis,2,M,HO,41
1494467112,60,Neutropenia,12,F,EXP,filgrastim,60,C,Haemorrhage intracranial,60,F,HO,7
1494467112,60,Neutropenia,12,F,EXP,filgrastim,60,C,Leukopenia,60,F,HO,7
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Abnormal sensation in eye,16,F,DS,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Abnormal sensation in eye,16,F,HO,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Asthenia,16,F,DS,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Asthenia,16,F,HO,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Decreased appetite,16,F,DS,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Decreased appetite,16,F,HO,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Depression,16,F,DS,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Depression,16,F,HO,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Dyschezia,16,F,DS,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Dyschezia,16,F,HO,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Hypocalcaemia,16,F,DS,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Hypocalcaemia,16,F,HO,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Lethargy,16,F,DS,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Lethargy,16,F,HO,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Migraine,16,F,DS,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Migraine,16,F,HO,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Nasopharyngitis,16,F,DS,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Nasopharyngitis,16,F,HO,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Oropharyngeal pain,16,F,DS,39
149633203,16,Prophylaxis,3,F,EXP,filgrastim,16,C,Oropharyngeal pain,16,F,HO,39
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Constipation,1,M,OT,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Constipation,1,M,HO,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Dermatitis acneiform,1,M,OT,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Dermatitis acneiform,1,M,HO,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Epistaxis,1,M,OT,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Epistaxis,1,M,HO,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Fatigue,1,M,OT,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Fatigue,1,M,HO,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Hypertension,1,M,OT,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Hypertension,1,M,HO,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Hypocalcaemia,1,M,OT,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Hypocalcaemia,1,M,HO,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Infection,1,M,OT,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Infection,1,M,HO,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Lymphocyte count decreased,1,M,OT,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Lymphocyte count decreased,1,M,HO,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Mucosal inflammation,1,M,OT,1
1496624914,1,Colorectal cancer metastatic,14,F,PER,panitumumab,1,PS,Mucosal inflammation,1,M,HO,1
149740642,3,Anal cancer,2,F,EXP,panitumumab,3,SS,Diarrhoea,3,F,HO,6
149740642,3,Anal cancer,2,F,EXP,panitumumab,3,SS,General physical health deterioration,3,F,HO,6
149793226,3,Plasma cell myeloma,6,F,EXP,pomalidomide,3,SS,Neutropenia,3,F,HO,13
149793226,3,Plasma cell myeloma,6,F,EXP,pomalidomide,3,SS,Thrombocytopenia,3,F,HO,13
1498729115,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,OT,13
1498729115,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Dermatitis exfoliative generalised,1,M,OT,13
1498729115,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,13
1498729115,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Hyperkeratosis,1,M,OT,13
1498729115,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,OT,13
1498729115,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Lymphocyte count decreased,1,M,OT,13
1498729115,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,13
1498729115,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Skin papilloma,1,M,OT,13
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Asthenia,3,M,LT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Asthenia,3,M,OT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Asthenia,3,M,DE,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Asthenia,3,M,HO,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Cognitive disorder,3,M,LT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Cognitive disorder,3,M,OT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Cognitive disorder,3,M,DE,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Cognitive disorder,3,M,HO,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Condition aggravated,3,M,LT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Condition aggravated,3,M,OT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Condition aggravated,3,M,DE,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Condition aggravated,3,M,HO,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Decreased appetite,3,M,LT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Decreased appetite,3,M,OT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Decreased appetite,3,M,DE,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Decreased appetite,3,M,HO,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Gait disturbance,3,M,LT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Gait disturbance,3,M,OT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Gait disturbance,3,M,DE,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Gait disturbance,3,M,HO,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,General physical health deterioration,3,M,LT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,General physical health deterioration,3,M,OT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,General physical health deterioration,3,M,DE,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,General physical health deterioration,3,M,HO,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,LT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,OT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,DE,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,HO,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Metastases to bone,3,M,LT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Metastases to bone,3,M,OT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Metastases to bone,3,M,DE,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Metastases to bone,3,M,HO,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Metastases to central nervous system,3,M,LT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Metastases to central nervous system,3,M,OT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Metastases to central nervous system,3,M,DE,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Metastases to central nervous system,3,M,HO,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Somnolence,3,M,LT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Somnolence,3,M,OT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Somnolence,3,M,DE,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Somnolence,3,M,HO,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Syncope,3,M,LT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Syncope,3,M,OT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Syncope,3,M,DE,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Syncope,3,M,HO,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Tendon disorder,3,M,LT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Tendon disorder,3,M,OT,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Tendon disorder,3,M,DE,4
149930555,3,Lung neoplasm malignant,5,F,EXP,nivolumab,3,SS,Tendon disorder,3,M,HO,4
149987282,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Asthenia,1,M,HO,53
149987282,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,53
149987282,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Asthenia,1,M,DE,53
149987282,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Death,1,M,HO,53
149987282,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Death,1,M,OT,53
149987282,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Death,1,M,DE,53
149987282,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Faeces discoloured,1,M,HO,53
149987282,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Faeces discoloured,1,M,OT,53
149987282,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Faeces discoloured,1,M,DE,53
149987282,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Product dose omission,1,M,HO,53
149987282,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Product dose omission,1,M,OT,53
149987282,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Product dose omission,1,M,DE,53
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Anxiety,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Balance disorder,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Blood pressure increased,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Bowel movement irregularity,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Confusional state,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Depression,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Diarrhoea,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Disturbance in attention,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Dyspnoea,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Gait disturbance,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Haemoglobin abnormal,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Haemoglobin decreased,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Hot flush,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Insomnia,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Lymphadenopathy,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Memory impairment,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Product dose omission,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Retching,1,M,OT,1
1499979914,1,Prostate cancer,14,F,EXP,enzalutamide,1,PS,Vomiting,1,M,OT,1
150118542,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,314
150118542,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,OT,314
150170943,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Asthenia,1,F,HO,3
150170943,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Asthenia,1,F,OT,3
150170943,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Autoimmune disorder,1,F,HO,3
150170943,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Autoimmune disorder,1,F,OT,3
150170943,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Dehydration,1,F,HO,3
150170943,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Dehydration,1,F,OT,3
150170943,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Inappropriate schedule of product administration,1,F,HO,3
150170943,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Inappropriate schedule of product administration,1,F,OT,3
150170943,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,HO,3
150170943,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,OT,3
150173454,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hepatotoxicity,1,M,OT,50
150173454,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hepatotoxicity,1,M,LT,50
150173454,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hepatotoxicity,1,M,HO,50
150173454,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hepatotoxicity,1,M,DE,50
150173454,2,Non-small cell lung cancer,4,F,EXP,ipilimumab,2,SS,Hepatotoxicity,2,M,OT,50
150173454,2,Non-small cell lung cancer,4,F,EXP,ipilimumab,2,SS,Hepatotoxicity,2,M,LT,50
150173454,2,Non-small cell lung cancer,4,F,EXP,ipilimumab,2,SS,Hepatotoxicity,2,M,HO,50
150173454,2,Non-small cell lung cancer,4,F,EXP,ipilimumab,2,SS,Hepatotoxicity,2,M,DE,50
150173454,4,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,4,SS,Hepatotoxicity,4,M,OT,50
150173454,4,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,4,SS,Hepatotoxicity,4,M,LT,50
150173454,4,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,4,SS,Hepatotoxicity,4,M,HO,50
150173454,4,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,4,SS,Hepatotoxicity,4,M,DE,50
150304805,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Atrial fibrillation,1,M,LT,282
150304805,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Atrial fibrillation,1,M,HO,282
150304805,3,Plasma cell myeloma,5,F,PER,daratumumab,3,SS,Atrial fibrillation,3,M,LT,282
150304805,3,Plasma cell myeloma,5,F,PER,daratumumab,3,SS,Atrial fibrillation,3,M,HO,282
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Bradycardia,1,M,DS,126
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Bradycardia,1,M,HO,126
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Bradycardia,1,M,OT,126
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Dehydration,1,M,DS,126
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Dehydration,1,M,HO,126
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Dehydration,1,M,OT,126
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Hyperkalaemia,1,M,DS,126
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Hyperkalaemia,1,M,HO,126
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Hyperkalaemia,1,M,OT,126
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Renal disorder,1,M,DS,126
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Renal disorder,1,M,HO,126
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Renal disorder,1,M,OT,126
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Renal impairment,1,M,DS,126
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Renal impairment,1,M,HO,126
150366166,1,Myelodysplastic syndrome,6,F,PER,darbepoetin alfa,1,PS,Renal impairment,1,M,OT,126
150410014,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,Malignant neoplasm progression,2,M,LT,21
150410014,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,Malignant neoplasm progression,2,M,OT,21
150410014,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,White blood cell count decreased,2,M,LT,21
150410014,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,White blood cell count decreased,2,M,OT,21
150410014,3,Product used for unknown indication,4,F,EXP,lenalidomide,3,SS,Malignant neoplasm progression,3,M,LT,1
150410014,3,Product used for unknown indication,4,F,EXP,lenalidomide,3,SS,Malignant neoplasm progression,3,M,OT,1
150410014,3,Product used for unknown indication,4,F,EXP,lenalidomide,3,SS,White blood cell count decreased,3,M,LT,1
150410014,3,Product used for unknown indication,4,F,EXP,lenalidomide,3,SS,White blood cell count decreased,3,M,OT,1
150477657,1,Transitional cell cancer of renal pelvis and ureter metastatic,7,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,51
150477657,1,Transitional cell cancer of renal pelvis and ureter metastatic,7,F,EXP,nivolumab,1,PS,Colitis,1,M,DE,51
150477657,1,Transitional cell cancer of renal pelvis and ureter metastatic,7,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,51
150477657,1,Transitional cell cancer of renal pelvis and ureter metastatic,7,F,EXP,nivolumab,1,PS,Intestinal perforation,1,M,HO,51
150477657,1,Transitional cell cancer of renal pelvis and ureter metastatic,7,F,EXP,nivolumab,1,PS,Intestinal perforation,1,M,DE,51
150477657,1,Transitional cell cancer of renal pelvis and ureter metastatic,7,F,EXP,nivolumab,1,PS,Intestinal perforation,1,M,OT,51
150477657,2,Transitional cell cancer of renal pelvis and ureter metastatic,7,F,EXP,ipilimumab,2,SS,Colitis,2,M,HO,51
150477657,2,Transitional cell cancer of renal pelvis and ureter metastatic,7,F,EXP,ipilimumab,2,SS,Colitis,2,M,DE,51
150477657,2,Transitional cell cancer of renal pelvis and ureter metastatic,7,F,EXP,ipilimumab,2,SS,Colitis,2,M,OT,51
150477657,2,Transitional cell cancer of renal pelvis and ureter metastatic,7,F,EXP,ipilimumab,2,SS,Intestinal perforation,2,M,HO,51
150477657,2,Transitional cell cancer of renal pelvis and ureter metastatic,7,F,EXP,ipilimumab,2,SS,Intestinal perforation,2,M,DE,51
150477657,2,Transitional cell cancer of renal pelvis and ureter metastatic,7,F,EXP,ipilimumab,2,SS,Intestinal perforation,2,M,OT,51
150495812,1,Prostate cancer metastatic,2,F,EXP,enzalutamide,1,PS,Cerebrovascular accident,1,M,HO,67
150495812,1,Prostate cancer metastatic,2,F,EXP,enzalutamide,1,PS,Cerebrovascular accident,1,M,OT,67
150495812,1,Prostate cancer metastatic,2,F,EXP,enzalutamide,1,PS,Intentional dose omission,1,M,HO,67
150495812,1,Prostate cancer metastatic,2,F,EXP,enzalutamide,1,PS,Intentional dose omission,1,M,OT,67
150495812,1,Prostate cancer metastatic,2,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,HO,67
150495812,1,Prostate cancer metastatic,2,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,OT,67
150511012,2,Renal cell carcinoma,2,F,EXP,avelumab,2,SS,Irregular sleep wake rhythm disorder,2,M,HO,232
150514804,3,Mantle cell lymphoma,4,F,EXP,ibrutinib,3,SS,Abdominal pain,3,M,HO,1220
150514804,3,Mantle cell lymphoma,4,F,EXP,ibrutinib,3,SS,Abdominal pain,3,M,OT,1220
150514804,3,Mantle cell lymphoma,4,F,EXP,ibrutinib,3,SS,Back pain,3,M,HO,1220
150514804,3,Mantle cell lymphoma,4,F,EXP,ibrutinib,3,SS,Back pain,3,M,OT,1220
150514804,3,Mantle cell lymphoma,4,F,EXP,ibrutinib,3,SS,Prostate cancer,3,M,HO,1220
150514804,3,Mantle cell lymphoma,4,F,EXP,ibrutinib,3,SS,Prostate cancer,3,M,OT,1220
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,Blood creatinine increased,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone increased,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,Crystal urine present,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,Crystalluria,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,Glycosuria,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,Lymphocyte count increased,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,Monocyte count increased,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,Neutrophil count decreased,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,Platelet count decreased,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,Platelet count increased,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,Platelet morphology abnormal,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,Thrombocytopenia,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,Thrombocytosis,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,M,OT,30
1505388624,1,Multiple sclerosis,24,F,EXP,alemtuzumab,1,PS,White blood cell count increased,1,M,OT,30
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Alanine aminotransferase increased,12,M,CA,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Alanine aminotransferase increased,12,M,DE,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Alanine aminotransferase increased,12,M,HO,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Blood alkaline phosphatase increased,12,M,CA,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Blood alkaline phosphatase increased,12,M,DE,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Blood alkaline phosphatase increased,12,M,HO,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,C-reactive protein increased,12,M,CA,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,C-reactive protein increased,12,M,DE,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,C-reactive protein increased,12,M,HO,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Diarrhoea,12,M,CA,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Diarrhoea,12,M,DE,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Diarrhoea,12,M,HO,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,General physical health deterioration,12,M,CA,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,General physical health deterioration,12,M,DE,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,General physical health deterioration,12,M,HO,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Laboratory test abnormal,12,M,CA,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Laboratory test abnormal,12,M,DE,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Laboratory test abnormal,12,M,HO,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Leukopenia,12,M,CA,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Leukopenia,12,M,DE,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Leukopenia,12,M,HO,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Mucosal inflammation,12,M,CA,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Mucosal inflammation,12,M,DE,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Mucosal inflammation,12,M,HO,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Non-small cell lung cancer,12,M,CA,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Non-small cell lung cancer,12,M,DE,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Non-small cell lung cancer,12,M,HO,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Stomatitis,12,M,CA,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Stomatitis,12,M,DE,17
150585206,12,Prophylaxis,6,F,EXP,granisetron,12,C,Stomatitis,12,M,HO,17
150619845,1,Gastric cancer,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,224
150619845,1,Gastric cancer,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,LT,224
150619845,1,Gastric cancer,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,224
150619845,1,Gastric cancer,5,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,224
150619845,1,Gastric cancer,5,F,EXP,nivolumab,1,PS,Sepsis,1,M,LT,224
150619845,1,Gastric cancer,5,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,224
150650134,1,Non-small cell lung cancer recurrent,4,F,EXP,nivolumab,1,PS,Cholangitis sclerosing,1,F,OT,328
150650134,1,Non-small cell lung cancer recurrent,4,F,EXP,nivolumab,1,PS,Cholangitis sclerosing,1,F,HO,328
150650134,1,Non-small cell lung cancer recurrent,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,328
150650134,1,Non-small cell lung cancer recurrent,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,328
150667249,11,Prophylaxis,9,F,EXP,rasburicase,11,C,Brain neoplasm,11,F,DE,88
150667249,11,Prophylaxis,9,F,EXP,rasburicase,11,C,Brain neoplasm,11,F,DS,88
150667249,11,Prophylaxis,9,F,EXP,rasburicase,11,C,Brain neoplasm,11,F,LT,88
150667249,11,Prophylaxis,9,F,EXP,rasburicase,11,C,Brain neoplasm,11,F,HO,88
150667249,11,Prophylaxis,9,F,EXP,rasburicase,11,C,Cerebral disorder,11,F,DE,88
150667249,11,Prophylaxis,9,F,EXP,rasburicase,11,C,Cerebral disorder,11,F,DS,88
150667249,11,Prophylaxis,9,F,EXP,rasburicase,11,C,Cerebral disorder,11,F,LT,88
150667249,11,Prophylaxis,9,F,EXP,rasburicase,11,C,Cerebral disorder,11,F,HO,88
150811947,1,Acute lymphocytic leukaemia,7,F,PER,blinatumomab,1,PS,Arthralgia,1,F,HO,24
150811947,1,Acute lymphocytic leukaemia,7,F,PER,blinatumomab,1,PS,Arthralgia,1,F,LT,24
150811947,1,Acute lymphocytic leukaemia,7,F,PER,blinatumomab,1,PS,Headache,1,F,HO,24
150811947,1,Acute lymphocytic leukaemia,7,F,PER,blinatumomab,1,PS,Headache,1,F,LT,24
150811947,1,Acute lymphocytic leukaemia,7,F,PER,blinatumomab,1,PS,Pain in extremity,1,F,HO,24
150811947,1,Acute lymphocytic leukaemia,7,F,PER,blinatumomab,1,PS,Pain in extremity,1,F,LT,24
150811947,1,Acute lymphocytic leukaemia,7,F,PER,blinatumomab,1,PS,Pyrexia,1,F,HO,24
150811947,1,Acute lymphocytic leukaemia,7,F,PER,blinatumomab,1,PS,Pyrexia,1,F,LT,24
150811947,1,Acute lymphocytic leukaemia,7,F,PER,blinatumomab,1,PS,White blood cell count increased,1,F,HO,24
150811947,1,Acute lymphocytic leukaemia,7,F,PER,blinatumomab,1,PS,White blood cell count increased,1,F,LT,24
150822316,16,Prophylaxis of nausea and vomiting,6,F,EXP,granisetron,16,C,Acute coronary syndrome,16,M,HO,14
150822316,16,Prophylaxis of nausea and vomiting,6,F,EXP,granisetron,16,C,Acute coronary syndrome,16,M,LT,14
150822316,16,Prophylaxis of nausea and vomiting,6,F,EXP,granisetron,16,C,Pharyngotonsillitis,16,M,HO,14
150822316,16,Prophylaxis of nausea and vomiting,6,F,EXP,granisetron,16,C,Pharyngotonsillitis,16,M,LT,14
150841232,3,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,3,SS,Hepatotoxicity,3,M,OT,45
150841232,3,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,3,SS,Hepatotoxicity,3,M,HO,45
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Atypical pneumonia,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Atypical pneumonia,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Atypical pneumonia,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Cough,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Cough,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Cough,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Dry mouth,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Dry mouth,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Dry mouth,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Gastroenteritis rotavirus,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Gastroenteritis rotavirus,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Gastroenteritis rotavirus,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Gastrointestinal infection,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Gastrointestinal infection,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Gastrointestinal infection,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Glucocorticoid deficiency,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Glucocorticoid deficiency,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Glucocorticoid deficiency,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Headache,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Headache,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Headache,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Hypoaesthesia oral,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Hypoaesthesia oral,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Hypoaesthesia oral,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Infection,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Infection,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Infection,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Lip discolouration,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Lip discolouration,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Lip discolouration,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Malaise,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Malaise,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Malaise,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Metastases to lymph nodes,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Metastases to lymph nodes,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Metastases to lymph nodes,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Metastases to muscle,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Metastases to muscle,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Metastases to muscle,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Mucosal discolouration,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Mucosal discolouration,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Mucosal discolouration,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Nausea,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Nephropathy toxic,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Nephropathy toxic,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Nephropathy toxic,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Pyrexia,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Pyrexia,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Rhinorrhoea,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Rhinorrhoea,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Rhinorrhoea,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Sepsis,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Sepsis,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Sepsis,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Trismus,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Trismus,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Trismus,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Vertigo,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Vertigo,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Vertigo,1,F,HO,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Vomiting,1,F,DE,6
1508441512,1,Non-small cell lung cancer,12,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,6
150877679,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Hepatotoxicity,1,F,HO,1
150877679,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Hepatotoxicity,1,F,LT,1
150877679,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Hot flush,1,F,HO,1
150877679,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Hot flush,1,F,LT,1
150877679,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Hypokalaemia,1,F,HO,1
150877679,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Hypokalaemia,1,F,LT,1
150877679,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Neutropenia,1,F,HO,1
150877679,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Neutropenia,1,F,LT,1
150877679,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Neutropenic sepsis,1,F,HO,1
150877679,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Neutropenic sepsis,1,F,LT,1
150877679,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Petechiae,1,F,HO,1
150877679,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Petechiae,1,F,LT,1
150877679,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Pyrexia,1,F,HO,1
150877679,1,Acute lymphocytic leukaemia,9,F,PER,blinatumomab,1,PS,Pyrexia,1,F,LT,1
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Abdominal pain,1,F,HO,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Abdominal pain,1,F,OT,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Arthritis,1,F,HO,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Arthritis,1,F,OT,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Back pain,1,F,HO,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Back pain,1,F,OT,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Bronchitis,1,F,HO,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Bronchitis,1,F,OT,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Haematochezia,1,F,HO,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Haematochezia,1,F,OT,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Headache,1,F,HO,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Headache,1,F,OT,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Influenza like illness,1,F,HO,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Influenza like illness,1,F,OT,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Paraesthesia,1,F,HO,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Paraesthesia,1,F,OT,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,F,HO,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,F,OT,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Skin disorder,1,F,HO,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Skin disorder,1,F,OT,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Transaminases increased,1,F,HO,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Transaminases increased,1,F,OT,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,HO,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,OT,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Vaginal discharge,1,F,HO,15
1509548716,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Vaginal discharge,1,F,OT,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Abdominal pain,2,F,HO,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Abdominal pain,2,F,OT,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Arthritis,2,F,HO,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Arthritis,2,F,OT,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Back pain,2,F,HO,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Back pain,2,F,OT,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Bronchitis,2,F,HO,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Bronchitis,2,F,OT,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Haematochezia,2,F,HO,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Haematochezia,2,F,OT,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Headache,2,F,HO,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Headache,2,F,OT,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Influenza like illness,2,F,HO,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Influenza like illness,2,F,OT,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Nausea,2,F,HO,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Nausea,2,F,OT,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Paraesthesia,2,F,HO,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Paraesthesia,2,F,OT,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Rash maculo-papular,2,F,HO,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Rash maculo-papular,2,F,OT,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Skin disorder,2,F,HO,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Skin disorder,2,F,OT,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Transaminases increased,2,F,HO,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Transaminases increased,2,F,OT,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Urinary tract infection,2,F,HO,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Urinary tract infection,2,F,OT,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Vaginal discharge,2,F,HO,15
1509548716,2,Product used for unknown indication,16,F,EXP,nivolumab,2,SS,Vaginal discharge,2,F,OT,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Abdominal pain,3,F,HO,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Abdominal pain,3,F,OT,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Arthritis,3,F,HO,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Arthritis,3,F,OT,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Back pain,3,F,HO,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Back pain,3,F,OT,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Bronchitis,3,F,HO,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Bronchitis,3,F,OT,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Haematochezia,3,F,HO,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Haematochezia,3,F,OT,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Headache,3,F,HO,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Headache,3,F,OT,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Influenza like illness,3,F,HO,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Influenza like illness,3,F,OT,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Nausea,3,F,HO,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Nausea,3,F,OT,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Paraesthesia,3,F,HO,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Paraesthesia,3,F,OT,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Rash maculo-papular,3,F,HO,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Rash maculo-papular,3,F,OT,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Skin disorder,3,F,HO,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Skin disorder,3,F,OT,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Transaminases increased,3,F,HO,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Transaminases increased,3,F,OT,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Urinary tract infection,3,F,HO,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Urinary tract infection,3,F,OT,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Vaginal discharge,3,F,HO,15
1509548716,3,Malignant melanoma,16,F,EXP,ipilimumab,3,SS,Vaginal discharge,3,F,OT,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Abdominal pain,4,F,HO,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Abdominal pain,4,F,OT,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Arthritis,4,F,HO,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Arthritis,4,F,OT,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Back pain,4,F,HO,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Back pain,4,F,OT,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Bronchitis,4,F,HO,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Bronchitis,4,F,OT,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Haematochezia,4,F,HO,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Haematochezia,4,F,OT,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Headache,4,F,HO,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Headache,4,F,OT,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Influenza like illness,4,F,HO,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Influenza like illness,4,F,OT,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Nausea,4,F,HO,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Nausea,4,F,OT,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Paraesthesia,4,F,HO,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Paraesthesia,4,F,OT,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Rash maculo-papular,4,F,HO,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Rash maculo-papular,4,F,OT,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Skin disorder,4,F,HO,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Skin disorder,4,F,OT,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Transaminases increased,4,F,HO,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Transaminases increased,4,F,OT,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Urinary tract infection,4,F,HO,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Urinary tract infection,4,F,OT,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Vaginal discharge,4,F,HO,15
1509548716,4,Product used for unknown indication,16,F,EXP,ipilimumab,4,SS,Vaginal discharge,4,F,OT,15
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,HO,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,OT,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,DE,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Asthenia,1,M,DE,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Autoimmune lung disease,1,M,HO,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Autoimmune lung disease,1,M,OT,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Autoimmune lung disease,1,M,DE,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Bone pain,1,M,HO,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Bone pain,1,M,OT,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Bone pain,1,M,DE,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Bronchitis,1,M,HO,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Bronchitis,1,M,OT,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Bronchitis,1,M,DE,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,HO,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,OT,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,DE,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dysuria,1,M,HO,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dysuria,1,M,OT,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Dysuria,1,M,DE,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,HO,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,OT,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,DE,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Limb deformity,1,M,HO,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Limb deformity,1,M,OT,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Limb deformity,1,M,DE,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Oxygen saturation decreased,1,M,HO,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Oxygen saturation decreased,1,M,OT,14
151002659,1,Lung neoplasm malignant,9,F,EXP,nivolumab,1,PS,Oxygen saturation decreased,1,M,DE,14
151050146,1,Plasma cell myeloma,6,F,PER,carfilzomib,1,PS,Sinusitis,1,F,HO,162
151050146,4,Plasma cell myeloma,6,F,PER,daratumumab,4,SS,Sinusitis,4,F,HO,162
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,C-reactive protein increased,5,M,OT,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,C-reactive protein increased,5,M,HO,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Chills,5,M,OT,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Chills,5,M,HO,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Cough,5,M,OT,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Cough,5,M,HO,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Dizziness,5,M,OT,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Dizziness,5,M,HO,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Dyspnoea,5,M,OT,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Dyspnoea,5,M,HO,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Dysuria,5,M,OT,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Dysuria,5,M,HO,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Fatigue,5,M,OT,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Fatigue,5,M,HO,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Flatulence,5,M,OT,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Flatulence,5,M,HO,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Headache,5,M,OT,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Headache,5,M,HO,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Malaise,5,M,OT,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Malaise,5,M,HO,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Pyrexia,5,M,OT,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Pyrexia,5,M,HO,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Sciatica,5,M,OT,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Sciatica,5,M,HO,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Vomiting,5,M,OT,1
1511046010,5,Metastatic malignant melanoma,10,F,EXP,trametinib,5,SS,Vomiting,5,M,HO,1
151174507,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Diabetic hyperosmolar coma,1,M,LT,73
151174507,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Diabetic hyperosmolar coma,1,M,HO,73
151174507,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Diabetic hyperosmolar coma,1,M,OT,73
151174507,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,M,LT,73
151174507,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,M,HO,73
151174507,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,M,OT,73
151174507,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,M,LT,73
151174507,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,M,HO,73
151174507,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,M,OT,73
151174507,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,LT,73
151174507,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,HO,73
151174507,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,OT,73
151174507,2,Gastric cancer,7,F,EXP,ipilimumab,2,SS,Diabetic hyperosmolar coma,2,M,LT,73
151174507,2,Gastric cancer,7,F,EXP,ipilimumab,2,SS,Diabetic hyperosmolar coma,2,M,HO,73
151174507,2,Gastric cancer,7,F,EXP,ipilimumab,2,SS,Diabetic hyperosmolar coma,2,M,OT,73
151174507,2,Gastric cancer,7,F,EXP,ipilimumab,2,SS,Hyperkalaemia,2,M,LT,73
151174507,2,Gastric cancer,7,F,EXP,ipilimumab,2,SS,Hyperkalaemia,2,M,HO,73
151174507,2,Gastric cancer,7,F,EXP,ipilimumab,2,SS,Hyperkalaemia,2,M,OT,73
151174507,2,Gastric cancer,7,F,EXP,ipilimumab,2,SS,Type 1 diabetes mellitus,2,M,LT,73
151174507,2,Gastric cancer,7,F,EXP,ipilimumab,2,SS,Type 1 diabetes mellitus,2,M,HO,73
151174507,2,Gastric cancer,7,F,EXP,ipilimumab,2,SS,Type 1 diabetes mellitus,2,M,OT,73
151174507,2,Gastric cancer,7,F,EXP,ipilimumab,2,SS,Upper gastrointestinal haemorrhage,2,M,LT,73
151174507,2,Gastric cancer,7,F,EXP,ipilimumab,2,SS,Upper gastrointestinal haemorrhage,2,M,HO,73
151174507,2,Gastric cancer,7,F,EXP,ipilimumab,2,SS,Upper gastrointestinal haemorrhage,2,M,OT,73
151216496,1,Plasma cell myeloma,6,F,EXP,daratumumab,1,PS,Sinusitis,1,F,HO,162
151216496,3,Plasma cell myeloma,6,F,EXP,carfilzomib,3,SS,Sinusitis,3,F,HO,162
151238783,4,Prophylaxis,3,F,EXP,filgrastim,4,C,Diarrhoea,4,F,HO,36
151238783,4,Prophylaxis,3,F,EXP,filgrastim,4,C,Fatigue,4,F,HO,36
151238783,4,Prophylaxis,3,F,EXP,filgrastim,4,C,Insomnia,4,F,HO,36
151238783,4,Prophylaxis,3,F,EXP,filgrastim,4,C,Pain in extremity,4,F,HO,36
151238783,4,Prophylaxis,3,F,EXP,filgrastim,4,C,Tooth extraction,4,F,HO,36
151238783,4,Prophylaxis,3,F,EXP,filgrastim,4,C,Tooth infection,4,F,HO,36
1512889816,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Cholelithiasis,1,M,OT,105
1512889816,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Cholelithiasis,1,M,HO,105
1512889816,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Diverticulum intestinal,1,M,OT,105
1512889816,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Diverticulum intestinal,1,M,HO,105
1512889816,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Ischaemia,1,M,OT,105
1512889816,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Ischaemia,1,M,HO,105
1512889816,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Nervous system disorder,1,M,OT,105
1512889816,1,Malignant melanoma,16,F,EXP,nivolumab,1,PS,Nervous system disorder,1,M,HO,105
151300423,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Neutropenia,3,M,OT,112
151308143,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Alanine aminotransferase increased,1,F,DE,8
151308143,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Alanine aminotransferase increased,1,F,OT,8
151308143,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Aspartate aminotransferase increased,1,F,DE,8
151308143,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Aspartate aminotransferase increased,1,F,OT,8
151308143,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Cardio-respiratory arrest,1,F,DE,8
151308143,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Cardio-respiratory arrest,1,F,OT,8
151308143,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Infusion related reaction,1,F,DE,8
151308143,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Infusion related reaction,1,F,OT,8
151308143,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Neutrophil count decreased,1,F,DE,8
151308143,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Neutrophil count decreased,1,F,OT,8
151308143,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Platelet count decreased,1,F,DE,8
151308143,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Platelet count decreased,1,F,OT,8
151308143,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,White blood cell count decreased,1,F,DE,8
151308143,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,White blood cell count decreased,1,F,OT,8
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Febrile neutropenia,1,M,DS,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Febrile neutropenia,1,M,LT,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Febrile neutropenia,1,M,OT,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Febrile neutropenia,1,M,HO,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Myelodysplastic syndrome,1,M,DS,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Myelodysplastic syndrome,1,M,LT,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Myelodysplastic syndrome,1,M,OT,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Myelodysplastic syndrome,1,M,HO,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia,1,M,DS,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia,1,M,LT,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia,1,M,OT,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia,1,M,HO,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,DS,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,LT,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,OT,42
151322795,1,Diffuse large B-cell lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,HO,42
151324218,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Acute kidney injury,1,M,OT,104
151324218,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Acute kidney injury,1,M,DS,104
151324218,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Acute kidney injury,1,M,HO,104
151324218,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Venoocclusive liver disease,1,M,OT,104
151324218,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Venoocclusive liver disease,1,M,DS,104
151324218,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Venoocclusive liver disease,1,M,HO,104
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Abdominal discomfort,1,F,OT,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Abdominal discomfort,1,F,HO,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Abdominal discomfort,1,F,DE,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,OT,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,HO,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,DE,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Hepatic failure,1,F,OT,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Hepatic failure,1,F,HO,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Hepatic failure,1,F,DE,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,DE,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Pyrexia,1,F,OT,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Pyrexia,1,F,DE,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Septic shock,1,F,OT,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Septic shock,1,F,HO,8
151330895,1,Non-small cell lung cancer metastatic,5,F,EXP,nivolumab,1,PS,Septic shock,1,F,DE,8
151495089,4,Plasma cell myeloma,9,F,EXP,pomalidomide,4,SS,Pneumonia streptococcal,4,F,OT,112
151506097,27,Plasma cell myeloma,7,F,EXP,lenalidomide,27,SS,Diarrhoea,27,M,OT,279
151506097,27,Plasma cell myeloma,7,F,EXP,lenalidomide,27,SS,Leukopenia,27,M,OT,279
151506097,27,Plasma cell myeloma,7,F,EXP,lenalidomide,27,SS,Lymphopenia,27,M,OT,279
151506097,27,Plasma cell myeloma,7,F,EXP,lenalidomide,27,SS,Neutropenia,27,M,OT,279
151506097,27,Plasma cell myeloma,7,F,EXP,lenalidomide,27,SS,Thrombocytopenia,27,M,OT,279
151506097,32,Plasma cell myeloma,7,F,EXP,carfilzomib,32,SS,Diarrhoea,32,M,OT,279
151506097,32,Plasma cell myeloma,7,F,EXP,carfilzomib,32,SS,Leukopenia,32,M,OT,279
151506097,32,Plasma cell myeloma,7,F,EXP,carfilzomib,32,SS,Lymphopenia,32,M,OT,279
151506097,32,Plasma cell myeloma,7,F,EXP,carfilzomib,32,SS,Neutropenia,32,M,OT,279
151506097,32,Plasma cell myeloma,7,F,EXP,carfilzomib,32,SS,Thrombocytopenia,32,M,OT,279
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Arthralgia,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Arthralgia,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Colitis,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Dizziness,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Dizziness,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Dizziness,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Fatigue,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Flank pain,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Flank pain,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Flank pain,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Headache,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Headache,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Headache,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Hyperhidrosis,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Hyperhidrosis,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Hyperhidrosis,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Ileus,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Ileus,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Ileus,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Iron deficiency anaemia,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Iron deficiency anaemia,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Iron deficiency anaemia,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Metastases to adrenals,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Metastases to adrenals,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Metastases to adrenals,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pain,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pain,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pain,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pain in extremity,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pain in extremity,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pain in extremity,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Palpitations,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Palpitations,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Palpitations,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Peritonitis bacterial,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Peritonitis bacterial,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Peritonitis bacterial,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,HO,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pyrexia,1,M,DE,43
1515064928,1,Renal cell carcinoma,28,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,43
151546835,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Aortic thrombosis,1,M,OT,783
151586149,1,Renal cell carcinoma,9,F,EXP,nivolumab,1,PS,Dehydration,1,F,OT,82
151586149,1,Renal cell carcinoma,9,F,EXP,nivolumab,1,PS,Dehydration,1,F,HO,82
151586149,1,Renal cell carcinoma,9,F,EXP,nivolumab,1,PS,Limbic encephalitis,1,F,OT,82
151586149,1,Renal cell carcinoma,9,F,EXP,nivolumab,1,PS,Limbic encephalitis,1,F,HO,82
151586149,2,Renal cell carcinoma,9,F,EXP,ipilimumab,2,SS,Dehydration,2,F,OT,82
151586149,2,Renal cell carcinoma,9,F,EXP,ipilimumab,2,SS,Dehydration,2,F,HO,82
151586149,2,Renal cell carcinoma,9,F,EXP,ipilimumab,2,SS,Limbic encephalitis,2,F,OT,82
151586149,2,Renal cell carcinoma,9,F,EXP,ipilimumab,2,SS,Limbic encephalitis,2,F,HO,82
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Adrenal insufficiency,1,F,DE,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Adrenal insufficiency,1,F,OT,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Adrenal insufficiency,1,F,HO,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Blood creatine phosphokinase increased,1,F,DE,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Blood creatine phosphokinase increased,1,F,OT,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Blood creatine phosphokinase increased,1,F,HO,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Hypothyroidism,1,F,DE,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Hypothyroidism,1,F,OT,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Hypothyroidism,1,F,HO,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Leukoderma,1,F,DE,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Leukoderma,1,F,OT,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Leukoderma,1,F,HO,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Liver disorder,1,F,DE,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Liver disorder,1,F,OT,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Liver disorder,1,F,HO,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,F,DE,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,F,OT,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,F,HO,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Renal impairment,1,F,DE,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Renal impairment,1,F,OT,152
151591518,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Renal impairment,1,F,HO,152
151599085,1,Hormone-refractory prostate cancer,5,F,EXP,cabazitaxel,1,PS,Colitis,1,M,DE,7
151599085,1,Hormone-refractory prostate cancer,5,F,EXP,cabazitaxel,1,PS,Colitis,1,M,HO,7
151599085,1,Hormone-refractory prostate cancer,5,F,EXP,cabazitaxel,1,PS,Febrile neutropenia,1,M,DE,7
151599085,1,Hormone-refractory prostate cancer,5,F,EXP,cabazitaxel,1,PS,Febrile neutropenia,1,M,HO,7
151599085,1,Hormone-refractory prostate cancer,5,F,EXP,cabazitaxel,1,PS,Haemobilia,1,M,DE,7
151599085,1,Hormone-refractory prostate cancer,5,F,EXP,cabazitaxel,1,PS,Haemobilia,1,M,HO,7
151599085,1,Hormone-refractory prostate cancer,5,F,EXP,cabazitaxel,1,PS,Hepatic failure,1,M,DE,7
151599085,1,Hormone-refractory prostate cancer,5,F,EXP,cabazitaxel,1,PS,Hepatic failure,1,M,HO,7
151732234,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Rash erythematous,1,F,HO,30
151732234,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Skin exfoliation,1,F,HO,30
151732234,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Rash erythematous,2,F,HO,30
151732234,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Skin exfoliation,2,F,HO,30
151807204,3,Diffuse large B-cell lymphoma refractory,4,F,EXP,axicabtagene ciloleucel,3,SS,Febrile neutropenia,3,M,HO,43
151807204,3,Diffuse large B-cell lymphoma refractory,4,F,EXP,axicabtagene ciloleucel,3,SS,Febrile neutropenia,3,M,DS,43
151807204,3,Diffuse large B-cell lymphoma refractory,4,F,EXP,axicabtagene ciloleucel,3,SS,Febrile neutropenia,3,M,LT,43
151807204,3,Diffuse large B-cell lymphoma refractory,4,F,EXP,axicabtagene ciloleucel,3,SS,Myelodysplastic syndrome,3,M,HO,43
151807204,3,Diffuse large B-cell lymphoma refractory,4,F,EXP,axicabtagene ciloleucel,3,SS,Myelodysplastic syndrome,3,M,DS,43
151807204,3,Diffuse large B-cell lymphoma refractory,4,F,EXP,axicabtagene ciloleucel,3,SS,Myelodysplastic syndrome,3,M,LT,43
151807204,3,Diffuse large B-cell lymphoma refractory,4,F,EXP,axicabtagene ciloleucel,3,SS,Pneumonia,3,M,HO,43
151807204,3,Diffuse large B-cell lymphoma refractory,4,F,EXP,axicabtagene ciloleucel,3,SS,Pneumonia,3,M,DS,43
151807204,3,Diffuse large B-cell lymphoma refractory,4,F,EXP,axicabtagene ciloleucel,3,SS,Pneumonia,3,M,LT,43
151807204,3,Diffuse large B-cell lymphoma refractory,4,F,EXP,axicabtagene ciloleucel,3,SS,Pyrexia,3,M,HO,43
151807204,3,Diffuse large B-cell lymphoma refractory,4,F,EXP,axicabtagene ciloleucel,3,SS,Pyrexia,3,M,DS,43
151807204,3,Diffuse large B-cell lymphoma refractory,4,F,EXP,axicabtagene ciloleucel,3,SS,Pyrexia,3,M,LT,43
151830025,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,SS,Enterocolitis,1,F,OT,48
151830025,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,SS,Enterocolitis,1,F,HO,48
151830025,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,PS,Enterocolitis,2,F,OT,48
151830025,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,PS,Enterocolitis,2,F,HO,48
1518361910,1,Acute lymphocytic leukaemia,10,F,PER,blinatumomab,1,PS,Back pain,1,M,HO,2
1518361910,1,Acute lymphocytic leukaemia,10,F,PER,blinatumomab,1,PS,Hepatotoxicity,1,M,HO,2
1518361910,1,Acute lymphocytic leukaemia,10,F,PER,blinatumomab,1,PS,Sepsis,1,M,HO,2
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Dehydration,1,M,DE,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,M,DE,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,M,OT,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,M,HO,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Inflammation,1,M,DE,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Inflammation,1,M,OT,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Inflammation,1,M,HO,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Off label use,1,M,DE,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Off label use,1,M,HO,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Peripheral ischaemia,1,M,DE,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Peripheral ischaemia,1,M,OT,6
151933087,1,Lung neoplasm malignant,7,F,EXP,nivolumab,1,PS,Peripheral ischaemia,1,M,HO,6
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,HO,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,OT,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Hypercalcaemia,1,F,HO,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Hypercalcaemia,1,F,OT,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,F,HO,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,F,OT,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Neutropenia,1,F,HO,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Neutropenia,1,F,OT,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia,1,F,HO,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia,1,F,OT,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia staphylococcal,1,F,HO,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia staphylococcal,1,F,OT,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,F,HO,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,F,OT,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Staphylococcal bacteraemia,1,F,HO,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Staphylococcal bacteraemia,1,F,OT,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Troponin I increased,1,F,HO,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Troponin I increased,1,F,OT,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Upper respiratory tract infection,1,F,HO,5
151964686,1,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,1,PS,Upper respiratory tract infection,1,F,OT,5
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Back pain,1,F,OT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Back pain,1,F,LT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Back pain,1,F,DE,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Fatigue,1,F,LT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Fatigue,1,F,DE,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,F,OT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,F,LT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,F,DE,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,LT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Nausea,1,F,LT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Nausea,1,F,DE,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Onychomycosis,1,F,OT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Onychomycosis,1,F,LT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Onychomycosis,1,F,DE,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Pneumonia,1,F,OT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Pneumonia,1,F,LT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Pneumonia,1,F,DE,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Rash,1,F,OT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Rash,1,F,LT,24
152004326,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Rash,1,F,DE,24
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Back pain,2,F,OT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Back pain,2,F,LT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Back pain,2,F,DE,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Fatigue,2,F,OT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Fatigue,2,F,LT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Fatigue,2,F,DE,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Hypercalcaemia,2,F,OT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Hypercalcaemia,2,F,LT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Hypercalcaemia,2,F,DE,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,F,OT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,F,LT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,F,DE,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Nausea,2,F,OT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Nausea,2,F,LT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Nausea,2,F,DE,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Onychomycosis,2,F,OT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Onychomycosis,2,F,LT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Onychomycosis,2,F,DE,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Pneumonia,2,F,OT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Pneumonia,2,F,LT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Pneumonia,2,F,DE,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Rash,2,F,OT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Rash,2,F,LT,10
152004326,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Rash,2,F,DE,10
152061217,1,Triple negative breast cancer,7,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,133
152061217,1,Triple negative breast cancer,7,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,133
152061217,1,Triple negative breast cancer,7,F,EXP,nivolumab,1,PS,Squamous cell carcinoma,1,F,HO,133
152061217,1,Triple negative breast cancer,7,F,EXP,nivolumab,1,PS,Squamous cell carcinoma,1,F,OT,133
152093007,1,Renal cell carcinoma,7,F,EXP,avelumab,1,SS,Diarrhoea,1,F,HO,210
152093007,1,Renal cell carcinoma,7,F,EXP,avelumab,1,SS,Hypokalaemia,1,F,HO,210
152093007,2,Renal cell carcinoma,7,F,EXP,axitinib,2,PS,Diarrhoea,2,F,HO,210
152093007,2,Renal cell carcinoma,7,F,EXP,axitinib,2,PS,Hypokalaemia,2,F,HO,210
152094433,1,Gastric cancer,3,F,EXP,nivolumab,1,PS,Blood corticotrophin decreased,1,M,OT,81
152094433,1,Gastric cancer,3,F,EXP,nivolumab,1,PS,Blood corticotrophin decreased,1,M,HO,81
152094433,1,Gastric cancer,3,F,EXP,nivolumab,1,PS,Hypoalbuminaemia,1,M,OT,81
152094433,1,Gastric cancer,3,F,EXP,nivolumab,1,PS,Hypoalbuminaemia,1,M,HO,81
152094433,1,Gastric cancer,3,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,81
152094433,1,Gastric cancer,3,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,81
152094433,2,Gastric cancer,3,F,EXP,ipilimumab,2,SS,Blood corticotrophin decreased,2,M,OT,81
152094433,2,Gastric cancer,3,F,EXP,ipilimumab,2,SS,Blood corticotrophin decreased,2,M,HO,81
152094433,2,Gastric cancer,3,F,EXP,ipilimumab,2,SS,Hypoalbuminaemia,2,M,OT,81
152094433,2,Gastric cancer,3,F,EXP,ipilimumab,2,SS,Hypoalbuminaemia,2,M,HO,81
152094433,2,Gastric cancer,3,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,M,OT,81
152094433,2,Gastric cancer,3,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,M,HO,81
152228399,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Headache,1,F,HO,148
152228399,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Headache,2,F,HO,148
152228399,4,Non-small cell lung cancer,9,F,EXP,pemetrexed disodium,4,SS,Headache,4,F,HO,148
152232903,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Anaemia,1,F,HO,30
152232903,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Anaemia,2,F,HO,30
152283666,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,232
152283666,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,232
152283666,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Anaemia,1,M,DE,232
152283666,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Flank pain,1,M,OT,232
152283666,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Flank pain,1,M,HO,232
152283666,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Flank pain,1,M,DE,232
152283666,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,232
152283666,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,232
152283666,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,232
152303088,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Cardiac disorder,1,F,HO,64
152303088,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Cardiac disorder,1,F,OT,64
152303088,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Guillain-Barre syndrome,1,F,HO,64
152303088,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Guillain-Barre syndrome,1,F,OT,64
152303088,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Haemophagocytic lymphohistiocytosis,1,F,HO,64
152303088,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Haemophagocytic lymphohistiocytosis,1,F,OT,64
152303088,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,HO,64
152303088,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,OT,64
152303088,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,64
152303088,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,64
152303088,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Cardiac disorder,2,F,HO,64
152303088,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Cardiac disorder,2,F,OT,64
152303088,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Guillain-Barre syndrome,2,F,HO,64
152303088,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Guillain-Barre syndrome,2,F,OT,64
152303088,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Haemophagocytic lymphohistiocytosis,2,F,HO,64
152303088,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Haemophagocytic lymphohistiocytosis,2,F,OT,64
152303088,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,F,HO,64
152303088,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,F,OT,64
152303088,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,HO,64
152303088,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,OT,64
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,HO,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,DE,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,OT,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,LT,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,HO,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,DE,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,OT,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,LT,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Erythema multiforme,1,M,HO,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Erythema multiforme,1,M,DE,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Erythema multiforme,1,M,OT,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Erythema multiforme,1,M,LT,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Small intestinal perforation,1,M,HO,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Small intestinal perforation,1,M,DE,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Small intestinal perforation,1,M,OT,45
152308026,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Small intestinal perforation,1,M,LT,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Autoimmune disorder,3,M,HO,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Autoimmune disorder,3,M,DE,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Autoimmune disorder,3,M,OT,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Autoimmune disorder,3,M,LT,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,C-reactive protein increased,3,M,HO,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,C-reactive protein increased,3,M,DE,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,C-reactive protein increased,3,M,OT,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,C-reactive protein increased,3,M,LT,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Erythema multiforme,3,M,HO,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Erythema multiforme,3,M,DE,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Erythema multiforme,3,M,OT,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Erythema multiforme,3,M,LT,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,HO,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,DE,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,OT,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,LT,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Small intestinal perforation,3,M,HO,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Small intestinal perforation,3,M,DE,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Small intestinal perforation,3,M,OT,45
152308026,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Small intestinal perforation,3,M,LT,45
152327103,1,Oesophageal squamous cell carcinoma,3,F,EXP,nivolumab,1,PS,Adult T-cell lymphoma/leukaemia,1,M,OT,40
152327103,1,Oesophageal squamous cell carcinoma,3,F,EXP,nivolumab,1,PS,Adult T-cell lymphoma/leukaemia,1,M,HO,40
152327103,2,Oesophageal squamous cell carcinoma,3,F,EXP,ipilimumab,2,SS,Adult T-cell lymphoma/leukaemia,2,M,OT,40
152327103,2,Oesophageal squamous cell carcinoma,3,F,EXP,ipilimumab,2,SS,Adult T-cell lymphoma/leukaemia,2,M,HO,40
152379842,1,Renal cell carcinoma,2,F,EXP,avelumab,1,SS,Pneumonia,1,F,HO,177
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Asthenia,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Asthenia,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Back pain,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Back pain,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Contusion,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Contusion,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Crying,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Crying,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Dyspnoea,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Dyspnoea,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Emotional disorder,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Emotional disorder,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Exposure during pregnancy,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Exposure during pregnancy,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Fatigue,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Fatigue,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Haemoglobin decreased,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Haemoglobin decreased,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Haemoptysis,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Haemoptysis,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Headache,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Headache,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Hernia,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Hernia,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Hyperthyroidism,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Hyperthyroidism,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Hypoaesthesia,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Hypoaesthesia,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Hypothyroidism,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Hypothyroidism,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Infection,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Infection,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Limb discomfort,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Limb discomfort,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Mouth ulceration,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Mouth ulceration,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Pain in extremity,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Pain in extremity,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Paraesthesia,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Paraesthesia,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Pollakiuria,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Pollakiuria,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Rash,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Rash,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Thyroid haemorrhage,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Thyroid haemorrhage,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Thyroid hormones increased,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Thyroid hormones increased,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Vertigo,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Vertigo,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Vomiting,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,Vomiting,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,White blood cell count abnormal,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,White blood cell count abnormal,1,F,OT,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,HO,23
1524106713,1,Relapsing-remitting multiple sclerosis,13,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,OT,23
1524300010,1,Bladder cancer,10,F,EXP,ipilimumab,1,PS,Acute kidney injury,1,M,DE,20
1524300010,1,Bladder cancer,10,F,EXP,ipilimumab,1,PS,Acute kidney injury,1,M,OT,20
1524300010,1,Bladder cancer,10,F,EXP,ipilimumab,1,PS,Acute kidney injury,1,M,HO,20
1524300010,2,Bladder cancer,10,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,DE,20
1524300010,2,Bladder cancer,10,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,OT,20
1524300010,2,Bladder cancer,10,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,HO,20
152434102,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Lipase increased,2,F,OT,956
152439724,1,Breast cancer metastatic,4,F,EXP,palbociclib,1,PS,Lipase increased,1,F,OT,956
152470147,1,B precursor type acute leukaemia,7,F,PER,blinatumomab,1,PS,Respiratory failure,1,M,DE,76
152470147,1,B precursor type acute leukaemia,7,F,PER,blinatumomab,1,PS,Respiratory failure,1,M,HO,76
152470147,1,B precursor type acute leukaemia,7,F,PER,blinatumomab,1,PS,Respiratory failure,1,M,LT,76
152512924,4,Plasma cell myeloma,4,F,EXP,lenalidomide,4,SS,Anaemia,4,F,OT,7
152512924,4,Plasma cell myeloma,4,F,EXP,lenalidomide,4,SS,Anaemia,4,F,HO,7
152512924,4,Plasma cell myeloma,4,F,EXP,lenalidomide,4,SS,Lymphocyte count decreased,4,F,OT,7
152512924,4,Plasma cell myeloma,4,F,EXP,lenalidomide,4,SS,Lymphocyte count decreased,4,F,HO,7
152512924,4,Plasma cell myeloma,4,F,EXP,lenalidomide,4,SS,Malignant neoplasm progression,4,F,OT,7
152512924,4,Plasma cell myeloma,4,F,EXP,lenalidomide,4,SS,Malignant neoplasm progression,4,F,HO,7
152512924,4,Plasma cell myeloma,4,F,EXP,lenalidomide,4,SS,Platelet count decreased,4,F,OT,7
152512924,4,Plasma cell myeloma,4,F,EXP,lenalidomide,4,SS,Platelet count decreased,4,F,HO,7
1525646823,4,Premedication,23,F,EXP,granisetron,4,C,Acute kidney injury,4,F,LT,29
1525646823,4,Premedication,23,F,EXP,granisetron,4,C,Acute kidney injury,4,F,HO,29
1525646823,4,Premedication,23,F,EXP,granisetron,4,C,Acute kidney injury,4,F,DE,29
1525646823,4,Premedication,23,F,EXP,granisetron,4,C,Sepsis,4,F,LT,29
1525646823,4,Premedication,23,F,EXP,granisetron,4,C,Sepsis,4,F,HO,29
1525646823,4,Premedication,23,F,EXP,granisetron,4,C,Sepsis,4,F,DE,29
1525646823,4,Premedication,23,F,EXP,granisetron,4,C,Thrombocytopenia,4,F,LT,29
1525646823,4,Premedication,23,F,EXP,granisetron,4,C,Thrombocytopenia,4,F,HO,29
1525646823,4,Premedication,23,F,EXP,granisetron,4,C,Thrombocytopenia,4,F,DE,29
152577414,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Diaphragmatic spasm,1,F,HO,35
152604698,2,Malignant melanoma,8,F,EXP,nivolumab,2,PS,Erythema,2,M,HO,273
152604698,2,Malignant melanoma,8,F,EXP,nivolumab,2,PS,Erythema,2,M,OT,273
152604698,2,Malignant melanoma,8,F,EXP,nivolumab,2,PS,Hepatic necrosis,2,M,HO,273
152604698,2,Malignant melanoma,8,F,EXP,nivolumab,2,PS,Hepatic necrosis,2,M,OT,273
152604698,2,Malignant melanoma,8,F,EXP,nivolumab,2,PS,Pancreatic enzymes increased,2,M,HO,273
152604698,2,Malignant melanoma,8,F,EXP,nivolumab,2,PS,Pancreatic enzymes increased,2,M,OT,273
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Chest pain,1,F,DE,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Chest pain,1,F,HO,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Chest pain,1,F,LT,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Chest pain,1,F,OT,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Coronary artery disease,1,F,DE,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Coronary artery disease,1,F,HO,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Coronary artery disease,1,F,LT,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Coronary artery disease,1,F,OT,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,DE,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,LT,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Femur fracture,1,F,DE,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Femur fracture,1,F,HO,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Femur fracture,1,F,LT,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Femur fracture,1,F,OT,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,LT,186
152611934,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,186
152630764,1,Acute lymphocytic leukaemia,4,F,PER,blinatumomab,1,PS,Malaise,1,M,OT,14
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Ageusia,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Ageusia,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Cystitis,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Cystitis,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Diarrhoea,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Diarrhoea,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Disturbance in attention,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Disturbance in attention,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Dizziness,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Dry skin,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Dry skin,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Fatigue,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Frequent bowel movements,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Frequent bowel movements,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Haematuria,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Haematuria,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Hypoaesthesia,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Hypoaesthesia,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Insomnia,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Insomnia,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Mass,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Mass,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Neuropathy peripheral,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Neuropathy peripheral,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Pain in extremity,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Pain in extremity,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Product storage error,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Product storage error,1,M,OT,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Urinary bladder haemorrhage,1,M,HO,4
1526479816,1,Hormone-refractory prostate cancer,16,F,EXP,enzalutamide,1,PS,Urinary bladder haemorrhage,1,M,OT,4
152712296,1,Renal cell carcinoma,6,F,EXP,axitinib,1,PS,Biliary tract disorder,1,M,LT,644
152712296,1,Renal cell carcinoma,6,F,EXP,axitinib,1,PS,Biliary tract disorder,1,M,HO,644
152712296,1,Renal cell carcinoma,6,F,EXP,axitinib,1,PS,Liver injury,1,M,LT,644
152712296,1,Renal cell carcinoma,6,F,EXP,axitinib,1,PS,Liver injury,1,M,HO,644
152712296,1,Renal cell carcinoma,6,F,EXP,axitinib,1,PS,Ureterolithiasis,1,M,LT,644
152712296,1,Renal cell carcinoma,6,F,EXP,axitinib,1,PS,Ureterolithiasis,1,M,HO,644
152714939,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,DE,19
152714939,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,19
152762747,1,Relapsing multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Blood glucose increased,1,M,OT,1
152762747,1,Relapsing multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Eye pain,1,M,OT,1
152762747,1,Relapsing multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Glucose urine present,1,M,OT,1
152762747,1,Relapsing multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Urinary incontinence,1,M,OT,1
152762747,1,Relapsing multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,M,OT,1
152811496,1,Anaemia,6,F,PER,darbepoetin alfa,1,PS,Angina unstable,1,F,OT,416
152811496,1,Anaemia,6,F,PER,darbepoetin alfa,1,PS,Angina unstable,1,F,HO,416
152868113,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,13
152868113,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,13
152868113,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,13
152868113,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,13
152868113,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,13
152868113,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,13
152900544,1,Glioblastoma,4,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,DE,114
152900544,1,Glioblastoma,4,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,DS,114
152900544,1,Glioblastoma,4,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,HO,114
152900544,1,Glioblastoma,4,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,OT,114
152900544,2,Glioblastoma,4,F,EXP,ipilimumab,2,SS,Encephalopathy,2,M,DE,114
152900544,2,Glioblastoma,4,F,EXP,ipilimumab,2,SS,Encephalopathy,2,M,DS,114
152900544,2,Glioblastoma,4,F,EXP,ipilimumab,2,SS,Encephalopathy,2,M,HO,114
152900544,2,Glioblastoma,4,F,EXP,ipilimumab,2,SS,Encephalopathy,2,M,OT,114
152902615,2,Plasma cell myeloma,5,F,EXP,pomalidomide,2,SS,Sepsis,2,F,DE,87
152902615,2,Plasma cell myeloma,5,F,EXP,pomalidomide,2,SS,Sepsis,2,F,HO,87
152903053,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Immune thrombocytopenic purpura,1,M,HO,184
152903053,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Immune thrombocytopenic purpura,1,M,LT,184
152903053,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Immune thrombocytopenic purpura,1,M,OT,184
152903053,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Immune thrombocytopenic purpura,2,M,HO,184
152903053,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Immune thrombocytopenic purpura,2,M,LT,184
152903053,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Immune thrombocytopenic purpura,2,M,OT,184
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Alopecia,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Alopecia,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Back pain,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Back pain,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Cellulitis,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Cellulitis,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Constipation,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Constipation,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Decreased appetite,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Decreased appetite,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Diarrhoea,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Diarrhoea,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Dyspnoea,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Dyspnoea,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Fatigue,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Fatigue,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Fungal infection,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Fungal infection,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Gastrooesophageal reflux disease,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Gastrooesophageal reflux disease,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Headache,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Headache,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Lower respiratory tract infection,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Lower respiratory tract infection,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Nasopharyngitis,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Nasopharyngitis,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Nausea,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Nausea,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Neuropathy peripheral,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Neuropathy peripheral,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Pain,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Pain,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Pain in extremity,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Pain in extremity,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Palmar-plantar erythrodysaesthesia syndrome,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Palmar-plantar erythrodysaesthesia syndrome,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Peripheral sensory neuropathy,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Peripheral sensory neuropathy,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Pneumonia,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Pneumonia,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Pyrexia,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Pyrexia,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Stomatitis,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Stomatitis,18,F,OT,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Vascular device infection,18,F,HO,31
152953334,18,Product used for unknown indication,4,F,EXP,denosumab,18,C,Vascular device infection,18,F,OT,31
152957845,6,Metastatic malignant melanoma,5,F,EXP,trametinib,6,SS,Anxiety disorder,6,F,OT,41
152957845,6,Metastatic malignant melanoma,5,F,EXP,trametinib,6,SS,Anxiety disorder,6,F,HO,41
152957845,6,Metastatic malignant melanoma,5,F,EXP,trametinib,6,SS,Eczema nummular,6,F,OT,41
152957845,6,Metastatic malignant melanoma,5,F,EXP,trametinib,6,SS,Eczema nummular,6,F,HO,41
152957845,6,Metastatic malignant melanoma,5,F,EXP,trametinib,6,SS,Feeling cold,6,F,OT,41
152957845,6,Metastatic malignant melanoma,5,F,EXP,trametinib,6,SS,Feeling cold,6,F,HO,41
152957845,6,Metastatic malignant melanoma,5,F,EXP,trametinib,6,SS,Hypertension,6,F,OT,41
152957845,6,Metastatic malignant melanoma,5,F,EXP,trametinib,6,SS,Hypertension,6,F,HO,41
152957845,6,Metastatic malignant melanoma,5,F,EXP,trametinib,6,SS,Oedema peripheral,6,F,OT,41
152957845,6,Metastatic malignant melanoma,5,F,EXP,trametinib,6,SS,Oedema peripheral,6,F,HO,41
152957845,6,Metastatic malignant melanoma,5,F,EXP,trametinib,6,SS,Pyrexia,6,F,OT,41
152957845,6,Metastatic malignant melanoma,5,F,EXP,trametinib,6,SS,Pyrexia,6,F,HO,41
153010365,7,Neutrophil count decreased,5,F,EXP,pegfilgrastim,7,C,Febrile neutropenia,7,F,HO,25
153050493,6,Lung neoplasm malignant,3,F,EXP,nivolumab,6,SS,Malignant neoplasm progression,6,M,OT,94
153050493,6,Lung neoplasm malignant,3,F,EXP,nivolumab,6,SS,Polyarthritis,6,M,OT,94
153050493,6,Lung neoplasm malignant,3,F,EXP,nivolumab,6,SS,Rheumatoid arthritis,6,M,OT,94
153092404,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Lung disorder,1,F,DE,58
153092404,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Lung disorder,1,F,HO,58
153092404,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Lung disorder,1,F,OT,58
153092404,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,58
153092404,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,58
153092404,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,58
153092404,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,DE,58
153092404,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,HO,58
153092404,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,OT,58
153092404,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Lung disorder,2,F,DE,8
153092404,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Lung disorder,2,F,HO,8
153092404,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Lung disorder,2,F,OT,8
153092404,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,DE,8
153092404,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,HO,8
153092404,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,OT,8
153092404,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Respiratory failure,2,F,DE,8
153092404,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Respiratory failure,2,F,HO,8
153092404,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Respiratory failure,2,F,OT,8
153152593,2,Prostate cancer metastatic,3,F,EXP,enzalutamide,2,SS,Back pain,2,M,HO,1097
153152593,2,Prostate cancer metastatic,3,F,EXP,enzalutamide,2,SS,Chest pain,2,M,HO,1097
153152593,2,Prostate cancer metastatic,3,F,EXP,enzalutamide,2,SS,Myalgia,2,M,HO,1097
1531651312,1,Relapsing multiple sclerosis,12,F,EXP,alemtuzumab,1,PS,Headache,1,F,HO,1
1531651312,1,Relapsing multiple sclerosis,12,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,F,HO,1
1531651312,1,Relapsing multiple sclerosis,12,F,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,F,HO,1
1531651312,1,Relapsing multiple sclerosis,12,F,EXP,alemtuzumab,1,PS,Rash,1,F,HO,1
1531651312,1,Relapsing multiple sclerosis,12,F,EXP,alemtuzumab,1,PS,Supraventricular tachycardia,1,F,HO,1
153171176,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Arrhythmia,1,F,OT,451
153171176,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Arrhythmia,1,F,HO,451
153171176,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Arthralgia,1,F,OT,451
153171176,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Arthralgia,1,F,HO,451
153171176,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Back pain,1,F,OT,451
153171176,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Back pain,1,F,HO,451
153171176,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Fungal infection,1,F,OT,451
153171176,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Fungal infection,1,F,HO,451
153171176,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Influenza,1,F,OT,451
153171176,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Influenza,1,F,HO,451
153171176,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Pneumonia,1,F,OT,451
153171176,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Pneumonia,1,F,HO,451
153173762,1,Gastrooesophageal cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,176
153173762,1,Gastrooesophageal cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,176
153173762,1,Gastrooesophageal cancer,2,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,176
153173762,1,Gastrooesophageal cancer,2,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,176
153236294,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Otitis media,1,M,HO,272
153236294,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Upper respiratory tract infection,1,M,HO,272
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Acute respiratory distress syndrome,1,F,OT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Acute respiratory distress syndrome,1,F,DE,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Acute respiratory distress syndrome,1,F,HO,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Acute respiratory distress syndrome,1,F,LT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Cystitis,1,F,OT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Cystitis,1,F,DE,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Cystitis,1,F,HO,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Cystitis,1,F,LT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Fall,1,F,OT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Fall,1,F,DE,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Fall,1,F,HO,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Fall,1,F,LT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Humerus fracture,1,F,OT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Humerus fracture,1,F,DE,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Humerus fracture,1,F,HO,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Humerus fracture,1,F,LT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Pneumonia,1,F,OT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Pneumonia,1,F,DE,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Pneumonia,1,F,HO,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Pneumonia,1,F,LT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Renal failure,1,F,OT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Renal failure,1,F,DE,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Renal failure,1,F,HO,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Renal failure,1,F,LT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Rib fracture,1,F,OT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Rib fracture,1,F,DE,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Rib fracture,1,F,HO,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Rib fracture,1,F,LT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Sepsis,1,F,OT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Sepsis,1,F,DE,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Sepsis,1,F,HO,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Sepsis,1,F,LT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Subdural haematoma,1,F,OT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Subdural haematoma,1,F,DE,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Subdural haematoma,1,F,HO,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Subdural haematoma,1,F,LT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Ureterolithiasis,1,F,OT,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Ureterolithiasis,1,F,DE,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Ureterolithiasis,1,F,HO,541
153239236,1,Immune thrombocytopenic purpura,6,F,PER,romiplostim,1,PS,Ureterolithiasis,1,F,LT,541
153256224,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,Neutropenia,2,F,LT,238
153256224,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,Pancytopenia,2,F,LT,238
153280202,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Hypophagia,1,M,HO,106
153281402,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Chronic sinusitis,1,F,HO,48
153281402,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Chronic sinusitis,1,F,OT,48
153281402,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Loss of consciousness,1,F,HO,48
153281402,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Loss of consciousness,1,F,OT,48
153281402,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Oedema peripheral,1,F,HO,48
153281402,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Oedema peripheral,1,F,OT,48
153281402,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Subdural haematoma,1,F,HO,48
153281402,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Subdural haematoma,1,F,OT,48
153313152,1,Optic glioma,2,F,EXP,trametinib,1,PS,Detachment of retinal pigment epithelium,1,F,OT,255
153313152,1,Optic glioma,2,F,EXP,trametinib,1,PS,Product use in unapproved indication,1,F,OT,255
153313152,1,Optic glioma,2,F,EXP,trametinib,1,PS,Retinopathy,1,F,OT,255
153313434,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Facial pain,1,F,HO,38
153338594,1,Transitional cell carcinoma,4,F,EXP,avelumab,1,PS,Miller Fisher syndrome,1,F,HO,71
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Drug-induced liver injury,1,M,OT,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Drug-induced liver injury,1,M,LT,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Drug-induced liver injury,1,M,HO,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Drug-induced liver injury,1,M,DE,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Infection,1,M,OT,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Infection,1,M,LT,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Infection,1,M,HO,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Infection,1,M,DE,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,OT,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,LT,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,HO,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,DE,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Liver function test increased,1,M,OT,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Liver function test increased,1,M,LT,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Liver function test increased,1,M,HO,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Liver function test increased,1,M,DE,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,239
153379205,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,239
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Drug-induced liver injury,2,M,OT,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Drug-induced liver injury,2,M,LT,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Drug-induced liver injury,2,M,HO,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Drug-induced liver injury,2,M,DE,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Infection,2,M,OT,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Infection,2,M,LT,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Infection,2,M,HO,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Infection,2,M,DE,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Interstitial lung disease,2,M,OT,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Interstitial lung disease,2,M,LT,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Interstitial lung disease,2,M,HO,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Interstitial lung disease,2,M,DE,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Liver function test increased,2,M,OT,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Liver function test increased,2,M,LT,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Liver function test increased,2,M,HO,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Liver function test increased,2,M,DE,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,LT,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,HO,141
153379205,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,DE,141
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Drug-induced liver injury,3,M,OT,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Drug-induced liver injury,3,M,LT,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Drug-induced liver injury,3,M,HO,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Drug-induced liver injury,3,M,DE,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Infection,3,M,OT,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Infection,3,M,LT,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Infection,3,M,HO,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Infection,3,M,DE,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Interstitial lung disease,3,M,OT,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Interstitial lung disease,3,M,LT,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Interstitial lung disease,3,M,HO,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Interstitial lung disease,3,M,DE,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Liver function test increased,3,M,OT,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Liver function test increased,3,M,LT,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Liver function test increased,3,M,HO,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Liver function test increased,3,M,DE,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,OT,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,LT,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,HO,29
153379205,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,DE,29
153440582,2,Malignant melanoma,2,F,EXP,trametinib,2,SS,Urinary tract infection,2,M,HO,56
153467714,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Anaemia,2,F,HO,13
153467714,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Influenza,2,F,HO,13
153467714,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Platelet count decreased,2,F,HO,13
153467714,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Thrombocytopenia,2,F,HO,13
153545274,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,19
153545274,3,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,3,SS,Vomiting,3,F,HO,19
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Cytokine release syndrome,2,F,LT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Cytokine release syndrome,2,F,HO,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Cytokine release syndrome,2,F,OT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Diarrhoea,2,F,LT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Diarrhoea,2,F,HO,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Diarrhoea,2,F,OT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Haemophagocytic lymphohistiocytosis,2,F,LT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Haemophagocytic lymphohistiocytosis,2,F,HO,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Haemophagocytic lymphohistiocytosis,2,F,OT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Hypokalaemia,2,F,LT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Hypokalaemia,2,F,HO,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Hypokalaemia,2,F,OT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Hypotension,2,F,LT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Hypotension,2,F,HO,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Hypotension,2,F,OT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Hypoxia,2,F,LT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Hypoxia,2,F,HO,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Hypoxia,2,F,OT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Leukopenia,2,F,LT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Leukopenia,2,F,HO,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Leukopenia,2,F,OT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Lymphopenia,2,F,LT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Lymphopenia,2,F,HO,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Lymphopenia,2,F,OT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Nausea,2,F,LT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Nausea,2,F,HO,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Nausea,2,F,OT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Neutropenia,2,F,LT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Neutropenia,2,F,HO,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Neutropenia,2,F,OT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Pneumonitis,2,F,LT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Pneumonitis,2,F,HO,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Pneumonitis,2,F,OT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Swelling face,2,F,LT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Swelling face,2,F,HO,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Swelling face,2,F,OT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Thrombocytopenia,2,F,LT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Thrombocytopenia,2,F,HO,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Thrombocytopenia,2,F,OT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Vomiting,2,F,LT,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Vomiting,2,F,HO,1
153605727,2,Diffuse large B-cell lymphoma refractory,7,F,EXP,axicabtagene ciloleucel,2,SS,Vomiting,2,F,OT,1
153623152,1,Gastrooesophageal cancer,2,F,EXP,nivolumab,1,PS,Myelodysplastic syndrome,1,F,OT,48
153628037,1,Prostate cancer metastatic,7,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,OT,41
153628037,1,Prostate cancer metastatic,7,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,HO,41
153642724,40,Product used for unknown indication,4,F,EXP,pegfilgrastim,40,C,Anxiety,40,F,HO,63
153642724,40,Product used for unknown indication,4,F,EXP,pegfilgrastim,40,C,Blood calcium decreased,40,F,HO,63
153642724,40,Product used for unknown indication,4,F,EXP,pegfilgrastim,40,C,Dermatitis acneiform,40,F,HO,63
153642724,40,Product used for unknown indication,4,F,EXP,pegfilgrastim,40,C,Joint stiffness,40,F,HO,63
153642724,40,Product used for unknown indication,4,F,EXP,pegfilgrastim,40,C,Neuropathy peripheral,40,F,HO,63
153642724,40,Product used for unknown indication,4,F,EXP,pegfilgrastim,40,C,Onychomadesis,40,F,HO,63
153642724,40,Product used for unknown indication,4,F,EXP,pegfilgrastim,40,C,Tooth abscess,40,F,HO,63
153642724,40,Product used for unknown indication,4,F,EXP,pegfilgrastim,40,C,Tooth infection,40,F,HO,63
153642724,40,Product used for unknown indication,4,F,EXP,pegfilgrastim,40,C,Tooth loss,40,F,HO,63
153642724,40,Product used for unknown indication,4,F,EXP,pegfilgrastim,40,C,Weight decreased,40,F,HO,63
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,DE,77
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,LT,77
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,OT,77
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Bone pain,1,M,DE,77
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Bone pain,1,M,LT,77
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Bone pain,1,M,OT,77
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,77
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,77
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,77
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Rib fracture,1,M,DE,77
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Rib fracture,1,M,LT,77
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Rib fracture,1,M,OT,77
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Vomiting,1,M,DE,77
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Vomiting,1,M,LT,77
153716676,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Abdominal pain,3,M,DE,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Abdominal pain,3,M,LT,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Abdominal pain,3,M,OT,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Bone pain,3,M,DE,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Bone pain,3,M,LT,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Bone pain,3,M,OT,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,DE,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,LT,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,OT,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Rib fracture,3,M,DE,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Rib fracture,3,M,LT,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Rib fracture,3,M,OT,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Vomiting,3,M,DE,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Vomiting,3,M,LT,77
153716676,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Vomiting,3,M,OT,77
153716893,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Aspergillus infection,1,M,HO,209
153716893,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Aspergillus infection,1,M,OT,209
153716893,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Pneumonia,1,M,HO,209
153716893,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Pneumonia,1,M,OT,209
153716893,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Systemic candida,1,M,HO,209
153716893,1,Chronic lymphocytic leukaemia,3,F,EXP,idelalisib,1,PS,Systemic candida,1,M,OT,209
153733922,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Colitis,1,F,HO,423
153733922,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Thrombocytopenia,1,F,HO,423
153747244,6,Plasma cell myeloma,4,F,EXP,pomalidomide,6,SS,Neutropenia,6,M,HO,14
153747244,6,Plasma cell myeloma,4,F,EXP,pomalidomide,6,SS,Sepsis,6,M,HO,14
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Blood count abnormal,1,M,HO,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Blood count abnormal,1,M,OT,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,HO,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,OT,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Dizziness,1,M,HO,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Fatigue,1,M,HO,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Headache,1,M,HO,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Headache,1,M,OT,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Malaise,1,M,HO,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Malaise,1,M,OT,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Nausea,1,M,HO,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Nausea,1,M,OT,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Prostatic specific antigen increased,1,M,HO,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Prostatic specific antigen increased,1,M,OT,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Pruritus,1,M,HO,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Pruritus,1,M,OT,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Renal impairment,1,M,HO,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Renal impairment,1,M,OT,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Somnolence,1,M,HO,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Somnolence,1,M,OT,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Therapy cessation,1,M,HO,343
153799335,1,Neoplasm malignant,5,F,EXP,enzalutamide,1,PS,Therapy cessation,1,M,OT,343
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Arthralgia,1,M,HO,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Arthralgia,1,M,OT,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Asthenia,1,M,HO,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Fall,1,M,HO,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Fall,1,M,OT,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Fatigue,1,M,HO,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Hip fracture,1,M,HO,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Hip fracture,1,M,OT,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Impaired healing,1,M,HO,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Impaired healing,1,M,OT,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Joint swelling,1,M,HO,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Joint swelling,1,M,OT,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Movement disorder,1,M,HO,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Movement disorder,1,M,OT,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Muscular weakness,1,M,HO,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Muscular weakness,1,M,OT,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Musculoskeletal stiffness,1,M,HO,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Musculoskeletal stiffness,1,M,OT,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Peripheral swelling,1,M,HO,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Peripheral swelling,1,M,OT,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Prostatic specific antigen abnormal,1,M,HO,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Prostatic specific antigen abnormal,1,M,OT,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Tooth loss,1,M,HO,14
153801393,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Tooth loss,1,M,OT,14
153805734,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Alopecia,1,M,OT,1157
153805734,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,1157
153805734,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Feeling abnormal,1,M,OT,1157
153805734,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,OT,1157
153805734,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Sleep disorder,1,M,OT,1157
153805734,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Therapy cessation,1,M,OT,1157
153809002,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,OT,79
153809002,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,79
153809002,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Hallucination,1,M,OT,79
153809002,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Hot flush,1,M,OT,79
153809002,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Insomnia,1,M,OT,79
153811563,1,Metastases to bone,3,F,EXP,enzalutamide,1,PS,Back pain,1,M,OT,187
153811563,1,Metastases to bone,3,F,EXP,enzalutamide,1,PS,Burning sensation,1,M,OT,187
153811563,1,Metastases to bone,3,F,EXP,enzalutamide,1,PS,Diarrhoea,1,M,OT,187
153811563,1,Metastases to bone,3,F,EXP,enzalutamide,1,PS,Eye disorder,1,M,OT,187
153811563,1,Metastases to bone,3,F,EXP,enzalutamide,1,PS,Fall,1,M,OT,187
153811563,1,Metastases to bone,3,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,187
153811563,1,Metastases to bone,3,F,EXP,enzalutamide,1,PS,Head injury,1,M,OT,187
153811563,1,Metastases to bone,3,F,EXP,enzalutamide,1,PS,Headache,1,M,OT,187
153811563,1,Metastases to bone,3,F,EXP,enzalutamide,1,PS,Pelvic pain,1,M,OT,187
153811563,1,Metastases to bone,3,F,EXP,enzalutamide,1,PS,Ulcer haemorrhage,1,M,OT,187
153811753,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Chills,1,M,OT,20
153811753,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Erectile dysfunction,1,M,OT,20
153811753,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Hot flush,1,M,OT,20
153811753,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Malaise,1,M,OT,20
153811753,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Product dose omission,1,M,OT,20
153811753,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Pruritus,1,M,OT,20
153811753,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Rash,1,M,OT,20
153812535,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Abnormal behaviour,1,M,OT,25
153812535,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Abnormal behaviour,1,M,HO,25
153812535,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Cellulitis,1,M,OT,25
153812535,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Cellulitis,1,M,HO,25
153812535,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Epistaxis,1,M,OT,25
153812535,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Epistaxis,1,M,HO,25
153812535,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Parkinson's disease,1,M,OT,25
153812535,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Parkinson's disease,1,M,HO,25
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Anxiety,1,M,OT,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Anxiety,1,M,HO,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Arthritis,1,M,OT,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Arthritis,1,M,HO,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Fatigue,1,M,HO,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Fear,1,M,OT,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Fear,1,M,HO,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Flushing,1,M,OT,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Flushing,1,M,HO,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Herpes zoster,1,M,OT,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Herpes zoster,1,M,HO,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Hypersomnia,1,M,OT,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Hypersomnia,1,M,HO,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Hypertension,1,M,OT,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Hypertension,1,M,HO,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Loss of personal independence in daily activities,1,M,OT,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Loss of personal independence in daily activities,1,M,HO,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Pain in extremity,1,M,OT,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Pain in extremity,1,M,HO,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Pneumonitis,1,M,OT,47
153820295,1,Prostate cancer,5,F,EXP,enzalutamide,1,PS,Pneumonitis,1,M,HO,47
153820723,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Intervertebral disc degeneration,1,M,OT,37
153820723,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Pruritus,1,M,OT,37
153820723,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Spinal stenosis,1,M,OT,37
153838792,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Abdominal discomfort,1,M,OT,1091
153838792,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Blood count abnormal,1,M,OT,1091
153838792,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Dysphonia,1,M,OT,1091
153838792,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Hot flush,1,M,OT,1091
153838792,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Nasopharyngitis,1,M,OT,1091
153838792,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Rash maculo-papular,1,M,OT,1091
153838792,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Rash pruritic,1,M,OT,1091
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,LT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,OT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,HO,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,DE,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,LT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,OT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,HO,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,DE,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,LT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,OT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,HO,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,DE,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,LT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,OT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,HO,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,DE,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Blood bilirubin increased,1,M,LT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Blood bilirubin increased,1,M,OT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Blood bilirubin increased,1,M,HO,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Blood bilirubin increased,1,M,DE,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,LT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,OT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,HO,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,DE,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,International normalised ratio increased,1,M,LT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,International normalised ratio increased,1,M,OT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,International normalised ratio increased,1,M,HO,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,International normalised ratio increased,1,M,DE,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Jaundice,1,M,LT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Jaundice,1,M,OT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Jaundice,1,M,HO,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Jaundice,1,M,DE,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,LT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,HO,152
153941364,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,DE,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Abdominal pain,2,M,LT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Abdominal pain,2,M,OT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Abdominal pain,2,M,HO,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Abdominal pain,2,M,DE,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Alanine aminotransferase increased,2,M,LT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Alanine aminotransferase increased,2,M,OT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Alanine aminotransferase increased,2,M,HO,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Alanine aminotransferase increased,2,M,DE,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Aspartate aminotransferase increased,2,M,LT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Aspartate aminotransferase increased,2,M,OT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Aspartate aminotransferase increased,2,M,HO,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Aspartate aminotransferase increased,2,M,DE,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Autoimmune disorder,2,M,LT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Autoimmune disorder,2,M,OT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Autoimmune disorder,2,M,HO,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Autoimmune disorder,2,M,DE,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Blood bilirubin increased,2,M,LT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Blood bilirubin increased,2,M,OT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Blood bilirubin increased,2,M,HO,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Blood bilirubin increased,2,M,DE,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Hepatic failure,2,M,LT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Hepatic failure,2,M,OT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Hepatic failure,2,M,HO,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Hepatic failure,2,M,DE,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,International normalised ratio increased,2,M,LT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,International normalised ratio increased,2,M,OT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,International normalised ratio increased,2,M,HO,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,International normalised ratio increased,2,M,DE,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Jaundice,2,M,LT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Jaundice,2,M,OT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Jaundice,2,M,HO,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Jaundice,2,M,DE,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Respiratory failure,2,M,LT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Respiratory failure,2,M,OT,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Respiratory failure,2,M,HO,152
153941364,2,Lung neoplasm malignant,4,F,EXP,ipilimumab,2,SS,Respiratory failure,2,M,DE,152
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Cardiac failure congestive,1,F,HO,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Cardiac failure congestive,1,F,LT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Cardiac failure congestive,1,F,DE,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Cardiac failure congestive,1,F,OT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Epilepsy,1,F,HO,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Epilepsy,1,F,LT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Epilepsy,1,F,DE,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Epilepsy,1,F,OT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Gait disturbance,1,F,HO,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Gait disturbance,1,F,LT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Gait disturbance,1,F,DE,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Gait disturbance,1,F,OT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Hepatitis cholestatic,1,F,HO,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Hepatitis cholestatic,1,F,LT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Hepatitis cholestatic,1,F,DE,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Hepatitis cholestatic,1,F,OT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Pneumonia,1,F,HO,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Pneumonia,1,F,LT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Pneumonia,1,F,DE,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Pneumonia,1,F,OT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Skin reaction,1,F,HO,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Skin reaction,1,F,LT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Skin reaction,1,F,DE,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Skin reaction,1,F,OT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Transaminases increased,1,F,HO,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Transaminases increased,1,F,LT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Transaminases increased,1,F,DE,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Transaminases increased,1,F,OT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Urosepsis,1,F,HO,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Urosepsis,1,F,LT,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Urosepsis,1,F,DE,1
153972147,1,Relapsing-remitting multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Urosepsis,1,F,OT,1
153981052,5,Prophylaxis,2,F,EXP,filgrastim,5,C,Diarrhoea,5,F,HO,36
153981052,5,Prophylaxis,2,F,EXP,filgrastim,5,C,Fatigue,5,F,HO,36
153981052,5,Prophylaxis,2,F,EXP,filgrastim,5,C,Insomnia,5,F,HO,36
153981052,5,Prophylaxis,2,F,EXP,filgrastim,5,C,Pain in extremity,5,F,HO,36
153981052,5,Prophylaxis,2,F,EXP,filgrastim,5,C,Tooth infection,5,F,HO,36
153983846,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Muscle necrosis,1,M,LT,34
153983846,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Muscle necrosis,1,M,DS,34
153983846,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Muscle necrosis,1,M,OT,34
153983846,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Muscle necrosis,1,M,HO,34
153983846,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Myocarditis,1,M,LT,34
153983846,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Myocarditis,1,M,DS,34
153983846,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Myocarditis,1,M,OT,34
153983846,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Myocarditis,1,M,HO,34
153983846,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,LT,34
153983846,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,DS,34
153983846,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,34
153983846,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,HO,34
154029563,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Abdominal pain upper,1,M,HO,25
154029563,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Decreased appetite,1,M,HO,25
154029563,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Diarrhoea,1,M,HO,25
154029563,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Fatigue,1,M,HO,25
154029563,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Headache,1,M,HO,25
154029563,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Intentional product use issue,1,M,HO,25
154029563,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Nausea,1,M,HO,25
154029563,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Vomiting,1,M,HO,25
154029563,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Weight decreased,1,M,HO,25
1540576913,1,Acute lymphocytic leukaemia,13,F,PER,carfilzomib,1,PS,Mucosal inflammation,1,M,HO,59
1540576913,1,Acute lymphocytic leukaemia,13,F,PER,carfilzomib,1,PS,Mucosal inflammation,1,M,LT,59
1540576913,1,Acute lymphocytic leukaemia,13,F,PER,carfilzomib,1,PS,Pneumonia,1,M,HO,59
1540576913,1,Acute lymphocytic leukaemia,13,F,PER,carfilzomib,1,PS,Pneumonia,1,M,LT,59
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Arrhythmia supraventricular,1,F,OT,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Arrhythmia supraventricular,1,F,DE,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Arrhythmia supraventricular,1,F,HO,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,F,OT,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,F,DE,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,F,HO,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Chest pain,1,F,OT,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Chest pain,1,F,DE,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Chest pain,1,F,HO,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pain,1,F,OT,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pain,1,F,DE,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pain,1,F,HO,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pericardial effusion,1,F,OT,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pericardial effusion,1,F,DE,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pericardial effusion,1,F,HO,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pleural effusion,1,F,OT,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pleural effusion,1,F,DE,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pleural effusion,1,F,HO,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,F,OT,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,F,DE,49
1541051211,1,Lung neoplasm malignant,11,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,F,HO,49
154129812,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Abdominal pain,3,M,HO,57
154129812,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Diarrhoea,3,M,HO,57
154129812,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Electrocardiogram abnormal,3,M,HO,57
154129812,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Enterocolitis,3,M,HO,57
154129812,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Nausea,3,M,HO,57
154129812,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Sepsis,3,M,HO,57
154129812,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Vomiting,3,M,HO,57
154139905,1,Prostate cancer,5,F,EXP,nivolumab,1,PS,Ileus paralytic,1,M,OT,27
154139905,1,Prostate cancer,5,F,EXP,nivolumab,1,PS,Ileus paralytic,1,M,HO,27
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Anxiety,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Anxiety,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Anxiety,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Blood glucose increased,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Blood glucose increased,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Blood glucose increased,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Chromaturia,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Chromaturia,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Chromaturia,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Cough,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Cough,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Cough,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Depression,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Depression,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Depression,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Dry mouth,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Dry mouth,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Dry mouth,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Dyspepsia,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Dyspepsia,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Dyspepsia,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Fatigue,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Nausea,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pain,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pain,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pain,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pyrexia,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Renal impairment,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Renal impairment,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Renal impairment,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Respiratory distress,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Respiratory distress,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Respiratory distress,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Somnolence,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Somnolence,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Somnolence,1,M,HO,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Vomiting,1,M,DE,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,13
154145045,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,13
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Death,1,M,DE,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Death,1,M,OT,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Death,1,M,HO,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Endophthalmitis,1,M,DE,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Endophthalmitis,1,M,OT,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Endophthalmitis,1,M,HO,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Hypophysitis,1,M,DE,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Hypophysitis,1,M,OT,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Hypophysitis,1,M,HO,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Pancytopenia,1,M,DE,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Pancytopenia,1,M,OT,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Pancytopenia,1,M,HO,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Staphylococcal infection,1,M,DE,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Staphylococcal infection,1,M,OT,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Staphylococcal infection,1,M,HO,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Type 3 diabetes mellitus,1,M,DE,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Type 3 diabetes mellitus,1,M,OT,83
1541683710,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Type 3 diabetes mellitus,1,M,HO,83
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Death,2,M,DE,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Death,2,M,OT,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Death,2,M,HO,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Endophthalmitis,2,M,DE,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Endophthalmitis,2,M,OT,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Endophthalmitis,2,M,HO,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Hypophysitis,2,M,DE,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Hypophysitis,2,M,OT,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Hypophysitis,2,M,HO,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Pancytopenia,2,M,DE,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Pancytopenia,2,M,OT,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Pancytopenia,2,M,HO,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Staphylococcal infection,2,M,DE,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Staphylococcal infection,2,M,OT,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Staphylococcal infection,2,M,HO,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Type 3 diabetes mellitus,2,M,DE,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Type 3 diabetes mellitus,2,M,OT,53
1541683710,2,Malignant melanoma,10,F,EXP,ipilimumab,2,SS,Type 3 diabetes mellitus,2,M,HO,53
154262925,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Disease recurrence,1,F,HO,1
154262925,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Headache,1,F,HO,1
154262925,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Insomnia,1,F,HO,1
154262925,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,F,HO,1
154262925,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Muscle spasticity,1,F,HO,1
154262925,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Oedema peripheral,1,F,HO,1
154262925,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Pruritus,1,F,HO,1
154262925,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Skin oedema,1,F,HO,1
154262925,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Skin reaction,1,F,HO,1
154262925,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Syncope,1,F,HO,1
154262925,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Thyroid hormones increased,1,F,HO,1
154262925,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,HO,1
154262925,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Urticaria,1,F,HO,1
154262925,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Vertigo,1,F,HO,1
154320946,1,Metastatic squamous cell carcinoma,6,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,HO,191
154320946,1,Metastatic squamous cell carcinoma,6,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,OT,191
154320946,1,Metastatic squamous cell carcinoma,6,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,191
154320946,1,Metastatic squamous cell carcinoma,6,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,191
154320946,1,Metastatic squamous cell carcinoma,6,F,EXP,nivolumab,1,PS,Metabolic encephalopathy,1,M,HO,191
154320946,1,Metastatic squamous cell carcinoma,6,F,EXP,nivolumab,1,PS,Metabolic encephalopathy,1,M,OT,191
154320946,2,Metastatic squamous cell carcinoma,6,F,EXP,ipilimumab,2,SS,Autoimmune thyroiditis,2,M,HO,191
154320946,2,Metastatic squamous cell carcinoma,6,F,EXP,ipilimumab,2,SS,Autoimmune thyroiditis,2,M,OT,191
154320946,2,Metastatic squamous cell carcinoma,6,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,M,HO,191
154320946,2,Metastatic squamous cell carcinoma,6,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,M,OT,191
154320946,2,Metastatic squamous cell carcinoma,6,F,EXP,ipilimumab,2,SS,Metabolic encephalopathy,2,M,HO,191
154320946,2,Metastatic squamous cell carcinoma,6,F,EXP,ipilimumab,2,SS,Metabolic encephalopathy,2,M,OT,191
154323185,1,Pleural mesothelioma,5,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,109
154323185,1,Pleural mesothelioma,5,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,109
154323185,3,Pleural mesothelioma,5,F,EXP,ipilimumab,3,SS,Renal failure,3,M,HO,109
154323185,3,Pleural mesothelioma,5,F,EXP,ipilimumab,3,SS,Renal failure,3,M,OT,109
154358554,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Blood urine present,1,M,HO,1
154358554,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Blood urine present,1,M,OT,1
154358554,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,1
154358554,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,1
154358554,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,1
154358554,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,1
154358554,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Infusion related reaction,1,M,HO,1
154358554,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Infusion related reaction,1,M,OT,1
154358554,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,HO,1
154358554,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,1
154358554,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,1
154358554,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,1
154358554,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Off label use,1,M,HO,1
154358554,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,1
154365834,3,Small cell lung cancer,4,F,EXP,dinutuximab,3,SS,Hypokalaemia,3,M,DE,63
154365834,3,Small cell lung cancer,4,F,EXP,dinutuximab,3,SS,Hypokalaemia,3,M,HO,63
154365834,3,Small cell lung cancer,4,F,EXP,dinutuximab,3,SS,Neurological decompensation,3,M,DE,63
154365834,3,Small cell lung cancer,4,F,EXP,dinutuximab,3,SS,Neurological decompensation,3,M,HO,63
154409198,1,Gastric cancer,8,F,EXP,nivolumab,1,PS,Infection,1,F,OT,22
154409198,1,Gastric cancer,8,F,EXP,nivolumab,1,PS,Infection,1,F,DE,22
154409198,1,Gastric cancer,8,F,EXP,nivolumab,1,PS,Infection,1,F,HO,22
154409198,1,Gastric cancer,8,F,EXP,nivolumab,1,PS,Infection,1,F,LT,22
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Neutropenia,1,F,HO,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Neutropenia,1,F,LT,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Neutropenia,1,F,DE,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Neutropenic sepsis,1,F,HO,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Neutropenic sepsis,1,F,LT,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Neutropenic sepsis,1,F,DE,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Pneumonia,1,F,HO,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Pneumonia,1,F,LT,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Pneumonia,1,F,DE,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Pneumonitis,1,F,HO,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Pneumonitis,1,F,LT,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Pneumonitis,1,F,DE,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Tachycardia,1,F,HO,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Tachycardia,1,F,LT,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Tachycardia,1,F,DE,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Thrombocytopenia,1,F,HO,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Thrombocytopenia,1,F,LT,2
1545211122,1,Plasma cell myeloma,22,F,EXP,pomalidomide,1,PS,Thrombocytopenia,1,F,DE,2
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Dry mouth,1,M,OT,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Dry mouth,1,M,HO,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Dry mouth,1,M,DE,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Fall,1,M,OT,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Fall,1,M,HO,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Fall,1,M,DE,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Fatigue,1,M,DE,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,OT,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,HO,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,DE,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Nasal injury,1,M,OT,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Nasal injury,1,M,HO,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Nasal injury,1,M,DE,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pruritus,1,M,OT,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pruritus,1,M,HO,32
154529016,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pruritus,1,M,DE,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Dry mouth,2,M,OT,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Dry mouth,2,M,HO,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Dry mouth,2,M,DE,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Fall,2,M,OT,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Fall,2,M,HO,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Fall,2,M,DE,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Fatigue,2,M,OT,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Fatigue,2,M,HO,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Fatigue,2,M,DE,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,M,OT,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,M,HO,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,M,DE,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,HO,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DE,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Nasal injury,2,M,OT,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Nasal injury,2,M,HO,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Nasal injury,2,M,DE,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Pruritus,2,M,OT,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Pruritus,2,M,HO,32
154529016,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Pruritus,2,M,DE,32
154540864,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,14
154541522,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Hypercalcaemia,2,F,HO,25
154541522,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Hypercalcaemia,2,F,DE,25
154541522,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Posterior reversible encephalopathy syndrome,2,F,HO,25
154541522,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Posterior reversible encephalopathy syndrome,2,F,DE,25
154541522,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Urinary tract infection,2,F,HO,25
154541522,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Urinary tract infection,2,F,DE,25
154548942,6,Plasma cell myeloma,2,F,EXP,pomalidomide,6,SS,Cough,6,F,HO,149
154548942,6,Plasma cell myeloma,2,F,EXP,pomalidomide,6,SS,Diarrhoea,6,F,HO,149
154548942,6,Plasma cell myeloma,2,F,EXP,pomalidomide,6,SS,Dysphonia,6,F,HO,149
154548942,6,Plasma cell myeloma,2,F,EXP,pomalidomide,6,SS,Fatigue,6,F,HO,149
154548942,6,Plasma cell myeloma,2,F,EXP,pomalidomide,6,SS,Laryngeal inflammation,6,F,HO,149
154548942,6,Plasma cell myeloma,2,F,EXP,pomalidomide,6,SS,Leukopenia,6,F,HO,149
154548942,6,Plasma cell myeloma,2,F,EXP,pomalidomide,6,SS,Neutropenia,6,F,HO,149
154548942,6,Plasma cell myeloma,2,F,EXP,pomalidomide,6,SS,Oral candidiasis,6,F,HO,149
154548942,6,Plasma cell myeloma,2,F,EXP,pomalidomide,6,SS,Pyrexia,6,F,HO,149
154548942,6,Plasma cell myeloma,2,F,EXP,pomalidomide,6,SS,Viral diarrhoea,6,F,HO,149
154548942,6,Plasma cell myeloma,2,F,EXP,pomalidomide,6,SS,Vomiting,6,F,HO,149
154619818,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Arthralgia,1,M,HO,35
154619818,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,35
154619818,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,HO,35
154619818,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,OT,35
154619818,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Chills,1,M,HO,35
154619818,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Chills,1,M,OT,35
154619818,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Cough,1,M,HO,35
154619818,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Cough,1,M,OT,35
154619818,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Muscular weakness,1,M,HO,35
154619818,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Muscular weakness,1,M,OT,35
154619818,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Toxicity to various agents,1,M,HO,35
154619818,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Toxicity to various agents,1,M,OT,35
154619818,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Arthralgia,3,M,HO,35
154619818,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Arthralgia,3,M,OT,35
154619818,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Blood creatinine increased,3,M,HO,35
154619818,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Blood creatinine increased,3,M,OT,35
154619818,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Chills,3,M,HO,35
154619818,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Chills,3,M,OT,35
154619818,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Cough,3,M,HO,35
154619818,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Cough,3,M,OT,35
154619818,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Muscular weakness,3,M,HO,35
154619818,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Muscular weakness,3,M,OT,35
154619818,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Toxicity to various agents,3,M,HO,35
154619818,3,Malignant melanoma,8,F,EXP,ipilimumab,3,SS,Toxicity to various agents,3,M,OT,35
154626284,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Temporal arteritis,1,M,HO,274
154626284,2,Lung neoplasm malignant,4,F,EXP,nivolumab,2,SS,Temporal arteritis,2,M,HO,260
154626284,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Temporal arteritis,3,M,HO,246
154626284,4,Product used for unknown indication,4,F,EXP,nivolumab,4,SS,Temporal arteritis,4,M,HO,230
154626284,5,Product used for unknown indication,4,F,EXP,nivolumab,5,SS,Temporal arteritis,5,M,HO,188
154626284,6,Product used for unknown indication,4,F,EXP,nivolumab,6,SS,Temporal arteritis,6,M,HO,202
154626284,7,Product used for unknown indication,4,F,EXP,nivolumab,7,SS,Temporal arteritis,7,M,HO,174
154626284,8,Product used for unknown indication,4,F,EXP,nivolumab,8,SS,Temporal arteritis,8,M,HO,160
154626284,9,Product used for unknown indication,4,F,EXP,nivolumab,9,SS,Temporal arteritis,9,M,HO,146
154626284,10,Product used for unknown indication,4,F,EXP,nivolumab,10,SS,Temporal arteritis,10,M,HO,118
154626284,11,Product used for unknown indication,4,F,EXP,nivolumab,11,SS,Temporal arteritis,11,M,HO,99
154626284,12,Product used for unknown indication,4,F,EXP,nivolumab,12,SS,Temporal arteritis,12,M,HO,83
154626284,13,Product used for unknown indication,4,F,EXP,nivolumab,13,SS,Temporal arteritis,13,M,HO,69
154626284,14,Product used for unknown indication,4,F,EXP,nivolumab,14,SS,Temporal arteritis,14,M,HO,13
154648973,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Leukopenia,6,M,OT,14
154648973,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Neutropenia,6,M,OT,14
154648973,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Peripheral sensory neuropathy,6,M,OT,14
154648973,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Thrombocytopenia,6,M,OT,14
154694435,1,Renal cell carcinoma,5,F,EXP,avelumab,1,SS,Hyperglycaemia,1,M,HO,14
154703223,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Back pain,2,M,OT,2
154703223,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Back pain,2,M,HO,2
154703223,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Leukopenia,2,M,OT,2
154703223,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Leukopenia,2,M,HO,2
154703223,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Lower respiratory tract infection,2,M,OT,2
154703223,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Lower respiratory tract infection,2,M,HO,2
154703223,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Neutropenia,2,M,OT,2
154703223,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Neutropenia,2,M,HO,2
154705693,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,34
154705693,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,34
154705693,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,34
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Confusional state,7,M,OT,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Confusional state,7,M,DE,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Confusional state,7,M,HO,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Lower respiratory tract infection,7,M,OT,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Lower respiratory tract infection,7,M,DE,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Lower respiratory tract infection,7,M,HO,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Mobility decreased,7,M,OT,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Mobility decreased,7,M,DE,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Mobility decreased,7,M,HO,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Neutropenia,7,M,OT,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Neutropenia,7,M,DE,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Neutropenia,7,M,HO,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Plasma cell myeloma,7,M,OT,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Plasma cell myeloma,7,M,DE,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Plasma cell myeloma,7,M,HO,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Rash maculo-papular,7,M,OT,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Rash maculo-papular,7,M,DE,14
154759542,7,Plasma cell myeloma,2,F,EXP,pomalidomide,7,SS,Rash maculo-papular,7,M,HO,14
154759594,12,Prophylaxis,4,F,EXP,granisetron,12,C,Back pain,12,M,LT,119
154759594,12,Prophylaxis,4,F,EXP,granisetron,12,C,Back pain,12,M,DE,119
154759594,12,Prophylaxis,4,F,EXP,granisetron,12,C,Back pain,12,M,HO,119
154759594,12,Prophylaxis,4,F,EXP,granisetron,12,C,Dry skin,12,M,LT,119
154759594,12,Prophylaxis,4,F,EXP,granisetron,12,C,Dry skin,12,M,DE,119
154759594,12,Prophylaxis,4,F,EXP,granisetron,12,C,Dry skin,12,M,HO,119
154759594,12,Prophylaxis,4,F,EXP,granisetron,12,C,General physical health deterioration,12,M,LT,119
154759594,12,Prophylaxis,4,F,EXP,granisetron,12,C,General physical health deterioration,12,M,DE,119
154759594,12,Prophylaxis,4,F,EXP,granisetron,12,C,General physical health deterioration,12,M,HO,119
154759594,12,Prophylaxis,4,F,EXP,granisetron,12,C,Polyneuropathy,12,M,LT,119
154759594,12,Prophylaxis,4,F,EXP,granisetron,12,C,Polyneuropathy,12,M,DE,119
154759594,12,Prophylaxis,4,F,EXP,granisetron,12,C,Polyneuropathy,12,M,HO,119
154797018,6,Plasma cell myeloma,8,F,EXP,pomalidomide,6,SS,Leukopenia,6,M,OT,14
154797018,6,Plasma cell myeloma,8,F,EXP,pomalidomide,6,SS,Neutropenia,6,M,OT,14
154797018,6,Plasma cell myeloma,8,F,EXP,pomalidomide,6,SS,Peripheral sensory neuropathy,6,M,OT,14
154797018,6,Plasma cell myeloma,8,F,EXP,pomalidomide,6,SS,Thrombocytopenia,6,M,OT,14
154875472,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Blood pressure systolic decreased,1,M,HO,782
154875472,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Chest pain,1,M,HO,782
154875472,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Dizziness,1,M,HO,782
154875472,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Dyspnoea,1,M,HO,782
154918913,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Blood potassium increased,1,F,OT,28
154918913,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Blood potassium increased,1,F,HO,28
154918913,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Iron deficiency anaemia,1,F,OT,28
154918913,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Iron deficiency anaemia,1,F,HO,28
154918913,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Meniere's disease,1,F,OT,28
154918913,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Meniere's disease,1,F,HO,28
154918913,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Oedema,1,F,OT,28
154918913,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Oedema,1,F,HO,28
154918913,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Pain in extremity,1,F,OT,28
154918913,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Pain in extremity,1,F,HO,28
154918913,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Pyrexia,1,F,OT,28
154918913,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Pyrexia,1,F,HO,28
154918913,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Sinus node dysfunction,1,F,OT,28
154918913,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Sinus node dysfunction,1,F,HO,28
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Colitis,1,F,HO,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Colitis,1,F,OT,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Colitis,1,F,LT,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,HO,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,OT,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,LT,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,LT,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Drug-induced liver injury,1,F,HO,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Drug-induced liver injury,1,F,OT,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Drug-induced liver injury,1,F,LT,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Hypotension,1,F,HO,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Hypotension,1,F,OT,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Hypotension,1,F,LT,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,LT,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Psoriasis,1,F,HO,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Psoriasis,1,F,OT,1
154919128,1,Lung neoplasm malignant,8,F,EXP,nivolumab,1,PS,Psoriasis,1,F,LT,1
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Adrenomegaly,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Adrenomegaly,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Adrenomegaly,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Adrenomegaly,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Adrenomegaly,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Blood pressure increased,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Blood pressure increased,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Blood pressure increased,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Blood pressure increased,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Blood pressure increased,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Chest pain,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Chest pain,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Chest pain,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Chest pain,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Chest pain,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Colitis,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Colitis,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Colitis,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Device related infection,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Device related infection,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Device related infection,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Device related infection,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Device related infection,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Heparin-induced thrombocytopenia,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Heparin-induced thrombocytopenia,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Heparin-induced thrombocytopenia,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Heparin-induced thrombocytopenia,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Heparin-induced thrombocytopenia,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Hypertensive crisis,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Hypertensive crisis,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Hypertensive crisis,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Hypertensive crisis,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Hypertensive crisis,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Klebsiella infection,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Klebsiella infection,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Klebsiella infection,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Klebsiella infection,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Klebsiella infection,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Meningitis,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Meningitis,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Meningitis,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Meningitis,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Meningitis,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Metastases to meninges,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Metastases to meninges,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Metastases to meninges,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Metastases to meninges,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Metastases to meninges,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Retinal detachment,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Retinal detachment,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Retinal detachment,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Retinal detachment,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Retinal detachment,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Tachycardia,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Tachycardia,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Tachycardia,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Tachycardia,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Tachycardia,1,M,LT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Urosepsis,1,M,DE,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Urosepsis,1,M,DS,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Urosepsis,1,M,OT,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Urosepsis,1,M,HO,6
1549343214,1,Malignant melanoma,14,F,EXP,nivolumab,1,PS,Urosepsis,1,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Adrenomegaly,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Adrenomegaly,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Adrenomegaly,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Adrenomegaly,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Adrenomegaly,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Blood pressure increased,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Blood pressure increased,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Blood pressure increased,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Blood pressure increased,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Blood pressure increased,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Chest pain,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Chest pain,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Chest pain,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Chest pain,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Chest pain,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Colitis,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Colitis,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Colitis,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Colitis,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Colitis,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Device related infection,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Device related infection,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Device related infection,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Device related infection,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Device related infection,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Dyspnoea,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Dyspnoea,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Dyspnoea,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Dyspnoea,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Dyspnoea,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Heparin-induced thrombocytopenia,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Heparin-induced thrombocytopenia,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Heparin-induced thrombocytopenia,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Heparin-induced thrombocytopenia,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Heparin-induced thrombocytopenia,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Hyperglycaemia,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Hyperglycaemia,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Hyperglycaemia,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Hyperglycaemia,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Hyperglycaemia,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Hypertensive crisis,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Hypertensive crisis,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Hypertensive crisis,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Hypertensive crisis,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Hypertensive crisis,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Klebsiella infection,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Klebsiella infection,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Klebsiella infection,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Klebsiella infection,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Klebsiella infection,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Meningitis,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Meningitis,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Meningitis,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Meningitis,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Meningitis,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Metastases to meninges,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Metastases to meninges,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Metastases to meninges,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Metastases to meninges,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Metastases to meninges,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Pulmonary oedema,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Pulmonary oedema,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Pulmonary oedema,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Pulmonary oedema,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Pulmonary oedema,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Retinal detachment,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Retinal detachment,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Retinal detachment,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Retinal detachment,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Retinal detachment,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Tachycardia,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Tachycardia,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Tachycardia,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Tachycardia,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Tachycardia,3,M,LT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Urosepsis,3,M,DE,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Urosepsis,3,M,DS,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Urosepsis,3,M,OT,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Urosepsis,3,M,HO,6
1549343214,3,Malignant melanoma,14,F,EXP,ipilimumab,3,SS,Urosepsis,3,M,LT,6
155097072,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Choking,1,M,OT,2
155097072,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Dysphagia,1,M,OT,2
155097072,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Dysphonia,1,M,OT,2
155097072,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Hypoaesthesia,1,M,OT,2
155097072,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Swelling,1,M,OT,2
155256747,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Pneumonia,1,M,HO,178
155256747,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Transient ischaemic attack,1,M,HO,178
155306774,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Corneal abrasion,1,M,OT,14
155306774,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Corneal abrasion,1,M,HO,14
155306774,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,14
155306774,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,14
155306774,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Mucosal inflammation,1,M,OT,14
155306774,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Mucosal inflammation,1,M,HO,14
155306774,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Neutropenia,1,M,OT,14
155306774,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Neutropenia,1,M,HO,14
155306774,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Prostate cancer,1,M,OT,14
155306774,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Prostate cancer,1,M,HO,14
155306774,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,OT,14
155306774,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,HO,14
155306774,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Rash maculo-papular,1,M,OT,14
155306774,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Rash maculo-papular,1,M,HO,14
155350364,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Arrhythmia,1,M,OT,16
155350364,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Cough,1,M,OT,16
155350364,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Discomfort,1,M,OT,16
155350364,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Dry throat,1,M,OT,16
155350364,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Dysgeusia,1,M,OT,16
155350364,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Ear discomfort,1,M,OT,16
155350364,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Epistaxis,1,M,OT,16
155350364,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,16
155350364,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Gastritis,1,M,OT,16
155350364,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Headache,1,M,OT,16
155350364,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Influenza,1,M,OT,16
155350364,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Laziness,1,M,OT,16
155350364,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Malaise,1,M,OT,16
155350364,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Thrombosis,1,M,OT,16
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,F,OT,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,F,HO,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Blood creatinine decreased,1,F,OT,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Blood creatinine decreased,1,F,HO,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Constipation,1,F,OT,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Constipation,1,F,HO,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Cough,1,F,OT,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Cough,1,F,HO,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,F,HO,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Fungal infection,1,F,OT,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Fungal infection,1,F,HO,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Headache,1,F,OT,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Headache,1,F,HO,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Infusion related reaction,1,F,OT,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Infusion related reaction,1,F,HO,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Intentional product use issue,1,F,OT,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Intentional product use issue,1,F,HO,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Migraine,1,F,OT,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Migraine,1,F,HO,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Night sweats,1,F,OT,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Night sweats,1,F,HO,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Weight decreased,1,F,OT,33
155359423,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Weight decreased,1,F,HO,33
155363436,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Diarrhoea,1,M,HO,14
155363436,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Diarrhoea,1,M,OT,14
155363436,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Pneumonia,1,M,HO,14
155363436,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Pneumonia,1,M,OT,14
155363436,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Pneumonitis,1,M,HO,14
155363436,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Pneumonitis,1,M,OT,14
155363436,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Pyrexia,1,M,HO,14
155363436,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Pyrexia,1,M,OT,14
155363436,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Rash maculo-papular,1,M,HO,14
155363436,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Rash maculo-papular,1,M,OT,14
155363436,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Rash pruritic,1,M,HO,14
155363436,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Rash pruritic,1,M,OT,14
155363436,3,Malignant melanoma,6,F,EXP,ipilimumab,3,PS,Diarrhoea,3,M,HO,14
155363436,3,Malignant melanoma,6,F,EXP,ipilimumab,3,PS,Diarrhoea,3,M,OT,14
155363436,3,Malignant melanoma,6,F,EXP,ipilimumab,3,PS,Pneumonia,3,M,HO,14
155363436,3,Malignant melanoma,6,F,EXP,ipilimumab,3,PS,Pneumonia,3,M,OT,14
155363436,3,Malignant melanoma,6,F,EXP,ipilimumab,3,PS,Pneumonitis,3,M,HO,14
155363436,3,Malignant melanoma,6,F,EXP,ipilimumab,3,PS,Pneumonitis,3,M,OT,14
155363436,3,Malignant melanoma,6,F,EXP,ipilimumab,3,PS,Pyrexia,3,M,HO,14
155363436,3,Malignant melanoma,6,F,EXP,ipilimumab,3,PS,Pyrexia,3,M,OT,14
155363436,3,Malignant melanoma,6,F,EXP,ipilimumab,3,PS,Rash maculo-papular,3,M,HO,14
155363436,3,Malignant melanoma,6,F,EXP,ipilimumab,3,PS,Rash maculo-papular,3,M,OT,14
155363436,3,Malignant melanoma,6,F,EXP,ipilimumab,3,PS,Rash pruritic,3,M,HO,14
155363436,3,Malignant melanoma,6,F,EXP,ipilimumab,3,PS,Rash pruritic,3,M,OT,14
155385998,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Cardiovascular insufficiency,1,M,HO,72
155385998,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Cardiovascular insufficiency,1,M,LT,72
155385998,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Cardiovascular insufficiency,1,M,OT,72
155385998,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Cardiovascular insufficiency,1,M,DE,72
155385998,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,72
155385998,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,LT,72
155385998,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,72
155385998,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,72
155385998,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Haemorrhage,1,M,HO,72
155385998,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Haemorrhage,1,M,LT,72
155385998,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Haemorrhage,1,M,OT,72
155385998,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Haemorrhage,1,M,DE,72
155385998,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Cardiovascular insufficiency,2,M,HO,72
155385998,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Cardiovascular insufficiency,2,M,LT,72
155385998,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Cardiovascular insufficiency,2,M,OT,72
155385998,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Cardiovascular insufficiency,2,M,DE,72
155385998,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,72
155385998,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,LT,72
155385998,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,72
155385998,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,DE,72
155385998,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Haemorrhage,2,M,HO,72
155385998,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Haemorrhage,2,M,LT,72
155385998,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Haemorrhage,2,M,OT,72
155385998,2,Non-small cell lung cancer,8,F,EXP,ipilimumab,2,SS,Haemorrhage,2,M,DE,72
155385998,4,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,4,SS,Cardiovascular insufficiency,4,M,HO,72
155385998,4,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,4,SS,Cardiovascular insufficiency,4,M,LT,72
155385998,4,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,4,SS,Cardiovascular insufficiency,4,M,OT,72
155385998,4,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,4,SS,Cardiovascular insufficiency,4,M,DE,72
155385998,4,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,4,SS,Diarrhoea,4,M,HO,72
155385998,4,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,4,SS,Diarrhoea,4,M,LT,72
155385998,4,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,4,SS,Diarrhoea,4,M,OT,72
155385998,4,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,4,SS,Diarrhoea,4,M,DE,72
155385998,4,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,4,SS,Haemorrhage,4,M,HO,72
155385998,4,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,4,SS,Haemorrhage,4,M,LT,72
155385998,4,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,4,SS,Haemorrhage,4,M,OT,72
155385998,4,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,4,SS,Haemorrhage,4,M,DE,72
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Bacteriuria,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Blood creatinine decreased,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone decreased,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone increased,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Cells in urine,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Crystal urine present,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Granulocyte count decreased,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Haematuria,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Neutrophil count decreased,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Nitrite urine present,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Platelet count decreased,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Protein urine present,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Red blood cells urine positive,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Urinary casts present,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Urinary tract infection bacterial,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Urobilinogen urine increased,1,F,OT,108
1554797210,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,OT,108
155491403,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,9
155491403,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,9
155491403,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,9
155491403,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,9
155491403,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Laryngeal oedema,1,M,HO,9
155491403,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Laryngeal oedema,1,M,OT,9
155491403,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Pruritus,1,M,HO,9
155491403,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Pruritus,1,M,OT,9
155491403,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Rash papular,1,M,HO,9
155491403,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Rash papular,1,M,OT,9
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Bile duct stone,1,M,HO,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Bile duct stone,1,M,DE,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Bile duct stone,1,M,OT,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Catheter site infection,1,M,HO,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Catheter site infection,1,M,DE,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Catheter site infection,1,M,OT,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Cholangitis,1,M,HO,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Cholangitis,1,M,DE,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Cholangitis,1,M,OT,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Cholelithiasis,1,M,HO,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Cholelithiasis,1,M,DE,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Cholelithiasis,1,M,OT,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Sepsis,1,M,DE,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Skin ulcer,1,M,HO,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Skin ulcer,1,M,DE,134
155497296,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Skin ulcer,1,M,OT,134
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Abdominal discomfort,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Abdominal discomfort,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Abdominal pain,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Abdominal pain,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Abdominal pain upper,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Abdominal pain upper,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Bacteriuria,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Bacteriuria,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Bladder dilatation,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Bladder dilatation,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Bladder hypertrophy,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Bladder hypertrophy,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Bladder trabeculation,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Bladder trabeculation,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone decreased,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone decreased,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone increased,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone increased,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Cholelithiasis,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Cholelithiasis,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Crystal urine present,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Crystal urine present,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Cystitis,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Cystitis,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Gallbladder neoplasm,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Gallbladder neoplasm,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Haematochezia,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Haematochezia,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Haematuria,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Haematuria,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Helicobacter gastritis,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Helicobacter gastritis,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Lymphocyte percentage decreased,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Lymphocyte percentage decreased,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Nausea,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Nausea,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Neutrophil count decreased,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Neutrophil count decreased,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Nitrite urine present,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Nitrite urine present,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pain,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Pain,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Post micturition dribble,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Post micturition dribble,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Urinary tract infection bacterial,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,Urinary tract infection bacterial,1,F,OT,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,HO,31
1555237318,1,Multiple sclerosis,18,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,OT,31
155547489,1,Chronic myeloid leukaemia,9,F,EXP,nilotinib,1,PS,Rhabdomyolysis,1,F,HO,1820
155547489,1,Chronic myeloid leukaemia,9,F,EXP,nilotinib,1,PS,Rhabdomyolysis,1,F,OT,1820
155678664,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Blood thyroid stimulating hormone increased,1,M,OT,56
155678664,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Blood thyroid stimulating hormone increased,1,M,HO,56
155678664,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Non-cardiac chest pain,1,M,OT,56
155678664,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Non-cardiac chest pain,1,M,HO,56
155678664,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Blood thyroid stimulating hormone increased,2,M,OT,56
155678664,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Blood thyroid stimulating hormone increased,2,M,HO,56
155678664,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Non-cardiac chest pain,2,M,OT,56
155678664,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Non-cardiac chest pain,2,M,HO,56
155694678,1,Squamous cell carcinoma of lung,8,F,EXP,nivolumab,1,PS,Arthropod bite,1,M,OT,182
155694678,1,Squamous cell carcinoma of lung,8,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,182
155694678,1,Squamous cell carcinoma of lung,8,F,EXP,nivolumab,1,PS,Erythema,1,M,OT,182
155694678,1,Squamous cell carcinoma of lung,8,F,EXP,nivolumab,1,PS,Neurodermatitis,1,M,OT,182
155694678,1,Squamous cell carcinoma of lung,8,F,EXP,nivolumab,1,PS,Peripheral swelling,1,M,OT,182
155694678,1,Squamous cell carcinoma of lung,8,F,EXP,nivolumab,1,PS,Respiratory tract infection,1,M,OT,182
155694678,1,Squamous cell carcinoma of lung,8,F,EXP,nivolumab,1,PS,Scleral hyperaemia,1,M,OT,182
155694678,1,Squamous cell carcinoma of lung,8,F,EXP,nivolumab,1,PS,Skin exfoliation,1,M,OT,182
155694678,1,Squamous cell carcinoma of lung,8,F,EXP,nivolumab,1,PS,Swelling face,1,M,OT,182
155705649,22,Metastases to bone,9,F,EXP,denosumab,22,C,Cellulitis,22,F,HO,418
155705649,22,Metastases to bone,9,F,EXP,denosumab,22,C,Constipation,22,F,HO,418
155705649,22,Metastases to bone,9,F,EXP,denosumab,22,C,Haemoptysis,22,F,HO,418
155705649,22,Metastases to bone,9,F,EXP,denosumab,22,C,Pyrexia,22,F,HO,418
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Abdominal pain upper,1,M,HO,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Abdominal pain upper,1,M,OT,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Blood count abnormal,1,M,HO,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Blood count abnormal,1,M,OT,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Exostosis,1,M,HO,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Exostosis,1,M,OT,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Fall,1,M,HO,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Fall,1,M,OT,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Nausea,1,M,HO,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Nausea,1,M,OT,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Oral infection,1,M,HO,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Oral infection,1,M,OT,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Osteonecrosis of jaw,1,M,HO,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Osteonecrosis of jaw,1,M,OT,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Rib fracture,1,M,HO,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Rib fracture,1,M,OT,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Thrombosis,1,M,HO,315
155735836,1,Prostate cancer,6,F,EXP,enzalutamide,1,PS,Thrombosis,1,M,OT,315
155886097,7,Plasma cell myeloma,7,F,EXP,pomalidomide,7,SS,Adenocarcinoma of colon,7,M,HO,210
155886097,7,Plasma cell myeloma,7,F,EXP,pomalidomide,7,SS,Adenocarcinoma of colon,7,M,OT,210
155886097,7,Plasma cell myeloma,7,F,EXP,pomalidomide,7,SS,Colon cancer,7,M,HO,210
155886097,7,Plasma cell myeloma,7,F,EXP,pomalidomide,7,SS,Colon cancer,7,M,OT,210
155886097,7,Plasma cell myeloma,7,F,EXP,pomalidomide,7,SS,Neuropathy peripheral,7,M,HO,210
155886097,7,Plasma cell myeloma,7,F,EXP,pomalidomide,7,SS,Neuropathy peripheral,7,M,OT,210
155986908,2,Metastatic malignant melanoma,8,F,EXP,trametinib,2,SS,Cytokine release syndrome,2,M,LT,31
155986908,2,Metastatic malignant melanoma,8,F,EXP,trametinib,2,SS,Cytokine release syndrome,2,M,HO,31
155986908,2,Metastatic malignant melanoma,8,F,EXP,trametinib,2,SS,Septic shock,2,M,LT,31
155986908,2,Metastatic malignant melanoma,8,F,EXP,trametinib,2,SS,Septic shock,2,M,HO,31
155994854,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Nerve compression,1,M,OT,22
155994854,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Nerve compression,1,M,HO,22
155994854,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,22
155994854,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,22
156033334,1,Chronic lymphocytic leukaemia,4,F,EXP,idelalisib,1,PS,Aphthous ulcer,1,M,OT,225
156033334,1,Chronic lymphocytic leukaemia,4,F,EXP,idelalisib,1,PS,Aphthous ulcer,1,M,HO,225
156033334,1,Chronic lymphocytic leukaemia,4,F,EXP,idelalisib,1,PS,Autoimmune thyroiditis,1,M,OT,225
156033334,1,Chronic lymphocytic leukaemia,4,F,EXP,idelalisib,1,PS,Autoimmune thyroiditis,1,M,HO,225
156033334,1,Chronic lymphocytic leukaemia,4,F,EXP,idelalisib,1,PS,Colitis,1,M,OT,225
156033334,1,Chronic lymphocytic leukaemia,4,F,EXP,idelalisib,1,PS,Colitis,1,M,HO,225
156033334,1,Chronic lymphocytic leukaemia,4,F,EXP,idelalisib,1,PS,Diarrhoea,1,M,OT,225
156033334,1,Chronic lymphocytic leukaemia,4,F,EXP,idelalisib,1,PS,Diarrhoea,1,M,HO,225
156049905,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Myocardial infarction,1,F,OT,385
156049905,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Myocardial infarction,1,F,HO,385
156049905,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Sarcoidosis,1,F,OT,385
156049905,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Sarcoidosis,1,F,HO,385
156049905,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Myocardial infarction,3,F,OT,196
156049905,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Myocardial infarction,3,F,HO,196
156049905,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Sarcoidosis,3,F,OT,196
156049905,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Sarcoidosis,3,F,HO,196
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Anxiety,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Anxiety,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Anxiety,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Back pain,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Back pain,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Back pain,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Breast tenderness,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Breast tenderness,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Breast tenderness,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Catheter site inflammation,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Catheter site inflammation,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Catheter site inflammation,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Claustrophobia,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Claustrophobia,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Claustrophobia,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Cushingoid,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Cushingoid,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Cushingoid,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Decreased appetite,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Decreased appetite,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Decreased appetite,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Dry eye,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Dry eye,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Dry eye,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Erythema,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Erythema,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Erythema,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Eye haemorrhage,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Eye haemorrhage,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Eye haemorrhage,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Eye pruritus,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Eye pruritus,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Eye pruritus,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Fatigue,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Fatigue,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Fatigue,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Hypocalcaemia,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Hypocalcaemia,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Hypocalcaemia,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Hypoglycaemia,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Hypoglycaemia,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Hypoglycaemia,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Impaired gastric emptying,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Impaired gastric emptying,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Impaired gastric emptying,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Lethargy,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Lethargy,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Lethargy,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Malaise,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Malaise,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Malaise,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Nausea,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Nausea,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Nausea,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Neoplasm progression,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Neoplasm progression,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Neoplasm progression,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Neuropathy peripheral,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Neuropathy peripheral,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Neuropathy peripheral,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Palpitations,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Palpitations,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Palpitations,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Pericardial effusion,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Pericardial effusion,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Pericardial effusion,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Pruritus,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Pruritus,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Pruritus,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Rash,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Rash,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Rash,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Rash erythematous,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Rash erythematous,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Rash erythematous,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Spinal fracture,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Spinal fracture,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Spinal fracture,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Vision blurred,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Vision blurred,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Vision blurred,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Visual impairment,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Visual impairment,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Visual impairment,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Vomiting,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Vomiting,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Vomiting,4,F,DE,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Weight increased,4,F,OT,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Weight increased,4,F,HO,591
156078253,4,HER-2 positive breast cancer,3,F,EXP,denosumab,4,SS,Weight increased,4,F,DE,591
156142669,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Bacteriuria,1,M,OT,30
156142669,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Basophil count decreased,1,M,OT,30
156142669,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Crystal urine present,1,M,OT,30
156142669,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Haematuria,1,M,OT,30
156142669,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Ketonuria,1,M,OT,30
156142669,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,M,OT,30
156142669,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,M,OT,30
156142669,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Nitrite urine present,1,M,OT,30
156142669,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Urinary tract infection bacterial,1,M,OT,30
156142669,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,M,OT,30
156147248,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,21
156147248,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Pain,1,M,HO,21
156147248,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,M,HO,21
156147248,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Pain,2,M,HO,21
156239664,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Prostate cancer recurrent,1,M,OT,971
156239664,3,Plasma cell myeloma,4,F,PER,lenalidomide,3,SS,Prostate cancer recurrent,3,M,OT,971
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Condition aggravated,3,F,DE,7
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Condition aggravated,3,F,HO,7
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Condition aggravated,3,F,LT,7
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Decreased appetite,3,F,DE,7
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Decreased appetite,3,F,HO,7
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Decreased appetite,3,F,LT,7
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Febrile neutropenia,3,F,DE,7
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Febrile neutropenia,3,F,HO,7
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Febrile neutropenia,3,F,LT,7
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Hepatic failure,3,F,DE,7
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Hepatic failure,3,F,HO,7
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Hepatic failure,3,F,LT,7
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Mucormycosis,3,F,DE,7
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Mucormycosis,3,F,HO,7
1562767816,3,Nausea,16,F,EXP,granisetron,3,C,Mucormycosis,3,F,LT,7
156281394,7,Plasma cell myeloma,4,F,EXP,carfilzomib,7,SS,Prostate cancer recurrent,7,M,OT,971
156307433,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,14
156307433,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Anaemia,1,M,DE,14
156307433,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,14
156307433,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,14
156307433,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Malnutrition,1,M,OT,14
156307433,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Malnutrition,1,M,DE,14
156351273,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,M,DE,22
156351273,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,M,OT,22
156393728,10,Metastases to bone,8,F,EXP,denosumab,10,C,Cellulitis,10,F,HO,418
156393728,10,Metastases to bone,8,F,EXP,denosumab,10,C,Constipation,10,F,HO,418
156393728,10,Metastases to bone,8,F,EXP,denosumab,10,C,Haemoptysis,10,F,HO,418
156393728,10,Metastases to bone,8,F,EXP,denosumab,10,C,Pyrexia,10,F,HO,418
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Cytokine release syndrome,1,M,OT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Cytokine release syndrome,1,M,LT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Cytokine release syndrome,1,M,HO,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Erythema multiforme,1,M,OT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Erythema multiforme,1,M,LT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Erythema multiforme,1,M,HO,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Fatigue,1,M,LT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hyperhidrosis,1,M,OT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hyperhidrosis,1,M,LT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hyperhidrosis,1,M,HO,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Neoplasm,1,M,OT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Neoplasm,1,M,LT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Neoplasm,1,M,HO,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Photosensitivity reaction,1,M,OT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Photosensitivity reaction,1,M,LT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Photosensitivity reaction,1,M,HO,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Skin hyperpigmentation,1,M,OT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Skin hyperpigmentation,1,M,LT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Skin hyperpigmentation,1,M,HO,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Skin hypopigmentation,1,M,OT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Skin hypopigmentation,1,M,LT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Skin hypopigmentation,1,M,HO,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Tumour pain,1,M,OT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Tumour pain,1,M,LT,1
156420987,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Tumour pain,1,M,HO,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Cytokine release syndrome,3,M,OT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Cytokine release syndrome,3,M,LT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Cytokine release syndrome,3,M,HO,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Erythema multiforme,3,M,OT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Erythema multiforme,3,M,LT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Erythema multiforme,3,M,HO,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Fatigue,3,M,OT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Fatigue,3,M,LT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Fatigue,3,M,HO,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Hyperhidrosis,3,M,OT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Hyperhidrosis,3,M,LT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Hyperhidrosis,3,M,HO,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Neoplasm,3,M,OT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Neoplasm,3,M,LT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Neoplasm,3,M,HO,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Photosensitivity reaction,3,M,OT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Photosensitivity reaction,3,M,LT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Photosensitivity reaction,3,M,HO,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Skin hyperpigmentation,3,M,OT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Skin hyperpigmentation,3,M,LT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Skin hyperpigmentation,3,M,HO,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Skin hypopigmentation,3,M,OT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Skin hypopigmentation,3,M,LT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Skin hypopigmentation,3,M,HO,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Tumour pain,3,M,OT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Tumour pain,3,M,LT,1
156420987,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Tumour pain,3,M,HO,1
156468436,4,Neutropenia,6,F,EXP,filgrastim,4,C,Circulatory collapse,4,F,OT,7
156468436,4,Neutropenia,6,F,EXP,filgrastim,4,C,Circulatory collapse,4,F,DE,7
156468436,4,Neutropenia,6,F,EXP,filgrastim,4,C,Haemolytic anaemia,4,F,OT,7
156468436,4,Neutropenia,6,F,EXP,filgrastim,4,C,Haemolytic anaemia,4,F,DE,7
156468436,4,Neutropenia,6,F,EXP,filgrastim,4,C,Intravascular haemolysis,4,F,OT,7
156468436,4,Neutropenia,6,F,EXP,filgrastim,4,C,Intravascular haemolysis,4,F,DE,7
156468436,4,Neutropenia,6,F,EXP,filgrastim,4,C,Multiple organ dysfunction syndrome,4,F,OT,7
156468436,4,Neutropenia,6,F,EXP,filgrastim,4,C,Multiple organ dysfunction syndrome,4,F,DE,7
156468436,4,Neutropenia,6,F,EXP,filgrastim,4,C,Shock,4,F,OT,7
156468436,4,Neutropenia,6,F,EXP,filgrastim,4,C,Shock,4,F,DE,7
156497577,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Cerebrovascular disorder,1,M,OT,2
156497577,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Confusional state,1,M,OT,2
156497577,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Cough,1,M,OT,2
156497577,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,2
156497577,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,2
156497577,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Headache,1,M,OT,2
156497577,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Infusion related reaction,1,M,OT,2
156497577,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Insomnia,1,M,OT,2
156497577,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,2
156497577,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Ocular hyperaemia,1,M,OT,2
156497577,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Presyncope,1,M,OT,2
156497577,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Pruritus,1,M,OT,2
156497577,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Rash,1,M,OT,2
156497577,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Scleral haemorrhage,1,M,OT,2
156497577,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Cerebrovascular disorder,2,M,OT,2
156497577,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Confusional state,2,M,OT,2
156497577,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Cough,2,M,OT,2
156497577,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Decreased appetite,2,M,OT,2
156497577,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Fatigue,2,M,OT,2
156497577,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Headache,2,M,OT,2
156497577,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Infusion related reaction,2,M,OT,2
156497577,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Insomnia,2,M,OT,2
156497577,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Intentional product use issue,2,M,OT,2
156497577,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Ocular hyperaemia,2,M,OT,2
156497577,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Presyncope,2,M,OT,2
156497577,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Pruritus,2,M,OT,2
156497577,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Rash,2,M,OT,2
156497577,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Scleral haemorrhage,2,M,OT,2
156499897,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Drug-induced liver injury,1,F,OT,6
156499897,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Drug-induced liver injury,1,F,HO,6
156499897,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,F,OT,6
156499897,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,F,HO,6
156499897,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Meningitis,1,F,OT,6
156499897,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Meningitis,1,F,HO,6
156499897,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Myalgia,1,F,OT,6
156499897,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Myalgia,1,F,HO,6
156499897,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Non-cardiogenic pulmonary oedema,1,F,OT,6
156499897,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Non-cardiogenic pulmonary oedema,1,F,HO,6
156499897,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Prescribed underdose,1,F,OT,6
156499897,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Prescribed underdose,1,F,HO,6
156499897,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pyrexia,1,F,OT,6
156499897,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,6
156499897,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Drug-induced liver injury,2,F,OT,6
156499897,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Drug-induced liver injury,2,F,HO,6
156499897,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,F,OT,6
156499897,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,F,HO,6
156499897,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Meningitis,2,F,OT,6
156499897,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Meningitis,2,F,HO,6
156499897,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Myalgia,2,F,OT,6
156499897,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Myalgia,2,F,HO,6
156499897,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Non-cardiogenic pulmonary oedema,2,F,OT,6
156499897,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Non-cardiogenic pulmonary oedema,2,F,HO,6
156499897,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Prescribed underdose,2,F,OT,6
156499897,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Prescribed underdose,2,F,HO,6
156499897,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Pyrexia,2,F,OT,6
156499897,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Pyrexia,2,F,HO,6
156502255,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,HO,28
156502255,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,OT,28
156502255,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Cough,1,M,HO,28
156502255,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Cough,1,M,OT,28
156502255,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Diabetes mellitus,1,M,HO,28
156502255,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Diabetes mellitus,1,M,OT,28
156502255,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Liver function test abnormal,1,M,HO,28
156502255,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Liver function test abnormal,1,M,OT,28
156502255,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Metabolic acidosis,1,M,HO,28
156502255,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Metabolic acidosis,1,M,OT,28
156502255,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,HO,28
156502255,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,OT,28
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Bacteraemia,4,M,DE,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Bacteraemia,4,M,HO,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Bacteraemia,4,M,LT,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Encephalopathy,4,M,DE,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Encephalopathy,4,M,HO,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Encephalopathy,4,M,LT,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Noninfective encephalitis,4,M,DE,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Noninfective encephalitis,4,M,HO,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Noninfective encephalitis,4,M,LT,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Pneumonia staphylococcal,4,M,DE,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Pneumonia staphylococcal,4,M,HO,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Pneumonia staphylococcal,4,M,LT,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Respiratory failure,4,M,DE,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Respiratory failure,4,M,HO,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Respiratory failure,4,M,LT,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Seizure,4,M,DE,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Seizure,4,M,HO,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Seizure,4,M,LT,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Urinary tract infection,4,M,DE,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Urinary tract infection,4,M,HO,5
156545896,4,Diffuse large B-cell lymphoma refractory,6,F,EXP,axicabtagene ciloleucel,4,SS,Urinary tract infection,4,M,LT,5
156561292,5,Glioma,2,F,EXP,nilotinib,5,SS,Aspartate aminotransferase increased,5,F,OT,46
156561292,5,Glioma,2,F,EXP,nilotinib,5,SS,Blood creatinine increased,5,F,OT,46
156561292,5,Glioma,2,F,EXP,nilotinib,5,SS,Blood lactate dehydrogenase increased,5,F,OT,46
156561292,5,Glioma,2,F,EXP,nilotinib,5,SS,Drug hypersensitivity,5,F,OT,46
156561292,5,Glioma,2,F,EXP,nilotinib,5,SS,Visual impairment,5,F,OT,46
156581106,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Autoimmune disorder,1,F,HO,332
156581106,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Autoimmune disorder,1,F,OT,332
156581106,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Gingival discolouration,1,F,HO,332
156581106,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Gingival discolouration,1,F,OT,332
156581106,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,F,HO,332
156581106,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,F,OT,332
156581106,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Petechiae,1,F,HO,332
156581106,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Petechiae,1,F,OT,332
156581106,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Platelet count decreased,1,F,HO,332
156581106,1,Multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Platelet count decreased,1,F,OT,332
156588883,1,Metastases to bone,3,F,PER,denosumab,1,PS,Pyrexia,1,M,HO,6
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Ataxia,1,F,OT,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Ataxia,1,F,HO,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,OT,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,HO,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Fall,1,F,OT,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Fall,1,F,HO,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Fatigue,1,F,HO,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Spinal fracture,1,F,OT,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Spinal fracture,1,F,HO,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Stomatitis,1,F,OT,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Stomatitis,1,F,HO,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Tremor,1,F,OT,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Tremor,1,F,HO,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Vitiligo,1,F,OT,61
1565930111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Vitiligo,1,F,HO,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Ataxia,5,F,OT,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Ataxia,5,F,HO,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Decreased appetite,5,F,OT,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Decreased appetite,5,F,HO,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Fall,5,F,OT,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Fall,5,F,HO,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Fatigue,5,F,OT,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Fatigue,5,F,HO,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Nausea,5,F,OT,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Nausea,5,F,HO,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Spinal fracture,5,F,OT,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Spinal fracture,5,F,HO,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Stomatitis,5,F,OT,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Stomatitis,5,F,HO,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Tremor,5,F,OT,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Tremor,5,F,HO,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Vitiligo,5,F,OT,61
1565930111,5,Malignant melanoma,11,F,EXP,ipilimumab,5,SS,Vitiligo,5,F,HO,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Ataxia,6,F,OT,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Ataxia,6,F,HO,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Decreased appetite,6,F,OT,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Decreased appetite,6,F,HO,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Fall,6,F,OT,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Fall,6,F,HO,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Fatigue,6,F,OT,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Fatigue,6,F,HO,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Nausea,6,F,OT,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Nausea,6,F,HO,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Spinal fracture,6,F,OT,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Spinal fracture,6,F,HO,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Stomatitis,6,F,OT,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Stomatitis,6,F,HO,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Tremor,6,F,OT,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Tremor,6,F,HO,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Vitiligo,6,F,OT,61
1565930111,6,Product used for unknown indication,11,F,EXP,ipilimumab,6,SS,Vitiligo,6,F,HO,61
156616756,5,Malignant melanoma,6,F,EXP,trametinib,5,SS,Epistaxis,5,M,OT,15
156616756,5,Malignant melanoma,6,F,EXP,trametinib,5,SS,Fatigue,5,M,OT,15
156616756,5,Malignant melanoma,6,F,EXP,trametinib,5,SS,Neutropenia,5,M,OT,15
156616756,5,Malignant melanoma,6,F,EXP,trametinib,5,SS,Pyrexia,5,M,OT,15
156616756,5,Malignant melanoma,6,F,EXP,trametinib,5,SS,Rash,5,M,OT,15
156616756,5,Malignant melanoma,6,F,EXP,trametinib,5,SS,Thrombocytopenia,5,M,OT,15
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Adrenomegaly,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Adrenomegaly,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Adrenomegaly,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Adrenomegaly,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Adrenomegaly,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Blood pressure increased,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Blood pressure increased,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Blood pressure increased,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Blood pressure increased,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Blood pressure increased,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Chest pain,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Chest pain,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Chest pain,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Chest pain,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Chest pain,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Colitis,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Colitis,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Colitis,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Colitis,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Colitis,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Device related infection,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Device related infection,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Device related infection,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Device related infection,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Device related infection,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Dyspnoea,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Dyspnoea,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Dyspnoea,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Dyspnoea,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Dyspnoea,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Heparin-induced thrombocytopenia,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Heparin-induced thrombocytopenia,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Heparin-induced thrombocytopenia,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Heparin-induced thrombocytopenia,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Heparin-induced thrombocytopenia,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hypertensive crisis,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hypertensive crisis,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hypertensive crisis,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hypertensive crisis,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hypertensive crisis,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Klebsiella infection,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Klebsiella infection,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Klebsiella infection,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Klebsiella infection,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Klebsiella infection,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Meningitis,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Meningitis,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Meningitis,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Meningitis,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Meningitis,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Metastases to meninges,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Metastases to meninges,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Metastases to meninges,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Metastases to meninges,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Metastases to meninges,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Pulmonary oedema,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Pulmonary oedema,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Pulmonary oedema,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Pulmonary oedema,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Pulmonary oedema,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Retinal detachment,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Retinal detachment,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Retinal detachment,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Retinal detachment,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Retinal detachment,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Retinopathy,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Retinopathy,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Retinopathy,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Retinopathy,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Retinopathy,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Tachycardia,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Tachycardia,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Tachycardia,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Tachycardia,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Tachycardia,2,M,DE,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Urosepsis,2,M,OT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Urosepsis,2,M,LT,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Urosepsis,2,M,HO,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Urosepsis,2,M,DS,6
156620015,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Urosepsis,2,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Acute kidney injury,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Acute kidney injury,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Acute kidney injury,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Acute kidney injury,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Acute kidney injury,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Adrenomegaly,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Adrenomegaly,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Adrenomegaly,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Adrenomegaly,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Adrenomegaly,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Blood pressure increased,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Blood pressure increased,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Blood pressure increased,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Blood pressure increased,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Blood pressure increased,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Chest pain,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Chest pain,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Chest pain,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Chest pain,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Chest pain,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Colitis,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Colitis,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Colitis,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Colitis,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Colitis,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Device related infection,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Device related infection,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Device related infection,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Device related infection,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Device related infection,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Dyspnoea,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Dyspnoea,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Dyspnoea,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Dyspnoea,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Dyspnoea,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Heparin-induced thrombocytopenia,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Heparin-induced thrombocytopenia,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Heparin-induced thrombocytopenia,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Heparin-induced thrombocytopenia,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Heparin-induced thrombocytopenia,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Hyperglycaemia,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Hyperglycaemia,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Hyperglycaemia,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Hyperglycaemia,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Hyperglycaemia,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Hypertensive crisis,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Hypertensive crisis,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Hypertensive crisis,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Hypertensive crisis,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Hypertensive crisis,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Klebsiella infection,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Klebsiella infection,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Klebsiella infection,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Klebsiella infection,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Klebsiella infection,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Malignant neoplasm progression,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Malignant neoplasm progression,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Malignant neoplasm progression,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Malignant neoplasm progression,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Malignant neoplasm progression,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Meningitis,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Meningitis,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Meningitis,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Meningitis,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Meningitis,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Metastases to meninges,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Metastases to meninges,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Metastases to meninges,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Metastases to meninges,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Metastases to meninges,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Pulmonary oedema,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Pulmonary oedema,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Pulmonary oedema,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Pulmonary oedema,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Pulmonary oedema,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Retinal detachment,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Retinal detachment,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Retinal detachment,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Retinal detachment,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Retinal detachment,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Retinopathy,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Retinopathy,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Retinopathy,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Retinopathy,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Retinopathy,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Tachycardia,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Tachycardia,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Tachycardia,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Tachycardia,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Tachycardia,4,M,DE,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Urosepsis,4,M,OT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Urosepsis,4,M,LT,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Urosepsis,4,M,HO,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Urosepsis,4,M,DS,6
156620015,4,Malignant melanoma,5,F,EXP,nivolumab,4,SS,Urosepsis,4,M,DE,6
156663274,5,Plasma cell myeloma,4,F,EXP,pomalidomide,5,SS,Oral pain,5,M,DE,26
156663274,5,Plasma cell myeloma,4,F,EXP,pomalidomide,5,SS,Oral pain,5,M,HO,26
156663274,5,Plasma cell myeloma,4,F,EXP,pomalidomide,5,SS,Peripheral sensorimotor neuropathy,5,M,DE,26
156663274,5,Plasma cell myeloma,4,F,EXP,pomalidomide,5,SS,Peripheral sensorimotor neuropathy,5,M,HO,26
156663274,5,Plasma cell myeloma,4,F,EXP,pomalidomide,5,SS,Plasma cell myeloma,5,M,DE,26
156663274,5,Plasma cell myeloma,4,F,EXP,pomalidomide,5,SS,Plasma cell myeloma,5,M,HO,26
156663274,5,Plasma cell myeloma,4,F,EXP,pomalidomide,5,SS,Sepsis,5,M,DE,26
156663274,5,Plasma cell myeloma,4,F,EXP,pomalidomide,5,SS,Sepsis,5,M,HO,26
156675712,9,Plasma cell myeloma recurrent,2,F,EXP,pomalidomide,9,SS,Anaemia,9,M,HO,14
156675712,9,Plasma cell myeloma recurrent,2,F,EXP,pomalidomide,9,SS,Anaemia,9,M,OT,14
156675712,9,Plasma cell myeloma recurrent,2,F,EXP,pomalidomide,9,SS,Atrial fibrillation,9,M,HO,14
156675712,9,Plasma cell myeloma recurrent,2,F,EXP,pomalidomide,9,SS,Atrial fibrillation,9,M,OT,14
156675712,9,Plasma cell myeloma recurrent,2,F,EXP,pomalidomide,9,SS,Bradycardia,9,M,HO,14
156675712,9,Plasma cell myeloma recurrent,2,F,EXP,pomalidomide,9,SS,Bradycardia,9,M,OT,14
156675712,9,Plasma cell myeloma recurrent,2,F,EXP,pomalidomide,9,SS,Hypotonia,9,M,HO,14
156675712,9,Plasma cell myeloma recurrent,2,F,EXP,pomalidomide,9,SS,Hypotonia,9,M,OT,14
156675712,9,Plasma cell myeloma recurrent,2,F,EXP,pomalidomide,9,SS,Neutropenic sepsis,9,M,HO,14
156675712,9,Plasma cell myeloma recurrent,2,F,EXP,pomalidomide,9,SS,Neutropenic sepsis,9,M,OT,14
156675712,9,Plasma cell myeloma recurrent,2,F,EXP,pomalidomide,9,SS,Pneumonia,9,M,HO,14
156675712,9,Plasma cell myeloma recurrent,2,F,EXP,pomalidomide,9,SS,Pneumonia,9,M,OT,14
156675712,9,Plasma cell myeloma recurrent,2,F,EXP,pomalidomide,9,SS,Syncope,9,M,HO,14
156675712,9,Plasma cell myeloma recurrent,2,F,EXP,pomalidomide,9,SS,Syncope,9,M,OT,14
156699632,3,Plasma cell myeloma,2,F,EXP,thalidomide,3,SS,Bronchitis,3,F,HO,143
1567034317,1,Metastatic renal cell carcinoma,17,F,EXP,axitinib,1,PS,Autoimmune pancreatitis,1,M,HO,387
1567034317,1,Metastatic renal cell carcinoma,17,F,EXP,axitinib,1,PS,Autoimmune pancreatitis,1,M,LT,387
156713854,1,Acute lymphocytic leukaemia,4,F,PER,carfilzomib,1,PS,Infection in an immunocompromised host,1,M,HO,67
156738832,2,Pancreatic carcinoma,2,F,EXP,nivolumab,2,SS,Alanine aminotransferase increased,2,F,HO,28
156738832,2,Pancreatic carcinoma,2,F,EXP,nivolumab,2,SS,Aspartate aminotransferase increased,2,F,HO,28
156738832,2,Pancreatic carcinoma,2,F,EXP,nivolumab,2,SS,Blood bilirubin increased,2,F,HO,28
156738832,2,Pancreatic carcinoma,2,F,EXP,nivolumab,2,SS,Pyrexia,2,F,HO,28
156773183,1,Prostate cancer metastatic,3,F,EXP,cabazitaxel,1,PS,Anaemia,1,M,OT,6
156773183,1,Prostate cancer metastatic,3,F,EXP,cabazitaxel,1,PS,Anaemia,1,M,HO,6
156773183,1,Prostate cancer metastatic,3,F,EXP,cabazitaxel,1,PS,Febrile neutropenia,1,M,OT,6
156773183,1,Prostate cancer metastatic,3,F,EXP,cabazitaxel,1,PS,Febrile neutropenia,1,M,HO,6
156773183,1,Prostate cancer metastatic,3,F,EXP,cabazitaxel,1,PS,Hyperglycaemia,1,M,OT,6
156773183,1,Prostate cancer metastatic,3,F,EXP,cabazitaxel,1,PS,Hyperglycaemia,1,M,HO,6
156773183,1,Prostate cancer metastatic,3,F,EXP,cabazitaxel,1,PS,Hypokalaemia,1,M,OT,6
156773183,1,Prostate cancer metastatic,3,F,EXP,cabazitaxel,1,PS,Hypokalaemia,1,M,HO,6
156773183,1,Prostate cancer metastatic,3,F,EXP,cabazitaxel,1,PS,Hyponatraemia,1,M,OT,6
156773183,1,Prostate cancer metastatic,3,F,EXP,cabazitaxel,1,PS,Hyponatraemia,1,M,HO,6
156773183,1,Prostate cancer metastatic,3,F,EXP,cabazitaxel,1,PS,Paraesthesia,1,M,OT,6
156773183,1,Prostate cancer metastatic,3,F,EXP,cabazitaxel,1,PS,Paraesthesia,1,M,HO,6
156773183,1,Prostate cancer metastatic,3,F,EXP,cabazitaxel,1,PS,Platelet count decreased,1,M,OT,6
156773183,1,Prostate cancer metastatic,3,F,EXP,cabazitaxel,1,PS,Platelet count decreased,1,M,HO,6
156788282,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Leukopenia,4,M,OT,538
156788282,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Lymphopenia,4,M,OT,538
156788282,5,Plasma cell myeloma,2,F,EXP,carfilzomib,5,SS,Leukopenia,5,M,OT,538
156788282,5,Plasma cell myeloma,2,F,EXP,carfilzomib,5,SS,Lymphopenia,5,M,OT,538
156788622,4,Plasma cell myeloma,2,F,EXP,thalidomide,4,SS,Hepatitis E,4,F,OT,490
156788622,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Hepatitis E,5,F,OT,490
156793932,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,F,OT,28
156793932,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,F,HO,28
156793932,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,F,OT,28
156793932,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,F,HO,28
156793932,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Blood bilirubin increased,1,F,OT,28
156793932,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Blood bilirubin increased,1,F,HO,28
156793932,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Chills,1,F,OT,28
156793932,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Chills,1,F,HO,28
156793932,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Cholangitis,1,F,OT,28
156793932,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Cholangitis,1,F,HO,28
156793932,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Pyrexia,1,F,OT,28
156793932,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,28
156834308,1,Neuroendocrine carcinoma of the skin,8,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,56
156834308,1,Neuroendocrine carcinoma of the skin,8,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,56
156834308,1,Neuroendocrine carcinoma of the skin,8,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,56
156834308,1,Neuroendocrine carcinoma of the skin,8,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,56
156834308,1,Neuroendocrine carcinoma of the skin,8,F,EXP,nivolumab,1,PS,Myalgia,1,M,HO,56
156834308,1,Neuroendocrine carcinoma of the skin,8,F,EXP,nivolumab,1,PS,Myalgia,1,M,OT,56
156834308,1,Neuroendocrine carcinoma of the skin,8,F,EXP,nivolumab,1,PS,Syncope,1,M,HO,56
156834308,1,Neuroendocrine carcinoma of the skin,8,F,EXP,nivolumab,1,PS,Syncope,1,M,OT,56
156849785,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Hepatic function abnormal,2,M,OT,1
156849785,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Hepatic function abnormal,2,M,HO,1
156849785,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Malignant neoplasm progression,2,M,OT,1
156849785,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Malignant neoplasm progression,2,M,HO,1
156849785,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Neutropenia,2,M,OT,1
156849785,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Neutropenia,2,M,HO,1
156849785,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Platelet count decreased,2,M,OT,1
156849785,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Platelet count decreased,2,M,HO,1
156849785,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,White blood cell count decreased,2,M,OT,1
156849785,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,White blood cell count decreased,2,M,HO,1
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Anxiety,1,M,LT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Anxiety,1,M,OT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Anxiety,1,M,DE,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Anxiety,1,M,HO,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,LT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,OT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,DE,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,HO,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Brain oedema,1,M,LT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Brain oedema,1,M,OT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Brain oedema,1,M,DE,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Brain oedema,1,M,HO,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,LT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,OT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,DE,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,HO,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,LT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,OT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,DE,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,HO,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hypovolaemic shock,1,M,LT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hypovolaemic shock,1,M,OT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hypovolaemic shock,1,M,DE,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hypovolaemic shock,1,M,HO,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hypoxia,1,M,LT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hypoxia,1,M,OT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hypoxia,1,M,DE,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hypoxia,1,M,HO,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,LT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,OT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,DE,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,HO,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Lower gastrointestinal haemorrhage,1,M,LT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Lower gastrointestinal haemorrhage,1,M,OT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Lower gastrointestinal haemorrhage,1,M,DE,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Lower gastrointestinal haemorrhage,1,M,HO,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Metastases to central nervous system,1,M,LT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Metastases to central nervous system,1,M,OT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Metastases to central nervous system,1,M,DE,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Metastases to central nervous system,1,M,HO,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Pulmonary toxicity,1,M,LT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Pulmonary toxicity,1,M,OT,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Pulmonary toxicity,1,M,DE,219
156850474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Pulmonary toxicity,1,M,HO,219
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Aphasia,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Aphasia,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Blood uric acid increased,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Blood uric acid increased,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Brain oedema,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Brain oedema,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Decreased appetite,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Decreased appetite,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Diarrhoea,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Diarrhoea,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Dysphonia,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Dysphonia,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Headache,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Headache,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Hypokalaemia,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Hypokalaemia,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Insomnia,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Insomnia,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Malignant neoplasm progression,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Malignant neoplasm progression,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Metastases to central nervous system,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Metastases to central nervous system,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Metastatic malignant melanoma,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Metastatic malignant melanoma,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Nausea,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Nausea,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Neuralgia,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Neuralgia,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Pyrexia,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Pyrexia,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Rash,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Rash,4,F,DE,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Sciatica,4,F,OT,44
156871767,4,Metastatic malignant melanoma,7,F,EXP,trametinib,4,SS,Sciatica,4,F,DE,44
156872244,10,Metastatic malignant melanoma,4,F,EXP,trametinib,10,SS,Asthenia,10,M,OT,13
156872244,10,Metastatic malignant melanoma,4,F,EXP,trametinib,10,SS,Bronchitis,10,M,OT,13
156872244,10,Metastatic malignant melanoma,4,F,EXP,trametinib,10,SS,Cough,10,M,OT,13
156872244,10,Metastatic malignant melanoma,4,F,EXP,trametinib,10,SS,Ejection fraction decreased,10,M,OT,13
156872244,10,Metastatic malignant melanoma,4,F,EXP,trametinib,10,SS,Gynaecomastia,10,M,OT,13
156872244,10,Metastatic malignant melanoma,4,F,EXP,trametinib,10,SS,Hepatotoxicity,10,M,OT,13
156872244,10,Metastatic malignant melanoma,4,F,EXP,trametinib,10,SS,Hyperkeratosis,10,M,OT,13
156872244,10,Metastatic malignant melanoma,4,F,EXP,trametinib,10,SS,Oedema,10,M,OT,13
156872244,10,Metastatic malignant melanoma,4,F,EXP,trametinib,10,SS,Pyrexia,10,M,OT,13
156872244,10,Metastatic malignant melanoma,4,F,EXP,trametinib,10,SS,Tachycardia,10,M,OT,13
156872244,10,Metastatic malignant melanoma,4,F,EXP,trametinib,10,SS,Toothache,10,M,OT,13
156872254,5,Metastatic malignant melanoma,4,F,EXP,trametinib,5,SS,Hyperkalaemia,5,M,OT,7
156872254,5,Metastatic malignant melanoma,4,F,EXP,trametinib,5,SS,Neutrophil count decreased,5,M,OT,7
156872254,5,Metastatic malignant melanoma,4,F,EXP,trametinib,5,SS,Platelet count decreased,5,M,OT,7
156872254,5,Metastatic malignant melanoma,4,F,EXP,trametinib,5,SS,Pyrexia,5,M,OT,7
156872254,5,Metastatic malignant melanoma,4,F,EXP,trametinib,5,SS,Thrombocytopenia,5,M,OT,7
156875694,1,Non-small cell lung cancer stage IV,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,73
156875694,1,Non-small cell lung cancer stage IV,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,73
156875694,2,Non-small cell lung cancer stage IV,4,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,HO,73
156875694,2,Non-small cell lung cancer stage IV,4,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,OT,73
156875694,5,Non-small cell lung cancer stage IV,4,F,EXP,pemetrexed disodium,5,SS,Acute kidney injury,5,M,HO,73
156875694,5,Non-small cell lung cancer stage IV,4,F,EXP,pemetrexed disodium,5,SS,Acute kidney injury,5,M,OT,73
156875694,6,Product used for unknown indication,4,F,EXP,pemetrexed disodium,6,SS,Acute kidney injury,6,M,HO,43
156875694,6,Product used for unknown indication,4,F,EXP,pemetrexed disodium,6,SS,Acute kidney injury,6,M,OT,43
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Alanine aminotransferase increased,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Alanine aminotransferase increased,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Asthenia,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Asthenia,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Bacteriuria,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Bacteriuria,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Chills,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Chills,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Fungal test positive,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Fungal test positive,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Haematocrit decreased,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Haematocrit decreased,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Haemoglobin decreased,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Haemoglobin decreased,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Jaundice,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Jaundice,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Lymphadenitis,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Lymphadenitis,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Neutrophil count decreased,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Neutrophil count decreased,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Nitrite urine present,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Nitrite urine present,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Peripheral swelling,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Peripheral swelling,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Pyrexia,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Pyrexia,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Rash,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Rash,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Red blood cells urine positive,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Red blood cells urine positive,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Urinary retention,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,Urinary retention,1,F,OT,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,HO,4
1569136022,1,Multiple sclerosis,22,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,OT,4
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Abdominal pain,3,F,HO,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Abdominal pain,3,F,OT,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Alanine aminotransferase increased,3,F,HO,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Alanine aminotransferase increased,3,F,OT,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Aspartate aminotransferase increased,3,F,HO,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Aspartate aminotransferase increased,3,F,OT,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Blood alkaline phosphatase increased,3,F,HO,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Blood alkaline phosphatase increased,3,F,OT,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Blood bilirubin increased,3,F,HO,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Blood bilirubin increased,3,F,OT,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Cholecystitis,3,F,HO,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Cholecystitis,3,F,OT,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Cholestasis,3,F,HO,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Cholestasis,3,F,OT,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Drug-induced liver injury,3,F,HO,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Drug-induced liver injury,3,F,OT,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Gamma-glutamyltransferase increased,3,F,HO,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Gamma-glutamyltransferase increased,3,F,OT,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Hepatocellular injury,3,F,HO,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Hepatocellular injury,3,F,OT,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Skin exfoliation,3,F,HO,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Skin exfoliation,3,F,OT,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Thrombocytopenia,3,F,HO,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Thrombocytopenia,3,F,OT,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Vomiting,3,F,HO,38
156932467,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Vomiting,3,F,OT,38
156958974,1,Osteogenesis imperfecta,4,F,PER,denosumab,1,PS,Femur fracture,1,F,HO,1051
157010374,1,Prostate cancer metastatic,4,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,OT,105
157010374,1,Prostate cancer metastatic,4,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,HO,105
157024972,1,Sarcoma,2,F,EXP,nivolumab,1,PS,Discharge,1,M,HO,60
157024972,1,Sarcoma,2,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,HO,60
157024972,2,Sarcoma,2,F,EXP,ipilimumab,2,SS,Discharge,2,M,HO,60
157024972,2,Sarcoma,2,F,EXP,ipilimumab,2,SS,Intentional product use issue,2,M,HO,60
157056373,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Autoimmune thyroid disorder,1,F,OT,4
157056373,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Back pain,1,F,OT,4
157056373,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Blood urine present,1,F,OT,4
157056373,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Headache,1,F,OT,4
157056373,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Memory impairment,1,F,OT,4
157056373,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Muscle spasms,1,F,OT,4
157056373,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Neck pain,1,F,OT,4
157056373,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Secondary progressive multiple sclerosis,1,F,OT,4
157056373,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,OT,4
157057368,1,Renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Hypotension,1,M,HO,36
157057368,1,Renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Hypotension,1,M,OT,36
157057368,1,Renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Interstitial lung disease,1,M,HO,36
157057368,1,Renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Interstitial lung disease,1,M,OT,36
157057368,1,Renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Off label use,1,M,HO,36
157057368,1,Renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Off label use,1,M,OT,36
157057368,1,Renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Rash,1,M,HO,36
157057368,1,Renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Rash,1,M,OT,36
157057368,1,Renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Shock,1,M,HO,36
157057368,1,Renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Shock,1,M,OT,36
157057368,1,Renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Thyroiditis,1,M,HO,36
157057368,1,Renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Thyroiditis,1,M,OT,36
157057368,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,SS,Hypotension,2,M,HO,36
157057368,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,SS,Hypotension,2,M,OT,36
157057368,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,SS,Interstitial lung disease,2,M,HO,36
157057368,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,SS,Interstitial lung disease,2,M,OT,36
157057368,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,SS,Off label use,2,M,HO,36
157057368,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,SS,Off label use,2,M,OT,36
157057368,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,SS,Rash,2,M,HO,36
157057368,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,SS,Rash,2,M,OT,36
157057368,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,SS,Shock,2,M,HO,36
157057368,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,SS,Shock,2,M,OT,36
157057368,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,SS,Thyroiditis,2,M,HO,36
157057368,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,SS,Thyroiditis,2,M,OT,36
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Ataxia,2,F,HO,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Ataxia,2,F,OT,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Decreased appetite,2,F,HO,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Decreased appetite,2,F,OT,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Dysdiadochokinesis,2,F,HO,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Dysdiadochokinesis,2,F,OT,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Fall,2,F,HO,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Fall,2,F,OT,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Fatigue,2,F,HO,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Fatigue,2,F,OT,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Nausea,2,F,HO,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Nausea,2,F,OT,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Spinal fracture,2,F,HO,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Spinal fracture,2,F,OT,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Stomatitis,2,F,HO,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Stomatitis,2,F,OT,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Tremor,2,F,HO,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Tremor,2,F,OT,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Vitiligo,2,F,HO,61
157071913,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Vitiligo,2,F,OT,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Ataxia,6,F,HO,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Ataxia,6,F,OT,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Decreased appetite,6,F,HO,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Decreased appetite,6,F,OT,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Dysdiadochokinesis,6,F,HO,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Dysdiadochokinesis,6,F,OT,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Fall,6,F,HO,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Fall,6,F,OT,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Fatigue,6,F,HO,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Fatigue,6,F,OT,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Nausea,6,F,HO,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Nausea,6,F,OT,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Spinal fracture,6,F,HO,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Spinal fracture,6,F,OT,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Stomatitis,6,F,HO,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Stomatitis,6,F,OT,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Tremor,6,F,HO,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Tremor,6,F,OT,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Vitiligo,6,F,HO,61
157071913,6,Malignant melanoma,3,F,EXP,ipilimumab,6,SS,Vitiligo,6,F,OT,61
157086434,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Encephalitis,1,F,HO,40
157086434,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Encephalitis,1,F,OT,40
157086434,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Headache,1,F,HO,40
157086434,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Headache,1,F,OT,40
157086434,2,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,ipilimumab,2,SS,Encephalitis,2,F,HO,40
157086434,2,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,ipilimumab,2,SS,Encephalitis,2,F,OT,40
157086434,2,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,ipilimumab,2,SS,Headache,2,F,HO,40
157086434,2,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,ipilimumab,2,SS,Headache,2,F,OT,40
157128166,1,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,1,PS,Back pain,1,M,OT,188
157128166,1,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,1,PS,Cerebrovascular accident,1,M,OT,188
157128166,1,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,1,PS,Diarrhoea,1,M,OT,188
157128166,1,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,1,PS,Dry mouth,1,M,OT,188
157128166,1,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,188
157209468,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Arthritis infective,1,M,OT,1
157209468,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Arthritis infective,1,M,DE,1
157209468,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Dermatitis exfoliative generalised,1,M,OT,1
157209468,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Dermatitis exfoliative generalised,1,M,DE,1
157209468,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Gamma-glutamyltransferase increased,1,M,OT,1
157209468,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Gamma-glutamyltransferase increased,1,M,DE,1
157209468,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Influenza like illness,1,M,OT,1
157209468,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Influenza like illness,1,M,DE,1
157209468,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,M,OT,1
157209468,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,M,DE,1
157209468,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Peripheral swelling,1,M,OT,1
157209468,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Peripheral swelling,1,M,DE,1
157209468,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Transaminases increased,1,M,OT,1
157209468,1,Malignant melanoma,8,F,EXP,nivolumab,1,SS,Transaminases increased,1,M,DE,1
157209468,2,Malignant melanoma,8,F,EXP,ipilimumab,2,PS,Arthritis infective,2,M,OT,1
157209468,2,Malignant melanoma,8,F,EXP,ipilimumab,2,PS,Arthritis infective,2,M,DE,1
157209468,2,Malignant melanoma,8,F,EXP,ipilimumab,2,PS,Dermatitis exfoliative generalised,2,M,OT,1
157209468,2,Malignant melanoma,8,F,EXP,ipilimumab,2,PS,Dermatitis exfoliative generalised,2,M,DE,1
157209468,2,Malignant melanoma,8,F,EXP,ipilimumab,2,PS,Gamma-glutamyltransferase increased,2,M,OT,1
157209468,2,Malignant melanoma,8,F,EXP,ipilimumab,2,PS,Gamma-glutamyltransferase increased,2,M,DE,1
157209468,2,Malignant melanoma,8,F,EXP,ipilimumab,2,PS,Influenza like illness,2,M,OT,1
157209468,2,Malignant melanoma,8,F,EXP,ipilimumab,2,PS,Influenza like illness,2,M,DE,1
157209468,2,Malignant melanoma,8,F,EXP,ipilimumab,2,PS,Malignant neoplasm progression,2,M,OT,1
157209468,2,Malignant melanoma,8,F,EXP,ipilimumab,2,PS,Malignant neoplasm progression,2,M,DE,1
157209468,2,Malignant melanoma,8,F,EXP,ipilimumab,2,PS,Peripheral swelling,2,M,OT,1
157209468,2,Malignant melanoma,8,F,EXP,ipilimumab,2,PS,Peripheral swelling,2,M,DE,1
157209468,2,Malignant melanoma,8,F,EXP,ipilimumab,2,PS,Transaminases increased,2,M,OT,1
157209468,2,Malignant melanoma,8,F,EXP,ipilimumab,2,PS,Transaminases increased,2,M,DE,1
157223405,23,Prophylaxis of nausea and vomiting,5,F,EXP,granisetron,23,C,Bone marrow failure,23,M,OT,12
157223405,23,Prophylaxis of nausea and vomiting,5,F,EXP,granisetron,23,C,Off label use,23,M,OT,12
157228338,1,Non-small cell lung cancer,8,F,EXP,crizotinib,1,PS,Chronic kidney disease,1,F,HO,1436
157228338,1,Non-small cell lung cancer,8,F,EXP,crizotinib,1,PS,Chronic kidney disease,1,F,DE,1436
157245646,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,190
157245646,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,HO,190
157247093,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,170
157247093,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,170
157247093,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,170
157247093,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,OT,170
157247093,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,HO,170
157247093,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,DE,170
157261387,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,HO,36
157261387,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,OT,36
157261387,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Off label use,1,M,HO,36
157261387,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,36
157261387,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Rash,1,M,HO,36
157261387,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Rash,1,M,OT,36
157261387,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Shock,1,M,HO,36
157261387,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Shock,1,M,OT,36
157261387,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Thyroiditis,1,M,HO,36
157261387,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Thyroiditis,1,M,OT,36
157261387,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Interstitial lung disease,2,M,HO,36
157261387,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Interstitial lung disease,2,M,OT,36
157261387,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Off label use,2,M,HO,36
157261387,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Off label use,2,M,OT,36
157261387,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Rash,2,M,HO,36
157261387,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Rash,2,M,OT,36
157261387,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Shock,2,M,HO,36
157261387,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Shock,2,M,OT,36
157261387,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Thyroiditis,2,M,HO,36
157261387,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Thyroiditis,2,M,OT,36
157326254,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,SS,Hypercalcaemia of malignancy,1,M,HO,28
157326254,2,Clear cell renal cell carcinoma,4,F,EXP,ipilimumab,2,PS,Hypercalcaemia of malignancy,2,M,HO,28
157429913,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Lung disorder,1,M,DE,43
157429913,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Lung disorder,1,M,OT,43
157429913,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,43
157429913,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,43
157435454,23,Acute lymphocytic leukaemia,4,F,EXP,filgrastim,23,C,Cerebral haemorrhage,23,F,DE,11
157435454,23,Acute lymphocytic leukaemia,4,F,EXP,filgrastim,23,C,Cerebral haemorrhage,23,F,OT,11
157435454,23,Acute lymphocytic leukaemia,4,F,EXP,filgrastim,23,C,Thrombotic microangiopathy,23,F,DE,11
157435454,23,Acute lymphocytic leukaemia,4,F,EXP,filgrastim,23,C,Thrombotic microangiopathy,23,F,OT,11
157435454,23,Acute lymphocytic leukaemia,4,F,EXP,filgrastim,23,C,Venoocclusive liver disease,23,F,DE,11
157435454,23,Acute lymphocytic leukaemia,4,F,EXP,filgrastim,23,C,Venoocclusive liver disease,23,F,OT,11
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Cachexia,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Cachexia,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Cachexia,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Dehydration,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Dysphagia,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Dysphagia,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Dysphagia,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Haemorrhage,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Haemorrhage,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Haemorrhage,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Headache,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Headache,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Headache,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypoglycaemia,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypoglycaemia,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypoglycaemia,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypomagnesaemia,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypomagnesaemia,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypomagnesaemia,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypophosphataemia,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypophosphataemia,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypophosphataemia,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Mucosal inflammation,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Mucosal inflammation,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Mucosal inflammation,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Muscle tightness,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Muscle tightness,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Muscle tightness,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Neck pain,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Neck pain,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Neck pain,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Stoma site infection,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Stoma site infection,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Stoma site infection,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Vitamin D deficiency,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Vitamin D deficiency,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Vitamin D deficiency,1,M,DE,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Weight decreased,1,M,HO,13
1574399213,1,Squamous cell carcinoma of head and neck,13,F,EXP,nivolumab,1,PS,Weight decreased,1,M,DE,13
157465695,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Face oedema,1,F,HO,65
157465695,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Rash papular,1,F,HO,65
157506023,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Cataract,1,F,OT,120
157506023,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Leukoderma,1,F,OT,120
157506023,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Uveitis,1,F,OT,120
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Cerebral haemorrhage,6,M,OT,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Cerebral haemorrhage,6,M,DE,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Cerebral haemorrhage,6,M,HO,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Gamma-glutamyltransferase increased,6,M,OT,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Gamma-glutamyltransferase increased,6,M,DE,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Gamma-glutamyltransferase increased,6,M,HO,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Malignant neoplasm progression,6,M,OT,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Malignant neoplasm progression,6,M,DE,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Malignant neoplasm progression,6,M,HO,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Metastases to central nervous system,6,M,OT,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Metastases to central nervous system,6,M,DE,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Metastases to central nervous system,6,M,HO,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Metastatic malignant melanoma,6,M,OT,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Metastatic malignant melanoma,6,M,DE,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Metastatic malignant melanoma,6,M,HO,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Partial seizures,6,M,OT,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Partial seizures,6,M,DE,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Partial seizures,6,M,HO,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Renal failure,6,M,OT,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Renal failure,6,M,DE,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Renal failure,6,M,HO,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Urinary tract infection,6,M,OT,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Urinary tract infection,6,M,DE,78
157515319,6,Metastatic malignant melanoma,9,F,EXP,trametinib,6,SS,Urinary tract infection,6,M,HO,78
157549034,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,261
157549034,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,261
157549034,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Bladder tamponade,1,M,HO,261
157549034,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Bladder tamponade,1,M,OT,261
157549034,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Haematuria,1,M,HO,261
157549034,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Haematuria,1,M,OT,261
157549034,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,261
157549034,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,261
157549034,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Urinary bladder haemorrhage,1,M,HO,261
157549034,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Urinary bladder haemorrhage,1,M,OT,261
157549034,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Urosepsis,1,M,HO,261
157549034,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Urosepsis,1,M,OT,261
157565804,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Generalised tonic-clonic seizure,1,F,OT,191
157565804,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Generalised tonic-clonic seizure,1,F,HO,191
1575773812,2,Hormone-refractory prostate cancer,12,F,EXP,enzalutamide,2,SS,Bone marrow failure,2,M,HO,62
1575773812,2,Hormone-refractory prostate cancer,12,F,EXP,enzalutamide,2,SS,Tumour pain,2,M,HO,62
1575934114,1,Bladder cancer,14,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,HO,81
1575934114,1,Bladder cancer,14,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,OT,81
1575934114,2,Bladder cancer,14,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,M,HO,81
1575934114,2,Bladder cancer,14,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,M,OT,81
157601298,3,Anaplastic thyroid cancer,8,F,EXP,trametinib,3,SS,Hallucination,3,F,HO,217
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Ascites,1,M,OT,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Ascites,1,M,HO,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,OT,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,HO,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Metastases to peritoneum,1,M,OT,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Metastases to peritoneum,1,M,HO,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,HO,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Splenic infarction,1,M,OT,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Splenic infarction,1,M,HO,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Staphylococcal infection,1,M,OT,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Staphylococcal infection,1,M,HO,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,M,OT,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,M,HO,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,OT,4
157602459,1,Pancreatic carcinoma metastatic,9,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,HO,4
157671365,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,SS,Face oedema,2,F,HO,65
157671365,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,SS,Rash papular,2,F,HO,65
157672654,1,Prostate cancer,4,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,OT,74
157672654,1,Prostate cancer,4,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,HO,74
157672654,1,Prostate cancer,4,F,EXP,nivolumab,1,PS,Neutropenia,1,M,OT,74
157672654,1,Prostate cancer,4,F,EXP,nivolumab,1,PS,Neutropenia,1,M,HO,74
157672654,13,Product used for unknown indication,4,F,EXP,zoledronic acid,13,C,Immune-mediated enterocolitis,13,M,OT,131
157672654,13,Product used for unknown indication,4,F,EXP,zoledronic acid,13,C,Immune-mediated enterocolitis,13,M,HO,131
157672654,13,Product used for unknown indication,4,F,EXP,zoledronic acid,13,C,Neutropenia,13,M,OT,131
157672654,13,Product used for unknown indication,4,F,EXP,zoledronic acid,13,C,Neutropenia,13,M,HO,131
157680783,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,M,DE,6
157680783,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,M,HO,6
157680783,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,M,OT,6
157680783,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Cardio-respiratory arrest,2,M,DE,6
157680783,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Cardio-respiratory arrest,2,M,HO,6
157680783,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Cardio-respiratory arrest,2,M,OT,6
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Conjunctivitis,1,M,DE,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Conjunctivitis,1,M,HO,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Conjunctivitis,1,M,LT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Conjunctivitis,1,M,OT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,LT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Dry skin,1,M,DE,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Dry skin,1,M,HO,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Dry skin,1,M,LT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Dry skin,1,M,OT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,LT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Infection,1,M,DE,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Infection,1,M,HO,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Infection,1,M,LT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Infection,1,M,OT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Metastases to central nervous system,1,M,DE,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Metastases to central nervous system,1,M,HO,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Metastases to central nervous system,1,M,LT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Metastases to central nervous system,1,M,OT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Myalgia,1,M,DE,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Myalgia,1,M,HO,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Myalgia,1,M,LT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Myalgia,1,M,OT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,DE,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,HO,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,LT,22
1576933210,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,OT,22
157723507,2,Pancreatic carcinoma,7,F,EXP,nivolumab,2,PS,Enterocolitis,2,M,OT,73
157723507,2,Pancreatic carcinoma,7,F,EXP,nivolumab,2,PS,Enterocolitis,2,M,HO,73
157723507,2,Pancreatic carcinoma,7,F,EXP,nivolumab,2,PS,Vomiting,2,M,OT,73
157723507,2,Pancreatic carcinoma,7,F,EXP,nivolumab,2,PS,Vomiting,2,M,HO,73
157725125,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone increased,1,M,HO,5
157725125,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone increased,1,M,OT,5
157725125,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Dyspnoea,1,M,HO,5
157725125,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Dyspnoea,1,M,OT,5
157725125,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Haemoptysis,1,M,HO,5
157725125,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Haemoptysis,1,M,OT,5
157725125,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Pulmonary alveolar haemorrhage,1,M,HO,5
157725125,1,Relapsing-remitting multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Pulmonary alveolar haemorrhage,1,M,OT,5
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Constipation,5,F,HO,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Constipation,5,F,OT,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Diarrhoea,5,F,HO,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Diarrhoea,5,F,OT,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Dizziness,5,F,HO,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Dizziness,5,F,OT,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Fatigue,5,F,HO,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Fatigue,5,F,OT,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,General physical health deterioration,5,F,HO,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,General physical health deterioration,5,F,OT,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Nausea,5,F,HO,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Nausea,5,F,OT,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Pain,5,F,HO,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Pain,5,F,OT,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Pulmonary embolism,5,F,HO,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Pulmonary embolism,5,F,OT,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Vomiting,5,F,HO,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,Vomiting,5,F,OT,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,White blood cell count decreased,5,F,HO,41
157731314,5,Metastases to bone,4,F,EXP,denosumab,5,C,White blood cell count decreased,5,F,OT,41
157824863,2,Lung neoplasm malignant,3,F,EXP,nivolumab,2,SS,Fatigue,2,M,OT,1
157824863,2,Lung neoplasm malignant,3,F,EXP,nivolumab,2,SS,Hypothyroidism,2,M,OT,1
157824863,2,Lung neoplasm malignant,3,F,EXP,nivolumab,2,SS,Insomnia,2,M,OT,1
157824863,2,Lung neoplasm malignant,3,F,EXP,nivolumab,2,SS,Nausea,2,M,OT,1
157907539,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,12
157907539,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,12
157907539,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,12
157907539,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,12
157907539,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Sinus bradycardia,1,M,HO,12
157907539,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Sinus bradycardia,1,M,OT,12
157907539,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,M,HO,12
157907539,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,M,OT,12
157907539,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,HO,12
157907539,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,OT,12
157907539,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Sinus bradycardia,2,M,HO,12
157907539,2,Non-small cell lung cancer,9,F,EXP,ipilimumab,2,SS,Sinus bradycardia,2,M,OT,12
157907539,3,Non-small cell lung cancer,9,F,EXP,pemetrexed disodium,3,SS,Adrenal insufficiency,3,M,HO,12
157907539,3,Non-small cell lung cancer,9,F,EXP,pemetrexed disodium,3,SS,Adrenal insufficiency,3,M,OT,12
157907539,3,Non-small cell lung cancer,9,F,EXP,pemetrexed disodium,3,SS,Pneumonia,3,M,HO,12
157907539,3,Non-small cell lung cancer,9,F,EXP,pemetrexed disodium,3,SS,Pneumonia,3,M,OT,12
157907539,3,Non-small cell lung cancer,9,F,EXP,pemetrexed disodium,3,SS,Sinus bradycardia,3,M,HO,12
157907539,3,Non-small cell lung cancer,9,F,EXP,pemetrexed disodium,3,SS,Sinus bradycardia,3,M,OT,12
157907539,10,Product used for unknown indication,9,F,EXP,denosumab,10,C,Adrenal insufficiency,10,M,HO,7
157907539,10,Product used for unknown indication,9,F,EXP,denosumab,10,C,Adrenal insufficiency,10,M,OT,7
157907539,10,Product used for unknown indication,9,F,EXP,denosumab,10,C,Pneumonia,10,M,HO,7
157907539,10,Product used for unknown indication,9,F,EXP,denosumab,10,C,Pneumonia,10,M,OT,7
157907539,10,Product used for unknown indication,9,F,EXP,denosumab,10,C,Sinus bradycardia,10,M,HO,7
157907539,10,Product used for unknown indication,9,F,EXP,denosumab,10,C,Sinus bradycardia,10,M,OT,7
157920797,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Arthropathy,1,M,OT,113
157920797,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Arthropathy,1,M,HO,113
157920797,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,113
157920797,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,113
157920797,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Muscular weakness,1,M,OT,113
157920797,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Muscular weakness,1,M,HO,113
157920797,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Respiratory tract infection viral,1,M,OT,113
157920797,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Respiratory tract infection viral,1,M,HO,113
157920797,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Arthropathy,3,M,OT,113
157920797,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Arthropathy,3,M,HO,113
157920797,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Dyspnoea,3,M,OT,113
157920797,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Dyspnoea,3,M,HO,113
157920797,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Muscular weakness,3,M,OT,113
157920797,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Muscular weakness,3,M,HO,113
157920797,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Respiratory tract infection viral,3,M,OT,113
157920797,3,Malignant melanoma,7,F,EXP,ipilimumab,3,SS,Respiratory tract infection viral,3,M,HO,113
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Anaemia,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Anaemia,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Anaemia,1,F,HO,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Arthralgia,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Arthralgia,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Arthralgia,1,F,HO,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Bone pain,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Bone pain,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Bone pain,1,F,HO,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Brachial plexopathy,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Brachial plexopathy,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Brachial plexopathy,1,F,HO,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Coma,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Coma,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Coma,1,F,HO,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Dizziness,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Dizziness,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Dizziness,1,F,HO,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Fatigue,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Fatigue,1,F,HO,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Nausea,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Paraesthesia,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Paraesthesia,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Paraesthesia,1,F,HO,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Radiation skin injury,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Radiation skin injury,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Radiation skin injury,1,F,HO,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,HO,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Vomiting,1,F,DE,23
1579673515,1,Malignant melanoma,15,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Anaemia,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Anaemia,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Anaemia,3,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Arthralgia,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Arthralgia,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Arthralgia,3,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Bone pain,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Bone pain,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Bone pain,3,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Brachial plexopathy,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Brachial plexopathy,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Brachial plexopathy,3,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Coma,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Coma,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Coma,3,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Diarrhoea,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Diarrhoea,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Diarrhoea,3,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Dizziness,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Dizziness,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Dizziness,3,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Fatigue,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Fatigue,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Fatigue,3,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,General physical health deterioration,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,General physical health deterioration,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,General physical health deterioration,3,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Nausea,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Nausea,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Nausea,3,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Paraesthesia,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Paraesthesia,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Paraesthesia,3,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Radiation skin injury,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Radiation skin injury,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Radiation skin injury,3,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Urinary tract infection,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Urinary tract infection,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Urinary tract infection,3,F,HO,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Vomiting,3,F,OT,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Vomiting,3,F,DE,23
1579673515,3,Product used for unknown indication,15,F,EXP,nivolumab,3,SS,Vomiting,3,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Anaemia,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Anaemia,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Anaemia,4,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Arthralgia,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Arthralgia,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Arthralgia,4,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Bone pain,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Bone pain,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Bone pain,4,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Brachial plexopathy,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Brachial plexopathy,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Brachial plexopathy,4,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Coma,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Coma,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Coma,4,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Diarrhoea,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Diarrhoea,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Diarrhoea,4,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Dizziness,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Dizziness,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Dizziness,4,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Fatigue,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Fatigue,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Fatigue,4,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,General physical health deterioration,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,General physical health deterioration,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,General physical health deterioration,4,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Nausea,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Nausea,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Nausea,4,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Paraesthesia,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Paraesthesia,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Paraesthesia,4,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Radiation skin injury,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Radiation skin injury,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Radiation skin injury,4,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Urinary tract infection,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Urinary tract infection,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Urinary tract infection,4,F,HO,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Vomiting,4,F,OT,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Vomiting,4,F,DE,23
1579673515,4,Malignant melanoma,15,F,EXP,ipilimumab,4,SS,Vomiting,4,F,HO,23
157978216,12,Chemotherapy,6,F,EXP,granisetron,12,C,Cardiac failure,12,M,HO,4
157978216,12,Chemotherapy,6,F,EXP,granisetron,12,C,Cardiac failure,12,M,LT,4
157978216,12,Chemotherapy,6,F,EXP,granisetron,12,C,Febrile neutropenia,12,M,HO,4
157978216,12,Chemotherapy,6,F,EXP,granisetron,12,C,Febrile neutropenia,12,M,LT,4
157978216,12,Chemotherapy,6,F,EXP,granisetron,12,C,Haematuria,12,M,HO,4
157978216,12,Chemotherapy,6,F,EXP,granisetron,12,C,Haematuria,12,M,LT,4
157978216,12,Chemotherapy,6,F,EXP,granisetron,12,C,Pneumonia,12,M,HO,4
157978216,12,Chemotherapy,6,F,EXP,granisetron,12,C,Pneumonia,12,M,LT,4
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Abdominal discomfort,1,F,HO,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Abdominal discomfort,1,F,OT,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Balance disorder,1,F,HO,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Balance disorder,1,F,OT,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,CD4 lymphocytes decreased,1,F,HO,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,CD4 lymphocytes decreased,1,F,OT,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Gait disturbance,1,F,HO,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Gait disturbance,1,F,OT,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Hypoaesthesia,1,F,HO,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Hypoaesthesia,1,F,OT,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,F,HO,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,F,OT,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Infusion related reaction,1,F,HO,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Infusion related reaction,1,F,OT,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Limb discomfort,1,F,HO,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Limb discomfort,1,F,OT,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Nausea,1,F,HO,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Nausea,1,F,OT,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Sensory loss,1,F,HO,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Sensory loss,1,F,OT,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,HO,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,OT,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Vomiting,1,F,HO,17
158057115,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Vomiting,1,F,OT,17
158066113,1,Squamous cell carcinoma of head and neck,3,F,EXP,avelumab,1,PS,Cholestatic liver injury,1,M,OT,21
158115263,1,Adenocarcinoma,3,F,EXP,brigatinib,1,PS,Accidental overdose,1,M,HO,40
158115263,1,Adenocarcinoma,3,F,EXP,brigatinib,1,PS,Hypertension,1,M,HO,40
158115263,1,Adenocarcinoma,3,F,EXP,brigatinib,1,PS,Nausea,1,M,HO,40
158115263,1,Adenocarcinoma,3,F,EXP,brigatinib,1,PS,Vomiting,1,M,HO,40
158127444,2,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,2,SS,Small intestinal perforation,2,M,DE,86
158127444,2,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,2,SS,Small intestinal perforation,2,M,OT,86
158127444,2,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,2,SS,Small intestinal perforation,2,M,LT,86
158127444,2,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,2,SS,Small intestinal perforation,2,M,HO,86
158132767,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,F,OT,8
158132767,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,F,HO,8
158132767,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,F,DE,8
158132767,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Non-small cell lung cancer,1,F,OT,8
158132767,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Non-small cell lung cancer,1,F,HO,8
158132767,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Non-small cell lung cancer,1,F,DE,8
158132767,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Panic attack,1,F,OT,8
158132767,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Panic attack,1,F,HO,8
158132767,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Panic attack,1,F,DE,8
158132767,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Pneumothorax,1,F,OT,8
158132767,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Pneumothorax,1,F,HO,8
158132767,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Pneumothorax,1,F,DE,8
158197163,1,Adenocarcinoma gastric,3,F,EXP,nivolumab,1,PS,Infection,1,F,HO,28
158197163,3,Adenocarcinoma gastric,3,F,EXP,ipilimumab,3,SS,Infection,3,F,HO,28
158198104,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,Anaemia,2,F,OT,191
158198104,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,C-reactive protein increased,2,F,OT,191
158198104,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,Neutrophil count decreased,2,F,OT,191
158198104,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,Platelet count decreased,2,F,OT,191
158274875,1,Acute lymphocytic leukaemia,5,F,PER,blinatumomab,1,PS,Aphasia,1,F,OT,6
158274875,1,Acute lymphocytic leukaemia,5,F,PER,blinatumomab,1,PS,Aphasia,1,F,HO,6
1583374912,1,Plasma cell myeloma,12,F,EXP,pomalidomide,1,PS,Alanine aminotransferase increased,1,F,HO,4
1583374912,1,Plasma cell myeloma,12,F,EXP,pomalidomide,1,PS,Alanine aminotransferase increased,1,F,DE,4
1583374912,1,Plasma cell myeloma,12,F,EXP,pomalidomide,1,PS,Alanine aminotransferase increased,1,F,LT,4
1583374912,1,Plasma cell myeloma,12,F,EXP,pomalidomide,1,PS,Non-cardiac chest pain,1,F,HO,4
1583374912,1,Plasma cell myeloma,12,F,EXP,pomalidomide,1,PS,Non-cardiac chest pain,1,F,DE,4
1583374912,1,Plasma cell myeloma,12,F,EXP,pomalidomide,1,PS,Non-cardiac chest pain,1,F,LT,4
1583374912,1,Plasma cell myeloma,12,F,EXP,pomalidomide,1,PS,Pneumonia,1,F,HO,4
1583374912,1,Plasma cell myeloma,12,F,EXP,pomalidomide,1,PS,Pneumonia,1,F,DE,4
1583374912,1,Plasma cell myeloma,12,F,EXP,pomalidomide,1,PS,Pneumonia,1,F,LT,4
158346677,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Meningitis aseptic,1,M,HO,792
158346677,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Meningitis aseptic,1,M,OT,792
158346677,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Meningitis aseptic,2,M,HO,792
158346677,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Meningitis aseptic,2,M,OT,792
158383862,18,Anaemia,2,F,EXP,darbepoetin alfa,18,C,Cellulitis,18,F,HO,154
158383862,18,Anaemia,2,F,EXP,darbepoetin alfa,18,C,Cellulitis,18,F,OT,154
158383862,31,Neutropenia,2,F,EXP,filgrastim,31,C,Cellulitis,31,F,HO,104
158383862,31,Neutropenia,2,F,EXP,filgrastim,31,C,Cellulitis,31,F,OT,104
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,DS,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,DE,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,OT,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,DS,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,DE,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,HO,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,OT,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,DS,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,DE,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,HO,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Multiple organ dysfunction syndrome,1,M,OT,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Multiple organ dysfunction syndrome,1,M,DS,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Multiple organ dysfunction syndrome,1,M,DE,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Multiple organ dysfunction syndrome,1,M,HO,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,OT,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,DS,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,DE,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,HO,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Sinus tachycardia,1,M,OT,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Sinus tachycardia,1,M,DS,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Sinus tachycardia,1,M,DE,4
158390575,1,B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Sinus tachycardia,1,M,HO,4
1584106510,2,Product used for unknown indication,10,F,EXP,nivolumab,2,SS,Abdominal wall haematoma,2,F,OT,70
1584106510,2,Product used for unknown indication,10,F,EXP,nivolumab,2,SS,Abdominal wall haematoma,2,F,LT,70
1584106510,2,Product used for unknown indication,10,F,EXP,nivolumab,2,SS,Abdominal wall haematoma,2,F,HO,70
1584106510,2,Product used for unknown indication,10,F,EXP,nivolumab,2,SS,Disseminated intravascular coagulation,2,F,OT,70
1584106510,2,Product used for unknown indication,10,F,EXP,nivolumab,2,SS,Disseminated intravascular coagulation,2,F,LT,70
1584106510,2,Product used for unknown indication,10,F,EXP,nivolumab,2,SS,Disseminated intravascular coagulation,2,F,HO,70
1584106510,2,Product used for unknown indication,10,F,EXP,nivolumab,2,SS,Haemophagocytic lymphohistiocytosis,2,F,OT,70
1584106510,2,Product used for unknown indication,10,F,EXP,nivolumab,2,SS,Haemophagocytic lymphohistiocytosis,2,F,LT,70
1584106510,2,Product used for unknown indication,10,F,EXP,nivolumab,2,SS,Haemophagocytic lymphohistiocytosis,2,F,HO,70
1584106510,2,Product used for unknown indication,10,F,EXP,nivolumab,2,SS,Prescribed overdose,2,F,OT,70
1584106510,2,Product used for unknown indication,10,F,EXP,nivolumab,2,SS,Prescribed overdose,2,F,LT,70
1584106510,2,Product used for unknown indication,10,F,EXP,nivolumab,2,SS,Prescribed overdose,2,F,HO,70
158414435,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Diplopia,1,M,HO,27
158414435,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Diplopia,2,M,HO,27
158435242,9,Plasma cell myeloma,2,F,EXP,daratumumab,9,C,Cerebrovascular accident,9,F,HO,294
158435242,9,Plasma cell myeloma,2,F,EXP,daratumumab,9,C,Cerebrovascular accident,9,F,DS,294
158435242,9,Plasma cell myeloma,2,F,EXP,daratumumab,9,C,Cerebrovascular accident,9,F,LT,294
158435242,9,Plasma cell myeloma,2,F,EXP,daratumumab,9,C,Hemiparesis,9,F,HO,294
158435242,9,Plasma cell myeloma,2,F,EXP,daratumumab,9,C,Hemiparesis,9,F,DS,294
158435242,9,Plasma cell myeloma,2,F,EXP,daratumumab,9,C,Hemiparesis,9,F,LT,294
158471545,1,Metastatic malignant melanoma,5,F,EXP,nivolumab,1,PS,Chest discomfort,1,M,OT,496
158471545,1,Metastatic malignant melanoma,5,F,EXP,nivolumab,1,PS,Cough,1,M,OT,496
158471545,1,Metastatic malignant melanoma,5,F,EXP,nivolumab,1,PS,Discomfort,1,M,OT,496
158471545,1,Metastatic malignant melanoma,5,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,496
158471545,1,Metastatic malignant melanoma,5,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,496
158471545,1,Metastatic malignant melanoma,5,F,EXP,nivolumab,1,PS,Influenza,1,M,OT,496
158471545,1,Metastatic malignant melanoma,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,496
158471545,1,Metastatic malignant melanoma,5,F,EXP,nivolumab,1,PS,Musculoskeletal chest pain,1,M,OT,496
158471545,1,Metastatic malignant melanoma,5,F,EXP,nivolumab,1,PS,Productive cough,1,M,OT,496
158471545,1,Metastatic malignant melanoma,5,F,EXP,nivolumab,1,PS,Tenderness,1,M,OT,496
158471545,1,Metastatic malignant melanoma,5,F,EXP,nivolumab,1,PS,Viral infection,1,M,OT,496
158566283,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,42
158566283,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,OT,42
158608764,2,Waldenstrom's macroglobulinaemia,4,F,EXP,idelalisib,2,SS,Bronchopulmonary aspergillosis,2,M,HO,183
158608764,2,Waldenstrom's macroglobulinaemia,4,F,EXP,idelalisib,2,SS,Interstitial lung disease,2,M,HO,183
158642438,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Aortic stenosis,1,M,HO,385
158642438,4,Plasma cell myeloma,8,F,PER,daratumumab,4,SS,Aortic stenosis,4,M,HO,385
158642742,1,Hormone-refractory prostate cancer,2,F,EXP,nivolumab,1,PS,Muscular weakness,1,M,LT,19
158642742,1,Hormone-refractory prostate cancer,2,F,EXP,nivolumab,1,PS,Muscular weakness,1,M,HO,19
158642742,1,Hormone-refractory prostate cancer,2,F,EXP,nivolumab,1,PS,Muscular weakness,1,M,OT,19
158644088,1,Non-small cell lung cancer,8,F,EXP,avelumab,1,SS,Respiratory failure,1,M,DE,39
158644088,1,Non-small cell lung cancer,8,F,EXP,avelumab,1,SS,Respiratory failure,1,M,LT,39
158644088,1,Non-small cell lung cancer,8,F,EXP,avelumab,1,SS,Respiratory failure,1,M,HO,39
158677965,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hepatitis,1,M,LT,42
158677965,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hepatitis,1,M,OT,42
158677965,3,Malignant melanoma,5,F,EXP,ipilimumab,3,SS,Hepatitis,3,M,LT,42
158677965,3,Malignant melanoma,5,F,EXP,ipilimumab,3,SS,Hepatitis,3,M,OT,42
158690596,1,Renal cell carcinoma,6,F,EXP,avelumab,1,SS,Gastroenteritis,1,M,HO,766
158768105,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hepatic infection,1,M,OT,42
158768105,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hepatic infection,1,M,LT,42
158768105,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Thyroiditis,1,M,OT,42
158768105,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Thyroiditis,1,M,LT,42
158768105,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hepatic infection,2,M,OT,42
158768105,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hepatic infection,2,M,LT,42
158768105,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Thyroiditis,2,M,OT,42
158768105,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Thyroiditis,2,M,LT,42
158819784,1,Waldenstrom's macroglobulinaemia,4,F,EXP,idelalisib,1,PS,Bronchopulmonary aspergillosis,1,M,OT,183
158819784,1,Waldenstrom's macroglobulinaemia,4,F,EXP,idelalisib,1,PS,Bronchopulmonary aspergillosis,1,M,HO,183
158819784,1,Waldenstrom's macroglobulinaemia,4,F,EXP,idelalisib,1,PS,Interstitial lung disease,1,M,OT,183
158819784,1,Waldenstrom's macroglobulinaemia,4,F,EXP,idelalisib,1,PS,Interstitial lung disease,1,M,HO,183
158907495,1,Prostate cancer metastatic,5,F,EXP,nivolumab,1,PS,Appendicitis,1,F,LT,55
158907495,1,Prostate cancer metastatic,5,F,EXP,nivolumab,1,PS,Appendicitis,1,F,OT,55
158952292,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Cerebrovascular accident,3,M,HO,52
158952292,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Cerebrovascular accident,3,M,LT,52
158956609,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Cellulitis,1,M,DE,85
158956609,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Cellulitis,1,M,HO,85
158956609,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Leukopenia,1,M,DE,85
158956609,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Leukopenia,1,M,HO,85
158956609,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Neutropenia,1,M,DE,85
158956609,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Neutropenia,1,M,HO,85
158956609,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Neutropenic sepsis,1,M,DE,85
158956609,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Neutropenic sepsis,1,M,HO,85
158973066,1,Metastatic squamous cell carcinoma,6,F,EXP,nivolumab,1,PS,Cytopenia,1,M,OT,196
158973066,1,Metastatic squamous cell carcinoma,6,F,EXP,nivolumab,1,PS,Cytopenia,1,M,HO,196
158973066,2,Metastatic squamous cell carcinoma,6,F,EXP,ipilimumab,2,SS,Cytopenia,2,M,OT,196
158973066,2,Metastatic squamous cell carcinoma,6,F,EXP,ipilimumab,2,SS,Cytopenia,2,M,HO,196
158977818,1,Head and neck cancer,8,F,EXP,nivolumab,1,PS,Drug-induced liver injury,1,M,HO,14
158977818,1,Head and neck cancer,8,F,EXP,nivolumab,1,PS,Drug-induced liver injury,1,M,OT,14
158977818,1,Head and neck cancer,8,F,EXP,nivolumab,1,PS,Hepatic fibrosis,1,M,HO,14
158977818,1,Head and neck cancer,8,F,EXP,nivolumab,1,PS,Hepatic fibrosis,1,M,OT,14
158977818,1,Head and neck cancer,8,F,EXP,nivolumab,1,PS,Hepatitis,1,M,HO,14
158977818,1,Head and neck cancer,8,F,EXP,nivolumab,1,PS,Hepatitis,1,M,OT,14
158977818,1,Head and neck cancer,8,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,HO,14
158977818,1,Head and neck cancer,8,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,OT,14
158998804,8,Nausea,4,F,EXP,granisetron,8,C,Syncope,8,M,HO,4
159020465,1,Waldenstrom's macroglobulinaemia,5,F,EXP,idelalisib,1,PS,Back pain,1,M,HO,533
159020465,1,Waldenstrom's macroglobulinaemia,5,F,EXP,idelalisib,1,PS,Back pain,1,M,OT,533
159020465,1,Waldenstrom's macroglobulinaemia,5,F,EXP,idelalisib,1,PS,Febrile bone marrow aplasia,1,M,HO,533
159020465,1,Waldenstrom's macroglobulinaemia,5,F,EXP,idelalisib,1,PS,Febrile bone marrow aplasia,1,M,OT,533
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Basedow's disease,1,F,OT,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Basedow's disease,1,F,HO,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Diabetic ketoacidosis,1,F,OT,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Diabetic ketoacidosis,1,F,HO,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Dysphonia,1,F,OT,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Dysphonia,1,F,HO,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Haemolytic anaemia,1,F,OT,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Haemolytic anaemia,1,F,HO,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Headache,1,F,OT,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Headache,1,F,HO,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Micturition urgency,1,F,OT,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Micturition urgency,1,F,HO,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,F,OT,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,F,HO,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Oral herpes,1,F,OT,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Oral herpes,1,F,HO,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Urinary incontinence,1,F,OT,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Urinary incontinence,1,F,HO,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,OT,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,HO,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Vertigo,1,F,OT,38
159324849,1,Relapsing multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Vertigo,1,F,HO,38
159348697,1,Glioblastoma,7,F,EXP,nivolumab,1,PS,Eosinophilic fasciitis,1,F,OT,470
159348697,1,Glioblastoma,7,F,EXP,nivolumab,1,PS,Eosinophilic fasciitis,1,F,DS,470
159348697,1,Glioblastoma,7,F,EXP,nivolumab,1,PS,Eosinophilic fasciitis,1,F,HO,470
159352312,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,SS,Urinary tract infection,1,M,HO,256
159352312,4,Transitional cell carcinoma,2,F,EXP,ipilimumab,4,PS,Urinary tract infection,4,M,HO,201
159392673,1,Plasma cell myeloma,3,F,EXP,thalidomide,1,PS,Prostate cancer,1,M,OT,2000
159394455,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pemphigoid,1,M,OT,159
159394455,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pemphigoid,1,M,HO,159
159394455,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Skin ulcer,1,M,OT,159
159394455,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Skin ulcer,1,M,HO,159
159394763,1,Haemophagocytic lymphohistiocytosis,3,F,EXP,alemtuzumab,1,PS,Cytomegalovirus infection,1,M,OT,10
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Device dislocation,1,M,DE,202
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Device dislocation,1,M,OT,202
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Device dislocation,1,M,HO,202
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Dysphagia,1,M,DE,202
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Dysphagia,1,M,OT,202
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Dysphagia,1,M,HO,202
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,202
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,202
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,202
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Peritonitis,1,M,DE,202
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Peritonitis,1,M,OT,202
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Peritonitis,1,M,HO,202
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Post procedural complication,1,M,DE,202
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Post procedural complication,1,M,OT,202
159464256,1,Squamous cell carcinoma of head and neck,6,F,EXP,nivolumab,1,PS,Post procedural complication,1,M,HO,202
159556663,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Acute febrile neutrophilic dermatosis,1,F,OT,53
159556663,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Headache,1,F,OT,53
159560132,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,13
159560132,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,13
159560132,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,13
159560132,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,13
159572855,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,F,OT,21
159572855,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,F,HO,21
159572855,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,F,OT,21
159572855,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,F,HO,21
159572855,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,OT,21
159572855,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,HO,21
159572855,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hypophysitis,1,F,OT,21
159572855,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hypophysitis,1,F,HO,21
159572855,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,OT,21
159572855,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,HO,21
159572855,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Fulminant type 1 diabetes mellitus,2,F,OT,21
159572855,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Fulminant type 1 diabetes mellitus,2,F,HO,21
159572855,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,F,OT,21
159572855,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,F,HO,21
159572855,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hyperthyroidism,2,F,OT,21
159572855,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hyperthyroidism,2,F,HO,21
159572855,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hypophysitis,2,F,OT,21
159572855,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hypophysitis,2,F,HO,21
159572855,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,F,OT,21
159572855,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,F,HO,21
1595801710,5,Bladder cancer,10,F,EXP,avelumab,5,SS,Mucosal inflammation,5,M,HO,36
1595801710,5,Bladder cancer,10,F,EXP,avelumab,5,SS,Mucosal inflammation,5,M,OT,36
1595801710,5,Bladder cancer,10,F,EXP,avelumab,5,SS,Neutropenia,5,M,HO,36
1595801710,5,Bladder cancer,10,F,EXP,avelumab,5,SS,Neutropenia,5,M,OT,36
1595801710,5,Bladder cancer,10,F,EXP,avelumab,5,SS,Pneumonia,5,M,HO,36
1595801710,5,Bladder cancer,10,F,EXP,avelumab,5,SS,Pneumonia,5,M,OT,36
1595801710,5,Bladder cancer,10,F,EXP,avelumab,5,SS,Thrombocytopenia,5,M,HO,36
1595801710,5,Bladder cancer,10,F,EXP,avelumab,5,SS,Thrombocytopenia,5,M,OT,36
159583254,1,Non-Hodgkin's lymphoma unspecified histology indolent,4,F,EXP,axicabtagene ciloleucel,1,PS,CAR T-cell-related encephalopathy syndrome,1,M,HO,3
159583254,1,Non-Hodgkin's lymphoma unspecified histology indolent,4,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,3
159583254,1,Non-Hodgkin's lymphoma unspecified histology indolent,4,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,HO,3
159583254,1,Non-Hodgkin's lymphoma unspecified histology indolent,4,F,EXP,axicabtagene ciloleucel,1,PS,Neutropenia,1,M,HO,3
159583254,1,Non-Hodgkin's lymphoma unspecified histology indolent,4,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,HO,3
159590968,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Atrial flutter,1,M,HO,447
159590968,2,Plasma cell myeloma,8,F,PER,daratumumab,2,SS,Atrial flutter,2,M,HO,447
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Blood pressure increased,2,F,HO,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Blood pressure increased,2,F,LT,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Blood pressure increased,2,F,OT,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Deep vein thrombosis,2,F,HO,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Deep vein thrombosis,2,F,LT,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Deep vein thrombosis,2,F,OT,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Haemoglobin decreased,2,F,HO,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Haemoglobin decreased,2,F,LT,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Haemoglobin decreased,2,F,OT,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Heart rate increased,2,F,HO,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Heart rate increased,2,F,LT,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Heart rate increased,2,F,OT,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Neutrophil count decreased,2,F,HO,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Neutrophil count decreased,2,F,LT,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Neutrophil count decreased,2,F,OT,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Pulmonary embolism,2,F,HO,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Pulmonary embolism,2,F,LT,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Pulmonary embolism,2,F,OT,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,White blood cell count decreased,2,F,HO,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,White blood cell count decreased,2,F,LT,193
159597133,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,White blood cell count decreased,2,F,OT,193
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,F,HO,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,F,OT,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Enterocolitis,1,F,HO,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Enterocolitis,1,F,OT,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,F,HO,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,F,OT,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,HO,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,OT,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Liver disorder,1,F,HO,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Liver disorder,1,F,OT,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Myositis,1,F,HO,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Myositis,1,F,OT,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pruritus,1,F,HO,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pruritus,1,F,OT,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,F,HO,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,F,OT,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,7
159644826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Blood creatine phosphokinase increased,3,F,HO,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Blood creatine phosphokinase increased,3,F,OT,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Diarrhoea,3,F,HO,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Diarrhoea,3,F,OT,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Enterocolitis,3,F,HO,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Enterocolitis,3,F,OT,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Hepatic function abnormal,3,F,HO,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Hepatic function abnormal,3,F,OT,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Hypothyroidism,3,F,HO,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Hypothyroidism,3,F,OT,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Liver disorder,3,F,HO,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Liver disorder,3,F,OT,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Myositis,3,F,HO,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Myositis,3,F,OT,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Pruritus,3,F,HO,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Pruritus,3,F,OT,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Rash maculo-papular,3,F,HO,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Rash maculo-papular,3,F,OT,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Vomiting,3,F,HO,7
159644826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Vomiting,3,F,OT,7
159646374,1,Neuroendocrine carcinoma of the skin,4,F,EXP,nivolumab,1,PS,Arthralgia,1,M,HO,387
159657287,21,Tumour lysis syndrome,7,F,EXP,rasburicase,21,C,Small intestinal obstruction,21,M,HO,22
159690753,3,Lung neoplasm malignant,3,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,OT,94
159690753,3,Lung neoplasm malignant,3,F,EXP,nivolumab,3,SS,Polyarthritis,3,M,OT,94
159690753,3,Lung neoplasm malignant,3,F,EXP,nivolumab,3,SS,Rheumatoid arthritis,3,M,OT,94
159782445,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Immune thrombocytopenic purpura,1,F,DS,41
159782445,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Immune thrombocytopenic purpura,1,F,OT,41
159782445,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Immune thrombocytopenic purpura,1,F,HO,41
159782445,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Immune thrombocytopenic purpura,1,F,DE,41
159782445,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DS,41
159782445,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,41
159782445,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,41
159782445,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,41
159782445,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,F,DS,41
159782445,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,F,OT,41
159782445,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,F,HO,41
159782445,1,Hodgkin's disease,5,F,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,F,DE,41
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,LT,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,LT,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,OT,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,HO,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,DE,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Lung disorder,1,M,LT,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Lung disorder,1,M,OT,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Lung disorder,1,M,HO,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Lung disorder,1,M,DE,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,LT,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,HO,480
159782963,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,DE,480
159788473,5,Plasma cell myeloma,3,F,EXP,pomalidomide,5,SS,Bronchitis,5,F,HO,78
159788473,5,Plasma cell myeloma,3,F,EXP,pomalidomide,5,SS,Dementia,5,F,HO,78
159788473,5,Plasma cell myeloma,3,F,EXP,pomalidomide,5,SS,General physical health deterioration,5,F,HO,78
159846632,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Acute febrile neutrophilic dermatosis,1,F,OT,53
159846632,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Headache,1,F,OT,53
159846794,3,Plasma cell myeloma,4,F,EXP,thalidomide,3,SS,Pneumonia,3,M,HO,31
159865643,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Chronic obstructive pulmonary disease,1,M,HO,481
159865643,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Chronic obstructive pulmonary disease,3,M,HO,481
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,DE,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Asthenia,1,M,DE,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,OT,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,HO,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,DE,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Blood thyroid stimulating hormone increased,1,M,OT,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Blood thyroid stimulating hormone increased,1,M,HO,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Blood thyroid stimulating hormone increased,1,M,DE,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Cough,1,M,OT,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Cough,1,M,HO,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Cough,1,M,DE,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Lung disorder,1,M,OT,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Lung disorder,1,M,HO,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Lung disorder,1,M,DE,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Renal failure,1,M,DE,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Respiratory tract congestion,1,M,OT,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Respiratory tract congestion,1,M,HO,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Respiratory tract congestion,1,M,DE,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,51
159883684,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Sepsis,1,M,DE,51
1598854610,1,Renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,HO,21
1598854610,1,Renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,LT,21
1598854610,1,Renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,OT,21
1598854610,1,Renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,21
1598854610,1,Renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,21
1598854610,1,Renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,21
1598854610,2,Renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Autoimmune hepatitis,2,M,HO,21
1598854610,2,Renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Autoimmune hepatitis,2,M,LT,21
1598854610,2,Renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Autoimmune hepatitis,2,M,OT,21
1598854610,2,Renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,HO,21
1598854610,2,Renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,LT,21
1598854610,2,Renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,21
159886009,1,Squamous cell carcinoma of head and neck,9,F,EXP,nivolumab,1,PS,Circulatory collapse,1,M,HO,13
159886009,1,Squamous cell carcinoma of head and neck,9,F,EXP,nivolumab,1,PS,Circulatory collapse,1,M,OT,13
159886009,1,Squamous cell carcinoma of head and neck,9,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,13
159886009,1,Squamous cell carcinoma of head and neck,9,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,13
159886009,1,Squamous cell carcinoma of head and neck,9,F,EXP,nivolumab,1,PS,Electrolyte imbalance,1,M,HO,13
159886009,1,Squamous cell carcinoma of head and neck,9,F,EXP,nivolumab,1,PS,Electrolyte imbalance,1,M,OT,13
159886009,1,Squamous cell carcinoma of head and neck,9,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,13
159886009,1,Squamous cell carcinoma of head and neck,9,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,13
159886009,1,Squamous cell carcinoma of head and neck,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,13
159886009,1,Squamous cell carcinoma of head and neck,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,13
159886009,1,Squamous cell carcinoma of head and neck,9,F,EXP,nivolumab,1,PS,Rash,1,M,HO,13
159886009,1,Squamous cell carcinoma of head and neck,9,F,EXP,nivolumab,1,PS,Rash,1,M,OT,13
159900754,8,Neutropenia,4,F,EXP,filgrastim,8,C,Neutrophil count decreased,8,F,OT,14
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Cancer surgery,1,F,OT,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Cancer surgery,1,F,HO,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Cancer surgery,1,F,DE,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Conjunctivitis,1,F,OT,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Conjunctivitis,1,F,HO,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Conjunctivitis,1,F,DE,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,DE,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Hyperthermia,1,F,OT,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Hyperthermia,1,F,HO,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Hyperthermia,1,F,DE,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,OT,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,HO,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,DE,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Pneumonia,1,F,OT,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Pneumonia,1,F,HO,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Pneumonia,1,F,DE,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Scab,1,F,OT,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Scab,1,F,HO,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Scab,1,F,DE,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Spinal disorder,1,F,OT,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Spinal disorder,1,F,HO,48
159902204,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Spinal disorder,1,F,DE,48
1599318515,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Herpes zoster meningoradiculitis,1,M,OT,86
1599318515,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Herpes zoster meningoradiculitis,1,M,HO,86
1599318515,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,OT,86
1599318515,1,Lung neoplasm malignant,15,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,HO,86
159935294,3,Plasma cell myeloma,4,F,EXP,pomalidomide,3,SS,Anaemia,3,F,HO,203
159935294,3,Plasma cell myeloma,4,F,EXP,pomalidomide,3,SS,Pneumonia,3,F,HO,203
159946984,1,Acute lymphocytic leukaemia,4,F,EXP,nilotinib,1,PS,Hepatitis E,1,F,OT,63
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Autoimmune hepatitis,2,M,HO,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Autoimmune hepatitis,2,M,DE,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Autoimmune hepatitis,2,M,LT,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Autoimmune hepatitis,2,M,OT,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Death,2,M,HO,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Death,2,M,DE,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Death,2,M,LT,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Death,2,M,OT,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Fungal infection,2,M,HO,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Fungal infection,2,M,DE,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Fungal infection,2,M,LT,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Fungal infection,2,M,OT,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Pneumonia,2,M,HO,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Pneumonia,2,M,DE,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Pneumonia,2,M,LT,122
160063283,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Pneumonia,2,M,OT,122
160152662,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,F,OT,198
160152662,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,F,HO,198
160152662,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Dysphagia,1,F,OT,198
160152662,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Dysphagia,1,F,HO,198
1601847111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Clostridium difficile infection,1,M,OT,32
1601847111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Clostridium difficile infection,1,M,HO,32
1601847111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,OT,32
1601847111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,HO,32
1601847111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,32
1601847111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,32
1601847111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Tubulointerstitial nephritis,1,M,OT,32
1601847111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Tubulointerstitial nephritis,1,M,HO,32
1601847111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Urosepsis,1,M,OT,32
1601847111,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Urosepsis,1,M,HO,32
1601847111,7,Malignant melanoma,11,F,EXP,ipilimumab,7,SS,Clostridium difficile infection,7,M,OT,32
1601847111,7,Malignant melanoma,11,F,EXP,ipilimumab,7,SS,Clostridium difficile infection,7,M,HO,32
1601847111,7,Malignant melanoma,11,F,EXP,ipilimumab,7,SS,Immune-mediated enterocolitis,7,M,OT,32
1601847111,7,Malignant melanoma,11,F,EXP,ipilimumab,7,SS,Immune-mediated enterocolitis,7,M,HO,32
1601847111,7,Malignant melanoma,11,F,EXP,ipilimumab,7,SS,Pyrexia,7,M,OT,32
1601847111,7,Malignant melanoma,11,F,EXP,ipilimumab,7,SS,Pyrexia,7,M,HO,32
1601847111,7,Malignant melanoma,11,F,EXP,ipilimumab,7,SS,Tubulointerstitial nephritis,7,M,OT,32
1601847111,7,Malignant melanoma,11,F,EXP,ipilimumab,7,SS,Tubulointerstitial nephritis,7,M,HO,32
1601847111,7,Malignant melanoma,11,F,EXP,ipilimumab,7,SS,Urosepsis,7,M,OT,32
1601847111,7,Malignant melanoma,11,F,EXP,ipilimumab,7,SS,Urosepsis,7,M,HO,32
160198225,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Pulmonary embolism,3,F,LT,58
160198225,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Pulmonary embolism,3,F,OT,58
160198225,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Pulmonary embolism,3,F,HO,58
160238833,3,Metastatic malignant melanoma,3,F,EXP,trametinib,3,SS,Malignant neoplasm progression,3,M,DE,445
160238833,3,Metastatic malignant melanoma,3,F,EXP,trametinib,3,SS,Malignant neoplasm progression,3,M,OT,445
160238833,3,Metastatic malignant melanoma,3,F,EXP,trametinib,3,SS,Malignant neoplasm progression,3,M,HO,445
160238833,3,Metastatic malignant melanoma,3,F,EXP,trametinib,3,SS,Metastatic malignant melanoma,3,M,DE,445
160238833,3,Metastatic malignant melanoma,3,F,EXP,trametinib,3,SS,Metastatic malignant melanoma,3,M,OT,445
160238833,3,Metastatic malignant melanoma,3,F,EXP,trametinib,3,SS,Metastatic malignant melanoma,3,M,HO,445
160238833,3,Metastatic malignant melanoma,3,F,EXP,trametinib,3,SS,Organising pneumonia,3,M,DE,445
160238833,3,Metastatic malignant melanoma,3,F,EXP,trametinib,3,SS,Organising pneumonia,3,M,OT,445
160238833,3,Metastatic malignant melanoma,3,F,EXP,trametinib,3,SS,Organising pneumonia,3,M,HO,445
160238833,3,Metastatic malignant melanoma,3,F,EXP,trametinib,3,SS,Vomiting,3,M,DE,445
160238833,3,Metastatic malignant melanoma,3,F,EXP,trametinib,3,SS,Vomiting,3,M,OT,445
160238833,3,Metastatic malignant melanoma,3,F,EXP,trametinib,3,SS,Vomiting,3,M,HO,445
160238833,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Malignant neoplasm progression,5,M,DE,494
160238833,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Malignant neoplasm progression,5,M,OT,494
160238833,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Malignant neoplasm progression,5,M,HO,494
160238833,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Metastatic malignant melanoma,5,M,DE,494
160238833,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Metastatic malignant melanoma,5,M,OT,494
160238833,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Metastatic malignant melanoma,5,M,HO,494
160238833,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Organising pneumonia,5,M,DE,494
160238833,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Organising pneumonia,5,M,OT,494
160238833,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Organising pneumonia,5,M,HO,494
160238833,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Vomiting,5,M,DE,494
160238833,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Vomiting,5,M,OT,494
160238833,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Vomiting,5,M,HO,494
160271415,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Cellulitis,1,M,OT,607
160271415,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Cellulitis,1,M,HO,607
160271415,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Lymphangitis,1,M,OT,607
160271415,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Lymphangitis,1,M,HO,607
160271415,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Necrosis,1,M,OT,607
160271415,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Necrosis,1,M,HO,607
160271415,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Soft tissue infection,1,M,OT,607
160271415,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Soft tissue infection,1,M,HO,607
160271415,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Cellulitis,2,M,OT,537
160271415,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Cellulitis,2,M,HO,537
160271415,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Lymphangitis,2,M,OT,537
160271415,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Lymphangitis,2,M,HO,537
160271415,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Necrosis,2,M,OT,537
160271415,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Necrosis,2,M,HO,537
160271415,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Soft tissue infection,2,M,OT,537
160271415,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Soft tissue infection,2,M,HO,537
160271415,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Cellulitis,3,M,OT,439
160271415,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Cellulitis,3,M,HO,439
160271415,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Lymphangitis,3,M,OT,439
160271415,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Lymphangitis,3,M,HO,439
160271415,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Necrosis,3,M,OT,439
160271415,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Necrosis,3,M,HO,439
160271415,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Soft tissue infection,3,M,OT,439
160271415,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Soft tissue infection,3,M,HO,439
160271415,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Cellulitis,4,M,OT,220
160271415,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Cellulitis,4,M,HO,220
160271415,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Lymphangitis,4,M,OT,220
160271415,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Lymphangitis,4,M,HO,220
160271415,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Necrosis,4,M,OT,220
160271415,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Necrosis,4,M,HO,220
160271415,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Soft tissue infection,4,M,OT,220
160271415,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Soft tissue infection,4,M,HO,220
160271415,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Cellulitis,5,M,OT,206
160271415,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Cellulitis,5,M,HO,206
160271415,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Lymphangitis,5,M,OT,206
160271415,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Lymphangitis,5,M,HO,206
160271415,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Necrosis,5,M,OT,206
160271415,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Necrosis,5,M,HO,206
160271415,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Soft tissue infection,5,M,OT,206
160271415,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Soft tissue infection,5,M,HO,206
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Colitis,1,F,DE,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Colitis,1,F,HO,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Colitis,1,F,LT,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Colitis,1,F,OT,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,F,DE,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,F,HO,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,F,LT,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,F,OT,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Disseminated intravascular coagulation,1,F,DE,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Disseminated intravascular coagulation,1,F,HO,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Disseminated intravascular coagulation,1,F,LT,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Disseminated intravascular coagulation,1,F,OT,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Hypoalbuminaemia,1,F,DE,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Hypoalbuminaemia,1,F,HO,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Hypoalbuminaemia,1,F,LT,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Hypoalbuminaemia,1,F,OT,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,F,DE,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,F,HO,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,F,LT,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,F,OT,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Oesophagitis,1,F,DE,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Oesophagitis,1,F,HO,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Oesophagitis,1,F,LT,72
1602736710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Oesophagitis,1,F,OT,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Colitis,2,F,DE,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Colitis,2,F,HO,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Colitis,2,F,LT,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Colitis,2,F,OT,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Diabetic ketoacidosis,2,F,DE,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Diabetic ketoacidosis,2,F,HO,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Diabetic ketoacidosis,2,F,LT,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Diabetic ketoacidosis,2,F,OT,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Disseminated intravascular coagulation,2,F,DE,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Disseminated intravascular coagulation,2,F,HO,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Disseminated intravascular coagulation,2,F,LT,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Disseminated intravascular coagulation,2,F,OT,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Hypoalbuminaemia,2,F,DE,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Hypoalbuminaemia,2,F,HO,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Hypoalbuminaemia,2,F,LT,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Hypoalbuminaemia,2,F,OT,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,F,DE,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,F,HO,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,F,LT,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,F,OT,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Oesophagitis,2,F,DE,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Oesophagitis,2,F,HO,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Oesophagitis,2,F,LT,72
1602736710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Oesophagitis,2,F,OT,72
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Colitis,3,F,DE,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Colitis,3,F,HO,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Colitis,3,F,LT,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Colitis,3,F,OT,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Diabetic ketoacidosis,3,F,DE,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Diabetic ketoacidosis,3,F,HO,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Diabetic ketoacidosis,3,F,LT,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Diabetic ketoacidosis,3,F,OT,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Disseminated intravascular coagulation,3,F,DE,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Disseminated intravascular coagulation,3,F,HO,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Disseminated intravascular coagulation,3,F,LT,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Disseminated intravascular coagulation,3,F,OT,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Hypoalbuminaemia,3,F,DE,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Hypoalbuminaemia,3,F,HO,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Hypoalbuminaemia,3,F,LT,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Hypoalbuminaemia,3,F,OT,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Multiple organ dysfunction syndrome,3,F,DE,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Multiple organ dysfunction syndrome,3,F,HO,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Multiple organ dysfunction syndrome,3,F,LT,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Multiple organ dysfunction syndrome,3,F,OT,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Oesophagitis,3,F,DE,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Oesophagitis,3,F,HO,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Oesophagitis,3,F,LT,51
1602736710,3,Product used for unknown indication,10,F,EXP,ipilimumab,3,SS,Oesophagitis,3,F,OT,51
160291252,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Pyrexia,2,M,HO,2
160328612,1,Thyroid cancer,2,F,EXP,nivolumab,1,PS,Asthenia,1,F,OT,98
160328612,1,Thyroid cancer,2,F,EXP,nivolumab,1,PS,Asthenia,1,F,HO,98
160328612,1,Thyroid cancer,2,F,EXP,nivolumab,1,PS,Colitis,1,F,OT,98
160328612,1,Thyroid cancer,2,F,EXP,nivolumab,1,PS,Colitis,1,F,HO,98
160328612,1,Thyroid cancer,2,F,EXP,nivolumab,1,PS,Depression,1,F,OT,98
160328612,1,Thyroid cancer,2,F,EXP,nivolumab,1,PS,Depression,1,F,HO,98
160328612,1,Thyroid cancer,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,98
160328612,1,Thyroid cancer,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,98
160328612,1,Thyroid cancer,2,F,EXP,nivolumab,1,PS,Failure to thrive,1,F,OT,98
160328612,1,Thyroid cancer,2,F,EXP,nivolumab,1,PS,Failure to thrive,1,F,HO,98
160328612,1,Thyroid cancer,2,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,98
160328612,1,Thyroid cancer,2,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,98
160328612,2,Thyroid cancer,2,F,EXP,ipilimumab,2,SS,Asthenia,2,F,OT,83
160328612,2,Thyroid cancer,2,F,EXP,ipilimumab,2,SS,Asthenia,2,F,HO,83
160328612,2,Thyroid cancer,2,F,EXP,ipilimumab,2,SS,Colitis,2,F,OT,83
160328612,2,Thyroid cancer,2,F,EXP,ipilimumab,2,SS,Colitis,2,F,HO,83
160328612,2,Thyroid cancer,2,F,EXP,ipilimumab,2,SS,Depression,2,F,OT,83
160328612,2,Thyroid cancer,2,F,EXP,ipilimumab,2,SS,Depression,2,F,HO,83
160328612,2,Thyroid cancer,2,F,EXP,ipilimumab,2,SS,Dyspnoea,2,F,OT,83
160328612,2,Thyroid cancer,2,F,EXP,ipilimumab,2,SS,Dyspnoea,2,F,HO,83
160328612,2,Thyroid cancer,2,F,EXP,ipilimumab,2,SS,Failure to thrive,2,F,OT,83
160328612,2,Thyroid cancer,2,F,EXP,ipilimumab,2,SS,Failure to thrive,2,F,HO,83
160328612,2,Thyroid cancer,2,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,F,OT,83
160328612,2,Thyroid cancer,2,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,F,HO,83
160421073,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Thrombocytopenia,1,F,LT,94
160421073,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Thrombocytopenia,1,F,HO,94
160421073,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Thrombocytopenia,1,F,DS,94
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Demyelinating polyneuropathy,1,M,OT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Demyelinating polyneuropathy,1,M,LT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Demyelinating polyneuropathy,1,M,HO,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Demyelinating polyneuropathy,1,M,DS,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,LT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DS,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Drug eruption,1,M,OT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Drug eruption,1,M,LT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Drug eruption,1,M,HO,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Drug eruption,1,M,DS,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Facial pain,1,M,OT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Facial pain,1,M,LT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Facial pain,1,M,HO,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Facial pain,1,M,DS,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Haematochezia,1,M,OT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Haematochezia,1,M,LT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Haematochezia,1,M,HO,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Haematochezia,1,M,DS,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,OT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,LT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,HO,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,DS,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Herpes zoster,1,M,OT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Herpes zoster,1,M,LT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Herpes zoster,1,M,HO,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Herpes zoster,1,M,DS,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,OT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,LT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,HO,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,DS,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Myositis,1,M,OT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Myositis,1,M,LT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Myositis,1,M,HO,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Myositis,1,M,DS,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Rash,1,M,OT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Rash,1,M,LT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Rash,1,M,HO,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Rash,1,M,DS,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Uveitis,1,M,OT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Uveitis,1,M,LT,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Uveitis,1,M,HO,17
1604489011,1,Malignant melanoma,11,F,EXP,nivolumab,1,PS,Uveitis,1,M,DS,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Demyelinating polyneuropathy,2,M,OT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Demyelinating polyneuropathy,2,M,LT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Demyelinating polyneuropathy,2,M,HO,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Demyelinating polyneuropathy,2,M,DS,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,LT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,DS,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Drug eruption,2,M,OT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Drug eruption,2,M,LT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Drug eruption,2,M,HO,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Drug eruption,2,M,DS,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Facial pain,2,M,OT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Facial pain,2,M,LT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Facial pain,2,M,HO,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Facial pain,2,M,DS,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Haematochezia,2,M,OT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Haematochezia,2,M,LT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Haematochezia,2,M,HO,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Haematochezia,2,M,DS,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,OT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,LT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,HO,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,DS,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Herpes zoster,2,M,OT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Herpes zoster,2,M,LT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Herpes zoster,2,M,HO,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Herpes zoster,2,M,DS,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,OT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,LT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,HO,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,DS,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Myositis,2,M,OT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Myositis,2,M,LT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Myositis,2,M,HO,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Myositis,2,M,DS,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Rash,2,M,OT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Rash,2,M,LT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Rash,2,M,HO,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Rash,2,M,DS,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Uveitis,2,M,OT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Uveitis,2,M,LT,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Uveitis,2,M,HO,17
1604489011,2,Malignant melanoma,11,F,EXP,ipilimumab,2,SS,Uveitis,2,M,DS,17
160480717,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,217
160480717,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,DS,217
160480717,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,217
160480717,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Peripheral sensorimotor neuropathy,1,F,HO,217
160480717,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Peripheral sensorimotor neuropathy,1,F,DS,217
160480717,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Peripheral sensorimotor neuropathy,1,F,OT,217
160480717,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Seizure,1,F,HO,217
160480717,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Seizure,1,F,DS,217
160480717,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Seizure,1,F,OT,217
160600843,1,Acute lymphocytic leukaemia,3,F,PER,blinatumomab,1,PS,Nervous system disorder,1,F,HO,1
160600843,1,Acute lymphocytic leukaemia,3,F,PER,blinatumomab,1,PS,Nervous system disorder,1,F,OT,1
160604894,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Fall,2,F,HO,208
160604894,4,Plasma cell myeloma,4,F,EXP,lenalidomide,4,SS,Fall,4,F,HO,208
160604894,6,Plasma cell myeloma,4,F,EXP,filgrastim,6,SS,Fall,6,F,HO,96
160606644,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Asthenia,1,M,HO,17
160606644,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,General physical health deterioration,1,M,HO,17
160606644,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Pyrexia,1,M,HO,17
1606318510,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Dizziness,1,F,HO,468
1606318510,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Epistaxis,1,F,HO,468
1606318510,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Herpes zoster,1,F,HO,468
1606318510,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Lower respiratory tract infection,1,F,HO,468
1606318510,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Menorrhagia,1,F,HO,468
1606318510,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,F,HO,468
1606318510,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Post herpetic neuralgia,1,F,HO,468
1606318510,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Trigeminal neuralgia,1,F,HO,468
1606318510,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Vomiting,1,F,HO,468
160641476,3,Plasma cell myeloma,6,F,EXP,thalidomide,3,SS,Febrile infection,3,M,HO,5
160641476,3,Plasma cell myeloma,6,F,EXP,thalidomide,3,SS,Pyrexia,3,M,HO,5
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Acute lymphocytic leukaemia refractory,1,M,OT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Acute lymphocytic leukaemia refractory,1,M,DE,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Acute lymphocytic leukaemia refractory,1,M,LT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Bacteraemia,1,M,OT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Bacteraemia,1,M,DE,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Bacteraemia,1,M,LT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Dyspnoea,1,M,OT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Dyspnoea,1,M,DE,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Dyspnoea,1,M,LT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Febrile neutropenia,1,M,OT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Febrile neutropenia,1,M,DE,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Febrile neutropenia,1,M,LT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Fungal infection,1,M,OT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Fungal infection,1,M,DE,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Fungal infection,1,M,LT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Oliguria,1,M,OT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Oliguria,1,M,DE,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Oliguria,1,M,LT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Rash maculo-papular,1,M,OT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Rash maculo-papular,1,M,DE,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Rash maculo-papular,1,M,LT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Systemic mycosis,1,M,OT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Systemic mycosis,1,M,DE,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Systemic mycosis,1,M,LT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Therapy non-responder,1,M,OT,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Therapy non-responder,1,M,DE,20
160693472,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Therapy non-responder,1,M,LT,20
1607422410,1,Oesophageal squamous cell carcinoma,10,F,EXP,nivolumab,1,PS,Dehydration,1,F,OT,5
1607422410,1,Oesophageal squamous cell carcinoma,10,F,EXP,nivolumab,1,PS,Dehydration,1,F,HO,5
1607422410,1,Oesophageal squamous cell carcinoma,10,F,EXP,nivolumab,1,PS,Mucosal inflammation,1,F,OT,5
1607422410,1,Oesophageal squamous cell carcinoma,10,F,EXP,nivolumab,1,PS,Mucosal inflammation,1,F,HO,5
1607422410,1,Oesophageal squamous cell carcinoma,10,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,5
1607422410,1,Oesophageal squamous cell carcinoma,10,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,5
160746037,1,Transitional cell carcinoma,7,F,EXP,nivolumab,1,PS,Immune-mediated encephalitis,1,M,LT,42
160746037,1,Transitional cell carcinoma,7,F,EXP,nivolumab,1,PS,Immune-mediated encephalitis,1,M,HO,42
160746037,1,Transitional cell carcinoma,7,F,EXP,nivolumab,1,PS,Immune-mediated encephalitis,1,M,DE,42
160746037,1,Transitional cell carcinoma,7,F,EXP,nivolumab,1,PS,Immune-mediated encephalitis,1,M,OT,42
160746037,1,Transitional cell carcinoma,7,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,LT,42
160746037,1,Transitional cell carcinoma,7,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,HO,42
160746037,1,Transitional cell carcinoma,7,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,DE,42
160746037,1,Transitional cell carcinoma,7,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,42
160746037,2,Transitional cell carcinoma,7,F,EXP,ipilimumab,2,SS,Immune-mediated encephalitis,2,M,LT,42
160746037,2,Transitional cell carcinoma,7,F,EXP,ipilimumab,2,SS,Immune-mediated encephalitis,2,M,HO,42
160746037,2,Transitional cell carcinoma,7,F,EXP,ipilimumab,2,SS,Immune-mediated encephalitis,2,M,DE,42
160746037,2,Transitional cell carcinoma,7,F,EXP,ipilimumab,2,SS,Immune-mediated encephalitis,2,M,OT,42
160746037,2,Transitional cell carcinoma,7,F,EXP,ipilimumab,2,SS,Respiratory failure,2,M,LT,42
160746037,2,Transitional cell carcinoma,7,F,EXP,ipilimumab,2,SS,Respiratory failure,2,M,HO,42
160746037,2,Transitional cell carcinoma,7,F,EXP,ipilimumab,2,SS,Respiratory failure,2,M,DE,42
160746037,2,Transitional cell carcinoma,7,F,EXP,ipilimumab,2,SS,Respiratory failure,2,M,OT,42
160746496,2,Non-small cell lung cancer,6,F,EXP,nivolumab,2,PS,Meningism,2,F,HO,229
160746496,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Meningism,3,F,HO,229
160746506,1,Prostate cancer metastatic,6,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,56
160746506,1,Prostate cancer metastatic,6,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,56
160746506,1,Prostate cancer metastatic,6,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,56
160746506,1,Prostate cancer metastatic,6,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,56
160746506,1,Prostate cancer metastatic,6,F,EXP,nivolumab,1,PS,Neutropenia,1,M,HO,56
160746506,1,Prostate cancer metastatic,6,F,EXP,nivolumab,1,PS,Neutropenia,1,M,OT,56
160746506,1,Prostate cancer metastatic,6,F,EXP,nivolumab,1,PS,Urosepsis,1,M,HO,56
160746506,1,Prostate cancer metastatic,6,F,EXP,nivolumab,1,PS,Urosepsis,1,M,OT,56
160795547,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,F,OT,17
160795547,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,F,HO,17
160795547,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,F,DE,17
160795547,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Dementia,1,F,OT,17
160795547,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Dementia,1,F,HO,17
160795547,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Dementia,1,F,DE,17
160795547,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,F,OT,17
160795547,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,F,HO,17
160795547,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,F,DE,17
160795547,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pneumonia aspiration,1,F,OT,17
160795547,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pneumonia aspiration,1,F,HO,17
160795547,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pneumonia aspiration,1,F,DE,17
160795547,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Blood creatine phosphokinase increased,2,F,OT,17
160795547,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Blood creatine phosphokinase increased,2,F,HO,17
160795547,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Blood creatine phosphokinase increased,2,F,DE,17
160795547,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Dementia,2,F,OT,17
160795547,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Dementia,2,F,HO,17
160795547,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Dementia,2,F,DE,17
160795547,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,F,OT,17
160795547,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,F,HO,17
160795547,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,F,DE,17
160795547,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Pneumonia aspiration,2,F,OT,17
160795547,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Pneumonia aspiration,2,F,HO,17
160795547,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Pneumonia aspiration,2,F,DE,17
160865863,1,Oesophageal squamous cell carcinoma,3,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,DE,74
160865863,1,Oesophageal squamous cell carcinoma,3,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,74
160865863,2,Oesophageal squamous cell carcinoma,3,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,DE,74
160865863,2,Oesophageal squamous cell carcinoma,3,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,HO,74
160875175,1,Relapsing multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Back pain,1,F,HO,134
160875175,1,Relapsing multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Dermatitis allergic,1,F,HO,134
160875175,1,Relapsing multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Herpes zoster,1,F,HO,134
160875175,1,Relapsing multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Myofascial pain syndrome,1,F,HO,134
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Aphasia,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Aphasia,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Aphasia,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Aphasia,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Aphasia,1,M,HO,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Blood bilirubin increased,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Blood bilirubin increased,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Blood bilirubin increased,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Blood bilirubin increased,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Blood bilirubin increased,1,M,HO,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,HO,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Haemophagocytic lymphohistiocytosis,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Haemophagocytic lymphohistiocytosis,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Haemophagocytic lymphohistiocytosis,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Haemophagocytic lymphohistiocytosis,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Haemophagocytic lymphohistiocytosis,1,M,HO,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,HO,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,HO,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia influenzal,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia influenzal,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia influenzal,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia influenzal,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia influenzal,1,M,HO,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,HO,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Restlessness,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Restlessness,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Restlessness,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Restlessness,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Restlessness,1,M,HO,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Sepsis,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Sepsis,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Sepsis,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Sepsis,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Sepsis,1,M,HO,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Somnolence,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Somnolence,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Somnolence,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Somnolence,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Somnolence,1,M,HO,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Tachycardia,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Tachycardia,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Tachycardia,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Tachycardia,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Tachycardia,1,M,HO,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Tremor,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Tremor,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Tremor,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Tremor,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Tremor,1,M,HO,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Vomiting,1,M,DS,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Vomiting,1,M,DE,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Vomiting,1,M,LT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Vomiting,1,M,OT,6
1609782117,1,Diffuse large B-cell lymphoma stage IV,17,F,EXP,axicabtagene ciloleucel,1,PS,Vomiting,1,M,HO,6
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Arthralgia,1,M,DE,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Arthralgia,1,M,HO,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Arthralgia,1,M,LT,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Cough,1,M,DE,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Cough,1,M,HO,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Cough,1,M,LT,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Dyspnoea,1,M,DE,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Dyspnoea,1,M,HO,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Dyspnoea,1,M,LT,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Lower respiratory tract infection,1,M,DE,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Lower respiratory tract infection,1,M,HO,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Lower respiratory tract infection,1,M,LT,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Multiple organ dysfunction syndrome,1,M,DE,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Multiple organ dysfunction syndrome,1,M,HO,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Multiple organ dysfunction syndrome,1,M,LT,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Pneumonia,1,M,DE,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Pneumonia,1,M,HO,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Pneumonia,1,M,LT,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Productive cough,1,M,DE,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Productive cough,1,M,HO,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Productive cough,1,M,LT,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Rhinorrhoea,1,M,DE,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Rhinorrhoea,1,M,HO,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Rhinorrhoea,1,M,LT,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Sepsis,1,M,DE,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Sepsis,1,M,HO,9
161010797,1,B-cell lymphoma,7,F,EXP,idelalisib,1,PS,Sepsis,1,M,LT,9
161029485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,37
161029485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Limb mass,1,M,OT,37
161029485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Lower respiratory tract infection,1,M,OT,37
161029485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Malignant melanoma,1,M,OT,37
161029485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Nasopharyngitis,1,M,OT,37
161029485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,OT,37
161029485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Rash,1,M,OT,37
161029485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Self-medication,1,M,OT,37
161029485,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Diarrhoea,2,M,OT,37
161029485,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Limb mass,2,M,OT,37
161029485,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Lower respiratory tract infection,2,M,OT,37
161029485,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Malignant melanoma,2,M,OT,37
161029485,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Nasopharyngitis,2,M,OT,37
161029485,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Prescribed overdose,2,M,OT,37
161029485,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Rash,2,M,OT,37
161029485,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Self-medication,2,M,OT,37
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Arrhythmia,1,M,OT,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Arrhythmia,1,M,HO,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Arrhythmia,1,M,DS,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Bone pain,1,M,OT,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Bone pain,1,M,HO,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Bone pain,1,M,DS,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Chronic kidney disease,1,M,OT,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Chronic kidney disease,1,M,HO,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Chronic kidney disease,1,M,DS,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DS,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Hot flush,1,M,OT,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Hot flush,1,M,HO,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Hot flush,1,M,DS,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DS,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Osteoporosis,1,M,OT,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Osteoporosis,1,M,HO,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Osteoporosis,1,M,DS,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Osteoporotic fracture,1,M,OT,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Osteoporotic fracture,1,M,HO,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Osteoporotic fracture,1,M,DS,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,2
161029547,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Pyrexia,1,M,DS,2
161029756,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Autoimmune haemolytic anaemia,1,F,OT,16
161029756,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Autoimmune haemolytic anaemia,1,F,HO,16
161029756,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Autoimmune haemolytic anaemia,2,F,OT,16
161029756,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Autoimmune haemolytic anaemia,2,F,HO,16
161029904,1,Metastatic neoplasm,4,F,EXP,nivolumab,1,PS,Small intestinal obstruction,1,F,OT,744
161029904,1,Metastatic neoplasm,4,F,EXP,nivolumab,1,PS,Small intestinal obstruction,1,F,LT,744
161029904,1,Metastatic neoplasm,4,F,EXP,nivolumab,1,PS,Small intestinal obstruction,1,F,HO,744
161051463,5,Metastatic malignant melanoma,3,F,EXP,trametinib,5,SS,Dermatitis acneiform,5,M,OT,17
161051463,5,Metastatic malignant melanoma,3,F,EXP,trametinib,5,SS,Fatigue,5,M,OT,17
161051463,5,Metastatic malignant melanoma,3,F,EXP,trametinib,5,SS,Pyrexia,5,M,OT,17
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Acute kidney injury,1,M,LT,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Acute kidney injury,1,M,DS,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Acute kidney injury,1,M,HO,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Acute kidney injury,1,M,OT,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Acute respiratory failure,1,M,LT,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Acute respiratory failure,1,M,DS,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Acute respiratory failure,1,M,HO,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Acute respiratory failure,1,M,OT,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Atrial fibrillation,1,M,LT,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Atrial fibrillation,1,M,DS,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Atrial fibrillation,1,M,HO,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Atrial fibrillation,1,M,OT,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Stomatitis,1,M,LT,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Stomatitis,1,M,DS,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Stomatitis,1,M,HO,431
161083748,1,Plasma cell myeloma,8,F,PER,carfilzomib,1,PS,Stomatitis,1,M,OT,431
161107653,1,Lung adenocarcinoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,1
161107653,1,Lung adenocarcinoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,LT,1
161107653,1,Lung adenocarcinoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,1
161116997,1,Anaemia,7,F,PER,darbepoetin alfa,1,PS,Ischaemic cardiomyopathy,1,M,OT,408
161116997,1,Anaemia,7,F,PER,darbepoetin alfa,1,PS,Ischaemic cardiomyopathy,1,M,LT,408
161116997,1,Anaemia,7,F,PER,darbepoetin alfa,1,PS,Ischaemic cardiomyopathy,1,M,HO,408
161116997,1,Anaemia,7,F,PER,darbepoetin alfa,1,PS,Seizure,1,M,OT,408
161116997,1,Anaemia,7,F,PER,darbepoetin alfa,1,PS,Seizure,1,M,LT,408
161116997,1,Anaemia,7,F,PER,darbepoetin alfa,1,PS,Seizure,1,M,HO,408
161156883,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Nosocomial infection,1,F,HO,2
161174477,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Autoimmune pancreatitis,1,M,OT,23
161174477,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Autoimmune pancreatitis,1,M,HO,23
161174477,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Autoimmune pancreatitis,1,M,LT,23
161174477,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Diabetic ketoacidotic hyperglycaemic coma,1,M,OT,23
161174477,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Diabetic ketoacidotic hyperglycaemic coma,1,M,HO,23
161174477,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Diabetic ketoacidotic hyperglycaemic coma,1,M,LT,23
161174477,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,OT,23
161174477,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,HO,23
161174477,1,Renal cancer,7,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,LT,23
161174477,2,Renal cancer,7,F,EXP,ipilimumab,2,SS,Autoimmune pancreatitis,2,M,OT,23
161174477,2,Renal cancer,7,F,EXP,ipilimumab,2,SS,Autoimmune pancreatitis,2,M,HO,23
161174477,2,Renal cancer,7,F,EXP,ipilimumab,2,SS,Autoimmune pancreatitis,2,M,LT,23
161174477,2,Renal cancer,7,F,EXP,ipilimumab,2,SS,Diabetic ketoacidotic hyperglycaemic coma,2,M,OT,23
161174477,2,Renal cancer,7,F,EXP,ipilimumab,2,SS,Diabetic ketoacidotic hyperglycaemic coma,2,M,HO,23
161174477,2,Renal cancer,7,F,EXP,ipilimumab,2,SS,Diabetic ketoacidotic hyperglycaemic coma,2,M,LT,23
161174477,2,Renal cancer,7,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,M,OT,23
161174477,2,Renal cancer,7,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,M,HO,23
161174477,2,Renal cancer,7,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,M,LT,23
161204817,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,96
161204817,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,96
161204817,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,DE,96
161204817,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Confusional state,1,M,HO,96
161204817,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Confusional state,1,M,OT,96
161204817,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Confusional state,1,M,DE,96
161204817,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Inflammation,1,M,HO,96
161204817,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Inflammation,1,M,OT,96
161204817,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Inflammation,1,M,DE,96
161204817,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,HO,96
161204817,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,OT,96
161204817,1,Non-small cell lung cancer,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,DE,96
161204817,2,Non-small cell lung cancer,7,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,HO,96
161204817,2,Non-small cell lung cancer,7,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,OT,96
161204817,2,Non-small cell lung cancer,7,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,DE,96
161204817,2,Non-small cell lung cancer,7,F,EXP,ipilimumab,2,SS,Confusional state,2,M,HO,96
161204817,2,Non-small cell lung cancer,7,F,EXP,ipilimumab,2,SS,Confusional state,2,M,OT,96
161204817,2,Non-small cell lung cancer,7,F,EXP,ipilimumab,2,SS,Confusional state,2,M,DE,96
161204817,2,Non-small cell lung cancer,7,F,EXP,ipilimumab,2,SS,Inflammation,2,M,HO,96
161204817,2,Non-small cell lung cancer,7,F,EXP,ipilimumab,2,SS,Inflammation,2,M,OT,96
161204817,2,Non-small cell lung cancer,7,F,EXP,ipilimumab,2,SS,Inflammation,2,M,DE,96
161204817,2,Non-small cell lung cancer,7,F,EXP,ipilimumab,2,SS,Septic shock,2,M,HO,96
161204817,2,Non-small cell lung cancer,7,F,EXP,ipilimumab,2,SS,Septic shock,2,M,OT,96
161204817,2,Non-small cell lung cancer,7,F,EXP,ipilimumab,2,SS,Septic shock,2,M,DE,96
161204817,3,Non-small cell lung cancer,7,F,EXP,pemetrexed disodium,3,SS,Acute kidney injury,3,M,HO,96
161204817,3,Non-small cell lung cancer,7,F,EXP,pemetrexed disodium,3,SS,Acute kidney injury,3,M,OT,96
161204817,3,Non-small cell lung cancer,7,F,EXP,pemetrexed disodium,3,SS,Acute kidney injury,3,M,DE,96
161204817,3,Non-small cell lung cancer,7,F,EXP,pemetrexed disodium,3,SS,Confusional state,3,M,HO,96
161204817,3,Non-small cell lung cancer,7,F,EXP,pemetrexed disodium,3,SS,Confusional state,3,M,OT,96
161204817,3,Non-small cell lung cancer,7,F,EXP,pemetrexed disodium,3,SS,Confusional state,3,M,DE,96
161204817,3,Non-small cell lung cancer,7,F,EXP,pemetrexed disodium,3,SS,Inflammation,3,M,HO,96
161204817,3,Non-small cell lung cancer,7,F,EXP,pemetrexed disodium,3,SS,Inflammation,3,M,OT,96
161204817,3,Non-small cell lung cancer,7,F,EXP,pemetrexed disodium,3,SS,Inflammation,3,M,DE,96
161204817,3,Non-small cell lung cancer,7,F,EXP,pemetrexed disodium,3,SS,Septic shock,3,M,HO,96
161204817,3,Non-small cell lung cancer,7,F,EXP,pemetrexed disodium,3,SS,Septic shock,3,M,OT,96
161204817,3,Non-small cell lung cancer,7,F,EXP,pemetrexed disodium,3,SS,Septic shock,3,M,DE,96
161205962,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,168
161205962,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,168
161205962,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,168
161205962,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,168
161205962,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,168
161205962,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,168
161209528,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Cognitive disorder,1,M,HO,111
161209528,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Cognitive disorder,1,M,OT,111
161209528,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypophysitis,1,M,HO,111
161209528,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypophysitis,1,M,OT,111
161209528,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Loss of personal independence in daily activities,1,M,HO,111
161209528,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Loss of personal independence in daily activities,1,M,OT,111
161209528,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,111
161209528,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,111
161209528,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Seizure,1,M,HO,111
161209528,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Seizure,1,M,OT,111
161209528,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Toxicity to various agents,1,M,HO,111
161209528,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Toxicity to various agents,1,M,OT,111
161209528,5,Malignant melanoma,8,F,EXP,ipilimumab,5,SS,Cognitive disorder,5,M,HO,111
161209528,5,Malignant melanoma,8,F,EXP,ipilimumab,5,SS,Cognitive disorder,5,M,OT,111
161209528,5,Malignant melanoma,8,F,EXP,ipilimumab,5,SS,Hypophysitis,5,M,HO,111
161209528,5,Malignant melanoma,8,F,EXP,ipilimumab,5,SS,Hypophysitis,5,M,OT,111
161209528,5,Malignant melanoma,8,F,EXP,ipilimumab,5,SS,Loss of personal independence in daily activities,5,M,HO,111
161209528,5,Malignant melanoma,8,F,EXP,ipilimumab,5,SS,Loss of personal independence in daily activities,5,M,OT,111
161209528,5,Malignant melanoma,8,F,EXP,ipilimumab,5,SS,Nausea,5,M,HO,111
161209528,5,Malignant melanoma,8,F,EXP,ipilimumab,5,SS,Nausea,5,M,OT,111
161209528,5,Malignant melanoma,8,F,EXP,ipilimumab,5,SS,Seizure,5,M,HO,111
161209528,5,Malignant melanoma,8,F,EXP,ipilimumab,5,SS,Seizure,5,M,OT,111
161209528,5,Malignant melanoma,8,F,EXP,ipilimumab,5,SS,Toxicity to various agents,5,M,HO,111
161209528,5,Malignant melanoma,8,F,EXP,ipilimumab,5,SS,Toxicity to various agents,5,M,OT,111
161211022,2,Plasma cell myeloma,2,F,EXP,carfilzomib,2,SS,Rectal haemorrhage,2,M,OT,9
161211022,2,Plasma cell myeloma,2,F,EXP,carfilzomib,2,SS,Rectal haemorrhage,2,M,HO,9
161248263,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Anaemia,3,M,OT,8
161248263,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Blood creatinine increased,3,M,OT,8
161248263,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Hypoalbuminaemia,3,M,OT,8
161248263,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Hypocalcaemia,3,M,OT,8
161248263,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Lymphocyte count decreased,3,M,OT,8
161248263,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Neutropenia,3,M,OT,8
161248263,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Pneumonia,3,M,OT,8
161248263,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Thrombocytopenia,3,M,OT,8
161248263,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,White blood cell count decreased,3,M,OT,8
161249655,1,Non-small cell lung cancer recurrent,5,F,EXP,nivolumab,1,PS,Diabetic nephropathy,1,M,OT,1980
161251874,8,Acute lymphocytic leukaemia,4,F,EXP,pegaspargase,8,C,Hemiparesis,8,M,HO,95
1612642013,2,Hormone-refractory prostate cancer,13,F,EXP,enzalutamide,2,SS,Fatigue,2,M,HO,331
1612642013,2,Hormone-refractory prostate cancer,13,F,EXP,enzalutamide,2,SS,Nephritis,2,M,HO,331
161351246,1,B-cell lymphoma,6,F,EXP,idelalisib,1,PS,Abdominal pain,1,M,HO,59
161351246,1,B-cell lymphoma,6,F,EXP,idelalisib,1,PS,Abdominal pain,1,M,OT,59
161351246,1,B-cell lymphoma,6,F,EXP,idelalisib,1,PS,Colitis,1,M,HO,59
161351246,1,B-cell lymphoma,6,F,EXP,idelalisib,1,PS,Colitis,1,M,OT,59
161351246,1,B-cell lymphoma,6,F,EXP,idelalisib,1,PS,Intestinal obstruction,1,M,HO,59
161351246,1,B-cell lymphoma,6,F,EXP,idelalisib,1,PS,Intestinal obstruction,1,M,OT,59
161351246,1,B-cell lymphoma,6,F,EXP,idelalisib,1,PS,Nausea,1,M,HO,59
161351246,1,B-cell lymphoma,6,F,EXP,idelalisib,1,PS,Nausea,1,M,OT,59
161351246,1,B-cell lymphoma,6,F,EXP,idelalisib,1,PS,Septic shock,1,M,HO,59
161351246,1,B-cell lymphoma,6,F,EXP,idelalisib,1,PS,Septic shock,1,M,OT,59
161499712,5,Plasma cell myeloma,2,F,EXP,pomalidomide,5,SS,Acute myeloid leukaemia,5,F,OT,413
161499712,13,Product used for unknown indication,2,F,EXP,daratumumab,13,C,Acute myeloid leukaemia,13,F,OT,120
161502375,2,Head and neck cancer metastatic,5,F,EXP,nivolumab,2,C,Dyspnoea,2,M,HO,133
161502375,2,Head and neck cancer metastatic,5,F,EXP,nivolumab,2,C,Dyspnoea,2,M,DE,133
161502375,2,Head and neck cancer metastatic,5,F,EXP,nivolumab,2,C,Fatigue,2,M,HO,133
161502375,2,Head and neck cancer metastatic,5,F,EXP,nivolumab,2,C,Fatigue,2,M,DE,133
161502375,2,Head and neck cancer metastatic,5,F,EXP,nivolumab,2,C,Myocarditis,2,M,HO,133
161502375,2,Head and neck cancer metastatic,5,F,EXP,nivolumab,2,C,Myocarditis,2,M,DE,133
161514276,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Behaviour disorder,1,F,OT,26
161514276,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Behaviour disorder,1,F,DE,26
161514276,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Behaviour disorder,1,F,HO,26
161514276,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Confusional state,1,F,OT,26
161514276,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Confusional state,1,F,DE,26
161514276,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Confusional state,1,F,HO,26
161514276,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,26
161514276,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,26
161514276,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,26
161514276,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Meningitis,1,F,OT,26
161514276,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Meningitis,1,F,DE,26
161514276,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Meningitis,1,F,HO,26
161514276,2,Metastatic malignant melanoma,6,F,EXP,ipilimumab,2,SS,Behaviour disorder,2,F,OT,26
161514276,2,Metastatic malignant melanoma,6,F,EXP,ipilimumab,2,SS,Behaviour disorder,2,F,DE,26
161514276,2,Metastatic malignant melanoma,6,F,EXP,ipilimumab,2,SS,Behaviour disorder,2,F,HO,26
161514276,2,Metastatic malignant melanoma,6,F,EXP,ipilimumab,2,SS,Confusional state,2,F,OT,26
161514276,2,Metastatic malignant melanoma,6,F,EXP,ipilimumab,2,SS,Confusional state,2,F,DE,26
161514276,2,Metastatic malignant melanoma,6,F,EXP,ipilimumab,2,SS,Confusional state,2,F,HO,26
161514276,2,Metastatic malignant melanoma,6,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,OT,26
161514276,2,Metastatic malignant melanoma,6,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,DE,26
161514276,2,Metastatic malignant melanoma,6,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,HO,26
161514276,2,Metastatic malignant melanoma,6,F,EXP,ipilimumab,2,SS,Meningitis,2,F,OT,26
161514276,2,Metastatic malignant melanoma,6,F,EXP,ipilimumab,2,SS,Meningitis,2,F,DE,26
161514276,2,Metastatic malignant melanoma,6,F,EXP,ipilimumab,2,SS,Meningitis,2,F,HO,26
161528167,15,Product used for unknown indication,7,F,EXP,filgrastim,15,C,Bone marrow failure,15,M,OT,14
161528167,15,Product used for unknown indication,7,F,EXP,filgrastim,15,C,Bone marrow failure,15,M,LT,14
161528167,15,Product used for unknown indication,7,F,EXP,filgrastim,15,C,Bone marrow failure,15,M,DE,14
161528167,15,Product used for unknown indication,7,F,EXP,filgrastim,15,C,Multiple organ dysfunction syndrome,15,M,OT,14
161528167,15,Product used for unknown indication,7,F,EXP,filgrastim,15,C,Multiple organ dysfunction syndrome,15,M,LT,14
161528167,15,Product used for unknown indication,7,F,EXP,filgrastim,15,C,Multiple organ dysfunction syndrome,15,M,DE,14
161604154,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,22
161604154,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Asthenia,1,M,DE,22
161604154,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,22
161604154,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Asthenia,1,M,LT,22
161604154,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Death,1,M,HO,22
161604154,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Death,1,M,DE,22
161604154,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Death,1,M,OT,22
161604154,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Death,1,M,LT,22
161604154,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,22
161604154,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,22
161604154,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,22
161604154,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,LT,22
161604154,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Asthenia,2,M,HO,22
161604154,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Asthenia,2,M,DE,22
161604154,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Asthenia,2,M,OT,22
161604154,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Asthenia,2,M,LT,22
161604154,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Death,2,M,HO,22
161604154,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Death,2,M,DE,22
161604154,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Death,2,M,OT,22
161604154,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Death,2,M,LT,22
161604154,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,HO,22
161604154,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,DE,22
161604154,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,OT,22
161604154,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,LT,22
161624062,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Neutropenia,2,F,HO,12
161624062,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Neutropenia,2,F,OT,12
161624062,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Neutropenia,2,F,DE,12
161624062,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Neutropenic sepsis,2,F,HO,12
161624062,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Neutropenic sepsis,2,F,OT,12
161624062,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Neutropenic sepsis,2,F,DE,12
161624062,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Plasma cell myeloma,2,F,HO,12
161624062,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Plasma cell myeloma,2,F,OT,12
161624062,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Plasma cell myeloma,2,F,DE,12
161624062,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Thrombocytopenia,2,F,HO,12
161624062,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Thrombocytopenia,2,F,OT,12
161624062,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Thrombocytopenia,2,F,DE,12
161635516,3,Plasma cell myeloma,6,F,EXP,lenalidomide,3,SS,Anaemia,3,M,OT,8
161635516,3,Plasma cell myeloma,6,F,EXP,lenalidomide,3,SS,Blood creatinine increased,3,M,OT,8
161635516,3,Plasma cell myeloma,6,F,EXP,lenalidomide,3,SS,Hypoalbuminaemia,3,M,OT,8
161635516,3,Plasma cell myeloma,6,F,EXP,lenalidomide,3,SS,Hypocalcaemia,3,M,OT,8
161635516,3,Plasma cell myeloma,6,F,EXP,lenalidomide,3,SS,Lymphocyte count decreased,3,M,OT,8
161635516,3,Plasma cell myeloma,6,F,EXP,lenalidomide,3,SS,Neutropenia,3,M,OT,8
161635516,3,Plasma cell myeloma,6,F,EXP,lenalidomide,3,SS,Pneumonia,3,M,OT,8
161635516,3,Plasma cell myeloma,6,F,EXP,lenalidomide,3,SS,Thrombocytopenia,3,M,OT,8
161635516,3,Plasma cell myeloma,6,F,EXP,lenalidomide,3,SS,White blood cell count decreased,3,M,OT,8
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,HO,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,OT,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Failure to thrive,1,M,HO,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Failure to thrive,1,M,OT,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,HO,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Rectal haemorrhage,1,M,HO,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Rectal haemorrhage,1,M,OT,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,HO,19
161644023,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,OT,19
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Cytopenia,1,M,HO,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Cytopenia,1,M,DE,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Cytopenia,1,M,OT,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Depressed level of consciousness,1,M,HO,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Depressed level of consciousness,1,M,DE,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Depressed level of consciousness,1,M,OT,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Pneumocystis jirovecii pneumonia,1,M,HO,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Pneumocystis jirovecii pneumonia,1,M,DE,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Pneumocystis jirovecii pneumonia,1,M,OT,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Renal disorder,1,M,HO,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Renal disorder,1,M,DE,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Renal disorder,1,M,OT,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Toxic encephalopathy,1,M,HO,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Toxic encephalopathy,1,M,DE,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Toxic encephalopathy,1,M,OT,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Tremor,1,M,HO,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Tremor,1,M,DE,15
161668019,1,Hodgkin's disease,9,F,EXP,nivolumab,1,PS,Tremor,1,M,OT,15
1616927611,1,Renal cell carcinoma,11,F,EXP,nivolumab,1,PS,Arthritis,1,F,HO,162
1616927611,2,Product used for unknown indication,11,F,EXP,nivolumab,2,SS,Arthritis,2,F,HO,8
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Acute hepatic failure,3,M,HO,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Acute hepatic failure,3,M,OT,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Acute hepatic failure,3,M,DE,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Blood creatine phosphokinase increased,3,M,HO,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Blood creatine phosphokinase increased,3,M,OT,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Blood creatine phosphokinase increased,3,M,DE,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Cough,3,M,HO,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Cough,3,M,OT,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Cough,3,M,DE,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Infection,3,M,HO,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Infection,3,M,OT,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Infection,3,M,DE,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Neutropenia,3,M,HO,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Neutropenia,3,M,OT,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Neutropenia,3,M,DE,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Pyrexia,3,M,HO,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Pyrexia,3,M,OT,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Pyrexia,3,M,DE,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Septic shock,3,M,HO,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Septic shock,3,M,OT,60
161702169,3,Metastatic malignant melanoma,9,F,EXP,trametinib,3,SS,Septic shock,3,M,DE,60
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Adverse event,1,F,OT,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Adverse event,1,F,HO,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,OT,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,HO,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Depressed mood,1,F,OT,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Depressed mood,1,F,HO,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Fatigue,1,F,HO,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,OT,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,HO,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Peripheral swelling,1,F,OT,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Peripheral swelling,1,F,HO,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,F,OT,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,F,HO,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Weight decreased,1,F,OT,14
161717993,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Weight decreased,1,F,HO,14
161741004,1,Relapsing multiple sclerosis,4,F,EXP,ofatumumab,1,PS,Urinary tract infection,1,M,HO,520
161767715,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,C,Interstitial lung disease,3,M,HO,23
161767715,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,C,Interstitial lung disease,3,M,OT,23
161767715,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,C,Interstitial lung disease,3,M,DE,23
161767715,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,C,Malignant neoplasm progression,3,M,HO,23
161767715,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,C,Malignant neoplasm progression,3,M,OT,23
161767715,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,C,Malignant neoplasm progression,3,M,DE,23
161768048,1,Non-small cell lung cancer metastatic,8,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,1455
161768048,1,Non-small cell lung cancer metastatic,8,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,1455
161768048,1,Non-small cell lung cancer metastatic,8,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,1455
161768048,1,Non-small cell lung cancer metastatic,8,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,1455
161769213,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Death,1,M,OT,105
161769213,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Death,1,M,DE,105
161769213,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Death,2,M,OT,105
161769213,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Death,2,M,DE,105
161773642,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,OT,16
161773642,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,LT,16
161773642,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,HO,16
161773642,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,DE,16
161773642,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Lymphadenopathy mediastinal,1,M,OT,16
161773642,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Lymphadenopathy mediastinal,1,M,LT,16
161773642,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Lymphadenopathy mediastinal,1,M,HO,16
161773642,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Lymphadenopathy mediastinal,1,M,DE,16
161773642,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,16
161773642,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,LT,16
161773642,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,16
161773642,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,16
161773642,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Atrial fibrillation,2,M,OT,16
161773642,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Atrial fibrillation,2,M,LT,16
161773642,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Atrial fibrillation,2,M,HO,16
161773642,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Atrial fibrillation,2,M,DE,16
161773642,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Lymphadenopathy mediastinal,2,M,OT,16
161773642,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Lymphadenopathy mediastinal,2,M,LT,16
161773642,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Lymphadenopathy mediastinal,2,M,HO,16
161773642,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Lymphadenopathy mediastinal,2,M,DE,16
161773642,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Pneumonia,2,M,OT,16
161773642,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Pneumonia,2,M,LT,16
161773642,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Pneumonia,2,M,HO,16
161773642,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Pneumonia,2,M,DE,16
1618208610,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Blood potassium increased,1,M,OT,26
1618208610,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,26
1618208610,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Extravasation,1,M,OT,26
1618208610,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Face oedema,1,M,OT,26
1618208610,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Facial paralysis,1,M,OT,26
1618208610,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,26
1618208610,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Incorrect drug administration rate,1,M,OT,26
1618208610,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Lethargy,1,M,OT,26
1618208610,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Musculoskeletal discomfort,1,M,OT,26
1618208610,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Rash,1,M,OT,26
1618208610,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Tumour pain,1,M,OT,26
1618208610,1,Malignant melanoma,10,F,EXP,nivolumab,1,PS,Viral infection,1,M,OT,26
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Cellulitis,2,M,OT,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Cellulitis,2,M,HO,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Cerebral disorder,2,M,OT,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Cerebral disorder,2,M,HO,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Fatigue,2,M,OT,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Fatigue,2,M,HO,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Gout,2,M,OT,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Gout,2,M,HO,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Headache,2,M,OT,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Headache,2,M,HO,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Hypertension,2,M,OT,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Hypertension,2,M,HO,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Insomnia,2,M,OT,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Insomnia,2,M,HO,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Oral candidiasis,2,M,OT,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Oral candidiasis,2,M,HO,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Pain,2,M,OT,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Pain,2,M,HO,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Syncope,2,M,OT,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Syncope,2,M,HO,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Vision blurred,2,M,OT,357
161843335,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Vision blurred,2,M,HO,357
161870093,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,124
161965745,3,Malignant melanoma,5,F,EXP,trametinib,3,SS,Ejection fraction decreased,3,F,OT,38
161965745,3,Malignant melanoma,5,F,EXP,trametinib,3,SS,Ejection fraction decreased,3,F,HO,38
161965745,3,Malignant melanoma,5,F,EXP,trametinib,3,SS,Orthostatic intolerance,3,F,OT,38
161965745,3,Malignant melanoma,5,F,EXP,trametinib,3,SS,Orthostatic intolerance,3,F,HO,38
161985248,11,Metastases to bone,8,F,EXP,denosumab,11,C,Cellulitis,11,F,HO,190
161985248,11,Metastases to bone,8,F,EXP,denosumab,11,C,Constipation,11,F,HO,190
161985248,11,Metastases to bone,8,F,EXP,denosumab,11,C,Haemoptysis,11,F,HO,190
161985248,11,Metastases to bone,8,F,EXP,denosumab,11,C,Pyrexia,11,F,HO,190
161993822,5,Plasma cell myeloma,2,F,EXP,pomalidomide,5,SS,Anaemia,5,F,DE,11
161993822,5,Plasma cell myeloma,2,F,EXP,pomalidomide,5,SS,Anaemia,5,F,OT,11
161993822,5,Plasma cell myeloma,2,F,EXP,pomalidomide,5,SS,Sepsis,5,F,DE,11
161993822,5,Plasma cell myeloma,2,F,EXP,pomalidomide,5,SS,Sepsis,5,F,OT,11
162061226,3,Plasma cell myeloma,6,F,EXP,thalidomide,3,C,Neutropenic sepsis,3,F,HO,155
162061226,3,Plasma cell myeloma,6,F,EXP,thalidomide,3,C,Neutropenic sepsis,3,F,LT,155
162061226,3,Plasma cell myeloma,6,F,EXP,thalidomide,3,C,Neutropenic sepsis,3,F,OT,155
162096183,4,Plasma cell myeloma,3,F,EXP,thalidomide,4,C,Bronchitis,4,F,HO,251
162118144,9,Non-small cell lung cancer,4,F,EXP,nivolumab,9,SS,Pneumonia,9,M,OT,642
162139996,10,Acute lymphocytic leukaemia,6,F,EXP,thioguanine,10,SS,Alanine aminotransferase increased,10,M,HO,14
162139996,10,Acute lymphocytic leukaemia,6,F,EXP,thioguanine,10,SS,Platelet count decreased,10,M,HO,14
162139996,10,Acute lymphocytic leukaemia,6,F,EXP,thioguanine,10,SS,Serum ferritin increased,10,M,HO,14
162139996,10,Acute lymphocytic leukaemia,6,F,EXP,thioguanine,10,SS,Venoocclusive liver disease,10,M,HO,14
162166742,3,Metastatic malignant melanoma,2,F,EXP,trametinib,3,SS,Fatigue,3,F,OT,55
162166742,3,Metastatic malignant melanoma,2,F,EXP,trametinib,3,SS,Hypomagnesaemia,3,F,OT,55
162166742,3,Metastatic malignant melanoma,2,F,EXP,trametinib,3,SS,Nausea,3,F,OT,55
162166742,3,Metastatic malignant melanoma,2,F,EXP,trametinib,3,SS,Vomiting,3,F,OT,55
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Anxiety,1,M,OT,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Anxiety,1,M,HO,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Anxiety,1,M,DE,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Depression,1,M,OT,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Depression,1,M,HO,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Depression,1,M,DE,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Facial paresis,1,M,OT,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Facial paresis,1,M,HO,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Facial paresis,1,M,DE,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Fatigue,1,M,DE,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Hemiparesis,1,M,OT,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Hemiparesis,1,M,HO,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Hemiparesis,1,M,DE,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Hepatobiliary disease,1,M,OT,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Hepatobiliary disease,1,M,HO,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Hepatobiliary disease,1,M,DE,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,OT,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,HO,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,DE,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Lymphocyte count decreased,1,M,OT,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Lymphocyte count decreased,1,M,HO,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Lymphocyte count decreased,1,M,DE,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Oedema,1,M,OT,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Oedema,1,M,HO,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Oedema,1,M,DE,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Off label use,1,M,HO,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Off label use,1,M,DE,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Weight decreased,1,M,HO,45
1622098113,1,Malignant melanoma,13,F,EXP,nivolumab,1,PS,Weight decreased,1,M,DE,45
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Arthralgia,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Arthralgia,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Colitis ischaemic,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Colitis ischaemic,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Colitis ischaemic,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Dyshidrotic eczema,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Dyshidrotic eczema,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Dyshidrotic eczema,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Eczema,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Eczema,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Eczema,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Gastrointestinal haemorrhage,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Gastrointestinal haemorrhage,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Gastrointestinal haemorrhage,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Limb injury,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Limb injury,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Limb injury,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pain in extremity,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pain in extremity,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pain in extremity,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pneumonia klebsiella,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pneumonia klebsiella,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pneumonia klebsiella,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Psoriatic arthropathy,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Psoriatic arthropathy,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Psoriatic arthropathy,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pulmonary infarction,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pulmonary infarction,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Pulmonary infarction,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Road traffic accident,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Road traffic accident,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Road traffic accident,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Septic shock,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Septic shock,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Septic shock,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Thrombophlebitis septic,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Thrombophlebitis septic,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Thrombophlebitis septic,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Traumatic haematoma,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Traumatic haematoma,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Traumatic haematoma,1,M,DE,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Weight decreased,1,M,HO,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,64
162212945,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Weight decreased,1,M,DE,64
162215777,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Encephalopathy,1,F,HO,111
162215777,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Encephalopathy,1,F,OT,111
162215777,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Fracture,1,F,HO,111
162215777,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Fracture,1,F,OT,111
162215777,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Musculoskeletal pain,1,F,HO,111
162215777,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Musculoskeletal pain,1,F,OT,111
162215777,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,HO,111
162215777,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,OT,111
162215777,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Paraneoplastic syndrome,1,F,HO,111
162215777,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Paraneoplastic syndrome,1,F,OT,111
1622189412,1,Relapsing multiple sclerosis,12,F,EXP,alemtuzumab,1,PS,Dyspnoea,1,F,HO,7
1622189412,1,Relapsing multiple sclerosis,12,F,EXP,alemtuzumab,1,PS,Hydronephrosis,1,F,HO,7
1622189412,1,Relapsing multiple sclerosis,12,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,F,HO,7
1622189412,1,Relapsing multiple sclerosis,12,F,EXP,alemtuzumab,1,PS,Rotator cuff syndrome,1,F,HO,7
1622189412,1,Relapsing multiple sclerosis,12,F,EXP,alemtuzumab,1,PS,Tachycardia,1,F,HO,7
162221435,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Acute respiratory failure,1,F,HO,357
162221435,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Acute respiratory failure,1,F,OT,357
162221435,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pulmonary fibrosis,1,F,HO,357
162221435,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pulmonary fibrosis,1,F,OT,357
162221435,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Toxicity to various agents,1,F,HO,357
162221435,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Toxicity to various agents,1,F,OT,357
162256405,2,Malignant melanoma,5,F,EXP,ipilimumab,2,PS,Anaphylactic reaction,2,M,OT,70
162256405,2,Malignant melanoma,5,F,EXP,ipilimumab,2,PS,Anaphylactic reaction,2,M,HO,70
162308656,1,Transitional cell cancer of renal pelvis and ureter metastatic,6,F,EXP,nivolumab,1,PS,Enterovesical fistula,1,M,DE,49
162308656,1,Transitional cell cancer of renal pelvis and ureter metastatic,6,F,EXP,nivolumab,1,PS,Enterovesical fistula,1,M,HO,49
162308656,1,Transitional cell cancer of renal pelvis and ureter metastatic,6,F,EXP,nivolumab,1,PS,Enterovesical fistula,1,M,OT,49
162308656,2,Transitional cell cancer of renal pelvis and ureter metastatic,6,F,EXP,ipilimumab,2,SS,Enterovesical fistula,2,M,DE,49
162308656,2,Transitional cell cancer of renal pelvis and ureter metastatic,6,F,EXP,ipilimumab,2,SS,Enterovesical fistula,2,M,HO,49
162308656,2,Transitional cell cancer of renal pelvis and ureter metastatic,6,F,EXP,ipilimumab,2,SS,Enterovesical fistula,2,M,OT,49
162313758,1,Metastatic renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Adrenal insufficiency,1,M,OT,61
162313758,1,Metastatic renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Altered state of consciousness,1,M,OT,61
162313758,1,Metastatic renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Cortisol decreased,1,M,OT,61
162313758,1,Metastatic renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Gastric cancer,1,M,OT,61
162313758,1,Metastatic renal cell carcinoma,8,F,EXP,ipilimumab,1,PS,Prescribed overdose,1,M,OT,61
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,HO,38
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,DS,38
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,OT,38
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,LT,38
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,DE,38
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,HO,38
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,DS,38
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,OT,38
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,LT,38
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,DE,38
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Petit mal epilepsy,1,M,HO,38
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Petit mal epilepsy,1,M,DS,38
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Petit mal epilepsy,1,M,OT,38
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Petit mal epilepsy,1,M,LT,38
162330327,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Petit mal epilepsy,1,M,DE,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Cardiac failure congestive,2,M,HO,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Cardiac failure congestive,2,M,DS,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Cardiac failure congestive,2,M,OT,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Cardiac failure congestive,2,M,LT,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Cardiac failure congestive,2,M,DE,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,M,HO,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,M,DS,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,M,OT,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,M,LT,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,M,DE,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Petit mal epilepsy,2,M,HO,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Petit mal epilepsy,2,M,DS,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Petit mal epilepsy,2,M,OT,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Petit mal epilepsy,2,M,LT,38
162330327,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Petit mal epilepsy,2,M,DE,38
162331872,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,C,Adrenal insufficiency,4,F,OT,53
162331872,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,C,Hypertension,4,F,OT,53
162335579,1,Acute myeloid leukaemia,9,F,EXP,midostaurin,1,PS,Pneumonia,1,F,OT,48
162335579,1,Acute myeloid leukaemia,9,F,EXP,midostaurin,1,PS,Pneumonia,1,F,HO,48
162355576,1,Malignant melanoma,6,F,EXP,ipilimumab,1,PS,Colitis,1,M,HO,27
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,HO,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,OT,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,DE,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Cardiac failure,1,M,HO,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Cardiac failure,1,M,OT,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Cardiac failure,1,M,DE,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Diverticulum intestinal,1,M,HO,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Diverticulum intestinal,1,M,OT,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Diverticulum intestinal,1,M,DE,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,HO,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,OT,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,DE,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Inflammation,1,M,HO,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Inflammation,1,M,OT,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Inflammation,1,M,DE,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,HO,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,OT,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,DE,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Petit mal epilepsy,1,M,HO,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Petit mal epilepsy,1,M,OT,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Petit mal epilepsy,1,M,DE,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Prostatic calcification,1,M,HO,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Prostatic calcification,1,M,OT,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Prostatic calcification,1,M,DE,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Prostatomegaly,1,M,HO,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Prostatomegaly,1,M,OT,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Prostatomegaly,1,M,DE,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Renal failure,1,M,DE,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Spinal ligament ossification,1,M,HO,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Spinal ligament ossification,1,M,OT,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Spinal ligament ossification,1,M,DE,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Spinal stenosis,1,M,HO,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Spinal stenosis,1,M,OT,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Spinal stenosis,1,M,DE,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Tonsillolith,1,M,HO,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Tonsillolith,1,M,OT,38
162360936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Tonsillolith,1,M,DE,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Acute myocardial infarction,2,M,HO,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Acute myocardial infarction,2,M,OT,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Acute myocardial infarction,2,M,DE,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Cardiac failure,2,M,HO,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Cardiac failure,2,M,OT,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Cardiac failure,2,M,DE,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Diverticulum intestinal,2,M,HO,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Diverticulum intestinal,2,M,OT,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Diverticulum intestinal,2,M,DE,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,M,HO,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,M,OT,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Hepatic enzyme increased,2,M,DE,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Inflammation,2,M,HO,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Inflammation,2,M,OT,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Inflammation,2,M,DE,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Oedema peripheral,2,M,HO,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Oedema peripheral,2,M,OT,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Oedema peripheral,2,M,DE,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Petit mal epilepsy,2,M,HO,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Petit mal epilepsy,2,M,OT,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Petit mal epilepsy,2,M,DE,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Prostatic calcification,2,M,HO,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Prostatic calcification,2,M,OT,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Prostatic calcification,2,M,DE,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Prostatomegaly,2,M,HO,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Prostatomegaly,2,M,OT,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Prostatomegaly,2,M,DE,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Renal failure,2,M,HO,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Renal failure,2,M,OT,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Renal failure,2,M,DE,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Spinal ligament ossification,2,M,HO,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Spinal ligament ossification,2,M,OT,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Spinal ligament ossification,2,M,DE,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Spinal stenosis,2,M,HO,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Spinal stenosis,2,M,OT,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Spinal stenosis,2,M,DE,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Tonsillolith,2,M,HO,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Tonsillolith,2,M,OT,38
162360936,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Tonsillolith,2,M,DE,38
162375874,1,Metastatic malignant melanoma,4,F,EXP,trametinib,1,PS,Cystitis,1,F,OT,49
162375874,1,Metastatic malignant melanoma,4,F,EXP,trametinib,1,PS,Erythema nodosum,1,F,OT,49
162375874,1,Metastatic malignant melanoma,4,F,EXP,trametinib,1,PS,Hyperthyroidism,1,F,OT,49
162375874,1,Metastatic malignant melanoma,4,F,EXP,trametinib,1,PS,Hypothyroidism,1,F,OT,49
162375874,1,Metastatic malignant melanoma,4,F,EXP,trametinib,1,PS,Peripheral swelling,1,F,OT,49
162375874,1,Metastatic malignant melanoma,4,F,EXP,trametinib,1,PS,Thrombosis,1,F,OT,49
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Adrenomegaly,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Adrenomegaly,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Adrenomegaly,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Adrenomegaly,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Adrenomegaly,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Blood pressure increased,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Blood pressure increased,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Blood pressure increased,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Blood pressure increased,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Blood pressure increased,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Chest pain,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Chest pain,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Chest pain,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Chest pain,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Chest pain,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Colitis,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Colitis,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Colitis,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Colitis,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Colitis,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Device related infection,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Device related infection,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Device related infection,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Device related infection,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Device related infection,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Heparin-induced thrombocytopenia,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Heparin-induced thrombocytopenia,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Heparin-induced thrombocytopenia,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Heparin-induced thrombocytopenia,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Heparin-induced thrombocytopenia,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Hyperglycaemia,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Hyperglycaemia,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Hyperglycaemia,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Hyperglycaemia,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Hyperglycaemia,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Hypertensive crisis,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Hypertensive crisis,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Hypertensive crisis,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Hypertensive crisis,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Hypertensive crisis,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Klebsiella infection,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Klebsiella infection,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Klebsiella infection,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Klebsiella infection,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Klebsiella infection,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Meningitis,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Meningitis,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Meningitis,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Meningitis,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Meningitis,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Metastases to meninges,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Metastases to meninges,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Metastases to meninges,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Metastases to meninges,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Metastases to meninges,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Pulmonary oedema,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Pulmonary oedema,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Pulmonary oedema,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Pulmonary oedema,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Pulmonary oedema,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Retinal detachment,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Retinal detachment,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Retinal detachment,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Retinal detachment,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Retinal detachment,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Retinopathy,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Retinopathy,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Retinopathy,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Retinopathy,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Retinopathy,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Tachycardia,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Tachycardia,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Tachycardia,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Tachycardia,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Tachycardia,2,M,LT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Urosepsis,2,M,OT,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Urosepsis,2,M,HO,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Urosepsis,2,M,DS,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Urosepsis,2,M,DE,6
162405146,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Urosepsis,2,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Acute kidney injury,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Acute kidney injury,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Acute kidney injury,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Acute kidney injury,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Acute kidney injury,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Adrenomegaly,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Adrenomegaly,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Adrenomegaly,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Adrenomegaly,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Adrenomegaly,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Blood pressure increased,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Blood pressure increased,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Blood pressure increased,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Blood pressure increased,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Blood pressure increased,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Chest pain,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Chest pain,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Chest pain,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Chest pain,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Chest pain,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Colitis,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Colitis,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Colitis,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Colitis,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Colitis,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Device related infection,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Device related infection,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Device related infection,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Device related infection,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Device related infection,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Dyspnoea,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Dyspnoea,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Dyspnoea,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Dyspnoea,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Dyspnoea,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Heparin-induced thrombocytopenia,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Heparin-induced thrombocytopenia,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Heparin-induced thrombocytopenia,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Heparin-induced thrombocytopenia,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Heparin-induced thrombocytopenia,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Hyperglycaemia,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Hyperglycaemia,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Hyperglycaemia,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Hyperglycaemia,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Hyperglycaemia,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Hypertensive crisis,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Hypertensive crisis,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Hypertensive crisis,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Hypertensive crisis,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Hypertensive crisis,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Klebsiella infection,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Klebsiella infection,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Klebsiella infection,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Klebsiella infection,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Klebsiella infection,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Meningitis,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Meningitis,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Meningitis,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Meningitis,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Meningitis,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Metastases to meninges,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Metastases to meninges,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Metastases to meninges,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Metastases to meninges,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Metastases to meninges,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Pulmonary oedema,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Pulmonary oedema,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Pulmonary oedema,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Pulmonary oedema,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Pulmonary oedema,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Retinal detachment,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Retinal detachment,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Retinal detachment,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Retinal detachment,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Retinal detachment,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Retinopathy,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Retinopathy,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Retinopathy,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Retinopathy,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Retinopathy,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Tachycardia,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Tachycardia,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Tachycardia,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Tachycardia,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Tachycardia,6,M,LT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Urosepsis,6,M,OT,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Urosepsis,6,M,HO,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Urosepsis,6,M,DS,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Urosepsis,6,M,DE,6
162405146,6,Malignant melanoma,6,F,EXP,ipilimumab,6,SS,Urosepsis,6,M,LT,6
162459742,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,288
162459742,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,288
162459742,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,F,HO,288
162459742,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Vomiting,2,F,HO,288
162462083,1,Oesophageal squamous cell carcinoma,3,F,EXP,nivolumab,1,PS,Cholangitis,1,M,OT,52
162462083,1,Oesophageal squamous cell carcinoma,3,F,EXP,nivolumab,1,PS,Cholangitis,1,M,HO,52
162462083,2,Oesophageal squamous cell carcinoma,3,F,EXP,ipilimumab,2,SS,Cholangitis,2,M,OT,52
162462083,2,Oesophageal squamous cell carcinoma,3,F,EXP,ipilimumab,2,SS,Cholangitis,2,M,HO,52
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Arthralgia,1,M,HO,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Chills,1,M,HO,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Chills,1,M,OT,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Constipation,1,M,HO,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Constipation,1,M,OT,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Muscle spasms,1,M,HO,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Muscle spasms,1,M,OT,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Pain,1,M,HO,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Pain,1,M,OT,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Sjogren's syndrome,1,M,HO,5
162492846,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Sjogren's syndrome,1,M,OT,5
162494662,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Intentional product use issue,2,M,HO,30
162494662,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Intentional product use issue,2,M,OT,30
162494662,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Prerenal failure,2,M,HO,30
162494662,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Prerenal failure,2,M,OT,30
162494662,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Product use in unapproved indication,2,M,HO,30
162494662,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Product use in unapproved indication,2,M,OT,30
162546812,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Lower respiratory tract infection,2,M,HO,31
162546812,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Streptococcal infection,2,M,HO,31
162569826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Duodenitis,1,M,HO,49
162569826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Duodenitis,1,M,DE,49
162569826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Duodenitis,1,M,OT,49
162569826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Gastritis erosive,1,M,HO,49
162569826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Gastritis erosive,1,M,DE,49
162569826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Gastritis erosive,1,M,OT,49
162569826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,49
162569826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,49
162569826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,49
162569826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,49
162569826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,DE,49
162569826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,49
162573744,1,Hodgkin's disease,4,F,EXP,brentuximab vedotin,1,PS,Guillain-Barre syndrome,1,F,HO,265
162573744,1,Hodgkin's disease,4,F,EXP,brentuximab vedotin,1,PS,Guillain-Barre syndrome,1,F,OT,265
162575893,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Autoimmune hepatitis,3,M,HO,55
162575893,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Autoimmune hepatitis,3,M,OT,55
162586827,7,Plasma cell myeloma,7,F,EXP,pomalidomide,7,SS,Leukopenia,7,M,DE,14
162586827,7,Plasma cell myeloma,7,F,EXP,pomalidomide,7,SS,Leukopenia,7,M,OT,14
162586827,7,Plasma cell myeloma,7,F,EXP,pomalidomide,7,SS,Neutropenia,7,M,DE,14
162586827,7,Plasma cell myeloma,7,F,EXP,pomalidomide,7,SS,Neutropenia,7,M,OT,14
162586827,7,Plasma cell myeloma,7,F,EXP,pomalidomide,7,SS,Peripheral sensory neuropathy,7,M,DE,14
162586827,7,Plasma cell myeloma,7,F,EXP,pomalidomide,7,SS,Peripheral sensory neuropathy,7,M,OT,14
162586827,7,Plasma cell myeloma,7,F,EXP,pomalidomide,7,SS,Thrombocytopenia,7,M,DE,14
162586827,7,Plasma cell myeloma,7,F,EXP,pomalidomide,7,SS,Thrombocytopenia,7,M,OT,14
162652745,2,Breast cancer metastatic,5,F,EXP,palbociclib,2,PS,Embolism,2,F,HO,69
162652745,2,Breast cancer metastatic,5,F,EXP,palbociclib,2,PS,Hyperglycaemia,2,F,HO,69
162667282,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Intentional product use issue,2,M,OT,30
162667282,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Intentional product use issue,2,M,HO,30
162667282,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Prerenal failure,2,M,OT,30
162667282,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Prerenal failure,2,M,HO,30
162675802,2,Chemotherapy,2,F,EXP,lenalidomide,2,SS,Chest discomfort,2,M,HO,6
162675802,2,Chemotherapy,2,F,EXP,lenalidomide,2,SS,Dyspnoea,2,M,HO,6
162675802,2,Chemotherapy,2,F,EXP,lenalidomide,2,SS,Oral pain,2,M,HO,6
162675802,2,Chemotherapy,2,F,EXP,lenalidomide,2,SS,Pain,2,M,HO,6
162675802,2,Chemotherapy,2,F,EXP,lenalidomide,2,SS,Rash pruritic,2,M,HO,6
162675802,2,Chemotherapy,2,F,EXP,lenalidomide,2,SS,Stevens-Johnson syndrome,2,M,HO,6
162685218,1,Hodgkin's disease,8,F,EXP,nivolumab,1,PS,Graft versus host disease,1,F,OT,9
162685218,1,Hodgkin's disease,8,F,EXP,nivolumab,1,PS,Graft versus host disease,1,F,HO,9
162685218,1,Hodgkin's disease,8,F,EXP,nivolumab,1,PS,Graft versus host disease,1,F,DE,9
162685218,1,Hodgkin's disease,8,F,EXP,nivolumab,1,PS,Malaise,1,F,OT,9
162685218,1,Hodgkin's disease,8,F,EXP,nivolumab,1,PS,Malaise,1,F,HO,9
162685218,1,Hodgkin's disease,8,F,EXP,nivolumab,1,PS,Malaise,1,F,DE,9
162685218,1,Hodgkin's disease,8,F,EXP,nivolumab,1,PS,Obliterative bronchiolitis,1,F,OT,9
162685218,1,Hodgkin's disease,8,F,EXP,nivolumab,1,PS,Obliterative bronchiolitis,1,F,HO,9
162685218,1,Hodgkin's disease,8,F,EXP,nivolumab,1,PS,Obliterative bronchiolitis,1,F,DE,9
162685218,1,Hodgkin's disease,8,F,EXP,nivolumab,1,PS,Prescribed underdose,1,F,OT,9
162685218,1,Hodgkin's disease,8,F,EXP,nivolumab,1,PS,Prescribed underdose,1,F,HO,9
162685218,1,Hodgkin's disease,8,F,EXP,nivolumab,1,PS,Prescribed underdose,1,F,DE,9
162687682,1,Breast cancer,2,F,EXP,nivolumab,1,PS,Upper respiratory tract infection,1,F,HO,95
162687682,2,Breast cancer,2,F,EXP,ipilimumab,2,SS,Upper respiratory tract infection,2,F,HO,95
162718262,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Aortic stenosis,1,M,HO,471
162718262,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Aortic stenosis,1,M,OT,471
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,LT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,OT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,LT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,OT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Amylase increased,1,M,LT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Amylase increased,1,M,OT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Arthralgia,1,M,LT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,M,LT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,M,OT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Depressed level of consciousness,1,M,LT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Depressed level of consciousness,1,M,OT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,LT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Gastrointestinal disorder,1,M,LT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Gastrointestinal disorder,1,M,OT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Influenza like illness,1,M,LT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Influenza like illness,1,M,OT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Lipase increased,1,M,LT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Lipase increased,1,M,OT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pancreatitis,1,M,LT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pancreatitis,1,M,OT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rash,1,M,LT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rash,1,M,OT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,LT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,OT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Vitiligo,1,M,LT,15
162721533,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Vitiligo,1,M,OT,15
162831346,1,Plasma cell myeloma,6,F,PER,carfilzomib,1,PS,Staphylococcal bacteraemia,1,M,OT,17
162831346,1,Plasma cell myeloma,6,F,PER,carfilzomib,1,PS,Staphylococcal bacteraemia,1,M,HO,17
162831346,3,Plasma cell myeloma,6,F,PER,lenalidomide,3,SS,Staphylococcal bacteraemia,3,M,OT,17
162831346,3,Plasma cell myeloma,6,F,PER,lenalidomide,3,SS,Staphylococcal bacteraemia,3,M,HO,17
162882613,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Embolism,1,M,OT,60
162882613,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Embolism,1,M,HO,60
162882613,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Embolism,2,M,OT,60
162882613,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Embolism,2,M,HO,60
162897034,2,Chronic lymphocytic leukaemia,4,F,EXP,ibrutinib,2,SS,Acute kidney injury,2,M,HO,1
162897034,2,Chronic lymphocytic leukaemia,4,F,EXP,ibrutinib,2,SS,Acute kidney injury,2,M,LT,1
162897034,2,Chronic lymphocytic leukaemia,4,F,EXP,ibrutinib,2,SS,Hyperuricaemia,2,M,HO,1
162897034,2,Chronic lymphocytic leukaemia,4,F,EXP,ibrutinib,2,SS,Hyperuricaemia,2,M,LT,1
162897034,2,Chronic lymphocytic leukaemia,4,F,EXP,ibrutinib,2,SS,Hypocalcaemia,2,M,HO,1
162897034,2,Chronic lymphocytic leukaemia,4,F,EXP,ibrutinib,2,SS,Hypocalcaemia,2,M,LT,1
162897034,2,Chronic lymphocytic leukaemia,4,F,EXP,ibrutinib,2,SS,Mitral valve disease,2,M,HO,1
162897034,2,Chronic lymphocytic leukaemia,4,F,EXP,ibrutinib,2,SS,Mitral valve disease,2,M,LT,1
162897034,2,Chronic lymphocytic leukaemia,4,F,EXP,ibrutinib,2,SS,Pneumonitis,2,M,HO,1
162897034,2,Chronic lymphocytic leukaemia,4,F,EXP,ibrutinib,2,SS,Pneumonitis,2,M,LT,1
162897034,2,Chronic lymphocytic leukaemia,4,F,EXP,ibrutinib,2,SS,Pulmonary oedema,2,M,HO,1
162897034,2,Chronic lymphocytic leukaemia,4,F,EXP,ibrutinib,2,SS,Pulmonary oedema,2,M,LT,1
162897034,2,Chronic lymphocytic leukaemia,4,F,EXP,ibrutinib,2,SS,Respiratory failure,2,M,HO,1
162897034,2,Chronic lymphocytic leukaemia,4,F,EXP,ibrutinib,2,SS,Respiratory failure,2,M,LT,1
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Blood corticotrophin decreased,1,M,OT,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Blood corticotrophin decreased,1,M,HO,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,General physical condition abnormal,1,M,OT,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,General physical condition abnormal,1,M,HO,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Hypoglycaemia,1,M,OT,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Hypoglycaemia,1,M,HO,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,OT,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,HO,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Urinary tract infection pseudomonal,1,M,OT,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Urinary tract infection pseudomonal,1,M,HO,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,277
162909776,1,Metastatic renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Weight decreased,1,M,HO,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Blood corticotrophin decreased,2,M,OT,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Blood corticotrophin decreased,2,M,HO,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Decreased appetite,2,M,OT,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Decreased appetite,2,M,HO,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Fatigue,2,M,OT,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Fatigue,2,M,HO,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,General physical condition abnormal,2,M,OT,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,General physical condition abnormal,2,M,HO,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Hypoglycaemia,2,M,OT,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Hypoglycaemia,2,M,HO,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,OT,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,HO,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,M,OT,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,M,HO,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Urinary tract infection pseudomonal,2,M,OT,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Urinary tract infection pseudomonal,2,M,HO,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Weight decreased,2,M,OT,277
162909776,2,Metastatic renal cell carcinoma,6,F,EXP,ipilimumab,2,SS,Weight decreased,2,M,HO,277
1629219112,3,Plasma cell myeloma,12,F,EXP,daratumumab,3,C,Pneumonia,3,M,HO,16
1629219112,3,Plasma cell myeloma,12,F,EXP,daratumumab,3,C,Pneumonia,3,M,LT,16
162941168,1,Gastrooesophageal cancer,8,F,EXP,nivolumab,1,PS,Facial nerve disorder,1,M,OT,47
162941168,1,Gastrooesophageal cancer,8,F,EXP,nivolumab,1,PS,Lhermitte's sign,1,M,OT,47
162962175,4,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,4,SS,Chest pain,4,M,HO,159
162962175,4,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,4,SS,Coronary artery disease,4,M,HO,159
162962175,4,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,4,SS,Ventricular arrhythmia,4,M,HO,159
162980783,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Lower respiratory tract infection,6,M,HO,31
162980783,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Lower respiratory tract infection,6,M,OT,31
162980783,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Streptococcal infection,6,M,HO,31
162980783,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Streptococcal infection,6,M,OT,31
162988933,1,Adenocarcinoma gastric,3,F,EXP,nivolumab,1,SS,Aortic valve stenosis,1,F,HO,67
162988933,1,Adenocarcinoma gastric,3,F,EXP,nivolumab,1,SS,Aortic valve stenosis,1,F,OT,67
162988933,1,Adenocarcinoma gastric,3,F,EXP,nivolumab,1,SS,Epilepsy,1,F,HO,67
162988933,1,Adenocarcinoma gastric,3,F,EXP,nivolumab,1,SS,Epilepsy,1,F,OT,67
162988933,2,Adenocarcinoma gastric,3,F,EXP,ipilimumab,2,PS,Aortic valve stenosis,2,F,HO,67
162988933,2,Adenocarcinoma gastric,3,F,EXP,ipilimumab,2,PS,Aortic valve stenosis,2,F,OT,67
162988933,2,Adenocarcinoma gastric,3,F,EXP,ipilimumab,2,PS,Epilepsy,2,F,HO,67
162988933,2,Adenocarcinoma gastric,3,F,EXP,ipilimumab,2,PS,Epilepsy,2,F,OT,67
162993252,9,Metastases to bone,2,F,EXP,denosumab,9,C,Headache,9,F,HO,906
162993252,9,Metastases to bone,2,F,EXP,denosumab,9,C,Pyrexia,9,F,HO,906
163008504,1,Product used for unknown indication,4,F,EXP,nivolumab,1,PS,Lymphadenitis,1,F,HO,77
163008504,2,Product used for unknown indication,4,F,EXP,ipilimumab,2,SS,Lymphadenitis,2,F,HO,77
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Abdominal pain,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Abdominal pain,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Abdominal pain,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Anaemia,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Anaemia,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Anaemia,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Arthralgia,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Arthralgia,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Arthralgia,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Bone pain,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Bone pain,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Bone pain,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Coma,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Coma,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Coma,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Decreased appetite,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Decreased appetite,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Decreased appetite,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Diarrhoea,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Diarrhoea,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Diarrhoea,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Discomfort,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Discomfort,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Discomfort,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Dizziness,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Dizziness,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Dizziness,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Fatigue,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Fatigue,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Fatigue,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,General physical health deterioration,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,General physical health deterioration,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,General physical health deterioration,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Hepatic enzyme increased,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Hepatic enzyme increased,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Hepatic enzyme increased,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Nausea,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Nausea,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Nausea,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Paraesthesia,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Paraesthesia,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Paraesthesia,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Pruritus,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Pruritus,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Pruritus,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Radiation skin injury,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Radiation skin injury,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Radiation skin injury,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Urinary tract infection,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Urinary tract infection,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Urinary tract infection,4,F,DE,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Vomiting,4,F,HO,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Vomiting,4,F,OT,23
163019453,4,Malignant melanoma,3,F,EXP,ipilimumab,4,SS,Vomiting,4,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Abdominal pain,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Abdominal pain,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Abdominal pain,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Anaemia,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Anaemia,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Anaemia,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Arthralgia,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Arthralgia,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Arthralgia,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Bone pain,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Bone pain,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Bone pain,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Coma,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Coma,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Coma,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Decreased appetite,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Decreased appetite,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Decreased appetite,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Diarrhoea,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Diarrhoea,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Diarrhoea,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Discomfort,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Discomfort,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Discomfort,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Dizziness,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Dizziness,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Dizziness,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Fatigue,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Fatigue,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Fatigue,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,General physical health deterioration,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,General physical health deterioration,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,General physical health deterioration,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Hepatic enzyme increased,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Hepatic enzyme increased,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Hepatic enzyme increased,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Malignant neoplasm progression,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Malignant neoplasm progression,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Malignant neoplasm progression,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Nausea,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Nausea,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Nausea,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Paraesthesia,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Paraesthesia,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Paraesthesia,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Pruritus,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Pruritus,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Pruritus,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Radiation skin injury,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Radiation skin injury,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Radiation skin injury,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Urinary tract infection,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Urinary tract infection,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Urinary tract infection,5,F,DE,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Vomiting,5,F,HO,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Vomiting,5,F,OT,23
163019453,5,Malignant melanoma,3,F,EXP,nivolumab,5,SS,Vomiting,5,F,DE,23
163019496,2,Relapsing multiple sclerosis,6,F,EXP,ofatumumab,2,SS,Cardiac failure acute,2,F,HO,18
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Anaemia,3,M,HO,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Anaemia,3,M,OT,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Contusion,3,M,HO,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Contusion,3,M,OT,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Hyperkalaemia,3,M,HO,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Hyperkalaemia,3,M,OT,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Influenza,3,M,HO,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Influenza,3,M,OT,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Lymphocyte count decreased,3,M,HO,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Lymphocyte count decreased,3,M,OT,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Malaise,3,M,HO,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Malaise,3,M,OT,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Neutrophil count decreased,3,M,HO,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Neutrophil count decreased,3,M,OT,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Platelet count decreased,3,M,HO,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Platelet count decreased,3,M,OT,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Pneumonia,3,M,HO,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Pneumonia,3,M,OT,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Pyrexia,3,M,HO,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,Pyrexia,3,M,OT,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,White blood cell count decreased,3,M,HO,84
163035347,3,Plasma cell myeloma,7,F,EXP,lenalidomide,3,SS,White blood cell count decreased,3,M,OT,84
163040184,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Balance disorder,1,M,OT,52
163040184,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Cerebrovascular accident,1,M,OT,52
163040184,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,52
163040184,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Fall,1,M,OT,52
163040184,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,52
163040184,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,OT,52
163040184,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Product dose omission,1,M,OT,52
163040184,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Thrombosis,1,M,OT,52
163040184,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Vertigo,1,M,OT,52
163050443,1,B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,6
163050443,1,B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,6
163050443,1,B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,HO,6
163050443,1,B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,OT,6
163050443,1,B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Excessive eye blinking,1,M,HO,6
163050443,1,B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Excessive eye blinking,1,M,OT,6
163105773,3,Lung neoplasm malignant,3,F,EXP,nivolumab,3,SS,Fatigue,3,M,OT,1
163105773,3,Lung neoplasm malignant,3,F,EXP,nivolumab,3,SS,Hypothyroidism,3,M,OT,1
163105773,3,Lung neoplasm malignant,3,F,EXP,nivolumab,3,SS,Insomnia,3,M,OT,1
163105773,3,Lung neoplasm malignant,3,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,OT,1
163105773,3,Lung neoplasm malignant,3,F,EXP,nivolumab,3,SS,Nausea,3,M,OT,1
163109962,1,Hormone-refractory prostate cancer,2,F,EXP,avelumab,1,PS,Hyperglycaemia,1,M,OT,14
163109962,1,Hormone-refractory prostate cancer,2,F,EXP,avelumab,1,PS,Hyperglycaemia,1,M,LT,14
163109962,1,Hormone-refractory prostate cancer,2,F,EXP,avelumab,1,PS,Hyperglycaemia,1,M,HO,14
163118308,1,Acute myeloid leukaemia,8,F,EXP,midostaurin,1,PS,Ulcerative duodenitis,1,F,LT,8
163118308,1,Acute myeloid leukaemia,8,F,EXP,midostaurin,1,PS,Ulcerative duodenitis,1,F,HO,8
163142496,1,Pancreatic carcinoma,6,F,EXP,avelumab,1,PS,Mucosal inflammation,1,F,HO,16
163142496,2,Pancreatic carcinoma,6,F,EXP,binimetinib,2,SS,Mucosal inflammation,2,F,HO,16
163166332,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,M,HO,55
163166332,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Chronic obstructive pulmonary disease,2,M,HO,55
163167124,1,Bladder cancer,4,F,EXP,nivolumab,1,PS,Peripheral embolism,1,M,OT,140
163167124,1,Bladder cancer,4,F,EXP,nivolumab,1,PS,Peripheral embolism,1,M,HO,140
163167124,1,Bladder cancer,4,F,EXP,nivolumab,1,PS,Peripheral embolism,1,M,DE,140
163167124,1,Bladder cancer,4,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,140
163167124,1,Bladder cancer,4,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,HO,140
163167124,1,Bladder cancer,4,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,DE,140
163167124,2,Bladder cancer,4,F,EXP,ipilimumab,2,SS,Peripheral embolism,2,M,OT,140
163167124,2,Bladder cancer,4,F,EXP,ipilimumab,2,SS,Peripheral embolism,2,M,HO,140
163167124,2,Bladder cancer,4,F,EXP,ipilimumab,2,SS,Peripheral embolism,2,M,DE,140
163167124,2,Bladder cancer,4,F,EXP,ipilimumab,2,SS,Pulmonary embolism,2,M,OT,140
163167124,2,Bladder cancer,4,F,EXP,ipilimumab,2,SS,Pulmonary embolism,2,M,HO,140
163167124,2,Bladder cancer,4,F,EXP,ipilimumab,2,SS,Pulmonary embolism,2,M,DE,140
163252642,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Anxiety,1,M,HO,9
163252642,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Anxiety,1,M,LT,9
163252642,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Anxiety,1,M,OT,9
163252642,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,M,HO,9
163252642,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,M,LT,9
163252642,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,M,OT,9
163252642,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,HO,9
163252642,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,LT,9
163252642,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,OT,9
163252642,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Haemorrhage intracranial,1,M,HO,9
163252642,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Haemorrhage intracranial,1,M,LT,9
163252642,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Haemorrhage intracranial,1,M,OT,9
163261094,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,OT,43
163261094,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,HO,43
163261094,2,Lung neoplasm malignant,4,F,EXP,nivolumab,2,SS,Abdominal pain,2,M,OT,10
163261094,2,Lung neoplasm malignant,4,F,EXP,nivolumab,2,SS,Abdominal pain,2,M,HO,10
163263134,1,Soft tissue sarcoma,4,F,EXP,trabectedin,1,PS,Febrile bone marrow aplasia,1,M,DE,50
163263134,1,Soft tissue sarcoma,4,F,EXP,trabectedin,1,PS,Febrile bone marrow aplasia,1,M,HO,50
163263936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,31
163263936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,31
163263936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,DE,31
163263936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,HO,31
163263936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,31
163263936,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,DE,31
163272598,1,Prostate cancer,8,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,DE,24
163272598,1,Prostate cancer,8,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,HO,24
163272598,1,Prostate cancer,8,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,OT,24
163272598,2,Prostate cancer,8,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,M,DE,24
163272598,2,Prostate cancer,8,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,M,HO,24
163272598,2,Prostate cancer,8,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,M,OT,24
163296243,1,Transitional cell cancer of renal pelvis and ureter metastatic,3,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,64
163296243,1,Transitional cell cancer of renal pelvis and ureter metastatic,3,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,64
163296243,2,Transitional cell cancer of renal pelvis and ureter metastatic,3,F,EXP,ipilimumab,2,SS,Decreased appetite,2,M,HO,64
163296243,2,Transitional cell cancer of renal pelvis and ureter metastatic,3,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,HO,64
1633186214,1,Multiple sclerosis,14,F,EXP,alemtuzumab,1,PS,Bacteriuria,1,F,HO,28
1633186214,1,Multiple sclerosis,14,F,EXP,alemtuzumab,1,PS,Bilirubin urine present,1,F,HO,28
1633186214,1,Multiple sclerosis,14,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone decreased,1,F,HO,28
1633186214,1,Multiple sclerosis,14,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone increased,1,F,HO,28
1633186214,1,Multiple sclerosis,14,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,HO,28
1633186214,1,Multiple sclerosis,14,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,HO,28
1633186214,1,Multiple sclerosis,14,F,EXP,alemtuzumab,1,PS,Neutrophil count decreased,1,F,HO,28
1633186214,1,Multiple sclerosis,14,F,EXP,alemtuzumab,1,PS,Platelet count decreased,1,F,HO,28
1633186214,1,Multiple sclerosis,14,F,EXP,alemtuzumab,1,PS,Red blood cell sedimentation rate increased,1,F,HO,28
1633186214,1,Multiple sclerosis,14,F,EXP,alemtuzumab,1,PS,Red blood cells urine positive,1,F,HO,28
1633186214,1,Multiple sclerosis,14,F,EXP,alemtuzumab,1,PS,Urine ketone body present,1,F,HO,28
1633186214,1,Multiple sclerosis,14,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,HO,28
163337712,4,Plasma cell myeloma,2,F,EXP,pomalidomide,4,SS,Fatigue,4,M,DE,224
163337712,4,Plasma cell myeloma,2,F,EXP,pomalidomide,4,SS,Fatigue,4,M,OT,224
163337712,4,Plasma cell myeloma,2,F,EXP,pomalidomide,4,SS,Leukopenia,4,M,DE,224
163337712,4,Plasma cell myeloma,2,F,EXP,pomalidomide,4,SS,Leukopenia,4,M,OT,224
163337712,4,Plasma cell myeloma,2,F,EXP,pomalidomide,4,SS,Neutropenia,4,M,DE,224
163337712,4,Plasma cell myeloma,2,F,EXP,pomalidomide,4,SS,Neutropenia,4,M,OT,224
163371029,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Bladder transitional cell carcinoma recurrent,1,M,HO,13
163371029,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Bladder transitional cell carcinoma recurrent,1,M,OT,13
163371029,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Transitional cell cancer of the renal pelvis and ureter,1,M,HO,13
163371029,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Transitional cell cancer of the renal pelvis and ureter,1,M,OT,13
163371029,16,Prophylaxis,9,F,EXP,zoledronic acid,16,C,Bladder transitional cell carcinoma recurrent,16,M,HO,674
163371029,16,Prophylaxis,9,F,EXP,zoledronic acid,16,C,Bladder transitional cell carcinoma recurrent,16,M,OT,674
163371029,16,Prophylaxis,9,F,EXP,zoledronic acid,16,C,Transitional cell cancer of the renal pelvis and ureter,16,M,HO,674
163371029,16,Prophylaxis,9,F,EXP,zoledronic acid,16,C,Transitional cell cancer of the renal pelvis and ureter,16,M,OT,674
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Atypical mycobacterial infection,6,F,DE,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Atypical mycobacterial infection,6,F,HO,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Atypical mycobacterial infection,6,F,OT,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Blood glucose increased,6,F,DE,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Blood glucose increased,6,F,HO,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Blood glucose increased,6,F,OT,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Diarrhoea,6,F,DE,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Diarrhoea,6,F,HO,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Diarrhoea,6,F,OT,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Interstitial lung disease,6,F,DE,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Interstitial lung disease,6,F,HO,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Interstitial lung disease,6,F,OT,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Malaise,6,F,DE,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Malaise,6,F,HO,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Malaise,6,F,OT,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Pulmonary embolism,6,F,DE,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Pulmonary embolism,6,F,HO,54
163396936,6,Metastases to bone,6,F,EXP,denosumab,6,C,Pulmonary embolism,6,F,OT,54
1634026411,2,Bladder cancer,11,F,EXP,nivolumab,2,PS,Guillain-Barre syndrome,2,M,DS,124
1634026411,2,Bladder cancer,11,F,EXP,nivolumab,2,PS,Guillain-Barre syndrome,2,M,HO,124
1634026411,2,Bladder cancer,11,F,EXP,nivolumab,2,PS,Guillain-Barre syndrome,2,M,OT,124
1634026411,2,Bladder cancer,11,F,EXP,nivolumab,2,PS,Guillain-Barre syndrome,2,M,LT,124
1634026411,2,Bladder cancer,11,F,EXP,nivolumab,2,PS,Sepsis,2,M,DS,124
1634026411,2,Bladder cancer,11,F,EXP,nivolumab,2,PS,Sepsis,2,M,HO,124
1634026411,2,Bladder cancer,11,F,EXP,nivolumab,2,PS,Sepsis,2,M,OT,124
1634026411,2,Bladder cancer,11,F,EXP,nivolumab,2,PS,Sepsis,2,M,LT,124
163441585,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Venoocclusive liver disease,1,M,LT,59
163441585,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Venoocclusive liver disease,1,M,DE,59
1634687610,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Gamma-glutamyltransferase increased,1,M,HO,156
1634687610,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Influenza,1,M,HO,156
1634687610,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Lipoma,1,M,HO,156
1634687610,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Neutropenia,1,M,HO,156
1634687610,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Pancytopenia,1,M,HO,156
1634687610,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Pneumonia bacterial,1,M,HO,156
1634687610,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Respiratory tract infection,1,M,HO,156
1634687610,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Thrombocytopenic purpura,1,M,HO,156
1634687610,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Upper respiratory tract infection,1,M,HO,156
1634687610,1,Relapsing multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Vitamin D deficiency,1,M,HO,156
163493046,1,Transitional cell carcinoma,6,F,EXP,nivolumab,1,PS,Colitis,1,F,HO,212
163493046,1,Transitional cell carcinoma,6,F,EXP,nivolumab,1,PS,Colitis,1,F,OT,212
163493046,1,Transitional cell carcinoma,6,F,EXP,nivolumab,1,PS,Hypertensive crisis,1,F,HO,212
163493046,1,Transitional cell carcinoma,6,F,EXP,nivolumab,1,PS,Hypertensive crisis,1,F,OT,212
163493046,1,Transitional cell carcinoma,6,F,EXP,nivolumab,1,PS,Metastases to liver,1,F,HO,212
163493046,1,Transitional cell carcinoma,6,F,EXP,nivolumab,1,PS,Metastases to liver,1,F,OT,212
163493046,1,Transitional cell carcinoma,6,F,EXP,nivolumab,1,PS,Pancreatitis,1,F,HO,212
163493046,1,Transitional cell carcinoma,6,F,EXP,nivolumab,1,PS,Pancreatitis,1,F,OT,212
163493046,2,Transitional cell carcinoma,6,F,EXP,ipilimumab,2,SS,Colitis,2,F,HO,89
163493046,2,Transitional cell carcinoma,6,F,EXP,ipilimumab,2,SS,Colitis,2,F,OT,89
163493046,2,Transitional cell carcinoma,6,F,EXP,ipilimumab,2,SS,Hypertensive crisis,2,F,HO,89
163493046,2,Transitional cell carcinoma,6,F,EXP,ipilimumab,2,SS,Hypertensive crisis,2,F,OT,89
163493046,2,Transitional cell carcinoma,6,F,EXP,ipilimumab,2,SS,Metastases to liver,2,F,HO,89
163493046,2,Transitional cell carcinoma,6,F,EXP,ipilimumab,2,SS,Metastases to liver,2,F,OT,89
163493046,2,Transitional cell carcinoma,6,F,EXP,ipilimumab,2,SS,Pancreatitis,2,F,HO,89
163493046,2,Transitional cell carcinoma,6,F,EXP,ipilimumab,2,SS,Pancreatitis,2,F,OT,89
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Bacterial infection,7,M,OT,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Bacterial infection,7,M,DE,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Candida infection,7,M,OT,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Candida infection,7,M,DE,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Chest pain,7,M,OT,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Chest pain,7,M,DE,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Cough,7,M,OT,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Cough,7,M,DE,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Death,7,M,OT,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Death,7,M,DE,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Dyspnoea,7,M,OT,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Dyspnoea,7,M,DE,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Fatigue,7,M,OT,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Fatigue,7,M,DE,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Gastric disorder,7,M,OT,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Gastric disorder,7,M,DE,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Malignant neoplasm progression,7,M,OT,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Malignant neoplasm progression,7,M,DE,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Musculoskeletal pain,7,M,OT,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Musculoskeletal pain,7,M,DE,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Pain,7,M,OT,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Pain,7,M,DE,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Pneumonia,7,M,OT,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Pneumonia,7,M,DE,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Vertigo,7,M,OT,209
163498036,7,Non-small cell lung cancer metastatic,6,F,EXP,nivolumab,7,SS,Vertigo,7,M,DE,209
163503345,1,Osteogenesis imperfecta,5,F,PER,denosumab,1,PS,Femur fracture,1,F,OT,291
163503345,1,Osteogenesis imperfecta,5,F,PER,denosumab,1,PS,Femur fracture,1,F,HO,291
163503345,1,Osteogenesis imperfecta,5,F,PER,denosumab,1,PS,Humerus fracture,1,F,OT,291
163503345,1,Osteogenesis imperfecta,5,F,PER,denosumab,1,PS,Humerus fracture,1,F,HO,291
163523637,1,Metastatic malignant melanoma,7,F,EXP,ipilimumab,1,PS,Adrenocortical insufficiency acute,1,M,HO,38
163523637,1,Metastatic malignant melanoma,7,F,EXP,ipilimumab,1,PS,Adrenocortical insufficiency acute,1,M,OT,38
163523637,1,Metastatic malignant melanoma,7,F,EXP,ipilimumab,1,PS,Colitis,1,M,HO,38
163523637,1,Metastatic malignant melanoma,7,F,EXP,ipilimumab,1,PS,Colitis,1,M,OT,38
163523637,1,Metastatic malignant melanoma,7,F,EXP,ipilimumab,1,PS,Diarrhoea,1,M,HO,38
163523637,1,Metastatic malignant melanoma,7,F,EXP,ipilimumab,1,PS,Diarrhoea,1,M,OT,38
163523637,1,Metastatic malignant melanoma,7,F,EXP,ipilimumab,1,PS,Gastrooesophageal reflux disease,1,M,HO,38
163523637,1,Metastatic malignant melanoma,7,F,EXP,ipilimumab,1,PS,Gastrooesophageal reflux disease,1,M,OT,38
163523637,1,Metastatic malignant melanoma,7,F,EXP,ipilimumab,1,PS,Hiatus hernia,1,M,HO,38
163523637,1,Metastatic malignant melanoma,7,F,EXP,ipilimumab,1,PS,Hiatus hernia,1,M,OT,38
163523637,1,Metastatic malignant melanoma,7,F,EXP,ipilimumab,1,PS,Oesophageal candidiasis,1,M,HO,38
163523637,1,Metastatic malignant melanoma,7,F,EXP,ipilimumab,1,PS,Oesophageal candidiasis,1,M,OT,38
163553195,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,HO,5
163553195,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,OT,5
163553195,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,DE,5
163553195,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,5
163553195,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,5
163553195,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,5
163553195,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Urticaria,1,M,HO,5
163553195,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Urticaria,1,M,OT,5
163553195,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Urticaria,1,M,DE,5
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Bone marrow failure,3,F,OT,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Bone marrow failure,3,F,HO,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Bone marrow failure,3,F,DE,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,C-reactive protein increased,3,F,OT,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,C-reactive protein increased,3,F,HO,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,C-reactive protein increased,3,F,DE,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Decreased appetite,3,F,OT,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Decreased appetite,3,F,HO,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Decreased appetite,3,F,DE,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Hepatic failure,3,F,OT,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Hepatic failure,3,F,HO,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Hepatic failure,3,F,DE,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Immune-mediated adverse reaction,3,F,OT,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Immune-mediated adverse reaction,3,F,HO,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Immune-mediated adverse reaction,3,F,DE,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Off label use,3,F,OT,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Off label use,3,F,HO,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Off label use,3,F,DE,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Pyrexia,3,F,OT,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Pyrexia,3,F,HO,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Pyrexia,3,F,DE,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Renal failure,3,F,OT,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Renal failure,3,F,HO,7
163553468,3,Non-small cell lung cancer,8,F,EXP,pemetrexed disodium,3,SS,Renal failure,3,F,DE,7
163562686,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,DE,4
163562686,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,HO,4
163562686,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,OT,4
163562686,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,4
163562686,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,4
163562686,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,4
163562686,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pyrexia,1,M,DE,4
163562686,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,4
163562686,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,4
163562686,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Rash pruritic,1,M,DE,4
163562686,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Rash pruritic,1,M,HO,4
163562686,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Rash pruritic,1,M,OT,4
163562686,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,M,DE,4
163562686,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,M,HO,4
163562686,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,M,OT,4
163562686,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DE,4
163562686,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,HO,4
163562686,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,4
163562686,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,DE,4
163562686,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,HO,4
163562686,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,OT,4
163562686,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Rash pruritic,2,M,DE,4
163562686,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Rash pruritic,2,M,HO,4
163562686,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Rash pruritic,2,M,OT,4
163566063,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Death,1,M,OT,212
163566063,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Death,1,M,DE,212
163571122,2,Breast cancer female,2,F,EXP,palbociclib,2,SS,Mental status changes,2,F,OT,17
163571122,2,Breast cancer female,2,F,EXP,palbociclib,2,SS,Mental status changes,2,F,HO,17
163571122,2,Breast cancer female,2,F,EXP,palbociclib,2,SS,Mental status changes,2,F,DS,17
163584165,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Large intestinal obstruction,1,F,OT,93
163584165,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Off label use,1,F,OT,93
163584823,1,Acute lymphocytic leukaemia,3,F,PER,blinatumomab,1,PS,Facial paralysis,1,F,DS,18
163584823,1,Acute lymphocytic leukaemia,3,F,PER,blinatumomab,1,PS,Nerve injury,1,F,DS,18
163587635,5,Metastatic malignant melanoma,5,F,EXP,trametinib,5,SS,Atrial fibrillation,5,M,LT,82
163594852,1,Product used for unknown indication,2,F,PER,carfilzomib,1,PS,Hepatotoxicity,1,M,OT,206
163594852,1,Product used for unknown indication,2,F,PER,carfilzomib,1,PS,Hepatotoxicity,1,M,HO,206
163594852,1,Product used for unknown indication,2,F,PER,carfilzomib,1,PS,Hepatotoxicity,1,M,DE,206
163594852,1,Product used for unknown indication,2,F,PER,carfilzomib,1,PS,Pneumonia,1,M,OT,206
163594852,1,Product used for unknown indication,2,F,PER,carfilzomib,1,PS,Pneumonia,1,M,HO,206
163594852,1,Product used for unknown indication,2,F,PER,carfilzomib,1,PS,Pneumonia,1,M,DE,206
163594852,1,Product used for unknown indication,2,F,PER,carfilzomib,1,PS,Sepsis,1,M,OT,206
163594852,1,Product used for unknown indication,2,F,PER,carfilzomib,1,PS,Sepsis,1,M,HO,206
163594852,1,Product used for unknown indication,2,F,PER,carfilzomib,1,PS,Sepsis,1,M,DE,206
163612127,2,Malignant melanoma,7,F,EXP,trametinib,2,SS,Acute leukaemia,2,F,HO,152
163612127,2,Malignant melanoma,7,F,EXP,trametinib,2,SS,Acute leukaemia,2,F,OT,152
163612127,2,Malignant melanoma,7,F,EXP,trametinib,2,SS,Second primary malignancy,2,F,HO,152
163612127,2,Malignant melanoma,7,F,EXP,trametinib,2,SS,Second primary malignancy,2,F,OT,152
163612385,2,Malignant melanoma,5,F,EXP,trametinib,2,SS,General physical health deterioration,2,M,HO,27
163612385,2,Malignant melanoma,5,F,EXP,trametinib,2,SS,General physical health deterioration,2,M,DE,27
163612385,2,Malignant melanoma,5,F,EXP,trametinib,2,SS,Pyrexia,2,M,HO,27
163612385,2,Malignant melanoma,5,F,EXP,trametinib,2,SS,Pyrexia,2,M,DE,27
163629307,17,Acute lymphocytic leukaemia,7,F,EXP,pegaspargase,17,SS,Anorectal cellulitis,17,M,HO,164
163629307,17,Acute lymphocytic leukaemia,7,F,EXP,pegaspargase,17,SS,Febrile neutropenia,17,M,HO,164
163629307,17,Acute lymphocytic leukaemia,7,F,EXP,pegaspargase,17,SS,Neutrophil count decreased,17,M,HO,164
163636706,1,Acute myeloid leukaemia,6,F,EXP,midostaurin,1,PS,Pulmonary haemorrhage,1,M,LT,11
163636706,1,Acute myeloid leukaemia,6,F,EXP,midostaurin,1,PS,Pulmonary haemorrhage,1,M,HO,11
163636706,1,Acute myeloid leukaemia,6,F,EXP,midostaurin,1,PS,Pulmonary haemorrhage,1,M,DE,11
163636706,23,Neutropenia,6,F,EXP,filgrastim,23,C,Pulmonary haemorrhage,23,M,LT,6
163636706,23,Neutropenia,6,F,EXP,filgrastim,23,C,Pulmonary haemorrhage,23,M,HO,6
163636706,23,Neutropenia,6,F,EXP,filgrastim,23,C,Pulmonary haemorrhage,23,M,DE,6
163636706,27,Prophylaxis,6,F,EXP,granisetron,27,C,Pulmonary haemorrhage,27,M,LT,10
163636706,27,Prophylaxis,6,F,EXP,granisetron,27,C,Pulmonary haemorrhage,27,M,HO,10
163636706,27,Prophylaxis,6,F,EXP,granisetron,27,C,Pulmonary haemorrhage,27,M,DE,10
163642882,1,Transitional cell cancer of renal pelvis and ureter metastatic,2,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,HO,42
163642882,1,Transitional cell cancer of renal pelvis and ureter metastatic,2,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,DE,42
163642882,1,Transitional cell cancer of renal pelvis and ureter metastatic,2,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,OT,42
163642882,2,Transitional cell cancer of renal pelvis and ureter metastatic,2,F,EXP,ipilimumab,2,SS,Autoimmune hepatitis,2,M,HO,42
163642882,2,Transitional cell cancer of renal pelvis and ureter metastatic,2,F,EXP,ipilimumab,2,SS,Autoimmune hepatitis,2,M,DE,42
163642882,2,Transitional cell cancer of renal pelvis and ureter metastatic,2,F,EXP,ipilimumab,2,SS,Autoimmune hepatitis,2,M,OT,42
163646135,1,Colorectal cancer metastatic,5,F,PER,panitumumab,1,PS,Abdominal pain,1,F,OT,7
163646135,1,Colorectal cancer metastatic,5,F,PER,panitumumab,1,PS,Diarrhoea,1,F,OT,7
163646135,1,Colorectal cancer metastatic,5,F,PER,panitumumab,1,PS,Hypomagnesaemia,1,F,OT,7
163646135,1,Colorectal cancer metastatic,5,F,PER,panitumumab,1,PS,Leukopenia,1,F,OT,7
163646135,1,Colorectal cancer metastatic,5,F,PER,panitumumab,1,PS,Nausea,1,F,OT,7
163646135,1,Colorectal cancer metastatic,5,F,PER,panitumumab,1,PS,Neutropenia,1,F,OT,7
163646135,1,Colorectal cancer metastatic,5,F,PER,panitumumab,1,PS,Stomatitis,1,F,OT,7
163659707,2,Metastatic malignant melanoma,7,F,EXP,ipilimumab,2,PS,Diarrhoea,2,M,HO,51
163659707,2,Metastatic malignant melanoma,7,F,EXP,ipilimumab,2,PS,Diarrhoea,2,M,OT,51
163659707,2,Metastatic malignant melanoma,7,F,EXP,ipilimumab,2,PS,General physical condition abnormal,2,M,HO,51
163659707,2,Metastatic malignant melanoma,7,F,EXP,ipilimumab,2,PS,General physical condition abnormal,2,M,OT,51
163659707,2,Metastatic malignant melanoma,7,F,EXP,ipilimumab,2,PS,Myocarditis,2,M,HO,51
163659707,2,Metastatic malignant melanoma,7,F,EXP,ipilimumab,2,PS,Myocarditis,2,M,OT,51
163663173,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Cardiac arrest,1,M,OT,41
163663173,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Cardiac arrest,1,M,DE,41
163663173,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Hypoxic-ischaemic encephalopathy,1,M,OT,41
163663173,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Hypoxic-ischaemic encephalopathy,1,M,DE,41
1636836312,1,Oesophageal squamous cell carcinoma,12,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,14
1636836312,1,Oesophageal squamous cell carcinoma,12,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,14
1636836312,1,Oesophageal squamous cell carcinoma,12,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,14
1636836312,1,Oesophageal squamous cell carcinoma,12,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,14
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Bacteraemia,1,F,HO,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Bacteraemia,1,F,LT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Bacteraemia,1,F,DE,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Bacteraemia,1,F,OT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Cardiac arrest,1,F,HO,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Cardiac arrest,1,F,LT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Cardiac arrest,1,F,DE,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Cardiac arrest,1,F,OT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Clostridium difficile colitis,1,F,HO,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Clostridium difficile colitis,1,F,LT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Clostridium difficile colitis,1,F,DE,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Clostridium difficile colitis,1,F,OT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Endocarditis,1,F,HO,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Endocarditis,1,F,LT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Endocarditis,1,F,DE,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Endocarditis,1,F,OT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Endocarditis staphylococcal,1,F,HO,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Endocarditis staphylococcal,1,F,LT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Endocarditis staphylococcal,1,F,DE,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Endocarditis staphylococcal,1,F,OT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Pneumonia serratia,1,F,HO,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Pneumonia serratia,1,F,LT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Pneumonia serratia,1,F,DE,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Pneumonia serratia,1,F,OT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Procedural pain,1,F,HO,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Procedural pain,1,F,LT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Procedural pain,1,F,DE,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Procedural pain,1,F,OT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Pulmonary hypertension,1,F,HO,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Pulmonary hypertension,1,F,LT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Pulmonary hypertension,1,F,DE,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Pulmonary hypertension,1,F,OT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Septic shock,1,F,HO,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Septic shock,1,F,LT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Septic shock,1,F,DE,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Septic shock,1,F,OT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Splenic infarction,1,F,HO,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Splenic infarction,1,F,LT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Splenic infarction,1,F,DE,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Splenic infarction,1,F,OT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Staphylococcal sepsis,1,F,HO,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Staphylococcal sepsis,1,F,LT,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Staphylococcal sepsis,1,F,DE,459
163696245,1,Anaemia,5,F,PER,darbepoetin alfa,1,PS,Staphylococcal sepsis,1,F,OT,459
163699932,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Eosinophil count increased,1,F,HO,512
163699932,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Gastrointestinal haemorrhage,1,F,HO,512
163714409,3,Breast cancer,9,F,EXP,palbociclib,3,SS,Cardiac failure congestive,3,F,DE,450
163714409,3,Breast cancer,9,F,EXP,palbociclib,3,SS,Cardiac failure congestive,3,F,HO,450
163714409,3,Breast cancer,9,F,EXP,palbociclib,3,SS,Cardiac failure congestive,3,F,DS,450
163745543,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Cerebral ischaemia,1,M,HO,1
163745543,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Cerebral ischaemia,1,M,DE,1
163745543,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Cerebral ischaemia,1,M,OT,1
163745543,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Intestinal perforation,1,M,HO,1
163745543,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Intestinal perforation,1,M,DE,1
163745543,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Intestinal perforation,1,M,OT,1
163745888,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Cholangitis,1,M,HO,155
163745888,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Cholangitis,1,M,DE,155
163745888,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Cholangitis,1,M,OT,155
163745888,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Cholecystitis acute,1,M,HO,155
163745888,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Cholecystitis acute,1,M,DE,155
163745888,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Cholecystitis acute,1,M,OT,155
163745888,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Cytomegalovirus infection,1,M,HO,155
163745888,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Cytomegalovirus infection,1,M,DE,155
163745888,1,Non-small cell lung cancer,8,F,EXP,nivolumab,1,PS,Cytomegalovirus infection,1,M,OT,155
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Back pain,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Back pain,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Back pain,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Central nervous system lesion,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Central nervous system lesion,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Central nervous system lesion,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Cough,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Cough,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Cough,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dehydration,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Embolism,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Embolism,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Embolism,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Epilepsy,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Epilepsy,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Epilepsy,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Facial paresis,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Facial paresis,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Facial paresis,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Fatigue,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Metastases to lymph nodes,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Metastases to lymph nodes,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Metastases to lymph nodes,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Metastases to meninges,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Metastases to meninges,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Metastases to meninges,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Neoplasm progression,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Neoplasm progression,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Neoplasm progression,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Night sweats,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Night sweats,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Night sweats,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Paraesthesia,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Paraesthesia,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Paraesthesia,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Upper respiratory tract infection,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Upper respiratory tract infection,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Upper respiratory tract infection,1,M,HO,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Weight decreased,1,M,DE,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,26
163758378,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Weight decreased,1,M,HO,26
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Back pain,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Back pain,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Back pain,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Central nervous system lesion,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Central nervous system lesion,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Central nervous system lesion,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Cough,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Cough,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Cough,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Decreased appetite,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Decreased appetite,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Decreased appetite,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Dehydration,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Dehydration,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Dehydration,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Embolism,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Embolism,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Embolism,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Epilepsy,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Epilepsy,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Epilepsy,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Facial paresis,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Facial paresis,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Facial paresis,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Fatigue,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Fatigue,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Fatigue,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,General physical health deterioration,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,General physical health deterioration,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,General physical health deterioration,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Metastases to lymph nodes,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Metastases to lymph nodes,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Metastases to lymph nodes,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Metastases to meninges,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Metastases to meninges,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Metastases to meninges,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Neoplasm progression,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Neoplasm progression,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Neoplasm progression,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Night sweats,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Night sweats,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Night sweats,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Paraesthesia,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Paraesthesia,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Paraesthesia,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Upper respiratory tract infection,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Upper respiratory tract infection,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Upper respiratory tract infection,2,M,HO,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Weight decreased,2,M,DE,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Weight decreased,2,M,OT,7
163758378,2,Product used for unknown indication,8,F,EXP,nivolumab,2,SS,Weight decreased,2,M,HO,7
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Back pain,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Back pain,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Back pain,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Central nervous system lesion,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Central nervous system lesion,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Central nervous system lesion,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Cough,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Cough,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Cough,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Decreased appetite,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Decreased appetite,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Decreased appetite,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Dehydration,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Dehydration,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Dehydration,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Dyspnoea,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Dyspnoea,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Dyspnoea,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Embolism,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Embolism,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Embolism,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Epilepsy,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Epilepsy,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Epilepsy,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Facial paresis,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Facial paresis,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Facial paresis,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Fatigue,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Fatigue,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Fatigue,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,General physical health deterioration,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,General physical health deterioration,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,General physical health deterioration,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Metastases to lymph nodes,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Metastases to lymph nodes,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Metastases to lymph nodes,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Metastases to meninges,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Metastases to meninges,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Metastases to meninges,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Neoplasm progression,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Neoplasm progression,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Neoplasm progression,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Night sweats,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Night sweats,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Night sweats,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Paraesthesia,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Paraesthesia,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Paraesthesia,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Upper respiratory tract infection,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Upper respiratory tract infection,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Upper respiratory tract infection,6,M,HO,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Weight decreased,6,M,DE,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Weight decreased,6,M,OT,26
163758378,6,Product used for unknown indication,8,F,EXP,nivolumab,6,SS,Weight decreased,6,M,HO,26
163760034,2,Chemotherapy,4,F,EXP,lenalidomide,2,SS,Chest discomfort,2,M,HO,6
163760034,2,Chemotherapy,4,F,EXP,lenalidomide,2,SS,Dyspnoea,2,M,HO,6
163760034,2,Chemotherapy,4,F,EXP,lenalidomide,2,SS,Off label use,2,M,HO,6
163760034,2,Chemotherapy,4,F,EXP,lenalidomide,2,SS,Oral pain,2,M,HO,6
163760034,2,Chemotherapy,4,F,EXP,lenalidomide,2,SS,Pain,2,M,HO,6
163760034,2,Chemotherapy,4,F,EXP,lenalidomide,2,SS,Rash pruritic,2,M,HO,6
163760034,2,Chemotherapy,4,F,EXP,lenalidomide,2,SS,Stevens-Johnson syndrome,2,M,HO,6
163760034,11,Product used for unknown indication,4,F,EXP,zoledronic acid,11,C,Chest discomfort,11,M,HO,6
163760034,11,Product used for unknown indication,4,F,EXP,zoledronic acid,11,C,Dyspnoea,11,M,HO,6
163760034,11,Product used for unknown indication,4,F,EXP,zoledronic acid,11,C,Off label use,11,M,HO,6
163760034,11,Product used for unknown indication,4,F,EXP,zoledronic acid,11,C,Oral pain,11,M,HO,6
163760034,11,Product used for unknown indication,4,F,EXP,zoledronic acid,11,C,Pain,11,M,HO,6
163760034,11,Product used for unknown indication,4,F,EXP,zoledronic acid,11,C,Rash pruritic,11,M,HO,6
163760034,11,Product used for unknown indication,4,F,EXP,zoledronic acid,11,C,Stevens-Johnson syndrome,11,M,HO,6
163779244,1,Gastric cancer,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,56
163779244,1,Gastric cancer,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,56
163779244,1,Gastric cancer,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,56
163779244,1,Gastric cancer,4,F,EXP,nivolumab,1,PS,Pemphigoid,1,M,HO,56
163779244,1,Gastric cancer,4,F,EXP,nivolumab,1,PS,Pemphigoid,1,M,DE,56
163779244,1,Gastric cancer,4,F,EXP,nivolumab,1,PS,Pemphigoid,1,M,OT,56
163779244,2,Gastric cancer,4,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,HO,56
163779244,2,Gastric cancer,4,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DE,56
163779244,2,Gastric cancer,4,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,56
163779244,2,Gastric cancer,4,F,EXP,ipilimumab,2,SS,Pemphigoid,2,M,HO,56
163779244,2,Gastric cancer,4,F,EXP,ipilimumab,2,SS,Pemphigoid,2,M,DE,56
163779244,2,Gastric cancer,4,F,EXP,ipilimumab,2,SS,Pemphigoid,2,M,OT,56
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Arthralgia,1,F,DS,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Arthralgia,1,F,HO,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Arthralgia,1,F,OT,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,DS,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Fatigue,1,F,DS,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Fatigue,1,F,HO,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Feeling of body temperature change,1,F,DS,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Feeling of body temperature change,1,F,HO,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Feeling of body temperature change,1,F,OT,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Lethargy,1,F,DS,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Lethargy,1,F,HO,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Lethargy,1,F,OT,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Lower respiratory tract infection,1,F,DS,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Lower respiratory tract infection,1,F,HO,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Lower respiratory tract infection,1,F,OT,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,DS,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,HO,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,OT,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Paraesthesia,1,F,DS,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Paraesthesia,1,F,HO,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Paraesthesia,1,F,OT,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Peripheral swelling,1,F,DS,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Peripheral swelling,1,F,HO,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Peripheral swelling,1,F,OT,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Pruritus,1,F,DS,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Pruritus,1,F,HO,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Pruritus,1,F,OT,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,White blood cell count increased,1,F,DS,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,White blood cell count increased,1,F,HO,314
163811914,1,Renal cancer,4,F,EXP,nivolumab,1,PS,White blood cell count increased,1,F,OT,314
163819397,1,Angiosarcoma,7,F,EXP,trametinib,1,PS,Acute respiratory distress syndrome,1,F,HO,21
163819397,1,Angiosarcoma,7,F,EXP,trametinib,1,PS,Acute respiratory distress syndrome,1,F,DE,21
163819397,1,Angiosarcoma,7,F,EXP,trametinib,1,PS,Acute respiratory distress syndrome,1,F,OT,21
163819397,1,Angiosarcoma,7,F,EXP,trametinib,1,PS,Ammonia abnormal,1,F,HO,21
163819397,1,Angiosarcoma,7,F,EXP,trametinib,1,PS,Ammonia abnormal,1,F,DE,21
163819397,1,Angiosarcoma,7,F,EXP,trametinib,1,PS,Ammonia abnormal,1,F,OT,21
163819397,1,Angiosarcoma,7,F,EXP,trametinib,1,PS,Encephalopathy,1,F,HO,21
163819397,1,Angiosarcoma,7,F,EXP,trametinib,1,PS,Encephalopathy,1,F,DE,21
163819397,1,Angiosarcoma,7,F,EXP,trametinib,1,PS,Encephalopathy,1,F,OT,21
163819397,1,Angiosarcoma,7,F,EXP,trametinib,1,PS,Pleural effusion,1,F,HO,21
163819397,1,Angiosarcoma,7,F,EXP,trametinib,1,PS,Pleural effusion,1,F,DE,21
163819397,1,Angiosarcoma,7,F,EXP,trametinib,1,PS,Pleural effusion,1,F,OT,21
163862489,1,Transitional cell carcinoma,9,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,56
163862489,1,Transitional cell carcinoma,9,F,EXP,nivolumab,1,PS,Colitis,1,M,DE,56
163862489,1,Transitional cell carcinoma,9,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,56
163862489,1,Transitional cell carcinoma,9,F,EXP,nivolumab,1,PS,Colitis,1,M,LT,56
163862489,1,Transitional cell carcinoma,9,F,EXP,nivolumab,1,PS,Intestinal perforation,1,M,OT,56
163862489,1,Transitional cell carcinoma,9,F,EXP,nivolumab,1,PS,Intestinal perforation,1,M,DE,56
163862489,1,Transitional cell carcinoma,9,F,EXP,nivolumab,1,PS,Intestinal perforation,1,M,HO,56
163862489,1,Transitional cell carcinoma,9,F,EXP,nivolumab,1,PS,Intestinal perforation,1,M,LT,56
163862489,1,Transitional cell carcinoma,9,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,M,OT,56
163862489,1,Transitional cell carcinoma,9,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,M,DE,56
163862489,1,Transitional cell carcinoma,9,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,M,HO,56
163862489,1,Transitional cell carcinoma,9,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,M,LT,56
163862489,2,Transitional cell carcinoma,9,F,EXP,ipilimumab,2,SS,Colitis,2,M,OT,56
163862489,2,Transitional cell carcinoma,9,F,EXP,ipilimumab,2,SS,Colitis,2,M,DE,56
163862489,2,Transitional cell carcinoma,9,F,EXP,ipilimumab,2,SS,Colitis,2,M,HO,56
163862489,2,Transitional cell carcinoma,9,F,EXP,ipilimumab,2,SS,Colitis,2,M,LT,56
163862489,2,Transitional cell carcinoma,9,F,EXP,ipilimumab,2,SS,Intestinal perforation,2,M,OT,56
163862489,2,Transitional cell carcinoma,9,F,EXP,ipilimumab,2,SS,Intestinal perforation,2,M,DE,56
163862489,2,Transitional cell carcinoma,9,F,EXP,ipilimumab,2,SS,Intestinal perforation,2,M,HO,56
163862489,2,Transitional cell carcinoma,9,F,EXP,ipilimumab,2,SS,Intestinal perforation,2,M,LT,56
163862489,2,Transitional cell carcinoma,9,F,EXP,ipilimumab,2,SS,Pulmonary sepsis,2,M,OT,56
163862489,2,Transitional cell carcinoma,9,F,EXP,ipilimumab,2,SS,Pulmonary sepsis,2,M,DE,56
163862489,2,Transitional cell carcinoma,9,F,EXP,ipilimumab,2,SS,Pulmonary sepsis,2,M,HO,56
163862489,2,Transitional cell carcinoma,9,F,EXP,ipilimumab,2,SS,Pulmonary sepsis,2,M,LT,56
163863183,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Disease progression,1,M,DE,245
163863183,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Disease progression,1,M,HO,245
163863183,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Haemochromatosis,1,M,DE,245
163863183,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Haemochromatosis,1,M,HO,245
163863183,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Platelet count decreased,1,M,DE,245
163863183,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Platelet count decreased,1,M,HO,245
163873512,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Lymphadenopathy,1,M,OT,55
163873512,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Lymphadenopathy,1,M,HO,55
163873512,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,55
163873512,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,55
163873512,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Orthostatic hypotension,1,M,OT,55
163873512,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Orthostatic hypotension,1,M,HO,55
163873512,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Pericarditis,1,M,OT,55
163873512,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Pericarditis,1,M,HO,55
163875503,1,Bone cancer,3,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,OT,1038
163875503,1,Bone cancer,3,F,EXP,enzalutamide,1,PS,Dementia,1,M,OT,1038
163875503,1,Bone cancer,3,F,EXP,enzalutamide,1,PS,Drug ineffective,1,M,OT,1038
163875503,1,Bone cancer,3,F,EXP,enzalutamide,1,PS,Hypersomnia,1,M,OT,1038
163875503,1,Bone cancer,3,F,EXP,enzalutamide,1,PS,Nausea,1,M,OT,1038
163875503,1,Bone cancer,3,F,EXP,enzalutamide,1,PS,Product dose omission,1,M,OT,1038
163875503,1,Bone cancer,3,F,EXP,enzalutamide,1,PS,Product use complaint,1,M,OT,1038
163875503,1,Bone cancer,3,F,EXP,enzalutamide,1,PS,Prostatic specific antigen increased,1,M,OT,1038
163875503,1,Bone cancer,3,F,EXP,enzalutamide,1,PS,Vomiting,1,M,OT,1038
163875503,1,Bone cancer,3,F,EXP,enzalutamide,1,PS,Weight decreased,1,M,OT,1038
163903504,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Cardiac failure acute,1,F,DE,438
163903504,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Cardiac failure acute,1,F,OT,438
163903504,2,Pleural mesothelioma,4,F,EXP,ipilimumab,2,SS,Cardiac failure acute,2,F,DE,438
163903504,2,Pleural mesothelioma,4,F,EXP,ipilimumab,2,SS,Cardiac failure acute,2,F,OT,438
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Dysuria,1,M,DE,15
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Dysuria,1,M,HO,15
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Dysuria,1,M,OT,15
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Purpura,1,M,DE,15
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Purpura,1,M,HO,15
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Purpura,1,M,OT,15
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Rectal haemorrhage,1,M,DE,15
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Rectal haemorrhage,1,M,HO,15
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Rectal haemorrhage,1,M,OT,15
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Renal cancer,1,M,DE,15
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Renal cancer,1,M,HO,15
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Renal cancer,1,M,OT,15
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Septic shock,1,M,DE,15
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Septic shock,1,M,HO,15
163927552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Septic shock,1,M,OT,15
163937665,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Disorientation,3,M,HO,28
163937665,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Disorientation,3,M,LT,28
163937665,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Disorientation,3,M,OT,28
163937665,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Tubulointerstitial nephritis,3,M,HO,28
163937665,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Tubulointerstitial nephritis,3,M,LT,28
163937665,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Tubulointerstitial nephritis,3,M,OT,28
163963122,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Cerebral ischaemia,2,M,OT,1
163963122,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Cerebral ischaemia,2,M,HO,1
163963122,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Cerebral ischaemia,2,M,DE,1
163963122,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Intestinal perforation,2,M,OT,1
163963122,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Intestinal perforation,2,M,HO,1
163963122,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Intestinal perforation,2,M,DE,1
163963305,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Bleeding varicose vein,1,F,OT,315
163963305,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Bleeding varicose vein,1,F,LT,315
163963305,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Bleeding varicose vein,1,F,HO,315
163963305,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Bleeding varicose vein,1,F,DS,315
163963305,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Portal vein thrombosis,1,F,OT,315
163963305,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Portal vein thrombosis,1,F,LT,315
163963305,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Portal vein thrombosis,1,F,HO,315
163963305,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Portal vein thrombosis,1,F,DS,315
164036357,6,B-cell lymphoma,7,F,EXP,ibrutinib,6,SS,Biliary tract infection,6,F,HO,73
164036357,6,B-cell lymphoma,7,F,EXP,ibrutinib,6,SS,Blood bilirubin increased,6,F,HO,73
164036357,6,B-cell lymphoma,7,F,EXP,ibrutinib,6,SS,Pyrexia,6,F,HO,73
164036357,12,B-cell lymphoma,7,F,EXP,lenalidomide,12,SS,Biliary tract infection,12,F,HO,73
164036357,12,B-cell lymphoma,7,F,EXP,lenalidomide,12,SS,Blood bilirubin increased,12,F,HO,73
164036357,12,B-cell lymphoma,7,F,EXP,lenalidomide,12,SS,Pyrexia,12,F,HO,73
164059905,1,Hodgkin's disease,5,F,EXP,brentuximab vedotin,1,PS,Seizure,1,M,OT,46
164059905,1,Hodgkin's disease,5,F,EXP,brentuximab vedotin,1,PS,Seizure,1,M,HO,46
164059905,1,Hodgkin's disease,5,F,EXP,brentuximab vedotin,1,PS,Seizure,1,M,LT,46
164063462,2,Mantle cell lymphoma,2,F,EXP,ibrutinib,2,SS,Pneumonia,2,M,HO,79
164064776,1,Hormone-refractory prostate cancer,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,159
164064776,1,Hormone-refractory prostate cancer,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,159
164064776,1,Hormone-refractory prostate cancer,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,159
164064776,1,Hormone-refractory prostate cancer,6,F,EXP,nivolumab,1,PS,Platelet count decreased,1,M,OT,159
164064776,1,Hormone-refractory prostate cancer,6,F,EXP,nivolumab,1,PS,Platelet count decreased,1,M,DE,159
164064776,1,Hormone-refractory prostate cancer,6,F,EXP,nivolumab,1,PS,Platelet count decreased,1,M,LT,159
164064776,3,Product used for unknown indication,6,F,EXP,cabazitaxel,3,SS,Malignant neoplasm progression,3,M,OT,4
164064776,3,Product used for unknown indication,6,F,EXP,cabazitaxel,3,SS,Malignant neoplasm progression,3,M,DE,4
164064776,3,Product used for unknown indication,6,F,EXP,cabazitaxel,3,SS,Malignant neoplasm progression,3,M,LT,4
164064776,3,Product used for unknown indication,6,F,EXP,cabazitaxel,3,SS,Platelet count decreased,3,M,OT,4
164064776,3,Product used for unknown indication,6,F,EXP,cabazitaxel,3,SS,Platelet count decreased,3,M,DE,4
164064776,3,Product used for unknown indication,6,F,EXP,cabazitaxel,3,SS,Platelet count decreased,3,M,LT,4
164066632,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Dermatitis,2,M,HO,152
164066693,2,Non-small cell lung cancer,3,F,EXP,nivolumab,2,PS,Pneumocystis jirovecii pneumonia,2,M,HO,421
164066693,2,Non-small cell lung cancer,3,F,EXP,nivolumab,2,PS,Pneumocystis jirovecii pneumonia,2,M,OT,421
164067384,4,Metastatic malignant melanoma,4,F,EXP,trametinib,4,SS,Fatigue,4,F,LT,320
164067384,4,Metastatic malignant melanoma,4,F,EXP,trametinib,4,SS,Fatigue,4,F,OT,320
164067384,4,Metastatic malignant melanoma,4,F,EXP,trametinib,4,SS,Hepatic enzyme increased,4,F,LT,320
164067384,4,Metastatic malignant melanoma,4,F,EXP,trametinib,4,SS,Hepatic enzyme increased,4,F,OT,320
164067384,4,Metastatic malignant melanoma,4,F,EXP,trametinib,4,SS,Nail bed inflammation,4,F,LT,320
164067384,4,Metastatic malignant melanoma,4,F,EXP,trametinib,4,SS,Nail bed inflammation,4,F,OT,320
164069444,1,Osteogenesis imperfecta,4,F,PER,denosumab,1,PS,Femur fracture,1,F,HO,326
164162983,3,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,3,C,Pericardial effusion,3,M,OT,36
164162983,3,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,3,C,Pericardial effusion,3,M,HO,36
164162983,3,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,3,C,Pericardial effusion,3,M,LT,36
164166445,3,Stem cell transplant,5,F,EXP,lenalidomide,3,SS,Basal cell carcinoma,3,M,OT,830
164166445,3,Stem cell transplant,5,F,EXP,lenalidomide,3,SS,Colon neoplasm,3,M,OT,830
164166445,3,Stem cell transplant,5,F,EXP,lenalidomide,3,SS,Second primary malignancy,3,M,OT,830
164167958,1,Breast cancer,8,F,EXP,palbociclib,1,PS,Sepsis,1,F,HO,435
164167958,1,Breast cancer,8,F,EXP,palbociclib,1,PS,Sepsis,1,F,LT,435
164167958,1,Breast cancer,8,F,EXP,palbociclib,1,PS,Sepsis,1,F,OT,435
164245782,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Cholangitis,1,M,OT,50
164245782,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Cholangitis,1,M,HO,50
164245782,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Hepatitis,1,M,OT,50
164245782,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Hepatitis,1,M,HO,50
164245782,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,50
164245782,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,50
164245782,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,50
164245782,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,50
164245782,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Cholangitis,2,M,OT,29
164245782,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Cholangitis,2,M,HO,29
164245782,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Hepatitis,2,M,OT,29
164245782,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Hepatitis,2,M,HO,29
164245782,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Pneumonia,2,M,OT,29
164245782,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Pneumonia,2,M,HO,29
164245782,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Pyrexia,2,M,OT,29
164245782,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Pyrexia,2,M,HO,29
164245782,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Cholangitis,3,M,OT,5
164245782,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Cholangitis,3,M,HO,5
164245782,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Hepatitis,3,M,OT,5
164245782,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Hepatitis,3,M,HO,5
164245782,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pneumonia,3,M,OT,5
164245782,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pneumonia,3,M,HO,5
164245782,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pyrexia,3,M,OT,5
164245782,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pyrexia,3,M,HO,5
164245782,4,Renal cancer metastatic,2,F,EXP,ipilimumab,4,SS,Cholangitis,4,M,OT,50
164245782,4,Renal cancer metastatic,2,F,EXP,ipilimumab,4,SS,Cholangitis,4,M,HO,50
164245782,4,Renal cancer metastatic,2,F,EXP,ipilimumab,4,SS,Hepatitis,4,M,OT,50
164245782,4,Renal cancer metastatic,2,F,EXP,ipilimumab,4,SS,Hepatitis,4,M,HO,50
164245782,4,Renal cancer metastatic,2,F,EXP,ipilimumab,4,SS,Pneumonia,4,M,OT,50
164245782,4,Renal cancer metastatic,2,F,EXP,ipilimumab,4,SS,Pneumonia,4,M,HO,50
164245782,4,Renal cancer metastatic,2,F,EXP,ipilimumab,4,SS,Pyrexia,4,M,OT,50
164245782,4,Renal cancer metastatic,2,F,EXP,ipilimumab,4,SS,Pyrexia,4,M,HO,50
164245782,5,Product used for unknown indication,2,F,EXP,ipilimumab,5,SS,Cholangitis,5,M,OT,29
164245782,5,Product used for unknown indication,2,F,EXP,ipilimumab,5,SS,Cholangitis,5,M,HO,29
164245782,5,Product used for unknown indication,2,F,EXP,ipilimumab,5,SS,Hepatitis,5,M,OT,29
164245782,5,Product used for unknown indication,2,F,EXP,ipilimumab,5,SS,Hepatitis,5,M,HO,29
164245782,5,Product used for unknown indication,2,F,EXP,ipilimumab,5,SS,Pneumonia,5,M,OT,29
164245782,5,Product used for unknown indication,2,F,EXP,ipilimumab,5,SS,Pneumonia,5,M,HO,29
164245782,5,Product used for unknown indication,2,F,EXP,ipilimumab,5,SS,Pyrexia,5,M,OT,29
164245782,5,Product used for unknown indication,2,F,EXP,ipilimumab,5,SS,Pyrexia,5,M,HO,29
164245782,6,Product used for unknown indication,2,F,EXP,ipilimumab,6,SS,Cholangitis,6,M,OT,5
164245782,6,Product used for unknown indication,2,F,EXP,ipilimumab,6,SS,Cholangitis,6,M,HO,5
164245782,6,Product used for unknown indication,2,F,EXP,ipilimumab,6,SS,Hepatitis,6,M,OT,5
164245782,6,Product used for unknown indication,2,F,EXP,ipilimumab,6,SS,Hepatitis,6,M,HO,5
164245782,6,Product used for unknown indication,2,F,EXP,ipilimumab,6,SS,Pneumonia,6,M,OT,5
164245782,6,Product used for unknown indication,2,F,EXP,ipilimumab,6,SS,Pneumonia,6,M,HO,5
164245782,6,Product used for unknown indication,2,F,EXP,ipilimumab,6,SS,Pyrexia,6,M,OT,5
164245782,6,Product used for unknown indication,2,F,EXP,ipilimumab,6,SS,Pyrexia,6,M,HO,5
164265646,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,OT,136
164265646,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,DE,136
164265646,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,HO,136
164265646,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,LT,136
164265646,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,OT,136
164265646,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,DE,136
164265646,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,HO,136
164265646,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,LT,136
164265646,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Autoimmune hepatitis,2,M,OT,16
164265646,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Autoimmune hepatitis,2,M,DE,16
164265646,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Autoimmune hepatitis,2,M,HO,16
164265646,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Autoimmune hepatitis,2,M,LT,16
164265646,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Multiple organ dysfunction syndrome,2,M,OT,16
164265646,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Multiple organ dysfunction syndrome,2,M,DE,16
164265646,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Multiple organ dysfunction syndrome,2,M,HO,16
164265646,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Multiple organ dysfunction syndrome,2,M,LT,16
164265646,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Autoimmune hepatitis,3,M,OT,121
164265646,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Autoimmune hepatitis,3,M,DE,121
164265646,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Autoimmune hepatitis,3,M,HO,121
164265646,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Autoimmune hepatitis,3,M,LT,121
164265646,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Multiple organ dysfunction syndrome,3,M,OT,121
164265646,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Multiple organ dysfunction syndrome,3,M,DE,121
164265646,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Multiple organ dysfunction syndrome,3,M,HO,121
164265646,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Multiple organ dysfunction syndrome,3,M,LT,121
164265646,4,Product used for unknown indication,6,F,EXP,nivolumab,4,SS,Autoimmune hepatitis,4,M,OT,107
164265646,4,Product used for unknown indication,6,F,EXP,nivolumab,4,SS,Autoimmune hepatitis,4,M,DE,107
164265646,4,Product used for unknown indication,6,F,EXP,nivolumab,4,SS,Autoimmune hepatitis,4,M,HO,107
164265646,4,Product used for unknown indication,6,F,EXP,nivolumab,4,SS,Autoimmune hepatitis,4,M,LT,107
164265646,4,Product used for unknown indication,6,F,EXP,nivolumab,4,SS,Multiple organ dysfunction syndrome,4,M,OT,107
164265646,4,Product used for unknown indication,6,F,EXP,nivolumab,4,SS,Multiple organ dysfunction syndrome,4,M,DE,107
164265646,4,Product used for unknown indication,6,F,EXP,nivolumab,4,SS,Multiple organ dysfunction syndrome,4,M,HO,107
164265646,4,Product used for unknown indication,6,F,EXP,nivolumab,4,SS,Multiple organ dysfunction syndrome,4,M,LT,107
164265646,5,Product used for unknown indication,6,F,EXP,nivolumab,5,SS,Autoimmune hepatitis,5,M,OT,93
164265646,5,Product used for unknown indication,6,F,EXP,nivolumab,5,SS,Autoimmune hepatitis,5,M,DE,93
164265646,5,Product used for unknown indication,6,F,EXP,nivolumab,5,SS,Autoimmune hepatitis,5,M,HO,93
164265646,5,Product used for unknown indication,6,F,EXP,nivolumab,5,SS,Autoimmune hepatitis,5,M,LT,93
164265646,5,Product used for unknown indication,6,F,EXP,nivolumab,5,SS,Multiple organ dysfunction syndrome,5,M,OT,93
164265646,5,Product used for unknown indication,6,F,EXP,nivolumab,5,SS,Multiple organ dysfunction syndrome,5,M,DE,93
164265646,5,Product used for unknown indication,6,F,EXP,nivolumab,5,SS,Multiple organ dysfunction syndrome,5,M,HO,93
164265646,5,Product used for unknown indication,6,F,EXP,nivolumab,5,SS,Multiple organ dysfunction syndrome,5,M,LT,93
164265646,6,Product used for unknown indication,6,F,EXP,nivolumab,6,SS,Autoimmune hepatitis,6,M,OT,65
164265646,6,Product used for unknown indication,6,F,EXP,nivolumab,6,SS,Autoimmune hepatitis,6,M,DE,65
164265646,6,Product used for unknown indication,6,F,EXP,nivolumab,6,SS,Autoimmune hepatitis,6,M,HO,65
164265646,6,Product used for unknown indication,6,F,EXP,nivolumab,6,SS,Autoimmune hepatitis,6,M,LT,65
164265646,6,Product used for unknown indication,6,F,EXP,nivolumab,6,SS,Multiple organ dysfunction syndrome,6,M,OT,65
164265646,6,Product used for unknown indication,6,F,EXP,nivolumab,6,SS,Multiple organ dysfunction syndrome,6,M,DE,65
164265646,6,Product used for unknown indication,6,F,EXP,nivolumab,6,SS,Multiple organ dysfunction syndrome,6,M,HO,65
164265646,6,Product used for unknown indication,6,F,EXP,nivolumab,6,SS,Multiple organ dysfunction syndrome,6,M,LT,65
164265646,7,Product used for unknown indication,6,F,EXP,nivolumab,7,SS,Autoimmune hepatitis,7,M,OT,51
164265646,7,Product used for unknown indication,6,F,EXP,nivolumab,7,SS,Autoimmune hepatitis,7,M,DE,51
164265646,7,Product used for unknown indication,6,F,EXP,nivolumab,7,SS,Autoimmune hepatitis,7,M,HO,51
164265646,7,Product used for unknown indication,6,F,EXP,nivolumab,7,SS,Autoimmune hepatitis,7,M,LT,51
164265646,7,Product used for unknown indication,6,F,EXP,nivolumab,7,SS,Multiple organ dysfunction syndrome,7,M,OT,51
164265646,7,Product used for unknown indication,6,F,EXP,nivolumab,7,SS,Multiple organ dysfunction syndrome,7,M,DE,51
164265646,7,Product used for unknown indication,6,F,EXP,nivolumab,7,SS,Multiple organ dysfunction syndrome,7,M,HO,51
164265646,7,Product used for unknown indication,6,F,EXP,nivolumab,7,SS,Multiple organ dysfunction syndrome,7,M,LT,51
164265646,8,Product used for unknown indication,6,F,EXP,nivolumab,8,SS,Autoimmune hepatitis,8,M,OT,40
164265646,8,Product used for unknown indication,6,F,EXP,nivolumab,8,SS,Autoimmune hepatitis,8,M,DE,40
164265646,8,Product used for unknown indication,6,F,EXP,nivolumab,8,SS,Autoimmune hepatitis,8,M,HO,40
164265646,8,Product used for unknown indication,6,F,EXP,nivolumab,8,SS,Autoimmune hepatitis,8,M,LT,40
164265646,8,Product used for unknown indication,6,F,EXP,nivolumab,8,SS,Multiple organ dysfunction syndrome,8,M,OT,40
164265646,8,Product used for unknown indication,6,F,EXP,nivolumab,8,SS,Multiple organ dysfunction syndrome,8,M,DE,40
164265646,8,Product used for unknown indication,6,F,EXP,nivolumab,8,SS,Multiple organ dysfunction syndrome,8,M,HO,40
164265646,8,Product used for unknown indication,6,F,EXP,nivolumab,8,SS,Multiple organ dysfunction syndrome,8,M,LT,40
164265646,9,Product used for unknown indication,6,F,EXP,nivolumab,9,SS,Autoimmune hepatitis,9,M,OT,37
164265646,9,Product used for unknown indication,6,F,EXP,nivolumab,9,SS,Autoimmune hepatitis,9,M,DE,37
164265646,9,Product used for unknown indication,6,F,EXP,nivolumab,9,SS,Autoimmune hepatitis,9,M,HO,37
164265646,9,Product used for unknown indication,6,F,EXP,nivolumab,9,SS,Autoimmune hepatitis,9,M,LT,37
164265646,9,Product used for unknown indication,6,F,EXP,nivolumab,9,SS,Multiple organ dysfunction syndrome,9,M,OT,37
164265646,9,Product used for unknown indication,6,F,EXP,nivolumab,9,SS,Multiple organ dysfunction syndrome,9,M,DE,37
164265646,9,Product used for unknown indication,6,F,EXP,nivolumab,9,SS,Multiple organ dysfunction syndrome,9,M,HO,37
164265646,9,Product used for unknown indication,6,F,EXP,nivolumab,9,SS,Multiple organ dysfunction syndrome,9,M,LT,37
164265646,10,Product used for unknown indication,6,F,EXP,nivolumab,10,SS,Autoimmune hepatitis,10,M,OT,16
164265646,10,Product used for unknown indication,6,F,EXP,nivolumab,10,SS,Autoimmune hepatitis,10,M,DE,16
164265646,10,Product used for unknown indication,6,F,EXP,nivolumab,10,SS,Autoimmune hepatitis,10,M,HO,16
164265646,10,Product used for unknown indication,6,F,EXP,nivolumab,10,SS,Autoimmune hepatitis,10,M,LT,16
164265646,10,Product used for unknown indication,6,F,EXP,nivolumab,10,SS,Multiple organ dysfunction syndrome,10,M,OT,16
164265646,10,Product used for unknown indication,6,F,EXP,nivolumab,10,SS,Multiple organ dysfunction syndrome,10,M,DE,16
164265646,10,Product used for unknown indication,6,F,EXP,nivolumab,10,SS,Multiple organ dysfunction syndrome,10,M,HO,16
164265646,10,Product used for unknown indication,6,F,EXP,nivolumab,10,SS,Multiple organ dysfunction syndrome,10,M,LT,16
164265646,11,Malignant melanoma,6,F,EXP,ipilimumab,11,SS,Autoimmune hepatitis,11,M,OT,37
164265646,11,Malignant melanoma,6,F,EXP,ipilimumab,11,SS,Autoimmune hepatitis,11,M,DE,37
164265646,11,Malignant melanoma,6,F,EXP,ipilimumab,11,SS,Autoimmune hepatitis,11,M,HO,37
164265646,11,Malignant melanoma,6,F,EXP,ipilimumab,11,SS,Autoimmune hepatitis,11,M,LT,37
164265646,11,Malignant melanoma,6,F,EXP,ipilimumab,11,SS,Multiple organ dysfunction syndrome,11,M,OT,37
164265646,11,Malignant melanoma,6,F,EXP,ipilimumab,11,SS,Multiple organ dysfunction syndrome,11,M,DE,37
164265646,11,Malignant melanoma,6,F,EXP,ipilimumab,11,SS,Multiple organ dysfunction syndrome,11,M,HO,37
164265646,11,Malignant melanoma,6,F,EXP,ipilimumab,11,SS,Multiple organ dysfunction syndrome,11,M,LT,37
164265646,12,Product used for unknown indication,6,F,EXP,ipilimumab,12,SS,Autoimmune hepatitis,12,M,OT,16
164265646,12,Product used for unknown indication,6,F,EXP,ipilimumab,12,SS,Autoimmune hepatitis,12,M,DE,16
164265646,12,Product used for unknown indication,6,F,EXP,ipilimumab,12,SS,Autoimmune hepatitis,12,M,HO,16
164265646,12,Product used for unknown indication,6,F,EXP,ipilimumab,12,SS,Autoimmune hepatitis,12,M,LT,16
164265646,12,Product used for unknown indication,6,F,EXP,ipilimumab,12,SS,Multiple organ dysfunction syndrome,12,M,OT,16
164265646,12,Product used for unknown indication,6,F,EXP,ipilimumab,12,SS,Multiple organ dysfunction syndrome,12,M,DE,16
164265646,12,Product used for unknown indication,6,F,EXP,ipilimumab,12,SS,Multiple organ dysfunction syndrome,12,M,HO,16
164265646,12,Product used for unknown indication,6,F,EXP,ipilimumab,12,SS,Multiple organ dysfunction syndrome,12,M,LT,16
164272702,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Cholangitis,1,F,OT,98
164272702,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Cholangitis,1,F,HO,98
164272702,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Hyperbilirubinaemia,1,F,OT,98
164272702,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Hyperbilirubinaemia,1,F,HO,98
164272702,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Pneumobilia,1,F,OT,98
164272702,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Pneumobilia,1,F,HO,98
164342125,15,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,15,SS,Anorectal cellulitis,15,M,HO,164
164342125,15,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,15,SS,Febrile neutropenia,15,M,HO,164
164342125,15,Acute lymphocytic leukaemia,5,F,EXP,pegaspargase,15,SS,Neutrophil count decreased,15,M,HO,164
164353003,1,Small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,DE,10
164353003,1,Small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,HO,10
164353003,1,Small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,LT,10
164353003,1,Small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,OT,10
164353003,1,Small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Hypotension,1,M,DE,10
164353003,1,Small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Hypotension,1,M,HO,10
164353003,1,Small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Hypotension,1,M,LT,10
164353003,1,Small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Hypotension,1,M,OT,10
164353003,1,Small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,10
164353003,1,Small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,10
164353003,1,Small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,10
164353003,1,Small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,10
164353003,2,Small cell lung cancer recurrent,3,F,EXP,ipilimumab,2,SS,Cardiac arrest,2,M,DE,10
164353003,2,Small cell lung cancer recurrent,3,F,EXP,ipilimumab,2,SS,Cardiac arrest,2,M,HO,10
164353003,2,Small cell lung cancer recurrent,3,F,EXP,ipilimumab,2,SS,Cardiac arrest,2,M,LT,10
164353003,2,Small cell lung cancer recurrent,3,F,EXP,ipilimumab,2,SS,Cardiac arrest,2,M,OT,10
164353003,2,Small cell lung cancer recurrent,3,F,EXP,ipilimumab,2,SS,Hypotension,2,M,DE,10
164353003,2,Small cell lung cancer recurrent,3,F,EXP,ipilimumab,2,SS,Hypotension,2,M,HO,10
164353003,2,Small cell lung cancer recurrent,3,F,EXP,ipilimumab,2,SS,Hypotension,2,M,LT,10
164353003,2,Small cell lung cancer recurrent,3,F,EXP,ipilimumab,2,SS,Hypotension,2,M,OT,10
164353003,2,Small cell lung cancer recurrent,3,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DE,10
164353003,2,Small cell lung cancer recurrent,3,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,HO,10
164353003,2,Small cell lung cancer recurrent,3,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,LT,10
164353003,2,Small cell lung cancer recurrent,3,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,10
164357875,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Renal impairment,1,F,OT,203
164357875,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Renal impairment,1,F,HO,203
1643889012,1,Prostate cancer,12,F,EXP,enzalutamide,1,PS,Colon cancer,1,M,OT,63
1643889012,1,Prostate cancer,12,F,EXP,enzalutamide,1,PS,Colon cancer,1,M,HO,63
1643889012,1,Prostate cancer,12,F,EXP,enzalutamide,1,PS,Delirium,1,M,OT,63
1643889012,1,Prostate cancer,12,F,EXP,enzalutamide,1,PS,Delirium,1,M,HO,63
1643889012,1,Prostate cancer,12,F,EXP,enzalutamide,1,PS,Hepatic function abnormal,1,M,OT,63
1643889012,1,Prostate cancer,12,F,EXP,enzalutamide,1,PS,Hepatic function abnormal,1,M,HO,63
164401079,3,Plasma cell myeloma,9,F,EXP,lenalidomide,3,SS,Pneumonia,3,F,OT,11
164401079,3,Plasma cell myeloma,9,F,EXP,lenalidomide,3,SS,Pneumonia,3,F,HO,11
164440632,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Dermatitis allergic,1,M,HO,4
164440632,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Lymphopenia,1,M,HO,4
164440632,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Pyrexia,1,M,HO,4
164475574,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Anaemia,1,F,HO,42
164475574,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Anaemia,1,F,OT,42
164475574,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Hepatocellular injury,1,F,HO,42
164475574,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Hepatocellular injury,1,F,OT,42
164475574,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Pyrexia,1,F,HO,42
164475574,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Pyrexia,1,F,OT,42
164494202,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Death,1,M,DE,20
164494202,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Death,1,M,OT,20
164494202,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Death,2,M,DE,20
164494202,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Death,2,M,OT,20
164517363,1,B-cell lymphoma,3,F,EXP,lenalidomide,1,PS,Breast cancer,1,F,OT,2450
164540273,14,Prophylaxis,3,F,EXP,granisetron,14,C,Bone marrow failure,14,M,DE,6
164540273,14,Prophylaxis,3,F,EXP,granisetron,14,C,Bone marrow failure,14,M,OT,6
164540273,14,Prophylaxis,3,F,EXP,granisetron,14,C,Decreased appetite,14,M,DE,6
164540273,14,Prophylaxis,3,F,EXP,granisetron,14,C,Decreased appetite,14,M,OT,6
164540273,14,Prophylaxis,3,F,EXP,granisetron,14,C,Leukopenia,14,M,DE,6
164540273,14,Prophylaxis,3,F,EXP,granisetron,14,C,Leukopenia,14,M,OT,6
164540273,14,Prophylaxis,3,F,EXP,granisetron,14,C,Nausea,14,M,DE,6
164540273,14,Prophylaxis,3,F,EXP,granisetron,14,C,Nausea,14,M,OT,6
164540273,14,Prophylaxis,3,F,EXP,granisetron,14,C,Neutrophil count decreased,14,M,DE,6
164540273,14,Prophylaxis,3,F,EXP,granisetron,14,C,Neutrophil count decreased,14,M,OT,6
164540273,14,Prophylaxis,3,F,EXP,granisetron,14,C,Platelet count decreased,14,M,DE,6
164540273,14,Prophylaxis,3,F,EXP,granisetron,14,C,Platelet count decreased,14,M,OT,6
164540273,14,Prophylaxis,3,F,EXP,granisetron,14,C,Pulmonary haemorrhage,14,M,DE,6
164540273,14,Prophylaxis,3,F,EXP,granisetron,14,C,Pulmonary haemorrhage,14,M,OT,6
164540957,1,Prostate cancer,7,F,EXP,enzalutamide,1,SS,Abdominal discomfort,1,M,HO,1371
164540957,1,Prostate cancer,7,F,EXP,enzalutamide,1,SS,Bone pain,1,M,HO,1371
164540957,1,Prostate cancer,7,F,EXP,enzalutamide,1,SS,Myocardial infarction,1,M,HO,1371
164623888,1,Non-small cell lung cancer,8,F,EXP,lorlatinib,1,PS,Malaise,1,F,HO,40
164623888,1,Non-small cell lung cancer,8,F,EXP,lorlatinib,1,PS,Malaise,1,F,DE,40
164623888,1,Non-small cell lung cancer,8,F,EXP,lorlatinib,1,PS,Neoplasm progression,1,F,HO,40
164623888,1,Non-small cell lung cancer,8,F,EXP,lorlatinib,1,PS,Neoplasm progression,1,F,DE,40
164638984,1,B precursor type acute leukaemia,4,F,PER,blinatumomab,1,PS,Blood lactate dehydrogenase increased,1,F,HO,8
164638984,1,B precursor type acute leukaemia,4,F,PER,blinatumomab,1,PS,Blood lactate dehydrogenase increased,1,F,OT,8
164638984,1,B precursor type acute leukaemia,4,F,PER,blinatumomab,1,PS,Hyperphosphataemia,1,F,HO,8
164638984,1,B precursor type acute leukaemia,4,F,PER,blinatumomab,1,PS,Hyperphosphataemia,1,F,OT,8
164638984,1,B precursor type acute leukaemia,4,F,PER,blinatumomab,1,PS,Hyperuricaemia,1,F,HO,8
164638984,1,B precursor type acute leukaemia,4,F,PER,blinatumomab,1,PS,Hyperuricaemia,1,F,OT,8
164638984,1,B precursor type acute leukaemia,4,F,PER,blinatumomab,1,PS,Tumour lysis syndrome,1,F,HO,8
164638984,1,B precursor type acute leukaemia,4,F,PER,blinatumomab,1,PS,Tumour lysis syndrome,1,F,OT,8
1646560010,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Bacteriuria,1,F,OT,29
1646560010,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Blood creatinine increased,1,F,OT,29
1646560010,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone decreased,1,F,OT,29
1646560010,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Blood urine present,1,F,OT,29
1646560010,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Carpal tunnel decompression,1,F,OT,29
1646560010,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Hypersensitivity,1,F,OT,29
1646560010,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,OT,29
1646560010,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,OT,29
1646560010,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Lymphocyte percentage decreased,1,F,OT,29
1646560010,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Neutrophil count decreased,1,F,OT,29
1646560010,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Nitrite urine present,1,F,OT,29
1646560010,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Red blood cells urine positive,1,F,OT,29
1646560010,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,Urinary tract infection bacterial,1,F,OT,29
1646560010,1,Multiple sclerosis,10,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,OT,29
164688025,1,Liposarcoma metastatic,5,F,EXP,cabazitaxel,1,PS,Erysipelas,1,F,HO,305
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,LT,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,HO,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,OT,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,LT,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,HO,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,OT,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,LT,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Insomnia,1,M,LT,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Insomnia,1,M,HO,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Insomnia,1,M,OT,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pain,1,M,LT,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pain,1,M,HO,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pain,1,M,OT,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pancreatitis,1,M,LT,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pancreatitis,1,M,HO,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pancreatitis,1,M,OT,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Renal failure,1,M,LT,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,210
164706485,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,210
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Constipation,2,M,LT,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Constipation,2,M,HO,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Constipation,2,M,OT,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Hyperglycaemia,2,M,LT,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Hyperglycaemia,2,M,HO,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Hyperglycaemia,2,M,OT,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Hypothyroidism,2,M,LT,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Hypothyroidism,2,M,HO,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Hypothyroidism,2,M,OT,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Insomnia,2,M,LT,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Insomnia,2,M,HO,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Insomnia,2,M,OT,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Pain,2,M,LT,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Pain,2,M,HO,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Pain,2,M,OT,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Pancreatitis,2,M,LT,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Pancreatitis,2,M,HO,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Pancreatitis,2,M,OT,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Renal failure,2,M,LT,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Renal failure,2,M,HO,196
164706485,2,Lung neoplasm malignant,5,F,EXP,nivolumab,2,SS,Renal failure,2,M,OT,196
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Constipation,3,M,LT,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Constipation,3,M,HO,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Constipation,3,M,OT,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Hyperglycaemia,3,M,LT,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Hyperglycaemia,3,M,HO,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Hyperglycaemia,3,M,OT,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Hypothyroidism,3,M,LT,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Hypothyroidism,3,M,HO,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Hypothyroidism,3,M,OT,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Insomnia,3,M,LT,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Insomnia,3,M,HO,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Insomnia,3,M,OT,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Pain,3,M,LT,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Pain,3,M,HO,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Pain,3,M,OT,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Pancreatitis,3,M,LT,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Pancreatitis,3,M,HO,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Pancreatitis,3,M,OT,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Renal failure,3,M,LT,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Renal failure,3,M,HO,182
164706485,3,Product used for unknown indication,5,F,EXP,nivolumab,3,SS,Renal failure,3,M,OT,182
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Constipation,4,M,LT,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Constipation,4,M,HO,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Constipation,4,M,OT,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Hyperglycaemia,4,M,LT,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Hyperglycaemia,4,M,HO,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Hyperglycaemia,4,M,OT,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Hypothyroidism,4,M,LT,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Hypothyroidism,4,M,HO,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Hypothyroidism,4,M,OT,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Insomnia,4,M,LT,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Insomnia,4,M,HO,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Insomnia,4,M,OT,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Pain,4,M,LT,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Pain,4,M,HO,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Pain,4,M,OT,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Pancreatitis,4,M,LT,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Pancreatitis,4,M,HO,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Pancreatitis,4,M,OT,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Renal failure,4,M,LT,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Renal failure,4,M,HO,168
164706485,4,Product used for unknown indication,5,F,EXP,nivolumab,4,SS,Renal failure,4,M,OT,168
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Constipation,5,M,LT,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Constipation,5,M,HO,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Constipation,5,M,OT,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Hyperglycaemia,5,M,LT,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Hyperglycaemia,5,M,HO,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Hyperglycaemia,5,M,OT,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Hypothyroidism,5,M,LT,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Hypothyroidism,5,M,HO,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Hypothyroidism,5,M,OT,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Insomnia,5,M,LT,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Insomnia,5,M,HO,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Insomnia,5,M,OT,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Pain,5,M,LT,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Pain,5,M,HO,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Pain,5,M,OT,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Pancreatitis,5,M,LT,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Pancreatitis,5,M,HO,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Pancreatitis,5,M,OT,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Renal failure,5,M,LT,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Renal failure,5,M,HO,127
164706485,5,Product used for unknown indication,5,F,EXP,nivolumab,5,SS,Renal failure,5,M,OT,127
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Constipation,6,M,LT,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Constipation,6,M,HO,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Constipation,6,M,OT,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Hyperglycaemia,6,M,LT,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Hyperglycaemia,6,M,HO,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Hyperglycaemia,6,M,OT,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Hypothyroidism,6,M,LT,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Hypothyroidism,6,M,HO,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Hypothyroidism,6,M,OT,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Insomnia,6,M,LT,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Insomnia,6,M,HO,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Insomnia,6,M,OT,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Pain,6,M,LT,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Pain,6,M,HO,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Pain,6,M,OT,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Pancreatitis,6,M,LT,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Pancreatitis,6,M,HO,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Pancreatitis,6,M,OT,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Renal failure,6,M,LT,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Renal failure,6,M,HO,112
164706485,6,Product used for unknown indication,5,F,EXP,nivolumab,6,SS,Renal failure,6,M,OT,112
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Constipation,7,M,LT,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Constipation,7,M,HO,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Constipation,7,M,OT,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Hyperglycaemia,7,M,LT,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Hyperglycaemia,7,M,HO,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Hyperglycaemia,7,M,OT,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Hypothyroidism,7,M,LT,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Hypothyroidism,7,M,HO,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Hypothyroidism,7,M,OT,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Insomnia,7,M,LT,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Insomnia,7,M,HO,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Insomnia,7,M,OT,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Pain,7,M,LT,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Pain,7,M,HO,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Pain,7,M,OT,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Pancreatitis,7,M,LT,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Pancreatitis,7,M,HO,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Pancreatitis,7,M,OT,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Renal failure,7,M,LT,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Renal failure,7,M,HO,98
164706485,7,Product used for unknown indication,5,F,EXP,nivolumab,7,SS,Renal failure,7,M,OT,98
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Constipation,8,M,LT,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Constipation,8,M,HO,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Constipation,8,M,OT,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Hyperglycaemia,8,M,LT,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Hyperglycaemia,8,M,HO,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Hyperglycaemia,8,M,OT,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Hypothyroidism,8,M,LT,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Hypothyroidism,8,M,HO,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Hypothyroidism,8,M,OT,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Insomnia,8,M,LT,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Insomnia,8,M,HO,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Insomnia,8,M,OT,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Pain,8,M,LT,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Pain,8,M,HO,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Pain,8,M,OT,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Pancreatitis,8,M,LT,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Pancreatitis,8,M,HO,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Pancreatitis,8,M,OT,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Renal failure,8,M,LT,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Renal failure,8,M,HO,85
164706485,8,Product used for unknown indication,5,F,EXP,nivolumab,8,SS,Renal failure,8,M,OT,85
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Constipation,9,M,LT,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Constipation,9,M,HO,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Constipation,9,M,OT,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Hyperglycaemia,9,M,LT,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Hyperglycaemia,9,M,HO,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Hyperglycaemia,9,M,OT,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Hypothyroidism,9,M,LT,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Hypothyroidism,9,M,HO,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Hypothyroidism,9,M,OT,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Insomnia,9,M,LT,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Insomnia,9,M,HO,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Insomnia,9,M,OT,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Pain,9,M,LT,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Pain,9,M,HO,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Pain,9,M,OT,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Pancreatitis,9,M,LT,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Pancreatitis,9,M,HO,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Pancreatitis,9,M,OT,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Renal failure,9,M,LT,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Renal failure,9,M,HO,57
164706485,9,Product used for unknown indication,5,F,EXP,nivolumab,9,SS,Renal failure,9,M,OT,57
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Constipation,10,M,LT,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Constipation,10,M,HO,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Constipation,10,M,OT,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Hyperglycaemia,10,M,LT,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Hyperglycaemia,10,M,HO,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Hyperglycaemia,10,M,OT,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Hypothyroidism,10,M,LT,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Hypothyroidism,10,M,HO,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Hypothyroidism,10,M,OT,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Insomnia,10,M,LT,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Insomnia,10,M,HO,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Insomnia,10,M,OT,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Pain,10,M,LT,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Pain,10,M,HO,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Pain,10,M,OT,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Pancreatitis,10,M,LT,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Pancreatitis,10,M,HO,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Pancreatitis,10,M,OT,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Renal failure,10,M,LT,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Renal failure,10,M,HO,42
164706485,10,Product used for unknown indication,5,F,EXP,nivolumab,10,SS,Renal failure,10,M,OT,42
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Constipation,11,M,LT,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Constipation,11,M,HO,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Constipation,11,M,OT,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Hyperglycaemia,11,M,LT,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Hyperglycaemia,11,M,HO,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Hyperglycaemia,11,M,OT,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Hypothyroidism,11,M,LT,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Hypothyroidism,11,M,HO,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Hypothyroidism,11,M,OT,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Insomnia,11,M,LT,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Insomnia,11,M,HO,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Insomnia,11,M,OT,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Pain,11,M,LT,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Pain,11,M,HO,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Pain,11,M,OT,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Pancreatitis,11,M,LT,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Pancreatitis,11,M,HO,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Pancreatitis,11,M,OT,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Renal failure,11,M,LT,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Renal failure,11,M,HO,28
164706485,11,Product used for unknown indication,5,F,EXP,nivolumab,11,SS,Renal failure,11,M,OT,28
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Constipation,12,M,LT,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Constipation,12,M,HO,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Constipation,12,M,OT,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Hyperglycaemia,12,M,LT,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Hyperglycaemia,12,M,HO,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Hyperglycaemia,12,M,OT,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Hypothyroidism,12,M,LT,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Hypothyroidism,12,M,HO,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Hypothyroidism,12,M,OT,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Insomnia,12,M,LT,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Insomnia,12,M,HO,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Insomnia,12,M,OT,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Pain,12,M,LT,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Pain,12,M,HO,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Pain,12,M,OT,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Pancreatitis,12,M,LT,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Pancreatitis,12,M,HO,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Pancreatitis,12,M,OT,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Renal failure,12,M,LT,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Renal failure,12,M,HO,14
164706485,12,Product used for unknown indication,5,F,EXP,nivolumab,12,SS,Renal failure,12,M,OT,14
164731563,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Enterocolitis,1,F,HO,2
164731563,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Enterocolitis,1,F,OT,2
164731563,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hypophysitis,1,F,HO,2
164731563,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hypophysitis,1,F,OT,2
164731563,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,HO,2
164731563,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,OT,2
164731563,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Iritis,1,F,HO,2
164731563,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Iritis,1,F,OT,2
164731563,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pruritus,1,F,HO,2
164731563,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pruritus,1,F,OT,2
164731563,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,F,HO,2
164731563,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,F,OT,2
164731563,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Enterocolitis,2,F,HO,2
164731563,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Enterocolitis,2,F,OT,2
164731563,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Hypophysitis,2,F,HO,2
164731563,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Hypophysitis,2,F,OT,2
164731563,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,F,HO,2
164731563,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,F,OT,2
164731563,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Iritis,2,F,HO,2
164731563,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Iritis,2,F,OT,2
164731563,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Pruritus,2,F,HO,2
164731563,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Pruritus,2,F,OT,2
164731563,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Rash maculo-papular,2,F,HO,2
164731563,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Rash maculo-papular,2,F,OT,2
164739356,1,Renal cell carcinoma,6,F,EXP,ipilimumab,1,PS,Adrenocorticotropic hormone deficiency,1,M,HO,108
164739356,1,Renal cell carcinoma,6,F,EXP,ipilimumab,1,PS,Adrenocorticotropic hormone deficiency,1,M,OT,108
164739356,1,Renal cell carcinoma,6,F,EXP,ipilimumab,1,PS,Delirium,1,M,HO,108
164739356,1,Renal cell carcinoma,6,F,EXP,ipilimumab,1,PS,Delirium,1,M,OT,108
164739356,1,Renal cell carcinoma,6,F,EXP,ipilimumab,1,PS,Hallucination,1,M,HO,108
164739356,1,Renal cell carcinoma,6,F,EXP,ipilimumab,1,PS,Hallucination,1,M,OT,108
164739356,1,Renal cell carcinoma,6,F,EXP,ipilimumab,1,PS,Pneumonia,1,M,HO,108
164739356,1,Renal cell carcinoma,6,F,EXP,ipilimumab,1,PS,Pneumonia,1,M,OT,108
164739356,2,Renal cell carcinoma,6,F,EXP,nivolumab,2,SS,Adrenocorticotropic hormone deficiency,2,M,HO,108
164739356,2,Renal cell carcinoma,6,F,EXP,nivolumab,2,SS,Adrenocorticotropic hormone deficiency,2,M,OT,108
164739356,2,Renal cell carcinoma,6,F,EXP,nivolumab,2,SS,Delirium,2,M,HO,108
164739356,2,Renal cell carcinoma,6,F,EXP,nivolumab,2,SS,Delirium,2,M,OT,108
164739356,2,Renal cell carcinoma,6,F,EXP,nivolumab,2,SS,Hallucination,2,M,HO,108
164739356,2,Renal cell carcinoma,6,F,EXP,nivolumab,2,SS,Hallucination,2,M,OT,108
164739356,2,Renal cell carcinoma,6,F,EXP,nivolumab,2,SS,Pneumonia,2,M,HO,108
164739356,2,Renal cell carcinoma,6,F,EXP,nivolumab,2,SS,Pneumonia,2,M,OT,108
164739356,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Adrenocorticotropic hormone deficiency,3,M,HO,3
164739356,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Adrenocorticotropic hormone deficiency,3,M,OT,3
164739356,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Delirium,3,M,HO,3
164739356,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Delirium,3,M,OT,3
164739356,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Hallucination,3,M,HO,3
164739356,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Hallucination,3,M,OT,3
164739356,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Pneumonia,3,M,HO,3
164739356,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Pneumonia,3,M,OT,3
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Asthenia,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Back pain,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Back pain,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Barrett's oesophagus,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Barrett's oesophagus,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Constipation,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Constipation,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Diverticulum intestinal,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Diverticulum intestinal,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Duodenal ulcer,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Duodenal ulcer,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Duodenitis,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Duodenitis,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Faeces hard,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Faeces hard,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Fatigue,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Gastritis,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Gastritis,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Gastroenteritis viral,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Gastroenteritis viral,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Joint swelling,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Joint swelling,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Joint warmth,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Joint warmth,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Limb discomfort,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Limb discomfort,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Nausea,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Nausea,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Nocturia,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Nocturia,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Paraesthesia,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Paraesthesia,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Peripheral swelling,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Peripheral swelling,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Peripheral vascular disorder,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Peripheral vascular disorder,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Rectal haemorrhage,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Rectal haemorrhage,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Thrombocytopenia,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Thrombocytopenia,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Visual impairment,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Visual impairment,1,M,HO,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Weight decreased,1,M,OT,274
164749077,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Weight decreased,1,M,HO,274
164760573,1,Metastatic malignant melanoma,3,F,EXP,nivolumab,1,PS,Eosinophilia,1,F,HO,88
164760573,1,Metastatic malignant melanoma,3,F,EXP,nivolumab,1,PS,Gastroenteritis,1,F,HO,88
164795252,24,Product used for unknown indication,2,F,EXP,zoledronic acid,24,C,Blood loss anaemia,24,F,OT,51
164795252,24,Product used for unknown indication,2,F,EXP,zoledronic acid,24,C,Blood loss anaemia,24,F,HO,51
164795252,24,Product used for unknown indication,2,F,EXP,zoledronic acid,24,C,Gastric ulcer haemorrhage,24,F,OT,51
164795252,24,Product used for unknown indication,2,F,EXP,zoledronic acid,24,C,Gastric ulcer haemorrhage,24,F,HO,51
164795252,24,Product used for unknown indication,2,F,EXP,zoledronic acid,24,C,Pneumonia,24,F,OT,51
164795252,24,Product used for unknown indication,2,F,EXP,zoledronic acid,24,C,Pneumonia,24,F,HO,51
164797865,1,Ovarian cancer,5,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,F,OT,12
164797865,1,Ovarian cancer,5,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,F,HO,12
164797865,1,Ovarian cancer,5,F,EXP,nivolumab,1,PS,Neutropenic sepsis,1,F,OT,12
164797865,1,Ovarian cancer,5,F,EXP,nivolumab,1,PS,Neutropenic sepsis,1,F,HO,12
164827263,5,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,5,SS,Febrile neutropenia,5,M,HO,13
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Acute kidney injury,1,M,HO,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Acute kidney injury,1,M,OT,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Autoimmune nephritis,1,M,HO,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Autoimmune nephritis,1,M,OT,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Coagulopathy,1,M,HO,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Coagulopathy,1,M,OT,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Dehydration,1,M,HO,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Dehydration,1,M,OT,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Dyspnoea,1,M,HO,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Dyspnoea,1,M,OT,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,General physical health deterioration,1,M,HO,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,General physical health deterioration,1,M,OT,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Immune-mediated enterocolitis,1,M,HO,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Immune-mediated enterocolitis,1,M,OT,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Immune-mediated hepatitis,1,M,HO,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Immune-mediated hepatitis,1,M,OT,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Intentional product use issue,1,M,HO,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Intentional product use issue,1,M,OT,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Lipoma,1,M,HO,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Lipoma,1,M,OT,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Metastases to adrenals,1,M,HO,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Metastases to adrenals,1,M,OT,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Prescribed underdose,1,M,HO,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Prescribed underdose,1,M,OT,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Renal cyst,1,M,HO,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Renal cyst,1,M,OT,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Vitamin K deficiency,1,M,HO,53
164833283,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Vitamin K deficiency,1,M,OT,53
164833617,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Abdominal pain upper,1,F,OT,10
164833617,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Asthenia,1,F,OT,10
164833617,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Diarrhoea,1,F,OT,10
164833617,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Dysuria,1,F,OT,10
164833617,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Nausea,1,F,OT,10
164833617,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Neuropathy peripheral,1,F,OT,10
164833617,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Rhinorrhoea,1,F,OT,10
164833617,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Vomiting,1,F,OT,10
164833617,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Vulvovaginal inflammation,1,F,OT,10
164878163,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Enterocolitis infectious,1,M,HO,7
164878163,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Hyperglycaemia,1,M,HO,7
164878163,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Hypokalaemia,1,M,HO,7
164878163,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Multiple organ dysfunction syndrome,1,M,HO,7
164878163,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Respiratory failure,1,M,HO,7
164878163,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Sepsis,1,M,HO,7
164878163,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Upper respiratory tract infection,1,M,HO,7
164979863,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Arthropod sting,1,M,OT,29
164979863,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Cataract operation,1,M,OT,29
164979863,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Constipation,1,M,OT,29
164979863,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Contrast media allergy,1,M,OT,29
164979863,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,OT,29
164979863,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Dental caries,1,M,OT,29
164979863,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Diabetes mellitus,1,M,OT,29
164979863,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,29
164979863,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Seborrhoeic keratosis,1,M,OT,29
164980773,1,Chronic myeloid leukaemia,3,F,EXP,nilotinib,1,PS,Lung disorder,1,F,OT,36
164980773,1,Chronic myeloid leukaemia,3,F,EXP,nilotinib,1,PS,Lung disorder,1,F,HO,36
164980773,1,Chronic myeloid leukaemia,3,F,EXP,nilotinib,1,PS,Myocardial infarction,1,F,OT,36
164980773,1,Chronic myeloid leukaemia,3,F,EXP,nilotinib,1,PS,Myocardial infarction,1,F,HO,36
165044907,1,Peripheral T-cell lymphoma unspecified,7,F,EXP,brentuximab vedotin,1,PS,Escherichia urinary tract infection,1,M,DE,24
165044907,1,Peripheral T-cell lymphoma unspecified,7,F,EXP,brentuximab vedotin,1,PS,Escherichia urinary tract infection,1,M,HO,24
165044907,1,Peripheral T-cell lymphoma unspecified,7,F,EXP,brentuximab vedotin,1,PS,Escherichia urinary tract infection,1,M,OT,24
165044907,1,Peripheral T-cell lymphoma unspecified,7,F,EXP,brentuximab vedotin,1,PS,Rash,1,M,DE,24
165044907,1,Peripheral T-cell lymphoma unspecified,7,F,EXP,brentuximab vedotin,1,PS,Rash,1,M,HO,24
165044907,1,Peripheral T-cell lymphoma unspecified,7,F,EXP,brentuximab vedotin,1,PS,Rash,1,M,OT,24
165044907,1,Peripheral T-cell lymphoma unspecified,7,F,EXP,brentuximab vedotin,1,PS,Sepsis,1,M,DE,24
165044907,1,Peripheral T-cell lymphoma unspecified,7,F,EXP,brentuximab vedotin,1,PS,Sepsis,1,M,HO,24
165044907,1,Peripheral T-cell lymphoma unspecified,7,F,EXP,brentuximab vedotin,1,PS,Sepsis,1,M,OT,24
165044907,1,Peripheral T-cell lymphoma unspecified,7,F,EXP,brentuximab vedotin,1,PS,Toxic skin eruption,1,M,DE,24
165044907,1,Peripheral T-cell lymphoma unspecified,7,F,EXP,brentuximab vedotin,1,PS,Toxic skin eruption,1,M,HO,24
165044907,1,Peripheral T-cell lymphoma unspecified,7,F,EXP,brentuximab vedotin,1,PS,Toxic skin eruption,1,M,OT,24
165238294,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,SS,Adrenal disorder,1,M,OT,37
165238294,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,SS,Interstitial lung disease,1,M,OT,37
165238294,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,SS,Pneumonia,1,M,OT,37
165238294,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Adrenal disorder,2,M,OT,5
165238294,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Interstitial lung disease,2,M,OT,5
165238294,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Pneumonia,2,M,OT,5
165238294,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,PS,Adrenal disorder,3,M,OT,37
165238294,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,PS,Interstitial lung disease,3,M,OT,37
165238294,3,Renal cell carcinoma,4,F,EXP,ipilimumab,3,PS,Pneumonia,3,M,OT,37
165249395,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,SS,Hyperglycaemia,1,M,HO,15
165249395,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,PS,Hyperglycaemia,2,M,HO,15
165253925,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,307
165253925,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,307
165253925,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,307
165253925,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Pneumonia,1,M,LT,307
165253925,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,DE,307
165253925,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,307
165253925,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,307
165253925,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,LT,307
165253925,2,Squamous cell carcinoma of head and neck,5,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,DE,307
165253925,2,Squamous cell carcinoma of head and neck,5,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,HO,307
165253925,2,Squamous cell carcinoma of head and neck,5,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,OT,307
165253925,2,Squamous cell carcinoma of head and neck,5,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,LT,307
165253925,2,Squamous cell carcinoma of head and neck,5,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,DE,307
165253925,2,Squamous cell carcinoma of head and neck,5,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,HO,307
165253925,2,Squamous cell carcinoma of head and neck,5,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,OT,307
165253925,2,Squamous cell carcinoma of head and neck,5,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,LT,307
165277868,1,Relapsing-remitting multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Alanine aminotransferase increased,1,F,HO,2
165277868,1,Relapsing-remitting multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Autoimmune neutropenia,1,F,HO,2
165277868,1,Relapsing-remitting multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,F,HO,2
165277868,1,Relapsing-remitting multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Influenza,1,F,HO,2
165279632,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Back pain,1,F,HO,2
165279632,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Respiratory failure,1,F,HO,2
165279632,3,Plasma cell myeloma,2,F,PER,lenalidomide,3,SS,Back pain,3,F,HO,2
165279632,3,Plasma cell myeloma,2,F,PER,lenalidomide,3,SS,Respiratory failure,3,F,HO,2
165281204,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,F,DE,476
165281204,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,F,HO,476
165281204,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,F,OT,476
165281204,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Rash maculo-papular,1,F,DE,476
165281204,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Rash maculo-papular,1,F,HO,476
165281204,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Rash maculo-papular,1,F,OT,476
165281204,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Seizure,1,F,DE,476
165281204,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Seizure,1,F,HO,476
165281204,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Seizure,1,F,OT,476
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Anaemia,1,M,LT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,LT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,HO,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,OT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,M,LT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,M,HO,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,M,OT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,M,LT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,M,HO,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,M,OT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,LT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,HO,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,OT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hypertension,1,M,LT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hypertension,1,M,HO,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Hypertension,1,M,OT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,LT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,HO,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,OT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Renal failure,1,M,LT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Small intestinal haemorrhage,1,M,LT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Small intestinal haemorrhage,1,M,HO,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Small intestinal haemorrhage,1,M,OT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Subcutaneous abscess,1,M,LT,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Subcutaneous abscess,1,M,HO,14
165281227,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Subcutaneous abscess,1,M,OT,14
165282058,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Angioedema,1,M,OT,75
165282058,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Arthralgia,1,M,OT,75
165282058,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Cataract operation,1,M,OT,75
165282058,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Dysgeusia,1,M,OT,75
165282058,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Fall,1,M,OT,75
165282058,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Malaise,1,M,OT,75
165282058,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Nasopharyngitis,1,M,OT,75
165282058,1,Hormone-refractory prostate cancer,8,F,EXP,enzalutamide,1,PS,Pyrexia,1,M,OT,75
165291349,1,Hormone-refractory prostate cancer,9,F,EXP,enzalutamide,1,PS,Abdominal discomfort,1,M,OT,27
165291349,1,Hormone-refractory prostate cancer,9,F,EXP,enzalutamide,1,PS,Cellulitis,1,M,OT,27
165291349,1,Hormone-refractory prostate cancer,9,F,EXP,enzalutamide,1,PS,Gastroenteritis radiation,1,M,OT,27
165291349,1,Hormone-refractory prostate cancer,9,F,EXP,enzalutamide,1,PS,Gingival pain,1,M,OT,27
165291349,1,Hormone-refractory prostate cancer,9,F,EXP,enzalutamide,1,PS,Hypoacusis,1,M,OT,27
165291349,1,Hormone-refractory prostate cancer,9,F,EXP,enzalutamide,1,PS,Injury,1,M,OT,27
165291349,1,Hormone-refractory prostate cancer,9,F,EXP,enzalutamide,1,PS,Malaise,1,M,OT,27
165291349,1,Hormone-refractory prostate cancer,9,F,EXP,enzalutamide,1,PS,Menopausal symptoms,1,M,OT,27
165291349,1,Hormone-refractory prostate cancer,9,F,EXP,enzalutamide,1,PS,Nasopharyngitis,1,M,OT,27
165291349,1,Hormone-refractory prostate cancer,9,F,EXP,enzalutamide,1,PS,Peripheral motor neuropathy,1,M,OT,27
165303826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Eosinophil count increased,1,M,OT,23
165303826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Eosinophil count increased,1,M,DS,23
165303826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Leukoderma,1,M,OT,23
165303826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Leukoderma,1,M,DS,23
165303826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Rash,1,M,OT,23
165303826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Rash,1,M,DS,23
165303826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Skin disorder,1,M,OT,23
165303826,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Skin disorder,1,M,DS,23
165303826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Eosinophil count increased,3,M,OT,23
165303826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Eosinophil count increased,3,M,DS,23
165303826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Leukoderma,3,M,OT,23
165303826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Leukoderma,3,M,DS,23
165303826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Rash,3,M,OT,23
165303826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Rash,3,M,DS,23
165303826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Skin disorder,3,M,OT,23
165303826,3,Malignant melanoma,6,F,EXP,ipilimumab,3,SS,Skin disorder,3,M,DS,23
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Abdominal pain,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Abdominal pain,8,F,HO,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Abdominal pain lower,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Abdominal pain lower,8,F,HO,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Asthenia,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Asthenia,8,F,HO,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Cellulitis,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Cellulitis,8,F,HO,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Cough,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Cough,8,F,HO,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Ejection fraction decreased,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Ejection fraction decreased,8,F,HO,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Headache,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Headache,8,F,HO,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Lower respiratory tract infection,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Lower respiratory tract infection,8,F,HO,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Mouth swelling,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Mouth swelling,8,F,HO,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Nausea,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Nausea,8,F,HO,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Pain in extremity,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Pain in extremity,8,F,HO,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Superinfection,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Superinfection,8,F,HO,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Swelling face,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Swelling face,8,F,HO,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Urinary tract infection,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Urinary tract infection,8,F,HO,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Vomiting,8,F,DE,36
165325162,8,Constipation,2,F,EXP,denosumab,8,C,Vomiting,8,F,HO,36
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Abdominal pain,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Abdominal pain,9,F,HO,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Abdominal pain lower,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Abdominal pain lower,9,F,HO,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Asthenia,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Asthenia,9,F,HO,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Cellulitis,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Cellulitis,9,F,HO,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Cough,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Cough,9,F,HO,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Ejection fraction decreased,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Ejection fraction decreased,9,F,HO,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Headache,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Headache,9,F,HO,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Lower respiratory tract infection,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Lower respiratory tract infection,9,F,HO,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Mouth swelling,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Mouth swelling,9,F,HO,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Nausea,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Nausea,9,F,HO,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Pain in extremity,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Pain in extremity,9,F,HO,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Superinfection,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Superinfection,9,F,HO,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Swelling face,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Swelling face,9,F,HO,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Urinary tract infection,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Urinary tract infection,9,F,HO,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Vomiting,9,F,DE,33
165325162,9,Constipation,2,F,EXP,denosumab,9,C,Vomiting,9,F,HO,33
1653340717,1,Plasma cell myeloma,17,F,PER,carfilzomib,1,PS,Decubitus ulcer,1,F,HO,18
1653340717,1,Plasma cell myeloma,17,F,PER,carfilzomib,1,PS,Decubitus ulcer,1,F,LT,18
1653340717,1,Plasma cell myeloma,17,F,PER,carfilzomib,1,PS,Pneumonia pseudomonal,1,F,HO,18
1653340717,1,Plasma cell myeloma,17,F,PER,carfilzomib,1,PS,Pneumonia pseudomonal,1,F,LT,18
1653340717,8,Plasma cell myeloma,17,F,PER,lenalidomide,8,SS,Decubitus ulcer,8,F,HO,18
1653340717,8,Plasma cell myeloma,17,F,PER,lenalidomide,8,SS,Decubitus ulcer,8,F,LT,18
1653340717,8,Plasma cell myeloma,17,F,PER,lenalidomide,8,SS,Pneumonia pseudomonal,8,F,HO,18
1653340717,8,Plasma cell myeloma,17,F,PER,lenalidomide,8,SS,Pneumonia pseudomonal,8,F,LT,18
165335733,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,5
165335733,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Urticaria,1,M,HO,5
165335733,6,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,6,SS,Pyrexia,6,M,HO,5
165335733,6,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,6,SS,Urticaria,6,M,HO,5
165336462,1,Glioma,2,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,OT,2
165336462,1,Glioma,2,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,HO,2
165336462,1,Glioma,2,F,EXP,nivolumab,1,PS,Hypocalcaemia,1,M,OT,2
165336462,1,Glioma,2,F,EXP,nivolumab,1,PS,Hypocalcaemia,1,M,HO,2
165336462,1,Glioma,2,F,EXP,nivolumab,1,PS,Meningitis aseptic,1,M,OT,2
165336462,1,Glioma,2,F,EXP,nivolumab,1,PS,Meningitis aseptic,1,M,HO,2
165339383,1,Non-small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,F,OT,70
165339383,1,Non-small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,F,HO,70
165339383,1,Non-small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,OT,70
165339383,1,Non-small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,HO,70
165339383,1,Non-small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Hypoalbuminaemia,1,F,OT,70
165339383,1,Non-small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Hypoalbuminaemia,1,F,HO,70
165339383,1,Non-small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,70
165339383,1,Non-small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,70
165339383,1,Non-small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Seizure,1,F,OT,70
165339383,1,Non-small cell lung cancer recurrent,3,F,EXP,nivolumab,1,PS,Seizure,1,F,HO,70
165346555,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Abdominal pain lower,1,M,LT,48
165346555,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Abdominal pain lower,1,M,HO,48
165346555,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Abdominal pain lower,1,M,DE,48
165346555,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Abdominal pain lower,1,M,OT,48
165346555,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,M,LT,48
165346555,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,M,HO,48
165346555,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,M,DE,48
165346555,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,M,OT,48
165346555,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,LT,48
165346555,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,HO,48
165346555,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,DE,48
165346555,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,OT,48
165346555,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Abdominal pain lower,2,M,LT,48
165346555,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Abdominal pain lower,2,M,HO,48
165346555,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Abdominal pain lower,2,M,DE,48
165346555,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Abdominal pain lower,2,M,OT,48
165346555,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Acute respiratory distress syndrome,2,M,LT,48
165346555,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Acute respiratory distress syndrome,2,M,HO,48
165346555,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Acute respiratory distress syndrome,2,M,DE,48
165346555,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Acute respiratory distress syndrome,2,M,OT,48
165346555,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Constipation,2,M,LT,48
165346555,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Constipation,2,M,HO,48
165346555,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Constipation,2,M,DE,48
165346555,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Constipation,2,M,OT,48
165348298,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Gastrointestinal perforation,1,M,OT,21
165348298,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Gastrointestinal perforation,1,M,LT,21
165348298,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Gastrointestinal perforation,1,M,DE,21
165348298,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Gastrointestinal perforation,1,M,HO,21
165348298,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Liver disorder,1,M,OT,21
165348298,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Liver disorder,1,M,LT,21
165348298,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Liver disorder,1,M,DE,21
165348298,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Liver disorder,1,M,HO,21
165348298,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,21
165348298,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,21
165348298,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,21
165348298,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,21
165348298,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Gastrointestinal perforation,2,M,OT,21
165348298,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Gastrointestinal perforation,2,M,LT,21
165348298,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Gastrointestinal perforation,2,M,DE,21
165348298,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Gastrointestinal perforation,2,M,HO,21
165348298,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Liver disorder,2,M,OT,21
165348298,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Liver disorder,2,M,LT,21
165348298,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Liver disorder,2,M,DE,21
165348298,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Liver disorder,2,M,HO,21
165348298,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,21
165348298,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,LT,21
165348298,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DE,21
165348298,2,Malignant melanoma,8,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,HO,21
165355835,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Arthritis,1,F,HO,309
165355835,2,Product used for unknown indication,5,F,EXP,nivolumab,2,SS,Arthritis,2,F,HO,3
165367006,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Neuropathy peripheral,1,M,OT,4
165367006,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Neuropathy peripheral,1,M,HO,4
165367006,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,4
165367006,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,4
165368422,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Hypersensitivity pneumonitis,1,F,DE,56
165368422,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Hypersensitivity pneumonitis,1,F,OT,56
165368422,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,56
165368422,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,56
165368422,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Musculoskeletal pain,1,F,DE,56
165368422,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Musculoskeletal pain,1,F,OT,56
165387154,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Encephalitis,1,F,OT,13
165387154,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Encephalitis,1,F,HO,13
165387154,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Headache,1,F,OT,13
165387154,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Headache,1,F,HO,13
165387154,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Hypophysitis,1,F,OT,13
165387154,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Hypophysitis,1,F,HO,13
165387154,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Malaise,1,F,OT,13
165387154,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Malaise,1,F,HO,13
165387154,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Pyrexia,1,F,OT,13
165387154,1,Malignant melanoma,4,F,EXP,nivolumab,1,SS,Pyrexia,1,F,HO,13
165387154,4,Malignant melanoma,4,F,EXP,ipilimumab,4,PS,Encephalitis,4,F,OT,13
165387154,4,Malignant melanoma,4,F,EXP,ipilimumab,4,PS,Encephalitis,4,F,HO,13
165387154,4,Malignant melanoma,4,F,EXP,ipilimumab,4,PS,Headache,4,F,OT,13
165387154,4,Malignant melanoma,4,F,EXP,ipilimumab,4,PS,Headache,4,F,HO,13
165387154,4,Malignant melanoma,4,F,EXP,ipilimumab,4,PS,Hypophysitis,4,F,OT,13
165387154,4,Malignant melanoma,4,F,EXP,ipilimumab,4,PS,Hypophysitis,4,F,HO,13
165387154,4,Malignant melanoma,4,F,EXP,ipilimumab,4,PS,Malaise,4,F,OT,13
165387154,4,Malignant melanoma,4,F,EXP,ipilimumab,4,PS,Malaise,4,F,HO,13
165387154,4,Malignant melanoma,4,F,EXP,ipilimumab,4,PS,Pyrexia,4,F,OT,13
165387154,4,Malignant melanoma,4,F,EXP,ipilimumab,4,PS,Pyrexia,4,F,HO,13
165392562,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Abdominal pain,1,F,HO,270
165392562,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,270
165392562,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Headache,1,F,HO,270
165392562,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Skin disorder,1,F,HO,270
165395004,18,Acute lymphocytic leukaemia,4,F,EXP,pegaspargase,18,SS,Anorectal cellulitis,18,M,OT,164
165395004,18,Acute lymphocytic leukaemia,4,F,EXP,pegaspargase,18,SS,Anorectal cellulitis,18,M,HO,164
165395004,18,Acute lymphocytic leukaemia,4,F,EXP,pegaspargase,18,SS,Febrile neutropenia,18,M,OT,164
165395004,18,Acute lymphocytic leukaemia,4,F,EXP,pegaspargase,18,SS,Febrile neutropenia,18,M,HO,164
165395004,18,Acute lymphocytic leukaemia,4,F,EXP,pegaspargase,18,SS,Neutropenia,18,M,OT,164
165395004,18,Acute lymphocytic leukaemia,4,F,EXP,pegaspargase,18,SS,Neutropenia,18,M,HO,164
165395004,18,Acute lymphocytic leukaemia,4,F,EXP,pegaspargase,18,SS,Neutrophil count decreased,18,M,OT,164
165395004,18,Acute lymphocytic leukaemia,4,F,EXP,pegaspargase,18,SS,Neutrophil count decreased,18,M,HO,164
165395004,18,Acute lymphocytic leukaemia,4,F,EXP,pegaspargase,18,SS,Platelet count decreased,18,M,OT,164
165395004,18,Acute lymphocytic leukaemia,4,F,EXP,pegaspargase,18,SS,Platelet count decreased,18,M,HO,164
165412104,1,Prostate cancer metastatic,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,LT,153
165412104,1,Prostate cancer metastatic,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,153
165412104,1,Prostate cancer metastatic,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,153
165412104,1,Prostate cancer metastatic,4,F,EXP,nivolumab,1,PS,Neutropenia,1,M,LT,153
165412104,1,Prostate cancer metastatic,4,F,EXP,nivolumab,1,PS,Neutropenia,1,M,OT,153
165412104,1,Prostate cancer metastatic,4,F,EXP,nivolumab,1,PS,Neutropenia,1,M,HO,153
165412104,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,LT,27
165412104,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,OT,27
165412104,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,HO,27
165412104,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Neutropenia,2,M,LT,27
165412104,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Neutropenia,2,M,OT,27
165412104,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Neutropenia,2,M,HO,27
165421253,1,Ovarian cancer,3,F,EXP,nivolumab,1,PS,Dehydration,1,F,HO,40
165421253,1,Ovarian cancer,3,F,EXP,nivolumab,1,PS,Dehydration,1,F,OT,40
165421253,1,Ovarian cancer,3,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,F,HO,40
165421253,1,Ovarian cancer,3,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,F,OT,40
165422404,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Pancreatic failure,1,M,HO,523
165422404,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Pancreatic failure,1,M,OT,523
165424029,1,Triple negative breast cancer,9,F,PER,talimogene laherparepvec,1,PS,Cytokine release syndrome,1,F,HO,1
165490984,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Embolism,1,M,DS,5
165490984,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Embolism,1,M,HO,5
165490984,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Headache,1,M,DS,5
165490984,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Headache,1,M,HO,5
165490984,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Neutrophil count decreased,1,M,DS,5
165490984,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Neutrophil count decreased,1,M,HO,5
165490984,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,DS,5
165490984,1,B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,HO,5
165491533,1,Ovarian cancer,3,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,F,OT,29
165491533,1,Ovarian cancer,3,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,F,HO,29
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Acute respiratory distress syndrome,3,M,OT,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Acute respiratory distress syndrome,3,M,DE,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Acute respiratory distress syndrome,3,M,LT,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Constipation,3,M,OT,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Constipation,3,M,DE,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Constipation,3,M,LT,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Decreased appetite,3,M,OT,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Decreased appetite,3,M,DE,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Decreased appetite,3,M,LT,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Nausea,3,M,OT,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Nausea,3,M,DE,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Nausea,3,M,LT,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Seizure,3,M,OT,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Seizure,3,M,DE,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Seizure,3,M,LT,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Sudden death,3,M,OT,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Sudden death,3,M,DE,2
165532505,3,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,3,SS,Sudden death,3,M,LT,2
165538313,4,Amyloidosis,3,F,EXP,daratumumab,4,SS,Dehydration,4,F,HO,152
165538313,4,Amyloidosis,3,F,EXP,daratumumab,4,SS,Weight decreased,4,F,HO,152
165553879,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Fatigue,1,M,HO,394
165553879,1,Plasma cell myeloma,9,F,EXP,pomalidomide,1,PS,Lower respiratory tract infection,1,M,HO,394
165562855,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Enterocolitis,1,F,HO,195
165562855,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Enterocolitis,1,F,OT,195
165562855,2,Non-small cell lung cancer,5,F,EXP,ipilimumab,2,SS,Enterocolitis,2,F,HO,195
165562855,2,Non-small cell lung cancer,5,F,EXP,ipilimumab,2,SS,Enterocolitis,2,F,OT,195
165574244,1,Renal cell carcinoma,4,F,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,M,HO,25
165574244,1,Renal cell carcinoma,4,F,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,M,OT,25
165574244,1,Renal cell carcinoma,4,F,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,M,DE,25
165574244,1,Renal cell carcinoma,4,F,EXP,ipilimumab,1,PS,Rheumatoid arthritis,1,M,HO,25
165574244,1,Renal cell carcinoma,4,F,EXP,ipilimumab,1,PS,Rheumatoid arthritis,1,M,OT,25
165574244,1,Renal cell carcinoma,4,F,EXP,ipilimumab,1,PS,Rheumatoid arthritis,1,M,DE,25
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Abdominal pain,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Abdominal pain,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Abdominal pain lower,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Abdominal pain lower,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Asthenia,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Asthenia,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Cellulitis,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Cellulitis,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Cough,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Cough,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Ejection fraction decreased,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Ejection fraction decreased,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Headache,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Headache,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Lower respiratory tract infection,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Lower respiratory tract infection,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Mouth swelling,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Mouth swelling,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Nausea,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Nausea,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Pain in extremity,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Pain in extremity,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Superinfection,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Superinfection,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Swelling face,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Swelling face,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Tooth extraction,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Tooth extraction,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Urinary tract infection,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Urinary tract infection,9,F,HO,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Vomiting,9,F,DE,36
165574432,9,Constipation,2,F,EXP,denosumab,9,C,Vomiting,9,F,HO,36
165614142,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,F,LT,52
165614142,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,F,OT,52
165614142,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,F,HO,52
165614142,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Adrenal insufficiency,3,F,LT,52
165614142,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Adrenal insufficiency,3,F,OT,52
165614142,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Adrenal insufficiency,3,F,HO,52
165630365,2,Amyloidosis,5,F,EXP,daratumumab,2,SS,Hepatomegaly,2,M,HO,21
165630365,2,Amyloidosis,5,F,EXP,daratumumab,2,SS,Hyperbilirubinaemia,2,M,HO,21
165630365,2,Amyloidosis,5,F,EXP,daratumumab,2,SS,Pleural effusion,2,M,HO,21
165632185,1,Myelodysplastic syndrome,5,F,PER,darbepoetin alfa,1,PS,Cardiac failure,1,M,OT,10
165632185,1,Myelodysplastic syndrome,5,F,PER,darbepoetin alfa,1,PS,Cardiac failure,1,M,HO,10
1656695210,2,Mantle cell lymphoma,10,F,EXP,ibrutinib,2,SS,Sudden death,2,M,DE,19
165671623,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,125
165671623,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,125
165671623,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Benign prostatic hyperplasia,1,M,HO,125
165671623,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Benign prostatic hyperplasia,1,M,OT,125
165671623,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,125
165671623,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,125
165671623,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Urinary tract disorder,1,M,HO,125
165671623,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Urinary tract disorder,1,M,OT,125
165677669,1,B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,B-cell lymphoma,1,F,DE,14
165677669,1,B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,B-cell lymphoma,1,F,HO,14
165677669,1,B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,F,DE,14
165677669,1,B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,F,HO,14
165677669,1,B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Cough,1,F,DE,14
165677669,1,B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Cough,1,F,HO,14
165677669,1,B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,F,DE,14
165677669,1,B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,F,HO,14
165677669,1,B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Lethargy,1,F,DE,14
165677669,1,B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Lethargy,1,F,HO,14
165677669,1,B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,F,DE,14
165677669,1,B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,F,HO,14
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Atrioventricular block complete,3,F,OT,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Atrioventricular block complete,3,F,HO,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Atrioventricular block complete,3,F,LT,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Atrioventricular block complete,3,F,DS,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Condition aggravated,3,F,OT,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Condition aggravated,3,F,HO,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Condition aggravated,3,F,LT,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Condition aggravated,3,F,DS,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Depressed level of consciousness,3,F,OT,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Depressed level of consciousness,3,F,HO,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Depressed level of consciousness,3,F,LT,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Depressed level of consciousness,3,F,DS,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Myocarditis,3,F,OT,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Myocarditis,3,F,HO,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Myocarditis,3,F,LT,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Myocarditis,3,F,DS,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Myositis,3,F,OT,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Myositis,3,F,HO,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Myositis,3,F,LT,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Myositis,3,F,DS,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Ventricular fibrillation,3,F,OT,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Ventricular fibrillation,3,F,HO,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Ventricular fibrillation,3,F,LT,47
165702206,3,Non-small cell lung cancer,6,F,EXP,pemetrexed disodium,3,C,Ventricular fibrillation,3,F,DS,47
165740133,1,Oesophageal squamous cell carcinoma,3,F,EXP,nivolumab,1,PS,Abdominal distension,1,M,HO,140
165740133,2,Oesophageal squamous cell carcinoma,3,F,EXP,ipilimumab,2,SS,Abdominal distension,2,M,HO,140
165748806,4,Anaplastic lymphoma kinase gene mutation,6,F,EXP,ceritinib,4,SS,Intentional self-injury,4,F,LT,691
165748806,4,Anaplastic lymphoma kinase gene mutation,6,F,EXP,ceritinib,4,SS,Intentional self-injury,4,F,HO,691
165748806,4,Anaplastic lymphoma kinase gene mutation,6,F,EXP,ceritinib,4,SS,Overdose,4,F,LT,691
165748806,4,Anaplastic lymphoma kinase gene mutation,6,F,EXP,ceritinib,4,SS,Overdose,4,F,HO,691
165748806,4,Anaplastic lymphoma kinase gene mutation,6,F,EXP,ceritinib,4,SS,Somnolence,4,F,LT,691
165748806,4,Anaplastic lymphoma kinase gene mutation,6,F,EXP,ceritinib,4,SS,Somnolence,4,F,HO,691
165764204,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Polyarthritis,1,M,HO,239
165764204,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Polyarthritis,1,M,OT,239
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Anxiety,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Arthralgia,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Balance disorder,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Bone lesion,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Bone pain,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Feeling abnormal,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Food aversion,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Insomnia,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Joint swelling,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Memory impairment,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Musculoskeletal pain,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Neuropathy peripheral,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Pain,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Poor quality sleep,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Product use in unapproved indication,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Prostatic specific antigen increased,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Restlessness,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Taste disorder,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Therapy cessation,1,M,OT,264
165764344,1,Bone cancer,4,F,EXP,enzalutamide,1,PS,Trigger finger,1,M,OT,264
165828915,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,244
165828915,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,LT,244
165828915,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,244
165828915,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Autoimmune nephritis,1,M,OT,244
165828915,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Autoimmune nephritis,1,M,LT,244
165828915,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Autoimmune nephritis,1,M,HO,244
165828915,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Ureterolithiasis,1,M,OT,244
165828915,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Ureterolithiasis,1,M,LT,244
165828915,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Ureterolithiasis,1,M,HO,244
165828915,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,OT,456
165828915,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,LT,456
165828915,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,HO,456
165828915,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Autoimmune nephritis,2,M,OT,456
165828915,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Autoimmune nephritis,2,M,LT,456
165828915,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Autoimmune nephritis,2,M,HO,456
165828915,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Ureterolithiasis,2,M,OT,456
165828915,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Ureterolithiasis,2,M,LT,456
165828915,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Ureterolithiasis,2,M,HO,456
165848793,2,Thyroid cancer metastatic,3,F,EXP,trametinib,2,SS,Infection,2,M,HO,58
165848793,2,Thyroid cancer metastatic,3,F,EXP,trametinib,2,SS,Klebsiella sepsis,2,M,HO,58
165848793,2,Thyroid cancer metastatic,3,F,EXP,trametinib,2,SS,Pneumonia klebsiella,2,M,HO,58
165848793,2,Thyroid cancer metastatic,3,F,EXP,trametinib,2,SS,Pyrexia,2,M,HO,58
165848793,2,Thyroid cancer metastatic,3,F,EXP,trametinib,2,SS,Sepsis,2,M,HO,58
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Blood creatinine increased,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Blood creatinine increased,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Blood creatinine increased,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Colitis,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Colitis,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Colitis,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Eye oedema,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Eye oedema,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Eye oedema,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Fatigue,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Fatigue,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Fatigue,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Hepatitis,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Hepatitis,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Hepatitis,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Hyperthyroidism,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Hyperthyroidism,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Hyperthyroidism,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Influenza like illness,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Influenza like illness,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Influenza like illness,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Keratosis follicular,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Keratosis follicular,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Keratosis follicular,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Lymphocyte count decreased,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Lymphocyte count decreased,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Lymphocyte count decreased,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Nausea,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Nausea,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Nausea,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Palmar-plantar erythrodysaesthesia syndrome,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Palmar-plantar erythrodysaesthesia syndrome,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Palmar-plantar erythrodysaesthesia syndrome,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Psoriasis,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Psoriasis,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Psoriasis,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Rash maculo-papular,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Rash maculo-papular,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Rash maculo-papular,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Seizure,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Seizure,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Seizure,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Transient acantholytic dermatosis,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Transient acantholytic dermatosis,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Transient acantholytic dermatosis,2,M,HO,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Vertigo,2,M,LT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Vertigo,2,M,OT,14
165888982,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Vertigo,2,M,HO,14
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Blood creatinine increased,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Blood creatinine increased,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Blood creatinine increased,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Colitis,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Colitis,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Colitis,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Eye oedema,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Eye oedema,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Eye oedema,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Fatigue,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Fatigue,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Fatigue,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Hepatitis,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Hepatitis,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Hepatitis,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Hyperthyroidism,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Hyperthyroidism,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Hyperthyroidism,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Influenza like illness,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Influenza like illness,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Influenza like illness,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Keratosis follicular,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Keratosis follicular,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Keratosis follicular,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Lymphocyte count decreased,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Lymphocyte count decreased,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Lymphocyte count decreased,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Nausea,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Nausea,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Nausea,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Palmar-plantar erythrodysaesthesia syndrome,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Palmar-plantar erythrodysaesthesia syndrome,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Palmar-plantar erythrodysaesthesia syndrome,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Psoriasis,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Psoriasis,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Psoriasis,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Rash maculo-papular,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Rash maculo-papular,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Rash maculo-papular,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Seizure,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Seizure,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Seizure,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Transient acantholytic dermatosis,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Transient acantholytic dermatosis,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Transient acantholytic dermatosis,6,M,HO,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Vertigo,6,M,LT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Vertigo,6,M,OT,165
165888982,6,Malignant melanoma,2,F,EXP,ipilimumab,6,SS,Vertigo,6,M,HO,165
165893703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Amylase increased,2,M,OT,60
165893703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Arthritis,2,M,OT,60
165893703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Bacterial infection,2,M,OT,60
165893703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Bone pain,2,M,OT,60
165893703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,OT,60
165893703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Endocrine disorder,2,M,OT,60
165893703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Fatigue,2,M,OT,60
165893703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Non-cardiac chest pain,2,M,OT,60
165893703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Rash maculo-papular,2,M,OT,60
165893703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Sialadenosis,2,M,OT,60
165893703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Spinal pain,2,M,OT,60
165922396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Cortisol decreased,1,M,DE,41
165922396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Cortisol decreased,1,M,HO,41
165922396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Cortisol decreased,1,M,OT,41
165922396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Enterocolitis,1,M,DE,41
165922396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Enterocolitis,1,M,HO,41
165922396,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Enterocolitis,1,M,OT,41
165922396,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Cortisol decreased,2,M,DE,41
165922396,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Cortisol decreased,2,M,HO,41
165922396,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Cortisol decreased,2,M,OT,41
165922396,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Enterocolitis,2,M,DE,41
165922396,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Enterocolitis,2,M,HO,41
165922396,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Enterocolitis,2,M,OT,41
165951606,29,Acute lymphocytic leukaemia,6,F,EXP,pegaspargase,29,SS,Cellulitis,29,M,HO,164
165951606,29,Acute lymphocytic leukaemia,6,F,EXP,pegaspargase,29,SS,Febrile neutropenia,29,M,HO,164
165951606,29,Acute lymphocytic leukaemia,6,F,EXP,pegaspargase,29,SS,Neutrophil count decreased,29,M,HO,164
165957605,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,DE,21
165957605,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,HO,21
165957605,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,OT,21
165957605,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Cortisol decreased,1,M,DE,21
165957605,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Cortisol decreased,1,M,HO,21
165957605,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Cortisol decreased,1,M,OT,21
165957605,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,21
165957605,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,21
165957605,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,21
165957605,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Enterocolitis,1,M,DE,21
165957605,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Enterocolitis,1,M,HO,21
165957605,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Enterocolitis,1,M,OT,21
165957605,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Constipation,2,M,DE,21
165957605,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Constipation,2,M,HO,21
165957605,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Constipation,2,M,OT,21
165957605,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Cortisol decreased,2,M,DE,21
165957605,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Cortisol decreased,2,M,HO,21
165957605,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Cortisol decreased,2,M,OT,21
165957605,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,DE,21
165957605,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,21
165957605,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,21
165957605,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Enterocolitis,2,M,DE,21
165957605,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Enterocolitis,2,M,HO,21
165957605,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Enterocolitis,2,M,OT,21
165996216,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Stomatitis,1,M,HO,265
165996216,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Stomatitis,2,M,HO,14
166132575,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Enteritis infectious,2,M,HO,20
166132575,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Neutrophil count decreased,2,M,HO,20
166132575,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Platelet count decreased,2,M,HO,20
166132575,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Pneumonia,2,M,HO,20
166162147,1,Bladder cancer,7,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,LT,125
166162147,1,Bladder cancer,7,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,125
166162147,1,Bladder cancer,7,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,125
166162147,1,Bladder cancer,7,F,EXP,nivolumab,1,PS,Candida infection,1,M,LT,125
166162147,1,Bladder cancer,7,F,EXP,nivolumab,1,PS,Candida infection,1,M,OT,125
166162147,1,Bladder cancer,7,F,EXP,nivolumab,1,PS,Candida infection,1,M,HO,125
166162147,1,Bladder cancer,7,F,EXP,nivolumab,1,PS,Gastrointestinal anastomotic leak,1,M,LT,125
166162147,1,Bladder cancer,7,F,EXP,nivolumab,1,PS,Gastrointestinal anastomotic leak,1,M,OT,125
166162147,1,Bladder cancer,7,F,EXP,nivolumab,1,PS,Gastrointestinal anastomotic leak,1,M,HO,125
166162147,1,Bladder cancer,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,LT,125
166162147,1,Bladder cancer,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,OT,125
166162147,1,Bladder cancer,7,F,EXP,nivolumab,1,PS,Septic shock,1,M,HO,125
166171074,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Pleural effusion,1,F,HO,7
166186077,7,Neoplasm malignant,7,F,EXP,nivolumab,7,C,Disease progression,7,F,HO,178
166186077,7,Neoplasm malignant,7,F,EXP,nivolumab,7,C,Disease progression,7,F,DE,178
166186077,7,Neoplasm malignant,7,F,EXP,nivolumab,7,C,Haematoma,7,F,HO,178
166186077,7,Neoplasm malignant,7,F,EXP,nivolumab,7,C,Haematoma,7,F,DE,178
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Abdominal pain,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Alanine aminotransferase increased,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Aspartate aminotransferase increased,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Azotaemia,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Blood alkaline phosphatase increased,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Blood cholesterol increased,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Blood lactate dehydrogenase increased,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Bronchitis,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,C-reactive protein increased,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Fatigue,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Gamma-glutamyltransferase increased,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Hypercreatininaemia,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Ocular discomfort,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Oedema peripheral,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Pyrexia,1,F,OT,87
166223295,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Red blood cell sedimentation rate increased,1,F,OT,87
166232524,1,Behcet's syndrome,4,F,EXP,thalidomide,1,PS,Pregnancy,1,F,OT,126
166264422,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Radiation skin injury,1,M,OT,209
166264422,2,Head and neck cancer,2,F,EXP,ipilimumab,2,SS,Radiation skin injury,2,M,OT,209
166275029,1,Neuroendocrine carcinoma,9,F,EXP,nivolumab,1,PS,Cognitive disorder,1,F,HO,28
166275029,1,Neuroendocrine carcinoma,9,F,EXP,nivolumab,1,PS,Cognitive disorder,1,F,OT,28
166275029,1,Neuroendocrine carcinoma,9,F,EXP,nivolumab,1,PS,Cognitive disorder,1,F,DE,28
166275029,1,Neuroendocrine carcinoma,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,28
166275029,1,Neuroendocrine carcinoma,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,28
166275029,1,Neuroendocrine carcinoma,9,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,28
166275029,2,Neuroendocrine carcinoma,9,F,EXP,ipilimumab,2,SS,Cognitive disorder,2,F,HO,28
166275029,2,Neuroendocrine carcinoma,9,F,EXP,ipilimumab,2,SS,Cognitive disorder,2,F,OT,28
166275029,2,Neuroendocrine carcinoma,9,F,EXP,ipilimumab,2,SS,Cognitive disorder,2,F,DE,28
166275029,2,Neuroendocrine carcinoma,9,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,HO,28
166275029,2,Neuroendocrine carcinoma,9,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,OT,28
166275029,2,Neuroendocrine carcinoma,9,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,DE,28
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Blood triglycerides increased,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Cough,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Diarrhoea,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Eczema,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Gastritis,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Gastroenteritis,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Hepatic enzyme increased,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,High density lipoprotein increased,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Influenza,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Lip swelling,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Neoplasm progression,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Neurofibroma,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Perichondritis,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Pneumonia,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Pyrexia,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Respiratory syncytial virus infection,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Scoliosis,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Skin abrasion,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Skin ulcer,2,F,OT,24
166299625,2,Neurofibroma,5,F,EXP,trametinib,2,SS,Upper respiratory tract infection,2,F,OT,24
166307752,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Ileus paralytic,1,M,HO,177
166307752,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Ileus paralytic,1,M,OT,177
166307752,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Ileus paralytic,2,M,HO,72
166307752,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Ileus paralytic,2,M,OT,72
166307752,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Ileus paralytic,3,M,HO,58
166307752,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Ileus paralytic,3,M,OT,58
166307944,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Gastric haemorrhage,1,M,OT,56
166307944,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Gastric haemorrhage,1,M,HO,56
166307944,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Insomnia,1,M,OT,56
166307944,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Insomnia,1,M,HO,56
166307944,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Syncope,1,M,OT,56
166307944,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Syncope,1,M,HO,56
166307944,2,Lung neoplasm malignant,4,F,EXP,nivolumab,2,SS,Gastric haemorrhage,2,M,OT,42
166307944,2,Lung neoplasm malignant,4,F,EXP,nivolumab,2,SS,Gastric haemorrhage,2,M,HO,42
166307944,2,Lung neoplasm malignant,4,F,EXP,nivolumab,2,SS,Insomnia,2,M,OT,42
166307944,2,Lung neoplasm malignant,4,F,EXP,nivolumab,2,SS,Insomnia,2,M,HO,42
166307944,2,Lung neoplasm malignant,4,F,EXP,nivolumab,2,SS,Syncope,2,M,OT,42
166307944,2,Lung neoplasm malignant,4,F,EXP,nivolumab,2,SS,Syncope,2,M,HO,42
166338207,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Type 2 diabetes mellitus,1,M,HO,239
166338207,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Type 2 diabetes mellitus,1,M,OT,239
166342432,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Lower limb fracture,1,M,OT,104
166342432,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Lower limb fracture,1,M,HO,104
166342432,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Nasopharyngitis,1,M,OT,104
166342432,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Nasopharyngitis,1,M,HO,104
166342432,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Transaminases increased,1,M,OT,104
166342432,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Transaminases increased,1,M,HO,104
166414772,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Dehydration,1,F,HO,396
166414772,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,396
166427058,4,Plasma cell myeloma,8,F,EXP,daratumumab,4,SS,Chronic kidney disease,4,F,HO,96
166427058,4,Plasma cell myeloma,8,F,EXP,daratumumab,4,SS,Constipation,4,F,HO,96
166427058,4,Plasma cell myeloma,8,F,EXP,daratumumab,4,SS,Dehydration,4,F,HO,96
166427058,4,Plasma cell myeloma,8,F,EXP,daratumumab,4,SS,Nausea,4,F,HO,96
166427058,4,Plasma cell myeloma,8,F,EXP,daratumumab,4,SS,Urinary retention,4,F,HO,96
166427058,4,Plasma cell myeloma,8,F,EXP,daratumumab,4,SS,Vomiting,4,F,HO,96
166452075,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,OT,7
166452075,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,HO,7
166452075,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,DE,7
166452075,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Systemic mycosis,1,F,OT,7
166452075,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Systemic mycosis,1,F,HO,7
166452075,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Systemic mycosis,1,F,DE,7
166540002,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,4
166540002,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Febrile neutropenia,1,M,OT,4
166540002,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Headache,1,M,OT,4
166540002,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Neutrophil count decreased,1,M,OT,4
166540002,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,OT,4
166618552,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Acute kidney injury,2,F,HO,113
166618552,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Acute kidney injury,2,F,OT,113
166618552,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pulmonary sepsis,2,F,HO,113
166618552,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pulmonary sepsis,2,F,OT,113
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Amylase increased,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Amylase increased,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Amylase increased,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase MB increased,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase MB increased,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase MB increased,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Bronchitis,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Bronchitis,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Bronchitis,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Chest pain,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Chest pain,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Chest pain,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Connective tissue disorder,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Connective tissue disorder,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Connective tissue disorder,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Dry eye,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Dry eye,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Dry eye,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Dry mouth,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Dry mouth,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Dry mouth,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Dry skin,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Dry skin,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Dry skin,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Embolism,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Embolism,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Embolism,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Headache,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Headache,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Headache,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Myocardial infarction,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Myocardial infarction,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Myocardial infarction,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Nausea,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pain,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pain,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pain,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Paraesthesia,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Paraesthesia,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Paraesthesia,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Prescribed underdose,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Prescribed underdose,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Prescribed underdose,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pruritus,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pruritus,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pruritus,1,F,LT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Skin disorder,1,F,HO,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Skin disorder,1,F,OT,14
166619024,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Skin disorder,1,F,LT,14
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Anxiety,1,F,OT,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Anxiety,1,F,HO,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Arthropathy,1,F,OT,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Arthropathy,1,F,HO,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Depression,1,F,OT,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Depression,1,F,HO,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Fatigue,1,F,HO,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Lung neoplasm,1,F,OT,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Lung neoplasm,1,F,HO,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Malaise,1,F,OT,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Malaise,1,F,HO,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Pain,1,F,OT,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Pain,1,F,HO,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,OT,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,HO,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Peripheral swelling,1,F,OT,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Peripheral swelling,1,F,HO,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Somnolence,1,F,OT,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Somnolence,1,F,HO,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Viral upper respiratory tract infection,1,F,OT,217
166641024,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Viral upper respiratory tract infection,1,F,HO,217
166702493,1,Prostate cancer metastatic,3,F,EXP,nivolumab,1,PS,Upper respiratory tract infection,1,M,HO,102
166702493,7,Product used for unknown indication,3,F,EXP,granisetron,7,C,Upper respiratory tract infection,7,M,HO,9
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Death,1,M,DE,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Death,1,M,OT,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Death,1,M,LT,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Death,1,M,HO,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,DE,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,LT,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Pyrexia,1,M,DE,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Pyrexia,1,M,LT,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Urosepsis,1,M,DE,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Urosepsis,1,M,OT,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Urosepsis,1,M,LT,12
166710965,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Urosepsis,1,M,HO,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Death,2,M,DE,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Death,2,M,OT,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Death,2,M,LT,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Death,2,M,HO,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,DE,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,OT,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,LT,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,HO,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,DE,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,OT,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,LT,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,HO,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Urosepsis,2,M,DE,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Urosepsis,2,M,OT,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Urosepsis,2,M,LT,12
166710965,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Urosepsis,2,M,HO,12
166722793,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,132
166722793,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,132
166722793,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Necrosis,1,M,OT,132
166722793,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Necrosis,1,M,HO,132
166722793,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Neuralgia,1,M,OT,132
166722793,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Neuralgia,1,M,HO,132
166739952,1,Adenocarcinoma gastric,2,F,EXP,nivolumab,1,PS,Abscess,1,M,HO,26
166739952,1,Adenocarcinoma gastric,2,F,EXP,nivolumab,1,PS,Abscess,1,M,OT,26
166739952,1,Adenocarcinoma gastric,2,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,26
166739952,1,Adenocarcinoma gastric,2,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,26
166739952,3,Adenocarcinoma gastric,2,F,EXP,ipilimumab,3,SS,Abscess,3,M,HO,26
166739952,3,Adenocarcinoma gastric,2,F,EXP,ipilimumab,3,SS,Abscess,3,M,OT,26
166739952,3,Adenocarcinoma gastric,2,F,EXP,ipilimumab,3,SS,Pyrexia,3,M,HO,26
166739952,3,Adenocarcinoma gastric,2,F,EXP,ipilimumab,3,SS,Pyrexia,3,M,OT,26
166755163,7,Plasma cell myeloma,3,F,EXP,pomalidomide,7,SS,Leukopenia,7,F,OT,292
166755163,7,Plasma cell myeloma,3,F,EXP,pomalidomide,7,SS,Neutropenia,7,F,OT,292
166755163,7,Plasma cell myeloma,3,F,EXP,pomalidomide,7,SS,Syncope,7,F,OT,292
166780492,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,F,OT,126
166780492,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,F,HO,126
166780492,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,F,OT,126
166780492,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,F,HO,126
166786092,8,Plasma cell myeloma,2,F,EXP,lenalidomide,8,C,Colitis ischaemic,8,F,LT,184
166786092,8,Plasma cell myeloma,2,F,EXP,lenalidomide,8,C,Colitis ischaemic,8,F,OT,184
166786092,8,Plasma cell myeloma,2,F,EXP,lenalidomide,8,C,Colitis ischaemic,8,F,HO,184
166786092,8,Plasma cell myeloma,2,F,EXP,lenalidomide,8,C,Large intestine perforation,8,F,LT,184
166786092,8,Plasma cell myeloma,2,F,EXP,lenalidomide,8,C,Large intestine perforation,8,F,OT,184
166786092,8,Plasma cell myeloma,2,F,EXP,lenalidomide,8,C,Large intestine perforation,8,F,HO,184
166786092,9,Product used for unknown indication,2,F,EXP,lenalidomide,9,C,Colitis ischaemic,9,F,LT,17
166786092,9,Product used for unknown indication,2,F,EXP,lenalidomide,9,C,Colitis ischaemic,9,F,OT,17
166786092,9,Product used for unknown indication,2,F,EXP,lenalidomide,9,C,Colitis ischaemic,9,F,HO,17
166786092,9,Product used for unknown indication,2,F,EXP,lenalidomide,9,C,Large intestine perforation,9,F,LT,17
166786092,9,Product used for unknown indication,2,F,EXP,lenalidomide,9,C,Large intestine perforation,9,F,OT,17
166786092,9,Product used for unknown indication,2,F,EXP,lenalidomide,9,C,Large intestine perforation,9,F,HO,17
166788844,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,HO,4
166788844,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,OT,4
166788844,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,DE,4
166788844,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Pneumonia aspiration,1,M,HO,4
166788844,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Pneumonia aspiration,1,M,OT,4
166788844,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Pneumonia aspiration,1,M,DE,4
166788844,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Atrial fibrillation,3,M,HO,4
166788844,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Atrial fibrillation,3,M,OT,4
166788844,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Atrial fibrillation,3,M,DE,4
166788844,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Pneumonia aspiration,3,M,HO,4
166788844,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Pneumonia aspiration,3,M,OT,4
166788844,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Pneumonia aspiration,3,M,DE,4
166788844,4,Renal cell carcinoma,4,F,EXP,ipilimumab,4,SS,Atrial fibrillation,4,M,HO,4
166788844,4,Renal cell carcinoma,4,F,EXP,ipilimumab,4,SS,Atrial fibrillation,4,M,OT,4
166788844,4,Renal cell carcinoma,4,F,EXP,ipilimumab,4,SS,Atrial fibrillation,4,M,DE,4
166788844,4,Renal cell carcinoma,4,F,EXP,ipilimumab,4,SS,Pneumonia aspiration,4,M,HO,4
166788844,4,Renal cell carcinoma,4,F,EXP,ipilimumab,4,SS,Pneumonia aspiration,4,M,OT,4
166788844,4,Renal cell carcinoma,4,F,EXP,ipilimumab,4,SS,Pneumonia aspiration,4,M,DE,4
166788844,5,Product used for unknown indication,4,F,EXP,ipilimumab,5,SS,Atrial fibrillation,5,M,HO,4
166788844,5,Product used for unknown indication,4,F,EXP,ipilimumab,5,SS,Atrial fibrillation,5,M,OT,4
166788844,5,Product used for unknown indication,4,F,EXP,ipilimumab,5,SS,Atrial fibrillation,5,M,DE,4
166788844,5,Product used for unknown indication,4,F,EXP,ipilimumab,5,SS,Pneumonia aspiration,5,M,HO,4
166788844,5,Product used for unknown indication,4,F,EXP,ipilimumab,5,SS,Pneumonia aspiration,5,M,OT,4
166788844,5,Product used for unknown indication,4,F,EXP,ipilimumab,5,SS,Pneumonia aspiration,5,M,DE,4
166788844,6,Product used for unknown indication,4,F,EXP,ipilimumab,6,SS,Atrial fibrillation,6,M,HO,4
166788844,6,Product used for unknown indication,4,F,EXP,ipilimumab,6,SS,Atrial fibrillation,6,M,OT,4
166788844,6,Product used for unknown indication,4,F,EXP,ipilimumab,6,SS,Atrial fibrillation,6,M,DE,4
166788844,6,Product used for unknown indication,4,F,EXP,ipilimumab,6,SS,Pneumonia aspiration,6,M,HO,4
166788844,6,Product used for unknown indication,4,F,EXP,ipilimumab,6,SS,Pneumonia aspiration,6,M,OT,4
166788844,6,Product used for unknown indication,4,F,EXP,ipilimumab,6,SS,Pneumonia aspiration,6,M,DE,4
166811832,1,Dedifferentiated liposarcoma,2,F,EXP,selinexor,1,PS,Pleural effusion,1,M,HO,21
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Back pain,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Back pain,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Bronchitis,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Bronchitis,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Eosinophilia,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Eosinophilia,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Erythropenia,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Erythropenia,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Haemoptysis,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Haemoptysis,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Hyperthermia,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Hyperthermia,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Leukocytosis,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Leukocytosis,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Monocyte count increased,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Monocyte count increased,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Neutrophilia,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Neutrophilia,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Psoriasis,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Psoriasis,1,M,HO,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Vascular device infection,1,M,OT,18
166813673,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Vascular device infection,1,M,HO,18
166826283,1,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,1,PS,Diarrhoea haemorrhagic,1,M,OT,19
166826283,1,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,1,PS,Diarrhoea haemorrhagic,1,M,HO,19
166826283,2,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Diarrhoea haemorrhagic,2,M,OT,19
166826283,2,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Diarrhoea haemorrhagic,2,M,HO,19
166848742,1,Acute myeloid leukaemia,2,F,EXP,nivolumab,1,PS,Bacteraemia,1,M,OT,30
166848742,1,Acute myeloid leukaemia,2,F,EXP,nivolumab,1,PS,Bacteraemia,1,M,HO,30
166848742,1,Acute myeloid leukaemia,2,F,EXP,nivolumab,1,PS,Bacteraemia,1,M,LT,30
166848742,1,Acute myeloid leukaemia,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,30
166848742,1,Acute myeloid leukaemia,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,30
166848742,1,Acute myeloid leukaemia,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,LT,30
166848742,1,Acute myeloid leukaemia,2,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,30
166848742,1,Acute myeloid leukaemia,2,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,30
166848742,1,Acute myeloid leukaemia,2,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,LT,30
166848742,2,Acute myeloid leukaemia,2,F,EXP,ipilimumab,2,SS,Bacteraemia,2,M,OT,30
166848742,2,Acute myeloid leukaemia,2,F,EXP,ipilimumab,2,SS,Bacteraemia,2,M,HO,30
166848742,2,Acute myeloid leukaemia,2,F,EXP,ipilimumab,2,SS,Bacteraemia,2,M,LT,30
166848742,2,Acute myeloid leukaemia,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,OT,30
166848742,2,Acute myeloid leukaemia,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,HO,30
166848742,2,Acute myeloid leukaemia,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,LT,30
166848742,2,Acute myeloid leukaemia,2,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,OT,30
166848742,2,Acute myeloid leukaemia,2,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,HO,30
166848742,2,Acute myeloid leukaemia,2,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,LT,30
166887482,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Autoimmune haemolytic anaemia,1,F,OT,1079
166887482,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Drug monitoring procedure not performed,1,F,OT,1079
166887482,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,F,OT,1079
166891645,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Colitis,1,F,HO,50
166891645,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Colitis,1,F,OT,50
166891645,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Delirium,1,F,HO,50
166891645,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Delirium,1,F,OT,50
166891645,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,50
166891645,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,50
166891645,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,F,HO,50
166891645,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,F,OT,50
166891645,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,F,HO,50
166891645,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,F,OT,50
166891645,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Rash,1,F,HO,50
166891645,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Rash,1,F,OT,50
166891645,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Colitis,2,F,HO,50
166891645,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Colitis,2,F,OT,50
166891645,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Delirium,2,F,HO,50
166891645,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Delirium,2,F,OT,50
166891645,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Diarrhoea,2,F,HO,50
166891645,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Diarrhoea,2,F,OT,50
166891645,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,F,HO,50
166891645,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,F,OT,50
166891645,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Interstitial lung disease,2,F,HO,50
166891645,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Interstitial lung disease,2,F,OT,50
166891645,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Rash,2,F,HO,50
166891645,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Rash,2,F,OT,50
166892614,5,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,5,C,Inflammation,5,F,OT,42
166892614,5,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,5,C,Inflammation,5,F,LT,42
166892614,5,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,5,C,Inflammation,5,F,HO,42
166892614,5,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,5,C,Renal impairment,5,F,OT,42
166892614,5,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,5,C,Renal impairment,5,F,LT,42
166892614,5,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,5,C,Renal impairment,5,F,HO,42
166896604,1,Non-small cell lung cancer,4,F,EXP,brigatinib,1,PS,Enteritis,1,M,HO,129
166896604,1,Non-small cell lung cancer,4,F,EXP,brigatinib,1,PS,Enteritis,1,M,OT,129
166896604,1,Non-small cell lung cancer,4,F,EXP,brigatinib,1,PS,Pancreatitis,1,M,HO,129
166896604,1,Non-small cell lung cancer,4,F,EXP,brigatinib,1,PS,Pancreatitis,1,M,OT,129
166897602,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,M,OT,490
166911892,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Colitis,1,F,OT,27
166911892,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cough,1,F,OT,27
166911892,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,F,OT,27
166934283,3,Plasma cell myeloma,3,F,EXP,thalidomide,3,C,Ischaemia,3,M,DE,226
166934283,3,Plasma cell myeloma,3,F,EXP,thalidomide,3,C,Ischaemia,3,M,HO,226
166937764,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Colitis,1,M,HO,32
166937764,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Colitis,1,M,OT,32
166937764,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Dehydration,1,M,HO,32
166937764,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Dehydration,1,M,OT,32
166937764,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Hyperglycaemic hyperosmolar nonketotic syndrome,1,M,HO,32
166937764,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Hyperglycaemic hyperosmolar nonketotic syndrome,1,M,OT,32
166949483,4,Renal cell carcinoma,3,F,EXP,nivolumab,4,SS,Abdominal distension,4,M,OT,18
166949483,4,Renal cell carcinoma,3,F,EXP,nivolumab,4,SS,Abdominal pain upper,4,M,OT,18
166949483,4,Renal cell carcinoma,3,F,EXP,nivolumab,4,SS,Decreased appetite,4,M,OT,18
166949483,4,Renal cell carcinoma,3,F,EXP,nivolumab,4,SS,Depression,4,M,OT,18
166949483,4,Renal cell carcinoma,3,F,EXP,nivolumab,4,SS,Diarrhoea,4,M,OT,18
166949483,4,Renal cell carcinoma,3,F,EXP,nivolumab,4,SS,Epistaxis,4,M,OT,18
166949483,4,Renal cell carcinoma,3,F,EXP,nivolumab,4,SS,Groin pain,4,M,OT,18
166949483,4,Renal cell carcinoma,3,F,EXP,nivolumab,4,SS,Hypertension,4,M,OT,18
166949483,4,Renal cell carcinoma,3,F,EXP,nivolumab,4,SS,Malignant neoplasm progression,4,M,OT,18
166949483,4,Renal cell carcinoma,3,F,EXP,nivolumab,4,SS,Night sweats,4,M,OT,18
166949483,4,Renal cell carcinoma,3,F,EXP,nivolumab,4,SS,Weight decreased,4,M,OT,18
166976073,1,Chronic lymphocytic leukaemia,3,F,EXP,lenalidomide,1,SS,Endometrial adenocarcinoma,1,F,DE,1129
166976073,3,Chronic lymphocytic leukaemia,3,F,EXP,chlorambucil,3,SS,Endometrial adenocarcinoma,3,F,DE,1137
166979235,1,Prostate cancer metastatic,5,F,EXP,enzalutamide,1,PS,Anaemia,1,M,HO,144
166979235,1,Prostate cancer metastatic,5,F,EXP,enzalutamide,1,PS,Back pain,1,M,HO,144
166979235,1,Prostate cancer metastatic,5,F,EXP,enzalutamide,1,PS,Bone pain,1,M,HO,144
166992376,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Non-cardiac chest pain,1,M,HO,2
166992376,2,Malignant melanoma,6,F,EXP,ipilimumab,2,SS,Non-cardiac chest pain,2,M,HO,2
167011723,1,Prostate cancer stage 0,3,F,EXP,enzalutamide,1,PS,Abdominal discomfort,1,M,OT,567
167011723,1,Prostate cancer stage 0,3,F,EXP,enzalutamide,1,PS,Dehydration,1,M,OT,567
167011723,1,Prostate cancer stage 0,3,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,567
167011723,1,Prostate cancer stage 0,3,F,EXP,enzalutamide,1,PS,Loss of consciousness,1,M,OT,567
167011723,1,Prostate cancer stage 0,3,F,EXP,enzalutamide,1,PS,Nausea,1,M,OT,567
167030125,2,Renal cell carcinoma,5,F,EXP,avelumab,2,SS,General physical health deterioration,2,M,HO,783
167035212,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Demyelinating polyneuropathy,2,M,HO,86
167035212,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Endocarditis,2,M,HO,86
167035212,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Immune-mediated adverse reaction,2,M,HO,86
167041655,1,Plasma cell myeloma,5,F,EXP,selinexor,1,PS,Carotid artery aneurysm,1,F,OT,173
167041655,1,Plasma cell myeloma,5,F,EXP,selinexor,1,PS,Carotid artery aneurysm,1,F,HO,173
167041655,1,Plasma cell myeloma,5,F,EXP,selinexor,1,PS,Encephalopathy,1,F,OT,173
167041655,1,Plasma cell myeloma,5,F,EXP,selinexor,1,PS,Encephalopathy,1,F,HO,173
167048604,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Inadequate diet,2,F,HO,11
167048604,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Inadequate diet,2,F,OT,11
167048604,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Nausea,2,F,HO,11
167048604,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Nausea,2,F,OT,11
167048604,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Pyrexia,2,F,HO,11
167048604,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Pyrexia,2,F,OT,11
167048604,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Thrombocytopenia,2,F,HO,11
167048604,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Thrombocytopenia,2,F,OT,11
167048604,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Vomiting,2,F,HO,11
167048604,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Vomiting,2,F,OT,11
1670542710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Blood glucose increased,1,M,HO,17
1670542710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Hypophysitis,1,M,HO,17
1670542710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Impaired insulin secretion,1,M,HO,17
1670542710,1,Metastatic renal cell carcinoma,10,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,HO,17
1670542710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Blood glucose increased,2,M,HO,17
1670542710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Hypophysitis,2,M,HO,17
1670542710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Impaired insulin secretion,2,M,HO,17
1670542710,2,Metastatic renal cell carcinoma,10,F,EXP,ipilimumab,2,SS,Prescribed overdose,2,M,HO,17
167055215,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Dermatitis allergic,3,M,OT,74
167055215,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Dermatitis allergic,3,M,HO,74
167055215,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Hepatitis E,3,M,OT,74
167055215,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Hepatitis E,3,M,HO,74
167056149,18,Neutropenia,9,F,EXP,filgrastim,18,C,Cardiac failure,18,F,HO,36
167056149,18,Neutropenia,9,F,EXP,filgrastim,18,C,Cardiac failure,18,F,DS,36
167056149,18,Neutropenia,9,F,EXP,filgrastim,18,C,Cardiac failure,18,F,LT,36
167056149,18,Neutropenia,9,F,EXP,filgrastim,18,C,Myocarditis,18,F,HO,36
167056149,18,Neutropenia,9,F,EXP,filgrastim,18,C,Myocarditis,18,F,DS,36
167056149,18,Neutropenia,9,F,EXP,filgrastim,18,C,Myocarditis,18,F,LT,36
167058222,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Death,2,M,DE,174
167058222,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Death,2,M,HO,174
167058222,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Metastases to central nervous system,2,M,DE,174
167058222,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Metastases to central nervous system,2,M,HO,174
167058222,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Seizure,2,M,DE,174
167058222,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Seizure,2,M,HO,174
167069513,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Acute kidney injury,1,M,HO,2
167069513,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Cranial nerve infection,1,M,HO,2
167069513,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Device related infection,1,M,HO,2
167069513,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Pericarditis infective,1,M,HO,2
167069513,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Sepsis,1,M,HO,2
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,1
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,1
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,LT,1
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,HO,1
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,OT,1
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,LT,1
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Neutropenia,1,M,HO,1
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Neutropenia,1,M,OT,1
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Neutropenia,1,M,LT,1
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,HO,1
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,OT,1
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,LT,1
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Sepsis,1,M,HO,1
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Sepsis,1,M,OT,1
167079113,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Sepsis,1,M,LT,1
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Back pain,1,M,HO,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Back pain,1,M,DE,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Back pain,1,M,OT,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Depressed level of consciousness,1,M,HO,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Depressed level of consciousness,1,M,DE,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Depressed level of consciousness,1,M,OT,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Electrolyte imbalance,1,M,HO,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Electrolyte imbalance,1,M,DE,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Electrolyte imbalance,1,M,OT,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,HO,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,DE,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,OT,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Malaise,1,M,HO,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Malaise,1,M,DE,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Malaise,1,M,OT,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,HO,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,DE,6
167087207,1,Metastatic renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,OT,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Back pain,2,M,HO,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Back pain,2,M,DE,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Back pain,2,M,OT,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Depressed level of consciousness,2,M,HO,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Depressed level of consciousness,2,M,DE,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Depressed level of consciousness,2,M,OT,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Electrolyte imbalance,2,M,HO,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Electrolyte imbalance,2,M,DE,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Electrolyte imbalance,2,M,OT,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,HO,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,DE,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,OT,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Malaise,2,M,HO,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Malaise,2,M,DE,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Malaise,2,M,OT,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Pleural effusion,2,M,HO,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Pleural effusion,2,M,DE,6
167087207,2,Metastatic renal cell carcinoma,7,F,EXP,ipilimumab,2,SS,Pleural effusion,2,M,OT,6
167092173,2,Metastatic malignant melanoma,3,F,EXP,trametinib,2,SS,Cardiac failure,2,M,OT,300
167094792,2,Breast cancer,2,F,EXP,palbociclib,2,SS,Constipation,2,F,OT,14
167094792,2,Breast cancer,2,F,EXP,palbociclib,2,SS,Dyspnoea,2,F,OT,14
167094792,2,Breast cancer,2,F,EXP,palbociclib,2,SS,Hyperbilirubinaemia,2,F,OT,14
167094792,2,Breast cancer,2,F,EXP,palbociclib,2,SS,Neutropenia,2,F,OT,14
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Acute respiratory failure,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Acute respiratory failure,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Acute respiratory failure,1,M,HO,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Anaemia,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,HO,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Atelectasis,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Atelectasis,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Atelectasis,1,M,HO,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Blood albumin decreased,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Blood albumin decreased,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Blood albumin decreased,1,M,HO,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Contusion,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Contusion,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Contusion,1,M,HO,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Dizziness,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Dizziness,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Dizziness,1,M,HO,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Hypoglycaemia,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Hypoglycaemia,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Hypoglycaemia,1,M,HO,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Lactic acidosis,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Lactic acidosis,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Lactic acidosis,1,M,HO,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Myositis,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Myositis,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Myositis,1,M,HO,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Proteinuria,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Proteinuria,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Proteinuria,1,M,HO,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,HO,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Sepsis,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Vomiting,1,M,LT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,513
167096355,1,Product used for unknown indication,5,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,513
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Death,1,M,LT,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Death,1,M,OT,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Death,1,M,DE,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Death,1,M,HO,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,LT,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Hypotension,1,M,LT,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Hypotension,1,M,OT,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Hypotension,1,M,DE,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Hypotension,1,M,HO,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Myopathy,1,M,LT,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Myopathy,1,M,OT,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Myopathy,1,M,DE,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Myopathy,1,M,HO,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Troponin increased,1,M,LT,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Troponin increased,1,M,OT,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Troponin increased,1,M,DE,27
167102214,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,PS,Troponin increased,1,M,HO,27
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Death,2,M,LT,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Death,2,M,OT,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Death,2,M,DE,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Death,2,M,HO,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,LT,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,OT,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,DE,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,HO,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Hypotension,2,M,LT,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Hypotension,2,M,OT,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Hypotension,2,M,DE,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Hypotension,2,M,HO,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Myopathy,2,M,LT,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Myopathy,2,M,OT,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Myopathy,2,M,DE,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Myopathy,2,M,HO,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Troponin increased,2,M,LT,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Troponin increased,2,M,OT,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Troponin increased,2,M,DE,5
167102214,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Troponin increased,2,M,HO,5
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Death,3,M,LT,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Death,3,M,OT,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Death,3,M,DE,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Death,3,M,HO,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Dyspnoea,3,M,LT,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Dyspnoea,3,M,OT,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Dyspnoea,3,M,DE,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Dyspnoea,3,M,HO,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Hypotension,3,M,LT,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Hypotension,3,M,OT,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Hypotension,3,M,DE,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Hypotension,3,M,HO,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Myopathy,3,M,LT,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Myopathy,3,M,OT,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Myopathy,3,M,DE,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Myopathy,3,M,HO,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Troponin increased,3,M,LT,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Troponin increased,3,M,OT,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Troponin increased,3,M,DE,27
167102214,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,SS,Troponin increased,3,M,HO,27
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Death,4,M,LT,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Death,4,M,OT,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Death,4,M,DE,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Death,4,M,HO,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Dyspnoea,4,M,LT,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Dyspnoea,4,M,OT,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Dyspnoea,4,M,DE,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Dyspnoea,4,M,HO,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Hypotension,4,M,LT,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Hypotension,4,M,OT,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Hypotension,4,M,DE,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Hypotension,4,M,HO,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Myopathy,4,M,LT,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Myopathy,4,M,OT,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Myopathy,4,M,DE,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Myopathy,4,M,HO,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Troponin increased,4,M,LT,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Troponin increased,4,M,OT,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Troponin increased,4,M,DE,5
167102214,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Troponin increased,4,M,HO,5
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Ascites,1,M,OT,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Ascites,1,M,HO,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Ascites,1,M,DE,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Back pain,1,M,OT,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Back pain,1,M,HO,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Back pain,1,M,DE,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Depressed level of consciousness,1,M,OT,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Depressed level of consciousness,1,M,HO,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Depressed level of consciousness,1,M,DE,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Electrolyte imbalance,1,M,OT,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Electrolyte imbalance,1,M,HO,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Electrolyte imbalance,1,M,DE,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,OT,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,HO,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,DE,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Metastasis,1,M,OT,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Metastasis,1,M,HO,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Metastasis,1,M,DE,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,OT,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,HO,6
167106616,1,Metastatic malignant melanoma,6,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,DE,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Ascites,3,M,OT,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Ascites,3,M,HO,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Ascites,3,M,DE,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Back pain,3,M,OT,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Back pain,3,M,HO,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Back pain,3,M,DE,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Depressed level of consciousness,3,M,OT,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Depressed level of consciousness,3,M,HO,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Depressed level of consciousness,3,M,DE,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Electrolyte imbalance,3,M,OT,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Electrolyte imbalance,3,M,HO,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Electrolyte imbalance,3,M,DE,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Hepatic function abnormal,3,M,OT,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Hepatic function abnormal,3,M,HO,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Hepatic function abnormal,3,M,DE,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Metastasis,3,M,OT,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Metastasis,3,M,HO,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Metastasis,3,M,DE,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Pleural effusion,3,M,OT,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Pleural effusion,3,M,HO,6
167106616,3,Metastatic malignant melanoma,6,F,EXP,ipilimumab,3,SS,Pleural effusion,3,M,DE,6
167109924,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Lung disorder,1,M,OT,70
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Blood fibrinogen decreased,1,F,OT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Blood fibrinogen decreased,1,F,LT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Blood fibrinogen decreased,1,F,HO,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Cardiac failure,1,F,OT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Cardiac failure,1,F,LT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Cardiac failure,1,F,HO,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,OT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,LT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,HO,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,F,OT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,F,LT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,F,HO,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,F,OT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,F,LT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,F,HO,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,F,OT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,F,LT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,F,HO,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Respiratory failure,1,F,OT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Respiratory failure,1,F,LT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Respiratory failure,1,F,HO,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Somnolence,1,F,OT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Somnolence,1,F,LT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Somnolence,1,F,HO,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Tachypnoea,1,F,OT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Tachypnoea,1,F,LT,1
167119934,1,Diffuse large B-cell lymphoma recurrent,4,F,EXP,axicabtagene ciloleucel,1,PS,Tachypnoea,1,F,HO,1
167120006,2,Renal cell carcinoma,6,F,EXP,nivolumab,2,SS,Hypothalamo-pituitary disorder,2,M,OT,446
167120006,2,Renal cell carcinoma,6,F,EXP,nivolumab,2,SS,Hypothalamo-pituitary disorder,2,M,HO,446
167123535,2,Mantle cell lymphoma,5,F,EXP,ibrutinib,2,SS,Pancytopenia,2,F,DE,240
167123535,2,Mantle cell lymphoma,5,F,EXP,ibrutinib,2,SS,Pancytopenia,2,F,HO,240
1671249010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Bone marrow failure,1,F,DE,29
1671249010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Bone marrow failure,1,F,LT,29
1671249010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Bone marrow failure,1,F,OT,29
1671249010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Bone marrow failure,1,F,HO,29
1671249010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Escherichia urinary tract infection,1,F,DE,29
1671249010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Escherichia urinary tract infection,1,F,LT,29
1671249010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Escherichia urinary tract infection,1,F,OT,29
1671249010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Escherichia urinary tract infection,1,F,HO,29
1671249010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Pneumonia,1,F,DE,29
1671249010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Pneumonia,1,F,LT,29
1671249010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Pneumonia,1,F,OT,29
1671249010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Pneumonia,1,F,HO,29
167127712,1,Prophylaxis,2,F,EXP,zoledronic acid,1,PS,Hypocalcaemia,1,M,HO,1
167127712,1,Prophylaxis,2,F,EXP,zoledronic acid,1,PS,Hypocalcaemia,1,M,LT,1
167127712,1,Prophylaxis,2,F,EXP,zoledronic acid,1,PS,Hypophosphataemia,1,M,HO,1
167127712,1,Prophylaxis,2,F,EXP,zoledronic acid,1,PS,Hypophosphataemia,1,M,LT,1
167127712,1,Prophylaxis,2,F,EXP,zoledronic acid,1,PS,Neutropenic sepsis,1,M,HO,1
167127712,1,Prophylaxis,2,F,EXP,zoledronic acid,1,PS,Neutropenic sepsis,1,M,LT,1
167127712,1,Prophylaxis,2,F,EXP,zoledronic acid,1,PS,Pancytopenia,1,M,HO,1
167127712,1,Prophylaxis,2,F,EXP,zoledronic acid,1,PS,Pancytopenia,1,M,LT,1
167127712,1,Prophylaxis,2,F,EXP,zoledronic acid,1,PS,Pyrexia,1,M,HO,1
167127712,1,Prophylaxis,2,F,EXP,zoledronic acid,1,PS,Pyrexia,1,M,LT,1
167129657,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Abdominal pain upper,1,F,OT,10
167129657,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Asthenia,1,F,OT,10
167129657,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Diarrhoea,1,F,OT,10
167129657,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Dysuria,1,F,OT,10
167129657,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Nausea,1,F,OT,10
167129657,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Neuropathy peripheral,1,F,OT,10
167129657,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Rhinorrhoea,1,F,OT,10
167129657,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Vomiting,1,F,OT,10
167129657,1,Breast cancer,7,F,EXP,zoledronic acid,1,PS,Vulvovaginal inflammation,1,F,OT,10
167163363,5,Metastatic malignant melanoma,3,F,EXP,trametinib,5,SS,Fatigue,5,F,OT,57
167163363,5,Metastatic malignant melanoma,3,F,EXP,trametinib,5,SS,Leukopenia,5,F,OT,57
167163363,5,Metastatic malignant melanoma,3,F,EXP,trametinib,5,SS,Lymphoedema,5,F,OT,57
167163363,5,Metastatic malignant melanoma,3,F,EXP,trametinib,5,SS,Neutropenia,5,F,OT,57
167163363,5,Metastatic malignant melanoma,3,F,EXP,trametinib,5,SS,Oropharyngeal pain,5,F,OT,57
167163363,5,Metastatic malignant melanoma,3,F,EXP,trametinib,5,SS,Paraesthesia oral,5,F,OT,57
167163363,5,Metastatic malignant melanoma,3,F,EXP,trametinib,5,SS,Peripheral swelling,5,F,OT,57
167164962,1,Liposarcoma,2,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,81
167164962,1,Liposarcoma,2,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,81
167164962,1,Liposarcoma,2,F,EXP,nivolumab,1,PS,Malnutrition,1,M,HO,81
167164962,1,Liposarcoma,2,F,EXP,nivolumab,1,PS,Malnutrition,1,M,OT,81
167164962,1,Liposarcoma,2,F,EXP,nivolumab,1,PS,Retroperitoneal cancer,1,M,HO,81
167164962,1,Liposarcoma,2,F,EXP,nivolumab,1,PS,Retroperitoneal cancer,1,M,OT,81
167164962,2,Liposarcoma,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,HO,81
167164962,2,Liposarcoma,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,OT,81
167164962,2,Liposarcoma,2,F,EXP,ipilimumab,2,SS,Malnutrition,2,M,HO,81
167164962,2,Liposarcoma,2,F,EXP,ipilimumab,2,SS,Malnutrition,2,M,OT,81
167164962,2,Liposarcoma,2,F,EXP,ipilimumab,2,SS,Retroperitoneal cancer,2,M,HO,81
167164962,2,Liposarcoma,2,F,EXP,ipilimumab,2,SS,Retroperitoneal cancer,2,M,OT,81
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Abdominal pain,1,F,LT,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Abdominal pain,1,F,DE,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Abdominal pain,1,F,HO,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Cytokine release syndrome,1,F,LT,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Cytokine release syndrome,1,F,DE,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Cytokine release syndrome,1,F,HO,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Hyperkalaemia,1,F,LT,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Hyperkalaemia,1,F,DE,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Hyperkalaemia,1,F,HO,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Infection,1,F,LT,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Infection,1,F,DE,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Infection,1,F,HO,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Nervous system disorder,1,F,LT,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Nervous system disorder,1,F,DE,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Nervous system disorder,1,F,HO,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Tumour lysis syndrome,1,F,LT,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Tumour lysis syndrome,1,F,DE,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Tumour lysis syndrome,1,F,HO,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Ventricular fibrillation,1,F,LT,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Ventricular fibrillation,1,F,DE,1
167210165,1,Acute lymphocytic leukaemia refractory,5,F,PER,blinatumomab,1,PS,Ventricular fibrillation,1,F,HO,1
167223623,1,Non-Hodgkin's lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Mental status changes,1,M,HO,21
167223623,1,Non-Hodgkin's lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia,1,M,HO,21
167223623,1,Non-Hodgkin's lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,HO,21
167237504,1,Small cell lung cancer limited stage,4,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,F,OT,29
167237504,1,Small cell lung cancer limited stage,4,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,F,HO,29
167237504,2,Small cell lung cancer limited stage,4,F,EXP,ipilimumab,2,SS,Autoimmune disorder,2,F,OT,29
167237504,2,Small cell lung cancer limited stage,4,F,EXP,ipilimumab,2,SS,Autoimmune disorder,2,F,HO,29
167248432,1,Diffuse large B-cell lymphoma,2,F,EXP,nivolumab,1,PS,Asthenia,1,F,HO,2
167248432,1,Diffuse large B-cell lymphoma,2,F,EXP,nivolumab,1,PS,Cough,1,F,HO,2
167248432,1,Diffuse large B-cell lymphoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,2
167248432,1,Diffuse large B-cell lymphoma,2,F,EXP,nivolumab,1,PS,Mental status changes,1,F,HO,2
167248432,2,Diffuse large B-cell lymphoma,2,F,EXP,ibrutinib,2,SS,Asthenia,2,F,HO,2
167248432,2,Diffuse large B-cell lymphoma,2,F,EXP,ibrutinib,2,SS,Cough,2,F,HO,2
167248432,2,Diffuse large B-cell lymphoma,2,F,EXP,ibrutinib,2,SS,Diarrhoea,2,F,HO,2
167248432,2,Diffuse large B-cell lymphoma,2,F,EXP,ibrutinib,2,SS,Mental status changes,2,F,HO,2
167264962,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pemphigoid,1,F,HO,43
167264962,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pemphigoid,1,F,OT,43
167283673,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Blood glucose abnormal,1,M,OT,30
167283673,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Circumstance or information capable of leading to medication error,1,M,OT,30
167283673,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,OT,30
167283673,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,30
167283673,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Weight decreased,1,M,OT,30
167293242,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,PS,Acute kidney injury,2,F,HO,328
167293242,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,PS,Anaemia,2,F,HO,328
167314773,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Atypical pneumonia,1,M,OT,208
167314773,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Atypical pneumonia,1,M,HO,208
167314773,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,208
167314773,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,208
167324163,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,M,OT,35
167324163,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,M,HO,35
167324163,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,OT,35
167324163,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,HO,35
167324163,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,OT,35
167324163,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,HO,35
167324163,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hepatic pain,1,M,OT,35
167324163,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hepatic pain,1,M,HO,35
167324163,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hypotension,1,M,OT,35
167324163,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hypotension,1,M,HO,35
167324163,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,35
167324163,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,35
167324163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Acute respiratory distress syndrome,2,M,OT,35
167324163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Acute respiratory distress syndrome,2,M,HO,35
167324163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Alanine aminotransferase increased,2,M,OT,35
167324163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Alanine aminotransferase increased,2,M,HO,35
167324163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Aspartate aminotransferase increased,2,M,OT,35
167324163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Aspartate aminotransferase increased,2,M,HO,35
167324163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hepatic pain,2,M,OT,35
167324163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hepatic pain,2,M,HO,35
167324163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hypotension,2,M,OT,35
167324163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hypotension,2,M,HO,35
167324163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,35
167324163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,HO,35
167324163,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Acute respiratory distress syndrome,3,M,OT,35
167324163,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Acute respiratory distress syndrome,3,M,HO,35
167324163,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Alanine aminotransferase increased,3,M,OT,35
167324163,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Alanine aminotransferase increased,3,M,HO,35
167324163,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Aspartate aminotransferase increased,3,M,OT,35
167324163,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Aspartate aminotransferase increased,3,M,HO,35
167324163,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hepatic pain,3,M,OT,35
167324163,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hepatic pain,3,M,HO,35
167324163,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hypotension,3,M,OT,35
167324163,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hypotension,3,M,HO,35
167324163,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,OT,35
167324163,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,HO,35
167342094,1,Non-small cell lung cancer stage IV,4,F,PER,denosumab,1,PS,Acute kidney injury,1,F,HO,179
167342094,1,Non-small cell lung cancer stage IV,4,F,PER,denosumab,1,PS,Acute kidney injury,1,F,DS,179
167342094,1,Non-small cell lung cancer stage IV,4,F,PER,denosumab,1,PS,Anaemia,1,F,HO,179
167342094,1,Non-small cell lung cancer stage IV,4,F,PER,denosumab,1,PS,Anaemia,1,F,DS,179
167348574,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Diverticulitis,2,M,HO,354
167356272,3,Breast cancer,2,F,EXP,pegfilgrastim,3,SS,Gastroduodenal ulcer,3,M,OT,163
167356272,3,Breast cancer,2,F,EXP,pegfilgrastim,3,SS,Gastroduodenal ulcer,3,M,HO,163
167356272,3,Breast cancer,2,F,EXP,pegfilgrastim,3,SS,Neoplasm progression,3,M,OT,163
167356272,3,Breast cancer,2,F,EXP,pegfilgrastim,3,SS,Neoplasm progression,3,M,HO,163
167360874,1,Hodgkin's disease,4,F,EXP,brentuximab vedotin,1,PS,Pneumocystis jirovecii pneumonia,1,M,HO,12
167360874,1,Hodgkin's disease,4,F,EXP,brentuximab vedotin,1,PS,Pneumonia,1,M,HO,12
167360874,1,Hodgkin's disease,4,F,EXP,brentuximab vedotin,1,PS,Retinal detachment,1,M,HO,12
167374333,1,Chronic lymphocytic leukaemia,3,F,EXP,selinexor,1,PS,Cataract,1,F,OT,792
167374333,2,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,2,SS,Cataract,2,F,OT,792
167375756,1,Breast cancer metastatic,6,F,EXP,palbociclib,1,PS,Cyanosis,1,F,OT,281
167375943,3,Renal cell carcinoma,3,F,EXP,axitinib,3,SS,Hyperglycaemia,3,M,HO,43
167377116,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Lichen planus,1,F,HO,253
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,HO,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,DS,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,OT,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Liver disorder,1,M,HO,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Liver disorder,1,M,DS,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Liver disorder,1,M,OT,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DS,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pancreatic enzymes increased,1,M,HO,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pancreatic enzymes increased,1,M,DS,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pancreatic enzymes increased,1,M,OT,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pneumocystis jirovecii pneumonia,1,M,HO,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pneumocystis jirovecii pneumonia,1,M,DS,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pneumocystis jirovecii pneumonia,1,M,OT,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pyrexia,1,M,DS,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,HO,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,DS,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,OT,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Renal disorder,1,M,HO,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Renal disorder,1,M,DS,14
167396465,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Renal disorder,1,M,OT,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Interstitial lung disease,2,M,HO,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Interstitial lung disease,2,M,DS,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Interstitial lung disease,2,M,OT,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Liver disorder,2,M,HO,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Liver disorder,2,M,DS,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Liver disorder,2,M,OT,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,HO,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DS,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Pancreatic enzymes increased,2,M,HO,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Pancreatic enzymes increased,2,M,DS,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Pancreatic enzymes increased,2,M,OT,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Pneumocystis jirovecii pneumonia,2,M,HO,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Pneumocystis jirovecii pneumonia,2,M,DS,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Pneumocystis jirovecii pneumonia,2,M,OT,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,HO,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,DS,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,OT,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Rash maculo-papular,2,M,HO,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Rash maculo-papular,2,M,DS,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Rash maculo-papular,2,M,OT,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Renal disorder,2,M,HO,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Renal disorder,2,M,DS,14
167396465,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Renal disorder,2,M,OT,14
167411522,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Abdominal pain,1,M,OT,55
167411522,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Abdominal pain,1,M,HO,55
167411522,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Cell death,1,M,OT,55
167411522,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Cell death,1,M,HO,55
167411522,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Colitis,1,M,OT,55
167411522,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Colitis,1,M,HO,55
167411522,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Hepatitis,1,M,OT,55
167411522,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Hepatitis,1,M,HO,55
167412459,1,Oesophageal squamous cell carcinoma,9,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,87
167412459,1,Oesophageal squamous cell carcinoma,9,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,87
167418184,16,Neutropenia,4,F,EXP,filgrastim,16,C,Meibomianitis,16,F,DS,16
167429913,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Basedow's disease,1,F,HO,193
167429913,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Eczema,1,F,HO,193
167429913,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Fungal infection,1,F,HO,193
167429913,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Gastritis,1,F,HO,193
167429913,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Herpes zoster,1,F,HO,193
167429913,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,F,HO,193
167429913,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Iron deficiency,1,F,HO,193
167429913,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Nephrolithiasis,1,F,HO,193
167439864,3,Renal cell carcinoma,4,F,EXP,axitinib,3,SS,Hyperglycaemia,3,M,HO,43
167439864,3,Renal cell carcinoma,4,F,EXP,axitinib,3,SS,Off label use,3,M,HO,43
167457687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,OT,14
167457687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,HO,14
167457687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Liver disorder,1,M,OT,14
167457687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Liver disorder,1,M,HO,14
167457687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pancreatic enzymes increased,1,M,OT,14
167457687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pancreatic enzymes increased,1,M,HO,14
167457687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pneumocystis jirovecii pneumonia,1,M,OT,14
167457687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pneumocystis jirovecii pneumonia,1,M,HO,14
167457687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,14
167457687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,14
167457687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,OT,14
167457687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,HO,14
167457687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Renal disorder,1,M,OT,14
167457687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Renal disorder,1,M,HO,14
167457687,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Interstitial lung disease,2,M,OT,14
167457687,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Interstitial lung disease,2,M,HO,14
167457687,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Liver disorder,2,M,OT,14
167457687,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Liver disorder,2,M,HO,14
167457687,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Pancreatic enzymes increased,2,M,OT,14
167457687,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Pancreatic enzymes increased,2,M,HO,14
167457687,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Pneumocystis jirovecii pneumonia,2,M,OT,14
167457687,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Pneumocystis jirovecii pneumonia,2,M,HO,14
167457687,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,OT,14
167457687,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,HO,14
167457687,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Rash maculo-papular,2,M,OT,14
167457687,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Rash maculo-papular,2,M,HO,14
167457687,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Renal disorder,2,M,OT,14
167457687,2,Malignant melanoma,7,F,EXP,ipilimumab,2,SS,Renal disorder,2,M,HO,14
167481455,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Aphasia,1,M,DS,7
167481455,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Aphasia,1,M,HO,7
167481455,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,M,DS,7
167481455,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,M,HO,7
167481455,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Dizziness,1,M,DS,7
167481455,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Dizziness,1,M,HO,7
167481455,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,DS,7
167481455,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,HO,7
167481455,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,DS,7
167481455,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,HO,7
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Bone marrow failure,2,F,DE,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Bone marrow failure,2,F,OT,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Bone marrow failure,2,F,HO,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Cardiac failure,2,F,DE,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Cardiac failure,2,F,OT,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Cardiac failure,2,F,HO,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Diarrhoea,2,F,DE,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Diarrhoea,2,F,OT,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Diarrhoea,2,F,HO,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Febrile neutropenia,2,F,DE,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Febrile neutropenia,2,F,OT,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Febrile neutropenia,2,F,HO,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Neutropenia,2,F,DE,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Neutropenia,2,F,OT,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Neutropenia,2,F,HO,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Pyrexia,2,F,DE,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Pyrexia,2,F,OT,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Pyrexia,2,F,HO,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Sepsis,2,F,DE,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Sepsis,2,F,OT,64
167496933,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Sepsis,2,F,HO,64
167526732,5,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,5,SS,Decreased appetite,5,F,HO,24
167526732,5,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,5,SS,Decreased appetite,5,F,OT,24
167526732,5,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,5,SS,Dehydration,5,F,HO,24
167526732,5,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,5,SS,Dehydration,5,F,OT,24
167526732,5,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,5,SS,Neutropenia,5,F,HO,24
167526732,5,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,5,SS,Neutropenia,5,F,OT,24
167526732,5,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,5,SS,Off label use,5,F,HO,24
167526732,5,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,5,SS,Off label use,5,F,OT,24
167526732,5,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,5,SS,Renal impairment,5,F,HO,24
167526732,5,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,5,SS,Renal impairment,5,F,OT,24
167526732,5,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,5,SS,Underdose,5,F,HO,24
167526732,5,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,5,SS,Underdose,5,F,OT,24
167546053,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Meningitis,1,M,HO,5
167546053,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Meningitis,1,M,OT,5
167546053,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,5
167546053,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,5
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Alanine aminotransferase increased,2,M,HO,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Alanine aminotransferase increased,2,M,OT,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Aspartate aminotransferase increased,2,M,HO,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Aspartate aminotransferase increased,2,M,OT,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Chills,2,M,HO,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Chills,2,M,OT,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Cough,2,M,HO,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Cough,2,M,OT,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Dysaesthesia,2,M,HO,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Dysaesthesia,2,M,OT,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Dyspnoea,2,M,HO,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Dyspnoea,2,M,OT,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Face oedema,2,M,HO,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Face oedema,2,M,OT,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Gamma-glutamyltransferase increased,2,M,HO,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Gamma-glutamyltransferase increased,2,M,OT,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,General physical health deterioration,2,M,HO,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,General physical health deterioration,2,M,OT,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Lipase increased,2,M,HO,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Lipase increased,2,M,OT,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Night sweats,2,M,HO,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Night sweats,2,M,OT,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Pneumonitis,2,M,HO,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Pneumonitis,2,M,OT,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Pyrexia,2,M,HO,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Pyrexia,2,M,OT,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Rash maculo-papular,2,M,HO,7
167546535,2,Malignant melanoma,5,F,PER,ipilimumab,2,SS,Rash maculo-papular,2,M,OT,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Alanine aminotransferase increased,3,M,HO,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Alanine aminotransferase increased,3,M,OT,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Aspartate aminotransferase increased,3,M,HO,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Aspartate aminotransferase increased,3,M,OT,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Chills,3,M,HO,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Chills,3,M,OT,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Cough,3,M,HO,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Cough,3,M,OT,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Dysaesthesia,3,M,HO,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Dysaesthesia,3,M,OT,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Dyspnoea,3,M,HO,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Dyspnoea,3,M,OT,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Face oedema,3,M,HO,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Face oedema,3,M,OT,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Gamma-glutamyltransferase increased,3,M,HO,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Gamma-glutamyltransferase increased,3,M,OT,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,General physical health deterioration,3,M,HO,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,General physical health deterioration,3,M,OT,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Lipase increased,3,M,HO,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Lipase increased,3,M,OT,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Night sweats,3,M,HO,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Night sweats,3,M,OT,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Pneumonitis,3,M,HO,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Pneumonitis,3,M,OT,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Pyrexia,3,M,HO,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Pyrexia,3,M,OT,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Rash maculo-papular,3,M,HO,7
167546535,3,Malignant melanoma,5,F,PER,nivolumab,3,SS,Rash maculo-papular,3,M,OT,7
167560053,1,Prostate cancer metastatic,3,F,EXP,apalutamide,1,PS,Rash,1,M,OT,223
167560053,1,Prostate cancer metastatic,3,F,EXP,apalutamide,1,PS,Skin ulcer,1,M,OT,223
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Aphasia,1,M,HO,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Aphasia,1,M,OT,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Aphasia,1,M,DE,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Arrhythmia,1,M,HO,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Arrhythmia,1,M,OT,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Arrhythmia,1,M,DE,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,M,HO,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,M,OT,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,M,DE,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,DE,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Cytopenia,1,M,HO,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Cytopenia,1,M,OT,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Cytopenia,1,M,DE,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Diffuse large B-cell lymphoma,1,M,HO,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Diffuse large B-cell lymphoma,1,M,OT,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Diffuse large B-cell lymphoma,1,M,DE,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,HO,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,OT,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,DE,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Migraine with aura,1,M,HO,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Migraine with aura,1,M,OT,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Migraine with aura,1,M,DE,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,HO,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,OT,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,DE,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,HO,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,OT,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,DE,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Tremor,1,M,HO,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Tremor,1,M,OT,5
167571299,1,Diffuse large B-cell lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Tremor,1,M,DE,5
167571337,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Cerebral infarction,1,F,HO,154
167571337,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Cerebral infarction,1,F,OT,154
167571337,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Colon adenoma,1,F,HO,154
167571337,1,Gastric cancer,7,F,EXP,nivolumab,1,PS,Colon adenoma,1,F,OT,154
167601143,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Septic shock,1,F,HO,470
167601143,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Septic shock,1,F,DE,470
167604522,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Neutropenia,2,M,OT,315
167619884,6,Product used for unknown indication,4,F,EXP,pegfilgrastim,6,C,Herpes zoster,6,M,HO,70
167621784,1,Chronic myeloid leukaemia,4,F,EXP,nilotinib,1,PS,Carotid artery occlusion,1,M,OT,2182
167621784,1,Chronic myeloid leukaemia,4,F,EXP,nilotinib,1,PS,Carotid artery occlusion,1,M,HO,2182
167621784,1,Chronic myeloid leukaemia,4,F,EXP,nilotinib,1,PS,Myocardial infarction,1,M,OT,2182
167621784,1,Chronic myeloid leukaemia,4,F,EXP,nilotinib,1,PS,Myocardial infarction,1,M,HO,2182
167633053,1,Plasma cell myeloma,3,F,EXP,selinexor,1,PS,Anaemia,1,M,HO,113
167633053,1,Plasma cell myeloma,3,F,EXP,selinexor,1,PS,Cardiac failure,1,M,HO,113
167633053,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Anaemia,2,M,HO,113
167633053,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Cardiac failure,2,M,HO,113
167638914,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,LT,20
167638914,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,HO,20
167638914,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Infusion related reaction,1,M,LT,20
167638914,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Infusion related reaction,1,M,HO,20
167638914,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pyrexia,1,M,LT,20
167638914,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,20
167638914,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Wound dehiscence,1,M,LT,20
167638914,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Wound dehiscence,1,M,HO,20
167638914,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,C-reactive protein increased,2,M,LT,20
167638914,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,C-reactive protein increased,2,M,HO,20
167638914,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Infusion related reaction,2,M,LT,20
167638914,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Infusion related reaction,2,M,HO,20
167638914,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,LT,20
167638914,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,HO,20
167638914,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Wound dehiscence,2,M,LT,20
167638914,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Wound dehiscence,2,M,HO,20
167644933,9,Colony stimulating factor therapy,3,F,EXP,filgrastim,9,C,Hepatitis E,9,F,HO,47
167644933,9,Colony stimulating factor therapy,3,F,EXP,filgrastim,9,C,Hepatocellular injury,9,F,HO,47
167663352,5,Colorectal cancer,2,F,EXP,avelumab,5,SS,Enterobacter infection,5,M,HO,28
167663352,5,Colorectal cancer,2,F,EXP,avelumab,5,SS,Kidney infection,5,M,HO,28
167663352,5,Colorectal cancer,2,F,EXP,avelumab,5,SS,Liver abscess,5,M,HO,28
167663352,5,Colorectal cancer,2,F,EXP,avelumab,5,SS,Pyrexia,5,M,HO,28
167663352,5,Colorectal cancer,2,F,EXP,avelumab,5,SS,Urinary tract infection,5,M,HO,28
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Bacteriuria,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Bacteriuria,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Dysstasia,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Dysstasia,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Eosinophil count increased,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Eosinophil count increased,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Gait disturbance,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Gait disturbance,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Haematuria,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Haematuria,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Headache,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Headache,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Hypoaesthesia,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Hypoaesthesia,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Loss of personal independence in daily activities,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Loss of personal independence in daily activities,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Monocyte count increased,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Monocyte count increased,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Nitrite urine present,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Nitrite urine present,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Red blood cells urine positive,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Red blood cells urine positive,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Urinary sediment present,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Urinary sediment present,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Urinary tract infection bacterial,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Urinary tract infection bacterial,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Urine abnormality,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,Urine abnormality,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,White blood cell count increased,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,White blood cell count increased,1,F,DS,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,pH urine increased,1,F,OT,244
167683718,1,Multiple sclerosis,8,F,EXP,alemtuzumab,1,PS,pH urine increased,1,F,DS,244
1676940813,1,Non-small cell lung cancer,13,F,EXP,brigatinib,1,PS,Decreased appetite,1,M,HO,2
1676940813,1,Non-small cell lung cancer,13,F,EXP,brigatinib,1,PS,Hypercalcaemia,1,M,HO,2
1676940813,1,Non-small cell lung cancer,13,F,EXP,brigatinib,1,PS,Hyperkalaemia,1,M,HO,2
1676940813,1,Non-small cell lung cancer,13,F,EXP,brigatinib,1,PS,Hyponatraemia,1,M,HO,2
167701103,4,Anaplastic lymphoma kinase gene mutation,3,F,EXP,ceritinib,4,SS,Intentional self-injury,4,F,HO,691
167701103,4,Anaplastic lymphoma kinase gene mutation,3,F,EXP,ceritinib,4,SS,Intentional self-injury,4,F,LT,691
167701103,4,Anaplastic lymphoma kinase gene mutation,3,F,EXP,ceritinib,4,SS,Overdose,4,F,HO,691
167701103,4,Anaplastic lymphoma kinase gene mutation,3,F,EXP,ceritinib,4,SS,Overdose,4,F,LT,691
167701103,4,Anaplastic lymphoma kinase gene mutation,3,F,EXP,ceritinib,4,SS,Somnolence,4,F,HO,691
167701103,4,Anaplastic lymphoma kinase gene mutation,3,F,EXP,ceritinib,4,SS,Somnolence,4,F,LT,691
167708292,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Disease progression,1,M,OT,21
167708292,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Disease progression,1,M,DE,21
167708292,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Pneumonia,1,M,OT,21
167708292,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Pneumonia,1,M,DE,21
167709813,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Infusion related reaction,1,M,HO,28
167709813,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Infusion related reaction,1,M,LT,28
167709813,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Infusion related reaction,2,M,HO,28
167709813,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Infusion related reaction,2,M,LT,28
167711842,1,Metastases to bone,2,F,EXP,zoledronic acid,1,PS,Jaw fracture,1,F,HO,512
167711842,1,Metastases to bone,2,F,EXP,zoledronic acid,1,PS,Osteonecrosis of jaw,1,F,HO,512
167711842,4,Breast cancer,2,F,EXP,alpelisib,4,SS,Jaw fracture,4,F,HO,307
167711842,4,Breast cancer,2,F,EXP,alpelisib,4,SS,Osteonecrosis of jaw,4,F,HO,307
167725865,1,Acute myeloid leukaemia,5,F,EXP,midostaurin,1,PS,Abdominal pain upper,1,F,HO,217
167726343,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Adverse event,3,M,HO,277
167726343,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Adverse event,3,M,DE,277
167726343,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Cardiac disorder,3,M,HO,277
167726343,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Cardiac disorder,3,M,DE,277
167726343,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Death,3,M,HO,277
167726343,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Death,3,M,DE,277
167726343,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Pharyngeal inflammation,3,M,HO,277
167726343,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Pharyngeal inflammation,3,M,DE,277
167726343,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Renal disorder,3,M,HO,277
167726343,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Renal disorder,3,M,DE,277
167726343,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Throat irritation,3,M,HO,277
167726343,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Throat irritation,3,M,DE,277
167752144,1,Lymphoma,4,F,EXP,selinexor,1,PS,Acute kidney injury,1,M,HO,7
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,F,LT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,F,HO,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,F,OT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,C-reactive protein increased,1,F,DE,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,LT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,HO,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,OT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,DE,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,LT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,HO,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,OT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,DE,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,LT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,DE,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,LT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pain,1,F,LT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pain,1,F,HO,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pain,1,F,OT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pain,1,F,DE,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Renal impairment,1,F,LT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Renal impairment,1,F,HO,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Renal impairment,1,F,OT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Renal impairment,1,F,DE,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Sepsis,1,F,LT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Sepsis,1,F,HO,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Sepsis,1,F,OT,26
167756703,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Sepsis,1,F,DE,26
167777513,1,Amyloidosis,3,F,EXP,daratumumab,1,PS,Cardiac failure,1,M,LT,72
167777513,1,Amyloidosis,3,F,EXP,daratumumab,1,PS,Cardiac failure,1,M,HO,72
167777513,1,Amyloidosis,3,F,EXP,daratumumab,1,PS,Cardiac failure,1,M,DE,72
167777513,1,Amyloidosis,3,F,EXP,daratumumab,1,PS,Sepsis,1,M,LT,72
167777513,1,Amyloidosis,3,F,EXP,daratumumab,1,PS,Sepsis,1,M,HO,72
167777513,1,Amyloidosis,3,F,EXP,daratumumab,1,PS,Sepsis,1,M,DE,72
167779246,9,Non-small cell lung cancer,6,F,EXP,granisetron,9,C,Febrile neutropenia,9,F,HO,10
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Abdominal distension,1,F,DE,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Abdominal distension,1,F,HO,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Abdominal distension,1,F,OT,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,DE,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,HO,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,OT,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Generalised oedema,1,F,DE,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Generalised oedema,1,F,HO,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Generalised oedema,1,F,OT,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hydronephrosis,1,F,DE,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hydronephrosis,1,F,HO,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hydronephrosis,1,F,OT,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,F,DE,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,F,HO,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,F,OT,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,F,DE,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,F,HO,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,F,OT,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Urinary tract infection staphylococcal,1,F,DE,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Urinary tract infection staphylococcal,1,F,HO,29
167797704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Urinary tract infection staphylococcal,1,F,OT,29
167801515,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,14
167801515,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,14
167801515,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,14
167801515,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,14
167801515,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Otitis media,1,M,OT,14
167801515,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Otitis media,1,M,HO,14
167801515,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Otorrhoea,1,M,OT,14
167801515,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Otorrhoea,1,M,HO,14
167801515,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Rash,1,M,OT,14
167801515,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Rash,1,M,HO,14
167801515,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Tumour haemorrhage,1,M,OT,14
167801515,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Tumour haemorrhage,1,M,HO,14
167801515,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Tumour pain,1,M,OT,14
167801515,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Tumour pain,1,M,HO,14
167807639,1,Non-small cell lung cancer,9,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,29
167807639,3,Non-small cell lung cancer,9,F,EXP,pemetrexed disodium,3,SS,Nausea,3,M,HO,29
167812238,1,Acute myeloid leukaemia,8,F,EXP,midostaurin,1,PS,Pneumonia,1,F,DE,2
167812238,1,Acute myeloid leukaemia,8,F,EXP,midostaurin,1,PS,Pneumonia,1,F,DS,2
167812238,1,Acute myeloid leukaemia,8,F,EXP,midostaurin,1,PS,Pneumonia,1,F,HO,2
167812238,1,Acute myeloid leukaemia,8,F,EXP,midostaurin,1,PS,Pneumonia,1,F,LT,2
167822785,2,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Chills,2,M,OT,347
167822785,2,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Chills,2,M,HO,347
167822785,2,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Nausea,2,M,OT,347
167822785,2,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Nausea,2,M,HO,347
167822785,2,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Pyrexia,2,M,OT,347
167822785,2,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Pyrexia,2,M,HO,347
167822785,2,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Vomiting,2,M,OT,347
167822785,2,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Vomiting,2,M,HO,347
167822962,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Encephalitis,1,M,HO,2207
167822962,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Encephalitis,1,M,OT,2207
167828866,1,Oesophageal squamous cell carcinoma,6,F,EXP,nivolumab,1,PS,Pneumonia,1,M,LT,39
167828866,1,Oesophageal squamous cell carcinoma,6,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,39
167828866,1,Oesophageal squamous cell carcinoma,6,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,39
167828866,1,Oesophageal squamous cell carcinoma,6,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,LT,39
167828866,1,Oesophageal squamous cell carcinoma,6,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,39
167828866,1,Oesophageal squamous cell carcinoma,6,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,39
167830404,1,Breast cancer,4,F,EXP,alpelisib,1,PS,Acute kidney injury,1,F,HO,127
167830404,1,Breast cancer,4,F,EXP,alpelisib,1,PS,Blood creatine phosphokinase increased,1,F,HO,127
167830404,1,Breast cancer,4,F,EXP,alpelisib,1,PS,Monoparesis,1,F,HO,127
167830404,1,Breast cancer,4,F,EXP,alpelisib,1,PS,Sepsis,1,F,HO,127
167830404,1,Breast cancer,4,F,EXP,alpelisib,1,PS,Skin ulcer,1,F,HO,127
167833155,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Blood calcium increased,1,M,HO,25
167833155,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Confusional state,1,M,HO,25
167833155,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,25
167833155,1,Lung neoplasm malignant,5,F,EXP,nivolumab,1,PS,Haemoglobin decreased,1,M,HO,25
167833622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Cardiac failure acute,1,F,DE,10
167833622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Cardiac failure acute,1,F,OT,10
167834272,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,42
167834272,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,42
167834272,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Erysipelas,1,F,OT,42
167834272,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Erysipelas,1,F,HO,42
167834272,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,OT,42
167834272,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,42
167834272,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Infection,1,F,OT,42
167834272,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Infection,1,F,HO,42
167834272,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,42
167834272,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,42
167834272,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Pyrexia,1,F,OT,42
167834272,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,42
167839406,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,6
167839406,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,M,HO,6
167839406,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,General physical condition abnormal,1,M,HO,6
167839406,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Hypercalcaemia of malignancy,1,M,HO,6
167839406,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,6
167839406,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,6
167839783,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,C,Inappropriate antidiuretic hormone secretion,2,M,HO,7
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Anhedonia,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Arthralgia,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Arthritis,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Attention deficit/hyperactivity disorder,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Back pain,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Breast mass,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Breast pain,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Burning sensation,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Depression,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Diarrhoea,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Dyspepsia,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Dyspnoea,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Flushing,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Headache,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Hot flush,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Hyperhidrosis,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Initial insomnia,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Loss of consciousness,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Malaise,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Muscular weakness,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Myalgia,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Nausea,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Pain in extremity,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Pyrexia,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Restless legs syndrome,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Sleep talking,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Somnolence,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Stress urinary incontinence,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Temperature intolerance,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Underdose,1,M,OT,1
167845903,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Urinary incontinence,1,M,OT,1
167845924,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Pyrexia,1,M,OT,190
167845924,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Pyrexia,1,M,HO,190
167845924,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Streptococcal sepsis,1,M,OT,190
167845924,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Streptococcal sepsis,1,M,HO,190
167853722,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Cellulitis,1,M,OT,175
167853722,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Discharge,1,M,OT,175
167853722,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Erythema,1,M,OT,175
167853722,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Paronychia,1,M,OT,175
167853722,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Rash erythematous,1,M,OT,175
167853722,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Skin exfoliation,1,M,OT,175
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,C-reactive protein increased,1,M,OT,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,C-reactive protein increased,1,M,HO,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,C-reactive protein increased,1,M,LT,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,M,OT,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,M,HO,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,M,LT,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Leukopenia,1,M,OT,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Leukopenia,1,M,HO,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Leukopenia,1,M,LT,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Rash macular,1,M,OT,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Rash macular,1,M,HO,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Rash macular,1,M,LT,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Respiratory tract infection,1,M,OT,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Respiratory tract infection,1,M,HO,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Respiratory tract infection,1,M,LT,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Thrombocytopenia,1,M,OT,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Thrombocytopenia,1,M,HO,1
167855626,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Thrombocytopenia,1,M,LT,1
167868414,2,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,2,SS,Chills,2,M,OT,347
167868414,2,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,2,SS,Chills,2,M,HO,347
167868414,2,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,2,SS,Nausea,2,M,OT,347
167868414,2,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,2,SS,Nausea,2,M,HO,347
167868414,2,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,2,SS,Pyrexia,2,M,OT,347
167868414,2,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,2,SS,Pyrexia,2,M,HO,347
167868414,2,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,2,SS,Vomiting,2,M,OT,347
167868414,2,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,2,SS,Vomiting,2,M,HO,347
167872262,1,Multiple sclerosis,2,F,PER,alemtuzumab,1,PS,Autoimmune disorder,1,F,OT,1
167872262,1,Multiple sclerosis,2,F,PER,alemtuzumab,1,PS,Pain,1,F,OT,1
167872262,1,Multiple sclerosis,2,F,PER,alemtuzumab,1,PS,Pyrexia,1,F,OT,1
167872262,1,Multiple sclerosis,2,F,PER,alemtuzumab,1,PS,Rash,1,F,OT,1
167879393,1,Non-Hodgkin's lymphoma unspecified histology indolent,3,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,F,OT,3
167879393,1,Non-Hodgkin's lymphoma unspecified histology indolent,3,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,OT,3
167879393,1,Non-Hodgkin's lymphoma unspecified histology indolent,3,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,F,OT,3
167879393,1,Non-Hodgkin's lymphoma unspecified histology indolent,3,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,F,OT,3
167879393,1,Non-Hodgkin's lymphoma unspecified histology indolent,3,F,EXP,axicabtagene ciloleucel,1,PS,Tachycardia,1,F,OT,3
167895324,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Alanine aminotransferase increased,1,F,OT,15
167895324,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Alanine aminotransferase increased,1,F,HO,15
167895324,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Aspartate aminotransferase increased,1,F,OT,15
167895324,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Aspartate aminotransferase increased,1,F,HO,15
167895324,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Enteritis,1,F,OT,15
167895324,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Enteritis,1,F,HO,15
167895324,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Pyrexia,1,F,OT,15
167895324,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Pyrexia,1,F,HO,15
167895324,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Rash,1,F,OT,15
167895324,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Rash,1,F,HO,15
167895324,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Alanine aminotransferase increased,3,F,OT,15
167895324,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Alanine aminotransferase increased,3,F,HO,15
167895324,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Aspartate aminotransferase increased,3,F,OT,15
167895324,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Aspartate aminotransferase increased,3,F,HO,15
167895324,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Enteritis,3,F,OT,15
167895324,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Enteritis,3,F,HO,15
167895324,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Pyrexia,3,F,OT,15
167895324,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Pyrexia,3,F,HO,15
167895324,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Rash,3,F,OT,15
167895324,3,Product used for unknown indication,4,F,EXP,nivolumab,3,SS,Rash,3,F,HO,15
167909525,4,Plasma cell myeloma,5,F,EXP,pomalidomide,4,SS,Lower respiratory tract infection,4,F,OT,15
167909525,4,Plasma cell myeloma,5,F,EXP,pomalidomide,4,SS,Lower respiratory tract infection,4,F,HO,15
167916307,1,Chronic myeloid leukaemia,7,F,EXP,bosutinib,1,PS,Cardiac failure,1,F,HO,1595
167917794,2,Melanoma recurrent,4,F,EXP,trametinib,2,SS,Febrile neutropenia,2,F,LT,14
167919313,7,Leukaemia,3,F,EXP,pegaspargase,7,SS,Anaemia,7,M,HO,17
167919313,7,Leukaemia,3,F,EXP,pegaspargase,7,SS,Dehydration,7,M,HO,17
167919313,7,Leukaemia,3,F,EXP,pegaspargase,7,SS,Platelet count decreased,7,M,HO,17
167919313,7,Leukaemia,3,F,EXP,pegaspargase,7,SS,Sepsis,7,M,HO,17
167919313,7,Leukaemia,3,F,EXP,pegaspargase,7,SS,Stomatitis,7,M,HO,17
167919313,7,Leukaemia,3,F,EXP,pegaspargase,7,SS,White blood cell count decreased,7,M,HO,17
167919722,1,Soft tissue sarcoma,2,F,EXP,trabectedin,1,PS,Complication associated with device,1,F,HO,365
167946575,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,HO,442
167946575,1,Squamous cell carcinoma of head and neck,5,F,EXP,nivolumab,1,PS,Hypotension,1,M,HO,442
167946575,2,Squamous cell carcinoma of head and neck,5,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,HO,442
167946575,2,Squamous cell carcinoma of head and neck,5,F,EXP,ipilimumab,2,SS,Hypotension,2,M,HO,442
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Adverse event,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Adverse event,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Alopecia,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Alopecia,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Asthenia,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Asthenia,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Cough,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Cough,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Drug ineffective,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Drug ineffective,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Gait disturbance,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Gait disturbance,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Insomnia,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Insomnia,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Loss of consciousness,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Loss of consciousness,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Memory impairment,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Memory impairment,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Muscle fatigue,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Muscle fatigue,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Off label use,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Off label use,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Pulmonary congestion,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Pulmonary congestion,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Rash macular,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Rash macular,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Visual impairment,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Visual impairment,1,F,LT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,36
167946589,1,Malignant melanoma,9,F,EXP,nivolumab,1,PS,Vomiting,1,F,LT,36
167948605,1,Neuroendocrine tumour,5,F,EXP,nivolumab,1,PS,Cushing's syndrome,1,M,HO,42
167948605,1,Neuroendocrine tumour,5,F,EXP,nivolumab,1,PS,Cushing's syndrome,1,M,OT,42
167948622,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Cholelithiasis,1,F,HO,39
167952485,33,Premedication,5,F,EXP,granisetron,33,C,Drug-induced liver injury,33,F,HO,127
167952485,33,Premedication,5,F,EXP,granisetron,33,C,Drug-induced liver injury,33,F,OT,127
167952485,33,Premedication,5,F,EXP,granisetron,33,C,Hepatic function abnormal,33,F,HO,127
167952485,33,Premedication,5,F,EXP,granisetron,33,C,Hepatic function abnormal,33,F,OT,127
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Anaemia,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Anaemia,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Anaemia,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Aspergillus infection,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Aspergillus infection,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Aspergillus infection,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,BK virus infection,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,BK virus infection,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,BK virus infection,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Bacteraemia,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Bacteraemia,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Bacteraemia,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Candida infection,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Candida infection,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Candida infection,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Cholecystitis,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Cholecystitis,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Cholecystitis,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Duodenitis,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Duodenitis,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Duodenitis,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Fatigue,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Fatigue,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Fatigue,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Febrile neutropenia,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Febrile neutropenia,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Febrile neutropenia,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Haematuria,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Haematuria,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Haematuria,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Headache,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Headache,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Headache,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Hypoxia,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Hypoxia,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Hypoxia,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Klebsiella infection,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Klebsiella infection,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Klebsiella infection,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Platelet count decreased,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Platelet count decreased,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Platelet count decreased,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Pneumonia,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Pneumonia,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Pneumonia,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Respiratory failure,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Respiratory failure,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Respiratory failure,6,M,LT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Skin bacterial infection,6,M,OT,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Skin bacterial infection,6,M,HO,12
167959843,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Skin bacterial infection,6,M,LT,12
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Anaemia,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Anaemia,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Anaemia,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Aspergillus infection,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Aspergillus infection,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Aspergillus infection,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,BK virus infection,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,BK virus infection,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,BK virus infection,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Bacteraemia,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Bacteraemia,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Bacteraemia,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Candida infection,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Candida infection,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Candida infection,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Cholecystitis,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Cholecystitis,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Cholecystitis,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Duodenitis,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Duodenitis,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Duodenitis,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Fatigue,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Fatigue,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Fatigue,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Febrile neutropenia,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Febrile neutropenia,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Febrile neutropenia,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Haematuria,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Haematuria,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Haematuria,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Headache,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Headache,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Headache,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Hypoxia,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Hypoxia,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Hypoxia,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Klebsiella infection,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Klebsiella infection,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Klebsiella infection,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Platelet count decreased,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Platelet count decreased,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Platelet count decreased,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Pneumonia,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Pneumonia,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Pneumonia,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Respiratory failure,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Respiratory failure,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Respiratory failure,7,M,LT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Skin bacterial infection,7,M,OT,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Skin bacterial infection,7,M,HO,201
167959843,7,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,7,SS,Skin bacterial infection,7,M,LT,201
167962242,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,SS,Gastroenteritis,1,F,HO,74
167962242,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,PS,Gastroenteritis,2,F,HO,11
167965604,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,118
167965604,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,118
167965604,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,M,OT,118
167965604,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,M,HO,118
167965604,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,OT,118
167965604,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,HO,118
167966525,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Cerebral infarction,1,M,DE,203
167966525,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Cerebral infarction,1,M,OT,203
167966525,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Cerebral infarction,1,M,HO,203
167966525,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Cerebrovascular accident,1,M,DE,203
167966525,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Cerebrovascular accident,1,M,OT,203
167966525,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Cerebrovascular accident,1,M,HO,203
167966525,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Pancreatic neoplasm,1,M,DE,203
167966525,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Pancreatic neoplasm,1,M,OT,203
167966525,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Pancreatic neoplasm,1,M,HO,203
167966525,18,Neutropenia,5,F,EXP,filgrastim,18,C,Cerebral infarction,18,M,DE,35
167966525,18,Neutropenia,5,F,EXP,filgrastim,18,C,Cerebral infarction,18,M,OT,35
167966525,18,Neutropenia,5,F,EXP,filgrastim,18,C,Cerebral infarction,18,M,HO,35
167966525,18,Neutropenia,5,F,EXP,filgrastim,18,C,Cerebrovascular accident,18,M,DE,35
167966525,18,Neutropenia,5,F,EXP,filgrastim,18,C,Cerebrovascular accident,18,M,OT,35
167966525,18,Neutropenia,5,F,EXP,filgrastim,18,C,Cerebrovascular accident,18,M,HO,35
167966525,18,Neutropenia,5,F,EXP,filgrastim,18,C,Pancreatic neoplasm,18,M,DE,35
167966525,18,Neutropenia,5,F,EXP,filgrastim,18,C,Pancreatic neoplasm,18,M,OT,35
167966525,18,Neutropenia,5,F,EXP,filgrastim,18,C,Pancreatic neoplasm,18,M,HO,35
167968422,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,PS,Toxic skin eruption,1,F,OT,5
167968422,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,PS,Toxic skin eruption,1,F,HO,5
167968422,2,Transitional cell carcinoma,2,F,EXP,ipilimumab,2,SS,Toxic skin eruption,2,F,OT,5
167968422,2,Transitional cell carcinoma,2,F,EXP,ipilimumab,2,SS,Toxic skin eruption,2,F,HO,5
168006133,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,92
168006133,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,92
168006133,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Neutrophil count decreased,1,M,OT,92
168006133,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Stomatitis,1,M,OT,92
168006133,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Decreased appetite,2,M,OT,92
168006133,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Fatigue,2,M,OT,92
168006133,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Neutrophil count decreased,2,M,OT,92
168006133,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Stomatitis,2,M,OT,92
168014027,1,Acute myeloid leukaemia,7,F,EXP,gemtuzumab ozogamicin,1,PS,Febrile neutropenia,1,M,LT,17
168014027,1,Acute myeloid leukaemia,7,F,EXP,gemtuzumab ozogamicin,1,PS,Febrile neutropenia,1,M,HO,17
168014027,1,Acute myeloid leukaemia,7,F,EXP,gemtuzumab ozogamicin,1,PS,Febrile neutropenia,1,M,DE,17
168024587,1,Oesophageal squamous cell carcinoma,7,F,EXP,nivolumab,1,PS,Facial paralysis,1,M,HO,194
168024587,1,Oesophageal squamous cell carcinoma,7,F,EXP,nivolumab,1,PS,Facial paralysis,1,M,OT,194
168032025,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,92
168032025,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,92
168032025,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Neutrophil count decreased,1,M,OT,92
168032025,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Stomatitis,1,M,OT,92
168032025,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Decreased appetite,2,M,OT,92
168032025,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Fatigue,2,M,OT,92
168032025,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Neutrophil count decreased,2,M,OT,92
168032025,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Stomatitis,2,M,OT,92
168049313,1,Ovarian cancer,3,F,EXP,avelumab,1,SS,Pleural effusion,1,F,HO,54
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Anxiety,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Anxiety,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Anxiety,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Appetite disorder,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Appetite disorder,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Appetite disorder,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Asthenia,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Back pain,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Back pain,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Back pain,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Contusion,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Contusion,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Contusion,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dehydration,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Diarrhoea haemorrhagic,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Diarrhoea haemorrhagic,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Diarrhoea haemorrhagic,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dizziness,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dizziness,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dizziness,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Fall,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Fall,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Fall,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Fatigue,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Gastroenteritis viral,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Gastroenteritis viral,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Gastroenteritis viral,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Gastrointestinal disorder,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Gastrointestinal disorder,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Gastrointestinal disorder,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypotension,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypotension,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Hypotension,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Infusion related reaction,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Infusion related reaction,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Infusion related reaction,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Insomnia,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Insomnia,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Insomnia,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Muscle strain,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Muscle strain,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Muscle strain,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Nausea,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Pain,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Pain,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Pain,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Polyuria,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Polyuria,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Polyuria,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Somnolence,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Somnolence,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Somnolence,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Thermal burn,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Thermal burn,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Thermal burn,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Weight decreased,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Weight decreased,1,M,HO,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Weight increased,1,M,DS,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Weight increased,1,M,OT,56
168058678,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Weight increased,1,M,HO,56
168072254,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,Hypersensitivity,2,F,HO,365
168072254,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,Neutropenia,2,F,HO,365
168072254,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,Pyrexia,2,F,HO,365
168072254,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,Transaminases increased,2,F,HO,365
168082103,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Diarrhoea,2,M,OT,279
168082103,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Hypoacusis,2,M,OT,279
168082103,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,279
168082103,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Metastases to central nervous system,2,M,OT,279
168082103,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Photosensitivity reaction,2,M,OT,279
168082103,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Tinnitus,2,M,OT,279
168082103,3,Lung neoplasm malignant,3,F,EXP,nivolumab,3,SS,Diarrhoea,3,M,OT,246
168082103,3,Lung neoplasm malignant,3,F,EXP,nivolumab,3,SS,Hypoacusis,3,M,OT,246
168082103,3,Lung neoplasm malignant,3,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,OT,246
168082103,3,Lung neoplasm malignant,3,F,EXP,nivolumab,3,SS,Metastases to central nervous system,3,M,OT,246
168082103,3,Lung neoplasm malignant,3,F,EXP,nivolumab,3,SS,Photosensitivity reaction,3,M,OT,246
168082103,3,Lung neoplasm malignant,3,F,EXP,nivolumab,3,SS,Tinnitus,3,M,OT,246
168082103,5,Malignant melanoma,3,F,EXP,ipilimumab,5,SS,Diarrhoea,5,M,OT,246
168082103,5,Malignant melanoma,3,F,EXP,ipilimumab,5,SS,Hypoacusis,5,M,OT,246
168082103,5,Malignant melanoma,3,F,EXP,ipilimumab,5,SS,Malignant neoplasm progression,5,M,OT,246
168082103,5,Malignant melanoma,3,F,EXP,ipilimumab,5,SS,Metastases to central nervous system,5,M,OT,246
168082103,5,Malignant melanoma,3,F,EXP,ipilimumab,5,SS,Photosensitivity reaction,5,M,OT,246
168082103,5,Malignant melanoma,3,F,EXP,ipilimumab,5,SS,Tinnitus,5,M,OT,246
168082103,6,Lung neoplasm malignant,3,F,EXP,ipilimumab,6,SS,Diarrhoea,6,M,OT,184
168082103,6,Lung neoplasm malignant,3,F,EXP,ipilimumab,6,SS,Hypoacusis,6,M,OT,184
168082103,6,Lung neoplasm malignant,3,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,M,OT,184
168082103,6,Lung neoplasm malignant,3,F,EXP,ipilimumab,6,SS,Metastases to central nervous system,6,M,OT,184
168082103,6,Lung neoplasm malignant,3,F,EXP,ipilimumab,6,SS,Photosensitivity reaction,6,M,OT,184
168082103,6,Lung neoplasm malignant,3,F,EXP,ipilimumab,6,SS,Tinnitus,6,M,OT,184
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Arthralgia,1,M,LT,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Arthralgia,1,M,HO,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Intestinal obstruction,1,M,LT,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Intestinal obstruction,1,M,HO,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Intestinal obstruction,1,M,OT,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Myalgia,1,M,LT,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Myalgia,1,M,HO,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Myalgia,1,M,OT,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Peripheral swelling,1,M,LT,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Peripheral swelling,1,M,HO,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Peripheral swelling,1,M,OT,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,LT,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,LT,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,HO,21
168083903,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,OT,21
168086013,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Amylase increased,1,M,OT,63
168086013,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,63
168086013,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Lipase increased,1,M,OT,63
168086013,2,Renal cancer,3,F,EXP,ipilimumab,2,SS,Amylase increased,2,M,OT,63
168086013,2,Renal cancer,3,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,63
168086013,2,Renal cancer,3,F,EXP,ipilimumab,2,SS,Lipase increased,2,M,OT,63
168106502,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Intentional product use issue,2,M,HO,30
168106502,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Intentional product use issue,2,M,OT,30
168106502,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Prerenal failure,2,M,HO,30
168106502,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Prerenal failure,2,M,OT,30
168106502,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Product use in unapproved indication,2,M,HO,30
168106502,2,Colorectal cancer metastatic,2,F,EXP,nivolumab,2,SS,Product use in unapproved indication,2,M,OT,30
168117642,1,B-cell lymphoma,2,F,EXP,pegfilgrastim,1,PS,Pulmonary embolism,1,M,OT,106
168117642,1,B-cell lymphoma,2,F,EXP,pegfilgrastim,1,PS,Thrombosis,1,M,OT,106
168138212,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Alanine aminotransferase increased,1,M,HO,15
168138212,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Aspartate aminotransferase increased,1,M,HO,15
168138212,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Chest discomfort,1,M,HO,15
168138212,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Cough,1,M,HO,15
168138212,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Dizziness,1,M,HO,15
168138212,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Erythema,1,M,HO,15
168138212,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Fall,1,M,HO,15
168138212,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Hyperferritinaemia,1,M,HO,15
168138212,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Malaise,1,M,HO,15
168138212,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Neuralgia,1,M,HO,15
168138212,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Rib fracture,1,M,HO,15
168138212,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Taste disorder,1,M,HO,15
168186353,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Pyrexia,1,F,HO,25
168193526,1,Diffuse large B-cell lymphoma,6,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,F,HO,8
168193526,1,Diffuse large B-cell lymphoma,6,F,EXP,axicabtagene ciloleucel,1,PS,Somnolence,1,F,HO,8
168229103,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Blood glucose increased,1,F,HO,51
168229103,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Blood glucose increased,1,F,OT,51
168229103,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Pyrexia,1,F,HO,51
168229103,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Pyrexia,1,F,OT,51
168229103,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Blood glucose increased,2,F,HO,51
168229103,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Blood glucose increased,2,F,OT,51
168229103,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Pyrexia,2,F,HO,51
168229103,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Pyrexia,2,F,OT,51
168233783,1,Relapsing multiple sclerosis,3,F,EXP,ofatumumab,1,PS,Gastrointestinal infection,1,F,LT,840
168233783,1,Relapsing multiple sclerosis,3,F,EXP,ofatumumab,1,PS,Gastrointestinal infection,1,F,HO,840
168247873,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Rheumatoid arthritis,1,F,OT,171
168247884,1,Oesophageal carcinoma,4,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,OT,16
168247884,1,Oesophageal carcinoma,4,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,LT,16
168247884,1,Oesophageal carcinoma,4,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,HO,16
168247884,1,Oesophageal carcinoma,4,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,DE,16
168247884,1,Oesophageal carcinoma,4,F,EXP,nivolumab,1,PS,Hepatitis fulminant,1,M,OT,16
168247884,1,Oesophageal carcinoma,4,F,EXP,nivolumab,1,PS,Hepatitis fulminant,1,M,LT,16
168247884,1,Oesophageal carcinoma,4,F,EXP,nivolumab,1,PS,Hepatitis fulminant,1,M,HO,16
168247884,1,Oesophageal carcinoma,4,F,EXP,nivolumab,1,PS,Hepatitis fulminant,1,M,DE,16
168249335,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Pneumonia,3,F,OT,11
168249335,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Pneumonia,3,F,HO,11
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Constipation,1,M,OT,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Constipation,1,M,HO,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Deep vein thrombosis,1,M,OT,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Deep vein thrombosis,1,M,HO,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Erythema,1,M,OT,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Erythema,1,M,HO,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Hyponatraemia,1,M,OT,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Hyponatraemia,1,M,HO,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Hypothyroidism,1,M,OT,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Hypothyroidism,1,M,HO,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Lung neoplasm malignant,1,M,OT,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Lung neoplasm malignant,1,M,HO,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Muscle spasms,1,M,OT,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Muscle spasms,1,M,HO,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Oedema,1,M,OT,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Oedema,1,M,HO,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Pharyngitis,1,M,OT,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Pharyngitis,1,M,HO,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Pneumonia,1,M,OT,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Pneumonia,1,M,HO,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Urinary tract infection,1,M,OT,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Urinary tract infection,1,M,HO,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Vomiting,1,M,OT,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Vomiting,1,M,HO,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Xeroderma,1,M,OT,97
168255222,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Xeroderma,1,M,HO,97
168300055,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,HO,230
168300055,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,OT,230
168300055,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,230
168300055,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,230
168300307,1,Metastatic malignant melanoma,7,F,EXP,nivolumab,1,PS,Rash,1,M,HO,41
168334632,1,Anaemia,2,F,PER,darbepoetin alfa,1,PS,Acute left ventricular failure,1,F,HO,329
168334632,1,Anaemia,2,F,PER,darbepoetin alfa,1,PS,Atrial flutter,1,F,HO,329
168334632,1,Anaemia,2,F,PER,darbepoetin alfa,1,PS,Cardiac valve disease,1,F,HO,329
168359554,6,Leukaemia,4,F,EXP,pegaspargase,6,SS,Anaemia,6,M,HO,17
168359554,6,Leukaemia,4,F,EXP,pegaspargase,6,SS,Dehydration,6,M,HO,17
168359554,6,Leukaemia,4,F,EXP,pegaspargase,6,SS,Platelet count decreased,6,M,HO,17
168359554,6,Leukaemia,4,F,EXP,pegaspargase,6,SS,Sepsis,6,M,HO,17
168359554,6,Leukaemia,4,F,EXP,pegaspargase,6,SS,Stomatitis,6,M,HO,17
168359554,6,Leukaemia,4,F,EXP,pegaspargase,6,SS,White blood cell count decreased,6,M,HO,17
168377302,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Decreased appetite,3,F,OT,12
168377302,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Decreased appetite,3,F,HO,12
168377302,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Infection,3,F,OT,12
168377302,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Infection,3,F,HO,12
168377302,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Lower respiratory tract infection,3,F,OT,12
168377302,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Lower respiratory tract infection,3,F,HO,12
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone decreased,1,F,OT,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone decreased,1,F,HO,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Contusion,1,F,OT,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Contusion,1,F,HO,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Crystal urine present,1,F,OT,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Crystal urine present,1,F,HO,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Depressed mood,1,F,OT,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Depressed mood,1,F,HO,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Dizziness,1,F,OT,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Dizziness,1,F,HO,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Fatigue,1,F,OT,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Fatigue,1,F,HO,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Haematochezia,1,F,OT,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Haematochezia,1,F,HO,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Haematoma,1,F,OT,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Haematoma,1,F,HO,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,OT,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,HO,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,OT,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,HO,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Mouth haemorrhage,1,F,OT,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Mouth haemorrhage,1,F,HO,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Petechiae,1,F,OT,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Petechiae,1,F,HO,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Platelet count decreased,1,F,OT,93
168396059,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Platelet count decreased,1,F,HO,93
168404905,2,Malignant melanoma,5,F,EXP,trametinib,2,SS,Hepatocellular injury,2,F,HO,25
168404905,2,Malignant melanoma,5,F,EXP,trametinib,2,SS,Pyrexia,2,F,HO,25
168417683,5,Breast cancer,3,F,EXP,palbociclib,5,SS,Osteonecrosis of jaw,5,F,HO,1917
1684226214,13,Prophylaxis,14,F,EXP,granisetron,13,C,Circulatory collapse,13,F,DE,29
1684226214,13,Prophylaxis,14,F,EXP,granisetron,13,C,Circulatory collapse,13,F,HO,29
1684226214,13,Prophylaxis,14,F,EXP,granisetron,13,C,Hip fracture,13,F,DE,29
1684226214,13,Prophylaxis,14,F,EXP,granisetron,13,C,Hip fracture,13,F,HO,29
1684226214,13,Prophylaxis,14,F,EXP,granisetron,13,C,Renal failure,13,F,DE,29
1684226214,13,Prophylaxis,14,F,EXP,granisetron,13,C,Renal failure,13,F,HO,29
168424265,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Microvascular coronary artery disease,1,M,HO,569
168424265,2,Plasma cell myeloma,5,F,PER,daratumumab,2,SS,Microvascular coronary artery disease,2,M,HO,569
168435482,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Back pain,1,F,OT,15
168435482,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Bone pain,1,F,OT,15
168435482,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Dyspnoea,1,F,OT,15
168435482,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Influenza,1,F,OT,15
168435482,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Nausea,1,F,OT,15
168435482,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Pruritus,1,F,OT,15
168435482,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Pyrexia,1,F,OT,15
168435482,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Rash,1,F,OT,15
168435482,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Somnolence,1,F,OT,15
168435482,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Trichorrhexis,1,F,OT,15
168435482,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Urinary tract inflammation,1,F,OT,15
168439272,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Pharyngeal haemorrhage,1,M,OT,54
168439272,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Pharyngeal haemorrhage,1,M,HO,54
168440082,1,Pleural mesothelioma malignant,2,F,EXP,nivolumab,1,PS,Death,1,F,DE,106
168440082,1,Pleural mesothelioma malignant,2,F,EXP,nivolumab,1,PS,Death,1,F,OT,106
168440082,1,Pleural mesothelioma malignant,2,F,EXP,nivolumab,1,PS,Intentional product use issue,1,F,DE,106
168440082,1,Pleural mesothelioma malignant,2,F,EXP,nivolumab,1,PS,Intentional product use issue,1,F,OT,106
168440082,1,Pleural mesothelioma malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,106
168440082,1,Pleural mesothelioma malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,106
168452412,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Pneumonia,1,M,DE,35
168452412,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Pneumonia,1,M,OT,35
168452412,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Pneumonia,1,M,HO,35
168464102,1,Osteoporosis,2,F,EXP,zoledronic acid,1,PS,Body temperature increased,1,F,OT,1
168464102,1,Osteoporosis,2,F,EXP,zoledronic acid,1,PS,Feeding disorder,1,F,OT,1
168464102,1,Osteoporosis,2,F,EXP,zoledronic acid,1,PS,Headache,1,F,OT,1
168464102,1,Osteoporosis,2,F,EXP,zoledronic acid,1,PS,Myalgia,1,F,OT,1
168464102,1,Osteoporosis,2,F,EXP,zoledronic acid,1,PS,Nausea,1,F,OT,1
168464102,1,Osteoporosis,2,F,EXP,zoledronic acid,1,PS,Poisoning,1,F,OT,1
168464102,1,Osteoporosis,2,F,EXP,zoledronic acid,1,PS,Vomiting,1,F,OT,1
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Asthenia,1,M,DE,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,DE,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,OT,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,HO,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Blood creatinine decreased,1,M,DE,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Blood creatinine decreased,1,M,OT,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Blood creatinine decreased,1,M,HO,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,DE,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Malaise,1,M,DE,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Malaise,1,M,OT,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Malaise,1,M,HO,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Nephritis,1,M,DE,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Nephritis,1,M,OT,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Nephritis,1,M,HO,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Renal failure,1,M,DE,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,25
168517495,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Asthenia,2,M,DE,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Asthenia,2,M,OT,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Asthenia,2,M,HO,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Atrial fibrillation,2,M,DE,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Atrial fibrillation,2,M,OT,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Atrial fibrillation,2,M,HO,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Blood creatinine decreased,2,M,DE,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Blood creatinine decreased,2,M,OT,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Blood creatinine decreased,2,M,HO,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Decreased appetite,2,M,DE,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Decreased appetite,2,M,OT,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Decreased appetite,2,M,HO,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,DE,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Malaise,2,M,DE,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Malaise,2,M,OT,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Malaise,2,M,HO,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Nephritis,2,M,DE,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Nephritis,2,M,OT,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Nephritis,2,M,HO,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Renal failure,2,M,DE,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Renal failure,2,M,OT,25
168517495,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Renal failure,2,M,HO,25
168521625,18,Product used for unknown indication,5,F,PER,pegfilgrastim,18,C,Dehydration,18,M,HO,2
168521625,18,Product used for unknown indication,5,F,PER,pegfilgrastim,18,C,Febrile neutropenia,18,M,HO,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Dizziness,1,M,DE,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Hot flush,1,M,OT,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Hot flush,1,M,DE,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Hyperhidrosis,1,M,OT,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Hyperhidrosis,1,M,DE,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Malignant neoplasm progression,1,M,OT,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Malignant neoplasm progression,1,M,DE,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Motor dysfunction,1,M,OT,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Motor dysfunction,1,M,DE,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Pain in extremity,1,M,OT,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Pain in extremity,1,M,DE,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Peripheral swelling,1,M,OT,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Peripheral swelling,1,M,DE,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Visual impairment,1,M,OT,2
168566057,1,Prostate cancer metastatic,7,F,EXP,enzalutamide,1,PS,Visual impairment,1,M,DE,2
168593602,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Lymphocyte count decreased,2,M,OT,14
168593602,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,White blood cell count decreased,2,M,OT,14
168624467,1,Salivary gland cancer,7,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,OT,15
168624467,1,Salivary gland cancer,7,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,15
168624467,1,Salivary gland cancer,7,F,EXP,nivolumab,1,PS,Hernia,1,M,OT,15
168624467,1,Salivary gland cancer,7,F,EXP,nivolumab,1,PS,Incorrect dose administered,1,M,OT,15
168624467,1,Salivary gland cancer,7,F,EXP,nivolumab,1,PS,Lymphocyte count increased,1,M,OT,15
168624467,1,Salivary gland cancer,7,F,EXP,nivolumab,1,PS,Melaena,1,M,OT,15
168624467,1,Salivary gland cancer,7,F,EXP,nivolumab,1,PS,Muscle injury,1,M,OT,15
168624467,1,Salivary gland cancer,7,F,EXP,nivolumab,1,PS,Myalgia,1,M,OT,15
168624467,1,Salivary gland cancer,7,F,EXP,nivolumab,1,PS,Pain in extremity,1,M,OT,15
168624467,1,Salivary gland cancer,7,F,EXP,nivolumab,1,PS,Rash,1,M,OT,15
168624467,2,Malignant melanoma,7,F,EXP,nivolumab,2,SS,Abdominal pain,2,M,OT,15
168624467,2,Malignant melanoma,7,F,EXP,nivolumab,2,SS,Fatigue,2,M,OT,15
168624467,2,Malignant melanoma,7,F,EXP,nivolumab,2,SS,Hernia,2,M,OT,15
168624467,2,Malignant melanoma,7,F,EXP,nivolumab,2,SS,Incorrect dose administered,2,M,OT,15
168624467,2,Malignant melanoma,7,F,EXP,nivolumab,2,SS,Lymphocyte count increased,2,M,OT,15
168624467,2,Malignant melanoma,7,F,EXP,nivolumab,2,SS,Melaena,2,M,OT,15
168624467,2,Malignant melanoma,7,F,EXP,nivolumab,2,SS,Muscle injury,2,M,OT,15
168624467,2,Malignant melanoma,7,F,EXP,nivolumab,2,SS,Myalgia,2,M,OT,15
168624467,2,Malignant melanoma,7,F,EXP,nivolumab,2,SS,Pain in extremity,2,M,OT,15
168624467,2,Malignant melanoma,7,F,EXP,nivolumab,2,SS,Rash,2,M,OT,15
168624467,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Abdominal pain,3,M,OT,15
168624467,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Fatigue,3,M,OT,15
168624467,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Hernia,3,M,OT,15
168624467,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Incorrect dose administered,3,M,OT,15
168624467,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Lymphocyte count increased,3,M,OT,15
168624467,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Melaena,3,M,OT,15
168624467,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Muscle injury,3,M,OT,15
168624467,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Myalgia,3,M,OT,15
168624467,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Pain in extremity,3,M,OT,15
168624467,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Rash,3,M,OT,15
168666103,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Atrial flutter,1,M,HO,42
168676964,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Abdominal discomfort,1,M,OT,363
168676964,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,363
168676964,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Constipation,1,M,OT,363
168676964,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,OT,363
168676964,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Haemoptysis,1,M,OT,363
168676964,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Influenza,1,M,OT,363
168676964,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Musculoskeletal stiffness,1,M,OT,363
168676964,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Nausea,1,M,OT,363
168680273,1,Plasma cell myeloma,3,F,EXP,selinexor,1,PS,Febrile neutropenia,1,M,HO,47
168689734,1,Plasma cell myeloma,4,F,EXP,daratumumab,1,PS,Anaemia,1,F,OT,1506
168689734,1,Plasma cell myeloma,4,F,EXP,daratumumab,1,PS,Anaemia,1,F,HO,1506
168689734,1,Plasma cell myeloma,4,F,EXP,daratumumab,1,PS,Plasmablastic lymphoma,1,F,OT,1506
168689734,1,Plasma cell myeloma,4,F,EXP,daratumumab,1,PS,Plasmablastic lymphoma,1,F,HO,1506
168701622,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Anaemia,1,M,DE,71
168701622,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,71
168701622,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,71
168701622,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Back injury,1,M,DE,71
168701622,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Back injury,1,M,OT,71
168701622,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Back injury,1,M,HO,71
168701622,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,71
168701622,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,71
168701622,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,71
168701982,6,Plasma cell myeloma,2,F,EXP,thalidomide,6,SS,Nausea,6,F,HO,20
168701982,6,Plasma cell myeloma,2,F,EXP,thalidomide,6,SS,Orthostatic hypotension,6,F,HO,20
168701982,6,Plasma cell myeloma,2,F,EXP,thalidomide,6,SS,Paraesthesia,6,F,HO,20
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Asthenia,1,F,DE,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Asthenia,1,F,HO,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Asthenia,1,F,OT,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Back pain,1,F,DE,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Back pain,1,F,HO,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Back pain,1,F,OT,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Brain neoplasm,1,F,DE,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Brain neoplasm,1,F,HO,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Brain neoplasm,1,F,OT,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Epilepsy,1,F,DE,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Epilepsy,1,F,HO,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Epilepsy,1,F,OT,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Erectile dysfunction,1,F,DE,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Erectile dysfunction,1,F,HO,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Erectile dysfunction,1,F,OT,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Nausea,1,F,DE,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pain,1,F,DE,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pain,1,F,HO,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pain,1,F,OT,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Spinal cord infection,1,F,DE,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Spinal cord infection,1,F,HO,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Spinal cord infection,1,F,OT,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Vomiting,1,F,DE,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,416
168719425,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,416
168720114,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,Syncope,2,F,OT,14
168720114,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,Syncope,2,F,HO,14
168726704,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Gastric ulcer,1,F,OT,372
168744144,1,Glioma,4,F,EXP,trametinib,1,PS,Tooth abscess,1,F,HO,116
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Anaemia,1,M,DE,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Asthenia,1,M,DE,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Cardiomyopathy,1,M,OT,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Cardiomyopathy,1,M,DE,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Cardiomyopathy,1,M,HO,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Cerebral haemorrhage,1,M,OT,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Cerebral haemorrhage,1,M,DE,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Cerebral haemorrhage,1,M,HO,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Ejection fraction,1,M,OT,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Ejection fraction,1,M,DE,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Ejection fraction,1,M,HO,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Escherichia infection,1,M,OT,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Escherichia infection,1,M,DE,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Escherichia infection,1,M,HO,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,DE,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,HO,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Pyrexia,1,M,DE,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,M,OT,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,M,DE,323
168746594,1,Clear cell renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,M,HO,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Anaemia,2,M,OT,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Anaemia,2,M,DE,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Anaemia,2,M,HO,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Asthenia,2,M,OT,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Asthenia,2,M,DE,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Asthenia,2,M,HO,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Cardiomyopathy,2,M,OT,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Cardiomyopathy,2,M,DE,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Cardiomyopathy,2,M,HO,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Cerebral haemorrhage,2,M,OT,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Cerebral haemorrhage,2,M,DE,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Cerebral haemorrhage,2,M,HO,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Ejection fraction,2,M,OT,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Ejection fraction,2,M,DE,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Ejection fraction,2,M,HO,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Escherichia infection,2,M,OT,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Escherichia infection,2,M,DE,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Escherichia infection,2,M,HO,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,General physical health deterioration,2,M,OT,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,General physical health deterioration,2,M,DE,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,General physical health deterioration,2,M,HO,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Intentional product use issue,2,M,OT,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Intentional product use issue,2,M,DE,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Intentional product use issue,2,M,HO,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,DE,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,HO,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Pyrexia,2,M,OT,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Pyrexia,2,M,DE,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Pyrexia,2,M,HO,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Thrombocytopenia,2,M,OT,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Thrombocytopenia,2,M,DE,323
168746594,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Thrombocytopenia,2,M,HO,323
168763133,4,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,4,SS,Alanine aminotransferase increased,4,F,HO,123
168763133,4,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,4,SS,Aspartate aminotransferase increased,4,F,HO,123
168773073,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Alopecia,1,M,OT,438
168773073,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,438
168773073,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Gastric ulcer haemorrhage,1,M,OT,438
168773363,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Abdominal pain,1,M,HO,222
168773363,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Constipation,1,M,HO,222
168787712,23,Plasma cell myeloma,2,F,PER,carfilzomib,23,SS,Sepsis,23,M,HO,1665
168787712,23,Plasma cell myeloma,2,F,PER,carfilzomib,23,SS,Sepsis,23,M,OT,1665
1687919510,32,Prophylaxis,10,F,EXP,rasburicase,32,C,Liver function test abnormal,32,M,OT,7
1687919510,32,Prophylaxis,10,F,EXP,rasburicase,32,C,Liver function test abnormal,32,M,DE,7
1687919510,32,Prophylaxis,10,F,EXP,rasburicase,32,C,Liver function test abnormal,32,M,HO,7
168794075,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Device related infection,1,F,HO,580
168794075,3,Plasma cell myeloma,5,F,PER,daratumumab,3,SS,Device related infection,3,F,HO,580
168805104,16,Metastases to bone,4,F,EXP,denosumab,16,C,Bone marrow failure,16,M,HO,15
168805104,16,Metastases to bone,4,F,EXP,denosumab,16,C,Bone marrow failure,16,M,OT,15
168805104,16,Metastases to bone,4,F,EXP,denosumab,16,C,Mechanical ileus,16,M,HO,15
168805104,16,Metastases to bone,4,F,EXP,denosumab,16,C,Mechanical ileus,16,M,OT,15
168815885,1,Plasma cell myeloma,5,F,EXP,lenalidomide,1,PS,Diarrhoea,1,M,DE,16
168815885,1,Plasma cell myeloma,5,F,EXP,lenalidomide,1,PS,Diarrhoea,1,M,HO,16
168815885,1,Plasma cell myeloma,5,F,EXP,lenalidomide,1,PS,Diarrhoea,1,M,LT,16
168815885,1,Plasma cell myeloma,5,F,EXP,lenalidomide,1,PS,Multiple organ dysfunction syndrome,1,M,DE,16
168815885,1,Plasma cell myeloma,5,F,EXP,lenalidomide,1,PS,Multiple organ dysfunction syndrome,1,M,HO,16
168815885,1,Plasma cell myeloma,5,F,EXP,lenalidomide,1,PS,Multiple organ dysfunction syndrome,1,M,LT,16
168815885,1,Plasma cell myeloma,5,F,EXP,lenalidomide,1,PS,Sepsis,1,M,DE,16
168815885,1,Plasma cell myeloma,5,F,EXP,lenalidomide,1,PS,Sepsis,1,M,HO,16
168815885,1,Plasma cell myeloma,5,F,EXP,lenalidomide,1,PS,Sepsis,1,M,LT,16
1688176811,1,B-cell lymphoma,11,F,EXP,idelalisib,1,PS,Abdominal pain upper,1,F,HO,11
1688176811,1,B-cell lymphoma,11,F,EXP,idelalisib,1,PS,Blood albumin decreased,1,F,HO,11
1688176811,1,B-cell lymphoma,11,F,EXP,idelalisib,1,PS,Diarrhoea,1,F,HO,11
1688176811,1,B-cell lymphoma,11,F,EXP,idelalisib,1,PS,Enteritis,1,F,HO,11
1688176811,1,B-cell lymphoma,11,F,EXP,idelalisib,1,PS,Fatigue,1,F,HO,11
1688176811,1,B-cell lymphoma,11,F,EXP,idelalisib,1,PS,Pleural effusion,1,F,HO,11
1688176811,1,B-cell lymphoma,11,F,EXP,idelalisib,1,PS,Pulmonary embolism,1,F,HO,11
1688176811,1,B-cell lymphoma,11,F,EXP,idelalisib,1,PS,Transaminases increased,1,F,HO,11
168830502,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,SS,Blood pressure increased,1,M,HO,3
168830502,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,SS,Diplopia,1,M,HO,3
168830502,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,SS,Drug hypersensitivity,1,M,HO,3
168830502,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,SS,Headache,1,M,HO,3
168830502,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,SS,Magnetic resonance imaging brain abnormal,1,M,HO,3
168830502,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,SS,Vascular occlusion,1,M,HO,3
168830502,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,SS,Vision blurred,1,M,HO,3
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Abdominal pain upper,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Bacterial test positive,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Blood cholinesterase increased,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Blood creatinine decreased,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Crystalluria,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Eosinophil count decreased,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Haematocrit decreased,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Herpes zoster,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Leukopenia,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Lymphocyte percentage decreased,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Mean cell haemoglobin concentration increased,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Monocyte percentage decreased,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Neck pain,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Neutrophil count decreased,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Protein urine present,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Rash,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Red blood cell count decreased,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Red cell distribution width increased,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Urinary sediment present,1,F,OT,31
168836432,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Urine abnormality,1,F,OT,31
168848015,5,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,5,SS,Hepatocellular injury,5,M,HO,61
168848015,5,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,5,SS,Hepatocellular injury,5,M,OT,61
168849443,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,OT,11
168849443,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,OT,11
168849443,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Rheumatoid arthritis,1,M,OT,11
168849443,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Atrial fibrillation,2,M,OT,11
168849443,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Autoimmune disorder,2,M,OT,11
168849443,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Rheumatoid arthritis,2,M,OT,11
168849903,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Blood glucose decreased,1,M,HO,714
168849903,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Blood glucose decreased,1,M,OT,714
168849903,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Diabetes mellitus,1,M,HO,714
168849903,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Diabetes mellitus,1,M,OT,714
168849903,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Heart rate increased,1,M,HO,714
168849903,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Heart rate increased,1,M,OT,714
168849903,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Intestinal obstruction,1,M,HO,714
168849903,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Intestinal obstruction,1,M,OT,714
168849903,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Malaise,1,M,HO,714
168849903,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Malaise,1,M,OT,714
168849903,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Unresponsive to stimuli,1,M,HO,714
168849903,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Unresponsive to stimuli,1,M,OT,714
168862632,1,Oesophageal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Dysphagia,1,F,HO,71
168862632,1,Oesophageal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Oesophagitis,1,F,HO,71
168862632,1,Oesophageal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Rash morbilliform,1,F,HO,71
168867584,7,Product used for unknown indication,4,F,EXP,granisetron,7,C,Colitis,7,M,HO,7
168867584,7,Product used for unknown indication,4,F,EXP,granisetron,7,C,Colitis,7,M,LT,7
168867584,7,Product used for unknown indication,4,F,EXP,granisetron,7,C,Sepsis,7,M,HO,7
168867584,7,Product used for unknown indication,4,F,EXP,granisetron,7,C,Sepsis,7,M,LT,7
168872503,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Cellulitis,1,M,HO,9
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Abdominal abscess,1,M,DE,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Abdominal abscess,1,M,HO,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Abdominal abscess,1,M,OT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Abdominal abscess,1,M,LT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Abdominal mass,1,M,DE,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Abdominal mass,1,M,HO,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Abdominal mass,1,M,OT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Abdominal mass,1,M,LT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Abdominal pain lower,1,M,DE,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Abdominal pain lower,1,M,HO,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Abdominal pain lower,1,M,OT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Abdominal pain lower,1,M,LT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,DE,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,LT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Bowel movement irregularity,1,M,DE,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Bowel movement irregularity,1,M,HO,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Bowel movement irregularity,1,M,OT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Bowel movement irregularity,1,M,LT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Confusional state,1,M,DE,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Confusional state,1,M,HO,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Confusional state,1,M,OT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Confusional state,1,M,LT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Intestinal perforation,1,M,DE,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Intestinal perforation,1,M,HO,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Intestinal perforation,1,M,OT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Intestinal perforation,1,M,LT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Liver abscess,1,M,DE,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Liver abscess,1,M,HO,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Liver abscess,1,M,OT,83
168875297,1,Small cell lung cancer,7,F,EXP,nivolumab,1,PS,Liver abscess,1,M,LT,83
168875474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,105
168875474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,105
168875474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Ejection fraction decreased,1,F,HO,105
168875474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Ejection fraction decreased,1,F,OT,105
168875474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Myocarditis,1,F,HO,105
168875474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Myocarditis,1,F,OT,105
168875474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,HO,105
168875474,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,OT,105
168875967,1,Squamous cell carcinoma of head and neck,7,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,28
168875967,1,Squamous cell carcinoma of head and neck,7,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,28
168875967,1,Squamous cell carcinoma of head and neck,7,F,EXP,nivolumab,1,PS,Ascites,1,M,OT,28
168875967,1,Squamous cell carcinoma of head and neck,7,F,EXP,nivolumab,1,PS,Ascites,1,M,HO,28
168875967,1,Squamous cell carcinoma of head and neck,7,F,EXP,nivolumab,1,PS,Hepatic cirrhosis,1,M,OT,28
168875967,1,Squamous cell carcinoma of head and neck,7,F,EXP,nivolumab,1,PS,Hepatic cirrhosis,1,M,HO,28
168875967,1,Squamous cell carcinoma of head and neck,7,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,OT,28
168875967,1,Squamous cell carcinoma of head and neck,7,F,EXP,nivolumab,1,PS,Hepatic failure,1,M,HO,28
168875967,1,Squamous cell carcinoma of head and neck,7,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,28
168875967,1,Squamous cell carcinoma of head and neck,7,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,28
168875967,1,Squamous cell carcinoma of head and neck,7,F,EXP,nivolumab,1,PS,Mucosal inflammation,1,M,OT,28
168875967,1,Squamous cell carcinoma of head and neck,7,F,EXP,nivolumab,1,PS,Mucosal inflammation,1,M,HO,28
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Bronchopulmonary aspergillosis,1,M,DE,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Bronchopulmonary aspergillosis,1,M,LT,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Bronchopulmonary aspergillosis,1,M,OT,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Constipation,1,M,DE,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Constipation,1,M,LT,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Constipation,1,M,OT,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Febrile neutropenia,1,M,DE,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Febrile neutropenia,1,M,LT,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Febrile neutropenia,1,M,OT,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Pneumonia,1,M,DE,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Pneumonia,1,M,LT,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Pneumonia,1,M,OT,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Transformation to acute myeloid leukaemia,1,M,DE,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Transformation to acute myeloid leukaemia,1,M,LT,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Transformation to acute myeloid leukaemia,1,M,OT,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Urinary tract infection,1,M,DE,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Urinary tract infection,1,M,LT,17
168890542,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Urinary tract infection,1,M,OT,17
168890773,1,Relapsing multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,M,LT,3
168890773,1,Relapsing multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,M,HO,3
168890773,1,Relapsing multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Rash,1,M,LT,3
168890773,1,Relapsing multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Rash,1,M,HO,3
168890892,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Hypokalaemia,1,M,OT,70
168890892,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Hypokalaemia,1,M,HO,70
168890892,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Restlessness,1,M,OT,70
168890892,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Restlessness,1,M,HO,70
168890892,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Urinary tract infection,1,M,OT,70
168890892,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Urinary tract infection,1,M,HO,70
168891513,1,Hodgkin's disease,3,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,HO,66
168891513,1,Hodgkin's disease,3,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,OT,66
168891513,1,Hodgkin's disease,3,F,EXP,nivolumab,1,PS,Tubulointerstitial nephritis,1,M,HO,66
168891513,1,Hodgkin's disease,3,F,EXP,nivolumab,1,PS,Tubulointerstitial nephritis,1,M,OT,66
168891513,1,Hodgkin's disease,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,HO,66
168891513,1,Hodgkin's disease,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,OT,66
168891513,1,Hodgkin's disease,3,F,EXP,nivolumab,1,PS,Urinary tract infection pseudomonal,1,M,HO,66
168891513,1,Hodgkin's disease,3,F,EXP,nivolumab,1,PS,Urinary tract infection pseudomonal,1,M,OT,66
168913235,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Syncope,3,F,HO,14
168913235,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Syncope,3,F,OT,14
168926244,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Lower respiratory tract infection,1,F,HO,547
168927793,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,PS,Blood creatine phosphokinase increased,2,M,HO,62
168934615,1,Plasma cell myeloma,5,F,EXP,selinexor,1,PS,Acute kidney injury,1,F,HO,509
168934615,1,Plasma cell myeloma,5,F,EXP,selinexor,1,PS,Diarrhoea,1,F,HO,509
168935473,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,M,HO,14
168935473,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,M,OT,14
168935473,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,14
168935473,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,14
168935473,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Pruritus,1,M,HO,14
168935473,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Pruritus,1,M,OT,14
168935473,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Swollen tongue,1,M,HO,14
168935473,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Swollen tongue,1,M,OT,14
168935473,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Transaminases increased,1,M,HO,14
168935473,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Transaminases increased,1,M,OT,14
168935473,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,HO,14
168935473,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,OT,14
168936774,3,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,3,SS,Hepatocellular injury,3,M,OT,61
168936774,3,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,3,SS,Hepatocellular injury,3,M,HO,61
168973562,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,41
168973562,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,41
168973562,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,LT,41
168973562,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,41
168973562,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,41
168973562,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,LT,41
168973562,4,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,4,SS,Diarrhoea,4,M,OT,41
168973562,4,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,4,SS,Diarrhoea,4,M,HO,41
168973562,4,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,4,SS,Diarrhoea,4,M,LT,41
168975995,1,Splenic marginal zone lymphoma,5,F,EXP,selinexor,1,PS,Atrial fibrillation,1,F,DE,1111
168975995,1,Splenic marginal zone lymphoma,5,F,EXP,selinexor,1,PS,Atrial fibrillation,1,F,HO,1111
168975995,1,Splenic marginal zone lymphoma,5,F,EXP,selinexor,1,PS,Cardiac failure,1,F,DE,1111
168975995,1,Splenic marginal zone lymphoma,5,F,EXP,selinexor,1,PS,Cardiac failure,1,F,HO,1111
168975995,1,Splenic marginal zone lymphoma,5,F,EXP,selinexor,1,PS,Disease progression,1,F,DE,1111
168975995,1,Splenic marginal zone lymphoma,5,F,EXP,selinexor,1,PS,Disease progression,1,F,HO,1111
168975995,1,Splenic marginal zone lymphoma,5,F,EXP,selinexor,1,PS,Fall,1,F,DE,1111
168975995,1,Splenic marginal zone lymphoma,5,F,EXP,selinexor,1,PS,Fall,1,F,HO,1111
168975995,1,Splenic marginal zone lymphoma,5,F,EXP,selinexor,1,PS,Subdural haematoma,1,F,DE,1111
168975995,1,Splenic marginal zone lymphoma,5,F,EXP,selinexor,1,PS,Subdural haematoma,1,F,HO,1111
168975995,1,Splenic marginal zone lymphoma,5,F,EXP,selinexor,1,PS,Tachycardia,1,F,DE,1111
168975995,1,Splenic marginal zone lymphoma,5,F,EXP,selinexor,1,PS,Tachycardia,1,F,HO,1111
168975995,2,Splenic marginal zone lymphoma,5,F,EXP,ibrutinib,2,SS,Atrial fibrillation,2,F,DE,1105
168975995,2,Splenic marginal zone lymphoma,5,F,EXP,ibrutinib,2,SS,Atrial fibrillation,2,F,HO,1105
168975995,2,Splenic marginal zone lymphoma,5,F,EXP,ibrutinib,2,SS,Cardiac failure,2,F,DE,1105
168975995,2,Splenic marginal zone lymphoma,5,F,EXP,ibrutinib,2,SS,Cardiac failure,2,F,HO,1105
168975995,2,Splenic marginal zone lymphoma,5,F,EXP,ibrutinib,2,SS,Disease progression,2,F,DE,1105
168975995,2,Splenic marginal zone lymphoma,5,F,EXP,ibrutinib,2,SS,Disease progression,2,F,HO,1105
168975995,2,Splenic marginal zone lymphoma,5,F,EXP,ibrutinib,2,SS,Fall,2,F,DE,1105
168975995,2,Splenic marginal zone lymphoma,5,F,EXP,ibrutinib,2,SS,Fall,2,F,HO,1105
168975995,2,Splenic marginal zone lymphoma,5,F,EXP,ibrutinib,2,SS,Subdural haematoma,2,F,DE,1105
168975995,2,Splenic marginal zone lymphoma,5,F,EXP,ibrutinib,2,SS,Subdural haematoma,2,F,HO,1105
168975995,2,Splenic marginal zone lymphoma,5,F,EXP,ibrutinib,2,SS,Tachycardia,2,F,DE,1105
168975995,2,Splenic marginal zone lymphoma,5,F,EXP,ibrutinib,2,SS,Tachycardia,2,F,HO,1105
168976503,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Enterocolitis,2,M,HO,26
168976503,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Enterocolitis,2,M,OT,26
168976503,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hypophysitis,2,M,HO,26
168976503,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hypophysitis,2,M,OT,26
168976503,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hypopituitarism,2,M,HO,26
168976503,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hypopituitarism,2,M,OT,26
168976503,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hypothyroidism,2,M,HO,26
168976503,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hypothyroidism,2,M,OT,26
168976503,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Prescribed overdose,2,M,HO,26
168976503,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Prescribed overdose,2,M,OT,26
168976503,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Enterocolitis,3,M,HO,26
168976503,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Enterocolitis,3,M,OT,26
168976503,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hypophysitis,3,M,HO,26
168976503,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hypophysitis,3,M,OT,26
168976503,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hypopituitarism,3,M,HO,26
168976503,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hypopituitarism,3,M,OT,26
168976503,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hypothyroidism,3,M,HO,26
168976503,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hypothyroidism,3,M,OT,26
168976503,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Prescribed overdose,3,M,HO,26
168976503,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Prescribed overdose,3,M,OT,26
168976743,2,B-cell lymphoma,3,F,EXP,filgrastim,2,SS,Ileus,2,F,DE,22
168976743,2,B-cell lymphoma,3,F,EXP,filgrastim,2,SS,Ileus,2,F,HO,22
168976743,2,B-cell lymphoma,3,F,EXP,filgrastim,2,SS,White blood cell count decreased,2,F,DE,22
168976743,2,B-cell lymphoma,3,F,EXP,filgrastim,2,SS,White blood cell count decreased,2,F,HO,22
168981963,1,Product used for unknown indication,3,F,EXP,zoledronic acid,1,PS,Blood pressure increased,1,F,OT,350
168985832,1,Adenocarcinoma gastric,2,F,EXP,nivolumab,1,PS,Cachexia,1,M,OT,4
168985832,1,Adenocarcinoma gastric,2,F,EXP,nivolumab,1,PS,Cachexia,1,M,HO,4
168985832,1,Adenocarcinoma gastric,2,F,EXP,nivolumab,1,PS,Fluid intake reduced,1,M,OT,4
168985832,1,Adenocarcinoma gastric,2,F,EXP,nivolumab,1,PS,Fluid intake reduced,1,M,HO,4
168985832,1,Adenocarcinoma gastric,2,F,EXP,nivolumab,1,PS,Hypophagia,1,M,OT,4
168985832,1,Adenocarcinoma gastric,2,F,EXP,nivolumab,1,PS,Hypophagia,1,M,HO,4
168985832,3,Oesophageal adenocarcinoma,2,F,EXP,ipilimumab,3,SS,Cachexia,3,M,OT,4
168985832,3,Oesophageal adenocarcinoma,2,F,EXP,ipilimumab,3,SS,Cachexia,3,M,HO,4
168985832,3,Oesophageal adenocarcinoma,2,F,EXP,ipilimumab,3,SS,Fluid intake reduced,3,M,OT,4
168985832,3,Oesophageal adenocarcinoma,2,F,EXP,ipilimumab,3,SS,Fluid intake reduced,3,M,HO,4
168985832,3,Oesophageal adenocarcinoma,2,F,EXP,ipilimumab,3,SS,Hypophagia,3,M,OT,4
168985832,3,Oesophageal adenocarcinoma,2,F,EXP,ipilimumab,3,SS,Hypophagia,3,M,HO,4
169005763,1,Breast cancer metastatic,3,F,EXP,nivolumab,1,PS,Asthenia,1,F,DE,9
169005763,1,Breast cancer metastatic,3,F,EXP,nivolumab,1,PS,Asthenia,1,F,HO,9
169005763,1,Breast cancer metastatic,3,F,EXP,nivolumab,1,PS,Disease progression,1,F,DE,9
169005763,1,Breast cancer metastatic,3,F,EXP,nivolumab,1,PS,Disease progression,1,F,HO,9
169005763,1,Breast cancer metastatic,3,F,EXP,nivolumab,1,PS,Dizziness,1,F,DE,9
169005763,1,Breast cancer metastatic,3,F,EXP,nivolumab,1,PS,Dizziness,1,F,HO,9
169005763,1,Breast cancer metastatic,3,F,EXP,nivolumab,1,PS,Fatigue,1,F,DE,9
169005763,1,Breast cancer metastatic,3,F,EXP,nivolumab,1,PS,Fatigue,1,F,HO,9
169005763,1,Breast cancer metastatic,3,F,EXP,nivolumab,1,PS,Night sweats,1,F,DE,9
169005763,1,Breast cancer metastatic,3,F,EXP,nivolumab,1,PS,Night sweats,1,F,HO,9
169016742,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Giardiasis,4,M,HO,387
169021744,1,Plasma cell myeloma,4,F,EXP,selinexor,1,PS,Urinary tract infection,1,F,HO,279
169021744,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Urinary tract infection,5,F,HO,279
169036842,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Pneumonia,1,M,HO,112
169036842,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Sepsis,1,M,HO,112
169036842,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Streptococcal bacteraemia,1,M,HO,112
169036842,3,Plasma cell myeloma,2,F,EXP,carfilzomib,3,SS,Pneumonia,3,M,HO,112
169036842,3,Plasma cell myeloma,2,F,EXP,carfilzomib,3,SS,Sepsis,3,M,HO,112
169036842,3,Plasma cell myeloma,2,F,EXP,carfilzomib,3,SS,Streptococcal bacteraemia,3,M,HO,112
169039433,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Hyperglycaemia,1,M,HO,62
169039433,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Hyperglycaemia,2,M,HO,62
169043335,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Death,1,M,OT,115
169043335,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Death,1,M,HO,115
169043335,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Death,1,M,DE,115
169043335,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,115
169043335,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,115
169043335,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,115
169043335,4,Product used for unknown indication,5,F,EXP,pemetrexed disodium,4,SS,Death,4,M,OT,115
169043335,4,Product used for unknown indication,5,F,EXP,pemetrexed disodium,4,SS,Death,4,M,HO,115
169043335,4,Product used for unknown indication,5,F,EXP,pemetrexed disodium,4,SS,Death,4,M,DE,115
169043335,4,Product used for unknown indication,5,F,EXP,pemetrexed disodium,4,SS,Pneumonia,4,M,OT,115
169043335,4,Product used for unknown indication,5,F,EXP,pemetrexed disodium,4,SS,Pneumonia,4,M,HO,115
169043335,4,Product used for unknown indication,5,F,EXP,pemetrexed disodium,4,SS,Pneumonia,4,M,DE,115
169056504,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Dysphagia,1,F,OT,5
169056504,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Dysphagia,1,F,HO,5
169056504,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Stomatitis,1,F,OT,5
169056504,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Stomatitis,1,F,HO,5
169063743,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,DE,29
169063743,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,OT,29
169063743,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,HO,29
169063743,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Ischaemic stroke,1,M,DE,29
169063743,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Ischaemic stroke,1,M,OT,29
169063743,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Ischaemic stroke,1,M,HO,29
169063743,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,29
169063743,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,29
169063743,1,Lung neoplasm malignant,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,29
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Acute kidney injury,3,M,DE,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Acute kidney injury,3,M,HO,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Acute kidney injury,3,M,LT,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Atrial fibrillation,3,M,DE,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Atrial fibrillation,3,M,HO,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Atrial fibrillation,3,M,LT,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Cerebrovascular accident,3,M,DE,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Cerebrovascular accident,3,M,HO,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Cerebrovascular accident,3,M,LT,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Death,3,M,DE,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Death,3,M,HO,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Death,3,M,LT,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Hyperglycaemia,3,M,DE,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Hyperglycaemia,3,M,HO,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Hyperglycaemia,3,M,LT,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Muscular weakness,3,M,DE,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Muscular weakness,3,M,HO,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Muscular weakness,3,M,LT,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Myocardial infarction,3,M,DE,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Myocardial infarction,3,M,HO,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Myocardial infarction,3,M,LT,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Pneumonia,3,M,DE,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Pneumonia,3,M,HO,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Pneumonia,3,M,LT,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Sepsis,3,M,DE,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Sepsis,3,M,HO,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Sepsis,3,M,LT,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Supraventricular tachycardia,3,M,DE,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Supraventricular tachycardia,3,M,HO,7
169076775,3,Chronic lymphocytic leukaemia,5,F,EXP,ibrutinib,3,SS,Supraventricular tachycardia,3,M,LT,7
169079552,31,Osteoporosis prophylaxis,2,F,EXP,zoledronic acid,31,C,Pneumonia,31,F,HO,80
169086313,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Hepatic failure,1,F,DE,124
169086313,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Hepatic failure,1,F,OT,124
169091284,3,Plasma cell myeloma,4,F,EXP,carfilzomib,3,C,Acute kidney injury,3,F,DE,6
169091284,3,Plasma cell myeloma,4,F,EXP,carfilzomib,3,C,Sepsis,3,F,DE,6
169094285,1,Squamous cell carcinoma of skin,5,F,EXP,axitinib,1,PS,Cardiac arrest,1,M,DE,32
169094934,1,Non-Hodgkin's lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Somnolence,1,M,HO,8
1690979113,1,Plasma cell myeloma,13,F,EXP,lenalidomide,1,PS,C-reactive protein increased,1,F,HO,54
1690979113,1,Plasma cell myeloma,13,F,EXP,lenalidomide,1,PS,C-reactive protein increased,1,F,LT,54
1690979113,1,Plasma cell myeloma,13,F,EXP,lenalidomide,1,PS,Clostridium difficile colitis,1,F,HO,54
1690979113,1,Plasma cell myeloma,13,F,EXP,lenalidomide,1,PS,Clostridium difficile colitis,1,F,LT,54
1690979113,1,Plasma cell myeloma,13,F,EXP,lenalidomide,1,PS,Hypoproteinaemia,1,F,HO,54
1690979113,1,Plasma cell myeloma,13,F,EXP,lenalidomide,1,PS,Hypoproteinaemia,1,F,LT,54
1690979113,1,Plasma cell myeloma,13,F,EXP,lenalidomide,1,PS,Infection,1,F,HO,54
1690979113,1,Plasma cell myeloma,13,F,EXP,lenalidomide,1,PS,Infection,1,F,LT,54
1690979113,1,Plasma cell myeloma,13,F,EXP,lenalidomide,1,PS,Pneumonia,1,F,HO,54
1690979113,1,Plasma cell myeloma,13,F,EXP,lenalidomide,1,PS,Pneumonia,1,F,LT,54
1690979113,1,Plasma cell myeloma,13,F,EXP,lenalidomide,1,PS,Somnolence,1,F,HO,54
1690979113,1,Plasma cell myeloma,13,F,EXP,lenalidomide,1,PS,Somnolence,1,F,LT,54
1690979113,1,Plasma cell myeloma,13,F,EXP,lenalidomide,1,PS,Splenic infarction,1,F,HO,54
1690979113,1,Plasma cell myeloma,13,F,EXP,lenalidomide,1,PS,Splenic infarction,1,F,LT,54
1690979113,3,Plasma cell myeloma,13,F,EXP,carfilzomib,3,SS,C-reactive protein increased,3,F,HO,54
1690979113,3,Plasma cell myeloma,13,F,EXP,carfilzomib,3,SS,C-reactive protein increased,3,F,LT,54
1690979113,3,Plasma cell myeloma,13,F,EXP,carfilzomib,3,SS,Clostridium difficile colitis,3,F,HO,54
1690979113,3,Plasma cell myeloma,13,F,EXP,carfilzomib,3,SS,Clostridium difficile colitis,3,F,LT,54
1690979113,3,Plasma cell myeloma,13,F,EXP,carfilzomib,3,SS,Hypoproteinaemia,3,F,HO,54
1690979113,3,Plasma cell myeloma,13,F,EXP,carfilzomib,3,SS,Hypoproteinaemia,3,F,LT,54
1690979113,3,Plasma cell myeloma,13,F,EXP,carfilzomib,3,SS,Infection,3,F,HO,54
1690979113,3,Plasma cell myeloma,13,F,EXP,carfilzomib,3,SS,Infection,3,F,LT,54
1690979113,3,Plasma cell myeloma,13,F,EXP,carfilzomib,3,SS,Pneumonia,3,F,HO,54
1690979113,3,Plasma cell myeloma,13,F,EXP,carfilzomib,3,SS,Pneumonia,3,F,LT,54
1690979113,3,Plasma cell myeloma,13,F,EXP,carfilzomib,3,SS,Somnolence,3,F,HO,54
1690979113,3,Plasma cell myeloma,13,F,EXP,carfilzomib,3,SS,Somnolence,3,F,LT,54
1690979113,3,Plasma cell myeloma,13,F,EXP,carfilzomib,3,SS,Splenic infarction,3,F,HO,54
1690979113,3,Plasma cell myeloma,13,F,EXP,carfilzomib,3,SS,Splenic infarction,3,F,LT,54
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Blood glucose increased,1,M,OT,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Blood glucose increased,1,M,HO,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cardiac disorder,1,M,OT,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cardiac disorder,1,M,HO,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Generalised oedema,1,M,OT,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Generalised oedema,1,M,HO,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hypertonia,1,M,OT,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hypertonia,1,M,HO,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,M,OT,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,M,HO,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,39
169101312,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,39
169104693,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,44
169104693,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,44
169104693,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Cytokine release syndrome,1,M,HO,44
169104693,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Cytokine release syndrome,1,M,OT,44
169104693,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,HO,1
169104693,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,OT,1
169104693,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Cytokine release syndrome,2,M,HO,1
169104693,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Cytokine release syndrome,2,M,OT,1
169116162,1,Renal cancer,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,202
169116162,1,Renal cancer,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,202
169116162,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,202
169116162,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,202
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Anaphylactic reaction,1,F,HO,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Anaphylactic reaction,1,F,OT,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Asthenia,1,F,HO,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Asthenia,1,F,OT,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Cardiovascular disorder,1,F,HO,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Cardiovascular disorder,1,F,OT,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Chest pain,1,F,HO,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Chest pain,1,F,OT,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Dizziness,1,F,HO,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Dizziness,1,F,OT,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Heart rate irregular,1,F,HO,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Heart rate irregular,1,F,OT,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Hypotension,1,F,HO,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Hypotension,1,F,OT,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Infusion related reaction,1,F,HO,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Infusion related reaction,1,F,OT,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Insomnia,1,F,HO,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Insomnia,1,F,OT,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Loss of consciousness,1,F,HO,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Loss of consciousness,1,F,OT,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Memory impairment,1,F,HO,2
169143834,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Memory impairment,1,F,OT,2
169146062,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Bacteraemia,2,F,HO,121
169146062,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Bacteraemia,3,F,HO,121
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Abdominal pain,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Abdominal pain lower,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Asthenia,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Cellulitis,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Cough,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Ejection fraction decreased,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Headache,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Lower respiratory tract infection,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Mouth swelling,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Nausea,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Pain in extremity,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Superinfection,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Swelling face,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Tooth extraction,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Urinary tract infection,9,F,HO,36
169146682,9,Constipation,2,F,EXP,denosumab,9,C,Vomiting,9,F,HO,36
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Atrial fibrillation,4,F,DE,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Atrial fibrillation,4,F,OT,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Atrial fibrillation,4,F,HO,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Diarrhoea,4,F,DE,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Diarrhoea,4,F,OT,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Diarrhoea,4,F,HO,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Dyspnoea,4,F,DE,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Dyspnoea,4,F,OT,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Dyspnoea,4,F,HO,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Hypotension,4,F,DE,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Hypotension,4,F,OT,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Hypotension,4,F,HO,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Renal impairment,4,F,DE,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Renal impairment,4,F,OT,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Renal impairment,4,F,HO,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Septic shock,4,F,DE,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Septic shock,4,F,OT,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Septic shock,4,F,HO,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Vomiting,4,F,DE,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Vomiting,4,F,OT,11
169147787,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Vomiting,4,F,HO,11
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Clostridium test positive,1,M,DE,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Clostridium test positive,1,M,HO,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Clostridium test positive,1,M,LT,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Clostridium test positive,1,M,OT,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Lower respiratory tract infection,1,M,DE,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Lower respiratory tract infection,1,M,HO,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Lower respiratory tract infection,1,M,LT,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Lower respiratory tract infection,1,M,OT,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Neutropenic sepsis,1,M,DE,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Neutropenic sepsis,1,M,HO,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Neutropenic sepsis,1,M,LT,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Neutropenic sepsis,1,M,OT,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Plasma cell myeloma recurrent,1,M,DE,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Plasma cell myeloma recurrent,1,M,HO,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Plasma cell myeloma recurrent,1,M,LT,19
169152927,1,Plasma cell myeloma,7,F,EXP,pomalidomide,1,PS,Plasma cell myeloma recurrent,1,M,OT,19
169158463,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Cholecystitis acute,1,F,LT,73
169158463,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Cholecystitis acute,1,F,HO,73
169158463,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Cholecystitis infective,1,F,LT,73
169158463,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Cholecystitis infective,1,F,HO,73
169158463,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Erysipelas,1,F,LT,73
169158463,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Erysipelas,1,F,HO,73
169158463,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Perihepatic abscess,1,F,LT,73
169158463,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Perihepatic abscess,1,F,HO,73
169158463,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Pulmonary embolism,1,F,LT,73
169158463,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Pulmonary embolism,1,F,HO,73
169158463,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Sepsis,1,F,LT,73
169158463,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Sepsis,1,F,HO,73
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Atrial fibrillation,2,F,OT,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Atrial fibrillation,2,F,HO,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Atrial fibrillation,2,F,DS,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Atrial fibrillation,2,F,DE,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Atrial fibrillation,2,F,CA,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Diarrhoea,2,F,OT,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Diarrhoea,2,F,HO,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Diarrhoea,2,F,DS,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Diarrhoea,2,F,DE,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Diarrhoea,2,F,CA,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Dyspnoea,2,F,OT,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Dyspnoea,2,F,HO,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Dyspnoea,2,F,DS,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Dyspnoea,2,F,DE,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Dyspnoea,2,F,CA,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Hypotension,2,F,OT,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Hypotension,2,F,HO,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Hypotension,2,F,DS,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Hypotension,2,F,DE,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Hypotension,2,F,CA,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Renal impairment,2,F,OT,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Renal impairment,2,F,HO,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Renal impairment,2,F,DS,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Renal impairment,2,F,DE,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Renal impairment,2,F,CA,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Septic shock,2,F,OT,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Septic shock,2,F,HO,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Septic shock,2,F,DS,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Septic shock,2,F,DE,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Septic shock,2,F,CA,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Vomiting,2,F,OT,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Vomiting,2,F,HO,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Vomiting,2,F,DS,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Vomiting,2,F,DE,11
169172868,2,Plasma cell myeloma,8,F,EXP,lenalidomide,2,SS,Vomiting,2,F,CA,11
169199782,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,400
169199782,3,Renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Diarrhoea,3,M,HO,288
169201033,1,Leiomyosarcoma,3,F,EXP,trabectedin,1,PS,Myocardial necrosis marker increased,1,M,HO,24
169209163,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Hepatic function abnormal,1,F,OT,12
169209163,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Hepatic function abnormal,1,F,LT,12
169209163,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Rash,1,F,OT,12
169209163,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Rash,1,F,LT,12
169209163,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Rash macular,1,F,OT,12
169209163,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Rash macular,1,F,LT,12
169216435,1,Colorectal cancer,5,F,EXP,nivolumab,1,PS,Death,1,M,DE,22
169216435,1,Colorectal cancer,5,F,EXP,nivolumab,1,PS,Death,1,M,HO,22
169216435,1,Colorectal cancer,5,F,EXP,nivolumab,1,PS,Death,1,M,OT,22
169216435,1,Colorectal cancer,5,F,EXP,nivolumab,1,PS,Enteritis,1,M,DE,22
169216435,1,Colorectal cancer,5,F,EXP,nivolumab,1,PS,Enteritis,1,M,HO,22
169216435,1,Colorectal cancer,5,F,EXP,nivolumab,1,PS,Enteritis,1,M,OT,22
169216435,2,Colorectal cancer,5,F,EXP,ipilimumab,2,SS,Death,2,M,DE,22
169216435,2,Colorectal cancer,5,F,EXP,ipilimumab,2,SS,Death,2,M,HO,22
169216435,2,Colorectal cancer,5,F,EXP,ipilimumab,2,SS,Death,2,M,OT,22
169216435,2,Colorectal cancer,5,F,EXP,ipilimumab,2,SS,Enteritis,2,M,DE,22
169216435,2,Colorectal cancer,5,F,EXP,ipilimumab,2,SS,Enteritis,2,M,HO,22
169216435,2,Colorectal cancer,5,F,EXP,ipilimumab,2,SS,Enteritis,2,M,OT,22
169228728,34,Prophylaxis,8,F,EXP,pegfilgrastim,34,C,Pulmonary embolism,34,F,HO,203
169228728,34,Prophylaxis,8,F,EXP,pegfilgrastim,34,C,Pulmonary embolism,34,F,LT,203
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Cerebrovascular accident,2,M,DE,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Cerebrovascular accident,2,M,OT,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Cerebrovascular accident,2,M,LT,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Cerebrovascular accident,2,M,HO,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Cerebrovascular accident,2,M,DS,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Immune-mediated pneumonitis,2,M,DE,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Immune-mediated pneumonitis,2,M,OT,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Immune-mediated pneumonitis,2,M,LT,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Immune-mediated pneumonitis,2,M,HO,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Immune-mediated pneumonitis,2,M,DS,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Pneumonia,2,M,DE,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Pneumonia,2,M,OT,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Pneumonia,2,M,LT,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Pneumonia,2,M,HO,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Pneumonia,2,M,DS,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Thoracic vertebral fracture,2,M,DE,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Thoracic vertebral fracture,2,M,OT,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Thoracic vertebral fracture,2,M,LT,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Thoracic vertebral fracture,2,M,HO,37
169245903,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Thoracic vertebral fracture,2,M,DS,37
169249643,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Jugular vein thrombosis,3,M,HO,943
169255542,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Aspiration,1,M,OT,171
169255542,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Aspiration,1,M,HO,171
169255542,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Aspiration,2,M,OT,100
169255542,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Aspiration,2,M,HO,100
169255542,3,Non-small cell lung cancer,2,F,EXP,ipilimumab,3,SS,Aspiration,3,M,OT,171
169255542,3,Non-small cell lung cancer,2,F,EXP,ipilimumab,3,SS,Aspiration,3,M,HO,171
169255542,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Aspiration,4,M,OT,130
169255542,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Aspiration,4,M,HO,130
169259044,1,Skin cancer,4,F,EXP,nivolumab,1,PS,Brain abscess,1,M,OT,86
169259044,1,Skin cancer,4,F,EXP,nivolumab,1,PS,Brain abscess,1,M,HO,86
169259044,1,Skin cancer,4,F,EXP,nivolumab,1,PS,Epilepsy,1,M,OT,86
169259044,1,Skin cancer,4,F,EXP,nivolumab,1,PS,Epilepsy,1,M,HO,86
169262092,2,Breast cancer metastatic,2,F,EXP,abemaciclib,2,SS,Haemodynamic instability,2,F,DE,64
169262092,2,Breast cancer metastatic,2,F,EXP,abemaciclib,2,SS,Haemodynamic instability,2,F,OT,64
169262092,2,Breast cancer metastatic,2,F,EXP,abemaciclib,2,SS,Hypokalaemia,2,F,DE,64
169262092,2,Breast cancer metastatic,2,F,EXP,abemaciclib,2,SS,Hypokalaemia,2,F,OT,64
169262092,2,Breast cancer metastatic,2,F,EXP,abemaciclib,2,SS,Metabolic acidosis,2,F,DE,64
169262092,2,Breast cancer metastatic,2,F,EXP,abemaciclib,2,SS,Metabolic acidosis,2,F,OT,64
169262092,2,Breast cancer metastatic,2,F,EXP,abemaciclib,2,SS,Neutropenic sepsis,2,F,DE,64
169262092,2,Breast cancer metastatic,2,F,EXP,abemaciclib,2,SS,Neutropenic sepsis,2,F,OT,64
169264092,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Device related infection,1,F,HO,121
169264092,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Device related infection,3,F,HO,121
169273793,1,Ovarian cancer,3,F,EXP,nivolumab,1,PS,Neutropenic colitis,1,F,HO,13
169273793,1,Ovarian cancer,3,F,EXP,nivolumab,1,PS,Neutropenic colitis,1,F,OT,13
169279172,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Atrial fibrillation,2,M,HO,25
169279172,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Pneumatosis intestinalis,2,M,HO,25
169279172,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Small intestinal obstruction,2,M,HO,25
169295982,1,Sarcoma,2,F,EXP,nivolumab,1,PS,Cardiac failure,1,M,HO,62
169295982,1,Sarcoma,2,F,EXP,nivolumab,1,PS,Cardiac failure,1,M,OT,62
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Abdominal pain,1,F,OT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Abdominal pain,1,F,LT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Acute kidney injury,1,F,OT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Acute kidney injury,1,F,LT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Ascites,1,F,OT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Ascites,1,F,LT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Asthenia,1,F,OT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Asthenia,1,F,LT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Blood count abnormal,1,F,OT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Blood count abnormal,1,F,LT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Diarrhoea,1,F,OT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Diarrhoea,1,F,LT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Hepatic cirrhosis,1,F,OT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Hepatic cirrhosis,1,F,LT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Nausea,1,F,OT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Nausea,1,F,LT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Neutropenic sepsis,1,F,OT,139
169299123,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Neutropenic sepsis,1,F,LT,139
169311062,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hypophysitis,1,M,OT,141
169311062,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hypopituitarism,1,M,OT,141
169311062,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,141
169311062,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pruritus,1,M,OT,141
169313544,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Haematoma,1,M,HO,654
169313544,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Haematoma,1,M,OT,654
169313544,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Motor dysfunction,1,M,HO,654
169313544,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Motor dysfunction,1,M,OT,654
169313544,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Spinal cord compression,1,M,HO,654
169313544,1,Lung neoplasm malignant,4,F,EXP,nivolumab,1,PS,Spinal cord compression,1,M,OT,654
169313774,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Arthralgia,1,M,HO,331
169313774,2,Non-small cell lung cancer,4,F,EXP,ipilimumab,2,SS,Arthralgia,2,M,HO,331
169313774,3,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,3,SS,Arthralgia,3,M,HO,331
169316734,1,Plasma cell myeloma,4,F,EXP,lenalidomide,1,PS,Atrial fibrillation,1,M,OT,13
169316734,1,Plasma cell myeloma,4,F,EXP,lenalidomide,1,PS,Atrial fibrillation,1,M,HO,13
169316734,1,Plasma cell myeloma,4,F,EXP,lenalidomide,1,PS,Chronic inflammatory demyelinating polyradiculoneuropathy,1,M,OT,13
169316734,1,Plasma cell myeloma,4,F,EXP,lenalidomide,1,PS,Chronic inflammatory demyelinating polyradiculoneuropathy,1,M,HO,13
169316734,1,Plasma cell myeloma,4,F,EXP,lenalidomide,1,PS,Infection,1,M,OT,13
169316734,1,Plasma cell myeloma,4,F,EXP,lenalidomide,1,PS,Infection,1,M,HO,13
169316734,1,Plasma cell myeloma,4,F,EXP,lenalidomide,1,PS,Paraesthesia,1,M,OT,13
169316734,1,Plasma cell myeloma,4,F,EXP,lenalidomide,1,PS,Paraesthesia,1,M,HO,13
169316734,1,Plasma cell myeloma,4,F,EXP,lenalidomide,1,PS,Peripheral motor neuropathy,1,M,OT,13
169316734,1,Plasma cell myeloma,4,F,EXP,lenalidomide,1,PS,Peripheral motor neuropathy,1,M,HO,13
169316734,1,Plasma cell myeloma,4,F,EXP,lenalidomide,1,PS,Peripheral sensory neuropathy,1,M,OT,13
169316734,1,Plasma cell myeloma,4,F,EXP,lenalidomide,1,PS,Peripheral sensory neuropathy,1,M,HO,13
169319174,1,Acute myeloid leukaemia,4,F,EXP,midostaurin,1,PS,Drug-induced liver injury,1,M,HO,47
169321628,1,Oesophageal squamous cell carcinoma,8,F,EXP,nivolumab,1,PS,Anaemia,1,M,DE,156
169321628,1,Oesophageal squamous cell carcinoma,8,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,156
169321628,1,Oesophageal squamous cell carcinoma,8,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,156
169321628,1,Oesophageal squamous cell carcinoma,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,156
169321628,1,Oesophageal squamous cell carcinoma,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,156
169321628,1,Oesophageal squamous cell carcinoma,8,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,156
169321628,1,Oesophageal squamous cell carcinoma,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,156
169321628,1,Oesophageal squamous cell carcinoma,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,156
169321628,1,Oesophageal squamous cell carcinoma,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,156
169321628,1,Oesophageal squamous cell carcinoma,8,F,EXP,nivolumab,1,PS,Renal failure,1,M,DE,156
169321628,1,Oesophageal squamous cell carcinoma,8,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,156
169321628,1,Oesophageal squamous cell carcinoma,8,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,156
169336156,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Clostridium difficile colitis,1,M,HO,212
169336156,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Diarrhoea,1,M,HO,212
169336156,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Fall,1,M,HO,212
169336156,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Fungal skin infection,1,M,HO,212
169336156,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Hypokalaemia,1,M,HO,212
169336156,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Pharyngitis streptococcal,1,M,HO,212
169336156,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,M,HO,212
169336156,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Urinary tract infection bacterial,1,M,HO,212
169336156,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Urosepsis,1,M,HO,212
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Asthenia,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Asthenia,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Blood urine present,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Blood urine present,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Burning sensation,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Burning sensation,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Culture urine positive,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Culture urine positive,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Dizziness,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Dizziness,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Gastric infection,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Gastric infection,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Gingival bleeding,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Gingival bleeding,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Haemolytic anaemia,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Haemolytic anaemia,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Increased tendency to bruise,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Increased tendency to bruise,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Infusion site erythema,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Infusion site erythema,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Pain in extremity,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Pain in extremity,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Paraesthesia,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Paraesthesia,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Platelet count decreased,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Platelet count decreased,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Protein urine present,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Protein urine present,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Pyrexia,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Pyrexia,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Rash,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Rash,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Red blood cells urine positive,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Red blood cells urine positive,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Urine abnormality,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Urine abnormality,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Urine leukocyte esterase positive,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Urine leukocyte esterase positive,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Urticaria,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Urticaria,1,F,OT,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Vomiting,1,F,HO,1
169336184,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Vomiting,1,F,OT,1
169336663,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Anaemia,1,M,HO,111
169336663,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Anaemia,1,M,OT,111
169336663,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Anaemia,1,M,LT,111
169336663,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Anaemia,1,M,DE,111
169336663,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Disseminated intravascular coagulation,1,M,HO,111
169336663,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Disseminated intravascular coagulation,1,M,OT,111
169336663,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Disseminated intravascular coagulation,1,M,LT,111
169336663,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Disseminated intravascular coagulation,1,M,DE,111
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Atrial fibrillation,4,F,OT,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Atrial fibrillation,4,F,HO,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Atrial fibrillation,4,F,DE,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Diarrhoea,4,F,OT,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Diarrhoea,4,F,HO,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Diarrhoea,4,F,DE,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Dyspnoea,4,F,OT,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Dyspnoea,4,F,HO,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Dyspnoea,4,F,DE,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Hypotension,4,F,OT,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Hypotension,4,F,HO,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Hypotension,4,F,DE,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Renal impairment,4,F,OT,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Renal impairment,4,F,HO,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Renal impairment,4,F,DE,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Septic shock,4,F,OT,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Septic shock,4,F,HO,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Septic shock,4,F,DE,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Vomiting,4,F,OT,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Vomiting,4,F,HO,11
169347817,4,Plasma cell myeloma,7,F,EXP,lenalidomide,4,SS,Vomiting,4,F,DE,11
169354933,2,Central nervous system lymphoma,3,F,EXP,lenalidomide,2,SS,Cytomegalovirus colitis,2,M,HO,20
169354933,2,Central nervous system lymphoma,3,F,EXP,lenalidomide,2,SS,Diarrhoea,2,M,HO,20
169354933,2,Central nervous system lymphoma,3,F,EXP,lenalidomide,2,SS,Encephalopathy,2,M,HO,20
169354933,2,Central nervous system lymphoma,3,F,EXP,lenalidomide,2,SS,Febrile neutropenia,2,M,HO,20
169354933,2,Central nervous system lymphoma,3,F,EXP,lenalidomide,2,SS,Gastroenteritis norovirus,2,M,HO,20
169354933,2,Central nervous system lymphoma,3,F,EXP,lenalidomide,2,SS,Marginal zone lymphoma,2,M,HO,20
169354933,2,Central nervous system lymphoma,3,F,EXP,lenalidomide,2,SS,Pneumonia,2,M,HO,20
169354933,2,Central nervous system lymphoma,3,F,EXP,lenalidomide,2,SS,Rhinovirus infection,2,M,HO,20
169354933,2,Central nervous system lymphoma,3,F,EXP,lenalidomide,2,SS,Upper respiratory tract infection,2,M,HO,20
169354933,2,Central nervous system lymphoma,3,F,EXP,lenalidomide,2,SS,Weight decreased,2,M,HO,20
169358603,1,Renal cancer metastatic,3,F,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,56
169358603,1,Renal cancer metastatic,3,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,56
169358603,1,Renal cancer metastatic,3,F,EXP,nivolumab,1,PS,Constipation,1,M,OT,56
169358603,1,Renal cancer metastatic,3,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,56
169358603,1,Renal cancer metastatic,3,F,EXP,nivolumab,1,PS,Mucosal inflammation,1,M,OT,56
169358603,1,Renal cancer metastatic,3,F,EXP,nivolumab,1,PS,Myalgia,1,M,OT,56
169358603,1,Renal cancer metastatic,3,F,EXP,nivolumab,1,PS,Pancreatitis,1,M,OT,56
169358603,1,Renal cancer metastatic,3,F,EXP,nivolumab,1,PS,Pruritus,1,M,OT,56
169358603,1,Renal cancer metastatic,3,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,56
169366422,38,Prophylaxis,2,F,EXP,granisetron,38,C,Neutropenia,38,M,OT,55
169366422,38,Prophylaxis,2,F,EXP,granisetron,38,C,Toothache,38,M,OT,55
169368452,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Neutrophil count decreased,1,F,HO,17
169368523,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,SS,Acute respiratory failure,1,M,OT,405
169368523,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,SS,Acute respiratory failure,1,M,HO,405
169368523,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,SS,Acute respiratory failure,1,M,LT,405
169368523,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,SS,Hepatocellular injury,1,M,OT,405
169368523,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,SS,Hepatocellular injury,1,M,HO,405
169368523,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,SS,Hepatocellular injury,1,M,LT,405
169368523,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,PS,Acute respiratory failure,2,M,OT,405
169368523,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,PS,Acute respiratory failure,2,M,HO,405
169368523,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,PS,Acute respiratory failure,2,M,LT,405
169368523,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,PS,Hepatocellular injury,2,M,OT,405
169368523,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,PS,Hepatocellular injury,2,M,HO,405
169368523,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,PS,Hepatocellular injury,2,M,LT,405
169368523,4,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,4,SS,Acute respiratory failure,4,M,OT,405
169368523,4,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,4,SS,Acute respiratory failure,4,M,HO,405
169368523,4,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,4,SS,Acute respiratory failure,4,M,LT,405
169368523,4,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,4,SS,Hepatocellular injury,4,M,OT,405
169368523,4,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,4,SS,Hepatocellular injury,4,M,HO,405
169368523,4,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,4,SS,Hepatocellular injury,4,M,LT,405
169379895,1,Acute myeloid leukaemia,5,F,EXP,midostaurin,1,PS,Septic shock,1,F,LT,14
169379895,1,Acute myeloid leukaemia,5,F,EXP,midostaurin,1,PS,Septic shock,1,F,HO,14
169381255,1,Breast cancer,5,F,EXP,alpelisib,1,PS,Pharyngitis,1,F,HO,17
169382962,2,Malignant melanoma,2,F,EXP,trametinib,2,SS,Death,2,M,DE,205
169385034,35,Anaemia,4,F,PER,darbepoetin alfa,35,C,Renal impairment,35,F,HO,13
169385242,2,Product used for unknown indication,2,F,EXP,trametinib,2,SS,Death,2,F,OT,192
169385242,2,Product used for unknown indication,2,F,EXP,trametinib,2,SS,Death,2,F,DE,192
169388474,26,Neutropenia,4,F,PER,pegfilgrastim,26,C,Abscess,26,F,HO,6
169391654,4,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,4,SS,Hepatocellular injury,4,M,HO,61
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute myeloid leukaemia,1,M,OT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute myeloid leukaemia,1,M,LT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Basal cell carcinoma,1,M,OT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Basal cell carcinoma,1,M,LT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,M,OT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Blood creatine phosphokinase increased,1,M,LT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Bronchitis,1,M,OT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Bronchitis,1,M,LT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Chronic lymphocytic leukaemia,1,M,OT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Chronic lymphocytic leukaemia,1,M,LT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Cystitis,1,M,OT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Cystitis,1,M,LT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Dysuria,1,M,OT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Dysuria,1,M,LT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,LT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Injection site reaction,1,M,OT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Injection site reaction,1,M,LT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Normocytic anaemia,1,M,OT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Normocytic anaemia,1,M,LT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pruritus,1,M,OT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pruritus,1,M,LT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,OT,28
169398313,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,LT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Acute myeloid leukaemia,2,M,OT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Acute myeloid leukaemia,2,M,LT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Basal cell carcinoma,2,M,OT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Basal cell carcinoma,2,M,LT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Blood creatine phosphokinase increased,2,M,OT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Blood creatine phosphokinase increased,2,M,LT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Bronchitis,2,M,OT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Bronchitis,2,M,LT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Chronic lymphocytic leukaemia,2,M,OT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Chronic lymphocytic leukaemia,2,M,LT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Cystitis,2,M,OT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Cystitis,2,M,LT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Dysuria,2,M,OT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Dysuria,2,M,LT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Fatigue,2,M,OT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Fatigue,2,M,LT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Injection site reaction,2,M,OT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Injection site reaction,2,M,LT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Normocytic anaemia,2,M,OT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Normocytic anaemia,2,M,LT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Pruritus,2,M,OT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Pruritus,2,M,LT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Urinary tract infection,2,M,OT,28
169398313,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Urinary tract infection,2,M,LT,28
169399463,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Hyperthermia,1,M,HO,24
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,DE,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Diverticulum intestinal,1,F,DE,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Diverticulum intestinal,1,F,OT,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Diverticulum intestinal,1,F,HO,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Gastric ulcer,1,F,DE,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Gastric ulcer,1,F,OT,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Gastric ulcer,1,F,HO,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,DE,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,OT,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Hiatus hernia,1,F,DE,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Hiatus hernia,1,F,OT,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Hiatus hernia,1,F,HO,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Malnutrition,1,F,DE,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Malnutrition,1,F,OT,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Malnutrition,1,F,HO,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Melaena,1,F,DE,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Melaena,1,F,OT,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Melaena,1,F,HO,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Muscle tightness,1,F,DE,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Muscle tightness,1,F,OT,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Muscle tightness,1,F,HO,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Nausea,1,F,DE,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Rhinitis,1,F,DE,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Rhinitis,1,F,OT,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Rhinitis,1,F,HO,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Ulcer haemorrhage,1,F,DE,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Ulcer haemorrhage,1,F,OT,55
169401434,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Ulcer haemorrhage,1,F,HO,55
169407605,1,Metastatic malignant melanoma,5,F,EXP,nivolumab,1,SS,Abdominal pain upper,1,M,HO,86
169407605,1,Metastatic malignant melanoma,5,F,EXP,nivolumab,1,SS,Diarrhoea,1,M,HO,86
169407605,2,Metastatic malignant melanoma,5,F,EXP,ipilimumab,2,PS,Abdominal pain upper,2,M,HO,86
169407605,2,Metastatic malignant melanoma,5,F,EXP,ipilimumab,2,PS,Diarrhoea,2,M,HO,86
169407605,3,Metastatic malignant melanoma,5,F,EXP,denosumab,3,SS,Abdominal pain upper,3,M,HO,86
169407605,3,Metastatic malignant melanoma,5,F,EXP,denosumab,3,SS,Diarrhoea,3,M,HO,86
169412762,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Atrial fibrillation,2,M,HO,149
169440774,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Liver disorder,1,F,OT,44
169440774,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Liver disorder,1,F,HO,44
169440774,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Liver disorder,2,F,OT,44
169440774,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Liver disorder,2,F,HO,44
169445197,1,Malignant melanoma,7,F,EXP,trametinib,1,PS,Abdominal pain upper,1,F,HO,3
169447632,3,Bronchial carcinoma,2,F,EXP,ramucirumab,3,SS,General physical health deterioration,3,F,HO,8
169447632,3,Bronchial carcinoma,2,F,EXP,ramucirumab,3,SS,General physical health deterioration,3,F,OT,8
169447632,3,Bronchial carcinoma,2,F,EXP,ramucirumab,3,SS,Pneumonia,3,F,HO,8
169447632,3,Bronchial carcinoma,2,F,EXP,ramucirumab,3,SS,Pneumonia,3,F,OT,8
169453742,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Dry skin,1,M,OT,14
169453742,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Dry skin,1,M,DE,14
169453742,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Faeces soft,1,M,OT,14
169453742,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Faeces soft,1,M,DE,14
169453742,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Lung disorder,1,M,OT,14
169453742,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Lung disorder,1,M,DE,14
169453742,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Neck pain,1,M,OT,14
169453742,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Neck pain,1,M,DE,14
169457187,1,Acute myeloid leukaemia,7,F,EXP,midostaurin,1,PS,Sepsis,1,F,LT,20
169457187,1,Acute myeloid leukaemia,7,F,EXP,midostaurin,1,PS,Sepsis,1,F,HO,20
169457663,4,Plasma cell myeloma,3,F,EXP,pomalidomide,4,SS,Chest pain,4,F,HO,465
169457663,4,Plasma cell myeloma,3,F,EXP,pomalidomide,4,SS,Neck pain,4,F,HO,465
169459182,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Fatigue,1,M,DE,50
169459182,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,50
169459182,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,50
169459182,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,50
169459182,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Hepatocellular injury,1,M,DE,50
169459182,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Hepatocellular injury,1,M,OT,50
169459182,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Nausea,1,M,DE,50
169459182,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,50
169459182,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,DE,50
169459182,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,50
169459182,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Renal failure,1,M,DE,50
169459182,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,50
169469652,2,Malignant melanoma,2,F,EXP,ipilimumab,2,PS,Pneumonia respiratory syncytial viral,2,M,OT,76
169469652,2,Malignant melanoma,2,F,EXP,ipilimumab,2,PS,Pneumonia respiratory syncytial viral,2,M,HO,76
169470906,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Disseminated intravascular coagulation,1,M,HO,191
169470906,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Disseminated intravascular coagulation,1,M,DE,191
169470906,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Disseminated intravascular coagulation,1,M,OT,191
169470906,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Haemorrhage,1,M,HO,191
169470906,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Haemorrhage,1,M,DE,191
169470906,1,Gastrooesophageal cancer,6,F,EXP,nivolumab,1,PS,Haemorrhage,1,M,OT,191
169474604,2,Metastatic malignant melanoma,4,F,EXP,trametinib,2,SS,Arthralgia,2,M,OT,2
169474604,2,Metastatic malignant melanoma,4,F,EXP,trametinib,2,SS,Blood alkaline phosphatase increased,2,M,OT,2
169474604,2,Metastatic malignant melanoma,4,F,EXP,trametinib,2,SS,Blood creatine phosphokinase increased,2,M,OT,2
169474604,2,Metastatic malignant melanoma,4,F,EXP,trametinib,2,SS,Diarrhoea,2,M,OT,2
169474604,2,Metastatic malignant melanoma,4,F,EXP,trametinib,2,SS,Influenza like illness,2,M,OT,2
169474604,2,Metastatic malignant melanoma,4,F,EXP,trametinib,2,SS,Neutropenia,2,M,OT,2
169474604,2,Metastatic malignant melanoma,4,F,EXP,trametinib,2,SS,Rash,2,M,OT,2
169474604,2,Metastatic malignant melanoma,4,F,EXP,trametinib,2,SS,Rectal haemorrhage,2,M,OT,2
169474604,2,Metastatic malignant melanoma,4,F,EXP,trametinib,2,SS,Visual impairment,2,M,OT,2
169484343,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Fall,1,M,OT,349
169484343,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Foot fracture,1,M,OT,349
169484343,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Fracture,1,M,OT,349
169484343,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Gait disturbance,1,M,OT,349
169500112,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Blast cell crisis,1,F,OT,77
169501303,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Diverticular perforation,1,F,OT,85
169501303,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Prescribed overdose,1,F,OT,85
169501303,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Diverticular perforation,2,F,OT,85
169501303,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Prescribed overdose,2,F,OT,85
169515865,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Neutropenia,1,M,LT,20
169517462,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,28
169517462,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,28
169517462,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Gastric haemorrhage,1,M,OT,28
169517462,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Gastric haemorrhage,1,M,HO,28
169520154,1,Malignant melanoma,4,F,EXP,ipilimumab,1,PS,Pyrexia,1,M,HO,28
169527483,2,Malignant melanoma,3,F,EXP,trametinib,2,SS,Photopsia,2,F,OT,194
169527483,2,Malignant melanoma,3,F,EXP,trametinib,2,SS,Seizure,2,F,OT,194
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Acute coronary syndrome,5,F,OT,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Acute coronary syndrome,5,F,DE,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Acute coronary syndrome,5,F,HO,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Anxiety,5,F,OT,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Anxiety,5,F,DE,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Anxiety,5,F,HO,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Dyspnoea,5,F,OT,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Dyspnoea,5,F,DE,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Dyspnoea,5,F,HO,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Escherichia bacteraemia,5,F,OT,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Escherichia bacteraemia,5,F,DE,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Escherichia bacteraemia,5,F,HO,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,General physical health deterioration,5,F,OT,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,General physical health deterioration,5,F,DE,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,General physical health deterioration,5,F,HO,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Haematotoxicity,5,F,OT,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Haematotoxicity,5,F,DE,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Haematotoxicity,5,F,HO,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Loss of consciousness,5,F,OT,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Loss of consciousness,5,F,DE,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Loss of consciousness,5,F,HO,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Malaise,5,F,OT,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Malaise,5,F,DE,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Malaise,5,F,HO,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Plasma cell myeloma,5,F,OT,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Plasma cell myeloma,5,F,DE,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,Plasma cell myeloma,5,F,HO,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,White matter lesion,5,F,OT,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,White matter lesion,5,F,DE,307
169529026,5,Plasma cell myeloma,6,F,EXP,lenalidomide,5,SS,White matter lesion,5,F,HO,307
169530833,3,Plasma cell myeloma,3,F,EXP,daratumumab,3,C,Spinal cord compression,3,M,HO,47
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Bacteriuria,1,F,HO,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Bacteriuria,1,F,OT,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone increased,1,F,HO,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone increased,1,F,OT,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Cough,1,F,HO,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Cough,1,F,OT,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Crystal urine present,1,F,HO,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Crystal urine present,1,F,OT,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Escherichia infection,1,F,HO,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Escherichia infection,1,F,OT,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Hypoaesthesia,1,F,HO,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Hypoaesthesia,1,F,OT,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Influenza,1,F,HO,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Influenza,1,F,OT,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,HO,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,OT,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,HO,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,OT,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Neutrophil count decreased,1,F,HO,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Neutrophil count decreased,1,F,OT,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Pelvic pain,1,F,HO,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Pelvic pain,1,F,OT,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,HO,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,OT,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Urine abnormality,1,F,HO,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,Urine abnormality,1,F,OT,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,HO,33
169536897,1,Multiple sclerosis,7,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,OT,33
169537323,47,Plasma cell myeloma,3,F,EXP,lenalidomide,47,C,Cytomegalovirus viraemia,47,M,HO,14
169543893,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Groin abscess,1,M,OT,18
169543893,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Groin abscess,1,M,HO,18
169543893,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Groin abscess,1,M,LT,18
169543893,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Pyrexia,1,M,OT,18
169543893,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Pyrexia,1,M,HO,18
169543893,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Pyrexia,1,M,LT,18
169543893,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Sepsis,1,M,OT,18
169543893,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Sepsis,1,M,HO,18
169543893,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Sepsis,1,M,LT,18
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Abdominal pain upper,1,F,OT,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Abdominal pain upper,1,F,HO,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Abdominal pain upper,1,F,DS,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Alanine aminotransferase increased,1,F,OT,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Alanine aminotransferase increased,1,F,HO,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Alanine aminotransferase increased,1,F,DS,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Aspartate aminotransferase increased,1,F,OT,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Aspartate aminotransferase increased,1,F,HO,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Aspartate aminotransferase increased,1,F,DS,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Blood alkaline phosphatase increased,1,F,OT,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Blood alkaline phosphatase increased,1,F,HO,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Blood alkaline phosphatase increased,1,F,DS,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Blood bilirubin increased,1,F,OT,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Blood bilirubin increased,1,F,HO,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Blood bilirubin increased,1,F,DS,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Blood fibrinogen decreased,1,F,OT,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Blood fibrinogen decreased,1,F,HO,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Blood fibrinogen decreased,1,F,DS,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,OT,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,HO,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,DS,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Haptoglobin decreased,1,F,OT,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Haptoglobin decreased,1,F,HO,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Haptoglobin decreased,1,F,DS,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,F,OT,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,F,HO,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,F,DS,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,F,OT,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,F,HO,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,F,DS,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Neutrophil count decreased,1,F,OT,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Neutrophil count decreased,1,F,HO,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Neutrophil count decreased,1,F,DS,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,F,OT,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,F,HO,1
169544544,1,Marginal zone lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,F,DS,1
169554204,1,Relapsing multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Bacteriuria,1,M,HO,36
169554204,1,Relapsing multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Varicella zoster virus infection,1,M,HO,36
169555092,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Death,1,M,OT,125
169555092,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Death,1,M,HO,125
169555092,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Death,1,M,DE,125
169555092,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Dehydration,1,M,OT,125
169555092,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Dehydration,1,M,HO,125
169555092,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Dehydration,1,M,DE,125
169568473,2,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,2,SS,Pulmonary embolism,2,M,HO,476
169571994,7,Metastatic malignant melanoma,4,F,EXP,trametinib,7,SS,Atrial fibrillation,7,F,OT,11
169571994,7,Metastatic malignant melanoma,4,F,EXP,trametinib,7,SS,Blood cholesterol increased,7,F,OT,11
169571994,7,Metastatic malignant melanoma,4,F,EXP,trametinib,7,SS,Dysphonia,7,F,OT,11
169571994,7,Metastatic malignant melanoma,4,F,EXP,trametinib,7,SS,Hypertension,7,F,OT,11
169571994,7,Metastatic malignant melanoma,4,F,EXP,trametinib,7,SS,Hypertensive crisis,7,F,OT,11
169571994,7,Metastatic malignant melanoma,4,F,EXP,trametinib,7,SS,Pyrexia,7,F,OT,11
169571994,7,Metastatic malignant melanoma,4,F,EXP,trametinib,7,SS,Stomatitis,7,F,OT,11
169571994,14,Metastases to bone,4,F,EXP,denosumab,14,C,Atrial fibrillation,14,F,OT,11
169571994,14,Metastases to bone,4,F,EXP,denosumab,14,C,Blood cholesterol increased,14,F,OT,11
169571994,14,Metastases to bone,4,F,EXP,denosumab,14,C,Dysphonia,14,F,OT,11
169571994,14,Metastases to bone,4,F,EXP,denosumab,14,C,Hypertension,14,F,OT,11
169571994,14,Metastases to bone,4,F,EXP,denosumab,14,C,Hypertensive crisis,14,F,OT,11
169571994,14,Metastases to bone,4,F,EXP,denosumab,14,C,Pyrexia,14,F,OT,11
169571994,14,Metastases to bone,4,F,EXP,denosumab,14,C,Stomatitis,14,F,OT,11
169572682,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,SS,Renal impairment,1,M,HO,65
169572682,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,SS,Renal impairment,1,M,OT,65
169572682,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,SS,Renal impairment,1,M,DE,65
169572682,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,SS,Rhabdomyolysis,1,M,HO,65
169572682,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,SS,Rhabdomyolysis,1,M,OT,65
169572682,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,SS,Rhabdomyolysis,1,M,DE,65
169572682,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,PS,Renal impairment,2,M,HO,65
169572682,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,PS,Renal impairment,2,M,OT,65
169572682,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,PS,Renal impairment,2,M,DE,65
169572682,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,PS,Rhabdomyolysis,2,M,HO,65
169572682,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,PS,Rhabdomyolysis,2,M,OT,65
169572682,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,PS,Rhabdomyolysis,2,M,DE,65
169572682,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Renal impairment,3,M,HO,43
169572682,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Renal impairment,3,M,OT,43
169572682,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Renal impairment,3,M,DE,43
169572682,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Rhabdomyolysis,3,M,HO,43
169572682,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Rhabdomyolysis,3,M,OT,43
169572682,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Rhabdomyolysis,3,M,DE,43
169576816,1,Plasma cell myeloma,6,F,EXP,pomalidomide,1,PS,Atrial fibrillation,1,M,HO,293
169576816,1,Plasma cell myeloma,6,F,EXP,pomalidomide,1,PS,Atrial flutter,1,M,HO,293
169576843,1,B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia,1,M,HO,373
169582146,1,Non-small cell lung cancer,6,F,EXP,lorlatinib,1,PS,Liver injury,1,F,DE,99
169582146,1,Non-small cell lung cancer,6,F,EXP,lorlatinib,1,PS,Liver injury,1,F,HO,99
169584052,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Bronchial obstruction,1,F,OT,82
169584052,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Bronchial obstruction,1,F,DE,82
169584052,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,General physical condition abnormal,1,F,OT,82
169584052,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,General physical condition abnormal,1,F,DE,82
169584052,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Ischaemic stroke,1,F,OT,82
169584052,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Ischaemic stroke,1,F,DE,82
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Acidosis,1,F,OT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Acidosis,1,F,LT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Acidosis,1,F,HO,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Anaemia,1,F,OT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Anaemia,1,F,LT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Anaemia,1,F,HO,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,OT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,LT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,HO,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hypoglycaemia,1,F,OT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hypoglycaemia,1,F,LT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hypoglycaemia,1,F,HO,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hypotension,1,F,OT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hypotension,1,F,LT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Hypotension,1,F,HO,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Lymphocyte count decreased,1,F,OT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Lymphocyte count decreased,1,F,LT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Lymphocyte count decreased,1,F,HO,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Myocardial infarction,1,F,OT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Myocardial infarction,1,F,LT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Myocardial infarction,1,F,HO,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Oesophagitis,1,F,OT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Oesophagitis,1,F,LT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Oesophagitis,1,F,HO,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Somnolence,1,F,OT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Somnolence,1,F,LT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Somnolence,1,F,HO,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Upper respiratory tract infection,1,F,OT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Upper respiratory tract infection,1,F,LT,299
169585944,1,Breast cancer,4,F,EXP,nivolumab,1,PS,Upper respiratory tract infection,1,F,HO,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Acidosis,2,F,OT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Acidosis,2,F,LT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Acidosis,2,F,HO,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Anaemia,2,F,OT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Anaemia,2,F,LT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Anaemia,2,F,HO,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,F,OT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,F,LT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,F,HO,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Hypoglycaemia,2,F,OT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Hypoglycaemia,2,F,LT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Hypoglycaemia,2,F,HO,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Hypotension,2,F,OT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Hypotension,2,F,LT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Hypotension,2,F,HO,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Lymphocyte count decreased,2,F,OT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Lymphocyte count decreased,2,F,LT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Lymphocyte count decreased,2,F,HO,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Myocardial infarction,2,F,OT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Myocardial infarction,2,F,LT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Myocardial infarction,2,F,HO,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Oesophagitis,2,F,OT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Oesophagitis,2,F,LT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Oesophagitis,2,F,HO,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Somnolence,2,F,OT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Somnolence,2,F,LT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Somnolence,2,F,HO,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Upper respiratory tract infection,2,F,OT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Upper respiratory tract infection,2,F,LT,299
169585944,2,Breast cancer,4,F,EXP,ipilimumab,2,SS,Upper respiratory tract infection,2,F,HO,299
169598724,3,B-cell lymphoma,4,F,EXP,ibrutinib,3,SS,Atrial fibrillation,3,M,HO,55
169598724,3,B-cell lymphoma,4,F,EXP,ibrutinib,3,SS,Coronary artery disease,3,M,HO,55
169598724,3,B-cell lymphoma,4,F,EXP,ibrutinib,3,SS,Non-cardiac chest pain,3,M,HO,55
169598724,5,B-cell lymphoma,4,F,EXP,lenalidomide,5,SS,Atrial fibrillation,5,M,HO,55
169598724,5,B-cell lymphoma,4,F,EXP,lenalidomide,5,SS,Coronary artery disease,5,M,HO,55
169598724,5,B-cell lymphoma,4,F,EXP,lenalidomide,5,SS,Non-cardiac chest pain,5,M,HO,55
169605263,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Gastritis,1,F,HO,129
169605263,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Off label use,1,F,HO,129
169605263,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Weight decreased,1,F,HO,129
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Anxiety disorder,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Anxiety disorder,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Anxiety disorder,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Body dysmorphic disorder,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Body dysmorphic disorder,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Body dysmorphic disorder,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Cholestasis,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Cholestasis,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Cholestasis,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Constipation,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Constipation,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Constipation,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Death,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Death,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Death,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Decubitus ulcer,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Decubitus ulcer,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Decubitus ulcer,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Diarrhoea,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Diarrhoea,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Diarrhoea,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Disease progression,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Disease progression,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Disease progression,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Dyspepsia,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Dyspepsia,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Dyspepsia,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,General physical health deterioration,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,General physical health deterioration,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,General physical health deterioration,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Hepatic cirrhosis,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Hepatic cirrhosis,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Hepatic cirrhosis,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Hepatocellular injury,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Hepatocellular injury,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Hepatocellular injury,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Joint ankylosis,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Joint ankylosis,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Joint ankylosis,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Loss of personal independence in daily activities,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Loss of personal independence in daily activities,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Loss of personal independence in daily activities,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Malnutrition,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Malnutrition,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Malnutrition,6,F,OT,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Sleep disorder,6,F,DE,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Sleep disorder,6,F,HO,18
169606362,6,Plasma cell myeloma,2,F,PER,thalidomide,6,SS,Sleep disorder,6,F,OT,18
169612803,4,Plasma cell myeloma,3,F,EXP,thalidomide,4,SS,Deep vein thrombosis,4,F,HO,111
169612803,4,Plasma cell myeloma,3,F,EXP,thalidomide,4,SS,Deep vein thrombosis,4,F,OT,111
169612803,4,Plasma cell myeloma,3,F,EXP,thalidomide,4,SS,Deep vein thrombosis,4,F,LT,111
169612803,4,Plasma cell myeloma,3,F,EXP,thalidomide,4,SS,Pulmonary embolism,4,F,HO,111
169612803,4,Plasma cell myeloma,3,F,EXP,thalidomide,4,SS,Pulmonary embolism,4,F,OT,111
169612803,4,Plasma cell myeloma,3,F,EXP,thalidomide,4,SS,Pulmonary embolism,4,F,LT,111
169612803,4,Plasma cell myeloma,3,F,EXP,thalidomide,4,SS,Pyrexia,4,F,HO,111
169612803,4,Plasma cell myeloma,3,F,EXP,thalidomide,4,SS,Pyrexia,4,F,OT,111
169612803,4,Plasma cell myeloma,3,F,EXP,thalidomide,4,SS,Pyrexia,4,F,LT,111
169613732,1,Relapsing-remitting multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Pneumonia,1,M,HO,73
169613732,1,Relapsing-remitting multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Pneumonia,1,M,DE,73
169613855,1,Chronic lymphocytic leukaemia,5,F,EXP,idelalisib,1,PS,Dermatitis psoriasiform,1,F,HO,221
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Asthenia,1,F,OT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Asthenia,1,F,HO,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Asthenia,1,F,LT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Catheter site haemorrhage,1,F,OT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Catheter site haemorrhage,1,F,HO,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Catheter site haemorrhage,1,F,LT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Chest pain,1,F,OT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Chest pain,1,F,HO,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Chest pain,1,F,LT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Constipation,1,F,OT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Constipation,1,F,HO,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Constipation,1,F,LT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,LT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Fatigue,1,F,HO,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Fatigue,1,F,LT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,OT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,LT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Hyperhidrosis,1,F,OT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Hyperhidrosis,1,F,HO,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Hyperhidrosis,1,F,LT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,LT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Pleural effusion,1,F,OT,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Pleural effusion,1,F,HO,63
169617866,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Pleural effusion,1,F,LT,63
169630044,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Immune-mediated enterocolitis,2,M,HO,6
169630044,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Immune-mediated enterocolitis,2,M,OT,6
169630044,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Prescribed overdose,2,M,HO,6
169630044,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Prescribed overdose,2,M,OT,6
169635773,1,Diffuse large B-cell lymphoma refractory,3,F,EXP,axicabtagene ciloleucel,1,PS,Agitation,1,M,HO,6
169635773,1,Diffuse large B-cell lymphoma refractory,3,F,EXP,axicabtagene ciloleucel,1,PS,Aphasia,1,M,HO,6
169635773,1,Diffuse large B-cell lymphoma refractory,3,F,EXP,axicabtagene ciloleucel,1,PS,Cognitive disorder,1,M,HO,6
169635773,1,Diffuse large B-cell lymphoma refractory,3,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,M,HO,6
169635773,1,Diffuse large B-cell lymphoma refractory,3,F,EXP,axicabtagene ciloleucel,1,PS,Tremor,1,M,HO,6
169636356,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Immune thrombocytopenic purpura,1,M,OT,509
169636356,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Immune thrombocytopenic purpura,1,M,HO,509
169640833,1,Acute lymphocytic leukaemia,3,F,PER,blinatumomab,1,PS,Meningoradiculitis,1,M,HO,72
169650665,3,Plasma cell myeloma,5,F,EXP,thalidomide,3,SS,Sepsis,3,M,HO,2
169650665,3,Plasma cell myeloma,5,F,EXP,thalidomide,3,SS,Sepsis,3,M,OT,2
169650665,3,Plasma cell myeloma,5,F,EXP,thalidomide,3,SS,Sepsis,3,M,LT,2
169681656,1,Gastric cancer,6,F,EXP,nivolumab,1,PS,Immune thrombocytopenic purpura,1,M,OT,303
169681656,1,Gastric cancer,6,F,EXP,nivolumab,1,PS,Immune thrombocytopenic purpura,1,M,HO,303
169681656,1,Gastric cancer,6,F,EXP,nivolumab,1,PS,Immune thrombocytopenic purpura,1,M,LT,303
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Anaemia,10,M,DE,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Anaemia,10,M,OT,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Anaemia,10,M,HO,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,General physical health deterioration,10,M,DE,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,General physical health deterioration,10,M,OT,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,General physical health deterioration,10,M,HO,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Leukopenia,10,M,DE,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Leukopenia,10,M,OT,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Leukopenia,10,M,HO,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Pneumonia,10,M,DE,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Pneumonia,10,M,OT,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Pneumonia,10,M,HO,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Pulmonary toxicity,10,M,DE,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Pulmonary toxicity,10,M,OT,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Pulmonary toxicity,10,M,HO,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Sepsis,10,M,DE,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Sepsis,10,M,OT,14
169688542,10,Nausea,2,F,EXP,granisetron,10,C,Sepsis,10,M,HO,14
169700393,1,Plasma cell myeloma,3,F,EXP,pomalidomide,1,PS,Pulmonary embolism,1,F,LT,4
169702684,4,B-cell type acute leukaemia,4,F,EXP,pegaspargase,4,SS,Drug hypersensitivity,4,F,HO,4
169702684,4,B-cell type acute leukaemia,4,F,EXP,pegaspargase,4,SS,Febrile neutropenia,4,F,HO,4
169702684,4,B-cell type acute leukaemia,4,F,EXP,pegaspargase,4,SS,Seizure,4,F,HO,4
169704356,1,Neuroblastoma,6,F,EXP,lorlatinib,1,PS,Psychotic disorder,1,M,HO,80
169713993,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Pruritus,1,M,OT,495
169713993,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Rash maculo-papular,1,M,OT,495
169714083,1,Non-small cell lung cancer,3,F,EXP,entrectinib,1,PS,Interstitial lung disease,1,F,HO,29
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Adenovirus infection,1,M,HO,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Adenovirus infection,1,M,DE,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Adenovirus infection,1,M,LT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Adenovirus infection,1,M,OT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Alanine aminotransferase increased,1,M,HO,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Alanine aminotransferase increased,1,M,DE,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Alanine aminotransferase increased,1,M,LT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Alanine aminotransferase increased,1,M,OT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Anaemia,1,M,HO,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Anaemia,1,M,DE,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Anaemia,1,M,LT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Anaemia,1,M,OT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Hypernatraemia,1,M,HO,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Hypernatraemia,1,M,DE,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Hypernatraemia,1,M,LT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Hypernatraemia,1,M,OT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Hyponatraemia,1,M,HO,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Hyponatraemia,1,M,DE,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Hyponatraemia,1,M,LT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Hyponatraemia,1,M,OT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Hypoxia,1,M,HO,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Hypoxia,1,M,DE,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Hypoxia,1,M,LT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Hypoxia,1,M,OT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Lipase increased,1,M,HO,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Lipase increased,1,M,DE,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Lipase increased,1,M,LT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Lipase increased,1,M,OT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Pneumonia aspiration,1,M,HO,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Pneumonia aspiration,1,M,DE,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Pneumonia aspiration,1,M,LT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Pneumonia aspiration,1,M,OT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Respiratory syncytial virus infection,1,M,HO,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Respiratory syncytial virus infection,1,M,DE,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Respiratory syncytial virus infection,1,M,LT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Respiratory syncytial virus infection,1,M,OT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Seizure,1,M,HO,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Seizure,1,M,DE,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Seizure,1,M,LT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Seizure,1,M,OT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Viral upper respiratory tract infection,1,M,HO,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Viral upper respiratory tract infection,1,M,DE,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Viral upper respiratory tract infection,1,M,LT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Viral upper respiratory tract infection,1,M,OT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Wound infection,1,M,HO,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Wound infection,1,M,DE,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Wound infection,1,M,LT,7
169730043,1,Neoplasm,3,F,EXP,entrectinib,1,PS,Wound infection,1,M,OT,7
169730699,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Disease recurrence,1,M,LT,828
169730699,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Disease recurrence,1,M,HO,828
169730699,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Epistaxis,1,M,LT,828
169730699,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Epistaxis,1,M,HO,828
169730699,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,M,LT,828
169730699,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,M,HO,828
169730699,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Mouth haemorrhage,1,M,LT,828
169730699,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Mouth haemorrhage,1,M,HO,828
169730699,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Petechiae,1,M,LT,828
169730699,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Petechiae,1,M,HO,828
169730699,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Platelet count decreased,1,M,LT,828
169730699,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Platelet count decreased,1,M,HO,828
169730699,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Traumatic haematoma,1,M,LT,828
169730699,1,Multiple sclerosis,9,F,EXP,alemtuzumab,1,PS,Traumatic haematoma,1,M,HO,828
169739962,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,396
169739962,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,396
169746625,1,Neoplasm malignant,5,F,EXP,crizotinib,1,PS,Hepatic failure,1,M,HO,110
169746625,1,Neoplasm malignant,5,F,EXP,crizotinib,1,PS,Hepatic failure,1,M,DE,110
169746625,1,Neoplasm malignant,5,F,EXP,crizotinib,1,PS,Impaired gastric emptying,1,M,HO,110
169746625,1,Neoplasm malignant,5,F,EXP,crizotinib,1,PS,Impaired gastric emptying,1,M,DE,110
169747374,1,Liposarcoma,4,F,EXP,selinexor,1,PS,Myelodysplastic syndrome,1,M,OT,239
169763722,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Blood creatinine increased,2,F,HO,309
169763722,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Blood creatinine increased,2,F,OT,309
169763722,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Sinus node dysfunction,2,F,HO,309
169763722,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Sinus node dysfunction,2,F,OT,309
169763722,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Upper respiratory tract inflammation,2,F,HO,309
169763722,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Upper respiratory tract inflammation,2,F,OT,309
1697679010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Cholecystitis,1,M,OT,185
1697679010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Cholecystitis,1,M,HO,185
1697679010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Lung disorder,1,M,OT,185
1697679010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Lung disorder,1,M,HO,185
1697679010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Malaise,1,M,OT,185
1697679010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Malaise,1,M,HO,185
1697679010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Rash,1,M,OT,185
1697679010,1,Pancreatic carcinoma,10,F,EXP,nivolumab,1,PS,Rash,1,M,HO,185
169770982,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,217
169770982,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,217
169770982,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,217
169770982,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,217
169770982,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Tuberculosis,1,M,OT,217
169770982,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Tuberculosis,1,M,HO,217
169774883,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Hypophysitis,1,F,HO,84
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Dry skin,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Dysphonia,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hepatitis,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Irritability,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Liver function test abnormal,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Macule,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pain,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Renal function test abnormal,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Sciatica,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Skin exfoliation,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,21
169796133,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,21
169802462,21,Prophylaxis,2,F,EXP,rasburicase,21,C,Pancytopenia,21,M,HO,50
169802624,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Venous thrombosis,1,F,LT,59
169805674,7,Prophylaxis of nausea and vomiting,4,F,EXP,granisetron,7,C,Febrile neutropenia,7,F,HO,96
169805674,7,Prophylaxis of nausea and vomiting,4,F,EXP,granisetron,7,C,Haemorrhoids,7,F,HO,96
169811083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Dysphagia,1,M,HO,40
169811083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,40
169811083,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Lethargy,1,M,HO,40
169850952,2,Product used for unknown indication,2,F,EXP,denosumab,2,C,Fatigue,2,M,HO,504
169850952,2,Product used for unknown indication,2,F,EXP,denosumab,2,C,Fatigue,2,M,OT,504
169850952,2,Product used for unknown indication,2,F,EXP,denosumab,2,C,Neoplasm progression,2,M,HO,504
169850952,2,Product used for unknown indication,2,F,EXP,denosumab,2,C,Neoplasm progression,2,M,OT,504
169850952,2,Product used for unknown indication,2,F,EXP,denosumab,2,C,Palpitations,2,M,HO,504
169850952,2,Product used for unknown indication,2,F,EXP,denosumab,2,C,Palpitations,2,M,OT,504
169850952,2,Product used for unknown indication,2,F,EXP,denosumab,2,C,Pericardial effusion,2,M,HO,504
169850952,2,Product used for unknown indication,2,F,EXP,denosumab,2,C,Pericardial effusion,2,M,OT,504
169850952,2,Product used for unknown indication,2,F,EXP,denosumab,2,C,Rash,2,M,HO,504
169850952,2,Product used for unknown indication,2,F,EXP,denosumab,2,C,Rash,2,M,OT,504
169852018,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Ischaemia,1,M,DE,313
169852018,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Ischaemia,1,M,HO,313
169852018,1,Metastatic malignant melanoma,8,F,EXP,nivolumab,1,PS,Ischaemia,1,M,LT,313
169858683,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Diarrhoea,1,F,OT,1
169858683,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Diarrhoea,1,F,HO,1
169858683,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Dry skin,1,F,OT,1
169858683,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Dry skin,1,F,HO,1
169858683,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Immune-mediated enterocolitis,1,F,OT,1
169858683,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Immune-mediated enterocolitis,1,F,HO,1
169858683,3,Malignant melanoma,3,F,EXP,nivolumab,3,PS,Diarrhoea,3,F,OT,1
169858683,3,Malignant melanoma,3,F,EXP,nivolumab,3,PS,Diarrhoea,3,F,HO,1
169858683,3,Malignant melanoma,3,F,EXP,nivolumab,3,PS,Dry skin,3,F,OT,1
169858683,3,Malignant melanoma,3,F,EXP,nivolumab,3,PS,Dry skin,3,F,HO,1
169858683,3,Malignant melanoma,3,F,EXP,nivolumab,3,PS,Immune-mediated enterocolitis,3,F,OT,1
169858683,3,Malignant melanoma,3,F,EXP,nivolumab,3,PS,Immune-mediated enterocolitis,3,F,HO,1
169882062,1,Acute lymphocytic leukaemia,2,F,PER,blinatumomab,1,PS,Peripheral sensory neuropathy,1,M,HO,130
169886475,1,Neoplasm,5,F,EXP,entrectinib,1,PS,Acute kidney injury,1,M,OT,101
169886475,1,Neoplasm,5,F,EXP,entrectinib,1,PS,Acute kidney injury,1,M,HO,101
169886475,1,Neoplasm,5,F,EXP,entrectinib,1,PS,Bladder diverticulum,1,M,OT,101
169886475,1,Neoplasm,5,F,EXP,entrectinib,1,PS,Bladder diverticulum,1,M,HO,101
169886475,1,Neoplasm,5,F,EXP,entrectinib,1,PS,Epilepsy,1,M,OT,101
169886475,1,Neoplasm,5,F,EXP,entrectinib,1,PS,Epilepsy,1,M,HO,101
169886475,1,Neoplasm,5,F,EXP,entrectinib,1,PS,Ventricular hypokinesia,1,M,OT,101
169886475,1,Neoplasm,5,F,EXP,entrectinib,1,PS,Ventricular hypokinesia,1,M,HO,101
169910902,1,Bronchial carcinoma,2,F,EXP,ramucirumab,1,PS,General physical health deterioration,1,F,HO,8
169910902,1,Bronchial carcinoma,2,F,EXP,ramucirumab,1,PS,General physical health deterioration,1,F,OT,8
169910902,1,Bronchial carcinoma,2,F,EXP,ramucirumab,1,PS,Pneumonia,1,F,HO,8
169910902,1,Bronchial carcinoma,2,F,EXP,ramucirumab,1,PS,Pneumonia,1,F,OT,8
169910902,3,Product used for unknown indication,2,F,EXP,pegfilgrastim,3,SS,General physical health deterioration,3,F,HO,7
169910902,3,Product used for unknown indication,2,F,EXP,pegfilgrastim,3,SS,General physical health deterioration,3,F,OT,7
169910902,3,Product used for unknown indication,2,F,EXP,pegfilgrastim,3,SS,Pneumonia,3,F,HO,7
169910902,3,Product used for unknown indication,2,F,EXP,pegfilgrastim,3,SS,Pneumonia,3,F,OT,7
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Acute coronary syndrome,5,F,HO,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Acute coronary syndrome,5,F,OT,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Acute coronary syndrome,5,F,DE,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Anxiety,5,F,HO,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Anxiety,5,F,OT,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Anxiety,5,F,DE,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Dyspnoea,5,F,HO,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Dyspnoea,5,F,OT,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Dyspnoea,5,F,DE,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Escherichia bacteraemia,5,F,HO,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Escherichia bacteraemia,5,F,OT,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Escherichia bacteraemia,5,F,DE,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,General physical health deterioration,5,F,HO,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,General physical health deterioration,5,F,OT,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,General physical health deterioration,5,F,DE,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Haematotoxicity,5,F,HO,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Haematotoxicity,5,F,OT,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Haematotoxicity,5,F,DE,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Loss of consciousness,5,F,HO,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Loss of consciousness,5,F,OT,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Loss of consciousness,5,F,DE,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Malaise,5,F,HO,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Malaise,5,F,OT,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Malaise,5,F,DE,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Plasma cell myeloma,5,F,HO,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Plasma cell myeloma,5,F,OT,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Plasma cell myeloma,5,F,DE,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,White matter lesion,5,F,HO,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,White matter lesion,5,F,OT,307
169913235,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,White matter lesion,5,F,DE,307
169916544,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,39
169916544,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,LT,39
169916544,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,39
169916544,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,39
169916544,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,LT,39
169916544,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,39
169916544,2,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,OT,39
169916544,2,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,LT,39
169916544,2,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,HO,39
169916544,2,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,39
169916544,2,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,LT,39
169916544,2,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,39
169943502,6,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,6,SS,Cough,6,M,OT,46
169943502,6,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,6,SS,Cough,6,M,HO,46
169943502,6,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,6,SS,Febrile neutropenia,6,M,OT,46
169943502,6,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,6,SS,Febrile neutropenia,6,M,HO,46
169943502,6,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,6,SS,Oropharyngeal pain,6,M,OT,46
169943502,6,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,6,SS,Oropharyngeal pain,6,M,HO,46
169943502,6,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,6,SS,Rhinorrhoea,6,M,OT,46
169943502,6,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,6,SS,Rhinorrhoea,6,M,HO,46
169943502,6,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,6,SS,Upper respiratory tract infection,6,M,OT,46
169943502,6,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,6,SS,Upper respiratory tract infection,6,M,HO,46
169951984,5,Triple negative breast cancer,4,F,EXP,pegfilgrastim,5,SS,Adrenocorticotropic hormone deficiency,5,F,HO,9
169951984,5,Triple negative breast cancer,4,F,EXP,pegfilgrastim,5,SS,General physical health deterioration,5,F,HO,9
169954332,22,Prophylaxis,2,F,PER,rasburicase,22,C,Pancytopenia,22,M,HO,50
169971923,24,Neutropenia,3,F,EXP,filgrastim,24,C,Cerebrovascular accident,24,M,HO,61
169971923,37,Neutropenia,3,F,EXP,pegfilgrastim,37,C,Cerebrovascular accident,37,M,HO,90
169984382,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Acute kidney injury,3,M,OT,215
169984382,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Dehydration,3,M,OT,215
169984382,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Oedema,3,M,OT,215
169984382,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Pyrexia,3,M,OT,215
169984382,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Uveitis,3,M,OT,215
169984473,6,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,6,SS,Blood bilirubin increased,6,M,HO,44
169984473,6,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,6,SS,Gastroenteritis viral,6,M,HO,44
169993863,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Febrile neutropenia,2,M,HO,21
169993863,3,Plasma cell myeloma,3,F,EXP,daratumumab,3,SS,Febrile neutropenia,3,M,HO,21
169995704,2,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,2,C,Loss of consciousness,2,M,HO,16
169995704,2,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,2,C,Loss of consciousness,2,M,OT,16
169995704,2,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,2,C,Subcutaneous haematoma,2,M,HO,16
169995704,2,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,2,C,Subcutaneous haematoma,2,M,OT,16
169995704,2,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,2,C,Ventricular tachycardia,2,M,HO,16
169995704,2,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,2,C,Ventricular tachycardia,2,M,OT,16
170001254,1,Breast cancer metastatic,4,F,EXP,palbociclib,1,PS,Sepsis,1,F,HO,1045
170001254,1,Breast cancer metastatic,4,F,EXP,palbociclib,1,PS,Urinary tract infection,1,F,HO,1045
170002444,8,Metastases to bone,4,F,EXP,zoledronic acid,8,C,Anaemia,8,F,HO,740
170002444,8,Metastases to bone,4,F,EXP,zoledronic acid,8,C,Pancytopenia,8,F,HO,740
170002444,8,Metastases to bone,4,F,EXP,zoledronic acid,8,C,Renal disorder,8,F,HO,740
170002444,8,Metastases to bone,4,F,EXP,zoledronic acid,8,C,Renal impairment,8,F,HO,740
170002444,8,Metastases to bone,4,F,EXP,zoledronic acid,8,C,Tachycardia,8,F,HO,740
170002444,8,Metastases to bone,4,F,EXP,zoledronic acid,8,C,Urosepsis,8,F,HO,740
170003645,1,Plasma cell myeloma,5,F,EXP,lenalidomide,1,PS,Myelodysplastic syndrome,1,M,LT,1363
170003645,1,Plasma cell myeloma,5,F,EXP,lenalidomide,1,PS,Myelodysplastic syndrome,1,M,HO,1363
170003645,10,Plasma cell myeloma,5,F,EXP,pegfilgrastim,10,SS,Myelodysplastic syndrome,10,M,LT,1359
170003645,10,Plasma cell myeloma,5,F,EXP,pegfilgrastim,10,SS,Myelodysplastic syndrome,10,M,HO,1359
170004612,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Anaphylactoid reaction,1,F,HO,21
170004612,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Anaphylactoid reaction,1,F,OT,21
170004612,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Myositis,1,F,HO,21
170004612,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Myositis,1,F,OT,21
170012536,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,LT,154
170012536,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,154
170012536,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Pericarditis,1,F,LT,154
170012536,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Pericarditis,1,F,OT,154
170012536,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Pyrexia,1,F,LT,154
170012536,1,Lung neoplasm malignant,6,F,EXP,nivolumab,1,PS,Pyrexia,1,F,OT,154
170012536,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,F,LT,134
170012536,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,F,OT,134
170012536,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Pericarditis,2,F,LT,134
170012536,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Pericarditis,2,F,OT,134
170012536,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Pyrexia,2,F,LT,134
170012536,2,Malignant melanoma,6,F,EXP,nivolumab,2,SS,Pyrexia,2,F,OT,134
170012536,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,F,LT,70
170012536,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,F,OT,70
170012536,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Pericarditis,3,F,LT,70
170012536,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Pericarditis,3,F,OT,70
170012536,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Pyrexia,3,F,LT,70
170012536,3,Product used for unknown indication,6,F,EXP,nivolumab,3,SS,Pyrexia,3,F,OT,70
170012536,6,Lung neoplasm malignant,6,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,F,LT,154
170012536,6,Lung neoplasm malignant,6,F,EXP,ipilimumab,6,SS,Malignant neoplasm progression,6,F,OT,154
170012536,6,Lung neoplasm malignant,6,F,EXP,ipilimumab,6,SS,Pericarditis,6,F,LT,154
170012536,6,Lung neoplasm malignant,6,F,EXP,ipilimumab,6,SS,Pericarditis,6,F,OT,154
170012536,6,Lung neoplasm malignant,6,F,EXP,ipilimumab,6,SS,Pyrexia,6,F,LT,154
170012536,6,Lung neoplasm malignant,6,F,EXP,ipilimumab,6,SS,Pyrexia,6,F,OT,154
170012536,7,Malignant melanoma,6,F,EXP,ipilimumab,7,SS,Malignant neoplasm progression,7,F,LT,134
170012536,7,Malignant melanoma,6,F,EXP,ipilimumab,7,SS,Malignant neoplasm progression,7,F,OT,134
170012536,7,Malignant melanoma,6,F,EXP,ipilimumab,7,SS,Pericarditis,7,F,LT,134
170012536,7,Malignant melanoma,6,F,EXP,ipilimumab,7,SS,Pericarditis,7,F,OT,134
170012536,7,Malignant melanoma,6,F,EXP,ipilimumab,7,SS,Pyrexia,7,F,LT,134
170012536,7,Malignant melanoma,6,F,EXP,ipilimumab,7,SS,Pyrexia,7,F,OT,134
170021993,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,HO,292
170021993,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,OT,292
170021993,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Infection,1,M,HO,292
170021993,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Infection,1,M,OT,292
170021993,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Lymphocytic hypophysitis,1,M,HO,292
170021993,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Lymphocytic hypophysitis,1,M,OT,292
170021993,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,292
170021993,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,292
170021993,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Gamma-glutamyltransferase increased,2,M,HO,292
170021993,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Gamma-glutamyltransferase increased,2,M,OT,292
170021993,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Infection,2,M,HO,292
170021993,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Infection,2,M,OT,292
170021993,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Lymphocytic hypophysitis,2,M,HO,292
170021993,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Lymphocytic hypophysitis,2,M,OT,292
170021993,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Renal failure,2,M,HO,292
170021993,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Renal failure,2,M,OT,292
170028142,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Dehydration,3,M,OT,215
170028142,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Oedema,3,M,OT,215
170028142,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Pyrexia,3,M,OT,215
170028142,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Uveitis,3,M,OT,215
170029662,1,Prostate cancer stage 0,2,F,EXP,enzalutamide,1,PS,Gallbladder disorder,1,M,HO,699
170029662,1,Prostate cancer stage 0,2,F,EXP,enzalutamide,1,PS,Gallbladder disorder,1,M,OT,699
170029662,1,Prostate cancer stage 0,2,F,EXP,enzalutamide,1,PS,Nephrolithiasis,1,M,HO,699
170029662,1,Prostate cancer stage 0,2,F,EXP,enzalutamide,1,PS,Nephrolithiasis,1,M,OT,699
170029662,1,Prostate cancer stage 0,2,F,EXP,enzalutamide,1,PS,Product dose omission,1,M,HO,699
170029662,1,Prostate cancer stage 0,2,F,EXP,enzalutamide,1,PS,Product dose omission,1,M,OT,699
170031962,2,Product used for unknown indication,2,F,EXP,axitinib,2,SS,Balance disorder,2,M,HO,30
170031962,2,Product used for unknown indication,2,F,EXP,axitinib,2,SS,Confusional state,2,M,HO,30
170048465,1,Non-small cell lung cancer,5,F,EXP,entrectinib,1,PS,Left ventricular dysfunction,1,F,HO,32
170048465,15,Metastases to bone,5,F,EXP,denosumab,15,C,Left ventricular dysfunction,15,F,HO,31
170054493,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Gastric ulcer perforation,1,F,OT,97
170054493,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Gastric ulcer perforation,1,F,DE,97
170054493,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Gastric ulcer perforation,1,F,DS,97
170054493,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Gastric ulcer perforation,1,F,HO,97
170054493,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Gastric ulcer perforation,1,F,LT,97
170054493,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Leukopenia,1,F,OT,97
170054493,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Leukopenia,1,F,DE,97
170054493,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Leukopenia,1,F,DS,97
170054493,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Leukopenia,1,F,HO,97
170054493,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Leukopenia,1,F,LT,97
170059436,1,Hormone-refractory prostate cancer,6,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,LT,285
170059436,1,Hormone-refractory prostate cancer,6,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,HO,285
170059436,2,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,2,SS,Hyponatraemia,2,M,LT,285
170059436,2,Hormone-refractory prostate cancer,6,F,EXP,enzalutamide,2,SS,Hyponatraemia,2,M,HO,285
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,B-cell lymphoma,1,M,OT,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,B-cell lymphoma,1,M,HO,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,B-cell lymphoma,1,M,DE,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,M,OT,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,M,HO,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,M,DE,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,DE,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Dysphagia,1,M,OT,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Dysphagia,1,M,HO,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Dysphagia,1,M,DE,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,OT,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,HO,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,DE,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,OT,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,HO,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,DE,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,OT,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,HO,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,DE,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Respiratory failure,1,M,OT,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Respiratory failure,1,M,HO,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Respiratory failure,1,M,DE,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Somnolence,1,M,OT,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Somnolence,1,M,HO,1
170067882,1,B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Somnolence,1,M,DE,1
170070332,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Plasma cell myeloma,3,M,DE,298
170070332,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Plasma cell myeloma,3,M,OT,298
170075414,1,Breast cancer,4,F,PER,pegfilgrastim,1,PS,Pneumonia,1,F,OT,51
170075414,1,Breast cancer,4,F,PER,pegfilgrastim,1,PS,Pneumonia,1,F,HO,51
170080452,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Hepatic function abnormal,1,F,HO,21
170080452,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Hepatic function abnormal,2,F,HO,21
170088364,1,Relapsing multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Diarrhoea,1,F,HO,367
170088364,1,Relapsing multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Sepsis,1,F,HO,367
170091273,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Diarrhoea,1,F,OT,7
170091273,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Hepatic function abnormal,1,F,OT,7
170091273,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Lipase increased,1,F,OT,7
170091273,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Diarrhoea,2,F,OT,7
170091273,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Hepatic function abnormal,2,F,OT,7
170091273,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Lipase increased,2,F,OT,7
170091348,1,Renal cancer metastatic,8,F,EXP,nivolumab,1,PS,Acute hepatic failure,1,M,DE,84
170091348,1,Renal cancer metastatic,8,F,EXP,nivolumab,1,PS,Acute hepatic failure,1,M,OT,84
170091348,1,Renal cancer metastatic,8,F,EXP,nivolumab,1,PS,Acute hepatic failure,1,M,HO,84
170091348,1,Renal cancer metastatic,8,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,DE,84
170091348,1,Renal cancer metastatic,8,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,84
170091348,1,Renal cancer metastatic,8,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,84
170091348,1,Renal cancer metastatic,8,F,EXP,nivolumab,1,PS,Streptococcus test,1,M,DE,84
170091348,1,Renal cancer metastatic,8,F,EXP,nivolumab,1,PS,Streptococcus test,1,M,OT,84
170091348,1,Renal cancer metastatic,8,F,EXP,nivolumab,1,PS,Streptococcus test,1,M,HO,84
170091348,3,Renal cancer metastatic,8,F,EXP,ipilimumab,3,SS,Acute hepatic failure,3,M,DE,84
170091348,3,Renal cancer metastatic,8,F,EXP,ipilimumab,3,SS,Acute hepatic failure,3,M,OT,84
170091348,3,Renal cancer metastatic,8,F,EXP,ipilimumab,3,SS,Acute hepatic failure,3,M,HO,84
170091348,3,Renal cancer metastatic,8,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,DE,84
170091348,3,Renal cancer metastatic,8,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,OT,84
170091348,3,Renal cancer metastatic,8,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,HO,84
170091348,3,Renal cancer metastatic,8,F,EXP,ipilimumab,3,SS,Streptococcus test,3,M,DE,84
170091348,3,Renal cancer metastatic,8,F,EXP,ipilimumab,3,SS,Streptococcus test,3,M,OT,84
170091348,3,Renal cancer metastatic,8,F,EXP,ipilimumab,3,SS,Streptococcus test,3,M,HO,84
170096863,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,OT,2
170096863,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,HO,2
170096863,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Gastrooesophageal reflux disease,1,M,OT,2
170096863,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Gastrooesophageal reflux disease,1,M,HO,2
170096863,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Metastasis,1,M,OT,2
170096863,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Metastasis,1,M,HO,2
170096863,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Sciatica,1,M,OT,2
170096863,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Sciatica,1,M,HO,2
170096863,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Small intestinal obstruction,1,M,OT,2
170096863,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Small intestinal obstruction,1,M,HO,2
170096863,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Spinal cord compression,1,M,OT,2
170096863,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Spinal cord compression,1,M,HO,2
170096863,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Urinary tract infection enterococcal,1,M,OT,2
170096863,1,Renal cancer,3,F,EXP,nivolumab,1,PS,Urinary tract infection enterococcal,1,M,HO,2
170098123,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Colitis,1,M,OT,12
170098123,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Colitis,1,M,HO,12
170098123,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Interstitial lung disease,1,M,OT,12
170098123,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Interstitial lung disease,1,M,HO,12
170098123,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Rash,1,M,OT,12
170098123,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Rash,1,M,HO,12
170098123,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Toxic skin eruption,1,M,OT,12
170098123,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Toxic skin eruption,1,M,HO,12
170098123,3,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,3,PS,Colitis,3,M,OT,12
170098123,3,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,3,PS,Colitis,3,M,HO,12
170098123,3,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,3,PS,Interstitial lung disease,3,M,OT,12
170098123,3,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,3,PS,Interstitial lung disease,3,M,HO,12
170098123,3,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,3,PS,Rash,3,M,OT,12
170098123,3,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,3,PS,Rash,3,M,HO,12
170098123,3,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,3,PS,Toxic skin eruption,3,M,OT,12
170098123,3,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,3,PS,Toxic skin eruption,3,M,HO,12
170104482,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Angular cheilitis,4,M,OT,29
170104482,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Influenza,4,M,OT,29
170104482,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Nausea,4,M,OT,29
170104482,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Platelet count decreased,4,M,OT,29
170104482,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Thrombophlebitis,4,M,OT,29
170109192,2,Non-small cell lung cancer,2,F,EXP,nivolumab,2,SS,Dermatitis acneiform,2,M,HO,13
170109192,2,Non-small cell lung cancer,2,F,EXP,nivolumab,2,SS,Dermatitis acneiform,2,M,OT,13
170109192,2,Non-small cell lung cancer,2,F,EXP,nivolumab,2,SS,Hyponatraemia,2,M,HO,13
170109192,2,Non-small cell lung cancer,2,F,EXP,nivolumab,2,SS,Hyponatraemia,2,M,OT,13
170109192,3,Non-small cell lung cancer,2,F,EXP,ipilimumab,3,SS,Dermatitis acneiform,3,M,HO,13
170109192,3,Non-small cell lung cancer,2,F,EXP,ipilimumab,3,SS,Dermatitis acneiform,3,M,OT,13
170109192,3,Non-small cell lung cancer,2,F,EXP,ipilimumab,3,SS,Hyponatraemia,3,M,HO,13
170109192,3,Non-small cell lung cancer,2,F,EXP,ipilimumab,3,SS,Hyponatraemia,3,M,OT,13
170110624,1,Pancreatic carcinoma,4,F,EXP,nivolumab,1,PS,Leukocytosis,1,F,HO,1
170110624,1,Pancreatic carcinoma,4,F,EXP,nivolumab,1,PS,Liver function test increased,1,F,HO,1
170118413,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,M,LT,50
170118413,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,M,OT,50
170118413,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,M,HO,50
170118413,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Diabetic ketoacidosis,2,M,LT,50
170118413,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Diabetic ketoacidosis,2,M,OT,50
170118413,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Diabetic ketoacidosis,2,M,HO,50
170123502,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Dermatitis acneiform,1,M,HO,13
170123502,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Dermatitis acneiform,1,M,OT,13
170123502,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,HO,13
170123502,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,OT,13
170123502,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Dermatitis acneiform,2,M,HO,13
170123502,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Dermatitis acneiform,2,M,OT,13
170123502,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,HO,13
170123502,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,OT,13
170125285,1,Prostate cancer metastatic,5,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,M,HO,375
170125285,1,Prostate cancer metastatic,5,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,M,LT,375
170125285,1,Prostate cancer metastatic,5,F,EXP,nivolumab,1,PS,Pulmonary sepsis,1,M,OT,375
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,HO,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,OT,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,HO,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,OT,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,HO,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,OT,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Sinus tachycardia,1,M,HO,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Sinus tachycardia,1,M,OT,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Skin disorder,1,M,HO,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Skin disorder,1,M,OT,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,12
170128754,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Abdominal pain,2,M,HO,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Abdominal pain,2,M,OT,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,HO,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,OT,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Autoimmune disorder,2,M,HO,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Autoimmune disorder,2,M,OT,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Hypokalaemia,2,M,HO,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Hypokalaemia,2,M,OT,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Sinus tachycardia,2,M,HO,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Sinus tachycardia,2,M,OT,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Skin disorder,2,M,HO,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Skin disorder,2,M,OT,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Vomiting,2,M,HO,12
170128754,2,Malignant melanoma,4,F,EXP,ipilimumab,2,SS,Vomiting,2,M,OT,12
170130202,1,Bladder cancer,2,F,EXP,ipilimumab,1,PS,Proteinuria,1,M,OT,21
170130202,2,Bladder cancer,2,F,EXP,nivolumab,2,SS,Proteinuria,2,M,OT,21
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Asthenia,1,F,HO,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Asthenia,1,F,OT,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,OT,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,HO,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,OT,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Mucosal inflammation,1,F,HO,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Mucosal inflammation,1,F,OT,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,HO,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,OT,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Weight decreased,1,F,HO,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Weight decreased,1,F,OT,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Xerosis,1,F,HO,26
170143585,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Xerosis,1,F,OT,26
170146102,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Dehydration,3,M,OT,215
170146102,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Oedema,3,M,OT,215
170146102,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Pyrexia,3,M,OT,215
170146102,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Uveitis,3,M,OT,215
170154892,3,Squamous cell carcinoma of head and neck,2,F,EXP,avelumab,3,C,Mucosal inflammation,3,M,HO,29
170158002,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,51
170158002,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Eye swelling,1,M,OT,51
170158002,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Hyperpyrexia,1,M,OT,51
170158002,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Mouth ulceration,1,M,OT,51
170158002,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Ocular hyperaemia,1,M,OT,51
170158002,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,51
170158002,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Rash,1,M,OT,51
170159822,1,Neuroblastoma,2,F,EXP,aldesleukin,1,PS,Hypersensitivity,1,F,HO,1
170159822,1,Neuroblastoma,2,F,EXP,aldesleukin,1,PS,Hypotension,1,F,HO,1
170159822,1,Neuroblastoma,2,F,EXP,aldesleukin,1,PS,Oedema,1,F,HO,1
170159822,1,Neuroblastoma,2,F,EXP,aldesleukin,1,PS,Off label use,1,F,HO,1
170159822,1,Neuroblastoma,2,F,EXP,aldesleukin,1,PS,Presyncope,1,F,HO,1
170159822,1,Neuroblastoma,2,F,EXP,aldesleukin,1,PS,Rash,1,F,HO,1
170159822,2,Neuroblastoma,2,F,EXP,dinutuximab,2,C,Hypersensitivity,2,F,HO,1
170159822,2,Neuroblastoma,2,F,EXP,dinutuximab,2,C,Hypotension,2,F,HO,1
170159822,2,Neuroblastoma,2,F,EXP,dinutuximab,2,C,Oedema,2,F,HO,1
170159822,2,Neuroblastoma,2,F,EXP,dinutuximab,2,C,Off label use,2,F,HO,1
170159822,2,Neuroblastoma,2,F,EXP,dinutuximab,2,C,Presyncope,2,F,HO,1
170159822,2,Neuroblastoma,2,F,EXP,dinutuximab,2,C,Rash,2,F,HO,1
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Diarrhoea,1,F,HO,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Diarrhoea,1,F,OT,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Escherichia infection,1,F,HO,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Escherichia infection,1,F,OT,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Iridocyclitis,1,F,HO,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Iridocyclitis,1,F,OT,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Photopsia,1,F,HO,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Photopsia,1,F,OT,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Pyrexia,1,F,HO,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Pyrexia,1,F,OT,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Urosepsis,1,F,HO,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Urosepsis,1,F,OT,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Vision blurred,1,F,HO,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Vision blurred,1,F,OT,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Vitreous floaters,1,F,HO,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Vitreous floaters,1,F,OT,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Vomiting,1,F,HO,23
170179632,1,Anaplastic thyroid cancer,2,F,EXP,trametinib,1,PS,Vomiting,1,F,OT,23
170180907,28,General physical condition,7,F,EXP,granisetron,28,C,Dyspnoea,28,F,HO,12
170180907,28,General physical condition,7,F,EXP,granisetron,28,C,Dyspnoea,28,F,DS,12
170180907,28,General physical condition,7,F,EXP,granisetron,28,C,Dyspnoea,28,F,DE,12
170180907,28,General physical condition,7,F,EXP,granisetron,28,C,Dyspnoea,28,F,LT,12
170182262,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Blood glucose fluctuation,1,M,HO,1050
170185015,1,Breast cancer,5,F,EXP,alpelisib,1,PS,Osteonecrosis of jaw,1,F,HO,1201
170185015,3,Metastases to bone,5,F,EXP,zoledronic acid,3,SS,Osteonecrosis of jaw,3,F,HO,3615
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Abdominal abscess,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Abdominal abscess,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Abdominal abscess,1,M,HO,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Acute kidney injury,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Acute kidney injury,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Acute kidney injury,1,M,HO,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Anaemia of chronic disease,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Anaemia of chronic disease,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Anaemia of chronic disease,1,M,HO,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Atrial fibrillation,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Atrial fibrillation,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Atrial fibrillation,1,M,HO,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Colitis,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Colitis,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Colitis,1,M,HO,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Delirium,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Delirium,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Delirium,1,M,HO,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Embolic stroke,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Embolic stroke,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Embolic stroke,1,M,HO,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Generalised oedema,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Generalised oedema,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Generalised oedema,1,M,HO,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Hyperglycaemia,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Hyperglycaemia,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Hyperglycaemia,1,M,HO,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Intestinal perforation,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Intestinal perforation,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Intestinal perforation,1,M,HO,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Lactic acidosis,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Lactic acidosis,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Lactic acidosis,1,M,HO,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Malnutrition,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Malnutrition,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Malnutrition,1,M,HO,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Sepsis,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Sepsis,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Sepsis,1,M,HO,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Subdural haematoma,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Subdural haematoma,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Subdural haematoma,1,M,HO,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Venous thrombosis limb,1,M,OT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Venous thrombosis limb,1,M,LT,41
170191626,1,Prostate cancer metastatic,6,F,EXP,ipilimumab,1,PS,Venous thrombosis limb,1,M,HO,41
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Abdominal abscess,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Abdominal abscess,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Abdominal abscess,2,M,HO,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Acute kidney injury,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Acute kidney injury,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Acute kidney injury,2,M,HO,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Anaemia of chronic disease,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Anaemia of chronic disease,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Anaemia of chronic disease,2,M,HO,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Atrial fibrillation,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Atrial fibrillation,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Atrial fibrillation,2,M,HO,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Colitis,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Colitis,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Colitis,2,M,HO,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Delirium,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Delirium,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Delirium,2,M,HO,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Embolic stroke,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Embolic stroke,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Embolic stroke,2,M,HO,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Generalised oedema,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Generalised oedema,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Generalised oedema,2,M,HO,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Hyperglycaemia,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Hyperglycaemia,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Hyperglycaemia,2,M,HO,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Intestinal perforation,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Intestinal perforation,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Intestinal perforation,2,M,HO,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Lactic acidosis,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Lactic acidosis,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Lactic acidosis,2,M,HO,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Malnutrition,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Malnutrition,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Malnutrition,2,M,HO,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Sepsis,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Sepsis,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Sepsis,2,M,HO,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Subdural haematoma,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Subdural haematoma,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Subdural haematoma,2,M,HO,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Venous thrombosis limb,2,M,OT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Venous thrombosis limb,2,M,LT,91
170191626,2,Prostate cancer metastatic,6,F,EXP,sipuleucel-t,2,SS,Venous thrombosis limb,2,M,HO,91
170202682,2,Plasma cell myeloma,2,F,EXP,carfilzomib,2,SS,Pyrexia,2,F,HO,35
170203753,6,Metastases to bone,3,F,EXP,denosumab,6,C,Abdominal pain,6,F,HO,221
170203753,6,Metastases to bone,3,F,EXP,denosumab,6,C,Mastitis,6,F,HO,221
170222532,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Pneumocystis jirovecii infection,1,M,HO,541
170222532,5,Plasma cell myeloma,2,F,PER,lenalidomide,5,SS,Pneumocystis jirovecii infection,5,M,HO,541
170231993,1,Non-Hodgkin's lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Pancytopenia,1,M,HO,23
170234173,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Hypophysitis,1,F,OT,41
170234173,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Hypophysitis,1,F,HO,41
170234173,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Secondary adrenocortical insufficiency,1,F,OT,41
170234173,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Secondary adrenocortical insufficiency,1,F,HO,41
170234173,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Secondary hypothyroidism,1,F,OT,41
170234173,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Secondary hypothyroidism,1,F,HO,41
170234173,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Type 1 diabetes mellitus,1,F,OT,41
170234173,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Type 1 diabetes mellitus,1,F,HO,41
170234173,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hypophysitis,2,F,OT,9
170234173,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hypophysitis,2,F,HO,9
170234173,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Secondary adrenocortical insufficiency,2,F,OT,9
170234173,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Secondary adrenocortical insufficiency,2,F,HO,9
170234173,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Secondary hypothyroidism,2,F,OT,9
170234173,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Secondary hypothyroidism,2,F,HO,9
170234173,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Type 1 diabetes mellitus,2,F,OT,9
170234173,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Type 1 diabetes mellitus,2,F,HO,9
170234173,4,Malignant melanoma,3,F,EXP,ipilimumab,4,PS,Hypophysitis,4,F,OT,41
170234173,4,Malignant melanoma,3,F,EXP,ipilimumab,4,PS,Hypophysitis,4,F,HO,41
170234173,4,Malignant melanoma,3,F,EXP,ipilimumab,4,PS,Secondary adrenocortical insufficiency,4,F,OT,41
170234173,4,Malignant melanoma,3,F,EXP,ipilimumab,4,PS,Secondary adrenocortical insufficiency,4,F,HO,41
170234173,4,Malignant melanoma,3,F,EXP,ipilimumab,4,PS,Secondary hypothyroidism,4,F,OT,41
170234173,4,Malignant melanoma,3,F,EXP,ipilimumab,4,PS,Secondary hypothyroidism,4,F,HO,41
170234173,4,Malignant melanoma,3,F,EXP,ipilimumab,4,PS,Type 1 diabetes mellitus,4,F,OT,41
170234173,4,Malignant melanoma,3,F,EXP,ipilimumab,4,PS,Type 1 diabetes mellitus,4,F,HO,41
170234173,5,Product used for unknown indication,3,F,EXP,ipilimumab,5,SS,Hypophysitis,5,F,OT,9
170234173,5,Product used for unknown indication,3,F,EXP,ipilimumab,5,SS,Hypophysitis,5,F,HO,9
170234173,5,Product used for unknown indication,3,F,EXP,ipilimumab,5,SS,Secondary adrenocortical insufficiency,5,F,OT,9
170234173,5,Product used for unknown indication,3,F,EXP,ipilimumab,5,SS,Secondary adrenocortical insufficiency,5,F,HO,9
170234173,5,Product used for unknown indication,3,F,EXP,ipilimumab,5,SS,Secondary hypothyroidism,5,F,OT,9
170234173,5,Product used for unknown indication,3,F,EXP,ipilimumab,5,SS,Secondary hypothyroidism,5,F,HO,9
170234173,5,Product used for unknown indication,3,F,EXP,ipilimumab,5,SS,Type 1 diabetes mellitus,5,F,OT,9
170234173,5,Product used for unknown indication,3,F,EXP,ipilimumab,5,SS,Type 1 diabetes mellitus,5,F,HO,9
170240626,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Coagulopathy,1,M,HO,132
170240652,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Inner ear disorder,1,M,HO,1234
170245523,1,Non-small cell lung cancer,3,F,EXP,selinexor,1,PS,Ascites,1,F,HO,31
170245523,1,Non-small cell lung cancer,3,F,EXP,selinexor,1,PS,Ascites,1,F,DE,31
170245523,1,Non-small cell lung cancer,3,F,EXP,selinexor,1,PS,Asthenia,1,F,HO,31
170245523,1,Non-small cell lung cancer,3,F,EXP,selinexor,1,PS,Asthenia,1,F,DE,31
170245523,1,Non-small cell lung cancer,3,F,EXP,selinexor,1,PS,Lung neoplasm malignant,1,F,HO,31
170245523,1,Non-small cell lung cancer,3,F,EXP,selinexor,1,PS,Lung neoplasm malignant,1,F,DE,31
170267542,1,Product used for unknown indication,2,F,EXP,nivolumab,1,PS,Death,1,M,OT,369
170267542,1,Product used for unknown indication,2,F,EXP,nivolumab,1,PS,Death,1,M,DE,369
170267542,1,Product used for unknown indication,2,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,369
170267542,1,Product used for unknown indication,2,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,DE,369
170271264,2,Malignant melanoma,4,F,EXP,trametinib,2,SS,Muscular weakness,2,M,OT,11
170275282,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Cardiac arrest,1,M,DE,1
170275282,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Cardiac arrest,1,M,OT,1
170275282,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Chest pain,1,M,DE,1
170275282,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Chest pain,1,M,OT,1
170275282,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Myocarditis,1,M,DE,1
170275282,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Myocarditis,1,M,OT,1
170275282,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Pulmonary oedema,1,M,DE,1
170275282,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Pulmonary oedema,1,M,OT,1
170277142,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Malignant neoplasm of unknown primary site,1,F,OT,2881
170277142,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Malignant neoplasm of unknown primary site,1,F,DE,2881
170280253,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Basal cell carcinoma,3,F,OT,2071
170283532,1,Immune thrombocytopenic purpura,2,F,EXP,fostamatinib disodium,1,PS,Erythema induratum,1,F,HO,1367
170283532,1,Immune thrombocytopenic purpura,2,F,EXP,fostamatinib disodium,1,PS,Nodular vasculitis,1,F,HO,1367
170283532,1,Immune thrombocytopenic purpura,2,F,EXP,fostamatinib disodium,1,PS,Tuberculosis,1,F,HO,1367
170284113,1,Oesophageal squamous cell carcinoma,3,F,EXP,nivolumab,1,SS,Hypercalcaemia,1,M,HO,28
170284113,2,Oesophageal squamous cell carcinoma,3,F,EXP,ipilimumab,2,PS,Hypercalcaemia,2,M,HO,28
170294082,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,PS,Autoimmune colitis,1,M,OT,48
170294082,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,PS,Autoimmune colitis,1,M,HO,48
170294082,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,PS,Autoimmune colitis,1,M,DE,48
170294082,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,48
170294082,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,48
170294082,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,48
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Abdominal pain,2,M,OT,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Abdominal pain,2,M,HO,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Abdominal pain,2,M,LT,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Abdominal pain,2,M,DE,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Intestinal metastasis,2,M,OT,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Intestinal metastasis,2,M,HO,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Intestinal metastasis,2,M,LT,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Intestinal metastasis,2,M,DE,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Intestinal perforation,2,M,OT,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Intestinal perforation,2,M,HO,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Intestinal perforation,2,M,LT,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Intestinal perforation,2,M,DE,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Respiratory disorder,2,M,OT,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Respiratory disorder,2,M,HO,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Respiratory disorder,2,M,LT,1
170303462,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Respiratory disorder,2,M,DE,1
170306462,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Abdominal pain upper,1,M,HO,441
170306462,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Nausea,1,M,HO,441
170306462,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Vomiting,1,M,HO,441
170306462,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,C,Abdominal pain upper,3,M,HO,441
170306462,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,C,Nausea,3,M,HO,441
170306462,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,C,Vomiting,3,M,HO,441
170306462,13,Prophylaxis,2,F,EXP,zoledronic acid,13,C,Abdominal pain upper,13,M,HO,1129
170306462,13,Prophylaxis,2,F,EXP,zoledronic acid,13,C,Nausea,13,M,HO,1129
170306462,13,Prophylaxis,2,F,EXP,zoledronic acid,13,C,Vomiting,13,M,HO,1129
170308262,2,Adjuvant therapy,2,F,EXP,trametinib,2,SS,Alopecia,2,F,OT,111
170308262,2,Adjuvant therapy,2,F,EXP,trametinib,2,SS,Cardiac discomfort,2,F,OT,111
170308262,2,Adjuvant therapy,2,F,EXP,trametinib,2,SS,Ejection fraction decreased,2,F,OT,111
170308417,1,Plasma cell myeloma,7,F,EXP,daratumumab,1,PS,Cellulitis,1,F,HO,155
170308417,1,Plasma cell myeloma,7,F,EXP,daratumumab,1,PS,Pseudomonal sepsis,1,F,HO,155
170310083,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Abdominal pain,1,M,HO,69
170310083,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Abdominal pain,1,M,DE,69
170310083,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Asthenia,1,M,HO,69
170310083,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Asthenia,1,M,DE,69
170310083,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Dyspnoea,1,M,HO,69
170310083,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Dyspnoea,1,M,DE,69
170310083,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Nausea,1,M,HO,69
170310083,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Nausea,1,M,DE,69
170310083,2,Colorectal cancer metastatic,3,F,PER,folfox,2,SS,Abdominal pain,2,M,HO,69
170310083,2,Colorectal cancer metastatic,3,F,PER,folfox,2,SS,Abdominal pain,2,M,DE,69
170310083,2,Colorectal cancer metastatic,3,F,PER,folfox,2,SS,Asthenia,2,M,HO,69
170310083,2,Colorectal cancer metastatic,3,F,PER,folfox,2,SS,Asthenia,2,M,DE,69
170310083,2,Colorectal cancer metastatic,3,F,PER,folfox,2,SS,Dyspnoea,2,M,HO,69
170310083,2,Colorectal cancer metastatic,3,F,PER,folfox,2,SS,Dyspnoea,2,M,DE,69
170310083,2,Colorectal cancer metastatic,3,F,PER,folfox,2,SS,Nausea,2,M,HO,69
170310083,2,Colorectal cancer metastatic,3,F,PER,folfox,2,SS,Nausea,2,M,DE,69
170322246,1,Sarcoma metastatic,6,F,EXP,trabectedin,1,PS,Septic shock,1,M,HO,95
170325615,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Engraftment syndrome,1,M,OT,140
170325615,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Engraftment syndrome,1,M,LT,140
170325615,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Engraftment syndrome,1,M,DE,140
170325615,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Engraftment syndrome,1,M,HO,140
170325615,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Pulmonary mycosis,1,M,OT,140
170325615,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Pulmonary mycosis,1,M,LT,140
170325615,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Pulmonary mycosis,1,M,DE,140
170325615,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Pulmonary mycosis,1,M,HO,140
170325615,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Venoocclusive liver disease,1,M,OT,140
170325615,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Venoocclusive liver disease,1,M,LT,140
170325615,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Venoocclusive liver disease,1,M,DE,140
170325615,1,Acute lymphocytic leukaemia,5,F,EXP,inotuzumab ozogamicin,1,PS,Venoocclusive liver disease,1,M,HO,140
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Bacterial sepsis,8,F,LT,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Bacterial sepsis,8,F,HO,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Bacterial sepsis,8,F,DS,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Bacterial sepsis,8,F,DE,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Cytokine release syndrome,8,F,LT,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Cytokine release syndrome,8,F,HO,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Cytokine release syndrome,8,F,DS,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Cytokine release syndrome,8,F,DE,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Gastrointestinal haemorrhage,8,F,LT,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Gastrointestinal haemorrhage,8,F,HO,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Gastrointestinal haemorrhage,8,F,DS,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Gastrointestinal haemorrhage,8,F,DE,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Myelitis transverse,8,F,LT,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Myelitis transverse,8,F,HO,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Myelitis transverse,8,F,DS,20
170330434,8,Pyrexia,4,F,EXP,filgrastim,8,C,Myelitis transverse,8,F,DE,20
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Bacterial sepsis,9,F,LT,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Bacterial sepsis,9,F,HO,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Bacterial sepsis,9,F,DS,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Bacterial sepsis,9,F,DE,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Cytokine release syndrome,9,F,LT,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Cytokine release syndrome,9,F,HO,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Cytokine release syndrome,9,F,DS,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Cytokine release syndrome,9,F,DE,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Gastrointestinal haemorrhage,9,F,LT,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Gastrointestinal haemorrhage,9,F,HO,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Gastrointestinal haemorrhage,9,F,DS,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Gastrointestinal haemorrhage,9,F,DE,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Myelitis transverse,9,F,LT,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Myelitis transverse,9,F,HO,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Myelitis transverse,9,F,DS,19
170330434,9,Neutrophil count decreased,4,F,EXP,filgrastim,9,C,Myelitis transverse,9,F,DE,19
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Bacterial sepsis,70,F,LT,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Bacterial sepsis,70,F,HO,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Bacterial sepsis,70,F,DS,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Bacterial sepsis,70,F,DE,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Cytokine release syndrome,70,F,LT,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Cytokine release syndrome,70,F,HO,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Cytokine release syndrome,70,F,DS,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Cytokine release syndrome,70,F,DE,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Gastrointestinal haemorrhage,70,F,LT,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Gastrointestinal haemorrhage,70,F,HO,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Gastrointestinal haemorrhage,70,F,DS,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Gastrointestinal haemorrhage,70,F,DE,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Myelitis transverse,70,F,LT,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Myelitis transverse,70,F,HO,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Myelitis transverse,70,F,DS,2
170330434,70,Premedication,4,F,EXP,rasburicase,70,C,Myelitis transverse,70,F,DE,2
170339184,1,Plasma cell myeloma,4,F,EXP,selinexor,1,PS,Pneumonia pneumococcal,1,M,HO,339
170339563,3,Mantle cell lymphoma,3,F,EXP,ibrutinib,3,SS,Cellulitis,3,M,HO,649
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,HO,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,OT,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Blood urine present,1,M,HO,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Blood urine present,1,M,OT,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Chest discomfort,1,M,HO,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Chest discomfort,1,M,OT,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Lower respiratory tract infection,1,M,HO,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Lower respiratory tract infection,1,M,OT,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Respiratory tract congestion,1,M,HO,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Respiratory tract congestion,1,M,OT,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,HO,44
170343895,1,Renal cancer,5,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,OT,44
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Abdominal distension,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Abdominal distension,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Abdominal distension,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Abdominal distension,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Acute respiratory failure,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Acute respiratory failure,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Acute respiratory failure,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Acute respiratory failure,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Agitation,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Agitation,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Agitation,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Agitation,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Atelectasis,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Atelectasis,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Atelectasis,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Atelectasis,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Blood fibrinogen decreased,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Blood fibrinogen decreased,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Blood fibrinogen decreased,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Blood fibrinogen decreased,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Bradycardia,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Bradycardia,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Bradycardia,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Bradycardia,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Brain oedema,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Brain oedema,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Brain oedema,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Brain oedema,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,C-reactive protein decreased,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,C-reactive protein decreased,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,C-reactive protein decreased,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,C-reactive protein decreased,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Cardiac arrest,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Cardiac arrest,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Cardiac arrest,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Cardiac arrest,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Chills,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Chills,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Chills,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Chills,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Coagulopathy,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Coagulopathy,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Coagulopathy,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Coagulopathy,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Confusional state,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Confusional state,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Confusional state,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Confusional state,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Conjunctival pigmentation,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Conjunctival pigmentation,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Conjunctival pigmentation,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Conjunctival pigmentation,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Cytokine release syndrome,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Cytokine release syndrome,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Cytokine release syndrome,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Cytokine release syndrome,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Disorientation,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Disorientation,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Disorientation,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Disorientation,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Disseminated intravascular coagulation,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Disseminated intravascular coagulation,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Disseminated intravascular coagulation,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Disseminated intravascular coagulation,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Dysphagia,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Dysphagia,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Dysphagia,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Dysphagia,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Dysstasia,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Dysstasia,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Dysstasia,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Dysstasia,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Encephalopathy,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Encephalopathy,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Encephalopathy,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Encephalopathy,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Epistaxis,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Epistaxis,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Epistaxis,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Epistaxis,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Eye disorder,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Eye disorder,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Eye disorder,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Eye disorder,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Fungaemia,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Fungaemia,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Fungaemia,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Fungaemia,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Haemophagocytic lymphohistiocytosis,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Haemophagocytic lymphohistiocytosis,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Haemophagocytic lymphohistiocytosis,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Haemophagocytic lymphohistiocytosis,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hepatic steatosis,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hepatic steatosis,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hepatic steatosis,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hepatic steatosis,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hepatotoxicity,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hepatotoxicity,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hepatotoxicity,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hepatotoxicity,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hyperbilirubinaemia,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hyperbilirubinaemia,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hyperbilirubinaemia,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hyperbilirubinaemia,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hyperfibrinolysis,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hyperfibrinolysis,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hyperfibrinolysis,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hyperfibrinolysis,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hyperuricaemia,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hyperuricaemia,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hyperuricaemia,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hyperuricaemia,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hypotension,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hypotension,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hypotension,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hypotension,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hypoxia,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hypoxia,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hypoxia,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Hypoxia,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Infection,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Infection,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Infection,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Infection,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Lactic acidosis,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Lactic acidosis,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Lactic acidosis,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Lactic acidosis,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Laryngeal oedema,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Laryngeal oedema,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Laryngeal oedema,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Laryngeal oedema,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Mycoplasma test positive,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Mycoplasma test positive,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Mycoplasma test positive,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Mycoplasma test positive,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Neuropathy peripheral,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Neuropathy peripheral,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Neuropathy peripheral,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Neuropathy peripheral,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Neurotoxicity,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Neurotoxicity,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Neurotoxicity,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Neurotoxicity,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pancytopenia,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pancytopenia,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pancytopenia,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pancytopenia,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pericardial effusion,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pericardial effusion,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pericardial effusion,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pericardial effusion,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pleural effusion,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pleural effusion,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pleural effusion,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pleural effusion,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pulmonary mass,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pulmonary mass,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pulmonary mass,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pulmonary mass,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pulmonary oedema,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pulmonary oedema,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pulmonary oedema,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pulmonary oedema,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pyrexia,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pyrexia,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pyrexia,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Pyrexia,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Renal failure,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Renal failure,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Renal failure,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Renal failure,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Restlessness,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Restlessness,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Restlessness,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Restlessness,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Sepsis,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Sepsis,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Sepsis,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Sepsis,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Serum ferritin increased,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Serum ferritin increased,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Serum ferritin increased,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Serum ferritin increased,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Somnolence,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Somnolence,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Somnolence,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Somnolence,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Tachycardia,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Tachycardia,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Tachycardia,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Tachycardia,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Tachypnoea,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Tachypnoea,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Tachypnoea,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Tachypnoea,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Toxicity to various agents,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Toxicity to various agents,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Toxicity to various agents,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Toxicity to various agents,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Tremor,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Tremor,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Tremor,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Tremor,4,M,DE,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Vomiting,4,M,HO,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Vomiting,4,M,OT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Vomiting,4,M,LT,2
170368243,4,Product used for unknown indication,3,F,EXP,rasburicase,4,C,Vomiting,4,M,DE,2
170376723,4,Endometrial cancer,3,F,EXP,lenvatinib mesylate,4,SS,Anaemia,4,F,HO,9
170376723,4,Endometrial cancer,3,F,EXP,lenvatinib mesylate,4,SS,Anaemia,4,F,OT,9
170376723,4,Endometrial cancer,3,F,EXP,lenvatinib mesylate,4,SS,Gastrointestinal haemorrhage,4,F,HO,9
170376723,4,Endometrial cancer,3,F,EXP,lenvatinib mesylate,4,SS,Gastrointestinal haemorrhage,4,F,OT,9
170376723,4,Endometrial cancer,3,F,EXP,lenvatinib mesylate,4,SS,Rectal haemorrhage,4,F,HO,9
170376723,4,Endometrial cancer,3,F,EXP,lenvatinib mesylate,4,SS,Rectal haemorrhage,4,F,OT,9
170389113,2,Plasma cell myeloma,3,F,EXP,daratumumab,2,SS,Febrile neutropenia,2,M,HO,34
170389113,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Febrile neutropenia,3,M,HO,34
170393396,1,Transitional cell cancer of renal pelvis and ureter metastatic,6,F,EXP,nivolumab,1,PS,Autoimmune pancreatitis,1,M,LT,65
170393396,1,Transitional cell cancer of renal pelvis and ureter metastatic,6,F,EXP,nivolumab,1,PS,Autoimmune pancreatitis,1,M,OT,65
170393396,2,Transitional cell cancer of renal pelvis and ureter metastatic,6,F,EXP,ipilimumab,2,SS,Autoimmune pancreatitis,2,M,LT,65
170393396,2,Transitional cell cancer of renal pelvis and ureter metastatic,6,F,EXP,ipilimumab,2,SS,Autoimmune pancreatitis,2,M,OT,65
170415866,1,Product used for unknown indication,6,F,EXP,nivolumab,1,PS,Campylobacter colitis,1,F,HO,24
170417233,5,Breast cancer metastatic,3,F,EXP,palbociclib,5,SS,Sepsis,5,F,OT,1045
170417233,5,Breast cancer metastatic,3,F,EXP,palbociclib,5,SS,Sepsis,5,F,HO,1045
170417233,5,Breast cancer metastatic,3,F,EXP,palbociclib,5,SS,Urinary tract infection,5,F,OT,1045
170417233,5,Breast cancer metastatic,3,F,EXP,palbociclib,5,SS,Urinary tract infection,5,F,HO,1045
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Back pain,1,F,DE,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Back pain,1,F,HO,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Back pain,1,F,OT,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,DE,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hepatitis,1,F,DE,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hepatitis,1,F,HO,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hepatitis,1,F,OT,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Ileus,1,F,DE,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Ileus,1,F,HO,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Ileus,1,F,OT,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Metastases to spine,1,F,DE,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Metastases to spine,1,F,HO,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Metastases to spine,1,F,OT,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,DE,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,HO,21
170419022,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,OT,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Back pain,2,F,DE,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Back pain,2,F,HO,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Back pain,2,F,OT,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,F,DE,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,F,HO,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,F,OT,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Hepatitis,2,F,DE,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Hepatitis,2,F,HO,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Hepatitis,2,F,OT,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Ileus,2,F,DE,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Ileus,2,F,HO,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Ileus,2,F,OT,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Metastases to spine,2,F,DE,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Metastases to spine,2,F,HO,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Metastases to spine,2,F,OT,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Pain in extremity,2,F,DE,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Pain in extremity,2,F,HO,21
170419022,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Pain in extremity,2,F,OT,21
170419392,23,Prophylaxis,2,F,EXP,rasburicase,23,C,Neurotoxicity,23,M,OT,11
170444752,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Basal cell carcinoma,3,F,OT,2071
170454535,1,Non-Hodgkin's lymphoma refractory,5,F,EXP,axicabtagene ciloleucel,1,PS,Febrile bone marrow aplasia,1,F,HO,124
170459192,1,Febrile neutropenia,2,F,PER,pegfilgrastim,1,PS,Drug ineffective,1,M,HO,7
170459192,1,Febrile neutropenia,2,F,PER,pegfilgrastim,1,PS,Drug ineffective,1,M,LT,7
170459192,1,Febrile neutropenia,2,F,PER,pegfilgrastim,1,PS,Drug ineffective,1,M,OT,7
170459192,1,Febrile neutropenia,2,F,PER,pegfilgrastim,1,PS,Neutropenia,1,M,HO,7
170459192,1,Febrile neutropenia,2,F,PER,pegfilgrastim,1,PS,Neutropenia,1,M,LT,7
170459192,1,Febrile neutropenia,2,F,PER,pegfilgrastim,1,PS,Neutropenia,1,M,OT,7
170459192,1,Febrile neutropenia,2,F,PER,pegfilgrastim,1,PS,Pancytopenia,1,M,HO,7
170459192,1,Febrile neutropenia,2,F,PER,pegfilgrastim,1,PS,Pancytopenia,1,M,LT,7
170459192,1,Febrile neutropenia,2,F,PER,pegfilgrastim,1,PS,Pancytopenia,1,M,OT,7
170459192,1,Febrile neutropenia,2,F,PER,pegfilgrastim,1,PS,Thrombocytopenia,1,M,HO,7
170459192,1,Febrile neutropenia,2,F,PER,pegfilgrastim,1,PS,Thrombocytopenia,1,M,LT,7
170459192,1,Febrile neutropenia,2,F,PER,pegfilgrastim,1,PS,Thrombocytopenia,1,M,OT,7
170465762,1,Adenocarcinoma of colon,2,F,PER,panitumumab,1,PS,Sepsis,1,M,OT,872
170465762,1,Adenocarcinoma of colon,2,F,PER,panitumumab,1,PS,Sepsis,1,M,HO,872
170465762,8,Prophylaxis,2,F,PER,pegfilgrastim,8,C,Sepsis,8,M,OT,142
170465762,8,Prophylaxis,2,F,PER,pegfilgrastim,8,C,Sepsis,8,M,HO,142
170471653,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Abdominal pain,1,M,OT,462
170471653,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Abdominal pain,1,M,HO,462
170471653,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Anti-thyroid antibody positive,1,M,OT,462
170471653,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Anti-thyroid antibody positive,1,M,HO,462
170471653,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Back pain,1,M,OT,462
170471653,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Back pain,1,M,HO,462
170471653,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Herpes zoster,1,M,OT,462
170471653,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Herpes zoster,1,M,HO,462
170471653,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Hyperthyroidism,1,M,OT,462
170471653,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Hyperthyroidism,1,M,HO,462
170471653,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Rash erythematous,1,M,OT,462
170471653,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Rash erythematous,1,M,HO,462
170471653,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Tri-iodothyronine increased,1,M,OT,462
170471653,1,Relapsing-remitting multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Tri-iodothyronine increased,1,M,HO,462
170495662,5,Renal cell carcinoma,2,F,EXP,ipilimumab,5,PS,Atrial fibrillation,5,M,HO,23
170495662,5,Renal cell carcinoma,2,F,EXP,ipilimumab,5,PS,Atrial fibrillation,5,M,OT,23
170495662,5,Renal cell carcinoma,2,F,EXP,ipilimumab,5,PS,Hyperthyroidism,5,M,HO,23
170495662,5,Renal cell carcinoma,2,F,EXP,ipilimumab,5,PS,Hyperthyroidism,5,M,OT,23
170495662,7,Renal cell carcinoma,2,F,EXP,nivolumab,7,SS,Atrial fibrillation,7,M,HO,23
170495662,7,Renal cell carcinoma,2,F,EXP,nivolumab,7,SS,Atrial fibrillation,7,M,OT,23
170495662,7,Renal cell carcinoma,2,F,EXP,nivolumab,7,SS,Hyperthyroidism,7,M,HO,23
170495662,7,Renal cell carcinoma,2,F,EXP,nivolumab,7,SS,Hyperthyroidism,7,M,OT,23
170496932,3,Product used for unknown indication,2,F,EXP,folfiri,3,C,Asthenia,3,M,HO,257
170496932,3,Product used for unknown indication,2,F,EXP,folfiri,3,C,Diarrhoea,3,M,HO,257
170496932,3,Product used for unknown indication,2,F,EXP,folfiri,3,C,Vomiting,3,M,HO,257
170503542,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Diverticulitis,3,M,OT,354
170503542,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Diverticulitis,3,M,HO,354
170504228,1,Renal cell carcinoma,8,F,EXP,nivolumab,1,PS,Pneumonia necrotising,1,M,OT,356
170504228,1,Renal cell carcinoma,8,F,EXP,nivolumab,1,PS,Pneumonia necrotising,1,M,LT,356
170504228,1,Renal cell carcinoma,8,F,EXP,nivolumab,1,PS,Pneumonia necrotising,1,M,HO,356
170504228,1,Renal cell carcinoma,8,F,EXP,nivolumab,1,PS,Pneumonia necrotising,1,M,DS,356
170513473,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Basedow's disease,1,F,OT,1041
170513473,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Fatigue,1,F,OT,1041
170513473,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Gastroenteritis,1,F,OT,1041
170513473,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,F,OT,1041
170513473,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Leukopenia,1,F,OT,1041
170513473,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Neutropenia,1,F,OT,1041
170513473,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Thrombocytopenia,1,F,OT,1041
170525435,13,Product used for unknown indication,5,F,EXP,filgrastim,13,C,Proctalgia,13,M,HO,139
170526822,7,Osteoporosis,2,F,EXP,denosumab,7,C,Death,7,F,DE,573
170555282,6,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,6,SS,Neutrophil count decreased,6,F,OT,117
170555282,6,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,6,SS,White blood cell count decreased,6,F,OT,117
170555654,3,Gallbladder cancer,4,F,PER,nivolumab,3,SS,Biliary tract infection,3,F,HO,14
170555654,3,Gallbladder cancer,4,F,PER,nivolumab,3,SS,Diarrhoea,3,F,HO,14
170555654,3,Gallbladder cancer,4,F,PER,nivolumab,3,SS,Encephalopathy,3,F,HO,14
170555654,3,Gallbladder cancer,4,F,PER,nivolumab,3,SS,Liver abscess,3,F,HO,14
170558135,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Autoimmune haemolytic anaemia,1,M,OT,5
170558135,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Autoimmune haemolytic anaemia,1,M,HO,5
170558135,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Hepatic function abnormal,1,M,OT,5
170558135,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Hepatic function abnormal,1,M,HO,5
170558135,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Intentional product use issue,1,M,OT,5
170558135,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Intentional product use issue,1,M,HO,5
170558135,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Tumour lysis syndrome,1,M,OT,5
170558135,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Tumour lysis syndrome,1,M,HO,5
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Abdominal pain upper,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Arthralgia,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Diarrhoea,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Discomfort,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Fall,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Hallucination,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Inappropriate schedule of product administration,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Insomnia,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Mental disorder,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Nausea,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Pain,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Product dose omission,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Prostatic specific antigen increased,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Somnolence,1,M,OT,21
170563433,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Spinal pain,1,M,OT,21
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Gastrointestinal disorder,1,M,OT,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Gastrointestinal disorder,1,M,HO,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Lower respiratory tract infection,1,M,OT,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Lower respiratory tract infection,1,M,HO,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pain,1,M,OT,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pain,1,M,HO,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,OT,25
170566085,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,HO,25
170570082,1,T-cell lymphoma,2,F,PER,carfilzomib,1,PS,Pneumonia,1,F,HO,69
170570082,1,T-cell lymphoma,2,F,PER,carfilzomib,1,PS,Pneumonia,1,F,LT,69
170570082,1,T-cell lymphoma,2,F,PER,carfilzomib,1,PS,Pneumonia,1,F,DE,69
170570082,1,T-cell lymphoma,2,F,PER,carfilzomib,1,PS,Pneumonia,1,F,OT,69
170570792,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Balance disorder,1,M,HO,41
170570792,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Endocrine disorder,1,M,HO,41
170570792,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,HO,41
170570792,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Balance disorder,2,M,HO,41
170570792,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Endocrine disorder,2,M,HO,41
170570792,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,M,HO,41
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Asthenia,1,M,HO,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Balance disorder,1,M,HO,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Balance disorder,1,M,OT,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Dizziness,1,M,HO,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Fall,1,M,HO,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Fall,1,M,OT,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Gait inability,1,M,HO,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Gait inability,1,M,OT,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Hypoaesthesia,1,M,HO,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Hypoaesthesia,1,M,OT,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Memory impairment,1,M,HO,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Memory impairment,1,M,OT,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Transient ischaemic attack,1,M,HO,97
170579653,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Transient ischaemic attack,1,M,OT,97
170580364,2,Hormone-refractory prostate cancer,4,F,PER,enzalutamide,2,SS,Atrial fibrillation,2,M,HO,421
170580364,2,Hormone-refractory prostate cancer,4,F,PER,enzalutamide,2,SS,Atrial fibrillation,2,M,DE,421
170580364,2,Hormone-refractory prostate cancer,4,F,PER,enzalutamide,2,SS,Nausea,2,M,HO,421
170580364,2,Hormone-refractory prostate cancer,4,F,PER,enzalutamide,2,SS,Nausea,2,M,DE,421
170580364,2,Hormone-refractory prostate cancer,4,F,PER,enzalutamide,2,SS,Prostate cancer,2,M,HO,421
170580364,2,Hormone-refractory prostate cancer,4,F,PER,enzalutamide,2,SS,Prostate cancer,2,M,DE,421
170580364,2,Hormone-refractory prostate cancer,4,F,PER,enzalutamide,2,SS,Vomiting,2,M,HO,421
170580364,2,Hormone-refractory prostate cancer,4,F,PER,enzalutamide,2,SS,Vomiting,2,M,DE,421
170607933,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,DE,36
170607933,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,OT,36
170607933,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,36
170607933,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,36
170607933,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,DE,36
170607933,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,36
170607933,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Cardiac arrest,2,M,DE,36
170607933,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Cardiac arrest,2,M,OT,36
170607933,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DE,36
170607933,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,36
170607933,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Pulmonary embolism,2,M,DE,36
170607933,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Pulmonary embolism,2,M,OT,36
170608874,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,LT,6
170608874,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,6
170608874,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Enterocolitis,1,M,LT,6
170608874,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Enterocolitis,1,M,OT,6
170608874,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,LT,6
170608874,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,OT,6
170608874,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Rash,1,M,LT,6
170608874,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Rash,1,M,OT,6
170608874,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Rash macular,1,M,LT,6
170608874,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Rash macular,1,M,OT,6
170608874,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Tubulointerstitial nephritis,1,M,LT,6
170608874,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Tubulointerstitial nephritis,1,M,OT,6
170608874,3,Malignant melanoma,4,F,EXP,ipilimumab,3,SS,Diarrhoea,3,M,LT,6
170608874,3,Malignant melanoma,4,F,EXP,ipilimumab,3,SS,Diarrhoea,3,M,OT,6
170608874,3,Malignant melanoma,4,F,EXP,ipilimumab,3,SS,Enterocolitis,3,M,LT,6
170608874,3,Malignant melanoma,4,F,EXP,ipilimumab,3,SS,Enterocolitis,3,M,OT,6
170608874,3,Malignant melanoma,4,F,EXP,ipilimumab,3,SS,Prescribed overdose,3,M,LT,6
170608874,3,Malignant melanoma,4,F,EXP,ipilimumab,3,SS,Prescribed overdose,3,M,OT,6
170608874,3,Malignant melanoma,4,F,EXP,ipilimumab,3,SS,Rash,3,M,LT,6
170608874,3,Malignant melanoma,4,F,EXP,ipilimumab,3,SS,Rash,3,M,OT,6
170608874,3,Malignant melanoma,4,F,EXP,ipilimumab,3,SS,Rash macular,3,M,LT,6
170608874,3,Malignant melanoma,4,F,EXP,ipilimumab,3,SS,Rash macular,3,M,OT,6
170608874,3,Malignant melanoma,4,F,EXP,ipilimumab,3,SS,Tubulointerstitial nephritis,3,M,LT,6
170608874,3,Malignant melanoma,4,F,EXP,ipilimumab,3,SS,Tubulointerstitial nephritis,3,M,OT,6
170618244,1,Diffuse large B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,1
170618244,1,Diffuse large B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Diffuse large B-cell lymphoma,1,M,OT,1
170618244,1,Diffuse large B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Ear infection,1,M,OT,1
170623165,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,OT,40
170623165,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,HO,40
170623165,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,LT,40
170623165,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Polymyositis,1,M,OT,40
170623165,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Polymyositis,1,M,HO,40
170623165,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Polymyositis,1,M,LT,40
170623165,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,OT,40
170623165,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,HO,40
170623165,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,LT,40
170623165,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Polymyositis,2,M,OT,40
170623165,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Polymyositis,2,M,HO,40
170623165,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Polymyositis,2,M,LT,40
170627542,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Enteritis,1,F,HO,29
170627542,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Enteritis,2,F,HO,29
170632332,1,Metastases to bone,2,F,EXP,zoledronic acid,1,PS,Electrocardiogram QT prolonged,1,F,HO,7
170632332,1,Metastases to bone,2,F,EXP,zoledronic acid,1,PS,Hypocalcaemia,1,F,HO,7
170632332,1,Metastases to bone,2,F,EXP,zoledronic acid,1,PS,Product communication issue,1,F,HO,7
170632332,1,Metastases to bone,2,F,EXP,zoledronic acid,1,PS,Product dose omission,1,F,HO,7
170633843,2,Malignant melanoma,3,F,EXP,trametinib,2,SS,Retinal vein occlusion,2,M,OT,211
170633843,2,Malignant melanoma,3,F,EXP,trametinib,2,SS,Retinal vein occlusion,2,M,DS,211
170641042,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Meningitis aseptic,1,F,OT,8
170641042,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Meningitis aseptic,1,F,HO,8
170641042,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Sjogren's syndrome,1,F,OT,8
170641042,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Sjogren's syndrome,1,F,HO,8
170641042,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Meningitis aseptic,2,F,OT,8
170641042,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Meningitis aseptic,2,F,HO,8
170641042,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Sjogren's syndrome,2,F,OT,8
170641042,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Sjogren's syndrome,2,F,HO,8
170645666,1,Relapsing multiple sclerosis,6,F,EXP,ofatumumab,1,PS,Myocardial infarction,1,M,HO,105
170654934,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Atelectasis,1,M,HO,19
170654934,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Atelectasis,1,M,OT,19
170654934,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,19
170654934,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,19
170654934,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Faecaloma,1,M,HO,19
170654934,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Faecaloma,1,M,OT,19
170654934,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Haematemesis,1,M,HO,19
170654934,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Haematemesis,1,M,OT,19
170654934,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Impaired gastric emptying,1,M,HO,19
170654934,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Impaired gastric emptying,1,M,OT,19
170654934,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,19
170654934,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,19
170654934,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Weight decreased,1,M,HO,19
170654934,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,19
170657973,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Leukocytosis,1,M,OT,11
170657973,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,11
170657973,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Neutropenia,1,M,OT,11
170657973,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,OT,11
170659093,1,Neoplasm,3,F,EXP,trabectedin,1,PS,Haematotoxicity,1,M,LT,45
170667973,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Anaphylactic shock,1,F,OT,21
170667973,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Anaphylactic shock,2,F,OT,21
170675122,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,F,OT,9
170675422,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Varicella zoster virus infection,1,M,HO,117
170675422,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Varicella zoster virus infection,2,M,HO,117
170680258,3,Plasma cell myeloma,8,F,EXP,selinexor,3,SS,Atrial fibrillation,3,F,DE,86
170680258,3,Plasma cell myeloma,8,F,EXP,selinexor,3,SS,Atrial fibrillation,3,F,HO,86
170680258,3,Plasma cell myeloma,8,F,EXP,selinexor,3,SS,Pericardial effusion,3,F,DE,86
170680258,3,Plasma cell myeloma,8,F,EXP,selinexor,3,SS,Pericardial effusion,3,F,HO,86
170680258,3,Plasma cell myeloma,8,F,EXP,selinexor,3,SS,Sepsis,3,F,DE,86
170680258,3,Plasma cell myeloma,8,F,EXP,selinexor,3,SS,Sepsis,3,F,HO,86
170680495,2,Metastatic malignant melanoma,5,F,EXP,ipilimumab,2,PS,Hypophysitis,2,F,HO,6
170680495,2,Metastatic malignant melanoma,5,F,EXP,ipilimumab,2,PS,Hypophysitis,2,F,OT,6
170690893,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Colitis,1,M,OT,12
170690893,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Colitis,1,M,HO,12
170690893,4,Malignant melanoma,3,F,EXP,ipilimumab,4,PS,Colitis,4,M,OT,12
170690893,4,Malignant melanoma,3,F,EXP,ipilimumab,4,PS,Colitis,4,M,HO,12
170692786,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,13
170692786,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,13
170692786,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Cholestasis,1,M,HO,13
170692786,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Cholestasis,1,M,OT,13
170692786,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,13
170692786,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,13
170692786,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,13
170692786,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,13
170692786,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,HO,13
170692786,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,OT,13
170692786,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,13
170692786,1,Renal cell carcinoma,6,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,13
170694803,2,Mantle cell lymphoma,3,F,EXP,lenalidomide,2,SS,Sarcoidosis,2,F,OT,1301
170717664,1,Breast cancer,4,F,EXP,palbociclib,1,PS,Febrile neutropenia,1,F,HO,27
170717664,1,Breast cancer,4,F,EXP,palbociclib,1,PS,General physical health deterioration,1,F,HO,27
170718873,8,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,8,SS,Febrile neutropenia,8,F,HO,19
170721042,7,Colorectal cancer,2,F,EXP,trametinib,7,SS,Acute kidney injury,7,F,HO,138
170721042,11,Colorectal cancer,2,F,EXP,panitumumab,11,SS,Acute kidney injury,11,F,HO,138
170726494,1,Lung adenocarcinoma,4,F,EXP,nivolumab,1,PS,Constipation,1,F,OT,483
170726494,1,Lung adenocarcinoma,4,F,EXP,nivolumab,1,PS,Constipation,1,F,LT,483
170726494,1,Lung adenocarcinoma,4,F,EXP,nivolumab,1,PS,Constipation,1,F,HO,483
170726494,1,Lung adenocarcinoma,4,F,EXP,nivolumab,1,PS,Constipation,1,F,DE,483
170726494,1,Lung adenocarcinoma,4,F,EXP,nivolumab,1,PS,Sepsis,1,F,OT,483
170726494,1,Lung adenocarcinoma,4,F,EXP,nivolumab,1,PS,Sepsis,1,F,LT,483
170726494,1,Lung adenocarcinoma,4,F,EXP,nivolumab,1,PS,Sepsis,1,F,HO,483
170726494,1,Lung adenocarcinoma,4,F,EXP,nivolumab,1,PS,Sepsis,1,F,DE,483
170727682,3,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,3,SS,Vision blurred,3,F,OT,52
170728482,4,Plasma cell myeloma,2,F,EXP,carfilzomib,4,C,Rash,4,M,OT,4
170730667,3,Renal cell carcinoma,7,F,EXP,nivolumab,3,SS,Pneumonia necrotising,3,M,OT,356
170730667,3,Renal cell carcinoma,7,F,EXP,nivolumab,3,SS,Pneumonia necrotising,3,M,DS,356
170730667,3,Renal cell carcinoma,7,F,EXP,nivolumab,3,SS,Pneumonia necrotising,3,M,HO,356
170730667,3,Renal cell carcinoma,7,F,EXP,nivolumab,3,SS,Pneumonia necrotising,3,M,LT,356
170732643,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Alanine aminotransferase increased,1,M,OT,20
170732643,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Alanine aminotransferase increased,1,M,HO,20
170732643,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Aspartate aminotransferase increased,1,M,OT,20
170732643,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Aspartate aminotransferase increased,1,M,HO,20
170732643,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Pyrexia,1,M,OT,20
170732643,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Pyrexia,1,M,HO,20
170732643,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Rash maculo-papular,1,M,OT,20
170732643,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Rash maculo-papular,1,M,HO,20
170732643,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Renal impairment,1,M,OT,20
170732643,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Renal impairment,1,M,HO,20
170732643,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Tubulointerstitial nephritis,1,M,OT,20
170732643,1,Malignant melanoma,3,F,EXP,ipilimumab,1,SS,Tubulointerstitial nephritis,1,M,HO,20
170732643,2,Malignant melanoma,3,F,EXP,nivolumab,2,PS,Alanine aminotransferase increased,2,M,OT,20
170732643,2,Malignant melanoma,3,F,EXP,nivolumab,2,PS,Alanine aminotransferase increased,2,M,HO,20
170732643,2,Malignant melanoma,3,F,EXP,nivolumab,2,PS,Aspartate aminotransferase increased,2,M,OT,20
170732643,2,Malignant melanoma,3,F,EXP,nivolumab,2,PS,Aspartate aminotransferase increased,2,M,HO,20
170732643,2,Malignant melanoma,3,F,EXP,nivolumab,2,PS,Pyrexia,2,M,OT,20
170732643,2,Malignant melanoma,3,F,EXP,nivolumab,2,PS,Pyrexia,2,M,HO,20
170732643,2,Malignant melanoma,3,F,EXP,nivolumab,2,PS,Rash maculo-papular,2,M,OT,20
170732643,2,Malignant melanoma,3,F,EXP,nivolumab,2,PS,Rash maculo-papular,2,M,HO,20
170732643,2,Malignant melanoma,3,F,EXP,nivolumab,2,PS,Renal impairment,2,M,OT,20
170732643,2,Malignant melanoma,3,F,EXP,nivolumab,2,PS,Renal impairment,2,M,HO,20
170732643,2,Malignant melanoma,3,F,EXP,nivolumab,2,PS,Tubulointerstitial nephritis,2,M,OT,20
170732643,2,Malignant melanoma,3,F,EXP,nivolumab,2,PS,Tubulointerstitial nephritis,2,M,HO,20
170733423,2,Marginal zone lymphoma,3,F,EXP,ibrutinib,2,SS,Pericardial effusion,2,F,HO,199
170734505,1,Transitional cell carcinoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,OT,12
170734505,1,Transitional cell carcinoma,5,F,EXP,nivolumab,1,PS,Constipation,1,M,HO,12
170734505,1,Transitional cell carcinoma,5,F,EXP,nivolumab,1,PS,Enterocolitis,1,M,OT,12
170734505,1,Transitional cell carcinoma,5,F,EXP,nivolumab,1,PS,Enterocolitis,1,M,HO,12
170734505,2,Transitional cell carcinoma,5,F,EXP,ipilimumab,2,SS,Constipation,2,M,OT,12
170734505,2,Transitional cell carcinoma,5,F,EXP,ipilimumab,2,SS,Constipation,2,M,HO,12
170734505,2,Transitional cell carcinoma,5,F,EXP,ipilimumab,2,SS,Enterocolitis,2,M,OT,12
170734505,2,Transitional cell carcinoma,5,F,EXP,ipilimumab,2,SS,Enterocolitis,2,M,HO,12
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Anxiety,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Anxiety,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Blood thyroid stimulating hormone increased,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Blood thyroid stimulating hormone increased,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Cellulitis,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Cellulitis,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Cough,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Cough,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Increased appetite,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Increased appetite,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Influenza,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Influenza,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Irregular sleep wake rhythm disorder,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Irregular sleep wake rhythm disorder,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Irritability,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Irritability,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malaise,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Malaise,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Rash,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Rash,1,M,OT,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Wound dehiscence,1,M,HO,6
170740746,1,Malignant melanoma,6,F,EXP,nivolumab,1,PS,Wound dehiscence,1,M,OT,6
170748293,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Central nervous system lesion,1,F,DS,7
170748293,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Central nervous system lesion,1,F,HO,7
170748293,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Central nervous system lesion,1,F,OT,7
170748293,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Central nervous system lesion,2,F,DS,7
170748293,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Central nervous system lesion,2,F,HO,7
170748293,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Central nervous system lesion,2,F,OT,7
1707618311,2,Non-small cell lung cancer,11,F,EXP,lenvatinib mesylate,2,C,Febrile neutropenia,2,M,DE,12
1707618311,2,Non-small cell lung cancer,11,F,EXP,lenvatinib mesylate,2,C,Febrile neutropenia,2,M,HO,12
1707618311,2,Non-small cell lung cancer,11,F,EXP,lenvatinib mesylate,2,C,Multiple organ dysfunction syndrome,2,M,DE,12
1707618311,2,Non-small cell lung cancer,11,F,EXP,lenvatinib mesylate,2,C,Multiple organ dysfunction syndrome,2,M,HO,12
1707618311,2,Non-small cell lung cancer,11,F,EXP,lenvatinib mesylate,2,C,Sepsis,2,M,DE,12
1707618311,2,Non-small cell lung cancer,11,F,EXP,lenvatinib mesylate,2,C,Sepsis,2,M,HO,12
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Anaemia,1,F,HO,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Anaemia,1,F,OT,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Cerebrovascular accident,1,F,HO,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Cerebrovascular accident,1,F,OT,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Change of bowel habit,1,F,HO,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Change of bowel habit,1,F,OT,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Constipation,1,F,HO,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Constipation,1,F,OT,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Diarrhoea,1,F,HO,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Diarrhoea,1,F,OT,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Fall,1,F,HO,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Fall,1,F,OT,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Haemoglobin abnormal,1,F,HO,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Haemoglobin abnormal,1,F,OT,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Hemiparesis,1,F,HO,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Hemiparesis,1,F,OT,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Joint dislocation,1,F,HO,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Joint dislocation,1,F,OT,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Limb injury,1,F,HO,746
170762822,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Limb injury,1,F,OT,746
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Clostridium difficile colitis,2,F,OT,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Clostridium difficile colitis,2,F,HO,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Clostridium difficile colitis,2,F,LT,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,General physical health deterioration,2,F,OT,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,General physical health deterioration,2,F,HO,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,General physical health deterioration,2,F,LT,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Hypoproteinaemia,2,F,OT,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Hypoproteinaemia,2,F,HO,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Hypoproteinaemia,2,F,LT,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Infection,2,F,OT,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Infection,2,F,HO,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Infection,2,F,LT,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Somnolence,2,F,OT,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Somnolence,2,F,HO,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Somnolence,2,F,LT,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Splenic infarction,2,F,OT,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Splenic infarction,2,F,HO,54
170769515,2,Plasma cell myeloma,5,F,EXP,carfilzomib,2,SS,Splenic infarction,2,F,LT,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Clostridium difficile colitis,3,F,OT,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Clostridium difficile colitis,3,F,HO,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Clostridium difficile colitis,3,F,LT,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,General physical health deterioration,3,F,OT,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,General physical health deterioration,3,F,HO,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,General physical health deterioration,3,F,LT,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Hypoproteinaemia,3,F,OT,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Hypoproteinaemia,3,F,HO,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Hypoproteinaemia,3,F,LT,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Infection,3,F,OT,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Infection,3,F,HO,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Infection,3,F,LT,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Somnolence,3,F,OT,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Somnolence,3,F,HO,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Somnolence,3,F,LT,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Splenic infarction,3,F,OT,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Splenic infarction,3,F,HO,54
170769515,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Splenic infarction,3,F,LT,54
170770033,1,Renal cell carcinoma,3,F,EXP,ipilimumab,1,PS,Hepatocellular injury,1,M,OT,20
170770033,1,Renal cell carcinoma,3,F,EXP,ipilimumab,1,PS,Hepatocellular injury,1,M,HO,20
170770033,1,Renal cell carcinoma,3,F,EXP,ipilimumab,1,PS,Renal failure,1,M,OT,20
170770033,1,Renal cell carcinoma,3,F,EXP,ipilimumab,1,PS,Renal failure,1,M,HO,20
170770033,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Hepatocellular injury,2,M,OT,20
170770033,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Hepatocellular injury,2,M,HO,20
170770033,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Renal failure,2,M,OT,20
170770033,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Renal failure,2,M,HO,20
170771208,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,PS,Acute kidney injury,2,M,HO,3
170771208,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,PS,Acute kidney injury,2,M,OT,3
170771208,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,PS,Acute kidney injury,2,M,DE,3
170771208,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,PS,Anaemia,2,M,HO,3
170771208,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,PS,Anaemia,2,M,OT,3
170771208,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,PS,Anaemia,2,M,DE,3
170771208,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,PS,Gastrointestinal haemorrhage,2,M,HO,3
170771208,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,PS,Gastrointestinal haemorrhage,2,M,OT,3
170771208,2,Renal cell carcinoma,8,F,EXP,nivolumab,2,PS,Gastrointestinal haemorrhage,2,M,DE,3
170775792,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Chronic obstructive pulmonary disease,1,M,HO,481
170775792,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Gait disturbance,1,M,HO,481
170775792,4,Plasma cell myeloma,2,F,PER,lenalidomide,4,SS,Chronic obstructive pulmonary disease,4,M,HO,481
170775792,4,Plasma cell myeloma,2,F,PER,lenalidomide,4,SS,Gait disturbance,4,M,HO,481
170778985,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Lower respiratory tract infection,1,M,HO,450
170778985,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Lower respiratory tract infection,1,M,OT,450
170779569,1,Non-Hodgkin's lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Cognitive disorder,1,M,LT,8
170779569,1,Non-Hodgkin's lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Cognitive disorder,1,M,HO,8
170779569,1,Non-Hodgkin's lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,M,LT,8
170779569,1,Non-Hodgkin's lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,M,HO,8
170779569,1,Non-Hodgkin's lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Human herpesvirus 6 encephalitis,1,M,LT,8
170779569,1,Non-Hodgkin's lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Human herpesvirus 6 encephalitis,1,M,HO,8
170779569,1,Non-Hodgkin's lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia,1,M,LT,8
170779569,1,Non-Hodgkin's lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia,1,M,HO,8
170779569,1,Non-Hodgkin's lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Seizure,1,M,LT,8
170779569,1,Non-Hodgkin's lymphoma,9,F,EXP,axicabtagene ciloleucel,1,PS,Seizure,1,M,HO,8
170781703,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Acute kidney injury,1,F,DE,17
170781703,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Acute kidney injury,1,F,HO,17
170781703,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Acute kidney injury,1,F,LT,17
170781703,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Cytomegalovirus colitis,1,F,DE,17
170781703,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Cytomegalovirus colitis,1,F,HO,17
170781703,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Cytomegalovirus colitis,1,F,LT,17
170781703,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Cytomegalovirus infection,1,F,DE,17
170781703,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Cytomegalovirus infection,1,F,HO,17
170781703,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Cytomegalovirus infection,1,F,LT,17
170781703,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Renal failure,1,F,DE,17
170781703,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Renal failure,1,F,HO,17
170781703,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Renal failure,1,F,LT,17
170781714,2,Head and neck cancer,4,F,EXP,nivolumab,2,PS,Pneumonitis,2,M,OT,132
170781714,2,Head and neck cancer,4,F,EXP,nivolumab,2,PS,Pneumonitis,2,M,HO,132
170781714,2,Head and neck cancer,4,F,EXP,nivolumab,2,PS,Pneumonitis,2,M,DE,132
170781714,2,Head and neck cancer,4,F,EXP,nivolumab,2,PS,Pulmonary fibrosis,2,M,OT,132
170781714,2,Head and neck cancer,4,F,EXP,nivolumab,2,PS,Pulmonary fibrosis,2,M,HO,132
170781714,2,Head and neck cancer,4,F,EXP,nivolumab,2,PS,Pulmonary fibrosis,2,M,DE,132
170785324,2,Malignant melanoma,4,F,EXP,nivolumab,2,PS,Haemolysis,2,F,HO,138
170785324,2,Malignant melanoma,4,F,EXP,nivolumab,2,PS,Haemolysis,2,F,OT,138
170785324,2,Malignant melanoma,4,F,EXP,nivolumab,2,PS,Pneumonia viral,2,F,HO,138
170785324,2,Malignant melanoma,4,F,EXP,nivolumab,2,PS,Pneumonia viral,2,F,OT,138
170785324,2,Malignant melanoma,4,F,EXP,nivolumab,2,PS,Pneumonitis,2,F,HO,138
170785324,2,Malignant melanoma,4,F,EXP,nivolumab,2,PS,Pneumonitis,2,F,OT,138
170785893,1,Renal cell carcinoma,3,F,EXP,ipilimumab,1,PS,Neuropathy peripheral,1,M,OT,104
170785893,1,Renal cell carcinoma,3,F,EXP,ipilimumab,1,PS,Neuropathy peripheral,1,M,HO,104
170785893,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Neuropathy peripheral,2,M,OT,104
170785893,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Neuropathy peripheral,2,M,HO,104
170804884,3,Invasive ductal breast carcinoma,4,F,EXP,abemaciclib,3,SS,Anaemia,3,F,HO,107
170804884,3,Invasive ductal breast carcinoma,4,F,EXP,abemaciclib,3,SS,Anaemia,3,F,OT,107
170804884,3,Invasive ductal breast carcinoma,4,F,EXP,abemaciclib,3,SS,Coronary artery disease,3,F,HO,107
170804884,3,Invasive ductal breast carcinoma,4,F,EXP,abemaciclib,3,SS,Coronary artery disease,3,F,OT,107
170804884,3,Invasive ductal breast carcinoma,4,F,EXP,abemaciclib,3,SS,Hypertension,3,F,HO,107
170804884,3,Invasive ductal breast carcinoma,4,F,EXP,abemaciclib,3,SS,Hypertension,3,F,OT,107
170804884,3,Invasive ductal breast carcinoma,4,F,EXP,abemaciclib,3,SS,Left ventricular hypertrophy,3,F,HO,107
170804884,3,Invasive ductal breast carcinoma,4,F,EXP,abemaciclib,3,SS,Left ventricular hypertrophy,3,F,OT,107
170804884,3,Invasive ductal breast carcinoma,4,F,EXP,abemaciclib,3,SS,Mitral valve incompetence,3,F,HO,107
170804884,3,Invasive ductal breast carcinoma,4,F,EXP,abemaciclib,3,SS,Mitral valve incompetence,3,F,OT,107
170804884,3,Invasive ductal breast carcinoma,4,F,EXP,abemaciclib,3,SS,Tricuspid valve incompetence,3,F,HO,107
170804884,3,Invasive ductal breast carcinoma,4,F,EXP,abemaciclib,3,SS,Tricuspid valve incompetence,3,F,OT,107
170805897,2,Plasma cell myeloma,7,F,EXP,lenalidomide,2,SS,Condition aggravated,2,M,OT,113
170805897,2,Plasma cell myeloma,7,F,EXP,lenalidomide,2,SS,Condition aggravated,2,M,HO,113
170805897,2,Plasma cell myeloma,7,F,EXP,lenalidomide,2,SS,Gingivitis,2,M,OT,113
170805897,2,Plasma cell myeloma,7,F,EXP,lenalidomide,2,SS,Gingivitis,2,M,HO,113
170805897,2,Plasma cell myeloma,7,F,EXP,lenalidomide,2,SS,Interstitial lung disease,2,M,OT,113
170805897,2,Plasma cell myeloma,7,F,EXP,lenalidomide,2,SS,Interstitial lung disease,2,M,HO,113
170805897,2,Plasma cell myeloma,7,F,EXP,lenalidomide,2,SS,Neutrophil count decreased,2,M,OT,113
170805897,2,Plasma cell myeloma,7,F,EXP,lenalidomide,2,SS,Neutrophil count decreased,2,M,HO,113
170805897,2,Plasma cell myeloma,7,F,EXP,lenalidomide,2,SS,Platelet count decreased,2,M,OT,113
170805897,2,Plasma cell myeloma,7,F,EXP,lenalidomide,2,SS,Platelet count decreased,2,M,HO,113
170805897,2,Plasma cell myeloma,7,F,EXP,lenalidomide,2,SS,Pneumonia,2,M,OT,113
170805897,2,Plasma cell myeloma,7,F,EXP,lenalidomide,2,SS,Pneumonia,2,M,HO,113
170815422,4,Plasma cell myeloma,2,F,EXP,daratumumab,4,SS,Intraductal proliferative breast lesion,4,F,OT,707
170815422,29,Routine health maintenance,2,F,EXP,zoledronic acid,29,C,Intraductal proliferative breast lesion,29,F,OT,302
170830342,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Colitis,1,F,HO,8
170830342,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Colitis,1,F,OT,8
170830342,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Fulminant type 1 diabetes mellitus,1,F,HO,8
170830342,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Fulminant type 1 diabetes mellitus,1,F,OT,8
170830342,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Headache,1,F,HO,8
170830342,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Headache,1,F,OT,8
170830342,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Liver disorder,1,F,HO,8
170830342,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Liver disorder,1,F,OT,8
170830342,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Pyrexia,1,F,HO,8
170830342,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Pyrexia,1,F,OT,8
170830342,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Colitis,3,F,HO,8
170830342,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Colitis,3,F,OT,8
170830342,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Fulminant type 1 diabetes mellitus,3,F,HO,8
170830342,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Fulminant type 1 diabetes mellitus,3,F,OT,8
170830342,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Headache,3,F,HO,8
170830342,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Headache,3,F,OT,8
170830342,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Liver disorder,3,F,HO,8
170830342,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Liver disorder,3,F,OT,8
170830342,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pyrexia,3,F,HO,8
170830342,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pyrexia,3,F,OT,8
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Blood creatinine increased,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Blood creatinine increased,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Blood creatinine increased,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Colitis,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Colitis,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Colitis,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Eye oedema,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Eye oedema,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Eye oedema,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Fatigue,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Fatigue,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Fatigue,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hepatitis,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hepatitis,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hepatitis,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hyperthyroidism,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hyperthyroidism,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hyperthyroidism,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Influenza like illness,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Influenza like illness,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Influenza like illness,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Keratosis follicular,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Keratosis follicular,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Keratosis follicular,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Lymphocyte count decreased,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Lymphocyte count decreased,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Lymphocyte count decreased,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Nausea,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Nausea,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Nausea,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Palmar-plantar erythrodysaesthesia syndrome,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Palmar-plantar erythrodysaesthesia syndrome,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Palmar-plantar erythrodysaesthesia syndrome,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Psoriasis,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Psoriasis,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Psoriasis,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Rash maculo-papular,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Rash maculo-papular,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Rash maculo-papular,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Seizure,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Seizure,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Seizure,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Transient acantholytic dermatosis,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Transient acantholytic dermatosis,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Transient acantholytic dermatosis,3,M,OT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Vertigo,3,M,LT,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Vertigo,3,M,HO,165
170831673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Vertigo,3,M,OT,165
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Blood creatinine increased,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Blood creatinine increased,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Blood creatinine increased,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Colitis,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Colitis,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Colitis,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Eye oedema,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Eye oedema,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Eye oedema,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Fatigue,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Fatigue,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Fatigue,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Hepatitis,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Hepatitis,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Hepatitis,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Hyperthyroidism,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Hyperthyroidism,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Hyperthyroidism,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Influenza like illness,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Influenza like illness,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Influenza like illness,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Keratosis follicular,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Keratosis follicular,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Keratosis follicular,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Lymphocyte count decreased,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Lymphocyte count decreased,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Lymphocyte count decreased,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Malignant neoplasm progression,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Malignant neoplasm progression,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Malignant neoplasm progression,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Nausea,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Nausea,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Nausea,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Palmar-plantar erythrodysaesthesia syndrome,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Palmar-plantar erythrodysaesthesia syndrome,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Palmar-plantar erythrodysaesthesia syndrome,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Psoriasis,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Psoriasis,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Psoriasis,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Rash maculo-papular,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Rash maculo-papular,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Rash maculo-papular,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Seizure,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Seizure,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Seizure,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Transient acantholytic dermatosis,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Transient acantholytic dermatosis,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Transient acantholytic dermatosis,4,M,OT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Vertigo,4,M,LT,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Vertigo,4,M,HO,14
170831673,4,Malignant melanoma,3,F,EXP,nivolumab,4,SS,Vertigo,4,M,OT,14
170831873,11,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,11,SS,Adenovirus infection,11,M,HO,140
170831873,11,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,11,SS,Sepsis,11,M,HO,140
170831873,11,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,11,SS,Tachycardia,11,M,HO,140
170836682,1,Non-small cell lung cancer,2,F,EXP,necitumumab,1,PS,Rash maculo-papular,1,F,OT,67
170841975,9,Premedication,5,F,EXP,granisetron,9,C,Pneumonia,9,F,DE,90
170845253,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Herpes zoster,1,F,HO,266
170845253,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Herpes zoster,2,F,HO,266
170845994,4,Breast cancer metastatic,4,F,EXP,zoledronic acid,4,SS,Alopecia,4,F,OT,72
170845994,4,Breast cancer metastatic,4,F,EXP,zoledronic acid,4,SS,Bone pain,4,F,OT,72
170845994,4,Breast cancer metastatic,4,F,EXP,zoledronic acid,4,SS,Neutropenia,4,F,OT,72
170846456,1,Bladder cancer,6,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,OT,42
170846456,1,Bladder cancer,6,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,HO,42
170846456,1,Bladder cancer,6,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,DE,42
170846456,1,Bladder cancer,6,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,LT,42
170846456,1,Bladder cancer,6,F,EXP,nivolumab,1,PS,Pyonephrosis,1,M,OT,42
170846456,1,Bladder cancer,6,F,EXP,nivolumab,1,PS,Pyonephrosis,1,M,HO,42
170846456,1,Bladder cancer,6,F,EXP,nivolumab,1,PS,Pyonephrosis,1,M,DE,42
170846456,1,Bladder cancer,6,F,EXP,nivolumab,1,PS,Pyonephrosis,1,M,LT,42
170846456,1,Bladder cancer,6,F,EXP,nivolumab,1,PS,Urinary tract inflammation,1,M,OT,42
170846456,1,Bladder cancer,6,F,EXP,nivolumab,1,PS,Urinary tract inflammation,1,M,HO,42
170846456,1,Bladder cancer,6,F,EXP,nivolumab,1,PS,Urinary tract inflammation,1,M,DE,42
170846456,1,Bladder cancer,6,F,EXP,nivolumab,1,PS,Urinary tract inflammation,1,M,LT,42
170846456,2,Bladder cancer,6,F,EXP,ipilimumab,2,SS,Blood creatinine increased,2,M,OT,42
170846456,2,Bladder cancer,6,F,EXP,ipilimumab,2,SS,Blood creatinine increased,2,M,HO,42
170846456,2,Bladder cancer,6,F,EXP,ipilimumab,2,SS,Blood creatinine increased,2,M,DE,42
170846456,2,Bladder cancer,6,F,EXP,ipilimumab,2,SS,Blood creatinine increased,2,M,LT,42
170846456,2,Bladder cancer,6,F,EXP,ipilimumab,2,SS,Pyonephrosis,2,M,OT,42
170846456,2,Bladder cancer,6,F,EXP,ipilimumab,2,SS,Pyonephrosis,2,M,HO,42
170846456,2,Bladder cancer,6,F,EXP,ipilimumab,2,SS,Pyonephrosis,2,M,DE,42
170846456,2,Bladder cancer,6,F,EXP,ipilimumab,2,SS,Pyonephrosis,2,M,LT,42
170846456,2,Bladder cancer,6,F,EXP,ipilimumab,2,SS,Urinary tract inflammation,2,M,OT,42
170846456,2,Bladder cancer,6,F,EXP,ipilimumab,2,SS,Urinary tract inflammation,2,M,HO,42
170846456,2,Bladder cancer,6,F,EXP,ipilimumab,2,SS,Urinary tract inflammation,2,M,DE,42
170846456,2,Bladder cancer,6,F,EXP,ipilimumab,2,SS,Urinary tract inflammation,2,M,LT,42
170847383,3,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Lower respiratory tract infection,3,M,OT,450
170847383,3,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Lower respiratory tract infection,3,M,HO,450
170848545,1,B-cell lymphoma,5,F,EXP,idelalisib,1,PS,Acute kidney injury,1,M,HO,56
170848545,1,B-cell lymphoma,5,F,EXP,idelalisib,1,PS,Atrial fibrillation,1,M,HO,56
170848545,1,B-cell lymphoma,5,F,EXP,idelalisib,1,PS,Infective exacerbation of chronic obstructive airways disease,1,M,HO,56
170848545,1,B-cell lymphoma,5,F,EXP,idelalisib,1,PS,Lower respiratory tract infection fungal,1,M,HO,56
170848545,1,B-cell lymphoma,5,F,EXP,idelalisib,1,PS,Nasopharyngitis,1,M,HO,56
170848545,1,B-cell lymphoma,5,F,EXP,idelalisib,1,PS,Pneumonia,1,M,HO,56
170852452,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Cardiac failure acute,1,M,HO,183
170852452,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Cardiac failure acute,1,M,OT,183
170852452,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Pericardial effusion,1,M,HO,183
170852452,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Pericardial effusion,1,M,OT,183
170866512,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Aphasia,1,F,OT,678
170866512,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Aphasia,1,F,HO,678
170866512,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Epilepsy,1,F,OT,678
170866512,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Epilepsy,1,F,HO,678
170871353,1,Hepatocellular carcinoma,3,F,EXP,nivolumab,1,PS,Appetite disorder,1,M,HO,8
170871353,1,Hepatocellular carcinoma,3,F,EXP,nivolumab,1,PS,Confusional state,1,M,HO,8
170871353,1,Hepatocellular carcinoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,8
170871353,1,Hepatocellular carcinoma,3,F,EXP,nivolumab,1,PS,Muscle spasms,1,M,HO,8
170871353,1,Hepatocellular carcinoma,3,F,EXP,nivolumab,1,PS,Somnolence,1,M,HO,8
170884572,2,Hormone-refractory prostate cancer,2,F,EXP,cabazitaxel,2,SS,Asthenia,2,M,OT,70
170884572,2,Hormone-refractory prostate cancer,2,F,EXP,cabazitaxel,2,SS,Asthenia,2,M,HO,70
170884572,2,Hormone-refractory prostate cancer,2,F,EXP,cabazitaxel,2,SS,General physical health deterioration,2,M,OT,70
170884572,2,Hormone-refractory prostate cancer,2,F,EXP,cabazitaxel,2,SS,General physical health deterioration,2,M,HO,70
170884572,2,Hormone-refractory prostate cancer,2,F,EXP,cabazitaxel,2,SS,Haematuria,2,M,OT,70
170884572,2,Hormone-refractory prostate cancer,2,F,EXP,cabazitaxel,2,SS,Haematuria,2,M,HO,70
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Acute kidney injury,1,M,OT,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Acute kidney injury,1,M,LT,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Acute kidney injury,1,M,DE,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Acute kidney injury,1,M,HO,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Diarrhoea,1,M,OT,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Diarrhoea,1,M,LT,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Diarrhoea,1,M,DE,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Diarrhoea,1,M,HO,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Sepsis,1,M,OT,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Sepsis,1,M,LT,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Sepsis,1,M,DE,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Sepsis,1,M,HO,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Vomiting,1,M,OT,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Vomiting,1,M,LT,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Vomiting,1,M,DE,1
170885712,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Vomiting,1,M,HO,1
170885813,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Duodenal ulcer haemorrhage,1,M,OT,47
170885813,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Duodenal ulcer haemorrhage,1,M,HO,47
170885813,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Duodenitis,1,M,OT,47
170885813,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Duodenitis,1,M,HO,47
170885813,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,OT,47
170885813,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,HO,47
170885813,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Duodenal ulcer haemorrhage,2,M,OT,47
170885813,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Duodenal ulcer haemorrhage,2,M,HO,47
170885813,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Duodenitis,2,M,OT,47
170885813,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Duodenitis,2,M,HO,47
170885813,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,OT,47
170885813,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,HO,47
170891752,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,10
170891752,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,10
170891752,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,10
170891752,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,10
170891752,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,10
170891752,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,DE,10
170891752,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,HO,10
170891752,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,DE,10
170893746,15,B precursor type acute leukaemia,6,F,EXP,pegaspargase,15,SS,Febrile neutropenia,15,M,HO,163
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Diarrhoea,1,M,HO,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Diarrhoea,1,M,OT,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Diarrhoea,1,M,DE,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Interstitial lung disease,1,M,HO,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Interstitial lung disease,1,M,OT,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Interstitial lung disease,1,M,DE,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Liver disorder,1,M,HO,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Liver disorder,1,M,OT,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Liver disorder,1,M,DE,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,M,HO,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,M,OT,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,M,DE,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Pancreatic enzymes increased,1,M,HO,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Pancreatic enzymes increased,1,M,OT,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Pancreatic enzymes increased,1,M,DE,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Rash,1,M,HO,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Rash,1,M,OT,13
170909714,1,Malignant melanoma stage IV,4,F,EXP,ipilimumab,1,PS,Rash,1,M,DE,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Diarrhoea,3,M,HO,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Diarrhoea,3,M,OT,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Diarrhoea,3,M,DE,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Interstitial lung disease,3,M,HO,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Interstitial lung disease,3,M,OT,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Interstitial lung disease,3,M,DE,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Liver disorder,3,M,HO,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Liver disorder,3,M,OT,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Liver disorder,3,M,DE,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,HO,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,OT,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,DE,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Pancreatic enzymes increased,3,M,HO,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Pancreatic enzymes increased,3,M,OT,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Pancreatic enzymes increased,3,M,DE,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Rash,3,M,HO,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Rash,3,M,OT,13
170909714,3,Malignant melanoma stage IV,4,F,EXP,nivolumab,3,SS,Rash,3,M,DE,13
170910704,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Cerebral disorder,1,F,OT,404
170910704,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Cerebral disorder,1,F,HO,404
170910704,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Colitis,1,F,OT,404
170910704,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Colitis,1,F,HO,404
170910704,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Drug ineffective,1,F,OT,404
170910704,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Drug ineffective,1,F,HO,404
170910704,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Hepatic pain,1,F,OT,404
170910704,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Hepatic pain,1,F,HO,404
170910704,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pain,1,F,OT,404
170910704,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pain,1,F,HO,404
170919292,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Cough,1,M,DE,14
170919292,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Cough,1,M,OT,14
170919292,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,14
170919292,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,14
170919292,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Headache,1,M,DE,14
170919292,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Headache,1,M,OT,14
170919292,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,14
170919292,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,14
170919292,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Polyneuropathy,1,M,DE,14
170919292,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Polyneuropathy,1,M,OT,14
170927604,1,Hormone-refractory prostate cancer,4,F,EXP,enzalutamide,1,PS,Hypocalcaemia,1,M,HO,142
170929403,1,Plasma cell myeloma,3,F,EXP,selinexor,1,PS,Platelet count decreased,1,M,OT,29
170929515,1,Non-small cell lung cancer,5,F,EXP,lorlatinib,1,PS,Hepatic function abnormal,1,M,HO,105
170939602,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,HO,34
170939602,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,OT,34
170939602,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,F,HO,34
170939602,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,F,OT,34
170941055,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Cardiac failure,2,M,HO,3
170941055,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Cardiac failure,2,M,OT,3
170941055,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Deep vein thrombosis,2,M,HO,3
170941055,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Deep vein thrombosis,2,M,OT,3
170941055,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Ejection fraction decreased,2,M,HO,3
170941055,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Ejection fraction decreased,2,M,OT,3
170941055,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Fluid overload,2,M,HO,3
170941055,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Fluid overload,2,M,OT,3
170941055,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Pneumonia,2,M,HO,3
170941055,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Pneumonia,2,M,OT,3
170943295,3,Malignant melanoma,5,F,EXP,trametinib,3,SS,Hyponatraemia,3,M,HO,18
170943295,3,Malignant melanoma,5,F,EXP,trametinib,3,SS,Syncope,3,M,HO,18
170957562,1,Rectal cancer metastatic,2,F,EXP,nivolumab,1,PS,Epistaxis,1,M,OT,41
170957562,1,Rectal cancer metastatic,2,F,EXP,nivolumab,1,PS,Epistaxis,1,M,HO,41
170957562,1,Rectal cancer metastatic,2,F,EXP,nivolumab,1,PS,Haemoptysis,1,M,OT,41
170957562,1,Rectal cancer metastatic,2,F,EXP,nivolumab,1,PS,Haemoptysis,1,M,HO,41
170957562,1,Rectal cancer metastatic,2,F,EXP,nivolumab,1,PS,Lower respiratory tract infection,1,M,OT,41
170957562,1,Rectal cancer metastatic,2,F,EXP,nivolumab,1,PS,Lower respiratory tract infection,1,M,HO,41
170957562,1,Rectal cancer metastatic,2,F,EXP,nivolumab,1,PS,Metastases to pelvis,1,M,OT,41
170957562,1,Rectal cancer metastatic,2,F,EXP,nivolumab,1,PS,Metastases to pelvis,1,M,HO,41
170957562,1,Rectal cancer metastatic,2,F,EXP,nivolumab,1,PS,Pruritus,1,M,OT,41
170957562,1,Rectal cancer metastatic,2,F,EXP,nivolumab,1,PS,Pruritus,1,M,HO,41
170957562,1,Rectal cancer metastatic,2,F,EXP,nivolumab,1,PS,Thrombosis,1,M,OT,41
170957562,1,Rectal cancer metastatic,2,F,EXP,nivolumab,1,PS,Thrombosis,1,M,HO,41
170969222,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Anaemia,1,M,HO,9
170969222,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Therapy cessation,1,M,HO,9
170977692,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,880
170977692,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,880
170977692,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Neoplasm,1,M,HO,880
170977692,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Neoplasm,1,M,OT,880
170981668,14,Prophylaxis,8,F,EXP,filgrastim,14,C,Neutropenic sepsis,14,M,HO,10
170981668,14,Prophylaxis,8,F,EXP,filgrastim,14,C,Neutropenic sepsis,14,M,OT,10
170990095,1,Renal cell carcinoma,5,F,EXP,axitinib,1,PS,Arthralgia,1,M,HO,546
170990095,1,Renal cell carcinoma,5,F,EXP,axitinib,1,PS,Device related infection,1,M,HO,546
170992352,1,Mantle cell lymphoma,2,F,EXP,ibrutinib,1,PS,Atrial fibrillation,1,M,HO,70
170992352,1,Mantle cell lymphoma,2,F,EXP,ibrutinib,1,PS,Atrioventricular block,1,M,HO,70
170992352,1,Mantle cell lymphoma,2,F,EXP,ibrutinib,1,PS,Left ventricular dysfunction,1,M,HO,70
170992352,1,Mantle cell lymphoma,2,F,EXP,ibrutinib,1,PS,Pericardial effusion,1,M,HO,70
170992352,1,Mantle cell lymphoma,2,F,EXP,ibrutinib,1,PS,Pneumonia,1,M,HO,70
170996264,4,Prophylaxis,4,F,EXP,zoledronic acid,4,C,Pleural effusion,4,F,HO,6
171003703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Amylase increased,2,M,OT,60
171003703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Arthritis,2,M,OT,60
171003703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Bacterial infection,2,M,OT,60
171003703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Bone pain,2,M,OT,60
171003703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Dyspnoea,2,M,OT,60
171003703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Endocrine disorder,2,M,OT,60
171003703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Fatigue,2,M,OT,60
171003703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Non-cardiac chest pain,2,M,OT,60
171003703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Rash maculo-papular,2,M,OT,60
171003703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Sialadenosis,2,M,OT,60
171003703,2,Malignant melanoma,3,F,EXP,nivolumab,2,SS,Spinal pain,2,M,OT,60
171015162,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Arthralgia,1,M,HO,72
171015162,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Malaise,1,M,HO,72
171015162,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Pyrexia,1,M,HO,72
171017693,2,Malignant melanoma,3,F,EXP,nivolumab,2,PS,Influenza,2,F,HO,2
171017914,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Anaemia,2,F,OT,13
171017914,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Neutropenia,2,F,OT,13
171017914,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Thrombocytopenia,2,F,OT,13
171018853,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,162
171018853,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,162
171018853,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,162
171018853,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,162
171018853,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Disorientation,1,M,HO,162
171018853,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Disorientation,1,M,OT,162
171018853,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Metabolic acidosis,1,M,HO,162
171018853,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Metabolic acidosis,1,M,OT,162
171018853,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,162
171018853,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,162
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Blood creatinine increased,1,F,DS,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Blood creatinine increased,1,F,OT,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Crystal urine present,1,F,DS,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Crystal urine present,1,F,OT,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Crystalluria,1,F,DS,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Crystalluria,1,F,OT,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Gait disturbance,1,F,DS,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Gait disturbance,1,F,OT,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Immunosuppression,1,F,DS,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Immunosuppression,1,F,OT,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,DS,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Leukocyturia,1,F,OT,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,DS,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,OT,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,DS,135
171024835,1,Multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,OT,135
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,M,OT,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,M,LT,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,M,HO,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Acute respiratory distress syndrome,1,M,DE,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Azotaemia,1,M,OT,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Azotaemia,1,M,LT,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Azotaemia,1,M,HO,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Azotaemia,1,M,DE,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,OT,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,LT,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,HO,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,DE,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,OT,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,LT,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,HO,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,DE,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Postoperative ileus,1,M,OT,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Postoperative ileus,1,M,LT,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Postoperative ileus,1,M,HO,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Postoperative ileus,1,M,DE,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Renal impairment,1,M,OT,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Renal impairment,1,M,LT,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Renal impairment,1,M,HO,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Renal impairment,1,M,DE,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Sepsis,1,M,LT,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,54
171027803,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Sepsis,1,M,DE,54
171039065,41,Prophylaxis,5,F,EXP,filgrastim,41,C,Febrile neutropenia,41,M,LT,132
171039065,41,Prophylaxis,5,F,EXP,filgrastim,41,C,Febrile neutropenia,41,M,HO,132
171039065,41,Prophylaxis,5,F,EXP,filgrastim,41,C,Herpes zoster,41,M,LT,132
171039065,41,Prophylaxis,5,F,EXP,filgrastim,41,C,Herpes zoster,41,M,HO,132
171039065,41,Prophylaxis,5,F,EXP,filgrastim,41,C,Neutrophil count decreased,41,M,LT,132
171039065,41,Prophylaxis,5,F,EXP,filgrastim,41,C,Neutrophil count decreased,41,M,HO,132
171039065,42,Prophylaxis,5,F,EXP,filgrastim,42,C,Febrile neutropenia,42,M,LT,99
171039065,42,Prophylaxis,5,F,EXP,filgrastim,42,C,Febrile neutropenia,42,M,HO,99
171039065,42,Prophylaxis,5,F,EXP,filgrastim,42,C,Herpes zoster,42,M,LT,99
171039065,42,Prophylaxis,5,F,EXP,filgrastim,42,C,Herpes zoster,42,M,HO,99
171039065,42,Prophylaxis,5,F,EXP,filgrastim,42,C,Neutrophil count decreased,42,M,LT,99
171039065,42,Prophylaxis,5,F,EXP,filgrastim,42,C,Neutrophil count decreased,42,M,HO,99
171039065,43,Prophylaxis,5,F,EXP,filgrastim,43,C,Febrile neutropenia,43,M,LT,35
171039065,43,Prophylaxis,5,F,EXP,filgrastim,43,C,Febrile neutropenia,43,M,HO,35
171039065,43,Prophylaxis,5,F,EXP,filgrastim,43,C,Herpes zoster,43,M,LT,35
171039065,43,Prophylaxis,5,F,EXP,filgrastim,43,C,Herpes zoster,43,M,HO,35
171039065,43,Prophylaxis,5,F,EXP,filgrastim,43,C,Neutrophil count decreased,43,M,LT,35
171039065,43,Prophylaxis,5,F,EXP,filgrastim,43,C,Neutrophil count decreased,43,M,HO,35
171049113,2,Malignant melanoma,3,F,EXP,trametinib,2,SS,Pancreatitis acute,2,M,HO,113
171050293,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,51
171050293,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,OT,51
171050293,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Depression,1,M,OT,51
171050293,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,51
171050293,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,51
171050293,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Kidney infection,1,M,OT,51
171050293,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Nephrolithiasis,1,M,OT,51
171050293,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,OT,51
171050293,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Salivary hypersecretion,1,M,OT,51
171050293,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Taste disorder,1,M,OT,51
171050786,6,Gallbladder cancer,6,F,EXP,nivolumab,6,SS,Biliary tract infection,6,F,HO,105
171050786,6,Gallbladder cancer,6,F,EXP,nivolumab,6,SS,Febrile neutropenia,6,F,HO,105
171050786,6,Gallbladder cancer,6,F,EXP,nivolumab,6,SS,Infection,6,F,HO,105
171051663,1,Non-Hodgkin's lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Pneumonia,1,M,HO,123
171059778,1,Plasma cell myeloma,8,F,EXP,lenalidomide,1,PS,Progressive multifocal leukoencephalopathy,1,M,LT,2261
171059778,1,Plasma cell myeloma,8,F,EXP,lenalidomide,1,PS,Progressive multifocal leukoencephalopathy,1,M,HO,2261
171059778,1,Plasma cell myeloma,8,F,EXP,lenalidomide,1,PS,Progressive multifocal leukoencephalopathy,1,M,DE,2261
171059778,1,Plasma cell myeloma,8,F,EXP,lenalidomide,1,PS,Progressive multifocal leukoencephalopathy,1,M,OT,2261
171060483,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Asthenia,1,F,OT,105
171060483,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Asthenia,1,F,HO,105
171060483,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Encephalitis,1,F,OT,105
171060483,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Encephalitis,1,F,HO,105
171060483,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Failure to thrive,1,F,OT,105
171060483,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Failure to thrive,1,F,HO,105
171060483,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Headache,1,F,OT,105
171060483,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Headache,1,F,HO,105
171060483,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Meningitis aseptic,1,F,OT,105
171060483,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Meningitis aseptic,1,F,HO,105
171068986,1,Hodgkin's disease,6,F,EXP,nivolumab,1,PS,Confusional state,1,F,OT,92
171068986,1,Hodgkin's disease,6,F,EXP,nivolumab,1,PS,Confusional state,1,F,HO,92
171068986,1,Hodgkin's disease,6,F,EXP,nivolumab,1,PS,General physical condition abnormal,1,F,OT,92
171068986,1,Hodgkin's disease,6,F,EXP,nivolumab,1,PS,General physical condition abnormal,1,F,HO,92
171068986,1,Hodgkin's disease,6,F,EXP,nivolumab,1,PS,Human herpesvirus 6 encephalitis,1,F,OT,92
171068986,1,Hodgkin's disease,6,F,EXP,nivolumab,1,PS,Human herpesvirus 6 encephalitis,1,F,HO,92
171068986,1,Hodgkin's disease,6,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,OT,92
171068986,1,Hodgkin's disease,6,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,HO,92
171068986,1,Hodgkin's disease,6,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,92
171068986,1,Hodgkin's disease,6,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,92
171068986,1,Hodgkin's disease,6,F,EXP,nivolumab,1,PS,Pain,1,F,OT,92
171068986,1,Hodgkin's disease,6,F,EXP,nivolumab,1,PS,Pain,1,F,HO,92
171072184,13,Product used for unknown indication,4,F,EXP,filgrastim,13,C,Syncope,13,F,HO,30
171077446,1,Plasma cell myeloma,6,F,EXP,lenalidomide,1,PS,Neuroendocrine carcinoma of the skin,1,M,OT,2541
171085945,1,Relapsing multiple sclerosis,5,F,EXP,alemtuzumab,1,PS,Leukopenia,1,F,HO,28
171088702,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Arthritis,1,F,HO,7
171088702,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Dermatitis,1,F,HO,7
171088702,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Arthritis,2,F,HO,7
171088702,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Dermatitis,2,F,HO,7
171089613,18,Prophylaxis of nausea and vomiting,3,F,PER,granisetron,18,C,Febrile neutropenia,18,F,HO,18
171089613,18,Prophylaxis of nausea and vomiting,3,F,PER,granisetron,18,C,Staphylococcal infection,18,F,HO,18
171096363,1,Anaemia,3,F,PER,darbepoetin alfa,1,PS,Death,1,M,DE,936
171097692,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Haemophagocytic lymphohistiocytosis,1,M,DE,51
171097692,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Haemophagocytic lymphohistiocytosis,1,M,OT,51
171100753,5,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,5,SS,Back pain,5,M,DE,62
171100753,5,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,5,SS,Back pain,5,M,HO,62
171100753,5,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,5,SS,Death,5,M,DE,62
171100753,5,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,5,SS,Death,5,M,HO,62
171100753,5,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,5,SS,Dyspnoea,5,M,DE,62
171100753,5,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,5,SS,Dyspnoea,5,M,HO,62
171100753,5,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,5,SS,Fatigue,5,M,DE,62
171100753,5,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,5,SS,Fatigue,5,M,HO,62
171100753,5,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,5,SS,Muscular weakness,5,M,DE,62
171100753,5,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,5,SS,Muscular weakness,5,M,HO,62
171102032,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Diarrhoea,1,F,OT,4
171102032,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Diarrhoea,1,F,HO,4
171102032,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Haemophagocytic lymphohistiocytosis,1,F,OT,4
171102032,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Haemophagocytic lymphohistiocytosis,1,F,HO,4
171102032,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Hepatic function abnormal,1,F,OT,4
171102032,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Hepatic function abnormal,1,F,HO,4
171102032,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Malaise,1,F,OT,4
171102032,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Malaise,1,F,HO,4
171102032,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Pancreatitis,1,F,OT,4
171102032,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Pancreatitis,1,F,HO,4
171102032,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Pyrexia,1,F,OT,4
171102032,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Pyrexia,1,F,HO,4
171102032,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Rash,1,F,OT,4
171102032,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Rash,1,F,HO,4
171113442,2,Product used for unknown indication,2,F,EXP,pomalidomide,2,SS,Atrial fibrillation,2,M,OT,3
171113442,2,Product used for unknown indication,2,F,EXP,pomalidomide,2,SS,Atrial flutter,2,M,OT,3
171113442,2,Product used for unknown indication,2,F,EXP,pomalidomide,2,SS,Neutropenia,2,M,OT,3
171113442,2,Product used for unknown indication,2,F,EXP,pomalidomide,2,SS,Platelet count decreased,2,M,OT,3
171113442,2,Product used for unknown indication,2,F,EXP,pomalidomide,2,SS,Sinusitis,2,M,OT,3
171113442,2,Product used for unknown indication,2,F,EXP,pomalidomide,2,SS,White blood cell count decreased,2,M,OT,3
171118932,1,Renal cell carcinoma,2,F,EXP,avelumab,1,PS,Diabetic ketoacidosis,1,F,HO,923
171122662,1,Breast cancer female,2,F,EXP,palbociclib,1,PS,Vertigo,1,F,HO,56
171136846,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Autoimmune thyroiditis,1,F,OT,295
171136846,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Autoimmune thyroiditis,1,F,HO,295
171136846,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Hyperbilirubinaemia,1,F,OT,295
171136846,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Hyperbilirubinaemia,1,F,HO,295
171136846,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Thrombotic thrombocytopenic purpura,1,F,OT,295
171136846,1,Relapsing multiple sclerosis,6,F,EXP,alemtuzumab,1,PS,Thrombotic thrombocytopenic purpura,1,F,HO,295
171143043,1,Metastatic malignant melanoma,3,F,EXP,selinexor,1,PS,Anaemia,1,M,HO,63
171144843,8,Metastatic malignant melanoma,3,F,EXP,trametinib,8,SS,Arrhythmia,8,M,OT,9
171144843,8,Metastatic malignant melanoma,3,F,EXP,trametinib,8,SS,Asthenia,8,M,OT,9
171144843,8,Metastatic malignant melanoma,3,F,EXP,trametinib,8,SS,Atrial fibrillation,8,M,OT,9
171144843,8,Metastatic malignant melanoma,3,F,EXP,trametinib,8,SS,Pyrexia,8,M,OT,9
171150453,1,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,1,PS,Pyelonephritis acute,1,M,HO,989
171155094,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Confusional state,1,M,HO,11
171155094,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Mental status changes,1,M,HO,11
171155112,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Drug ineffective,1,M,HO,682
171155112,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Drug ineffective,1,M,OT,682
171155112,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Mobility decreased,1,M,HO,682
171155112,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Mobility decreased,1,M,OT,682
171155112,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Neoplasm,1,M,HO,682
171155112,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Neoplasm,1,M,OT,682
171155112,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Seizure,1,M,HO,682
171155112,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Seizure,1,M,OT,682
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Abdominal pain,4,F,OT,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Abdominal pain,4,F,HO,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Abdominal pain upper,4,F,OT,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Abdominal pain upper,4,F,HO,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Colitis,4,F,OT,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Colitis,4,F,HO,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Diarrhoea,4,F,OT,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Diarrhoea,4,F,HO,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Diarrhoea haemorrhagic,4,F,OT,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Diarrhoea haemorrhagic,4,F,HO,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Gallbladder adenoma,4,F,OT,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Gallbladder adenoma,4,F,HO,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Nausea,4,F,OT,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Nausea,4,F,HO,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Renal cyst,4,F,OT,5
171156532,4,Breast cancer,2,F,EXP,abemaciclib,4,SS,Renal cyst,4,F,HO,5
171156673,6,Acute lymphocytic leukaemia,3,F,EXP,thioguanine,6,SS,Febrile neutropenia,6,M,HO,18
171156673,8,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,8,SS,Febrile neutropenia,8,M,HO,4
171161333,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Infectious pleural effusion,1,F,OT,21
171161333,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Infectious pleural effusion,1,F,HO,21
171161333,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Infectious pleural effusion,2,F,OT,21
171161333,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Infectious pleural effusion,2,F,HO,21
171164673,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Gastrointestinal disorder,1,M,HO,281
171164673,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Tooth disorder,1,M,HO,281
171164673,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Gastrointestinal disorder,3,M,HO,281
171164673,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Tooth disorder,3,M,HO,281
171167726,1,Head and neck cancer metastatic,6,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,14
171167726,1,Head and neck cancer metastatic,6,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,14
171167726,1,Head and neck cancer metastatic,6,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,14
171167726,1,Head and neck cancer metastatic,6,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,14
171167726,1,Head and neck cancer metastatic,6,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,14
171167726,1,Head and neck cancer metastatic,6,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,14
171167726,1,Head and neck cancer metastatic,6,F,EXP,nivolumab,1,PS,Dysphagia,1,M,HO,14
171167726,1,Head and neck cancer metastatic,6,F,EXP,nivolumab,1,PS,Dysphagia,1,M,OT,14
171167726,1,Head and neck cancer metastatic,6,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,14
171167726,1,Head and neck cancer metastatic,6,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,14
171167726,1,Head and neck cancer metastatic,6,F,EXP,nivolumab,1,PS,Hemiplegia,1,M,HO,14
171167726,1,Head and neck cancer metastatic,6,F,EXP,nivolumab,1,PS,Hemiplegia,1,M,OT,14
171167726,1,Head and neck cancer metastatic,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,14
171167726,1,Head and neck cancer metastatic,6,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,14
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Asthenia,3,M,OT,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Asthenia,3,M,HO,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Asthenia,3,M,DE,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Asthenia,3,M,DS,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Blood alkaline phosphatase increased,3,M,OT,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Blood alkaline phosphatase increased,3,M,HO,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Blood alkaline phosphatase increased,3,M,DE,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Blood alkaline phosphatase increased,3,M,DS,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Compression fracture,3,M,OT,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Compression fracture,3,M,HO,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Compression fracture,3,M,DE,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Compression fracture,3,M,DS,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Malignant melanoma,3,M,OT,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Malignant melanoma,3,M,HO,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Malignant melanoma,3,M,DE,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Malignant melanoma,3,M,DS,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Malignant neoplasm progression,3,M,OT,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Malignant neoplasm progression,3,M,HO,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Malignant neoplasm progression,3,M,DE,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Malignant neoplasm progression,3,M,DS,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Metastasis,3,M,OT,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Metastasis,3,M,HO,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Metastasis,3,M,DE,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Metastasis,3,M,DS,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Musculoskeletal pain,3,M,OT,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Musculoskeletal pain,3,M,HO,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Musculoskeletal pain,3,M,DE,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Musculoskeletal pain,3,M,DS,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Oedema,3,M,OT,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Oedema,3,M,HO,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Oedema,3,M,DE,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Oedema,3,M,DS,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Pain in extremity,3,M,OT,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Pain in extremity,3,M,HO,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Pain in extremity,3,M,DE,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Pain in extremity,3,M,DS,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Spinal pain,3,M,OT,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Spinal pain,3,M,HO,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Spinal pain,3,M,DE,28
171169772,3,Malignant melanoma,2,F,EXP,trametinib,3,SS,Spinal pain,3,M,DS,28
171176382,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Cytopenia,2,F,OT,147
171176762,2,Small cell lung cancer,2,F,EXP,avelumab,2,SS,Anaemia,2,M,LT,73
171176762,2,Small cell lung cancer,2,F,EXP,avelumab,2,SS,Anaemia,2,M,HO,73
171176762,2,Small cell lung cancer,2,F,EXP,avelumab,2,SS,Hyponatraemia,2,M,LT,73
171176762,2,Small cell lung cancer,2,F,EXP,avelumab,2,SS,Hyponatraemia,2,M,HO,73
171176762,2,Small cell lung cancer,2,F,EXP,avelumab,2,SS,Platelet count decreased,2,M,LT,73
171176762,2,Small cell lung cancer,2,F,EXP,avelumab,2,SS,Platelet count decreased,2,M,HO,73
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,LT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Delirium,1,M,OT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Delirium,1,M,HO,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Delirium,1,M,LT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Hypertension,1,M,OT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Hypertension,1,M,HO,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Hypertension,1,M,LT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Hypertensive urgency,1,M,OT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Hypertensive urgency,1,M,HO,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Hypertensive urgency,1,M,LT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,OT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,HO,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,LT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Meningioma,1,M,OT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Meningioma,1,M,HO,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Meningioma,1,M,LT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,LT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,OT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,HO,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,LT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,10
171177043,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Vomiting,1,M,LT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,M,OT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,M,HO,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,M,LT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Delirium,2,M,OT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Delirium,2,M,HO,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Delirium,2,M,LT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Hypertension,2,M,OT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Hypertension,2,M,HO,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Hypertension,2,M,LT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Hypertensive urgency,2,M,OT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Hypertensive urgency,2,M,HO,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Hypertensive urgency,2,M,LT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,OT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,HO,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,LT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Meningioma,2,M,OT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Meningioma,2,M,HO,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Meningioma,2,M,LT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,OT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,HO,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,LT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Urinary tract infection,2,M,OT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Urinary tract infection,2,M,HO,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Urinary tract infection,2,M,LT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Vomiting,2,M,OT,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Vomiting,2,M,HO,10
171177043,2,Bladder cancer,3,F,EXP,ipilimumab,2,SS,Vomiting,2,M,LT,10
171182055,2,Prostate cancer,5,F,EXP,nivolumab,2,PS,Atrial fibrillation,2,M,HO,25
171182055,2,Prostate cancer,5,F,EXP,nivolumab,2,PS,Atrial fibrillation,2,M,OT,25
171182055,2,Prostate cancer,5,F,EXP,nivolumab,2,PS,Hyperthyroidism,2,M,HO,25
171182055,2,Prostate cancer,5,F,EXP,nivolumab,2,PS,Hyperthyroidism,2,M,OT,25
171184822,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pustular psoriasis,1,M,HO,616
171184822,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Pustular psoriasis,2,M,HO,616
171186393,2,Breast cancer,3,F,EXP,palbociclib,2,SS,Febrile neutropenia,2,F,HO,27
171186393,2,Breast cancer,3,F,EXP,palbociclib,2,SS,Febrile neutropenia,2,F,OT,27
171186393,2,Breast cancer,3,F,EXP,palbociclib,2,SS,General physical health deterioration,2,F,HO,27
171186393,2,Breast cancer,3,F,EXP,palbociclib,2,SS,General physical health deterioration,2,F,OT,27
171191712,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,SS,Hyperglycaemia,1,M,HO,6
171191712,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,SS,Myocardial infarction,1,M,HO,6
171191712,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,SS,Troponin T increased,1,M,HO,6
171191724,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Oedema,1,F,HO,8
171191724,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Oedema,1,F,OT,8
171191724,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Renal failure,1,F,HO,8
171191724,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Renal failure,1,F,OT,8
171191724,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,HO,8
171191724,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,OT,8
171191724,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Oedema,3,F,HO,8
171191724,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Oedema,3,F,OT,8
171191724,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Renal failure,3,F,HO,8
171191724,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Renal failure,3,F,OT,8
171191724,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Urinary tract infection,3,F,HO,8
171191724,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Urinary tract infection,3,F,OT,8
171193525,2,Anaemia,5,F,PER,epoetin alfa,2,C,Pleurisy,2,F,DE,471
171193525,2,Anaemia,5,F,PER,epoetin alfa,2,C,Pleurisy,2,F,HO,471
171200182,1,Malignant melanoma,2,F,EXP,trametinib,1,PS,Hypotension,1,M,HO,962
171200182,1,Malignant melanoma,2,F,EXP,trametinib,1,PS,Pyrexia,1,M,HO,962
171200182,1,Malignant melanoma,2,F,EXP,trametinib,1,PS,Sepsis,1,M,HO,962
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Cough,1,F,HO,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Cough,1,F,OT,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,HO,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,OT,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Liver function test abnormal,1,F,HO,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Liver function test abnormal,1,F,OT,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Mental impairment,1,F,HO,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Mental impairment,1,F,OT,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Nail disorder,1,F,HO,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Nail disorder,1,F,OT,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Night sweats,1,F,HO,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Night sweats,1,F,OT,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Rash pruritic,1,F,HO,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Rash pruritic,1,F,OT,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Restless legs syndrome,1,F,HO,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Restless legs syndrome,1,F,OT,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Retching,1,F,HO,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Retching,1,F,OT,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Skin discolouration,1,F,HO,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Skin discolouration,1,F,OT,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Urticaria,1,F,HO,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Urticaria,1,F,OT,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Viral infection,1,F,HO,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Viral infection,1,F,OT,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,118
171201032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Cough,2,F,HO,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Cough,2,F,OT,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Decreased appetite,2,F,HO,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Decreased appetite,2,F,OT,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Liver function test abnormal,2,F,HO,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Liver function test abnormal,2,F,OT,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Mental impairment,2,F,HO,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Mental impairment,2,F,OT,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Nail disorder,2,F,HO,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Nail disorder,2,F,OT,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Nausea,2,F,HO,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Nausea,2,F,OT,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Night sweats,2,F,HO,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Night sweats,2,F,OT,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Rash pruritic,2,F,HO,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Rash pruritic,2,F,OT,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Restless legs syndrome,2,F,HO,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Restless legs syndrome,2,F,OT,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Retching,2,F,HO,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Retching,2,F,OT,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Skin discolouration,2,F,HO,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Skin discolouration,2,F,OT,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Urticaria,2,F,HO,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Urticaria,2,F,OT,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Viral infection,2,F,HO,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Viral infection,2,F,OT,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Vomiting,2,F,HO,118
171201032,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Vomiting,2,F,OT,118
171201113,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Anaemia,3,M,OT,81
171201113,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Leukopenia,3,M,OT,81
171201113,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Pancytopenia,3,M,OT,81
171201113,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Thrombocytopenia,3,M,OT,81
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Abdominal pain,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Abdominal pain,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Asthenia,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Asthenia,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Dyspnoea,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Dyspnoea,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Fatigue,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Fatigue,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Glioma,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Glioma,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Infectious pleural effusion,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Infectious pleural effusion,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Insomnia,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Insomnia,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Nausea,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Nausea,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Paranasal sinus and nasal cavity malignant neoplasm,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Paranasal sinus and nasal cavity malignant neoplasm,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Pneumonitis,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Pneumonitis,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Pruritus,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Pruritus,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Pyrexia,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Pyrexia,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Rash erythematous,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Rash erythematous,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Second primary malignancy,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Second primary malignancy,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Syncope,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Syncope,6,M,OT,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Toxicity to various agents,6,M,HO,77
171235132,6,Malignant melanoma,2,F,EXP,trametinib,6,SS,Toxicity to various agents,6,M,OT,77
171238293,5,Ovarian cancer recurrent,3,F,EXP,trabectedin,5,SS,Asthenia,5,F,LT,24
171238293,5,Ovarian cancer recurrent,3,F,EXP,trabectedin,5,SS,Asthenia,5,F,OT,24
171238293,5,Ovarian cancer recurrent,3,F,EXP,trabectedin,5,SS,Asthenia,5,F,DS,24
171238293,5,Ovarian cancer recurrent,3,F,EXP,trabectedin,5,SS,Decreased appetite,5,F,LT,24
171238293,5,Ovarian cancer recurrent,3,F,EXP,trabectedin,5,SS,Decreased appetite,5,F,OT,24
171238293,5,Ovarian cancer recurrent,3,F,EXP,trabectedin,5,SS,Decreased appetite,5,F,DS,24
171238293,5,Ovarian cancer recurrent,3,F,EXP,trabectedin,5,SS,Mood altered,5,F,LT,24
171238293,5,Ovarian cancer recurrent,3,F,EXP,trabectedin,5,SS,Mood altered,5,F,OT,24
171238293,5,Ovarian cancer recurrent,3,F,EXP,trabectedin,5,SS,Mood altered,5,F,DS,24
171238293,5,Ovarian cancer recurrent,3,F,EXP,trabectedin,5,SS,Neutropenia,5,F,LT,24
171238293,5,Ovarian cancer recurrent,3,F,EXP,trabectedin,5,SS,Neutropenia,5,F,OT,24
171238293,5,Ovarian cancer recurrent,3,F,EXP,trabectedin,5,SS,Neutropenia,5,F,DS,24
171245422,1,Mantle cell lymphoma,2,F,EXP,ibrutinib,1,PS,Pericarditis,1,M,HO,628
171249852,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Platelet count decreased,1,F,HO,9
171249852,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,9
171249852,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,F,HO,9
171252173,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Pneumonia,1,M,LT,665
171252173,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Pneumonia,1,M,OT,665
171252173,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Pneumonia,1,M,HO,665
171252173,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Pulmonary embolism,1,M,LT,665
171252173,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Pulmonary embolism,1,M,OT,665
171252173,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Pulmonary embolism,1,M,HO,665
171262212,1,Neoplasm,2,F,EXP,nivolumab,1,SS,Diabetic ketoacidosis,1,F,HO,13
171262212,1,Neoplasm,2,F,EXP,nivolumab,1,SS,Diabetic ketoacidosis,1,F,OT,13
171262212,2,Neoplasm,2,F,EXP,ipilimumab,2,PS,Diabetic ketoacidosis,2,F,HO,13
171262212,2,Neoplasm,2,F,EXP,ipilimumab,2,PS,Diabetic ketoacidosis,2,F,OT,13
171286092,5,Triple negative breast cancer,2,F,EXP,pegfilgrastim,5,SS,Lymphadenopathy mediastinal,5,F,HO,112
171286534,2,Non-small cell lung cancer,4,F,EXP,pemetrexed disodium,2,SS,Lymphocyte count decreased,2,F,HO,61
171303282,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Vocal cord disorder,1,M,HO,43
171303282,3,Plasma cell myeloma,2,F,PER,lenalidomide,3,SS,Vocal cord disorder,3,M,HO,43
171306143,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Anaphylactic reaction,1,F,OT,42
171306143,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Anaphylactic reaction,1,F,LT,42
171306143,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Anaphylactic reaction,1,F,HO,42
171306143,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Cytokine release syndrome,1,F,OT,42
171306143,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Cytokine release syndrome,1,F,LT,42
171306143,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Cytokine release syndrome,1,F,HO,42
171306143,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Hypotension,1,F,OT,42
171306143,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Hypotension,1,F,LT,42
171306143,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Hypotension,1,F,HO,42
171310286,7,Product used for unknown indication,6,F,PER,zoledronic acid,7,C,Deep vein thrombosis,7,M,OT,81
171310286,7,Product used for unknown indication,6,F,PER,zoledronic acid,7,C,Deep vein thrombosis,7,M,HO,81
171310286,7,Product used for unknown indication,6,F,PER,zoledronic acid,7,C,Pleural effusion,7,M,OT,81
171310286,7,Product used for unknown indication,6,F,PER,zoledronic acid,7,C,Pleural effusion,7,M,HO,81
171310286,7,Product used for unknown indication,6,F,PER,zoledronic acid,7,C,Pneumonia,7,M,OT,81
171310286,7,Product used for unknown indication,6,F,PER,zoledronic acid,7,C,Pneumonia,7,M,HO,81
171312214,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Hypotension,1,M,HO,380
171321172,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,24
171321172,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,24
171321172,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,24
171321172,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,DE,24
171321172,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,OT,24
171321172,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,HO,24
171324234,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,Cytopenia,4,M,OT,73
171324234,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,Cytopenia,4,M,HO,73
171324234,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,Prothrombin time shortened,4,M,OT,73
171324234,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,Prothrombin time shortened,4,M,HO,73
171324234,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,Pulmonary haemorrhage,4,M,OT,73
171324234,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,Pulmonary haemorrhage,4,M,HO,73
171324234,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,White blood cell count decreased,4,M,OT,73
171324234,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,White blood cell count decreased,4,M,HO,73
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Blood lactate dehydrogenase increased,1,F,HO,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Blood lactate dehydrogenase increased,1,F,OT,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Flatulence,1,F,HO,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Flatulence,1,F,OT,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Large intestine perforation,1,F,HO,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Large intestine perforation,1,F,OT,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Leukoderma,1,F,HO,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Leukoderma,1,F,OT,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Macular detachment,1,F,HO,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Macular detachment,1,F,OT,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Pyrexia,1,F,OT,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Rash,1,F,HO,42
171333687,1,Malignant melanoma,7,F,EXP,nivolumab,1,PS,Rash,1,F,OT,42
171341113,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Dermatitis,1,M,HO,65
171353964,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Oesophageal haemorrhage,1,M,OT,122
171353964,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Oesophageal haemorrhage,1,M,HO,122
171353964,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Oesophageal haemorrhage,2,M,OT,445
171353964,2,Oesophageal squamous cell carcinoma,4,F,EXP,ipilimumab,2,SS,Oesophageal haemorrhage,2,M,HO,445
171367183,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Dehydration,1,F,HO,102
171367183,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Febrile neutropenia,1,F,HO,102
171367183,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Pyrexia,1,F,HO,102
171367213,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Septic shock,2,F,DE,4
171367213,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,White blood cell count decreased,2,F,DE,4
171368932,9,Product used for unknown indication,2,F,EXP,granisetron,9,C,Blast cell count increased,9,M,HO,98
171369424,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Embolism,1,M,HO,1
171369424,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Embolism,1,M,OT,1
171369424,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,HO,1
171369424,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,OT,1
171369462,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cortisol deficiency,1,M,OT,224
171369462,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cortisol deficiency,1,M,HO,224
171372525,1,Pancreatic carcinoma,5,F,EXP,nivolumab,1,PS,Capillary leak syndrome,1,F,OT,181
171372525,1,Pancreatic carcinoma,5,F,EXP,nivolumab,1,PS,Capillary leak syndrome,1,F,HO,181
171372525,1,Pancreatic carcinoma,5,F,EXP,nivolumab,1,PS,Capillary leak syndrome,1,F,DS,181
171372525,1,Pancreatic carcinoma,5,F,EXP,nivolumab,1,PS,Capillary leak syndrome,1,F,LT,181
171372525,1,Pancreatic carcinoma,5,F,EXP,nivolumab,1,PS,Haematoma,1,F,OT,181
171372525,1,Pancreatic carcinoma,5,F,EXP,nivolumab,1,PS,Haematoma,1,F,HO,181
171372525,1,Pancreatic carcinoma,5,F,EXP,nivolumab,1,PS,Haematoma,1,F,DS,181
171372525,1,Pancreatic carcinoma,5,F,EXP,nivolumab,1,PS,Haematoma,1,F,LT,181
171372782,1,Waldenstrom's macroglobulinaemia,2,F,EXP,idelalisib,1,PS,Squamous cell carcinoma of skin,1,M,OT,379
171377574,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,F,OT,58
171377574,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,F,LT,58
171377574,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,F,HO,58
171377574,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Asthenia,1,F,OT,58
171377574,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Asthenia,1,F,LT,58
171377574,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Asthenia,1,F,HO,58
171377574,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Enteritis,1,F,OT,58
171377574,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Enteritis,1,F,LT,58
171377574,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Enteritis,1,F,HO,58
171377574,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Myocarditis,1,F,OT,58
171377574,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Myocarditis,1,F,LT,58
171377574,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Myocarditis,1,F,HO,58
171379983,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Asthenia,3,F,DE,772
171379983,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Asthenia,3,F,HO,772
171379983,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Asthenia,3,F,OT,772
171379983,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Fatigue,3,F,DE,772
171379983,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Fatigue,3,F,HO,772
171379983,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Fatigue,3,F,OT,772
171379983,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Liver function test abnormal,3,F,DE,772
171379983,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Liver function test abnormal,3,F,HO,772
171379983,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Liver function test abnormal,3,F,OT,772
171379983,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Myocardial infarction,3,F,DE,772
171379983,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Myocardial infarction,3,F,HO,772
171379983,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Myocardial infarction,3,F,OT,772
171388172,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Gastric haemorrhage,1,M,HO,1
171388172,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Gastric haemorrhage,1,M,LT,1
171388172,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Gastric haemorrhage,1,M,OT,1
171388172,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Haemorrhagic stroke,1,M,HO,1
171388172,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Haemorrhagic stroke,1,M,LT,1
171388172,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Haemorrhagic stroke,1,M,OT,1
171388172,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Renal failure,1,M,HO,1
171388172,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Renal failure,1,M,LT,1
171388172,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Renal failure,1,M,OT,1
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Colitis,1,M,DE,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Colitis,1,M,LT,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,M,DE,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,M,HO,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,M,LT,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,M,OT,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,DE,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,HO,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,LT,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,OT,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,DE,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,LT,151
171405135,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,151
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Colitis,2,M,DE,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Colitis,2,M,HO,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Colitis,2,M,LT,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Colitis,2,M,OT,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Diabetic ketoacidosis,2,M,DE,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Diabetic ketoacidosis,2,M,HO,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Diabetic ketoacidosis,2,M,LT,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Diabetic ketoacidosis,2,M,OT,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,DE,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,HO,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,LT,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,OT,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,DE,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,HO,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,LT,39
171405135,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pneumonitis,2,M,OT,39
171411004,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Back pain,1,M,OT,4
171411004,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Crystalluria,1,M,OT,4
171411004,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Dizziness,1,M,OT,4
171411004,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,M,OT,4
171411004,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Nausea,1,M,OT,4
171411004,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Syncope,1,M,OT,4
171411004,1,Multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,M,OT,4
171413212,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Autoimmune colitis,1,F,HO,212
171413212,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Fibroadenoma of breast,1,F,HO,212
171413212,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,HO,212
171415073,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Mucosal inflammation,1,F,OT,68
171415073,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Mucosal inflammation,1,F,HO,68
171415073,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Pyrexia,1,F,OT,68
171415073,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Pyrexia,1,F,HO,68
171415073,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Vomiting,1,F,OT,68
171415073,1,Hodgkin's disease,3,F,EXP,brentuximab vedotin,1,PS,Vomiting,1,F,HO,68
171417242,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Anxiety,1,M,OT,23
171417242,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Arthralgia,1,M,OT,23
171417242,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Back pain,1,M,OT,23
171417242,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Dry skin,1,M,OT,23
171417242,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,23
171417242,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Haemoglobin decreased,1,M,OT,23
171417242,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Intentional dose omission,1,M,OT,23
171417242,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Somnolence,1,M,OT,23
171417242,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Urinary tract infection,1,M,OT,23
171417242,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Walking aid user,1,M,OT,23
171419843,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Pneumococcal infection,3,M,HO,299
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Dizziness,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Dyspnoea,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Eye inflammation,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Eye pain,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Fatigue,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Gastric disorder,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Headache,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Influenza like illness,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Malaise,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Myalgia,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Nervousness,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Ocular hyperaemia,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Off label use,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Pain,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Product use in unapproved indication,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Pyrexia,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Stress,1,F,OT,1
171421454,1,Osteoporosis,4,F,EXP,zoledronic acid,1,PS,Syncope,1,F,OT,1
171422682,1,Plasma cell myeloma refractory,2,F,EXP,thalidomide,1,PS,Hyperglycaemia,1,M,HO,131
171422682,1,Plasma cell myeloma refractory,2,F,EXP,thalidomide,1,PS,Hyperglycaemia,1,M,OT,131
171422682,1,Plasma cell myeloma refractory,2,F,EXP,thalidomide,1,PS,Sepsis,1,M,HO,131
171422682,1,Plasma cell myeloma refractory,2,F,EXP,thalidomide,1,PS,Sepsis,1,M,OT,131
171422682,1,Plasma cell myeloma refractory,2,F,EXP,thalidomide,1,PS,Spinal fracture,1,M,HO,131
171422682,1,Plasma cell myeloma refractory,2,F,EXP,thalidomide,1,PS,Spinal fracture,1,M,OT,131
171424572,2,Hepatocellular carcinoma,2,F,PER,nivolumab,2,SS,Pyrexia,2,M,HO,21
171426642,3,Mantle cell lymphoma,2,F,EXP,lenalidomide,3,C,Cytopenia,3,F,HO,94
171427672,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,SS,Pain in extremity,1,M,HO,70
171427672,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,SS,Polyneuropathy,1,M,HO,70
171428332,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Chest discomfort,2,F,OT,3632
171428332,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Headache,2,F,OT,3632
171428332,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Paraesthesia,2,F,OT,3632
171428332,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Thrombocytopenia,2,F,OT,3632
171428332,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Visual impairment,2,F,OT,3632
171428332,9,Prophylaxis,2,F,EXP,zoledronic acid,9,C,Chest discomfort,9,F,OT,2995
171428332,9,Prophylaxis,2,F,EXP,zoledronic acid,9,C,Headache,9,F,OT,2995
171428332,9,Prophylaxis,2,F,EXP,zoledronic acid,9,C,Paraesthesia,9,F,OT,2995
171428332,9,Prophylaxis,2,F,EXP,zoledronic acid,9,C,Thrombocytopenia,9,F,OT,2995
171428332,9,Prophylaxis,2,F,EXP,zoledronic acid,9,C,Visual impairment,9,F,OT,2995
171428902,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Vocal cord disorder,1,M,HO,43
171428902,3,Plasma cell myeloma,2,F,EXP,carfilzomib,3,SS,Vocal cord disorder,3,M,HO,43
171431215,1,Pleural mesothelioma,5,F,EXP,nivolumab,1,PS,Nephrotic syndrome,1,M,HO,125
171431215,1,Pleural mesothelioma,5,F,EXP,nivolumab,1,PS,Nephrotic syndrome,1,M,OT,125
171431215,2,Pleural mesothelioma,5,F,EXP,ipilimumab,2,SS,Nephrotic syndrome,2,M,HO,125
171431215,2,Pleural mesothelioma,5,F,EXP,ipilimumab,2,SS,Nephrotic syndrome,2,M,OT,125
171438886,8,Premedication,6,F,EXP,granisetron,8,C,Anaemia,8,F,HO,14
171438886,8,Premedication,6,F,EXP,granisetron,8,C,Asthenia,8,F,HO,14
171438886,8,Premedication,6,F,EXP,granisetron,8,C,Pyrexia,8,F,HO,14
171438886,8,Premedication,6,F,EXP,granisetron,8,C,Syncope,8,F,HO,14
171440642,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Diabetic metabolic decompensation,1,M,OT,707
171440642,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Diabetic metabolic decompensation,1,M,HO,707
171440642,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,707
171440642,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,707
171440642,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,707
171440642,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,707
171440642,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Pain,1,M,OT,707
171440642,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Pain,1,M,HO,707
171440642,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Phlebitis,1,M,OT,707
171440642,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Phlebitis,1,M,HO,707
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,HO,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,LT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,OT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Adrenal insufficiency,3,M,HO,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Adrenal insufficiency,3,M,LT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Adrenal insufficiency,3,M,OT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Delirium,3,M,HO,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Delirium,3,M,LT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Delirium,3,M,OT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Hypertension,3,M,HO,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Hypertension,3,M,LT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Hypertension,3,M,OT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Hyponatraemia,3,M,HO,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Hyponatraemia,3,M,LT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Hyponatraemia,3,M,OT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Hypoxia,3,M,HO,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Hypoxia,3,M,LT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Hypoxia,3,M,OT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Lymphocyte count decreased,3,M,HO,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Lymphocyte count decreased,3,M,LT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Lymphocyte count decreased,3,M,OT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Meningioma,3,M,HO,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Meningioma,3,M,LT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Meningioma,3,M,OT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Pneumonia,3,M,HO,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Pneumonia,3,M,LT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Pneumonia,3,M,OT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Respiratory failure,3,M,HO,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Respiratory failure,3,M,LT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Respiratory failure,3,M,OT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Sepsis,3,M,HO,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Sepsis,3,M,LT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Sepsis,3,M,OT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Urinary tract infection,3,M,HO,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Urinary tract infection,3,M,LT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Urinary tract infection,3,M,OT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Vomiting,3,M,HO,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Vomiting,3,M,LT,32
171441833,3,Transitional cell carcinoma,3,F,EXP,ipilimumab,3,SS,Vomiting,3,M,OT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Acute kidney injury,4,M,HO,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Acute kidney injury,4,M,LT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Acute kidney injury,4,M,OT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Adrenal insufficiency,4,M,HO,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Adrenal insufficiency,4,M,LT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Adrenal insufficiency,4,M,OT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Delirium,4,M,HO,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Delirium,4,M,LT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Delirium,4,M,OT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Hypertension,4,M,HO,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Hypertension,4,M,LT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Hypertension,4,M,OT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Hyponatraemia,4,M,HO,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Hyponatraemia,4,M,LT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Hyponatraemia,4,M,OT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Hypoxia,4,M,HO,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Hypoxia,4,M,LT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Hypoxia,4,M,OT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Lymphocyte count decreased,4,M,HO,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Lymphocyte count decreased,4,M,LT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Lymphocyte count decreased,4,M,OT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Meningioma,4,M,HO,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Meningioma,4,M,LT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Meningioma,4,M,OT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Pneumonia,4,M,HO,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Pneumonia,4,M,LT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Pneumonia,4,M,OT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Respiratory failure,4,M,HO,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Respiratory failure,4,M,LT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Respiratory failure,4,M,OT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Sepsis,4,M,HO,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Sepsis,4,M,LT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Sepsis,4,M,OT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Urinary tract infection,4,M,HO,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Urinary tract infection,4,M,LT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Urinary tract infection,4,M,OT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Vomiting,4,M,HO,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Vomiting,4,M,LT,32
171441833,4,Transitional cell carcinoma,3,F,EXP,nivolumab,4,SS,Vomiting,4,M,OT,32
171445012,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,SS,Atrial fibrillation,1,F,HO,68
171445012,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,SS,Atrial fibrillation,1,F,OT,68
171445012,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,SS,Hypertension,1,F,HO,68
171445012,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,SS,Hypertension,1,F,OT,68
171445012,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,SS,Neutrophil count decreased,1,F,HO,68
171445012,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,SS,Neutrophil count decreased,1,F,OT,68
171445012,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,SS,Non-cardiac chest pain,1,F,HO,68
171445012,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,SS,Non-cardiac chest pain,1,F,OT,68
171448234,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Chronic graft versus host disease,1,F,OT,40
171448234,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Chronic graft versus host disease,1,F,DE,40
171448234,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Lung disorder,1,F,OT,40
171448234,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Lung disorder,1,F,DE,40
171448234,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Maternal exposure during pregnancy,1,F,OT,40
171448234,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Maternal exposure during pregnancy,1,F,DE,40
171448234,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Spinal fracture,1,F,OT,40
171448234,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Spinal fracture,1,F,DE,40
171448234,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Staphylococcal sepsis,1,F,OT,40
171448234,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Staphylococcal sepsis,1,F,DE,40
171448234,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Unintended pregnancy,1,F,OT,40
171448234,1,Hodgkin's disease,4,F,EXP,nivolumab,1,PS,Unintended pregnancy,1,F,DE,40
171459644,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Anal fissure,1,F,HO,379
171459644,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Neutrophil count decreased,1,F,HO,379
171459644,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Anal fissure,2,F,HO,197
171459644,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Neutrophil count decreased,2,F,HO,197
171460192,23,Plasma cell myeloma,2,F,EXP,daratumumab,23,C,Abdominal abscess,23,M,OT,23
171460192,23,Plasma cell myeloma,2,F,EXP,daratumumab,23,C,Abdominal abscess,23,M,DE,23
171460192,23,Plasma cell myeloma,2,F,EXP,daratumumab,23,C,Diverticular perforation,23,M,OT,23
171460192,23,Plasma cell myeloma,2,F,EXP,daratumumab,23,C,Diverticular perforation,23,M,DE,23
171460192,23,Plasma cell myeloma,2,F,EXP,daratumumab,23,C,Ileus,23,M,OT,23
171460192,23,Plasma cell myeloma,2,F,EXP,daratumumab,23,C,Ileus,23,M,DE,23
171460192,23,Plasma cell myeloma,2,F,EXP,daratumumab,23,C,Neutrophil count decreased,23,M,OT,23
171460192,23,Plasma cell myeloma,2,F,EXP,daratumumab,23,C,Neutrophil count decreased,23,M,DE,23
171460192,23,Plasma cell myeloma,2,F,EXP,daratumumab,23,C,Plasma cell myeloma,23,M,OT,23
171460192,23,Plasma cell myeloma,2,F,EXP,daratumumab,23,C,Plasma cell myeloma,23,M,DE,23
171460192,23,Plasma cell myeloma,2,F,EXP,daratumumab,23,C,Platelet count decreased,23,M,OT,23
171460192,23,Plasma cell myeloma,2,F,EXP,daratumumab,23,C,Platelet count decreased,23,M,DE,23
171460192,23,Plasma cell myeloma,2,F,EXP,daratumumab,23,C,Pneumonia,23,M,OT,23
171460192,23,Plasma cell myeloma,2,F,EXP,daratumumab,23,C,Pneumonia,23,M,DE,23
171462053,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Interstitial lung disease,2,F,DE,27
171462053,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Interstitial lung disease,2,F,HO,27
171462053,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Interstitial lung disease,2,F,OT,27
171462053,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Lymphangiosis carcinomatosa,2,F,DE,27
171462053,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Lymphangiosis carcinomatosa,2,F,HO,27
171462053,2,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,2,SS,Lymphangiosis carcinomatosa,2,F,OT,27
171465212,5,Alveolar rhabdomyosarcoma,2,F,EXP,dactinomycin,5,SS,Clostridium difficile colitis,5,M,HO,240
171465212,5,Alveolar rhabdomyosarcoma,2,F,EXP,dactinomycin,5,SS,Dehydration,5,M,HO,240
171465212,5,Alveolar rhabdomyosarcoma,2,F,EXP,dactinomycin,5,SS,Diarrhoea,5,M,HO,240
171465212,5,Alveolar rhabdomyosarcoma,2,F,EXP,dactinomycin,5,SS,Gastroenteritis Escherichia coli,5,M,HO,240
171465212,5,Alveolar rhabdomyosarcoma,2,F,EXP,dactinomycin,5,SS,Gastroenteritis sapovirus,5,M,HO,240
171465285,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Cardiac failure congestive,2,M,HO,30
171465285,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Cardiac failure congestive,2,M,OT,30
171465285,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Myocarditis,2,M,HO,30
171465285,2,Renal cell carcinoma,5,F,EXP,nivolumab,2,PS,Myocarditis,2,M,OT,30
171465362,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Device related thrombosis,1,M,OT,176
171465362,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Device related thrombosis,1,M,HO,176
171465362,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Haematuria,1,M,OT,176
171465362,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Haematuria,1,M,HO,176
171465362,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Urinary retention,1,M,OT,176
171465362,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Urinary retention,1,M,HO,176
171465362,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Device related thrombosis,2,M,OT,176
171465362,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Device related thrombosis,2,M,HO,176
171465362,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Haematuria,2,M,OT,176
171465362,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Haematuria,2,M,HO,176
171465362,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Urinary retention,2,M,OT,176
171465362,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Urinary retention,2,M,HO,176
171466602,1,Breast cancer,2,F,EXP,alpelisib,1,PS,Chills,1,F,HO,26
171466602,1,Breast cancer,2,F,EXP,alpelisib,1,PS,Pyrexia,1,F,HO,26
171466602,1,Breast cancer,2,F,EXP,alpelisib,1,PS,Vomiting,1,F,HO,26
171467762,1,Plasma cell myeloma,2,F,EXP,thalidomide,1,PS,Acetabulum fracture,1,F,HO,271
171467762,1,Plasma cell myeloma,2,F,EXP,thalidomide,1,PS,Osteoarthritis,1,F,HO,271
171467913,3,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,3,C,Arthralgia,3,F,OT,14
171467913,3,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,3,C,Arthralgia,3,F,HO,14
171467913,3,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,3,C,Polymyalgia rheumatica,3,F,OT,14
171467913,3,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,3,C,Polymyalgia rheumatica,3,F,HO,14
171467913,3,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,3,C,Rash,3,F,OT,14
171467913,3,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,3,C,Rash,3,F,HO,14
171471522,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,SS,Cholangitis sclerosing,3,M,OT,17
171471522,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,SS,Cholangitis sclerosing,3,M,HO,17
171471522,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,SS,Drug-induced liver injury,3,M,OT,17
171471522,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,SS,Drug-induced liver injury,3,M,HO,17
171473984,1,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Acute coronary syndrome,1,M,OT,584
171473984,1,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Acute coronary syndrome,1,M,HO,584
171473984,1,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Acute coronary syndrome,1,M,LT,584
171473984,1,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,OT,584
171473984,1,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,HO,584
171473984,1,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,LT,584
171473984,1,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Myocardial infarction,1,M,OT,584
171473984,1,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Myocardial infarction,1,M,HO,584
171473984,1,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Myocardial infarction,1,M,LT,584
171473984,1,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Myocarditis,1,M,OT,584
171473984,1,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Myocarditis,1,M,HO,584
171473984,1,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Myocarditis,1,M,LT,584
171473984,2,Metastatic renal cell carcinoma,4,F,EXP,axitinib,2,SS,Acute coronary syndrome,2,M,OT,591
171473984,2,Metastatic renal cell carcinoma,4,F,EXP,axitinib,2,SS,Acute coronary syndrome,2,M,HO,591
171473984,2,Metastatic renal cell carcinoma,4,F,EXP,axitinib,2,SS,Acute coronary syndrome,2,M,LT,591
171473984,2,Metastatic renal cell carcinoma,4,F,EXP,axitinib,2,SS,Cardiac failure congestive,2,M,OT,591
171473984,2,Metastatic renal cell carcinoma,4,F,EXP,axitinib,2,SS,Cardiac failure congestive,2,M,HO,591
171473984,2,Metastatic renal cell carcinoma,4,F,EXP,axitinib,2,SS,Cardiac failure congestive,2,M,LT,591
171473984,2,Metastatic renal cell carcinoma,4,F,EXP,axitinib,2,SS,Myocardial infarction,2,M,OT,591
171473984,2,Metastatic renal cell carcinoma,4,F,EXP,axitinib,2,SS,Myocardial infarction,2,M,HO,591
171473984,2,Metastatic renal cell carcinoma,4,F,EXP,axitinib,2,SS,Myocardial infarction,2,M,LT,591
171473984,2,Metastatic renal cell carcinoma,4,F,EXP,axitinib,2,SS,Myocarditis,2,M,OT,591
171473984,2,Metastatic renal cell carcinoma,4,F,EXP,axitinib,2,SS,Myocarditis,2,M,HO,591
171473984,2,Metastatic renal cell carcinoma,4,F,EXP,axitinib,2,SS,Myocarditis,2,M,LT,591
171476913,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Abdominal distension,2,M,OT,18
171476913,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Abdominal pain upper,2,M,OT,18
171476913,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Decreased appetite,2,M,OT,18
171476913,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Depression,2,M,OT,18
171476913,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Diarrhoea,2,M,OT,18
171476913,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Epistaxis,2,M,OT,18
171476913,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Groin pain,2,M,OT,18
171476913,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Hypertension,2,M,OT,18
171476913,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,18
171476913,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Night sweats,2,M,OT,18
171476913,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Weight decreased,2,M,OT,18
171478292,2,Renal cancer metastatic,2,F,EXP,nivolumab,2,SS,Device related infection,2,M,OT,104
171478292,2,Renal cancer metastatic,2,F,EXP,nivolumab,2,SS,Device related infection,2,M,HO,104
171478292,2,Renal cancer metastatic,2,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,104
171478292,2,Renal cancer metastatic,2,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,HO,104
171478292,2,Renal cancer metastatic,2,F,EXP,nivolumab,2,SS,Nephrotic syndrome,2,M,OT,104
171478292,2,Renal cancer metastatic,2,F,EXP,nivolumab,2,SS,Nephrotic syndrome,2,M,HO,104
171478292,2,Renal cancer metastatic,2,F,EXP,nivolumab,2,SS,Pyrexia,2,M,OT,104
171478292,2,Renal cancer metastatic,2,F,EXP,nivolumab,2,SS,Pyrexia,2,M,HO,104
171478292,2,Renal cancer metastatic,2,F,EXP,nivolumab,2,SS,Renal failure,2,M,OT,104
171478292,2,Renal cancer metastatic,2,F,EXP,nivolumab,2,SS,Renal failure,2,M,HO,104
171478292,2,Renal cancer metastatic,2,F,EXP,nivolumab,2,SS,Urinary tract infection bacterial,2,M,OT,104
171478292,2,Renal cancer metastatic,2,F,EXP,nivolumab,2,SS,Urinary tract infection bacterial,2,M,HO,104
171478463,6,Plasma cell myeloma,3,F,EXP,thalidomide,6,SS,Squamous cell carcinoma of skin,6,M,OT,1726
171478463,7,Plasma cell myeloma,3,F,EXP,lenalidomide,7,SS,Squamous cell carcinoma of skin,7,M,OT,266
171478516,1,Plasma cell myeloma,6,F,PER,pomalidomide,1,PS,Pneumonia,1,F,HO,1253
171479584,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Acidosis,1,M,OT,114
171479584,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Acidosis,1,M,HO,114
171479584,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Acidosis,1,M,LT,114
171479584,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,114
171479584,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,114
171479584,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,LT,114
171479584,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,OT,114
171479584,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,HO,114
171479584,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,LT,114
171479584,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,OT,114
171479584,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,HO,114
171479584,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,LT,114
171479753,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Amylase increased,2,M,OT,34
171479753,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Amylase increased,2,M,HO,34
171479753,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Hepatitis,2,M,OT,34
171479753,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Hepatitis,2,M,HO,34
171479753,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Lipase increased,2,M,OT,34
171479753,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Lipase increased,2,M,HO,34
171479753,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Amylase increased,3,M,OT,34
171479753,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Amylase increased,3,M,HO,34
171479753,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Hepatitis,3,M,OT,34
171479753,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Hepatitis,3,M,HO,34
171479753,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Lipase increased,3,M,OT,34
171479753,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Lipase increased,3,M,HO,34
171484282,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Anaemia,1,M,OT,504
171484282,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Anaemia,1,M,DE,504
171484282,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Basal cell carcinoma,1,M,OT,504
171484282,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Basal cell carcinoma,1,M,DE,504
171484282,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Eosinophil count increased,1,M,OT,504
171484282,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Eosinophil count increased,1,M,DE,504
171484282,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Lung neoplasm malignant,1,M,OT,504
171484282,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Lung neoplasm malignant,1,M,DE,504
171484722,1,Squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Septic shock,1,M,OT,57
171484722,1,Squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Septic shock,1,M,LT,57
171484722,1,Squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Septic shock,1,M,HO,57
171486033,1,Gastric cancer,3,F,EXP,nivolumab,1,PS,Visual impairment,1,M,DS,373
171486033,1,Gastric cancer,3,F,EXP,nivolumab,1,PS,Visual impairment,1,M,OT,373
171486642,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Myocardial infarction,1,M,HO,2
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Diverticulitis,10,F,OT,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Diverticulitis,10,F,HO,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Dyspnoea,10,F,OT,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Dyspnoea,10,F,HO,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Nausea,10,F,OT,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Nausea,10,F,HO,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Neutropenia,10,F,OT,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Neutropenia,10,F,HO,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Plasma cell myeloma,10,F,OT,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Plasma cell myeloma,10,F,HO,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Sinus tachycardia,10,F,OT,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Sinus tachycardia,10,F,HO,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Thrombocytopenia,10,F,OT,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Thrombocytopenia,10,F,HO,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Toothache,10,F,OT,3
171491646,10,Plasma cell myeloma,6,F,EXP,nivolumab,10,C,Toothache,10,F,HO,3
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Diverticulitis,24,F,OT,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Diverticulitis,24,F,HO,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Dyspnoea,24,F,OT,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Dyspnoea,24,F,HO,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Nausea,24,F,OT,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Nausea,24,F,HO,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Neutropenia,24,F,OT,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Neutropenia,24,F,HO,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Plasma cell myeloma,24,F,OT,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Plasma cell myeloma,24,F,HO,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Sinus tachycardia,24,F,OT,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Sinus tachycardia,24,F,HO,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Thrombocytopenia,24,F,OT,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Thrombocytopenia,24,F,HO,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Toothache,24,F,OT,17
171491646,24,Plasma cell myeloma,6,F,EXP,daratumumab,24,C,Toothache,24,F,HO,17
171502003,5,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,5,SS,Ascites,5,M,HO,141
171502003,5,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,5,SS,Generalised oedema,5,M,HO,141
171502003,5,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,5,SS,Portal hypertension,5,M,HO,141
171516643,1,Lung adenocarcinoma,3,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,OT,29
171516643,1,Lung adenocarcinoma,3,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,HO,29
171516643,1,Lung adenocarcinoma,3,F,EXP,nivolumab,1,PS,Drug eruption,1,F,OT,29
171516643,1,Lung adenocarcinoma,3,F,EXP,nivolumab,1,PS,Drug eruption,1,F,HO,29
171516643,2,Lung adenocarcinoma,3,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,OT,29
171516643,2,Lung adenocarcinoma,3,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,HO,29
171516643,2,Lung adenocarcinoma,3,F,EXP,ipilimumab,2,SS,Drug eruption,2,F,OT,29
171516643,2,Lung adenocarcinoma,3,F,EXP,ipilimumab,2,SS,Drug eruption,2,F,HO,29
171522822,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cough,1,M,OT,11
171522822,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cough,1,M,HO,11
171522822,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Disease progression,1,M,OT,11
171522822,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Disease progression,1,M,HO,11
171522822,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hospitalisation,1,M,OT,11
171522822,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hospitalisation,1,M,HO,11
171522822,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pain in extremity,1,M,OT,11
171522822,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pain in extremity,1,M,HO,11
171524463,2,Lymphoma,3,F,EXP,bleomycin sulfate,2,SS,Ear pain,2,F,OT,1
171524463,2,Lymphoma,3,F,EXP,bleomycin sulfate,2,SS,Pyrexia,2,F,OT,1
171524463,2,Lymphoma,3,F,EXP,bleomycin sulfate,2,SS,Tinnitus,2,F,OT,1
171528242,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Dysphagia,1,F,HO,28
171528242,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,General physical health deterioration,1,F,HO,28
171528242,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Oral candidiasis,1,F,HO,28
171529033,26,Prophylaxis of nausea and vomiting,3,F,EXP,granisetron,26,C,Depressed level of consciousness,26,M,HO,385
171530895,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Hypoxia,1,F,HO,454
171530895,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Organising pneumonia,1,F,HO,454
171530895,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Pneumonia,1,F,HO,454
171530895,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Pulmonary hypertension,1,F,HO,454
171531553,4,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,4,SS,Ascites,4,M,HO,141
171531553,4,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,4,SS,Generalised oedema,4,M,HO,141
171531553,4,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,4,SS,Portal hypertension,4,M,HO,141
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Dysphagia,1,M,OT,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Dysphagia,1,M,HO,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Electrocardiogram QT prolonged,1,M,OT,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Electrocardiogram QT prolonged,1,M,HO,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Electrolyte imbalance,1,M,OT,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Electrolyte imbalance,1,M,HO,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Hypotension,1,M,OT,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Hypotension,1,M,HO,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Nodal arrhythmia,1,M,OT,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Nodal arrhythmia,1,M,HO,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Norovirus test positive,1,M,OT,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Norovirus test positive,1,M,HO,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Pneumonia aspiration,1,M,OT,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Pneumonia aspiration,1,M,HO,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,202
171533186,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,202
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,OT,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,HO,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Adrenal insufficiency,2,M,OT,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Adrenal insufficiency,2,M,HO,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Dehydration,2,M,OT,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Dehydration,2,M,HO,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Dysphagia,2,M,OT,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Dysphagia,2,M,HO,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Electrocardiogram QT prolonged,2,M,OT,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Electrocardiogram QT prolonged,2,M,HO,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Electrolyte imbalance,2,M,OT,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Electrolyte imbalance,2,M,HO,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Hypotension,2,M,OT,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Hypotension,2,M,HO,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Nodal arrhythmia,2,M,OT,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Nodal arrhythmia,2,M,HO,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Norovirus test positive,2,M,OT,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Norovirus test positive,2,M,HO,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Pneumonia,2,M,OT,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Pneumonia,2,M,HO,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Pneumonia aspiration,2,M,OT,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Pneumonia aspiration,2,M,HO,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Pneumonitis,2,M,OT,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Pneumonitis,2,M,HO,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Sepsis,2,M,OT,16
171533186,2,Product used for unknown indication,6,F,EXP,nivolumab,2,SS,Sepsis,2,M,HO,16
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,OT,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,HO,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Adrenal insufficiency,3,M,OT,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Adrenal insufficiency,3,M,HO,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Dehydration,3,M,OT,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Dehydration,3,M,HO,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Dysphagia,3,M,OT,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Dysphagia,3,M,HO,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Electrocardiogram QT prolonged,3,M,OT,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Electrocardiogram QT prolonged,3,M,HO,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Electrolyte imbalance,3,M,OT,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Electrolyte imbalance,3,M,HO,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Hypotension,3,M,OT,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Hypotension,3,M,HO,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Nodal arrhythmia,3,M,OT,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Nodal arrhythmia,3,M,HO,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Norovirus test positive,3,M,OT,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Norovirus test positive,3,M,HO,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Pneumonia,3,M,OT,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Pneumonia,3,M,HO,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Pneumonia aspiration,3,M,OT,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Pneumonia aspiration,3,M,HO,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Pneumonitis,3,M,OT,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Pneumonitis,3,M,HO,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Sepsis,3,M,OT,202
171533186,3,Non-small cell lung cancer,6,F,EXP,ipilimumab,3,SS,Sepsis,3,M,HO,202
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Acute kidney injury,4,M,OT,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Acute kidney injury,4,M,HO,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Adrenal insufficiency,4,M,OT,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Adrenal insufficiency,4,M,HO,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Dehydration,4,M,OT,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Dehydration,4,M,HO,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Dysphagia,4,M,OT,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Dysphagia,4,M,HO,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Electrocardiogram QT prolonged,4,M,OT,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Electrocardiogram QT prolonged,4,M,HO,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Electrolyte imbalance,4,M,OT,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Electrolyte imbalance,4,M,HO,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Hypotension,4,M,OT,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Hypotension,4,M,HO,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Nodal arrhythmia,4,M,OT,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Nodal arrhythmia,4,M,HO,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Norovirus test positive,4,M,OT,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Norovirus test positive,4,M,HO,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Pneumonia,4,M,OT,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Pneumonia,4,M,HO,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Pneumonia aspiration,4,M,OT,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Pneumonia aspiration,4,M,HO,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Pneumonitis,4,M,OT,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Pneumonitis,4,M,HO,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Sepsis,4,M,OT,113
171533186,4,Product used for unknown indication,6,F,EXP,ipilimumab,4,SS,Sepsis,4,M,HO,113
171537133,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,37
171537133,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,37
171537133,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,37
171537133,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,37
171537133,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Headache,1,M,HO,37
171537133,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Headache,1,M,OT,37
171537133,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,M,HO,37
171537133,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,M,OT,37
171537133,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,37
171537133,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,37
171537133,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Lymphocytic hypophysitis,1,M,HO,37
171537133,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Lymphocytic hypophysitis,1,M,OT,37
171537133,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,M,HO,37
171537133,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,M,OT,37
171537133,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Fatigue,2,M,HO,37
171537133,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Fatigue,2,M,OT,37
171537133,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Headache,2,M,HO,37
171537133,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Headache,2,M,OT,37
171537133,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Hyperthyroidism,2,M,HO,37
171537133,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Hyperthyroidism,2,M,OT,37
171537133,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,M,HO,37
171537133,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,M,OT,37
171537133,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Lymphocytic hypophysitis,2,M,HO,37
171537133,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Lymphocytic hypophysitis,2,M,OT,37
171546262,3,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,3,SS,Neutrophil count decreased,3,F,HO,112
171546262,3,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,3,SS,Otitis media,3,F,HO,112
171546262,3,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,3,SS,Pharyngitis,3,F,HO,112
171558316,1,Plasma cell myeloma,6,F,PER,carfilzomib,1,PS,Acute kidney injury,1,M,HO,2
171558316,1,Plasma cell myeloma,6,F,PER,carfilzomib,1,PS,Haematuria,1,M,HO,2
171558316,1,Plasma cell myeloma,6,F,PER,carfilzomib,1,PS,Urinary tract infection,1,M,HO,2
171558316,5,Plasma cell myeloma,6,F,PER,lenalidomide,5,SS,Acute kidney injury,5,M,HO,2
171558316,5,Plasma cell myeloma,6,F,PER,lenalidomide,5,SS,Haematuria,5,M,HO,2
171558316,5,Plasma cell myeloma,6,F,PER,lenalidomide,5,SS,Urinary tract infection,5,M,HO,2
171562892,1,Triple negative breast cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,F,HO,127
171562892,1,Triple negative breast cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,F,OT,127
171562892,2,Triple negative breast cancer,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,F,HO,127
171562892,2,Triple negative breast cancer,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,F,OT,127
171590573,3,Metastases to bone,3,F,EXP,zoledronic acid,3,SS,Anaemia,3,F,OT,15
171590573,3,Metastases to bone,3,F,EXP,zoledronic acid,3,SS,Blood pressure increased,3,F,OT,15
171590573,3,Metastases to bone,3,F,EXP,zoledronic acid,3,SS,Diarrhoea,3,F,OT,15
171590573,3,Metastases to bone,3,F,EXP,zoledronic acid,3,SS,Nausea,3,F,OT,15
171590573,3,Metastases to bone,3,F,EXP,zoledronic acid,3,SS,Renal impairment,3,F,OT,15
171591302,1,Renal cell carcinoma,2,F,EXP,avelumab,1,PS,Hyperglycaemic hyperosmolar nonketotic syndrome,1,F,HO,931
171595573,1,Relapsing multiple sclerosis,3,F,EXP,ofatumumab,1,PS,Status epilepticus,1,M,LT,170
171595573,1,Relapsing multiple sclerosis,3,F,EXP,ofatumumab,1,PS,Status epilepticus,1,M,HO,170
171595573,2,Relapsing multiple sclerosis,3,F,EXP,ofatumumab,2,SS,Status epilepticus,2,M,LT,176
171595573,2,Relapsing multiple sclerosis,3,F,EXP,ofatumumab,2,SS,Status epilepticus,2,M,HO,176
171596292,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,PS,Pneumonia,1,F,HO,344
171596292,3,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,3,SS,Pneumonia,3,F,HO,9
171603344,1,Neuroendocrine tumour,4,F,EXP,nivolumab,1,PS,Dermatitis exfoliative generalised,1,M,HO,130
171603344,1,Neuroendocrine tumour,4,F,EXP,nivolumab,1,PS,Dermatitis exfoliative generalised,1,M,DE,130
171603344,1,Neuroendocrine tumour,4,F,EXP,nivolumab,1,PS,Dermatitis exfoliative generalised,1,M,OT,130
171603344,1,Neuroendocrine tumour,4,F,EXP,nivolumab,1,PS,Erythrodermic psoriasis,1,M,HO,130
171603344,1,Neuroendocrine tumour,4,F,EXP,nivolumab,1,PS,Erythrodermic psoriasis,1,M,DE,130
171603344,1,Neuroendocrine tumour,4,F,EXP,nivolumab,1,PS,Erythrodermic psoriasis,1,M,OT,130
171603344,1,Neuroendocrine tumour,4,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,130
171603344,1,Neuroendocrine tumour,4,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,130
171603344,1,Neuroendocrine tumour,4,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,130
171603344,1,Neuroendocrine tumour,4,F,EXP,nivolumab,1,PS,Septic shock,1,M,HO,130
171603344,1,Neuroendocrine tumour,4,F,EXP,nivolumab,1,PS,Septic shock,1,M,DE,130
171603344,1,Neuroendocrine tumour,4,F,EXP,nivolumab,1,PS,Septic shock,1,M,OT,130
171603344,2,Neuroendocrine tumour,4,F,EXP,ipilimumab,2,SS,Dermatitis exfoliative generalised,2,M,HO,130
171603344,2,Neuroendocrine tumour,4,F,EXP,ipilimumab,2,SS,Dermatitis exfoliative generalised,2,M,DE,130
171603344,2,Neuroendocrine tumour,4,F,EXP,ipilimumab,2,SS,Dermatitis exfoliative generalised,2,M,OT,130
171603344,2,Neuroendocrine tumour,4,F,EXP,ipilimumab,2,SS,Erythrodermic psoriasis,2,M,HO,130
171603344,2,Neuroendocrine tumour,4,F,EXP,ipilimumab,2,SS,Erythrodermic psoriasis,2,M,DE,130
171603344,2,Neuroendocrine tumour,4,F,EXP,ipilimumab,2,SS,Erythrodermic psoriasis,2,M,OT,130
171603344,2,Neuroendocrine tumour,4,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,HO,130
171603344,2,Neuroendocrine tumour,4,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,DE,130
171603344,2,Neuroendocrine tumour,4,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,OT,130
171603344,2,Neuroendocrine tumour,4,F,EXP,ipilimumab,2,SS,Septic shock,2,M,HO,130
171603344,2,Neuroendocrine tumour,4,F,EXP,ipilimumab,2,SS,Septic shock,2,M,DE,130
171603344,2,Neuroendocrine tumour,4,F,EXP,ipilimumab,2,SS,Septic shock,2,M,OT,130
171603732,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Febrile neutropenia,2,M,HO,44
171604512,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Accidental death,1,M,OT,34
171604512,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Accidental death,1,M,DE,34
171606042,2,BRAF V600E mutation positive,2,F,EXP,trametinib,2,SS,Radicular pain,2,M,HO,152
171606042,2,BRAF V600E mutation positive,2,F,EXP,trametinib,2,SS,Radicular pain,2,M,DS,152
171607044,9,Prophylaxis,4,F,EXP,zoledronic acid,9,C,Lung carcinoma cell type unspecified recurrent,9,M,OT,1717
171607044,9,Prophylaxis,4,F,EXP,zoledronic acid,9,C,Thyroid cancer,9,M,OT,1717
171607832,4,Plasma cell myeloma,2,F,EXP,pomalidomide,4,SS,Hepatotoxicity,4,M,OT,32
171607832,7,Plasma cell myeloma,2,F,EXP,thalidomide,7,C,Hepatotoxicity,7,M,OT,327
171607832,8,Plasma cell myeloma,2,F,EXP,lenalidomide,8,C,Hepatotoxicity,8,M,OT,247
171608914,2,Plasma cell myeloma,4,F,EXP,lenalidomide,2,SS,Infection,2,M,HO,105
171610262,1,Peripheral T-cell lymphoma unspecified,2,F,EXP,brentuximab vedotin,1,PS,Cough,1,M,HO,11
171610262,1,Peripheral T-cell lymphoma unspecified,2,F,EXP,brentuximab vedotin,1,PS,Fatigue,1,M,HO,11
171610262,1,Peripheral T-cell lymphoma unspecified,2,F,EXP,brentuximab vedotin,1,PS,Peripheral T-cell lymphoma unspecified,1,M,HO,11
171610942,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Alanine aminotransferase increased,2,M,HO,34
171610942,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Amylase increased,2,M,HO,34
171610942,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Aspartate aminotransferase increased,2,M,HO,34
171610942,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Lipase increased,2,M,HO,34
171610942,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,PS,Alanine aminotransferase increased,3,M,HO,34
171610942,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,PS,Amylase increased,3,M,HO,34
171610942,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,PS,Aspartate aminotransferase increased,3,M,HO,34
171610942,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,PS,Lipase increased,3,M,HO,34
171611512,6,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,6,SS,Neutrophil count decreased,6,F,HO,112
171611512,6,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,6,SS,Otitis media,6,F,HO,112
171611512,6,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,6,SS,Pharyngitis,6,F,HO,112
171611983,2,Prostate cancer metastatic,3,F,EXP,cabazitaxel,2,SS,Decreased appetite,2,M,HO,259
171611983,2,Prostate cancer metastatic,3,F,EXP,cabazitaxel,2,SS,Diarrhoea,2,M,HO,259
171611983,2,Prostate cancer metastatic,3,F,EXP,cabazitaxel,2,SS,Weight decreased,2,M,HO,259
171617592,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Benign prostatic hyperplasia,1,M,HO,44
171617592,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Benign prostatic hyperplasia,1,M,OT,44
171617592,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Chronic inflammatory demyelinating polyradiculoneuropathy,1,M,HO,44
171617592,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Chronic inflammatory demyelinating polyradiculoneuropathy,1,M,OT,44
171617592,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,44
171617592,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,44
171617592,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Neuropathy peripheral,1,M,HO,44
171617592,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Neuropathy peripheral,1,M,OT,44
171617592,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Benign prostatic hyperplasia,2,M,HO,44
171617592,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Benign prostatic hyperplasia,2,M,OT,44
171617592,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Chronic inflammatory demyelinating polyradiculoneuropathy,2,M,HO,44
171617592,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Chronic inflammatory demyelinating polyradiculoneuropathy,2,M,OT,44
171617592,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Decreased appetite,2,M,HO,44
171617592,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Decreased appetite,2,M,OT,44
171617592,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Neuropathy peripheral,2,M,HO,44
171617592,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Neuropathy peripheral,2,M,OT,44
171632152,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Glomerulonephritis rapidly progressive,1,F,HO,56
171632152,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Glomerulonephritis rapidly progressive,1,F,OT,56
171632152,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Glomerulonephritis rapidly progressive,2,F,HO,56
171632152,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Glomerulonephritis rapidly progressive,2,F,OT,56
171644232,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Abdominal pain lower,1,M,HO,10
171644232,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Abdominal pain lower,1,M,OT,10
171644232,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,10
171644232,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,10
171644232,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Infection,1,M,HO,10
171644232,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Infection,1,M,OT,10
171644232,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,HO,10
171644232,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,OT,10
171646162,1,Anaemia,2,F,PER,darbepoetin alfa,1,PS,Pneumonia,1,M,HO,581
171646162,1,Anaemia,2,F,PER,darbepoetin alfa,1,PS,Pneumonia,1,M,OT,581
171657393,1,Relapsing multiple sclerosis,3,F,EXP,ofatumumab,1,PS,Pleurisy,1,F,HO,153
171657393,2,Relapsing multiple sclerosis,3,F,EXP,ofatumumab,2,SS,Pleurisy,2,F,HO,146
171658233,1,Neutropenia,3,F,PER,pegfilgrastim,1,PS,Neutropenia,1,F,HO,85
171658233,1,Neutropenia,3,F,PER,pegfilgrastim,1,PS,Pyrexia,1,F,HO,85
171662466,1,Multiple sclerosis relapse,6,F,EXP,ofatumumab,1,PS,Dermatitis allergic,1,F,OT,88
171662466,1,Multiple sclerosis relapse,6,F,EXP,ofatumumab,1,PS,Dermatitis allergic,1,F,HO,88
171662466,2,Multiple sclerosis relapse,6,F,EXP,ofatumumab,2,SS,Dermatitis allergic,2,F,OT,82
171662466,2,Multiple sclerosis relapse,6,F,EXP,ofatumumab,2,SS,Dermatitis allergic,2,F,HO,82
171665293,29,Routine health maintenance,3,F,EXP,zoledronic acid,29,C,Pneumococcal infection,29,M,HO,476
171675912,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Cerebral infarction,1,M,OT,32
171675912,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Cerebral thrombosis,1,M,OT,32
171676042,3,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,3,SS,Neutrophil count decreased,3,F,OT,112
171676042,3,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,3,SS,White blood cell count decreased,3,F,OT,112
171678592,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Transformation to acute myeloid leukaemia,1,M,DE,43
171678592,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Transformation to acute myeloid leukaemia,1,M,OT,43
171695542,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Blood potassium increased,1,M,HO,14
171695542,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Blood potassium increased,1,M,OT,14
171695542,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Depression,1,M,HO,14
171695542,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Depression,1,M,OT,14
171695542,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Drug ineffective,1,M,HO,14
171695542,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Drug ineffective,1,M,OT,14
171695542,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Hypersensitivity,1,M,HO,14
171695542,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Hypersensitivity,1,M,OT,14
171695542,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,14
171695542,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,14
171696233,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,25
171696233,1,Non-small cell lung cancer metastatic,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,25
171701112,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,HO,221
171701112,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Pleural effusion,2,M,HO,29
171701112,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pleural effusion,3,M,HO,11
171701664,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Anaemia,1,F,OT,68
171701664,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Anaemia,1,F,HO,68
171701664,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,68
171701664,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,68
171701664,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,OT,68
171701664,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Hypothyroidism,1,F,HO,68
171701664,2,Non-small cell lung cancer,4,F,EXP,ipilimumab,2,SS,Anaemia,2,F,OT,68
171701664,2,Non-small cell lung cancer,4,F,EXP,ipilimumab,2,SS,Anaemia,2,F,HO,68
171701664,2,Non-small cell lung cancer,4,F,EXP,ipilimumab,2,SS,Dyspnoea,2,F,OT,68
171701664,2,Non-small cell lung cancer,4,F,EXP,ipilimumab,2,SS,Dyspnoea,2,F,HO,68
171701664,2,Non-small cell lung cancer,4,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,F,OT,68
171701664,2,Non-small cell lung cancer,4,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,F,HO,68
171703513,2,Lymphoma,3,F,EXP,bleomycin sulfate,2,SS,Ear pain,2,F,OT,1
171703513,2,Lymphoma,3,F,EXP,bleomycin sulfate,2,SS,Pyrexia,2,F,OT,1
171703513,2,Lymphoma,3,F,EXP,bleomycin sulfate,2,SS,Tinnitus,2,F,OT,1
171705902,1,Non-small cell lung cancer,2,F,EXP,lorlatinib,1,PS,Chondrocalcinosis pyrophosphate,1,F,HO,51
171705902,1,Non-small cell lung cancer,2,F,EXP,lorlatinib,1,PS,Urinary tract infection,1,F,HO,51
171706426,1,Plasma cell myeloma,6,F,EXP,pomalidomide,1,PS,Diarrhoea,1,F,OT,125
171706426,1,Plasma cell myeloma,6,F,EXP,pomalidomide,1,PS,Diarrhoea,1,F,DS,125
171706426,1,Plasma cell myeloma,6,F,EXP,pomalidomide,1,PS,Gastrointestinal toxicity,1,F,OT,125
171706426,1,Plasma cell myeloma,6,F,EXP,pomalidomide,1,PS,Gastrointestinal toxicity,1,F,DS,125
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Autoimmune pancreatitis,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Autoimmune pancreatitis,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Back pain,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Back pain,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Basal cell carcinoma,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Basal cell carcinoma,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Erythema migrans,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Erythema migrans,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Immune-mediated hepatitis,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Immune-mediated hepatitis,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Immune-mediated neuropathy,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Immune-mediated neuropathy,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Metastases to lung,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Metastases to lung,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Off label use,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Pancreatitis,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Pancreatitis,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Peripheral motor neuropathy,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Peripheral motor neuropathy,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Pustule,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Pustule,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Rash,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Rash,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Telangiectasia,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Telangiectasia,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Transaminases increased,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Transaminases increased,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Vertigo,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Vertigo,1,M,OT,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Xerosis,1,M,HO,17
171708858,1,Malignant melanoma,8,F,EXP,nivolumab,1,PS,Xerosis,1,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Autoimmune pancreatitis,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Autoimmune pancreatitis,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Autoimmune thyroiditis,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Autoimmune thyroiditis,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Back pain,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Back pain,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Basal cell carcinoma,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Basal cell carcinoma,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Erythema migrans,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Erythema migrans,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Fatigue,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Fatigue,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Immune-mediated hepatitis,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Immune-mediated hepatitis,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Immune-mediated neuropathy,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Immune-mediated neuropathy,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Metastases to lung,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Metastases to lung,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Off label use,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Off label use,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Pancreatitis,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Pancreatitis,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Peripheral motor neuropathy,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Peripheral motor neuropathy,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Pustule,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Pustule,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Rash,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Rash,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Rash maculo-papular,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Rash maculo-papular,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Telangiectasia,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Telangiectasia,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Transaminases increased,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Transaminases increased,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Vertigo,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Vertigo,3,M,OT,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Xerosis,3,M,HO,17
171708858,3,Product used for unknown indication,8,F,EXP,nivolumab,3,SS,Xerosis,3,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Autoimmune pancreatitis,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Autoimmune pancreatitis,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Autoimmune thyroiditis,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Autoimmune thyroiditis,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Back pain,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Back pain,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Basal cell carcinoma,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Basal cell carcinoma,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Erythema migrans,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Erythema migrans,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Fatigue,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Fatigue,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Immune-mediated hepatitis,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Immune-mediated hepatitis,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Immune-mediated neuropathy,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Immune-mediated neuropathy,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Malignant neoplasm progression,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Metastases to lung,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Metastases to lung,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Off label use,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Off label use,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Pancreatitis,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Pancreatitis,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Peripheral motor neuropathy,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Peripheral motor neuropathy,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Pustule,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Pustule,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Rash,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Rash,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Rash maculo-papular,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Rash maculo-papular,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Telangiectasia,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Telangiectasia,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Transaminases increased,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Transaminases increased,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Vertigo,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Vertigo,4,M,OT,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Xerosis,4,M,HO,17
171708858,4,Malignant melanoma,8,F,EXP,ipilimumab,4,SS,Xerosis,4,M,OT,17
171710014,6,Plasma cell myeloma,4,F,EXP,daratumumab,6,SS,Intraductal proliferative breast lesion,6,F,HO,63
171710014,6,Plasma cell myeloma,4,F,EXP,daratumumab,6,SS,Intraductal proliferative breast lesion,6,F,OT,63
171716652,4,Angioimmunoblastic T-cell lymphoma,2,F,EXP,chop,4,C,Myelodysplastic syndrome,4,F,HO,1414
171716652,4,Angioimmunoblastic T-cell lymphoma,2,F,EXP,chop,4,C,Myelodysplastic syndrome,4,F,OT,1414
171723452,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Herpes zoster,1,M,HO,132
171723452,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Intervertebral disc protrusion,1,M,HO,132
171723452,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Myositis,1,M,HO,132
171723452,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Pharyngitis,1,M,HO,132
171723452,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Post herpetic neuralgia,1,M,HO,132
171723452,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Sinusitis,1,M,HO,132
171723793,1,Glioblastoma,3,F,EXP,nivolumab,1,PS,Optic neuritis,1,F,OT,430
171723793,1,Glioblastoma,3,F,EXP,nivolumab,1,PS,Optic neuritis,1,F,HO,430
171724012,1,Non-small cell lung cancer,2,F,EXP,selinexor,1,PS,Dehydration,1,F,HO,4
171724012,1,Non-small cell lung cancer,2,F,EXP,selinexor,1,PS,Embolism,1,F,HO,4
171728242,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Acute myocardial infarction,2,F,HO,423
171728242,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Acute myocardial infarction,2,F,OT,423
171728242,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Asthma,2,F,HO,423
171728242,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Asthma,2,F,OT,423
171728242,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pneumonia,2,F,HO,423
171728242,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pneumonia,2,F,OT,423
171728242,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pyrexia,2,F,HO,423
171728242,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pyrexia,2,F,OT,423
171729224,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Bone pain,1,F,HO,108
171729224,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Headache,1,F,HO,108
171729224,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,108
171729224,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,108
171729224,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Bone pain,2,F,HO,108
171729224,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Headache,2,F,HO,108
171729224,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Pyrexia,2,F,HO,108
171729224,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Vomiting,2,F,HO,108
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Abdominal lymphadenopathy,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Abdominal pain,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Blood lactate dehydrogenase increased,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Blood prolactin increased,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,C-reactive protein increased,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Dyspepsia,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Gastrointestinal disorder,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Gastrointestinal inflammation,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Hyperreflexia,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Jejunal ulcer perforation,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Malaise,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Oedema,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Paraesthesia,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Pyrexia,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Renal cyst,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Vomiting,2,M,OT,112
171729292,2,Product used for unknown indication,2,F,EXP,trametinib,2,C,Weight decreased,2,M,OT,112
171731814,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Systemic inflammatory response syndrome,1,M,OT,41
171731814,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Systemic inflammatory response syndrome,1,M,HO,41
171731814,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Systemic inflammatory response syndrome,2,M,OT,55
171731814,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Systemic inflammatory response syndrome,2,M,HO,55
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Acute respiratory distress syndrome,1,F,DE,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Acute respiratory distress syndrome,1,F,HO,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Acute respiratory distress syndrome,1,F,LT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Acute respiratory distress syndrome,1,F,OT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Enterocolitis,1,F,DE,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Enterocolitis,1,F,HO,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Enterocolitis,1,F,LT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Enterocolitis,1,F,OT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Graft complication,1,F,DE,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Graft complication,1,F,HO,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Graft complication,1,F,LT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Graft complication,1,F,OT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Hepatic failure,1,F,DE,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Hepatic failure,1,F,HO,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Hepatic failure,1,F,LT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Hepatic failure,1,F,OT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Hepatorenal syndrome,1,F,DE,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Hepatorenal syndrome,1,F,HO,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Hepatorenal syndrome,1,F,LT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Hepatorenal syndrome,1,F,OT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Intentional product use issue,1,F,DE,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Intentional product use issue,1,F,HO,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Intentional product use issue,1,F,LT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Intentional product use issue,1,F,OT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Lung disorder,1,F,DE,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Lung disorder,1,F,HO,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Lung disorder,1,F,LT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Lung disorder,1,F,OT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Shock haemorrhagic,1,F,DE,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Shock haemorrhagic,1,F,HO,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Shock haemorrhagic,1,F,LT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Shock haemorrhagic,1,F,OT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Venoocclusive disease,1,F,DE,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Venoocclusive disease,1,F,HO,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Venoocclusive disease,1,F,LT,17
171733152,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Venoocclusive disease,1,F,OT,17
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Acute respiratory distress syndrome,2,F,DE,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Acute respiratory distress syndrome,2,F,HO,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Acute respiratory distress syndrome,2,F,LT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Acute respiratory distress syndrome,2,F,OT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Enterocolitis,2,F,DE,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Enterocolitis,2,F,HO,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Enterocolitis,2,F,LT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Enterocolitis,2,F,OT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Graft complication,2,F,DE,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Graft complication,2,F,HO,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Graft complication,2,F,LT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Graft complication,2,F,OT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Hepatic failure,2,F,DE,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Hepatic failure,2,F,HO,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Hepatic failure,2,F,LT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Hepatic failure,2,F,OT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Hepatorenal syndrome,2,F,DE,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Hepatorenal syndrome,2,F,HO,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Hepatorenal syndrome,2,F,LT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Hepatorenal syndrome,2,F,OT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Intentional product use issue,2,F,DE,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Intentional product use issue,2,F,HO,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Intentional product use issue,2,F,LT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Intentional product use issue,2,F,OT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Lung disorder,2,F,DE,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Lung disorder,2,F,HO,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Lung disorder,2,F,LT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Lung disorder,2,F,OT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Shock haemorrhagic,2,F,DE,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Shock haemorrhagic,2,F,HO,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Shock haemorrhagic,2,F,LT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Shock haemorrhagic,2,F,OT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Venoocclusive disease,2,F,DE,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Venoocclusive disease,2,F,HO,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Venoocclusive disease,2,F,LT,52
171733152,2,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,2,SS,Venoocclusive disease,2,F,OT,52
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Acute respiratory distress syndrome,3,F,DE,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Acute respiratory distress syndrome,3,F,HO,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Acute respiratory distress syndrome,3,F,LT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Acute respiratory distress syndrome,3,F,OT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Enterocolitis,3,F,DE,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Enterocolitis,3,F,HO,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Enterocolitis,3,F,LT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Enterocolitis,3,F,OT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Graft complication,3,F,DE,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Graft complication,3,F,HO,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Graft complication,3,F,LT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Graft complication,3,F,OT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Hepatic failure,3,F,DE,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Hepatic failure,3,F,HO,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Hepatic failure,3,F,LT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Hepatic failure,3,F,OT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Hepatorenal syndrome,3,F,DE,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Hepatorenal syndrome,3,F,HO,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Hepatorenal syndrome,3,F,LT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Hepatorenal syndrome,3,F,OT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Intentional product use issue,3,F,DE,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Intentional product use issue,3,F,HO,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Intentional product use issue,3,F,LT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Intentional product use issue,3,F,OT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Lung disorder,3,F,DE,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Lung disorder,3,F,HO,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Lung disorder,3,F,LT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Lung disorder,3,F,OT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Shock haemorrhagic,3,F,DE,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Shock haemorrhagic,3,F,HO,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Shock haemorrhagic,3,F,LT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Shock haemorrhagic,3,F,OT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Venoocclusive disease,3,F,DE,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Venoocclusive disease,3,F,HO,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Venoocclusive disease,3,F,LT,31
171733152,3,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,3,SS,Venoocclusive disease,3,F,OT,31
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Acute respiratory distress syndrome,7,F,DE,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Acute respiratory distress syndrome,7,F,HO,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Acute respiratory distress syndrome,7,F,LT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Acute respiratory distress syndrome,7,F,OT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Enterocolitis,7,F,DE,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Enterocolitis,7,F,HO,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Enterocolitis,7,F,LT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Enterocolitis,7,F,OT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Graft complication,7,F,DE,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Graft complication,7,F,HO,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Graft complication,7,F,LT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Graft complication,7,F,OT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Hepatic failure,7,F,DE,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Hepatic failure,7,F,HO,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Hepatic failure,7,F,LT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Hepatic failure,7,F,OT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Hepatorenal syndrome,7,F,DE,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Hepatorenal syndrome,7,F,HO,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Hepatorenal syndrome,7,F,LT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Hepatorenal syndrome,7,F,OT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Intentional product use issue,7,F,DE,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Intentional product use issue,7,F,HO,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Intentional product use issue,7,F,LT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Intentional product use issue,7,F,OT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Lung disorder,7,F,DE,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Lung disorder,7,F,HO,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Lung disorder,7,F,LT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Lung disorder,7,F,OT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Shock haemorrhagic,7,F,DE,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Shock haemorrhagic,7,F,HO,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Shock haemorrhagic,7,F,LT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Shock haemorrhagic,7,F,OT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Venoocclusive disease,7,F,DE,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Venoocclusive disease,7,F,HO,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Venoocclusive disease,7,F,LT,24
171733152,7,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,7,SS,Venoocclusive disease,7,F,OT,24
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Acute respiratory distress syndrome,8,F,DE,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Acute respiratory distress syndrome,8,F,HO,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Acute respiratory distress syndrome,8,F,LT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Acute respiratory distress syndrome,8,F,OT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Enterocolitis,8,F,DE,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Enterocolitis,8,F,HO,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Enterocolitis,8,F,LT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Enterocolitis,8,F,OT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Graft complication,8,F,DE,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Graft complication,8,F,HO,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Graft complication,8,F,LT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Graft complication,8,F,OT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Hepatic failure,8,F,DE,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Hepatic failure,8,F,HO,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Hepatic failure,8,F,LT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Hepatic failure,8,F,OT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Hepatorenal syndrome,8,F,DE,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Hepatorenal syndrome,8,F,HO,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Hepatorenal syndrome,8,F,LT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Hepatorenal syndrome,8,F,OT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Intentional product use issue,8,F,DE,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Intentional product use issue,8,F,HO,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Intentional product use issue,8,F,LT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Intentional product use issue,8,F,OT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Lung disorder,8,F,DE,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Lung disorder,8,F,HO,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Lung disorder,8,F,LT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Lung disorder,8,F,OT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Shock haemorrhagic,8,F,DE,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Shock haemorrhagic,8,F,HO,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Shock haemorrhagic,8,F,LT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Shock haemorrhagic,8,F,OT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Venoocclusive disease,8,F,DE,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Venoocclusive disease,8,F,HO,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Venoocclusive disease,8,F,LT,45
171733152,8,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,8,SS,Venoocclusive disease,8,F,OT,45
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Acute lymphocytic leukaemia recurrent,1,M,HO,1
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Acute lymphocytic leukaemia recurrent,1,M,LT,1
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Acute lymphocytic leukaemia recurrent,1,M,DE,1
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Cytokine release syndrome,1,M,HO,1
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Cytokine release syndrome,1,M,LT,1
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Cytokine release syndrome,1,M,DE,1
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Graft versus host disease in gastrointestinal tract,1,M,HO,1
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Graft versus host disease in gastrointestinal tract,1,M,LT,1
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Graft versus host disease in gastrointestinal tract,1,M,DE,1
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Pneumonia,1,M,HO,1
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Pneumonia,1,M,LT,1
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Pneumonia,1,M,DE,1
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Pulmonary oedema,1,M,HO,1
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Pulmonary oedema,1,M,LT,1
171738413,1,Acute lymphocytic leukaemia refractory,3,F,PER,blinatumomab,1,PS,Pulmonary oedema,1,M,DE,1
171740602,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Hypotension,2,M,HO,7
171740602,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Muscular weakness,2,M,HO,7
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Acute kidney injury,10,M,OT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Acute kidney injury,10,M,HO,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Acute kidney injury,10,M,LT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Coma hepatic,10,M,OT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Coma hepatic,10,M,HO,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Coma hepatic,10,M,LT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Engraftment syndrome,10,M,OT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Engraftment syndrome,10,M,HO,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Engraftment syndrome,10,M,LT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Graft versus host disease,10,M,OT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Graft versus host disease,10,M,HO,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Graft versus host disease,10,M,LT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Hepatic encephalopathy,10,M,OT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Hepatic encephalopathy,10,M,HO,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Hepatic encephalopathy,10,M,LT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Hepatic failure,10,M,OT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Hepatic failure,10,M,HO,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Hepatic failure,10,M,LT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Platelet count decreased,10,M,OT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Platelet count decreased,10,M,HO,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Platelet count decreased,10,M,LT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Venoocclusive liver disease,10,M,OT,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Venoocclusive liver disease,10,M,HO,16
171742985,10,Medical procedure,5,F,EXP,granisetron,10,C,Venoocclusive liver disease,10,M,LT,16
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Acute kidney injury,23,M,OT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Acute kidney injury,23,M,HO,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Acute kidney injury,23,M,LT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Coma hepatic,23,M,OT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Coma hepatic,23,M,HO,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Coma hepatic,23,M,LT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Engraftment syndrome,23,M,OT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Engraftment syndrome,23,M,HO,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Engraftment syndrome,23,M,LT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Graft versus host disease,23,M,OT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Graft versus host disease,23,M,HO,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Graft versus host disease,23,M,LT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Hepatic encephalopathy,23,M,OT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Hepatic encephalopathy,23,M,HO,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Hepatic encephalopathy,23,M,LT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Hepatic failure,23,M,OT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Hepatic failure,23,M,HO,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Hepatic failure,23,M,LT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Platelet count decreased,23,M,OT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Platelet count decreased,23,M,HO,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Platelet count decreased,23,M,LT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Venoocclusive liver disease,23,M,OT,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Venoocclusive liver disease,23,M,HO,6
171742985,23,Medical procedure,5,F,EXP,filgrastim,23,C,Venoocclusive liver disease,23,M,LT,6
171745303,1,Gastric cancer,3,F,EXP,ramucirumab,1,PS,Tumour haemorrhage,1,M,HO,116
171753882,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Aortic aneurysm,1,M,HO,227
171757342,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pyrexia,2,F,HO,21
171757342,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Viral upper respiratory tract infection,2,F,HO,21
171767322,1,Prostatic specific antigen increased,2,F,EXP,enzalutamide,1,PS,Cerebrovascular accident,1,M,OT,212
171767322,1,Prostatic specific antigen increased,2,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,212
171767322,1,Prostatic specific antigen increased,2,F,EXP,enzalutamide,1,PS,Micturition urgency,1,M,OT,212
171778005,1,Dedifferentiated liposarcoma,5,F,EXP,selinexor,1,PS,Cerebrovascular accident,1,M,HO,129
171778005,1,Dedifferentiated liposarcoma,5,F,EXP,selinexor,1,PS,Cerebrovascular accident,1,M,OT,129
171784702,1,Malignant melanoma,2,F,EXP,nivolumab,1,SS,Pneumonitis,1,F,HO,439
171784702,1,Malignant melanoma,2,F,EXP,nivolumab,1,SS,Pneumonitis,1,F,OT,439
171784702,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Pneumonitis,2,F,HO,419
171784702,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Pneumonitis,2,F,OT,419
171784702,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pneumonitis,3,F,HO,398
171784702,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pneumonitis,3,F,OT,398
171784702,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Pneumonitis,4,F,HO,377
171784702,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Pneumonitis,4,F,OT,377
171784702,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Pneumonitis,5,F,HO,356
171784702,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Pneumonitis,5,F,OT,356
171784702,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Pneumonitis,6,F,HO,342
171784702,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Pneumonitis,6,F,OT,342
171784702,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Pneumonitis,7,F,HO,328
171784702,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Pneumonitis,7,F,OT,328
171784702,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Pneumonitis,8,F,HO,314
171784702,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Pneumonitis,8,F,OT,314
171784702,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Pneumonitis,9,F,HO,298
171784702,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Pneumonitis,9,F,OT,298
171784702,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Pneumonitis,10,F,HO,286
171784702,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Pneumonitis,10,F,OT,286
171784702,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Pneumonitis,11,F,HO,272
171784702,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Pneumonitis,11,F,OT,272
171784702,12,Product used for unknown indication,2,F,EXP,nivolumab,12,SS,Pneumonitis,12,F,HO,258
171784702,12,Product used for unknown indication,2,F,EXP,nivolumab,12,SS,Pneumonitis,12,F,OT,258
171784702,13,Product used for unknown indication,2,F,EXP,nivolumab,13,SS,Pneumonitis,13,F,HO,244
171784702,13,Product used for unknown indication,2,F,EXP,nivolumab,13,SS,Pneumonitis,13,F,OT,244
171784702,14,Product used for unknown indication,2,F,EXP,nivolumab,14,SS,Pneumonitis,14,F,HO,230
171784702,14,Product used for unknown indication,2,F,EXP,nivolumab,14,SS,Pneumonitis,14,F,OT,230
171784702,15,Product used for unknown indication,2,F,EXP,nivolumab,15,SS,Pneumonitis,15,F,HO,216
171784702,15,Product used for unknown indication,2,F,EXP,nivolumab,15,SS,Pneumonitis,15,F,OT,216
171784702,16,Product used for unknown indication,2,F,EXP,nivolumab,16,SS,Pneumonitis,16,F,HO,202
171784702,16,Product used for unknown indication,2,F,EXP,nivolumab,16,SS,Pneumonitis,16,F,OT,202
171784702,17,Product used for unknown indication,2,F,EXP,nivolumab,17,SS,Pneumonitis,17,F,HO,188
171784702,17,Product used for unknown indication,2,F,EXP,nivolumab,17,SS,Pneumonitis,17,F,OT,188
171784702,18,Product used for unknown indication,2,F,EXP,nivolumab,18,SS,Pneumonitis,18,F,HO,174
171784702,18,Product used for unknown indication,2,F,EXP,nivolumab,18,SS,Pneumonitis,18,F,OT,174
171784702,19,Product used for unknown indication,2,F,EXP,nivolumab,19,SS,Pneumonitis,19,F,HO,159
171784702,19,Product used for unknown indication,2,F,EXP,nivolumab,19,SS,Pneumonitis,19,F,OT,159
171784702,20,Product used for unknown indication,2,F,EXP,nivolumab,20,SS,Pneumonitis,20,F,HO,145
171784702,20,Product used for unknown indication,2,F,EXP,nivolumab,20,SS,Pneumonitis,20,F,OT,145
171784702,21,Product used for unknown indication,2,F,EXP,nivolumab,21,SS,Pneumonitis,21,F,HO,131
171784702,21,Product used for unknown indication,2,F,EXP,nivolumab,21,SS,Pneumonitis,21,F,OT,131
171784702,22,Product used for unknown indication,2,F,EXP,nivolumab,22,SS,Pneumonitis,22,F,HO,117
171784702,22,Product used for unknown indication,2,F,EXP,nivolumab,22,SS,Pneumonitis,22,F,OT,117
171784702,23,Product used for unknown indication,2,F,EXP,nivolumab,23,SS,Pneumonitis,23,F,HO,103
171784702,23,Product used for unknown indication,2,F,EXP,nivolumab,23,SS,Pneumonitis,23,F,OT,103
171784702,24,Product used for unknown indication,2,F,EXP,nivolumab,24,SS,Pneumonitis,24,F,HO,89
171784702,24,Product used for unknown indication,2,F,EXP,nivolumab,24,SS,Pneumonitis,24,F,OT,89
171784702,25,Product used for unknown indication,2,F,EXP,nivolumab,25,SS,Pneumonitis,25,F,HO,75
171784702,25,Product used for unknown indication,2,F,EXP,nivolumab,25,SS,Pneumonitis,25,F,OT,75
171784702,26,Product used for unknown indication,2,F,EXP,nivolumab,26,SS,Pneumonitis,26,F,HO,61
171784702,26,Product used for unknown indication,2,F,EXP,nivolumab,26,SS,Pneumonitis,26,F,OT,61
171784702,27,Product used for unknown indication,2,F,EXP,nivolumab,27,SS,Pneumonitis,27,F,HO,47
171784702,27,Product used for unknown indication,2,F,EXP,nivolumab,27,SS,Pneumonitis,27,F,OT,47
171784702,28,Product used for unknown indication,2,F,EXP,nivolumab,28,SS,Pneumonitis,28,F,HO,33
171784702,28,Product used for unknown indication,2,F,EXP,nivolumab,28,SS,Pneumonitis,28,F,OT,33
171784702,29,Product used for unknown indication,2,F,EXP,nivolumab,29,SS,Pneumonitis,29,F,HO,19
171784702,29,Product used for unknown indication,2,F,EXP,nivolumab,29,SS,Pneumonitis,29,F,OT,19
171784702,30,Malignant melanoma,2,F,EXP,ipilimumab,30,PS,Pneumonitis,30,F,HO,439
171784702,30,Malignant melanoma,2,F,EXP,ipilimumab,30,PS,Pneumonitis,30,F,OT,439
171784702,31,Lung neoplasm malignant,2,F,EXP,ipilimumab,31,SS,Pneumonitis,31,F,HO,419
171784702,31,Lung neoplasm malignant,2,F,EXP,ipilimumab,31,SS,Pneumonitis,31,F,OT,419
171784702,32,Product used for unknown indication,2,F,EXP,ipilimumab,32,SS,Pneumonitis,32,F,HO,398
171784702,32,Product used for unknown indication,2,F,EXP,ipilimumab,32,SS,Pneumonitis,32,F,OT,398
171784702,33,Product used for unknown indication,2,F,EXP,ipilimumab,33,SS,Pneumonitis,33,F,HO,377
171784702,33,Product used for unknown indication,2,F,EXP,ipilimumab,33,SS,Pneumonitis,33,F,OT,377
171786243,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Aortic aneurysm,1,F,HO,29
171786243,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Aphthous ulcer,1,F,HO,29
171786243,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Back pain,1,F,HO,29
171786243,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Drug-induced liver injury,1,F,HO,29
171786243,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Endocarditis bacterial,1,F,HO,29
171786243,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Myopathy,1,F,HO,29
171786243,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Oedema,1,F,HO,29
171786243,1,B-cell lymphoma,3,F,EXP,idelalisib,1,PS,Pneumonia,1,F,HO,29
171788904,1,Plasma cell myeloma,4,F,EXP,selinexor,1,PS,Pneumonia,1,M,HO,359
171788904,6,Plasma cell myeloma,4,F,EXP,carfilzomib,6,SS,Pneumonia,6,M,HO,359
171791275,5,Anaplastic lymphoma kinase gene mutation,5,F,EXP,ceritinib,5,SS,Intentional self-injury,5,F,HO,691
171791275,5,Anaplastic lymphoma kinase gene mutation,5,F,EXP,ceritinib,5,SS,Intentional self-injury,5,F,LT,691
171791275,5,Anaplastic lymphoma kinase gene mutation,5,F,EXP,ceritinib,5,SS,Overdose,5,F,HO,691
171791275,5,Anaplastic lymphoma kinase gene mutation,5,F,EXP,ceritinib,5,SS,Overdose,5,F,LT,691
171791275,5,Anaplastic lymphoma kinase gene mutation,5,F,EXP,ceritinib,5,SS,Somnolence,5,F,HO,691
171791275,5,Anaplastic lymphoma kinase gene mutation,5,F,EXP,ceritinib,5,SS,Somnolence,5,F,LT,691
171791372,9,Colony stimulating factor therapy,2,F,EXP,filgrastim,9,C,Hepatitis E,9,F,HO,47
171791372,9,Colony stimulating factor therapy,2,F,EXP,filgrastim,9,C,Hepatocellular injury,9,F,HO,47
171795153,1,Prostate cancer,3,F,EXP,cabazitaxel,1,PS,Asthenia,1,M,HO,28
171795153,1,Prostate cancer,3,F,EXP,cabazitaxel,1,PS,Gait disturbance,1,M,HO,28
171795153,1,Prostate cancer,3,F,EXP,cabazitaxel,1,PS,Pain,1,M,HO,28
171795153,1,Prostate cancer,3,F,EXP,cabazitaxel,1,PS,Pyrexia,1,M,HO,28
171795153,1,Prostate cancer,3,F,EXP,cabazitaxel,1,PS,Urinary tract infection,1,M,HO,28
171795153,1,Prostate cancer,3,F,EXP,cabazitaxel,1,PS,Vomiting,1,M,HO,28
171807404,30,Prophylaxis,4,F,EXP,zoledronic acid,30,C,Respiratory tract infection,30,M,HO,330
171807404,30,Prophylaxis,4,F,EXP,zoledronic acid,30,C,Respiratory tract infection,30,M,OT,330
171807404,30,Prophylaxis,4,F,EXP,zoledronic acid,30,C,Respiratory tract infection viral,30,M,HO,330
171807404,30,Prophylaxis,4,F,EXP,zoledronic acid,30,C,Respiratory tract infection viral,30,M,OT,330
171814723,3,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Encephalitis,3,F,HO,269
171814723,3,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Encephalitis,3,F,OT,269
171814723,10,Product used for unknown indication,3,F,EXP,zoledronic acid,10,C,Encephalitis,10,F,HO,185
171814723,10,Product used for unknown indication,3,F,EXP,zoledronic acid,10,C,Encephalitis,10,F,OT,185
171823092,5,Renal cell carcinoma,2,F,EXP,nivolumab,5,SS,Acute kidney injury,5,M,HO,77
171823092,5,Renal cell carcinoma,2,F,EXP,nivolumab,5,SS,Acute kidney injury,5,M,OT,77
171823092,5,Renal cell carcinoma,2,F,EXP,nivolumab,5,SS,Fatigue,5,M,HO,77
171823092,5,Renal cell carcinoma,2,F,EXP,nivolumab,5,SS,Fatigue,5,M,OT,77
171823092,6,Renal cell carcinoma,2,F,EXP,ipilimumab,6,PS,Acute kidney injury,6,M,HO,77
171823092,6,Renal cell carcinoma,2,F,EXP,ipilimumab,6,PS,Acute kidney injury,6,M,OT,77
171823092,6,Renal cell carcinoma,2,F,EXP,ipilimumab,6,PS,Fatigue,6,M,HO,77
171823092,6,Renal cell carcinoma,2,F,EXP,ipilimumab,6,PS,Fatigue,6,M,OT,77
171833544,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Death,1,M,OT,119
171833544,1,Squamous cell carcinoma of head and neck,4,F,EXP,nivolumab,1,PS,Death,1,M,DE,119
171834662,8,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,8,SS,Febrile neutropenia,8,F,HO,172
171834662,8,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,8,SS,Pneumonia fungal,8,F,HO,172
171834662,8,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,8,SS,Viral upper respiratory tract infection,8,F,HO,172
171834662,9,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,9,SS,Febrile neutropenia,9,F,HO,18
171834662,9,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,9,SS,Pneumonia fungal,9,F,HO,18
171834662,9,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,9,SS,Viral upper respiratory tract infection,9,F,HO,18
171838782,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,HO,8
171838782,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Abdominal pain,2,M,HO,8
171838782,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,SS,Abdominal pain,3,M,HO,8
171846312,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Enteritis,1,M,HO,8
171846312,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Headache,1,M,HO,8
171856056,1,Diffuse large B-cell lymphoma,6,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,4
171856056,1,Diffuse large B-cell lymphoma,6,F,EXP,axicabtagene ciloleucel,1,PS,Neutrophil count decreased,1,M,HO,4
171856056,1,Diffuse large B-cell lymphoma,6,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,HO,4
171859653,2,Breast cancer,3,F,EXP,palbociclib,2,SS,Anaemia,2,F,OT,13
171859653,2,Breast cancer,3,F,EXP,palbociclib,2,SS,Neutropenia,2,F,OT,13
171859653,2,Breast cancer,3,F,EXP,palbociclib,2,SS,Off label use,2,F,OT,13
171859653,2,Breast cancer,3,F,EXP,palbociclib,2,SS,Platelet count decreased,2,F,OT,13
171859653,2,Breast cancer,3,F,EXP,palbociclib,2,SS,Thrombocytopenia,2,F,OT,13
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Abdominal pain,1,M,OT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Abdominal pain,1,M,LT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Abdominal pain,1,M,HO,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Anaemia,1,M,OT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Anaemia,1,M,LT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Anaemia,1,M,HO,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Cytomegalovirus infection,1,M,OT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Cytomegalovirus infection,1,M,LT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Cytomegalovirus infection,1,M,HO,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Dysarthria,1,M,OT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Dysarthria,1,M,LT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Dysarthria,1,M,HO,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,OT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,LT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,HO,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,OT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,LT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,HO,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Neutrophil count decreased,1,M,OT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Neutrophil count decreased,1,M,LT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Neutrophil count decreased,1,M,HO,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Platelet count decreased,1,M,OT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Platelet count decreased,1,M,LT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Platelet count decreased,1,M,HO,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,OT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,LT,8
171860805,1,Diffuse large B-cell lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,HO,8
171862212,1,Product used for unknown indication,2,F,EXP,rolapitant hydrochloride,1,PS,Hysterectomy,1,F,HO,90
171862212,1,Product used for unknown indication,2,F,EXP,rolapitant hydrochloride,1,PS,Hysterectomy,1,F,OT,90
171862574,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,Cytopenia,4,M,OT,73
171862574,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,Cytopenia,4,M,HO,73
171862574,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,Haemoptysis,4,M,OT,73
171862574,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,Haemoptysis,4,M,HO,73
171862574,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,Prothrombin time shortened,4,M,OT,73
171862574,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,Prothrombin time shortened,4,M,HO,73
171862574,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,Pulmonary haemorrhage,4,M,OT,73
171862574,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,Pulmonary haemorrhage,4,M,HO,73
171862574,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,White blood cell count decreased,4,M,OT,73
171862574,4,Anaemia,4,F,EXP,darbepoetin alfa,4,C,White blood cell count decreased,4,M,HO,73
171864474,1,Non-small cell lung cancer metastatic,4,F,EXP,lorlatinib,1,PS,Cholelithiasis,1,M,HO,121
171865573,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Hepatitis,1,M,OT,21
171865573,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Hepatitis,1,M,HO,21
171865573,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Hepatitis,2,M,OT,21
171865573,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Hepatitis,2,M,HO,21
171866552,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,29
171866552,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Colitis,1,M,LT,29
171866552,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Colitis,1,M,DE,29
171866552,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,29
171866552,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Death,1,M,OT,29
171866552,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Death,1,M,LT,29
171866552,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Death,1,M,DE,29
171866552,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Death,1,M,HO,29
171866552,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Large intestine perforation,1,M,OT,29
171866552,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Large intestine perforation,1,M,LT,29
171866552,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Large intestine perforation,1,M,DE,29
171866552,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Large intestine perforation,1,M,HO,29
171866552,2,Non-small cell lung cancer metastatic,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,OT,57
171866552,2,Non-small cell lung cancer metastatic,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,LT,57
171866552,2,Non-small cell lung cancer metastatic,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,DE,57
171866552,2,Non-small cell lung cancer metastatic,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,HO,57
171866552,2,Non-small cell lung cancer metastatic,2,F,EXP,ipilimumab,2,SS,Death,2,M,OT,57
171866552,2,Non-small cell lung cancer metastatic,2,F,EXP,ipilimumab,2,SS,Death,2,M,LT,57
171866552,2,Non-small cell lung cancer metastatic,2,F,EXP,ipilimumab,2,SS,Death,2,M,DE,57
171866552,2,Non-small cell lung cancer metastatic,2,F,EXP,ipilimumab,2,SS,Death,2,M,HO,57
171866552,2,Non-small cell lung cancer metastatic,2,F,EXP,ipilimumab,2,SS,Large intestine perforation,2,M,OT,57
171866552,2,Non-small cell lung cancer metastatic,2,F,EXP,ipilimumab,2,SS,Large intestine perforation,2,M,LT,57
171866552,2,Non-small cell lung cancer metastatic,2,F,EXP,ipilimumab,2,SS,Large intestine perforation,2,M,DE,57
171866552,2,Non-small cell lung cancer metastatic,2,F,EXP,ipilimumab,2,SS,Large intestine perforation,2,M,HO,57
171866585,1,Oesophageal squamous cell carcinoma,5,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,10
171866585,2,Oesophageal squamous cell carcinoma,5,F,EXP,ipilimumab,2,SS,Dyspnoea,2,M,DE,10
171867684,1,Breast cancer,4,F,EXP,alpelisib,1,PS,Arthralgia,1,F,HO,3
171867713,1,Head and neck cancer,3,F,EXP,alpelisib,1,PS,Influenza,1,M,DE,70
171867713,1,Head and neck cancer,3,F,EXP,alpelisib,1,PS,Influenza,1,M,HO,70
171867713,1,Head and neck cancer,3,F,EXP,alpelisib,1,PS,Pneumonia,1,M,DE,70
171867713,1,Head and neck cancer,3,F,EXP,alpelisib,1,PS,Pneumonia,1,M,HO,70
171868983,5,Product used for unknown indication,3,F,EXP,zoledronic acid,5,C,Mesenteric vein thrombosis,5,F,HO,57
171869613,2,Transitional cell carcinoma,3,F,EXP,nivolumab,2,PS,Acute kidney injury,2,M,HO,112
171869613,2,Transitional cell carcinoma,3,F,EXP,nivolumab,2,PS,Acute kidney injury,2,M,OT,112
171869613,2,Transitional cell carcinoma,3,F,EXP,nivolumab,2,PS,Eosinophilia,2,M,HO,112
171869613,2,Transitional cell carcinoma,3,F,EXP,nivolumab,2,PS,Eosinophilia,2,M,OT,112
171869646,1,Transitional cell cancer of renal pelvis and ureter metastatic,6,F,EXP,nivolumab,1,PS,Autoimmune encephalopathy,1,F,OT,75
171869646,1,Transitional cell cancer of renal pelvis and ureter metastatic,6,F,EXP,nivolumab,1,PS,Autoimmune encephalopathy,1,F,LT,75
171869646,2,Transitional cell cancer of renal pelvis and ureter metastatic,6,F,EXP,ipilimumab,2,SS,Autoimmune encephalopathy,2,F,OT,75
171869646,2,Transitional cell cancer of renal pelvis and ureter metastatic,6,F,EXP,ipilimumab,2,SS,Autoimmune encephalopathy,2,F,LT,75
171871878,2,Bladder cancer,8,F,EXP,nivolumab,2,PS,Embolism,2,M,OT,29
171871878,2,Bladder cancer,8,F,EXP,nivolumab,2,PS,Embolism,2,M,HO,29
171871878,2,Bladder cancer,8,F,EXP,nivolumab,2,PS,Pneumonia,2,M,OT,29
171871878,2,Bladder cancer,8,F,EXP,nivolumab,2,PS,Pneumonia,2,M,HO,29
171873144,14,Neutropenia,4,F,EXP,filgrastim,14,C,Delirium,14,M,HO,605
171873144,14,Neutropenia,4,F,EXP,filgrastim,14,C,Diarrhoea,14,M,HO,605
171873144,14,Neutropenia,4,F,EXP,filgrastim,14,C,Pneumonia,14,M,HO,605
171892624,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,M,HO,21
171892624,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,M,OT,21
171892624,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,HO,21
171892624,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,OT,21
171892624,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Hypopituitarism,1,M,HO,21
171892624,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Hypopituitarism,1,M,OT,21
171892624,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,21
171892624,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,21
171892624,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Off label use,1,M,HO,21
171892624,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,21
171892624,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Rash,1,M,HO,21
171892624,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Rash,1,M,OT,21
171892624,5,Malignant melanoma,4,F,EXP,ipilimumab,5,SS,Fulminant type 1 diabetes mellitus,5,M,HO,21
171892624,5,Malignant melanoma,4,F,EXP,ipilimumab,5,SS,Fulminant type 1 diabetes mellitus,5,M,OT,21
171892624,5,Malignant melanoma,4,F,EXP,ipilimumab,5,SS,Hepatic function abnormal,5,M,HO,21
171892624,5,Malignant melanoma,4,F,EXP,ipilimumab,5,SS,Hepatic function abnormal,5,M,OT,21
171892624,5,Malignant melanoma,4,F,EXP,ipilimumab,5,SS,Hypopituitarism,5,M,HO,21
171892624,5,Malignant melanoma,4,F,EXP,ipilimumab,5,SS,Hypopituitarism,5,M,OT,21
171892624,5,Malignant melanoma,4,F,EXP,ipilimumab,5,SS,Hypothyroidism,5,M,HO,21
171892624,5,Malignant melanoma,4,F,EXP,ipilimumab,5,SS,Hypothyroidism,5,M,OT,21
171892624,5,Malignant melanoma,4,F,EXP,ipilimumab,5,SS,Off label use,5,M,HO,21
171892624,5,Malignant melanoma,4,F,EXP,ipilimumab,5,SS,Off label use,5,M,OT,21
171892624,5,Malignant melanoma,4,F,EXP,ipilimumab,5,SS,Rash,5,M,HO,21
171892624,5,Malignant melanoma,4,F,EXP,ipilimumab,5,SS,Rash,5,M,OT,21
171892802,4,Non-Hodgkin's lymphoma,2,F,EXP,plerixafor,4,SS,Multiple organ dysfunction syndrome,4,M,DE,62
171892802,4,Non-Hodgkin's lymphoma,2,F,EXP,plerixafor,4,SS,Neutropenic sepsis,4,M,DE,62
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,HO,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,OT,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Amylase increased,1,M,HO,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Amylase increased,1,M,OT,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,HO,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,OT,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hypocalcaemia,1,M,HO,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hypocalcaemia,1,M,OT,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,HO,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,OT,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Lipase increased,1,M,HO,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Lipase increased,1,M,OT,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,49
171896072,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Alanine aminotransferase increased,2,M,HO,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Alanine aminotransferase increased,2,M,OT,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Amylase increased,2,M,HO,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Amylase increased,2,M,OT,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Aspartate aminotransferase increased,2,M,HO,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Aspartate aminotransferase increased,2,M,OT,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Hypocalcaemia,2,M,HO,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Hypocalcaemia,2,M,OT,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Hypokalaemia,2,M,HO,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Hypokalaemia,2,M,OT,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Lipase increased,2,M,HO,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Lipase increased,2,M,OT,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Renal failure,2,M,HO,49
171896072,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Renal failure,2,M,OT,49
171902612,1,Lymphoma,2,F,EXP,bleomycin sulfate,1,PS,Ear pain,1,F,OT,1
171902612,1,Lymphoma,2,F,EXP,bleomycin sulfate,1,PS,Pyrexia,1,F,OT,1
171902612,1,Lymphoma,2,F,EXP,bleomycin sulfate,1,PS,Tinnitus,1,F,OT,1
171914022,1,Juvenile chronic myelomonocytic leukaemia,2,F,EXP,trametinib,1,PS,Sepsis,1,M,HO,28
171914022,1,Juvenile chronic myelomonocytic leukaemia,2,F,EXP,trametinib,1,PS,Stridor,1,M,HO,28
171916782,1,Neoplasm,2,F,EXP,entrectinib,1,PS,Tumour lysis syndrome,1,F,HO,14
171919942,8,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,8,SS,Febrile neutropenia,8,M,HO,4
171919942,9,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,9,SS,Febrile neutropenia,9,M,HO,18
171921862,1,Gastric cancer,2,F,EXP,ramucirumab,1,PS,Abdominal pain upper,1,M,HO,245
171921862,1,Gastric cancer,2,F,EXP,ramucirumab,1,PS,Neutropenia,1,M,HO,245
171923344,1,Diffuse large B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,M,HO,9
171923344,1,Diffuse large B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,9
171924372,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,78
171924372,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,78
171924372,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Erythema multiforme,1,M,HO,78
171924372,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Erythema multiforme,1,M,OT,78
171924372,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,78
171924372,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,78
171924372,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,M,HO,78
171924372,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,M,OT,78
171924372,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Erythema multiforme,2,M,HO,78
171924372,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Erythema multiforme,2,M,OT,78
171924372,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,HO,78
171924372,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,OT,78
171925243,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,5q minus syndrome,1,M,OT,902
171931622,1,Neoplasm malignant,2,F,EXP,avelumab,1,PS,Disease progression,1,M,DE,25
171931622,1,Neoplasm malignant,2,F,EXP,avelumab,1,PS,Disease progression,1,M,LT,25
171931622,1,Neoplasm malignant,2,F,EXP,avelumab,1,PS,Hepatic failure,1,M,DE,25
171931622,1,Neoplasm malignant,2,F,EXP,avelumab,1,PS,Hepatic failure,1,M,LT,25
171931622,1,Neoplasm malignant,2,F,EXP,avelumab,1,PS,Sepsis,1,M,DE,25
171931622,1,Neoplasm malignant,2,F,EXP,avelumab,1,PS,Sepsis,1,M,LT,25
171935772,4,Prostate cancer,2,F,EXP,cabazitaxel,4,SS,Abdominal distension,4,M,HO,166
171935772,6,Product used for unknown indication,2,F,EXP,pegfilgrastim,6,SS,Abdominal distension,6,M,HO,8
171936265,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,General physical condition abnormal,1,F,HO,20
171936512,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,PS,Chest pain,2,M,LT,14
171936512,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,PS,Chest pain,2,M,HO,14
171936512,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,PS,Dyspnoea,2,M,LT,14
171936512,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,PS,Dyspnoea,2,M,HO,14
171937855,2,Bladder cancer,5,F,EXP,nivolumab,2,PS,Acute kidney injury,2,F,HO,35
171937855,2,Bladder cancer,5,F,EXP,nivolumab,2,PS,Acute kidney injury,2,F,OT,35
171941692,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Skin disorder,1,M,HO,102
171943282,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,OT,42
171943282,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,DS,42
171943282,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,OT,42
171943282,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,DS,42
171943282,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Proctalgia,1,M,OT,42
171943282,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Proctalgia,1,M,DS,42
171943282,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,OT,42
171943282,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,DS,42
171943282,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,OT,42
171943282,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,DS,42
171943282,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Prescribed overdose,2,M,OT,42
171943282,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Prescribed overdose,2,M,DS,42
171943282,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Proctalgia,2,M,OT,42
171943282,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Proctalgia,2,M,DS,42
171943282,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,M,OT,42
171943282,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,M,DS,42
171943962,6,Prophylaxis,2,F,EXP,rasburicase,6,C,Cystitis,6,F,OT,13
171943962,6,Prophylaxis,2,F,EXP,rasburicase,6,C,Device related infection,6,F,OT,13
171943962,6,Prophylaxis,2,F,EXP,rasburicase,6,C,Hyperuricaemia,6,F,OT,13
171943962,6,Prophylaxis,2,F,EXP,rasburicase,6,C,Neutropenia,6,F,OT,13
171943962,6,Prophylaxis,2,F,EXP,rasburicase,6,C,Pneumonia,6,F,OT,13
171943962,6,Prophylaxis,2,F,EXP,rasburicase,6,C,Respiratory disorder,6,F,OT,13
171945033,1,Renal cell carcinoma,3,F,EXP,ipilimumab,1,PS,Adrenal insufficiency,1,M,OT,78
171945033,1,Renal cell carcinoma,3,F,EXP,ipilimumab,1,PS,Adrenal insufficiency,1,M,HO,78
171945033,1,Renal cell carcinoma,3,F,EXP,ipilimumab,1,PS,Erythema multiforme,1,M,OT,78
171945033,1,Renal cell carcinoma,3,F,EXP,ipilimumab,1,PS,Erythema multiforme,1,M,HO,78
171945033,1,Renal cell carcinoma,3,F,EXP,ipilimumab,1,PS,Interstitial lung disease,1,M,OT,78
171945033,1,Renal cell carcinoma,3,F,EXP,ipilimumab,1,PS,Interstitial lung disease,1,M,HO,78
171945033,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Adrenal insufficiency,2,M,OT,78
171945033,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Adrenal insufficiency,2,M,HO,78
171945033,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Erythema multiforme,2,M,OT,78
171945033,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Erythema multiforme,2,M,HO,78
171945033,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Interstitial lung disease,2,M,OT,78
171945033,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Interstitial lung disease,2,M,HO,78
171945083,1,Squamous cell carcinoma of head and neck,3,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,10
171948095,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,81
171948095,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,81
171948095,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Failure to thrive,1,M,OT,81
171948095,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Failure to thrive,1,M,HO,81
171948095,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,OT,81
171948095,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,HO,81
171948095,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Hypophagia,1,M,OT,81
171948095,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Hypophagia,1,M,HO,81
171948095,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Nausea,1,M,OT,81
171948095,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Nausea,1,M,HO,81
171948095,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Pain,1,M,OT,81
171948095,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Pain,1,M,HO,81
171948095,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,81
171948095,1,Head and neck cancer,5,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,81
171948102,1,Meningioma,2,F,EXP,nivolumab,1,PS,Confusional state,1,M,HO,53
171948102,1,Meningioma,2,F,EXP,nivolumab,1,PS,Gait disturbance,1,M,HO,53
171948102,1,Meningioma,2,F,EXP,nivolumab,1,PS,Muscular weakness,1,M,HO,53
171952112,1,Neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,26
171952112,1,Neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,26
171952112,1,Neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,26
171956433,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,M,OT,21
171956433,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,M,HO,21
171956433,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,OT,21
171956433,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,HO,21
171956433,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hypopituitarism,1,M,OT,21
171956433,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hypopituitarism,1,M,HO,21
171956433,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,21
171956433,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,21
171956433,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,OT,21
171956433,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,HO,21
171956433,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rash,1,M,OT,21
171956433,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rash,1,M,HO,21
171956433,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Fulminant type 1 diabetes mellitus,3,M,OT,21
171956433,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Fulminant type 1 diabetes mellitus,3,M,HO,21
171956433,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hepatic function abnormal,3,M,OT,21
171956433,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hepatic function abnormal,3,M,HO,21
171956433,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hypopituitarism,3,M,OT,21
171956433,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hypopituitarism,3,M,HO,21
171956433,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hypothyroidism,3,M,OT,21
171956433,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Hypothyroidism,3,M,HO,21
171956433,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Prescribed overdose,3,M,OT,21
171956433,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Prescribed overdose,3,M,HO,21
171956433,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Rash,3,M,OT,21
171956433,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Rash,3,M,HO,21
171957913,1,Pancreatic neuroendocrine tumour,3,F,EXP,lanreotide acetate,1,PS,Neutropenia,1,M,OT,788
171960522,1,Acute lymphocytic leukaemia,2,F,PER,blinatumomab,1,PS,Alanine aminotransferase increased,1,M,OT,1
171964412,4,Neoplasm malignant,2,F,EXP,avelumab,4,SS,Abdominal pain,4,F,HO,15
171964412,4,Neoplasm malignant,2,F,EXP,avelumab,4,SS,Blood bilirubin increased,4,F,HO,15
171964412,4,Neoplasm malignant,2,F,EXP,avelumab,4,SS,Gallbladder rupture,4,F,HO,15
171968352,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Condition aggravated,2,F,OT,81
171968352,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Condition aggravated,2,F,HO,81
171968352,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Neuropathy peripheral,2,F,OT,81
171968352,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Neuropathy peripheral,2,F,HO,81
171968352,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pneumonia,2,F,OT,81
171968352,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pneumonia,2,F,HO,81
171973223,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Ileus,1,F,DS,705
171973223,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Ileus,1,F,HO,705
171973223,2,Plasma cell myeloma,3,F,PER,daratumumab,2,SS,Ileus,2,F,DS,705
171973223,2,Plasma cell myeloma,3,F,PER,daratumumab,2,SS,Ileus,2,F,HO,705
171975572,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Sepsis,5,M,HO,9
171975572,7,Plasma cell myeloma,2,F,EXP,lenalidomide,7,SS,Sepsis,7,M,HO,9
171976302,1,Non-Hodgkin's lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Sinusitis,1,M,OT,157
171978524,1,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,1,PS,Hepatic function abnormal,1,M,DS,407
171978524,1,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,1,PS,Hepatic function abnormal,1,M,OT,407
171978524,1,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,1,PS,Proctalgia,1,M,DS,407
171978524,1,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,1,PS,Proctalgia,1,M,OT,407
171978524,1,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,1,PS,Rhabdomyolysis,1,M,DS,407
171978524,1,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,1,PS,Rhabdomyolysis,1,M,OT,407
171978524,2,Product used for unknown indication,4,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,DS,21
171978524,2,Product used for unknown indication,4,F,EXP,ipilimumab,2,SS,Hepatic function abnormal,2,M,OT,21
171978524,2,Product used for unknown indication,4,F,EXP,ipilimumab,2,SS,Proctalgia,2,M,DS,21
171978524,2,Product used for unknown indication,4,F,EXP,ipilimumab,2,SS,Proctalgia,2,M,OT,21
171978524,2,Product used for unknown indication,4,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,M,DS,21
171978524,2,Product used for unknown indication,4,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,M,OT,21
171978524,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Hepatic function abnormal,3,M,DS,42
171978524,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Hepatic function abnormal,3,M,OT,42
171978524,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Proctalgia,3,M,DS,42
171978524,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Proctalgia,3,M,OT,42
171978524,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Rhabdomyolysis,3,M,DS,42
171978524,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Rhabdomyolysis,3,M,OT,42
171978524,4,Product used for unknown indication,4,F,EXP,nivolumab,4,SS,Hepatic function abnormal,4,M,DS,21
171978524,4,Product used for unknown indication,4,F,EXP,nivolumab,4,SS,Hepatic function abnormal,4,M,OT,21
171978524,4,Product used for unknown indication,4,F,EXP,nivolumab,4,SS,Proctalgia,4,M,DS,21
171978524,4,Product used for unknown indication,4,F,EXP,nivolumab,4,SS,Proctalgia,4,M,OT,21
171978524,4,Product used for unknown indication,4,F,EXP,nivolumab,4,SS,Rhabdomyolysis,4,M,DS,21
171978524,4,Product used for unknown indication,4,F,EXP,nivolumab,4,SS,Rhabdomyolysis,4,M,OT,21
171981212,1,Non-renal cell carcinoma of kidney,2,F,EXP,nivolumab,1,PS,Hypotension,1,M,HO,45
171981212,1,Non-renal cell carcinoma of kidney,2,F,EXP,nivolumab,1,PS,Hypotension,1,M,LT,45
171981212,2,Non-renal cell carcinoma of kidney,2,F,EXP,ipilimumab,2,SS,Hypotension,2,M,HO,45
171981212,2,Non-renal cell carcinoma of kidney,2,F,EXP,ipilimumab,2,SS,Hypotension,2,M,LT,45
171989662,33,Prophylaxis,2,F,EXP,pegfilgrastim,33,C,Hypotension,33,F,HO,8
171994043,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Asthma,1,M,HO,194
171994043,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Asthma,2,M,HO,194
171994052,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Nephropathy toxic,1,M,HO,20
171994052,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Nephropathy toxic,2,M,HO,20
172008553,1,Plasma cell myeloma,3,F,EXP,pomalidomide,1,PS,Supraventricular tachycardia,1,F,OT,43
172016291,1,Non-small cell lung cancer,1,I,DIR,crizotinib,1,PS,Hepatic failure,1,F,DE,36
172025122,8,B-cell type acute leukaemia,2,F,EXP,pegaspargase,8,SS,Febrile neutropenia,8,F,HO,19
172025122,8,B-cell type acute leukaemia,2,F,EXP,pegaspargase,8,SS,Febrile neutropenia,8,F,OT,19
172025122,8,B-cell type acute leukaemia,2,F,EXP,pegaspargase,8,SS,Herpes virus infection,8,F,HO,19
172025122,8,B-cell type acute leukaemia,2,F,EXP,pegaspargase,8,SS,Herpes virus infection,8,F,OT,19
172025122,8,B-cell type acute leukaemia,2,F,EXP,pegaspargase,8,SS,Hypophagia,8,F,HO,19
172025122,8,B-cell type acute leukaemia,2,F,EXP,pegaspargase,8,SS,Hypophagia,8,F,OT,19
172025122,8,B-cell type acute leukaemia,2,F,EXP,pegaspargase,8,SS,Malnutrition,8,F,HO,19
172025122,8,B-cell type acute leukaemia,2,F,EXP,pegaspargase,8,SS,Malnutrition,8,F,OT,19
172025122,8,B-cell type acute leukaemia,2,F,EXP,pegaspargase,8,SS,Weight decreased,8,F,HO,19
172025122,8,B-cell type acute leukaemia,2,F,EXP,pegaspargase,8,SS,Weight decreased,8,F,OT,19
172042425,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Febrile neutropenia,3,M,OT,21
172042425,3,Plasma cell myeloma,5,F,EXP,pomalidomide,3,SS,Febrile neutropenia,3,M,HO,21
172042425,6,Plasma cell myeloma,5,F,EXP,daratumumab,6,SS,Febrile neutropenia,6,M,OT,21
172042425,6,Plasma cell myeloma,5,F,EXP,daratumumab,6,SS,Febrile neutropenia,6,M,HO,21
172043202,1,Non-small cell lung cancer recurrent,2,F,EXP,nivolumab,1,PS,Influenza,1,M,HO,45
172043232,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Cushing's syndrome,1,F,HO,84
172043232,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Cushing's syndrome,1,F,OT,84
172043272,1,Small cell lung cancer,2,F,EXP,nivolumab,1,SS,Adrenal insufficiency,1,M,HO,6
172043272,1,Small cell lung cancer,2,F,EXP,nivolumab,1,SS,Adrenal insufficiency,1,M,OT,6
172043272,2,Small cell lung cancer,2,F,EXP,ipilimumab,2,PS,Adrenal insufficiency,2,M,HO,6
172043272,2,Small cell lung cancer,2,F,EXP,ipilimumab,2,PS,Adrenal insufficiency,2,M,OT,6
172043282,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,33
172043282,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,33
172043282,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,HO,33
172043282,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,OT,33
172047473,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,42
172047473,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Hypersensitivity,1,F,OT,42
172047473,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Neoplasm,1,F,OT,42
172047473,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Fatigue,2,F,OT,42
172047473,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Hypersensitivity,2,F,OT,42
172047473,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Neoplasm,2,F,OT,42
172051672,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,HO,32
172051672,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,OT,32
172051672,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,32
172051672,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,32
172051672,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,HO,32
172051672,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,OT,32
172051672,2,Ovarian cancer,2,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,HO,32
172051672,2,Ovarian cancer,2,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,OT,32
172051672,2,Ovarian cancer,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,F,HO,32
172051672,2,Ovarian cancer,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,F,OT,32
172051672,2,Ovarian cancer,2,F,EXP,ipilimumab,2,SS,Urinary tract infection,2,F,HO,32
172051672,2,Ovarian cancer,2,F,EXP,ipilimumab,2,SS,Urinary tract infection,2,F,OT,32
172054352,1,Small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,106
172054352,2,Small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Pyrexia,2,F,HO,106
172054562,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Leukopenia,1,M,HO,97
172054562,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Respiratory tract infection,1,M,HO,97
172054562,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,M,HO,97
172054562,1,Relapsing multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Urosepsis,1,M,HO,97
172055862,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Disorientation,1,M,HO,122
172055862,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Disorientation,1,M,OT,122
172055862,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Infection,1,M,HO,122
172055862,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Infection,1,M,OT,122
172055862,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,HO,122
172055862,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,OT,122
172055862,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Unresponsive to stimuli,1,M,HO,122
172055862,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Unresponsive to stimuli,1,M,OT,122
172056893,3,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,3,C,Atrioventricular block complete,3,M,HO,80
172056893,3,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,3,C,Atrioventricular block complete,3,M,OT,80
172056893,3,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,3,C,Immune-mediated myocarditis,3,M,HO,80
172056893,3,Non-small cell lung cancer,3,F,EXP,pemetrexed disodium,3,C,Immune-mediated myocarditis,3,M,OT,80
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Dyspnoea exertional,1,M,HO,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Dyspnoea exertional,1,M,OT,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Gait disturbance,1,M,HO,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Gait disturbance,1,M,OT,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,HO,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,OT,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,HO,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,OT,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Physical deconditioning,1,M,HO,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Physical deconditioning,1,M,OT,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,HO,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,OT,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Restlessness,1,M,HO,120
172057702,1,Colon cancer stage IV,2,F,EXP,nivolumab,1,PS,Restlessness,1,M,OT,120
172057722,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Facial paralysis,1,M,HO,546
172057722,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Facial paralysis,1,M,OT,546
172057722,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Facial paralysis,2,M,HO,125
172057722,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Facial paralysis,2,M,OT,125
172057823,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Sinus tachycardia,1,F,HO,8
172057823,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Sinus tachycardia,2,F,HO,8
172059055,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Prescribed overdose,1,F,DE,1
172059055,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Prescribed overdose,1,F,OT,1
172059055,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Prescribed overdose,1,F,HO,1
172059055,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,F,DE,1
172059055,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,F,OT,1
172059055,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,F,HO,1
172059055,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pyrexia,1,F,DE,1
172059055,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pyrexia,1,F,OT,1
172059055,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,1
172059055,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Rash,1,F,DE,1
172059055,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Rash,1,F,OT,1
172059055,1,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Rash,1,F,HO,1
172059055,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Prescribed overdose,2,F,DE,1
172059055,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Prescribed overdose,2,F,OT,1
172059055,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Prescribed overdose,2,F,HO,1
172059055,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pulmonary embolism,2,F,DE,1
172059055,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pulmonary embolism,2,F,OT,1
172059055,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pulmonary embolism,2,F,HO,1
172059055,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pyrexia,2,F,DE,1
172059055,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pyrexia,2,F,OT,1
172059055,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Pyrexia,2,F,HO,1
172059055,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Rash,2,F,DE,1
172059055,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Rash,2,F,OT,1
172059055,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Rash,2,F,HO,1
172061672,1,Dedifferentiated liposarcoma,2,F,EXP,selinexor,1,PS,Abdominal pain,1,F,HO,79
172062742,1,Oesophageal adenocarcinoma,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,LT,61
172062742,1,Oesophageal adenocarcinoma,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,61
172062742,3,Oesophageal adenocarcinoma,2,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,LT,61
172062742,3,Oesophageal adenocarcinoma,2,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,OT,61
172079662,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Body temperature increased,1,F,HO,48
172079662,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Emphysema,1,F,HO,48
172079662,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Febrile neutropenia,1,F,HO,48
172079662,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,General physical health deterioration,1,F,HO,48
172079662,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Pneumonia,1,F,HO,48
172079662,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Productive cough,1,F,HO,48
172084612,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Accidental overdose,2,F,HO,28
172084612,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Accidental overdose,2,F,DE,28
172084612,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Accidental overdose,2,F,LT,28
172084612,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Incorrect dose administered,2,F,HO,28
172084612,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Incorrect dose administered,2,F,DE,28
172084612,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Incorrect dose administered,2,F,LT,28
172084612,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Multiple organ dysfunction syndrome,2,F,HO,28
172084612,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Multiple organ dysfunction syndrome,2,F,DE,28
172084612,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Multiple organ dysfunction syndrome,2,F,LT,28
172084612,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Pneumonia aspiration,2,F,HO,28
172084612,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Pneumonia aspiration,2,F,DE,28
172084612,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Pneumonia aspiration,2,F,LT,28
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,OT,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,HO,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,DE,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,OT,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,HO,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,DE,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Blood bilirubin increased,1,M,OT,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Blood bilirubin increased,1,M,HO,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Blood bilirubin increased,1,M,DE,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Hidradenitis,1,M,OT,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Hidradenitis,1,M,HO,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Hidradenitis,1,M,DE,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,OT,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,HO,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,DE,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Rheumatoid arthritis,1,M,OT,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Rheumatoid arthritis,1,M,HO,18
172086792,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Rheumatoid arthritis,1,M,DE,18
172091183,2,Plasma cell myeloma,3,F,EXP,daratumumab,2,SS,Intraductal proliferative breast lesion,2,F,HO,63
172091183,2,Plasma cell myeloma,3,F,EXP,daratumumab,2,SS,Intraductal proliferative breast lesion,2,F,OT,63
172091183,4,Plasma cell myeloma,3,F,EXP,lenalidomide,4,SS,Intraductal proliferative breast lesion,4,F,HO,63
172091183,4,Plasma cell myeloma,3,F,EXP,lenalidomide,4,SS,Intraductal proliferative breast lesion,4,F,OT,63
172092242,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Febrile neutropenia,1,M,HO,7
172092363,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Abnormal behaviour,1,M,OT,9
172092363,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Abnormal behaviour,1,M,HO,9
172092363,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Amnesia,1,M,OT,9
172092363,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Amnesia,1,M,HO,9
172092363,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hospitalisation,1,M,OT,9
172092363,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hospitalisation,1,M,HO,9
172092363,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,9
172092363,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,9
172092363,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Abnormal behaviour,2,M,OT,9
172092363,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Abnormal behaviour,2,M,HO,9
172092363,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Amnesia,2,M,OT,9
172092363,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Amnesia,2,M,HO,9
172092363,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Hospitalisation,2,M,OT,9
172092363,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Hospitalisation,2,M,HO,9
172092363,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,OT,9
172092363,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,HO,9
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Chills,1,M,OT,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Chills,1,M,HO,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Energy increased,1,M,OT,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Energy increased,1,M,HO,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Heart rate decreased,1,M,OT,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Heart rate decreased,1,M,HO,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Lymphoedema,1,M,OT,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Lymphoedema,1,M,HO,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Muscle strain,1,M,OT,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Muscle strain,1,M,HO,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Myalgia,1,M,OT,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Myalgia,1,M,HO,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Night sweats,1,M,OT,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Night sweats,1,M,HO,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Therapeutic response unexpected,1,M,OT,5
172098355,1,Malignant melanoma,5,F,EXP,nivolumab,1,PS,Therapeutic response unexpected,1,M,HO,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Chills,2,M,OT,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Chills,2,M,HO,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Energy increased,2,M,OT,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Energy increased,2,M,HO,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Heart rate decreased,2,M,OT,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Heart rate decreased,2,M,HO,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Lymphoedema,2,M,OT,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Lymphoedema,2,M,HO,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Muscle strain,2,M,OT,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Muscle strain,2,M,HO,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Myalgia,2,M,OT,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Myalgia,2,M,HO,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Night sweats,2,M,OT,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Night sweats,2,M,HO,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Therapeutic response unexpected,2,M,OT,5
172098355,2,Malignant melanoma,5,F,EXP,ipilimumab,2,SS,Therapeutic response unexpected,2,M,HO,5
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,DS,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Enterobacter infection,1,M,HO,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Enterobacter infection,1,M,DS,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Enterobacter infection,1,M,OT,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Fluid retention,1,M,HO,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Fluid retention,1,M,DS,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Fluid retention,1,M,OT,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Lymphadenopathy,1,M,HO,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Lymphadenopathy,1,M,DS,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Lymphadenopathy,1,M,OT,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,HO,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,DS,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,OT,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Tumour necrosis,1,M,HO,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Tumour necrosis,1,M,DS,2
172098863,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Tumour necrosis,1,M,OT,2
172103022,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Constipation,1,M,OT,4
172103022,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Constipation,1,M,DE,4
172103022,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Constipation,1,M,HO,4
172103022,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,4
172103022,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,4
172103022,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,4
172103022,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Urinary retention,1,M,OT,4
172103022,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Urinary retention,1,M,DE,4
172103022,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Urinary retention,1,M,HO,4
172105562,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Pneumonitis,1,M,HO,27
172105562,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pneumonitis,2,M,HO,27
172105792,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Nephropathy toxic,1,M,HO,20
172105792,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,HO,20
172105792,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Nephropathy toxic,2,M,HO,20
172105792,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Prescribed overdose,2,M,HO,20
172105892,3,Malignant melanoma,2,F,EXP,nivolumab,3,PS,Renal failure,3,M,HO,622
172105892,3,Malignant melanoma,2,F,EXP,nivolumab,3,PS,Renal failure,3,M,OT,622
172105892,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Renal failure,4,M,HO,28
172105892,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Renal failure,4,M,OT,28
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Hypophysitis,1,M,OT,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Hypophysitis,1,M,HO,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Hypophysitis,1,M,DE,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Hypopituitarism,1,M,OT,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Hypopituitarism,1,M,HO,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Hypopituitarism,1,M,DE,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Hypothyroidism,1,M,OT,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Hypothyroidism,1,M,HO,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Hypothyroidism,1,M,DE,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Ileus,1,M,OT,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Ileus,1,M,HO,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Ileus,1,M,DE,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Intentional product use issue,1,M,OT,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Intentional product use issue,1,M,HO,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Intentional product use issue,1,M,DE,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Liver disorder,1,M,OT,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Liver disorder,1,M,HO,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Liver disorder,1,M,DE,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,M,OT,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,M,HO,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,M,DE,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Small intestine carcinoma,1,M,OT,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Small intestine carcinoma,1,M,HO,63
172105903,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Small intestine carcinoma,1,M,DE,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Hypophysitis,2,M,OT,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Hypophysitis,2,M,HO,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Hypophysitis,2,M,DE,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Hypopituitarism,2,M,OT,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Hypopituitarism,2,M,HO,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Hypopituitarism,2,M,DE,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Hypothyroidism,2,M,OT,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Hypothyroidism,2,M,HO,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Hypothyroidism,2,M,DE,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Ileus,2,M,OT,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Ileus,2,M,HO,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Ileus,2,M,DE,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Intentional product use issue,2,M,OT,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Intentional product use issue,2,M,HO,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Intentional product use issue,2,M,DE,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Liver disorder,2,M,OT,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Liver disorder,2,M,HO,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Liver disorder,2,M,DE,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Malignant neoplasm progression,2,M,OT,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Malignant neoplasm progression,2,M,HO,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Malignant neoplasm progression,2,M,DE,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Small intestine carcinoma,2,M,OT,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Small intestine carcinoma,2,M,HO,63
172105903,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Small intestine carcinoma,2,M,DE,63
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,396
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,DE,396
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,396
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,396
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,DE,396
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,HO,396
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Pain,1,M,OT,396
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Pain,1,M,DE,396
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Pain,1,M,HO,396
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,396
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,396
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,396
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,396
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Renal failure,1,M,DE,396
172106044,1,Pleural mesothelioma,4,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,396
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,M,OT,31
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,M,DE,31
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Hypothyroidism,2,M,HO,31
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Intentional product use issue,2,M,OT,31
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Intentional product use issue,2,M,DE,31
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Intentional product use issue,2,M,HO,31
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Pain,2,M,OT,31
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Pain,2,M,DE,31
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Pain,2,M,HO,31
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,OT,31
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,DE,31
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,HO,31
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Renal failure,2,M,OT,31
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Renal failure,2,M,DE,31
172106044,2,Mesothelioma,4,F,EXP,ipilimumab,2,SS,Renal failure,2,M,HO,31
172106052,1,Alveolar soft part sarcoma,2,F,EXP,nivolumab,1,PS,Pleural infection,1,M,HO,306
172106052,1,Alveolar soft part sarcoma,2,F,EXP,nivolumab,1,PS,Pleural infection,1,M,OT,306
172106052,1,Alveolar soft part sarcoma,2,F,EXP,nivolumab,1,PS,Tumour haemorrhage,1,M,HO,306
172106052,1,Alveolar soft part sarcoma,2,F,EXP,nivolumab,1,PS,Tumour haemorrhage,1,M,OT,306
172107394,1,Fallopian tube cancer stage IV,4,F,EXP,nivolumab,1,PS,Paraneoplastic neurological syndrome,1,F,HO,182
172107394,1,Fallopian tube cancer stage IV,4,F,EXP,nivolumab,1,PS,Paraneoplastic neurological syndrome,1,F,OT,182
172107394,1,Fallopian tube cancer stage IV,4,F,EXP,nivolumab,1,PS,Paraneoplastic syndrome,1,F,HO,182
172107394,1,Fallopian tube cancer stage IV,4,F,EXP,nivolumab,1,PS,Paraneoplastic syndrome,1,F,OT,182
172109564,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Hiccups,1,M,HO,673
172109564,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Interstitial lung disease,1,M,HO,673
172109564,2,Plasma cell myeloma,4,F,PER,daratumumab,2,SS,Hiccups,2,M,HO,673
172109564,2,Plasma cell myeloma,4,F,PER,daratumumab,2,SS,Interstitial lung disease,2,M,HO,673
172110085,1,Metastatic malignant melanoma,5,F,EXP,trametinib,1,PS,Electrocardiogram QT prolonged,1,M,OT,323
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Abdominal pain,24,M,LT,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Abdominal pain,24,M,HO,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Constipation,24,M,LT,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Constipation,24,M,HO,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Decreased appetite,24,M,LT,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Decreased appetite,24,M,HO,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Dehydration,24,M,LT,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Dehydration,24,M,HO,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Hypoglycaemia,24,M,LT,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Hypoglycaemia,24,M,HO,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Lethargy,24,M,LT,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Lethargy,24,M,HO,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Mucosal inflammation,24,M,LT,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Mucosal inflammation,24,M,HO,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Vomiting,24,M,LT,21
172110102,24,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,24,SS,Vomiting,24,M,HO,21
172110113,30,B precursor type acute leukaemia,3,F,EXP,pegaspargase,30,SS,Febrile neutropenia,30,M,HO,163
172112032,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,2
172112032,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,2
172112032,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Metastases to meninges,1,M,HO,2
172112032,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Metastases to meninges,1,M,OT,2
172112032,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Mucosal inflammation,1,M,HO,2
172112032,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Mucosal inflammation,1,M,OT,2
172112032,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,White blood cell count increased,1,M,HO,2
172112032,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,White blood cell count increased,1,M,OT,2
172114812,1,Meningioma malignant,2,F,EXP,trametinib,1,PS,Hyperglycaemia,1,F,HO,11
172116302,2,Plasma cell myeloma,2,F,PER,lenalidomide,2,SS,Herpes zoster,2,M,HO,709
172131133,3,Malignant melanoma,3,F,EXP,trametinib,3,SS,Atrial flutter,3,M,HO,224
172131133,3,Malignant melanoma,3,F,EXP,trametinib,3,SS,Atrial flutter,3,M,OT,224
172131133,3,Malignant melanoma,3,F,EXP,trametinib,3,SS,Atrial flutter,3,M,DE,224
172131133,3,Malignant melanoma,3,F,EXP,trametinib,3,SS,Ejection fraction decreased,3,M,HO,224
172131133,3,Malignant melanoma,3,F,EXP,trametinib,3,SS,Ejection fraction decreased,3,M,OT,224
172131133,3,Malignant melanoma,3,F,EXP,trametinib,3,SS,Ejection fraction decreased,3,M,DE,224
172131133,3,Malignant melanoma,3,F,EXP,trametinib,3,SS,Small intestinal haemorrhage,3,M,HO,224
172131133,3,Malignant melanoma,3,F,EXP,trametinib,3,SS,Small intestinal haemorrhage,3,M,OT,224
172131133,3,Malignant melanoma,3,F,EXP,trametinib,3,SS,Small intestinal haemorrhage,3,M,DE,224
172131133,3,Malignant melanoma,3,F,EXP,trametinib,3,SS,Urinary tract infection,3,M,HO,224
172131133,3,Malignant melanoma,3,F,EXP,trametinib,3,SS,Urinary tract infection,3,M,OT,224
172131133,3,Malignant melanoma,3,F,EXP,trametinib,3,SS,Urinary tract infection,3,M,DE,224
172131202,1,Breast cancer,2,F,EXP,lapatinib ditosylate,1,PS,Acute myocardial infarction,1,F,HO,3144
172132742,7,Pain in extremity,2,F,EXP,zoledronic acid,7,C,Diarrhoea,7,M,HO,67
172133333,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Torsade de pointes,1,F,HO,665
172136983,1,Cholangiocarcinoma,3,F,EXP,abemaciclib,1,PS,Gastroenteritis,1,F,HO,14
172137213,1,Lung neoplasm malignant,3,F,EXP,lorlatinib,1,PS,Pericardial effusion,1,F,LT,14
172137213,1,Lung neoplasm malignant,3,F,EXP,lorlatinib,1,PS,Pericardial effusion,1,F,OT,14
172137213,1,Lung neoplasm malignant,3,F,EXP,lorlatinib,1,PS,Pericardial effusion,1,F,HO,14
172145403,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Anaphylactic reaction,2,M,HO,63
172145403,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Anaphylactic reaction,2,M,OT,63
172145482,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Febrile neutropenia,2,M,HO,6
172157462,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Angioedema,1,M,OT,3
172157462,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Angioedema,1,M,HO,3
172157462,2,Plasma cell myeloma,2,F,PER,lenalidomide,2,SS,Angioedema,2,M,OT,3
172157462,2,Plasma cell myeloma,2,F,PER,lenalidomide,2,SS,Angioedema,2,M,HO,3
172157633,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Chest pain,1,F,HO,10
172157633,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Chest pain,1,F,OT,10
172157633,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Myocarditis,1,F,HO,10
172157633,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Myocarditis,1,F,OT,10
172157633,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Troponin I increased,1,F,HO,10
172157633,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Troponin I increased,1,F,OT,10
172157633,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Chest pain,2,F,HO,10
172157633,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Chest pain,2,F,OT,10
172157633,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Myocarditis,2,F,HO,10
172157633,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Myocarditis,2,F,OT,10
172157633,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Troponin I increased,2,F,HO,10
172157633,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Troponin I increased,2,F,OT,10
172159114,14,Neutropenia,4,F,EXP,filgrastim,14,C,Delirium,14,M,HO,605
172159114,14,Neutropenia,4,F,EXP,filgrastim,14,C,Diarrhoea,14,M,HO,605
172159114,14,Neutropenia,4,F,EXP,filgrastim,14,C,Pneumonia,14,M,HO,605
172161502,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Epistaxis,1,M,HO,61
172163862,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,PS,Bile duct stone,1,M,OT,42
172163862,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,PS,Bile duct stone,1,M,HO,42
172163862,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,PS,Cholecystitis,1,M,OT,42
172163862,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,PS,Cholecystitis,1,M,HO,42
172163903,29,Prophylaxis,3,F,EXP,rasburicase,29,C,Pneumonitis,29,F,HO,709
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Acute graft versus host disease,1,F,DE,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Acute graft versus host disease,1,F,HO,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Acute graft versus host disease,1,F,OT,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Alanine aminotransferase increased,1,F,DE,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Alanine aminotransferase increased,1,F,HO,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Alanine aminotransferase increased,1,F,OT,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Aspartate aminotransferase increased,1,F,DE,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Aspartate aminotransferase increased,1,F,HO,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Aspartate aminotransferase increased,1,F,OT,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Blood alkaline phosphatase increased,1,F,DE,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Blood alkaline phosphatase increased,1,F,HO,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Blood alkaline phosphatase increased,1,F,OT,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Blood bilirubin increased,1,F,DE,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Blood bilirubin increased,1,F,HO,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Blood bilirubin increased,1,F,OT,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Blood lactate dehydrogenase increased,1,F,DE,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Blood lactate dehydrogenase increased,1,F,HO,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Blood lactate dehydrogenase increased,1,F,OT,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Gamma-glutamyltransferase increased,1,F,DE,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Gamma-glutamyltransferase increased,1,F,HO,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Gamma-glutamyltransferase increased,1,F,OT,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Graft versus host disease in liver,1,F,DE,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Graft versus host disease in liver,1,F,HO,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Graft versus host disease in liver,1,F,OT,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Hypopituitarism,1,F,DE,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Hypopituitarism,1,F,HO,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Hypopituitarism,1,F,OT,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Pneumonia,1,F,DE,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Pneumonia,1,F,HO,11
172169032,1,Acute myeloid leukaemia,2,F,EXP,ipilimumab,1,PS,Pneumonia,1,F,OT,11
172173895,2,Plasma cell myeloma,5,F,EXP,daratumumab,2,SS,Cytomegalovirus gastroenteritis,2,F,HO,209
172173895,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Cytomegalovirus gastroenteritis,3,F,HO,209
172175563,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Asthma,1,M,OT,190
172175563,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,OT,190
172175563,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Chest discomfort,1,M,OT,190
172175563,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Dizziness,1,M,OT,190
172175563,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,190
172175563,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Dysstasia,1,M,OT,190
172175563,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Gait disturbance,1,M,OT,190
172175563,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Hyperhidrosis,1,M,OT,190
172175563,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Skin disorder,1,M,OT,190
172175563,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,190
172185522,6,Anaemia,2,F,EXP,epoetin alfa,6,C,Transient ischaemic attack,6,F,OT,561
172185522,6,Anaemia,2,F,EXP,epoetin alfa,6,C,Transient ischaemic attack,6,F,HO,561
172187693,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Ileus,1,F,DS,705
172187693,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Ileus,1,F,HO,705
172187693,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Ileus,2,F,DS,705
172187693,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Ileus,2,F,HO,705
172188882,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Confusional state,1,F,HO,442
172188892,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Leukopenia,1,F,HO,14
172188892,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Neutropenia,1,F,HO,14
172188892,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Pain,1,F,HO,14
172188892,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Thrombocytopenia,1,F,HO,14
172188954,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Leukopenia,2,F,HO,14
172188954,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Neutropenia,2,F,HO,14
172188954,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Pain,2,F,HO,14
172188954,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Thrombocytopenia,2,F,HO,14
172192834,1,Acute myeloid leukaemia,4,F,EXP,midostaurin,1,PS,Thrombocytopenia,1,M,HO,32
172192944,1,Acute lymphocytic leukaemia,4,F,PER,blinatumomab,1,PS,Hepatotoxicity,1,M,DE,10
172192944,1,Acute lymphocytic leukaemia,4,F,PER,blinatumomab,1,PS,Hepatotoxicity,1,M,OT,10
172192944,1,Acute lymphocytic leukaemia,4,F,PER,blinatumomab,1,PS,Hepatotoxicity,1,M,LT,10
172197222,1,Malignant melanoma,2,F,EXP,trametinib,1,PS,Dermatitis acneiform,1,M,OT,10
172197563,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,OT,42
172197563,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,HO,42
172197563,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Embolism,1,M,OT,42
172197563,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Embolism,1,M,HO,42
172197563,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Hypoacusis,1,M,OT,42
172197563,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Hypoacusis,1,M,HO,42
172197563,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,42
172197563,1,Colon cancer,3,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,42
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Ascites,4,F,OT,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Ascites,4,F,HO,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Ascites,4,F,DE,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Bronchopulmonary aspergillosis,4,F,OT,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Bronchopulmonary aspergillosis,4,F,HO,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Bronchopulmonary aspergillosis,4,F,DE,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Confusional state,4,F,OT,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Confusional state,4,F,HO,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Confusional state,4,F,DE,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Hodgkin's disease,4,F,OT,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Hodgkin's disease,4,F,HO,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Hodgkin's disease,4,F,DE,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Mucosal inflammation,4,F,OT,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Mucosal inflammation,4,F,HO,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Mucosal inflammation,4,F,DE,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Off label use,4,F,OT,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Off label use,4,F,HO,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Off label use,4,F,DE,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Pancytopenia,4,F,OT,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Pancytopenia,4,F,HO,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Pancytopenia,4,F,DE,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Venoocclusive disease,4,F,OT,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Venoocclusive disease,4,F,HO,92
172201142,4,Hodgkin's disease,2,F,EXP,brentuximab vedotin,4,SS,Venoocclusive disease,4,F,DE,92
172201232,2,Hormone-refractory prostate cancer,2,F,EXP,cabazitaxel,2,SS,Asthenia,2,M,OT,70
172201232,2,Hormone-refractory prostate cancer,2,F,EXP,cabazitaxel,2,SS,Asthenia,2,M,HO,70
172201232,2,Hormone-refractory prostate cancer,2,F,EXP,cabazitaxel,2,SS,General physical health deterioration,2,M,OT,70
172201232,2,Hormone-refractory prostate cancer,2,F,EXP,cabazitaxel,2,SS,General physical health deterioration,2,M,HO,70
172201232,2,Hormone-refractory prostate cancer,2,F,EXP,cabazitaxel,2,SS,Haematuria,2,M,OT,70
172201232,2,Hormone-refractory prostate cancer,2,F,EXP,cabazitaxel,2,SS,Haematuria,2,M,HO,70
172201702,1,Prostate cancer,2,F,EXP,nivolumab,1,PS,Muscular weakness,1,M,HO,6
172201822,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Abdominal pain upper,1,F,OT,10
172201822,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Asthenia,1,F,OT,10
172201822,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Diarrhoea,1,F,OT,10
172201822,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Dysuria,1,F,OT,10
172201822,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Nausea,1,F,OT,10
172201822,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Neuropathy peripheral,1,F,OT,10
172201822,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Rhinorrhoea,1,F,OT,10
172201822,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Vomiting,1,F,OT,10
172201822,1,Breast cancer,2,F,EXP,zoledronic acid,1,PS,Vulvovaginal inflammation,1,F,OT,10
172203883,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Immune-mediated enterocolitis,1,M,HO,109
172203883,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Immune-mediated enterocolitis,1,M,OT,109
172203883,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Staphylococcal sepsis,1,M,HO,109
172203883,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Staphylococcal sepsis,1,M,OT,109
172203883,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Thrombosis,1,M,HO,109
172203883,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Thrombosis,1,M,OT,109
172203883,2,Product used for unknown indication,3,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,M,HO,26
172203883,2,Product used for unknown indication,3,F,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,M,OT,26
172203883,2,Product used for unknown indication,3,F,EXP,ipilimumab,2,SS,Staphylococcal sepsis,2,M,HO,26
172203883,2,Product used for unknown indication,3,F,EXP,ipilimumab,2,SS,Staphylococcal sepsis,2,M,OT,26
172203883,2,Product used for unknown indication,3,F,EXP,ipilimumab,2,SS,Thrombosis,2,M,HO,26
172203883,2,Product used for unknown indication,3,F,EXP,ipilimumab,2,SS,Thrombosis,2,M,OT,26
172205332,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Clostridium difficile infection,2,M,HO,2321
172205332,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Clostridium difficile infection,2,M,OT,2321
172207603,1,Endometrial stromal sarcoma,3,F,EXP,ipilimumab,1,PS,Pleural effusion,1,F,OT,6
172207603,1,Endometrial stromal sarcoma,3,F,EXP,ipilimumab,1,PS,Pleural effusion,1,F,HO,6
172207603,1,Endometrial stromal sarcoma,3,F,EXP,ipilimumab,1,PS,Pneumothorax,1,F,OT,6
172207603,1,Endometrial stromal sarcoma,3,F,EXP,ipilimumab,1,PS,Pneumothorax,1,F,HO,6
172207603,1,Endometrial stromal sarcoma,3,F,EXP,ipilimumab,1,PS,Pulmonary embolism,1,F,OT,6
172207603,1,Endometrial stromal sarcoma,3,F,EXP,ipilimumab,1,PS,Pulmonary embolism,1,F,HO,6
172207603,3,Endometrial stromal sarcoma,3,F,EXP,nivolumab,3,SS,Pleural effusion,3,F,OT,6
172207603,3,Endometrial stromal sarcoma,3,F,EXP,nivolumab,3,SS,Pleural effusion,3,F,HO,6
172207603,3,Endometrial stromal sarcoma,3,F,EXP,nivolumab,3,SS,Pneumothorax,3,F,OT,6
172207603,3,Endometrial stromal sarcoma,3,F,EXP,nivolumab,3,SS,Pneumothorax,3,F,HO,6
172207603,3,Endometrial stromal sarcoma,3,F,EXP,nivolumab,3,SS,Pulmonary embolism,3,F,OT,6
172207603,3,Endometrial stromal sarcoma,3,F,EXP,nivolumab,3,SS,Pulmonary embolism,3,F,HO,6
172207733,1,Gastric cancer,3,F,EXP,ramucirumab,1,PS,Pulmonary haemorrhage,1,M,HO,333
172208004,1,Bladder cancer,4,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,71
172208004,1,Bladder cancer,4,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,71
172208004,2,Bladder cancer,4,F,EXP,ipilimumab,2,SS,Renal failure,2,M,OT,71
172208004,2,Bladder cancer,4,F,EXP,ipilimumab,2,SS,Renal failure,2,M,HO,71
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Abdominal pain,16,M,LT,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Abdominal pain,16,M,HO,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Constipation,16,M,LT,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Constipation,16,M,HO,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Decreased appetite,16,M,LT,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Decreased appetite,16,M,HO,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Dehydration,16,M,LT,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Dehydration,16,M,HO,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Hypoglycaemia,16,M,LT,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Hypoglycaemia,16,M,HO,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Lethargy,16,M,LT,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Lethargy,16,M,HO,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Mucosal inflammation,16,M,LT,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Mucosal inflammation,16,M,HO,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Vomiting,16,M,LT,21
172208052,16,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,16,SS,Vomiting,16,M,HO,21
172208272,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,PS,Superior vena cava syndrome,2,F,HO,8
172208272,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,SS,Superior vena cava syndrome,3,F,HO,8
172208482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,379
172208482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,379
172208482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,LT,379
172208482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,379
172208482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,379
172208482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,379
172208482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Sepsis,1,M,LT,379
172208482,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Sepsis,1,M,DE,379
172208482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,HO,379
172208482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,OT,379
172208482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,LT,379
172208482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,DE,379
172208482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Sepsis,2,M,HO,379
172208482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Sepsis,2,M,OT,379
172208482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Sepsis,2,M,LT,379
172208482,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Sepsis,2,M,DE,379
172213302,9,Plasma cell myeloma,2,F,EXP,daratumumab,9,C,Diverticulitis,9,F,OT,65
172213302,9,Plasma cell myeloma,2,F,EXP,daratumumab,9,C,Diverticulitis,9,F,HO,65
172213302,9,Plasma cell myeloma,2,F,EXP,daratumumab,9,C,Neutropenia,9,F,OT,65
172213302,9,Plasma cell myeloma,2,F,EXP,daratumumab,9,C,Neutropenia,9,F,HO,65
172213302,9,Plasma cell myeloma,2,F,EXP,daratumumab,9,C,Thrombocytopenia,9,F,OT,65
172213302,9,Plasma cell myeloma,2,F,EXP,daratumumab,9,C,Thrombocytopenia,9,F,HO,65
172213302,29,Plasma cell myeloma,2,F,EXP,nivolumab,29,C,Diverticulitis,29,F,OT,51
172213302,29,Plasma cell myeloma,2,F,EXP,nivolumab,29,C,Diverticulitis,29,F,HO,51
172213302,29,Plasma cell myeloma,2,F,EXP,nivolumab,29,C,Neutropenia,29,F,OT,51
172213302,29,Plasma cell myeloma,2,F,EXP,nivolumab,29,C,Neutropenia,29,F,HO,51
172213302,29,Plasma cell myeloma,2,F,EXP,nivolumab,29,C,Thrombocytopenia,29,F,OT,51
172213302,29,Plasma cell myeloma,2,F,EXP,nivolumab,29,C,Thrombocytopenia,29,F,HO,51
172213641,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Anaemia,1,F,HO,8
172213641,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Anaemia,1,F,OT,8
172213641,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Anaemia,1,F,LT,8
172214791,50,Product used for unknown indication,1,I,EXP,granisetron,50,C,Cardiac sarcoidosis,50,F,OT,70
172214791,50,Product used for unknown indication,1,I,EXP,granisetron,50,C,Cardiomyopathy,50,F,OT,70
172214791,50,Product used for unknown indication,1,I,EXP,granisetron,50,C,Diastolic dysfunction,50,F,OT,70
172214791,50,Product used for unknown indication,1,I,EXP,granisetron,50,C,Rash,50,F,OT,70
172214791,50,Product used for unknown indication,1,I,EXP,granisetron,50,C,Vena cava thrombosis,50,F,OT,70
172216021,1,Product used for unknown indication,1,I,PER,darbepoetin alfa,1,PS,Allergic transfusion reaction,1,F,DE,175
172216021,1,Product used for unknown indication,1,I,PER,darbepoetin alfa,1,PS,Allergic transfusion reaction,1,F,LT,175
172216021,1,Product used for unknown indication,1,I,PER,darbepoetin alfa,1,PS,Alveolar proteinosis,1,F,DE,175
172216021,1,Product used for unknown indication,1,I,PER,darbepoetin alfa,1,PS,Alveolar proteinosis,1,F,LT,175
172216021,1,Product used for unknown indication,1,I,PER,darbepoetin alfa,1,PS,Cardiac failure,1,F,DE,175
172216021,1,Product used for unknown indication,1,I,PER,darbepoetin alfa,1,PS,Cardiac failure,1,F,LT,175
172216021,1,Product used for unknown indication,1,I,PER,darbepoetin alfa,1,PS,Myelodysplastic syndrome,1,F,DE,175
172216021,1,Product used for unknown indication,1,I,PER,darbepoetin alfa,1,PS,Myelodysplastic syndrome,1,F,LT,175
172216021,1,Product used for unknown indication,1,I,PER,darbepoetin alfa,1,PS,Stress cardiomyopathy,1,F,DE,175
172216021,1,Product used for unknown indication,1,I,PER,darbepoetin alfa,1,PS,Stress cardiomyopathy,1,F,LT,175
172216021,1,Product used for unknown indication,1,I,PER,darbepoetin alfa,1,PS,Transfusion-related circulatory overload,1,F,DE,175
172216021,1,Product used for unknown indication,1,I,PER,darbepoetin alfa,1,PS,Transfusion-related circulatory overload,1,F,LT,175
172216021,1,Product used for unknown indication,1,I,PER,darbepoetin alfa,1,PS,Upper respiratory tract inflammation,1,F,DE,175
172216021,1,Product used for unknown indication,1,I,PER,darbepoetin alfa,1,PS,Upper respiratory tract inflammation,1,F,LT,175
172218111,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Skin lesion,1,M,OT,20
172218414,2,Chronic lymphocytic leukaemia,4,F,EXP,chlorambucil,2,SS,Staphylococcal infection,2,M,HO,1467
172220241,2,Malignant melanoma,1,I,EXP,nivolumab,2,I,Pemphigoid,2,M,OT,903
172221509,1,Plasma cell myeloma,9,F,PER,carfilzomib,1,PS,Pneumonia,1,M,DE,8
172221509,1,Plasma cell myeloma,9,F,PER,carfilzomib,1,PS,Pneumonia,1,M,OT,8
172221509,1,Plasma cell myeloma,9,F,PER,carfilzomib,1,PS,Septic shock,1,M,DE,8
172221509,1,Plasma cell myeloma,9,F,PER,carfilzomib,1,PS,Septic shock,1,M,OT,8
172221509,2,Plasma cell myeloma,9,F,PER,lenalidomide,2,SS,Pneumonia,2,M,DE,8
172221509,2,Plasma cell myeloma,9,F,PER,lenalidomide,2,SS,Pneumonia,2,M,OT,8
172221509,2,Plasma cell myeloma,9,F,PER,lenalidomide,2,SS,Septic shock,2,M,DE,8
172221509,2,Plasma cell myeloma,9,F,PER,lenalidomide,2,SS,Septic shock,2,M,OT,8
172221891,1,Lung neoplasm malignant,1,I,EXP,brigatinib,1,PS,Back pain,1,F,DE,141
172221891,1,Lung neoplasm malignant,1,I,EXP,brigatinib,1,PS,Chills,1,F,DE,141
172221891,1,Lung neoplasm malignant,1,I,EXP,brigatinib,1,PS,Cough,1,F,DE,141
172221891,1,Lung neoplasm malignant,1,I,EXP,brigatinib,1,PS,Death,1,F,DE,141
172221891,1,Lung neoplasm malignant,1,I,EXP,brigatinib,1,PS,Decreased appetite,1,F,DE,141
172221891,1,Lung neoplasm malignant,1,I,EXP,brigatinib,1,PS,Diarrhoea,1,F,DE,141
172221891,1,Lung neoplasm malignant,1,I,EXP,brigatinib,1,PS,Epistaxis,1,F,DE,141
172221891,1,Lung neoplasm malignant,1,I,EXP,brigatinib,1,PS,Fatigue,1,F,DE,141
172221891,1,Lung neoplasm malignant,1,I,EXP,brigatinib,1,PS,Product dose omission,1,F,DE,141
172225473,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Shunt occlusion,1,M,OT,77
172225473,1,Myelodysplastic syndrome,3,F,PER,darbepoetin alfa,1,PS,Skin ulcer,1,M,OT,77
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Aspartate aminotransferase increased,1,F,LT,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Aspartate aminotransferase increased,1,F,DE,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Aspartate aminotransferase increased,1,F,OT,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Blood alkaline phosphatase increased,1,F,LT,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Blood alkaline phosphatase increased,1,F,DE,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Blood alkaline phosphatase increased,1,F,OT,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Blood bilirubin increased,1,F,LT,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Blood bilirubin increased,1,F,DE,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Blood bilirubin increased,1,F,OT,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Blood lactate dehydrogenase increased,1,F,LT,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Blood lactate dehydrogenase increased,1,F,DE,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Blood lactate dehydrogenase increased,1,F,OT,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Blood urea increased,1,F,LT,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Blood urea increased,1,F,DE,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Blood urea increased,1,F,OT,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Death,1,F,LT,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Death,1,F,DE,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Death,1,F,OT,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Hepatosplenic abscess,1,F,LT,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Hepatosplenic abscess,1,F,DE,131
172225991,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Hepatosplenic abscess,1,F,OT,131
172228562,7,Non-small cell lung cancer,2,F,PER,pemetrexed disodium,7,C,Immune-mediated pneumonitis,7,F,OT,175
172229171,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,95
172229171,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,95
172229171,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,95
172229171,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Intentional product use issue,1,M,DE,95
172230501,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Pemphigoid,1,M,OT,903
172230801,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Urosepsis,1,M,HO,188
172233161,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,SS,Bronchitis,1,M,OT,130
172233161,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,PS,Bronchitis,2,M,OT,130
172234522,2,Invasive ductal breast carcinoma,2,F,EXP,palbociclib,2,SS,Deep vein thrombosis,2,F,HO,46
172234522,2,Invasive ductal breast carcinoma,2,F,EXP,palbociclib,2,SS,Deep vein thrombosis,2,F,OT,46
172234522,2,Invasive ductal breast carcinoma,2,F,EXP,palbociclib,2,SS,Pulmonary embolism,2,F,HO,46
172234522,2,Invasive ductal breast carcinoma,2,F,EXP,palbociclib,2,SS,Pulmonary embolism,2,F,OT,46
172236051,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Osteoradionecrosis,1,M,OT,66
172236051,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Spinal cord injury cervical,1,M,OT,66
172236051,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Osteoradionecrosis,2,M,OT,52
172236051,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Spinal cord injury cervical,2,M,OT,52
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Anaemia,1,M,HO,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Anaemia,1,M,OT,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Anaemia,1,M,DE,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Cold sweat,1,M,HO,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Cold sweat,1,M,OT,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Cold sweat,1,M,DE,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Constipation,1,M,HO,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Constipation,1,M,OT,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Constipation,1,M,DE,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Death,1,M,HO,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Death,1,M,OT,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Death,1,M,DE,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Delirium,1,M,HO,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Delirium,1,M,OT,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Delirium,1,M,DE,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Femur fracture,1,M,HO,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Femur fracture,1,M,OT,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Femur fracture,1,M,DE,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Gastric ulcer,1,M,HO,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Gastric ulcer,1,M,OT,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Gastric ulcer,1,M,DE,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Hyperglycaemia,1,M,HO,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Hyperglycaemia,1,M,OT,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Hyperglycaemia,1,M,DE,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Hypotension,1,M,HO,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Hypotension,1,M,OT,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Hypotension,1,M,DE,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Memory impairment,1,M,HO,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Memory impairment,1,M,OT,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Memory impairment,1,M,DE,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Neuropathy peripheral,1,M,HO,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Neuropathy peripheral,1,M,OT,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Neuropathy peripheral,1,M,DE,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Pain,1,M,HO,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Pain,1,M,OT,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Pain,1,M,DE,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Urinary tract infection,1,M,HO,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Urinary tract infection,1,M,OT,354
172236093,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Urinary tract infection,1,M,DE,354
172237061,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,LT,11
172237061,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,OT,11
172237061,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,HO,11
172237061,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,DE,11
172237061,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Pulmonary oedema,3,M,LT,11
172237061,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Pulmonary oedema,3,M,OT,11
172237061,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Pulmonary oedema,3,M,HO,11
172237061,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Pulmonary oedema,3,M,DE,11
172237262,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Bronchitis,1,F,HO,560
172237262,7,Prophylaxis,2,F,EXP,zoledronic acid,7,C,Bronchitis,7,F,HO,90
172237652,1,Glioblastoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,102
172237652,1,Glioblastoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,102
172237736,1,Plasma cell myeloma,6,F,EXP,pomalidomide,1,PS,Dizziness,1,F,HO,2
172237736,1,Plasma cell myeloma,6,F,EXP,pomalidomide,1,PS,Lower respiratory tract infection,1,F,HO,2
172242691,1,Penile cancer,1,I,EXP,nivolumab,1,SS,Pneumonia,1,M,HO,41
172242691,1,Penile cancer,1,I,EXP,nivolumab,1,SS,Pneumonia,1,M,OT,41
172242691,1,Penile cancer,1,I,EXP,nivolumab,1,SS,Urinary tract infection,1,M,HO,41
172242691,1,Penile cancer,1,I,EXP,nivolumab,1,SS,Urinary tract infection,1,M,OT,41
172242691,2,Penile cancer,1,I,EXP,ipilimumab,2,PS,Pneumonia,2,M,HO,41
172242691,2,Penile cancer,1,I,EXP,ipilimumab,2,PS,Pneumonia,2,M,OT,41
172242691,2,Penile cancer,1,I,EXP,ipilimumab,2,PS,Urinary tract infection,2,M,HO,41
172242691,2,Penile cancer,1,I,EXP,ipilimumab,2,PS,Urinary tract infection,2,M,OT,41
172243333,3,Glioma,3,F,EXP,trametinib,3,SS,Renal colic,3,F,HO,395
172245663,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Anaemia,1,M,HO,54
172246671,7,Vomiting,1,I,EXP,granisetron,7,C,Leukopenia,7,F,HO,8
172246671,7,Vomiting,1,I,EXP,granisetron,7,C,Leukopenia,7,F,OT,8
172246671,7,Vomiting,1,I,EXP,granisetron,7,C,Leukopenia,7,F,DS,8
172246671,7,Vomiting,1,I,EXP,granisetron,7,C,Stomatitis,7,F,HO,8
172246671,7,Vomiting,1,I,EXP,granisetron,7,C,Stomatitis,7,F,OT,8
172246671,7,Vomiting,1,I,EXP,granisetron,7,C,Stomatitis,7,F,DS,8
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Death,3,F,OT,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Death,3,F,DE,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Delirium,3,F,OT,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Delirium,3,F,DE,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Dermatitis,3,F,OT,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Dermatitis,3,F,DE,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Fatigue,3,F,OT,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Fatigue,3,F,DE,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Hypokalaemia,3,F,OT,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Hypokalaemia,3,F,DE,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Hyponatraemia,3,F,OT,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Hyponatraemia,3,F,DE,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Inappropriate antidiuretic hormone secretion,3,F,OT,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Inappropriate antidiuretic hormone secretion,3,F,DE,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Leukopenia,3,F,OT,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Leukopenia,3,F,DE,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,F,OT,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,F,DE,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Metastases to meninges,3,F,OT,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Metastases to meninges,3,F,DE,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Paraparesis,3,F,OT,518
172247022,3,Non-small cell lung cancer,2,F,EXP,nivolumab,3,SS,Paraparesis,3,F,DE,518
172247292,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Pneumonia,1,M,OT,127
172247292,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Pneumonia,1,M,HO,127
172247292,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Thrombocytopenia,1,M,OT,127
172247292,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Thrombocytopenia,1,M,HO,127
172249102,1,Non-Hodgkin's lymphoma,2,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,15
172249102,1,Non-Hodgkin's lymphoma,2,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,DE,15
172249102,1,Non-Hodgkin's lymphoma,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,15
172249102,1,Non-Hodgkin's lymphoma,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,DE,15
172250141,2,Prostate cancer metastatic,1,I,EXP,cabazitaxel,2,SS,Malnutrition,2,M,HO,74
172250141,2,Prostate cancer metastatic,1,I,EXP,cabazitaxel,2,SS,Urinary tract infection,2,M,HO,74
172250692,19,Product used for unknown indication,2,F,EXP,granisetron,19,C,General physical health deterioration,19,F,HO,38
172251082,1,Osteoporosis,2,F,EXP,zoledronic acid,1,PS,Body temperature increased,1,F,OT,1
172251082,1,Osteoporosis,2,F,EXP,zoledronic acid,1,PS,Feeding disorder,1,F,OT,1
172251082,1,Osteoporosis,2,F,EXP,zoledronic acid,1,PS,Headache,1,F,OT,1
172251082,1,Osteoporosis,2,F,EXP,zoledronic acid,1,PS,Myalgia,1,F,OT,1
172251082,1,Osteoporosis,2,F,EXP,zoledronic acid,1,PS,Nausea,1,F,OT,1
172251082,1,Osteoporosis,2,F,EXP,zoledronic acid,1,PS,Poisoning,1,F,OT,1
172251082,1,Osteoporosis,2,F,EXP,zoledronic acid,1,PS,Vomiting,1,F,OT,1
172251211,20,Plasma cell myeloma,1,I,PER,daratumumab,20,SS,Pain,20,M,HO,279
172252583,13,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,13,SS,Acute kidney injury,13,M,HO,29
172252583,13,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,13,SS,Device related infection,13,M,HO,29
172252583,13,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,13,SS,Febrile neutropenia,13,M,HO,29
172252583,13,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,13,SS,Pancreatitis,13,M,HO,29
172252583,13,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,13,SS,Pneumonia,13,M,HO,29
172252583,13,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,13,SS,Sepsis,13,M,HO,29
172254922,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,HO,56
172254922,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,56
172254922,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Venous thrombosis,1,M,HO,56
172254922,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Venous thrombosis,1,M,OT,56
172254922,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Pulmonary embolism,2,M,HO,41
172254922,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Pulmonary embolism,2,M,OT,41
172254922,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Venous thrombosis,2,M,HO,41
172254922,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Venous thrombosis,2,M,OT,41
172255094,9,Pain in extremity,4,F,EXP,zoledronic acid,9,C,Death,9,M,LT,69
172255094,9,Pain in extremity,4,F,EXP,zoledronic acid,9,C,Death,9,M,DE,69
172255094,9,Pain in extremity,4,F,EXP,zoledronic acid,9,C,Death,9,M,HO,69
172256052,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Influenza,2,M,OT,100
172256052,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Influenza,2,M,HO,100
172256052,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Pneumonia,2,M,OT,100
172256052,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Pneumonia,2,M,HO,100
172256052,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Influenza,3,M,OT,100
172256052,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Influenza,3,M,HO,100
172256052,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Pneumonia,3,M,OT,100
172256052,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Pneumonia,3,M,HO,100
172257041,2,Product used for unknown indication,1,I,EXP,palbociclib,2,SS,Leukopenia,2,F,OT,33
172257041,2,Product used for unknown indication,1,I,EXP,palbociclib,2,SS,Neutropenia,2,F,OT,33
172261241,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Aortic dissection,1,F,OT,151
172261241,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Aortic dissection,1,F,HO,151
172261241,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Aortic dissection,2,F,OT,151
172261241,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Aortic dissection,2,F,HO,151
172261241,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Aortic dissection,3,F,OT,60
172261241,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Aortic dissection,3,F,HO,60
172265293,2,Prostate cancer,3,F,EXP,nivolumab,2,PS,Dehydration,2,M,HO,66
172265842,1,Pancreatic carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Subdural haematoma,1,F,HO,67
172265842,1,Pancreatic carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Subdural haematoma,1,F,OT,67
172265842,1,Pancreatic carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Subdural haematoma,1,F,DE,67
172265842,1,Pancreatic carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Syncope,1,F,HO,67
172265842,1,Pancreatic carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Syncope,1,F,OT,67
172265842,1,Pancreatic carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Syncope,1,F,DE,67
172265842,2,Pancreatic carcinoma metastatic,2,F,EXP,ipilimumab,2,SS,Subdural haematoma,2,F,HO,67
172265842,2,Pancreatic carcinoma metastatic,2,F,EXP,ipilimumab,2,SS,Subdural haematoma,2,F,OT,67
172265842,2,Pancreatic carcinoma metastatic,2,F,EXP,ipilimumab,2,SS,Subdural haematoma,2,F,DE,67
172265842,2,Pancreatic carcinoma metastatic,2,F,EXP,ipilimumab,2,SS,Syncope,2,F,HO,67
172265842,2,Pancreatic carcinoma metastatic,2,F,EXP,ipilimumab,2,SS,Syncope,2,F,OT,67
172265842,2,Pancreatic carcinoma metastatic,2,F,EXP,ipilimumab,2,SS,Syncope,2,F,DE,67
172268065,1,Acute myeloid leukaemia,5,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,10
172268065,1,Acute myeloid leukaemia,5,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,LT,10
172268065,1,Acute myeloid leukaemia,5,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,10
172268065,1,Acute myeloid leukaemia,5,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,M,HO,10
172268065,1,Acute myeloid leukaemia,5,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,M,LT,10
172268065,1,Acute myeloid leukaemia,5,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,M,OT,10
172268065,2,Acute myeloid leukaemia,5,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,HO,10
172268065,2,Acute myeloid leukaemia,5,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,LT,10
172268065,2,Acute myeloid leukaemia,5,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,OT,10
172268065,2,Acute myeloid leukaemia,5,F,EXP,ipilimumab,2,SS,Hypercalcaemia,2,M,HO,10
172268065,2,Acute myeloid leukaemia,5,F,EXP,ipilimumab,2,SS,Hypercalcaemia,2,M,LT,10
172268065,2,Acute myeloid leukaemia,5,F,EXP,ipilimumab,2,SS,Hypercalcaemia,2,M,OT,10
172268382,1,Colon cancer,2,F,EXP,nivolumab,1,PS,Euthanasia,1,F,DE,34
172268382,1,Colon cancer,2,F,EXP,nivolumab,1,PS,Intentional product use issue,1,F,DE,34
172269331,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Lymphoedema,1,F,HO,153
172270001,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Death,1,F,DE,34
172270001,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Death,1,F,OT,34
172271243,1,Salivary gland cancer,3,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,29
172271243,1,Salivary gland cancer,3,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,29
172271243,1,Salivary gland cancer,3,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,29
172271243,1,Salivary gland cancer,3,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,29
172271243,1,Salivary gland cancer,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,29
172271243,1,Salivary gland cancer,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,29
172271243,1,Salivary gland cancer,3,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,OT,29
172271243,1,Salivary gland cancer,3,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,HO,29
172271243,1,Salivary gland cancer,3,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,29
172271243,1,Salivary gland cancer,3,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,29
172271243,1,Salivary gland cancer,3,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,OT,29
172271243,1,Salivary gland cancer,3,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,HO,29
172272475,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Multiple organ dysfunction syndrome,1,M,DE,67
172272475,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Multiple organ dysfunction syndrome,1,M,OT,67
172272475,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Multiple organ dysfunction syndrome,1,M,HO,67
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Dizziness,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Dyspnoea,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Eye inflammation,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Eye pain,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Fatigue,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Gastric disorder,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Headache,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Influenza like illness,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Malaise,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Musculoskeletal pain,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Myalgia,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Neck pain,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Nervousness,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Ocular hyperaemia,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Pain,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Pyrexia,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Stress,10,F,OT,1
172273921,10,Osteoporosis,1,I,EXP,zoledronic acid,10,SS,Syncope,10,F,OT,1
172275772,1,Lung neoplasm malignant,2,F,EXP,brigatinib,1,PS,Blood creatine phosphokinase increased,1,F,HO,14
172276164,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,12
172276164,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,12
172276164,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,HO,12
172276164,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,OT,12
172276164,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,12
172276164,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,12
172276164,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pruritus,1,M,HO,12
172276164,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Pruritus,1,M,OT,12
172278443,1,Hepatic neoplasm,3,F,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,23
172278443,1,Hepatic neoplasm,3,F,EXP,nivolumab,1,PS,Constipation,1,M,OT,23
172278443,1,Hepatic neoplasm,3,F,EXP,nivolumab,1,PS,Dry mouth,1,M,OT,23
172278443,1,Hepatic neoplasm,3,F,EXP,nivolumab,1,PS,Dry skin,1,M,OT,23
172278443,1,Hepatic neoplasm,3,F,EXP,nivolumab,1,PS,Dyspepsia,1,M,OT,23
172278443,1,Hepatic neoplasm,3,F,EXP,nivolumab,1,PS,Flatulence,1,M,OT,23
172278443,1,Hepatic neoplasm,3,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,23
172278443,1,Hepatic neoplasm,3,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,23
172278443,1,Hepatic neoplasm,3,F,EXP,nivolumab,1,PS,Trigger finger,1,M,OT,23
172278443,1,Hepatic neoplasm,3,F,EXP,nivolumab,1,PS,Xerophthalmia,1,M,OT,23
172278632,1,Sarcomatoid carcinoma of the lung,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,492
172278632,1,Sarcomatoid carcinoma of the lung,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,492
172279393,1,Metastatic malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,50
172279393,1,Metastatic malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,50
172279393,1,Metastatic malignant melanoma,3,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,50
172279393,1,Metastatic malignant melanoma,3,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,50
172279393,1,Metastatic malignant melanoma,3,F,EXP,nivolumab,1,PS,Small intestinal obstruction,1,M,OT,50
172279393,1,Metastatic malignant melanoma,3,F,EXP,nivolumab,1,PS,Small intestinal obstruction,1,M,HO,50
172279393,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,OT,29
172279393,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Acute kidney injury,2,M,HO,29
172279393,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Colitis,2,M,OT,29
172279393,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Colitis,2,M,HO,29
172279393,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Small intestinal obstruction,2,M,OT,29
172279393,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Small intestinal obstruction,2,M,HO,29
172279393,3,Metastatic malignant melanoma,3,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,OT,50
172279393,3,Metastatic malignant melanoma,3,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,HO,50
172279393,3,Metastatic malignant melanoma,3,F,EXP,ipilimumab,3,SS,Colitis,3,M,OT,50
172279393,3,Metastatic malignant melanoma,3,F,EXP,ipilimumab,3,SS,Colitis,3,M,HO,50
172279393,3,Metastatic malignant melanoma,3,F,EXP,ipilimumab,3,SS,Small intestinal obstruction,3,M,OT,50
172279393,3,Metastatic malignant melanoma,3,F,EXP,ipilimumab,3,SS,Small intestinal obstruction,3,M,HO,50
172279393,4,Product used for unknown indication,3,F,EXP,ipilimumab,4,SS,Acute kidney injury,4,M,OT,29
172279393,4,Product used for unknown indication,3,F,EXP,ipilimumab,4,SS,Acute kidney injury,4,M,HO,29
172279393,4,Product used for unknown indication,3,F,EXP,ipilimumab,4,SS,Colitis,4,M,OT,29
172279393,4,Product used for unknown indication,3,F,EXP,ipilimumab,4,SS,Colitis,4,M,HO,29
172279393,4,Product used for unknown indication,3,F,EXP,ipilimumab,4,SS,Small intestinal obstruction,4,M,OT,29
172279393,4,Product used for unknown indication,3,F,EXP,ipilimumab,4,SS,Small intestinal obstruction,4,M,HO,29
172279664,1,Product used for unknown indication,4,F,EXP,rolapitant hydrochloride,1,PS,Confusional state,1,F,OT,21
172279664,1,Product used for unknown indication,4,F,EXP,rolapitant hydrochloride,1,PS,Decreased appetite,1,F,OT,21
172279664,1,Product used for unknown indication,4,F,EXP,rolapitant hydrochloride,1,PS,Dehydration,1,F,OT,21
172279664,1,Product used for unknown indication,4,F,EXP,rolapitant hydrochloride,1,PS,Diarrhoea,1,F,OT,21
172279664,1,Product used for unknown indication,4,F,EXP,rolapitant hydrochloride,1,PS,Full blood count decreased,1,F,OT,21
172279664,1,Product used for unknown indication,4,F,EXP,rolapitant hydrochloride,1,PS,Haemoglobin decreased,1,F,OT,21
172279664,1,Product used for unknown indication,4,F,EXP,rolapitant hydrochloride,1,PS,Hypotension,1,F,OT,21
172279664,1,Product used for unknown indication,4,F,EXP,rolapitant hydrochloride,1,PS,Nausea,1,F,OT,21
172279664,1,Product used for unknown indication,4,F,EXP,rolapitant hydrochloride,1,PS,Transfusion,1,F,OT,21
172279664,1,Product used for unknown indication,4,F,EXP,rolapitant hydrochloride,1,PS,Vomiting,1,F,OT,21
172282941,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Nausea,1,F,OT,351
172282941,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Pain,1,F,OT,351
172282941,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Renal failure,1,F,OT,351
172282941,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Vomiting,1,F,OT,351
172283033,56,Product used for unknown indication,3,F,EXP,darbepoetin alfa,56,C,Bone sequestrum,56,M,DE,41
172283033,56,Product used for unknown indication,3,F,EXP,darbepoetin alfa,56,C,Bone sequestrum,56,M,OT,41
172283033,56,Product used for unknown indication,3,F,EXP,darbepoetin alfa,56,C,Extremity necrosis,56,M,DE,41
172283033,56,Product used for unknown indication,3,F,EXP,darbepoetin alfa,56,C,Extremity necrosis,56,M,OT,41
172283033,56,Product used for unknown indication,3,F,EXP,darbepoetin alfa,56,C,Sepsis,56,M,DE,41
172283033,56,Product used for unknown indication,3,F,EXP,darbepoetin alfa,56,C,Sepsis,56,M,OT,41
172283033,57,Product used for unknown indication,3,F,EXP,epoetin alfa,57,C,Bone sequestrum,57,M,DE,305
172283033,57,Product used for unknown indication,3,F,EXP,epoetin alfa,57,C,Bone sequestrum,57,M,OT,305
172283033,57,Product used for unknown indication,3,F,EXP,epoetin alfa,57,C,Extremity necrosis,57,M,DE,305
172283033,57,Product used for unknown indication,3,F,EXP,epoetin alfa,57,C,Extremity necrosis,57,M,OT,305
172283033,57,Product used for unknown indication,3,F,EXP,epoetin alfa,57,C,Sepsis,57,M,DE,305
172283033,57,Product used for unknown indication,3,F,EXP,epoetin alfa,57,C,Sepsis,57,M,OT,305
172285964,1,Prostate cancer,4,F,EXP,enzalutamide,1,PS,Alanine aminotransferase increased,1,M,HO,57
172285964,2,Prostate cancer,4,F,EXP,goserelin acetate,2,SS,Alanine aminotransferase increased,2,M,HO,57
172286792,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Pneumonia,2,M,HO,647
172286792,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Rhinovirus infection,2,M,HO,647
172287911,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Chills,1,M,OT,78
172287911,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Chills,1,M,HO,78
172287911,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Malaise,1,M,OT,78
172287911,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Malaise,1,M,HO,78
172287911,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Neutropenic sepsis,1,M,OT,78
172287911,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Neutropenic sepsis,1,M,HO,78
172287911,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Pain,1,M,OT,78
172287911,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Pain,1,M,HO,78
172287911,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Pyrexia,1,M,OT,78
172287911,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Pyrexia,1,M,HO,78
172288011,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Abdominal pain,1,M,HO,3
172288011,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Chest discomfort,1,M,HO,3
172288011,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Decreased appetite,1,M,HO,3
172288011,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Diarrhoea,1,M,HO,3
172288011,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Dizziness,1,M,HO,3
172288011,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Dyspnoea,1,M,HO,3
172288011,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Malaise,1,M,HO,3
172288011,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Pleural effusion,1,M,HO,3
172288011,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Tongue discolouration,1,M,HO,3
172288011,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Vomiting,1,M,HO,3
172288373,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Hypotension,1,M,HO,63
172288373,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Hypotonia,1,M,HO,63
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Condition aggravated,8,F,OT,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Condition aggravated,8,F,DE,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Cytopenia,8,F,OT,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Cytopenia,8,F,DE,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Drug ineffective for unapproved indication,8,F,OT,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Drug ineffective for unapproved indication,8,F,DE,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Lung disorder,8,F,OT,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Lung disorder,8,F,DE,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Off label use,8,F,OT,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Off label use,8,F,DE,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Pulmonary haemorrhage,8,F,OT,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Pulmonary haemorrhage,8,F,DE,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Respiratory tract haemorrhage,8,F,OT,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Respiratory tract haemorrhage,8,F,DE,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Staphylococcal infection,8,F,OT,46
172288931,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Staphylococcal infection,8,F,DE,46
172290031,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Death,1,F,OT,14
172290031,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Death,1,F,DE,14
172290641,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Febrile neutropenia,7,F,HO,19
172290641,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Febrile neutropenia,7,F,OT,19
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Acute kidney injury,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Acute kidney injury,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Anuria,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Anuria,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Blood creatinine increased,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Blood creatinine increased,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Breast cancer,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Breast cancer,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Cardiac arrest,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Cardiac arrest,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Dyspnoea,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Dyspnoea,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Hypercapnia,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Hypercapnia,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Hypophagia,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Hypophagia,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Hypotension,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Hypotension,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Inflammatory marker increased,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Inflammatory marker increased,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Malignant neoplasm progression,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Malignant neoplasm progression,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Orthopnoea,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Orthopnoea,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Pleural effusion,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Pleural effusion,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Prerenal failure,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Prerenal failure,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Rales,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Rales,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Rhonchi,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Rhonchi,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Sepsis,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Sepsis,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Somnolence,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Somnolence,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Urine output decreased,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Urine output decreased,2,F,DE,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Wheezing,2,F,HO,200
172290753,2,Breast cancer,3,F,EXP,abemaciclib,2,SS,Wheezing,2,F,DE,200
172292221,2,Breast cancer,1,I,EXP,zoledronic acid,2,PS,Abdominal pain upper,2,F,OT,10
172292221,2,Breast cancer,1,I,EXP,zoledronic acid,2,PS,Asthenia,2,F,OT,10
172292221,2,Breast cancer,1,I,EXP,zoledronic acid,2,PS,Diarrhoea,2,F,OT,10
172292221,2,Breast cancer,1,I,EXP,zoledronic acid,2,PS,Dysuria,2,F,OT,10
172292221,2,Breast cancer,1,I,EXP,zoledronic acid,2,PS,Nausea,2,F,OT,10
172292221,2,Breast cancer,1,I,EXP,zoledronic acid,2,PS,Neuropathy peripheral,2,F,OT,10
172292221,2,Breast cancer,1,I,EXP,zoledronic acid,2,PS,Rhinorrhoea,2,F,OT,10
172292221,2,Breast cancer,1,I,EXP,zoledronic acid,2,PS,Vomiting,2,F,OT,10
172292221,2,Breast cancer,1,I,EXP,zoledronic acid,2,PS,Vulvovaginal inflammation,2,F,OT,10
172293791,1,Insulinoma,1,I,DIR,ipilimumab,1,PS,Dyspnoea,1,M,HO,96
172293791,1,Insulinoma,1,I,DIR,ipilimumab,1,PS,Hepatic enzyme increased,1,M,HO,96
172293791,1,Insulinoma,1,I,DIR,ipilimumab,1,PS,Immune-mediated hepatitis,1,M,HO,96
172293791,1,Insulinoma,1,I,DIR,ipilimumab,1,PS,Malaise,1,M,HO,96
172293791,2,Metastatic malignant melanoma,1,I,DIR,nivolumab,2,SS,Dyspnoea,2,M,HO,96
172293791,2,Metastatic malignant melanoma,1,I,DIR,nivolumab,2,SS,Hepatic enzyme increased,2,M,HO,96
172293791,2,Metastatic malignant melanoma,1,I,DIR,nivolumab,2,SS,Immune-mediated hepatitis,2,M,HO,96
172293791,2,Metastatic malignant melanoma,1,I,DIR,nivolumab,2,SS,Malaise,2,M,HO,96
172295572,1,Breast cancer,2,F,EXP,palbociclib,1,PS,Upper respiratory tract infection,1,F,HO,132
172295643,17,B precursor type acute leukaemia,3,F,EXP,pegaspargase,17,SS,Febrile neutropenia,17,M,HO,163
172295702,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Lung disorder,2,F,OT,133
172295702,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Lung disorder,2,F,HO,133
172295974,1,Hepatic angiosarcoma,4,F,EXP,avelumab,1,SS,Febrile neutropenia,1,M,HO,126
172295974,1,Hepatic angiosarcoma,4,F,EXP,avelumab,1,SS,Vasculitis,1,M,HO,126
172296051,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Circulatory collapse,1,M,HO,7
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Anaemia,2,F,LT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Anaemia,2,F,OT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Anaemia,2,F,HO,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Arthralgia,2,F,LT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Arthralgia,2,F,OT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Arthralgia,2,F,HO,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Asthenia,2,F,LT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Asthenia,2,F,OT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Asthenia,2,F,HO,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Dehydration,2,F,LT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Dehydration,2,F,OT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Dehydration,2,F,HO,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Dizziness,2,F,LT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Dizziness,2,F,OT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Dizziness,2,F,HO,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Drug eruption,2,F,LT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Drug eruption,2,F,OT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Drug eruption,2,F,HO,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,General physical health deterioration,2,F,LT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,General physical health deterioration,2,F,OT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,General physical health deterioration,2,F,HO,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Hyperaemia,2,F,LT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Hyperaemia,2,F,OT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Hyperaemia,2,F,HO,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Hypotension,2,F,LT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Hypotension,2,F,OT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Hypotension,2,F,HO,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Papule,2,F,LT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Papule,2,F,OT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Papule,2,F,HO,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Pleural effusion,2,F,LT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Pleural effusion,2,F,OT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Pleural effusion,2,F,HO,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Thrombocytopenia,2,F,LT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Thrombocytopenia,2,F,OT,4
172296471,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Thrombocytopenia,2,F,HO,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Anaemia,3,F,LT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Anaemia,3,F,OT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Anaemia,3,F,HO,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Arthralgia,3,F,LT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Arthralgia,3,F,OT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Arthralgia,3,F,HO,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Asthenia,3,F,LT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Asthenia,3,F,OT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Asthenia,3,F,HO,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Dehydration,3,F,LT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Dehydration,3,F,OT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Dehydration,3,F,HO,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Dizziness,3,F,LT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Dizziness,3,F,OT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Dizziness,3,F,HO,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Drug eruption,3,F,LT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Drug eruption,3,F,OT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Drug eruption,3,F,HO,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,General physical health deterioration,3,F,LT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,General physical health deterioration,3,F,OT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,General physical health deterioration,3,F,HO,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Hyperaemia,3,F,LT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Hyperaemia,3,F,OT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Hyperaemia,3,F,HO,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Hypotension,3,F,LT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Hypotension,3,F,OT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Hypotension,3,F,HO,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Papule,3,F,LT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Papule,3,F,OT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Papule,3,F,HO,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Pleural effusion,3,F,LT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Pleural effusion,3,F,OT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Pleural effusion,3,F,HO,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Thrombocytopenia,3,F,LT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Thrombocytopenia,3,F,OT,4
172296471,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Thrombocytopenia,3,F,HO,4
172298041,2,Metastases to bone,1,I,EXP,zoledronic acid,2,PS,Anaemia,2,F,OT,63
172298041,2,Metastases to bone,1,I,EXP,zoledronic acid,2,PS,Epistaxis,2,F,OT,63
172298041,2,Metastases to bone,1,I,EXP,zoledronic acid,2,PS,Haematemesis,2,F,OT,63
172298291,1,Metastatic malignant melanoma,1,I,EXP,trametinib,1,PS,Retinal haemorrhage,1,F,OT,95
172298291,1,Metastatic malignant melanoma,1,I,EXP,trametinib,1,PS,Visual acuity reduced,1,F,OT,95
172298382,1,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,1,PS,Acute myeloid leukaemia,1,M,DE,226
172298382,1,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,1,PS,Second primary malignancy,1,M,DE,226
172299662,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,146
172299662,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,146
172300913,2,Mantle cell lymphoma,3,F,EXP,ibrutinib,2,SS,Herpes zoster,2,M,HO,240
172301351,1,Glioblastoma,1,I,EXP,ipilimumab,1,PS,Type IV hypersensitivity reaction,1,M,HO,9
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Asthenia,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Asthenia,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Asthenia,17,M,HO,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Candida infection,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Candida infection,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Candida infection,17,M,HO,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Enterobacter infection,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Enterobacter infection,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Enterobacter infection,17,M,HO,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Enterovirus infection,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Enterovirus infection,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Enterovirus infection,17,M,HO,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Erythema,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Erythema,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Erythema,17,M,HO,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Febrile neutropenia,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Febrile neutropenia,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Febrile neutropenia,17,M,HO,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Feeling hot,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Feeling hot,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Feeling hot,17,M,HO,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Fungal infection,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Fungal infection,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Fungal infection,17,M,HO,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Herpes virus infection,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Herpes virus infection,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Herpes virus infection,17,M,HO,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Moaning,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Moaning,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Moaning,17,M,HO,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Oral disorder,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Oral disorder,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Oral disorder,17,M,HO,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Pyrexia,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Pyrexia,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Pyrexia,17,M,HO,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Rectal fissure,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Rectal fissure,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Rectal fissure,17,M,HO,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Rhinovirus infection,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Rhinovirus infection,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Rhinovirus infection,17,M,HO,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Skin lesion,17,M,OT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Skin lesion,17,M,LT,163
172302213,17,Acute lymphocytic leukaemia,3,F,EXP,pegaspargase,17,SS,Skin lesion,17,M,HO,163
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal distension,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal distension,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal distension,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal distension,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal infection,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal infection,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal infection,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal infection,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal pain,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal pain,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal pain,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal pain,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal sepsis,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal sepsis,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal sepsis,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Abdominal sepsis,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Acute kidney injury,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Acute kidney injury,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Acute kidney injury,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Acute kidney injury,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Breast cancer,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Breast cancer,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Breast cancer,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Breast cancer,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Cardiac arrest,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Cardiac arrest,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Cardiac arrest,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Cardiac arrest,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Confusional state,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Confusional state,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Confusional state,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Confusional state,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Diarrhoea,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Diarrhoea,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Diarrhoea,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Diarrhoea,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Dyspepsia,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Dyspepsia,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Dyspepsia,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Dyspepsia,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Electrolyte imbalance,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Electrolyte imbalance,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Electrolyte imbalance,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Electrolyte imbalance,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Fatigue,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Fatigue,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Fatigue,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Fatigue,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Haemodynamic instability,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Haemodynamic instability,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Haemodynamic instability,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Haemodynamic instability,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Intestinal ischaemia,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Intestinal ischaemia,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Intestinal ischaemia,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Intestinal ischaemia,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Respiratory disorder,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Respiratory disorder,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Respiratory disorder,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Respiratory disorder,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Respiratory rate increased,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Respiratory rate increased,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Respiratory rate increased,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Respiratory rate increased,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Sepsis,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Sepsis,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Sepsis,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Sepsis,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Septic shock,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Septic shock,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Septic shock,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Septic shock,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Tachycardia,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Tachycardia,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Tachycardia,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Tachycardia,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Urine output decreased,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Urine output decreased,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Urine output decreased,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Urine output decreased,3,F,DE,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Vomiting,3,F,OT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Vomiting,3,F,LT,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Vomiting,3,F,HO,121
172302311,3,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,3,SS,Vomiting,3,F,DE,121
172302381,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Febrile neutropenia,1,F,HO,96
172302381,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,General physical health deterioration,1,F,HO,96
172302381,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Off label use,1,F,HO,96
172302381,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Pancytopenia,1,F,HO,96
172302381,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Sepsis,1,F,HO,96
172302681,7,Acute lymphocytic leukaemia,1,I,EXP,inotuzumab ozogamicin,7,SS,Febrile neutropenia,7,M,HO,44
172303022,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,C,Hepatic function abnormal,2,F,OT,1
172303041,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,C,Pancreatitis acute,2,M,OT,3
172303242,1,Hormone-refractory prostate cancer,2,F,EXP,apalutamide,1,PS,Ischaemic stroke,1,M,HO,1770
172303274,1,Plasma cell myeloma,4,F,EXP,daratumumab,1,PS,Hiccups,1,M,HO,673
172303274,1,Plasma cell myeloma,4,F,EXP,daratumumab,1,PS,Interstitial lung disease,1,M,HO,673
172303274,2,Plasma cell myeloma,4,F,EXP,carfilzomib,2,SS,Hiccups,2,M,HO,673
172303274,2,Plasma cell myeloma,4,F,EXP,carfilzomib,2,SS,Interstitial lung disease,2,M,HO,673
172303471,2,Plasma cell myeloma,1,I,EXP,thalidomide,2,SS,Blastic plasmacytoid dendritic cell neoplasia,2,M,OT,1059
172303471,2,Plasma cell myeloma,1,I,EXP,thalidomide,2,SS,Blastic plasmacytoid dendritic cell neoplasia,2,M,HO,1059
172303471,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Blastic plasmacytoid dendritic cell neoplasia,3,M,OT,742
172303471,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Blastic plasmacytoid dendritic cell neoplasia,3,M,HO,742
172305981,1,Plasma cell myeloma,1,I,EXP,panobinostat,1,PS,Anaemia,1,M,HO,28
172305981,1,Plasma cell myeloma,1,I,EXP,panobinostat,1,PS,Asthenia,1,M,HO,28
172305981,1,Plasma cell myeloma,1,I,EXP,panobinostat,1,PS,Dehydration,1,M,HO,28
172305981,1,Plasma cell myeloma,1,I,EXP,panobinostat,1,PS,Diarrhoea,1,M,HO,28
172305981,1,Plasma cell myeloma,1,I,EXP,panobinostat,1,PS,Haematotoxicity,1,M,HO,28
172305981,1,Plasma cell myeloma,1,I,EXP,panobinostat,1,PS,Hypokalaemia,1,M,HO,28
172305981,1,Plasma cell myeloma,1,I,EXP,panobinostat,1,PS,Neutrophil count decreased,1,M,HO,28
172305981,1,Plasma cell myeloma,1,I,EXP,panobinostat,1,PS,Renal impairment,1,M,HO,28
172305981,1,Plasma cell myeloma,1,I,EXP,panobinostat,1,PS,Rhabdomyolysis,1,M,HO,28
172305981,1,Plasma cell myeloma,1,I,EXP,panobinostat,1,PS,Thrombocytopenia,1,M,HO,28
172307462,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pyrexia,2,M,HO,14
172308013,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Acute kidney injury,2,M,OT,15
172308013,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Acute kidney injury,2,M,HO,15
172308013,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Hypertension,2,M,OT,15
172308013,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Hypertension,2,M,HO,15
172308013,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Lung disorder,2,M,OT,15
172308013,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Lung disorder,2,M,HO,15
172308613,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Influenza,1,M,DE,162
172318092,2,Glioblastoma multiforme,2,F,EXP,nivolumab,2,PS,Aphasia,2,F,HO,75
172318092,2,Glioblastoma multiforme,2,F,EXP,nivolumab,2,PS,Memory impairment,2,F,HO,75
172318124,1,Plasma cell myeloma,4,F,EXP,selinexor,1,PS,Hypokalaemia,1,F,HO,19
172327461,16,Plasma cell myeloma,1,I,EXP,carfilzomib,16,SS,Plasma cell myeloma,16,F,DE,74
172327461,18,Plasma cell myeloma,1,I,EXP,daratumumab,18,SS,Plasma cell myeloma,18,F,DE,465
172328876,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,15
172328876,1,Non-small cell lung cancer,6,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,15
172328876,2,Non-small cell lung cancer,6,F,EXP,ipilimumab,2,SS,Anaemia,2,M,HO,15
172328876,2,Non-small cell lung cancer,6,F,EXP,ipilimumab,2,SS,Dyspnoea,2,M,HO,15
172330581,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Facial paralysis,1,F,HO,112
172330581,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Otitis externa,1,F,HO,112
172330581,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Facial paralysis,3,F,HO,112
172330581,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Otitis externa,3,F,HO,112
172331211,14,Anaemia,1,I,EXP,darbepoetin alfa,14,C,Cellulitis,14,F,HO,154
172331211,24,Neutropenia,1,I,EXP,filgrastim,24,C,Cellulitis,24,F,HO,104
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Death,3,F,OT,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Death,3,F,DE,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Delirium,3,F,OT,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Delirium,3,F,DE,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Dermatitis,3,F,OT,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Dermatitis,3,F,DE,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Fatigue,3,F,OT,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Fatigue,3,F,DE,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Hypokalaemia,3,F,OT,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Hypokalaemia,3,F,DE,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Hyponatraemia,3,F,OT,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Hyponatraemia,3,F,DE,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Inappropriate antidiuretic hormone secretion,3,F,OT,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Inappropriate antidiuretic hormone secretion,3,F,DE,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Leukopenia,3,F,OT,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Leukopenia,3,F,DE,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,F,OT,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,F,DE,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Metastases to meninges,3,F,OT,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Metastases to meninges,3,F,DE,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Paraparesis,3,F,OT,518
172332571,3,Non-small cell lung cancer,1,I,EXP,nivolumab,3,SS,Paraparesis,3,F,DE,518
172332691,2,Lung neoplasm malignant,1,I,EXP,pemetrexed disodium,2,SS,Bone marrow toxicity,2,M,OT,21
172336184,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Cell death,1,M,HO,195
172336184,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Cell death,1,M,OT,195
172336184,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Cholelithiasis,1,M,HO,195
172336184,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Cholelithiasis,1,M,OT,195
172336184,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Cholestasis,1,M,HO,195
172336184,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Cholestasis,1,M,OT,195
172336184,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Hepatitis,1,M,HO,195
172336184,1,Renal cancer,4,F,EXP,nivolumab,1,PS,Hepatitis,1,M,OT,195
172337661,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,F,OT,94
172337661,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,F,HO,94
172337661,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Febrile neutropenia,1,F,OT,94
172337661,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Febrile neutropenia,1,F,HO,94
172337661,2,Sarcoma,1,I,EXP,trabectedin,2,SS,Acute kidney injury,2,F,OT,108
172337661,2,Sarcoma,1,I,EXP,trabectedin,2,SS,Acute kidney injury,2,F,HO,108
172337661,2,Sarcoma,1,I,EXP,trabectedin,2,SS,Febrile neutropenia,2,F,OT,108
172337661,2,Sarcoma,1,I,EXP,trabectedin,2,SS,Febrile neutropenia,2,F,HO,108
172337661,3,Sarcoma,1,I,EXP,ipilimumab,3,SS,Acute kidney injury,3,F,OT,94
172337661,3,Sarcoma,1,I,EXP,ipilimumab,3,SS,Acute kidney injury,3,F,HO,94
172337661,3,Sarcoma,1,I,EXP,ipilimumab,3,SS,Febrile neutropenia,3,F,OT,94
172337661,3,Sarcoma,1,I,EXP,ipilimumab,3,SS,Febrile neutropenia,3,F,HO,94
172338812,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,F,OT,73
172338812,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,F,HO,73
172338812,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Atrial fibrillation,2,F,OT,73
172338812,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Atrial fibrillation,2,F,HO,73
172339911,27,Plasma cell myeloma,1,I,PER,carfilzomib,27,SS,Haematuria,27,M,HO,2498
172351562,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Haemoptysis,1,M,OT,8
172351562,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Haemoptysis,1,M,HO,8
172351562,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,8
172351562,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,8
172354331,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Hypertension,1,M,OT,15
172354331,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Neuropathy peripheral,1,M,OT,15
172354331,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Underdose,1,M,OT,15
172355681,3,Metastases to bone,1,I,EXP,zoledronic acid,3,SS,Anaemia,3,F,OT,63
172355681,3,Metastases to bone,1,I,EXP,zoledronic acid,3,SS,Epistaxis,3,F,OT,63
172355681,3,Metastases to bone,1,I,EXP,zoledronic acid,3,SS,Haematemesis,3,F,OT,63
172355851,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Cerebral infarction,1,F,DE,1
172355851,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Cerebral infarction,1,F,HO,1
172355851,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Generalised tonic-clonic seizure,1,F,DE,1
172355851,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Generalised tonic-clonic seizure,1,F,HO,1
172355851,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hemiparesis,1,F,DE,1
172355851,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hemiparesis,1,F,HO,1
172356142,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Femur fracture,1,F,HO,646
172356142,17,Plasma cell myeloma,2,F,EXP,zoledronic acid,17,C,Femur fracture,17,F,HO,339
172360852,7,Plasma cell myeloma,2,F,EXP,daratumumab,7,C,Diverticulitis,7,F,OT,65
172360852,7,Plasma cell myeloma,2,F,EXP,daratumumab,7,C,Diverticulitis,7,F,HO,65
172360852,7,Plasma cell myeloma,2,F,EXP,daratumumab,7,C,Neutropenia,7,F,OT,65
172360852,7,Plasma cell myeloma,2,F,EXP,daratumumab,7,C,Neutropenia,7,F,HO,65
172360852,7,Plasma cell myeloma,2,F,EXP,daratumumab,7,C,Thrombocytopenia,7,F,OT,65
172360852,7,Plasma cell myeloma,2,F,EXP,daratumumab,7,C,Thrombocytopenia,7,F,HO,65
172360852,19,Plasma cell myeloma,2,F,EXP,nivolumab,19,C,Diverticulitis,19,F,OT,51
172360852,19,Plasma cell myeloma,2,F,EXP,nivolumab,19,C,Diverticulitis,19,F,HO,51
172360852,19,Plasma cell myeloma,2,F,EXP,nivolumab,19,C,Neutropenia,19,F,OT,51
172360852,19,Plasma cell myeloma,2,F,EXP,nivolumab,19,C,Neutropenia,19,F,HO,51
172360852,19,Plasma cell myeloma,2,F,EXP,nivolumab,19,C,Thrombocytopenia,19,F,OT,51
172360852,19,Plasma cell myeloma,2,F,EXP,nivolumab,19,C,Thrombocytopenia,19,F,HO,51
172360852,33,Plasma cell myeloma,2,F,EXP,daratumumab,33,C,Diverticulitis,33,F,OT,23
172360852,33,Plasma cell myeloma,2,F,EXP,daratumumab,33,C,Diverticulitis,33,F,HO,23
172360852,33,Plasma cell myeloma,2,F,EXP,daratumumab,33,C,Neutropenia,33,F,OT,23
172360852,33,Plasma cell myeloma,2,F,EXP,daratumumab,33,C,Neutropenia,33,F,HO,23
172360852,33,Plasma cell myeloma,2,F,EXP,daratumumab,33,C,Thrombocytopenia,33,F,OT,23
172360852,33,Plasma cell myeloma,2,F,EXP,daratumumab,33,C,Thrombocytopenia,33,F,HO,23
172360852,34,Plasma cell myeloma,2,F,EXP,daratumumab,34,C,Diverticulitis,34,F,OT,58
172360852,34,Plasma cell myeloma,2,F,EXP,daratumumab,34,C,Diverticulitis,34,F,HO,58
172360852,34,Plasma cell myeloma,2,F,EXP,daratumumab,34,C,Neutropenia,34,F,OT,58
172360852,34,Plasma cell myeloma,2,F,EXP,daratumumab,34,C,Neutropenia,34,F,HO,58
172360852,34,Plasma cell myeloma,2,F,EXP,daratumumab,34,C,Thrombocytopenia,34,F,OT,58
172360852,34,Plasma cell myeloma,2,F,EXP,daratumumab,34,C,Thrombocytopenia,34,F,HO,58
172360852,35,Plasma cell myeloma,2,F,EXP,nivolumab,35,C,Diverticulitis,35,F,OT,51
172360852,35,Plasma cell myeloma,2,F,EXP,nivolumab,35,C,Diverticulitis,35,F,HO,51
172360852,35,Plasma cell myeloma,2,F,EXP,nivolumab,35,C,Neutropenia,35,F,OT,51
172360852,35,Plasma cell myeloma,2,F,EXP,nivolumab,35,C,Neutropenia,35,F,HO,51
172360852,35,Plasma cell myeloma,2,F,EXP,nivolumab,35,C,Thrombocytopenia,35,F,OT,51
172360852,35,Plasma cell myeloma,2,F,EXP,nivolumab,35,C,Thrombocytopenia,35,F,HO,51
172360852,37,Plasma cell myeloma,2,F,EXP,daratumumab,37,C,Diverticulitis,37,F,OT,51
172360852,37,Plasma cell myeloma,2,F,EXP,daratumumab,37,C,Diverticulitis,37,F,HO,51
172360852,37,Plasma cell myeloma,2,F,EXP,daratumumab,37,C,Neutropenia,37,F,OT,51
172360852,37,Plasma cell myeloma,2,F,EXP,daratumumab,37,C,Neutropenia,37,F,HO,51
172360852,37,Plasma cell myeloma,2,F,EXP,daratumumab,37,C,Thrombocytopenia,37,F,OT,51
172360852,37,Plasma cell myeloma,2,F,EXP,daratumumab,37,C,Thrombocytopenia,37,F,HO,51
172360852,38,Plasma cell myeloma,2,F,EXP,daratumumab,38,C,Diverticulitis,38,F,OT,65
172360852,38,Plasma cell myeloma,2,F,EXP,daratumumab,38,C,Diverticulitis,38,F,HO,65
172360852,38,Plasma cell myeloma,2,F,EXP,daratumumab,38,C,Neutropenia,38,F,OT,65
172360852,38,Plasma cell myeloma,2,F,EXP,daratumumab,38,C,Neutropenia,38,F,HO,65
172360852,38,Plasma cell myeloma,2,F,EXP,daratumumab,38,C,Thrombocytopenia,38,F,OT,65
172360852,38,Plasma cell myeloma,2,F,EXP,daratumumab,38,C,Thrombocytopenia,38,F,HO,65
172360852,39,Plasma cell myeloma,2,F,EXP,daratumumab,39,C,Diverticulitis,39,F,OT,30
172360852,39,Plasma cell myeloma,2,F,EXP,daratumumab,39,C,Diverticulitis,39,F,HO,30
172360852,39,Plasma cell myeloma,2,F,EXP,daratumumab,39,C,Neutropenia,39,F,OT,30
172360852,39,Plasma cell myeloma,2,F,EXP,daratumumab,39,C,Neutropenia,39,F,HO,30
172360852,39,Plasma cell myeloma,2,F,EXP,daratumumab,39,C,Thrombocytopenia,39,F,OT,30
172360852,39,Plasma cell myeloma,2,F,EXP,daratumumab,39,C,Thrombocytopenia,39,F,HO,30
172360852,40,Plasma cell myeloma,2,F,EXP,nivolumab,40,C,Diverticulitis,40,F,OT,37
172360852,40,Plasma cell myeloma,2,F,EXP,nivolumab,40,C,Diverticulitis,40,F,HO,37
172360852,40,Plasma cell myeloma,2,F,EXP,nivolumab,40,C,Neutropenia,40,F,OT,37
172360852,40,Plasma cell myeloma,2,F,EXP,nivolumab,40,C,Neutropenia,40,F,HO,37
172360852,40,Plasma cell myeloma,2,F,EXP,nivolumab,40,C,Thrombocytopenia,40,F,OT,37
172360852,40,Plasma cell myeloma,2,F,EXP,nivolumab,40,C,Thrombocytopenia,40,F,HO,37
172360852,41,Plasma cell myeloma,2,F,EXP,daratumumab,41,C,Diverticulitis,41,F,OT,16
172360852,41,Plasma cell myeloma,2,F,EXP,daratumumab,41,C,Diverticulitis,41,F,HO,16
172360852,41,Plasma cell myeloma,2,F,EXP,daratumumab,41,C,Neutropenia,41,F,OT,16
172360852,41,Plasma cell myeloma,2,F,EXP,daratumumab,41,C,Neutropenia,41,F,HO,16
172360852,41,Plasma cell myeloma,2,F,EXP,daratumumab,41,C,Thrombocytopenia,41,F,OT,16
172360852,41,Plasma cell myeloma,2,F,EXP,daratumumab,41,C,Thrombocytopenia,41,F,HO,16
172360852,42,Plasma cell myeloma,2,F,EXP,daratumumab,42,C,Diverticulitis,42,F,OT,37
172360852,42,Plasma cell myeloma,2,F,EXP,daratumumab,42,C,Diverticulitis,42,F,HO,37
172360852,42,Plasma cell myeloma,2,F,EXP,daratumumab,42,C,Neutropenia,42,F,OT,37
172360852,42,Plasma cell myeloma,2,F,EXP,daratumumab,42,C,Neutropenia,42,F,HO,37
172360852,42,Plasma cell myeloma,2,F,EXP,daratumumab,42,C,Thrombocytopenia,42,F,OT,37
172360852,42,Plasma cell myeloma,2,F,EXP,daratumumab,42,C,Thrombocytopenia,42,F,HO,37
172360852,44,Plasma cell myeloma,2,F,EXP,daratumumab,44,C,Diverticulitis,44,F,OT,44
172360852,44,Plasma cell myeloma,2,F,EXP,daratumumab,44,C,Diverticulitis,44,F,HO,44
172360852,44,Plasma cell myeloma,2,F,EXP,daratumumab,44,C,Neutropenia,44,F,OT,44
172360852,44,Plasma cell myeloma,2,F,EXP,daratumumab,44,C,Neutropenia,44,F,HO,44
172360852,44,Plasma cell myeloma,2,F,EXP,daratumumab,44,C,Thrombocytopenia,44,F,OT,44
172360852,44,Plasma cell myeloma,2,F,EXP,daratumumab,44,C,Thrombocytopenia,44,F,HO,44
172362772,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Abdominal pain,1,M,OT,4
172362772,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,4
172362772,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Cerebrovascular accident,1,M,OT,4
172362772,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Diarrhoea,1,M,OT,4
172362772,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,4
172362772,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Encephalopathy,1,M,OT,4
172362772,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,4
172362772,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Flatulence,1,M,OT,4
172362772,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Headache,1,M,OT,4
172362772,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Myalgia,1,M,OT,4
172362772,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Prescribed underdose,1,M,OT,4
172362772,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Somnolence,1,M,OT,4
172362772,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Weight decreased,1,M,OT,4
172362831,1,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,1,SS,Multiple organ dysfunction syndrome,1,M,LT,10
172362831,1,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,1,SS,Multiple organ dysfunction syndrome,1,M,OT,10
172362831,1,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,1,SS,Multiple organ dysfunction syndrome,1,M,HO,10
172362831,1,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,1,SS,Pneumonitis,1,M,LT,10
172362831,1,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,1,SS,Pneumonitis,1,M,OT,10
172362831,1,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,1,SS,Pneumonitis,1,M,HO,10
172362831,1,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,1,SS,Sepsis,1,M,LT,10
172362831,1,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,1,SS,Sepsis,1,M,OT,10
172362831,1,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,1,SS,Sepsis,1,M,HO,10
172362831,1,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,1,SS,Septic shock,1,M,LT,10
172362831,1,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,1,SS,Septic shock,1,M,OT,10
172362831,1,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,1,SS,Septic shock,1,M,HO,10
172364792,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,PS,Atrial fibrillation,1,F,HO,1429
172364792,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,PS,Cardiac failure,1,F,HO,1429
172368711,31,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,31,C,Platelet count decreased,31,F,OT,8
172368711,31,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,31,C,Platelet count decreased,31,F,HO,8
172372232,1,Transitional cell carcinoma,2,F,EXP,avelumab,1,PS,Death,1,M,DE,140
172374081,1,Breast cancer,1,I,EXP,pegfilgrastim,1,PS,Anaemia,1,F,HO,34
172374081,1,Breast cancer,1,I,EXP,pegfilgrastim,1,PS,Dyspnoea exertional,1,F,HO,34
172374091,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Malignant neoplasm of pleura,1,M,HO,7
172374542,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Accidental overdose,1,F,DE,28
172374542,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Accidental overdose,1,F,HO,28
172374542,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Accidental overdose,1,F,LT,28
172374542,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Multiple organ dysfunction syndrome,1,F,DE,28
172374542,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Multiple organ dysfunction syndrome,1,F,HO,28
172374542,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Multiple organ dysfunction syndrome,1,F,LT,28
172374542,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Pneumonia aspiration,1,F,DE,28
172374542,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Pneumonia aspiration,1,F,HO,28
172374542,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Pneumonia aspiration,1,F,LT,28
172375481,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Thyroid function test abnormal,1,M,OT,380
172376272,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Immune-mediated hepatitis,2,M,HO,78
172376272,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Pancytopenia,2,M,HO,78
172376512,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,PS,Cerebrovascular accident,1,M,HO,246
172376555,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Infective exacerbation of bronchiectasis,1,F,HO,18
172378252,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Pemphigoid,1,M,OT,17
172378252,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Pemphigoid,1,M,HO,17
172381932,1,Hodgkin's disease,2,F,EXP,brentuximab vedotin,1,PS,Neutrophil count decreased,1,M,OT,200
172381932,1,Hodgkin's disease,2,F,EXP,brentuximab vedotin,1,PS,Neutrophil count decreased,1,M,HO,200
172381932,1,Hodgkin's disease,2,F,EXP,brentuximab vedotin,1,PS,White blood cell count decreased,1,M,OT,200
172381932,1,Hodgkin's disease,2,F,EXP,brentuximab vedotin,1,PS,White blood cell count decreased,1,M,HO,200
172382231,1,Immunosuppression,1,I,EXP,zoledronic acid,1,PS,Bone marrow failure,1,M,HO,9
172382231,8,Immunosuppression,1,I,EXP,pemetrexed disodium,8,SS,Bone marrow failure,8,M,HO,10
172382571,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,General physical condition abnormal,1,M,DE,15
172382571,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,General physical condition abnormal,1,M,OT,15
172382571,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,General physical condition abnormal,1,M,HO,15
172382571,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Pyrexia,1,M,DE,15
172382571,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,15
172382571,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,15
172382571,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Sepsis,1,M,DE,15
172382571,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Sepsis,1,M,OT,15
172382571,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Sepsis,1,M,HO,15
172385203,1,Marginal zone lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,1
172385203,1,Marginal zone lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,LT,1
172385203,1,Marginal zone lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Tracheal obstruction,1,M,OT,1
172385203,1,Marginal zone lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Tracheal obstruction,1,M,LT,1
172386022,1,Diffuse large B-cell lymphoma,2,F,EXP,lenalidomide,1,PS,Atrial flutter,1,M,HO,371
172386022,3,Diffuse large B-cell lymphoma,2,F,EXP,ibrutinib,3,SS,Atrial flutter,3,M,HO,371
172387383,1,B-cell lymphoma,3,F,EXP,lenalidomide,1,PS,Acute respiratory failure,1,M,HO,267
172387383,1,B-cell lymphoma,3,F,EXP,lenalidomide,1,PS,Acute respiratory failure,1,M,LT,267
172387383,1,B-cell lymphoma,3,F,EXP,lenalidomide,1,PS,General physical health deterioration,1,M,HO,267
172387383,1,B-cell lymphoma,3,F,EXP,lenalidomide,1,PS,General physical health deterioration,1,M,LT,267
172394732,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Disseminated intravascular coagulation,1,M,DE,621
172394732,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Disseminated intravascular coagulation,1,M,OT,621
172394732,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Disseminated intravascular coagulation,1,M,HO,621
172397141,1,Lung adenocarcinoma stage IV,1,I,EXP,nivolumab,1,PS,Bronchiectasis,1,M,DE,7
172397141,1,Lung adenocarcinoma stage IV,1,I,EXP,nivolumab,1,PS,Bronchiectasis,1,M,OT,7
172397141,1,Lung adenocarcinoma stage IV,1,I,EXP,nivolumab,1,PS,Respiratory failure,1,M,DE,7
172397141,1,Lung adenocarcinoma stage IV,1,I,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,7
172397844,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,SS,Constipation,1,M,HO,45
172397844,1,Metastatic malignant melanoma,4,F,EXP,nivolumab,1,SS,Hypoaesthesia,1,M,HO,45
172397844,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Constipation,2,M,HO,22
172397844,2,Product used for unknown indication,4,F,EXP,nivolumab,2,SS,Hypoaesthesia,2,M,HO,22
172397844,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,PS,Constipation,3,M,HO,45
172397844,3,Metastatic malignant melanoma,4,F,EXP,ipilimumab,3,PS,Hypoaesthesia,3,M,HO,45
172397844,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Constipation,4,M,HO,22
172397844,4,Product used for unknown indication,4,F,EXP,ipilimumab,4,SS,Hypoaesthesia,4,M,HO,22
172398281,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Anaemia,1,F,OT,63
172398281,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Epistaxis,1,F,OT,63
172398281,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Haematemesis,1,F,OT,63
172400082,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Neutropenia,1,M,HO,24
172400082,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Neutropenia,1,M,OT,24
172400082,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Neutropenia,1,M,LT,24
172400082,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Neutropenia,2,M,HO,24
172400082,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Neutropenia,2,M,OT,24
172400082,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Neutropenia,2,M,LT,24
172400505,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Cardiac failure,1,M,LT,18
172400505,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Cardiac failure,1,M,HO,18
172400505,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Cardiac failure,1,M,DE,18
172400505,1,Malignant melanoma,5,F,EXP,ipilimumab,1,PS,Cardiac failure,1,M,OT,18
172400802,1,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,1,PS,Second primary malignancy,1,M,OT,272
172400802,1,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,1,PS,Squamous cell carcinoma of skin,1,M,OT,272
172404054,2,Invasive ductal breast carcinoma,4,F,EXP,palbociclib,2,SS,Deep vein thrombosis,2,F,OT,46
172404054,2,Invasive ductal breast carcinoma,4,F,EXP,palbociclib,2,SS,Deep vein thrombosis,2,F,HO,46
172404054,2,Invasive ductal breast carcinoma,4,F,EXP,palbociclib,2,SS,Pulmonary embolism,2,F,OT,46
172404054,2,Invasive ductal breast carcinoma,4,F,EXP,palbociclib,2,SS,Pulmonary embolism,2,F,HO,46
172404932,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,PS,Autoimmune colitis,1,F,HO,93
172404932,1,Transitional cell carcinoma,2,F,EXP,nivolumab,1,PS,Autoimmune colitis,1,F,OT,93
172404932,3,Transitional cell carcinoma,2,F,EXP,ipilimumab,3,SS,Autoimmune colitis,3,F,HO,38
172404932,3,Transitional cell carcinoma,2,F,EXP,ipilimumab,3,SS,Autoimmune colitis,3,F,OT,38
172404961,4,Plasma cell myeloma,1,I,PER,daratumumab,4,SS,Anaemia,4,M,HO,15
172404961,4,Plasma cell myeloma,1,I,PER,daratumumab,4,SS,Anaemia,4,M,DE,15
172404961,4,Plasma cell myeloma,1,I,PER,daratumumab,4,SS,Femur fracture,4,M,HO,15
172404961,4,Plasma cell myeloma,1,I,PER,daratumumab,4,SS,Femur fracture,4,M,DE,15
172404961,4,Plasma cell myeloma,1,I,PER,daratumumab,4,SS,Respiratory failure,4,M,HO,15
172404961,4,Plasma cell myeloma,1,I,PER,daratumumab,4,SS,Respiratory failure,4,M,DE,15
172406801,1,5q minus syndrome,1,I,PER,lenalidomide,1,PS,Pyrexia,1,F,HO,29
172406801,1,5q minus syndrome,1,I,PER,lenalidomide,1,PS,White blood cell count decreased,1,F,HO,29
172408892,4,Plasma cell myeloma,2,F,PER,daratumumab,4,C,Neutropenia,4,F,OT,15
172408892,4,Plasma cell myeloma,2,F,PER,daratumumab,4,C,Thrombocytopenia,4,F,OT,15
172411251,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Cerebral infarction,1,F,DE,1
172411251,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Cerebral infarction,1,F,HO,1
172411251,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Generalised tonic-clonic seizure,1,F,DE,1
172411251,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Generalised tonic-clonic seizure,1,F,HO,1
172411251,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hemiparesis,1,F,DE,1
172411251,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hemiparesis,1,F,HO,1
172411892,1,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,1,SS,Pneumonia,1,M,HO,6
172413021,2,Plasma cell myeloma,1,I,PER,daratumumab,2,SS,Pneumonia,2,F,HO,17
172413021,3,Plasma cell myeloma,1,I,PER,thalidomide,3,SS,Pneumonia,3,F,HO,16
172413802,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Decreased appetite,1,M,OT,14
172413802,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Diabetes mellitus,1,M,OT,14
172413802,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Discomfort,1,M,OT,14
172413802,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,14
172413802,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Dry mouth,1,M,OT,14
172413802,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Dysphonia,1,M,OT,14
172413802,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,14
172413802,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Headache,1,M,OT,14
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Atrial fibrillation,1,F,HO,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Atrial fibrillation,1,F,DE,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Atrial fibrillation,1,F,OT,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Diarrhoea,1,F,HO,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Diarrhoea,1,F,DE,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Diarrhoea,1,F,OT,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Dyspnoea,1,F,HO,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Dyspnoea,1,F,DE,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Dyspnoea,1,F,OT,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Hypotension,1,F,HO,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Hypotension,1,F,DE,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Hypotension,1,F,OT,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Renal impairment,1,F,HO,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Renal impairment,1,F,DE,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Renal impairment,1,F,OT,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Septic shock,1,F,HO,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Septic shock,1,F,DE,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Septic shock,1,F,OT,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Vomiting,1,F,HO,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Vomiting,1,F,DE,11
172415941,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Vomiting,1,F,OT,11
172422244,1,Adenocarcinoma of colon,4,F,PER,panitumumab,1,PS,Anaemia,1,M,OT,11
172422244,1,Adenocarcinoma of colon,4,F,PER,panitumumab,1,PS,Anaemia,1,M,HO,11
172422244,1,Adenocarcinoma of colon,4,F,PER,panitumumab,1,PS,Intestinal obstruction,1,M,OT,11
172422244,1,Adenocarcinoma of colon,4,F,PER,panitumumab,1,PS,Intestinal obstruction,1,M,HO,11
172422244,1,Adenocarcinoma of colon,4,F,PER,panitumumab,1,PS,Neutropenia,1,M,OT,11
172422244,1,Adenocarcinoma of colon,4,F,PER,panitumumab,1,PS,Neutropenia,1,M,HO,11
172422244,1,Adenocarcinoma of colon,4,F,PER,panitumumab,1,PS,Thrombocytopenia,1,M,OT,11
172422244,1,Adenocarcinoma of colon,4,F,PER,panitumumab,1,PS,Thrombocytopenia,1,M,HO,11
172423461,1,Colorectal cancer metastatic,1,I,EXP,cabazitaxel,1,PS,Bone marrow failure,1,M,OT,7
172423461,1,Colorectal cancer metastatic,1,I,EXP,cabazitaxel,1,PS,Fatigue,1,M,OT,7
172428525,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Febrile neutropenia,1,M,LT,45
172428525,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Febrile neutropenia,1,M,HO,45
172428692,3,Prostate cancer metastatic,2,F,EXP,cabazitaxel,3,SS,Malnutrition,3,M,HO,74
172428692,3,Prostate cancer metastatic,2,F,EXP,cabazitaxel,3,SS,Urinary tract infection,3,M,HO,74
172430193,1,Diffuse large B-cell lymphoma,3,F,EXP,ibrutinib,1,PS,Atrial flutter,1,M,HO,371
172430193,2,Diffuse large B-cell lymphoma,3,F,EXP,lenalidomide,2,SS,Atrial flutter,2,M,HO,371
172433452,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Chronic obstructive pulmonary disease,1,F,HO,324
172433452,3,Plasma cell myeloma,2,F,PER,lenalidomide,3,SS,Chronic obstructive pulmonary disease,3,F,HO,324
172434722,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Oedema,1,F,HO,148
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Activated partial thromboplastin time prolonged,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Atrial natriuretic peptide increased,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Blood creatinine increased,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Bundle branch block right,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,C-reactive protein increased,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Constipation,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Discomfort,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Escherichia infection,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Fibrin D dimer increased,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Glomerular filtration rate decreased,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Hypertension,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,International normalised ratio decreased,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Malaise,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Oedema peripheral,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Presyncope,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Pulmonary embolism,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Red blood cells urine positive,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Troponin increased,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Urinary tract infection,2,F,HO,539
172435052,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,pH body fluid decreased,2,F,HO,539
172436061,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Alopecia,1,M,DS,129
172436061,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Rash,1,M,DS,129
172436293,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Balance disorder,2,F,HO,126
172436293,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Orthostatic hypotension,2,F,HO,126
172436611,2,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,2,SS,Anaemia,2,F,HO,10
172436611,2,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,2,SS,Asthenia,2,F,HO,10
172436611,2,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,2,SS,Decreased appetite,2,F,HO,10
172436611,2,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,2,SS,Platelet count decreased,2,F,HO,10
172436611,2,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,2,SS,Vomiting,2,F,HO,10
172436611,2,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,2,SS,White blood cell count decreased,2,F,HO,10
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Anaemia,1,F,DE,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Anaemia,1,F,HO,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Anaemia,1,F,OT,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Blood potassium increased,1,F,DE,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Blood potassium increased,1,F,HO,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Blood potassium increased,1,F,OT,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Chest pain,1,F,DE,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Chest pain,1,F,HO,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Chest pain,1,F,OT,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Constipation,1,F,DE,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Constipation,1,F,HO,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Constipation,1,F,OT,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Death,1,F,DE,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Death,1,F,HO,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Death,1,F,OT,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Decreased appetite,1,F,DE,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Decreased appetite,1,F,HO,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Decreased appetite,1,F,OT,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Nausea,1,F,DE,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Nausea,1,F,HO,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Nausea,1,F,OT,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Platelet count decreased,1,F,DE,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Platelet count decreased,1,F,HO,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Platelet count decreased,1,F,OT,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Product dose omission,1,F,DE,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Product dose omission,1,F,HO,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Product dose omission,1,F,OT,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Red blood cell count decreased,1,F,DE,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Red blood cell count decreased,1,F,HO,8
172436763,1,Product used for unknown indication,3,F,EXP,rolapitant hydrochloride,1,PS,Red blood cell count decreased,1,F,OT,8
172439383,1,Product used for unknown indication,3,F,EXP,pegfilgrastim,1,PS,Chills,1,M,HO,54
172439383,1,Product used for unknown indication,3,F,EXP,pegfilgrastim,1,PS,Diarrhoea,1,M,HO,54
172439383,1,Product used for unknown indication,3,F,EXP,pegfilgrastim,1,PS,Hyperglycaemia,1,M,HO,54
172439383,1,Product used for unknown indication,3,F,EXP,pegfilgrastim,1,PS,Pain,1,M,HO,54
172439383,1,Product used for unknown indication,3,F,EXP,pegfilgrastim,1,PS,Pneumonia,1,M,HO,54
172439383,1,Product used for unknown indication,3,F,EXP,pegfilgrastim,1,PS,Thrombosis,1,M,HO,54
172439933,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Infective exacerbation of chronic obstructive airways disease,1,M,HO,132
172439933,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Infective exacerbation of chronic obstructive airways disease,1,M,LT,132
172439933,5,Plasma cell myeloma,3,F,EXP,lenalidomide,5,SS,Infective exacerbation of chronic obstructive airways disease,5,M,HO,132
172439933,5,Plasma cell myeloma,3,F,EXP,lenalidomide,5,SS,Infective exacerbation of chronic obstructive airways disease,5,M,LT,132
172440533,1,Bladder cancer,3,F,EXP,nivolumab,1,PS,Confusional state,1,M,HO,524
172440542,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Arthropathy,1,M,DS,392
172440542,2,Squamous cell carcinoma of head and neck,2,F,EXP,ipilimumab,2,SS,Arthropathy,2,M,DS,392
172440583,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,54
172440583,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,54
172440583,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,54
172440583,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,54
172440583,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hepatocellular injury,1,M,HO,54
172440583,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Hepatocellular injury,1,M,OT,54
172440583,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,HO,54
172440583,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Rhabdomyolysis,1,M,OT,54
172440583,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,HO,54
172440583,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,OT,54
172440583,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,54
172440583,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,54
172440583,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Hepatocellular injury,2,M,HO,54
172440583,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Hepatocellular injury,2,M,OT,54
172440583,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,M,HO,54
172440583,2,Malignant melanoma,3,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,M,OT,54
172440844,4,Metastatic malignant melanoma,4,F,EXP,trametinib,4,SS,Amnesia,4,F,OT,8
172440844,4,Metastatic malignant melanoma,4,F,EXP,trametinib,4,SS,Bone pain,4,F,OT,8
172440844,4,Metastatic malignant melanoma,4,F,EXP,trametinib,4,SS,Headache,4,F,OT,8
172440844,4,Metastatic malignant melanoma,4,F,EXP,trametinib,4,SS,Pyrexia,4,F,OT,8
172440844,4,Metastatic malignant melanoma,4,F,EXP,trametinib,4,SS,Rash erythematous,4,F,OT,8
172440844,4,Metastatic malignant melanoma,4,F,EXP,trametinib,4,SS,Skin exfoliation,4,F,OT,8
172440844,4,Metastatic malignant melanoma,4,F,EXP,trametinib,4,SS,Toxic skin eruption,4,F,OT,8
172440912,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,309
172440912,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,DE,309
172440912,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Respiratory failure,2,M,OT,309
172440912,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Respiratory failure,2,M,DE,309
172441837,1,Breast cancer,7,F,EXP,palbociclib,1,PS,Pneumonia,1,F,LT,8
172441837,1,Breast cancer,7,F,EXP,palbociclib,1,PS,Pneumonia,1,F,HO,8
172441837,1,Breast cancer,7,F,EXP,palbociclib,1,PS,Pneumonia,1,F,DS,8
172441837,1,Breast cancer,7,F,EXP,palbociclib,1,PS,Respiratory failure,1,F,LT,8
172441837,1,Breast cancer,7,F,EXP,palbociclib,1,PS,Respiratory failure,1,F,HO,8
172441837,1,Breast cancer,7,F,EXP,palbociclib,1,PS,Respiratory failure,1,F,DS,8
172441837,1,Breast cancer,7,F,EXP,palbociclib,1,PS,Sepsis,1,F,LT,8
172441837,1,Breast cancer,7,F,EXP,palbociclib,1,PS,Sepsis,1,F,HO,8
172441837,1,Breast cancer,7,F,EXP,palbociclib,1,PS,Sepsis,1,F,DS,8
172442336,1,Oesophageal adenocarcinoma,6,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,203
172442336,1,Oesophageal adenocarcinoma,6,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,DS,203
172442336,1,Oesophageal adenocarcinoma,6,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,203
172442336,1,Oesophageal adenocarcinoma,6,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,LT,203
172442336,23,Product used for unknown indication,6,F,EXP,pegfilgrastim,23,C,Acute kidney injury,23,M,OT,26
172442336,23,Product used for unknown indication,6,F,EXP,pegfilgrastim,23,C,Acute kidney injury,23,M,DS,26
172442336,23,Product used for unknown indication,6,F,EXP,pegfilgrastim,23,C,Acute kidney injury,23,M,HO,26
172442336,23,Product used for unknown indication,6,F,EXP,pegfilgrastim,23,C,Acute kidney injury,23,M,LT,26
172447481,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Pneumonia bacterial,2,M,HO,90
172448221,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Sepsis,1,M,OT,27
172448221,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Sepsis,1,M,HO,27
172448221,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Sepsis,2,M,OT,27
172448221,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Sepsis,2,M,HO,27
172450353,1,Lung adenocarcinoma,3,F,EXP,nivolumab,1,PS,Dehydration,1,F,HO,340
172450353,1,Lung adenocarcinoma,3,F,EXP,nivolumab,1,PS,Muscular weakness,1,F,HO,340
172450612,1,Small cell lung cancer,2,F,EXP,nivolumab,1,PS,Enterocolitis,1,M,HO,32
172450612,1,Small cell lung cancer,2,F,EXP,nivolumab,1,PS,Enterocolitis,1,M,OT,32
172450612,1,Small cell lung cancer,2,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,HO,32
172450612,1,Small cell lung cancer,2,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,OT,32
172450612,2,Small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Enterocolitis,2,M,HO,32
172450612,2,Small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Enterocolitis,2,M,OT,32
172450612,2,Small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,HO,32
172450612,2,Small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,OT,32
172451162,1,Ewing's sarcoma,2,F,EXP,ipilimumab,1,PS,Dehydration,1,M,OT,6
172451162,1,Ewing's sarcoma,2,F,EXP,ipilimumab,1,PS,Dehydration,1,M,HO,6
172451162,1,Ewing's sarcoma,2,F,EXP,ipilimumab,1,PS,Diarrhoea,1,M,OT,6
172451162,1,Ewing's sarcoma,2,F,EXP,ipilimumab,1,PS,Diarrhoea,1,M,HO,6
172451162,1,Ewing's sarcoma,2,F,EXP,ipilimumab,1,PS,Hypomagnesaemia,1,M,OT,6
172451162,1,Ewing's sarcoma,2,F,EXP,ipilimumab,1,PS,Hypomagnesaemia,1,M,HO,6
172451162,1,Ewing's sarcoma,2,F,EXP,ipilimumab,1,PS,Hypophosphataemia,1,M,OT,6
172451162,1,Ewing's sarcoma,2,F,EXP,ipilimumab,1,PS,Hypophosphataemia,1,M,HO,6
172451162,1,Ewing's sarcoma,2,F,EXP,ipilimumab,1,PS,Nausea,1,M,OT,6
172451162,1,Ewing's sarcoma,2,F,EXP,ipilimumab,1,PS,Nausea,1,M,HO,6
172451162,1,Ewing's sarcoma,2,F,EXP,ipilimumab,1,PS,Vomiting,1,M,OT,6
172451162,1,Ewing's sarcoma,2,F,EXP,ipilimumab,1,PS,Vomiting,1,M,HO,6
172451162,2,Ewing's sarcoma,2,F,EXP,nivolumab,2,SS,Dehydration,2,M,OT,6
172451162,2,Ewing's sarcoma,2,F,EXP,nivolumab,2,SS,Dehydration,2,M,HO,6
172451162,2,Ewing's sarcoma,2,F,EXP,nivolumab,2,SS,Diarrhoea,2,M,OT,6
172451162,2,Ewing's sarcoma,2,F,EXP,nivolumab,2,SS,Diarrhoea,2,M,HO,6
172451162,2,Ewing's sarcoma,2,F,EXP,nivolumab,2,SS,Hypomagnesaemia,2,M,OT,6
172451162,2,Ewing's sarcoma,2,F,EXP,nivolumab,2,SS,Hypomagnesaemia,2,M,HO,6
172451162,2,Ewing's sarcoma,2,F,EXP,nivolumab,2,SS,Hypophosphataemia,2,M,OT,6
172451162,2,Ewing's sarcoma,2,F,EXP,nivolumab,2,SS,Hypophosphataemia,2,M,HO,6
172451162,2,Ewing's sarcoma,2,F,EXP,nivolumab,2,SS,Nausea,2,M,OT,6
172451162,2,Ewing's sarcoma,2,F,EXP,nivolumab,2,SS,Nausea,2,M,HO,6
172451162,2,Ewing's sarcoma,2,F,EXP,nivolumab,2,SS,Vomiting,2,M,OT,6
172451162,2,Ewing's sarcoma,2,F,EXP,nivolumab,2,SS,Vomiting,2,M,HO,6
172451702,1,Lung neoplasm malignant,2,F,EXP,brigatinib,1,PS,Urinary tract infection,1,F,HO,143
172453847,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Myocarditis,1,M,DE,27
172453847,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Myocarditis,1,M,OT,27
172453847,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Myocarditis,1,M,LT,27
172453847,1,Renal cell carcinoma,7,F,EXP,nivolumab,1,PS,Myocarditis,1,M,HO,27
172453847,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Myocarditis,2,M,DE,27
172453847,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Myocarditis,2,M,OT,27
172453847,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Myocarditis,2,M,LT,27
172453847,2,Product used for unknown indication,7,F,EXP,nivolumab,2,SS,Myocarditis,2,M,HO,27
172453847,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Myocarditis,3,M,DE,13
172453847,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Myocarditis,3,M,OT,13
172453847,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Myocarditis,3,M,LT,13
172453847,3,Product used for unknown indication,7,F,EXP,nivolumab,3,SS,Myocarditis,3,M,HO,13
172453847,4,Renal cell carcinoma,7,F,EXP,ipilimumab,4,SS,Myocarditis,4,M,DE,27
172453847,4,Renal cell carcinoma,7,F,EXP,ipilimumab,4,SS,Myocarditis,4,M,OT,27
172453847,4,Renal cell carcinoma,7,F,EXP,ipilimumab,4,SS,Myocarditis,4,M,LT,27
172453847,4,Renal cell carcinoma,7,F,EXP,ipilimumab,4,SS,Myocarditis,4,M,HO,27
172453847,5,Product used for unknown indication,7,F,EXP,ipilimumab,5,SS,Myocarditis,5,M,DE,13
172453847,5,Product used for unknown indication,7,F,EXP,ipilimumab,5,SS,Myocarditis,5,M,OT,13
172453847,5,Product used for unknown indication,7,F,EXP,ipilimumab,5,SS,Myocarditis,5,M,LT,13
172453847,5,Product used for unknown indication,7,F,EXP,ipilimumab,5,SS,Myocarditis,5,M,HO,13
172453902,1,Prostate cancer,2,F,EXP,ipilimumab,1,PS,Gastroenteritis viral,1,M,HO,205
172453902,3,Prostate cancer,2,F,EXP,apalutamide,3,SS,Gastroenteritis viral,3,M,HO,266
172453902,4,Product used for unknown indication,2,F,EXP,apalutamide,4,SS,Gastroenteritis viral,4,M,HO,129
172455012,14,B precursor type acute leukaemia,2,F,EXP,pegaspargase,14,SS,Febrile neutropenia,14,M,OT,182
172455012,14,B precursor type acute leukaemia,2,F,EXP,pegaspargase,14,SS,Febrile neutropenia,14,M,HO,182
172456712,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Adverse drug reaction,1,F,HO,20
172459523,2,Plasma cell myeloma,3,F,EXP,daratumumab,2,SS,Infective exacerbation of chronic obstructive airways disease,2,M,LT,132
172459523,2,Plasma cell myeloma,3,F,EXP,daratumumab,2,SS,Infective exacerbation of chronic obstructive airways disease,2,M,HO,132
172459523,5,Plasma cell myeloma,3,F,EXP,lenalidomide,5,SS,Infective exacerbation of chronic obstructive airways disease,5,M,LT,132
172459523,5,Plasma cell myeloma,3,F,EXP,lenalidomide,5,SS,Infective exacerbation of chronic obstructive airways disease,5,M,HO,132
172460451,2,Renal cancer metastatic,1,I,EXP,nivolumab,2,SS,Device related infection,2,M,HO,104
172460451,2,Renal cancer metastatic,1,I,EXP,nivolumab,2,SS,Device related infection,2,M,OT,104
172460451,2,Renal cancer metastatic,1,I,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,HO,104
172460451,2,Renal cancer metastatic,1,I,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,104
172460451,2,Renal cancer metastatic,1,I,EXP,nivolumab,2,SS,Nephrotic syndrome,2,M,HO,104
172460451,2,Renal cancer metastatic,1,I,EXP,nivolumab,2,SS,Nephrotic syndrome,2,M,OT,104
172460451,2,Renal cancer metastatic,1,I,EXP,nivolumab,2,SS,Pyrexia,2,M,HO,104
172460451,2,Renal cancer metastatic,1,I,EXP,nivolumab,2,SS,Pyrexia,2,M,OT,104
172460451,2,Renal cancer metastatic,1,I,EXP,nivolumab,2,SS,Renal failure,2,M,HO,104
172460451,2,Renal cancer metastatic,1,I,EXP,nivolumab,2,SS,Renal failure,2,M,OT,104
172460451,2,Renal cancer metastatic,1,I,EXP,nivolumab,2,SS,Urinary tract infection bacterial,2,M,HO,104
172460451,2,Renal cancer metastatic,1,I,EXP,nivolumab,2,SS,Urinary tract infection bacterial,2,M,OT,104
172463171,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Leukopenia,1,F,OT,3
172463171,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Unevaluable event,1,F,OT,3
172463242,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,142
172463242,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,142
172463242,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Headache,1,M,HO,142
172463242,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Headache,1,M,OT,142
172463242,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,HO,142
172463242,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,OT,142
172463242,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Syncope,1,M,HO,142
172463242,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Syncope,1,M,OT,142
172463242,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,M,HO,53
172463242,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,M,OT,53
172463242,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Headache,2,M,HO,53
172463242,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Headache,2,M,OT,53
172463242,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,HO,53
172463242,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,M,OT,53
172463242,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Syncope,2,M,HO,53
172463242,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Syncope,2,M,OT,53
172467923,1,Small cell lung cancer,3,F,EXP,avelumab,1,SS,Respiratory tract infection,1,M,HO,31
172473152,1,Rectal cancer,2,F,EXP,nivolumab,1,PS,Urinary tract infection enterococcal,1,M,OT,1
172473152,1,Rectal cancer,2,F,EXP,nivolumab,1,PS,Urinary tract infection enterococcal,1,M,HO,1
172473152,2,Rectal cancer,2,F,EXP,ipilimumab,2,SS,Urinary tract infection enterococcal,2,M,OT,15
172473152,2,Rectal cancer,2,F,EXP,ipilimumab,2,SS,Urinary tract infection enterococcal,2,M,HO,15
172473881,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Syncope,1,F,OT,25
172476121,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Leukopenia,1,F,HO,36
172476121,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Pyrexia,1,F,HO,36
172478132,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Cataract,1,F,OT,155
172478171,1,Metastatic malignant melanoma,1,I,EXP,selinexor,1,PS,Diarrhoea,1,M,HO,24
172480592,3,Product used for unknown indication,2,F,EXP,palbociclib,3,SS,Anaemia,3,F,OT,13
172480592,3,Product used for unknown indication,2,F,EXP,palbociclib,3,SS,Diarrhoea,3,F,OT,13
172480592,3,Product used for unknown indication,2,F,EXP,palbociclib,3,SS,Fatigue,3,F,OT,13
172480592,3,Product used for unknown indication,2,F,EXP,palbociclib,3,SS,Gastrooesophageal reflux disease,3,F,OT,13
172480592,3,Product used for unknown indication,2,F,EXP,palbociclib,3,SS,Hypertension,3,F,OT,13
172480592,3,Product used for unknown indication,2,F,EXP,palbociclib,3,SS,Mucosal inflammation,3,F,OT,13
172480592,3,Product used for unknown indication,2,F,EXP,palbociclib,3,SS,Pain,3,F,OT,13
172480592,3,Product used for unknown indication,2,F,EXP,palbociclib,3,SS,Rash,3,F,OT,13
172480592,3,Product used for unknown indication,2,F,EXP,palbociclib,3,SS,Thrombocytopenia,3,F,OT,13
172482082,1,Neoplasm,2,F,EXP,trabectedin,1,PS,Abdominal pain,1,M,HO,155
172483081,3,Tumour lysis syndrome,1,I,EXP,rasburicase,3,SS,Haemolytic anaemia,3,M,HO,1
172483081,3,Tumour lysis syndrome,1,I,EXP,rasburicase,3,SS,Methaemoglobinaemia,3,M,HO,1
172483256,1,Colorectal cancer,6,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,HO,21
172483256,1,Colorectal cancer,6,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,OT,21
172483256,1,Colorectal cancer,6,F,EXP,nivolumab,1,PS,Myositis,1,M,HO,21
172483256,1,Colorectal cancer,6,F,EXP,nivolumab,1,PS,Myositis,1,M,OT,21
172483262,1,Ewing's sarcoma,2,F,EXP,nivolumab,1,PS,Anorectal infection,1,M,HO,28
172483262,1,Ewing's sarcoma,2,F,EXP,nivolumab,1,PS,Anorectal infection,1,M,OT,28
172483262,1,Ewing's sarcoma,2,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,HO,28
172483262,1,Ewing's sarcoma,2,F,EXP,nivolumab,1,PS,Autoimmune hepatitis,1,M,OT,28
172483262,1,Ewing's sarcoma,2,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,HO,28
172483262,1,Ewing's sarcoma,2,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,OT,28
172483262,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Anorectal infection,2,M,HO,7
172483262,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Anorectal infection,2,M,OT,7
172483262,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Autoimmune hepatitis,2,M,HO,7
172483262,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Autoimmune hepatitis,2,M,OT,7
172483262,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Autoimmune thyroiditis,2,M,HO,7
172483262,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Autoimmune thyroiditis,2,M,OT,7
172483262,3,Ewing's sarcoma,2,F,EXP,ipilimumab,3,SS,Anorectal infection,3,M,HO,28
172483262,3,Ewing's sarcoma,2,F,EXP,ipilimumab,3,SS,Anorectal infection,3,M,OT,28
172483262,3,Ewing's sarcoma,2,F,EXP,ipilimumab,3,SS,Autoimmune hepatitis,3,M,HO,28
172483262,3,Ewing's sarcoma,2,F,EXP,ipilimumab,3,SS,Autoimmune hepatitis,3,M,OT,28
172483262,3,Ewing's sarcoma,2,F,EXP,ipilimumab,3,SS,Autoimmune thyroiditis,3,M,HO,28
172483262,3,Ewing's sarcoma,2,F,EXP,ipilimumab,3,SS,Autoimmune thyroiditis,3,M,OT,28
172483262,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Anorectal infection,4,M,HO,7
172483262,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Anorectal infection,4,M,OT,7
172483262,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Autoimmune hepatitis,4,M,HO,7
172483262,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Autoimmune hepatitis,4,M,OT,7
172483262,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Autoimmune thyroiditis,4,M,HO,7
172483262,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Autoimmune thyroiditis,4,M,OT,7
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,M,OT,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,M,LT,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,M,HO,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,M,OT,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,M,LT,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,M,HO,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Device related infection,1,M,OT,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Device related infection,1,M,LT,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Device related infection,1,M,HO,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Pericarditis,1,M,OT,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Pericarditis,1,M,LT,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Pericarditis,1,M,HO,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Quadriparesis,1,M,OT,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Quadriparesis,1,M,LT,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Quadriparesis,1,M,HO,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Septic shock,1,M,OT,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Septic shock,1,M,LT,193
1724840010,1,Hodgkin's disease,10,F,EXP,nivolumab,1,PS,Septic shock,1,M,HO,193
172484133,1,Gastric cancer,3,F,EXP,nivolumab,1,PS,Pancreatic fistula,1,F,OT,39
172484133,1,Gastric cancer,3,F,EXP,nivolumab,1,PS,Pancreatic fistula,1,F,HO,39
172485172,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Alveolar lung disease,1,M,HO,7
172485172,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Alveolar lung disease,1,M,OT,7
172485172,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Pneumonia,1,M,HO,7
172485172,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Pneumonia,1,M,OT,7
172485362,3,Squamous cell carcinoma,2,F,EXP,nivolumab,3,SS,Hepatitis acute,3,M,HO,59
172486522,2,Prostate cancer,2,F,EXP,nivolumab,2,PS,Fluid overload,2,M,HO,73
172486831,1,Plasma cell myeloma,1,I,PER,lenalidomide,1,PS,Haemoglobin decreased,1,F,OT,69
172488502,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pneumonia influenzal,2,F,OT,87
172488502,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pneumonia influenzal,2,F,HO,87
172488502,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Upper respiratory tract inflammation,2,F,OT,87
172488502,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Upper respiratory tract inflammation,2,F,HO,87
172488502,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Pneumonia influenzal,3,F,OT,87
172488502,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Pneumonia influenzal,3,F,HO,87
172488502,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Upper respiratory tract inflammation,3,F,OT,87
172488502,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Upper respiratory tract inflammation,3,F,HO,87
172491941,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Bronchitis,1,F,HO,331
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Chills,1,M,DE,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Chills,1,M,HO,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Chills,1,M,OT,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Chills,1,M,LT,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Haemophagocytic lymphohistiocytosis,1,M,DE,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Haemophagocytic lymphohistiocytosis,1,M,HO,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Haemophagocytic lymphohistiocytosis,1,M,OT,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Haemophagocytic lymphohistiocytosis,1,M,LT,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Pseudomonal sepsis,1,M,DE,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Pseudomonal sepsis,1,M,HO,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Pseudomonal sepsis,1,M,OT,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Pseudomonal sepsis,1,M,LT,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Tachycardia,1,M,DE,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Tachycardia,1,M,HO,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Tachycardia,1,M,OT,5
172492782,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Tachycardia,1,M,LT,5
172498642,2,Product used for unknown indication,2,F,EXP,palbociclib,2,SS,Leukopenia,2,F,OT,33
172498642,2,Product used for unknown indication,2,F,EXP,palbociclib,2,SS,Neutropenia,2,F,OT,33
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Cough,1,M,OT,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Cough,1,M,LT,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Cough,1,M,HO,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Cough,1,M,DE,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,LT,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Fatigue,1,M,LT,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Fatigue,1,M,DE,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Off label use,1,M,OT,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Off label use,1,M,LT,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Off label use,1,M,HO,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Off label use,1,M,DE,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Respiratory arrest,1,M,OT,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Respiratory arrest,1,M,LT,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Respiratory arrest,1,M,HO,13
172500732,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Respiratory arrest,1,M,DE,13
172505434,25,Premedication,4,F,EXP,granisetron,25,C,Pneumonia,25,F,HO,147
172507382,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Pneumonia,1,M,HO,242
172507382,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Pneumonia,1,M,LT,242
172507382,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Pneumonia,1,M,DE,242
172507382,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Pulmonary oedema,1,M,HO,242
172507382,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Pulmonary oedema,1,M,LT,242
172507382,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Pulmonary oedema,1,M,DE,242
172509542,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,36
172509542,1,Renal cancer metastatic,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,36
172509542,2,Renal cancer metastatic,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DE,36
172509542,2,Renal cancer metastatic,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,36
172509652,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Gallbladder obstruction,1,M,HO,86
172509652,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Gallbladder obstruction,1,M,OT,86
172509652,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pain,1,M,HO,86
172509652,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pain,1,M,OT,86
172509652,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Gallbladder obstruction,2,M,HO,86
172509652,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Gallbladder obstruction,2,M,OT,86
172509652,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Pain,2,M,HO,86
172509652,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Pain,2,M,OT,86
172513132,1,Metastatic malignant melanoma,2,F,EXP,selinexor,1,PS,Alanine aminotransferase increased,1,F,OT,15
172513132,1,Metastatic malignant melanoma,2,F,EXP,selinexor,1,PS,Aspartate aminotransferase increased,1,F,OT,15
172516151,4,Plasma cell myeloma,1,I,PER,thalidomide,4,SS,Pneumonia,4,F,HO,16
172517612,6,Osteoporosis,2,F,EXP,denosumab,6,C,Pelvic fracture,6,F,HO,365
172519191,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Leukopenia,1,M,OT,7
172519651,1,Plasma cell myeloma,1,I,PER,lenalidomide,1,PS,Dyspnoea,1,M,OT,4
172519651,1,Plasma cell myeloma,1,I,PER,lenalidomide,1,PS,Rash,1,M,OT,4
172519651,1,Plasma cell myeloma,1,I,PER,lenalidomide,1,PS,Skin exfoliation,1,M,OT,4
172519921,1,Plasma cell myeloma,1,I,EXP,panobinostat,1,PS,Pneumonia pneumococcal,1,M,HO,153
172519921,1,Plasma cell myeloma,1,I,EXP,panobinostat,1,PS,Pyrexia,1,M,HO,153
172519921,1,Plasma cell myeloma,1,I,EXP,panobinostat,1,PS,Respiratory tract infection,1,M,HO,153
172525012,1,Lung adenocarcinoma stage IV,2,F,EXP,lorlatinib,1,PS,Respiratory failure,1,M,DE,99
172525982,1,Breast cancer,2,F,EXP,selinexor,1,PS,Alanine aminotransferase increased,1,F,HO,27
172525982,1,Breast cancer,2,F,EXP,selinexor,1,PS,Aspartate aminotransferase increased,1,F,HO,27
172528541,6,Pneumonia,1,I,EXP,zoledronic acid,6,SS,Bone marrow failure,6,M,HO,5
172528541,6,Pneumonia,1,I,EXP,zoledronic acid,6,SS,Nausea,6,M,HO,5
172528541,6,Pneumonia,1,I,EXP,zoledronic acid,6,SS,Oropharyngeal pain,6,M,HO,5
172528541,6,Pneumonia,1,I,EXP,zoledronic acid,6,SS,Productive cough,6,M,HO,5
172528541,6,Pneumonia,1,I,EXP,zoledronic acid,6,SS,Pyrexia,6,M,HO,5
172528541,6,Pneumonia,1,I,EXP,zoledronic acid,6,SS,Vomiting,6,M,HO,5
172528541,8,Pneumonia,1,I,EXP,pemetrexed disodium,8,SS,Bone marrow failure,8,M,HO,6
172528541,8,Pneumonia,1,I,EXP,pemetrexed disodium,8,SS,Nausea,8,M,HO,6
172528541,8,Pneumonia,1,I,EXP,pemetrexed disodium,8,SS,Oropharyngeal pain,8,M,HO,6
172528541,8,Pneumonia,1,I,EXP,pemetrexed disodium,8,SS,Productive cough,8,M,HO,6
172528541,8,Pneumonia,1,I,EXP,pemetrexed disodium,8,SS,Pyrexia,8,M,HO,6
172528541,8,Pneumonia,1,I,EXP,pemetrexed disodium,8,SS,Vomiting,8,M,HO,6
172531502,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Immune-mediated encephalitis,1,M,OT,391
172531502,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Immune-mediated encephalitis,1,M,HO,391
172531502,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Immune-mediated encephalitis,2,M,OT,391
172531502,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Immune-mediated encephalitis,2,M,HO,391
172531502,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,SS,Immune-mediated encephalitis,3,M,OT,391
172531502,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,SS,Immune-mediated encephalitis,3,M,HO,391
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Anaemia,1,F,HO,8
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Anaemia,1,F,DS,8
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Anaemia,1,F,OT,8
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Device related infection,1,F,HO,8
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Device related infection,1,F,DS,8
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Device related infection,1,F,OT,8
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Febrile neutropenia,1,F,HO,8
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Febrile neutropenia,1,F,DS,8
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Febrile neutropenia,1,F,OT,8
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Neutropenia,1,F,HO,8
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Neutropenia,1,F,DS,8
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Neutropenia,1,F,OT,8
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Thrombocytopenia,1,F,HO,8
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Thrombocytopenia,1,F,DS,8
172533133,1,Diffuse large B-cell lymphoma,3,F,EXP,axicabtagene ciloleucel,1,PS,Thrombocytopenia,1,F,OT,8
172533521,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Dyspnoea,2,M,HO,12
172533521,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Febrile neutropenia,2,M,HO,12
172538733,1,Colorectal cancer,3,F,EXP,nivolumab,1,PS,Hypertension,1,M,HO,7
172540122,1,Pancreatic carcinoma,2,F,EXP,pegfilgrastim,1,PS,Cardiac arrest,1,M,DE,70
172540122,1,Pancreatic carcinoma,2,F,EXP,pegfilgrastim,1,PS,Cardiac arrest,1,M,OT,70
172540122,1,Pancreatic carcinoma,2,F,EXP,pegfilgrastim,1,PS,Leukocytosis,1,M,DE,70
172540122,1,Pancreatic carcinoma,2,F,EXP,pegfilgrastim,1,PS,Leukocytosis,1,M,OT,70
172540122,1,Pancreatic carcinoma,2,F,EXP,pegfilgrastim,1,PS,Off label use,1,M,DE,70
172540122,1,Pancreatic carcinoma,2,F,EXP,pegfilgrastim,1,PS,Off label use,1,M,OT,70
172543033,3,Renal cancer metastatic,3,F,EXP,nivolumab,3,SS,Device related infection,3,M,OT,104
172543033,3,Renal cancer metastatic,3,F,EXP,nivolumab,3,SS,Device related infection,3,M,HO,104
172543033,3,Renal cancer metastatic,3,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,OT,104
172543033,3,Renal cancer metastatic,3,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,HO,104
172543033,3,Renal cancer metastatic,3,F,EXP,nivolumab,3,SS,Nephrotic syndrome,3,M,OT,104
172543033,3,Renal cancer metastatic,3,F,EXP,nivolumab,3,SS,Nephrotic syndrome,3,M,HO,104
172543033,3,Renal cancer metastatic,3,F,EXP,nivolumab,3,SS,Pyrexia,3,M,OT,104
172543033,3,Renal cancer metastatic,3,F,EXP,nivolumab,3,SS,Pyrexia,3,M,HO,104
172543033,3,Renal cancer metastatic,3,F,EXP,nivolumab,3,SS,Renal failure,3,M,OT,104
172543033,3,Renal cancer metastatic,3,F,EXP,nivolumab,3,SS,Renal failure,3,M,HO,104
172543033,3,Renal cancer metastatic,3,F,EXP,nivolumab,3,SS,Urinary tract infection bacterial,3,M,OT,104
172543033,3,Renal cancer metastatic,3,F,EXP,nivolumab,3,SS,Urinary tract infection bacterial,3,M,HO,104
172544254,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Pneumonia,1,F,HO,242
172544254,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Pneumonia,1,F,LT,242
172544254,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Pneumonia,2,F,HO,242
172544254,2,Plasma cell myeloma,4,F,EXP,daratumumab,2,SS,Pneumonia,2,F,LT,242
172545192,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Acute lymphocytic leukaemia,1,F,HO,2149
172545192,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Acute lymphocytic leukaemia,1,F,LT,2149
172545192,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Acute lymphocytic leukaemia,1,F,OT,2149
172545211,2,Product used for unknown indication,1,I,EXP,lenalidomide,2,SS,Neutropenia,2,F,OT,18
172547843,1,Waldenstrom's macroglobulinaemia,3,F,EXP,idelalisib,1,PS,Glioblastoma,1,M,OT,698
172547843,1,Waldenstrom's macroglobulinaemia,3,F,EXP,idelalisib,1,PS,Glioblastoma,1,M,HO,698
172550021,10,Plasma cell myeloma,1,I,PER,daratumumab,10,SS,Pneumonia,10,F,HO,402
172550992,1,Kaposi's sarcoma,2,F,EXP,nivolumab,1,PS,Chills,1,M,HO,39
172550992,1,Kaposi's sarcoma,2,F,EXP,nivolumab,1,PS,Pain,1,M,HO,39
172550992,1,Kaposi's sarcoma,2,F,EXP,nivolumab,1,PS,Productive cough,1,M,HO,39
172550992,1,Kaposi's sarcoma,2,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,39
172550992,2,Kaposi's sarcoma,2,F,EXP,ipilimumab,2,SS,Chills,2,M,HO,39
172550992,2,Kaposi's sarcoma,2,F,EXP,ipilimumab,2,SS,Pain,2,M,HO,39
172550992,2,Kaposi's sarcoma,2,F,EXP,ipilimumab,2,SS,Productive cough,2,M,HO,39
172550992,2,Kaposi's sarcoma,2,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,HO,39
172554893,6,Waldenstrom's macroglobulinaemia,3,F,EXP,idelalisib,6,SS,Glioblastoma,6,M,HO,704
172557521,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,SS,Cytokine release syndrome,1,F,OT,3
172557521,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,SS,Febrile neutropenia,1,F,OT,3
172557711,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Phlebitis,1,F,OT,138
172557711,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Product leakage,1,F,OT,138
172562653,1,Metastases to bone,3,F,EXP,zoledronic acid,1,PS,Blood creatinine increased,1,F,OT,525
172562653,1,Metastases to bone,3,F,EXP,zoledronic acid,1,PS,Hypocalcaemia,1,F,OT,525
172562653,1,Metastases to bone,3,F,EXP,zoledronic acid,1,PS,Pain,1,F,OT,525
172562653,1,Metastases to bone,3,F,EXP,zoledronic acid,1,PS,Renal impairment,1,F,OT,525
172562653,1,Metastases to bone,3,F,EXP,zoledronic acid,1,PS,Spinal pain,1,F,OT,525
172563293,1,Glioblastoma,3,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,F,OT,272
172563293,1,Glioblastoma,3,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,F,HO,272
172563293,1,Glioblastoma,3,F,EXP,nivolumab,1,PS,Chronic kidney disease,1,F,OT,272
172563293,1,Glioblastoma,3,F,EXP,nivolumab,1,PS,Chronic kidney disease,1,F,HO,272
172563293,1,Glioblastoma,3,F,EXP,nivolumab,1,PS,Enterocolitis infectious,1,F,OT,272
172563293,1,Glioblastoma,3,F,EXP,nivolumab,1,PS,Enterocolitis infectious,1,F,HO,272
172563293,1,Glioblastoma,3,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,272
172563293,1,Glioblastoma,3,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,272
172564861,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Anaemia,1,M,HO,122
172565471,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Febrile neutropenia,1,F,OT,48
172565471,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Febrile neutropenia,1,F,HO,48
172565621,3,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,3,SS,Stomatitis,3,M,OT,159
172568253,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,HO,7
172568253,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,OT,7
172568253,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Leukopenia,1,M,HO,7
172568253,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Leukopenia,1,M,OT,7
172572372,8,Metastases to bone,2,F,EXP,denosumab,8,C,Electrocardiogram QT prolonged,8,F,OT,21
172572372,8,Metastases to bone,2,F,EXP,denosumab,8,C,Influenza like illness,8,F,OT,21
172572372,8,Metastases to bone,2,F,EXP,denosumab,8,C,Malaise,8,F,OT,21
172572372,8,Metastases to bone,2,F,EXP,denosumab,8,C,Nausea,8,F,OT,21
172572372,8,Metastases to bone,2,F,EXP,denosumab,8,C,Neutropenia,8,F,OT,21
172572372,8,Metastases to bone,2,F,EXP,denosumab,8,C,Rash,8,F,OT,21
172574192,2,Adenocarcinoma of colon,2,F,EXP,folfiri,2,SS,Adenocarcinoma of colon,2,F,OT,114
172574192,2,Adenocarcinoma of colon,2,F,EXP,folfiri,2,SS,Malignant neoplasm progression,2,F,OT,114
172574192,2,Adenocarcinoma of colon,2,F,EXP,folfiri,2,SS,Metastases to bone,2,F,OT,114
172574192,2,Adenocarcinoma of colon,2,F,EXP,folfiri,2,SS,Metastases to spine,2,F,OT,114
172574192,2,Adenocarcinoma of colon,2,F,EXP,folfiri,2,SS,Second primary malignancy,2,F,OT,114
172574471,3,Prostate cancer,1,I,EXP,enzalutamide,3,SS,Cerebrovascular accident,3,M,HO,1095
172574811,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Brain neoplasm,1,M,OT,742
172574811,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Brain neoplasm,1,M,HO,742
172574811,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Fall,1,M,OT,742
172574811,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Fall,1,M,HO,742
172574811,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Head injury,1,M,OT,742
172574811,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Head injury,1,M,HO,742
172574811,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Syncope,1,M,OT,742
172574811,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Syncope,1,M,HO,742
172576812,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Neutropenia,1,F,OT,73
172576812,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Neutropenia,1,F,HO,73
172576831,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Fatigue,1,F,HO,8
172576831,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Fatigue,1,F,OT,8
172579991,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Diverticulitis,6,F,OT,65
172579991,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Diverticulitis,6,F,HO,65
172579991,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Neutropenia,6,F,OT,65
172579991,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Neutropenia,6,F,HO,65
172579991,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Thrombocytopenia,6,F,OT,65
172579991,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Thrombocytopenia,6,F,HO,65
172579991,19,Plasma cell myeloma,1,I,EXP,nivolumab,19,C,Diverticulitis,19,F,OT,51
172579991,19,Plasma cell myeloma,1,I,EXP,nivolumab,19,C,Diverticulitis,19,F,HO,51
172579991,19,Plasma cell myeloma,1,I,EXP,nivolumab,19,C,Neutropenia,19,F,OT,51
172579991,19,Plasma cell myeloma,1,I,EXP,nivolumab,19,C,Neutropenia,19,F,HO,51
172579991,19,Plasma cell myeloma,1,I,EXP,nivolumab,19,C,Thrombocytopenia,19,F,OT,51
172579991,19,Plasma cell myeloma,1,I,EXP,nivolumab,19,C,Thrombocytopenia,19,F,HO,51
172580191,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Skin lesion,1,M,OT,20
172581132,10,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,10,SS,Acute kidney injury,10,M,HO,29
172581132,10,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,10,SS,Febrile neutropenia,10,M,HO,29
172581132,10,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,10,SS,Pancreatitis,10,M,HO,29
172581132,10,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,10,SS,Pneumonia,10,M,HO,29
172581132,10,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,10,SS,Pulmonary mass,10,M,HO,29
172581132,10,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,10,SS,Respiratory tract infection fungal,10,M,HO,29
172581132,10,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,10,SS,Sepsis,10,M,HO,29
172581132,10,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,10,SS,Staphylococcal infection,10,M,HO,29
172582512,4,Breast cancer metastatic,2,F,EXP,tucatinib,4,SS,Asthenia,4,F,HO,288
172582512,4,Breast cancer metastatic,2,F,EXP,tucatinib,4,SS,Chest pain,4,F,HO,288
172582512,4,Breast cancer metastatic,2,F,EXP,tucatinib,4,SS,Cystitis,4,F,HO,288
172582512,4,Breast cancer metastatic,2,F,EXP,tucatinib,4,SS,Dysuria,4,F,HO,288
172582512,4,Breast cancer metastatic,2,F,EXP,tucatinib,4,SS,Lethargy,4,F,HO,288
172582512,4,Breast cancer metastatic,2,F,EXP,tucatinib,4,SS,Myalgia,4,F,HO,288
172582512,4,Breast cancer metastatic,2,F,EXP,tucatinib,4,SS,Pyrexia,4,F,HO,288
172582512,4,Breast cancer metastatic,2,F,EXP,tucatinib,4,SS,Sepsis,4,F,HO,288
172582512,4,Breast cancer metastatic,2,F,EXP,tucatinib,4,SS,Tachycardia,4,F,HO,288
172582512,4,Breast cancer metastatic,2,F,EXP,tucatinib,4,SS,Urinary tract infection,4,F,HO,288
172582641,1,Plasma cell myeloma,1,I,EXP,pomalidomide,1,PS,Respiratory tract infection,1,M,HO,14
172582731,27,B precursor type acute leukaemia,1,I,EXP,pegaspargase,27,SS,Dehydration,27,M,HO,87
172582731,27,B precursor type acute leukaemia,1,I,EXP,pegaspargase,27,SS,Stomatitis,27,M,HO,87
172583343,1,ALK gene rearrangement positive,3,F,EXP,lorlatinib,1,PS,Pneumonia,1,F,OT,160
172583571,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Pneumonia,5,F,HO,16
172583982,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,C,Cervical spinal stenosis,3,M,OT,3
172583982,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,C,Deafness neurosensory,3,M,OT,3
172583982,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,C,Gout,3,M,OT,3
172583982,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,C,Hypertension,3,M,OT,3
172583982,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,C,Hypoaesthesia,3,M,OT,3
172583982,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,C,Lacunar infarction,3,M,OT,3
172583982,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,C,Malaise,3,M,OT,3
172583982,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,C,Nausea,3,M,OT,3
172583982,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,C,Sensory disturbance,3,M,OT,3
172583982,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,C,Spinal osteoarthritis,3,M,OT,3
172583982,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,C,Vomiting,3,M,OT,3
172583982,24,Prophylaxis,2,F,EXP,granisetron,24,C,Cervical spinal stenosis,24,M,OT,3
172583982,24,Prophylaxis,2,F,EXP,granisetron,24,C,Deafness neurosensory,24,M,OT,3
172583982,24,Prophylaxis,2,F,EXP,granisetron,24,C,Gout,24,M,OT,3
172583982,24,Prophylaxis,2,F,EXP,granisetron,24,C,Hypertension,24,M,OT,3
172583982,24,Prophylaxis,2,F,EXP,granisetron,24,C,Hypoaesthesia,24,M,OT,3
172583982,24,Prophylaxis,2,F,EXP,granisetron,24,C,Lacunar infarction,24,M,OT,3
172583982,24,Prophylaxis,2,F,EXP,granisetron,24,C,Malaise,24,M,OT,3
172583982,24,Prophylaxis,2,F,EXP,granisetron,24,C,Nausea,24,M,OT,3
172583982,24,Prophylaxis,2,F,EXP,granisetron,24,C,Sensory disturbance,24,M,OT,3
172583982,24,Prophylaxis,2,F,EXP,granisetron,24,C,Spinal osteoarthritis,24,M,OT,3
172583982,24,Prophylaxis,2,F,EXP,granisetron,24,C,Vomiting,24,M,OT,3
172584041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Chronic myelomonocytic leukaemia,1,M,OT,2466
172584584,1,Endometrial stromal sarcoma,4,F,EXP,ipilimumab,1,SS,Acute respiratory failure,1,F,LT,44
172584584,1,Endometrial stromal sarcoma,4,F,EXP,ipilimumab,1,SS,Acute respiratory failure,1,F,HO,44
172584584,1,Endometrial stromal sarcoma,4,F,EXP,ipilimumab,1,SS,Acute respiratory failure,1,F,OT,44
172584584,1,Endometrial stromal sarcoma,4,F,EXP,ipilimumab,1,SS,Pulmonary haemorrhage,1,F,LT,44
172584584,1,Endometrial stromal sarcoma,4,F,EXP,ipilimumab,1,SS,Pulmonary haemorrhage,1,F,HO,44
172584584,1,Endometrial stromal sarcoma,4,F,EXP,ipilimumab,1,SS,Pulmonary haemorrhage,1,F,OT,44
172585252,1,Non-Hodgkin's lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,LT,5
172585321,1,Myelodysplastic syndrome,1,I,PER,lenalidomide,1,PS,Neutrophil count decreased,1,M,OT,81
172585652,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,SS,Dyspnoea,1,M,OT,42
172585652,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,SS,Dyspnoea,1,M,DS,42
172585652,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,SS,Dyspnoea,1,M,HO,42
172585652,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,SS,Hyperglycaemia,1,M,OT,42
172585652,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,SS,Hyperglycaemia,1,M,DS,42
172585652,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,SS,Hyperglycaemia,1,M,HO,42
172585652,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,SS,Hyperthyroidism,1,M,OT,42
172585652,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,SS,Hyperthyroidism,1,M,DS,42
172585652,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,SS,Hyperthyroidism,1,M,HO,42
172585652,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,PS,Dyspnoea,2,M,OT,42
172585652,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,PS,Dyspnoea,2,M,DS,42
172585652,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,PS,Dyspnoea,2,M,HO,42
172585652,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,PS,Hyperglycaemia,2,M,OT,42
172585652,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,PS,Hyperglycaemia,2,M,DS,42
172585652,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,PS,Hyperglycaemia,2,M,HO,42
172585652,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,PS,Hyperthyroidism,2,M,OT,42
172585652,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,PS,Hyperthyroidism,2,M,DS,42
172585652,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,PS,Hyperthyroidism,2,M,HO,42
172585932,1,Acute lymphocytic leukaemia,2,F,PER,blinatumomab,1,PS,Hyperglycaemia,1,M,HO,61
172586624,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Myositis,1,M,DE,95
172586624,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Myositis,1,M,HO,95
172586624,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Myositis,2,M,DE,95
172586624,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Myositis,2,M,HO,95
172587472,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,SS,Pneumonitis,1,M,LT,60
172587472,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,SS,Pneumonitis,1,M,HO,60
172587472,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,SS,Pneumonitis,1,M,DE,60
172587472,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,SS,Pneumonitis,1,M,OT,60
172587472,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,PS,Pneumonitis,2,M,LT,60
172587472,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,PS,Pneumonitis,2,M,HO,60
172587472,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,PS,Pneumonitis,2,M,DE,60
172587472,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,PS,Pneumonitis,2,M,OT,60
172588512,1,Small cell lung cancer,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,OT,1301
172588512,1,Small cell lung cancer,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,HO,1301
172588512,2,Small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Cerebrovascular accident,2,M,OT,1301
172588512,2,Small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Cerebrovascular accident,2,M,HO,1301
172588553,1,Product used for unknown indication,3,F,EXP,pegfilgrastim,1,PS,Dysphagia,1,F,HO,28
172588553,1,Product used for unknown indication,3,F,EXP,pegfilgrastim,1,PS,General physical health deterioration,1,F,HO,28
172588553,1,Product used for unknown indication,3,F,EXP,pegfilgrastim,1,PS,Oral candidiasis,1,F,HO,28
172588982,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,OT,49
172588982,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,DE,49
172588982,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,HO,49
172588982,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,49
172588982,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,DE,49
172588982,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,49
172588982,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,OT,49
172588982,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,DE,49
172588982,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Oedema peripheral,1,M,HO,49
172588982,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,OT,49
172588982,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,DE,49
172588982,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,HO,49
172588982,4,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Acute myocardial infarction,4,M,OT,49
172588982,4,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Acute myocardial infarction,4,M,DE,49
172588982,4,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Acute myocardial infarction,4,M,HO,49
172588982,4,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Adrenal insufficiency,4,M,OT,49
172588982,4,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Adrenal insufficiency,4,M,DE,49
172588982,4,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Adrenal insufficiency,4,M,HO,49
172588982,4,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Oedema peripheral,4,M,OT,49
172588982,4,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Oedema peripheral,4,M,DE,49
172588982,4,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Oedema peripheral,4,M,HO,49
172588982,4,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Prescribed overdose,4,M,OT,49
172588982,4,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Prescribed overdose,4,M,DE,49
172588982,4,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Prescribed overdose,4,M,HO,49
172589232,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,M,LT,49
172589232,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,M,OT,49
172589232,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,M,HO,49
172589232,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,M,LT,49
172589232,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,M,OT,49
172589232,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Hyperthyroidism,1,M,HO,49
172589451,3,Plasma cell myeloma,1,I,EXP,pomalidomide,3,SS,Acute kidney injury,3,M,HO,8
172589451,3,Plasma cell myeloma,1,I,EXP,pomalidomide,3,SS,Acute kidney injury,3,M,LT,8
172589451,3,Plasma cell myeloma,1,I,EXP,pomalidomide,3,SS,Acute kidney injury,3,M,OT,8
172589921,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Atrial fibrillation,1,F,HO,89
172589921,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Atrial fibrillation,1,F,LT,89
172589921,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Atrial fibrillation,1,F,OT,89
172589921,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Bundle branch block left,1,F,HO,89
172589921,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Bundle branch block left,1,F,LT,89
172589921,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Bundle branch block left,1,F,OT,89
172591583,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Abdominal pain,1,F,HO,52
172591583,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Hepatic enzyme increased,1,F,HO,52
172592022,3,Plasma cell myeloma,2,F,EXP,pomalidomide,3,SS,Supraventricular tachycardia,3,F,OT,43
172594043,1,HER-2 positive breast cancer,3,F,EXP,palbociclib,1,PS,Pneumonia,1,F,DE,299
172594043,1,HER-2 positive breast cancer,3,F,EXP,palbociclib,1,PS,Pneumonia,1,F,HO,299
172595262,25,Neutropenia,2,F,EXP,pegfilgrastim,25,C,Febrile neutropenia,25,M,HO,23
172598025,1,Plasma cell myeloma,5,F,PER,carfilzomib,1,PS,Bacteraemia,1,M,HO,15
172598252,2,Gastric cancer,2,F,EXP,ramucirumab,2,SS,Decubitus ulcer,2,M,OT,12
172598252,2,Gastric cancer,2,F,EXP,ramucirumab,2,SS,Diarrhoea,2,M,OT,12
172598252,2,Gastric cancer,2,F,EXP,ramucirumab,2,SS,Gastroenteritis norovirus,2,M,OT,12
172598252,2,Gastric cancer,2,F,EXP,ramucirumab,2,SS,Hypokalaemia,2,M,OT,12
172600892,2,Ovarian cancer,2,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,HO,181
172600892,4,Ovarian cancer,2,F,EXP,nivolumab,4,SS,Acute kidney injury,4,F,HO,181
172601331,2,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,2,SS,Immune-mediated hepatitis,2,M,HO,78
172601331,2,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,2,SS,Pancytopenia,2,M,HO,78
172601921,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Staphylococcal bacteraemia,1,M,HO,39
172601941,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,OT,4
172601941,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Back pain,1,F,OT,4
172601941,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Diarrhoea,1,F,OT,4
172601941,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Fatigue,1,F,OT,4
172601941,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Flatulence,1,F,OT,4
172601941,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,OT,4
172601941,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Papule,1,F,OT,4
172601941,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Peripheral swelling,1,F,OT,4
172601941,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Urticaria,1,F,OT,4
172601941,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Vaccination site pain,1,F,OT,4
172601941,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Vomiting,1,F,OT,4
172602141,1,Plasma cell myeloma,1,I,EXP,vorinostat,1,PS,Completed suicide,1,M,OT,13
172602141,1,Plasma cell myeloma,1,I,EXP,vorinostat,1,PS,Completed suicide,1,M,DE,13
172603712,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Acute myocardial infarction,1,M,DE,49
172603712,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Acute myocardial infarction,1,M,HO,49
172603712,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Acute myocardial infarction,1,M,OT,49
172603712,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Adrenal insufficiency,1,M,DE,49
172603712,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Adrenal insufficiency,1,M,HO,49
172603712,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Adrenal insufficiency,1,M,OT,49
172604521,36,Prophylaxis,1,I,EXP,granisetron,36,C,Gastrointestinal infection,36,M,OT,52
172604521,36,Prophylaxis,1,I,EXP,granisetron,36,C,Respiratory tract infection,36,M,OT,52
172604521,36,Prophylaxis,1,I,EXP,granisetron,36,C,Seasonal allergy,36,M,OT,52
172604521,36,Prophylaxis,1,I,EXP,granisetron,36,C,Tendonitis,36,M,OT,52
172604824,2,B-cell lymphoma,4,F,EXP,idelalisib,2,SS,Pyrexia,2,F,HO,38
172604824,2,B-cell lymphoma,4,F,EXP,idelalisib,2,SS,Respiratory failure,2,F,HO,38
172605012,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,57
172605012,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,57
172605012,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,57
172605012,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DE,57
172605661,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Acute kidney injury,1,M,HO,15
172605661,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Acute kidney injury,1,M,OT,15
172605661,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Condition aggravated,1,M,HO,15
172605661,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Condition aggravated,1,M,OT,15
172605661,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Dyspnoea,1,M,HO,15
172605661,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Dyspnoea,1,M,OT,15
172605661,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Lower respiratory tract infection,1,M,HO,15
172605661,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Lower respiratory tract infection,1,M,OT,15
172605661,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Peripheral swelling,1,M,HO,15
172605661,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Peripheral swelling,1,M,OT,15
172605661,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,White blood cell count increased,1,M,HO,15
172605661,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,White blood cell count increased,1,M,OT,15
172606211,1,Bladder transitional cell carcinoma,1,I,EXP,nivolumab,1,PS,Dehydration,1,M,HO,29
172606211,1,Bladder transitional cell carcinoma,1,I,EXP,nivolumab,1,PS,Dehydration,1,M,DE,29
172606211,1,Bladder transitional cell carcinoma,1,I,EXP,nivolumab,1,PS,Dehydration,1,M,OT,29
172606211,1,Bladder transitional cell carcinoma,1,I,EXP,nivolumab,1,PS,Hepatic failure,1,M,HO,29
172606211,1,Bladder transitional cell carcinoma,1,I,EXP,nivolumab,1,PS,Hepatic failure,1,M,DE,29
172606211,1,Bladder transitional cell carcinoma,1,I,EXP,nivolumab,1,PS,Hepatic failure,1,M,OT,29
172606211,1,Bladder transitional cell carcinoma,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,29
172606211,1,Bladder transitional cell carcinoma,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,29
172606211,1,Bladder transitional cell carcinoma,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,29
172606211,2,Bladder transitional cell carcinoma,1,I,EXP,ipilimumab,2,SS,Dehydration,2,M,HO,29
172606211,2,Bladder transitional cell carcinoma,1,I,EXP,ipilimumab,2,SS,Dehydration,2,M,DE,29
172606211,2,Bladder transitional cell carcinoma,1,I,EXP,ipilimumab,2,SS,Dehydration,2,M,OT,29
172606211,2,Bladder transitional cell carcinoma,1,I,EXP,ipilimumab,2,SS,Hepatic failure,2,M,HO,29
172606211,2,Bladder transitional cell carcinoma,1,I,EXP,ipilimumab,2,SS,Hepatic failure,2,M,DE,29
172606211,2,Bladder transitional cell carcinoma,1,I,EXP,ipilimumab,2,SS,Hepatic failure,2,M,OT,29
172606211,2,Bladder transitional cell carcinoma,1,I,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,HO,29
172606211,2,Bladder transitional cell carcinoma,1,I,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DE,29
172606211,2,Bladder transitional cell carcinoma,1,I,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,29
172607393,2,Renal cell carcinoma,3,F,EXP,avelumab,2,SS,Haematochezia,2,M,HO,864
172607393,2,Renal cell carcinoma,3,F,EXP,avelumab,2,SS,Haematochezia,2,M,DE,864
172607393,2,Renal cell carcinoma,3,F,EXP,avelumab,2,SS,Pulmonary embolism,2,M,HO,864
172607393,2,Renal cell carcinoma,3,F,EXP,avelumab,2,SS,Pulmonary embolism,2,M,DE,864
172607393,3,Renal cell carcinoma,3,F,EXP,axitinib,3,SS,Haematochezia,3,M,HO,493
172607393,3,Renal cell carcinoma,3,F,EXP,axitinib,3,SS,Haematochezia,3,M,DE,493
172607393,3,Renal cell carcinoma,3,F,EXP,axitinib,3,SS,Pulmonary embolism,3,M,HO,493
172607393,3,Renal cell carcinoma,3,F,EXP,axitinib,3,SS,Pulmonary embolism,3,M,DE,493
172608853,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Anaemia,3,F,HO,1
172608853,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Pain,3,F,HO,1
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Bronchitis,1,F,OT,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Bronchitis,1,F,HO,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diverticulitis,1,F,OT,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diverticulitis,1,F,HO,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Dry mouth,1,F,OT,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Dry mouth,1,F,HO,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Dysaesthesia,1,F,OT,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Dysaesthesia,1,F,HO,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Erythema,1,F,OT,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Erythema,1,F,HO,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Fatigue,1,F,HO,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Flatulence,1,F,OT,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Flatulence,1,F,HO,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Gastrooesophageal reflux disease,1,F,OT,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Gastrooesophageal reflux disease,1,F,HO,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hypotension,1,F,OT,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hypotension,1,F,HO,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Neuritis,1,F,OT,14
172609152,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Neuritis,1,F,HO,14
172609261,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Visual impairment,1,M,HO,95
172612381,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Herpes zoster cutaneous disseminated,1,F,OT,116
172612381,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Herpes zoster cutaneous disseminated,1,F,HO,116
172612431,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,HO,165
172612431,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,OT,165
172612501,1,Gastrointestinal adenocarcinoma,1,I,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,DE,13
172612501,1,Gastrointestinal adenocarcinoma,1,I,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,LT,13
172612501,1,Gastrointestinal adenocarcinoma,1,I,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,OT,13
172612501,2,Gastrointestinal adenocarcinoma,1,I,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,M,DE,13
172612501,2,Gastrointestinal adenocarcinoma,1,I,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,M,LT,13
172612501,2,Gastrointestinal adenocarcinoma,1,I,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,M,OT,13
172614134,1,Ovarian cancer,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,OT,15
172614134,1,Ovarian cancer,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,DS,15
172614134,1,Ovarian cancer,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,HO,15
172614134,1,Ovarian cancer,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,DE,15
172614134,1,Ovarian cancer,4,F,EXP,nivolumab,1,PS,Encephalitis,1,F,OT,15
172614134,1,Ovarian cancer,4,F,EXP,nivolumab,1,PS,Encephalitis,1,F,DS,15
172614134,1,Ovarian cancer,4,F,EXP,nivolumab,1,PS,Encephalitis,1,F,HO,15
172614134,1,Ovarian cancer,4,F,EXP,nivolumab,1,PS,Encephalitis,1,F,DE,15
172614134,1,Ovarian cancer,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,F,OT,15
172614134,1,Ovarian cancer,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,F,DS,15
172614134,1,Ovarian cancer,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,F,HO,15
172614134,1,Ovarian cancer,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,F,DE,15
172614134,2,Ovarian cancer,4,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,OT,90
172614134,2,Ovarian cancer,4,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,DS,90
172614134,2,Ovarian cancer,4,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,HO,90
172614134,2,Ovarian cancer,4,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,DE,90
172614134,2,Ovarian cancer,4,F,EXP,ipilimumab,2,SS,Encephalitis,2,F,OT,90
172614134,2,Ovarian cancer,4,F,EXP,ipilimumab,2,SS,Encephalitis,2,F,DS,90
172614134,2,Ovarian cancer,4,F,EXP,ipilimumab,2,SS,Encephalitis,2,F,HO,90
172614134,2,Ovarian cancer,4,F,EXP,ipilimumab,2,SS,Encephalitis,2,F,DE,90
172614134,2,Ovarian cancer,4,F,EXP,ipilimumab,2,SS,Hepatic failure,2,F,OT,90
172614134,2,Ovarian cancer,4,F,EXP,ipilimumab,2,SS,Hepatic failure,2,F,DS,90
172614134,2,Ovarian cancer,4,F,EXP,ipilimumab,2,SS,Hepatic failure,2,F,HO,90
172614134,2,Ovarian cancer,4,F,EXP,ipilimumab,2,SS,Hepatic failure,2,F,DE,90
172617751,1,Myelodysplastic syndrome,1,I,EXP,lenalidomide,1,PS,Anaemia postoperative,1,M,HO,26
172617902,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Asthenia,1,F,HO,102
172617902,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Asthenia,1,F,OT,102
172617902,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Dehydration,1,F,HO,102
172617902,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Dehydration,1,F,OT,102
172617902,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Failure to thrive,1,F,HO,102
172617902,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Failure to thrive,1,F,OT,102
172617902,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Haemoglobin decreased,1,F,HO,102
172617902,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Haemoglobin decreased,1,F,OT,102
172617902,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,102
172617902,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,102
172618001,1,Lung neoplasm malignant,1,I,EXP,crizotinib,1,PS,Neoplasm progression,1,F,OT,154
172618001,1,Lung neoplasm malignant,1,I,EXP,crizotinib,1,PS,Spinal compression fracture,1,F,OT,154
172618001,1,Lung neoplasm malignant,1,I,EXP,crizotinib,1,PS,Spinal cord infection,1,F,OT,154
172620322,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Respiratory tract infection,1,F,HO,369
172620322,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Respiratory tract infection,3,F,HO,369
172626882,13,Premedication,2,F,EXP,granisetron,13,C,Cardio-respiratory arrest,13,M,HO,53
172626882,13,Premedication,2,F,EXP,granisetron,13,C,Cardio-respiratory arrest,13,M,DE,53
172626882,13,Premedication,2,F,EXP,granisetron,13,C,Cardio-respiratory arrest,13,M,LT,53
172627791,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Leukopenia,1,M,OT,75
172628541,2,Renal cancer,1,I,EXP,ipilimumab,2,SS,Diverticulum intestinal,2,M,OT,83
172628541,2,Renal cancer,1,I,EXP,ipilimumab,2,SS,Diverticulum intestinal,2,M,HO,83
172628541,2,Renal cancer,1,I,EXP,ipilimumab,2,SS,Enteritis infectious,2,M,OT,83
172628541,2,Renal cancer,1,I,EXP,ipilimumab,2,SS,Enteritis infectious,2,M,HO,83
172628541,2,Renal cancer,1,I,EXP,ipilimumab,2,SS,Gastroenteritis,2,M,OT,83
172628541,2,Renal cancer,1,I,EXP,ipilimumab,2,SS,Gastroenteritis,2,M,HO,83
172628541,2,Renal cancer,1,I,EXP,ipilimumab,2,SS,Gastrointestinal melanosis,2,M,OT,83
172628541,2,Renal cancer,1,I,EXP,ipilimumab,2,SS,Gastrointestinal melanosis,2,M,HO,83
172628541,2,Renal cancer,1,I,EXP,ipilimumab,2,SS,Haemorrhoids,2,M,OT,83
172628541,2,Renal cancer,1,I,EXP,ipilimumab,2,SS,Haemorrhoids,2,M,HO,83
172628541,2,Renal cancer,1,I,EXP,ipilimumab,2,SS,Large intestine infection,2,M,OT,83
172628541,2,Renal cancer,1,I,EXP,ipilimumab,2,SS,Large intestine infection,2,M,HO,83
172628541,2,Renal cancer,1,I,EXP,ipilimumab,2,SS,Pyrexia,2,M,OT,83
172628541,2,Renal cancer,1,I,EXP,ipilimumab,2,SS,Pyrexia,2,M,HO,83
172628541,3,Renal cancer,1,I,EXP,nivolumab,3,SS,Diverticulum intestinal,3,M,OT,83
172628541,3,Renal cancer,1,I,EXP,nivolumab,3,SS,Diverticulum intestinal,3,M,HO,83
172628541,3,Renal cancer,1,I,EXP,nivolumab,3,SS,Enteritis infectious,3,M,OT,83
172628541,3,Renal cancer,1,I,EXP,nivolumab,3,SS,Enteritis infectious,3,M,HO,83
172628541,3,Renal cancer,1,I,EXP,nivolumab,3,SS,Gastroenteritis,3,M,OT,83
172628541,3,Renal cancer,1,I,EXP,nivolumab,3,SS,Gastroenteritis,3,M,HO,83
172628541,3,Renal cancer,1,I,EXP,nivolumab,3,SS,Gastrointestinal melanosis,3,M,OT,83
172628541,3,Renal cancer,1,I,EXP,nivolumab,3,SS,Gastrointestinal melanosis,3,M,HO,83
172628541,3,Renal cancer,1,I,EXP,nivolumab,3,SS,Haemorrhoids,3,M,OT,83
172628541,3,Renal cancer,1,I,EXP,nivolumab,3,SS,Haemorrhoids,3,M,HO,83
172628541,3,Renal cancer,1,I,EXP,nivolumab,3,SS,Large intestine infection,3,M,OT,83
172628541,3,Renal cancer,1,I,EXP,nivolumab,3,SS,Large intestine infection,3,M,HO,83
172628541,3,Renal cancer,1,I,EXP,nivolumab,3,SS,Pyrexia,3,M,OT,83
172628541,3,Renal cancer,1,I,EXP,nivolumab,3,SS,Pyrexia,3,M,HO,83
172628572,1,Hepatocellular carcinoma,2,F,EXP,avelumab,1,PS,Rash,1,M,HO,8
172631521,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Dizziness,1,M,DS,41
172631521,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Dizziness,1,M,HO,41
172631521,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Dizziness,1,M,OT,41
172631521,4,Plasma cell myeloma,1,I,EXP,daratumumab,4,SS,Dizziness,4,M,DS,41
172631521,4,Plasma cell myeloma,1,I,EXP,daratumumab,4,SS,Dizziness,4,M,HO,41
172631521,4,Plasma cell myeloma,1,I,EXP,daratumumab,4,SS,Dizziness,4,M,OT,41
172635311,1,Malignant urinary tract neoplasm,1,I,EXP,avelumab,1,PS,Neutropenia,1,M,OT,28
172636381,3,Lung neoplasm malignant,1,I,EXP,pemetrexed disodium,3,SS,Cholangitis,3,M,HO,31
172636803,4,Plasma cell myeloma,3,F,EXP,daratumumab,4,SS,Breast cancer,4,F,OT,818
172637342,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Febrile neutropenia,3,M,HO,18
172637342,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Influenza,3,M,HO,18
172639942,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Acute kidney injury,1,M,HO,2
172639942,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Acute kidney injury,1,M,OT,2
172639942,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Atrial fibrillation,1,M,HO,2
172639942,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Atrial fibrillation,1,M,OT,2
172639942,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,HO,2
172639942,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,M,OT,2
172639942,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,HO,2
172639942,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Hypotension,1,M,OT,2
172639942,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,HO,2
172639942,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,M,OT,2
172639942,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,HO,2
172639942,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,M,OT,2
172640631,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Confusional state,1,M,HO,17
172640631,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Confusional state,1,M,LT,17
172640631,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Hyponatraemia,1,M,HO,17
172640631,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Hyponatraemia,1,M,LT,17
172640631,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Syncope,1,M,HO,17
172640631,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Syncope,1,M,LT,17
172642582,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Encephalitis,1,M,OT,22
172642582,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Encephalitis,1,M,HO,22
172642582,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Encephalitis,1,M,DS,22
172642582,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,OT,22
172642582,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,HO,22
172642582,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,DS,22
172647501,1,Adenoid cystic carcinoma,1,I,EXP,nivolumab,1,PS,Device malfunction,1,M,HO,411
172647501,2,Adenoid cystic carcinoma,1,I,EXP,ipilimumab,2,SS,Device malfunction,2,M,HO,411
172648683,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,303
172648683,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,303
172648683,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,OT,303
172648683,2,Non-small cell lung cancer,3,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,HO,303
172648862,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Hypotension,2,F,HO,12
172648862,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Vomiting,2,F,HO,12
172648862,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Hypotension,3,F,HO,12
172648862,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Vomiting,3,F,HO,12
172649082,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Neutropenia,1,F,HO,119
172649082,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Neutropenia,1,F,OT,119
172649092,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Pyrexia,2,M,HO,15
172649092,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,PS,Pyrexia,3,M,HO,15
172650364,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,43
172650364,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,43
172650364,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,OT,43
172650364,1,Malignant melanoma,4,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,HO,43
172650552,6,Anaemia,2,F,EXP,epoetin alfa,6,C,Hypercalcaemia,6,F,HO,579
172651382,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Enterovirus infection,3,M,HO,463
172651382,5,Plasma cell myeloma,2,F,EXP,lenalidomide,5,SS,Enterovirus infection,5,M,HO,463
172651382,7,Plasma cell myeloma,2,F,EXP,filgrastim,7,SS,Enterovirus infection,7,M,HO,338
172654361,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Hepatocellular injury,1,F,HO,15
172654361,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Hepatocellular injury,1,F,OT,15
172654361,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Pancytopenia,1,F,HO,15
172654361,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Pancytopenia,1,F,OT,15
172662132,1,Metastatic neoplasm,2,F,EXP,entrectinib,1,PS,Pneumonia,1,M,HO,700
172662132,1,Metastatic neoplasm,2,F,EXP,entrectinib,1,PS,Sepsis,1,M,HO,700
172664021,3,Malignant melanoma,1,I,EXP,trametinib,3,SS,Ejection fraction decreased,3,F,OT,111
172664021,3,Malignant melanoma,1,I,EXP,trametinib,3,SS,Ejection fraction decreased,3,F,HO,111
172664021,3,Malignant melanoma,1,I,EXP,trametinib,3,SS,Spinal fracture,3,F,OT,111
172664021,3,Malignant melanoma,1,I,EXP,trametinib,3,SS,Spinal fracture,3,F,HO,111
172664351,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Loose tooth,1,F,OT,78
172664351,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Tooth dislocation,1,F,OT,78
172665492,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Back pain,1,M,OT,25
172665492,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Back pain,1,M,HO,25
172665492,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,25
172665492,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Fatigue,1,M,HO,25
172665492,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Inability to afford medication,1,M,OT,25
172665492,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Inability to afford medication,1,M,HO,25
172665492,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Large intestinal obstruction,1,M,OT,25
172665492,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Large intestinal obstruction,1,M,HO,25
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Anaemia,7,M,OT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Anaemia,7,M,HO,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Anaemia,7,M,LT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Fatigue,7,M,OT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Fatigue,7,M,HO,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Fatigue,7,M,LT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Febrile neutropenia,7,M,OT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Febrile neutropenia,7,M,HO,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Febrile neutropenia,7,M,LT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Haematuria,7,M,OT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Haematuria,7,M,HO,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Haematuria,7,M,LT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Hypoxia,7,M,OT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Hypoxia,7,M,HO,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Hypoxia,7,M,LT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Platelet count decreased,7,M,OT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Platelet count decreased,7,M,HO,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Platelet count decreased,7,M,LT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Pneumonia,7,M,OT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Pneumonia,7,M,HO,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Pneumonia,7,M,LT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Respiratory failure,7,M,OT,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Respiratory failure,7,M,HO,203
172667981,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Respiratory failure,7,M,LT,203
172668733,1,Plasma cell myeloma,3,F,EXP,selinexor,1,PS,Pneumonia,1,M,HO,28
172671731,1,Glioblastoma,1,I,EXP,palbociclib,1,PS,Tumour pseudoprogression,1,F,HO,48
172675802,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Neutropenia,2,F,LT,245
172675802,3,Plasma cell myeloma,2,F,EXP,thalidomide,3,SS,Neutropenia,3,F,LT,245
172677743,2,Plasma cell myeloma,3,F,EXP,daratumumab,2,SS,Influenza,2,M,LT,19
172677743,2,Plasma cell myeloma,3,F,EXP,daratumumab,2,SS,Influenza,2,M,HO,19
172677743,2,Plasma cell myeloma,3,F,EXP,daratumumab,2,SS,Neutropenia,2,M,LT,19
172677743,2,Plasma cell myeloma,3,F,EXP,daratumumab,2,SS,Neutropenia,2,M,HO,19
172680161,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Radiation pneumonitis,1,M,HO,269
172691911,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Abdominal pain upper,2,M,HO,32
172691911,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Cough,2,M,HO,32
172691911,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Diarrhoea,2,M,HO,32
172691911,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Dyspnoea,2,M,HO,32
172691911,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Hypophagia,2,M,HO,32
172691911,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Influenza virus test positive,2,M,HO,32
172691911,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Pneumonia,2,M,HO,32
172691911,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Pyrexia,2,M,HO,32
172692101,16,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,16,SS,Lichenoid keratosis,16,M,HO,210
172692101,16,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,16,SS,Lichenoid keratosis,16,M,OT,210
172692101,17,Bronchial carcinoma,1,I,EXP,pemetrexed disodium,17,SS,Lichenoid keratosis,17,M,HO,189
172692101,17,Bronchial carcinoma,1,I,EXP,pemetrexed disodium,17,SS,Lichenoid keratosis,17,M,OT,189
172694344,7,Neutropenia,4,F,EXP,filgrastim,7,C,Neutropenia,7,M,HO,156
172694344,7,Neutropenia,4,F,EXP,filgrastim,7,C,Small intestinal obstruction,7,M,HO,156
172695692,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,30
172695692,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,30
172695692,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Mental status changes,1,M,OT,30
172695692,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Mental status changes,1,M,HO,30
172696101,1,B-cell lymphoma,1,I,EXP,alemtuzumab,1,PS,Haematotoxicity,1,M,OT,2
172698571,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Corona virus infection,1,F,HO,26
172698571,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Upper respiratory tract infection bacterial,1,F,HO,26
172700042,1,Hodgkin's disease,2,F,EXP,brentuximab vedotin,1,PS,Diabetic ketoacidosis,1,M,HO,165
172700042,5,Hodgkin's disease,2,F,EXP,nivolumab,5,SS,Diabetic ketoacidosis,5,M,HO,49
172701683,2,Bladder transitional cell carcinoma,3,F,EXP,avelumab,2,SS,Anal abscess,2,M,HO,28
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Neutropenia,2,F,OT,85
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Neutropenia,2,F,LT,85
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Neutropenia,2,F,HO,85
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pneumonia,2,F,OT,85
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pneumonia,2,F,LT,85
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pneumonia,2,F,HO,85
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Polyneuropathy,2,F,OT,85
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Polyneuropathy,2,F,LT,85
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Polyneuropathy,2,F,HO,85
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Septic shock,2,F,OT,85
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Septic shock,2,F,LT,85
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Septic shock,2,F,HO,85
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Thrombocytopenia,2,F,OT,85
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Thrombocytopenia,2,F,LT,85
172704882,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Thrombocytopenia,2,F,HO,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Neutropenia,5,F,OT,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Neutropenia,5,F,LT,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Neutropenia,5,F,HO,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Pneumonia,5,F,OT,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Pneumonia,5,F,LT,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Pneumonia,5,F,HO,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Polyneuropathy,5,F,OT,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Polyneuropathy,5,F,LT,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Polyneuropathy,5,F,HO,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Septic shock,5,F,OT,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Septic shock,5,F,LT,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Septic shock,5,F,HO,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Thrombocytopenia,5,F,OT,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Thrombocytopenia,5,F,LT,85
172704882,5,Plasma cell myeloma,2,F,EXP,daratumumab,5,SS,Thrombocytopenia,5,F,HO,85
172704942,1,Oesophageal squamous cell carcinoma,2,F,EXP,nivolumab,1,SS,Pneumonitis,1,F,HO,38
172704942,2,Oesophageal squamous cell carcinoma,2,F,EXP,ipilimumab,2,PS,Pneumonitis,2,F,HO,38
172705423,1,Colorectal cancer metastatic,3,F,EXP,ramucirumab,1,PS,Oesophageal varices haemorrhage,1,F,HO,45
172705524,1,B-cell lymphoma,4,F,EXP,idelalisib,1,PS,Pyrexia,1,F,OT,38
172705524,1,B-cell lymphoma,4,F,EXP,idelalisib,1,PS,Pyrexia,1,F,HO,38
172705524,1,B-cell lymphoma,4,F,EXP,idelalisib,1,PS,Respiratory failure,1,F,OT,38
172705524,1,B-cell lymphoma,4,F,EXP,idelalisib,1,PS,Respiratory failure,1,F,HO,38
172705702,11,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,11,SS,Acute kidney injury,11,M,HO,32
172705702,11,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,11,SS,Acute kidney injury,11,M,OT,32
172705702,11,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,11,SS,Febrile neutropenia,11,M,HO,32
172705702,11,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,11,SS,Febrile neutropenia,11,M,OT,32
172705702,11,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,11,SS,Pancreatitis,11,M,HO,32
172705702,11,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,11,SS,Pancreatitis,11,M,OT,32
172707521,14,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,14,SS,Anaemia,14,M,HO,13
172707521,14,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,14,SS,Neutropenia,14,M,HO,13
172707521,14,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,14,SS,Pancytopenia,14,M,HO,13
172707521,14,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,14,SS,Pertussis,14,M,HO,13
172707521,14,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,14,SS,Platelet count decreased,14,M,HO,13
172707521,14,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,14,SS,Pyrexia,14,M,HO,13
172707521,14,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,14,SS,Streptococcal infection,14,M,HO,13
172707521,44,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,44,SS,Anaemia,44,M,HO,166
172707521,44,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,44,SS,Neutropenia,44,M,HO,166
172707521,44,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,44,SS,Pancytopenia,44,M,HO,166
172707521,44,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,44,SS,Pertussis,44,M,HO,166
172707521,44,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,44,SS,Platelet count decreased,44,M,HO,166
172707521,44,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,44,SS,Pyrexia,44,M,HO,166
172707521,44,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,44,SS,Streptococcal infection,44,M,HO,166
172709232,5,Anaemia,2,F,EXP,epoetin alfa,5,C,Hypercalcaemia,5,F,HO,579
172715072,3,Colorectal cancer metastatic,2,F,EXP,avelumab,3,SS,Cystitis,3,F,HO,52
172715072,3,Colorectal cancer metastatic,2,F,EXP,avelumab,3,SS,General physical health deterioration,3,F,HO,52
172715072,3,Colorectal cancer metastatic,2,F,EXP,avelumab,3,SS,Malignant neoplasm progression,3,F,HO,52
172715072,3,Colorectal cancer metastatic,2,F,EXP,avelumab,3,SS,Pyrexia,3,F,HO,52
172715251,1,Neoplasm,1,I,EXP,entrectinib,1,PS,Hypervolaemia,1,F,HO,175
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Abdominal pain,1,F,HO,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Abdominal pain,1,F,OT,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Alanine aminotransferase increased,1,F,HO,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Alanine aminotransferase increased,1,F,OT,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Aspartate aminotransferase increased,1,F,HO,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Aspartate aminotransferase increased,1,F,OT,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Blood alkaline phosphatase increased,1,F,HO,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Blood alkaline phosphatase increased,1,F,OT,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Blood bilirubin increased,1,F,HO,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Blood bilirubin increased,1,F,OT,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Cholecystitis,1,F,HO,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Cholecystitis,1,F,OT,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Cholestasis,1,F,HO,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Cholestasis,1,F,OT,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Drug-induced liver injury,1,F,HO,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Drug-induced liver injury,1,F,OT,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Gamma-glutamyltransferase increased,1,F,HO,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Gamma-glutamyltransferase increased,1,F,OT,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Hepatocellular injury,1,F,HO,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Hepatocellular injury,1,F,OT,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Skin exfoliation,1,F,HO,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Skin exfoliation,1,F,OT,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Thrombocytopenia,1,F,HO,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Thrombocytopenia,1,F,OT,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Vomiting,1,F,HO,38
172719871,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Vomiting,1,F,OT,38
172721776,1,Myelodysplastic syndrome,6,F,EXP,lenalidomide,1,PS,Oesophageal adenocarcinoma,1,M,OT,1639
172723102,35,Prophylaxis,2,F,EXP,rasburicase,35,C,Subcutaneous abscess,35,F,HO,221
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Bone marrow failure,7,M,DS,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Bone marrow failure,7,M,DE,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Bone marrow failure,7,M,OT,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Febrile neutropenia,7,M,DS,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Febrile neutropenia,7,M,DE,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Febrile neutropenia,7,M,OT,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Pharyngeal inflammation,7,M,DS,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Pharyngeal inflammation,7,M,DE,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Pharyngeal inflammation,7,M,OT,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Pneumonia aspiration,7,M,DS,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Pneumonia aspiration,7,M,DE,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Pneumonia aspiration,7,M,OT,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Renal impairment,7,M,DS,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Renal impairment,7,M,DE,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Renal impairment,7,M,OT,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Toxic encephalopathy,7,M,DS,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Toxic encephalopathy,7,M,DE,1
172723534,7,Prophylaxis,4,F,EXP,pegfilgrastim,7,C,Toxic encephalopathy,7,M,OT,1
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,566
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Balance disorder,1,M,OT,566
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Cough,1,M,OT,566
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,566
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Feeding disorder,1,M,OT,566
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Feeling abnormal,1,M,OT,566
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Feeling jittery,1,M,OT,566
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Gait disturbance,1,M,OT,566
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Headache,1,M,OT,566
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Hot flush,1,M,OT,566
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Insomnia,1,M,OT,566
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Mobility decreased,1,M,OT,566
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Nausea,1,M,OT,566
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Peripheral swelling,1,M,OT,566
172724102,1,Product used for unknown indication,2,F,EXP,enzalutamide,1,PS,Product colour issue,1,M,OT,566
172725592,16,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,16,SS,Anorectal cellulitis,16,M,HO,164
172725592,16,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,16,SS,Anorectal cellulitis,16,M,LT,164
172725592,16,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,16,SS,Febrile neutropenia,16,M,HO,164
172725592,16,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,16,SS,Febrile neutropenia,16,M,LT,164
172725592,16,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,16,SS,Neutrophil count decreased,16,M,HO,164
172725592,16,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,16,SS,Neutrophil count decreased,16,M,LT,164
172725592,16,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,16,SS,Platelet count decreased,16,M,HO,164
172725592,16,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,16,SS,Platelet count decreased,16,M,LT,164
172736191,1,Thyroid cancer,1,I,DIR,nivolumab,1,PS,Drug hypersensitivity,1,M,HO,419
172736191,2,Thyroid cancer,1,I,DIR,ipilimumab,2,C,Drug hypersensitivity,2,M,HO,433
172739962,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,PS,Pneumonia,1,M,HO,143
172740002,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Pulmonary embolism,1,M,OT,14
172740002,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Pulmonary embolism,1,M,HO,14
172740002,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Respiratory syncytial virus test positive,1,M,OT,14
172740002,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Respiratory syncytial virus test positive,1,M,HO,14
172740002,2,Plasma cell myeloma,2,F,PER,daratumumab,2,SS,Pulmonary embolism,2,M,OT,27
172740002,2,Plasma cell myeloma,2,F,PER,daratumumab,2,SS,Pulmonary embolism,2,M,HO,27
172740002,2,Plasma cell myeloma,2,F,PER,daratumumab,2,SS,Respiratory syncytial virus test positive,2,M,OT,27
172740002,2,Plasma cell myeloma,2,F,PER,daratumumab,2,SS,Respiratory syncytial virus test positive,2,M,HO,27
172740991,3,Mantle cell lymphoma,1,I,EXP,ibrutinib,3,SS,Gastrointestinal haemorrhage,3,M,HO,336
172742573,4,Plasma cell myeloma,3,F,EXP,lenalidomide,4,C,Lower respiratory tract infection,4,M,HO,37
172742573,4,Plasma cell myeloma,3,F,EXP,lenalidomide,4,C,Pyrexia,4,M,HO,37
172745133,2,Plasma cell myeloma,3,F,EXP,lenalidomide,2,SS,Cellulitis,2,F,HO,17
172747302,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Cardiac failure,1,M,OT,70
172747302,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Cardiac failure,1,M,HO,70
172747302,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Cardiac failure,1,M,DE,70
172747302,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,70
172747302,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,70
172747302,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,70
172747302,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Loss of consciousness,1,M,OT,70
172747302,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Loss of consciousness,1,M,HO,70
172747302,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Loss of consciousness,1,M,DE,70
172747302,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,70
172747302,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,70
172747302,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,70
172747882,1,Osteogenesis imperfecta,2,F,PER,denosumab,1,PS,Femur fracture,1,F,HO,248
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Emotional distress,1,M,OT,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Emotional distress,1,M,HO,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Emotional distress,1,M,LT,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hepatitis,1,M,OT,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hepatitis,1,M,HO,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hepatitis,1,M,LT,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Myocarditis,1,M,OT,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Myocarditis,1,M,HO,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Myocarditis,1,M,LT,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Myositis,1,M,OT,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Myositis,1,M,HO,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Myositis,1,M,LT,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,HO,27
172749272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,LT,27
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Emotional distress,2,M,OT,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Emotional distress,2,M,HO,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Emotional distress,2,M,LT,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Hepatitis,2,M,OT,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Hepatitis,2,M,HO,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Hepatitis,2,M,LT,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,OT,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,HO,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,M,LT,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Myocarditis,2,M,OT,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Myocarditis,2,M,HO,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Myocarditis,2,M,LT,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Myositis,2,M,OT,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Myositis,2,M,HO,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Myositis,2,M,LT,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Respiratory failure,2,M,OT,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Respiratory failure,2,M,HO,20
172749272,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Respiratory failure,2,M,LT,20
172750102,1,Metastases to bone,2,F,PER,denosumab,1,PS,Osteonecrosis of jaw,1,M,HO,1160
172750102,1,Metastases to bone,2,F,PER,denosumab,1,PS,Osteonecrosis of jaw,1,M,OT,1160
172750102,1,Metastases to bone,2,F,PER,denosumab,1,PS,Osteonecrosis of jaw,1,M,DE,1160
172750102,1,Metastases to bone,2,F,PER,denosumab,1,PS,Prostate cancer,1,M,HO,1160
172750102,1,Metastases to bone,2,F,PER,denosumab,1,PS,Prostate cancer,1,M,OT,1160
172750102,1,Metastases to bone,2,F,PER,denosumab,1,PS,Prostate cancer,1,M,DE,1160
172751582,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Abdominal pain lower,1,F,OT,24
172751582,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Blood count abnormal,1,F,OT,24
172751582,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Cervical cyst,1,F,OT,24
172751582,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Febrile neutropenia,1,F,OT,24
172751582,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Inappropriate schedule of product administration,1,F,OT,24
172751582,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Intra-abdominal fluid collection,1,F,OT,24
172751582,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Neutropenia,1,F,OT,24
172751582,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Neutrophil count abnormal,1,F,OT,24
172751582,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Ovarian cyst,1,F,OT,24
172751582,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Ovarian cyst ruptured,1,F,OT,24
172751582,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Pain,1,F,OT,24
172751582,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,White blood cell count abnormal,1,F,OT,24
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,LT,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,OT,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,HO,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Nasopharyngitis,1,M,LT,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Nasopharyngitis,1,M,OT,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Nasopharyngitis,1,M,HO,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Pyrexia,1,M,LT,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Sepsis,1,M,LT,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Sepsis,1,M,OT,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Sepsis,1,M,HO,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Thrombosis,1,M,LT,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Thrombosis,1,M,OT,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Thrombosis,1,M,HO,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Urinary tract infection,1,M,LT,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Urinary tract infection,1,M,OT,139
172752781,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Urinary tract infection,1,M,HO,139
172756571,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Liver disorder,1,F,HO,429
172757951,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Nausea,2,F,OT,119
172757951,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Thrombocytopenia,2,F,OT,119
172757951,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Vomiting,2,F,OT,119
172757951,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Weight decreased,2,F,OT,119
172760171,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,OT,1
172760171,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,DS,1
172760171,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Dupuytren's contracture,1,F,OT,1
172760171,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Dupuytren's contracture,1,F,DS,1
172760171,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Muscle fatigue,1,F,OT,1
172760171,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Muscle fatigue,1,F,DS,1
172760171,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,OT,1
172760171,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,DS,1
172760171,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Tendonitis,1,F,OT,1
172760171,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Tendonitis,1,F,DS,1
172764797,1,Non-small cell lung cancer recurrent,7,F,EXP,nivolumab,1,PS,Optic neuritis,1,M,OT,130
172764797,1,Non-small cell lung cancer recurrent,7,F,EXP,nivolumab,1,PS,Optic neuritis,1,M,HO,130
172766261,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Syncope,2,F,HO,14
172766761,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Cerebral infarction,1,F,HO,1
172766761,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Cerebral infarction,1,F,DE,1
172766761,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Generalised tonic-clonic seizure,1,F,HO,1
172766761,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Generalised tonic-clonic seizure,1,F,DE,1
172766761,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hemiparesis,1,F,HO,1
172766761,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hemiparesis,1,F,DE,1
172767214,11,Plasma cell myeloma,4,F,EXP,daratumumab,11,SS,Neutropenia,11,M,LT,49
172769531,1,Plasma cell myeloma,1,I,DIR,daratumumab,1,PS,Corona virus infection,1,F,HO,45
172769531,1,Plasma cell myeloma,1,I,DIR,daratumumab,1,PS,Dyspnoea,1,F,HO,45
172769531,1,Plasma cell myeloma,1,I,DIR,daratumumab,1,PS,Hypoxia,1,F,HO,45
172769531,1,Plasma cell myeloma,1,I,DIR,daratumumab,1,PS,Respiratory syncytial virus infection,1,F,HO,45
172769531,1,Plasma cell myeloma,1,I,DIR,daratumumab,1,PS,Tachycardia,1,F,HO,45
172769781,1,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,1,PS,Bradycardia,1,M,OT,105
172769781,1,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,1,PS,Hot flush,1,M,OT,105
172769781,1,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,1,PS,Hyperhidrosis,1,M,OT,105
172769781,1,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,1,PS,Pallor,1,M,OT,105
172769781,1,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,1,PS,Presyncope,1,M,OT,105
172772411,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,63
172772411,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,63
172774001,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Sciatica,1,M,HO,273
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Abdominal pain,17,M,LT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Abdominal pain,17,M,OT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Abdominal pain,17,M,HO,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Anaemia,17,M,LT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Anaemia,17,M,OT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Anaemia,17,M,HO,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Constipation,17,M,LT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Constipation,17,M,OT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Constipation,17,M,HO,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Decreased appetite,17,M,LT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Decreased appetite,17,M,OT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Decreased appetite,17,M,HO,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Dehydration,17,M,LT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Dehydration,17,M,OT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Dehydration,17,M,HO,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Hypoglycaemia,17,M,LT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Hypoglycaemia,17,M,OT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Hypoglycaemia,17,M,HO,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Lethargy,17,M,LT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Lethargy,17,M,OT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Lethargy,17,M,HO,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Mucosal inflammation,17,M,LT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Mucosal inflammation,17,M,OT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Mucosal inflammation,17,M,HO,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Vomiting,17,M,LT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Vomiting,17,M,OT,21
172775762,17,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,17,SS,Vomiting,17,M,HO,21
172776681,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Back pain,1,M,LT,28
172776681,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Diarrhoea,1,M,LT,28
172776681,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Headache,1,M,LT,28
172776681,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Hypersensitivity,1,M,LT,28
172776681,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Palpitations,1,M,LT,28
172778213,1,Breast cancer,3,F,EXP,palbociclib,1,PS,Death,1,F,DE,536
172778272,1,B-cell lymphoma,2,F,EXP,ibrutinib,1,PS,Pericardial effusion,1,F,HO,62
172778272,1,B-cell lymphoma,2,F,EXP,ibrutinib,1,PS,Pleural effusion,1,F,HO,62
172784721,1,Oesophageal adenocarcinoma,1,I,EXP,ramucirumab,1,PS,Meningism,1,M,HO,87
172785511,3,Malignant melanoma,1,I,EXP,nivolumab,3,PS,Chills,3,M,HO,14
172787343,1,Lung neoplasm malignant,3,F,EXP,lorlatinib,1,PS,Pulmonary arterial hypertension,1,M,OT,623
172789622,5,Colony stimulating factor therapy,2,F,EXP,filgrastim,5,C,Neutrophil count decreased,5,M,OT,3
172790081,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Lower respiratory tract infection viral,1,F,HO,13
172790081,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Lower respiratory tract infection viral,1,F,OT,13
172790081,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Pain,1,F,HO,13
172790081,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Pain,1,F,OT,13
172790322,12,Product used for unknown indication,2,F,EXP,denosumab,12,C,Cellulitis,12,F,HO,845
172790683,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Sinusitis,1,M,HO,13
172790683,3,Plasma cell myeloma,3,F,PER,lenalidomide,3,SS,Sinusitis,3,M,HO,13
172790721,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Bundle branch block right,4,M,HO,1002
172790721,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Dizziness,4,M,HO,1002
172790721,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Feeling hot,4,M,HO,1002
172790721,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Hyperhidrosis,4,M,HO,1002
172790721,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Presyncope,4,M,HO,1002
172790721,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Troponin increased,4,M,HO,1002
172791344,1,Lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Brain oedema,1,F,HO,6
172791344,1,Lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Brain oedema,1,F,OT,6
172791344,1,Lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,HO,6
172791344,1,Lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,OT,6
172791344,1,Lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Lymphoma,1,F,HO,6
172791344,1,Lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Lymphoma,1,F,OT,6
172791344,1,Lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,F,HO,6
172791344,1,Lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,F,OT,6
172791661,10,Plasma cell myeloma,1,I,PER,daratumumab,10,SS,Pneumonia,10,M,HO,137
172791661,10,Plasma cell myeloma,1,I,PER,daratumumab,10,SS,Pyrexia,10,M,HO,137
172791714,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Chronic kidney disease,1,M,OT,283
172791714,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,283
172791714,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Chronic kidney disease,2,M,OT,283
172791714,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,283
172791951,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,43
172791951,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,43
172792281,4,Adenocarcinoma of colon,1,I,EXP,ramucirumab,4,C,Fatigue,4,F,HO,37
172792281,4,Adenocarcinoma of colon,1,I,EXP,ramucirumab,4,C,General physical health deterioration,4,F,HO,37
172792911,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Pneumonia,2,M,HO,363
172794192,7,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,7,SS,Febrile neutropenia,7,M,HO,19
172794192,7,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,7,SS,Upper gastrointestinal haemorrhage,7,M,HO,19
172794431,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,140
172794431,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,140
172795711,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Infection,1,M,HO,2422
172795711,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Pneumonia,1,M,HO,2422
172796171,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Pneumonia,1,M,HO,2263
172799842,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Hyperkalaemia,1,M,HO,76
172799842,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Hyperkalaemia,1,M,OT,76
172799842,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Renal failure,1,M,HO,76
172799842,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Renal failure,1,M,OT,76
172799842,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Hyperkalaemia,2,M,HO,76
172799842,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Hyperkalaemia,2,M,OT,76
172799842,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Renal failure,2,M,HO,76
172799842,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Renal failure,2,M,OT,76
172802322,4,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,4,SS,Acute kidney injury,4,M,OT,37
172802322,4,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,4,SS,Acute kidney injury,4,M,HO,37
172802322,4,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,4,SS,Pancreatitis,4,M,OT,37
172802322,4,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,4,SS,Pancreatitis,4,M,HO,37
172802391,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Cardiac failure,1,M,HO,202
172802391,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Cardiac failure,1,M,OT,202
172802391,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Facial bones fracture,1,M,HO,202
172802391,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Facial bones fracture,1,M,OT,202
172802391,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Fall,1,M,HO,202
172802391,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Fall,1,M,OT,202
172802391,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Hepatocellular injury,1,M,HO,202
172802391,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Hepatocellular injury,1,M,OT,202
172802391,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Lactic acidosis,1,M,HO,202
172802391,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Lactic acidosis,1,M,OT,202
172802391,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Thrombotic microangiopathy,1,M,HO,202
172802391,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Thrombotic microangiopathy,1,M,OT,202
172802512,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,OT,20
172802512,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,DE,20
172802512,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Encephalopathy,1,M,HO,20
172802512,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,OT,20
172802512,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,DE,20
172802512,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Pulmonary oedema,1,M,HO,20
172802512,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Syncope,1,M,OT,20
172802512,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Syncope,1,M,DE,20
172802512,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Syncope,1,M,HO,20
172802512,2,Bladder cancer,2,F,EXP,ipilimumab,2,SS,Encephalopathy,2,M,OT,20
172802512,2,Bladder cancer,2,F,EXP,ipilimumab,2,SS,Encephalopathy,2,M,DE,20
172802512,2,Bladder cancer,2,F,EXP,ipilimumab,2,SS,Encephalopathy,2,M,HO,20
172802512,2,Bladder cancer,2,F,EXP,ipilimumab,2,SS,Pulmonary oedema,2,M,OT,20
172802512,2,Bladder cancer,2,F,EXP,ipilimumab,2,SS,Pulmonary oedema,2,M,DE,20
172802512,2,Bladder cancer,2,F,EXP,ipilimumab,2,SS,Pulmonary oedema,2,M,HO,20
172802512,2,Bladder cancer,2,F,EXP,ipilimumab,2,SS,Syncope,2,M,OT,20
172802512,2,Bladder cancer,2,F,EXP,ipilimumab,2,SS,Syncope,2,M,DE,20
172802512,2,Bladder cancer,2,F,EXP,ipilimumab,2,SS,Syncope,2,M,HO,20
172802551,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Death,1,F,OT,16
172802551,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Death,1,F,DE,16
172807322,2,Chronic graft versus host disease,2,F,EXP,ibrutinib,2,C,Hypoxia,2,M,OT,174
172807322,2,Chronic graft versus host disease,2,F,EXP,ibrutinib,2,C,Hypoxia,2,M,HO,174
172807322,2,Chronic graft versus host disease,2,F,EXP,ibrutinib,2,C,Lung opacity,2,M,OT,174
172807322,2,Chronic graft versus host disease,2,F,EXP,ibrutinib,2,C,Lung opacity,2,M,HO,174
172807322,2,Chronic graft versus host disease,2,F,EXP,ibrutinib,2,C,Pneumonia,2,M,OT,174
172807322,2,Chronic graft versus host disease,2,F,EXP,ibrutinib,2,C,Pneumonia,2,M,HO,174
172807322,2,Chronic graft versus host disease,2,F,EXP,ibrutinib,2,C,Pyrexia,2,M,OT,174
172807322,2,Chronic graft versus host disease,2,F,EXP,ibrutinib,2,C,Pyrexia,2,M,HO,174
172808401,5,Non-Hodgkin's lymphoma,1,I,EXP,etoposide phosphate,5,C,Drug resistance,5,M,OT,141
172808401,5,Non-Hodgkin's lymphoma,1,I,EXP,etoposide phosphate,5,C,Therapy non-responder,5,M,OT,141
172810422,1,Neoplasm malignant,2,F,EXP,enzalutamide,1,PS,Dysphagia,1,M,OT,39
172810422,1,Neoplasm malignant,2,F,EXP,enzalutamide,1,PS,Dysphagia,1,M,HO,39
172810422,2,Prostate cancer,2,F,EXP,enzalutamide,2,SS,Dysphagia,2,M,OT,36
172810422,2,Prostate cancer,2,F,EXP,enzalutamide,2,SS,Dysphagia,2,M,HO,36
172811142,1,Colorectal cancer,2,F,PER,panitumumab,1,PS,Urinary tract infection,1,F,HO,158
172812032,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Chest pain,1,F,HO,372
172812032,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,372
172812032,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Intentional product use issue,1,F,HO,372
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Activated partial thromboplastin time prolonged,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Atrial natriuretic peptide increased,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Blood creatinine increased,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Bundle branch block right,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,C-reactive protein increased,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Constipation,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Discomfort,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Escherichia infection,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Fibrin D dimer increased,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Glomerular filtration rate decreased,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Haematuria,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Hypertension,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,International normalised ratio decreased,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Malaise,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Oedema peripheral,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Presyncope,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Pulmonary embolism,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Troponin increased,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Urinary tract infection,2,F,HO,539
172812752,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,pH body fluid decreased,2,F,HO,539
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Abdominal discomfort,1,F,HO,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Abdominal discomfort,1,F,OT,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Adrenal insufficiency,1,F,HO,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Adrenal insufficiency,1,F,OT,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Blood potassium increased,1,F,HO,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Blood potassium increased,1,F,OT,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Decreased appetite,1,F,HO,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Decreased appetite,1,F,OT,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Fatigue,1,F,HO,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Fatigue,1,F,OT,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Goitre,1,F,HO,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Goitre,1,F,OT,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Headache,1,F,HO,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Headache,1,F,OT,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Hepatic function abnormal,1,F,HO,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Hepatic function abnormal,1,F,OT,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Hyponatraemia,1,F,HO,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Hyponatraemia,1,F,OT,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Nausea,1,F,HO,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Nausea,1,F,OT,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Pruritus,1,F,HO,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Pruritus,1,F,OT,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Secondary hypothyroidism,1,F,HO,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Secondary hypothyroidism,1,F,OT,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Vomiting,1,F,HO,9
172816822,1,Product used for unknown indication,2,F,EXP,ipilimumab,1,SS,Vomiting,1,F,OT,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Abdominal discomfort,3,F,HO,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Abdominal discomfort,3,F,OT,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Adrenal insufficiency,3,F,HO,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Adrenal insufficiency,3,F,OT,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Blood potassium increased,3,F,HO,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Blood potassium increased,3,F,OT,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Decreased appetite,3,F,HO,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Decreased appetite,3,F,OT,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Fatigue,3,F,HO,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Fatigue,3,F,OT,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Goitre,3,F,HO,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Goitre,3,F,OT,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Headache,3,F,HO,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Headache,3,F,OT,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Hepatic function abnormal,3,F,HO,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Hepatic function abnormal,3,F,OT,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Hyponatraemia,3,F,HO,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Hyponatraemia,3,F,OT,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Nausea,3,F,HO,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Nausea,3,F,OT,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Pruritus,3,F,HO,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Pruritus,3,F,OT,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Secondary hypothyroidism,3,F,HO,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Secondary hypothyroidism,3,F,OT,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Vomiting,3,F,HO,9
172816822,3,Product used for unknown indication,2,F,EXP,nivolumab,3,PS,Vomiting,3,F,OT,9
172818741,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Dermatitis contact,1,M,HO,48
172818741,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Drug hypersensitivity,1,M,HO,48
172818741,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Eczema,1,M,HO,48
172821104,2,Plasma cell myeloma,4,F,EXP,pomalidomide,2,SS,Neutropenia,2,M,OT,49
172821104,3,Plasma cell myeloma,4,F,EXP,daratumumab,3,SS,Neutropenia,3,M,OT,49
172821211,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Enteritis,1,F,HO,80
172821211,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Enteritis,1,F,OT,80
172821211,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Hypokalaemia,1,F,HO,80
172821211,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Hypokalaemia,1,F,OT,80
172824132,12,Prophylaxis,2,F,EXP,granisetron,12,C,Lymphangiosis carcinomatosa,12,M,HO,6
172824132,12,Prophylaxis,2,F,EXP,granisetron,12,C,Lymphangiosis carcinomatosa,12,M,OT,6
172824132,12,Prophylaxis,2,F,EXP,granisetron,12,C,Neutrophil count decreased,12,M,HO,6
172824132,12,Prophylaxis,2,F,EXP,granisetron,12,C,Neutrophil count decreased,12,M,OT,6
172824132,12,Prophylaxis,2,F,EXP,granisetron,12,C,Pneumonitis,12,M,HO,6
172824132,12,Prophylaxis,2,F,EXP,granisetron,12,C,Pneumonitis,12,M,OT,6
172825692,1,Adenocarcinoma of appendix,2,F,EXP,nivolumab,1,PS,Myocarditis,1,F,OT,14
172825692,1,Adenocarcinoma of appendix,2,F,EXP,nivolumab,1,PS,Myocarditis,1,F,DE,14
172825692,1,Adenocarcinoma of appendix,2,F,EXP,nivolumab,1,PS,Myocarditis,1,F,HO,14
172825692,1,Adenocarcinoma of appendix,2,F,EXP,nivolumab,1,PS,Pleural effusion,1,F,OT,14
172825692,1,Adenocarcinoma of appendix,2,F,EXP,nivolumab,1,PS,Pleural effusion,1,F,DE,14
172825692,1,Adenocarcinoma of appendix,2,F,EXP,nivolumab,1,PS,Pleural effusion,1,F,HO,14
172825692,2,Adenocarcinoma of appendix,2,F,EXP,ipilimumab,2,SS,Myocarditis,2,F,OT,14
172825692,2,Adenocarcinoma of appendix,2,F,EXP,ipilimumab,2,SS,Myocarditis,2,F,DE,14
172825692,2,Adenocarcinoma of appendix,2,F,EXP,ipilimumab,2,SS,Myocarditis,2,F,HO,14
172825692,2,Adenocarcinoma of appendix,2,F,EXP,ipilimumab,2,SS,Pleural effusion,2,F,OT,14
172825692,2,Adenocarcinoma of appendix,2,F,EXP,ipilimumab,2,SS,Pleural effusion,2,F,DE,14
172825692,2,Adenocarcinoma of appendix,2,F,EXP,ipilimumab,2,SS,Pleural effusion,2,F,HO,14
172828051,4,Prophylaxis,1,I,EXP,filgrastim,4,C,Clostridium difficile infection,4,F,HO,4
172828051,4,Prophylaxis,1,I,EXP,filgrastim,4,C,Clostridium difficile infection,4,F,LT,4
172828051,4,Prophylaxis,1,I,EXP,filgrastim,4,C,Clostridium difficile infection,4,F,OT,4
172828051,4,Prophylaxis,1,I,EXP,filgrastim,4,C,Neutropenic sepsis,4,F,HO,4
172828051,4,Prophylaxis,1,I,EXP,filgrastim,4,C,Neutropenic sepsis,4,F,LT,4
172828051,4,Prophylaxis,1,I,EXP,filgrastim,4,C,Neutropenic sepsis,4,F,OT,4
172829083,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Acute kidney injury,1,M,LT,11
172829083,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Acute kidney injury,1,M,OT,11
172829083,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Acute kidney injury,1,M,HO,11
172829083,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Pyrexia,1,M,LT,11
172829083,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Pyrexia,1,M,OT,11
172829083,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Pyrexia,1,M,HO,11
172829083,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Sepsis,1,M,LT,11
172829083,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Sepsis,1,M,OT,11
172829083,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Sepsis,1,M,HO,11
172829083,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Tumour lysis syndrome,1,M,LT,11
172829083,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Tumour lysis syndrome,1,M,OT,11
172829083,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Tumour lysis syndrome,1,M,HO,11
172829083,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Acute kidney injury,3,M,LT,11
172829083,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Acute kidney injury,3,M,OT,11
172829083,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Acute kidney injury,3,M,HO,11
172829083,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Pyrexia,3,M,LT,11
172829083,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Pyrexia,3,M,OT,11
172829083,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Pyrexia,3,M,HO,11
172829083,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Sepsis,3,M,LT,11
172829083,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Sepsis,3,M,OT,11
172829083,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Sepsis,3,M,HO,11
172829083,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Tumour lysis syndrome,3,M,LT,11
172829083,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Tumour lysis syndrome,3,M,OT,11
172829083,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Tumour lysis syndrome,3,M,HO,11
172831323,1,Glioblastoma,3,F,EXP,ipilimumab,1,PS,Thrombocytopenia,1,M,OT,42
172831323,1,Glioblastoma,3,F,EXP,ipilimumab,1,PS,Thrombocytopenia,1,M,HO,42
172831323,1,Glioblastoma,3,F,EXP,ipilimumab,1,PS,Thrombocytopenia,1,M,LT,42
172831432,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Appendicitis,1,M,HO,637
172831432,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Escherichia bacteraemia,1,M,HO,637
172831432,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Febrile neutropenia,1,M,HO,637
172831432,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Sepsis,1,M,HO,637
172835008,5,Precursor B-lymphoblastic lymphoma,8,F,EXP,pegaspargase,5,SS,Asthenia,5,F,HO,17
172835008,5,Precursor B-lymphoblastic lymphoma,8,F,EXP,pegaspargase,5,SS,Hypoxia,5,F,HO,17
172835008,5,Precursor B-lymphoblastic lymphoma,8,F,EXP,pegaspargase,5,SS,Pain,5,F,HO,17
172835008,5,Precursor B-lymphoblastic lymphoma,8,F,EXP,pegaspargase,5,SS,Septic shock,5,F,HO,17
172838802,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,General physical health deterioration,1,F,OT,7
172838802,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,General physical health deterioration,1,F,HO,7
172838802,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Pneumonia,1,F,OT,7
172838802,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Pneumonia,1,F,HO,7
172838802,3,Bronchial carcinoma,2,F,EXP,ramucirumab,3,SS,General physical health deterioration,3,F,OT,8
172838802,3,Bronchial carcinoma,2,F,EXP,ramucirumab,3,SS,General physical health deterioration,3,F,HO,8
172838802,3,Bronchial carcinoma,2,F,EXP,ramucirumab,3,SS,Pneumonia,3,F,OT,8
172838802,3,Bronchial carcinoma,2,F,EXP,ramucirumab,3,SS,Pneumonia,3,F,HO,8
172838821,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Staphylococcal bacteraemia,1,M,HO,39
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Hypotension,1,M,OT,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Hypotension,1,M,HO,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Hypotension,1,M,LT,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Hypotension,1,M,DS,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Iridocyclitis,1,M,OT,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Iridocyclitis,1,M,HO,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Iridocyclitis,1,M,LT,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Iridocyclitis,1,M,DS,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,LT,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DS,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Retinal vasculitis,1,M,OT,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Retinal vasculitis,1,M,HO,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Retinal vasculitis,1,M,LT,226
172839163,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Retinal vasculitis,1,M,DS,226
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hypotension,2,M,OT,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hypotension,2,M,HO,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hypotension,2,M,LT,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Hypotension,2,M,DS,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Iridocyclitis,2,M,OT,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Iridocyclitis,2,M,HO,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Iridocyclitis,2,M,LT,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Iridocyclitis,2,M,DS,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Pneumonia,2,M,OT,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Pneumonia,2,M,HO,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Pneumonia,2,M,LT,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Pneumonia,2,M,DS,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Retinal vasculitis,2,M,OT,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Retinal vasculitis,2,M,HO,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Retinal vasculitis,2,M,LT,43
172839163,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Retinal vasculitis,2,M,DS,43
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Hypotension,3,M,OT,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Hypotension,3,M,HO,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Hypotension,3,M,LT,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Hypotension,3,M,DS,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Iridocyclitis,3,M,OT,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Iridocyclitis,3,M,HO,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Iridocyclitis,3,M,LT,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Iridocyclitis,3,M,DS,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Pneumonia,3,M,OT,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Pneumonia,3,M,HO,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Pneumonia,3,M,LT,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Pneumonia,3,M,DS,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Retinal vasculitis,3,M,OT,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Retinal vasculitis,3,M,HO,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Retinal vasculitis,3,M,LT,226
172839163,3,Prostate cancer,3,F,EXP,ipilimumab,3,SS,Retinal vasculitis,3,M,DS,226
172839781,67,Hyperuricaemia,1,I,EXP,rasburicase,67,C,Acute respiratory distress syndrome,67,F,DE,1
172845112,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Chronic obstructive pulmonary disease,1,M,HO,200
172845112,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Upper respiratory tract infection,1,M,HO,200
172845112,3,Plasma cell myeloma,2,F,PER,lenalidomide,3,SS,Chronic obstructive pulmonary disease,3,M,HO,200
172845112,3,Plasma cell myeloma,2,F,PER,lenalidomide,3,SS,Upper respiratory tract infection,3,M,HO,200
172845261,2,Adjuvant therapy,1,I,EXP,trametinib,2,SS,Acute kidney injury,2,M,OT,144
172845261,2,Adjuvant therapy,1,I,EXP,trametinib,2,SS,Dehydration,2,M,OT,144
172845261,2,Adjuvant therapy,1,I,EXP,trametinib,2,SS,Hyperpyrexia,2,M,OT,144
172845261,2,Adjuvant therapy,1,I,EXP,trametinib,2,SS,Oedema,2,M,OT,144
172845261,2,Adjuvant therapy,1,I,EXP,trametinib,2,SS,Pyrexia,2,M,OT,144
172845261,2,Adjuvant therapy,1,I,EXP,trametinib,2,SS,Uveitis,2,M,OT,144
172845261,2,Adjuvant therapy,1,I,EXP,trametinib,2,SS,Visual acuity reduced,2,M,OT,144
172846132,4,Plasma cell myeloma,2,F,EXP,daratumumab,4,PS,Breast cancer,4,F,OT,818
172849692,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Cardiac failure,1,F,DE,397
172849692,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Cardiac failure,1,F,HO,397
172849692,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Cardiac failure,1,F,OT,397
172849692,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,F,DE,397
172849692,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,F,HO,397
172849692,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,F,OT,397
172849692,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Cardiac failure,2,F,DE,59
172849692,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Cardiac failure,2,F,HO,59
172849692,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Cardiac failure,2,F,OT,59
172849692,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,F,DE,59
172849692,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,F,HO,59
172849692,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,F,OT,59
172849713,1,Hepatocellular carcinoma,3,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,OT,1268
172849713,1,Hepatocellular carcinoma,3,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,HO,1268
172849713,2,Hepatocellular carcinoma,3,F,EXP,ipilimumab,2,SS,Hypokalaemia,2,M,OT,1268
172849713,2,Hepatocellular carcinoma,3,F,EXP,ipilimumab,2,SS,Hypokalaemia,2,M,HO,1268
172849782,1,Chronic lymphocytic leukaemia,2,F,EXP,idelalisib,1,PS,Diarrhoea,1,M,OT,1448
172849782,1,Chronic lymphocytic leukaemia,2,F,EXP,idelalisib,1,PS,Pneumonia haemophilus,1,M,OT,1448
172852034,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,F,DE,6
172852034,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,F,OT,6
172852034,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,F,LT,6
172852034,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Hepatic failure,1,F,HO,6
172852034,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Metastases to liver,1,F,DE,6
172852034,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Metastases to liver,1,F,OT,6
172852034,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Metastases to liver,1,F,LT,6
172852034,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Metastases to liver,1,F,HO,6
172852034,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Tumour lysis syndrome,1,F,DE,6
172852034,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Tumour lysis syndrome,1,F,OT,6
172852034,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Tumour lysis syndrome,1,F,LT,6
172852034,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Tumour lysis syndrome,1,F,HO,6
172852034,9,Prophylaxis of nausea and vomiting,4,F,EXP,granisetron,9,C,Hepatic failure,9,F,DE,6
172852034,9,Prophylaxis of nausea and vomiting,4,F,EXP,granisetron,9,C,Hepatic failure,9,F,OT,6
172852034,9,Prophylaxis of nausea and vomiting,4,F,EXP,granisetron,9,C,Hepatic failure,9,F,LT,6
172852034,9,Prophylaxis of nausea and vomiting,4,F,EXP,granisetron,9,C,Hepatic failure,9,F,HO,6
172852034,9,Prophylaxis of nausea and vomiting,4,F,EXP,granisetron,9,C,Metastases to liver,9,F,DE,6
172852034,9,Prophylaxis of nausea and vomiting,4,F,EXP,granisetron,9,C,Metastases to liver,9,F,OT,6
172852034,9,Prophylaxis of nausea and vomiting,4,F,EXP,granisetron,9,C,Metastases to liver,9,F,LT,6
172852034,9,Prophylaxis of nausea and vomiting,4,F,EXP,granisetron,9,C,Metastases to liver,9,F,HO,6
172852034,9,Prophylaxis of nausea and vomiting,4,F,EXP,granisetron,9,C,Tumour lysis syndrome,9,F,DE,6
172852034,9,Prophylaxis of nausea and vomiting,4,F,EXP,granisetron,9,C,Tumour lysis syndrome,9,F,OT,6
172852034,9,Prophylaxis of nausea and vomiting,4,F,EXP,granisetron,9,C,Tumour lysis syndrome,9,F,LT,6
172852034,9,Prophylaxis of nausea and vomiting,4,F,EXP,granisetron,9,C,Tumour lysis syndrome,9,F,HO,6
172852112,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Cholangitis,1,M,HO,105
172852112,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Cholangitis,1,M,LT,105
172852112,1,Pancreatic carcinoma,2,F,EXP,nivolumab,1,PS,Cholangitis,1,M,OT,105
172854745,3,Renal cell carcinoma,5,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,F,OT,50
172854745,3,Renal cell carcinoma,5,F,EXP,ipilimumab,3,SS,Acute kidney injury,3,F,HO,50
172854745,3,Renal cell carcinoma,5,F,EXP,ipilimumab,3,SS,Alanine aminotransferase increased,3,F,OT,50
172854745,3,Renal cell carcinoma,5,F,EXP,ipilimumab,3,SS,Alanine aminotransferase increased,3,F,HO,50
172854745,3,Renal cell carcinoma,5,F,EXP,ipilimumab,3,SS,Colitis,3,F,OT,50
172854745,3,Renal cell carcinoma,5,F,EXP,ipilimumab,3,SS,Colitis,3,F,HO,50
172854745,3,Renal cell carcinoma,5,F,EXP,ipilimumab,3,SS,Diarrhoea,3,F,OT,50
172854745,3,Renal cell carcinoma,5,F,EXP,ipilimumab,3,SS,Diarrhoea,3,F,HO,50
172854745,3,Renal cell carcinoma,5,F,EXP,ipilimumab,3,SS,Large intestine perforation,3,F,OT,50
172854745,3,Renal cell carcinoma,5,F,EXP,ipilimumab,3,SS,Large intestine perforation,3,F,HO,50
172854745,3,Renal cell carcinoma,5,F,EXP,ipilimumab,3,SS,Nausea,3,F,OT,50
172854745,3,Renal cell carcinoma,5,F,EXP,ipilimumab,3,SS,Nausea,3,F,HO,50
172854745,3,Renal cell carcinoma,5,F,EXP,ipilimumab,3,SS,Vomiting,3,F,OT,50
172854745,3,Renal cell carcinoma,5,F,EXP,ipilimumab,3,SS,Vomiting,3,F,HO,50
172854745,4,Renal cell carcinoma,5,F,EXP,nivolumab,4,SS,Acute kidney injury,4,F,OT,50
172854745,4,Renal cell carcinoma,5,F,EXP,nivolumab,4,SS,Acute kidney injury,4,F,HO,50
172854745,4,Renal cell carcinoma,5,F,EXP,nivolumab,4,SS,Alanine aminotransferase increased,4,F,OT,50
172854745,4,Renal cell carcinoma,5,F,EXP,nivolumab,4,SS,Alanine aminotransferase increased,4,F,HO,50
172854745,4,Renal cell carcinoma,5,F,EXP,nivolumab,4,SS,Colitis,4,F,OT,50
172854745,4,Renal cell carcinoma,5,F,EXP,nivolumab,4,SS,Colitis,4,F,HO,50
172854745,4,Renal cell carcinoma,5,F,EXP,nivolumab,4,SS,Diarrhoea,4,F,OT,50
172854745,4,Renal cell carcinoma,5,F,EXP,nivolumab,4,SS,Diarrhoea,4,F,HO,50
172854745,4,Renal cell carcinoma,5,F,EXP,nivolumab,4,SS,Large intestine perforation,4,F,OT,50
172854745,4,Renal cell carcinoma,5,F,EXP,nivolumab,4,SS,Large intestine perforation,4,F,HO,50
172854745,4,Renal cell carcinoma,5,F,EXP,nivolumab,4,SS,Nausea,4,F,OT,50
172854745,4,Renal cell carcinoma,5,F,EXP,nivolumab,4,SS,Nausea,4,F,HO,50
172854745,4,Renal cell carcinoma,5,F,EXP,nivolumab,4,SS,Vomiting,4,F,OT,50
172854745,4,Renal cell carcinoma,5,F,EXP,nivolumab,4,SS,Vomiting,4,F,HO,50
172855052,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Ascites,1,M,HO,52
172855052,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Ascites,1,M,OT,52
172855472,3,Renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Immune-mediated hepatitis,3,M,OT,51
172855472,3,Renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Immune-mediated hepatitis,3,M,HO,51
172855472,4,Renal cell carcinoma,2,F,EXP,nivolumab,4,SS,Immune-mediated hepatitis,4,M,OT,51
172855472,4,Renal cell carcinoma,2,F,EXP,nivolumab,4,SS,Immune-mediated hepatitis,4,M,HO,51
172859321,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Acute febrile neutrophilic dermatosis,1,M,HO,11
172859321,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Hyperlipidaemia,1,M,HO,11
172859321,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Myocardial ischaemia,1,M,HO,11
172859321,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Peripheral arterial occlusive disease,1,M,HO,11
172860481,3,Breast cancer,1,I,EXP,alpelisib,3,SS,Blood glucose increased,3,F,OT,7
172860481,3,Breast cancer,1,I,EXP,alpelisib,3,SS,Drug intolerance,3,F,OT,7
172860481,3,Breast cancer,1,I,EXP,alpelisib,3,SS,Glycosylated haemoglobin increased,3,F,OT,7
172863343,1,Colorectal cancer metastatic,3,F,EXP,trametinib,1,PS,Cardiogenic shock,1,F,DE,14
172863343,1,Colorectal cancer metastatic,3,F,EXP,trametinib,1,PS,Cardiogenic shock,1,F,HO,14
172863343,1,Colorectal cancer metastatic,3,F,EXP,trametinib,1,PS,Cough,1,F,DE,14
172863343,1,Colorectal cancer metastatic,3,F,EXP,trametinib,1,PS,Cough,1,F,HO,14
172863343,1,Colorectal cancer metastatic,3,F,EXP,trametinib,1,PS,Dyspnoea,1,F,DE,14
172863343,1,Colorectal cancer metastatic,3,F,EXP,trametinib,1,PS,Dyspnoea,1,F,HO,14
172863343,1,Colorectal cancer metastatic,3,F,EXP,trametinib,1,PS,Hypothermia,1,F,DE,14
172863343,1,Colorectal cancer metastatic,3,F,EXP,trametinib,1,PS,Hypothermia,1,F,HO,14
172863343,1,Colorectal cancer metastatic,3,F,EXP,trametinib,1,PS,Ventricular dysfunction,1,F,DE,14
172863343,1,Colorectal cancer metastatic,3,F,EXP,trametinib,1,PS,Ventricular dysfunction,1,F,HO,14
172864322,1,Colorectal cancer,2,F,PER,panitumumab,1,PS,Dermatitis,1,F,HO,126
172864322,1,Colorectal cancer,2,F,PER,panitumumab,1,PS,Paronychia,1,F,HO,126
172864322,1,Colorectal cancer,2,F,PER,panitumumab,1,PS,Pneumonia,1,F,HO,126
172864322,1,Colorectal cancer,2,F,PER,panitumumab,1,PS,Spinal cord compression,1,F,HO,126
172866832,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Interstitial lung disease,1,F,OT,61
172866832,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Interstitial lung disease,1,F,HO,61
172866832,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Liver disorder,1,F,OT,61
172866832,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Liver disorder,1,F,HO,61
172866832,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Interstitial lung disease,2,F,OT,61
172866832,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Interstitial lung disease,2,F,HO,61
172866832,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Liver disorder,2,F,OT,61
172866832,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Liver disorder,2,F,HO,61
172869161,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,34
172869161,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,34
172869161,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Pneumonia,2,M,DE,21
172869161,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Pneumonia,2,M,OT,21
172869161,3,Product used for unknown indication,1,I,EXP,nivolumab,3,SS,Pneumonia,3,M,DE,8
172869161,3,Product used for unknown indication,1,I,EXP,nivolumab,3,SS,Pneumonia,3,M,OT,8
172872941,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Bone marrow failure,1,F,OT,108
172872941,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Bone marrow failure,1,F,HO,108
172872941,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Bone marrow failure,1,F,DE,108
172872941,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Myocardial infarction,1,F,OT,108
172872941,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Myocardial infarction,1,F,HO,108
172872941,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Myocardial infarction,1,F,DE,108
172872941,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Renal failure,1,F,OT,108
172872941,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Renal failure,1,F,HO,108
172872941,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Renal failure,1,F,DE,108
172872941,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Rhabdomyolysis,1,F,OT,108
172872941,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Rhabdomyolysis,1,F,HO,108
172872941,1,Sarcoma,1,I,EXP,nivolumab,1,PS,Rhabdomyolysis,1,F,DE,108
172872941,2,Sarcoma,1,I,EXP,ipilimumab,2,SS,Bone marrow failure,2,F,OT,108
172872941,2,Sarcoma,1,I,EXP,ipilimumab,2,SS,Bone marrow failure,2,F,HO,108
172872941,2,Sarcoma,1,I,EXP,ipilimumab,2,SS,Bone marrow failure,2,F,DE,108
172872941,2,Sarcoma,1,I,EXP,ipilimumab,2,SS,Myocardial infarction,2,F,OT,108
172872941,2,Sarcoma,1,I,EXP,ipilimumab,2,SS,Myocardial infarction,2,F,HO,108
172872941,2,Sarcoma,1,I,EXP,ipilimumab,2,SS,Myocardial infarction,2,F,DE,108
172872941,2,Sarcoma,1,I,EXP,ipilimumab,2,SS,Renal failure,2,F,OT,108
172872941,2,Sarcoma,1,I,EXP,ipilimumab,2,SS,Renal failure,2,F,HO,108
172872941,2,Sarcoma,1,I,EXP,ipilimumab,2,SS,Renal failure,2,F,DE,108
172872941,2,Sarcoma,1,I,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,F,OT,108
172872941,2,Sarcoma,1,I,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,F,HO,108
172872941,2,Sarcoma,1,I,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,F,DE,108
172872941,3,Sarcoma,1,I,EXP,trabectedin,3,SS,Bone marrow failure,3,F,OT,122
172872941,3,Sarcoma,1,I,EXP,trabectedin,3,SS,Bone marrow failure,3,F,HO,122
172872941,3,Sarcoma,1,I,EXP,trabectedin,3,SS,Bone marrow failure,3,F,DE,122
172872941,3,Sarcoma,1,I,EXP,trabectedin,3,SS,Myocardial infarction,3,F,OT,122
172872941,3,Sarcoma,1,I,EXP,trabectedin,3,SS,Myocardial infarction,3,F,HO,122
172872941,3,Sarcoma,1,I,EXP,trabectedin,3,SS,Myocardial infarction,3,F,DE,122
172872941,3,Sarcoma,1,I,EXP,trabectedin,3,SS,Renal failure,3,F,OT,122
172872941,3,Sarcoma,1,I,EXP,trabectedin,3,SS,Renal failure,3,F,HO,122
172872941,3,Sarcoma,1,I,EXP,trabectedin,3,SS,Renal failure,3,F,DE,122
172872941,3,Sarcoma,1,I,EXP,trabectedin,3,SS,Rhabdomyolysis,3,F,OT,122
172872941,3,Sarcoma,1,I,EXP,trabectedin,3,SS,Rhabdomyolysis,3,F,HO,122
172872941,3,Sarcoma,1,I,EXP,trabectedin,3,SS,Rhabdomyolysis,3,F,DE,122
172875872,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Abdominal infection,1,F,HO,5
172875872,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Abdominal infection,1,F,OT,5
172876285,1,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,1,PS,Hepatic failure,1,M,OT,64
172876285,1,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,1,PS,Hepatic failure,1,M,DE,64
172876285,1,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,1,PS,Hepatic function abnormal,1,M,OT,64
172876285,1,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,1,PS,Hepatic function abnormal,1,M,DE,64
172876285,2,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,2,SS,Hepatic failure,2,M,OT,64
172876285,2,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,2,SS,Hepatic failure,2,M,DE,64
172876285,2,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,2,SS,Hepatic function abnormal,2,M,OT,64
172876285,2,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,2,SS,Hepatic function abnormal,2,M,DE,64
172879282,2,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,2,SS,Cholangiocarcinoma,2,F,DE,1475
172879282,2,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,2,SS,Cholangiocarcinoma,2,F,HO,1475
172879282,2,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,2,SS,Hepatic cancer,2,F,DE,1475
172879282,2,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,2,SS,Hepatic cancer,2,F,HO,1475
172879282,2,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,2,SS,Neoplasm malignant,2,F,DE,1475
172879282,2,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,2,SS,Neoplasm malignant,2,F,HO,1475
172879282,2,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,2,SS,Pneumonia,2,F,DE,1475
172879282,2,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,2,SS,Pneumonia,2,F,HO,1475
172879282,2,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,2,SS,Pulmonary embolism,2,F,DE,1475
172879282,2,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,2,SS,Pulmonary embolism,2,F,HO,1475
172880174,1,Plasma cell myeloma,4,F,EXP,selinexor,1,PS,Febrile neutropenia,1,M,HO,4
172881441,3,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,3,C,Device related infection,3,M,HO,18
172881441,3,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,3,C,Device related infection,3,M,OT,18
172881441,3,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,3,C,Dysphagia,3,M,HO,18
172881441,3,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,3,C,Dysphagia,3,M,OT,18
172881441,3,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,3,C,Radiation mucositis,3,M,HO,18
172881441,3,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,3,C,Radiation mucositis,3,M,OT,18
172881441,3,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,3,C,Radiation skin injury,3,M,HO,18
172881441,3,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,3,C,Radiation skin injury,3,M,OT,18
172881441,3,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,3,C,Staphylococcal infection,3,M,HO,18
172881441,3,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,3,C,Staphylococcal infection,3,M,OT,18
172881441,3,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,3,C,Weight decreased,3,M,HO,18
172881441,3,Squamous cell carcinoma of head and neck,1,I,EXP,avelumab,3,C,Weight decreased,3,M,OT,18
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,DE,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,HO,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,LT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Cardiac arrest,1,M,OT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,LT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Liver function test abnormal,1,M,DE,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Liver function test abnormal,1,M,HO,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Liver function test abnormal,1,M,LT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Liver function test abnormal,1,M,OT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Non-cardiac chest pain,1,M,DE,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Non-cardiac chest pain,1,M,HO,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Non-cardiac chest pain,1,M,LT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Non-cardiac chest pain,1,M,OT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,LT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,DE,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,LT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,DE,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,HO,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,LT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Respiratory distress,1,M,DE,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Respiratory distress,1,M,HO,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Respiratory distress,1,M,LT,305
172882202,1,Papillary renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Respiratory distress,1,M,OT,305
172884421,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Confusional state,2,M,LT,17
172884421,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Confusional state,2,M,HO,17
172884421,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Hyponatraemia,2,M,LT,17
172884421,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Hyponatraemia,2,M,HO,17
172884421,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Syncope,2,M,LT,17
172884421,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Syncope,2,M,HO,17
172884752,1,Glioblastoma,2,F,EXP,ipilimumab,1,PS,Gastritis,1,M,HO,43
172890571,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Interstitial lung disease,1,F,OT,61
172890571,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Interstitial lung disease,1,F,HO,61
172890571,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Liver disorder,1,F,OT,61
172890571,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Liver disorder,1,F,HO,61
172890571,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Prescribed overdose,1,F,OT,61
172890571,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Prescribed overdose,1,F,HO,61
172890571,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Interstitial lung disease,2,F,OT,61
172890571,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Interstitial lung disease,2,F,HO,61
172890571,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Liver disorder,2,F,OT,61
172890571,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Liver disorder,2,F,HO,61
172890571,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Prescribed overdose,2,F,OT,61
172890571,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Prescribed overdose,2,F,HO,61
172891202,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Hyponatraemia,1,M,HO,285
172891202,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Hyponatraemia,1,M,LT,285
172891202,2,Hormone-refractory prostate cancer,2,F,EXP,nivolumab,2,SS,Hyponatraemia,2,M,HO,285
172891202,2,Hormone-refractory prostate cancer,2,F,EXP,nivolumab,2,SS,Hyponatraemia,2,M,LT,285
172892081,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Diarrhoea,5,F,HO,56
172892081,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Diarrhoea,5,F,OT,56
172892081,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Febrile neutropenia,5,F,HO,56
172892081,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Febrile neutropenia,5,F,OT,56
172892081,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Inappropriate schedule of product administration,5,F,HO,56
172892081,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Inappropriate schedule of product administration,5,F,OT,56
172892081,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Malignant neoplasm progression,5,F,HO,56
172892081,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Malignant neoplasm progression,5,F,OT,56
172892081,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Nausea,5,F,HO,56
172892081,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Nausea,5,F,OT,56
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Chest pain,1,M,HO,180
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Chest pain,1,M,DE,180
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Chest pain,1,M,OT,180
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Death,1,M,HO,180
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Death,1,M,DE,180
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Death,1,M,OT,180
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Gastric infection,1,M,HO,180
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Gastric infection,1,M,DE,180
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Gastric infection,1,M,OT,180
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Nausea,1,M,HO,180
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Nausea,1,M,DE,180
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Nausea,1,M,OT,180
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Vomiting,1,M,HO,180
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Vomiting,1,M,DE,180
172893702,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Vomiting,1,M,OT,180
172895342,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Febrile infection,1,F,HO,347
172895342,4,Plasma cell myeloma,2,F,PER,lenalidomide,4,SS,Febrile infection,4,F,HO,347
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Acute coronary syndrome,5,F,HO,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Acute coronary syndrome,5,F,DE,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Acute coronary syndrome,5,F,OT,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Anxiety,5,F,HO,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Anxiety,5,F,DE,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Anxiety,5,F,OT,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Dyspnoea,5,F,HO,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Dyspnoea,5,F,DE,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Dyspnoea,5,F,OT,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Escherichia bacteraemia,5,F,HO,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Escherichia bacteraemia,5,F,DE,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Escherichia bacteraemia,5,F,OT,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,General physical health deterioration,5,F,HO,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,General physical health deterioration,5,F,DE,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,General physical health deterioration,5,F,OT,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Haematotoxicity,5,F,HO,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Haematotoxicity,5,F,DE,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Haematotoxicity,5,F,OT,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Loss of consciousness,5,F,HO,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Loss of consciousness,5,F,DE,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Loss of consciousness,5,F,OT,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Malaise,5,F,HO,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Malaise,5,F,DE,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Malaise,5,F,OT,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Plasma cell myeloma,5,F,HO,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Plasma cell myeloma,5,F,DE,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,Plasma cell myeloma,5,F,OT,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,White matter lesion,5,F,HO,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,White matter lesion,5,F,DE,307
172895535,5,Plasma cell myeloma,5,F,EXP,lenalidomide,5,SS,White matter lesion,5,F,OT,307
172897441,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Atrial enlargement,1,F,HO,593
172897441,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Oedema peripheral,1,F,HO,593
172897441,2,Plasma cell myeloma,1,I,PER,daratumumab,2,SS,Atrial enlargement,2,F,HO,593
172897441,2,Plasma cell myeloma,1,I,PER,daratumumab,2,SS,Oedema peripheral,2,F,HO,593
172900826,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Hyperthyroidism,1,M,HO,25
172900826,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Hyperthyroidism,1,M,OT,25
172900826,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Hypophysitis,1,M,HO,25
172900826,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Hypophysitis,1,M,OT,25
172900826,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Hypothyroidism,1,M,HO,25
172900826,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Hypothyroidism,1,M,OT,25
172900826,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Prescribed overdose,1,M,HO,25
172900826,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Prescribed overdose,1,M,OT,25
172900826,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Secondary adrenocortical insufficiency,1,M,HO,25
172900826,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Secondary adrenocortical insufficiency,1,M,OT,25
172900826,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Uveitis,1,M,HO,25
172900826,1,Malignant melanoma,6,F,EXP,nivolumab,1,SS,Uveitis,1,M,OT,25
172900826,2,Malignant melanoma,6,F,EXP,ipilimumab,2,PS,Hyperthyroidism,2,M,HO,25
172900826,2,Malignant melanoma,6,F,EXP,ipilimumab,2,PS,Hyperthyroidism,2,M,OT,25
172900826,2,Malignant melanoma,6,F,EXP,ipilimumab,2,PS,Hypophysitis,2,M,HO,25
172900826,2,Malignant melanoma,6,F,EXP,ipilimumab,2,PS,Hypophysitis,2,M,OT,25
172900826,2,Malignant melanoma,6,F,EXP,ipilimumab,2,PS,Hypothyroidism,2,M,HO,25
172900826,2,Malignant melanoma,6,F,EXP,ipilimumab,2,PS,Hypothyroidism,2,M,OT,25
172900826,2,Malignant melanoma,6,F,EXP,ipilimumab,2,PS,Prescribed overdose,2,M,HO,25
172900826,2,Malignant melanoma,6,F,EXP,ipilimumab,2,PS,Prescribed overdose,2,M,OT,25
172900826,2,Malignant melanoma,6,F,EXP,ipilimumab,2,PS,Secondary adrenocortical insufficiency,2,M,HO,25
172900826,2,Malignant melanoma,6,F,EXP,ipilimumab,2,PS,Secondary adrenocortical insufficiency,2,M,OT,25
172900826,2,Malignant melanoma,6,F,EXP,ipilimumab,2,PS,Uveitis,2,M,HO,25
172900826,2,Malignant melanoma,6,F,EXP,ipilimumab,2,PS,Uveitis,2,M,OT,25
172901002,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Pneumocystis jirovecii infection,1,M,OT,541
172901002,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Pneumocystis jirovecii infection,1,M,HO,541
172901371,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,OT,1
172901371,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,DS,1
172901371,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Dupuytren's contracture,1,F,OT,1
172901371,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Dupuytren's contracture,1,F,DS,1
172901371,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Muscle fatigue,1,F,OT,1
172901371,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Muscle fatigue,1,F,DS,1
172901371,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,OT,1
172901371,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,DS,1
172901371,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Tendonitis,1,F,OT,1
172901371,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Tendonitis,1,F,DS,1
172907432,1,Cervix carcinoma,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,HO,317
172907432,1,Cervix carcinoma,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,OT,317
172907432,1,Cervix carcinoma,2,F,EXP,nivolumab,1,PS,Device related infection,1,F,HO,317
172907432,1,Cervix carcinoma,2,F,EXP,nivolumab,1,PS,Device related infection,1,F,OT,317
172907432,1,Cervix carcinoma,2,F,EXP,nivolumab,1,PS,Peritonitis,1,F,HO,317
172907432,1,Cervix carcinoma,2,F,EXP,nivolumab,1,PS,Peritonitis,1,F,OT,317
172907432,1,Cervix carcinoma,2,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,HO,317
172907432,1,Cervix carcinoma,2,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,OT,317
172907442,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Confusional state,1,M,HO,704
172907442,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Confusional state,1,M,OT,704
172907442,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Delirium,1,M,HO,704
172907442,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Delirium,1,M,OT,704
172907442,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Depressive symptom,1,M,HO,704
172907442,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Depressive symptom,1,M,OT,704
172907442,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Suicide attempt,1,M,HO,704
172907442,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Suicide attempt,1,M,OT,704
172907493,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,HO,32
172907493,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Abdominal pain upper,1,M,OT,32
172907493,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,32
172907493,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,32
172907493,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Hypophagia,1,M,HO,32
172907493,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Hypophagia,1,M,OT,32
172907493,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Influenza,1,M,HO,32
172907493,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Influenza,1,M,OT,32
172907493,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Liver function test increased,1,M,HO,32
172907493,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Liver function test increased,1,M,OT,32
172907493,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,32
172907493,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,32
172907561,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Asthenia,1,M,DE,52
172907561,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Asthenia,1,M,HO,52
172907561,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Asthenia,1,M,OT,52
172907561,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Bedridden,1,M,DE,52
172907561,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Bedridden,1,M,HO,52
172907561,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Bedridden,1,M,OT,52
172907561,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,52
172907561,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,HO,52
172907561,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,52
172907561,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,52
172907561,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,52
172907561,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,52
172908182,1,Metastases to bone,2,F,EXP,zoledronic acid,1,PS,Hypocalcaemia,1,F,OT,560
172908182,1,Metastases to bone,2,F,EXP,zoledronic acid,1,PS,Pain,1,F,OT,560
172908182,1,Metastases to bone,2,F,EXP,zoledronic acid,1,PS,Renal impairment,1,F,OT,560
172908182,1,Metastases to bone,2,F,EXP,zoledronic acid,1,PS,Spinal pain,1,F,OT,560
172912661,1,Oesophageal adenocarcinoma,1,I,EXP,nivolumab,1,PS,C-reactive protein increased,1,F,HO,281
172912661,1,Oesophageal adenocarcinoma,1,I,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,281
172913133,1,Plasma cell myeloma,3,F,EXP,selinexor,1,PS,Sudden death,1,F,DE,16
172913133,3,Prophylaxis of nausea and vomiting,3,F,EXP,granisetron,3,C,Sudden death,3,F,DE,350
172917331,3,Plasma cell myeloma,1,I,PER,carfilzomib,3,SS,Dyspnoea,3,M,HO,1276
172917331,12,Plasma cell myeloma,1,I,PER,daratumumab,12,SS,Dyspnoea,12,M,HO,499
172920401,1,Non-Hodgkin's lymphoma,1,I,EXP,nivolumab,1,PS,Bacterial sepsis,1,M,HO,11
172920401,1,Non-Hodgkin's lymphoma,1,I,EXP,nivolumab,1,PS,Bacterial sepsis,1,M,OT,11
172920401,5,Non-Hodgkin's lymphoma,1,I,EXP,pegfilgrastim,5,SS,Bacterial sepsis,5,M,HO,8
172920401,5,Non-Hodgkin's lymphoma,1,I,EXP,pegfilgrastim,5,SS,Bacterial sepsis,5,M,OT,8
172924511,1,Glioblastoma,1,I,DIR,nivolumab,1,PS,Disease progression,1,F,DE,267
172924511,1,Glioblastoma,1,I,DIR,nivolumab,1,PS,Hepatic failure,1,F,DE,267
172932043,1,Dedifferentiated liposarcoma,3,F,EXP,selinexor,1,PS,Transaminases increased,1,M,HO,28
172933104,3,Breast cancer female,4,F,EXP,palbociclib,3,SS,Alopecia,3,F,OT,88
172933104,3,Breast cancer female,4,F,EXP,palbociclib,3,SS,Asthenia,3,F,OT,88
172933104,3,Breast cancer female,4,F,EXP,palbociclib,3,SS,Back pain,3,F,OT,88
172933104,3,Breast cancer female,4,F,EXP,palbociclib,3,SS,Dyspnoea,3,F,OT,88
172933104,3,Breast cancer female,4,F,EXP,palbociclib,3,SS,Musculoskeletal chest pain,3,F,OT,88
172933104,3,Breast cancer female,4,F,EXP,palbociclib,3,SS,Musculoskeletal discomfort,3,F,OT,88
172933104,3,Breast cancer female,4,F,EXP,palbociclib,3,SS,Neutropenia,3,F,OT,88
172933104,3,Breast cancer female,4,F,EXP,palbociclib,3,SS,Spinal pain,3,F,OT,88
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Blood creatine phosphokinase increased,2,F,DS,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Blood creatine phosphokinase increased,2,F,HO,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Dermatomyositis,2,F,DS,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Dermatomyositis,2,F,HO,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Dysphagia,2,F,DS,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Dysphagia,2,F,HO,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Fatigue,2,F,DS,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Fatigue,2,F,HO,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Myalgia,2,F,DS,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Myalgia,2,F,HO,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Myopathy,2,F,DS,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Myopathy,2,F,HO,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Rash,2,F,DS,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Rash,2,F,HO,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Swelling face,2,F,DS,73
172934761,2,Metastatic malignant melanoma,1,I,EXP,trametinib,2,SS,Swelling face,2,F,HO,73
172936161,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Eosinophil percentage decreased,1,M,OT,419
172936161,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Fatigue,1,M,OT,419
172936161,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Laboratory test abnormal,1,M,OT,419
172936161,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,M,OT,419
172936161,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Lymphocyte percentage decreased,1,M,OT,419
172936161,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Mean platelet volume abnormal,1,M,OT,419
172936161,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Neutrophil count increased,1,M,OT,419
172936161,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Platelet count decreased,1,M,OT,419
172936161,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Thrombocytopenia,1,M,OT,419
172936161,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Thyroxine decreased,1,M,OT,419
172936161,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,M,OT,419
172942553,1,Metastatic malignant melanoma,3,F,EXP,nivolumab,1,PS,Syncope,1,F,OT,730
172942553,1,Metastatic malignant melanoma,3,F,EXP,nivolumab,1,PS,Syncope,1,F,HO,730
172942553,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Syncope,2,F,OT,646
172942553,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Syncope,2,F,HO,646
172942553,3,Metastatic malignant melanoma,3,F,EXP,ipilimumab,3,SS,Syncope,3,F,OT,730
172942553,3,Metastatic malignant melanoma,3,F,EXP,ipilimumab,3,SS,Syncope,3,F,HO,730
172946031,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Cellulitis,2,M,HO,102
172947812,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Influenza,2,M,HO,19
172947812,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Neutropenia,2,M,HO,19
172947812,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Influenza,3,M,HO,19
172947812,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Neutropenia,3,M,HO,19
172950273,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Musculoskeletal disorder,1,M,OT,988
172950273,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Musculoskeletal disorder,1,M,HO,988
172950273,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Pneumonia,1,M,OT,988
172950273,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Pneumonia,1,M,HO,988
172950273,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,OT,988
172950273,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,HO,988
172950372,3,Glioma,2,F,EXP,trametinib,3,SS,Pyrexia,3,F,HO,14
172950523,1,Plasma cell myeloma,3,F,EXP,selinexor,1,PS,Hyponatraemia,1,F,HO,35
172950523,1,Plasma cell myeloma,3,F,EXP,selinexor,1,PS,Personality change,1,F,HO,35
172950943,16,Plasma cell myeloma,3,F,EXP,carfilzomib,16,SS,Pyrexia,16,M,DE,419
172950943,16,Plasma cell myeloma,3,F,EXP,carfilzomib,16,SS,Pyrexia,16,M,HO,419
172950943,18,Plasma cell myeloma,3,F,EXP,daratumumab,18,SS,Pyrexia,18,M,DE,774
172950943,18,Plasma cell myeloma,3,F,EXP,daratumumab,18,SS,Pyrexia,18,M,HO,774
172950971,1,Non-small cell lung cancer recurrent,1,I,EXP,nivolumab,1,PS,Chronic hepatitis C,1,M,OT,28
172950971,1,Non-small cell lung cancer recurrent,1,I,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,OT,28
172960705,3,Transitional cell cancer of the renal pelvis and ureter,5,F,EXP,nivolumab,3,PS,Blood creatine increased,3,M,HO,27
172960705,3,Transitional cell cancer of the renal pelvis and ureter,5,F,EXP,nivolumab,3,PS,General physical health deterioration,3,M,HO,27
172960705,3,Transitional cell cancer of the renal pelvis and ureter,5,F,EXP,nivolumab,3,PS,Pyrexia,3,M,HO,27
172960943,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Pneumonia,2,M,HO,233
172961023,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Fall,3,F,HO,441
172961023,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Lower respiratory tract infection,3,F,HO,441
172961971,11,Product used for unknown indication,1,I,EXP,dactinomycin,11,SS,Urinary tract obstruction,11,M,HO,87
172964901,1,Clear cell renal cell carcinoma,1,I,EXP,zoledronic acid,1,PS,Metastases to lung,1,F,OT,132
172964901,1,Clear cell renal cell carcinoma,1,I,EXP,zoledronic acid,1,PS,Off label use,1,F,OT,132
172964901,1,Clear cell renal cell carcinoma,1,I,EXP,zoledronic acid,1,PS,Renal impairment,1,F,OT,132
172967481,3,Diffuse large B-cell lymphoma,1,I,EXP,chop,3,C,Diffuse large B-cell lymphoma refractory,3,F,OT,198
172967871,1,Neoplasm,1,I,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,18
172967871,1,Neoplasm,1,I,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,18
172967871,1,Neoplasm,1,I,EXP,nivolumab,1,PS,Delirium,1,M,HO,18
172967871,1,Neoplasm,1,I,EXP,nivolumab,1,PS,Delirium,1,M,OT,18
172967871,2,Neoplasm,1,I,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,M,HO,18
172967871,2,Neoplasm,1,I,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,M,OT,18
172967871,2,Neoplasm,1,I,EXP,ipilimumab,2,SS,Delirium,2,M,HO,18
172967871,2,Neoplasm,1,I,EXP,ipilimumab,2,SS,Delirium,2,M,OT,18
172969172,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Bladder sphincter atony,1,M,OT,10
172969172,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Bladder sphincter atony,1,M,HO,10
172969172,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Blood test abnormal,1,M,OT,10
172969172,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Blood test abnormal,1,M,HO,10
172969172,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cardiomyopathy,1,M,OT,10
172969172,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cardiomyopathy,1,M,HO,10
172969172,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,10
172969172,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,10
172969172,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,10
172969172,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,10
172969172,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Muscular weakness,1,M,OT,10
172969172,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Muscular weakness,1,M,HO,10
172969172,3,Malignant melanoma,2,F,EXP,ipilimumab,3,SS,Bladder sphincter atony,3,M,OT,10
172969172,3,Malignant melanoma,2,F,EXP,ipilimumab,3,SS,Bladder sphincter atony,3,M,HO,10
172969172,3,Malignant melanoma,2,F,EXP,ipilimumab,3,SS,Blood test abnormal,3,M,OT,10
172969172,3,Malignant melanoma,2,F,EXP,ipilimumab,3,SS,Blood test abnormal,3,M,HO,10
172969172,3,Malignant melanoma,2,F,EXP,ipilimumab,3,SS,Cardiomyopathy,3,M,OT,10
172969172,3,Malignant melanoma,2,F,EXP,ipilimumab,3,SS,Cardiomyopathy,3,M,HO,10
172969172,3,Malignant melanoma,2,F,EXP,ipilimumab,3,SS,Decreased appetite,3,M,OT,10
172969172,3,Malignant melanoma,2,F,EXP,ipilimumab,3,SS,Decreased appetite,3,M,HO,10
172969172,3,Malignant melanoma,2,F,EXP,ipilimumab,3,SS,Diarrhoea,3,M,OT,10
172969172,3,Malignant melanoma,2,F,EXP,ipilimumab,3,SS,Diarrhoea,3,M,HO,10
172969172,3,Malignant melanoma,2,F,EXP,ipilimumab,3,SS,Muscular weakness,3,M,OT,10
172969172,3,Malignant melanoma,2,F,EXP,ipilimumab,3,SS,Muscular weakness,3,M,HO,10
172970151,1,Product used for unknown indication,1,I,EXP,dactinomycin,1,PS,Urinary tract obstruction,1,M,OT,87
172970151,1,Product used for unknown indication,1,I,EXP,dactinomycin,1,PS,Urinary tract obstruction,1,M,HO,87
172972261,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Hepatic function abnormal,5,M,HO,43
172972261,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Non-alcoholic steatohepatitis,5,M,HO,43
172972483,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Subdural haematoma,1,F,HO,1934
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Blood cholesterol increased,1,F,OT,584
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Diarrhoea,1,F,OT,584
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Epistaxis,1,F,OT,584
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Glomerular filtration rate decreased,1,F,OT,584
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Hepatic mass,1,F,OT,584
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Hepatic steatosis,1,F,OT,584
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Hypertension,1,F,OT,584
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Iron deficiency anaemia,1,F,OT,584
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Malignant neoplasm progression,1,F,OT,584
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Metastases to bone,1,F,OT,584
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Metastases to lung,1,F,OT,584
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Mitral valve incompetence,1,F,OT,584
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Pulmonary mass,1,F,OT,584
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Renal disorder,1,F,OT,584
172972721,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Renal impairment,1,F,OT,584
172973373,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Hypertransaminasaemia,1,M,DE,27
172973373,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Hypertransaminasaemia,1,M,HO,27
172973373,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Hypertransaminasaemia,1,M,OT,27
172973373,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Jaundice,1,M,DE,27
172973373,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Jaundice,1,M,HO,27
172973373,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Jaundice,1,M,OT,27
172973373,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,DE,27
172973373,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,HO,27
172973373,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,OT,27
172973373,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Ocular icterus,1,M,DE,27
172973373,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Ocular icterus,1,M,HO,27
172973373,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Ocular icterus,1,M,OT,27
172973373,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Hypertransaminasaemia,2,M,DE,27
172973373,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Hypertransaminasaemia,2,M,HO,27
172973373,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Hypertransaminasaemia,2,M,OT,27
172973373,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Jaundice,2,M,DE,27
172973373,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Jaundice,2,M,HO,27
172973373,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Jaundice,2,M,OT,27
172973373,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,M,DE,27
172973373,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,M,HO,27
172973373,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,M,OT,27
172973373,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Ocular icterus,2,M,DE,27
172973373,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Ocular icterus,2,M,HO,27
172973373,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Ocular icterus,2,M,OT,27
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Abdominal pain,5,F,HO,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Abdominal pain,5,F,OT,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Alanine aminotransferase increased,5,F,HO,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Alanine aminotransferase increased,5,F,OT,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Aspartate aminotransferase increased,5,F,HO,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Aspartate aminotransferase increased,5,F,OT,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Blood alkaline phosphatase increased,5,F,HO,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Blood alkaline phosphatase increased,5,F,OT,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Blood bilirubin increased,5,F,HO,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Blood bilirubin increased,5,F,OT,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Cholecystitis,5,F,HO,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Cholecystitis,5,F,OT,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Cholestasis,5,F,HO,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Cholestasis,5,F,OT,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Drug-induced liver injury,5,F,HO,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Drug-induced liver injury,5,F,OT,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Gamma-glutamyltransferase increased,5,F,HO,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Gamma-glutamyltransferase increased,5,F,OT,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Hepatocellular injury,5,F,HO,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Hepatocellular injury,5,F,OT,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Skin exfoliation,5,F,HO,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Skin exfoliation,5,F,OT,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Thrombocytopenia,5,F,HO,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Thrombocytopenia,5,F,OT,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Vomiting,5,F,HO,38
172976721,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Vomiting,5,F,OT,38
172977141,1,Plasma cell myeloma,1,I,EXP,pomalidomide,1,SS,Pneumonitis,1,F,HO,7
172978672,1,Lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,OT,91
172978672,1,Lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,HO,91
172978672,1,Lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,DE,91
172978722,1,Malignant neoplasm of renal pelvis,2,F,EXP,nivolumab,1,PS,Renal failure,1,F,OT,126
172978722,1,Malignant neoplasm of renal pelvis,2,F,EXP,nivolumab,1,PS,Renal failure,1,F,HO,126
172978722,2,Malignant neoplasm of renal pelvis,2,F,EXP,ipilimumab,2,SS,Renal failure,2,F,OT,126
172978722,2,Malignant neoplasm of renal pelvis,2,F,EXP,ipilimumab,2,SS,Renal failure,2,F,HO,126
172978733,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Blood alkaline phosphatase increased,1,M,OT,106
172978733,1,Prostate cancer,3,F,EXP,enzalutamide,1,PS,Hepatic enzyme increased,1,M,OT,106
172978832,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Large intestine perforation,1,M,HO,185
172979152,6,Plasma cell myeloma,2,F,EXP,pomalidomide,6,SS,Lower respiratory tract infection,6,M,HO,31
172979152,6,Plasma cell myeloma,2,F,EXP,pomalidomide,6,SS,Streptococcal infection,6,M,HO,31
172979443,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Arthralgia,1,M,HO,28
172979443,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,28
172979443,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,28
172979443,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Musculoskeletal stiffness,1,M,HO,28
172979443,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Pain,1,M,HO,28
172980121,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Generalised oedema,1,M,DE,3
172980121,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Generalised oedema,1,M,HO,3
172980301,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Adrenal insufficiency,5,M,OT,118
172980301,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Adrenal insufficiency,5,M,HO,118
172980301,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Dehydration,5,M,OT,118
172980301,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Dehydration,5,M,HO,118
172980301,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Diabetes mellitus,5,M,OT,118
172980301,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Diabetes mellitus,5,M,HO,118
172980301,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Neutropenia,5,M,OT,118
172980301,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Neutropenia,5,M,HO,118
172981653,1,Plasma cell myeloma,3,F,EXP,pomalidomide,1,PS,Sepsis,1,M,LT,6
172981653,1,Plasma cell myeloma,3,F,EXP,pomalidomide,1,PS,Sepsis,1,M,HO,6
172981822,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Hepatic enzyme increased,1,M,HO,28
172981822,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Infection,1,M,HO,28
172981822,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Renal impairment,1,M,HO,28
172982493,3,Product used for unknown indication,3,F,EXP,palbociclib,3,SS,Urinary retention,3,F,HO,261
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Abdominal distension,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Abdominal distension,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Abdominal distension,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Abdominal distension,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Abdominal pain,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Abdominal pain,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Abdominal pain,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Abdominal pain,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Abdominal sepsis,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Abdominal sepsis,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Abdominal sepsis,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Abdominal sepsis,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Acute kidney injury,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Acute kidney injury,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Acute kidney injury,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Acute kidney injury,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Cardiac arrest,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Cardiac arrest,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Cardiac arrest,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Cardiac arrest,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Confusional state,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Confusional state,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Confusional state,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Confusional state,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Diarrhoea,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Diarrhoea,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Diarrhoea,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Diarrhoea,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Dyspepsia,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Dyspepsia,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Dyspepsia,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Dyspepsia,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Electrolyte imbalance,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Electrolyte imbalance,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Electrolyte imbalance,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Electrolyte imbalance,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Fatigue,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Fatigue,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Fatigue,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Fatigue,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Intestinal ischaemia,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Intestinal ischaemia,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Intestinal ischaemia,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Intestinal ischaemia,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Intestinal perforation,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Intestinal perforation,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Intestinal perforation,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Intestinal perforation,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Respiratory rate increased,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Respiratory rate increased,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Respiratory rate increased,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Respiratory rate increased,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Tachycardia,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Tachycardia,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Tachycardia,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Tachycardia,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Urine output decreased,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Urine output decreased,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Urine output decreased,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Urine output decreased,2,F,HO,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Vomiting,2,F,LT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Vomiting,2,F,DE,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Vomiting,2,F,OT,138
172984551,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Vomiting,2,F,HO,138
172984851,1,Malignant melanoma,1,I,EXP,trametinib,1,PS,Acute coronary syndrome,1,M,HO,10
172985321,1,Chemotherapy,1,I,EXP,lenalidomide,1,PS,Chest discomfort,1,M,HO,6
172985321,1,Chemotherapy,1,I,EXP,lenalidomide,1,PS,Dyspnoea,1,M,HO,6
172985321,1,Chemotherapy,1,I,EXP,lenalidomide,1,PS,Oral pain,1,M,HO,6
172985321,1,Chemotherapy,1,I,EXP,lenalidomide,1,PS,Pain,1,M,HO,6
172985321,1,Chemotherapy,1,I,EXP,lenalidomide,1,PS,Rash pruritic,1,M,HO,6
172985321,1,Chemotherapy,1,I,EXP,lenalidomide,1,PS,Stevens-Johnson syndrome,1,M,HO,6
172985321,18,Product used for unknown indication,1,I,EXP,zoledronic acid,18,C,Chest discomfort,18,M,HO,6
172985321,18,Product used for unknown indication,1,I,EXP,zoledronic acid,18,C,Dyspnoea,18,M,HO,6
172985321,18,Product used for unknown indication,1,I,EXP,zoledronic acid,18,C,Oral pain,18,M,HO,6
172985321,18,Product used for unknown indication,1,I,EXP,zoledronic acid,18,C,Pain,18,M,HO,6
172985321,18,Product used for unknown indication,1,I,EXP,zoledronic acid,18,C,Rash pruritic,18,M,HO,6
172985321,18,Product used for unknown indication,1,I,EXP,zoledronic acid,18,C,Stevens-Johnson syndrome,18,M,HO,6
172985791,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Cerebellar ischaemia,1,M,HO,2082
172987403,2,Prophylaxis,3,F,EXP,rasburicase,2,C,Herpes zoster,2,F,OT,385
172987403,2,Prophylaxis,3,F,EXP,rasburicase,2,C,Herpes zoster,2,F,HO,385
172988541,1,Colorectal cancer,1,I,EXP,ibrutinib,1,PS,Pneumonia,1,M,HO,47
172988592,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Back pain,1,F,HO,676
172988801,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Neutropenic sepsis,1,F,HO,7
172989272,4,Metastases to bone,2,F,EXP,denosumab,4,C,Gastric ulcer,4,F,HO,1391
172992272,2,Metastatic gastric cancer,2,F,EXP,ramucirumab,2,C,Febrile neutropenia,2,M,LT,7
172992272,2,Metastatic gastric cancer,2,F,EXP,ramucirumab,2,C,Pneumonitis,2,M,LT,7
172993971,12,Product used for unknown indication,1,I,PER,carfilzomib,12,C,Asthenia,12,M,HO,1155
172993971,12,Product used for unknown indication,1,I,PER,carfilzomib,12,C,Gait inability,12,M,HO,1155
172993971,13,Product used for unknown indication,1,I,PER,daratumumab,13,C,Asthenia,13,M,HO,447
172993971,13,Product used for unknown indication,1,I,PER,daratumumab,13,C,Gait inability,13,M,HO,447
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Decreased appetite,1,F,HO,45
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Decreased appetite,1,F,OT,45
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Decreased appetite,1,F,DE,45
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,F,HO,45
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,F,OT,45
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,F,DE,45
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Nausea,1,F,HO,45
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Nausea,1,F,OT,45
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Nausea,1,F,DE,45
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Vomiting,1,F,HO,45
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Vomiting,1,F,OT,45
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Vomiting,1,F,DE,45
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Weight decreased,1,F,HO,45
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Weight decreased,1,F,OT,45
172994071,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Weight decreased,1,F,DE,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Decreased appetite,2,F,HO,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Decreased appetite,2,F,OT,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Decreased appetite,2,F,DE,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,F,HO,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,F,OT,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Malignant neoplasm progression,2,F,DE,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Nausea,2,F,HO,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Nausea,2,F,OT,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Nausea,2,F,DE,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Vomiting,2,F,HO,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Vomiting,2,F,OT,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Vomiting,2,F,DE,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Weight decreased,2,F,HO,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Weight decreased,2,F,OT,45
172994071,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Weight decreased,2,F,DE,45
172996343,1,Plasma cell myeloma,3,F,PER,pomalidomide,1,PS,Acute kidney injury,1,M,HO,92
172996343,1,Plasma cell myeloma,3,F,PER,pomalidomide,1,PS,Metabolic encephalopathy,1,M,HO,92
172996343,1,Plasma cell myeloma,3,F,PER,pomalidomide,1,PS,Neutropenic sepsis,1,M,HO,92
172996343,1,Plasma cell myeloma,3,F,PER,pomalidomide,1,PS,Pneumonia streptococcal,1,M,HO,92
172996343,1,Plasma cell myeloma,3,F,PER,pomalidomide,1,PS,Septic shock,1,M,HO,92
172996343,9,Plasma cell myeloma,3,F,PER,daratumumab,9,SS,Acute kidney injury,9,M,HO,316
172996343,9,Plasma cell myeloma,3,F,PER,daratumumab,9,SS,Metabolic encephalopathy,9,M,HO,316
172996343,9,Plasma cell myeloma,3,F,PER,daratumumab,9,SS,Neutropenic sepsis,9,M,HO,316
172996343,9,Plasma cell myeloma,3,F,PER,daratumumab,9,SS,Pneumonia streptococcal,9,M,HO,316
172996343,9,Plasma cell myeloma,3,F,PER,daratumumab,9,SS,Septic shock,9,M,HO,316
172996483,2,Bladder cancer,3,F,EXP,nivolumab,2,PS,Anaemia,2,F,HO,66
172996483,2,Bladder cancer,3,F,EXP,nivolumab,2,PS,Anaemia,2,F,OT,66
172996483,2,Bladder cancer,3,F,EXP,nivolumab,2,PS,Anaemia,2,F,LT,66
172996483,6,Product used for unknown indication,3,F,EXP,filgrastim,6,C,Anaemia,6,F,HO,2
172996483,6,Product used for unknown indication,3,F,EXP,filgrastim,6,C,Anaemia,6,F,OT,2
172996483,6,Product used for unknown indication,3,F,EXP,filgrastim,6,C,Anaemia,6,F,LT,2
173012111,1,Product used for unknown indication,1,I,EXP,filgrastim,1,PS,Dental restoration failure,1,M,DS,7
173012111,1,Product used for unknown indication,1,I,EXP,filgrastim,1,PS,Inadequate osteointegration,1,M,DS,7
173012111,6,Product used for unknown indication,1,I,EXP,darbepoetin alfa,6,C,Dental restoration failure,6,M,DS,7
173012111,6,Product used for unknown indication,1,I,EXP,darbepoetin alfa,6,C,Inadequate osteointegration,6,M,DS,7
173012331,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Cerebral infarction,1,F,HO,1
173012331,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Cerebral infarction,1,F,DE,1
173012331,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Generalised tonic-clonic seizure,1,F,HO,1
173012331,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Generalised tonic-clonic seizure,1,F,DE,1
173012331,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hemiparesis,1,F,HO,1
173012331,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hemiparesis,1,F,DE,1
173013931,1,Transitional cell carcinoma,1,I,EXP,nivolumab,1,PS,Renal failure,1,M,HO,89
173013931,1,Transitional cell carcinoma,1,I,EXP,nivolumab,1,PS,Renal failure,1,M,OT,89
173013931,2,Transitional cell carcinoma,1,I,EXP,ipilimumab,2,SS,Renal failure,2,M,HO,89
173013931,2,Transitional cell carcinoma,1,I,EXP,ipilimumab,2,SS,Renal failure,2,M,OT,89
173015121,1,Plasma cell myeloma,1,I,EXP,pomalidomide,1,PS,Cardiac disorder,1,M,DE,15
173015121,1,Plasma cell myeloma,1,I,EXP,pomalidomide,1,PS,Troponin increased,1,M,DE,15
173018702,1,Colorectal cancer metastatic,2,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,F,HO,443
173018702,1,Colorectal cancer metastatic,2,F,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,F,OT,443
173018702,35,Product used for unknown indication,2,F,EXP,granisetron,35,C,Immune-mediated enterocolitis,35,F,HO,8
173018702,35,Product used for unknown indication,2,F,EXP,granisetron,35,C,Immune-mediated enterocolitis,35,F,OT,8
173018781,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Colitis,1,M,HO,119
173018781,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Colitis,1,M,LT,119
173018781,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Hypotension,1,M,HO,119
173018781,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Hypotension,1,M,LT,119
173018781,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Colitis,2,M,HO,119
173018781,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Colitis,2,M,LT,119
173018781,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Hypotension,2,M,HO,119
173018781,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Hypotension,2,M,LT,119
173026822,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,HO,3
173026822,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Psoriasis,1,F,HO,3
173026822,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Renal pain,1,F,HO,3
173026822,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Oedema peripheral,2,F,HO,3
173026822,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Psoriasis,2,F,HO,3
173026822,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Renal pain,2,F,HO,3
173029512,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Breast cancer,1,F,OT,1214
173034892,1,Gastric cancer,2,F,EXP,nivolumab,1,SS,Hypothyroidism,1,M,HO,68
173034892,1,Gastric cancer,2,F,EXP,nivolumab,1,SS,Hypothyroidism,1,M,OT,68
173034892,1,Gastric cancer,2,F,EXP,nivolumab,1,SS,Pneumonia,1,M,HO,68
173034892,1,Gastric cancer,2,F,EXP,nivolumab,1,SS,Pneumonia,1,M,OT,68
173034892,1,Gastric cancer,2,F,EXP,nivolumab,1,SS,Pyrexia,1,M,HO,68
173034892,1,Gastric cancer,2,F,EXP,nivolumab,1,SS,Pyrexia,1,M,OT,68
173034892,2,Gastric cancer,2,F,EXP,ipilimumab,2,PS,Hypothyroidism,2,M,HO,68
173034892,2,Gastric cancer,2,F,EXP,ipilimumab,2,PS,Hypothyroidism,2,M,OT,68
173034892,2,Gastric cancer,2,F,EXP,ipilimumab,2,PS,Pneumonia,2,M,HO,68
173034892,2,Gastric cancer,2,F,EXP,ipilimumab,2,PS,Pneumonia,2,M,OT,68
173034892,2,Gastric cancer,2,F,EXP,ipilimumab,2,PS,Pyrexia,2,M,HO,68
173034892,2,Gastric cancer,2,F,EXP,ipilimumab,2,PS,Pyrexia,2,M,OT,68
173041212,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Autoimmune hepatitis,2,M,OT,49
173041212,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Autoimmune hepatitis,2,M,LT,49
173041212,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Autoimmune hepatitis,2,M,HO,49
173041212,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Rash,2,M,OT,49
173041212,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Rash,2,M,LT,49
173041212,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Rash,2,M,HO,49
173041212,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,M,OT,49
173041212,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,M,LT,49
173041212,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Rhabdomyolysis,2,M,HO,49
173041212,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,SS,Autoimmune hepatitis,3,M,OT,49
173041212,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,SS,Autoimmune hepatitis,3,M,LT,49
173041212,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,SS,Autoimmune hepatitis,3,M,HO,49
173041212,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,SS,Rash,3,M,OT,49
173041212,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,SS,Rash,3,M,LT,49
173041212,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,SS,Rash,3,M,HO,49
173041212,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,SS,Rhabdomyolysis,3,M,OT,49
173041212,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,SS,Rhabdomyolysis,3,M,LT,49
173041212,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,SS,Rhabdomyolysis,3,M,HO,49
173047221,1,Head and neck cancer,1,I,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,F,OT,80
173047221,1,Head and neck cancer,1,I,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,F,DE,80
173052011,2,Product used for unknown indication,1,I,EXP,pomalidomide,2,SS,Gastrointestinal haemorrhage,2,M,LT,41
173052011,2,Product used for unknown indication,1,I,EXP,pomalidomide,2,SS,Gastrointestinal haemorrhage,2,M,HO,41
173052011,2,Product used for unknown indication,1,I,EXP,pomalidomide,2,SS,Gastrointestinal haemorrhage,2,M,OT,41
173053394,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Myocarditis,1,F,HO,56
173053394,1,Non-small cell lung cancer,4,F,EXP,nivolumab,1,PS,Myocarditis,1,F,OT,56
173053394,2,Non-small cell lung cancer,4,F,EXP,ipilimumab,2,SS,Myocarditis,2,F,HO,56
173053394,2,Non-small cell lung cancer,4,F,EXP,ipilimumab,2,SS,Myocarditis,2,F,OT,56
173055691,1,Bladder cancer,1,I,EXP,nivolumab,1,PS,Febrile neutropenia,1,F,OT,13
173055691,1,Bladder cancer,1,I,EXP,nivolumab,1,PS,Febrile neutropenia,1,F,HO,13
173055691,1,Bladder cancer,1,I,EXP,nivolumab,1,PS,Urinary tract infection,1,F,OT,13
173055691,1,Bladder cancer,1,I,EXP,nivolumab,1,PS,Urinary tract infection,1,F,HO,13
173056002,1,Gallbladder cancer,2,F,EXP,nivolumab,1,PS,Haematuria,1,M,OT,18
173056002,1,Gallbladder cancer,2,F,EXP,nivolumab,1,PS,Haematuria,1,M,HO,18
173056002,1,Gallbladder cancer,2,F,EXP,nivolumab,1,PS,Hemiparesis,1,M,OT,18
173056002,1,Gallbladder cancer,2,F,EXP,nivolumab,1,PS,Hemiparesis,1,M,HO,18
173056002,1,Gallbladder cancer,2,F,EXP,nivolumab,1,PS,Malnutrition,1,M,OT,18
173056002,1,Gallbladder cancer,2,F,EXP,nivolumab,1,PS,Malnutrition,1,M,HO,18
173056643,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Anaemia,1,M,HO,74
173056643,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Neutropenia,1,M,HO,74
173057531,1,B-cell lymphoma,1,I,EXP,pegfilgrastim,1,PS,Oral pain,1,F,HO,62
173059232,31,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,31,SS,Pancytopenia,31,M,HO,13
173059232,31,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,31,SS,Pertussis,31,M,HO,13
173059232,31,Acute lymphocytic leukaemia,2,F,EXP,thioguanine,31,SS,Streptococcal infection,31,M,HO,13
173059232,35,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,35,SS,Pancytopenia,35,M,HO,166
173059232,35,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,35,SS,Pertussis,35,M,HO,166
173059232,35,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,35,SS,Streptococcal infection,35,M,HO,166
173060122,1,Breast cancer metastatic,2,F,EXP,palbociclib,1,PS,Mental status changes,1,F,HO,268
173064251,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Death,1,M,DE,310
173064251,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Death,1,M,OT,310
173067452,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,3
173067452,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,OT,3
173067452,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Neutropenia,1,M,OT,3
173067452,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Sinusitis,1,M,OT,3
173071651,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,OT,1
173071651,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,DS,1
173071651,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Dupuytren's contracture,1,F,OT,1
173071651,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Dupuytren's contracture,1,F,DS,1
173071651,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Muscle fatigue,1,F,OT,1
173071651,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Muscle fatigue,1,F,DS,1
173071651,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,OT,1
173071651,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,DS,1
173071651,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Tendonitis,1,F,OT,1
173071651,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Tendonitis,1,F,DS,1
173072961,32,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,32,SS,Pancytopenia,32,M,HO,22
173072961,32,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,32,SS,Pertussis,32,M,HO,22
173072961,32,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,32,SS,Pyrexia,32,M,HO,22
173072961,32,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,32,SS,Streptococcal infection,32,M,HO,22
173072961,40,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,40,SS,Pancytopenia,40,M,HO,8
173072961,40,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,40,SS,Pertussis,40,M,HO,8
173072961,40,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,40,SS,Pyrexia,40,M,HO,8
173072961,40,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,40,SS,Streptococcal infection,40,M,HO,8
173075043,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Intentional product use issue,1,M,OT,15
173075043,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Intentional product use issue,1,M,HO,15
173075043,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Liver disorder,1,M,OT,15
173075043,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Liver disorder,1,M,HO,15
173075043,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Liver injury,1,M,OT,15
173075043,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Liver injury,1,M,HO,15
173075043,4,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,4,PS,Intentional product use issue,4,M,OT,15
173075043,4,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,4,PS,Intentional product use issue,4,M,HO,15
173075043,4,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,4,PS,Liver disorder,4,M,OT,15
173075043,4,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,4,PS,Liver disorder,4,M,HO,15
173075043,4,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,4,PS,Liver injury,4,M,OT,15
173075043,4,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,4,PS,Liver injury,4,M,HO,15
173075793,5,Breast cancer metastatic,3,F,EXP,palbociclib,5,SS,Sepsis,5,F,HO,1045
173075793,5,Breast cancer metastatic,3,F,EXP,palbociclib,5,SS,Urinary tract infection,5,F,HO,1045
173075932,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Cytokine release syndrome,1,M,LT,1
173075932,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Cytokine release syndrome,1,M,HO,1
173075932,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Hepatic function abnormal,1,M,LT,1
173075932,1,Acute lymphocytic leukaemia refractory,2,F,PER,blinatumomab,1,PS,Hepatic function abnormal,1,M,HO,1
173076451,1,Malignant glioma,1,I,EXP,entrectinib,1,PS,Aspiration,1,M,OT,151
173076451,1,Malignant glioma,1,I,EXP,entrectinib,1,PS,Urinary tract infection,1,M,OT,151
173076511,1,Non-small cell lung cancer,1,I,EXP,brigatinib,1,PS,Drug ineffective,1,F,OT,163
173076511,1,Non-small cell lung cancer,1,I,EXP,brigatinib,1,PS,Drug ineffective,1,F,DE,163
173076511,1,Non-small cell lung cancer,1,I,EXP,brigatinib,1,PS,Non-small cell lung cancer,1,F,OT,163
173076511,1,Non-small cell lung cancer,1,I,EXP,brigatinib,1,PS,Non-small cell lung cancer,1,F,DE,163
173076713,1,Metastatic malignant melanoma,3,F,EXP,selinexor,1,PS,Diarrhoea,1,M,HO,99
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Neutropenia,5,F,DE,18
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Neutropenia,5,F,HO,18
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Neutropenia,5,F,OT,18
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Plasma cell myeloma,5,F,DE,18
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Plasma cell myeloma,5,F,HO,18
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Plasma cell myeloma,5,F,OT,18
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Pneumonia,5,F,DE,18
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Pneumonia,5,F,HO,18
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Pneumonia,5,F,OT,18
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Septic shock,5,F,DE,18
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Septic shock,5,F,HO,18
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Septic shock,5,F,OT,18
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Thrombocytopenia,5,F,DE,18
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Thrombocytopenia,5,F,HO,18
173077591,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Thrombocytopenia,5,F,OT,18
173077791,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Lower respiratory tract infection,5,M,HO,31
173077791,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Streptococcal infection,5,M,HO,31
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Alopecia,3,F,HO,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Alopecia,3,F,OT,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Constipation,3,F,HO,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Constipation,3,F,OT,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Febrile neutropenia,3,F,HO,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Febrile neutropenia,3,F,OT,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Headache,3,F,HO,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Headache,3,F,OT,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Nausea,3,F,HO,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Nausea,3,F,OT,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Neurotoxicity,3,F,HO,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Neurotoxicity,3,F,OT,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Oropharyngeal pain,3,F,HO,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Oropharyngeal pain,3,F,OT,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Rectal haemorrhage,3,F,HO,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Rectal haemorrhage,3,F,OT,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Stomatitis,3,F,HO,132
173078541,3,Breast cancer,1,I,EXP,denosumab,3,SS,Stomatitis,3,F,OT,132
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Alopecia,17,F,HO,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Alopecia,17,F,OT,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Constipation,17,F,HO,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Constipation,17,F,OT,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Febrile neutropenia,17,F,HO,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Febrile neutropenia,17,F,OT,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Headache,17,F,HO,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Headache,17,F,OT,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Nausea,17,F,HO,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Nausea,17,F,OT,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Neurotoxicity,17,F,HO,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Neurotoxicity,17,F,OT,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Oropharyngeal pain,17,F,HO,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Oropharyngeal pain,17,F,OT,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Rectal haemorrhage,17,F,HO,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Rectal haemorrhage,17,F,OT,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Stomatitis,17,F,HO,6
173078541,17,Product used for unknown indication,1,I,EXP,denosumab,17,SS,Stomatitis,17,F,OT,6
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Alopecia,20,F,HO,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Alopecia,20,F,OT,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Constipation,20,F,HO,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Constipation,20,F,OT,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Febrile neutropenia,20,F,HO,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Febrile neutropenia,20,F,OT,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Headache,20,F,HO,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Headache,20,F,OT,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Nausea,20,F,HO,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Nausea,20,F,OT,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Neurotoxicity,20,F,HO,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Neurotoxicity,20,F,OT,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Oropharyngeal pain,20,F,HO,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Oropharyngeal pain,20,F,OT,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Rectal haemorrhage,20,F,HO,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Rectal haemorrhage,20,F,OT,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Stomatitis,20,F,HO,104
173078541,20,Product used for unknown indication,1,I,EXP,denosumab,20,SS,Stomatitis,20,F,OT,104
173078651,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Anaemia,1,M,HO,98
173080792,1,Breast cancer,2,F,EXP,palbociclib,1,PS,Vertigo CNS origin,1,F,HO,608
173081722,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Pneumonia,1,M,HO,13
173081765,1,Plasma cell myeloma,5,F,EXP,selinexor,1,PS,Pneumonia,1,M,HO,18
173083051,3,Breast cancer,1,I,EXP,alpelisib,3,SS,Breast cancer,3,F,OT,11
173083051,3,Breast cancer,1,I,EXP,alpelisib,3,SS,Drug ineffective,3,F,OT,11
173083051,3,Breast cancer,1,I,EXP,alpelisib,3,SS,Liver disorder,3,F,OT,11
173083051,3,Breast cancer,1,I,EXP,alpelisib,3,SS,Malignant neoplasm progression,3,F,OT,11
173083051,3,Breast cancer,1,I,EXP,alpelisib,3,SS,Rash,3,F,OT,11
173083051,3,Breast cancer,1,I,EXP,alpelisib,3,SS,Rash erythematous,3,F,OT,11
173083051,3,Breast cancer,1,I,EXP,alpelisib,3,SS,Skin toxicity,3,F,OT,11
173083092,3,Breast cancer female,2,F,EXP,palbociclib,3,SS,Alopecia,3,F,OT,88
173083092,3,Breast cancer female,2,F,EXP,palbociclib,3,SS,Asthenia,3,F,OT,88
173083092,3,Breast cancer female,2,F,EXP,palbociclib,3,SS,Back pain,3,F,OT,88
173083092,3,Breast cancer female,2,F,EXP,palbociclib,3,SS,Dyspnoea,3,F,OT,88
173083092,3,Breast cancer female,2,F,EXP,palbociclib,3,SS,Musculoskeletal chest pain,3,F,OT,88
173083092,3,Breast cancer female,2,F,EXP,palbociclib,3,SS,Musculoskeletal discomfort,3,F,OT,88
173083092,3,Breast cancer female,2,F,EXP,palbociclib,3,SS,Neutropenia,3,F,OT,88
173083092,3,Breast cancer female,2,F,EXP,palbociclib,3,SS,Spinal pain,3,F,OT,88
173083382,3,Plasma cell myeloma,2,F,EXP,thalidomide,3,SS,Pneumonia,3,M,HO,103
173084131,23,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,23,C,Gastrointestinal haemorrhage,23,M,LT,77
173084131,23,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,23,C,Gastrointestinal haemorrhage,23,M,HO,77
173084131,23,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,23,C,Sepsis,23,M,LT,77
173084131,23,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,23,C,Sepsis,23,M,HO,77
173095381,19,Product used for unknown indication,1,I,PER,carfilzomib,19,C,Cytopenia,19,M,DS,693
173095381,19,Product used for unknown indication,1,I,PER,carfilzomib,19,C,Cytopenia,19,M,HO,693
173095381,19,Product used for unknown indication,1,I,PER,carfilzomib,19,C,Plasma cell myeloma,19,M,DS,693
173095381,19,Product used for unknown indication,1,I,PER,carfilzomib,19,C,Plasma cell myeloma,19,M,HO,693
173095381,19,Product used for unknown indication,1,I,PER,carfilzomib,19,C,Tumour lysis syndrome,19,M,DS,693
173095381,19,Product used for unknown indication,1,I,PER,carfilzomib,19,C,Tumour lysis syndrome,19,M,HO,693
173112745,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,PS,Immune-mediated hepatitis,2,M,OT,49
173112745,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,PS,Immune-mediated hepatitis,2,M,HO,49
173112745,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,PS,Immune-mediated hepatitis,2,M,LT,49
173112745,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,PS,Rash,2,M,OT,49
173112745,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,PS,Rash,2,M,HO,49
173112745,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,PS,Rash,2,M,LT,49
173112745,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,PS,Rhabdomyolysis,2,M,OT,49
173112745,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,PS,Rhabdomyolysis,2,M,HO,49
173112745,2,Metastatic renal cell carcinoma,5,F,EXP,ipilimumab,2,PS,Rhabdomyolysis,2,M,LT,49
173112745,3,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,3,SS,Immune-mediated hepatitis,3,M,OT,49
173112745,3,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,3,SS,Immune-mediated hepatitis,3,M,HO,49
173112745,3,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,3,SS,Immune-mediated hepatitis,3,M,LT,49
173112745,3,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,3,SS,Rash,3,M,OT,49
173112745,3,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,3,SS,Rash,3,M,HO,49
173112745,3,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,3,SS,Rash,3,M,LT,49
173112745,3,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,3,SS,Rhabdomyolysis,3,M,OT,49
173112745,3,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,3,SS,Rhabdomyolysis,3,M,HO,49
173112745,3,Metastatic renal cell carcinoma,5,F,EXP,nivolumab,3,SS,Rhabdomyolysis,3,M,LT,49
173113072,2,Hodgkin's disease,2,F,EXP,nivolumab,2,PS,Pneumonia,2,F,HO,356
173113072,2,Hodgkin's disease,2,F,EXP,nivolumab,2,PS,Pneumonia,2,F,OT,356
173117352,2,Malignant melanoma,2,F,EXP,nivolumab,2,PS,Vertigo,2,F,HO,14
173127511,5,Product used for unknown indication,1,I,EXP,brentuximab vedotin,5,C,Cytokine release syndrome,5,F,OT,37
173127511,5,Product used for unknown indication,1,I,EXP,brentuximab vedotin,5,C,Erythema,5,F,OT,37
173127511,5,Product used for unknown indication,1,I,EXP,brentuximab vedotin,5,C,Hot flush,5,F,OT,37
173127511,5,Product used for unknown indication,1,I,EXP,brentuximab vedotin,5,C,Neurotoxicity,5,F,OT,37
173127511,5,Product used for unknown indication,1,I,EXP,brentuximab vedotin,5,C,Rash,5,F,OT,37
173130902,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Neutropenia,2,F,LT,245
173130902,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Neutropenia,2,F,OT,245
173130902,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Neutrophil count decreased,2,F,LT,245
173130902,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Neutrophil count decreased,2,F,OT,245
173130902,3,Plasma cell myeloma,2,F,EXP,thalidomide,3,SS,Neutropenia,3,F,LT,245
173130902,3,Plasma cell myeloma,2,F,EXP,thalidomide,3,SS,Neutropenia,3,F,OT,245
173130902,3,Plasma cell myeloma,2,F,EXP,thalidomide,3,SS,Neutrophil count decreased,3,F,LT,245
173130902,3,Plasma cell myeloma,2,F,EXP,thalidomide,3,SS,Neutrophil count decreased,3,F,OT,245
173132871,1,B-cell lymphoma,1,I,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,HO,3
173132871,1,B-cell lymphoma,1,I,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,OT,3
173132871,1,B-cell lymphoma,1,I,EXP,nivolumab,1,PS,Pseudomonas infection,1,M,HO,3
173132871,1,B-cell lymphoma,1,I,EXP,nivolumab,1,PS,Pseudomonas infection,1,M,OT,3
173132871,1,B-cell lymphoma,1,I,EXP,nivolumab,1,PS,Tumour associated fever,1,M,HO,3
173132871,1,B-cell lymphoma,1,I,EXP,nivolumab,1,PS,Tumour associated fever,1,M,OT,3
173132952,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Clostridium difficile infection,1,F,OT,5
173132952,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Clostridium difficile infection,1,F,HO,5
173132952,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Urethral fistula,1,F,OT,5
173132952,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Urethral fistula,1,F,HO,5
173137821,2,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,2,SS,CAR T-cell-related encephalopathy syndrome,2,F,LT,4
173137821,2,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,2,SS,CAR T-cell-related encephalopathy syndrome,2,F,OT,4
173137821,2,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,2,SS,Cytokine release syndrome,2,F,LT,4
173137821,2,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,2,SS,Cytokine release syndrome,2,F,OT,4
173137821,2,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,2,SS,Disease progression,2,F,LT,4
173137821,2,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,2,SS,Disease progression,2,F,OT,4
173139622,1,Plasma cell myeloma,2,F,PER,lenalidomide,1,PS,Acute kidney injury,1,F,HO,110
173139622,1,Plasma cell myeloma,2,F,PER,lenalidomide,1,PS,Dehydration,1,F,HO,110
173140632,1,Non-small cell lung cancer,2,F,EXP,selinexor,1,PS,Dehydration,1,M,HO,35
173140632,1,Non-small cell lung cancer,2,F,EXP,selinexor,1,PS,Dehydration,1,M,DE,35
173140632,1,Non-small cell lung cancer,2,F,EXP,selinexor,1,PS,Diarrhoea,1,M,HO,35
173140632,1,Non-small cell lung cancer,2,F,EXP,selinexor,1,PS,Diarrhoea,1,M,DE,35
173140632,1,Non-small cell lung cancer,2,F,EXP,selinexor,1,PS,Neutropenia,1,M,HO,35
173140632,1,Non-small cell lung cancer,2,F,EXP,selinexor,1,PS,Neutropenia,1,M,DE,35
173140632,1,Non-small cell lung cancer,2,F,EXP,selinexor,1,PS,Respiratory failure,1,M,HO,35
173140632,1,Non-small cell lung cancer,2,F,EXP,selinexor,1,PS,Respiratory failure,1,M,DE,35
173140682,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Clostridium difficile infection,1,F,HO,61
173143083,5,Breast cancer,3,F,EXP,filgrastim,5,SS,Atrial fibrillation,5,F,HO,24
173143083,5,Breast cancer,3,F,EXP,filgrastim,5,SS,Cardiac failure,5,F,HO,24
173144941,1,Glioblastoma,1,I,EXP,ipilimumab,1,PS,Lower respiratory tract infection,1,M,HO,5
173144941,1,Glioblastoma,1,I,EXP,ipilimumab,1,PS,Lower respiratory tract infection,1,M,OT,5
173144941,1,Glioblastoma,1,I,EXP,ipilimumab,1,PS,Pulmonary embolism,1,M,HO,5
173144941,1,Glioblastoma,1,I,EXP,ipilimumab,1,PS,Pulmonary embolism,1,M,OT,5
173144941,1,Glioblastoma,1,I,EXP,ipilimumab,1,PS,Seizure,1,M,HO,5
173144941,1,Glioblastoma,1,I,EXP,ipilimumab,1,PS,Seizure,1,M,OT,5
173144941,1,Glioblastoma,1,I,EXP,ipilimumab,1,PS,Urinary retention,1,M,HO,5
173144941,1,Glioblastoma,1,I,EXP,ipilimumab,1,PS,Urinary retention,1,M,OT,5
173146351,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Cerebral infarction,1,M,OT,359
173146351,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Cerebral infarction,1,M,LT,359
173146351,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Cerebral infarction,1,M,HO,359
173146351,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Cerebral infarction,1,M,DE,359
173146551,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Nocardia test positive,1,M,HO,110
173146551,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Pneumonia,1,M,HO,110
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Anxiety disorder,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Anxiety disorder,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Body dysmorphic disorder,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Body dysmorphic disorder,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Cholestasis,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Cholestasis,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Constipation,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Constipation,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Death,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Death,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Decubitus ulcer,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Decubitus ulcer,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Diarrhoea,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Diarrhoea,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Disease progression,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Disease progression,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Dyspepsia,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Dyspepsia,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,General physical health deterioration,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,General physical health deterioration,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Hepatic cirrhosis,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Hepatic cirrhosis,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Hepatocellular injury,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Hepatocellular injury,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Joint ankylosis,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Joint ankylosis,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Loss of personal independence in daily activities,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Loss of personal independence in daily activities,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Malnutrition,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Malnutrition,5,F,HO,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Sleep disorder,5,F,DE,18
173146721,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Sleep disorder,5,F,HO,18
173147242,2,Prostate cancer metastatic,2,F,EXP,enzalutamide,2,SS,Hypovolaemia,2,M,HO,97
173147242,4,Prophylaxis,2,F,EXP,denosumab,4,C,Hypovolaemia,4,M,HO,889
173152531,2,Gastritis prophylaxis,1,I,EXP,granisetron,2,C,Dyspnoea,2,F,DE,2
173152711,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Death,1,F,DE,391
173152711,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Death,1,F,OT,391
173152711,2,Product used for unknown indication,1,I,EXP,ipilimumab,2,SS,Death,2,F,DE,391
173152711,2,Product used for unknown indication,1,I,EXP,ipilimumab,2,SS,Death,2,F,OT,391
173155592,2,Prostate cancer,2,F,EXP,enzalutamide,2,SS,Cerebrovascular accident,2,M,HO,2514
173155592,2,Prostate cancer,2,F,EXP,enzalutamide,2,SS,Myocardial infarction,2,M,HO,2514
173161071,2,Prostate cancer,1,I,EXP,cabazitaxel,2,SS,Neutropenia,2,M,OT,7
173163121,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Drug ineffective,1,M,OT,6
173163121,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Drug ineffective,1,M,LT,6
173163121,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutropenia,1,M,OT,6
173163121,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutropenia,1,M,LT,6
173163121,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,M,OT,6
173163121,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,M,LT,6
173163661,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Drug ineffective,1,F,OT,5
173163661,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Drug ineffective,1,F,LT,5
173163661,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutropenia,1,F,OT,5
173163661,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutropenia,1,F,LT,5
173163661,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,F,OT,5
173163661,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,F,LT,5
173163683,1,Neutropenia,3,F,EXP,pegfilgrastim,1,PS,Drug ineffective,1,M,OT,7
173163683,1,Neutropenia,3,F,EXP,pegfilgrastim,1,PS,Drug ineffective,1,M,LT,7
173163683,1,Neutropenia,3,F,EXP,pegfilgrastim,1,PS,Drug ineffective,1,M,HO,7
173163683,1,Neutropenia,3,F,EXP,pegfilgrastim,1,PS,Neutropenia,1,M,OT,7
173163683,1,Neutropenia,3,F,EXP,pegfilgrastim,1,PS,Neutropenia,1,M,LT,7
173163683,1,Neutropenia,3,F,EXP,pegfilgrastim,1,PS,Neutropenia,1,M,HO,7
173163683,1,Neutropenia,3,F,EXP,pegfilgrastim,1,PS,Pancytopenia,1,M,OT,7
173163683,1,Neutropenia,3,F,EXP,pegfilgrastim,1,PS,Pancytopenia,1,M,LT,7
173163683,1,Neutropenia,3,F,EXP,pegfilgrastim,1,PS,Pancytopenia,1,M,HO,7
173163683,1,Neutropenia,3,F,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,M,OT,7
173163683,1,Neutropenia,3,F,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,M,LT,7
173163683,1,Neutropenia,3,F,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,M,HO,7
173164114,1,Neoplasm malignant,4,F,EXP,trametinib,1,PS,Influenza like illness,1,M,HO,1621
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Diverticulitis,17,F,OT,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Diverticulitis,17,F,HO,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Dyspnoea,17,F,OT,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Dyspnoea,17,F,HO,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Nausea,17,F,OT,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Nausea,17,F,HO,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Neutropenia,17,F,OT,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Neutropenia,17,F,HO,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Plasma cell myeloma,17,F,OT,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Plasma cell myeloma,17,F,HO,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Sinus tachycardia,17,F,OT,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Sinus tachycardia,17,F,HO,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Thrombocytopenia,17,F,OT,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Thrombocytopenia,17,F,HO,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Toothache,17,F,OT,17
173166651,17,Plasma cell myeloma,1,I,EXP,daratumumab,17,C,Toothache,17,F,HO,17
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Diverticulitis,25,F,OT,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Diverticulitis,25,F,HO,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Dyspnoea,25,F,OT,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Dyspnoea,25,F,HO,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Nausea,25,F,OT,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Nausea,25,F,HO,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Neutropenia,25,F,OT,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Neutropenia,25,F,HO,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Plasma cell myeloma,25,F,OT,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Plasma cell myeloma,25,F,HO,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Sinus tachycardia,25,F,OT,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Sinus tachycardia,25,F,HO,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Thrombocytopenia,25,F,OT,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Thrombocytopenia,25,F,HO,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Toothache,25,F,OT,3
173166651,25,Plasma cell myeloma,1,I,EXP,nivolumab,25,C,Toothache,25,F,HO,3
173170241,2,Oesophageal adenocarcinoma,1,I,EXP,ramucirumab,2,SS,Meningism,2,M,HO,87
173180341,1,Lymphoma,1,I,PER,carfilzomib,1,PS,Atrioventricular block,1,M,HO,127
173180341,4,Lymphoma,1,I,PER,chop,4,SS,Atrioventricular block,4,M,HO,127
173181842,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Dementia,1,F,HO,1190
173181842,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,C,Dementia,3,F,HO,1190
173181961,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Influenza,3,F,HO,46
173181961,7,Plasma cell myeloma,1,I,EXP,carfilzomib,7,SS,Influenza,7,F,HO,46
173182823,2,Acute lymphocytic leukaemia,3,F,EXP,inotuzumab ozogamicin,2,SS,Multiple organ dysfunction syndrome,2,F,DE,62
173183653,1,Lung neoplasm malignant,3,F,EXP,lorlatinib,1,PS,Bronchial haemorrhage,1,M,HO,156
173183923,1,Metaplastic breast carcinoma,3,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,F,HO,570
173183923,1,Metaplastic breast carcinoma,3,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,F,OT,570
173183923,1,Metaplastic breast carcinoma,3,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,HO,570
173183923,1,Metaplastic breast carcinoma,3,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,OT,570
173183923,1,Metaplastic breast carcinoma,3,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,570
173183923,1,Metaplastic breast carcinoma,3,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,570
173183923,1,Metaplastic breast carcinoma,3,F,EXP,nivolumab,1,PS,Presyncope,1,F,HO,570
173183923,1,Metaplastic breast carcinoma,3,F,EXP,nivolumab,1,PS,Presyncope,1,F,OT,570
173183923,1,Metaplastic breast carcinoma,3,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,F,HO,570
173183923,1,Metaplastic breast carcinoma,3,F,EXP,nivolumab,1,PS,Rash maculo-papular,1,F,OT,570
173183923,1,Metaplastic breast carcinoma,3,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,570
173183923,1,Metaplastic breast carcinoma,3,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,570
173183923,2,Metaplastic breast carcinoma,3,F,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,F,HO,570
173183923,2,Metaplastic breast carcinoma,3,F,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,F,OT,570
173183923,2,Metaplastic breast carcinoma,3,F,EXP,ipilimumab,2,SS,Hypokalaemia,2,F,HO,570
173183923,2,Metaplastic breast carcinoma,3,F,EXP,ipilimumab,2,SS,Hypokalaemia,2,F,OT,570
173183923,2,Metaplastic breast carcinoma,3,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,F,HO,570
173183923,2,Metaplastic breast carcinoma,3,F,EXP,ipilimumab,2,SS,Hyponatraemia,2,F,OT,570
173183923,2,Metaplastic breast carcinoma,3,F,EXP,ipilimumab,2,SS,Presyncope,2,F,HO,570
173183923,2,Metaplastic breast carcinoma,3,F,EXP,ipilimumab,2,SS,Presyncope,2,F,OT,570
173183923,2,Metaplastic breast carcinoma,3,F,EXP,ipilimumab,2,SS,Rash maculo-papular,2,F,HO,570
173183923,2,Metaplastic breast carcinoma,3,F,EXP,ipilimumab,2,SS,Rash maculo-papular,2,F,OT,570
173183923,2,Metaplastic breast carcinoma,3,F,EXP,ipilimumab,2,SS,Vomiting,2,F,HO,570
173183923,2,Metaplastic breast carcinoma,3,F,EXP,ipilimumab,2,SS,Vomiting,2,F,OT,570
173184042,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Cardiac failure,1,F,HO,187
173184042,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Cardiac failure,1,F,DE,187
173184042,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Influenza,1,F,HO,187
173184042,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Influenza,1,F,DE,187
173184042,3,Plasma cell myeloma,2,F,EXP,carfilzomib,3,SS,Cardiac failure,3,F,HO,187
173184042,3,Plasma cell myeloma,2,F,EXP,carfilzomib,3,SS,Cardiac failure,3,F,DE,187
173184042,3,Plasma cell myeloma,2,F,EXP,carfilzomib,3,SS,Influenza,3,F,HO,187
173184042,3,Plasma cell myeloma,2,F,EXP,carfilzomib,3,SS,Influenza,3,F,DE,187
173184042,9,Plasma cell myeloma,2,F,EXP,filgrastim,9,C,Cardiac failure,9,F,HO,6
173184042,9,Plasma cell myeloma,2,F,EXP,filgrastim,9,C,Cardiac failure,9,F,DE,6
173184042,9,Plasma cell myeloma,2,F,EXP,filgrastim,9,C,Influenza,9,F,HO,6
173184042,9,Plasma cell myeloma,2,F,EXP,filgrastim,9,C,Influenza,9,F,DE,6
173184472,2,Mantle cell lymphoma,2,F,EXP,carfilzomib,2,SS,Blood bilirubin increased,2,M,HO,68
173184472,2,Mantle cell lymphoma,2,F,EXP,carfilzomib,2,SS,Blood bilirubin increased,2,M,LT,68
173184472,2,Mantle cell lymphoma,2,F,EXP,carfilzomib,2,SS,Hepatotoxicity,2,M,HO,68
173184472,2,Mantle cell lymphoma,2,F,EXP,carfilzomib,2,SS,Hepatotoxicity,2,M,LT,68
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Anaemia,1,F,LT,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Anaemia,1,F,OT,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Anaemia,1,F,HO,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Anaemia,1,F,DS,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Aortic valve disease,1,F,LT,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Aortic valve disease,1,F,OT,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Aortic valve disease,1,F,HO,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Aortic valve disease,1,F,DS,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Arteriosclerosis,1,F,LT,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Arteriosclerosis,1,F,OT,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Arteriosclerosis,1,F,HO,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Arteriosclerosis,1,F,DS,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Fatigue,1,F,LT,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Fatigue,1,F,OT,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Fatigue,1,F,HO,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Fatigue,1,F,DS,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Melaena,1,F,LT,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Melaena,1,F,OT,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Melaena,1,F,HO,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Melaena,1,F,DS,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Squamous cell carcinoma,1,F,LT,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Squamous cell carcinoma,1,F,OT,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Squamous cell carcinoma,1,F,HO,2406
173185201,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Squamous cell carcinoma,1,F,DS,2406
173186422,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Septic shock,1,M,DE,22
173186422,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Septic shock,1,M,HO,22
173186422,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Septic shock,1,M,LT,22
173186422,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Septic shock,1,M,OT,22
173188632,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Generalised oedema,1,M,HO,898
173188903,16,Plasma cell myeloma,3,F,PER,carfilzomib,16,SS,Acute myocardial infarction,16,M,DE,194
173188903,16,Plasma cell myeloma,3,F,PER,carfilzomib,16,SS,Acute myocardial infarction,16,M,HO,194
173188903,16,Plasma cell myeloma,3,F,PER,carfilzomib,16,SS,Myocardial infarction,16,M,DE,194
173188903,16,Plasma cell myeloma,3,F,PER,carfilzomib,16,SS,Myocardial infarction,16,M,HO,194
173188903,17,Plasma cell myeloma,3,F,PER,daratumumab,17,SS,Acute myocardial infarction,17,M,DE,1223
173188903,17,Plasma cell myeloma,3,F,PER,daratumumab,17,SS,Acute myocardial infarction,17,M,HO,1223
173188903,17,Plasma cell myeloma,3,F,PER,daratumumab,17,SS,Myocardial infarction,17,M,DE,1223
173188903,17,Plasma cell myeloma,3,F,PER,daratumumab,17,SS,Myocardial infarction,17,M,HO,1223
173194251,6,Bone cancer,1,I,EXP,doxorubicin hydrochloride liposome,6,SS,Bone marrow failure,6,M,HO,10
173194251,6,Bone cancer,1,I,EXP,doxorubicin hydrochloride liposome,6,SS,Bone marrow failure,6,M,OT,10
173194251,6,Bone cancer,1,I,EXP,doxorubicin hydrochloride liposome,6,SS,Neutropenia,6,M,HO,10
173194251,6,Bone cancer,1,I,EXP,doxorubicin hydrochloride liposome,6,SS,Neutropenia,6,M,OT,10
173194251,6,Bone cancer,1,I,EXP,doxorubicin hydrochloride liposome,6,SS,Platelet count decreased,6,M,HO,10
173194251,6,Bone cancer,1,I,EXP,doxorubicin hydrochloride liposome,6,SS,Platelet count decreased,6,M,OT,10
173194251,6,Bone cancer,1,I,EXP,doxorubicin hydrochloride liposome,6,SS,White blood cell count decreased,6,M,HO,10
173194251,6,Bone cancer,1,I,EXP,doxorubicin hydrochloride liposome,6,SS,White blood cell count decreased,6,M,OT,10
173195111,16,Plasma cell myeloma,1,I,PER,daratumumab,16,SS,Pneumonia viral,16,M,HO,171
173195111,16,Plasma cell myeloma,1,I,PER,daratumumab,16,SS,Respiratory failure,16,M,HO,171
173195111,16,Plasma cell myeloma,1,I,PER,daratumumab,16,SS,Superinfection bacterial,16,M,HO,171
173196601,1,Osteoporosis,1,I,PER,zoledronic acid,1,PS,Cerebral infarction,1,F,DE,1
173196601,1,Osteoporosis,1,I,PER,zoledronic acid,1,PS,Cerebral infarction,1,F,HO,1
173196601,1,Osteoporosis,1,I,PER,zoledronic acid,1,PS,Generalised tonic-clonic seizure,1,F,DE,1
173196601,1,Osteoporosis,1,I,PER,zoledronic acid,1,PS,Generalised tonic-clonic seizure,1,F,HO,1
173196601,1,Osteoporosis,1,I,PER,zoledronic acid,1,PS,Hemiparesis,1,F,DE,1
173196601,1,Osteoporosis,1,I,PER,zoledronic acid,1,PS,Hemiparesis,1,F,HO,1
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Altered state of consciousness,1,F,OT,115
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Altered state of consciousness,1,F,LT,115
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Altered state of consciousness,1,F,DE,115
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Blood lactate dehydrogenase increased,1,F,OT,115
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Blood lactate dehydrogenase increased,1,F,LT,115
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Blood lactate dehydrogenase increased,1,F,DE,115
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Constipation,1,F,OT,115
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Constipation,1,F,LT,115
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Constipation,1,F,DE,115
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Hyperkalaemia,1,F,OT,115
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Hyperkalaemia,1,F,LT,115
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Hyperkalaemia,1,F,DE,115
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Insomnia,1,F,OT,115
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Insomnia,1,F,LT,115
173196622,1,Myelodysplastic syndrome,2,F,PER,darbepoetin alfa,1,PS,Insomnia,1,F,DE,115
173196742,1,Aplastic anaemia,2,F,PER,romiplostim,1,PS,Hypertension,1,M,HO,35
173196742,1,Aplastic anaemia,2,F,PER,romiplostim,1,PS,Hypertension,1,M,DS,35
173196742,1,Aplastic anaemia,2,F,PER,romiplostim,1,PS,Hypertension,1,M,OT,35
173196742,1,Aplastic anaemia,2,F,PER,romiplostim,1,PS,Renal impairment,1,M,HO,35
173196742,1,Aplastic anaemia,2,F,PER,romiplostim,1,PS,Renal impairment,1,M,DS,35
173196742,1,Aplastic anaemia,2,F,PER,romiplostim,1,PS,Renal impairment,1,M,OT,35
173198045,2,Plasma cell myeloma,5,F,EXP,daratumumab,2,SS,Mucormycosis,2,M,HO,55
173198045,3,Plasma cell myeloma,5,F,EXP,lenalidomide,3,SS,Mucormycosis,3,M,HO,55
173199201,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Generalised oedema,1,M,HO,3
173199201,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Generalised oedema,1,M,DE,3
173199221,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,SS,Colitis,7,M,HO,13
173202092,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,15
173202092,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,15
173202092,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,DE,15
173202092,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Cholecystitis,1,M,OT,15
173202092,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Cholecystitis,1,M,HO,15
173202092,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Cholecystitis,1,M,DE,15
173202092,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Infection,1,M,OT,15
173202092,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Infection,1,M,HO,15
173202092,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Infection,1,M,DE,15
173202092,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,OT,15
173202092,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,HO,15
173202092,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,DE,15
173202092,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,OT,15
173202092,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,HO,15
173202092,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,DE,15
173202092,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Cholecystitis,2,M,OT,15
173202092,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Cholecystitis,2,M,HO,15
173202092,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Cholecystitis,2,M,DE,15
173202092,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Infection,2,M,OT,15
173202092,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Infection,2,M,HO,15
173202092,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Infection,2,M,DE,15
173202092,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,M,OT,15
173202092,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,M,HO,15
173202092,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Multiple organ dysfunction syndrome,2,M,DE,15
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Asthenia,1,M,HO,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Back pain,1,M,HO,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Back pain,1,M,OT,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Depression,1,M,HO,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Depression,1,M,OT,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Fatigue,1,M,HO,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Gait inability,1,M,HO,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Gait inability,1,M,OT,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Limb discomfort,1,M,HO,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Limb discomfort,1,M,OT,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Neuropathy peripheral,1,M,HO,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Neuropathy peripheral,1,M,OT,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Product use in unapproved indication,1,M,HO,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Product use in unapproved indication,1,M,OT,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Sciatica,1,M,HO,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Sciatica,1,M,OT,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Tendon injury,1,M,HO,967
173215571,1,Ankle fracture,1,I,EXP,enzalutamide,1,PS,Tendon injury,1,M,OT,967
173228804,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Enterococcal infection,1,M,DE,59
173228804,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Enterococcal infection,1,M,LT,59
173228804,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Enterococcal infection,1,M,HO,59
173228804,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Enterococcal infection,1,M,OT,59
173228804,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Lung infiltration,1,M,DE,59
173228804,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Lung infiltration,1,M,LT,59
173228804,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Lung infiltration,1,M,HO,59
173228804,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Lung infiltration,1,M,OT,59
173228804,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Sepsis,1,M,DE,59
173228804,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Sepsis,1,M,LT,59
173228804,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,59
173228804,1,Adenocarcinoma gastric,4,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,59
173228804,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Enterococcal infection,3,M,DE,59
173228804,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Enterococcal infection,3,M,LT,59
173228804,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Enterococcal infection,3,M,HO,59
173228804,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Enterococcal infection,3,M,OT,59
173228804,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Lung infiltration,3,M,DE,59
173228804,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Lung infiltration,3,M,LT,59
173228804,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Lung infiltration,3,M,HO,59
173228804,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Lung infiltration,3,M,OT,59
173228804,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Sepsis,3,M,DE,59
173228804,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Sepsis,3,M,LT,59
173228804,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Sepsis,3,M,HO,59
173228804,3,Adenocarcinoma gastric,4,F,EXP,ipilimumab,3,SS,Sepsis,3,M,OT,59
173234841,1,Metastatic malignant melanoma,1,I,EXP,ipilimumab,1,PS,Haemophagocytic lymphohistiocytosis,1,F,OT,66
173234841,1,Metastatic malignant melanoma,1,I,EXP,ipilimumab,1,PS,Haemophagocytic lymphohistiocytosis,1,F,LT,66
173234841,1,Metastatic malignant melanoma,1,I,EXP,ipilimumab,1,PS,Off label use,1,F,OT,66
173234841,1,Metastatic malignant melanoma,1,I,EXP,ipilimumab,1,PS,Off label use,1,F,LT,66
173235071,2,Plasma cell myeloma,1,I,PER,carfilzomib,2,SS,Syncope,2,F,HO,62
173239562,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Delirium,1,M,OT,125
173239562,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Delirium,1,M,HO,125
173242541,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Bone marrow failure,5,M,OT,7
173242541,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Chest discomfort,5,M,OT,7
173242541,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Dizziness,5,M,OT,7
173242541,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Nausea,5,M,OT,7
173242541,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Visual impairment,5,M,OT,7
173244171,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Epistaxis,1,M,HO,54
173244302,7,Plasma cell myeloma,2,F,EXP,daratumumab,7,SS,Bone marrow failure,7,M,OT,12
173244302,7,Plasma cell myeloma,2,F,EXP,daratumumab,7,SS,Influenza,7,M,OT,12
173245432,13,Plasma cell myeloma,2,F,PER,daratumumab,13,SS,Basal cell carcinoma,13,M,OT,1009
173249871,4,Plasma cell myeloma,1,I,EXP,daratumumab,4,SS,Toxic skin eruption,4,M,HO,108
173249932,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,HO,15
173249932,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,OT,15
173249932,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Lichenoid keratosis,1,M,HO,15
173249932,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Lichenoid keratosis,1,M,OT,15
173249932,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Autoimmune thyroiditis,2,M,HO,15
173249932,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Autoimmune thyroiditis,2,M,OT,15
173249932,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Lichenoid keratosis,2,M,HO,15
173249932,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Lichenoid keratosis,2,M,OT,15
173251062,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Cerebrovascular accident,1,F,HO,974
173252331,23,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,23,C,Gastrointestinal haemorrhage,23,M,LT,77
173252331,23,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,23,C,Gastrointestinal haemorrhage,23,M,HO,77
173252331,23,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,23,C,Sepsis,23,M,LT,77
173252331,23,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,23,C,Sepsis,23,M,HO,77
173253001,2,Product used for unknown indication,1,I,EXP,daratumumab,2,SS,Diverticulitis,2,M,HO,354
173254601,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Renal failure,1,M,HO,70
173257901,3,Metastatic malignant melanoma,1,I,EXP,encorafenib,3,SS,Supraventricular tachycardia,3,F,HO,24
173257901,4,Metastatic malignant melanoma,1,I,EXP,binimetinib,4,SS,Supraventricular tachycardia,4,F,HO,24
173258081,1,B-cell lymphoma,1,I,EXP,pegfilgrastim,1,PS,Gastroduodenal ulcer,1,M,OT,163
173258081,1,B-cell lymphoma,1,I,EXP,pegfilgrastim,1,PS,Gastroduodenal ulcer,1,M,HO,163
173258081,1,B-cell lymphoma,1,I,EXP,pegfilgrastim,1,PS,Neoplasm progression,1,M,OT,163
173258081,1,B-cell lymphoma,1,I,EXP,pegfilgrastim,1,PS,Neoplasm progression,1,M,HO,163
173265731,3,Neoplasm malignant,1,I,EXP,pegfilgrastim,3,C,Anaemia,3,M,HO,2
173265731,3,Neoplasm malignant,1,I,EXP,pegfilgrastim,3,C,Drug interaction,3,M,HO,2
173265731,3,Neoplasm malignant,1,I,EXP,pegfilgrastim,3,C,Neutropenia,3,M,HO,2
173265731,3,Neoplasm malignant,1,I,EXP,pegfilgrastim,3,C,Thrombocytopenia,3,M,HO,2
173273661,7,Neutropenia,1,I,EXP,pegfilgrastim,7,C,Syncope,7,F,HO,30
173275473,2,Malignant melanoma,3,F,EXP,trametinib,2,SS,Acute myeloid leukaemia,2,F,HO,139
173275473,2,Malignant melanoma,3,F,EXP,trametinib,2,SS,Acute myeloid leukaemia,2,F,OT,139
173275473,2,Malignant melanoma,3,F,EXP,trametinib,2,SS,Acute myeloid leukaemia,2,F,DE,139
173275473,2,Malignant melanoma,3,F,EXP,trametinib,2,SS,Bone marrow failure,2,F,HO,139
173275473,2,Malignant melanoma,3,F,EXP,trametinib,2,SS,Bone marrow failure,2,F,OT,139
173275473,2,Malignant melanoma,3,F,EXP,trametinib,2,SS,Bone marrow failure,2,F,DE,139
173275473,2,Malignant melanoma,3,F,EXP,trametinib,2,SS,Second primary malignancy,2,F,HO,139
173275473,2,Malignant melanoma,3,F,EXP,trametinib,2,SS,Second primary malignancy,2,F,OT,139
173275473,2,Malignant melanoma,3,F,EXP,trametinib,2,SS,Second primary malignancy,2,F,DE,139
173275872,1,Juvenile chronic myelomonocytic leukaemia,2,F,EXP,trametinib,1,PS,Upper respiratory tract infection,1,M,HO,34
173275891,1,Plasma cell myeloma,1,I,EXP,pomalidomide,1,PS,Toxic epidermal necrolysis,1,M,HO,11
173275891,1,Plasma cell myeloma,1,I,EXP,pomalidomide,1,PS,Toxic epidermal necrolysis,1,M,OT,11
173275891,1,Plasma cell myeloma,1,I,EXP,pomalidomide,1,PS,Toxic epidermal necrolysis,1,M,LT,11
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Acute hepatic failure,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Acute hepatic failure,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Acute hepatic failure,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Ascites,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Ascites,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Ascites,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Diarrhoea,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Diarrhoea,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Diarrhoea,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Dysphagia,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Dysphagia,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Dysphagia,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Fatigue,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Fatigue,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Fatigue,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,General physical health deterioration,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,General physical health deterioration,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,General physical health deterioration,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Haemoglobin decreased,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Haemoglobin decreased,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Haemoglobin decreased,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Hepatic cyst,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Hepatic cyst,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Hepatic cyst,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Hypersensitivity,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Hypersensitivity,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Hypersensitivity,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Nausea,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Nausea,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Nausea,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Ovarian cancer,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Ovarian cancer,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Ovarian cancer,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Pancytopenia,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Pancytopenia,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Pancytopenia,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Pleural effusion,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Pleural effusion,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Pleural effusion,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Pruritus,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Pruritus,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Pruritus,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Pyrexia,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Pyrexia,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Pyrexia,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Rash,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Rash,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Rash,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Retroperitoneal cancer,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Retroperitoneal cancer,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Retroperitoneal cancer,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Thrombocytopenia,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Thrombocytopenia,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Thrombocytopenia,11,F,LT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Vomiting,11,F,HO,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Vomiting,11,F,OT,27
173279916,11,Pain,6,F,EXP,palbociclib,11,C,Vomiting,11,F,LT,27
173285371,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Febrile neutropenia,3,M,HO,13
173285371,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Febrile neutropenia,3,M,DE,13
173285371,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Febrile neutropenia,3,M,OT,13
173285371,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Malignant neoplasm progression,3,M,HO,13
173285371,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Malignant neoplasm progression,3,M,DE,13
173285371,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Malignant neoplasm progression,3,M,OT,13
173287041,3,Colorectal cancer,1,I,EXP,panitumumab,3,SS,Death,3,F,OT,904
173287041,3,Colorectal cancer,1,I,EXP,panitumumab,3,SS,Death,3,F,DE,904
173287041,3,Colorectal cancer,1,I,EXP,panitumumab,3,SS,Diarrhoea,3,F,OT,904
173287041,3,Colorectal cancer,1,I,EXP,panitumumab,3,SS,Diarrhoea,3,F,DE,904
173287041,3,Colorectal cancer,1,I,EXP,panitumumab,3,SS,Vomiting,3,F,OT,904
173287041,3,Colorectal cancer,1,I,EXP,panitumumab,3,SS,Vomiting,3,F,DE,904
173287691,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Cholangitis,1,F,HO,5
173289431,4,Lung neoplasm malignant,1,I,EXP,nivolumab,4,SS,Malignant neoplasm progression,4,M,OT,636
173289431,4,Lung neoplasm malignant,1,I,EXP,nivolumab,4,SS,Malignant neoplasm progression,4,M,DE,636
173291581,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Asthenia,1,M,HO,132
173291581,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Confusional state,1,M,HO,132
173291581,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Decreased appetite,1,M,HO,132
173291581,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Dehydration,1,M,HO,132
173291581,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Delirium,1,M,HO,132
173291581,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Fatigue,1,M,HO,132
173291581,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Hyponatraemia,1,M,HO,132
173291581,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Malaise,1,M,HO,132
173291581,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Mental status changes,1,M,HO,132
173291581,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Muscular weakness,1,M,HO,132
173291581,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Pneumonia,1,M,HO,132
173291581,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Urinary retention,1,M,HO,132
173294193,1,Prostate cancer metastatic,3,F,EXP,apalutamide,1,PS,Dehydration,1,M,HO,561
173294292,1,Non-Hodgkin's lymphoma refractory,2,F,EXP,axicabtagene ciloleucel,1,PS,Seizure,1,M,HO,16
173294292,1,Non-Hodgkin's lymphoma refractory,2,F,EXP,axicabtagene ciloleucel,1,PS,Seizure,1,M,LT,16
173295101,1,Prostate cancer,1,I,DIR,enzalutamide,1,PS,Disease progression,1,M,HO,1381
173295101,1,Prostate cancer,1,I,DIR,enzalutamide,1,PS,Hypoaesthesia,1,M,HO,1381
173295101,1,Prostate cancer,1,I,DIR,enzalutamide,1,PS,Intervertebral disc protrusion,1,M,HO,1381
173295101,1,Prostate cancer,1,I,DIR,enzalutamide,1,PS,Musculoskeletal pain,1,M,HO,1381
173295101,1,Prostate cancer,1,I,DIR,enzalutamide,1,PS,Neck pain,1,M,HO,1381
173295101,1,Prostate cancer,1,I,DIR,enzalutamide,1,PS,Paraesthesia,1,M,HO,1381
173295101,1,Prostate cancer,1,I,DIR,enzalutamide,1,PS,Spinal cord compression,1,M,HO,1381
173297181,1,Bladder cancer,1,I,DIR,abemaciclib,1,PS,Abdominal pain,1,M,HO,86
173297181,1,Bladder cancer,1,I,DIR,abemaciclib,1,PS,Atrial fibrillation,1,M,HO,86
173297181,1,Bladder cancer,1,I,DIR,abemaciclib,1,PS,Nausea,1,M,HO,86
173297181,1,Bladder cancer,1,I,DIR,abemaciclib,1,PS,Small intestinal obstruction,1,M,HO,86
173297181,1,Bladder cancer,1,I,DIR,abemaciclib,1,PS,Vomiting,1,M,HO,86
173298152,1,Prostate cancer,2,F,EXP,apalutamide,1,PS,Diarrhoea,1,M,OT,422
173298152,1,Prostate cancer,2,F,EXP,apalutamide,1,PS,Diarrhoea,1,M,HO,422
173298152,1,Prostate cancer,2,F,EXP,apalutamide,1,PS,Metabolic acidosis,1,M,OT,422
173298152,1,Prostate cancer,2,F,EXP,apalutamide,1,PS,Metabolic acidosis,1,M,HO,422
173298152,1,Prostate cancer,2,F,EXP,apalutamide,1,PS,Renal failure,1,M,OT,422
173298152,1,Prostate cancer,2,F,EXP,apalutamide,1,PS,Renal failure,1,M,HO,422
173298672,2,Non-small cell lung cancer,2,F,EXP,trametinib,2,SS,Blood creatine phosphokinase increased,2,M,HO,82
173298672,2,Non-small cell lung cancer,2,F,EXP,trametinib,2,SS,Hypotension,2,M,HO,82
173298672,2,Non-small cell lung cancer,2,F,EXP,trametinib,2,SS,Pyrexia,2,M,HO,82
173304511,7,Blood uric acid increased,1,I,EXP,rasburicase,7,C,Cytokine release syndrome,7,M,OT,5
173304511,7,Blood uric acid increased,1,I,EXP,rasburicase,7,C,Cytokine release syndrome,7,M,DE,5
173304511,7,Blood uric acid increased,1,I,EXP,rasburicase,7,C,Hypotension,7,M,OT,5
173304511,7,Blood uric acid increased,1,I,EXP,rasburicase,7,C,Hypotension,7,M,DE,5
173304511,7,Blood uric acid increased,1,I,EXP,rasburicase,7,C,Neurotoxicity,7,M,OT,5
173304511,7,Blood uric acid increased,1,I,EXP,rasburicase,7,C,Neurotoxicity,7,M,DE,5
173304511,7,Blood uric acid increased,1,I,EXP,rasburicase,7,C,Pulseless electrical activity,7,M,OT,5
173304511,7,Blood uric acid increased,1,I,EXP,rasburicase,7,C,Pulseless electrical activity,7,M,DE,5
173304511,7,Blood uric acid increased,1,I,EXP,rasburicase,7,C,Ventricular tachycardia,7,M,OT,5
173304511,7,Blood uric acid increased,1,I,EXP,rasburicase,7,C,Ventricular tachycardia,7,M,DE,5
173304511,8,Tumour lysis syndrome,1,I,EXP,rasburicase,8,C,Cytokine release syndrome,8,M,OT,4
173304511,8,Tumour lysis syndrome,1,I,EXP,rasburicase,8,C,Cytokine release syndrome,8,M,DE,4
173304511,8,Tumour lysis syndrome,1,I,EXP,rasburicase,8,C,Hypotension,8,M,OT,4
173304511,8,Tumour lysis syndrome,1,I,EXP,rasburicase,8,C,Hypotension,8,M,DE,4
173304511,8,Tumour lysis syndrome,1,I,EXP,rasburicase,8,C,Neurotoxicity,8,M,OT,4
173304511,8,Tumour lysis syndrome,1,I,EXP,rasburicase,8,C,Neurotoxicity,8,M,DE,4
173304511,8,Tumour lysis syndrome,1,I,EXP,rasburicase,8,C,Pulseless electrical activity,8,M,OT,4
173304511,8,Tumour lysis syndrome,1,I,EXP,rasburicase,8,C,Pulseless electrical activity,8,M,DE,4
173304511,8,Tumour lysis syndrome,1,I,EXP,rasburicase,8,C,Ventricular tachycardia,8,M,OT,4
173304511,8,Tumour lysis syndrome,1,I,EXP,rasburicase,8,C,Ventricular tachycardia,8,M,DE,4
173305102,6,Bone marrow conditioning regimen,2,F,EXP,lenalidomide,6,SS,Lymphatic disorder,6,M,HO,1675
173308432,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,C,Deep vein thrombosis,3,F,OT,190
173308432,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,C,Thrombocytopenia,3,F,OT,190
173309532,4,Plasma cell myeloma,2,F,EXP,carfilzomib,4,SS,Sepsis,4,M,DE,2442
173309532,4,Plasma cell myeloma,2,F,EXP,carfilzomib,4,SS,Sepsis,4,M,HO,2442
173315861,1,Relapsing multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Depression,1,F,OT,38
173315861,1,Relapsing multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Eating disorder,1,F,OT,38
173315861,1,Relapsing multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Lymphopenia,1,F,OT,38
173318792,1,Neutropenia,2,F,EXP,pegfilgrastim,1,PS,Breast discharge,1,F,HO,8
173318792,1,Neutropenia,2,F,EXP,pegfilgrastim,1,PS,Breast swelling,1,F,HO,8
173321731,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Bone pain,1,M,OT,1
173321731,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Dyspnoea,1,M,OT,1
173321731,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hypotension,1,M,OT,1
173321731,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hypoxia,1,M,OT,1
173321731,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Myalgia,1,M,OT,1
173321731,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Nausea,1,M,OT,1
173321731,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Pyrexia,1,M,OT,1
173321731,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Vomiting,1,M,OT,1
173321822,1,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Pneumonitis,1,M,HO,7
173321822,1,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Stress cardiomyopathy,1,M,HO,7
173321822,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Pneumonitis,2,M,HO,7
173321822,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Stress cardiomyopathy,2,M,HO,7
173324091,39,Premedication,1,I,EXP,granisetron,39,C,Pseudomonal bacteraemia,39,M,HO,324
173324672,5,Plasma cell myeloma,2,F,PER,carfilzomib,5,SS,Urinary tract infection,5,F,HO,242
173324672,13,Plasma cell myeloma,2,F,PER,daratumumab,13,C,Urinary tract infection,13,F,HO,645
173327232,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,21
173327232,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,21
173327232,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,21
173327232,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,21
173327232,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hyperuricaemia,1,M,OT,21
173327232,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hyperuricaemia,1,M,HO,21
173327232,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Lipase increased,1,M,OT,21
173327232,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Lipase increased,1,M,HO,21
173327232,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,OT,21
173327232,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,HO,21
173327232,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,21
173327232,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,21
173327232,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hyperuricaemia,2,M,OT,21
173327232,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hyperuricaemia,2,M,HO,21
173327232,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Lipase increased,2,M,OT,21
173327232,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Lipase increased,2,M,HO,21
173329851,1,Neuroendocrine carcinoma of the skin,1,I,EXP,nivolumab,1,PS,Cardiac failure,1,M,OT,38
173329851,1,Neuroendocrine carcinoma of the skin,1,I,EXP,nivolumab,1,PS,Cardiac failure,1,M,HO,38
173333983,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Gastrointestinal toxicity,1,M,OT,49
173333983,3,Plasma cell myeloma,3,F,EXP,carfilzomib,3,SS,Gastrointestinal toxicity,3,M,OT,49
173335731,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Abdominal pain,1,M,HO,441
173335731,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Abdominal pain,1,M,OT,441
173335731,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,441
173335731,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,441
173335731,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Leukocytosis,1,M,HO,441
173335731,1,Pancreatic carcinoma metastatic,1,I,EXP,nivolumab,1,PS,Leukocytosis,1,M,OT,441
173339942,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Pubis fracture,1,F,HO,373
173339982,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,269
173341243,1,Neuroendocrine carcinoma,3,F,EXP,nivolumab,1,PS,Confusional state,1,M,HO,11
173341243,1,Neuroendocrine carcinoma,3,F,EXP,nivolumab,1,PS,Lethargy,1,M,HO,11
173341243,2,Neuroendocrine carcinoma,3,F,EXP,ipilimumab,2,SS,Confusional state,2,M,HO,11
173341243,2,Neuroendocrine carcinoma,3,F,EXP,ipilimumab,2,SS,Lethargy,2,M,HO,11
173342142,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Diarrhoea,2,M,OT,31
173342142,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Lymphocyte count decreased,2,M,OT,31
173342142,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Platelet count decreased,2,M,OT,31
173344543,1,Hodgkin's disease,3,F,EXP,nivolumab,1,PS,Angina pectoris,1,M,HO,3
173344543,1,Hodgkin's disease,3,F,EXP,nivolumab,1,PS,Angina pectoris,1,M,OT,3
173345031,2,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,2,PS,Diffuse large B-cell lymphoma,2,F,DE,50
173345031,2,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,2,PS,Diffuse large B-cell lymphoma,2,F,OT,50
173345031,2,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,2,PS,Lymphopenia,2,F,DE,50
173345031,2,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,2,PS,Lymphopenia,2,F,OT,50
173345031,2,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,2,PS,Neutropenia,2,F,DE,50
173345031,2,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,2,PS,Neutropenia,2,F,OT,50
173345722,1,Hodgkin's disease,2,F,EXP,brentuximab vedotin,1,PS,Acute respiratory failure,1,M,HO,107
173345722,1,Hodgkin's disease,2,F,EXP,brentuximab vedotin,1,PS,Pleural effusion,1,M,HO,107
173345722,5,Hodgkin's disease,2,F,EXP,pegfilgrastim,5,SS,Acute respiratory failure,5,M,HO,107
173345722,5,Hodgkin's disease,2,F,EXP,pegfilgrastim,5,SS,Pleural effusion,5,M,HO,107
173347601,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Weight decreased,1,M,HO,58
173347601,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Weight decreased,3,M,HO,28
173351181,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Breast cancer,1,F,OT,476
173353321,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,HO,7
173353321,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,OT,7
173353321,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,7
173353321,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,7
173353321,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Stress cardiomyopathy,1,M,HO,7
173353321,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Stress cardiomyopathy,1,M,OT,7
173353321,3,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Interstitial lung disease,3,M,HO,7
173353321,3,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Interstitial lung disease,3,M,OT,7
173353321,3,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Pneumonitis,3,M,HO,7
173353321,3,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Pneumonitis,3,M,OT,7
173353321,3,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Stress cardiomyopathy,3,M,HO,7
173353321,3,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Stress cardiomyopathy,3,M,OT,7
173354732,1,Peritoneal neoplasm,2,F,EXP,nivolumab,1,PS,Lower gastrointestinal haemorrhage,1,M,HO,141
173354732,1,Peritoneal neoplasm,2,F,EXP,nivolumab,1,PS,Lower gastrointestinal haemorrhage,1,M,OT,141
173354732,1,Peritoneal neoplasm,2,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,HO,141
173354732,1,Peritoneal neoplasm,2,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,141
173354732,1,Peritoneal neoplasm,2,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,HO,141
173354732,1,Peritoneal neoplasm,2,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,OT,141
173354732,2,Peritoneal neoplasm,2,F,EXP,ipilimumab,2,SS,Lower gastrointestinal haemorrhage,2,M,HO,141
173354732,2,Peritoneal neoplasm,2,F,EXP,ipilimumab,2,SS,Lower gastrointestinal haemorrhage,2,M,OT,141
173354732,2,Peritoneal neoplasm,2,F,EXP,ipilimumab,2,SS,Pulmonary embolism,2,M,HO,141
173354732,2,Peritoneal neoplasm,2,F,EXP,ipilimumab,2,SS,Pulmonary embolism,2,M,OT,141
173354732,2,Peritoneal neoplasm,2,F,EXP,ipilimumab,2,SS,Upper gastrointestinal haemorrhage,2,M,HO,141
173354732,2,Peritoneal neoplasm,2,F,EXP,ipilimumab,2,SS,Upper gastrointestinal haemorrhage,2,M,OT,141
173354762,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Atelectasis,1,M,HO,22
173354762,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,HO,22
173354762,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Atelectasis,2,M,HO,22
173354762,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Pleural effusion,2,M,HO,22
173356201,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Rheumatoid arthritis,1,F,OT,203
173356201,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Rheumatoid arthritis,2,F,OT,153
173356201,3,Product used for unknown indication,1,I,EXP,nivolumab,3,SS,Rheumatoid arthritis,3,F,OT,49
173356201,4,Product used for unknown indication,1,I,EXP,nivolumab,4,SS,Rheumatoid arthritis,4,F,OT,14
173356271,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,OT,1
173356271,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,DS,1
173356271,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Dupuytren's contracture,1,F,OT,1
173356271,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Dupuytren's contracture,1,F,DS,1
173356271,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Muscle fatigue,1,F,OT,1
173356271,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Muscle fatigue,1,F,DS,1
173356271,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,OT,1
173356271,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,DS,1
173356271,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Tendonitis,1,F,OT,1
173356271,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Tendonitis,1,F,DS,1
173357861,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,17
173357861,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,17
173359521,3,Diffuse large B-cell lymphoma,1,I,EXP,ibrutinib,3,SS,Leukopenia,3,M,OT,161
173360061,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Gastroenteritis,1,F,HO,4
173360061,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Leukopenia,1,F,HO,4
173360081,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,General physical health deterioration,1,M,HO,68
173361601,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Bone pain,1,M,HO,425
173361601,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Chills,1,M,HO,425
173361601,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Constipation,1,M,HO,425
173361601,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Dizziness,1,M,HO,425
173361601,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Fatigue,1,M,HO,425
173361601,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Hot flush,1,M,HO,425
173361601,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Hyperhidrosis,1,M,HO,425
173361601,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Muscle spasms,1,M,HO,425
173361601,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Nausea,1,M,HO,425
173361601,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Swelling,1,M,HO,425
173361601,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Weight decreased,1,M,HO,425
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Autoimmune hepatitis,3,M,OT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Autoimmune hepatitis,3,M,HO,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Autoimmune hepatitis,3,M,DE,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Autoimmune hepatitis,3,M,LT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Brain abscess,3,M,OT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Brain abscess,3,M,HO,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Brain abscess,3,M,DE,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Brain abscess,3,M,LT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Iris adhesions,3,M,OT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Iris adhesions,3,M,HO,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Iris adhesions,3,M,DE,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Iris adhesions,3,M,LT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Multiple allergies,3,M,OT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Multiple allergies,3,M,HO,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Multiple allergies,3,M,DE,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Multiple allergies,3,M,LT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Pancytopenia,3,M,OT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Pancytopenia,3,M,HO,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Pancytopenia,3,M,DE,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Pancytopenia,3,M,LT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Pneumonia,3,M,OT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Pneumonia,3,M,HO,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Pneumonia,3,M,DE,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Pneumonia,3,M,LT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Rash,3,M,OT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Rash,3,M,HO,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Rash,3,M,DE,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Rash,3,M,LT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Sepsis,3,M,OT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Sepsis,3,M,HO,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Sepsis,3,M,DE,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Sepsis,3,M,LT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Toxic epidermal necrolysis,3,M,OT,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Toxic epidermal necrolysis,3,M,HO,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Toxic epidermal necrolysis,3,M,DE,48
173362741,3,Malignant melanoma,1,I,EXP,nivolumab,3,SS,Toxic epidermal necrolysis,3,M,LT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Autoimmune hepatitis,5,M,OT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Autoimmune hepatitis,5,M,HO,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Autoimmune hepatitis,5,M,DE,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Autoimmune hepatitis,5,M,LT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Brain abscess,5,M,OT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Brain abscess,5,M,HO,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Brain abscess,5,M,DE,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Brain abscess,5,M,LT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Iris adhesions,5,M,OT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Iris adhesions,5,M,HO,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Iris adhesions,5,M,DE,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Iris adhesions,5,M,LT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Multiple allergies,5,M,OT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Multiple allergies,5,M,HO,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Multiple allergies,5,M,DE,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Multiple allergies,5,M,LT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Pancytopenia,5,M,OT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Pancytopenia,5,M,HO,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Pancytopenia,5,M,DE,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Pancytopenia,5,M,LT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Pneumonia,5,M,OT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Pneumonia,5,M,HO,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Pneumonia,5,M,DE,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Pneumonia,5,M,LT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Rash,5,M,OT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Rash,5,M,HO,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Rash,5,M,DE,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Rash,5,M,LT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Sepsis,5,M,OT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Sepsis,5,M,HO,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Sepsis,5,M,DE,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Sepsis,5,M,LT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Toxic epidermal necrolysis,5,M,OT,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Toxic epidermal necrolysis,5,M,HO,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Toxic epidermal necrolysis,5,M,DE,48
173362741,5,Malignant melanoma,1,I,EXP,ipilimumab,5,SS,Toxic epidermal necrolysis,5,M,LT,48
173363432,1,Adenocarcinoma gastric,2,F,EXP,nivolumab,1,SS,General physical health deterioration,1,M,DE,75
173363432,3,Oesophageal adenocarcinoma,2,F,EXP,ipilimumab,3,PS,General physical health deterioration,3,M,DE,75
173364892,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Cerebral haemorrhage,1,M,HO,3
173364892,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Cerebral haemorrhage,1,M,LT,3
173364892,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Cerebral haemorrhage,1,M,OT,3
173364892,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Cerebral haemorrhage,1,M,DE,3
173364892,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,HO,3
173364892,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,LT,3
173364892,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,OT,3
173364892,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,DE,3
173364892,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,3
173364892,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,3
173364892,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,3
173364892,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,3
173365751,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Arthritis,1,M,OT,33
173365751,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Arthritis,2,M,OT,33
173366242,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diverticulitis,1,M,OT,420
173366242,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Large intestinal obstruction,1,M,OT,420
173366292,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,182
173366292,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,182
173366292,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,182
173366292,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Nervous system disorder,1,F,DE,182
173366292,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Nervous system disorder,1,F,HO,182
173366292,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Nervous system disorder,1,F,OT,182
173366292,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Off label use,1,F,DE,182
173366292,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Off label use,1,F,HO,182
173366292,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Off label use,1,F,OT,182
173367842,2,Prostate cancer metastatic,2,F,EXP,cabazitaxel,2,SS,Dehydration,2,M,HO,54
173367842,2,Prostate cancer metastatic,2,F,EXP,cabazitaxel,2,SS,Diarrhoea,2,M,HO,54
173367842,2,Prostate cancer metastatic,2,F,EXP,cabazitaxel,2,SS,Malnutrition,2,M,HO,54
173368481,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Myalgia,1,F,HO,2
173368481,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Nausea,1,F,HO,2
173368481,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Oedema peripheral,1,F,HO,2
173368481,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,HO,2
173368481,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Pyrexia,1,F,HO,2
173368551,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Chest pain,1,M,HO,43
173368551,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Chest pain,1,M,OT,43
173368571,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,28
173368571,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Dysgeusia,1,M,OT,28
173368571,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Escherichia urinary tract infection,1,M,OT,28
173368571,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Haematuria,1,M,OT,28
173368571,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Hepatic pain,1,M,OT,28
173368762,2,Breast cancer,2,F,EXP,alpelisib,2,SS,Alanine aminotransferase increased,2,F,HO,30
173368762,2,Breast cancer,2,F,EXP,alpelisib,2,SS,Aspartate aminotransferase increased,2,F,HO,30
173369612,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Bladder transitional cell carcinoma stage 0,1,M,OT,2043
173371362,1,Chronic myeloid leukaemia,2,F,EXP,nilotinib,1,PS,Cardiac arrest,1,M,DE,1377
173374432,15,Prophylaxis,2,F,EXP,zoledronic acid,15,C,Asthma,15,M,HO,22
173374432,15,Prophylaxis,2,F,EXP,zoledronic acid,15,C,Chronic obstructive pulmonary disease,15,M,HO,22
173374432,15,Prophylaxis,2,F,EXP,zoledronic acid,15,C,Drug eruption,15,M,HO,22
173374432,15,Prophylaxis,2,F,EXP,zoledronic acid,15,C,Infection,15,M,HO,22
173374432,15,Prophylaxis,2,F,EXP,zoledronic acid,15,C,Radiation skin injury,15,M,HO,22
173374432,15,Prophylaxis,2,F,EXP,zoledronic acid,15,C,Urinary tract infection,15,M,HO,22
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Asthenia,4,M,HO,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Asthenia,4,M,DE,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Asthenia,4,M,OT,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Death,4,M,HO,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Death,4,M,DE,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Death,4,M,OT,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Febrile neutropenia,4,M,HO,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Febrile neutropenia,4,M,DE,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Febrile neutropenia,4,M,OT,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Haematuria,4,M,HO,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Haematuria,4,M,DE,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Haematuria,4,M,OT,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Hyperlipidaemia,4,M,HO,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Hyperlipidaemia,4,M,DE,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Hyperlipidaemia,4,M,OT,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Hypertension,4,M,HO,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Hypertension,4,M,DE,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Hypertension,4,M,OT,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Joint swelling,4,M,HO,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Joint swelling,4,M,DE,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Joint swelling,4,M,OT,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Limb discomfort,4,M,HO,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Limb discomfort,4,M,DE,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Limb discomfort,4,M,OT,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Myocardial infarction,4,M,HO,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Myocardial infarction,4,M,DE,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Myocardial infarction,4,M,OT,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Oedema peripheral,4,M,HO,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Oedema peripheral,4,M,DE,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Oedema peripheral,4,M,OT,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Peripheral swelling,4,M,HO,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Peripheral swelling,4,M,DE,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Peripheral swelling,4,M,OT,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Urinary tract infection,4,M,HO,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Urinary tract infection,4,M,DE,369
173376461,4,Prostate cancer,1,I,EXP,enzalutamide,4,SS,Urinary tract infection,4,M,OT,369
173377584,1,Ovarian clear cell carcinoma,4,F,EXP,ipilimumab,1,PS,Disturbance in attention,1,F,OT,39
173377584,1,Ovarian clear cell carcinoma,4,F,EXP,ipilimumab,1,PS,Disturbance in attention,1,F,HO,39
173377584,1,Ovarian clear cell carcinoma,4,F,EXP,ipilimumab,1,PS,Eye movement disorder,1,F,OT,39
173377584,1,Ovarian clear cell carcinoma,4,F,EXP,ipilimumab,1,PS,Eye movement disorder,1,F,HO,39
173377584,1,Ovarian clear cell carcinoma,4,F,EXP,ipilimumab,1,PS,Postural tremor,1,F,OT,39
173377584,1,Ovarian clear cell carcinoma,4,F,EXP,ipilimumab,1,PS,Postural tremor,1,F,HO,39
173377584,2,Ovarian clear cell carcinoma,4,F,EXP,nivolumab,2,SS,Disturbance in attention,2,F,OT,39
173377584,2,Ovarian clear cell carcinoma,4,F,EXP,nivolumab,2,SS,Disturbance in attention,2,F,HO,39
173377584,2,Ovarian clear cell carcinoma,4,F,EXP,nivolumab,2,SS,Eye movement disorder,2,F,OT,39
173377584,2,Ovarian clear cell carcinoma,4,F,EXP,nivolumab,2,SS,Eye movement disorder,2,F,HO,39
173377584,2,Ovarian clear cell carcinoma,4,F,EXP,nivolumab,2,SS,Postural tremor,2,F,OT,39
173377584,2,Ovarian clear cell carcinoma,4,F,EXP,nivolumab,2,SS,Postural tremor,2,F,HO,39
173380431,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,SS,Confusional state,1,M,DE,7
173380431,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,SS,Confusional state,1,M,OT,7
173380431,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,SS,Cytokine release syndrome,1,M,DE,7
173380431,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,SS,Cytokine release syndrome,1,M,OT,7
173380431,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,SS,Diffuse large B-cell lymphoma,1,M,DE,7
173380431,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,SS,Diffuse large B-cell lymphoma,1,M,OT,7
173380431,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,SS,Neurotoxicity,1,M,DE,7
173380431,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,SS,Neurotoxicity,1,M,OT,7
173380681,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Anaemia,3,F,OT,13
173380681,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Diarrhoea,3,F,OT,13
173380681,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Fatigue,3,F,OT,13
173380681,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Gastrooesophageal reflux disease,3,F,OT,13
173380681,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Hypertension,3,F,OT,13
173380681,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Mucosal inflammation,3,F,OT,13
173380681,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Pain,3,F,OT,13
173380681,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Rash,3,F,OT,13
173380681,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Thrombocytopenia,3,F,OT,13
173381451,1,Neutropenia,1,I,PER,filgrastim,1,PS,Abdominal pain upper,1,M,OT,13
173381451,1,Neutropenia,1,I,PER,filgrastim,1,PS,Epistaxis,1,M,OT,13
173381451,1,Neutropenia,1,I,PER,filgrastim,1,PS,Night sweats,1,M,OT,13
173381451,1,Neutropenia,1,I,PER,filgrastim,1,PS,Pancytopenia,1,M,OT,13
173381451,1,Neutropenia,1,I,PER,filgrastim,1,PS,Rhinitis,1,M,OT,13
173383782,2,Thyroid cancer metastatic,2,F,EXP,trametinib,2,SS,Asthenia,2,M,HO,11
173383782,2,Thyroid cancer metastatic,2,F,EXP,trametinib,2,SS,Dyspnoea,2,M,HO,11
173383782,2,Thyroid cancer metastatic,2,F,EXP,trametinib,2,SS,Enterococcal infection,2,M,HO,11
173383782,2,Thyroid cancer metastatic,2,F,EXP,trametinib,2,SS,Incorrect dose administered,2,M,HO,11
173383782,2,Thyroid cancer metastatic,2,F,EXP,trametinib,2,SS,Pulmonary embolism,2,M,HO,11
173383782,2,Thyroid cancer metastatic,2,F,EXP,trametinib,2,SS,Pyrexia,2,M,HO,11
173383782,2,Thyroid cancer metastatic,2,F,EXP,trametinib,2,SS,Urinary tract infection,2,M,HO,11
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Abdominal pain upper,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Alanine aminotransferase increased,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Aspartate aminotransferase increased,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Blood bilirubin increased,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Blood creatinine increased,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Diarrhoea,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Epstein-Barr virus test positive,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Hypoalbuminaemia,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Hypomagnesaemia,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Hyponatraemia,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Hypophagia,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Influenza,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Liver function test increased,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Pneumonia,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Productive cough,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Pyrexia,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Sputum purulent,2,M,HO,32
173388851,2,Small cell lung cancer,1,I,DIR,nivolumab,2,SS,Thrombocytopenia,2,M,HO,32
173389222,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Depression,1,F,OT,38
173389222,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Lymphopenia,1,F,OT,38
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Abdominal pain,1,F,HO,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Abdominal pain,1,F,OT,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Brain oedema,1,F,HO,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Brain oedema,1,F,OT,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Dehydration,1,F,HO,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Dehydration,1,F,OT,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Dizziness,1,F,HO,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Dizziness,1,F,OT,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Dry skin,1,F,HO,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Dry skin,1,F,OT,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Feeling hot,1,F,HO,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Feeling hot,1,F,OT,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Nausea,1,F,HO,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Nausea,1,F,OT,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Pyrexia,1,F,OT,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Vertigo,1,F,HO,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Vertigo,1,F,OT,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Vomiting,1,F,HO,57
173389771,1,Renal cancer metastatic,1,I,EXP,nivolumab,1,PS,Vomiting,1,F,OT,57
173392191,2,Endometrial neoplasm,1,I,PER,lenvatinib mesylate,2,I,Drug interaction,2,F,HO,66
173392191,2,Endometrial neoplasm,1,I,PER,lenvatinib mesylate,2,I,Headache,2,F,HO,66
173396571,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Cardiac disorder,1,M,HO,15
173396571,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Fall,1,M,HO,15
173396571,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Humerus fracture,1,M,HO,15
173396571,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Pain,1,M,HO,15
173396571,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Cardiac disorder,2,M,HO,15
173396571,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Fall,2,M,HO,15
173396571,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Humerus fracture,2,M,HO,15
173396571,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Pain,2,M,HO,15
173404121,1,Breast cancer metastatic,1,I,PER,alpelisib,1,PS,Hyperglycaemia,1,F,OT,7
173424392,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Chills,1,M,HO,54
173424392,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Diarrhoea,1,M,HO,54
173424392,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Hyperglycaemia,1,M,HO,54
173424392,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Pain,1,M,HO,54
173424392,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Pneumonia,1,M,HO,54
173424392,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Thrombosis,1,M,HO,54
173431994,1,Hodgkin's disease,4,F,EXP,brentuximab vedotin,1,PS,Neutrophil count decreased,1,M,HO,40
173431994,1,Hodgkin's disease,4,F,EXP,brentuximab vedotin,1,PS,Neutrophil count decreased,1,M,OT,40
173431994,1,Hodgkin's disease,4,F,EXP,brentuximab vedotin,1,PS,Pneumonia,1,M,HO,40
173431994,1,Hodgkin's disease,4,F,EXP,brentuximab vedotin,1,PS,Pneumonia,1,M,OT,40
173438222,1,Breast cancer metastatic,2,F,EXP,palbociclib,1,PS,Lower respiratory tract infection,1,F,HO,31
173440711,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Neutropenic sepsis,1,F,HO,7
173442496,1,Plasma cell myeloma,6,F,EXP,pomalidomide,1,PS,Pneumonia,1,M,LT,315
173442496,1,Plasma cell myeloma,6,F,EXP,pomalidomide,1,PS,Pneumonia,1,M,DE,315
173442496,1,Plasma cell myeloma,6,F,EXP,pomalidomide,1,PS,Pneumonia,1,M,HO,315
173442496,2,Plasma cell myeloma,6,F,EXP,daratumumab,2,SS,Pneumonia,2,M,LT,315
173442496,2,Plasma cell myeloma,6,F,EXP,daratumumab,2,SS,Pneumonia,2,M,DE,315
173442496,2,Plasma cell myeloma,6,F,EXP,daratumumab,2,SS,Pneumonia,2,M,HO,315
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,OT,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,DS,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Dupuytren's contracture,1,F,OT,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Dupuytren's contracture,1,F,DS,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Movement disorder,1,F,OT,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Movement disorder,1,F,DS,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Muscle fatigue,1,F,OT,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Muscle fatigue,1,F,DS,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Off label use,1,F,OT,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Off label use,1,F,DS,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,OT,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,DS,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Product use in unapproved indication,1,F,OT,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Product use in unapproved indication,1,F,DS,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Tendonitis,1,F,OT,1
173443351,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Tendonitis,1,F,DS,1
173449342,7,Nausea,2,F,EXP,granisetron,7,C,Epistaxis,7,M,HO,75
173449791,1,Non-small cell lung cancer,1,I,EXP,avelumab,1,SS,Dyspnoea,1,M,DE,54
173449791,1,Non-small cell lung cancer,1,I,EXP,avelumab,1,SS,Dyspnoea,1,M,HO,54
173454102,11,Stem cell transplant,2,F,EXP,plerixafor,11,C,Sepsis,11,F,HO,3
173454692,1,Colorectal cancer metastatic,2,F,PER,panitumumab,1,PS,Anaemia,1,M,HO,135
173455751,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Leukopenia,3,M,OT,105
173455751,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Neutrophil count decreased,3,M,OT,105
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Alopecia,2,F,HO,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Alopecia,2,F,OT,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Constipation,2,F,HO,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Constipation,2,F,OT,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Febrile neutropenia,2,F,HO,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Febrile neutropenia,2,F,OT,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Headache,2,F,HO,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Headache,2,F,OT,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Nausea,2,F,HO,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Nausea,2,F,OT,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Neurotoxicity,2,F,HO,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Neurotoxicity,2,F,OT,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Oropharyngeal pain,2,F,HO,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Oropharyngeal pain,2,F,OT,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Rectal haemorrhage,2,F,HO,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Rectal haemorrhage,2,F,OT,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Stomatitis,2,F,HO,132
173455991,2,Breast cancer,1,I,EXP,denosumab,2,SS,Stomatitis,2,F,OT,132
173461041,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Fatigue,2,F,HO,31
173461041,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Flank pain,2,F,HO,31
173461041,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Hyponatraemia,2,F,HO,31
173483071,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Transformation to acute myeloid leukaemia,1,F,LT,307
173483071,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Transformation to acute myeloid leukaemia,1,F,OT,307
173483071,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Transformation to acute myeloid leukaemia,1,F,DE,307
173483901,1,Lymphoma,1,I,DIR,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,1
173483901,1,Lymphoma,1,I,DIR,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,HO,1
173487031,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Back pain,1,M,OT,11
173487031,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Back pain,1,M,HO,11
173487031,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Osteonecrosis of jaw,1,M,OT,11
173487031,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Osteonecrosis of jaw,1,M,HO,11
173487671,2,Nephrogenic anaemia,1,I,EXP,epoetin alfa,2,SS,Constipation,2,M,HO,97
173487671,2,Nephrogenic anaemia,1,I,EXP,epoetin alfa,2,SS,Vomiting,2,M,HO,97
173487671,3,Nephrogenic anaemia,1,I,EXP,darbepoetin alfa,3,SS,Constipation,3,M,HO,97
173487671,3,Nephrogenic anaemia,1,I,EXP,darbepoetin alfa,3,SS,Vomiting,3,M,HO,97
173488701,3,Extranodal marginal zone B-cell lymphoma (MALT type),1,I,EXP,chlorambucil,3,SS,Leukoencephalopathy,3,M,DS,1320
173491422,1,Desmoid tumour,2,F,EXP,nivolumab,1,PS,Depression,1,F,LT,112
173491422,1,Desmoid tumour,2,F,EXP,nivolumab,1,PS,Depression,1,F,OT,112
173491422,1,Desmoid tumour,2,F,EXP,nivolumab,1,PS,Depression,1,F,HO,112
173491422,1,Desmoid tumour,2,F,EXP,nivolumab,1,PS,Suicide attempt,1,F,LT,112
173491422,1,Desmoid tumour,2,F,EXP,nivolumab,1,PS,Suicide attempt,1,F,OT,112
173491422,1,Desmoid tumour,2,F,EXP,nivolumab,1,PS,Suicide attempt,1,F,HO,112
173491422,2,Desmoid tumour,2,F,EXP,ipilimumab,2,SS,Depression,2,F,LT,112
173491422,2,Desmoid tumour,2,F,EXP,ipilimumab,2,SS,Depression,2,F,OT,112
173491422,2,Desmoid tumour,2,F,EXP,ipilimumab,2,SS,Depression,2,F,HO,112
173491422,2,Desmoid tumour,2,F,EXP,ipilimumab,2,SS,Suicide attempt,2,F,LT,112
173491422,2,Desmoid tumour,2,F,EXP,ipilimumab,2,SS,Suicide attempt,2,F,OT,112
173491422,2,Desmoid tumour,2,F,EXP,ipilimumab,2,SS,Suicide attempt,2,F,HO,112
173491531,1,Lung adenocarcinoma stage IV,1,I,EXP,nivolumab,1,PS,Cardiac tamponade,1,F,HO,66
173491531,1,Lung adenocarcinoma stage IV,1,I,EXP,nivolumab,1,PS,Cardiac tamponade,1,F,OT,66
173491531,1,Lung adenocarcinoma stage IV,1,I,EXP,nivolumab,1,PS,Pericardial effusion,1,F,HO,66
173491531,1,Lung adenocarcinoma stage IV,1,I,EXP,nivolumab,1,PS,Pericardial effusion,1,F,OT,66
173491531,3,Lung adenocarcinoma stage IV,1,I,EXP,ipilimumab,3,SS,Cardiac tamponade,3,F,HO,66
173491531,3,Lung adenocarcinoma stage IV,1,I,EXP,ipilimumab,3,SS,Cardiac tamponade,3,F,OT,66
173491531,3,Lung adenocarcinoma stage IV,1,I,EXP,ipilimumab,3,SS,Pericardial effusion,3,F,HO,66
173491531,3,Lung adenocarcinoma stage IV,1,I,EXP,ipilimumab,3,SS,Pericardial effusion,3,F,OT,66
173491741,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Febrile neutropenia,1,F,HO,6
173491741,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Febrile neutropenia,1,F,OT,6
173491951,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Leukopenia,1,F,HO,6
173491951,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Leukopenia,1,F,OT,6
173491971,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Leukopenia,1,F,OT,27
173491971,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Leukopenia,1,F,HO,27
173492172,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,179
173492172,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Dyspepsia,1,M,HO,179
173492172,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,179
173492172,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,179
173492172,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Dyspepsia,2,M,HO,179
173492172,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Dyspnoea,2,M,HO,179
173492471,1,Basosquamous carcinoma,1,I,DIR,nivolumab,1,PS,Back pain,1,M,HO,62
173492471,1,Basosquamous carcinoma,1,I,DIR,nivolumab,1,PS,Chest pain,1,M,HO,62
173492471,1,Basosquamous carcinoma,1,I,DIR,nivolumab,1,PS,Drug hypersensitivity,1,M,HO,62
173492471,1,Basosquamous carcinoma,1,I,DIR,nivolumab,1,PS,Drug intolerance,1,M,HO,62
173492471,1,Basosquamous carcinoma,1,I,DIR,nivolumab,1,PS,Muscle spasms,1,M,HO,62
173492471,1,Basosquamous carcinoma,1,I,DIR,nivolumab,1,PS,Pain in extremity,1,M,HO,62
173492471,1,Basosquamous carcinoma,1,I,DIR,nivolumab,1,PS,Pruritus,1,M,HO,62
173492471,1,Metastatic squamous cell carcinoma,1,I,DIR,nivolumab,1,PS,Back pain,1,M,HO,62
173492471,1,Metastatic squamous cell carcinoma,1,I,DIR,nivolumab,1,PS,Chest pain,1,M,HO,62
173492471,1,Metastatic squamous cell carcinoma,1,I,DIR,nivolumab,1,PS,Drug hypersensitivity,1,M,HO,62
173492471,1,Metastatic squamous cell carcinoma,1,I,DIR,nivolumab,1,PS,Drug intolerance,1,M,HO,62
173492471,1,Metastatic squamous cell carcinoma,1,I,DIR,nivolumab,1,PS,Muscle spasms,1,M,HO,62
173492471,1,Metastatic squamous cell carcinoma,1,I,DIR,nivolumab,1,PS,Pain in extremity,1,M,HO,62
173492471,1,Metastatic squamous cell carcinoma,1,I,DIR,nivolumab,1,PS,Pruritus,1,M,HO,62
173493221,1,Plasma cell myeloma,1,I,EXP,thalidomide,1,PS,Cell death,1,F,HO,26
173493221,1,Plasma cell myeloma,1,I,EXP,thalidomide,1,PS,Rash,1,F,HO,26
173494032,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Angina pectoris,2,M,HO,23
173494032,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Angina pectoris,2,M,OT,23
173494032,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Myocardial infarction,2,M,HO,23
173494032,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Myocardial infarction,2,M,OT,23
173494032,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Pleural effusion,2,M,HO,23
173494032,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Pleural effusion,2,M,OT,23
173494032,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Thyroid gland abscess,2,M,HO,23
173494032,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Thyroid gland abscess,2,M,OT,23
173494032,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Ventricular tachycardia,2,M,HO,23
173494032,2,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,2,SS,Ventricular tachycardia,2,M,OT,23
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Acute kidney injury,2,M,HO,392
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Acute kidney injury,2,M,OT,392
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Acute kidney injury,2,M,LT,392
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Atypical pneumonia,2,M,HO,392
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Atypical pneumonia,2,M,OT,392
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Atypical pneumonia,2,M,LT,392
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Influenza virus test,2,M,HO,392
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Influenza virus test,2,M,OT,392
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Influenza virus test,2,M,LT,392
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Pyrexia,2,M,HO,392
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Pyrexia,2,M,OT,392
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Pyrexia,2,M,LT,392
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Thrombotic microangiopathy,2,M,HO,392
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Thrombotic microangiopathy,2,M,OT,392
173494495,2,Plasma cell myeloma,5,F,EXP,lenalidomide,2,SS,Thrombotic microangiopathy,2,M,LT,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Acute kidney injury,3,M,HO,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Acute kidney injury,3,M,OT,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Acute kidney injury,3,M,LT,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Atypical pneumonia,3,M,HO,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Atypical pneumonia,3,M,OT,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Atypical pneumonia,3,M,LT,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Influenza virus test,3,M,HO,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Influenza virus test,3,M,OT,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Influenza virus test,3,M,LT,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Pyrexia,3,M,HO,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Pyrexia,3,M,OT,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Pyrexia,3,M,LT,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Thrombotic microangiopathy,3,M,HO,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Thrombotic microangiopathy,3,M,OT,392
173494495,3,Plasma cell myeloma,5,F,EXP,carfilzomib,3,SS,Thrombotic microangiopathy,3,M,LT,392
173499102,1,Lung cancer metastatic,2,F,EXP,lorlatinib,1,PS,Fall,1,F,HO,219
173499102,1,Lung cancer metastatic,2,F,EXP,lorlatinib,1,PS,Hallucination,1,F,HO,219
173503701,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Myasthenia gravis,1,M,HO,94
173503701,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Myasthenia gravis,1,M,OT,94
173503701,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Salmonella sepsis,1,M,HO,94
173503701,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Salmonella sepsis,1,M,OT,94
173503701,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Myasthenia gravis,2,M,HO,94
173503701,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Myasthenia gravis,2,M,OT,94
173503701,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Salmonella sepsis,2,M,HO,94
173503701,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Salmonella sepsis,2,M,OT,94
173505271,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Fatigue,1,F,HO,41
173505271,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Flank pain,1,F,HO,41
173506361,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Renal abscess,1,F,HO,60
173506541,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Urosepsis,1,F,HO,39
173509985,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Neutropenia,1,F,DE,291
173509985,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Neutropenia,1,F,HO,291
173509985,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Neutropenia,1,F,LT,291
173509985,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Pneumonia,1,F,DE,291
173509985,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Pneumonia,1,F,HO,291
173509985,1,Plasma cell myeloma,5,F,EXP,pomalidomide,1,PS,Pneumonia,1,F,LT,291
173513431,1,Colorectal cancer metastatic,1,I,PER,panitumumab,1,PS,Disease progression,1,F,HO,70
173513653,1,Neutropenia,3,F,PER,pegfilgrastim,1,PS,Angina pectoris,1,M,HO,1
173515091,7,Plasma cell myeloma,1,I,PER,daratumumab,7,SS,Urinary tract infection,7,M,HO,13
173515091,15,Plasma cell myeloma,1,I,PER,carfilzomib,15,SS,Urinary tract infection,15,M,HO,1777
173516851,10,B precursor type acute leukaemia,1,I,EXP,pegaspargase,10,SS,Colitis,10,M,HO,251
173516851,10,B precursor type acute leukaemia,1,I,EXP,pegaspargase,10,SS,Colitis,10,M,LT,251
173516851,10,B precursor type acute leukaemia,1,I,EXP,pegaspargase,10,SS,Pyrexia,10,M,HO,251
173516851,10,B precursor type acute leukaemia,1,I,EXP,pegaspargase,10,SS,Pyrexia,10,M,LT,251
173517862,1,Hormone-dependent prostate cancer,2,F,EXP,degarelix,1,PS,Anaphylactic shock,1,M,HO,112
173517862,1,Hormone-dependent prostate cancer,2,F,EXP,degarelix,1,PS,Anaphylactic shock,1,M,LT,112
173518082,1,Mesothelioma malignant,2,F,EXP,nivolumab,1,PS,Death,1,M,DE,42
173518082,1,Mesothelioma malignant,2,F,EXP,nivolumab,1,PS,Death,1,M,OT,42
173518221,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,General physical health deterioration,1,F,HO,47
173518682,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,24
173518682,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,24
173520081,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Cytopenia,1,M,HO,11
173520081,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Cytopenia,1,M,DE,11
173520081,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Cytopenia,1,M,OT,11
173520081,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Infection,1,M,HO,11
173520081,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Infection,1,M,DE,11
173520081,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Infection,1,M,OT,11
173520081,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Plasma cell myeloma,1,M,HO,11
173520081,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Plasma cell myeloma,1,M,DE,11
173520081,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Plasma cell myeloma,1,M,OT,11
173520081,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Cytopenia,2,M,HO,11
173520081,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Cytopenia,2,M,DE,11
173520081,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Cytopenia,2,M,OT,11
173520081,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Infection,2,M,HO,11
173520081,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Infection,2,M,DE,11
173520081,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Infection,2,M,OT,11
173520081,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Plasma cell myeloma,2,M,HO,11
173520081,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Plasma cell myeloma,2,M,DE,11
173520081,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Plasma cell myeloma,2,M,OT,11
173522402,1,Epithelioid mesothelioma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,132
173522402,1,Epithelioid mesothelioma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,132
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Condition aggravated,1,M,DS,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Condition aggravated,1,M,HO,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Condition aggravated,1,M,OT,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Cough,1,M,DS,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Cough,1,M,HO,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Cough,1,M,OT,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Decreased appetite,1,M,DS,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,DS,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DS,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DS,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Respiratory disorder,1,M,DS,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Respiratory disorder,1,M,HO,16
173522621,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Respiratory disorder,1,M,OT,16
173522651,1,Colony stimulating factor therapy,1,I,PER,pegfilgrastim,1,PS,Metastases to central nervous system,1,M,OT,3
173522651,1,Colony stimulating factor therapy,1,I,PER,pegfilgrastim,1,PS,Neutrophil count increased,1,M,OT,3
173522651,1,Colony stimulating factor therapy,1,I,PER,pegfilgrastim,1,PS,White blood cell count increased,1,M,OT,3
173522791,1,Colony stimulating factor therapy,1,I,PER,pegfilgrastim,1,PS,Diplegia,1,F,OT,1
173523686,1,Oesophageal carcinoma,6,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,44
173523686,1,Oesophageal carcinoma,6,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,44
173523686,1,Oesophageal carcinoma,6,F,EXP,nivolumab,1,PS,Oesophageal ulcer,1,M,OT,44
173523686,1,Oesophageal carcinoma,6,F,EXP,nivolumab,1,PS,Oesophageal ulcer,1,M,HO,44
173523686,1,Oesophageal carcinoma,6,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,OT,44
173523686,1,Oesophageal carcinoma,6,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,HO,44
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,LT,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,M,OT,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,M,LT,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Diabetic ketoacidosis,1,M,HO,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,OT,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,LT,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,M,HO,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,OT,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,LT,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,HO,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Pancreatitis,1,M,OT,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Pancreatitis,1,M,LT,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Pancreatitis,1,M,HO,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Vomiting,1,M,LT,135
173525693,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,135
173527921,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,SS,Hyperglycaemia,1,F,HO,260
173527921,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,SS,Lymphocytic hypophysitis,1,F,HO,260
173527921,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,PS,Hyperglycaemia,2,F,HO,260
173527921,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,PS,Lymphocytic hypophysitis,2,F,HO,260
173529221,3,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,3,C,Abdominal discomfort,3,M,OT,1
173529221,3,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,3,C,Nausea,3,M,OT,1
173529221,3,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,3,C,Supraventricular tachycardia,3,M,OT,1
173529221,3,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,3,C,Vomiting,3,M,OT,1
173530212,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Pneumonia,1,M,HO,14
173531541,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Neutropenia,1,F,HO,6
173532691,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Upper respiratory tract infection,1,M,HO,610
173535922,1,Non-Hodgkin's lymphoma,2,F,EXP,nivolumab,1,PS,Hypersensitivity,1,F,HO,14
173535922,5,Non-Hodgkin's lymphoma,2,F,EXP,pegfilgrastim,5,C,Hypersensitivity,5,F,HO,12
173536021,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Splenic infarction,1,F,OT,70
173536021,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Splenic infarction,1,F,HO,70
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Alopecia,6,F,OT,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Alopecia,6,F,HO,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Constipation,6,F,OT,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Constipation,6,F,HO,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Febrile neutropenia,6,F,OT,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Febrile neutropenia,6,F,HO,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Headache,6,F,OT,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Headache,6,F,HO,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Nausea,6,F,OT,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Nausea,6,F,HO,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Neurotoxicity,6,F,OT,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Neurotoxicity,6,F,HO,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Oropharyngeal pain,6,F,OT,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Oropharyngeal pain,6,F,HO,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Rectal haemorrhage,6,F,OT,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Rectal haemorrhage,6,F,HO,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Stomatitis,6,F,OT,132
173537571,6,Breast cancer,1,I,EXP,denosumab,6,SS,Stomatitis,6,F,HO,132
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Cough,14,F,HO,51
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Cough,14,F,DE,51
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Cough,14,F,OT,51
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Device occlusion,14,F,HO,51
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Device occlusion,14,F,DE,51
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Device occlusion,14,F,OT,51
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Dyspnoea,14,F,HO,51
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Dyspnoea,14,F,DE,51
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Dyspnoea,14,F,OT,51
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Peripheral swelling,14,F,HO,51
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Peripheral swelling,14,F,DE,51
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Peripheral swelling,14,F,OT,51
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Pneumonia,14,F,HO,51
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Pneumonia,14,F,DE,51
173537611,14,Product used for unknown indication,1,I,EXP,zoledronic acid,14,C,Pneumonia,14,F,OT,51
173543691,1,Plasma cell myeloma,1,I,PER,pomalidomide,1,PS,Neutrophil count decreased,1,M,OT,26
173549721,1,Chronic lymphocytic leukaemia,1,I,EXP,chlorambucil,1,PS,Staphylococcal infection,1,M,OT,1467
173549721,1,Chronic lymphocytic leukaemia,1,I,EXP,chlorambucil,1,PS,Staphylococcal infection,1,M,HO,1467
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Anxiety,1,M,OT,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Anxiety,1,M,DS,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Back pain,1,M,OT,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Back pain,1,M,DS,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Crying,1,M,OT,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Crying,1,M,DS,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Deafness,1,M,OT,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Deafness,1,M,DS,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Fatigue,1,M,OT,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Fatigue,1,M,DS,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Gait disturbance,1,M,OT,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Gait disturbance,1,M,DS,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Muscle disorder,1,M,OT,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Muscle disorder,1,M,DS,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Muscle rigidity,1,M,OT,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Muscle rigidity,1,M,DS,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Musculoskeletal stiffness,1,M,OT,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Musculoskeletal stiffness,1,M,DS,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Pharyngitis streptococcal,1,M,OT,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Pharyngitis streptococcal,1,M,DS,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Tinnitus,1,M,OT,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Tinnitus,1,M,DS,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Uhthoff's phenomenon,1,M,OT,3
173549741,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Uhthoff's phenomenon,1,M,DS,3
173550101,6,Malignant melanoma stage IV,1,I,EXP,trametinib,6,SS,Death,6,M,DE,501
173550101,6,Malignant melanoma stage IV,1,I,EXP,trametinib,6,SS,Death,6,M,OT,501
173550101,6,Malignant melanoma stage IV,1,I,EXP,trametinib,6,SS,Melaena,6,M,DE,501
173550101,6,Malignant melanoma stage IV,1,I,EXP,trametinib,6,SS,Melaena,6,M,OT,501
173550101,6,Malignant melanoma stage IV,1,I,EXP,trametinib,6,SS,Pneumonia,6,M,DE,501
173550101,6,Malignant melanoma stage IV,1,I,EXP,trametinib,6,SS,Pneumonia,6,M,OT,501
173550101,6,Malignant melanoma stage IV,1,I,EXP,trametinib,6,SS,Pyrexia,6,M,DE,501
173550101,6,Malignant melanoma stage IV,1,I,EXP,trametinib,6,SS,Pyrexia,6,M,OT,501
173550101,6,Malignant melanoma stage IV,1,I,EXP,trametinib,6,SS,Vomiting,6,M,DE,501
173550101,6,Malignant melanoma stage IV,1,I,EXP,trametinib,6,SS,Vomiting,6,M,OT,501
173551311,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Hyperkalaemia,2,M,HO,2
173554081,5,Prostate cancer metastatic,1,I,EXP,zoledronic acid,5,C,Alanine aminotransferase increased,5,M,OT,459
173554081,5,Prostate cancer metastatic,1,I,EXP,zoledronic acid,5,C,Aspartate aminotransferase increased,5,M,OT,459
173554081,5,Prostate cancer metastatic,1,I,EXP,zoledronic acid,5,C,Pulmonary embolism,5,M,OT,459
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Acute kidney injury,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Acute kidney injury,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Acute kidney injury,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Cancer pain,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Cancer pain,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Cancer pain,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Cataract,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Cataract,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Cataract,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Clostridium difficile infection,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Clostridium difficile infection,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Clostridium difficile infection,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Constipation,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Constipation,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Constipation,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Delirium,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Delirium,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Delirium,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Diarrhoea,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Diarrhoea,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Diarrhoea,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Fatigue,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Fatigue,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Fatigue,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Muscular weakness,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Muscular weakness,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Muscular weakness,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Nasopharyngitis,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Nasopharyngitis,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Nasopharyngitis,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Nausea,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Nausea,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Nausea,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Plasma cell myeloma,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Plasma cell myeloma,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Plasma cell myeloma,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Platelet count decreased,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Platelet count decreased,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Platelet count decreased,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Pyrexia,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Pyrexia,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Pyrexia,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Red blood cell count decreased,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Red blood cell count decreased,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Red blood cell count decreased,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Somnolence,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Somnolence,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Somnolence,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Spinal compression fracture,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Spinal compression fracture,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Spinal compression fracture,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Thermal burn,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Thermal burn,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Thermal burn,4,M,OT,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,White blood cell count decreased,4,M,DE,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,White blood cell count decreased,4,M,HO,4
173554671,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,White blood cell count decreased,4,M,OT,4
173555621,6,Product used for unknown indication,1,I,EXP,filgrastim,6,C,Death,6,M,HO,32
173555621,6,Product used for unknown indication,1,I,EXP,filgrastim,6,C,Death,6,M,DE,32
173555621,6,Product used for unknown indication,1,I,EXP,filgrastim,6,C,Pain,6,M,HO,32
173555621,6,Product used for unknown indication,1,I,EXP,filgrastim,6,C,Pain,6,M,DE,32
173555621,6,Product used for unknown indication,1,I,EXP,filgrastim,6,C,Vomiting,6,M,HO,32
173555621,6,Product used for unknown indication,1,I,EXP,filgrastim,6,C,Vomiting,6,M,DE,32
173555621,7,Product used for unknown indication,1,I,EXP,epoetin alfa,7,C,Death,7,M,HO,24
173555621,7,Product used for unknown indication,1,I,EXP,epoetin alfa,7,C,Death,7,M,DE,24
173555621,7,Product used for unknown indication,1,I,EXP,epoetin alfa,7,C,Pain,7,M,HO,24
173555621,7,Product used for unknown indication,1,I,EXP,epoetin alfa,7,C,Pain,7,M,DE,24
173555621,7,Product used for unknown indication,1,I,EXP,epoetin alfa,7,C,Vomiting,7,M,HO,24
173555621,7,Product used for unknown indication,1,I,EXP,epoetin alfa,7,C,Vomiting,7,M,DE,24
173555621,24,Product used for unknown indication,1,I,EXP,granisetron,24,C,Death,24,M,HO,73
173555621,24,Product used for unknown indication,1,I,EXP,granisetron,24,C,Death,24,M,DE,73
173555621,24,Product used for unknown indication,1,I,EXP,granisetron,24,C,Pain,24,M,HO,73
173555621,24,Product used for unknown indication,1,I,EXP,granisetron,24,C,Pain,24,M,DE,73
173555621,24,Product used for unknown indication,1,I,EXP,granisetron,24,C,Vomiting,24,M,HO,73
173555621,24,Product used for unknown indication,1,I,EXP,granisetron,24,C,Vomiting,24,M,DE,73
173560531,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Cardiac failure,1,F,DE,187
173560531,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Cardiac failure,1,F,HO,187
173560531,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Cardiac failure,1,F,OT,187
173560531,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Influenza,1,F,DE,187
173560531,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Influenza,1,F,HO,187
173560531,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Influenza,1,F,OT,187
173560531,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Cardiac failure,3,F,DE,187
173560531,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Cardiac failure,3,F,HO,187
173560531,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Cardiac failure,3,F,OT,187
173560531,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Influenza,3,F,DE,187
173560531,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Influenza,3,F,HO,187
173560531,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Influenza,3,F,OT,187
173560991,1,Enteropathy-associated T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Endocarditis,1,M,HO,27
173560991,1,Enteropathy-associated T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Endocarditis,1,M,OT,27
173560991,1,Enteropathy-associated T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Klebsiella bacteraemia,1,M,HO,27
173560991,1,Enteropathy-associated T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Klebsiella bacteraemia,1,M,OT,27
173560991,1,Enteropathy-associated T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Urinary tract infection,1,M,HO,27
173560991,1,Enteropathy-associated T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Urinary tract infection,1,M,OT,27
173561451,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Drug ineffective,1,M,OT,7
173561451,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Drug ineffective,1,M,LT,7
173561451,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Drug ineffective,1,M,HO,7
173561451,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutropenia,1,M,OT,7
173561451,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutropenia,1,M,LT,7
173561451,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutropenia,1,M,HO,7
173561451,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Pancytopenia,1,M,OT,7
173561451,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Pancytopenia,1,M,LT,7
173561451,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Pancytopenia,1,M,HO,7
173561451,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,M,OT,7
173561451,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,M,LT,7
173561451,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,M,HO,7
173561591,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Diarrhoea,3,M,HO,6
173561591,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Diarrhoea,3,M,DE,6
173561591,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Neutropenic sepsis,3,M,HO,6
173561591,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Neutropenic sepsis,3,M,DE,6
173562431,1,Neurofibroma,1,I,DIR,binimetinib,1,PS,Anaemia,1,F,HO,39
173562431,1,Neurofibroma,1,I,DIR,binimetinib,1,PS,Anaemia,1,F,OT,39
173562431,1,Neurofibroma,1,I,DIR,binimetinib,1,PS,Headache,1,F,HO,39
173562431,1,Neurofibroma,1,I,DIR,binimetinib,1,PS,Headache,1,F,OT,39
173562431,1,Neurofibroma,1,I,DIR,binimetinib,1,PS,Menorrhagia,1,F,HO,39
173562431,1,Neurofibroma,1,I,DIR,binimetinib,1,PS,Menorrhagia,1,F,OT,39
173562431,1,Neurofibroma,1,I,DIR,binimetinib,1,PS,Palpitations,1,F,HO,39
173562431,1,Neurofibroma,1,I,DIR,binimetinib,1,PS,Palpitations,1,F,OT,39
173562431,1,Neurofibroma,1,I,DIR,binimetinib,1,PS,Tachycardia,1,F,HO,39
173562431,1,Neurofibroma,1,I,DIR,binimetinib,1,PS,Tachycardia,1,F,OT,39
173562543,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Upper limb fracture,1,F,HO,2700
173564802,1,Neoplasm,2,F,EXP,nivolumab,1,PS,Asthenia,1,M,LT,132
173564802,1,Neoplasm,2,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,132
173567233,6,Amyloidosis,3,F,EXP,daratumumab,6,SS,Confusional state,6,F,HO,103
173567233,6,Amyloidosis,3,F,EXP,daratumumab,6,SS,Pneumonia,6,F,HO,103
173568121,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Uveitis,1,F,OT,311
173568182,15,Plasma cell myeloma,2,F,PER,carfilzomib,15,SS,Coronary artery disease,15,F,HO,1678
173568182,15,Plasma cell myeloma,2,F,PER,carfilzomib,15,SS,Pneumonia,15,F,HO,1678
173568321,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Cytopenia,1,M,HO,26
173568371,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Diarrhoea,1,F,HO,4
173568371,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Dysgeusia,1,F,HO,4
173568371,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Hepatic function abnormal,1,F,HO,4
173568371,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Nasopharyngitis,1,F,HO,4
173568371,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Oral herpes,1,F,HO,4
173568371,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Peripheral sensory neuropathy,1,F,HO,4
173568371,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Platelet count decreased,1,F,HO,4
173568371,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Prinzmetal angina,1,F,HO,4
173568371,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Rash,1,F,HO,4
173574131,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Disease progression,1,M,OT,54
173574381,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Neutrophil count decreased,1,M,OT,7
173574381,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Neutrophil count decreased,1,M,LT,7
173574381,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Pancreatitis,1,M,OT,7
173574381,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Pancreatitis,1,M,LT,7
173575011,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Chronic lymphocytic leukaemia,1,F,DE,811
173575011,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Chronic lymphocytic leukaemia,1,F,OT,811
173575011,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Chronic lymphocytic leukaemia,1,F,HO,811
173575011,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Death,1,F,DE,811
173575011,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Death,1,F,OT,811
173575011,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Death,1,F,HO,811
173575011,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Pneumonia,1,F,DE,811
173575011,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Pneumonia,1,F,OT,811
173575011,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Pneumonia,1,F,HO,811
173575011,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Urinary tract infection,1,F,DE,811
173575011,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Urinary tract infection,1,F,OT,811
173575011,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Urinary tract infection,1,F,HO,811
173582645,2,Plasma cell myeloma,5,F,EXP,pomalidomide,2,SS,Neutropenia,2,F,LT,271
173582645,2,Plasma cell myeloma,5,F,EXP,pomalidomide,2,SS,Neutropenia,2,F,DE,271
173582645,2,Plasma cell myeloma,5,F,EXP,pomalidomide,2,SS,Neutropenia,2,F,HO,271
173582645,2,Plasma cell myeloma,5,F,EXP,pomalidomide,2,SS,Pneumonia,2,F,LT,271
173582645,2,Plasma cell myeloma,5,F,EXP,pomalidomide,2,SS,Pneumonia,2,F,DE,271
173582645,2,Plasma cell myeloma,5,F,EXP,pomalidomide,2,SS,Pneumonia,2,F,HO,271
173586051,4,Product used for unknown indication,1,I,EXP,panitumumab,4,SS,Mental impairment,4,F,HO,5
173586051,4,Product used for unknown indication,1,I,EXP,panitumumab,4,SS,Mental impairment,4,F,LT,5
173586051,20,Colorectal cancer metastatic,1,I,EXP,panitumumab,20,SS,Mental impairment,20,F,HO,96
173586051,20,Colorectal cancer metastatic,1,I,EXP,panitumumab,20,SS,Mental impairment,20,F,LT,96
173586051,21,Product used for unknown indication,1,I,EXP,panitumumab,21,SS,Mental impairment,21,F,HO,40
173586051,21,Product used for unknown indication,1,I,EXP,panitumumab,21,SS,Mental impairment,21,F,LT,40
173587251,35,Prophylaxis,1,I,EXP,granisetron,35,C,Neutropenia,35,M,OT,55
173587251,35,Prophylaxis,1,I,EXP,granisetron,35,C,Toothache,35,M,OT,55
173587411,4,B-cell lymphoma,1,I,EXP,pegfilgrastim,4,SS,Oral pain,4,F,HO,62
173588931,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Drug ineffective,1,F,LT,5
173588931,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Drug ineffective,1,F,OT,5
173588931,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutropenia,1,F,LT,5
173588931,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutropenia,1,F,OT,5
173588931,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,F,LT,5
173588931,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,F,OT,5
173589651,1,Bladder cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,63
173589651,1,Bladder cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,63
173593061,1,Adenocarcinoma gastric,1,I,EXP,nivolumab,1,PS,Dehydration,1,M,OT,72
173593061,1,Adenocarcinoma gastric,1,I,EXP,nivolumab,1,PS,Dehydration,1,M,HO,72
173593061,1,Adenocarcinoma gastric,1,I,EXP,nivolumab,1,PS,Hydronephrosis,1,M,OT,72
173593061,1,Adenocarcinoma gastric,1,I,EXP,nivolumab,1,PS,Hydronephrosis,1,M,HO,72
173593061,1,Adenocarcinoma gastric,1,I,EXP,nivolumab,1,PS,Hyperbilirubinaemia,1,M,OT,72
173593061,1,Adenocarcinoma gastric,1,I,EXP,nivolumab,1,PS,Hyperbilirubinaemia,1,M,HO,72
173593061,1,Adenocarcinoma gastric,1,I,EXP,nivolumab,1,PS,Nausea,1,M,OT,72
173593061,1,Adenocarcinoma gastric,1,I,EXP,nivolumab,1,PS,Nausea,1,M,HO,72
173593061,1,Adenocarcinoma gastric,1,I,EXP,nivolumab,1,PS,Thrombocytopenia,1,M,OT,72
173593061,1,Adenocarcinoma gastric,1,I,EXP,nivolumab,1,PS,Thrombocytopenia,1,M,HO,72
173593061,2,Adenocarcinoma gastric,1,I,EXP,ipilimumab,2,SS,Dehydration,2,M,OT,72
173593061,2,Adenocarcinoma gastric,1,I,EXP,ipilimumab,2,SS,Dehydration,2,M,HO,72
173593061,2,Adenocarcinoma gastric,1,I,EXP,ipilimumab,2,SS,Hydronephrosis,2,M,OT,72
173593061,2,Adenocarcinoma gastric,1,I,EXP,ipilimumab,2,SS,Hydronephrosis,2,M,HO,72
173593061,2,Adenocarcinoma gastric,1,I,EXP,ipilimumab,2,SS,Hyperbilirubinaemia,2,M,OT,72
173593061,2,Adenocarcinoma gastric,1,I,EXP,ipilimumab,2,SS,Hyperbilirubinaemia,2,M,HO,72
173593061,2,Adenocarcinoma gastric,1,I,EXP,ipilimumab,2,SS,Nausea,2,M,OT,72
173593061,2,Adenocarcinoma gastric,1,I,EXP,ipilimumab,2,SS,Nausea,2,M,HO,72
173593061,2,Adenocarcinoma gastric,1,I,EXP,ipilimumab,2,SS,Thrombocytopenia,2,M,OT,72
173593061,2,Adenocarcinoma gastric,1,I,EXP,ipilimumab,2,SS,Thrombocytopenia,2,M,HO,72
173593761,3,Product used for unknown indication,1,I,EXP,pegfilgrastim,3,SS,Febrile neutropenia,3,F,HO,12
173593761,3,Product used for unknown indication,1,I,EXP,pegfilgrastim,3,SS,General physical health deterioration,3,F,HO,12
173593761,3,Product used for unknown indication,1,I,EXP,pegfilgrastim,3,SS,Off label use,3,F,HO,12
173593761,3,Product used for unknown indication,1,I,EXP,pegfilgrastim,3,SS,Pancytopenia,3,F,HO,12
173593761,3,Product used for unknown indication,1,I,EXP,pegfilgrastim,3,SS,Sepsis,3,F,HO,12
173594254,11,Febrile neutropenia,4,F,EXP,filgrastim,11,C,Blood alkaline phosphatase increased,11,M,HO,492
173594254,11,Febrile neutropenia,4,F,EXP,filgrastim,11,C,Urostomy complication,11,M,HO,492
173595314,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,OT,18
173595314,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,HO,18
173595314,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Immune-mediated hepatitis,1,F,OT,18
173595314,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Immune-mediated hepatitis,1,F,HO,18
173595314,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Liver injury,1,F,OT,18
173595314,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Liver injury,1,F,HO,18
173595314,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Platelet count decreased,1,F,OT,18
173595314,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Platelet count decreased,1,F,HO,18
173595314,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Urinary tract infection enterococcal,1,F,OT,18
173595314,1,Transitional cell cancer of renal pelvis and ureter metastatic,4,F,EXP,nivolumab,1,PS,Urinary tract infection enterococcal,1,F,HO,18
173595492,3,Non-Hodgkin's lymphoma,2,F,EXP,ibrutinib,3,SS,Impaired gastric emptying,3,F,HO,557
173599381,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,SS,Pneumonitis,1,M,HO,119
173599381,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,SS,Pneumonitis,1,M,LT,119
173599381,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Pneumonitis,2,M,HO,48
173599381,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Pneumonitis,2,M,LT,48
173599381,3,Non-small cell lung cancer,1,I,EXP,ipilimumab,3,PS,Pneumonitis,3,M,HO,119
173599381,3,Non-small cell lung cancer,1,I,EXP,ipilimumab,3,PS,Pneumonitis,3,M,LT,119
173599381,4,Product used for unknown indication,1,I,EXP,ipilimumab,4,SS,Pneumonitis,4,M,HO,78
173599381,4,Product used for unknown indication,1,I,EXP,ipilimumab,4,SS,Pneumonitis,4,M,LT,78
173600461,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Neutropenia,2,F,OT,12
173600461,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Neutropenia,2,F,HO,12
173600461,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Neutropenia,2,F,DE,12
173600461,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Neutropenic sepsis,2,F,OT,12
173600461,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Neutropenic sepsis,2,F,HO,12
173600461,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Neutropenic sepsis,2,F,DE,12
173600461,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Plasma cell myeloma,2,F,OT,12
173600461,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Plasma cell myeloma,2,F,HO,12
173600461,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Plasma cell myeloma,2,F,DE,12
173600461,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Thrombocytopenia,2,F,OT,12
173600461,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Thrombocytopenia,2,F,HO,12
173600461,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Thrombocytopenia,2,F,DE,12
173601931,2,B-cell lymphoma,1,I,EXP,lenalidomide,2,SS,Bronchitis,2,M,HO,156
173601931,2,B-cell lymphoma,1,I,EXP,lenalidomide,2,SS,Febrile neutropenia,2,M,HO,156
173605711,1,Glioblastoma multiforme,1,I,DIR,ipilimumab,1,PS,Fall,1,F,HO,107
173605711,1,Glioblastoma multiforme,1,I,DIR,ipilimumab,1,PS,Feeding disorder,1,F,HO,107
173605711,1,Glioblastoma multiforme,1,I,DIR,ipilimumab,1,PS,Hypotension,1,F,HO,107
173605711,1,Glioblastoma multiforme,1,I,DIR,ipilimumab,1,PS,Ketonuria,1,F,HO,107
173605711,1,Glioblastoma multiforme,1,I,DIR,ipilimumab,1,PS,Metabolic acidosis,1,F,HO,107
173605711,1,Glioblastoma multiforme,1,I,DIR,ipilimumab,1,PS,Muscular weakness,1,F,HO,107
173605711,1,Glioblastoma multiforme,1,I,DIR,ipilimumab,1,PS,Musculoskeletal pain,1,F,HO,107
173605711,1,Glioblastoma multiforme,1,I,DIR,ipilimumab,1,PS,Nausea,1,F,HO,107
173605711,1,Glioblastoma multiforme,1,I,DIR,ipilimumab,1,PS,Neurotoxicity,1,F,HO,107
173605711,1,Glioblastoma multiforme,1,I,DIR,ipilimumab,1,PS,Pelvic pain,1,F,HO,107
173605711,1,Glioblastoma multiforme,1,I,DIR,ipilimumab,1,PS,Seizure,1,F,HO,107
173605711,1,Glioblastoma multiforme,1,I,DIR,ipilimumab,1,PS,Streptococcus test positive,1,F,HO,107
173605711,1,Glioblastoma multiforme,1,I,DIR,ipilimumab,1,PS,Tachycardia,1,F,HO,107
173605711,1,Glioblastoma multiforme,1,I,DIR,ipilimumab,1,PS,Tendon injury,1,F,HO,107
173605711,2,Glioblastoma multiforme,1,I,DIR,nivolumab,2,SS,Fall,2,F,HO,107
173605711,2,Glioblastoma multiforme,1,I,DIR,nivolumab,2,SS,Feeding disorder,2,F,HO,107
173605711,2,Glioblastoma multiforme,1,I,DIR,nivolumab,2,SS,Hypotension,2,F,HO,107
173605711,2,Glioblastoma multiforme,1,I,DIR,nivolumab,2,SS,Ketonuria,2,F,HO,107
173605711,2,Glioblastoma multiforme,1,I,DIR,nivolumab,2,SS,Metabolic acidosis,2,F,HO,107
173605711,2,Glioblastoma multiforme,1,I,DIR,nivolumab,2,SS,Muscular weakness,2,F,HO,107
173605711,2,Glioblastoma multiforme,1,I,DIR,nivolumab,2,SS,Musculoskeletal pain,2,F,HO,107
173605711,2,Glioblastoma multiforme,1,I,DIR,nivolumab,2,SS,Nausea,2,F,HO,107
173605711,2,Glioblastoma multiforme,1,I,DIR,nivolumab,2,SS,Neurotoxicity,2,F,HO,107
173605711,2,Glioblastoma multiforme,1,I,DIR,nivolumab,2,SS,Pelvic pain,2,F,HO,107
173605711,2,Glioblastoma multiforme,1,I,DIR,nivolumab,2,SS,Seizure,2,F,HO,107
173605711,2,Glioblastoma multiforme,1,I,DIR,nivolumab,2,SS,Streptococcus test positive,2,F,HO,107
173605711,2,Glioblastoma multiforme,1,I,DIR,nivolumab,2,SS,Tachycardia,2,F,HO,107
173605711,2,Glioblastoma multiforme,1,I,DIR,nivolumab,2,SS,Tendon injury,2,F,HO,107
173616724,3,Plasma cell myeloma,4,F,EXP,daratumumab,3,SS,Adenovirus infection,3,M,HO,439
173616724,4,Plasma cell leukaemia,4,F,EXP,daratumumab,4,SS,Adenovirus infection,4,M,HO,25
173616724,7,Plasma cell myeloma,4,F,EXP,lenalidomide,7,SS,Adenovirus infection,7,M,HO,439
173616724,13,Plasma cell myeloma,4,F,EXP,filgrastim,13,SS,Adenovirus infection,13,M,HO,346
173616724,14,Plasma cell leukaemia,4,F,EXP,filgrastim,14,SS,Adenovirus infection,14,M,HO,334
173617481,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Back pain,1,M,OT,551
173617481,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Fatigue,1,M,OT,551
173617481,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Irritable bowel syndrome,1,M,OT,551
173617481,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Neuropathy peripheral,1,M,OT,551
173617481,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Back pain,3,M,OT,551
173617481,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Fatigue,3,M,OT,551
173617481,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Irritable bowel syndrome,3,M,OT,551
173617481,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Neuropathy peripheral,3,M,OT,551
173618242,1,Breast cancer metastatic,2,F,EXP,palbociclib,1,PS,Toxic skin eruption,1,F,OT,378
173618901,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Anaemia,2,M,OT,8
173618901,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Blood creatinine increased,2,M,OT,8
173618901,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Hypoalbuminaemia,2,M,OT,8
173618901,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Hypocalcaemia,2,M,OT,8
173618901,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Lymphocyte count decreased,2,M,OT,8
173618901,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Neutropenia,2,M,OT,8
173618901,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Pneumonia,2,M,OT,8
173618901,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Thrombocytopenia,2,M,OT,8
173618901,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,White blood cell count decreased,2,M,OT,8
173619671,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Febrile neutropenia,3,F,HO,19
173619671,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Febrile neutropenia,3,F,OT,19
173619671,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Pneumonia,3,F,HO,19
173619671,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Pneumonia,3,F,OT,19
173619671,7,Plasma cell myeloma,1,I,EXP,daratumumab,7,SS,Febrile neutropenia,7,F,HO,19
173619671,7,Plasma cell myeloma,1,I,EXP,daratumumab,7,SS,Febrile neutropenia,7,F,OT,19
173619671,7,Plasma cell myeloma,1,I,EXP,daratumumab,7,SS,Pneumonia,7,F,HO,19
173619671,7,Plasma cell myeloma,1,I,EXP,daratumumab,7,SS,Pneumonia,7,F,OT,19
173620073,1,Adrenocortical carcinoma,3,F,EXP,nivolumab,1,PS,Intracranial tumour haemorrhage,1,M,HO,8
173620073,1,Adrenocortical carcinoma,3,F,EXP,nivolumab,1,PS,Intracranial tumour haemorrhage,1,M,LT,8
173620073,1,Adrenocortical carcinoma,3,F,EXP,nivolumab,1,PS,Intracranial tumour haemorrhage,1,M,OT,8
173620651,2,Immune thrombocytopenic purpura,1,I,EXP,romiplostim,2,SS,Hepatotoxicity,2,F,DE,73
173620651,2,Immune thrombocytopenic purpura,1,I,EXP,romiplostim,2,SS,Hepatotoxicity,2,F,OT,73
173620651,2,Immune thrombocytopenic purpura,1,I,EXP,romiplostim,2,SS,Mouth haemorrhage,2,F,DE,73
173620651,2,Immune thrombocytopenic purpura,1,I,EXP,romiplostim,2,SS,Mouth haemorrhage,2,F,OT,73
173620651,2,Immune thrombocytopenic purpura,1,I,EXP,romiplostim,2,SS,Pulmonary haemorrhage,2,F,DE,73
173620651,2,Immune thrombocytopenic purpura,1,I,EXP,romiplostim,2,SS,Pulmonary haemorrhage,2,F,OT,73
173620651,2,Immune thrombocytopenic purpura,1,I,EXP,romiplostim,2,SS,Therapy non-responder,2,F,DE,73
173620651,2,Immune thrombocytopenic purpura,1,I,EXP,romiplostim,2,SS,Therapy non-responder,2,F,OT,73
173621012,1,Neuroendocrine carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,F,LT,147
173621012,1,Neuroendocrine carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,F,HO,147
173621012,1,Neuroendocrine carcinoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,F,OT,147
173621012,1,Neuroendocrine carcinoma,2,F,EXP,nivolumab,1,PS,Pyelonephritis,1,F,LT,147
173621012,1,Neuroendocrine carcinoma,2,F,EXP,nivolumab,1,PS,Pyelonephritis,1,F,HO,147
173621012,1,Neuroendocrine carcinoma,2,F,EXP,nivolumab,1,PS,Pyelonephritis,1,F,OT,147
173621012,1,Neuroendocrine carcinoma,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,LT,147
173621012,1,Neuroendocrine carcinoma,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,HO,147
173621012,1,Neuroendocrine carcinoma,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,OT,147
173621012,2,Neuroendocrine carcinoma,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,F,LT,147
173621012,2,Neuroendocrine carcinoma,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,F,HO,147
173621012,2,Neuroendocrine carcinoma,2,F,EXP,ipilimumab,2,SS,Pneumonia,2,F,OT,147
173621012,2,Neuroendocrine carcinoma,2,F,EXP,ipilimumab,2,SS,Pyelonephritis,2,F,LT,147
173621012,2,Neuroendocrine carcinoma,2,F,EXP,ipilimumab,2,SS,Pyelonephritis,2,F,HO,147
173621012,2,Neuroendocrine carcinoma,2,F,EXP,ipilimumab,2,SS,Pyelonephritis,2,F,OT,147
173621012,2,Neuroendocrine carcinoma,2,F,EXP,ipilimumab,2,SS,Respiratory failure,2,F,LT,147
173621012,2,Neuroendocrine carcinoma,2,F,EXP,ipilimumab,2,SS,Respiratory failure,2,F,HO,147
173621012,2,Neuroendocrine carcinoma,2,F,EXP,ipilimumab,2,SS,Respiratory failure,2,F,OT,147
173621012,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Pneumonia,3,F,LT,147
173621012,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Pneumonia,3,F,HO,147
173621012,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Pneumonia,3,F,OT,147
173621012,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Pyelonephritis,3,F,LT,147
173621012,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Pyelonephritis,3,F,HO,147
173621012,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Pyelonephritis,3,F,OT,147
173621012,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Respiratory failure,3,F,LT,147
173621012,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Respiratory failure,3,F,HO,147
173621012,3,Product used for unknown indication,2,F,EXP,ipilimumab,3,SS,Respiratory failure,3,F,OT,147
173622952,16,Plasma cell myeloma,2,F,PER,carfilzomib,16,SS,Upper gastrointestinal haemorrhage,16,F,HO,2069
173622952,19,Plasma cell myeloma,2,F,PER,daratumumab,19,SS,Upper gastrointestinal haemorrhage,19,F,HO,436
173623361,6,Plasma cell myeloma,1,I,EXP,pomalidomide,6,C,Alanine aminotransferase increased,6,M,OT,21
173623361,6,Plasma cell myeloma,1,I,EXP,pomalidomide,6,C,Anaemia,6,M,OT,21
173623361,6,Plasma cell myeloma,1,I,EXP,pomalidomide,6,C,Blood alkaline phosphatase increased,6,M,OT,21
173623361,6,Plasma cell myeloma,1,I,EXP,pomalidomide,6,C,Neutropenia,6,M,OT,21
173624321,13,Plasma cell myeloma,1,I,EXP,carfilzomib,13,SS,Orthostatic hypotension,13,F,HO,1582
173624321,18,Plasma cell myeloma,1,I,EXP,daratumumab,18,SS,Orthostatic hypotension,18,F,HO,474
173624591,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Neutropenia,2,F,OT,392
173624591,13,Product used for unknown indication,1,I,EXP,filgrastim,13,C,Neutropenia,13,F,OT,164
173627683,3,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Soft tissue infection,3,M,HO,286
173627683,3,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Soft tissue infection,3,M,OT,286
173630111,6,Breast cancer metastatic,1,I,EXP,palbociclib,6,SS,Sepsis,6,F,HO,1045
173630111,6,Breast cancer metastatic,1,I,EXP,palbociclib,6,SS,Urinary tract infection,6,F,HO,1045
173630361,3,Oesophageal carcinoma,1,I,EXP,avelumab,3,SS,Acute kidney injury,3,M,OT,1
173630361,3,Oesophageal carcinoma,1,I,EXP,avelumab,3,SS,Acute kidney injury,3,M,HO,1
173630361,3,Oesophageal carcinoma,1,I,EXP,avelumab,3,SS,Hyperkalaemia,3,M,OT,1
173630361,3,Oesophageal carcinoma,1,I,EXP,avelumab,3,SS,Hyperkalaemia,3,M,HO,1
173630361,3,Oesophageal carcinoma,1,I,EXP,avelumab,3,SS,Hypotension,3,M,OT,1
173630361,3,Oesophageal carcinoma,1,I,EXP,avelumab,3,SS,Hypotension,3,M,HO,1
173631132,2,Breast cancer stage II,2,F,EXP,abemaciclib,2,SS,Abdominal pain,2,F,HO,250
173631132,2,Breast cancer stage II,2,F,EXP,abemaciclib,2,SS,Blood creatinine increased,2,F,HO,250
173631132,2,Breast cancer stage II,2,F,EXP,abemaciclib,2,SS,C-reactive protein increased,2,F,HO,250
173631132,2,Breast cancer stage II,2,F,EXP,abemaciclib,2,SS,Diarrhoea,2,F,HO,250
173631132,2,Breast cancer stage II,2,F,EXP,abemaciclib,2,SS,Pyrexia,2,F,HO,250
173631132,2,Breast cancer stage II,2,F,EXP,abemaciclib,2,SS,Rectal haemorrhage,2,F,HO,250
173631132,2,Breast cancer stage II,2,F,EXP,abemaciclib,2,SS,Vomiting,2,F,HO,250
173631534,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,HO,75
173631534,1,Oesophageal squamous cell carcinoma,4,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,OT,75
173631773,9,Prophylaxis,3,F,EXP,filgrastim,9,C,Infection,9,M,HO,12
173633841,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Anaemia,2,F,HO,19
173633841,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Anaemia,2,F,OT,19
173633841,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Pyrexia,2,F,HO,19
173633841,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Pyrexia,2,F,OT,19
173633871,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Nausea,2,F,OT,119
173633871,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Thrombocytopenia,2,F,OT,119
173633871,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Vomiting,2,F,OT,119
173633871,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Weight decreased,2,F,OT,119
173634063,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Retinal haemorrhage,1,F,HO,122
173634361,1,Glioblastoma,1,I,EXP,nivolumab,1,PS,Cognitive disorder,1,F,HO,196
173634521,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Back pain,2,M,OT,551
173634521,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Fatigue,2,M,OT,551
173634521,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Irritable bowel syndrome,2,M,OT,551
173634521,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Neuropathy peripheral,2,M,OT,551
173634521,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Back pain,3,M,OT,551
173634521,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Fatigue,3,M,OT,551
173634521,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Irritable bowel syndrome,3,M,OT,551
173634521,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Neuropathy peripheral,3,M,OT,551
173634623,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Acute kidney injury,2,F,OT,50
173634623,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Acute kidney injury,2,F,HO,50
173634623,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Alanine aminotransferase increased,2,F,OT,50
173634623,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Alanine aminotransferase increased,2,F,HO,50
173634623,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Colitis,2,F,OT,50
173634623,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Colitis,2,F,HO,50
173634623,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Diarrhoea,2,F,OT,50
173634623,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Diarrhoea,2,F,HO,50
173634623,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Large intestine perforation,2,F,OT,50
173634623,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Large intestine perforation,2,F,HO,50
173634623,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Nausea,2,F,OT,50
173634623,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Nausea,2,F,HO,50
173634623,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Vomiting,2,F,OT,50
173634623,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Vomiting,2,F,HO,50
173634623,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Acute kidney injury,3,F,OT,50
173634623,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Acute kidney injury,3,F,HO,50
173634623,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Alanine aminotransferase increased,3,F,OT,50
173634623,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Alanine aminotransferase increased,3,F,HO,50
173634623,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Colitis,3,F,OT,50
173634623,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Colitis,3,F,HO,50
173634623,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Diarrhoea,3,F,OT,50
173634623,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Diarrhoea,3,F,HO,50
173634623,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Large intestine perforation,3,F,OT,50
173634623,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Large intestine perforation,3,F,HO,50
173634623,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Nausea,3,F,OT,50
173634623,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Nausea,3,F,HO,50
173634623,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Vomiting,3,F,OT,50
173634623,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Vomiting,3,F,HO,50
173634841,10,Plasma cell myeloma,1,I,PER,carfilzomib,10,SS,Neutrophil count decreased,10,M,OT,217
173634841,12,Plasma cell myeloma,1,I,PER,daratumumab,12,SS,Neutrophil count decreased,12,M,OT,111
173635112,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Aphasia,1,F,HO,4
173635112,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,F,HO,4
173635112,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Depressed level of consciousness,1,F,HO,4
173635112,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Somnolence,1,F,HO,4
173635112,30,Product used for unknown indication,2,F,EXP,rasburicase,30,C,Aphasia,30,F,HO,16
173635112,30,Product used for unknown indication,2,F,EXP,rasburicase,30,C,Confusional state,30,F,HO,16
173635112,30,Product used for unknown indication,2,F,EXP,rasburicase,30,C,Depressed level of consciousness,30,F,HO,16
173635112,30,Product used for unknown indication,2,F,EXP,rasburicase,30,C,Somnolence,30,F,HO,16
173635112,41,Product used for unknown indication,2,F,EXP,filgrastim,41,C,Aphasia,41,F,HO,9
173635112,41,Product used for unknown indication,2,F,EXP,filgrastim,41,C,Confusional state,41,F,HO,9
173635112,41,Product used for unknown indication,2,F,EXP,filgrastim,41,C,Depressed level of consciousness,41,F,HO,9
173635112,41,Product used for unknown indication,2,F,EXP,filgrastim,41,C,Somnolence,41,F,HO,9
173638251,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Blood alkaline phosphatase increased,1,M,OT,32
173638251,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Blood potassium increased,1,M,OT,32
173638251,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Blood triglycerides increased,1,M,OT,32
173638251,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Cataract,1,M,OT,32
173638251,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Diabetes mellitus,1,M,OT,32
173638251,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Diarrhoea,1,M,OT,32
173638251,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Extrasystoles,1,M,OT,32
173638251,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Nephrolithiasis,1,M,OT,32
173638251,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Skin lesion,1,M,OT,32
173638251,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Thrombocytopenia,1,M,OT,32
173638391,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Conjunctival hyperaemia,1,M,OT,44
173638391,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Corneal erosion,1,M,OT,44
173638391,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Eyelid cyst,1,M,OT,44
173638511,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Aspartate aminotransferase increased,1,M,HO,50
173638511,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Aspartate aminotransferase increased,1,M,OT,50
173638511,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Lymphocyte count decreased,1,M,HO,50
173638511,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Lymphocyte count decreased,1,M,OT,50
173638511,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Pyrexia,1,M,HO,50
173638511,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Pyrexia,1,M,OT,50
173638511,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Aspartate aminotransferase increased,2,M,HO,50
173638511,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Aspartate aminotransferase increased,2,M,OT,50
173638511,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Lymphocyte count decreased,2,M,HO,50
173638511,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Lymphocyte count decreased,2,M,OT,50
173638511,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Pyrexia,2,M,HO,50
173638511,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Pyrexia,2,M,OT,50
173639392,1,Laryngeal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,208
173639392,1,Laryngeal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,208
173639392,1,Laryngeal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Laryngeal inflammation,1,F,OT,208
173639392,1,Laryngeal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Laryngeal inflammation,1,F,HO,208
173639392,1,Laryngeal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Laryngeal oedema,1,F,OT,208
173639392,1,Laryngeal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Laryngeal oedema,1,F,HO,208
173639392,2,Laryngeal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Dyspnoea,2,F,OT,208
173639392,2,Laryngeal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Dyspnoea,2,F,HO,208
173639392,2,Laryngeal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Laryngeal inflammation,2,F,OT,208
173639392,2,Laryngeal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Laryngeal inflammation,2,F,HO,208
173639392,2,Laryngeal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Laryngeal oedema,2,F,OT,208
173639392,2,Laryngeal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Laryngeal oedema,2,F,HO,208
173639401,1,Oropharyngeal cancer,1,I,EXP,nivolumab,1,PS,Haemoptysis,1,M,OT,124
173639401,1,Oropharyngeal cancer,1,I,EXP,nivolumab,1,PS,Haemoptysis,1,M,HO,124
173639401,1,Oropharyngeal cancer,1,I,EXP,nivolumab,1,PS,Oral pain,1,M,OT,124
173639401,1,Oropharyngeal cancer,1,I,EXP,nivolumab,1,PS,Oral pain,1,M,HO,124
173639401,1,Oropharyngeal cancer,1,I,EXP,nivolumab,1,PS,Rhinalgia,1,M,OT,124
173639401,1,Oropharyngeal cancer,1,I,EXP,nivolumab,1,PS,Rhinalgia,1,M,HO,124
173639401,1,Oropharyngeal cancer,1,I,EXP,nivolumab,1,PS,Rhinorrhoea,1,M,OT,124
173639401,1,Oropharyngeal cancer,1,I,EXP,nivolumab,1,PS,Rhinorrhoea,1,M,HO,124
173639742,2,Malignant melanoma,2,F,EXP,nivolumab,2,SS,Lung disorder,2,M,OT,70
173640222,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Blood disorder,1,M,OT,183
173640222,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Blood disorder,1,M,HO,183
173640222,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Graft versus host disease,1,M,OT,183
173640222,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Graft versus host disease,1,M,HO,183
173640222,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,OT,183
173640222,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Hepatic function abnormal,1,M,HO,183
173640222,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Renal disorder,1,M,OT,183
173640222,1,Hodgkin's disease,2,F,EXP,nivolumab,1,PS,Renal disorder,1,M,HO,183
173643091,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Physical deconditioning,1,F,OT,21
173643091,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Physical deconditioning,1,F,HO,21
173644662,1,Cervix carcinoma,2,F,EXP,nivolumab,1,PS,Infection,1,F,HO,22
173646672,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Haematuria,1,M,HO,96
173646672,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Haematuria,2,M,HO,96
173647141,4,Product used for unknown indication,1,I,EXP,denosumab,4,C,Upper gastrointestinal haemorrhage,4,F,OT,500
173647141,4,Product used for unknown indication,1,I,EXP,denosumab,4,C,Upper gastrointestinal haemorrhage,4,F,HO,500
173648101,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Pneumonia,1,M,HO,1383
173648101,5,Plasma cell myeloma,1,I,EXP,pomalidomide,5,SS,Pneumonia,5,M,HO,1383
173648112,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Cataract,1,F,OT,537
173648231,1,Colon cancer,1,I,EXP,nivolumab,1,PS,Anaemia,1,F,HO,15
173648231,1,Colon cancer,1,I,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,15
173648231,1,Colon cancer,1,I,EXP,nivolumab,1,PS,Gastrointestinal infection,1,F,HO,15
173648231,1,Colon cancer,1,I,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,15
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Cardiac failure congestive,1,M,OT,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Cardiac failure congestive,1,M,HO,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Cardiac failure congestive,1,M,DE,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Death,1,M,OT,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Death,1,M,HO,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Death,1,M,DE,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Dementia,1,M,OT,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Dementia,1,M,HO,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Dementia,1,M,DE,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Dysphagia,1,M,OT,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Dysphagia,1,M,HO,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Dysphagia,1,M,DE,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Prostatic specific antigen increased,1,M,OT,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Prostatic specific antigen increased,1,M,HO,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Prostatic specific antigen increased,1,M,DE,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Urinary tract infection,1,M,OT,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Urinary tract infection,1,M,HO,159
173651291,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Urinary tract infection,1,M,DE,159
173653092,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Influenza,1,M,OT,137
173653092,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,137
173653092,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Nephrolithiasis,1,M,OT,137
173653092,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Product prescribing error,1,M,OT,137
173655522,2,Prostate cancer,2,F,EXP,enzalutamide,2,SS,Cerebrovascular accident,2,M,OT,2514
173655522,2,Prostate cancer,2,F,EXP,enzalutamide,2,SS,Cerebrovascular accident,2,M,HO,2514
173655522,2,Prostate cancer,2,F,EXP,enzalutamide,2,SS,Myocardial infarction,2,M,OT,2514
173655522,2,Prostate cancer,2,F,EXP,enzalutamide,2,SS,Myocardial infarction,2,M,HO,2514
173659072,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Pyrexia,1,F,HO,4
173659072,6,Plasma cell myeloma,2,F,EXP,carfilzomib,6,SS,Pyrexia,6,F,HO,4
173659721,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Drug ineffective,1,M,LT,6
173659721,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Drug ineffective,1,M,OT,6
173659721,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutropenia,1,M,LT,6
173659721,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutropenia,1,M,OT,6
173659721,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,M,LT,6
173659721,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,M,OT,6
173661641,3,Plasma cell myeloma,1,I,EXP,thalidomide,3,SS,Cell death,3,F,HO,26
173661641,3,Plasma cell myeloma,1,I,EXP,thalidomide,3,SS,Rash,3,F,HO,26
173663151,2,Renal cell carcinoma,1,I,PER,avelumab,2,SS,Haemorrhage,2,M,HO,99
173663151,2,Renal cell carcinoma,1,I,PER,avelumab,2,SS,Haemorrhage,2,M,OT,99
173664781,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Dyspnoea,4,F,OT,36
173664781,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Thrombocytopenia,4,F,OT,36
173664781,14,Prophylaxis,1,I,EXP,zoledronic acid,14,C,Dyspnoea,14,F,OT,3023
173664781,14,Prophylaxis,1,I,EXP,zoledronic acid,14,C,Thrombocytopenia,14,F,OT,3023
173666524,1,Plasma cell myeloma,4,F,EXP,daratumumab,1,PS,Adenovirus infection,1,M,HO,439
173666524,2,Plasma cell leukaemia,4,F,EXP,daratumumab,2,SS,Adenovirus infection,2,M,HO,25
173666524,7,Plasma cell myeloma,4,F,EXP,lenalidomide,7,SS,Adenovirus infection,7,M,HO,439
173666524,13,Plasma cell myeloma,4,F,EXP,filgrastim,13,SS,Adenovirus infection,13,M,HO,346
173666524,14,Plasma cell leukaemia,4,F,EXP,filgrastim,14,SS,Adenovirus infection,14,M,HO,334
173667463,2,Chronic graft versus host disease,3,F,EXP,ibrutinib,2,SS,Acute respiratory distress syndrome,2,F,DE,41
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Acute kidney injury,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Acute kidney injury,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Acute kidney injury,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Cancer pain,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Cancer pain,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Cancer pain,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Cataract,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Cataract,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Cataract,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Clostridium difficile infection,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Clostridium difficile infection,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Clostridium difficile infection,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Constipation,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Constipation,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Constipation,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Delirium,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Delirium,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Delirium,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Diarrhoea,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Diarrhoea,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Diarrhoea,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Fatigue,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Fatigue,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Fatigue,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Muscular weakness,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Muscular weakness,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Muscular weakness,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Nasopharyngitis,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Nasopharyngitis,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Nasopharyngitis,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Nausea,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Nausea,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Nausea,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Plasma cell myeloma,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Plasma cell myeloma,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Plasma cell myeloma,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Platelet count decreased,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Platelet count decreased,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Platelet count decreased,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Pyrexia,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Pyrexia,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Pyrexia,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Red blood cell count decreased,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Red blood cell count decreased,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Red blood cell count decreased,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Somnolence,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Somnolence,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Somnolence,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Spinal compression fracture,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Spinal compression fracture,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Spinal compression fracture,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Thermal burn,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Thermal burn,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Thermal burn,5,M,DE,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,White blood cell count decreased,5,M,OT,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,White blood cell count decreased,5,M,HO,4
173667701,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,White blood cell count decreased,5,M,DE,4
173667722,13,Plasma cell myeloma,2,F,EXP,carfilzomib,13,SS,Acute respiratory failure,13,F,HO,1686
173667722,13,Plasma cell myeloma,2,F,EXP,carfilzomib,13,SS,Hypoxia,13,F,HO,1686
173667722,13,Plasma cell myeloma,2,F,EXP,carfilzomib,13,SS,Respiratory syncytial virus infection,13,F,HO,1686
173667722,18,Plasma cell myeloma,2,F,EXP,daratumumab,18,SS,Acute respiratory failure,18,F,HO,578
173667722,18,Plasma cell myeloma,2,F,EXP,daratumumab,18,SS,Hypoxia,18,F,HO,578
173667722,18,Plasma cell myeloma,2,F,EXP,daratumumab,18,SS,Respiratory syncytial virus infection,18,F,HO,578
173669522,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Sepsis,1,F,HO,14
173669522,2,Plasma cell myeloma,2,F,EXP,carfilzomib,2,SS,Sepsis,2,F,HO,14
173670371,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Death,1,M,OT,475
173670371,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Death,1,M,DE,475
173670895,1,Breast cancer,5,F,EXP,palbociclib,1,PS,Syncope,1,F,HO,11
173672811,1,Acute lymphocytic leukaemia refractory,1,I,PER,blinatumomab,1,PS,Arthralgia,1,F,OT,30
173672811,1,Acute lymphocytic leukaemia refractory,1,I,PER,blinatumomab,1,PS,Arthralgia,1,F,HO,30
173672811,1,Acute lymphocytic leukaemia refractory,1,I,PER,blinatumomab,1,PS,Herpes zoster,1,F,OT,30
173672811,1,Acute lymphocytic leukaemia refractory,1,I,PER,blinatumomab,1,PS,Herpes zoster,1,F,HO,30
173672912,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Thrombocytopenia,2,F,OT,55
173672912,8,Prophylaxis,2,F,EXP,zoledronic acid,8,C,Thrombocytopenia,8,F,OT,3070
173673441,1,T-cell type acute leukaemia,1,I,EXP,nelarabine,1,PS,Areflexia,1,M,LT,6
173673441,1,T-cell type acute leukaemia,1,I,EXP,nelarabine,1,PS,Areflexia,1,M,HO,6
173673441,1,T-cell type acute leukaemia,1,I,EXP,nelarabine,1,PS,Mental status changes,1,M,LT,6
173673441,1,T-cell type acute leukaemia,1,I,EXP,nelarabine,1,PS,Mental status changes,1,M,HO,6
173673441,1,T-cell type acute leukaemia,1,I,EXP,nelarabine,1,PS,Neurotoxicity,1,M,LT,6
173673441,1,T-cell type acute leukaemia,1,I,EXP,nelarabine,1,PS,Neurotoxicity,1,M,HO,6
173673441,1,T-cell type acute leukaemia,1,I,EXP,nelarabine,1,PS,Peripheral sensory neuropathy,1,M,LT,6
173673441,1,T-cell type acute leukaemia,1,I,EXP,nelarabine,1,PS,Peripheral sensory neuropathy,1,M,HO,6
173673441,1,T-cell type acute leukaemia,1,I,EXP,nelarabine,1,PS,Seizure,1,M,LT,6
173673441,1,T-cell type acute leukaemia,1,I,EXP,nelarabine,1,PS,Seizure,1,M,HO,6
173673441,1,T-cell type acute leukaemia,1,I,EXP,nelarabine,1,PS,Sensory loss,1,M,LT,6
173673441,1,T-cell type acute leukaemia,1,I,EXP,nelarabine,1,PS,Sensory loss,1,M,HO,6
173677091,1,Lip and/or oral cavity cancer,1,I,DIR,nivolumab,1,PS,Cardiac arrest,1,F,DE,221
173677091,1,Lip and/or oral cavity cancer,1,I,DIR,nivolumab,1,PS,Cardiac arrest,1,F,HO,221
173677091,1,Lip and/or oral cavity cancer,1,I,DIR,nivolumab,1,PS,Hyponatraemia,1,F,DE,221
173677091,1,Lip and/or oral cavity cancer,1,I,DIR,nivolumab,1,PS,Hyponatraemia,1,F,HO,221
173677091,1,Lip and/or oral cavity cancer,1,I,DIR,nivolumab,1,PS,Unresponsive to stimuli,1,F,DE,221
173677091,1,Lip and/or oral cavity cancer,1,I,DIR,nivolumab,1,PS,Unresponsive to stimuli,1,F,HO,221
173677342,1,Breast cancer metastatic,2,F,EXP,palbociclib,1,PS,Arthritis,1,F,HO,63
173679082,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Encephalitis,1,F,OT,33
173679082,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Encephalitis,1,F,HO,33
173680221,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Pneumonia,1,F,DE,171
173680221,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Pneumonia,1,F,OT,171
173680221,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Pneumonia,1,F,HO,171
173680591,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Syncope,1,F,HO,238
173681265,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,OT,175
173681265,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,HO,175
173681265,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Escherichia urinary tract infection,1,M,OT,175
173681265,1,Renal cell carcinoma,5,F,EXP,nivolumab,1,PS,Escherichia urinary tract infection,1,M,HO,175
173681265,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Acute myocardial infarction,2,M,OT,105
173681265,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Acute myocardial infarction,2,M,HO,105
173681265,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Escherichia urinary tract infection,2,M,OT,105
173681265,2,Renal cell carcinoma,5,F,EXP,ipilimumab,2,SS,Escherichia urinary tract infection,2,M,HO,105
173681571,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Arthralgia,1,F,HO,228
173681571,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Arthralgia,2,F,HO,228
173682561,1,Adenocarcinoma of colon,1,I,EXP,nivolumab,1,PS,Palmar-plantar erythrodysaesthesia syndrome,1,M,OT,14
173682561,1,Adenocarcinoma of colon,1,I,EXP,nivolumab,1,PS,Rectal haemorrhage,1,M,OT,14
173685355,1,Plasma cell myeloma,5,F,EXP,lenalidomide,1,PS,Acute lymphocytic leukaemia,1,F,LT,2024
173685355,1,Plasma cell myeloma,5,F,EXP,lenalidomide,1,PS,Acute lymphocytic leukaemia,1,F,HO,2024
173685355,1,Plasma cell myeloma,5,F,EXP,lenalidomide,1,PS,Acute lymphocytic leukaemia,1,F,OT,2024
173688632,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Brain abscess,1,M,OT,295
173688632,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Brain abscess,1,M,HO,295
173688632,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Brain abscess,2,M,OT,295
173688632,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Brain abscess,2,M,HO,295
173689542,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Adrenal insufficiency,1,F,OT,94
173689542,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Adrenal insufficiency,1,F,LT,94
173689542,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Adrenal insufficiency,1,F,HO,94
173689542,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Adrenal insufficiency,2,F,OT,94
173689542,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Adrenal insufficiency,2,F,LT,94
173689542,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Adrenal insufficiency,2,F,HO,94
173689752,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Abdominal discomfort,1,F,OT,1
173689752,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Abdominal pain lower,1,F,OT,1
173689752,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,CD4 lymphocytes decreased,1,F,OT,1
173689752,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Dry throat,1,F,OT,1
173689752,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Dysuria,1,F,OT,1
173689752,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Fatigue,1,F,OT,1
173689752,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Feeling abnormal,1,F,OT,1
173689752,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Immunodeficiency,1,F,OT,1
173689752,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Nasopharyngitis,1,F,OT,1
173689752,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Pollakiuria,1,F,OT,1
173689752,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,OT,1
173690134,2,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,2,PS,Immune-mediated hepatitis,2,M,LT,42
173690134,2,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,2,PS,Immune-mediated hepatitis,2,M,HO,42
173690134,2,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,2,PS,Immune-mediated hepatitis,2,M,OT,42
173690134,2,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,2,PS,Immune-mediated nephritis,2,M,LT,42
173690134,2,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,2,PS,Immune-mediated nephritis,2,M,HO,42
173690134,2,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,2,PS,Immune-mediated nephritis,2,M,OT,42
173690134,2,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,2,PS,Thrombocytopenia,2,M,LT,42
173690134,2,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,2,PS,Thrombocytopenia,2,M,HO,42
173690134,2,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,2,PS,Thrombocytopenia,2,M,OT,42
173690134,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Immune-mediated hepatitis,3,M,LT,42
173690134,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Immune-mediated hepatitis,3,M,HO,42
173690134,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Immune-mediated hepatitis,3,M,OT,42
173690134,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Immune-mediated nephritis,3,M,LT,42
173690134,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Immune-mediated nephritis,3,M,HO,42
173690134,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Immune-mediated nephritis,3,M,OT,42
173690134,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Thrombocytopenia,3,M,LT,42
173690134,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Thrombocytopenia,3,M,HO,42
173690134,3,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Thrombocytopenia,3,M,OT,42
173690184,1,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,DE,598
173690184,1,Metastatic renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,OT,598
173690184,2,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Acute myocardial infarction,2,M,DE,598
173690184,2,Metastatic renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Acute myocardial infarction,2,M,OT,598
173692181,1,Malignant melanoma stage IV,1,I,PER,trametinib,1,PS,Drug ineffective,1,M,OT,168
173692181,1,Malignant melanoma stage IV,1,I,PER,trametinib,1,PS,Metastases to liver,1,M,OT,168
173692181,1,Malignant melanoma stage IV,1,I,PER,trametinib,1,PS,Metastases to spleen,1,M,OT,168
173692181,1,Malignant melanoma stage IV,1,I,PER,trametinib,1,PS,Splenic lesion,1,M,OT,168
173693411,1,Squamous cell carcinoma,1,I,DIR,nivolumab,1,PS,Ataxia,1,F,DE,218
173693411,1,Squamous cell carcinoma,1,I,DIR,nivolumab,1,PS,Ataxia,1,F,HO,218
173693411,1,Squamous cell carcinoma,1,I,DIR,nivolumab,1,PS,Hyponatraemia,1,F,DE,218
173693411,1,Squamous cell carcinoma,1,I,DIR,nivolumab,1,PS,Hyponatraemia,1,F,HO,218
173694541,3,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,3,SS,Febrile neutropenia,3,F,HO,51
173694541,3,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,3,SS,Febrile neutropenia,3,F,OT,51
173694541,3,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,3,SS,Lung infiltration,3,F,HO,51
173694541,3,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,3,SS,Lung infiltration,3,F,OT,51
173694541,3,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,3,SS,Pneumonia,3,F,HO,51
173694541,3,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,3,SS,Pneumonia,3,F,OT,51
173694541,3,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,3,SS,Pneumonia klebsiella,3,F,HO,51
173694541,3,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,3,SS,Pneumonia klebsiella,3,F,OT,51
173694541,3,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,3,SS,Thrombocytopenia,3,F,HO,51
173694541,3,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,3,SS,Thrombocytopenia,3,F,OT,51
173695441,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,C,Anaemia,4,F,OT,124
173698171,1,Non-small cell lung cancer,1,I,EXP,ipilimumab,1,PS,Cytokine release syndrome,1,F,HO,1
173698171,1,Non-small cell lung cancer,1,I,EXP,ipilimumab,1,PS,Cytokine release syndrome,1,F,DE,1
173698171,1,Non-small cell lung cancer,1,I,EXP,ipilimumab,1,PS,Cytokine release syndrome,1,F,OT,1
173698171,1,Non-small cell lung cancer,1,I,EXP,ipilimumab,1,PS,Intentional product use issue,1,F,HO,1
173698171,1,Non-small cell lung cancer,1,I,EXP,ipilimumab,1,PS,Intentional product use issue,1,F,DE,1
173698171,1,Non-small cell lung cancer,1,I,EXP,ipilimumab,1,PS,Intentional product use issue,1,F,OT,1
173698171,1,Non-small cell lung cancer,1,I,EXP,ipilimumab,1,PS,Multiple organ dysfunction syndrome,1,F,HO,1
173698171,1,Non-small cell lung cancer,1,I,EXP,ipilimumab,1,PS,Multiple organ dysfunction syndrome,1,F,DE,1
173698171,1,Non-small cell lung cancer,1,I,EXP,ipilimumab,1,PS,Multiple organ dysfunction syndrome,1,F,OT,1
173698171,1,Non-small cell lung cancer,1,I,EXP,ipilimumab,1,PS,Skin reaction,1,F,HO,1
173698171,1,Non-small cell lung cancer,1,I,EXP,ipilimumab,1,PS,Skin reaction,1,F,DE,1
173698171,1,Non-small cell lung cancer,1,I,EXP,ipilimumab,1,PS,Skin reaction,1,F,OT,1
173700002,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pneumonia,2,F,OT,22
173700002,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Pneumonia,2,F,HO,22
173700181,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,F,OT,9
173700181,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,F,HO,9
173700181,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Peripheral ischaemia,1,F,OT,9
173700181,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Peripheral ischaemia,1,F,HO,9
173701622,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Cardiac tamponade,1,M,OT,5
173701622,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Cardiac tamponade,1,M,LT,5
173701622,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Cardiac tamponade,1,M,HO,5
173701622,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Pericardial effusion,1,M,OT,5
173701622,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Pericardial effusion,1,M,LT,5
173701622,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Pericardial effusion,1,M,HO,5
173701622,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,SS,Cardiac tamponade,2,M,OT,5
173701622,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,SS,Cardiac tamponade,2,M,LT,5
173701622,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,SS,Cardiac tamponade,2,M,HO,5
173701622,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,SS,Pericardial effusion,2,M,OT,5
173701622,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,SS,Pericardial effusion,2,M,LT,5
173701622,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,SS,Pericardial effusion,2,M,HO,5
173702721,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Lower respiratory tract infection,3,M,OT,37
173702721,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Lower respiratory tract infection,3,M,HO,37
173702721,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Toxicity to various agents,3,M,OT,37
173702721,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Toxicity to various agents,3,M,HO,37
173704241,7,B precursor type acute leukaemia,1,I,EXP,pegaspargase,7,SS,Febrile neutropenia,7,M,HO,217
173709283,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Diarrhoea,1,F,OT,29
173709283,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Diarrhoea,1,F,HO,29
173709283,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Hepatic steatosis,1,F,OT,29
173709283,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Hepatic steatosis,1,F,HO,29
173709283,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Nausea,1,F,OT,29
173709283,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Nausea,1,F,HO,29
173709283,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Vomiting,1,F,OT,29
173709283,1,Metastatic malignant melanoma,3,F,EXP,ipilimumab,1,PS,Vomiting,1,F,HO,29
173713553,1,Plasma cell myeloma,3,F,EXP,pomalidomide,1,PS,Herpes zoster,1,F,OT,702
173713553,1,Plasma cell myeloma,3,F,EXP,pomalidomide,1,PS,Herpes zoster,1,F,HO,702
173713553,1,Plasma cell myeloma,3,F,EXP,pomalidomide,1,PS,Post herpetic neuralgia,1,F,OT,702
173713553,1,Plasma cell myeloma,3,F,EXP,pomalidomide,1,PS,Post herpetic neuralgia,1,F,HO,702
173717453,2,Mantle cell lymphoma,3,F,EXP,ibrutinib,2,SS,Pneumonia,2,M,HO,264
173724431,4,Plasma cell myeloma,1,I,EXP,thalidomide,4,SS,Neutropenia,4,F,LT,245
173724431,4,Plasma cell myeloma,1,I,EXP,thalidomide,4,SS,Neutropenia,4,F,OT,245
173725371,1,Lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Conjunctivitis viral,1,F,OT,294
173727271,1,Lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Gait disturbance,1,F,OT,330
173727271,1,Lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Intentional product use issue,1,F,OT,330
173727271,1,Lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Tremor,1,F,OT,330
173727731,1,Lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Dry skin,1,F,OT,330
173727731,1,Lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Erythema,1,F,OT,330
173727731,1,Lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Off label use,1,F,OT,330
173727731,1,Lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Pruritus,1,F,OT,330
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Cardiac arrest,1,F,HO,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Cardiac arrest,1,F,OT,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Cardiac arrest,1,F,DE,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Hyponatraemia,1,F,DE,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Hypotension,1,F,HO,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Hypotension,1,F,OT,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Hypotension,1,F,DE,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Inappropriate antidiuretic hormone secretion,1,F,HO,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Inappropriate antidiuretic hormone secretion,1,F,OT,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Inappropriate antidiuretic hormone secretion,1,F,DE,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Renal tubular dysfunction,1,F,HO,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Renal tubular dysfunction,1,F,OT,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Renal tubular dysfunction,1,F,DE,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,HO,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,OT,218
173728582,1,Squamous cell carcinoma of the oral cavity,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,F,DE,218
173728601,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,PS,Malnutrition,2,M,HO,164
173728642,1,Chronic lymphocytic leukaemia,2,F,EXP,idelalisib,1,PS,Diarrhoea,1,F,DE,17
173728642,1,Chronic lymphocytic leukaemia,2,F,EXP,idelalisib,1,PS,Diarrhoea,1,F,HO,17
173729881,1,Neuroendocrine carcinoma of the skin,1,I,EXP,avelumab,1,PS,Interstitial lung disease,1,F,HO,168
173729881,2,Neuroendocrine carcinoma of the skin,1,I,EXP,nivolumab,2,SS,Interstitial lung disease,2,F,HO,953
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Bone marrow failure,1,F,OT,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Bone marrow failure,1,F,HO,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Bone marrow failure,1,F,DE,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Cardiac failure,1,F,OT,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Cardiac failure,1,F,HO,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Cardiac failure,1,F,DE,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Diarrhoea,1,F,OT,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Diarrhoea,1,F,HO,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Diarrhoea,1,F,DE,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Febrile neutropenia,1,F,OT,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Febrile neutropenia,1,F,HO,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Febrile neutropenia,1,F,DE,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Neutropenia,1,F,OT,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Neutropenia,1,F,HO,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Neutropenia,1,F,DE,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Pyrexia,1,F,OT,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Pyrexia,1,F,HO,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Pyrexia,1,F,DE,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Sepsis,1,F,OT,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Sepsis,1,F,HO,64
173730041,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Sepsis,1,F,DE,64
173730853,1,Astrocytoma,3,F,EXP,trametinib,1,PS,Retinal depigmentation,1,F,OT,47
173734071,4,Breast cancer,1,I,EXP,denosumab,4,SS,Alopecia,4,F,HO,132
173734071,4,Breast cancer,1,I,EXP,denosumab,4,SS,Constipation,4,F,HO,132
173734071,4,Breast cancer,1,I,EXP,denosumab,4,SS,Febrile neutropenia,4,F,HO,132
173734071,4,Breast cancer,1,I,EXP,denosumab,4,SS,Headache,4,F,HO,132
173734071,4,Breast cancer,1,I,EXP,denosumab,4,SS,Nausea,4,F,HO,132
173734071,4,Breast cancer,1,I,EXP,denosumab,4,SS,Neurotoxicity,4,F,HO,132
173734071,4,Breast cancer,1,I,EXP,denosumab,4,SS,Oropharyngeal pain,4,F,HO,132
173734071,4,Breast cancer,1,I,EXP,denosumab,4,SS,Rectal haemorrhage,4,F,HO,132
173734071,4,Breast cancer,1,I,EXP,denosumab,4,SS,Stomatitis,4,F,HO,132
173734157,1,Squamous cell carcinoma of the oral cavity,7,F,EXP,nivolumab,1,PS,Confusional state,1,F,HO,161
173737553,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Intellectual disability,1,M,OT,174
173737553,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Product availability issue,1,M,OT,174
173737553,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Product dose omission,1,M,OT,174
173737781,2,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,2,SS,Haemoptysis,2,F,HO,6
173737781,2,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,2,SS,Lower respiratory tract infection,2,F,HO,6
173744783,2,Prostate cancer,3,F,EXP,cabazitaxel,2,SS,Neutropenia,2,M,OT,7
173745692,1,Anaemia,2,F,PER,darbepoetin alfa,1,PS,Arterial insufficiency,1,M,HO,208
173748231,4,Plasma cell myeloma,1,I,EXP,pomalidomide,4,SS,Basal cell carcinoma,4,M,OT,196
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Anaemia,1,F,DE,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Anaemia,1,F,OT,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Anaemia,1,F,HO,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Aphasia,1,F,DE,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Aphasia,1,F,OT,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Aphasia,1,F,HO,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Asthenia,1,F,DE,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Asthenia,1,F,OT,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Asthenia,1,F,HO,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Confusional state,1,F,DE,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Confusional state,1,F,OT,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Confusional state,1,F,HO,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Constipation,1,F,DE,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Constipation,1,F,OT,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Constipation,1,F,HO,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Cough,1,F,DE,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Cough,1,F,OT,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Cough,1,F,HO,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Dysphonia,1,F,DE,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Dysphonia,1,F,OT,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Dysphonia,1,F,HO,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,DE,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,OT,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Pyrexia,1,F,DE,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Pyrexia,1,F,OT,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Sneezing,1,F,DE,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Sneezing,1,F,OT,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Sneezing,1,F,HO,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,DE,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,OT,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,HO,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Vertigo,1,F,DE,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Vertigo,1,F,OT,3
173749552,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Vertigo,1,F,HO,3
173750044,2,Neoplasm malignant,4,F,EXP,alpelisib,2,SS,Peripheral embolism,2,F,HO,311
173750851,1,Plasma cell myeloma,1,I,EXP,pomalidomide,1,PS,Cholangiocarcinoma,1,F,OT,103
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Alopecia,9,F,OT,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Alopecia,9,F,HO,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Constipation,9,F,OT,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Constipation,9,F,HO,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Febrile neutropenia,9,F,OT,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Febrile neutropenia,9,F,HO,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Headache,9,F,OT,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Headache,9,F,HO,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Nausea,9,F,OT,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Nausea,9,F,HO,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Neurotoxicity,9,F,OT,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Neurotoxicity,9,F,HO,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Oropharyngeal pain,9,F,OT,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Oropharyngeal pain,9,F,HO,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Rectal haemorrhage,9,F,OT,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Rectal haemorrhage,9,F,HO,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Stomatitis,9,F,OT,132
173751261,9,Breast cancer,1,I,EXP,denosumab,9,SS,Stomatitis,9,F,HO,132
173753581,1,Breast cancer,1,I,EXP,palbociclib,1,PS,Asthenia,1,F,DS,264
173753581,1,Breast cancer,1,I,EXP,palbociclib,1,PS,Fatigue,1,F,DS,264
173753581,1,Breast cancer,1,I,EXP,palbociclib,1,PS,Malaise,1,F,DS,264
173753611,1,Diffuse large B-cell lymphoma refractory,1,I,EXP,axicabtagene ciloleucel,1,PS,Dysarthria,1,F,HO,6
173753611,1,Diffuse large B-cell lymphoma refractory,1,I,EXP,axicabtagene ciloleucel,1,PS,Dysarthria,1,F,OT,6
173753611,1,Diffuse large B-cell lymphoma refractory,1,I,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,F,HO,6
173753611,1,Diffuse large B-cell lymphoma refractory,1,I,EXP,axicabtagene ciloleucel,1,PS,Encephalopathy,1,F,OT,6
173753611,1,Diffuse large B-cell lymphoma refractory,1,I,EXP,axicabtagene ciloleucel,1,PS,Nervous system disorder,1,F,HO,6
173753611,1,Diffuse large B-cell lymphoma refractory,1,I,EXP,axicabtagene ciloleucel,1,PS,Nervous system disorder,1,F,OT,6
173753611,1,Diffuse large B-cell lymphoma refractory,1,I,EXP,axicabtagene ciloleucel,1,PS,Paraesthesia,1,F,HO,6
173753611,1,Diffuse large B-cell lymphoma refractory,1,I,EXP,axicabtagene ciloleucel,1,PS,Paraesthesia,1,F,OT,6
173753611,1,Diffuse large B-cell lymphoma refractory,1,I,EXP,axicabtagene ciloleucel,1,PS,Visual field defect,1,F,HO,6
173753611,1,Diffuse large B-cell lymphoma refractory,1,I,EXP,axicabtagene ciloleucel,1,PS,Visual field defect,1,F,OT,6
173753611,51,Cytokine release syndrome,1,I,EXP,siltuximab,51,C,Dysarthria,51,F,HO,6
173753611,51,Cytokine release syndrome,1,I,EXP,siltuximab,51,C,Dysarthria,51,F,OT,6
173753611,51,Cytokine release syndrome,1,I,EXP,siltuximab,51,C,Encephalopathy,51,F,HO,6
173753611,51,Cytokine release syndrome,1,I,EXP,siltuximab,51,C,Encephalopathy,51,F,OT,6
173753611,51,Cytokine release syndrome,1,I,EXP,siltuximab,51,C,Nervous system disorder,51,F,HO,6
173753611,51,Cytokine release syndrome,1,I,EXP,siltuximab,51,C,Nervous system disorder,51,F,OT,6
173753611,51,Cytokine release syndrome,1,I,EXP,siltuximab,51,C,Paraesthesia,51,F,HO,6
173753611,51,Cytokine release syndrome,1,I,EXP,siltuximab,51,C,Paraesthesia,51,F,OT,6
173753611,51,Cytokine release syndrome,1,I,EXP,siltuximab,51,C,Visual field defect,51,F,HO,6
173753611,51,Cytokine release syndrome,1,I,EXP,siltuximab,51,C,Visual field defect,51,F,OT,6
173754401,1,Colorectal cancer,1,I,PER,panitumumab,1,PS,Abdominal pain,1,M,HO,40
173754401,1,Colorectal cancer,1,I,PER,panitumumab,1,PS,Gastrointestinal stoma complication,1,M,HO,40
173755001,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Back pain,3,M,OT,551
173755001,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Fatigue,3,M,OT,551
173755001,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Irritable bowel syndrome,3,M,OT,551
173755001,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Neuropathy peripheral,3,M,OT,551
173755371,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Autoimmune hepatitis,1,F,DE,19
173755371,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Autoimmune hepatitis,1,F,HO,19
173755371,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Autoimmune hepatitis,1,F,OT,19
173755371,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Suicide attempt,1,F,DE,19
173755371,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Suicide attempt,1,F,HO,19
173755371,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Suicide attempt,1,F,OT,19
173755371,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Uveitis,1,F,DE,19
173755371,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Uveitis,1,F,HO,19
173755371,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Uveitis,1,F,OT,19
173755371,3,Malignant melanoma,1,I,EXP,ipilimumab,3,PS,Autoimmune hepatitis,3,F,DE,19
173755371,3,Malignant melanoma,1,I,EXP,ipilimumab,3,PS,Autoimmune hepatitis,3,F,HO,19
173755371,3,Malignant melanoma,1,I,EXP,ipilimumab,3,PS,Autoimmune hepatitis,3,F,OT,19
173755371,3,Malignant melanoma,1,I,EXP,ipilimumab,3,PS,Suicide attempt,3,F,DE,19
173755371,3,Malignant melanoma,1,I,EXP,ipilimumab,3,PS,Suicide attempt,3,F,HO,19
173755371,3,Malignant melanoma,1,I,EXP,ipilimumab,3,PS,Suicide attempt,3,F,OT,19
173755371,3,Malignant melanoma,1,I,EXP,ipilimumab,3,PS,Uveitis,3,F,DE,19
173755371,3,Malignant melanoma,1,I,EXP,ipilimumab,3,PS,Uveitis,3,F,HO,19
173755371,3,Malignant melanoma,1,I,EXP,ipilimumab,3,PS,Uveitis,3,F,OT,19
173766481,2,Metastases to bone,1,I,EXP,zoledronic acid,2,SS,Osteonecrosis of jaw,2,F,HO,28
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Arthralgia,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Arthralgia,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,B-lymphocyte count increased,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,B-lymphocyte count increased,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Bedridden,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Bedridden,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Cognitive disorder,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Cognitive disorder,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Drug ineffective,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Drug ineffective,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Drug monitoring procedure not performed,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Drug monitoring procedure not performed,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Dysarthria,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Dysarthria,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Dysgraphia,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Dysgraphia,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Dysphonia,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Dysphonia,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Dysstasia,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Dysstasia,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Dysuria,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Dysuria,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Erythema,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Erythema,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Fatigue,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Fatigue,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,General physical health deterioration,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,General physical health deterioration,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Hyperaesthesia,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Hyperaesthesia,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Hypertonia,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Hypertonia,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Memory impairment,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Memory impairment,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Multiple sclerosis,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Multiple sclerosis,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Muscular weakness,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Muscular weakness,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Primary progressive multiple sclerosis,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Primary progressive multiple sclerosis,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Rash,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Rash,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Rash pruritic,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Rash pruritic,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Somnolence,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Somnolence,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Temperature intolerance,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Temperature intolerance,1,M,OT,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Walking aid user,1,M,DS,4
173766681,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Walking aid user,1,M,OT,4
173766821,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,729
173766821,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,729
173766821,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Death,2,M,DE,729
173766821,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Death,2,M,OT,729
173769262,1,Transitional cell carcinoma,2,F,EXP,avelumab,1,PS,Sudden death,1,M,DE,49
173771122,3,B-cell lymphoma,2,F,EXP,lenalidomide,3,SS,Lung disorder,3,F,HO,858
173784831,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Hyponatraemia,1,M,HO,151
173784831,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Oedema peripheral,1,M,HO,151
173784831,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Pneumonia,1,M,HO,151
173784831,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Pyrexia,1,M,HO,151
173784831,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Therapy cessation,1,M,HO,151
173808785,7,Acute lymphocytic leukaemia,5,F,PER,pegaspargase,7,SS,Febrile neutropenia,7,F,HO,10
173826341,1,Colorectal cancer metastatic,1,I,PER,panitumumab,1,PS,Pyrexia,1,M,HO,275
173826341,1,Colorectal cancer metastatic,1,I,PER,panitumumab,1,PS,Septic shock,1,M,HO,275
173853182,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Hypophysitis,1,M,DE,42
173853182,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Hypophysitis,1,M,OT,42
173853182,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Hypophysitis,1,M,DS,42
173853182,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,M,DE,42
173853182,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,M,OT,42
173853182,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,M,DS,42
173853182,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Uveitis,1,M,DE,42
173853182,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Uveitis,1,M,OT,42
173853182,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Uveitis,1,M,DS,42
173853182,3,Malignant melanoma,2,F,EXP,nivolumab,3,SS,Hypophysitis,3,M,DE,42
173853182,3,Malignant melanoma,2,F,EXP,nivolumab,3,SS,Hypophysitis,3,M,OT,42
173853182,3,Malignant melanoma,2,F,EXP,nivolumab,3,SS,Hypophysitis,3,M,DS,42
173853182,3,Malignant melanoma,2,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,DE,42
173853182,3,Malignant melanoma,2,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,OT,42
173853182,3,Malignant melanoma,2,F,EXP,nivolumab,3,SS,Malignant neoplasm progression,3,M,DS,42
173853182,3,Malignant melanoma,2,F,EXP,nivolumab,3,SS,Uveitis,3,M,DE,42
173853182,3,Malignant melanoma,2,F,EXP,nivolumab,3,SS,Uveitis,3,M,OT,42
173853182,3,Malignant melanoma,2,F,EXP,nivolumab,3,SS,Uveitis,3,M,DS,42
173863291,1,Colorectal cancer,1,I,PER,panitumumab,1,PS,Enterocutaneous fistula,1,M,HO,22
173863291,1,Colorectal cancer,1,I,PER,panitumumab,1,PS,Subcutaneous abscess,1,M,HO,22
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Asthenia,1,M,DE,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Asthenia,1,M,OT,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Asthenia,1,M,HO,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,DE,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,OT,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Interstitial lung disease,1,M,HO,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pneumonitis,1,M,DE,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pulmonary fibrosis,1,M,DE,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pulmonary fibrosis,1,M,OT,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pulmonary fibrosis,1,M,HO,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Respiratory failure,1,M,DE,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,577
173864391,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Respiratory failure,1,M,HO,577
173865762,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,OT,121
173865762,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,HO,121
173865762,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Anaemia,1,F,OT,121
173865762,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Anaemia,1,F,HO,121
173865762,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Orthostatic hypotension,1,F,OT,121
173865762,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Orthostatic hypotension,1,F,HO,121
173865951,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Pneumonia,2,M,HO,74
173865951,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Pneumonia,3,M,HO,74
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,M,DE,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Dehydration,1,M,OT,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Dehydration,1,M,HO,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Dehydration,1,M,DE,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Fatigue,1,M,OT,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Fatigue,1,M,HO,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Fatigue,1,M,DE,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Generalised oedema,1,M,OT,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Generalised oedema,1,M,HO,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Generalised oedema,1,M,DE,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Oedema genital,1,M,OT,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Oedema genital,1,M,HO,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Oedema genital,1,M,DE,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Pericardial effusion,1,M,OT,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Pericardial effusion,1,M,HO,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Pericardial effusion,1,M,DE,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Rash,1,M,OT,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Rash,1,M,HO,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Rash,1,M,DE,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Urinary tract infection,1,M,OT,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Urinary tract infection,1,M,HO,15
173866011,1,Angiosarcoma,1,I,EXP,nivolumab,1,PS,Urinary tract infection,1,M,DE,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,OT,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,HO,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Acute kidney injury,2,M,DE,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Dehydration,2,M,OT,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Dehydration,2,M,HO,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Dehydration,2,M,DE,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Fatigue,2,M,OT,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Fatigue,2,M,HO,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Fatigue,2,M,DE,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Generalised oedema,2,M,OT,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Generalised oedema,2,M,HO,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Generalised oedema,2,M,DE,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Oedema genital,2,M,OT,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Oedema genital,2,M,HO,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Oedema genital,2,M,DE,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Pericardial effusion,2,M,OT,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Pericardial effusion,2,M,HO,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Pericardial effusion,2,M,DE,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Rash,2,M,OT,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Rash,2,M,HO,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Rash,2,M,DE,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Urinary tract infection,2,M,OT,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Urinary tract infection,2,M,HO,15
173866011,2,Angiosarcoma,1,I,EXP,ipilimumab,2,SS,Urinary tract infection,2,M,DE,15
173866121,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Anaemia,1,M,OT,8
173866121,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Hypercalcaemia,1,M,OT,8
173866671,8,Nausea,1,I,EXP,granisetron,8,C,Acute hepatic failure,8,M,DE,1
173866671,8,Nausea,1,I,EXP,granisetron,8,C,Acute hepatic failure,8,M,OT,1
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,Infection,2,M,HO,12
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,Infection,2,M,LT,12
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,Infection,2,M,OT,12
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,Lymphocyte count decreased,2,M,HO,12
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,Lymphocyte count decreased,2,M,LT,12
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,Lymphocyte count decreased,2,M,OT,12
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,Neutrophil count decreased,2,M,HO,12
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,Neutrophil count decreased,2,M,LT,12
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,Neutrophil count decreased,2,M,OT,12
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,Platelet count decreased,2,M,HO,12
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,Platelet count decreased,2,M,LT,12
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,Platelet count decreased,2,M,OT,12
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,White blood cell count decreased,2,M,HO,12
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,White blood cell count decreased,2,M,LT,12
173868391,2,Chronic lymphocytic leukaemia,1,I,PER,pomalidomide,2,SS,White blood cell count decreased,2,M,OT,12
173869501,4,Plasma cell myeloma,1,I,EXP,daratumumab,4,SS,Toxic skin eruption,4,M,HO,108
173869791,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,C,Hypertension,4,M,OT,196
173872213,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Pneumonia,1,F,HO,258
173872213,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Pneumonia,1,F,OT,258
173872213,17,Product used for unknown indication,3,F,EXP,axitinib,17,C,Pneumonia,17,F,HO,16
173872213,17,Product used for unknown indication,3,F,EXP,axitinib,17,C,Pneumonia,17,F,OT,16
173885983,3,Renal cell carcinoma,3,F,EXP,ipilimumab,3,SS,Stevens-Johnson syndrome,3,M,HO,21
173885983,3,Renal cell carcinoma,3,F,EXP,ipilimumab,3,SS,Stevens-Johnson syndrome,3,M,OT,21
173885983,5,Renal cell carcinoma,3,F,EXP,nivolumab,5,SS,Stevens-Johnson syndrome,5,M,HO,21
173885983,5,Renal cell carcinoma,3,F,EXP,nivolumab,5,SS,Stevens-Johnson syndrome,5,M,OT,21
173889121,2,Plasma cell myeloma,1,I,EXP,thalidomide,2,SS,Cell death,2,F,HO,26
173889121,2,Plasma cell myeloma,1,I,EXP,thalidomide,2,SS,Rash,2,F,HO,26
173892432,1,Prostate cancer metastatic,2,F,EXP,enzalutamide,1,PS,Erectile dysfunction,1,M,OT,15
173893351,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Constipation,1,F,OT,28
173893351,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Dental caries,1,F,OT,28
173893351,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Diarrhoea,1,F,OT,28
173893351,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Enteritis infectious,1,F,OT,28
173893351,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Gingivitis,1,F,OT,28
173893351,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Nasopharyngitis,1,F,OT,28
173893351,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Refractory anaemia with an excess of blasts,1,F,OT,28
173893351,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Rhinitis allergic,1,F,OT,28
173893351,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Seasonal allergy,1,F,OT,28
173894121,1,Non-small cell lung cancer,1,I,EXP,brigatinib,1,PS,Death,1,F,DE,38
173899782,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Asthenia,2,M,DE,497
173899782,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Asthenia,2,M,HO,497
173899782,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,General physical health deterioration,2,M,DE,497
173899782,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,General physical health deterioration,2,M,HO,497
173899782,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Hanging,2,M,DE,497
173899782,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Hanging,2,M,HO,497
173899782,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Nausea,2,M,DE,497
173899782,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Nausea,2,M,HO,497
173900072,6,Precursor B-lymphoblastic lymphoma,2,F,EXP,pegaspargase,6,SS,Asthenia,6,F,HO,20
173900072,6,Precursor B-lymphoblastic lymphoma,2,F,EXP,pegaspargase,6,SS,Back pain,6,F,HO,20
173900072,6,Precursor B-lymphoblastic lymphoma,2,F,EXP,pegaspargase,6,SS,Bacterial infection,6,F,HO,20
173900072,6,Precursor B-lymphoblastic lymphoma,2,F,EXP,pegaspargase,6,SS,Blood lactic acid increased,6,F,HO,20
173900072,6,Precursor B-lymphoblastic lymphoma,2,F,EXP,pegaspargase,6,SS,Cardiac dysfunction,6,F,HO,20
173900072,6,Precursor B-lymphoblastic lymphoma,2,F,EXP,pegaspargase,6,SS,Fluid overload,6,F,HO,20
173900072,6,Precursor B-lymphoblastic lymphoma,2,F,EXP,pegaspargase,6,SS,Hypotension,6,F,HO,20
173900072,6,Precursor B-lymphoblastic lymphoma,2,F,EXP,pegaspargase,6,SS,Hypoxia,6,F,HO,20
173900072,6,Precursor B-lymphoblastic lymphoma,2,F,EXP,pegaspargase,6,SS,Pain,6,F,HO,20
173900072,6,Precursor B-lymphoblastic lymphoma,2,F,EXP,pegaspargase,6,SS,Pain in extremity,6,F,HO,20
173900072,6,Precursor B-lymphoblastic lymphoma,2,F,EXP,pegaspargase,6,SS,Septic shock,6,F,HO,20
173902021,1,Non-small cell lung cancer,1,I,EXP,avelumab,1,PS,Diabetic ketoacidosis,1,F,HO,611
173902111,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Diarrhoea,5,F,HO,56
173902111,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Diarrhoea,5,F,OT,56
173902111,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Febrile neutropenia,5,F,HO,56
173902111,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Febrile neutropenia,5,F,OT,56
173902111,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Inappropriate schedule of product administration,5,F,HO,56
173902111,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Inappropriate schedule of product administration,5,F,OT,56
173902111,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Malignant neoplasm progression,5,F,HO,56
173902111,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Malignant neoplasm progression,5,F,OT,56
173902111,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Nausea,5,F,HO,56
173902111,5,Non-small cell lung cancer stage IV,1,I,EXP,pemetrexed disodium,5,SS,Nausea,5,F,OT,56
173903604,6,Colorectal cancer,4,F,EXP,nivolumab,6,SS,Encephalopathy,6,M,OT,21
173903604,6,Colorectal cancer,4,F,EXP,nivolumab,6,SS,Encephalopathy,6,M,HO,21
173903604,6,Colorectal cancer,4,F,EXP,nivolumab,6,SS,Encephalopathy,6,M,DE,21
173903604,6,Colorectal cancer,4,F,EXP,nivolumab,6,SS,Myositis,6,M,OT,21
173903604,6,Colorectal cancer,4,F,EXP,nivolumab,6,SS,Myositis,6,M,HO,21
173903604,6,Colorectal cancer,4,F,EXP,nivolumab,6,SS,Myositis,6,M,DE,21
173904081,5,B-cell lymphoma,1,I,EXP,pegfilgrastim,5,SS,Decubitus ulcer,5,F,HO,130
173906861,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Multiple organ dysfunction syndrome,1,F,HO,1258
173906861,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Multiple organ dysfunction syndrome,1,F,DE,1258
173912781,3,Breast cancer metastatic,1,I,EXP,palbociclib,3,SS,Arrhythmia,3,F,HO,24
173912781,3,Breast cancer metastatic,1,I,EXP,palbociclib,3,SS,Atrial flutter,3,F,HO,24
173912781,3,Breast cancer metastatic,1,I,EXP,palbociclib,3,SS,Cardiac failure,3,F,HO,24
173912781,3,Breast cancer metastatic,1,I,EXP,palbociclib,3,SS,Haemoglobin decreased,3,F,HO,24
173912781,3,Breast cancer metastatic,1,I,EXP,palbociclib,3,SS,Tachycardia,3,F,HO,24
173912781,3,Breast cancer metastatic,1,I,EXP,palbociclib,3,SS,White blood cell count decreased,3,F,HO,24
173915712,40,Neutropenia,2,F,EXP,filgrastim,40,C,Haematuria,40,M,HO,13
173915712,40,Neutropenia,2,F,EXP,filgrastim,40,C,Haematuria,40,M,OT,13
173915712,40,Neutropenia,2,F,EXP,filgrastim,40,C,Thrombocytopenia,40,M,HO,13
173915712,40,Neutropenia,2,F,EXP,filgrastim,40,C,Thrombocytopenia,40,M,OT,13
173915852,1,Glioblastoma multiforme,2,F,EXP,nivolumab,1,PS,Chills,1,M,HO,14
173915951,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Pain in jaw,1,F,OT,115
173916712,2,Metastatic malignant melanoma,2,F,EXP,nivolumab,2,PS,Myocarditis,2,F,HO,44
173916712,2,Metastatic malignant melanoma,2,F,EXP,nivolumab,2,PS,Myocarditis,2,F,OT,44
173917461,1,Chronic myeloid leukaemia,1,I,EXP,nilotinib,1,PS,Respiratory failure,1,F,HO,2277
173917461,1,Chronic myeloid leukaemia,1,I,EXP,nilotinib,1,PS,Syncope,1,F,HO,2277
173917642,2,Malignant melanoma,2,F,EXP,nivolumab,2,PS,Cardiac failure,2,F,DE,42
173917642,2,Malignant melanoma,2,F,EXP,nivolumab,2,PS,Cardiac failure,2,F,HO,42
173917642,2,Malignant melanoma,2,F,EXP,nivolumab,2,PS,Cardiac failure,2,F,OT,42
173917642,2,Malignant melanoma,2,F,EXP,nivolumab,2,PS,Malignant neoplasm progression,2,F,DE,42
173917642,2,Malignant melanoma,2,F,EXP,nivolumab,2,PS,Malignant neoplasm progression,2,F,HO,42
173917642,2,Malignant melanoma,2,F,EXP,nivolumab,2,PS,Malignant neoplasm progression,2,F,OT,42
173918821,17,Product used for unknown indication,1,I,EXP,bosutinib,17,C,Hepatocellular injury,17,F,OT,125
173918821,17,Product used for unknown indication,1,I,EXP,bosutinib,17,C,Hepatocellular injury,17,F,HO,125
173918821,17,Product used for unknown indication,1,I,EXP,bosutinib,17,C,Pyrexia,17,F,OT,125
173918821,17,Product used for unknown indication,1,I,EXP,bosutinib,17,C,Pyrexia,17,F,HO,125
173918821,20,Product used for unknown indication,1,I,EXP,nilotinib,20,C,Hepatocellular injury,20,F,OT,125
173918821,20,Product used for unknown indication,1,I,EXP,nilotinib,20,C,Hepatocellular injury,20,F,HO,125
173918821,20,Product used for unknown indication,1,I,EXP,nilotinib,20,C,Pyrexia,20,F,OT,125
173918821,20,Product used for unknown indication,1,I,EXP,nilotinib,20,C,Pyrexia,20,F,HO,125
173919032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Encephalopathy,1,F,LT,53
173919032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Encephalopathy,1,F,HO,53
173919032,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Encephalopathy,1,F,OT,53
173921691,4,Plasma cell myeloma,1,I,EXP,daratumumab,4,SS,Toxic skin eruption,4,M,HO,108
173921862,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,SS,Immune-mediated enterocolitis,1,M,HO,42
173921862,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,SS,Immune-mediated enterocolitis,1,M,OT,42
173921862,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,SS,Immune-mediated enterocolitis,1,M,DE,42
173921862,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,SS,Pneumonia,1,M,HO,42
173921862,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,SS,Pneumonia,1,M,OT,42
173921862,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,SS,Pneumonia,1,M,DE,42
173921862,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,PS,Immune-mediated enterocolitis,2,M,HO,42
173921862,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,PS,Immune-mediated enterocolitis,2,M,OT,42
173921862,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,PS,Immune-mediated enterocolitis,2,M,DE,42
173921862,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,PS,Pneumonia,2,M,HO,42
173921862,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,PS,Pneumonia,2,M,OT,42
173921862,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,PS,Pneumonia,2,M,DE,42
173922353,2,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Stevens-Johnson syndrome,2,M,HO,21
173922353,2,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,2,SS,Stevens-Johnson syndrome,2,M,OT,21
173922353,3,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,3,PS,Stevens-Johnson syndrome,3,M,HO,21
173922353,3,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,3,PS,Stevens-Johnson syndrome,3,M,OT,21
173922485,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Lung neoplasm malignant,1,F,HO,137
173922485,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Lung neoplasm malignant,1,F,OT,137
173922485,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Lung neoplasm malignant,1,F,DE,137
173922485,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Meningitis,1,F,HO,137
173922485,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Meningitis,1,F,OT,137
173922485,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Meningitis,1,F,DE,137
173922485,2,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,2,SS,Lung neoplasm malignant,2,F,HO,137
173922485,2,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,2,SS,Lung neoplasm malignant,2,F,OT,137
173922485,2,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,2,SS,Lung neoplasm malignant,2,F,DE,137
173922485,2,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,2,SS,Meningitis,2,F,HO,137
173922485,2,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,2,SS,Meningitis,2,F,OT,137
173922485,2,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,2,SS,Meningitis,2,F,DE,137
173922485,10,Product used for unknown indication,5,F,EXP,zoledronic acid,10,C,Lung neoplasm malignant,10,F,HO,166
173922485,10,Product used for unknown indication,5,F,EXP,zoledronic acid,10,C,Lung neoplasm malignant,10,F,OT,166
173922485,10,Product used for unknown indication,5,F,EXP,zoledronic acid,10,C,Lung neoplasm malignant,10,F,DE,166
173922485,10,Product used for unknown indication,5,F,EXP,zoledronic acid,10,C,Meningitis,10,F,HO,166
173922485,10,Product used for unknown indication,5,F,EXP,zoledronic acid,10,C,Meningitis,10,F,OT,166
173922485,10,Product used for unknown indication,5,F,EXP,zoledronic acid,10,C,Meningitis,10,F,DE,166
173922861,1,Relapsing-remitting multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,M,OT,860
173922861,1,Relapsing-remitting multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,M,LT,860
173922861,1,Relapsing-remitting multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,M,HO,860
173923011,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Rheumatoid arthritis,1,M,OT,291
173923011,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Rheumatoid arthritis,1,M,HO,291
173923281,1,Malignant neoplasm of thymus,1,I,EXP,nivolumab,1,PS,Myositis,1,M,OT,69
173923281,1,Malignant neoplasm of thymus,1,I,EXP,nivolumab,1,PS,Myositis,1,M,HO,69
173923281,1,Malignant neoplasm of thymus,1,I,EXP,nivolumab,1,PS,Polyarthritis,1,M,OT,69
173923281,1,Malignant neoplasm of thymus,1,I,EXP,nivolumab,1,PS,Polyarthritis,1,M,HO,69
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Asthenia,2,M,HO,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Asthenia,2,M,LT,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Asthenia,2,M,OT,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Asthenia,2,M,DE,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Cellulitis,2,M,HO,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Cellulitis,2,M,LT,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Cellulitis,2,M,OT,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Cellulitis,2,M,DE,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Escherichia sepsis,2,M,HO,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Escherichia sepsis,2,M,LT,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Escherichia sepsis,2,M,OT,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Escherichia sepsis,2,M,DE,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Multiple organ dysfunction syndrome,2,M,HO,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Multiple organ dysfunction syndrome,2,M,LT,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Multiple organ dysfunction syndrome,2,M,OT,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Multiple organ dysfunction syndrome,2,M,DE,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Myocardial infarction,2,M,HO,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Myocardial infarction,2,M,LT,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Myocardial infarction,2,M,OT,28
173925361,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Myocardial infarction,2,M,DE,28
173931883,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Aspartate aminotransferase increased,1,M,DE,19
173931883,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Aspartate aminotransferase increased,1,M,HO,19
173932361,2,Clear cell renal cell carcinoma,1,I,PER,axitinib,2,SS,Asthenia,2,F,HO,80
173932361,2,Clear cell renal cell carcinoma,1,I,PER,axitinib,2,SS,Decreased appetite,2,F,HO,80
173932361,2,Clear cell renal cell carcinoma,1,I,PER,axitinib,2,SS,Fall,2,F,HO,80
173932361,2,Clear cell renal cell carcinoma,1,I,PER,axitinib,2,SS,Hyponatraemia,2,F,HO,80
173932361,2,Clear cell renal cell carcinoma,1,I,PER,axitinib,2,SS,Muscle spasms,2,F,HO,80
173932361,2,Clear cell renal cell carcinoma,1,I,PER,axitinib,2,SS,Nausea,2,F,HO,80
173932361,2,Clear cell renal cell carcinoma,1,I,PER,axitinib,2,SS,Weight decreased,2,F,HO,80
173933712,1,Rectal cancer,2,F,PER,panitumumab,1,PS,Condition aggravated,1,M,OT,656
173933712,1,Rectal cancer,2,F,PER,panitumumab,1,PS,Hypomagnesaemia,1,M,OT,656
173933712,1,Rectal cancer,2,F,PER,panitumumab,1,PS,Rectal cancer,1,M,OT,656
173935351,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Cellulitis,1,M,OT,3
173935351,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Cellulitis,1,M,HO,3
173935351,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Peripheral swelling,1,M,OT,3
173935351,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Peripheral swelling,1,M,HO,3
173935351,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,3
173935351,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,3
173938202,1,Colon cancer,2,F,PER,panitumumab,1,PS,Colon cancer,1,F,OT,314
173938202,1,Colon cancer,2,F,PER,panitumumab,1,PS,Condition aggravated,1,F,OT,314
173938202,1,Colon cancer,2,F,PER,panitumumab,1,PS,Hypomagnesaemia,1,F,OT,314
173938952,4,Plasma cell myeloma,2,F,PER,lenalidomide,4,C,Chronic kidney disease,4,M,OT,6
173939521,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Autoimmune colitis,1,M,HO,324
173939521,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Autoimmune colitis,1,M,OT,324
173939521,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Cholestasis,1,M,HO,324
173939521,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Cholestasis,1,M,OT,324
173939521,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Diabetes mellitus,1,M,HO,324
173939521,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Diabetes mellitus,1,M,OT,324
173939521,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Autoimmune colitis,2,M,HO,324
173939521,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Autoimmune colitis,2,M,OT,324
173939521,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Cholestasis,2,M,HO,324
173939521,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Cholestasis,2,M,OT,324
173939521,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Diabetes mellitus,2,M,HO,324
173939521,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Diabetes mellitus,2,M,OT,324
173940841,1,Plasma cell myeloma,1,I,EXP,carfilzomib,1,SS,Cardiac failure,1,M,OT,2
173940841,1,Plasma cell myeloma,1,I,EXP,carfilzomib,1,SS,Cardiac failure,1,M,HO,2
173940841,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Cardiac failure,5,M,OT,2
173940841,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Cardiac failure,5,M,HO,2
173941181,1,Mantle cell lymphoma,1,I,EXP,ibrutinib,1,PS,Colorectal adenocarcinoma,1,M,DE,747
173941181,1,Mantle cell lymphoma,1,I,EXP,ibrutinib,1,PS,Metastases to kidney,1,M,DE,747
173941181,1,Mantle cell lymphoma,1,I,EXP,ibrutinib,1,PS,Metastases to liver,1,M,DE,747
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Intentional product use issue,1,F,HO,32
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Intentional product use issue,1,F,DE,32
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Intentional product use issue,1,F,OT,32
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,32
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,32
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,32
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Metastases to heart,1,F,HO,32
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Metastases to heart,1,F,DE,32
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Metastases to heart,1,F,OT,32
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Septic shock,1,F,HO,32
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Septic shock,1,F,DE,32
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Septic shock,1,F,OT,32
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,HO,32
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,DE,32
173945263,1,Cervix carcinoma,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,OT,32
173945611,15,Product used for unknown indication,1,I,EXP,rasburicase,15,C,Acute kidney injury,15,M,LT,14
173945611,15,Product used for unknown indication,1,I,EXP,rasburicase,15,C,Acute kidney injury,15,M,HO,14
173945611,15,Product used for unknown indication,1,I,EXP,rasburicase,15,C,Cytokine release syndrome,15,M,LT,14
173945611,15,Product used for unknown indication,1,I,EXP,rasburicase,15,C,Cytokine release syndrome,15,M,HO,14
173945611,15,Product used for unknown indication,1,I,EXP,rasburicase,15,C,Intestinal perforation,15,M,LT,14
173945611,15,Product used for unknown indication,1,I,EXP,rasburicase,15,C,Intestinal perforation,15,M,HO,14
173945611,15,Product used for unknown indication,1,I,EXP,rasburicase,15,C,Neutropenia,15,M,LT,14
173945611,15,Product used for unknown indication,1,I,EXP,rasburicase,15,C,Neutropenia,15,M,HO,14
173945611,15,Product used for unknown indication,1,I,EXP,rasburicase,15,C,Pneumonitis,15,M,LT,14
173945611,15,Product used for unknown indication,1,I,EXP,rasburicase,15,C,Pneumonitis,15,M,HO,14
173945611,15,Product used for unknown indication,1,I,EXP,rasburicase,15,C,Sepsis,15,M,LT,14
173945611,15,Product used for unknown indication,1,I,EXP,rasburicase,15,C,Sepsis,15,M,HO,14
173945691,6,Product used for unknown indication,1,I,EXP,filgrastim,6,C,Depressed level of consciousness,6,F,OT,2
173945691,6,Product used for unknown indication,1,I,EXP,filgrastim,6,C,Depressed level of consciousness,6,F,HO,2
173945691,6,Product used for unknown indication,1,I,EXP,filgrastim,6,C,Memory impairment,6,F,OT,2
173945691,6,Product used for unknown indication,1,I,EXP,filgrastim,6,C,Memory impairment,6,F,HO,2
173945691,6,Product used for unknown indication,1,I,EXP,filgrastim,6,C,Pyrexia,6,F,OT,2
173945691,6,Product used for unknown indication,1,I,EXP,filgrastim,6,C,Pyrexia,6,F,HO,2
173946671,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Pain,1,F,DE,35
173946671,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Pain,1,F,HO,35
173946671,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Septic shock,1,F,DE,35
173946671,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Septic shock,1,F,HO,35
173946671,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Pain,3,F,DE,35
173946671,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Pain,3,F,HO,35
173946671,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Septic shock,3,F,DE,35
173946671,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Septic shock,3,F,HO,35
173947662,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Hyperglycaemia,1,M,OT,29
173947662,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Rash,1,M,OT,29
173947662,1,Renal cell carcinoma,2,F,EXP,ipilimumab,1,PS,Renal impairment,1,M,OT,29
173947662,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Hyperglycaemia,2,M,OT,29
173947662,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Rash,2,M,OT,29
173947662,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Renal impairment,2,M,OT,29
173949253,1,Breast cancer,3,F,EXP,alpelisib,1,PS,Blood glucose increased,1,F,OT,6
173949253,1,Breast cancer,3,F,EXP,alpelisib,1,PS,Blood glucose increased,1,F,DE,6
173949253,1,Breast cancer,3,F,EXP,alpelisib,1,PS,Blood glucose increased,1,F,HO,6
173949253,1,Breast cancer,3,F,EXP,alpelisib,1,PS,Death,1,F,OT,6
173949253,1,Breast cancer,3,F,EXP,alpelisib,1,PS,Death,1,F,DE,6
173949253,1,Breast cancer,3,F,EXP,alpelisib,1,PS,Death,1,F,HO,6
173949253,1,Breast cancer,3,F,EXP,alpelisib,1,PS,Hyperglycaemic hyperosmolar nonketotic syndrome,1,F,OT,6
173949253,1,Breast cancer,3,F,EXP,alpelisib,1,PS,Hyperglycaemic hyperosmolar nonketotic syndrome,1,F,DE,6
173949253,1,Breast cancer,3,F,EXP,alpelisib,1,PS,Hyperglycaemic hyperosmolar nonketotic syndrome,1,F,HO,6
173952752,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Ventricular arrhythmia,1,M,OT,602
173952752,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Ventricular arrhythmia,1,M,LT,602
173952752,1,Bladder cancer,2,F,EXP,nivolumab,1,PS,Ventricular arrhythmia,1,M,HO,602
173952752,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Ventricular arrhythmia,2,M,OT,503
173952752,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Ventricular arrhythmia,2,M,LT,503
173952752,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Ventricular arrhythmia,2,M,HO,503
173952752,3,Bladder cancer,2,F,EXP,ipilimumab,3,SS,Ventricular arrhythmia,3,M,OT,602
173952752,3,Bladder cancer,2,F,EXP,ipilimumab,3,SS,Ventricular arrhythmia,3,M,LT,602
173952752,3,Bladder cancer,2,F,EXP,ipilimumab,3,SS,Ventricular arrhythmia,3,M,HO,602
173955701,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Bone pain,1,F,OT,512
173955701,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Chills,1,F,OT,512
173955701,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Dizziness,1,F,OT,512
173955701,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,512
173955701,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Headache,1,F,OT,512
173955701,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Psychiatric symptom,1,F,OT,512
173955701,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Syncope,1,F,OT,512
173955701,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Ulcer,1,F,OT,512
173955701,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Vomiting,1,F,OT,512
173955771,1,Product used for unknown indication,1,I,EXP,alpelisib,1,PS,Accidental overdose,1,F,HO,34
173955771,1,Product used for unknown indication,1,I,EXP,alpelisib,1,PS,Diarrhoea,1,F,HO,34
173955771,1,Product used for unknown indication,1,I,EXP,alpelisib,1,PS,Hyperglycaemia,1,F,HO,34
173955771,1,Product used for unknown indication,1,I,EXP,alpelisib,1,PS,Ketoacidosis,1,F,HO,34
173956322,2,Breast cancer,2,F,EXP,zoledronic acid,2,SS,Abdominal pain upper,2,F,OT,10
173956322,2,Breast cancer,2,F,EXP,zoledronic acid,2,SS,Asthenia,2,F,OT,10
173956322,2,Breast cancer,2,F,EXP,zoledronic acid,2,SS,Diarrhoea,2,F,OT,10
173956322,2,Breast cancer,2,F,EXP,zoledronic acid,2,SS,Dysuria,2,F,OT,10
173956322,2,Breast cancer,2,F,EXP,zoledronic acid,2,SS,Nausea,2,F,OT,10
173956322,2,Breast cancer,2,F,EXP,zoledronic acid,2,SS,Neuropathy peripheral,2,F,OT,10
173956322,2,Breast cancer,2,F,EXP,zoledronic acid,2,SS,Rhinorrhoea,2,F,OT,10
173956322,2,Breast cancer,2,F,EXP,zoledronic acid,2,SS,Vomiting,2,F,OT,10
173956322,2,Breast cancer,2,F,EXP,zoledronic acid,2,SS,Vulvovaginal inflammation,2,F,OT,10
173958503,5,Metastases to bone,3,F,EXP,denosumab,5,C,Alopecia,5,F,OT,56
173958503,5,Metastases to bone,3,F,EXP,denosumab,5,C,Hypocalcaemia,5,F,OT,56
173958503,5,Metastases to bone,3,F,EXP,denosumab,5,C,Nausea,5,F,OT,56
173958503,5,Metastases to bone,3,F,EXP,denosumab,5,C,Pollakiuria,5,F,OT,56
173960801,1,Breast cancer stage IV,1,I,EXP,abemaciclib,1,PS,Hepatic function abnormal,1,F,HO,9
173963953,1,Prostate cancer metastatic,3,F,EXP,enzalutamide,1,PS,Death,1,M,DE,40
173963953,1,Prostate cancer metastatic,3,F,EXP,enzalutamide,1,PS,Death,1,M,OT,40
173963953,1,Prostate cancer metastatic,3,F,EXP,enzalutamide,1,PS,Death,1,M,HO,40
173963953,1,Prostate cancer metastatic,3,F,EXP,enzalutamide,1,PS,Pain,1,M,DE,40
173963953,1,Prostate cancer metastatic,3,F,EXP,enzalutamide,1,PS,Pain,1,M,OT,40
173963953,1,Prostate cancer metastatic,3,F,EXP,enzalutamide,1,PS,Pain,1,M,HO,40
173963961,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Hypotension,1,M,HO,179
173963961,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Intentional dose omission,1,M,HO,179
173969762,2,Relapsing-remitting multiple sclerosis,2,F,EXP,alemtuzumab,2,SS,Basedow's disease,2,F,OT,3
173969762,2,Relapsing-remitting multiple sclerosis,2,F,EXP,alemtuzumab,2,SS,Diarrhoea,2,F,OT,3
173969762,2,Relapsing-remitting multiple sclerosis,2,F,EXP,alemtuzumab,2,SS,Dry mouth,2,F,OT,3
173969762,2,Relapsing-remitting multiple sclerosis,2,F,EXP,alemtuzumab,2,SS,Headache,2,F,OT,3
173969762,2,Relapsing-remitting multiple sclerosis,2,F,EXP,alemtuzumab,2,SS,Pruritus,2,F,OT,3
173969762,2,Relapsing-remitting multiple sclerosis,2,F,EXP,alemtuzumab,2,SS,Tachycardia,2,F,OT,3
173969762,2,Relapsing-remitting multiple sclerosis,2,F,EXP,alemtuzumab,2,SS,Urinary tract infection,2,F,OT,3
173969762,2,Relapsing-remitting multiple sclerosis,2,F,EXP,alemtuzumab,2,SS,Urticaria,2,F,OT,3
173969771,9,Metastases to bone,1,I,EXP,denosumab,9,C,Pneumonia,9,F,HO,702
173972921,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,HO,3
173972921,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,OT,3
173972921,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Pancytopenia,1,F,HO,3
173972921,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Pancytopenia,1,F,OT,3
173974481,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Renal failure,1,M,HO,70
173978091,4,Breast cancer,1,I,EXP,zoledronic acid,4,SS,Abdominal pain upper,4,F,OT,10
173978091,4,Breast cancer,1,I,EXP,zoledronic acid,4,SS,Asthenia,4,F,OT,10
173978091,4,Breast cancer,1,I,EXP,zoledronic acid,4,SS,Diarrhoea,4,F,OT,10
173978091,4,Breast cancer,1,I,EXP,zoledronic acid,4,SS,Dysuria,4,F,OT,10
173978091,4,Breast cancer,1,I,EXP,zoledronic acid,4,SS,Nausea,4,F,OT,10
173978091,4,Breast cancer,1,I,EXP,zoledronic acid,4,SS,Neuropathy peripheral,4,F,OT,10
173978091,4,Breast cancer,1,I,EXP,zoledronic acid,4,SS,Rhinorrhoea,4,F,OT,10
173978091,4,Breast cancer,1,I,EXP,zoledronic acid,4,SS,Vomiting,4,F,OT,10
173978091,4,Breast cancer,1,I,EXP,zoledronic acid,4,SS,Vulvovaginal inflammation,4,F,OT,10
173979431,1,Prophylaxis,1,I,EXP,zoledronic acid,1,PS,Muscle spasms,1,F,OT,7
173979431,1,Prophylaxis,1,I,EXP,zoledronic acid,1,PS,Tinnitus,1,F,OT,7
173980984,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Syncope,1,F,HO,39
173980984,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Syncope,1,F,OT,39
173980984,3,Plasma cell myeloma,4,F,PER,lenalidomide,3,SS,Syncope,3,F,HO,39
173980984,3,Plasma cell myeloma,4,F,PER,lenalidomide,3,SS,Syncope,3,F,OT,39
173980984,4,Plasma cell myeloma,4,F,PER,daratumumab,4,SS,Syncope,4,F,HO,39
173980984,4,Plasma cell myeloma,4,F,PER,daratumumab,4,SS,Syncope,4,F,OT,39
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Asphyxia,1,M,HO,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Asphyxia,1,M,OT,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Asphyxia,1,M,DE,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Asthenia,1,M,HO,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Asthenia,1,M,OT,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Asthenia,1,M,DE,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Decreased appetite,1,M,HO,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Decreased appetite,1,M,OT,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Decreased appetite,1,M,DE,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Oxygen saturation decreased,1,M,HO,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Oxygen saturation decreased,1,M,OT,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Oxygen saturation decreased,1,M,DE,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Respiratory arrest,1,M,HO,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Respiratory arrest,1,M,OT,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Respiratory arrest,1,M,DE,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Therapy cessation,1,M,HO,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Therapy cessation,1,M,OT,27
173981692,1,Prostate cancer metastatic,2,F,EXP,cabazitaxel,1,PS,Therapy cessation,1,M,DE,27
173982082,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Sciatica,1,M,HO,2708
173985112,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,SS,Blood sodium abnormal,1,M,HO,627
173985112,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,SS,Intentional product use issue,1,M,HO,627
173985112,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,SS,Malaise,1,M,HO,627
173985112,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,SS,Oropharyngeal pain,1,M,HO,627
173985112,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Blood sodium abnormal,2,M,HO,14
173985112,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Intentional product use issue,2,M,HO,14
173985112,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Malaise,2,M,HO,14
173985112,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Oropharyngeal pain,2,M,HO,14
173985112,3,Metastatic malignant melanoma,2,F,EXP,ipilimumab,3,PS,Blood sodium abnormal,3,M,HO,616
173985112,3,Metastatic malignant melanoma,2,F,EXP,ipilimumab,3,PS,Intentional product use issue,3,M,HO,616
173985112,3,Metastatic malignant melanoma,2,F,EXP,ipilimumab,3,PS,Malaise,3,M,HO,616
173985112,3,Metastatic malignant melanoma,2,F,EXP,ipilimumab,3,PS,Oropharyngeal pain,3,M,HO,616
173985483,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Large intestinal obstruction,1,F,LT,72
173985483,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Large intestinal obstruction,1,F,HO,72
173985915,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,HO,473
173985915,1,Non-small cell lung cancer,5,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,LT,473
173985915,2,Non-small cell lung cancer,5,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,M,HO,473
173985915,2,Non-small cell lung cancer,5,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,M,LT,473
173985915,4,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,4,SS,Hyperglycaemia,4,M,HO,473
173985915,4,Non-small cell lung cancer,5,F,EXP,pemetrexed disodium,4,SS,Hyperglycaemia,4,M,LT,473
173988552,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Neutropenia,1,M,LT,20
173988552,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Neutropenia,1,M,HO,20
173988552,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Osteolysis,1,M,LT,20
173988552,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Osteolysis,1,M,HO,20
173988602,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,331
173988602,2,Metastatic malignant melanoma,2,F,EXP,trametinib,2,SS,Pyrexia,2,M,HO,331
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Aphasia,42,F,LT,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Aphasia,42,F,HO,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Aphasia,42,F,DE,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Cytokine release syndrome,42,F,LT,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Cytokine release syndrome,42,F,HO,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Cytokine release syndrome,42,F,DE,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Encephalopathy,42,F,LT,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Encephalopathy,42,F,HO,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Encephalopathy,42,F,DE,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Enterococcal bacteraemia,42,F,LT,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Enterococcal bacteraemia,42,F,HO,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Enterococcal bacteraemia,42,F,DE,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Pleural effusion,42,F,LT,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Pleural effusion,42,F,HO,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Pleural effusion,42,F,DE,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Pneumonia,42,F,LT,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Pneumonia,42,F,HO,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Pneumonia,42,F,DE,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Pulmonary oedema,42,F,LT,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Pulmonary oedema,42,F,HO,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Pulmonary oedema,42,F,DE,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Sepsis,42,F,LT,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Sepsis,42,F,HO,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Sepsis,42,F,DE,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Systemic candida,42,F,LT,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Systemic candida,42,F,HO,1
173989161,42,Product used for unknown indication,1,I,EXP,rasburicase,42,C,Systemic candida,42,F,DE,1
173989231,6,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,6,SS,Neutrophil count decreased,6,F,LT,94
173989231,6,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,6,SS,Neutrophil count decreased,6,F,OT,94
173989231,6,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,6,SS,Platelet count decreased,6,F,LT,94
173989231,6,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,6,SS,Platelet count decreased,6,F,OT,94
173989231,6,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,6,SS,White blood cell count decreased,6,F,LT,94
173989231,6,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,6,SS,White blood cell count decreased,6,F,OT,94
173989452,4,Renal cell carcinoma,2,F,EXP,nivolumab,4,SS,Hepatitis,4,F,OT,61
173989452,4,Renal cell carcinoma,2,F,EXP,nivolumab,4,SS,Hepatitis,4,F,HO,61
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Blood pressure increased,1,M,HO,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Blood pressure increased,1,M,OT,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Incarcerated inguinal hernia,1,M,HO,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Incarcerated inguinal hernia,1,M,OT,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Iron overload,1,M,HO,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Iron overload,1,M,OT,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Pneumonia,1,M,HO,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Pneumonia,1,M,OT,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Post procedural haematoma,1,M,HO,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Post procedural haematoma,1,M,OT,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Post procedural haemorrhage,1,M,HO,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Post procedural haemorrhage,1,M,OT,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Postoperative abscess,1,M,HO,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Postoperative abscess,1,M,OT,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Refractory anaemia with an excess of blasts,1,M,HO,257
173990921,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Refractory anaemia with an excess of blasts,1,M,OT,257
173991762,1,Rectal cancer,2,F,PER,panitumumab,1,PS,Disease progression,1,M,OT,146
173991762,1,Rectal cancer,2,F,PER,panitumumab,1,PS,Hypomagnesaemia,1,M,OT,146
173991762,1,Rectal cancer,2,F,PER,panitumumab,1,PS,Rectal cancer,1,M,OT,146
173994471,1,Neoplasm,1,I,EXP,entrectinib,1,PS,Femur fracture,1,M,HO,117
173994471,1,Neoplasm,1,I,EXP,entrectinib,1,PS,Periostitis,1,M,HO,117
173994961,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Liver disorder,1,M,HO,323
173994961,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Liver disorder,1,M,OT,323
173994961,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Off label use,1,M,HO,323
173994961,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Off label use,1,M,OT,323
173994961,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Liver disorder,2,M,HO,294
173994961,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Liver disorder,2,M,OT,294
173994961,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Off label use,2,M,HO,294
173994961,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Off label use,2,M,OT,294
173994961,4,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,4,SS,Liver disorder,4,M,HO,323
173994961,4,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,4,SS,Liver disorder,4,M,OT,323
173994961,4,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,4,SS,Off label use,4,M,HO,323
173994961,4,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,4,SS,Off label use,4,M,OT,323
173997062,2,B-cell lymphoma,2,F,EXP,ibrutinib,2,SS,Hypoaesthesia,2,F,HO,405
173997062,2,B-cell lymphoma,2,F,EXP,ibrutinib,2,SS,Pain in extremity,2,F,HO,405
173997251,1,Head and neck cancer,1,I,EXP,nivolumab,1,PS,Dehydration,1,M,HO,69
173997251,2,Head and neck cancer,1,I,EXP,ipilimumab,2,SS,Dehydration,2,M,HO,69
173997731,9,Product used for unknown indication,1,I,EXP,zoledronic acid,9,C,Hypertension,9,F,OT,401
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Aphasia,35,F,HO,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Aphasia,35,F,LT,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Aphasia,35,F,DE,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Cytokine release syndrome,35,F,HO,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Cytokine release syndrome,35,F,LT,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Cytokine release syndrome,35,F,DE,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Disease progression,35,F,HO,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Disease progression,35,F,LT,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Disease progression,35,F,DE,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Encephalopathy,35,F,HO,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Encephalopathy,35,F,LT,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Encephalopathy,35,F,DE,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Enterococcal bacteraemia,35,F,HO,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Enterococcal bacteraemia,35,F,LT,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Enterococcal bacteraemia,35,F,DE,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Pleural effusion,35,F,HO,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Pleural effusion,35,F,LT,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Pleural effusion,35,F,DE,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Pneumonia,35,F,HO,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Pneumonia,35,F,LT,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Pneumonia,35,F,DE,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Pulmonary oedema,35,F,HO,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Pulmonary oedema,35,F,LT,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Pulmonary oedema,35,F,DE,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Sepsis,35,F,HO,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Sepsis,35,F,LT,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Sepsis,35,F,DE,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Systemic candida,35,F,HO,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Systemic candida,35,F,LT,4
174000201,35,Product used for unknown indication,1,I,EXP,rasburicase,35,C,Systemic candida,35,F,DE,4
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Aphasia,40,F,HO,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Aphasia,40,F,LT,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Aphasia,40,F,DE,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Cytokine release syndrome,40,F,HO,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Cytokine release syndrome,40,F,LT,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Cytokine release syndrome,40,F,DE,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Disease progression,40,F,HO,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Disease progression,40,F,LT,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Disease progression,40,F,DE,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Encephalopathy,40,F,HO,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Encephalopathy,40,F,LT,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Encephalopathy,40,F,DE,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Enterococcal bacteraemia,40,F,HO,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Enterococcal bacteraemia,40,F,LT,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Enterococcal bacteraemia,40,F,DE,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Pleural effusion,40,F,HO,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Pleural effusion,40,F,LT,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Pleural effusion,40,F,DE,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Pneumonia,40,F,HO,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Pneumonia,40,F,LT,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Pneumonia,40,F,DE,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Pulmonary oedema,40,F,HO,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Pulmonary oedema,40,F,LT,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Pulmonary oedema,40,F,DE,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Sepsis,40,F,HO,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Sepsis,40,F,LT,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Sepsis,40,F,DE,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Systemic candida,40,F,HO,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Systemic candida,40,F,LT,1
174000201,40,Product used for unknown indication,1,I,EXP,filgrastim,40,C,Systemic candida,40,F,DE,1
174001911,3,Product used for unknown indication,1,I,EXP,pegfilgrastim,3,SS,Febrile neutropenia,3,F,HO,12
174001911,3,Product used for unknown indication,1,I,EXP,pegfilgrastim,3,SS,General physical health deterioration,3,F,HO,12
174001911,3,Product used for unknown indication,1,I,EXP,pegfilgrastim,3,SS,Off label use,3,F,HO,12
174001911,3,Product used for unknown indication,1,I,EXP,pegfilgrastim,3,SS,Pancytopenia,3,F,HO,12
174001911,3,Product used for unknown indication,1,I,EXP,pegfilgrastim,3,SS,Sepsis,3,F,HO,12
174002951,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Dyspnoea,2,F,HO,27
174003451,7,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,7,C,Bone marrow failure,7,M,HO,7
174003451,7,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,7,C,Bone marrow failure,7,M,LT,7
174003451,7,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,7,C,Bone marrow failure,7,M,OT,7
174003451,7,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,7,C,Infectious pleural effusion,7,M,HO,7
174003451,7,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,7,C,Infectious pleural effusion,7,M,LT,7
174003451,7,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,7,C,Infectious pleural effusion,7,M,OT,7
174003451,7,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,7,C,Pneumonia,7,M,HO,7
174003451,7,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,7,C,Pneumonia,7,M,LT,7
174003451,7,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,7,C,Pneumonia,7,M,OT,7
174003662,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,103
174003662,2,Neuroendocrine tumour,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,HO,103
174006981,7,Plasma cell myeloma,1,I,EXP,lenalidomide,7,SS,Cardiac failure,7,F,OT,11
174006981,7,Plasma cell myeloma,1,I,EXP,lenalidomide,7,SS,Thrombocytopenia,7,F,OT,11
174007471,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Inappropriate antidiuretic hormone secretion,1,M,HO,2
174007871,6,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,6,SS,Febrile neutropenia,6,M,OT,7
174007871,6,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,6,SS,Febrile neutropenia,6,M,HO,7
174009782,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Pneumonia,2,M,HO,74
174009782,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Pneumonia,2,M,OT,74
174009782,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Pneumonia,3,M,HO,74
174009782,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Pneumonia,3,M,OT,74
174010621,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Asthma,1,M,OT,421
174010621,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Asthma,1,M,DE,421
174010621,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Myocardial infarction,1,M,OT,421
174010621,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Myocardial infarction,1,M,DE,421
174011132,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,PS,Autoimmune neutropenia,1,M,HO,1519
174011132,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,PS,Autoimmune neutropenia,1,M,LT,1519
174011132,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,PS,Urinary retention,1,M,HO,1519
174011132,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,PS,Urinary retention,1,M,LT,1519
174013462,2,Prostate cancer metastatic,2,F,EXP,cabazitaxel,2,SS,Dehydration,2,M,HO,54
174013462,2,Prostate cancer metastatic,2,F,EXP,cabazitaxel,2,SS,Diarrhoea,2,M,HO,54
174013462,2,Prostate cancer metastatic,2,F,EXP,cabazitaxel,2,SS,Malnutrition,2,M,HO,54
174014072,2,Prostate cancer,2,F,EXP,enzalutamide,2,SS,Cerebrovascular accident,2,M,LT,2514
174014072,2,Prostate cancer,2,F,EXP,enzalutamide,2,SS,Cerebrovascular accident,2,M,HO,2514
174014072,2,Prostate cancer,2,F,EXP,enzalutamide,2,SS,Myocardial infarction,2,M,LT,2514
174014072,2,Prostate cancer,2,F,EXP,enzalutamide,2,SS,Myocardial infarction,2,M,HO,2514
174014431,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Cholangitis,1,F,HO,5
174016031,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Confusional state,1,F,HO,53
174016031,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Confusional state,1,F,OT,53
174016031,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Subclavian artery thrombosis,1,F,HO,53
174016031,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Subclavian artery thrombosis,1,F,OT,53
174016031,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Confusional state,2,F,HO,53
174016031,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Confusional state,2,F,OT,53
174016031,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Subclavian artery thrombosis,2,F,HO,53
174016031,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Subclavian artery thrombosis,2,F,OT,53
174019803,1,Lung neoplasm malignant,3,F,EXP,brigatinib,1,PS,Epistaxis,1,F,HO,297
174022551,10,B precursor type acute leukaemia,1,I,EXP,pegaspargase,10,SS,Abdominal pain,10,M,HO,249
174022551,10,B precursor type acute leukaemia,1,I,EXP,pegaspargase,10,SS,Cholelithiasis,10,M,HO,249
174022551,10,B precursor type acute leukaemia,1,I,EXP,pegaspargase,10,SS,Colitis,10,M,HO,249
174022551,10,B precursor type acute leukaemia,1,I,EXP,pegaspargase,10,SS,Hepatic mass,10,M,HO,249
174022551,10,B precursor type acute leukaemia,1,I,EXP,pegaspargase,10,SS,Hepatic steatosis,10,M,HO,249
174022551,10,B precursor type acute leukaemia,1,I,EXP,pegaspargase,10,SS,Iron overload,10,M,HO,249
174022551,10,B precursor type acute leukaemia,1,I,EXP,pegaspargase,10,SS,Petechiae,10,M,HO,249
174022551,10,B precursor type acute leukaemia,1,I,EXP,pegaspargase,10,SS,Pyelonephritis,10,M,HO,249
174022551,10,B precursor type acute leukaemia,1,I,EXP,pegaspargase,10,SS,Pyrexia,10,M,HO,249
174022551,10,B precursor type acute leukaemia,1,I,EXP,pegaspargase,10,SS,Thrombocytopenia,10,M,HO,249
174028741,3,Prostate cancer metastatic,1,I,EXP,cabazitaxel,3,SS,Malnutrition,3,M,HO,74
174028741,3,Prostate cancer metastatic,1,I,EXP,cabazitaxel,3,SS,Urinary tract infection,3,M,HO,74
174029101,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Lung disorder,2,M,OT,17
174029343,4,Plasma cell myeloma,3,F,EXP,lenalidomide,4,SS,Pain in extremity,4,M,HO,70
174029343,4,Plasma cell myeloma,3,F,EXP,lenalidomide,4,SS,Polyneuropathy,4,M,HO,70
174029391,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Erythema,2,M,OT,273
174029391,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Erythema,2,M,HO,273
174029391,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Hepatic necrosis,2,M,OT,273
174029391,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Hepatic necrosis,2,M,HO,273
174029391,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Pancreatic enzymes increased,2,M,OT,273
174029391,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Pancreatic enzymes increased,2,M,HO,273
174029461,3,Product used for unknown indication,1,I,EXP,lenalidomide,3,SS,Diarrhoea,3,F,HO,205
174029461,3,Product used for unknown indication,1,I,EXP,lenalidomide,3,SS,Pancytopenia,3,F,HO,205
174029501,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Acute kidney injury,2,M,OT,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Asthenia,1,F,HO,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Asthenia,1,F,OT,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Confusional state,1,F,HO,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Confusional state,1,F,OT,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Constipation,1,F,HO,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Constipation,1,F,OT,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,HO,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Decreased appetite,1,F,OT,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Depressed level of consciousness,1,F,HO,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Depressed level of consciousness,1,F,OT,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Gait disturbance,1,F,HO,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Gait disturbance,1,F,OT,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Loss of personal independence in daily activities,1,F,HO,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Loss of personal independence in daily activities,1,F,OT,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,HO,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pain in extremity,1,F,OT,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Peripheral swelling,1,F,HO,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Peripheral swelling,1,F,OT,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,HO,17
174029522,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Urinary tract infection,1,F,OT,17
174031301,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,B-cell aplasia,1,F,OT,1
174031301,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,F,OT,1
174031301,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Cytopenia,1,F,OT,1
174031301,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Neutropenia,1,F,OT,1
174032351,4,Colon cancer,1,I,EXP,panitumumab,4,SS,Death,4,F,OT,904
174032351,4,Colon cancer,1,I,EXP,panitumumab,4,SS,Death,4,F,DE,904
174032351,4,Colon cancer,1,I,EXP,panitumumab,4,SS,Diarrhoea,4,F,OT,904
174032351,4,Colon cancer,1,I,EXP,panitumumab,4,SS,Diarrhoea,4,F,DE,904
174032351,4,Colon cancer,1,I,EXP,panitumumab,4,SS,Vomiting,4,F,OT,904
174032351,4,Colon cancer,1,I,EXP,panitumumab,4,SS,Vomiting,4,F,DE,904
174032351,5,Colorectal cancer,1,I,EXP,panitumumab,5,SS,Death,5,F,OT,387
174032351,5,Colorectal cancer,1,I,EXP,panitumumab,5,SS,Death,5,F,DE,387
174032351,5,Colorectal cancer,1,I,EXP,panitumumab,5,SS,Diarrhoea,5,F,OT,387
174032351,5,Colorectal cancer,1,I,EXP,panitumumab,5,SS,Diarrhoea,5,F,DE,387
174032351,5,Colorectal cancer,1,I,EXP,panitumumab,5,SS,Vomiting,5,F,OT,387
174032351,5,Colorectal cancer,1,I,EXP,panitumumab,5,SS,Vomiting,5,F,DE,387
174033541,1,Pleural mesothelioma malignant,1,I,EXP,nivolumab,1,PS,Intentional product use issue,1,M,DE,31
174033541,1,Pleural mesothelioma malignant,1,I,EXP,nivolumab,1,PS,Intentional product use issue,1,M,HO,31
174033541,1,Pleural mesothelioma malignant,1,I,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,31
174033541,1,Pleural mesothelioma malignant,1,I,EXP,nivolumab,1,PS,Lung disorder,1,M,DE,31
174033541,1,Pleural mesothelioma malignant,1,I,EXP,nivolumab,1,PS,Lung disorder,1,M,HO,31
174033541,1,Pleural mesothelioma malignant,1,I,EXP,nivolumab,1,PS,Lung disorder,1,M,OT,31
174033541,1,Pleural mesothelioma malignant,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,31
174033541,1,Pleural mesothelioma malignant,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,31
174033541,1,Pleural mesothelioma malignant,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,31
174034091,1,Osteogenesis imperfecta,1,I,PER,denosumab,1,PS,Femur fracture,1,M,HO,89
174035071,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Hepatitis,1,M,HO,52
174035071,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Hepatitis,1,M,OT,52
174035071,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Hepatitis,1,M,LT,52
174035071,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Pyrexia,1,M,HO,52
174035071,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Pyrexia,1,M,OT,52
174035071,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Pyrexia,1,M,LT,52
174035331,4,Agranulocytosis,1,I,EXP,pegfilgrastim,4,SS,Multiple organ dysfunction syndrome,4,M,HO,21
174035331,4,Agranulocytosis,1,I,EXP,pegfilgrastim,4,SS,Multiple organ dysfunction syndrome,4,M,OT,21
174035331,4,Agranulocytosis,1,I,EXP,pegfilgrastim,4,SS,Multiple organ dysfunction syndrome,4,M,DE,21
174035331,4,Agranulocytosis,1,I,EXP,pegfilgrastim,4,SS,Pneumonia,4,M,HO,21
174035331,4,Agranulocytosis,1,I,EXP,pegfilgrastim,4,SS,Pneumonia,4,M,OT,21
174035331,4,Agranulocytosis,1,I,EXP,pegfilgrastim,4,SS,Pneumonia,4,M,DE,21
174035331,4,Agranulocytosis,1,I,EXP,pegfilgrastim,4,SS,Sepsis,4,M,HO,21
174035331,4,Agranulocytosis,1,I,EXP,pegfilgrastim,4,SS,Sepsis,4,M,OT,21
174035331,4,Agranulocytosis,1,I,EXP,pegfilgrastim,4,SS,Sepsis,4,M,DE,21
174035342,8,Product used for unknown indication,2,F,EXP,filgrastim,8,C,Periorbital cellulitis,8,M,OT,13
174035342,8,Product used for unknown indication,2,F,EXP,filgrastim,8,C,Uveitis,8,M,OT,13
174042911,1,Metastatic malignant melanoma,1,I,EXP,nivolumab,1,PS,Myocarditis,1,M,HO,17
174042911,1,Metastatic malignant melanoma,1,I,EXP,nivolumab,1,PS,Myocarditis,1,M,DE,17
174042911,1,Metastatic malignant melanoma,1,I,EXP,nivolumab,1,PS,Myocarditis,1,M,OT,17
174042911,2,Metastatic malignant melanoma,1,I,EXP,ipilimumab,2,SS,Myocarditis,2,M,HO,17
174042911,2,Metastatic malignant melanoma,1,I,EXP,ipilimumab,2,SS,Myocarditis,2,M,DE,17
174042911,2,Metastatic malignant melanoma,1,I,EXP,ipilimumab,2,SS,Myocarditis,2,M,OT,17
174044342,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Neutropenia,2,M,OT,85
174044342,3,Plasma cell myeloma,2,F,EXP,pomalidomide,3,SS,Neutropenia,3,M,OT,85
174044882,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,PS,Acute kidney injury,2,F,HO,501
174045603,22,Prophylaxis,3,F,EXP,rasburicase,22,C,Pneumonitis,22,F,HO,751
174045975,1,Non-Hodgkin's lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Infection,1,F,LT,233
174045975,1,Non-Hodgkin's lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Infection,1,F,HO,233
174045975,1,Non-Hodgkin's lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Sepsis,1,F,LT,233
174045975,1,Non-Hodgkin's lymphoma,5,F,EXP,axicabtagene ciloleucel,1,PS,Sepsis,1,F,HO,233
174047981,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Arthritis,1,F,HO,7
174047981,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Dermatitis,1,F,HO,7
174047981,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Arthritis,2,F,HO,7
174047981,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Dermatitis,2,F,HO,7
174048991,2,Chordoma,1,I,EXP,nivolumab,2,PS,Headache,2,M,OT,120
174049311,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Colitis ulcerative,2,M,HO,97
174049821,24,Diffuse large B-cell lymphoma,1,I,EXP,lenalidomide,24,C,Multiple organ dysfunction syndrome,24,M,DE,24
174049821,24,Diffuse large B-cell lymphoma,1,I,EXP,lenalidomide,24,C,Multiple organ dysfunction syndrome,24,M,HO,24
174049821,24,Diffuse large B-cell lymphoma,1,I,EXP,lenalidomide,24,C,Neutropenia,24,M,DE,24
174049821,24,Diffuse large B-cell lymphoma,1,I,EXP,lenalidomide,24,C,Neutropenia,24,M,HO,24
174049821,24,Diffuse large B-cell lymphoma,1,I,EXP,lenalidomide,24,C,Thrombocytopenia,24,M,DE,24
174049821,24,Diffuse large B-cell lymphoma,1,I,EXP,lenalidomide,24,C,Thrombocytopenia,24,M,HO,24
174051103,4,Plasma cell myeloma,3,F,EXP,pomalidomide,4,SS,Disease progression,4,F,DE,7
174051103,4,Plasma cell myeloma,3,F,EXP,pomalidomide,4,SS,Disease progression,4,F,HO,7
174051103,4,Plasma cell myeloma,3,F,EXP,pomalidomide,4,SS,Pyrexia,4,F,DE,7
174051103,4,Plasma cell myeloma,3,F,EXP,pomalidomide,4,SS,Pyrexia,4,F,HO,7
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Alopecia,8,F,OT,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Alopecia,8,F,HO,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Candida infection,8,F,OT,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Candida infection,8,F,HO,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Decreased appetite,8,F,OT,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Decreased appetite,8,F,HO,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Fatigue,8,F,OT,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Fatigue,8,F,HO,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Haematemesis,8,F,OT,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Haematemesis,8,F,HO,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Hypernatraemia,8,F,OT,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Hypernatraemia,8,F,HO,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Malaise,8,F,OT,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Malaise,8,F,HO,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Nausea,8,F,OT,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Nausea,8,F,HO,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Neutropenia,8,F,OT,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Neutropenia,8,F,HO,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Onychalgia,8,F,OT,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Onychalgia,8,F,HO,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Pain in jaw,8,F,OT,8
174054072,8,Premedication,2,F,EXP,granisetron,8,C,Pain in jaw,8,F,HO,8
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Acute kidney injury,1,M,OT,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Acute kidney injury,1,M,HO,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Acute kidney injury,1,M,DE,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Anaemia,1,M,OT,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Anaemia,1,M,HO,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Anaemia,1,M,DE,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Cerebrovascular accident,1,M,OT,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Cerebrovascular accident,1,M,HO,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Cerebrovascular accident,1,M,DE,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Colitis,1,M,OT,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Colitis,1,M,HO,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Colitis,1,M,DE,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Hypoxia,1,M,OT,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Hypoxia,1,M,HO,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Hypoxia,1,M,DE,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Thrombocytopenia,1,M,OT,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Thrombocytopenia,1,M,HO,56
174054711,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Thrombocytopenia,1,M,DE,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Acute kidney injury,2,M,OT,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Acute kidney injury,2,M,HO,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Acute kidney injury,2,M,DE,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Anaemia,2,M,OT,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Anaemia,2,M,HO,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Anaemia,2,M,DE,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Cerebrovascular accident,2,M,OT,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Cerebrovascular accident,2,M,HO,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Cerebrovascular accident,2,M,DE,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Colitis,2,M,OT,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Colitis,2,M,HO,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Colitis,2,M,DE,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Hypoxia,2,M,OT,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Hypoxia,2,M,HO,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Hypoxia,2,M,DE,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Thrombocytopenia,2,M,OT,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Thrombocytopenia,2,M,HO,56
174054711,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Thrombocytopenia,2,M,DE,56
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Eye disorder,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Eye pain,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Gynaecomastia,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Influenza like illness,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Liver disorder,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Liver function test increased,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Malaise,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Musculoskeletal chest pain,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Nipple pain,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Oropharyngeal pain,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pulmonary pain,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Rash,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Tooth disorder,1,M,HO,15
174057373,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Diarrhoea,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Eye disorder,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Eye pain,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Gynaecomastia,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Influenza like illness,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Liver disorder,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Liver function test increased,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Malaise,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Musculoskeletal chest pain,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Nipple pain,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Oropharyngeal pain,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Pulmonary pain,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Pyrexia,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Rash,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Tooth disorder,2,M,HO,15
174057373,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Urinary tract infection,2,M,HO,15
174058033,1,Pancreatic carcinoma,3,F,EXP,nivolumab,1,PS,Ascites,1,F,HO,303
174058033,1,Pancreatic carcinoma,3,F,EXP,nivolumab,1,PS,Ascites,1,F,OT,303
174058033,1,Pancreatic carcinoma,3,F,EXP,nivolumab,1,PS,Bile duct obstruction,1,F,HO,303
174058033,1,Pancreatic carcinoma,3,F,EXP,nivolumab,1,PS,Bile duct obstruction,1,F,OT,303
174058033,1,Pancreatic carcinoma,3,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,F,HO,303
174058033,1,Pancreatic carcinoma,3,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,F,OT,303
174058033,1,Pancreatic carcinoma,3,F,EXP,nivolumab,1,PS,Blood bilirubin increased,1,F,HO,303
174058033,1,Pancreatic carcinoma,3,F,EXP,nivolumab,1,PS,Blood bilirubin increased,1,F,OT,303
174058033,1,Pancreatic carcinoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,F,HO,303
174058033,1,Pancreatic carcinoma,3,F,EXP,nivolumab,1,PS,Fatigue,1,F,OT,303
174058033,1,Pancreatic carcinoma,3,F,EXP,nivolumab,1,PS,Metastases to lung,1,F,HO,303
174058033,1,Pancreatic carcinoma,3,F,EXP,nivolumab,1,PS,Metastases to lung,1,F,OT,303
174061991,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Inappropriate antidiuretic hormone secretion,1,M,OT,2
174061991,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Inappropriate antidiuretic hormone secretion,1,M,HO,2
174070582,1,Metastases to bone,2,F,EXP,zoledronic acid,1,PS,Anaemia,1,F,OT,63
174070582,1,Metastases to bone,2,F,EXP,zoledronic acid,1,PS,Epistaxis,1,F,OT,63
174070582,1,Metastases to bone,2,F,EXP,zoledronic acid,1,PS,Haematemesis,1,F,OT,63
174070922,1,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,1,SS,Inflammation,1,F,OT,74
174071602,1,Neuroendocrine carcinoma of the skin,2,F,EXP,nivolumab,1,PS,Cardiac failure,1,M,HO,37
174071602,1,Neuroendocrine carcinoma of the skin,2,F,EXP,nivolumab,1,PS,Cardiac failure,1,M,OT,37
174071602,1,Neuroendocrine carcinoma of the skin,2,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,HO,37
174071602,1,Neuroendocrine carcinoma of the skin,2,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,OT,37
174080771,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Nausea,1,F,OT,351
174080771,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Pain,1,F,OT,351
174080771,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Renal failure,1,F,OT,351
174080771,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Vomiting,1,F,OT,351
174081003,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Breast cancer recurrent,3,F,OT,1034
174081003,4,Plasma cell myeloma,3,F,EXP,pomalidomide,4,SS,Breast cancer recurrent,4,F,OT,862
174081472,3,Endometrial cancer recurrent,2,F,EXP,lenvatinib mesylate,3,SS,Diabetic coma,3,F,LT,27
174081472,3,Endometrial cancer recurrent,2,F,EXP,lenvatinib mesylate,3,SS,Diabetic coma,3,F,HO,27
174081472,3,Endometrial cancer recurrent,2,F,EXP,lenvatinib mesylate,3,SS,Diabetic coma,3,F,DE,27
174081472,3,Endometrial cancer recurrent,2,F,EXP,lenvatinib mesylate,3,SS,Diabetic coma,3,F,OT,27
174081472,3,Endometrial cancer recurrent,2,F,EXP,lenvatinib mesylate,3,SS,Diabetic ketoacidosis,3,F,LT,27
174081472,3,Endometrial cancer recurrent,2,F,EXP,lenvatinib mesylate,3,SS,Diabetic ketoacidosis,3,F,HO,27
174081472,3,Endometrial cancer recurrent,2,F,EXP,lenvatinib mesylate,3,SS,Diabetic ketoacidosis,3,F,DE,27
174081472,3,Endometrial cancer recurrent,2,F,EXP,lenvatinib mesylate,3,SS,Diabetic ketoacidosis,3,F,OT,27
174081472,3,Endometrial cancer recurrent,2,F,EXP,lenvatinib mesylate,3,SS,Product use in unapproved indication,3,F,LT,27
174081472,3,Endometrial cancer recurrent,2,F,EXP,lenvatinib mesylate,3,SS,Product use in unapproved indication,3,F,HO,27
174081472,3,Endometrial cancer recurrent,2,F,EXP,lenvatinib mesylate,3,SS,Product use in unapproved indication,3,F,DE,27
174081472,3,Endometrial cancer recurrent,2,F,EXP,lenvatinib mesylate,3,SS,Product use in unapproved indication,3,F,OT,27
174083111,1,Product used for unknown indication,1,I,EXP,rolapitant hydrochloride,1,PS,Decreased appetite,1,F,HO,6
174083111,1,Product used for unknown indication,1,I,EXP,rolapitant hydrochloride,1,PS,Hospitalisation,1,F,HO,6
174083111,1,Product used for unknown indication,1,I,EXP,rolapitant hydrochloride,1,PS,Nausea,1,F,HO,6
174087321,2,Acute lymphocytic leukaemia,1,I,EXP,inotuzumab ozogamicin,2,SS,Urosepsis,2,F,HO,127
174096931,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Atrial fibrillation,1,M,LT,230
174096931,2,Plasma cell myeloma,1,I,PER,lenalidomide,2,C,Atrial fibrillation,2,M,LT,230
174098491,4,Plasma cell myeloma,1,I,EXP,pomalidomide,4,SS,Neuropathy peripheral,4,M,HO,110
174098491,4,Plasma cell myeloma,1,I,EXP,pomalidomide,4,SS,Pneumonia,4,M,HO,110
174098491,4,Plasma cell myeloma,1,I,EXP,pomalidomide,4,SS,Polyneuropathy,4,M,HO,110
174100714,1,Diffuse large B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Pancytopenia,1,F,DS,70
174100714,1,Diffuse large B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Pancytopenia,1,F,OT,70
174100714,1,Diffuse large B-cell lymphoma,4,F,EXP,axicabtagene ciloleucel,1,PS,Pancytopenia,1,F,HO,70
174101161,64,Product used for unknown indication,1,I,EXP,filgrastim,64,C,Cytokine release syndrome,64,F,DE,6
174101161,64,Product used for unknown indication,1,I,EXP,filgrastim,64,C,Cytokine release syndrome,64,F,HO,6
174101161,64,Product used for unknown indication,1,I,EXP,filgrastim,64,C,Cytokine release syndrome,64,F,LT,6
174101161,64,Product used for unknown indication,1,I,EXP,filgrastim,64,C,Encephalopathy,64,F,DE,6
174101161,64,Product used for unknown indication,1,I,EXP,filgrastim,64,C,Encephalopathy,64,F,HO,6
174101161,64,Product used for unknown indication,1,I,EXP,filgrastim,64,C,Encephalopathy,64,F,LT,6
174101161,64,Product used for unknown indication,1,I,EXP,filgrastim,64,C,Staphylococcal sepsis,64,F,DE,6
174101161,64,Product used for unknown indication,1,I,EXP,filgrastim,64,C,Staphylococcal sepsis,64,F,HO,6
174101161,64,Product used for unknown indication,1,I,EXP,filgrastim,64,C,Staphylococcal sepsis,64,F,LT,6
174101511,1,B-cell lymphoma,1,I,EXP,idelalisib,1,PS,Disease progression,1,M,OT,279
174103384,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,SS,Pneumonia aspiration,1,M,OT,71
174103384,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,SS,Pneumonia aspiration,1,M,HO,71
174103384,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,PS,Pneumonia aspiration,2,M,OT,71
174103384,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,PS,Pneumonia aspiration,2,M,HO,71
174105351,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Syncope,1,M,HO,150
174106561,4,Plasma cell myeloma,1,I,EXP,daratumumab,4,SS,Clostridium colitis,4,F,HO,51
174107442,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Abdominal pain,1,F,HO,108
174107442,1,Ovarian cancer,2,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,108
174107561,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Death,1,F,DE,167
174107561,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Death,1,F,OT,167
174107583,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Renal impairment,1,M,HO,23
174107583,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,SS,Renal impairment,1,M,OT,23
174107583,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Renal impairment,2,M,HO,23
174107583,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Renal impairment,2,M,OT,23
174109104,1,Renal cell carcinoma,4,F,EXP,ipilimumab,1,PS,Nausea,1,M,HO,94
174109104,1,Renal cell carcinoma,4,F,EXP,ipilimumab,1,PS,Proctitis,1,M,HO,94
174109104,2,Renal cell carcinoma,4,F,EXP,nivolumab,2,SS,Nausea,2,M,HO,94
174109104,2,Renal cell carcinoma,4,F,EXP,nivolumab,2,SS,Proctitis,2,M,HO,94
174109181,1,Colorectal cancer metastatic,1,I,EXP,nivolumab,1,PS,Myocarditis,1,M,DE,41
174109181,1,Colorectal cancer metastatic,1,I,EXP,nivolumab,1,PS,Myocarditis,1,M,HO,41
174109181,1,Colorectal cancer metastatic,1,I,EXP,nivolumab,1,PS,Myocarditis,1,M,OT,41
174109181,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Myocarditis,2,M,DE,13
174109181,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Myocarditis,2,M,HO,13
174109181,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Myocarditis,2,M,OT,13
174109311,16,Plasma cell myeloma,1,I,PER,daratumumab,16,SS,Febrile neutropenia,16,F,HO,58
174111072,1,Oesophageal adenocarcinoma,2,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,150
174111072,1,Oesophageal adenocarcinoma,2,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,150
174111072,1,Oesophageal adenocarcinoma,2,F,EXP,nivolumab,1,PS,Syncope,1,M,OT,150
174111072,1,Oesophageal adenocarcinoma,2,F,EXP,nivolumab,1,PS,Syncope,1,M,HO,150
174112042,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,416
174112042,1,Gastric cancer,2,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,LT,416
174113081,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Oesophageal squamous cell carcinoma,1,M,HO,389
174113081,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Oesophageal squamous cell carcinoma,1,M,DE,389
174113081,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Pneumonia bacterial,1,M,HO,389
174113081,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Pneumonia bacterial,1,M,DE,389
174113081,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Respiratory failure,1,M,HO,389
174113081,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Respiratory failure,1,M,DE,389
174113081,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Respiratory tract infection,1,M,HO,389
174113081,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Respiratory tract infection,1,M,DE,389
174113081,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Septic shock,1,M,HO,389
174113081,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Septic shock,1,M,DE,389
174114161,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Basal cell carcinoma,4,M,OT,628
174114161,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Squamous cell carcinoma,4,M,OT,628
174115243,1,Small cell lung cancer,3,F,EXP,nivolumab,1,SS,Post herpetic neuralgia,1,M,HO,126
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Acute kidney injury,4,M,LT,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Acute kidney injury,4,M,HO,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Acute kidney injury,4,M,DE,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Dyspnoea,4,M,LT,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Dyspnoea,4,M,HO,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Dyspnoea,4,M,DE,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Myocardial infarction,4,M,LT,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Myocardial infarction,4,M,HO,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Myocardial infarction,4,M,DE,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Pneumonia,4,M,LT,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Pneumonia,4,M,HO,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Pneumonia,4,M,DE,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Pulmonary oedema,4,M,LT,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Pulmonary oedema,4,M,HO,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Pulmonary oedema,4,M,DE,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Respiratory failure,4,M,LT,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Respiratory failure,4,M,HO,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Respiratory failure,4,M,DE,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Sepsis,4,M,LT,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Sepsis,4,M,HO,271
174115262,4,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,4,SS,Sepsis,4,M,DE,271
174118082,5,Hodgkin's disease,2,F,EXP,nivolumab,5,SS,Troponin I increased,5,M,HO,56
174125191,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Pneumonia,1,F,HO,486
174125201,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Pneumonia,1,F,HO,82
174125641,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,37
174125641,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,37
174129912,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,2
174129912,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,2
174129912,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Anaemia,1,M,DE,2
174129912,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,OT,2
174129912,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,HO,2
174129912,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,DE,2
174129912,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Chronic kidney disease,1,M,OT,2
174129912,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Chronic kidney disease,1,M,HO,2
174129912,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Chronic kidney disease,1,M,DE,2
174129912,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,OT,2
174129912,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,HO,2
174129912,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Multiple organ dysfunction syndrome,1,M,DE,2
174132841,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,OT,98
174132841,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Atrioventricular block,1,M,OT,98
174132841,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,98
174132841,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Feeling hot,1,M,OT,98
174132841,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Flushing,1,M,OT,98
174132841,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Hyperhidrosis,1,M,OT,98
174132841,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Off label use,1,M,OT,98
174136281,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Gastroenteritis,1,F,HO,4
174136281,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Leukopenia,1,F,HO,4
174136501,4,Lung adenocarcinoma stage IV,1,I,EXP,pemetrexed disodium,4,SS,Immune-mediated adverse reaction,4,M,HO,7
174136501,4,Lung adenocarcinoma stage IV,1,I,EXP,pemetrexed disodium,4,SS,Inappropriate schedule of product administration,4,M,HO,7
174136501,4,Lung adenocarcinoma stage IV,1,I,EXP,pemetrexed disodium,4,SS,Platelet count decreased,4,M,HO,7
174136501,4,Lung adenocarcinoma stage IV,1,I,EXP,pemetrexed disodium,4,SS,Skin toxicity,4,M,HO,7
174139151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,28
174139151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Cognitive disorder,1,M,OT,28
174139151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Depression,1,M,OT,28
174139151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,28
174139151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Gait disturbance,1,M,OT,28
174139151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Muscular weakness,1,M,OT,28
174139151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Visual acuity reduced,1,M,OT,28
174142832,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Bronchitis,2,M,HO,802
174142832,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Hypogammaglobulinaemia,2,M,HO,802
174142832,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Pneumocystis jirovecii pneumonia,2,M,HO,802
174143592,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Electrocardiogram QT prolonged,4,F,OT,66
174145921,2,Breast cancer,1,I,EXP,palbociclib,2,SS,Sepsis,2,F,HO,503
174146201,4,Embryonal rhabdomyosarcoma,1,I,EXP,dactinomycin,4,SS,Device related infection,4,M,OT,14
174146201,4,Embryonal rhabdomyosarcoma,1,I,EXP,dactinomycin,4,SS,Device related infection,4,M,HO,14
174146201,4,Embryonal rhabdomyosarcoma,1,I,EXP,dactinomycin,4,SS,Pyrexia,4,M,OT,14
174146201,4,Embryonal rhabdomyosarcoma,1,I,EXP,dactinomycin,4,SS,Pyrexia,4,M,HO,14
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,DE,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Feeding disorder,1,F,DE,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Feeding disorder,1,F,HO,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Feeding disorder,1,F,OT,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Inflammation,1,F,DE,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Inflammation,1,F,HO,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Inflammation,1,F,OT,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,DE,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,HO,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Oedema peripheral,1,F,OT,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Pruritus,1,F,DE,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Pruritus,1,F,HO,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Pruritus,1,F,OT,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Vomiting,1,F,DE,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,34
174146954,1,Renal cell carcinoma,4,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Diarrhoea,2,F,DE,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Diarrhoea,2,F,HO,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Diarrhoea,2,F,OT,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Feeding disorder,2,F,DE,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Feeding disorder,2,F,HO,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Feeding disorder,2,F,OT,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Inflammation,2,F,DE,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Inflammation,2,F,HO,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Inflammation,2,F,OT,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,DE,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,HO,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,OT,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Oedema peripheral,2,F,DE,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Oedema peripheral,2,F,HO,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Oedema peripheral,2,F,OT,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Pruritus,2,F,DE,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Pruritus,2,F,HO,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Pruritus,2,F,OT,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Vomiting,2,F,DE,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Vomiting,2,F,HO,34
174146954,2,Renal cell carcinoma,4,F,EXP,ipilimumab,2,SS,Vomiting,2,F,OT,34
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Abdominal discomfort,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Abdominal discomfort,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Abdominal discomfort,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Alanine aminotransferase increased,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Aspartate aminotransferase increased,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Blood alkaline phosphatase increased,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cellulitis,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cellulitis,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cellulitis,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cough,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cough,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Cough,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Flushing,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Flushing,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Flushing,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Gamma-glutamyltransferase increased,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hairy cell leukaemia,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hairy cell leukaemia,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hairy cell leukaemia,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Joint dislocation,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Joint dislocation,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Joint dislocation,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Nasopharyngitis,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Nasopharyngitis,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Nasopharyngitis,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pollakiuria,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pollakiuria,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pollakiuria,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Rash,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Rash,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Rash,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Tinea infection,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Tinea infection,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Tinea infection,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Upper respiratory tract infection,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Upper respiratory tract infection,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Upper respiratory tract infection,1,M,HO,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,OT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,LT,1
174147202,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Urinary tract infection,1,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Abdominal discomfort,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Abdominal discomfort,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Abdominal discomfort,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Alanine aminotransferase increased,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Alanine aminotransferase increased,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Alanine aminotransferase increased,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Aspartate aminotransferase increased,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Aspartate aminotransferase increased,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Aspartate aminotransferase increased,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Blood alkaline phosphatase increased,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Blood alkaline phosphatase increased,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Blood alkaline phosphatase increased,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Cellulitis,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Cellulitis,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Cellulitis,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Cough,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Cough,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Cough,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Flushing,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Flushing,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Flushing,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Gamma-glutamyltransferase increased,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Gamma-glutamyltransferase increased,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Gamma-glutamyltransferase increased,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Hairy cell leukaemia,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Hairy cell leukaemia,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Hairy cell leukaemia,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Joint dislocation,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Joint dislocation,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Joint dislocation,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Nasopharyngitis,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Nasopharyngitis,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Nasopharyngitis,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Pollakiuria,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Pollakiuria,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Pollakiuria,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Rash,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Rash,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Rash,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Tinea infection,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Tinea infection,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Tinea infection,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Upper respiratory tract infection,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Upper respiratory tract infection,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Upper respiratory tract infection,4,M,HO,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Urinary tract infection,4,M,OT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Urinary tract infection,4,M,LT,1
174147202,4,Malignant melanoma,2,F,EXP,ipilimumab,4,SS,Urinary tract infection,4,M,HO,1
174147641,7,Product used for unknown indication,1,I,EXP,filgrastim,7,C,Depressed level of consciousness,7,F,OT,2
174147641,7,Product used for unknown indication,1,I,EXP,filgrastim,7,C,Depressed level of consciousness,7,F,HO,2
174147641,7,Product used for unknown indication,1,I,EXP,filgrastim,7,C,Febrile neutropenia,7,F,OT,2
174147641,7,Product used for unknown indication,1,I,EXP,filgrastim,7,C,Febrile neutropenia,7,F,HO,2
174147641,7,Product used for unknown indication,1,I,EXP,filgrastim,7,C,Memory impairment,7,F,OT,2
174147641,7,Product used for unknown indication,1,I,EXP,filgrastim,7,C,Memory impairment,7,F,HO,2
174148442,8,Chronic lymphocytic leukaemia,2,F,EXP,ofatumumab,8,SS,Respiratory distress,8,M,DE,2261
174148661,11,Plasma cell myeloma,1,I,PER,carfilzomib,11,SS,Cardiac failure congestive,11,M,HO,1285
174148661,11,Plasma cell myeloma,1,I,PER,carfilzomib,11,SS,Pneumonia,11,M,HO,1285
174148661,12,Plasma cell myeloma,1,I,PER,daratumumab,12,SS,Cardiac failure congestive,12,M,HO,1250
174148661,12,Plasma cell myeloma,1,I,PER,daratumumab,12,SS,Pneumonia,12,M,HO,1250
174149831,2,Breast cancer metastatic,1,I,EXP,palbociclib,2,SS,Neoplasm malignant,2,F,OT,173
174149831,2,Breast cancer metastatic,1,I,EXP,palbociclib,2,SS,Neoplasm progression,2,F,OT,173
174149831,2,Breast cancer metastatic,1,I,EXP,palbociclib,2,SS,Second primary malignancy,2,F,OT,173
174150833,1,Non-small cell lung cancer,3,F,EXP,lorlatinib,1,PS,Neoplasm progression,1,M,LT,19
174150833,1,Non-small cell lung cancer,3,F,EXP,lorlatinib,1,PS,Neoplasm progression,1,M,DE,19
174150833,1,Non-small cell lung cancer,3,F,EXP,lorlatinib,1,PS,Neoplasm progression,1,M,HO,19
174150833,1,Non-small cell lung cancer,3,F,EXP,lorlatinib,1,PS,Neoplasm progression,1,M,OT,19
174150833,1,Non-small cell lung cancer,3,F,EXP,lorlatinib,1,PS,Respiratory distress,1,M,LT,19
174150833,1,Non-small cell lung cancer,3,F,EXP,lorlatinib,1,PS,Respiratory distress,1,M,DE,19
174150833,1,Non-small cell lung cancer,3,F,EXP,lorlatinib,1,PS,Respiratory distress,1,M,HO,19
174150833,1,Non-small cell lung cancer,3,F,EXP,lorlatinib,1,PS,Respiratory distress,1,M,OT,19
174151101,2,Hormone-refractory prostate cancer,1,I,EXP,cabazitaxel,2,SS,Febrile neutropenia,2,M,HO,7
174151571,9,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,9,SS,Chronic obstructive pulmonary disease,9,F,HO,115
174151571,9,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,9,SS,Dyspnoea,9,F,HO,115
174151571,9,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,9,SS,Non-cardiac chest pain,9,F,HO,115
174157811,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Atrial fibrillation,1,M,HO,716
174157811,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Left ventricular dysfunction,1,M,HO,716
174157811,3,Plasma cell myeloma,1,I,EXP,thalidomide,3,C,Atrial fibrillation,3,M,HO,1023
174157811,3,Plasma cell myeloma,1,I,EXP,thalidomide,3,C,Left ventricular dysfunction,3,M,HO,1023
174158011,2,Mantle cell lymphoma recurrent,1,I,EXP,ibrutinib,2,SS,Hepatitis B,2,M,OT,414
174160861,62,Product used for unknown indication,1,I,EXP,filgrastim,62,C,Cytokine release syndrome,62,F,DE,6
174160861,62,Product used for unknown indication,1,I,EXP,filgrastim,62,C,Cytokine release syndrome,62,F,LT,6
174160861,62,Product used for unknown indication,1,I,EXP,filgrastim,62,C,Cytokine release syndrome,62,F,HO,6
174160861,62,Product used for unknown indication,1,I,EXP,filgrastim,62,C,Encephalopathy,62,F,DE,6
174160861,62,Product used for unknown indication,1,I,EXP,filgrastim,62,C,Encephalopathy,62,F,LT,6
174160861,62,Product used for unknown indication,1,I,EXP,filgrastim,62,C,Encephalopathy,62,F,HO,6
174160861,62,Product used for unknown indication,1,I,EXP,filgrastim,62,C,Staphylococcal sepsis,62,F,DE,6
174160861,62,Product used for unknown indication,1,I,EXP,filgrastim,62,C,Staphylococcal sepsis,62,F,LT,6
174160861,62,Product used for unknown indication,1,I,EXP,filgrastim,62,C,Staphylococcal sepsis,62,F,HO,6
174161504,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Anaemia,1,F,OT,11
174161504,1,Plasma cell myeloma,4,F,EXP,pomalidomide,1,PS,Anaemia,1,F,DE,11
174161931,11,Neutrophil count decreased,1,I,EXP,filgrastim,11,C,Neutropenia,11,M,OT,6
174161931,11,Neutrophil count decreased,1,I,EXP,filgrastim,11,C,Neutropenia,11,M,HO,6
174161931,11,Neutrophil count decreased,1,I,EXP,filgrastim,11,C,Thrombocytopenia,11,M,OT,6
174161931,11,Neutrophil count decreased,1,I,EXP,filgrastim,11,C,Thrombocytopenia,11,M,HO,6
174161931,26,Diffuse large B-cell lymphoma,1,I,EXP,lenalidomide,26,C,Neutropenia,26,M,OT,33
174161931,26,Diffuse large B-cell lymphoma,1,I,EXP,lenalidomide,26,C,Neutropenia,26,M,HO,33
174161931,26,Diffuse large B-cell lymphoma,1,I,EXP,lenalidomide,26,C,Thrombocytopenia,26,M,OT,33
174161931,26,Diffuse large B-cell lymphoma,1,I,EXP,lenalidomide,26,C,Thrombocytopenia,26,M,HO,33
174163471,1,Plasma cell myeloma,1,I,DIR,lenalidomide,1,PS,Alanine aminotransferase increased,1,M,OT,264
174163471,1,Plasma cell myeloma,1,I,DIR,lenalidomide,1,PS,Aspartate aminotransferase increased,1,M,OT,264
174163471,1,Plasma cell myeloma,1,I,DIR,lenalidomide,1,PS,Hepatitis B reactivation,1,M,OT,264
174163471,1,Plasma cell myeloma,1,I,DIR,lenalidomide,1,PS,Plasma cell myeloma recurrent,1,M,OT,264
174164851,1,End stage renal disease,1,I,DIR,epoetin alfa,1,PS,Facial paralysis,1,F,LT,740
174164851,1,End stage renal disease,1,I,DIR,epoetin alfa,1,PS,Facial paralysis,1,F,HO,740
174164851,1,End stage renal disease,1,I,DIR,epoetin alfa,1,PS,Gastrointestinal haemorrhage,1,F,LT,740
174164851,1,End stage renal disease,1,I,DIR,epoetin alfa,1,PS,Gastrointestinal haemorrhage,1,F,HO,740
174164851,1,End stage renal disease,1,I,DIR,epoetin alfa,1,PS,Hemiparesis,1,F,LT,740
174164851,1,End stage renal disease,1,I,DIR,epoetin alfa,1,PS,Hemiparesis,1,F,HO,740
174164851,1,End stage renal disease,1,I,DIR,epoetin alfa,1,PS,Mental status changes,1,F,LT,740
174164851,1,End stage renal disease,1,I,DIR,epoetin alfa,1,PS,Mental status changes,1,F,HO,740
174166441,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Hypotension,2,M,HO,1
174166441,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Large intestinal haemorrhage,2,M,HO,1
174166441,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Lymphocyte count decreased,2,M,HO,1
174167661,3,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,3,C,Bronchitis,3,M,HO,123
174167661,3,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,3,C,Bronchitis,3,M,OT,123
174167661,3,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,3,C,Bronchopneumopathy,3,M,HO,123
174167661,3,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,3,C,Bronchopneumopathy,3,M,OT,123
174167661,3,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,3,C,Cough,3,M,HO,123
174167661,3,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,3,C,Cough,3,M,OT,123
174167661,3,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,3,C,Productive cough,3,M,HO,123
174167661,3,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,3,C,Productive cough,3,M,OT,123
174167661,3,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,3,C,Sinusitis,3,M,HO,123
174167661,3,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,3,C,Sinusitis,3,M,OT,123
174171311,3,Plasma cell myeloma,1,I,PER,daratumumab,3,C,White blood cell count decreased,3,M,OT,8
174176541,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Basal cell carcinoma,2,F,OT,1302
174176541,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Basal cell carcinoma,2,F,HO,1302
174176541,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Pneumonia,2,F,OT,1302
174176541,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Pneumonia,2,F,HO,1302
174176762,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,42
174176762,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,42
174176762,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Enterocolitis haemorrhagic,1,M,HO,42
174176762,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Enterocolitis haemorrhagic,1,M,OT,42
174176762,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Anaemia,2,M,HO,42
174176762,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Anaemia,2,M,OT,42
174176762,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Enterocolitis haemorrhagic,2,M,HO,42
174176762,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Enterocolitis haemorrhagic,2,M,OT,42
174177492,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Polymyalgia rheumatica,1,M,OT,833
174177492,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Polymyalgia rheumatica,1,M,HO,833
174177531,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Febrile neutropenia,1,F,HO,6
174180011,1,Product used for unknown indication,1,I,EXP,ipilimumab,1,PS,Diabetes mellitus,1,F,OT,42
174180011,1,Product used for unknown indication,1,I,EXP,ipilimumab,1,PS,Diabetes mellitus,1,F,HO,42
174180011,3,Product used for unknown indication,1,I,EXP,trametinib,3,SS,Diabetes mellitus,3,F,OT,280
174180011,3,Product used for unknown indication,1,I,EXP,trametinib,3,SS,Diabetes mellitus,3,F,HO,280
174181103,3,Product used for unknown indication,3,F,EXP,palbociclib,3,SS,Thrombocytopenia,3,F,OT,256
174181792,6,Plasma cell myeloma,2,F,EXP,daratumumab,6,SS,Bronchitis,6,F,HO,52
174181792,6,Plasma cell myeloma,2,F,EXP,daratumumab,6,SS,Influenza,6,F,HO,52
174181792,6,Plasma cell myeloma,2,F,EXP,daratumumab,6,SS,Pneumonia,6,F,HO,52
174181792,6,Plasma cell myeloma,2,F,EXP,daratumumab,6,SS,Urinary tract infection,6,F,HO,52
174182641,1,Nasopharyngeal cancer,1,I,EXP,nivolumab,1,PS,Bacteraemia,1,M,OT,136
174182641,1,Nasopharyngeal cancer,1,I,EXP,nivolumab,1,PS,Bacteraemia,1,M,HO,136
174182641,1,Nasopharyngeal cancer,1,I,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,OT,136
174182641,1,Nasopharyngeal cancer,1,I,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,HO,136
174182641,1,Nasopharyngeal cancer,1,I,EXP,nivolumab,1,PS,Tachycardia,1,M,OT,136
174182641,1,Nasopharyngeal cancer,1,I,EXP,nivolumab,1,PS,Tachycardia,1,M,HO,136
174182661,1,Cervix carcinoma,1,I,EXP,nivolumab,1,PS,Hypotension,1,F,HO,28
174183532,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,OT,138
174183532,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Autoimmune thyroiditis,1,M,HO,138
174183532,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Dehydration,1,M,OT,138
174183532,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Dehydration,1,M,HO,138
174183532,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,138
174183532,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,138
174183532,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Autoimmune thyroiditis,2,M,OT,138
174183532,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Autoimmune thyroiditis,2,M,HO,138
174183532,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Dehydration,2,M,OT,138
174183532,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Dehydration,2,M,HO,138
174183532,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,OT,138
174183532,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,HO,138
174183761,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,17
174183761,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,17
174183761,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,17
174183761,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,17
174183761,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,17
174183761,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,17
174184691,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Pulmonary embolism,1,M,HO,25
174185143,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Alanine aminotransferase increased,6,M,HO,12
174185143,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Alanine aminotransferase increased,6,M,OT,12
174185143,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Anaemia,6,M,HO,12
174185143,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Anaemia,6,M,OT,12
174185143,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Hypophosphataemia,6,M,HO,12
174185143,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Hypophosphataemia,6,M,OT,12
174185143,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Leukopenia,6,M,HO,12
174185143,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Leukopenia,6,M,OT,12
174185143,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Neutropenia,6,M,HO,12
174185143,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Neutropenia,6,M,OT,12
174185143,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Neutropenic sepsis,6,M,HO,12
174185143,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Neutropenic sepsis,6,M,OT,12
174185143,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Thrombocytopenia,6,M,HO,12
174185143,6,Plasma cell myeloma,3,F,EXP,pomalidomide,6,SS,Thrombocytopenia,6,M,OT,12
174185971,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Inappropriate antidiuretic hormone secretion,1,M,HO,2
174186131,9,B-cell type acute leukaemia,1,I,EXP,pegaspargase,9,SS,Abdominal pain,9,M,HO,13
174186131,9,B-cell type acute leukaemia,1,I,EXP,pegaspargase,9,SS,Colitis,9,M,HO,13
174186131,9,B-cell type acute leukaemia,1,I,EXP,pegaspargase,9,SS,Diarrhoea,9,M,HO,13
174186131,9,B-cell type acute leukaemia,1,I,EXP,pegaspargase,9,SS,Neutropenia,9,M,HO,13
174186131,9,B-cell type acute leukaemia,1,I,EXP,pegaspargase,9,SS,Oxygen saturation decreased,9,M,HO,13
174186131,9,B-cell type acute leukaemia,1,I,EXP,pegaspargase,9,SS,Pyrexia,9,M,HO,13
174186541,1,Chronic lymphocytic leukaemia,1,I,EXP,lenalidomide,1,SS,Basal cell carcinoma,1,M,OT,1422
174186541,3,Chronic lymphocytic leukaemia,1,I,EXP,chlorambucil,3,SS,Basal cell carcinoma,3,M,OT,1450
174186573,2,Chronic lymphocytic leukaemia,3,F,EXP,lenalidomide,2,SS,Basal cell carcinoma,2,M,OT,1323
174186573,2,Chronic lymphocytic leukaemia,3,F,EXP,lenalidomide,2,SS,Metastasis,2,M,OT,1323
174186573,3,Chronic lymphocytic leukaemia,3,F,EXP,chlorambucil,3,SS,Basal cell carcinoma,3,M,OT,1351
174186573,3,Chronic lymphocytic leukaemia,3,F,EXP,chlorambucil,3,SS,Metastasis,3,M,OT,1351
174187022,3,Rectal adenocarcinoma,2,F,EXP,avelumab,3,SS,Scrotal swelling,3,M,HO,68
174187152,1,Glioblastoma,2,F,EXP,ipilimumab,1,PS,Presyncope,1,M,HO,97
174187152,2,Product used for unknown indication,2,F,EXP,ipilimumab,2,SS,Presyncope,2,M,HO,22
174189351,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Skin lesion,1,M,OT,20
174189781,2,Breast cancer metastatic,1,I,PER,palbociclib,2,SS,Febrile neutropenia,2,F,HO,14
174189781,2,Breast cancer metastatic,1,I,PER,palbociclib,2,SS,Rash,2,F,HO,14
174189962,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Autoimmune neutropenia,1,M,OT,402
174189962,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Intentional product use issue,1,M,OT,402
174189962,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Mucosal ulceration,1,M,OT,402
174189962,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Non-small cell lung cancer recurrent,1,M,OT,402
174190791,6,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,6,SS,Febrile neutropenia,6,M,HO,7
174190791,6,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,6,SS,Febrile neutropenia,6,M,OT,7
174190881,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Abdominal pain lower,1,F,DE,1
174190881,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Flank pain,1,F,DE,1
174190881,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hydronephrosis,1,F,DE,1
174190881,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Nephrolithiasis,1,F,DE,1
174190881,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Pallor,1,F,DE,1
174190881,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Pyrexia,1,F,DE,1
174190881,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Sepsis,1,F,DE,1
174190881,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Somnolence,1,F,DE,1
174190881,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Tachycardia,1,F,DE,1
174190881,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Urinary tract obstruction,1,F,DE,1
174190881,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Vomiting,1,F,DE,1
174193791,1,Transitional cell cancer of the renal pelvis and ureter,1,I,EXP,nivolumab,1,PS,Hypotension,1,M,HO,2
174193802,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,F,DE,291
174193802,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,F,OT,291
174193802,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,F,HO,291
174193802,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Pneumonia,2,F,DE,276
174193802,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Pneumonia,2,F,OT,276
174193802,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Pneumonia,2,F,HO,276
174193802,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pneumonia,3,F,DE,262
174193802,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pneumonia,3,F,OT,262
174193802,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pneumonia,3,F,HO,262
174193802,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Pneumonia,4,F,DE,241
174193802,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Pneumonia,4,F,OT,241
174193802,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Pneumonia,4,F,HO,241
174193802,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Pneumonia,5,F,DE,227
174193802,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Pneumonia,5,F,OT,227
174193802,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Pneumonia,5,F,HO,227
174193802,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Pneumonia,6,F,DE,171
174193802,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Pneumonia,6,F,OT,171
174193802,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Pneumonia,6,F,HO,171
174193802,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Pneumonia,7,F,DE,143
174193802,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Pneumonia,7,F,OT,143
174193802,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Pneumonia,7,F,HO,143
174193802,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Pneumonia,8,F,DE,115
174193802,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Pneumonia,8,F,OT,115
174193802,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Pneumonia,8,F,HO,115
174193802,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Pneumonia,9,F,DE,87
174193802,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Pneumonia,9,F,OT,87
174193802,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Pneumonia,9,F,HO,87
174193802,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Pneumonia,10,F,DE,59
174193802,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Pneumonia,10,F,OT,59
174193802,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Pneumonia,10,F,HO,59
174193802,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Pneumonia,11,F,DE,24
174193802,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Pneumonia,11,F,OT,24
174193802,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Pneumonia,11,F,HO,24
174194461,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Death,1,M,DE,75
174196421,5,B precursor type acute leukaemia,1,I,EXP,pegaspargase,5,SS,Body temperature abnormal,5,M,HO,217
174196421,5,B precursor type acute leukaemia,1,I,EXP,pegaspargase,5,SS,Fatigue,5,M,HO,217
174196421,5,B precursor type acute leukaemia,1,I,EXP,pegaspargase,5,SS,Febrile neutropenia,5,M,HO,217
174196421,5,B precursor type acute leukaemia,1,I,EXP,pegaspargase,5,SS,Hypertension,5,M,HO,217
174196421,5,B precursor type acute leukaemia,1,I,EXP,pegaspargase,5,SS,Nausea,5,M,HO,217
174196421,5,B precursor type acute leukaemia,1,I,EXP,pegaspargase,5,SS,Pancytopenia,5,M,HO,217
174196421,5,B precursor type acute leukaemia,1,I,EXP,pegaspargase,5,SS,Tachycardia,5,M,HO,217
174197642,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Lower respiratory tract infection bacterial,1,M,HO,31
174198791,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Acute kidney injury,1,F,OT,21
174198791,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Acute kidney injury,1,F,HO,21
174198791,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Colitis,1,F,OT,21
174198791,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Colitis,1,F,HO,21
174202891,19,Plasma cell myeloma,1,I,PER,daratumumab,19,SS,Fall,19,M,HO,725
174202891,23,Plasma cell myeloma,1,I,PER,carfilzomib,23,SS,Fall,23,M,HO,2261
174204581,1,Leukaemia,1,I,EXP,midostaurin,1,PS,Pneumonitis,1,F,OT,9
174204581,1,Leukaemia,1,I,EXP,midostaurin,1,PS,Pneumonitis,1,F,HO,9
174204581,1,Leukaemia,1,I,EXP,midostaurin,1,PS,Sepsis,1,F,OT,9
174204581,1,Leukaemia,1,I,EXP,midostaurin,1,PS,Sepsis,1,F,HO,9
174205431,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Osteonecrosis of jaw,1,F,DS,607
174206011,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Pathological fracture,1,M,OT,3418
174211361,1,Acute lymphocytic leukaemia,1,I,PER,blinatumomab,1,PS,Loss of consciousness,1,M,LT,2
174211361,1,Acute lymphocytic leukaemia,1,I,PER,blinatumomab,1,PS,Loss of consciousness,1,M,OT,2
174212201,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Hyperpyrexia,1,M,OT,49
174212201,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Hyperpyrexia,1,M,HO,49
174212201,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,49
174212201,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,49
174212201,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,49
174212201,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Respiratory failure,1,M,HO,49
174212992,1,Breast cancer,2,F,EXP,palbociclib,1,PS,Ischaemic stroke,1,F,HO,500
174212992,9,Prophylaxis,2,F,EXP,zoledronic acid,9,C,Ischaemic stroke,9,F,HO,360
174214023,1,Oesophageal squamous cell carcinoma,3,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,133
174214023,1,Oesophageal squamous cell carcinoma,3,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,133
174214023,1,Oesophageal squamous cell carcinoma,3,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,DE,133
174214023,1,Oesophageal squamous cell carcinoma,3,F,EXP,nivolumab,1,PS,Respiratory tract infection,1,M,HO,133
174214023,1,Oesophageal squamous cell carcinoma,3,F,EXP,nivolumab,1,PS,Respiratory tract infection,1,M,OT,133
174214023,1,Oesophageal squamous cell carcinoma,3,F,EXP,nivolumab,1,PS,Respiratory tract infection,1,M,DE,133
174214061,10,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,10,SS,Febrile neutropenia,10,M,HO,6
174214061,10,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,10,SS,Herpes simplex,10,M,HO,6
174214061,10,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,10,SS,Staphylococcal infection,10,M,HO,6
174220372,8,Product used for unknown indication,2,F,EXP,zoledronic acid,8,C,Mastitis,8,F,HO,191
174221282,1,Chronic lymphocytic leukaemia,2,F,EXP,idelalisib,1,PS,Diarrhoea,1,F,HO,153
174221282,1,Chronic lymphocytic leukaemia,2,F,EXP,idelalisib,1,PS,Infection reactivation,1,F,HO,153
174222961,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Hypertransaminasaemia,2,M,OT,34
174222961,3,Renal cell carcinoma,1,I,EXP,nivolumab,3,SS,Hypertransaminasaemia,3,M,OT,34
174224711,4,Adenocarcinoma of colon,1,I,EXP,panitumumab,4,SS,Peritonitis,4,F,HO,15
174224711,4,Adenocarcinoma of colon,1,I,EXP,panitumumab,4,SS,Peritonitis,4,F,LT,15
174224711,4,Adenocarcinoma of colon,1,I,EXP,panitumumab,4,SS,Peritonitis,4,F,OT,15
174224711,4,Adenocarcinoma of colon,1,I,EXP,panitumumab,4,SS,Rash,4,F,HO,15
174224711,4,Adenocarcinoma of colon,1,I,EXP,panitumumab,4,SS,Rash,4,F,LT,15
174224711,4,Adenocarcinoma of colon,1,I,EXP,panitumumab,4,SS,Rash,4,F,OT,15
174224711,4,Adenocarcinoma of colon,1,I,EXP,panitumumab,4,SS,Rectal perforation,4,F,HO,15
174224711,4,Adenocarcinoma of colon,1,I,EXP,panitumumab,4,SS,Rectal perforation,4,F,LT,15
174224711,4,Adenocarcinoma of colon,1,I,EXP,panitumumab,4,SS,Rectal perforation,4,F,OT,15
174225262,3,Breast cancer metastatic,2,F,EXP,palbociclib,3,SS,Arthritis,3,F,HO,63
174228041,25,Prophylaxis,1,I,EXP,granisetron,25,C,Subcutaneous abscess,25,M,OT,32
174229382,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,467
174229382,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Influenza A virus test positive,1,M,HO,467
174229482,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Failure to thrive,1,F,HO,134
174229482,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Failure to thrive,1,F,OT,134
174229482,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Feeding disorder,1,F,HO,134
174229482,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Feeding disorder,1,F,OT,134
174229482,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Nausea,1,F,HO,134
174229482,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Nausea,1,F,OT,134
174229482,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Refeeding syndrome,1,F,HO,134
174229482,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Refeeding syndrome,1,F,OT,134
174229482,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Vomiting,1,F,HO,134
174229482,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Vomiting,1,F,OT,134
174229482,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Weight decreased,1,F,HO,134
174229482,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Weight decreased,1,F,OT,134
174233471,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Cholecystectomy,1,M,HO,913
174236011,1,Lymphoproliferative disorder,1,I,EXP,ibrutinib,1,PS,Off label use,1,M,HO,94
174236011,1,Lymphoproliferative disorder,1,I,EXP,ibrutinib,1,PS,Product use in unapproved indication,1,M,HO,94
174236011,1,Lymphoproliferative disorder,1,I,EXP,ibrutinib,1,PS,Rectal haemorrhage,1,M,HO,94
174241931,3,Prophylaxis,1,I,EXP,denosumab,3,C,Tumour lysis syndrome,3,F,DE,10
174242872,1,Sarcoma,2,F,EXP,nivolumab,1,PS,Leukopenia,1,F,OT,7
174242872,1,Sarcoma,2,F,EXP,nivolumab,1,PS,Leukopenia,1,F,HO,7
174242872,1,Sarcoma,2,F,EXP,nivolumab,1,PS,Pyrexia,1,F,OT,7
174242872,1,Sarcoma,2,F,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,7
174242872,1,Sarcoma,2,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,OT,7
174242872,1,Sarcoma,2,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,HO,7
174243022,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,PS,Gastritis,2,F,HO,105
174244711,1,Diffuse large B-cell lymphoma,1,I,EXP,selinexor,1,PS,Febrile neutropenia,1,M,HO,23
174248102,1,Glioblastoma,2,F,EXP,nivolumab,1,PS,Corona virus infection,1,F,OT,91
174248102,1,Glioblastoma,2,F,EXP,nivolumab,1,PS,Corona virus infection,1,F,HO,91
174248283,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Facial paralysis,1,M,OT,94
174248283,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Facial paralysis,2,M,OT,94
174249761,4,Nausea,1,I,EXP,granisetron,4,C,Anaemia,4,M,HO,14
174249761,4,Nausea,1,I,EXP,granisetron,4,C,Anaemia,4,M,DE,14
174249761,4,Nausea,1,I,EXP,granisetron,4,C,General physical health deterioration,4,M,HO,14
174249761,4,Nausea,1,I,EXP,granisetron,4,C,General physical health deterioration,4,M,DE,14
174249761,4,Nausea,1,I,EXP,granisetron,4,C,Leukopenia,4,M,HO,14
174249761,4,Nausea,1,I,EXP,granisetron,4,C,Leukopenia,4,M,DE,14
174249761,4,Nausea,1,I,EXP,granisetron,4,C,Pneumonia,4,M,HO,14
174249761,4,Nausea,1,I,EXP,granisetron,4,C,Pneumonia,4,M,DE,14
174249761,4,Nausea,1,I,EXP,granisetron,4,C,Pulmonary toxicity,4,M,HO,14
174249761,4,Nausea,1,I,EXP,granisetron,4,C,Pulmonary toxicity,4,M,DE,14
174249761,4,Nausea,1,I,EXP,granisetron,4,C,Sepsis,4,M,HO,14
174249761,4,Nausea,1,I,EXP,granisetron,4,C,Sepsis,4,M,DE,14
174254981,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Dermatitis allergic,2,M,OT,74
174254981,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Dermatitis allergic,2,M,HO,74
174254981,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Hepatitis E,2,M,OT,74
174254981,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Hepatitis E,2,M,HO,74
174255561,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Bile duct stenosis,1,M,HO,3
174255561,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Leukocytosis,1,M,HO,3
174255561,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutrophilia,1,M,HO,3
174255852,1,Neuroendocrine carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Oesophageal haemorrhage,1,M,OT,9
174255852,1,Neuroendocrine carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Oesophageal haemorrhage,1,M,HO,9
174255852,1,Neuroendocrine carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Oesophageal haemorrhage,1,M,DE,9
174255852,1,Neuroendocrine carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Oesophagitis,1,M,OT,9
174255852,1,Neuroendocrine carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Oesophagitis,1,M,HO,9
174255852,1,Neuroendocrine carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Oesophagitis,1,M,DE,9
174255852,1,Neuroendocrine carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,9
174255852,1,Neuroendocrine carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,9
174255852,1,Neuroendocrine carcinoma metastatic,2,F,EXP,nivolumab,1,PS,Sepsis,1,M,DE,9
174255981,2,Renal cancer stage IV,1,I,EXP,axitinib,2,C,Hepatotoxicity,2,F,HO,62
174257432,1,Breast cancer,2,F,EXP,palbociclib,1,PS,Bronchitis,1,F,HO,249
174257641,1,Gallbladder cancer,1,I,EXP,nivolumab,1,SS,Hypercalcaemia,1,F,HO,162
174257641,2,Gallbladder cancer,1,I,EXP,ipilimumab,2,PS,Hypercalcaemia,2,F,HO,162
174260642,2,Prostate cancer metastatic,2,F,EXP,cabazitaxel,2,SS,Myocardial infarction,2,M,HO,2
174262501,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Drug reaction with eosinophilia and systemic symptoms,5,F,HO,7
174265201,4,Malignant melanoma,1,I,EXP,nivolumab,4,SS,Abdominal pain,4,M,HO,129
174265201,4,Malignant melanoma,1,I,EXP,nivolumab,4,SS,Back pain,4,M,HO,129
174266401,1,Non-Hodgkin's lymphoma,1,I,EXP,nivolumab,1,PS,Hypersensitivity,1,F,HO,14
174266401,5,Non-Hodgkin's lymphoma,1,I,EXP,pegfilgrastim,5,SS,Hypersensitivity,5,F,HO,12
174270731,1,Lung adenocarcinoma,1,I,EXP,nivolumab,1,PS,Anuria,1,M,OT,17
174270731,1,Lung adenocarcinoma,1,I,EXP,nivolumab,1,PS,Anuria,1,M,DS,17
174270731,1,Lung adenocarcinoma,1,I,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,OT,17
174270731,1,Lung adenocarcinoma,1,I,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,DS,17
174270731,1,Lung adenocarcinoma,1,I,EXP,nivolumab,1,PS,Kidney transplant rejection,1,M,OT,17
174270731,1,Lung adenocarcinoma,1,I,EXP,nivolumab,1,PS,Kidney transplant rejection,1,M,DS,17
174272761,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Cholangitis,1,F,OT,97
174272761,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Cholangitis,1,F,HO,97
174272761,2,Product used for unknown indication,1,I,EXP,ipilimumab,2,SS,Cholangitis,2,F,OT,97
174272761,2,Product used for unknown indication,1,I,EXP,ipilimumab,2,SS,Cholangitis,2,F,HO,97
174275971,1,Familial haemophagocytic lymphohistiocytosis,1,I,EXP,alemtuzumab,1,PS,Lung disorder,1,M,LT,63
174275971,1,Familial haemophagocytic lymphohistiocytosis,1,I,EXP,alemtuzumab,1,PS,Lung disorder,1,M,DE,63
174275971,1,Familial haemophagocytic lymphohistiocytosis,1,I,EXP,alemtuzumab,1,PS,Pulmonary alveolar haemorrhage,1,M,LT,63
174275971,1,Familial haemophagocytic lymphohistiocytosis,1,I,EXP,alemtuzumab,1,PS,Pulmonary alveolar haemorrhage,1,M,DE,63
174276101,1,Colorectal cancer metastatic,1,I,PER,panitumumab,1,PS,Neutropenia,1,M,DE,54
174276101,1,Colorectal cancer metastatic,1,I,PER,panitumumab,1,PS,Neutropenia,1,M,OT,54
174279631,2,Prostate cancer,1,I,EXP,cabazitaxel,2,SS,Loss of consciousness,2,M,HO,67
174279901,1,Colony stimulating factor therapy,1,I,PER,pegfilgrastim,1,PS,Back pain,1,M,OT,54
174279901,1,Colony stimulating factor therapy,1,I,PER,pegfilgrastim,1,PS,Febrile neutropenia,1,M,OT,54
174279901,1,Colony stimulating factor therapy,1,I,PER,pegfilgrastim,1,PS,Neuropathy peripheral,1,M,OT,54
174281601,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,205
174281601,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,205
174281601,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Death,2,M,DE,173
174281601,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Death,2,M,OT,173
174284831,1,Kaposi's sarcoma,1,I,EXP,nivolumab,1,PS,Dizziness,1,M,HO,73
174284831,1,Kaposi's sarcoma,1,I,EXP,nivolumab,1,PS,Hand fracture,1,M,HO,73
174284831,2,Kaposi's sarcoma,1,I,EXP,ipilimumab,2,SS,Dizziness,2,M,HO,73
174284831,2,Kaposi's sarcoma,1,I,EXP,ipilimumab,2,SS,Hand fracture,2,M,HO,73
174285601,2,Prostate cancer,1,I,EXP,enzalutamide,2,SS,Angina pectoris,2,M,HO,631
174286532,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,53
174286532,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,53
174286532,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Pneumonia,2,M,OT,39
174286532,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Pneumonia,2,M,HO,39
174286532,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pneumonia,3,M,OT,18
174286532,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pneumonia,3,M,HO,18
174286611,1,Lymphoma,1,I,EXP,ibrutinib,1,PS,Subdural haemorrhage,1,M,LT,39
174286611,1,Lymphoma,1,I,EXP,ibrutinib,1,PS,Subdural haemorrhage,1,M,OT,39
174289851,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Haemorrhage intracranial,1,M,HO,507
174289851,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Haemorrhage intracranial,1,M,LT,507
174291871,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Vomiting,1,F,HO,199
174293812,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Bronchitis,1,F,HO,52
174293812,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Dyspnoea,1,F,HO,52
174295472,1,Hepatoblastoma,2,F,EXP,palbociclib,1,PS,Febrile neutropenia,1,F,LT,15
174295472,1,Hepatoblastoma,2,F,EXP,palbociclib,1,PS,Febrile neutropenia,1,F,HO,15
174295472,1,Hepatoblastoma,2,F,EXP,palbociclib,1,PS,Hypotension,1,F,LT,15
174295472,1,Hepatoblastoma,2,F,EXP,palbociclib,1,PS,Hypotension,1,F,HO,15
174295641,3,Breast cancer,1,I,PER,palbociclib,3,SS,Nausea,3,F,HO,220
174295641,3,Breast cancer,1,I,PER,palbociclib,3,SS,Vomiting,3,F,HO,220
174297621,1,Head and neck cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,173
174297621,1,Head and neck cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,173
174297621,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Death,2,M,DE,173
174297621,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Death,2,M,OT,173
174306941,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Abdominal pain,1,M,DE,3
174306941,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Abdominal pain,1,M,OT,3
174306941,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Death,1,M,DE,3
174306941,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Death,1,M,OT,3
174306941,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Oedema peripheral,1,M,DE,3
174306941,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Oedema peripheral,1,M,OT,3
174306941,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Penile oedema,1,M,DE,3
174306941,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Penile oedema,1,M,OT,3
174308341,1,B-cell small lymphocytic lymphoma,1,I,EXP,idelalisib,1,PS,Death,1,M,OT,370
174308341,1,B-cell small lymphocytic lymphoma,1,I,EXP,idelalisib,1,PS,Death,1,M,DE,370
174308652,1,Non-small cell lung cancer,2,F,EXP,lorlatinib,1,PS,Hepatic function abnormal,1,F,OT,15
174308652,1,Non-small cell lung cancer,2,F,EXP,lorlatinib,1,PS,Hepatic function abnormal,1,F,HO,15
174308652,1,Non-small cell lung cancer,2,F,EXP,lorlatinib,1,PS,Hepatic function abnormal,1,F,DE,15
174309762,1,Endometrial cancer,2,F,EXP,avelumab,1,PS,Myositis,1,F,DE,62
174309762,1,Endometrial cancer,2,F,EXP,avelumab,1,PS,Myositis,1,F,HO,62
174311871,1,Acute lymphocytic leukaemia,1,I,PER,blinatumomab,1,PS,Neutropenic sepsis,1,F,LT,15
174312521,1,Mantle cell lymphoma,1,I,EXP,ibrutinib,1,PS,Atrial fibrillation,1,M,HO,174
174312521,1,Mantle cell lymphoma,1,I,EXP,ibrutinib,1,PS,Chest pain,1,M,HO,174
174312521,1,Mantle cell lymphoma,1,I,EXP,ibrutinib,1,PS,Cough,1,M,HO,174
174312521,1,Mantle cell lymphoma,1,I,EXP,ibrutinib,1,PS,Dyspnoea,1,M,HO,174
174312521,1,Mantle cell lymphoma,1,I,EXP,ibrutinib,1,PS,Pleuritic pain,1,M,HO,174
174312521,1,Mantle cell lymphoma,1,I,EXP,ibrutinib,1,PS,Pneumonia,1,M,HO,174
174313071,1,Acute lymphocytic leukaemia,1,I,PER,blinatumomab,1,PS,Neutropenic sepsis,1,F,LT,8
174314531,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Febrile neutropenia,1,M,HO,115
174314531,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Hypotension,1,M,HO,115
174314531,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Soft tissue infection,1,M,HO,115
174314531,5,Hodgkin's disease,1,I,EXP,pegfilgrastim,5,SS,Febrile neutropenia,5,M,HO,115
174314531,5,Hodgkin's disease,1,I,EXP,pegfilgrastim,5,SS,Hypotension,5,M,HO,115
174314531,5,Hodgkin's disease,1,I,EXP,pegfilgrastim,5,SS,Soft tissue infection,5,M,HO,115
174315082,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Skin lesion,1,M,OT,2455
174315783,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Cholestasis,2,M,HO,1
174315783,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Hepatocellular injury,2,M,HO,1
174315783,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Liver function test abnormal,2,M,HO,1
174315783,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Prothrombin time shortened,2,M,HO,1
174315783,3,Plasma cell myeloma,3,F,EXP,daratumumab,3,SS,Cholestasis,3,M,HO,1
174315783,3,Plasma cell myeloma,3,F,EXP,daratumumab,3,SS,Hepatocellular injury,3,M,HO,1
174315783,3,Plasma cell myeloma,3,F,EXP,daratumumab,3,SS,Liver function test abnormal,3,M,HO,1
174315783,3,Plasma cell myeloma,3,F,EXP,daratumumab,3,SS,Prothrombin time shortened,3,M,HO,1
174317951,1,Plasma cell myeloma,1,I,EXP,thalidomide,1,PS,Infusion related reaction,1,F,HO,21
174319111,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Colitis,9,M,HO,316
174319262,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,58
174319262,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Sepsis,1,M,DE,58
174319651,1,Acute lymphocytic leukaemia,1,I,PER,blinatumomab,1,PS,Neutropenic sepsis,1,F,LT,20
174321002,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,51
174321002,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,51
174321002,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Altered state of consciousness,1,M,HO,51
174321002,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Altered state of consciousness,1,M,OT,51
174321002,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Haemorrhage,1,M,HO,51
174321002,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Haemorrhage,1,M,OT,51
174321002,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Metastases to central nervous system,1,M,HO,51
174321002,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Metastases to central nervous system,1,M,OT,51
174321002,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Paralysis,1,M,HO,51
174321002,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Paralysis,1,M,OT,51
174321002,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Adrenal insufficiency,2,M,HO,27
174321002,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Adrenal insufficiency,2,M,OT,27
174321002,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Altered state of consciousness,2,M,HO,27
174321002,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Altered state of consciousness,2,M,OT,27
174321002,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Haemorrhage,2,M,HO,27
174321002,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Haemorrhage,2,M,OT,27
174321002,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Metastases to central nervous system,2,M,HO,27
174321002,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Metastases to central nervous system,2,M,OT,27
174321002,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Paralysis,2,M,HO,27
174321002,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Paralysis,2,M,OT,27
174321002,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Adrenal insufficiency,3,M,HO,51
174321002,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Adrenal insufficiency,3,M,OT,51
174321002,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Altered state of consciousness,3,M,HO,51
174321002,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Altered state of consciousness,3,M,OT,51
174321002,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Haemorrhage,3,M,HO,51
174321002,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Haemorrhage,3,M,OT,51
174321002,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Metastases to central nervous system,3,M,HO,51
174321002,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Metastases to central nervous system,3,M,OT,51
174321002,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Paralysis,3,M,HO,51
174321002,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Paralysis,3,M,OT,51
174321002,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Adrenal insufficiency,4,M,HO,27
174321002,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Adrenal insufficiency,4,M,OT,27
174321002,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Altered state of consciousness,4,M,HO,27
174321002,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Altered state of consciousness,4,M,OT,27
174321002,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Haemorrhage,4,M,HO,27
174321002,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Haemorrhage,4,M,OT,27
174321002,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Metastases to central nervous system,4,M,HO,27
174321002,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Metastases to central nervous system,4,M,OT,27
174321002,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Paralysis,4,M,HO,27
174321002,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Paralysis,4,M,OT,27
174324373,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,144
174324373,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Influenza like illness,1,F,HO,144
174324373,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Diarrhoea,2,F,HO,144
174324373,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Influenza like illness,2,F,HO,144
174324402,2,Renal cell carcinoma,2,F,EXP,nivolumab,2,PS,Anaemia,2,M,HO,7
174324451,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Basal cell carcinoma,2,M,OT,1391
174325192,1,Glioblastoma,2,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,88
174325192,1,Glioblastoma,2,F,EXP,nivolumab,1,PS,Fall,1,M,HO,88
174325192,1,Glioblastoma,2,F,EXP,nivolumab,1,PS,Performance status decreased,1,M,HO,88
174325461,21,Plasma cell myeloma,1,I,PER,selinexor,21,SS,Syncope,21,M,HO,15
174325461,24,Plasma cell myeloma,1,I,PER,carfilzomib,24,SS,Syncope,24,M,HO,2465
174325461,28,Plasma cell myeloma,1,I,PER,daratumumab,28,SS,Syncope,28,M,HO,1024
174327922,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Osteonecrosis of jaw,2,F,HO,374
174327922,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Osteonecrosis of jaw,2,F,OT,374
174330034,3,Renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Mucosal inflammation,3,M,HO,90
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,M,OT,22
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,M,HO,22
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Cardio-respiratory arrest,1,M,DE,22
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,22
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,22
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,22
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pleural effusion,1,M,OT,22
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pleural effusion,1,M,HO,22
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pleural effusion,1,M,DE,22
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Respiratory tract infection,1,M,OT,22
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Respiratory tract infection,1,M,HO,22
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Respiratory tract infection,1,M,DE,22
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Supraventricular tachycardia,1,M,OT,22
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Supraventricular tachycardia,1,M,HO,22
174330051,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Supraventricular tachycardia,1,M,DE,22
174331511,1,Squamous cell carcinoma,1,I,EXP,nivolumab,1,PS,Respiratory distress,1,F,HO,184
174331511,1,Squamous cell carcinoma,1,I,EXP,nivolumab,1,PS,Respiratory distress,1,F,OT,184
174331641,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Hyperthyroidism,1,M,HO,35
174331641,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Hyperthyroidism,1,M,OT,35
174331641,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Neutrophil count decreased,1,M,HO,35
174331641,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Neutrophil count decreased,1,M,OT,35
174331641,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Hyperthyroidism,2,M,HO,35
174331641,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Hyperthyroidism,2,M,OT,35
174331641,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Neutrophil count decreased,2,M,HO,35
174331641,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Neutrophil count decreased,2,M,OT,35
174336533,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Gastritis,1,F,OT,3
174336533,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Glucose urine present,1,F,OT,3
174336533,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,OT,3
174336533,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Protein urine present,1,F,OT,3
174336533,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Rash,1,F,OT,3
174336533,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Red blood cell sedimentation rate increased,1,F,OT,3
174336533,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Respiratory distress,1,F,OT,3
174336533,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Throat irritation,1,F,OT,3
174336533,1,Multiple sclerosis,3,F,EXP,alemtuzumab,1,PS,Urine ketone body present,1,F,OT,3
174336703,1,Plasma cell myeloma,3,F,EXP,selinexor,1,PS,Thrombocytopenia,1,M,HO,45
174336703,1,Plasma cell myeloma,3,F,EXP,selinexor,1,PS,Upper respiratory tract infection,1,M,HO,45
174338183,1,Plasma cell myeloma,3,F,EXP,selinexor,1,PS,Hyponatraemia,1,M,HO,45
174348131,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Death,1,M,OT,309
174348131,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Death,1,M,DE,309
174349201,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Breast discharge,1,F,HO,8
174349201,1,Neutropenia,1,I,EXP,pegfilgrastim,1,PS,Breast swelling,1,F,HO,8
174350562,3,Breast cancer metastatic,2,F,EXP,nivolumab,3,SS,Encephalopathy,3,F,HO,65
174350781,2,Renal cell carcinoma,1,I,EXP,axitinib,2,SS,Cellulitis,2,M,OT,126
174350781,2,Renal cell carcinoma,1,I,EXP,axitinib,2,SS,Cellulitis,2,M,DE,126
174350781,2,Renal cell carcinoma,1,I,EXP,axitinib,2,SS,Death,2,M,OT,126
174350781,2,Renal cell carcinoma,1,I,EXP,axitinib,2,SS,Death,2,M,DE,126
174350781,2,Renal cell carcinoma,1,I,EXP,axitinib,2,SS,Pain,2,M,OT,126
174350781,2,Renal cell carcinoma,1,I,EXP,axitinib,2,SS,Pain,2,M,DE,126
174351801,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Pulmonary sepsis,3,M,HO,238
174351801,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Pulmonary sepsis,3,M,OT,238
174352773,1,Non-small cell lung cancer,3,F,EXP,trametinib,1,PS,Pneumonia,1,M,HO,38
174352773,1,Non-small cell lung cancer,3,F,EXP,trametinib,1,PS,Pulmonary embolism,1,M,HO,38
174352823,10,Prophylaxis,3,F,EXP,denosumab,10,C,Cough,10,M,OT,502
174352823,10,Prophylaxis,3,F,EXP,denosumab,10,C,Cough,10,M,HO,502
174352823,10,Prophylaxis,3,F,EXP,denosumab,10,C,Fibrin D dimer increased,10,M,OT,502
174352823,10,Prophylaxis,3,F,EXP,denosumab,10,C,Fibrin D dimer increased,10,M,HO,502
174352823,10,Prophylaxis,3,F,EXP,denosumab,10,C,Hypoxia,10,M,OT,502
174352823,10,Prophylaxis,3,F,EXP,denosumab,10,C,Hypoxia,10,M,HO,502
174352823,10,Prophylaxis,3,F,EXP,denosumab,10,C,Pneumonitis,10,M,OT,502
174352823,10,Prophylaxis,3,F,EXP,denosumab,10,C,Pneumonitis,10,M,HO,502
174352823,10,Prophylaxis,3,F,EXP,denosumab,10,C,Pulmonary mass,10,M,OT,502
174352823,10,Prophylaxis,3,F,EXP,denosumab,10,C,Pulmonary mass,10,M,HO,502
174358901,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Febrile neutropenia,1,F,HO,51
174360341,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Bone pain,1,M,OT,1
174360341,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Dyspnoea,1,M,OT,1
174360341,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hypotension,1,M,OT,1
174360341,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hypoxia,1,M,OT,1
174360341,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Myalgia,1,M,OT,1
174360341,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Nausea,1,M,OT,1
174360341,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Pyrexia,1,M,OT,1
174360341,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Vomiting,1,M,OT,1
174360593,1,Plasma cell myeloma,3,F,EXP,selinexor,1,PS,Mouth ulceration,1,M,HO,19
174361261,4,Acute graft versus host disease,1,I,EXP,ruxolitinib phosphate,4,C,Encephalitis viral,4,M,OT,48
174361261,4,Acute graft versus host disease,1,I,EXP,ruxolitinib phosphate,4,C,Encephalitis viral,4,M,DE,48
174361261,4,Acute graft versus host disease,1,I,EXP,ruxolitinib phosphate,4,C,Post transplant lymphoproliferative disorder,4,M,OT,48
174361261,4,Acute graft versus host disease,1,I,EXP,ruxolitinib phosphate,4,C,Post transplant lymphoproliferative disorder,4,M,DE,48
174371883,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Myocardial infarction,1,M,OT,3
174371883,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Myocardial infarction,1,M,HO,3
174371883,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Myocardial infarction,1,M,LT,3
174371883,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Syncope,1,M,OT,3
174371883,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Syncope,1,M,HO,3
174371883,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Syncope,1,M,LT,3
174371883,2,Plasma cell myeloma,3,F,PER,lenalidomide,2,SS,Myocardial infarction,2,M,OT,3
174371883,2,Plasma cell myeloma,3,F,PER,lenalidomide,2,SS,Myocardial infarction,2,M,HO,3
174371883,2,Plasma cell myeloma,3,F,PER,lenalidomide,2,SS,Myocardial infarction,2,M,LT,3
174371883,2,Plasma cell myeloma,3,F,PER,lenalidomide,2,SS,Syncope,2,M,OT,3
174371883,2,Plasma cell myeloma,3,F,PER,lenalidomide,2,SS,Syncope,2,M,HO,3
174371883,2,Plasma cell myeloma,3,F,PER,lenalidomide,2,SS,Syncope,2,M,LT,3
174372531,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Bacteraemia,1,M,HO,26
174372531,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Clostridium difficile infection,1,M,HO,26
174372531,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Febrile neutropenia,1,M,HO,26
174372531,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Gastroenteritis salmonella,1,M,HO,26
174372531,5,Prophylaxis,1,I,EXP,pegfilgrastim,5,SS,Bacteraemia,5,M,HO,26
174372531,5,Prophylaxis,1,I,EXP,pegfilgrastim,5,SS,Clostridium difficile infection,5,M,HO,26
174372531,5,Prophylaxis,1,I,EXP,pegfilgrastim,5,SS,Febrile neutropenia,5,M,HO,26
174372531,5,Prophylaxis,1,I,EXP,pegfilgrastim,5,SS,Gastroenteritis salmonella,5,M,HO,26
174372732,1,Prostate cancer metastatic,2,F,EXP,apalutamide,1,PS,Urticaria,1,M,HO,10
174373101,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,PS,Hypertransaminasaemia,2,M,OT,34
174373101,3,Renal cell carcinoma,1,I,EXP,nivolumab,3,SS,Hypertransaminasaemia,3,M,OT,34
174373113,1,Ovarian cancer,3,F,EXP,trabectedin,1,PS,Haemorrhage intracranial,1,F,HO,129
174373113,3,Neutropenia,3,F,EXP,filgrastim,3,C,Haemorrhage intracranial,3,F,HO,7
174375151,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Anaemia,1,M,LT,43
174375151,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Anaemia,1,M,HO,43
174375151,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Anaemia,1,M,OT,43
174375151,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Hypotension,1,M,LT,43
174375151,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Hypotension,1,M,HO,43
174375151,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Hypotension,1,M,OT,43
174375151,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Melaena,1,M,LT,43
174375151,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Melaena,1,M,HO,43
174375151,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Melaena,1,M,OT,43
174375151,2,Non-small cell lung cancer metastatic,1,I,EXP,ipilimumab,2,SS,Anaemia,2,M,LT,43
174375151,2,Non-small cell lung cancer metastatic,1,I,EXP,ipilimumab,2,SS,Anaemia,2,M,HO,43
174375151,2,Non-small cell lung cancer metastatic,1,I,EXP,ipilimumab,2,SS,Anaemia,2,M,OT,43
174375151,2,Non-small cell lung cancer metastatic,1,I,EXP,ipilimumab,2,SS,Hypotension,2,M,LT,43
174375151,2,Non-small cell lung cancer metastatic,1,I,EXP,ipilimumab,2,SS,Hypotension,2,M,HO,43
174375151,2,Non-small cell lung cancer metastatic,1,I,EXP,ipilimumab,2,SS,Hypotension,2,M,OT,43
174375151,2,Non-small cell lung cancer metastatic,1,I,EXP,ipilimumab,2,SS,Melaena,2,M,LT,43
174375151,2,Non-small cell lung cancer metastatic,1,I,EXP,ipilimumab,2,SS,Melaena,2,M,HO,43
174375151,2,Non-small cell lung cancer metastatic,1,I,EXP,ipilimumab,2,SS,Melaena,2,M,OT,43
174376881,1,Non-Hodgkin's lymphoma stage IV,1,I,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,3
174376881,1,Non-Hodgkin's lymphoma stage IV,1,I,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,LT,3
174376881,1,Non-Hodgkin's lymphoma stage IV,1,I,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,3
174376881,1,Non-Hodgkin's lymphoma stage IV,1,I,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,OT,3
174376881,1,Non-Hodgkin's lymphoma stage IV,1,I,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,LT,3
174376881,1,Non-Hodgkin's lymphoma stage IV,1,I,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,HO,3
174376881,1,Non-Hodgkin's lymphoma stage IV,1,I,EXP,axicabtagene ciloleucel,1,PS,Primary mediastinal large B-cell lymphoma stage IV,1,M,OT,3
174376881,1,Non-Hodgkin's lymphoma stage IV,1,I,EXP,axicabtagene ciloleucel,1,PS,Primary mediastinal large B-cell lymphoma stage IV,1,M,LT,3
174376881,1,Non-Hodgkin's lymphoma stage IV,1,I,EXP,axicabtagene ciloleucel,1,PS,Primary mediastinal large B-cell lymphoma stage IV,1,M,HO,3
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Abdominal distension,1,F,OT,1
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Dizziness,1,F,OT,1
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Dyspepsia,1,F,OT,1
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Fall,1,F,OT,1
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Joint swelling,1,F,OT,1
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Nausea,1,F,OT,1
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Periorbital swelling,1,F,OT,1
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Peripheral swelling,1,F,OT,1
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Pruritus,1,F,OT,1
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Rash,1,F,OT,1
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Scratch,1,F,OT,1
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Seizure,1,F,OT,1
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Swelling face,1,F,OT,1
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Syncope,1,F,OT,1
174379641,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Xanthelasma,1,F,OT,1
174381241,1,Hodgkin's disease,1,I,EXP,brentuximab vedotin,1,PS,Clostridium difficile infection,1,M,HO,73
174381241,5,Hodgkin's disease,1,I,EXP,pegfilgrastim,5,SS,Clostridium difficile infection,5,M,HO,73
174382122,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,99
174386532,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,HO,28
174386532,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,F,OT,28
174386532,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Tumour lysis syndrome,1,F,HO,28
174386532,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Tumour lysis syndrome,1,F,OT,28
174386532,2,Colorectal cancer,2,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,HO,28
174386532,2,Colorectal cancer,2,F,EXP,ipilimumab,2,SS,Acute kidney injury,2,F,OT,28
174386532,2,Colorectal cancer,2,F,EXP,ipilimumab,2,SS,Tumour lysis syndrome,2,F,HO,28
174386532,2,Colorectal cancer,2,F,EXP,ipilimumab,2,SS,Tumour lysis syndrome,2,F,OT,28
174387041,1,Oesophageal adenocarcinoma,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,110
174387041,1,Oesophageal adenocarcinoma,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,M,LT,110
174387041,3,Oesophageal adenocarcinoma,1,I,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,OT,110
174387041,3,Oesophageal adenocarcinoma,1,I,EXP,ipilimumab,3,SS,Acute kidney injury,3,M,LT,110
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Asthenia,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Asthenia,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Asthenia,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Atelectasis,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Atelectasis,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Atelectasis,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Blood creatinine increased,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Blood creatinine increased,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Blood creatinine increased,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Bronchiolitis,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Bronchiolitis,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Bronchiolitis,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Bronchitis,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Bronchitis,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Bronchitis,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Capillary fragility decreased,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Capillary fragility decreased,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Capillary fragility decreased,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Chills,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Chills,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Chills,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Cough,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Cough,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Cough,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Diarrhoea,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Diarrhoea,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Diarrhoea,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Enterococcus test positive,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Enterococcus test positive,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Enterococcus test positive,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Enterovirus infection,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Enterovirus infection,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Enterovirus infection,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Hyperkalaemia,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Hyperkalaemia,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Hyperkalaemia,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Hyponatraemia,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Hyponatraemia,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Hyponatraemia,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Hypoxia,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Hypoxia,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Hypoxia,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Mean cell haemoglobin increased,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Mean cell haemoglobin increased,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Mean cell haemoglobin increased,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Mean cell volume increased,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Mean cell volume increased,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Mean cell volume increased,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Nasal congestion,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Nasal congestion,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Nasal congestion,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Oxygen consumption increased,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Oxygen consumption increased,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Oxygen consumption increased,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Paronychia,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Paronychia,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Paronychia,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Pseudomonal bacteraemia,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Pseudomonal bacteraemia,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Pseudomonal bacteraemia,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Pyrexia,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Pyrexia,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Pyrexia,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Respiratory failure,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Respiratory failure,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Respiratory failure,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Respiratory syncytial virus test positive,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Respiratory syncytial virus test positive,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Respiratory syncytial virus test positive,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Retching,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Retching,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Retching,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Rhinorrhoea,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Rhinorrhoea,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Rhinorrhoea,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Rhinovirus infection,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Rhinovirus infection,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Rhinovirus infection,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Secretion discharge,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Secretion discharge,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Secretion discharge,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Sepsis,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Sepsis,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Sepsis,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Tracheal inflammation,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Tracheal inflammation,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Tracheal inflammation,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Tracheal oedema,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Tracheal oedema,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Tracheal oedema,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Tremor,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Tremor,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Tremor,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Upper respiratory tract infection,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Upper respiratory tract infection,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,Upper respiratory tract infection,1,F,OT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,White blood cell count increased,1,F,LT,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,White blood cell count increased,1,F,HO,144
174388115,1,Neurofibromatosis,5,F,EXP,trametinib,1,PS,White blood cell count increased,1,F,OT,144
174396771,11,Breast cancer metastatic,1,I,EXP,palbociclib,11,C,Osteonecrosis of jaw,11,F,OT,312
174399521,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Chills,3,M,HO,623
174399521,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Pleurisy,3,M,HO,623
174400751,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Fibrosis,1,F,OT,178
174400751,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Fibrosis,1,F,HO,178
174400751,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Fibrosis,1,F,LT,178
174400751,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Pneumonia,1,F,OT,178
174400751,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Pneumonia,1,F,HO,178
174400751,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Pneumonia,1,F,LT,178
174401652,1,Ovarian cancer,2,F,EXP,trametinib,1,PS,Product use in unapproved indication,1,F,OT,25
174401652,1,Ovarian cancer,2,F,EXP,trametinib,1,PS,Retinal oedema,1,F,OT,25
174401652,1,Ovarian cancer,2,F,EXP,trametinib,1,PS,Retinal thickening,1,F,OT,25
174401652,1,Ovarian cancer,2,F,EXP,trametinib,1,PS,Vision blurred,1,F,OT,25
174404571,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Anxiety,1,M,OT,361
174404571,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,361
174404571,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Diarrhoea,1,M,OT,361
174404571,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,361
174404571,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Dry skin,1,M,OT,361
174404571,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Dyspnoea,1,M,OT,361
174404571,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,361
174404571,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Hallucination,1,M,OT,361
174404571,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Hot flush,1,M,OT,361
174404571,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Oral fungal infection,1,M,OT,361
174404571,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Product dose omission,1,M,OT,361
174404571,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Vision blurred,1,M,OT,361
174404742,1,Malignant urinary tract neoplasm,2,F,EXP,avelumab,1,PS,Brain natriuretic peptide increased,1,M,HO,115
174404742,1,Malignant urinary tract neoplasm,2,F,EXP,avelumab,1,PS,Pleural effusion,1,M,HO,115
174410523,3,Plasma cell myeloma,3,F,EXP,pomalidomide,3,SS,Pneumonia,3,M,HO,40
174415461,1,Prostate cancer,1,I,EXP,apalutamide,1,PS,Myocardial infarction,1,M,HO,1378
174416963,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Myocardial infarction,1,M,OT,875
174416963,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Myocardial infarction,1,M,HO,875
174417062,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Aortic valve stenosis,1,M,OT,676
174417062,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Aortic valve stenosis,1,M,DE,676
174417992,1,Prostate cancer,2,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,HO,349
174417992,1,Prostate cancer,2,F,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,OT,349
174417992,1,Prostate cancer,2,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,349
174417992,1,Prostate cancer,2,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,349
174417992,2,Prostate cancer,2,F,EXP,ipilimumab,2,SS,Atrial fibrillation,2,M,HO,349
174417992,2,Prostate cancer,2,F,EXP,ipilimumab,2,SS,Atrial fibrillation,2,M,OT,349
174417992,2,Prostate cancer,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,HO,349
174417992,2,Prostate cancer,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,OT,349
174418071,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Cerebral infarction,1,F,HO,1
174418071,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Cerebral infarction,1,F,DE,1
174418071,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Generalised tonic-clonic seizure,1,F,HO,1
174418071,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Generalised tonic-clonic seizure,1,F,DE,1
174418071,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hemiparesis,1,F,HO,1
174418071,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hemiparesis,1,F,DE,1
174419001,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Urosepsis,1,F,HO,39
174419743,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Renal cancer,1,F,OT,2401
174421494,1,Diffuse large B-cell lymphoma,4,F,EXP,ibrutinib,1,PS,Febrile neutropenia,1,F,LT,72
174421494,1,Diffuse large B-cell lymphoma,4,F,EXP,ibrutinib,1,PS,Febrile neutropenia,1,F,HO,72
174421494,1,Diffuse large B-cell lymphoma,4,F,EXP,ibrutinib,1,PS,Leukopenia,1,F,LT,72
174421494,1,Diffuse large B-cell lymphoma,4,F,EXP,ibrutinib,1,PS,Leukopenia,1,F,HO,72
174421494,1,Diffuse large B-cell lymphoma,4,F,EXP,ibrutinib,1,PS,Neutropenia,1,F,LT,72
174421494,1,Diffuse large B-cell lymphoma,4,F,EXP,ibrutinib,1,PS,Neutropenia,1,F,HO,72
174421494,1,Diffuse large B-cell lymphoma,4,F,EXP,ibrutinib,1,PS,Stomatitis,1,F,LT,72
174421494,1,Diffuse large B-cell lymphoma,4,F,EXP,ibrutinib,1,PS,Stomatitis,1,F,HO,72
174421494,1,Diffuse large B-cell lymphoma,4,F,EXP,ibrutinib,1,PS,Urinary tract infection,1,F,LT,72
174421494,1,Diffuse large B-cell lymphoma,4,F,EXP,ibrutinib,1,PS,Urinary tract infection,1,F,HO,72
174421882,1,Plasma cell myeloma,2,F,EXP,daratumumab,1,PS,Respiratory distress,1,M,HO,586
174421882,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Respiratory distress,2,M,HO,333
174423392,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Hyponatraemia,1,M,HO,36
174424293,1,Ovarian cancer,3,F,EXP,nivolumab,1,PS,Neutropenic infection,1,F,HO,31
174424293,1,Ovarian cancer,3,F,EXP,nivolumab,1,PS,Neutropenic infection,1,F,OT,31
174424731,2,Malignant melanoma,1,I,EXP,nivolumab,2,PS,Immune-mediated myocarditis,2,M,OT,142
174424731,2,Malignant melanoma,1,I,EXP,nivolumab,2,PS,Immune-mediated myocarditis,2,M,HO,142
174424731,3,Malignant melanoma,1,I,EXP,ipilimumab,3,SS,Immune-mediated myocarditis,3,M,OT,142
174424731,3,Malignant melanoma,1,I,EXP,ipilimumab,3,SS,Immune-mediated myocarditis,3,M,HO,142
174425601,3,Plasma cell myeloma,1,I,PER,carfilzomib,3,SS,Febrile neutropenia,3,M,HO,112
174426511,1,Bladder cancer,1,I,EXP,nivolumab,1,SS,Dyspnoea,1,M,HO,11
174426511,1,Bladder cancer,1,I,EXP,nivolumab,1,SS,Dyspnoea,1,M,OT,11
174426511,1,Bladder cancer,1,I,EXP,nivolumab,1,SS,Pyrexia,1,M,HO,11
174426511,1,Bladder cancer,1,I,EXP,nivolumab,1,SS,Pyrexia,1,M,OT,11
174426511,1,Bladder cancer,1,I,EXP,nivolumab,1,SS,Rash maculo-papular,1,M,HO,11
174426511,1,Bladder cancer,1,I,EXP,nivolumab,1,SS,Rash maculo-papular,1,M,OT,11
174426511,1,Bladder cancer,1,I,EXP,nivolumab,1,SS,Sepsis,1,M,HO,11
174426511,1,Bladder cancer,1,I,EXP,nivolumab,1,SS,Sepsis,1,M,OT,11
174426511,2,Bladder cancer,1,I,EXP,ipilimumab,2,PS,Dyspnoea,2,M,HO,11
174426511,2,Bladder cancer,1,I,EXP,ipilimumab,2,PS,Dyspnoea,2,M,OT,11
174426511,2,Bladder cancer,1,I,EXP,ipilimumab,2,PS,Pyrexia,2,M,HO,11
174426511,2,Bladder cancer,1,I,EXP,ipilimumab,2,PS,Pyrexia,2,M,OT,11
174426511,2,Bladder cancer,1,I,EXP,ipilimumab,2,PS,Rash maculo-papular,2,M,HO,11
174426511,2,Bladder cancer,1,I,EXP,ipilimumab,2,PS,Rash maculo-papular,2,M,OT,11
174426511,2,Bladder cancer,1,I,EXP,ipilimumab,2,PS,Sepsis,2,M,HO,11
174426511,2,Bladder cancer,1,I,EXP,ipilimumab,2,PS,Sepsis,2,M,OT,11
174426962,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,SS,Hepatotoxicity,1,M,OT,498
174426962,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,SS,Hepatotoxicity,1,M,HO,498
174426962,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,PS,Hepatotoxicity,2,M,OT,498
174426962,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,PS,Hepatotoxicity,2,M,HO,498
174428561,1,Gastrointestinal haemorrhage,1,I,PER,thalidomide,1,PS,Death,1,M,DE,299
174429181,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Death,1,F,OT,384
174429181,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Death,1,F,DE,384
174430171,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Conjunctivitis bacterial,1,F,OT,21
174430171,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Hypertension,1,F,OT,21
174430171,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Oedema peripheral,1,F,OT,21
174430171,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Pruritus,1,F,OT,21
174430761,1,Synovial sarcoma,1,I,EXP,nivolumab,1,PS,Acute monocytic leukaemia,1,M,HO,673
174430761,1,Synovial sarcoma,1,I,EXP,nivolumab,1,PS,Acute monocytic leukaemia,1,M,OT,673
174430761,2,Synovial sarcoma,1,I,EXP,ipilimumab,2,SS,Acute monocytic leukaemia,2,M,HO,659
174430761,2,Synovial sarcoma,1,I,EXP,ipilimumab,2,SS,Acute monocytic leukaemia,2,M,OT,659
174430761,3,Synovial sarcoma,1,I,EXP,trabectedin,3,SS,Acute monocytic leukaemia,3,M,HO,673
174430761,3,Synovial sarcoma,1,I,EXP,trabectedin,3,SS,Acute monocytic leukaemia,3,M,OT,673
174430773,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,M,HO,63
174430773,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Fulminant type 1 diabetes mellitus,1,M,OT,63
174430773,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Fulminant type 1 diabetes mellitus,2,M,HO,35
174430773,2,Product used for unknown indication,3,F,EXP,nivolumab,2,SS,Fulminant type 1 diabetes mellitus,2,M,OT,35
174430773,3,Product used for unknown indication,3,F,EXP,nivolumab,3,SS,Fulminant type 1 diabetes mellitus,3,M,HO,14
174430773,3,Product used for unknown indication,3,F,EXP,nivolumab,3,SS,Fulminant type 1 diabetes mellitus,3,M,OT,14
174430773,4,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,4,SS,Fulminant type 1 diabetes mellitus,4,M,HO,63
174430773,4,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,4,SS,Fulminant type 1 diabetes mellitus,4,M,OT,63
174430773,5,Product used for unknown indication,3,F,EXP,ipilimumab,5,SS,Fulminant type 1 diabetes mellitus,5,M,HO,35
174430773,5,Product used for unknown indication,3,F,EXP,ipilimumab,5,SS,Fulminant type 1 diabetes mellitus,5,M,OT,35
174430773,6,Product used for unknown indication,3,F,EXP,ipilimumab,6,SS,Fulminant type 1 diabetes mellitus,6,M,HO,14
174430773,6,Product used for unknown indication,3,F,EXP,ipilimumab,6,SS,Fulminant type 1 diabetes mellitus,6,M,OT,14
174431582,1,Prostate cancer,2,F,EXP,ipilimumab,1,PS,Diarrhoea,1,M,HO,35
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Ataxia,1,M,HO,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Ataxia,1,M,LT,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Ataxia,1,M,OT,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Ataxia,1,M,DE,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Colitis,1,M,LT,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Colitis,1,M,DE,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,LT,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Headache,1,M,HO,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Headache,1,M,LT,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Headache,1,M,OT,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Headache,1,M,DE,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Vertigo,1,M,HO,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Vertigo,1,M,LT,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Vertigo,1,M,OT,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Vertigo,1,M,DE,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Vomiting,1,M,LT,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,64
174436392,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Vomiting,1,M,DE,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Ataxia,2,M,HO,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Ataxia,2,M,LT,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Ataxia,2,M,OT,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Ataxia,2,M,DE,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,HO,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,LT,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,OT,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Colitis,2,M,DE,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,LT,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,DE,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Headache,2,M,HO,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Headache,2,M,LT,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Headache,2,M,OT,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Headache,2,M,DE,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,HO,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,LT,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DE,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Vertigo,2,M,HO,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Vertigo,2,M,LT,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Vertigo,2,M,OT,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Vertigo,2,M,DE,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Vomiting,2,M,HO,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Vomiting,2,M,LT,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Vomiting,2,M,OT,64
174436392,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Vomiting,2,M,DE,64
174437131,1,Hodgkin's disease stage III,1,I,EXP,brentuximab vedotin,1,PS,Neutrophil count decreased,1,F,OT,10
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Bacterial test positive,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Bacterial test positive,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Bladder catheterisation,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Bladder catheterisation,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Caesarean section,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Caesarean section,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Crystalluria,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Crystalluria,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Depressed mood,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Depressed mood,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Dizziness,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Dizziness,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Expanded disability status scale score increased,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Expanded disability status scale score increased,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Exposure during pregnancy,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Exposure during pregnancy,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Fall,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Fall,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Hyperoxaluria,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Hyperoxaluria,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Leukopenia,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Leukopenia,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Lymphopenia,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Lymphopenia,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Mean platelet volume increased,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Mean platelet volume increased,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Multiple sclerosis,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Multiple sclerosis,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Myalgia,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Myalgia,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Oropharyngeal pain,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Oropharyngeal pain,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Protein urine present,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Protein urine present,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Pruritus,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Pruritus,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Pyrexia,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Pyrexia,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Spinal cord injury,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Spinal cord injury,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Urine analysis abnormal,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Urine analysis abnormal,1,F,DS,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Walking aid user,1,F,OT,1
174441854,1,Relapsing-remitting multiple sclerosis,4,F,EXP,alemtuzumab,1,PS,Walking aid user,1,F,DS,1
174454233,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Angina unstable,1,M,HO,379
174454711,1,Plasma cell myeloma,1,I,EXP,zoledronic acid,1,PS,Osteonecrosis,1,F,OT,672
174454911,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Deep vein thrombosis,2,F,LT,392
174454911,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Deep vein thrombosis,2,F,HO,392
174454911,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Dyspnoea,2,F,LT,392
174454911,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Dyspnoea,2,F,HO,392
174454911,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Oedema peripheral,2,F,LT,392
174454911,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Oedema peripheral,2,F,HO,392
174454911,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Palpitations,2,F,LT,392
174454911,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Palpitations,2,F,HO,392
174454911,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Pneumonitis,2,F,LT,392
174454911,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Pneumonitis,2,F,HO,392
174454911,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Productive cough,2,F,LT,392
174454911,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Productive cough,2,F,HO,392
174454911,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Pulmonary embolism,2,F,LT,392
174454911,2,Invasive ductal breast carcinoma,1,I,EXP,abemaciclib,2,SS,Pulmonary embolism,2,F,HO,392
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Condition aggravated,1,F,DE,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Condition aggravated,1,F,HO,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Condition aggravated,1,F,OT,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Dyspnoea,1,F,DE,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Dyspnoea,1,F,HO,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Dyspnoea,1,F,OT,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Performance status decreased,1,F,DE,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Performance status decreased,1,F,HO,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Performance status decreased,1,F,OT,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Pleural effusion,1,F,DE,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Pleural effusion,1,F,HO,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Pleural effusion,1,F,OT,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Pneumonitis,1,F,DE,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Pneumonitis,1,F,HO,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Pneumonitis,1,F,OT,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Respiratory failure,1,F,DE,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Respiratory failure,1,F,HO,42
174456003,1,Breast cancer metastatic,3,F,EXP,palbociclib,1,PS,Respiratory failure,1,F,OT,42
174458142,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Dyspnoea,1,F,HO,59
174459392,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Mobility decreased,3,M,HO,51
174459392,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Vertebral foraminal stenosis,3,M,HO,51
174459392,5,Plasma cell myeloma,2,F,EXP,carfilzomib,5,SS,Mobility decreased,5,M,HO,51
174459392,5,Plasma cell myeloma,2,F,EXP,carfilzomib,5,SS,Vertebral foraminal stenosis,5,M,HO,51
174459491,2,Plasma cell myeloma,1,I,EXP,thalidomide,2,SS,Blastic plasmacytoid dendritic cell neoplasia,2,M,HO,1059
174459491,2,Plasma cell myeloma,1,I,EXP,thalidomide,2,SS,Blastic plasmacytoid dendritic cell neoplasia,2,M,OT,1059
174459491,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Blastic plasmacytoid dendritic cell neoplasia,3,M,HO,742
174459491,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Blastic plasmacytoid dendritic cell neoplasia,3,M,OT,742
174459551,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Hepatitis E,2,F,OT,490
174459551,5,Plasma cell myeloma,1,I,EXP,thalidomide,5,SS,Hepatitis E,5,F,OT,490
174459732,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Cachexia,1,M,DE,28
174459732,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Cachexia,1,M,OT,28
174459732,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Graft versus host disease,1,M,DE,28
174459732,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Graft versus host disease,1,M,OT,28
174459732,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Hepatotoxicity,1,M,DE,28
174459732,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Hepatotoxicity,1,M,OT,28
174459732,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Neoplasm recurrence,1,M,DE,28
174459732,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Neoplasm recurrence,1,M,OT,28
174459732,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Urinary tract infection enterococcal,1,M,DE,28
174459732,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Urinary tract infection enterococcal,1,M,OT,28
174459732,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Venoocclusive liver disease,1,M,DE,28
174459732,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Venoocclusive liver disease,1,M,OT,28
174459941,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,C,Bone marrow failure,3,M,OT,13
174459941,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,C,Infection,3,M,OT,13
174460032,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Soft tissue necrosis,1,M,HO,600
174460032,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Soft tissue necrosis,1,M,OT,600
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Abdominal distension,3,M,HO,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Abdominal distension,3,M,OT,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,C-reactive protein increased,3,M,HO,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,C-reactive protein increased,3,M,OT,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Malaise,3,M,HO,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Malaise,3,M,OT,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Pericardial effusion,3,M,HO,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Pericardial effusion,3,M,OT,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Pleural effusion,3,M,HO,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Pleural effusion,3,M,OT,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Pyrexia,3,M,HO,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Pyrexia,3,M,OT,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Rash pustular,3,M,HO,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Rash pustular,3,M,OT,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Splenic infarction,3,M,HO,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Splenic infarction,3,M,OT,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Staphylococcal infection,3,M,HO,4
174468172,3,Product use in unapproved indication,2,F,EXP,plerixafor,3,PS,Staphylococcal infection,3,M,OT,4
174471562,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,OT,91
174471562,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,HO,91
174471562,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,DE,91
174471562,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Cerebrovascular accident,1,M,LT,91
174471562,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Cerebrovascular accident,2,M,OT,91
174471562,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Cerebrovascular accident,2,M,HO,91
174471562,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Cerebrovascular accident,2,M,DE,91
174471562,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Cerebrovascular accident,2,M,LT,91
174473144,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Encephalopathy,1,F,OT,43
174473144,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Encephalopathy,1,F,LT,43
174473144,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Encephalopathy,1,F,HO,43
174473144,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Urosepsis,1,F,OT,43
174473144,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Urosepsis,1,F,LT,43
174473144,1,Plasma cell myeloma,4,F,PER,carfilzomib,1,PS,Urosepsis,1,F,HO,43
174473144,2,Plasma cell myeloma,4,F,PER,pomalidomide,2,SS,Encephalopathy,2,F,OT,43
174473144,2,Plasma cell myeloma,4,F,PER,pomalidomide,2,SS,Encephalopathy,2,F,LT,43
174473144,2,Plasma cell myeloma,4,F,PER,pomalidomide,2,SS,Encephalopathy,2,F,HO,43
174473144,2,Plasma cell myeloma,4,F,PER,pomalidomide,2,SS,Urosepsis,2,F,OT,43
174473144,2,Plasma cell myeloma,4,F,PER,pomalidomide,2,SS,Urosepsis,2,F,LT,43
174473144,2,Plasma cell myeloma,4,F,PER,pomalidomide,2,SS,Urosepsis,2,F,HO,43
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Abdominal pain upper,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Blood cholesterol increased,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Constipation,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Dry eye,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Dry mouth,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Dysphonia,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Enamel anomaly,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Fatigue,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Muscle spasms,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Nausea,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Positron emission tomogram abnormal,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Rash,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Spinal compression fracture,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Thyroid hormones increased,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Urinary tract infection,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Vomiting,2,F,OT,50
174475931,2,Endometrial cancer,1,I,EXP,lenvatinib mesylate,2,SS,Vulvovaginal mycotic infection,2,F,OT,50
174476022,2,Oropharyngeal cancer,2,F,EXP,nivolumab,2,SS,Decreased appetite,2,M,HO,99
174476022,2,Oropharyngeal cancer,2,F,EXP,nivolumab,2,SS,Dysphagia,2,M,HO,99
174476022,2,Oropharyngeal cancer,2,F,EXP,nivolumab,2,SS,Weight decreased,2,M,HO,99
174476432,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,DE,194
174476432,2,Non-small cell lung cancer,2,F,EXP,ipilimumab,2,SS,Decreased appetite,2,M,DE,194
174476432,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,SS,Decreased appetite,3,M,DE,194
174477043,1,Mantle cell lymphoma,3,F,EXP,ibrutinib,1,PS,Acute kidney injury,1,M,HO,124
174477043,1,Mantle cell lymphoma,3,F,EXP,ibrutinib,1,PS,Febrile neutropenia,1,M,HO,124
174477043,1,Mantle cell lymphoma,3,F,EXP,ibrutinib,1,PS,Mucosal inflammation,1,M,HO,124
174478693,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,PS,Renal failure,2,M,OT,15
174478693,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,PS,Renal failure,2,M,HO,15
174478693,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,PS,Renal failure,2,M,LT,15
174480971,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Pyrexia,1,F,HO,41
174481001,5,Plasma cell myeloma,1,I,EXP,nivolumab,5,C,Diverticulitis,5,F,HO,51
174481001,5,Plasma cell myeloma,1,I,EXP,nivolumab,5,C,Diverticulitis,5,F,OT,51
174481001,5,Plasma cell myeloma,1,I,EXP,nivolumab,5,C,Neutropenia,5,F,HO,51
174481001,5,Plasma cell myeloma,1,I,EXP,nivolumab,5,C,Neutropenia,5,F,OT,51
174481001,5,Plasma cell myeloma,1,I,EXP,nivolumab,5,C,Thrombocytopenia,5,F,HO,51
174481001,5,Plasma cell myeloma,1,I,EXP,nivolumab,5,C,Thrombocytopenia,5,F,OT,51
174481001,20,Plasma cell myeloma,1,I,EXP,daratumumab,20,C,Diverticulitis,20,F,HO,65
174481001,20,Plasma cell myeloma,1,I,EXP,daratumumab,20,C,Diverticulitis,20,F,OT,65
174481001,20,Plasma cell myeloma,1,I,EXP,daratumumab,20,C,Neutropenia,20,F,HO,65
174481001,20,Plasma cell myeloma,1,I,EXP,daratumumab,20,C,Neutropenia,20,F,OT,65
174481001,20,Plasma cell myeloma,1,I,EXP,daratumumab,20,C,Thrombocytopenia,20,F,HO,65
174481001,20,Plasma cell myeloma,1,I,EXP,daratumumab,20,C,Thrombocytopenia,20,F,OT,65
174483192,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Fall,1,M,OT,40
174483192,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Fall,1,M,HO,40
174483192,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Femur fracture,1,M,OT,40
174483192,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Femur fracture,1,M,HO,40
174483192,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,40
174483192,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,40
174483192,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,OT,40
174483192,1,Renal cancer,2,F,EXP,nivolumab,1,PS,Prescribed overdose,1,M,HO,40
174483301,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Gastrointestinal toxicity,1,F,HO,34
174483301,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Gastrointestinal toxicity,1,F,OT,34
174483301,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Thrombocytopenia,1,F,HO,34
174483301,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Thrombocytopenia,1,F,OT,34
174483462,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pleural effusion,1,M,DE,3
174484491,1,B-cell lymphoma,1,I,EXP,nivolumab,1,PS,Febrile infection,1,M,HO,1
174484491,5,B-cell lymphoma,1,I,EXP,pegfilgrastim,5,SS,Febrile infection,5,M,HO,20
174484502,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,OT,358
174484502,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,DE,358
174484502,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,HO,358
174484502,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Respiratory failure,1,M,LT,358
174486571,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Hypophysitis,1,M,LT,26
174486571,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Hypophysitis,1,M,OT,26
174486571,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Hypophysitis,1,M,HO,26
174486571,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Limbic encephalitis,1,M,LT,26
174486571,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Limbic encephalitis,1,M,OT,26
174486571,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Limbic encephalitis,1,M,HO,26
174488762,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,32
174488762,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Platelet count decreased,1,M,HO,32
174488762,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,32
174488762,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Diarrhoea,2,M,HO,21
174488762,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Platelet count decreased,2,M,HO,21
174488762,2,Product used for unknown indication,2,F,EXP,nivolumab,2,SS,Pyrexia,2,M,HO,21
174490601,11,Plasma cell myeloma,1,I,PER,carfilzomib,11,SS,Rhinovirus infection,11,M,HO,2092
174490601,14,Plasma cell myeloma,1,I,PER,daratumumab,14,SS,Rhinovirus infection,14,M,HO,1343
174493551,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Arthritis,1,M,OT,664
174506471,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Renal abscess,1,F,HO,60
174507293,3,Plasma cell myeloma,3,F,EXP,lenalidomide,3,SS,Hepatotoxicity,3,F,OT,626
174507293,10,Plasma cell myeloma,3,F,EXP,carfilzomib,10,SS,Hepatotoxicity,10,F,OT,581
174510292,2,Breast cancer,2,F,EXP,palbociclib,2,SS,Febrile neutropenia,2,F,HO,27
174510292,2,Breast cancer,2,F,EXP,palbociclib,2,SS,General physical health deterioration,2,F,HO,27
174510565,18,Prophylaxis,5,F,EXP,granisetron,18,C,Disease progression,18,M,DE,19
174510565,18,Prophylaxis,5,F,EXP,granisetron,18,C,Disease progression,18,M,HO,19
174510565,18,Prophylaxis,5,F,EXP,granisetron,18,C,Pneumonia,18,M,DE,19
174510565,18,Prophylaxis,5,F,EXP,granisetron,18,C,Pneumonia,18,M,HO,19
174518051,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Alopecia,1,M,OT,2
174518051,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Diabetic neuropathy,1,M,OT,2
174518051,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Dysphonia,1,M,OT,2
174518051,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,2
174518051,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Hypoaesthesia,1,M,OT,2
174518051,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Muscle disorder,1,M,OT,2
174518051,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Productive cough,1,M,OT,2
174520221,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Chills,1,M,HO,623
174520221,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Pleurisy,1,M,HO,623
174520732,1,Mantle cell lymphoma,2,F,EXP,lenalidomide,1,PS,Balance disorder,1,F,HO,30
174521401,1,Non-small cell lung cancer,1,I,EXP,brigatinib,1,PS,Death,1,F,DE,380
174522642,1,Off label use,2,F,EXP,lenalidomide,1,PS,Ventricular tachycardia,1,M,OT,6
174525392,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Pneumonia,2,M,OT,10
174525392,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Pneumonia,2,M,HO,10
174525392,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Upper respiratory tract infection,2,M,OT,10
174525392,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Upper respiratory tract infection,2,M,HO,10
174525392,3,Plasma cell myeloma,2,F,EXP,pomalidomide,3,SS,Pneumonia,3,M,OT,10
174525392,3,Plasma cell myeloma,2,F,EXP,pomalidomide,3,SS,Pneumonia,3,M,HO,10
174525392,3,Plasma cell myeloma,2,F,EXP,pomalidomide,3,SS,Upper respiratory tract infection,3,M,OT,10
174525392,3,Plasma cell myeloma,2,F,EXP,pomalidomide,3,SS,Upper respiratory tract infection,3,M,HO,10
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Abdominal distension,1,F,OT,1
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Dizziness,1,F,OT,1
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Dyspepsia,1,F,OT,1
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Fall,1,F,OT,1
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Joint swelling,1,F,OT,1
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Nausea,1,F,OT,1
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Periorbital swelling,1,F,OT,1
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Peripheral swelling,1,F,OT,1
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Pruritus,1,F,OT,1
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Rash,1,F,OT,1
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Scratch,1,F,OT,1
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Seizure,1,F,OT,1
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Swelling face,1,F,OT,1
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Syncope,1,F,OT,1
174525631,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Xanthelasma,1,F,OT,1
174527202,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Seizure,1,M,HO,278
174527202,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Seizure,1,M,OT,278
174527202,2,Plasma cell myeloma,2,F,PER,daratumumab,2,SS,Seizure,2,M,HO,278
174527202,2,Plasma cell myeloma,2,F,PER,daratumumab,2,SS,Seizure,2,M,OT,278
174527202,4,Plasma cell myeloma,2,F,PER,lenalidomide,4,SS,Seizure,4,M,HO,278
174527202,4,Plasma cell myeloma,2,F,PER,lenalidomide,4,SS,Seizure,4,M,OT,278
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Coma,6,F,LT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Coma,6,F,OT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Coma,6,F,HO,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Cytomegalovirus test positive,6,F,LT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Cytomegalovirus test positive,6,F,OT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Cytomegalovirus test positive,6,F,HO,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Diarrhoea,6,F,LT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Diarrhoea,6,F,OT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Diarrhoea,6,F,HO,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Escherichia sepsis,6,F,LT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Escherichia sepsis,6,F,OT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Escherichia sepsis,6,F,HO,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Hypotension,6,F,LT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Hypotension,6,F,OT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Hypotension,6,F,HO,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Hypotonia,6,F,LT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Hypotonia,6,F,OT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Hypotonia,6,F,HO,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Intensive care unit acquired weakness,6,F,LT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Intensive care unit acquired weakness,6,F,OT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Intensive care unit acquired weakness,6,F,HO,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Neutropenia,6,F,LT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Neutropenia,6,F,OT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Neutropenia,6,F,HO,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Pneumonia,6,F,LT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Pneumonia,6,F,OT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Pneumonia,6,F,HO,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Respiratory failure,6,F,LT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Respiratory failure,6,F,OT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Respiratory failure,6,F,HO,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Septic shock,6,F,LT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Septic shock,6,F,OT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Septic shock,6,F,HO,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Thrombocytopenia,6,F,LT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Thrombocytopenia,6,F,OT,85
174527321,6,Plasma cell myeloma,1,I,EXP,daratumumab,6,C,Thrombocytopenia,6,F,HO,85
174530601,2,Multiple sclerosis relapse,1,I,EXP,ofatumumab,2,SS,Myocarditis,2,M,HO,154
174530612,1,Hypopharyngeal cancer,2,F,EXP,alpelisib,1,PS,Pneumonia,1,M,HO,56
174530612,1,Hypopharyngeal cancer,2,F,EXP,alpelisib,1,PS,Pneumonia,1,M,DE,56
174530612,1,Hypopharyngeal cancer,2,F,EXP,alpelisib,1,PS,Respiratory failure,1,M,HO,56
174530612,1,Hypopharyngeal cancer,2,F,EXP,alpelisib,1,PS,Respiratory failure,1,M,DE,56
174530622,5,Plasma cell myeloma,2,F,EXP,lenalidomide,5,SS,Febrile neutropenia,5,F,HO,14
174530622,5,Plasma cell myeloma,2,F,EXP,lenalidomide,5,SS,Nausea,5,F,HO,14
174530622,5,Plasma cell myeloma,2,F,EXP,lenalidomide,5,SS,Streptococcal sepsis,5,F,HO,14
174531352,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,F,OT,6
174531352,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,F,HO,6
174531352,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Hypothyroidism,1,F,OT,6
174531352,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Hypothyroidism,1,F,HO,6
174531352,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Memory impairment,1,F,OT,6
174531352,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Memory impairment,1,F,HO,6
174531532,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,PS,Anaemia,2,M,HO,178
174531532,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,PS,Anaemia,2,M,OT,178
174531532,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,PS,Streptococcal sepsis,2,M,HO,178
174531532,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,PS,Streptococcal sepsis,2,M,OT,178
174531911,2,Product used for unknown indication,1,I,EXP,pegfilgrastim,2,SS,Condition aggravated,2,F,HO,45
174531911,2,Product used for unknown indication,1,I,EXP,pegfilgrastim,2,SS,Mucosal inflammation,2,F,HO,45
174531921,9,Plasma cell myeloma,1,I,EXP,pomalidomide,9,SS,Anaemia,9,M,OT,30
174531921,9,Plasma cell myeloma,1,I,EXP,pomalidomide,9,SS,Neutropenia,9,M,OT,30
174531921,9,Plasma cell myeloma,1,I,EXP,pomalidomide,9,SS,Thrombocytopenia,9,M,OT,30
174535091,1,Chronic myeloid leukaemia,1,I,EXP,nilotinib,1,PS,Lymphoedema,1,M,DS,568
174536191,1,Non-small cell lung cancer,1,I,EXP,ipilimumab,1,PS,Chronic obstructive pulmonary disease,1,F,HO,41
174536191,2,Non-small cell lung cancer,1,I,EXP,nivolumab,2,SS,Chronic obstructive pulmonary disease,2,F,HO,13
174536202,1,B-cell lymphoma,2,F,EXP,idelalisib,1,PS,Amaurosis fugax,1,M,HO,162
174536202,1,B-cell lymphoma,2,F,EXP,idelalisib,1,PS,Amaurosis fugax,1,M,OT,162
174536202,1,B-cell lymphoma,2,F,EXP,idelalisib,1,PS,Dyspnoea,1,M,HO,162
174536202,1,B-cell lymphoma,2,F,EXP,idelalisib,1,PS,Dyspnoea,1,M,OT,162
174536202,1,B-cell lymphoma,2,F,EXP,idelalisib,1,PS,Infection,1,M,HO,162
174536202,1,B-cell lymphoma,2,F,EXP,idelalisib,1,PS,Infection,1,M,OT,162
174536202,15,Neutrophil count decreased,2,F,EXP,filgrastim,15,C,Amaurosis fugax,15,M,HO,161
174536202,15,Neutrophil count decreased,2,F,EXP,filgrastim,15,C,Amaurosis fugax,15,M,OT,161
174536202,15,Neutrophil count decreased,2,F,EXP,filgrastim,15,C,Dyspnoea,15,M,HO,161
174536202,15,Neutrophil count decreased,2,F,EXP,filgrastim,15,C,Dyspnoea,15,M,OT,161
174536202,15,Neutrophil count decreased,2,F,EXP,filgrastim,15,C,Infection,15,M,HO,161
174536202,15,Neutrophil count decreased,2,F,EXP,filgrastim,15,C,Infection,15,M,OT,161
174536271,10,Plasma cell myeloma,1,I,PER,carfilzomib,10,SS,Rhinovirus infection,10,M,HO,2092
174536433,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Metapneumovirus infection,2,F,HO,124
174536433,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Metapneumovirus infection,2,F,LT,124
174536433,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Neutropenia,2,F,HO,124
174536433,2,Plasma cell myeloma,3,F,EXP,pomalidomide,2,SS,Neutropenia,2,F,LT,124
174536433,5,Plasma cell myeloma,3,F,EXP,daratumumab,5,SS,Metapneumovirus infection,5,F,HO,125
174536433,5,Plasma cell myeloma,3,F,EXP,daratumumab,5,SS,Metapneumovirus infection,5,F,LT,125
174536433,5,Plasma cell myeloma,3,F,EXP,daratumumab,5,SS,Neutropenia,5,F,HO,125
174536433,5,Plasma cell myeloma,3,F,EXP,daratumumab,5,SS,Neutropenia,5,F,LT,125
174537571,1,Lung adenocarcinoma,1,I,EXP,brigatinib,1,PS,Hyponatraemia,1,M,DE,56
174537571,1,Lung adenocarcinoma,1,I,EXP,brigatinib,1,PS,Hyponatraemia,1,M,OT,56
174537571,1,Lung adenocarcinoma,1,I,EXP,brigatinib,1,PS,Hyponatraemia,1,M,HO,56
174537571,1,Lung adenocarcinoma,1,I,EXP,brigatinib,1,PS,Neoplasm progression,1,M,DE,56
174537571,1,Lung adenocarcinoma,1,I,EXP,brigatinib,1,PS,Neoplasm progression,1,M,OT,56
174537571,1,Lung adenocarcinoma,1,I,EXP,brigatinib,1,PS,Neoplasm progression,1,M,HO,56
174537851,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Blindness unilateral,2,F,OT,25
174537851,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Eye irritation,2,F,OT,25
174537851,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Eye pain,2,F,OT,25
174537851,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Inflammation,2,F,OT,25
174537851,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Iris adhesions,2,F,OT,25
174537851,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Iris haemorrhage,2,F,OT,25
174537851,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Iritis,2,F,OT,25
174537851,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Macular oedema,2,F,OT,25
174537851,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Ocular discomfort,2,F,OT,25
174537851,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Ocular hyperaemia,2,F,OT,25
174537851,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Uveitis,2,F,OT,25
174537851,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Vision blurred,2,F,OT,25
174537851,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Visual impairment,2,F,OT,25
174538051,8,Prophylaxis,1,I,EXP,rasburicase,8,C,Febrile neutropenia,8,M,HO,1
174538051,8,Prophylaxis,1,I,EXP,rasburicase,8,C,Febrile neutropenia,8,M,LT,1
174538994,2,Transitional cell carcinoma,4,F,EXP,nivolumab,2,PS,Myocarditis,2,M,OT,27
174538994,2,Transitional cell carcinoma,4,F,EXP,nivolumab,2,PS,Myocarditis,2,M,HO,27
174538994,2,Transitional cell carcinoma,4,F,EXP,nivolumab,2,PS,Myocarditis,2,M,DE,27
174539203,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Alanine aminotransferase increased,2,F,HO,56
174539203,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Alanine aminotransferase increased,2,F,OT,56
174539203,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Aspartate aminotransferase increased,2,F,HO,56
174539203,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Aspartate aminotransferase increased,2,F,OT,56
174539203,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Gamma-glutamyltransferase increased,2,F,HO,56
174539203,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Gamma-glutamyltransferase increased,2,F,OT,56
174539203,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Hyperbilirubinaemia,2,F,HO,56
174539203,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Hyperbilirubinaemia,2,F,OT,56
174539203,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Alanine aminotransferase increased,3,F,HO,56
174539203,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Alanine aminotransferase increased,3,F,OT,56
174539203,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Aspartate aminotransferase increased,3,F,HO,56
174539203,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Aspartate aminotransferase increased,3,F,OT,56
174539203,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Gamma-glutamyltransferase increased,3,F,HO,56
174539203,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Gamma-glutamyltransferase increased,3,F,OT,56
174539203,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Hyperbilirubinaemia,3,F,HO,56
174539203,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Hyperbilirubinaemia,3,F,OT,56
174540681,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Eosinophilia,1,M,OT,322
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Dehydration,1,M,HO,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Dehydration,1,M,DE,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Dehydration,1,M,OT,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Diarrhoea,1,M,DE,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Pyrexia,1,M,DE,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Renal impairment,1,M,HO,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Renal impairment,1,M,DE,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Renal impairment,1,M,OT,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Ventricular dysfunction,1,M,HO,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Ventricular dysfunction,1,M,DE,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Ventricular dysfunction,1,M,OT,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Vomiting,1,M,HO,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Vomiting,1,M,DE,134
174541601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Vomiting,1,M,OT,134
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Dehydration,2,M,HO,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Dehydration,2,M,DE,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Dehydration,2,M,OT,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Diarrhoea,2,M,HO,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Diarrhoea,2,M,DE,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Diarrhoea,2,M,OT,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Pyrexia,2,M,HO,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Pyrexia,2,M,DE,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Pyrexia,2,M,OT,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Renal impairment,2,M,HO,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Renal impairment,2,M,DE,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Renal impairment,2,M,OT,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Ventricular dysfunction,2,M,HO,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Ventricular dysfunction,2,M,DE,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Ventricular dysfunction,2,M,OT,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Vomiting,2,M,HO,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Vomiting,2,M,DE,22
174541601,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Vomiting,2,M,OT,22
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Dehydration,3,M,HO,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Dehydration,3,M,DE,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Dehydration,3,M,OT,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Diarrhoea,3,M,HO,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Diarrhoea,3,M,DE,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Diarrhoea,3,M,OT,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Pyrexia,3,M,HO,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Pyrexia,3,M,DE,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Pyrexia,3,M,OT,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Renal impairment,3,M,HO,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Renal impairment,3,M,DE,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Renal impairment,3,M,OT,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Ventricular dysfunction,3,M,HO,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Ventricular dysfunction,3,M,DE,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Ventricular dysfunction,3,M,OT,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Vomiting,3,M,HO,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Vomiting,3,M,DE,134
174541601,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Vomiting,3,M,OT,134
174546412,1,Bladder neoplasm,2,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,HO,93
174546412,1,Bladder neoplasm,2,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,M,OT,93
174546412,1,Bladder neoplasm,2,F,EXP,nivolumab,1,PS,Kidney infection,1,M,HO,93
174546412,1,Bladder neoplasm,2,F,EXP,nivolumab,1,PS,Kidney infection,1,M,OT,93
174546412,1,Bladder neoplasm,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,93
174546412,1,Bladder neoplasm,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,93
174546412,1,Bladder neoplasm,2,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,93
174546412,1,Bladder neoplasm,2,F,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,93
174546412,1,Bladder neoplasm,2,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,HO,93
174546412,1,Bladder neoplasm,2,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,93
174546423,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Pulmonary sepsis,1,M,DE,32
174546423,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Pulmonary sepsis,1,M,HO,32
174546423,1,Malignant melanoma,3,F,EXP,ipilimumab,1,PS,Pulmonary sepsis,1,M,OT,32
174548411,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Pneumonia,1,M,HO,110
174548951,1,Cholangiocarcinoma,1,I,EXP,nivolumab,1,PS,Death,1,F,OT,804
174548951,1,Cholangiocarcinoma,1,I,EXP,nivolumab,1,PS,Death,1,F,DE,804
174548951,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Death,2,F,OT,692
174548951,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Death,2,F,DE,692
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Blood creatinine decreased,1,F,OT,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Blood creatinine decreased,1,F,HO,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone decreased,1,F,OT,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Blood thyroid stimulating hormone decreased,1,F,HO,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Crystal urine present,1,F,OT,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Crystal urine present,1,F,HO,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Haematocrit decreased,1,F,OT,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Haematocrit decreased,1,F,HO,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Haemoglobin decreased,1,F,OT,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Haemoglobin decreased,1,F,HO,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,OT,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Lymphocyte count decreased,1,F,HO,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Monocyte count decreased,1,F,OT,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Monocyte count decreased,1,F,HO,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Neutrophil count decreased,1,F,OT,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Neutrophil count decreased,1,F,HO,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Platelet count decreased,1,F,OT,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Platelet count decreased,1,F,HO,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Red blood cell count decreased,1,F,OT,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Red blood cell count decreased,1,F,HO,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Tachycardia,1,F,OT,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Tachycardia,1,F,HO,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Thrombocytopenia,1,F,OT,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Thrombocytopenia,1,F,HO,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,OT,1
174549142,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,White blood cell count decreased,1,F,HO,1
174551191,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Confusional state,1,M,HO,132
174551191,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Decreased appetite,1,M,HO,132
174551191,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Dehydration,1,M,HO,132
174551191,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Delirium,1,M,HO,132
174551191,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Fatigue,1,M,HO,132
174551191,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Hyponatraemia,1,M,HO,132
174551191,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Malaise,1,M,HO,132
174551191,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Muscular weakness,1,M,HO,132
174551191,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Urinary retention,1,M,HO,132
174551301,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Hypogammaglobulinaemia,1,M,HO,151
174551301,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Hyponatraemia,1,M,HO,151
174551301,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Oedema,1,M,HO,151
174551301,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Oedema peripheral,1,M,HO,151
174551301,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Pneumonia,1,M,HO,151
174551301,1,Waldenstrom's macroglobulinaemia,1,I,DIR,ibrutinib,1,PS,Pyrexia,1,M,HO,151
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Asthenia,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Decreased appetite,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Dermatitis acneiform,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Dyspepsia,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Dysuria,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Fatigue,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Flatulence,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Groin pain,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Haematuria,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Headache,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Malignant neoplasm progression,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Metastatic malignant melanoma,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Mucosal haemorrhage,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Muscle twitching,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Musculoskeletal pain,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Nausea,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Neck pain,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Product prescribing error,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Rash,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Sinus polyp,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Sinusitis,7,M,OT,1
174552901,7,Product used for unknown indication,1,I,EXP,trametinib,7,SS,Urticaria,7,M,OT,1
174554232,7,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,7,SS,Febrile neutropenia,7,F,OT,10
174554232,7,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,7,SS,Febrile neutropenia,7,F,HO,10
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Asthenia,2,M,DE,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Asthenia,2,M,LT,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Asthenia,2,M,HO,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Asthenia,2,M,OT,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Cellulitis,2,M,DE,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Cellulitis,2,M,LT,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Cellulitis,2,M,HO,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Cellulitis,2,M,OT,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Escherichia sepsis,2,M,DE,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Escherichia sepsis,2,M,LT,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Escherichia sepsis,2,M,HO,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Escherichia sepsis,2,M,OT,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Multiple organ dysfunction syndrome,2,M,DE,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Multiple organ dysfunction syndrome,2,M,LT,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Multiple organ dysfunction syndrome,2,M,HO,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Multiple organ dysfunction syndrome,2,M,OT,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Myocardial infarction,2,M,DE,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Myocardial infarction,2,M,LT,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Myocardial infarction,2,M,HO,28
174554622,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Myocardial infarction,2,M,OT,28
174556401,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Cough,1,M,OT,101
174556401,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Malaise,1,M,OT,101
174556401,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Oropharyngeal pain,1,M,OT,101
174556401,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Respiratory tract infection,1,M,OT,101
174556401,1,Prostate cancer,1,I,EXP,cabazitaxel,1,PS,Upper respiratory tract infection,1,M,OT,101
174558831,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,C,Altered state of consciousness,7,F,HO,5
174558831,7,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,7,C,Seizure,7,F,HO,5
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Cardiac failure,1,F,OT,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Cardiac failure,1,F,HO,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Cardiogenic shock,1,F,OT,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Cardiogenic shock,1,F,HO,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Feeling cold,1,F,OT,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Feeling cold,1,F,HO,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Headache,1,F,OT,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Headache,1,F,HO,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Hot flush,1,F,OT,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Hot flush,1,F,HO,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Incorrect dose administered,1,F,OT,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Incorrect dose administered,1,F,HO,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Memory impairment,1,F,OT,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Memory impairment,1,F,HO,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Ocular discomfort,1,F,OT,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Ocular discomfort,1,F,HO,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Palpitations,1,F,OT,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Palpitations,1,F,HO,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Tremor,1,F,OT,2
174562431,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Tremor,1,F,HO,2
174563621,1,Breast cancer metastatic,1,I,DIR,alpelisib,1,PS,Skin exfoliation,1,F,OT,29
174567521,1,Oesophageal adenocarcinoma,1,I,EXP,nivolumab,1,PS,Dehydration,1,M,HO,8
174567521,1,Oesophageal adenocarcinoma,1,I,EXP,nivolumab,1,PS,Hypotension,1,M,HO,8
174568732,1,Prostate cancer,2,F,EXP,nivolumab,1,PS,Dizziness postural,1,M,HO,168
174568732,1,Prostate cancer,2,F,EXP,nivolumab,1,PS,Hypotension,1,M,HO,168
174571321,1,Amyloidosis,1,I,EXP,pomalidomide,1,PS,Death,1,M,DE,203
174573692,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,General physical health deterioration,1,F,HO,6
174573692,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Pancytopenia,1,F,HO,6
174575004,7,Premedication,4,F,EXP,granisetron,7,C,Thrombosis,7,M,DE,10
174575004,7,Premedication,4,F,EXP,granisetron,7,C,Thrombosis,7,M,HO,10
174575004,14,Neutropenia,4,F,EXP,filgrastim,14,C,Thrombosis,14,M,DE,3
174575004,14,Neutropenia,4,F,EXP,filgrastim,14,C,Thrombosis,14,M,HO,3
174577511,4,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,4,SS,Dermatitis allergic,4,M,OT,409
174577511,4,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,4,SS,Dermatitis allergic,4,M,HO,409
174581581,6,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,6,SS,Febrile neutropenia,6,M,HO,19
174581581,6,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,6,SS,Upper gastrointestinal haemorrhage,6,M,HO,19
174582033,1,Plasma cell myeloma,3,F,PER,carfilzomib,1,PS,Infection,1,F,HO,69
174582033,6,Plasma cell myeloma,3,F,PER,lenalidomide,6,SS,Infection,6,F,HO,69
174582502,6,Product used for unknown indication,2,F,EXP,ruxolitinib phosphate,6,SS,Interstitial lung disease,6,F,LT,51
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Acute kidney injury,1,F,LT,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Acute kidney injury,1,F,DE,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Acute kidney injury,1,F,HO,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Anaemia,1,F,LT,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Anaemia,1,F,DE,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Anaemia,1,F,HO,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Febrile neutropenia,1,F,LT,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Febrile neutropenia,1,F,DE,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Febrile neutropenia,1,F,HO,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Hepatic encephalopathy,1,F,LT,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Hepatic encephalopathy,1,F,DE,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Hepatic encephalopathy,1,F,HO,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Hepatic failure,1,F,LT,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Hepatic failure,1,F,DE,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Hepatic failure,1,F,HO,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Multiple organ dysfunction syndrome,1,F,LT,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Multiple organ dysfunction syndrome,1,F,DE,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Multiple organ dysfunction syndrome,1,F,HO,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Neutropenia,1,F,LT,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Neutropenia,1,F,DE,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Neutropenia,1,F,HO,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Pneumonia,1,F,LT,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Pneumonia,1,F,DE,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Pneumonia,1,F,HO,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Renal failure,1,F,LT,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Renal failure,1,F,DE,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Renal failure,1,F,HO,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Sepsis,1,F,LT,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Sepsis,1,F,DE,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Sepsis,1,F,HO,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Septic shock,1,F,LT,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Septic shock,1,F,DE,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Septic shock,1,F,HO,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Thrombocytopenia,1,F,LT,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Thrombocytopenia,1,F,DE,16
174589282,1,Lymphoma,2,F,EXP,ibrutinib,1,PS,Thrombocytopenia,1,F,HO,16
174589672,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,F,HO,85
174589672,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Deep vein thrombosis,1,F,OT,85
174589672,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,SS,Deep vein thrombosis,3,F,HO,85
174589672,3,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,3,SS,Deep vein thrombosis,3,F,OT,85
174589672,4,Product used for unknown indication,2,F,EXP,denosumab,4,C,Deep vein thrombosis,4,F,HO,1437
174589672,4,Product used for unknown indication,2,F,EXP,denosumab,4,C,Deep vein thrombosis,4,F,OT,1437
174590211,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Anaemia,3,F,OT,13
174590211,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Diarrhoea,3,F,OT,13
174590211,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Fatigue,3,F,OT,13
174590211,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Gastrooesophageal reflux disease,3,F,OT,13
174590211,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Hypertension,3,F,OT,13
174590211,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Mucosal inflammation,3,F,OT,13
174590211,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Pain,3,F,OT,13
174590211,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Rash,3,F,OT,13
174590211,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Thrombocytopenia,3,F,OT,13
174592981,4,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,4,SS,Febrile neutropenia,4,M,OT,18
174592981,4,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,4,SS,Febrile neutropenia,4,M,HO,18
174592981,4,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,4,SS,Hyperammonaemia,4,M,OT,18
174592981,4,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,4,SS,Hyperammonaemia,4,M,HO,18
174592981,4,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,4,SS,Upper gastrointestinal haemorrhage,4,M,OT,18
174592981,4,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,4,SS,Upper gastrointestinal haemorrhage,4,M,HO,18
174593681,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Pancreatitis acute,1,M,HO,7
174593681,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Pancreatitis acute,1,M,OT,7
174593802,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Pneumonia,1,M,HO,1705
174594541,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Mental status changes,1,F,HO,5
174594541,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Respiratory syncytial virus infection,1,F,HO,5
174594681,17,Plasma cell myeloma,1,I,PER,carfilzomib,17,C,Pneumonia,17,M,HO,1847
174594681,19,Plasma cell myeloma,1,I,PER,daratumumab,19,C,Pneumonia,19,M,HO,455
174596833,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Alanine aminotransferase increased,2,F,OT,56
174596833,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Alanine aminotransferase increased,2,F,HO,56
174596833,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Aspartate aminotransferase increased,2,F,OT,56
174596833,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Aspartate aminotransferase increased,2,F,HO,56
174596833,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Gamma-glutamyltransferase increased,2,F,OT,56
174596833,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Gamma-glutamyltransferase increased,2,F,HO,56
174596833,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Hyperbilirubinaemia,2,F,OT,56
174596833,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,PS,Hyperbilirubinaemia,2,F,HO,56
174596833,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Alanine aminotransferase increased,3,F,OT,56
174596833,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Alanine aminotransferase increased,3,F,HO,56
174596833,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Aspartate aminotransferase increased,3,F,OT,56
174596833,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Aspartate aminotransferase increased,3,F,HO,56
174596833,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Gamma-glutamyltransferase increased,3,F,OT,56
174596833,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Gamma-glutamyltransferase increased,3,F,HO,56
174596833,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Hyperbilirubinaemia,3,F,OT,56
174596833,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Hyperbilirubinaemia,3,F,HO,56
174603101,3,Plasma cell myeloma,1,I,EXP,pomalidomide,3,SS,Fatigue,3,M,OT,51
174603101,3,Plasma cell myeloma,1,I,EXP,pomalidomide,3,SS,Neutropenia,3,M,OT,51
174603182,1,Bone giant cell tumour,2,F,PER,denosumab,1,PS,Pericarditis,1,M,HO,465
174603473,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Diarrhoea,1,F,DE,63
174603473,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Diarrhoea,1,F,HO,63
174603473,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Neutropenia,1,F,DE,63
174603473,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Neutropenia,1,F,HO,63
174603473,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Stomatitis,1,F,DE,63
174603473,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Stomatitis,1,F,HO,63
174603473,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Vomiting,1,F,DE,63
174603473,1,Colorectal cancer metastatic,3,F,PER,panitumumab,1,PS,Vomiting,1,F,HO,63
174608082,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Anaemia,1,M,HO,7
174608082,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Renal impairment,1,M,HO,7
174608082,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Respiratory tract infection,1,M,HO,7
174608082,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Thrombocytopenia,1,M,HO,7
174608521,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Atrial fibrillation,1,M,OT,1079
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Blood corticotrophin decreased,2,M,OT,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Blood corticotrophin decreased,2,M,HO,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Decreased appetite,2,M,OT,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Decreased appetite,2,M,HO,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Fatigue,2,M,OT,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Fatigue,2,M,HO,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,General physical health deterioration,2,M,OT,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,General physical health deterioration,2,M,HO,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Hypoglycaemia,2,M,OT,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Hypoglycaemia,2,M,HO,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Hyponatraemia,2,M,OT,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Hyponatraemia,2,M,HO,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Hypothyroidism,2,M,OT,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Hypothyroidism,2,M,HO,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Urinary tract infection pseudomonal,2,M,OT,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Urinary tract infection pseudomonal,2,M,HO,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Weight decreased,2,M,OT,277
174611282,2,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,2,SS,Weight decreased,2,M,HO,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Blood corticotrophin decreased,3,M,OT,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Blood corticotrophin decreased,3,M,HO,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Decreased appetite,3,M,OT,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Decreased appetite,3,M,HO,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Fatigue,3,M,OT,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Fatigue,3,M,HO,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,General physical health deterioration,3,M,OT,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,General physical health deterioration,3,M,HO,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Hypoglycaemia,3,M,OT,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Hypoglycaemia,3,M,HO,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Hyponatraemia,3,M,OT,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Hyponatraemia,3,M,HO,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Hypothyroidism,3,M,OT,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Hypothyroidism,3,M,HO,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Urinary tract infection pseudomonal,3,M,OT,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Urinary tract infection pseudomonal,3,M,HO,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Weight decreased,3,M,OT,277
174611282,3,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,3,SS,Weight decreased,3,M,HO,277
174612741,2,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,2,SS,Angle closure glaucoma,2,F,DS,11
174612741,2,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,2,SS,Blindness,2,F,DS,11
174614501,1,Plasma cell myeloma,1,I,DIR,lenalidomide,1,PS,Adenocarcinoma,1,M,OT,1185
174614501,1,Plasma cell myeloma,1,I,DIR,lenalidomide,1,PS,Adenoma benign,1,M,OT,1185
174614501,1,Plasma cell myeloma,1,I,DIR,lenalidomide,1,PS,Inguinal hernia,1,M,OT,1185
174614501,1,Plasma cell myeloma,1,I,DIR,lenalidomide,1,PS,Rectal polyp,1,M,OT,1185
174617191,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Pituitary haemorrhage,1,M,OT,148
174617191,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Pituitary haemorrhage,1,M,HO,148
174617191,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Tumour lysis syndrome,1,M,OT,148
174617191,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Tumour lysis syndrome,1,M,HO,148
174624181,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Infusion related reaction,2,M,OT,20
174624181,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Prescribed underdose,2,M,OT,20
174625361,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Chills,1,M,HO,28
174625361,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Off label use,1,M,HO,28
174625361,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,28
174625361,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Rash,1,M,HO,28
174625361,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Chills,2,M,HO,28
174625361,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Off label use,2,M,HO,28
174625361,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Pyrexia,2,M,HO,28
174625361,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Rash,2,M,HO,28
174625972,1,Renal cancer,2,F,EXP,nivolumab,1,SS,Drug ineffective,1,F,HO,317
174625972,1,Renal cancer,2,F,EXP,nivolumab,1,SS,Drug ineffective,1,F,OT,317
174625972,1,Renal cancer,2,F,EXP,nivolumab,1,SS,Fluid retention,1,F,HO,317
174625972,1,Renal cancer,2,F,EXP,nivolumab,1,SS,Fluid retention,1,F,OT,317
174625972,1,Renal cancer,2,F,EXP,nivolumab,1,SS,Haemorrhage,1,F,HO,317
174625972,1,Renal cancer,2,F,EXP,nivolumab,1,SS,Haemorrhage,1,F,OT,317
174625982,1,Mantle cell lymphoma,2,F,EXP,ibrutinib,1,PS,Pericardial effusion,1,M,LT,82
174625982,1,Mantle cell lymphoma,2,F,EXP,ibrutinib,1,PS,Pericardial effusion,1,M,HO,82
174625982,1,Mantle cell lymphoma,2,F,EXP,ibrutinib,1,PS,Pneumonia,1,M,LT,82
174625982,1,Mantle cell lymphoma,2,F,EXP,ibrutinib,1,PS,Pneumonia,1,M,HO,82
174626181,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,White blood cell count increased,1,M,HO,35
174627261,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,50
174627261,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,50
174627261,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,50
174627261,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,DE,50
174627452,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Circulatory collapse,3,M,HO,1073
174627452,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Dehydration,3,M,HO,1073
174627741,1,Chronic lymphocytic leukaemia,1,I,EXP,idelalisib,1,PS,Death,1,M,OT,197
174627741,1,Chronic lymphocytic leukaemia,1,I,EXP,idelalisib,1,PS,Death,1,M,DE,197
174628511,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,DS,1
174628511,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,OT,1
174628511,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Dupuytren's contracture,1,F,DS,1
174628511,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Dupuytren's contracture,1,F,OT,1
174628511,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Muscle fatigue,1,F,DS,1
174628511,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Muscle fatigue,1,F,OT,1
174628511,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,DS,1
174628511,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,OT,1
174628511,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Tendonitis,1,F,DS,1
174628511,1,Osteoarthritis,1,I,EXP,zoledronic acid,1,PS,Tendonitis,1,F,OT,1
174628961,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Hypoaesthesia,1,M,HO,255
174628961,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Hypothyroidism,1,M,HO,255
174628961,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Immune thrombocytopenic purpura,1,M,HO,255
174628961,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Multiple sclerosis relapse,1,M,HO,255
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Asthenia,1,M,OT,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Asthenia,1,M,DE,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Asthenia,1,M,HO,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Back pain,1,M,OT,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Back pain,1,M,DE,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Back pain,1,M,HO,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Off label use,1,M,OT,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Off label use,1,M,DE,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Off label use,1,M,HO,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Rash,1,M,OT,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Rash,1,M,DE,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Rash,1,M,HO,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Seborrhoeic keratosis,1,M,OT,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Seborrhoeic keratosis,1,M,DE,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Seborrhoeic keratosis,1,M,HO,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Weight decreased,1,M,DE,33
174630441,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Weight decreased,1,M,HO,33
174631742,4,Premedication,2,F,EXP,granisetron,4,C,Fall,4,M,HO,198
174631742,4,Premedication,2,F,EXP,granisetron,4,C,Hip fracture,4,M,HO,198
174633703,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,116
174633703,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,116
174633703,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Diaphragmatic hernia,1,M,HO,116
174633703,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Diaphragmatic hernia,1,M,OT,116
174633703,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Embolism,1,M,HO,116
174633703,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Embolism,1,M,OT,116
174633703,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,HO,116
174633703,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,116
174634122,2,Plasma cell myeloma,2,F,EXP,daratumumab,2,SS,Basal cell carcinoma,2,M,OT,261
174634181,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,114
174634181,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,114
174634542,14,B precursor type acute leukaemia,2,F,EXP,pegaspargase,14,SS,Cystitis haemorrhagic,14,M,HO,11
174634551,4,Diffuse large B-cell lymphoma,1,I,EXP,chop,4,SS,Activated partial thromboplastin time shortened,4,F,OT,620
174634551,4,Diffuse large B-cell lymphoma,1,I,EXP,chop,4,SS,Blood creatinine increased,4,F,OT,620
174634551,4,Diffuse large B-cell lymphoma,1,I,EXP,chop,4,SS,Congestive cardiomyopathy,4,F,OT,620
174634551,4,Diffuse large B-cell lymphoma,1,I,EXP,chop,4,SS,Haemoglobin decreased,4,F,OT,620
174634551,4,Diffuse large B-cell lymphoma,1,I,EXP,chop,4,SS,International normalised ratio decreased,4,F,OT,620
174634551,4,Diffuse large B-cell lymphoma,1,I,EXP,chop,4,SS,Platelet count decreased,4,F,OT,620
174634591,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Colitis,1,F,HO,873
174634591,5,Plasma cell myeloma,1,I,EXP,lenalidomide,5,SS,Colitis,5,F,HO,873
174637052,1,Prostate cancer,2,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,M,LT,14
174637052,1,Prostate cancer,2,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,M,HO,14
174637052,1,Prostate cancer,2,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,M,OT,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,HO,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,OT,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,LT,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Atrioventricular block complete,1,M,HO,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Atrioventricular block complete,1,M,OT,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Atrioventricular block complete,1,M,LT,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Dysphagia,1,M,HO,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Dysphagia,1,M,OT,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Dysphagia,1,M,LT,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,General physical health deterioration,1,M,LT,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Hypertensive crisis,1,M,HO,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Hypertensive crisis,1,M,OT,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Hypertensive crisis,1,M,LT,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Myalgia,1,M,HO,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Myalgia,1,M,OT,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Myalgia,1,M,LT,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Off label use,1,M,HO,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Off label use,1,M,OT,14
174638701,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Off label use,1,M,LT,14
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Aortic aneurysm,2,F,HO,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Aortic aneurysm,2,F,OT,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Aphthous ulcer,2,F,HO,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Aphthous ulcer,2,F,OT,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Back pain,2,F,HO,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Back pain,2,F,OT,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Drug-induced liver injury,2,F,HO,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Drug-induced liver injury,2,F,OT,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Endocarditis bacterial,2,F,HO,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Endocarditis bacterial,2,F,OT,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Myopathy,2,F,HO,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Myopathy,2,F,OT,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Oedema,2,F,HO,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Oedema,2,F,OT,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Pneumonia,2,F,HO,29
174639211,2,B-cell lymphoma,1,I,EXP,idelalisib,2,SS,Pneumonia,2,F,OT,29
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Arrhythmia,15,F,HO,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Arrhythmia,15,F,OT,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Chest pain,15,F,HO,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Chest pain,15,F,OT,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Decreased appetite,15,F,HO,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Decreased appetite,15,F,OT,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Dyspnoea,15,F,HO,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Dyspnoea,15,F,OT,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Hypoxia,15,F,HO,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Hypoxia,15,F,OT,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Infection,15,F,HO,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Infection,15,F,OT,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Nausea,15,F,HO,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Nausea,15,F,OT,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Neoplasm progression,15,F,HO,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Neoplasm progression,15,F,OT,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Pyrexia,15,F,HO,49
174642212,15,Metastases to bone,2,F,EXP,denosumab,15,C,Pyrexia,15,F,OT,49
174642603,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,PS,Sepsis,2,M,HO,81
174642603,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,PS,Sepsis,2,M,OT,81
174642603,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,PS,Urinary tract infection,2,M,HO,81
174642603,2,Renal cell carcinoma,3,F,EXP,nivolumab,2,PS,Urinary tract infection,2,M,OT,81
174643241,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Febrile neutropenia,9,M,HO,6
174643241,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Herpes simplex,9,M,HO,6
174643241,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Staphylococcal infection,9,M,HO,6
174644691,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Chills,2,M,HO,623
174644691,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Pleurisy,2,M,HO,623
174647233,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Acute kidney injury,1,M,OT,34
174647233,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Acute kidney injury,1,M,HO,34
174647233,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Dermatitis exfoliative generalised,1,M,OT,34
174647233,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Dermatitis exfoliative generalised,1,M,HO,34
174647233,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Influenza,1,M,OT,34
174647233,1,Plasma cell myeloma,3,F,EXP,lenalidomide,1,PS,Influenza,1,M,HO,34
174647233,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Acute kidney injury,2,M,OT,34
174647233,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Acute kidney injury,2,M,HO,34
174647233,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Dermatitis exfoliative generalised,2,M,OT,34
174647233,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Dermatitis exfoliative generalised,2,M,HO,34
174647233,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Influenza,2,M,OT,34
174647233,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Influenza,2,M,HO,34
174649784,3,Renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Adrenal insufficiency,3,F,OT,536
174649784,3,Renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Adrenal insufficiency,3,F,HO,536
174649784,3,Renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Hypophysitis,3,F,OT,536
174649784,3,Renal cell carcinoma,4,F,EXP,nivolumab,3,SS,Hypophysitis,3,F,HO,536
174650431,2,Plasma cell myeloma,1,I,EXP,carfilzomib,2,SS,Mental status changes,2,F,HO,5
174650431,2,Plasma cell myeloma,1,I,EXP,carfilzomib,2,SS,Respiratory syncytial virus infection,2,F,HO,5
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Aphasia,1,M,HO,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Aphasia,1,M,OT,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Ataxia,1,M,HO,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Ataxia,1,M,OT,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Bradyphrenia,1,M,HO,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Bradyphrenia,1,M,OT,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Depressed level of consciousness,1,M,HO,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Depressed level of consciousness,1,M,OT,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Headache,1,M,HO,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Headache,1,M,OT,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Memory impairment,1,M,HO,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Memory impairment,1,M,OT,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Nausea,1,M,HO,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Nausea,1,M,OT,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Tremor,1,M,HO,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Tremor,1,M,OT,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Vomiting,1,M,HO,4
174651082,1,Diffuse large B-cell lymphoma,2,F,EXP,axicabtagene ciloleucel,1,PS,Vomiting,1,M,OT,4
174651112,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Anaemia,1,M,OT,21
174651112,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Anaemia,1,M,HO,21
174651112,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Ileus,1,M,OT,21
174651112,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Ileus,1,M,HO,21
174651112,4,Renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Anaemia,4,M,OT,21
174651112,4,Renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Anaemia,4,M,HO,21
174651112,4,Renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Ileus,4,M,OT,21
174651112,4,Renal cell carcinoma,2,F,EXP,ipilimumab,4,SS,Ileus,4,M,HO,21
174653321,2,Plasma cell myeloma,1,I,PER,lenalidomide,2,C,Staphylococcal infection,2,M,OT,69
174653811,2,Chronic hepatitis C,1,I,EXP,peginterferon alfa-2b,2,SS,Depression,2,F,HO,47
174653811,2,Chronic hepatitis C,1,I,EXP,peginterferon alfa-2b,2,SS,Depression,2,F,OT,47
174653811,2,Chronic hepatitis C,1,I,EXP,peginterferon alfa-2b,2,SS,Suicide attempt,2,F,HO,47
174653811,2,Chronic hepatitis C,1,I,EXP,peginterferon alfa-2b,2,SS,Suicide attempt,2,F,OT,47
174655101,1,Renal cancer,1,I,EXP,ipilimumab,1,PS,Diarrhoea,1,M,HO,164
174655101,1,Renal cancer,1,I,EXP,ipilimumab,1,PS,Presyncope,1,M,HO,164
174655101,2,Renal cancer,1,I,EXP,nivolumab,2,SS,Diarrhoea,2,M,HO,164
174655101,2,Renal cancer,1,I,EXP,nivolumab,2,SS,Presyncope,2,M,HO,164
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Abdominal distension,1,F,OT,1
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Dizziness,1,F,OT,1
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Dyspepsia,1,F,OT,1
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Fall,1,F,OT,1
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Joint swelling,1,F,OT,1
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Nausea,1,F,OT,1
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Periorbital swelling,1,F,OT,1
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Peripheral swelling,1,F,OT,1
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Pruritus,1,F,OT,1
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Rash,1,F,OT,1
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Scratch,1,F,OT,1
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Seizure,1,F,OT,1
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Swelling face,1,F,OT,1
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Syncope,1,F,OT,1
174661161,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Xanthelasma,1,F,OT,1
174664701,1,Relapsing multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Herpes zoster,1,M,HO,205
174664701,1,Relapsing multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Pneumonia,1,M,HO,205
174664701,1,Relapsing multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Urosepsis,1,M,HO,205
174665221,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Herpes zoster,1,M,OT,44
174665221,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Herpes zoster,1,M,HO,44
174665221,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Renal failure,1,M,OT,44
174665221,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Renal failure,1,M,HO,44
174665221,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Herpes zoster,2,M,OT,44
174665221,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Herpes zoster,2,M,HO,44
174665221,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Renal failure,2,M,OT,44
174665221,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Renal failure,2,M,HO,44
174667562,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Progressive multifocal leukoencephalopathy,1,M,LT,2261
174667562,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Progressive multifocal leukoencephalopathy,1,M,OT,2261
174667562,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Progressive multifocal leukoencephalopathy,1,M,HO,2261
174675761,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Cardiac failure congestive,1,M,HO,12
174675761,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Cardiac failure congestive,1,M,OT,12
174675761,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Throat tightness,1,M,HO,12
174675761,1,Product used for unknown indication,1,I,EXP,enzalutamide,1,PS,Throat tightness,1,M,OT,12
174675921,1,Jessner's lymphocytic infiltration,1,I,EXP,thalidomide,1,PS,Trismus,1,M,HO,2
174684741,3,Plasma cell myeloma,1,I,PER,daratumumab,3,SS,Abdominal pain,3,F,HO,12
174684741,3,Plasma cell myeloma,1,I,PER,daratumumab,3,SS,Abdominal pain,3,F,LT,12
174684741,3,Plasma cell myeloma,1,I,PER,daratumumab,3,SS,Pain in extremity,3,F,HO,12
174684741,3,Plasma cell myeloma,1,I,PER,daratumumab,3,SS,Pain in extremity,3,F,LT,12
174684741,3,Plasma cell myeloma,1,I,PER,daratumumab,3,SS,Pyrexia,3,F,HO,12
174684741,3,Plasma cell myeloma,1,I,PER,daratumumab,3,SS,Pyrexia,3,F,LT,12
174688071,1,Glioblastoma,1,I,DIR,abemaciclib,1,PS,Arrhythmia,1,M,DE,139
174688071,1,Glioblastoma,1,I,DIR,abemaciclib,1,PS,Dehydration,1,M,DE,139
174688071,1,Glioblastoma,1,I,DIR,abemaciclib,1,PS,Diarrhoea,1,M,DE,139
174688071,1,Glioblastoma,1,I,DIR,abemaciclib,1,PS,Fatigue,1,M,DE,139
174688071,1,Glioblastoma,1,I,DIR,abemaciclib,1,PS,Glioblastoma,1,M,DE,139
174688071,1,Glioblastoma,1,I,DIR,abemaciclib,1,PS,Lethargy,1,M,DE,139
174688071,1,Glioblastoma,1,I,DIR,abemaciclib,1,PS,Supraventricular tachycardia,1,M,DE,139
174692921,1,Chronic hepatitis C,1,I,EXP,peginterferon alfa-2b,1,PS,Syncope,1,M,HO,15
174693302,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Hypoxia,3,F,HO,1
174693302,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Pneumonia,3,F,HO,1
174693302,5,Plasma cell myeloma,2,F,EXP,lenalidomide,5,SS,Hypoxia,5,F,HO,1
174693302,5,Plasma cell myeloma,2,F,EXP,lenalidomide,5,SS,Pneumonia,5,F,HO,1
174694762,27,White blood cell count increased,2,F,EXP,filgrastim,27,C,Influenza,27,M,HO,171
174694982,8,Plasma cell myeloma,2,F,PER,carfilzomib,8,SS,Sepsis,8,M,HO,1261
174694982,10,Plasma cell myeloma,2,F,PER,daratumumab,10,SS,Sepsis,10,M,HO,1003
174695411,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Lung cancer metastatic,1,M,OT,2998
174695411,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Lung cancer metastatic,1,M,DE,2998
174695896,1,Renal cell carcinoma,6,F,EXP,axitinib,1,PS,Hepatitis,1,M,HO,814
174695931,1,Non-small cell lung cancer,1,I,EXP,lorlatinib,1,PS,Death,1,M,DE,56
174696402,1,Inflammatory myofibroblastic tumour,2,F,EXP,crizotinib,1,PS,Influenza,1,F,HO,53
174696713,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Respiratory failure,1,M,HO,278
174696713,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Seizure,1,M,HO,278
174696713,1,Plasma cell myeloma,3,F,EXP,daratumumab,1,PS,Septic shock,1,M,HO,278
174696713,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Respiratory failure,2,M,HO,278
174696713,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Seizure,2,M,HO,278
174696713,2,Plasma cell myeloma,3,F,EXP,carfilzomib,2,SS,Septic shock,2,M,HO,278
174696842,1,Non-small cell lung cancer stage IV,2,F,EXP,nivolumab,1,PS,Myocardial necrosis marker increased,1,M,HO,49
174696842,1,Non-small cell lung cancer stage IV,2,F,EXP,nivolumab,1,PS,Myocardial necrosis marker increased,1,M,OT,49
174696842,2,Non-small cell lung cancer stage IV,2,F,EXP,ipilimumab,2,SS,Myocardial necrosis marker increased,2,M,HO,49
174696842,2,Non-small cell lung cancer stage IV,2,F,EXP,ipilimumab,2,SS,Myocardial necrosis marker increased,2,M,OT,49
174696842,4,Non-small cell lung cancer stage IV,2,F,EXP,pemetrexed disodium,4,SS,Myocardial necrosis marker increased,4,M,HO,49
174696842,4,Non-small cell lung cancer stage IV,2,F,EXP,pemetrexed disodium,4,SS,Myocardial necrosis marker increased,4,M,OT,49
174697711,45,Prophylaxis,1,I,EXP,zoledronic acid,45,C,Respiratory tract infection,45,M,HO,330
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Cholangitis,1,M,DE,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Cholangitis,1,M,HO,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Cholangitis,1,M,OT,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Drug eruption,1,M,DE,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Drug eruption,1,M,HO,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Drug eruption,1,M,OT,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Hepatic function abnormal,1,M,DE,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Hepatic function abnormal,1,M,HO,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Hepatic function abnormal,1,M,OT,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,M,DE,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,M,HO,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Malignant neoplasm progression,1,M,OT,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Pancreatitis,1,M,DE,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Pancreatitis,1,M,HO,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Pancreatitis,1,M,OT,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Prescribed overdose,1,M,DE,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Prescribed overdose,1,M,HO,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Prescribed overdose,1,M,OT,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Pyrexia,1,M,DE,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Pyrexia,1,M,HO,53
174698501,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Pyrexia,1,M,OT,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Cholangitis,2,M,DE,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Cholangitis,2,M,HO,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Cholangitis,2,M,OT,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Drug eruption,2,M,DE,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Drug eruption,2,M,HO,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Drug eruption,2,M,OT,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Hepatic function abnormal,2,M,DE,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Hepatic function abnormal,2,M,HO,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Hepatic function abnormal,2,M,OT,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Malignant neoplasm progression,2,M,DE,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Malignant neoplasm progression,2,M,HO,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Malignant neoplasm progression,2,M,OT,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Pancreatitis,2,M,DE,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Pancreatitis,2,M,HO,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Pancreatitis,2,M,OT,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Prescribed overdose,2,M,DE,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Prescribed overdose,2,M,HO,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Prescribed overdose,2,M,OT,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Pyrexia,2,M,DE,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Pyrexia,2,M,HO,53
174698501,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Pyrexia,2,M,OT,53
174699921,1,Thyroid cancer,1,I,EXP,nivolumab,1,PS,Dizziness,1,F,HO,681
174699921,1,Thyroid cancer,1,I,EXP,nivolumab,1,PS,Hypotension,1,F,HO,681
174699921,2,Thyroid cancer,1,I,EXP,ipilimumab,2,SS,Dizziness,2,F,HO,672
174699921,2,Thyroid cancer,1,I,EXP,ipilimumab,2,SS,Hypotension,2,F,HO,672
174699952,5,Plasma cell myeloma,2,F,EXP,carfilzomib,5,SS,Dyspnoea,5,F,HO,7
174699952,5,Plasma cell myeloma,2,F,EXP,carfilzomib,5,SS,Pneumonia,5,F,HO,7
174699952,7,Plasma cell myeloma,2,F,EXP,lenalidomide,7,SS,Dyspnoea,7,F,HO,99
174699952,7,Plasma cell myeloma,2,F,EXP,lenalidomide,7,SS,Pneumonia,7,F,HO,99
174700031,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Pyrexia,3,F,HO,60
174700031,5,Plasma cell myeloma,1,I,EXP,carfilzomib,5,SS,Pyrexia,5,F,HO,60
174701221,3,Breast cancer,1,I,EXP,alpelisib,3,SS,Blood glucose increased,3,F,OT,7
174701221,3,Breast cancer,1,I,EXP,alpelisib,3,SS,Drug intolerance,3,F,OT,7
174701221,3,Breast cancer,1,I,EXP,alpelisib,3,SS,Glycosylated haemoglobin increased,3,F,OT,7
174701483,2,Small cell lung cancer,3,F,EXP,avelumab,2,SS,Respiratory tract infection,2,M,HO,31
174706451,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Atrial fibrillation,2,M,OT,6
174706451,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Atrial fibrillation,2,M,HO,6
174706451,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Neutrophil count decreased,2,M,OT,6
174706451,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Neutrophil count decreased,2,M,HO,6
174706451,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Platelet count decreased,2,M,OT,6
174706451,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Platelet count decreased,2,M,HO,6
174706451,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Sepsis,2,M,OT,6
174706451,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Sepsis,2,M,HO,6
174712821,1,Head and neck cancer,1,I,EXP,nivolumab,1,PS,Chest discomfort,1,M,HO,63
174712821,1,Head and neck cancer,1,I,EXP,nivolumab,1,PS,Dyspnoea exertional,1,M,HO,63
174714181,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Neutropenia,2,M,HO,41
174714181,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Neutropenia,2,M,OT,41
174714181,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Varicella,2,M,HO,41
174714181,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Varicella,2,M,OT,41
174715552,1,Neoplasm,2,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,HO,33
174715552,1,Neoplasm,2,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,OT,33
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Abdominal distension,1,F,OT,1
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Dizziness,1,F,OT,1
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Dyspepsia,1,F,OT,1
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Fall,1,F,OT,1
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Joint swelling,1,F,OT,1
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Nausea,1,F,OT,1
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Periorbital swelling,1,F,OT,1
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Peripheral swelling,1,F,OT,1
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Pruritus,1,F,OT,1
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Rash,1,F,OT,1
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Scratch,1,F,OT,1
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Seizure,1,F,OT,1
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Swelling face,1,F,OT,1
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Syncope,1,F,OT,1
174719811,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Xanthelasma,1,F,OT,1
174723471,2,Product used for unknown indication,1,I,EXP,ipilimumab,2,SS,Mental status changes,2,M,HO,495
174723471,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Mental status changes,3,M,HO,474
174723471,4,Product used for unknown indication,1,I,EXP,ipilimumab,4,SS,Mental status changes,4,M,HO,455
174723471,5,Prostate cancer,1,I,EXP,apalutamide,5,SS,Mental status changes,5,M,HO,584
174726951,1,Bladder cancer,1,I,DIR,degarelix,1,PS,Asthenia,1,M,HO,243
174726951,1,Bladder cancer,1,I,DIR,degarelix,1,PS,Blood glucose increased,1,M,HO,243
174726951,1,Bladder cancer,1,I,DIR,degarelix,1,PS,Diabetic hyperosmolar coma,1,M,HO,243
174726951,1,Bladder cancer,1,I,DIR,degarelix,1,PS,Dysarthria,1,M,HO,243
174726951,1,Bladder cancer,1,I,DIR,degarelix,1,PS,Dysphagia,1,M,HO,243
174726951,1,Bladder cancer,1,I,DIR,degarelix,1,PS,Fatigue,1,M,HO,243
174726951,1,Bladder cancer,1,I,DIR,degarelix,1,PS,Mental status changes,1,M,HO,243
174726951,1,Bladder cancer,1,I,DIR,degarelix,1,PS,Muscle spasms,1,M,HO,243
174726951,1,Bladder cancer,1,I,DIR,degarelix,1,PS,Thirst,1,M,HO,243
174727351,1,Breast cancer metastatic,1,I,DIR,abemaciclib,1,PS,Malignant neoplasm progression,1,F,DE,39
174727351,1,Breast cancer metastatic,1,I,DIR,abemaciclib,1,PS,Pneumonitis,1,F,DE,39
174727351,1,Breast cancer metastatic,1,I,DIR,abemaciclib,1,PS,Pulmonary alveolar haemorrhage,1,F,DE,39
174727351,1,Breast cancer metastatic,1,I,DIR,abemaciclib,1,PS,Pulmonary embolism,1,F,DE,39
174727351,1,Breast cancer metastatic,1,I,DIR,abemaciclib,1,PS,Pulmonary oedema,1,F,DE,39
174727351,1,Breast cancer metastatic,1,I,DIR,abemaciclib,1,PS,Respiratory failure,1,F,DE,39
174727351,1,Breast cancer metastatic,1,I,DIR,abemaciclib,1,PS,Upper respiratory tract infection,1,F,DE,39
174732651,14,Product used for unknown indication,1,I,PER,daratumumab,14,SS,Sepsis,14,M,HO,6
174732651,14,Product used for unknown indication,1,I,PER,daratumumab,14,SS,Urosepsis,14,M,HO,6
174735681,1,Malignant melanoma,1,I,EXP,trametinib,1,PS,Uveitis,1,F,HO,168
174735681,1,Malignant melanoma,1,I,EXP,trametinib,1,PS,Uveitis,1,F,OT,168
174736672,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Tumour lysis syndrome,1,F,OT,1
174736672,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Tumour lysis syndrome,1,F,HO,1
174736672,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Tumour lysis syndrome,1,F,LT,1
174736672,3,Plasma cell myeloma,2,F,PER,lenalidomide,3,SS,Tumour lysis syndrome,3,F,OT,28
174736672,3,Plasma cell myeloma,2,F,PER,lenalidomide,3,SS,Tumour lysis syndrome,3,F,HO,28
174736672,3,Plasma cell myeloma,2,F,PER,lenalidomide,3,SS,Tumour lysis syndrome,3,F,LT,28
174736672,9,Bone disorder,2,F,PER,zoledronic acid,9,C,Tumour lysis syndrome,9,F,OT,1
174736672,9,Bone disorder,2,F,PER,zoledronic acid,9,C,Tumour lysis syndrome,9,F,HO,1
174736672,9,Bone disorder,2,F,PER,zoledronic acid,9,C,Tumour lysis syndrome,9,F,LT,1
174737081,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Colitis,1,M,HO,27
174752071,1,Mantle cell lymphoma,1,I,EXP,lenalidomide,1,PS,Lip squamous cell carcinoma,1,M,OT,139
174760771,3,Metastases to bone,1,I,EXP,zoledronic acid,3,C,Face oedema,3,F,OT,82
174760771,3,Metastases to bone,1,I,EXP,zoledronic acid,3,C,Hepatic function abnormal,3,F,OT,82
174760771,3,Metastases to bone,1,I,EXP,zoledronic acid,3,C,Neutropenia,3,F,OT,82
174760771,3,Metastases to bone,1,I,EXP,zoledronic acid,3,C,Rash pruritic,3,F,OT,82
174764411,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Altered state of consciousness,8,F,HO,5
174764411,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Seizure,8,F,HO,5
174770281,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,18
174773611,1,Colorectal cancer metastatic,1,I,PER,panitumumab,1,PS,Malnutrition,1,M,HO,64
174776102,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Hypotension,1,F,OT,47
174776102,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Hypotension,1,F,HO,47
174776102,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Hypotension,1,F,LT,47
174776102,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Immune-mediated myocarditis,1,F,OT,47
174776102,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Immune-mediated myocarditis,1,F,HO,47
174776102,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Immune-mediated myocarditis,1,F,LT,47
174776102,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Ventricular tachycardia,1,F,OT,47
174776102,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Ventricular tachycardia,1,F,HO,47
174776102,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,PS,Ventricular tachycardia,1,F,LT,47
174776102,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hypotension,2,F,OT,47
174776102,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hypotension,2,F,HO,47
174776102,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hypotension,2,F,LT,47
174776102,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Immune-mediated myocarditis,2,F,OT,47
174776102,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Immune-mediated myocarditis,2,F,HO,47
174776102,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Immune-mediated myocarditis,2,F,LT,47
174776102,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Ventricular tachycardia,2,F,OT,47
174776102,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Ventricular tachycardia,2,F,HO,47
174776102,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,SS,Ventricular tachycardia,2,F,LT,47
174776271,1,Non-small cell lung cancer metastatic,1,I,EXP,brigatinib,1,PS,Non-small cell lung cancer,1,F,OT,79
174776492,1,Ovarian cancer metastatic,2,F,EXP,nivolumab,1,PS,Age-related macular degeneration,1,F,OT,34
174776492,1,Ovarian cancer metastatic,2,F,EXP,nivolumab,1,PS,Lymphocyte count decreased,1,F,OT,34
174776492,1,Ovarian cancer metastatic,2,F,EXP,nivolumab,1,PS,Neutrophil count decreased,1,F,OT,34
174776492,1,Ovarian cancer metastatic,2,F,EXP,nivolumab,1,PS,Retinal artery occlusion,1,F,OT,34
174776492,1,Ovarian cancer metastatic,2,F,EXP,nivolumab,1,PS,Retinal vascular disorder,1,F,OT,34
174776492,1,Ovarian cancer metastatic,2,F,EXP,nivolumab,1,PS,Vision blurred,1,F,OT,34
174776492,3,Ovarian cancer metastatic,2,F,EXP,ipilimumab,3,SS,Age-related macular degeneration,3,F,OT,34
174776492,3,Ovarian cancer metastatic,2,F,EXP,ipilimumab,3,SS,Lymphocyte count decreased,3,F,OT,34
174776492,3,Ovarian cancer metastatic,2,F,EXP,ipilimumab,3,SS,Neutrophil count decreased,3,F,OT,34
174776492,3,Ovarian cancer metastatic,2,F,EXP,ipilimumab,3,SS,Retinal artery occlusion,3,F,OT,34
174776492,3,Ovarian cancer metastatic,2,F,EXP,ipilimumab,3,SS,Retinal vascular disorder,3,F,OT,34
174776492,3,Ovarian cancer metastatic,2,F,EXP,ipilimumab,3,SS,Vision blurred,3,F,OT,34
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Alopecia,9,F,OT,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Alopecia,9,F,HO,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Constipation,9,F,OT,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Constipation,9,F,HO,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Febrile neutropenia,9,F,OT,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Febrile neutropenia,9,F,HO,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Headache,9,F,OT,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Headache,9,F,HO,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Nausea,9,F,OT,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Nausea,9,F,HO,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Neurotoxicity,9,F,OT,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Neurotoxicity,9,F,HO,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Oropharyngeal pain,9,F,OT,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Oropharyngeal pain,9,F,HO,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Rectal haemorrhage,9,F,OT,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Rectal haemorrhage,9,F,HO,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Stomatitis,9,F,OT,132
174777401,9,Breast cancer,1,I,EXP,denosumab,9,SS,Stomatitis,9,F,HO,132
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Abdominal pain,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Alanine aminotransferase increased,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Anaemia,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Aspartate aminotransferase increased,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Blood creatinine increased,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Blood urea increased,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Constipation,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Decreased appetite,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Device related infection,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Diarrhoea,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Dry skin,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Face oedema,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Gamma-glutamyltransferase increased,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Haematocrit decreased,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Hypernatraemia,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Hypoalbuminaemia,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Hypokalaemia,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Leukocyturia,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Lymphocyte count decreased,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Malaise,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Pain,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Platelet count decreased,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Pyrexia,1,F,OT,3
174778201,1,Neuroblastoma,1,I,PER,filgrastim,1,PS,Vomiting,1,F,OT,3
174778411,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Adenocarcinoma,2,M,OT,1185
174779011,1,Adenoid cystic carcinoma,1,I,EXP,axitinib,1,PS,Death,1,M,HO,177
174779011,1,Adenoid cystic carcinoma,1,I,EXP,axitinib,1,PS,Death,1,M,DE,177
174779011,1,Adenoid cystic carcinoma,1,I,EXP,axitinib,1,PS,Dehydration,1,M,HO,177
174779011,1,Adenoid cystic carcinoma,1,I,EXP,axitinib,1,PS,Dehydration,1,M,DE,177
174779011,1,Adenoid cystic carcinoma,1,I,EXP,axitinib,1,PS,Dyspnoea,1,M,HO,177
174779011,1,Adenoid cystic carcinoma,1,I,EXP,axitinib,1,PS,Dyspnoea,1,M,DE,177
174779011,2,Adenoid cystic carcinoma,1,I,EXP,avelumab,2,SS,Death,2,M,HO,177
174779011,2,Adenoid cystic carcinoma,1,I,EXP,avelumab,2,SS,Death,2,M,DE,177
174779011,2,Adenoid cystic carcinoma,1,I,EXP,avelumab,2,SS,Dehydration,2,M,HO,177
174779011,2,Adenoid cystic carcinoma,1,I,EXP,avelumab,2,SS,Dehydration,2,M,DE,177
174779011,2,Adenoid cystic carcinoma,1,I,EXP,avelumab,2,SS,Dyspnoea,2,M,HO,177
174779011,2,Adenoid cystic carcinoma,1,I,EXP,avelumab,2,SS,Dyspnoea,2,M,DE,177
174779731,1,Metastatic malignant melanoma,1,I,EXP,nivolumab,1,PS,Ketoacidosis,1,M,LT,38
174779731,1,Metastatic malignant melanoma,1,I,EXP,nivolumab,1,PS,Ketoacidosis,1,M,HO,38
174779731,1,Metastatic malignant melanoma,1,I,EXP,nivolumab,1,PS,Ketoacidosis,1,M,OT,38
174779731,1,Metastatic malignant melanoma,1,I,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,M,LT,38
174779731,1,Metastatic malignant melanoma,1,I,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,M,HO,38
174779731,1,Metastatic malignant melanoma,1,I,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,M,OT,38
174783693,1,Plasma cell myeloma,3,F,EXP,thalidomide,1,PS,Bone marrow failure,1,M,DE,183
174783693,1,Plasma cell myeloma,3,F,EXP,thalidomide,1,PS,Plasma cell myeloma,1,M,DE,183
174783693,1,Plasma cell myeloma,3,F,EXP,thalidomide,1,PS,Sepsis,1,M,DE,183
174789171,2,Uterine cancer,1,I,EXP,nivolumab,2,SS,Anal fistula,2,F,OT,315
174793031,1,Squamous cell carcinoma of lung,1,I,EXP,nivolumab,1,PS,Facial bones fracture,1,F,OT,1165
174793031,1,Squamous cell carcinoma of lung,1,I,EXP,nivolumab,1,PS,Syncope,1,F,OT,1165
174795351,1,Cervix carcinoma,1,I,EXP,nivolumab,1,PS,Anaemia,1,F,LT,42
174795351,1,Cervix carcinoma,1,I,EXP,nivolumab,1,PS,Anaemia,1,F,HO,42
174795351,2,Cervix carcinoma,1,I,EXP,ipilimumab,2,SS,Anaemia,2,F,LT,42
174795351,2,Cervix carcinoma,1,I,EXP,ipilimumab,2,SS,Anaemia,2,F,HO,42
174796991,2,Plasma cell myeloma,1,I,PER,pomalidomide,2,SS,Inguinal hernia,2,M,HO,461
174798111,3,Plasma cell myeloma,1,I,EXP,pomalidomide,3,SS,Neutropenia,3,F,OT,135
174798501,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Pain in jaw,1,F,OT,115
174800041,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Hepatotoxicity,1,M,OT,81
174800041,1,Renal cell carcinoma,1,I,EXP,ipilimumab,1,PS,Hepatotoxicity,1,M,HO,81
174800041,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Hepatotoxicity,2,M,OT,81
174800041,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Hepatotoxicity,2,M,HO,81
174800322,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Small intestinal perforation,1,M,LT,86
174800322,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Small intestinal perforation,1,M,DE,86
174800322,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Small intestinal perforation,1,M,HO,86
174800322,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Small intestinal perforation,1,M,OT,86
174800984,1,Prostate cancer,4,F,EXP,nivolumab,1,PS,Paraparesis,1,M,OT,128
174800984,1,Prostate cancer,4,F,EXP,nivolumab,1,PS,Paraparesis,1,M,LT,128
174800984,1,Prostate cancer,4,F,EXP,nivolumab,1,PS,Paraparesis,1,M,HO,128
174800984,1,Prostate cancer,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,128
174800984,1,Prostate cancer,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,LT,128
174800984,1,Prostate cancer,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,128
174800984,2,Prostate cancer,4,F,EXP,ipilimumab,2,SS,Paraparesis,2,M,OT,128
174800984,2,Prostate cancer,4,F,EXP,ipilimumab,2,SS,Paraparesis,2,M,LT,128
174800984,2,Prostate cancer,4,F,EXP,ipilimumab,2,SS,Paraparesis,2,M,HO,128
174800984,2,Prostate cancer,4,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,OT,128
174800984,2,Prostate cancer,4,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,LT,128
174800984,2,Prostate cancer,4,F,EXP,ipilimumab,2,SS,Pneumonia,2,M,HO,128
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Abdominal pain upper,1,F,HO,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Abdominal pain upper,1,F,OT,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Bundle branch block,1,F,HO,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Bundle branch block,1,F,OT,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Deep vein thrombosis,1,F,HO,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Deep vein thrombosis,1,F,OT,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Fluid overload,1,F,HO,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Fluid overload,1,F,OT,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pain in extremity,1,F,HO,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pain in extremity,1,F,OT,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Peripheral swelling,1,F,HO,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Peripheral swelling,1,F,OT,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pulmonary embolism,1,F,HO,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Pulmonary embolism,1,F,OT,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Sinus tachycardia,1,F,HO,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Sinus tachycardia,1,F,OT,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Tumour thrombosis,1,F,HO,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Tumour thrombosis,1,F,OT,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Vaginal haemorrhage,1,F,HO,30
174804271,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Vaginal haemorrhage,1,F,OT,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Abdominal pain upper,2,F,HO,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Abdominal pain upper,2,F,OT,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Bundle branch block,2,F,HO,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Bundle branch block,2,F,OT,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Deep vein thrombosis,2,F,HO,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Deep vein thrombosis,2,F,OT,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Fluid overload,2,F,HO,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Fluid overload,2,F,OT,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,HO,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,F,OT,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Pain in extremity,2,F,HO,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Pain in extremity,2,F,OT,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Peripheral swelling,2,F,HO,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Peripheral swelling,2,F,OT,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Pulmonary embolism,2,F,HO,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Pulmonary embolism,2,F,OT,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Sinus tachycardia,2,F,HO,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Sinus tachycardia,2,F,OT,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Tumour thrombosis,2,F,HO,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Tumour thrombosis,2,F,OT,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Vaginal haemorrhage,2,F,HO,30
174804271,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Vaginal haemorrhage,2,F,OT,30
174806121,1,Acute lymphocytic leukaemia,1,I,EXP,nilotinib,1,PS,Febrile bone marrow aplasia,1,F,HO,62
174807572,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,DS,19
174807572,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,DE,19
174807572,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Acute myocardial infarction,1,M,OT,19
174807572,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DS,19
174807572,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,19
174807572,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,19
174808781,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Colitis,1,M,OT,3
174808781,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Colitis,1,M,HO,3
174808781,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,3
174808781,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,3
174808781,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Diarrhoea haemorrhagic,1,M,OT,3
174808781,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Diarrhoea haemorrhagic,1,M,HO,3
174808781,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Ulcer,1,M,OT,3
174808781,1,Product used for unknown indication,1,I,EXP,nivolumab,1,PS,Ulcer,1,M,HO,3
174808781,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Colitis,2,M,OT,3
174808781,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Colitis,2,M,HO,3
174808781,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Diarrhoea,2,M,OT,3
174808781,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Diarrhoea,2,M,HO,3
174808781,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Diarrhoea haemorrhagic,2,M,OT,3
174808781,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Diarrhoea haemorrhagic,2,M,HO,3
174808781,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Ulcer,2,M,OT,3
174808781,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Ulcer,2,M,HO,3
174808781,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Colitis,3,M,OT,3
174808781,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Colitis,3,M,HO,3
174808781,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Diarrhoea,3,M,OT,3
174808781,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Diarrhoea,3,M,HO,3
174808781,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Diarrhoea haemorrhagic,3,M,OT,3
174808781,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Diarrhoea haemorrhagic,3,M,HO,3
174808781,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Ulcer,3,M,OT,3
174808781,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Ulcer,3,M,HO,3
174808952,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,DE,59
174808952,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,59
174808962,3,Plasma cell myeloma,2,F,EXP,thalidomide,3,SS,Progressive multifocal leukoencephalopathy,3,F,OT,288
174808962,3,Plasma cell myeloma,2,F,EXP,thalidomide,3,SS,Progressive multifocal leukoencephalopathy,3,F,LT,288
174808962,3,Plasma cell myeloma,2,F,EXP,thalidomide,3,SS,Progressive multifocal leukoencephalopathy,3,F,HO,288
174809822,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Infection,1,F,HO,60
174809822,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Pyrexia,1,F,HO,60
174809822,4,Plasma cell myeloma,2,F,PER,lenalidomide,4,SS,Infection,4,F,HO,60
174809822,4,Plasma cell myeloma,2,F,PER,lenalidomide,4,SS,Pyrexia,4,F,HO,60
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Alanine aminotransferase increased,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Anaemia,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Aspartate aminotransferase increased,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Back pain,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Blepharitis,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Blood bilirubin increased,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Constipation,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Dry skin,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Eyelid oedema,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Face oedema,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Gamma-glutamyltransferase increased,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hyperkalaemia,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypernatraemia,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypotension,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Lymphocyte count decreased,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Neutrophil count decreased,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Oedema peripheral,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Pain,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Pruritus,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Pyrexia,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Urticaria,1,M,OT,3
174810781,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,White blood cell count decreased,1,M,OT,3
174810941,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Cough,1,M,OT,98
174810941,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Immune-mediated arthritis,1,M,OT,98
174810941,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,98
174811461,38,Prophylaxis,1,I,EXP,granisetron,38,C,Sepsis,38,F,HO,99
174811461,39,Premedication,1,I,EXP,granisetron,39,C,Sepsis,39,F,HO,100
174811671,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Abdominal pain,1,M,OT,3
174811671,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Alanine aminotransferase increased,1,M,OT,3
174811671,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Anaemia,1,M,OT,3
174811671,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Aspartate aminotransferase increased,1,M,OT,3
174811671,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Decreased appetite,1,M,OT,3
174811671,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Diarrhoea,1,M,OT,3
174811671,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Eyelid infection,1,M,OT,3
174811671,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypoalbuminaemia,1,M,OT,3
174811671,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypoxia,1,M,OT,3
174811671,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Neutrophil count decreased,1,M,OT,3
174811671,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Oedema,1,M,OT,3
174811671,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Pain,1,M,OT,3
174811671,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Pyrexia,1,M,OT,3
174811671,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Vomiting,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Alanine aminotransferase increased,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Anaemia,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Aspartate aminotransferase increased,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Constipation,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Device related infection,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Diarrhoea,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Eyelid oedema,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Face oedema,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Gamma-glutamyltransferase increased,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypersensitivity,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypoalbuminaemia,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypokalaemia,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hyponatraemia,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Lymphocyte count decreased,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Malaise,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Neutrophil count decreased,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Platelet count decreased,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Pyrexia,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Urticaria,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Vomiting,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Weight increased,1,M,OT,3
174812721,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,White blood cells urine positive,1,M,OT,3
174813433,2,Product used for unknown indication,3,F,EXP,denosumab,2,SS,Chronic kidney disease,2,F,OT,11
174813542,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Death,1,M,DE,523
174813542,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Death,1,M,OT,523
174814251,1,Diffuse large B-cell lymphoma,1,I,EXP,selinexor,1,PS,Hypotension,1,F,HO,109
174814251,1,Diffuse large B-cell lymphoma,1,I,EXP,selinexor,1,PS,Pyrexia,1,F,HO,109
174815141,1,Immune thrombocytopenic purpura,1,I,PER,romiplostim,1,PS,Spinal stenosis,1,F,OT,245
174815141,1,Immune thrombocytopenic purpura,1,I,PER,romiplostim,1,PS,Thrombocytopenia,1,F,OT,245
174819261,12,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,12,SS,Altered state of consciousness,12,F,HO,5
174819261,12,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,12,SS,Seizure,12,F,HO,5
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Asthenia,4,F,DE,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Asthenia,4,F,OT,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Death,4,F,DE,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Death,4,F,OT,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Gastrointestinal disorder,4,F,DE,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Gastrointestinal disorder,4,F,OT,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Headache,4,F,DE,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Headache,4,F,OT,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Hyperpyrexia,4,F,DE,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Hyperpyrexia,4,F,OT,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Rash pruritic,4,F,DE,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Rash pruritic,4,F,OT,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Seizure,4,F,DE,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Seizure,4,F,OT,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Somnolence,4,F,DE,15
174820252,4,Metastatic malignant melanoma,2,F,EXP,trametinib,4,SS,Somnolence,4,F,OT,15
174821311,1,Prophylaxis,1,I,EXP,zoledronic acid,1,PS,Muscle spasms,1,F,OT,7
174821311,1,Prophylaxis,1,I,EXP,zoledronic acid,1,PS,Tinnitus,1,F,OT,7
174822852,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Death,2,M,DE,8
174822852,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Death,2,M,HO,8
174822852,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Death,2,M,OT,8
174822852,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Pneumonia,2,M,DE,8
174822852,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Pneumonia,2,M,HO,8
174822852,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Pneumonia,2,M,OT,8
174824442,3,Product used for unknown indication,2,F,PER,palbociclib,3,SS,Myocardial infarction,3,F,HO,130
174824442,3,Product used for unknown indication,2,F,PER,palbociclib,3,SS,Myocardial infarction,3,F,LT,130
174826511,25,Product used for unknown indication,1,I,PER,daratumumab,25,SS,Pleural effusion,25,M,HO,339
174826511,25,Product used for unknown indication,1,I,PER,daratumumab,25,SS,Pneumonia,25,M,HO,339
174826511,25,Product used for unknown indication,1,I,PER,daratumumab,25,SS,Sepsis,25,M,HO,339
174827022,1,Relapsing multiple sclerosis,2,F,EXP,ofatumumab,1,PS,Squamous cell carcinoma,1,F,OT,183
174827022,1,Relapsing multiple sclerosis,2,F,EXP,ofatumumab,1,PS,Squamous cell carcinoma,1,F,LT,183
174827022,2,Relapsing multiple sclerosis,2,F,EXP,ofatumumab,2,SS,Squamous cell carcinoma,2,F,OT,190
174827022,2,Relapsing multiple sclerosis,2,F,EXP,ofatumumab,2,SS,Squamous cell carcinoma,2,F,LT,190
174827942,3,Endometrial cancer metastatic,2,F,EXP,lenvatinib mesylate,3,SS,Aphasia,3,F,DE,20
174827942,3,Endometrial cancer metastatic,2,F,EXP,lenvatinib mesylate,3,SS,Cerebral infarction,3,F,DE,20
174827942,3,Endometrial cancer metastatic,2,F,EXP,lenvatinib mesylate,3,SS,Hemiparesis,3,F,DE,20
174827942,3,Endometrial cancer metastatic,2,F,EXP,lenvatinib mesylate,3,SS,Posterior reversible encephalopathy syndrome,3,F,DE,20
174827942,3,Endometrial cancer metastatic,2,F,EXP,lenvatinib mesylate,3,SS,Pulmonary embolism,3,F,DE,20
174832511,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Abdominal pain upper,1,F,OT,10
174832511,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Asthenia,1,F,OT,10
174832511,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Diarrhoea,1,F,OT,10
174832511,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Dysuria,1,F,OT,10
174832511,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Nausea,1,F,OT,10
174832511,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Neuropathy peripheral,1,F,OT,10
174832511,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Rhinorrhoea,1,F,OT,10
174832511,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Vomiting,1,F,OT,10
174832511,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Vulvovaginal inflammation,1,F,OT,10
174835001,1,Breast cancer,1,I,EXP,palbociclib,1,PS,Rectal haemorrhage,1,F,OT,125
174839412,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Blood glucose abnormal,1,M,HO,22
174839412,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Blood glucose abnormal,1,M,OT,22
174839412,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hypophysitis,1,M,HO,22
174839412,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hypophysitis,1,M,OT,22
174839412,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Jaundice cholestatic,1,M,HO,22
174839412,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Jaundice cholestatic,1,M,OT,22
174839412,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,HO,22
174839412,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Upper gastrointestinal haemorrhage,1,M,OT,22
174839412,5,Renal cell carcinoma,2,F,EXP,ipilimumab,5,SS,Blood glucose abnormal,5,M,HO,22
174839412,5,Renal cell carcinoma,2,F,EXP,ipilimumab,5,SS,Blood glucose abnormal,5,M,OT,22
174839412,5,Renal cell carcinoma,2,F,EXP,ipilimumab,5,SS,Hypophysitis,5,M,HO,22
174839412,5,Renal cell carcinoma,2,F,EXP,ipilimumab,5,SS,Hypophysitis,5,M,OT,22
174839412,5,Renal cell carcinoma,2,F,EXP,ipilimumab,5,SS,Jaundice cholestatic,5,M,HO,22
174839412,5,Renal cell carcinoma,2,F,EXP,ipilimumab,5,SS,Jaundice cholestatic,5,M,OT,22
174839412,5,Renal cell carcinoma,2,F,EXP,ipilimumab,5,SS,Upper gastrointestinal haemorrhage,5,M,HO,22
174839412,5,Renal cell carcinoma,2,F,EXP,ipilimumab,5,SS,Upper gastrointestinal haemorrhage,5,M,OT,22
174840841,3,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,3,SS,Cytokine release syndrome,3,F,OT,3
174840841,3,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,3,SS,Febrile neutropenia,3,F,OT,3
174842911,5,Small cell lung cancer extensive stage,1,I,EXP,etoposide phosphate,5,SS,Deep vein thrombosis,5,M,DE,49
174843891,3,Neutropenia,1,I,EXP,filgrastim,3,SS,Colitis,3,F,HO,3
174845703,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Amylase increased,2,M,HO,74
174845703,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Amylase increased,2,M,OT,74
174845703,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Campylobacter infection,2,M,HO,74
174845703,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Campylobacter infection,2,M,OT,74
174845703,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,74
174845703,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,74
174845703,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Hypokalaemia,2,M,HO,74
174845703,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Hypokalaemia,2,M,OT,74
174845703,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Lipase increased,2,M,HO,74
174845703,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Lipase increased,2,M,OT,74
174845703,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Nausea,2,M,HO,74
174845703,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Nausea,2,M,OT,74
174845703,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Vomiting,2,M,HO,74
174845703,2,Renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Vomiting,2,M,OT,74
174845703,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Amylase increased,3,M,HO,74
174845703,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Amylase increased,3,M,OT,74
174845703,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Campylobacter infection,3,M,HO,74
174845703,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Campylobacter infection,3,M,OT,74
174845703,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Diarrhoea,3,M,HO,74
174845703,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Diarrhoea,3,M,OT,74
174845703,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Hypokalaemia,3,M,HO,74
174845703,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Hypokalaemia,3,M,OT,74
174845703,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Lipase increased,3,M,HO,74
174845703,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Lipase increased,3,M,OT,74
174845703,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Nausea,3,M,HO,74
174845703,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Nausea,3,M,OT,74
174845703,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Vomiting,3,M,HO,74
174845703,3,Renal cell carcinoma,3,F,EXP,nivolumab,3,SS,Vomiting,3,M,OT,74
174846481,1,Plasma cell myeloma,1,I,EXP,pomalidomide,1,PS,Pneumonia,1,F,HO,56
174846481,1,Plasma cell myeloma,1,I,EXP,pomalidomide,1,PS,Pneumonia,1,F,DE,56
174849161,1,Endometrial cancer,1,I,EXP,avelumab,1,SS,Myositis,1,F,DE,62
174849161,1,Endometrial cancer,1,I,EXP,avelumab,1,SS,Myositis,1,F,HO,62
174849792,1,Prostate cancer metastatic,2,F,EXP,apalutamide,1,PS,Mental status changes,1,M,HO,584
174849792,4,Product used for unknown indication,2,F,EXP,ipilimumab,4,SS,Mental status changes,4,M,HO,495
174849822,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,83
174849832,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pemphigoid,1,M,OT,448
174849832,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pemphigoid,1,M,HO,448
174850362,16,Plasma cell myeloma,2,F,EXP,carfilzomib,16,SS,Myelodysplastic syndrome,16,M,OT,329
174852841,1,Lymphoma,1,I,EXP,idelalisib,1,PS,Diarrhoea,1,M,OT,58
174852841,1,Lymphoma,1,I,EXP,idelalisib,1,PS,Hypertransaminasaemia,1,M,OT,58
174853492,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Sinusitis,1,F,HO,295
174853722,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Hydrocephalus,1,M,DE,566
174853722,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Hydrocephalus,1,M,OT,566
174853722,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Hydrocephalus,1,M,HO,566
174853722,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Hydrocephalus,2,M,DE,566
174853722,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Hydrocephalus,2,M,OT,566
174853722,2,Non-small cell lung cancer,2,F,EXP,pemetrexed disodium,2,SS,Hydrocephalus,2,M,HO,566
174854011,1,Diffuse large B-cell lymphoma refractory,1,I,EXP,axicabtagene ciloleucel,1,PS,CAR T-cell-related encephalopathy syndrome,1,M,OT,8
174854011,1,Diffuse large B-cell lymphoma refractory,1,I,EXP,axicabtagene ciloleucel,1,PS,CAR T-cell-related encephalopathy syndrome,1,M,HO,8
174854201,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,716
174854201,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,716
174857092,2,Plasma cell myeloma,2,F,EXP,thalidomide,2,SS,Basal cell carcinoma,2,F,OT,1218
174861003,25,Nausea,3,F,EXP,granisetron,25,C,Hypophysitis,25,F,HO,60
174861003,25,Nausea,3,F,EXP,granisetron,25,C,Pneumonitis,25,F,HO,60
174865052,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Pneumonia,1,F,HO,69
174865052,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Pneumonia,3,F,HO,69
174865291,2,Chronic hepatitis C,1,I,EXP,peginterferon alfa-2b,2,SS,Depression,2,F,HO,47
174865291,2,Chronic hepatitis C,1,I,EXP,peginterferon alfa-2b,2,SS,Suicide attempt,2,F,HO,47
174867571,2,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Cerebral haemorrhage,2,M,HO,20
174867571,2,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Partial seizures,2,M,HO,20
174867571,2,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Thrombosis,2,M,HO,20
174872735,1,Hormone-refractory prostate cancer,5,F,EXP,enzalutamide,1,PS,Hepatic function abnormal,1,M,OT,27
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Abdominal pain,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Alanine aminotransferase increased,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Anaemia,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Aspartate aminotransferase increased,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Constipation,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Diarrhoea,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Epistaxis,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Face oedema,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Gamma-glutamyltransferase increased,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Haematocrit decreased,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypernatraemia,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypoalbuminaemia,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypokalaemia,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hyponatraemia,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypophosphataemia,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Lymphocyte count decreased,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Malaise,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Neck pain,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Neutrophil count decreased,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Pain,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Pain in extremity,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Platelet count decreased,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Pyrexia,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Upper respiratory tract infection,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Urticaria,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Vomiting,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Weight increased,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,White blood cell count decreased,1,F,OT,3
174874151,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,White blood cells urine positive,1,F,OT,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Circulatory collapse,2,F,OT,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Circulatory collapse,2,F,DE,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Dyspnoea,2,F,OT,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Dyspnoea,2,F,DE,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Hepatic failure,2,F,OT,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Hepatic failure,2,F,DE,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Pyrexia,2,F,OT,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Pyrexia,2,F,DE,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Respiratory failure,2,F,OT,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Respiratory failure,2,F,DE,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Skin lesion,2,F,OT,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Skin lesion,2,F,DE,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Staphylococcal infection,2,F,OT,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Staphylococcal infection,2,F,DE,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Transaminases increased,2,F,OT,3
174878092,2,Prophylaxis,2,F,EXP,pegfilgrastim,2,C,Transaminases increased,2,F,DE,3
174878703,3,Prophylaxis,3,F,EXP,rasburicase,3,C,Infection,3,F,HO,29
174878703,3,Prophylaxis,3,F,EXP,rasburicase,3,C,Neutropenia,3,F,HO,29
174878922,1,Type 2 lepra reaction,2,F,EXP,thalidomide,1,PS,Type 2 lepra reaction,1,M,HO,39
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Abdominal pain,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Alanine aminotransferase increased,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Anaemia,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Aspartate aminotransferase increased,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Blood urea increased,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Constipation,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Cough,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Diarrhoea,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Dysphonia,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Face oedema,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Flushing,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Gamma-glutamyltransferase increased,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypernatraemia,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypoalbuminaemia,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypokalaemia,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypophosphataemia,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Hypoxia,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Localised oedema,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Lymphocyte count decreased,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Malaise,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Neutrophil count decreased,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Otitis media,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Platelet count decreased,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Pruritus,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Pyrexia,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Stomatitis,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Urticaria,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,Weight increased,1,F,OT,3
174886771,1,Product used for unknown indication,1,I,PER,filgrastim,1,PS,White blood cells urine positive,1,F,OT,3
174887671,2,Non-small cell lung cancer,1,I,DIR,bosutinib,2,SS,Clinical trial participant,2,M,HO,42
174887671,2,Non-small cell lung cancer,1,I,DIR,bosutinib,2,SS,Drug-induced liver injury,2,M,HO,42
174887671,2,Non-small cell lung cancer,1,I,DIR,bosutinib,2,SS,Hepatocellular injury,2,M,HO,42
174889511,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,14
174889511,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Dysstasia,1,M,OT,14
174889511,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Hepatic failure,1,M,OT,14
174889511,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Somnolence,1,M,OT,14
174889511,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Toxicity to various agents,1,M,OT,14
174892651,3,Prostate cancer metastatic,1,I,EXP,cabazitaxel,3,SS,Lower respiratory tract infection,3,M,HO,134
174892651,3,Prostate cancer metastatic,1,I,EXP,cabazitaxel,3,SS,Pyrexia,3,M,HO,134
174892991,2,Squamous cell carcinoma of head and neck,1,I,EXP,palbociclib,2,C,Febrile neutropenia,2,M,HO,24
174894241,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Nausea,2,F,OT,119
174894241,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Thrombocytopenia,2,F,OT,119
174894241,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Vomiting,2,F,OT,119
174894241,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Weight decreased,2,F,OT,119
174908012,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,381
174908012,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,F,DE,381
174908012,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,381
174908012,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,DE,381
174908012,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,F,HO,381
174908012,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Hypercalcaemia,1,F,DE,381
174908012,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Sciatica,1,F,HO,381
174908012,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Sciatica,1,F,DE,381
174910671,1,Cutaneous T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Acute kidney injury,1,M,HO,187
174910671,1,Cutaneous T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Acute kidney injury,1,M,OT,187
174910671,1,Cutaneous T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Chills,1,M,HO,187
174910671,1,Cutaneous T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Chills,1,M,OT,187
174910671,1,Cutaneous T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Decreased appetite,1,M,HO,187
174910671,1,Cutaneous T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Decreased appetite,1,M,OT,187
174910671,1,Cutaneous T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Nasopharyngitis,1,M,HO,187
174910671,1,Cutaneous T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Nasopharyngitis,1,M,OT,187
174910671,1,Cutaneous T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Pyrexia,1,M,HO,187
174910671,1,Cutaneous T-cell lymphoma,1,I,EXP,brentuximab vedotin,1,PS,Pyrexia,1,M,OT,187
174911323,1,Hormone-refractory prostate cancer,3,F,EXP,enzalutamide,1,PS,Rash maculo-papular,1,M,HO,11
174911402,1,Hodgkin's disease,2,F,EXP,brentuximab vedotin,1,PS,Pyrexia,1,M,HO,149
174911402,1,Hodgkin's disease,2,F,EXP,brentuximab vedotin,1,PS,Pyrexia,1,M,OT,149
174911402,1,Hodgkin's disease,2,F,EXP,brentuximab vedotin,1,PS,Pyrexia,1,M,DE,149
174911402,1,Hodgkin's disease,2,F,EXP,brentuximab vedotin,1,PS,Respiratory tract infection,1,M,HO,149
174911402,1,Hodgkin's disease,2,F,EXP,brentuximab vedotin,1,PS,Respiratory tract infection,1,M,OT,149
174911402,1,Hodgkin's disease,2,F,EXP,brentuximab vedotin,1,PS,Respiratory tract infection,1,M,DE,149
174913601,1,Lung neoplasm,1,I,EXP,nivolumab,1,PS,Hemiparaesthesia,1,M,OT,857
174913601,1,Lung neoplasm,1,I,EXP,nivolumab,1,PS,Off label use,1,M,OT,857
174913601,1,Lung neoplasm,1,I,EXP,nivolumab,1,PS,Paraesthesia,1,M,OT,857
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Atrial flutter,2,M,HO,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Atrial flutter,2,M,LT,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Corona virus infection,2,M,HO,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Corona virus infection,2,M,LT,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Dyspnoea,2,M,HO,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Dyspnoea,2,M,LT,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Melaena,2,M,HO,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Melaena,2,M,LT,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Platelet count decreased,2,M,HO,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Platelet count decreased,2,M,LT,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Pyrexia,2,M,HO,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Pyrexia,2,M,LT,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Renal failure,2,M,HO,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Renal failure,2,M,LT,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Septic shock,2,M,HO,5
174917662,2,Mantle cell lymphoma,2,F,EXP,lenalidomide,2,C,Septic shock,2,M,LT,5
174922701,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Sinusitis,1,F,HO,295
174922701,4,Plasma cell myeloma,1,I,PER,lenalidomide,4,SS,Sinusitis,4,F,HO,295
174922911,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Cardiac failure,1,F,OT,35
174922911,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Hyperthyroidism,1,F,OT,35
174922911,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Renal failure,1,F,OT,35
174923872,1,Ovarian cancer,2,F,EXP,trabectedin,1,PS,Anaemia,1,F,HO,14
174923872,1,Ovarian cancer,2,F,EXP,trabectedin,1,PS,Device related infection,1,F,HO,14
174923872,1,Ovarian cancer,2,F,EXP,trabectedin,1,PS,Febrile neutropenia,1,F,HO,14
174923872,1,Ovarian cancer,2,F,EXP,trabectedin,1,PS,Sepsis,1,F,HO,14
174923872,1,Ovarian cancer,2,F,EXP,trabectedin,1,PS,Thrombocytopenia,1,F,HO,14
174925841,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Confusional state,2,F,HO,169
174925841,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Paranoia,2,F,HO,169
174928333,1,Non-Hodgkin's lymphoma unspecified histology aggressive refractory,3,F,EXP,axicabtagene ciloleucel,1,PS,Respiratory failure,1,F,DE,16
174928333,1,Non-Hodgkin's lymphoma unspecified histology aggressive refractory,3,F,EXP,axicabtagene ciloleucel,1,PS,Respiratory failure,1,F,HO,16
174928333,1,Non-Hodgkin's lymphoma unspecified histology aggressive refractory,3,F,EXP,axicabtagene ciloleucel,1,PS,Toxic skin eruption,1,F,DE,16
174928333,1,Non-Hodgkin's lymphoma unspecified histology aggressive refractory,3,F,EXP,axicabtagene ciloleucel,1,PS,Toxic skin eruption,1,F,HO,16
174928711,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Abdominal hernia,1,M,HO,36
174928711,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Abdominal hernia,1,M,OT,36
174928711,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Adrenocortical insufficiency acute,1,M,HO,36
174928711,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Adrenocortical insufficiency acute,1,M,OT,36
174928711,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,36
174928711,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,36
174928711,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,36
174928711,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,36
174928711,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,36
174928711,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,36
174928711,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Abdominal hernia,2,M,HO,36
174928711,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Abdominal hernia,2,M,OT,36
174928711,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Adrenocortical insufficiency acute,2,M,HO,36
174928711,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Adrenocortical insufficiency acute,2,M,OT,36
174928711,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,36
174928711,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,36
174928711,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Dyspnoea,2,M,HO,36
174928711,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Dyspnoea,2,M,OT,36
174928711,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,HO,36
174928711,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,OT,36
174928773,3,Malignant melanoma,3,F,EXP,nivolumab,3,SS,Serous retinopathy,3,M,OT,19
174928773,3,Malignant melanoma,3,F,EXP,nivolumab,3,SS,Skin discolouration,3,M,OT,19
174928773,3,Malignant melanoma,3,F,EXP,nivolumab,3,SS,Thyroiditis,3,M,OT,19
174928971,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Myelodysplastic syndrome,3,M,OT,1245
174935641,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Seizure,1,F,HO,54
174935641,1,Neoplasm malignant,1,I,EXP,nivolumab,1,PS,Seizure,1,F,OT,54
174935641,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Seizure,2,F,HO,54
174935641,2,Neoplasm malignant,1,I,EXP,ipilimumab,2,SS,Seizure,2,F,OT,54
174939472,12,Acute lymphocytic leukaemia,2,F,PER,pegaspargase,12,SS,Febrile neutropenia,12,M,HO,10
174956354,3,Plasma cell myeloma,4,F,EXP,pomalidomide,3,SS,Pneumonia influenzal,3,M,HO,505
174957971,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,16
174957971,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,16
174960071,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Confusional state,1,F,HO,169
174960071,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Paranoia,1,F,HO,169
174960292,1,Plasma cell myeloma,2,F,EXP,pomalidomide,1,PS,Pneumonia,1,F,HO,350
174960292,3,Plasma cell myeloma,2,F,EXP,daratumumab,3,SS,Pneumonia,3,F,HO,350
174962081,7,Acute lymphocytic leukaemia,1,I,PER,pegaspargase,7,SS,Nausea,7,F,HO,28
174962081,7,Acute lymphocytic leukaemia,1,I,PER,pegaspargase,7,SS,Pyrexia,7,F,HO,28
174962081,7,Acute lymphocytic leukaemia,1,I,PER,pegaspargase,7,SS,Rhinovirus infection,7,F,HO,28
174962081,7,Acute lymphocytic leukaemia,1,I,PER,pegaspargase,7,SS,Vomiting,7,F,HO,28
174962361,2,Prostate cancer metastatic,1,I,EXP,cabazitaxel,2,SS,Febrile neutropenia,2,M,HO,10
174962361,2,Prostate cancer metastatic,1,I,EXP,cabazitaxel,2,SS,Septic shock,2,M,HO,10
174962821,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Disturbance in attention,1,M,DE,642
174962821,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Disturbance in attention,1,M,HO,642
174962821,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Disturbance in attention,1,M,OT,642
174962821,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Paraneoplastic syndrome,1,M,DE,642
174962821,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Paraneoplastic syndrome,1,M,HO,642
174962821,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Paraneoplastic syndrome,1,M,OT,642
174966502,2,Bone cancer,2,F,EXP,zoledronic acid,2,SS,Blood pressure increased,2,F,OT,165
174966502,2,Bone cancer,2,F,EXP,zoledronic acid,2,SS,Diarrhoea,2,F,OT,165
174966502,2,Bone cancer,2,F,EXP,zoledronic acid,2,SS,Haematuria,2,F,OT,165
174966502,2,Bone cancer,2,F,EXP,zoledronic acid,2,SS,Haemorrhage,2,F,OT,165
174966502,2,Bone cancer,2,F,EXP,zoledronic acid,2,SS,Menstruation irregular,2,F,OT,165
174966502,2,Bone cancer,2,F,EXP,zoledronic acid,2,SS,Nausea,2,F,OT,165
174966502,2,Bone cancer,2,F,EXP,zoledronic acid,2,SS,Renal impairment,2,F,OT,165
174971162,34,Leukopenia,2,F,EXP,filgrastim,34,C,Influenza,34,M,HO,171
174977031,1,Breast cancer metastatic,1,I,EXP,palbociclib,1,PS,Dyspnoea,1,F,OT,444
174977031,1,Breast cancer metastatic,1,I,EXP,palbociclib,1,PS,Ejection fraction decreased,1,F,OT,444
174981872,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Fall,1,F,HO,14
174981872,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Fall,1,F,OT,14
174981872,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Hip fracture,1,F,HO,14
174981872,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Hip fracture,1,F,OT,14
174981872,2,Plasma cell myeloma,2,F,PER,lenalidomide,2,SS,Fall,2,F,HO,14
174981872,2,Plasma cell myeloma,2,F,PER,lenalidomide,2,SS,Fall,2,F,OT,14
174981872,2,Plasma cell myeloma,2,F,PER,lenalidomide,2,SS,Hip fracture,2,F,HO,14
174981872,2,Plasma cell myeloma,2,F,PER,lenalidomide,2,SS,Hip fracture,2,F,OT,14
174981872,4,Plasma cell myeloma,2,F,PER,daratumumab,4,SS,Fall,4,F,HO,14
174981872,4,Plasma cell myeloma,2,F,PER,daratumumab,4,SS,Fall,4,F,OT,14
174981872,4,Plasma cell myeloma,2,F,PER,daratumumab,4,SS,Hip fracture,4,F,HO,14
174981872,4,Plasma cell myeloma,2,F,PER,daratumumab,4,SS,Hip fracture,4,F,OT,14
174982071,3,Plasma cell myeloma,1,I,EXP,pomalidomide,3,SS,Anxiety,3,F,OT,13
174982071,3,Plasma cell myeloma,1,I,EXP,pomalidomide,3,SS,Neutropenia,3,F,OT,13
174984501,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Dementia Alzheimer's type,1,F,OT,512
174986191,1,Breast cancer,1,I,EXP,abemaciclib,1,PS,Hypokalaemia,1,F,HO,202
174986191,1,Breast cancer,1,I,EXP,abemaciclib,1,PS,Hypokalaemia,1,F,LT,202
174986191,1,Breast cancer,1,I,EXP,abemaciclib,1,PS,Metabolic acidosis,1,F,HO,202
174986191,1,Breast cancer,1,I,EXP,abemaciclib,1,PS,Metabolic acidosis,1,F,LT,202
174986381,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Arthritis,1,M,OT,47
174986381,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Constipation,1,M,OT,47
174988731,2,B-cell lymphoma,1,I,EXP,lenalidomide,2,SS,Atrial flutter,2,M,HO,371
174989082,1,Pancreatic carcinoma,2,F,EXP,trametinib,1,PS,Respiratory failure,1,F,DE,40
174989082,1,Pancreatic carcinoma,2,F,EXP,trametinib,1,PS,Respiratory failure,1,F,HO,40
174990653,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Immune-mediated pneumonitis,1,M,OT,6
174990653,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Immune-mediated pneumonitis,1,M,HO,6
174990653,1,Non-small cell lung cancer,3,F,EXP,nivolumab,1,PS,Immune-mediated pneumonitis,1,M,DE,6
174992092,3,Plasma cell myeloma,2,F,EXP,pomalidomide,3,SS,Influenza like illness,3,F,HO,13
174992092,3,Plasma cell myeloma,2,F,EXP,pomalidomide,3,SS,Pneumonia,3,F,HO,13
174993033,3,Metastatic malignant melanoma,3,F,EXP,nivolumab,3,PS,Platelet count decreased,3,F,OT,15
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Acute myocardial infarction,2,M,OT,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Acute myocardial infarction,2,M,LT,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Acute myocardial infarction,2,M,HO,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Atrioventricular block complete,2,M,OT,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Atrioventricular block complete,2,M,LT,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Atrioventricular block complete,2,M,HO,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Dysphagia,2,M,OT,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Dysphagia,2,M,LT,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Dysphagia,2,M,HO,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,General physical health deterioration,2,M,OT,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,General physical health deterioration,2,M,LT,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,General physical health deterioration,2,M,HO,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Hypertensive crisis,2,M,OT,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Hypertensive crisis,2,M,LT,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Hypertensive crisis,2,M,HO,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Myalgia,2,M,OT,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Myalgia,2,M,LT,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Myalgia,2,M,HO,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Off label use,2,M,OT,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Off label use,2,M,LT,14
174993321,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Off label use,2,M,HO,14
174993511,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,SS,Pyrexia,2,M,HO,83
174994582,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,PS,Syncope,1,F,HO,1620
174994582,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,PS,Upper gastrointestinal haemorrhage,1,F,HO,1620
175001681,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,M,HO,136
175001681,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,M,OT,136
175001681,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,136
175001681,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,136
175005561,5,Chronic myeloid leukaemia,1,I,EXP,bosutinib,5,C,Acute kidney injury,5,F,HO,553
175005561,5,Chronic myeloid leukaemia,1,I,EXP,bosutinib,5,C,Drug interaction,5,F,HO,553
175012653,2,Acute lymphocytic leukaemia,3,F,EXP,inotuzumab ozogamicin,2,SS,Venoocclusive liver disease,2,F,DE,37
175012653,2,Acute lymphocytic leukaemia,3,F,EXP,inotuzumab ozogamicin,2,SS,Venoocclusive liver disease,2,F,OT,37
175013791,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Asthma,1,F,HO,35
175014371,1,Colony stimulating factor therapy,1,I,EXP,pegfilgrastim,1,PS,Diplegia,1,F,OT,1
175019051,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Dehydration,1,F,HO,9
175019051,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Stomatitis,1,F,HO,9
175024412,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,White blood cell count decreased,1,F,HO,60
175024634,11,Neutropenia,4,F,EXP,filgrastim,11,C,Bronchitis,11,F,HO,1030
175024634,11,Neutropenia,4,F,EXP,filgrastim,11,C,Dyspnoea,11,F,HO,1030
175024634,12,Prophylaxis,4,F,EXP,filgrastim,12,C,Bronchitis,12,F,HO,1023
175024634,12,Prophylaxis,4,F,EXP,filgrastim,12,C,Dyspnoea,12,F,HO,1023
175024634,48,Prophylaxis,4,F,EXP,pegfilgrastim,48,C,Bronchitis,48,F,HO,897
175024634,48,Prophylaxis,4,F,EXP,pegfilgrastim,48,C,Dyspnoea,48,F,HO,897
175030321,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Abdominal distension,1,M,HO,32
175030321,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Abdominal distension,1,M,OT,32
175030321,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Jaundice,1,M,HO,32
175030321,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Jaundice,1,M,OT,32
175030321,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Malaise,1,M,HO,32
175030321,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Malaise,1,M,OT,32
175030321,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Neutropenic sepsis,1,M,HO,32
175030321,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Neutropenic sepsis,1,M,OT,32
175030321,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Pancytopenia,1,M,HO,32
175030321,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Pancytopenia,1,M,OT,32
175030321,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Peripheral swelling,1,M,HO,32
175030321,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Peripheral swelling,1,M,OT,32
175030321,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Productive cough,1,M,HO,32
175030321,1,Prostate cancer metastatic,1,I,EXP,enzalutamide,1,PS,Productive cough,1,M,OT,32
175034911,2,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,2,SS,Arthropod sting,2,M,OT,29
175034911,2,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,2,SS,Constipation,2,M,OT,29
175034911,2,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,2,SS,Contrast media allergy,2,M,OT,29
175034911,2,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,2,SS,Decreased appetite,2,M,OT,29
175034911,2,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,2,SS,Dental caries,2,M,OT,29
175034911,2,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,2,SS,Diabetes mellitus,2,M,OT,29
175034911,2,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,2,SS,Fatigue,2,M,OT,29
175034911,2,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,2,SS,Pruritus,2,M,OT,29
175034911,2,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,2,SS,Rash,2,M,OT,29
175034911,2,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,2,SS,Seborrhoeic keratosis,2,M,OT,29
175040861,1,Malignant melanoma,1,I,EXP,trametinib,1,PS,Asthenia,1,F,OT,38
175040861,1,Malignant melanoma,1,I,EXP,trametinib,1,PS,Dermatophytosis,1,F,OT,38
175040861,1,Malignant melanoma,1,I,EXP,trametinib,1,PS,Epilepsy,1,F,OT,38
175040861,1,Malignant melanoma,1,I,EXP,trametinib,1,PS,Fall,1,F,OT,38
175040861,1,Malignant melanoma,1,I,EXP,trametinib,1,PS,Myalgia,1,F,OT,38
175040861,1,Malignant melanoma,1,I,EXP,trametinib,1,PS,Tinea manuum,1,F,OT,38
175040861,1,Malignant melanoma,1,I,EXP,trametinib,1,PS,Visual field defect,1,F,OT,38
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,LT,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,HO,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,LT,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,OT,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,HO,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Cellulitis,1,M,LT,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Cellulitis,1,M,OT,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Cellulitis,1,M,HO,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Hypotension,1,M,LT,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Hypotension,1,M,OT,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Hypotension,1,M,HO,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,LT,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Sepsis,1,M,LT,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Skin infection,1,M,LT,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Skin infection,1,M,OT,17
175049214,1,Kaposi's sarcoma AIDS related,4,F,EXP,nivolumab,1,PS,Skin infection,1,M,HO,17
175049292,1,B-cell lymphoma refractory,2,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,4
175049292,1,B-cell lymphoma refractory,2,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,4
175049292,1,B-cell lymphoma refractory,2,F,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,LT,4
175049292,1,B-cell lymphoma refractory,2,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,OT,4
175049292,1,B-cell lymphoma refractory,2,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,HO,4
175049292,1,B-cell lymphoma refractory,2,F,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,LT,4
175049292,1,B-cell lymphoma refractory,2,F,EXP,axicabtagene ciloleucel,1,PS,Seizure,1,M,OT,4
175049292,1,B-cell lymphoma refractory,2,F,EXP,axicabtagene ciloleucel,1,PS,Seizure,1,M,HO,4
175049292,1,B-cell lymphoma refractory,2,F,EXP,axicabtagene ciloleucel,1,PS,Seizure,1,M,LT,4
175050291,1,Plasma cell myeloma,1,I,EXP,nivolumab,1,PS,Cerebellar stroke,1,F,HO,199
175050291,1,Plasma cell myeloma,1,I,EXP,nivolumab,1,PS,Cerebellar stroke,1,F,OT,199
175050291,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Cerebellar stroke,2,F,HO,199
175050291,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Cerebellar stroke,2,F,OT,199
175050442,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,LT,111
175050442,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,OT,111
175050442,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Hypokalaemia,1,M,HO,111
175050442,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,LT,111
175050442,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,111
175050442,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,111
175051782,32,Plasma cell myeloma,2,F,PER,daratumumab,32,C,Pneumonia,32,M,DS,36
175051782,32,Plasma cell myeloma,2,F,PER,daratumumab,32,C,Pneumonia,32,M,HO,36
175052861,1,Mantle cell lymphoma,1,I,EXP,ibrutinib,1,PS,Chronic obstructive pulmonary disease,1,M,HO,26
175056911,3,Plasma cell myeloma,1,I,EXP,pomalidomide,3,SS,Pneumonia,3,F,HO,245
175057683,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Chronic kidney disease,1,M,HO,168
175057683,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Chronic kidney disease,1,M,OT,168
175057683,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Kidney infection,1,M,HO,168
175057683,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Kidney infection,1,M,OT,168
175057683,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,168
175057683,1,Renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,168
175057821,2,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,2,PS,Anaemia,2,M,OT,67
175057821,2,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,2,PS,Anaemia,2,M,HO,67
175057821,2,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,2,PS,Decreased appetite,2,M,OT,67
175057821,2,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,2,PS,Decreased appetite,2,M,HO,67
175057821,2,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,2,PS,Dysphagia,2,M,OT,67
175057821,2,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,2,PS,Dysphagia,2,M,HO,67
175057821,2,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,2,PS,Mucosal inflammation,2,M,OT,67
175057821,2,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,2,PS,Mucosal inflammation,2,M,HO,67
175065991,3,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,3,SS,Cerebral haemorrhage,3,M,HO,20
175065991,3,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,3,SS,Partial seizures,3,M,HO,20
175065991,3,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,3,SS,Thrombosis,3,M,HO,20
175067301,1,Plasma cell myeloma,1,I,PER,lenalidomide,1,PS,Staphylococcal infection,1,F,HO,60
175067881,2,Mantle cell lymphoma,1,I,EXP,chop,2,C,Blood creatinine increased,2,M,HO,104
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Amylase increased,1,M,HO,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Amylase increased,1,M,OT,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Arthralgia,1,M,HO,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Arthralgia,1,M,OT,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Colitis,1,M,HO,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Colitis,1,M,OT,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Cough,1,M,HO,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Cough,1,M,OT,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Diarrhoea,1,M,HO,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Diarrhoea,1,M,OT,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Embolism,1,M,HO,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Embolism,1,M,OT,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Headache,1,M,HO,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Headache,1,M,OT,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Limb discomfort,1,M,HO,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Limb discomfort,1,M,OT,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Lipase increased,1,M,HO,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Lipase increased,1,M,OT,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Nasopharyngitis,1,M,HO,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Nasopharyngitis,1,M,OT,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Rash pruritic,1,M,HO,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Rash pruritic,1,M,OT,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Upper respiratory tract infection,1,M,HO,7
175076433,1,Malignant melanoma,3,F,EXP,nivolumab,1,SS,Upper respiratory tract infection,1,M,OT,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Amylase increased,2,M,HO,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Amylase increased,2,M,OT,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Arthralgia,2,M,HO,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Arthralgia,2,M,OT,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Colitis,2,M,HO,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Colitis,2,M,OT,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Cough,2,M,HO,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Cough,2,M,OT,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Diarrhoea,2,M,HO,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Diarrhoea,2,M,OT,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Embolism,2,M,HO,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Embolism,2,M,OT,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Headache,2,M,HO,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Headache,2,M,OT,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Limb discomfort,2,M,HO,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Limb discomfort,2,M,OT,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Lipase increased,2,M,HO,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Lipase increased,2,M,OT,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Nasopharyngitis,2,M,HO,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Nasopharyngitis,2,M,OT,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Rash pruritic,2,M,HO,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Rash pruritic,2,M,OT,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Upper respiratory tract infection,2,M,HO,7
175076433,2,Malignant melanoma,3,F,EXP,ipilimumab,2,PS,Upper respiratory tract infection,2,M,OT,7
175076902,2,Malignant melanoma,2,F,EXP,nivolumab,2,PS,Malignant neoplasm progression,2,M,OT,70
175076902,2,Malignant melanoma,2,F,EXP,nivolumab,2,PS,Malignant neoplasm progression,2,M,HO,70
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Alopecia,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Cheilitis,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Dermatitis,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Dry skin,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Eczema,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Erythema multiforme,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Hair colour changes,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Infection,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Iris neovascularisation,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Mouth ulceration,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Oral pain,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Palmar-plantar erythrodysaesthesia syndrome,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Paronychia,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Pyrexia,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Skin infection,1,F,OT,63
175079422,1,Neurofibroma,2,F,EXP,trametinib,1,PS,Skin irritation,1,F,OT,63
175080092,1,K-ras gene mutation,2,F,EXP,trametinib,1,PS,Product use in unapproved indication,1,F,HO,56
175080092,1,K-ras gene mutation,2,F,EXP,trametinib,1,PS,Pyrexia,1,F,HO,56
175081781,1,Neoplasm malignant,1,I,EXP,ipilimumab,1,PS,Jaundice cholestatic,1,M,OT,61
175081781,2,Neoplasm malignant,1,I,EXP,nivolumab,2,SS,Jaundice cholestatic,2,M,OT,61
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Abdominal pain,6,F,OT,314
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Abdominal pain,6,F,HO,314
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Abdominal pain,6,F,DE,314
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Constipation,6,F,OT,314
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Constipation,6,F,HO,314
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Constipation,6,F,DE,314
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Intracranial pressure increased,6,F,OT,314
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Intracranial pressure increased,6,F,HO,314
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Intracranial pressure increased,6,F,DE,314
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Malignant neoplasm progression,6,F,OT,314
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Malignant neoplasm progression,6,F,HO,314
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Malignant neoplasm progression,6,F,DE,314
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Metastatic malignant melanoma,6,F,OT,314
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Metastatic malignant melanoma,6,F,HO,314
175081972,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Metastatic malignant melanoma,6,F,DE,314
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,OT,1
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Back pain,1,F,OT,1
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Constipation,1,F,OT,1
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Diarrhoea,1,F,OT,1
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Dizziness,1,F,OT,1
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Ear pain,1,F,OT,1
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Erythema,1,F,OT,1
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Influenza like illness,1,F,OT,1
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Malaise,1,F,OT,1
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Ocular hyperaemia,1,F,OT,1
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Oral pain,1,F,OT,1
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,OT,1
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Paraesthesia,1,F,OT,1
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Pollakiuria,1,F,OT,1
175082841,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Pruritus,1,F,OT,1
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Axillary pain,1,M,HO,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Axillary pain,1,M,OT,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Axillary pain,1,M,DE,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,HO,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,OT,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,DE,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Dry skin,1,M,HO,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Dry skin,1,M,OT,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Dry skin,1,M,DE,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Fall,1,M,HO,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Fall,1,M,OT,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Fall,1,M,DE,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,DE,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,H1N1 influenza,1,M,HO,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,H1N1 influenza,1,M,OT,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,H1N1 influenza,1,M,DE,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Hypothyroidism,1,M,DE,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Lipoma,1,M,HO,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Lipoma,1,M,OT,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Lipoma,1,M,DE,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Lymphadenopathy,1,M,HO,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Lymphadenopathy,1,M,OT,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Lymphadenopathy,1,M,DE,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malnutrition,1,M,HO,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malnutrition,1,M,OT,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Malnutrition,1,M,DE,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Nervous system disorder,1,M,HO,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Nervous system disorder,1,M,OT,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Nervous system disorder,1,M,DE,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,DE,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Radiation skin injury,1,M,HO,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Radiation skin injury,1,M,OT,109
175083282,1,Lung neoplasm malignant,2,F,EXP,nivolumab,1,PS,Radiation skin injury,1,M,DE,109
175083521,1,Relapsing multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Lymphopenia,1,M,OT,1
175083521,1,Relapsing multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Rash,1,M,OT,1
175095072,1,Plasma cell myeloma,2,F,EXP,thalidomide,1,PS,Superficial spreading melanoma stage II,1,M,OT,471
175099001,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Epilepsy,1,M,OT,911
175099001,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Epilepsy,1,M,HO,911
175099001,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Prescribed underdose,1,M,OT,911
175099001,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Prescribed underdose,1,M,HO,911
175099001,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Epilepsy,2,M,OT,813
175099001,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Epilepsy,2,M,HO,813
175099001,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Prescribed underdose,2,M,OT,813
175099001,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Prescribed underdose,2,M,HO,813
175099001,3,Product used for unknown indication,1,I,EXP,nivolumab,3,SS,Epilepsy,3,M,OT,540
175099001,3,Product used for unknown indication,1,I,EXP,nivolumab,3,SS,Epilepsy,3,M,HO,540
175099001,3,Product used for unknown indication,1,I,EXP,nivolumab,3,SS,Prescribed underdose,3,M,OT,540
175099001,3,Product used for unknown indication,1,I,EXP,nivolumab,3,SS,Prescribed underdose,3,M,HO,540
175099001,4,Malignant melanoma,1,I,EXP,ipilimumab,4,SS,Epilepsy,4,M,OT,911
175099001,4,Malignant melanoma,1,I,EXP,ipilimumab,4,SS,Epilepsy,4,M,HO,911
175099001,4,Malignant melanoma,1,I,EXP,ipilimumab,4,SS,Prescribed underdose,4,M,OT,911
175099001,4,Malignant melanoma,1,I,EXP,ipilimumab,4,SS,Prescribed underdose,4,M,HO,911
175099072,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Cerebrovascular accident,1,M,OT,553
175099072,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Cerebrovascular accident,1,M,HO,553
175099072,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Drug intolerance,1,M,OT,553
175099072,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Drug intolerance,1,M,HO,553
175099072,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,553
175099072,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Fatigue,1,M,HO,553
175099072,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Feeling abnormal,1,M,OT,553
175099072,1,Prostate cancer,2,F,EXP,enzalutamide,1,PS,Feeling abnormal,1,M,HO,553
175108301,8,Metastases to bone,1,I,EXP,denosumab,8,C,Pneumonia,8,F,HO,702
175111642,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Nausea,1,F,HO,17
175111642,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Pyloric stenosis,1,F,HO,17
175111642,1,Product used for unknown indication,2,F,EXP,pegfilgrastim,1,PS,Vomiting,1,F,HO,17
175111821,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Acute kidney injury,2,F,HO,63
175113061,1,Myelofibrosis,1,I,EXP,pomalidomide,1,PS,Thrombosis,1,F,HO,718
175113962,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Immune-mediated enterocolitis,1,M,HO,11
175113962,1,Malignant melanoma,2,F,EXP,ipilimumab,1,PS,Immune-mediated enterocolitis,1,M,OT,11
175114061,1,Squamous cell carcinoma of the tongue,1,I,EXP,nivolumab,1,PS,Abscess oral,1,M,HO,6
175114391,1,Acute lymphocytic leukaemia,1,I,EXP,daratumumab,1,PS,Cellulitis,1,M,HO,29
175114982,1,Breast cancer,2,F,EXP,alpelisib,1,PS,Pneumonia,1,F,HO,91
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Abdominal pain,6,F,OT,279
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Abdominal pain,6,F,HO,279
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Abdominal pain,6,F,DE,279
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Constipation,6,F,OT,279
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Constipation,6,F,HO,279
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Constipation,6,F,DE,279
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Intracranial pressure increased,6,F,OT,279
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Intracranial pressure increased,6,F,HO,279
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Intracranial pressure increased,6,F,DE,279
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Malignant neoplasm progression,6,F,OT,279
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Malignant neoplasm progression,6,F,HO,279
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Malignant neoplasm progression,6,F,DE,279
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Metastatic malignant melanoma,6,F,OT,279
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Metastatic malignant melanoma,6,F,HO,279
175115802,6,Metastatic malignant melanoma,2,F,EXP,trametinib,6,SS,Metastatic malignant melanoma,6,F,DE,279
175118471,1,Malignant melanoma,1,I,EXP,trametinib,1,PS,Asthenia,1,M,DS,155
175118471,1,Malignant melanoma,1,I,EXP,trametinib,1,PS,Cachexia,1,M,DS,155
175118471,1,Malignant melanoma,1,I,EXP,trametinib,1,PS,Pyrexia,1,M,DS,155
175118641,3,Metastatic malignant melanoma,1,I,EXP,trametinib,3,SS,Dehydration,3,M,HO,16
175130533,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Cholestasis,1,F,HO,53
175130533,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Cholestasis,1,F,OT,53
175130533,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Drug-induced liver injury,1,F,HO,53
175130533,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Drug-induced liver injury,1,F,OT,53
175130533,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Prescribed overdose,1,F,HO,53
175130533,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Prescribed overdose,1,F,OT,53
175130533,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Cholestasis,2,F,HO,53
175130533,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Cholestasis,2,F,OT,53
175130533,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Drug-induced liver injury,2,F,HO,53
175130533,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Drug-induced liver injury,2,F,OT,53
175130533,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Prescribed overdose,2,F,HO,53
175130533,2,Metastatic renal cell carcinoma,3,F,EXP,ipilimumab,2,SS,Prescribed overdose,2,F,OT,53
175132372,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Circulatory collapse,2,M,HO,1073
175132372,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Dehydration,2,M,HO,1073
175133141,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Cyanosis,8,F,OT,5
175133141,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Cyanosis,8,F,HO,5
175133141,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Irregular breathing,8,F,OT,5
175133141,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Irregular breathing,8,F,HO,5
175133141,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Loss of consciousness,8,F,OT,5
175133141,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Loss of consciousness,8,F,HO,5
175133141,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Seizure,8,F,OT,5
175133141,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Seizure,8,F,HO,5
175133611,2,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,2,PS,Immunodeficiency,2,M,OT,12
175133611,2,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,2,PS,Immunodeficiency,2,M,HO,12
175133611,2,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,2,PS,Pyrexia,2,M,OT,12
175133611,2,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,2,PS,Pyrexia,2,M,HO,12
175133901,1,Renal cell carcinoma,1,I,EXP,avelumab,1,PS,Diabetes mellitus,1,F,HO,843
175134312,18,Prophylaxis,2,F,EXP,rasburicase,18,C,Respiratory tract infection,18,M,HO,2032
175137832,1,B-cell small lymphocytic lymphoma,2,F,EXP,idelalisib,1,PS,Clostridium difficile infection,1,F,OT,745
175137832,1,B-cell small lymphocytic lymphoma,2,F,EXP,idelalisib,1,PS,Clostridium difficile infection,1,F,DS,745
175137832,1,B-cell small lymphocytic lymphoma,2,F,EXP,idelalisib,1,PS,Herpes zoster,1,F,OT,745
175137832,1,B-cell small lymphocytic lymphoma,2,F,EXP,idelalisib,1,PS,Herpes zoster,1,F,DS,745
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,OT,1
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Back pain,1,F,OT,1
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Constipation,1,F,OT,1
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Diarrhoea,1,F,OT,1
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Dizziness,1,F,OT,1
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Ear pain,1,F,OT,1
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Erythema,1,F,OT,1
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Influenza like illness,1,F,OT,1
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Malaise,1,F,OT,1
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Ocular hyperaemia,1,F,OT,1
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Oral pain,1,F,OT,1
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,OT,1
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Paraesthesia,1,F,OT,1
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Pollakiuria,1,F,OT,1
175146541,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Pruritus,1,F,OT,1
175147641,2,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,2,SS,Constipation,2,F,LT,31
175147641,2,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,2,SS,Constipation,2,F,HO,31
175147641,2,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,2,SS,Neutropenia,2,F,LT,31
175147641,2,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,2,SS,Neutropenia,2,F,HO,31
175147641,2,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,2,SS,Pulmonary embolism,2,F,LT,31
175147641,2,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,2,SS,Pulmonary embolism,2,F,HO,31
175147701,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,SS,Respiratory distress,1,M,OT,11
175147701,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,SS,Respiratory distress,1,M,HO,11
175147701,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,PS,Respiratory distress,2,M,OT,11
175147701,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,PS,Respiratory distress,2,M,HO,11
175150361,1,Head and neck cancer,1,I,EXP,nivolumab,1,PS,Pneumonia aspiration,1,M,OT,109
175150361,1,Head and neck cancer,1,I,EXP,nivolumab,1,PS,Pneumonia aspiration,1,M,HO,109
175153131,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Pneumonia,1,M,HO,44
175153131,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Pneumonia,1,M,OT,44
175153131,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Renal disorder,1,M,HO,44
175153131,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Renal disorder,1,M,OT,44
175153572,3,Breast cancer metastatic,2,F,EXP,alpelisib,3,SS,Breast cancer metastatic,3,F,OT,53
175153572,3,Breast cancer metastatic,2,F,EXP,alpelisib,3,SS,Malignant neoplasm progression,3,F,OT,53
175153572,3,Breast cancer metastatic,2,F,EXP,alpelisib,3,SS,Metastases to liver,3,F,OT,53
175155781,1,Acute myeloid leukaemia recurrent,1,I,EXP,ipilimumab,1,PS,Chest pain,1,F,DE,41
175155781,1,Acute myeloid leukaemia recurrent,1,I,EXP,ipilimumab,1,PS,Chest pain,1,F,OT,41
175155781,1,Acute myeloid leukaemia recurrent,1,I,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,F,DE,41
175155781,1,Acute myeloid leukaemia recurrent,1,I,EXP,ipilimumab,1,PS,Malignant neoplasm progression,1,F,OT,41
175155781,1,Acute myeloid leukaemia recurrent,1,I,EXP,ipilimumab,1,PS,Troponin increased,1,F,DE,41
175155781,1,Acute myeloid leukaemia recurrent,1,I,EXP,ipilimumab,1,PS,Troponin increased,1,F,OT,41
175156722,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Neoplasm malignant,2,F,OT,173
175156722,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Neoplasm progression,2,F,OT,173
175156722,2,Breast cancer metastatic,2,F,EXP,palbociclib,2,SS,Second primary malignancy,2,F,OT,173
175157881,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Death,1,M,DE,75
175158181,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Death,1,M,DE,87
175158801,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Gastrointestinal haemorrhage,2,M,OT,251
175158801,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Gastrointestinal haemorrhage,2,M,HO,251
175158801,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Thrombocytopenia,2,M,OT,251
175158801,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Thrombocytopenia,2,M,HO,251
175158801,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Gastrointestinal haemorrhage,3,M,OT,251
175158801,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Gastrointestinal haemorrhage,3,M,HO,251
175158801,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Thrombocytopenia,3,M,OT,251
175158801,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Thrombocytopenia,3,M,HO,251
175159591,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Eye swelling,1,M,OT,25
175159591,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Lip swelling,1,M,OT,25
175159591,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Pruritus,1,M,OT,25
175159591,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Swelling face,1,M,OT,25
175160711,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Lung disorder,2,M,OT,70
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Asthenia,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Bacterial test,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Blood calcitonin decreased,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Blood creatinine decreased,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Cough,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Crystal urine present,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Eosinophil count decreased,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Haematocrit increased,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Haematuria,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Haemoglobin increased,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Haemoglobin urine present,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Herpes virus infection,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Influenza,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Malaise,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Mean cell haemoglobin concentration decreased,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Monocyte count decreased,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Muscular weakness,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Nitrite urine present,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Red blood cell count increased,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Red cell distribution width increased,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Thyroxine decreased,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Tri-iodothyronine decreased,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Urinary sediment present,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Urine abnormality,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,Urine leukocyte esterase positive,1,F,OT,176
175160732,1,Multiple sclerosis,2,F,EXP,alemtuzumab,1,PS,White blood cells urine positive,1,F,OT,176
175162024,4,Gastrooesophageal cancer,4,F,EXP,avelumab,4,SS,Splenic abscess,4,M,HO,180
175162131,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Skin lesion,1,M,OT,20
175169861,2,Breast cancer metastatic,1,I,DIR,palbociclib,2,SS,Anaemia,2,F,HO,134
175169861,2,Breast cancer metastatic,1,I,DIR,palbociclib,2,SS,Colitis,2,F,HO,134
175169861,2,Breast cancer metastatic,1,I,DIR,palbociclib,2,SS,Dehydration,2,F,HO,134
175169861,2,Breast cancer metastatic,1,I,DIR,palbociclib,2,SS,Electrolyte imbalance,2,F,HO,134
175169861,2,Breast cancer metastatic,1,I,DIR,palbociclib,2,SS,Hypotension,2,F,HO,134
175169861,2,Breast cancer metastatic,1,I,DIR,palbociclib,2,SS,Rectal haemorrhage,2,F,HO,134
175171031,1,Breast cancer metastatic,1,I,EXP,zoledronic acid,1,PS,Alopecia,1,F,OT,72
175171031,1,Breast cancer metastatic,1,I,EXP,zoledronic acid,1,PS,Bone pain,1,F,OT,72
175171031,1,Breast cancer metastatic,1,I,EXP,zoledronic acid,1,PS,Lymphoedema,1,F,OT,72
175171031,1,Breast cancer metastatic,1,I,EXP,zoledronic acid,1,PS,Neutropenia,1,F,OT,72
175176961,7,Leukaemia,1,I,EXP,pegaspargase,7,SS,Anaemia,7,M,HO,11
175176961,7,Leukaemia,1,I,EXP,pegaspargase,7,SS,Back pain,7,M,HO,11
175176961,7,Leukaemia,1,I,EXP,pegaspargase,7,SS,Dehydration,7,M,HO,11
175176961,7,Leukaemia,1,I,EXP,pegaspargase,7,SS,Fatigue,7,M,HO,11
175176961,7,Leukaemia,1,I,EXP,pegaspargase,7,SS,Malaise,7,M,HO,11
175176961,7,Leukaemia,1,I,EXP,pegaspargase,7,SS,Oropharyngeal pain,7,M,HO,11
175176961,7,Leukaemia,1,I,EXP,pegaspargase,7,SS,Platelet count decreased,7,M,HO,11
175176961,7,Leukaemia,1,I,EXP,pegaspargase,7,SS,Sepsis,7,M,HO,11
175176961,7,Leukaemia,1,I,EXP,pegaspargase,7,SS,Stomatitis,7,M,HO,11
175176961,7,Leukaemia,1,I,EXP,pegaspargase,7,SS,Toothache,7,M,HO,11
175176961,7,Leukaemia,1,I,EXP,pegaspargase,7,SS,Underdose,7,M,HO,11
175176961,7,Leukaemia,1,I,EXP,pegaspargase,7,SS,White blood cell count decreased,7,M,HO,11
175177651,1,Colorectal adenocarcinoma,1,I,PER,panitumumab,1,PS,Hypomagnesaemia,1,M,LT,219
175177651,1,Colorectal adenocarcinoma,1,I,PER,panitumumab,1,PS,Hypomagnesaemia,1,M,HO,219
175179831,1,Non-small cell lung cancer,1,I,EXP,brigatinib,1,PS,Pneumonitis,1,F,HO,56
175179831,1,Non-small cell lung cancer,1,I,EXP,brigatinib,1,PS,Rash,1,F,HO,56
175179963,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Colitis,2,F,HO,134
175179963,2,Breast cancer metastatic,3,F,EXP,palbociclib,2,SS,Hypotension,2,F,HO,134
175180572,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Seizure,1,M,HO,7
175180572,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Seizure,1,M,OT,7
175180572,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Seizure,2,M,HO,7
175180572,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Seizure,2,M,OT,7
175182031,5,Chronic myeloid leukaemia,1,I,EXP,bosutinib,5,C,Acute kidney injury,5,F,HO,553
175182031,5,Chronic myeloid leukaemia,1,I,EXP,bosutinib,5,C,Acute kidney injury,5,F,OT,553
175182092,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,29
175182092,1,Non-small cell lung cancer,2,F,EXP,nivolumab,1,PS,Pain,1,M,OT,29
175182731,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Cerebral microangiopathy,1,F,OT,360
175182731,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Leukoencephalopathy,1,F,OT,360
175182731,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Off label use,1,F,OT,360
175183591,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Syncope,1,M,OT,38
175184551,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Abdominal pain,1,M,HO,7
175184551,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Abdominal pain,1,M,DE,7
175184551,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Constipation,1,M,HO,7
175184551,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Constipation,1,M,DE,7
175184551,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Diarrhoea,1,M,HO,7
175184551,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Diarrhoea,1,M,DE,7
175184551,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Hyperkalaemia,1,M,HO,7
175184551,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Hyperkalaemia,1,M,DE,7
175184551,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Influenza,1,M,HO,7
175184551,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Influenza,1,M,DE,7
175184551,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Neutrophil count decreased,1,M,HO,7
175184551,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Neutrophil count decreased,1,M,DE,7
175184551,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Pneumonia,1,M,HO,7
175184551,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Pneumonia,1,M,DE,7
175184551,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Abdominal pain,3,M,HO,7
175184551,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Abdominal pain,3,M,DE,7
175184551,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Constipation,3,M,HO,7
175184551,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Constipation,3,M,DE,7
175184551,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Diarrhoea,3,M,HO,7
175184551,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Diarrhoea,3,M,DE,7
175184551,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Hyperkalaemia,3,M,HO,7
175184551,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Hyperkalaemia,3,M,DE,7
175184551,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Influenza,3,M,HO,7
175184551,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Influenza,3,M,DE,7
175184551,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Neutrophil count decreased,3,M,HO,7
175184551,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Neutrophil count decreased,3,M,DE,7
175184551,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Pneumonia,3,M,HO,7
175184551,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Pneumonia,3,M,DE,7
175185052,5,Non-Hodgkin's lymphoma,2,F,EXP,thalidomide,5,C,Bone marrow failure,5,M,OT,150
175185052,5,Non-Hodgkin's lymphoma,2,F,EXP,thalidomide,5,C,Cognitive disorder,5,M,OT,150
175185052,5,Non-Hodgkin's lymphoma,2,F,EXP,thalidomide,5,C,Coma,5,M,OT,150
175185052,5,Non-Hodgkin's lymphoma,2,F,EXP,thalidomide,5,C,Drug ineffective,5,M,OT,150
175185052,5,Non-Hodgkin's lymphoma,2,F,EXP,thalidomide,5,C,Haemorrhage,5,M,OT,150
175185052,5,Non-Hodgkin's lymphoma,2,F,EXP,thalidomide,5,C,Hemiplegia,5,M,OT,150
175185052,5,Non-Hodgkin's lymphoma,2,F,EXP,thalidomide,5,C,Intentional product use issue,5,M,OT,150
175185052,5,Non-Hodgkin's lymphoma,2,F,EXP,thalidomide,5,C,Off label use,5,M,OT,150
175185052,5,Non-Hodgkin's lymphoma,2,F,EXP,thalidomide,5,C,Pneumonia,5,M,OT,150
175185052,5,Non-Hodgkin's lymphoma,2,F,EXP,thalidomide,5,C,Prostatomegaly,5,M,OT,150
175185052,5,Non-Hodgkin's lymphoma,2,F,EXP,thalidomide,5,C,Renal cyst,5,M,OT,150
175185052,5,Non-Hodgkin's lymphoma,2,F,EXP,thalidomide,5,C,Spinal osteoarthritis,5,M,OT,150
175185052,5,Non-Hodgkin's lymphoma,2,F,EXP,thalidomide,5,C,Splenomegaly,5,M,OT,150
175185052,5,Non-Hodgkin's lymphoma,2,F,EXP,thalidomide,5,C,Waldenstrom's macroglobulinaemia,5,M,OT,150
175185052,8,Non-Hodgkin's lymphoma,2,F,EXP,chlorambucil,8,C,Bone marrow failure,8,M,OT,241
175185052,8,Non-Hodgkin's lymphoma,2,F,EXP,chlorambucil,8,C,Cognitive disorder,8,M,OT,241
175185052,8,Non-Hodgkin's lymphoma,2,F,EXP,chlorambucil,8,C,Coma,8,M,OT,241
175185052,8,Non-Hodgkin's lymphoma,2,F,EXP,chlorambucil,8,C,Drug ineffective,8,M,OT,241
175185052,8,Non-Hodgkin's lymphoma,2,F,EXP,chlorambucil,8,C,Haemorrhage,8,M,OT,241
175185052,8,Non-Hodgkin's lymphoma,2,F,EXP,chlorambucil,8,C,Hemiplegia,8,M,OT,241
175185052,8,Non-Hodgkin's lymphoma,2,F,EXP,chlorambucil,8,C,Intentional product use issue,8,M,OT,241
175185052,8,Non-Hodgkin's lymphoma,2,F,EXP,chlorambucil,8,C,Off label use,8,M,OT,241
175185052,8,Non-Hodgkin's lymphoma,2,F,EXP,chlorambucil,8,C,Pneumonia,8,M,OT,241
175185052,8,Non-Hodgkin's lymphoma,2,F,EXP,chlorambucil,8,C,Prostatomegaly,8,M,OT,241
175185052,8,Non-Hodgkin's lymphoma,2,F,EXP,chlorambucil,8,C,Renal cyst,8,M,OT,241
175185052,8,Non-Hodgkin's lymphoma,2,F,EXP,chlorambucil,8,C,Spinal osteoarthritis,8,M,OT,241
175185052,8,Non-Hodgkin's lymphoma,2,F,EXP,chlorambucil,8,C,Splenomegaly,8,M,OT,241
175185052,8,Non-Hodgkin's lymphoma,2,F,EXP,chlorambucil,8,C,Waldenstrom's macroglobulinaemia,8,M,OT,241
175185354,1,Peripheral T-cell lymphoma unspecified,4,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,OT,40
175185354,1,Peripheral T-cell lymphoma unspecified,4,F,EXP,nivolumab,1,PS,Febrile neutropenia,1,M,HO,40
175185354,1,Peripheral T-cell lymphoma unspecified,4,F,EXP,nivolumab,1,PS,Gastritis,1,M,OT,40
175185354,1,Peripheral T-cell lymphoma unspecified,4,F,EXP,nivolumab,1,PS,Gastritis,1,M,HO,40
175185354,1,Peripheral T-cell lymphoma unspecified,4,F,EXP,nivolumab,1,PS,Stevens-Johnson syndrome,1,M,OT,40
175185354,1,Peripheral T-cell lymphoma unspecified,4,F,EXP,nivolumab,1,PS,Stevens-Johnson syndrome,1,M,HO,40
175186051,10,Acute lymphocytic leukaemia,1,I,PER,pegaspargase,10,SS,Febrile neutropenia,10,M,HO,45
175186331,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Dehydration,1,F,OT,10
175186331,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Dehydration,1,F,HO,10
175186331,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Hypophysitis,1,F,OT,10
175186331,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Hypophysitis,1,F,HO,10
175186331,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Dehydration,2,F,OT,38
175186331,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Dehydration,2,F,HO,38
175186331,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Hypophysitis,2,F,OT,38
175186331,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Hypophysitis,2,F,HO,38
175187911,1,Nodular melanoma,1,I,EXP,nivolumab,1,PS,Influenza,1,F,HO,58
175187911,1,Nodular melanoma,1,I,EXP,nivolumab,1,PS,Intentional product use issue,1,F,HO,58
175187911,1,Nodular melanoma,1,I,EXP,nivolumab,1,PS,Maternal exposure during pregnancy,1,F,HO,58
175187911,1,Nodular melanoma,1,I,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,58
175189931,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Cardiac failure,1,M,OT,9
175194242,27,Prophylaxis,2,F,PER,pegfilgrastim,27,C,Febrile neutropenia,27,M,HO,8
175196331,4,Breast cancer,1,I,EXP,doxorubicin hydrochloride liposome,4,SS,Bone marrow failure,4,F,HO,11
175196832,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Myocardial infarction,1,M,OT,31
175196832,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Myocardial infarction,1,M,DE,31
175196832,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Myocardial infarction,2,M,OT,31
175196832,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Myocardial infarction,2,M,DE,31
175197041,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Cytopenia,1,F,LT,37
175197041,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Cytopenia,1,F,OT,37
175197041,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Haemoglobin decreased,1,F,LT,37
175197041,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Haemoglobin decreased,1,F,OT,37
175197041,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Hypotension,1,F,LT,37
175197041,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Hypotension,1,F,OT,37
175197041,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Malignant neoplasm progression,1,F,LT,37
175197041,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Malignant neoplasm progression,1,F,OT,37
175197041,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Neutropenia,1,F,LT,37
175197041,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Neutropenia,1,F,OT,37
175197041,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Pulmonary embolism,1,F,LT,37
175197041,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Pulmonary embolism,1,F,OT,37
175197041,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Thrombocytopenia,1,F,LT,37
175197041,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Thrombocytopenia,1,F,OT,37
175198381,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Anaemia,1,F,OT,63
175198381,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Epistaxis,1,F,OT,63
175198381,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Haematemesis,1,F,OT,63
175200171,2,Product used for unknown indication,1,I,EXP,ibrutinib,2,SS,Hyperkalaemia,2,M,HO,58
175200171,2,Product used for unknown indication,1,I,EXP,ibrutinib,2,SS,Hyperphosphataemia,2,M,HO,58
175200171,2,Product used for unknown indication,1,I,EXP,ibrutinib,2,SS,Tumour lysis syndrome,2,M,HO,58
175202141,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Confusional state,2,F,HO,169
175202141,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Paranoia,2,F,HO,169
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Acute right ventricular failure,1,F,OT,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Acute right ventricular failure,1,F,DE,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Agitation,1,F,OT,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Agitation,1,F,DE,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Confusional state,1,F,OT,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Confusional state,1,F,DE,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Haemodynamic instability,1,F,OT,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Haemodynamic instability,1,F,DE,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Haemolytic anaemia,1,F,OT,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Haemolytic anaemia,1,F,DE,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Headache,1,F,OT,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Headache,1,F,DE,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Metabolic acidosis,1,F,OT,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Metabolic acidosis,1,F,DE,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Pyrexia,1,F,OT,17
175208981,1,Breast cancer metastatic,1,I,EXP,abemaciclib,1,PS,Pyrexia,1,F,DE,17
175209432,1,Non-small cell lung cancer recurrent,2,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,OT,84
175209432,1,Non-small cell lung cancer recurrent,2,F,EXP,nivolumab,1,PS,Abdominal pain,1,M,HO,84
175209432,1,Non-small cell lung cancer recurrent,2,F,EXP,nivolumab,1,PS,Brain oedema,1,M,OT,84
175209432,1,Non-small cell lung cancer recurrent,2,F,EXP,nivolumab,1,PS,Brain oedema,1,M,HO,84
175209432,1,Non-small cell lung cancer recurrent,2,F,EXP,nivolumab,1,PS,Gastroenteritis,1,M,OT,84
175209432,1,Non-small cell lung cancer recurrent,2,F,EXP,nivolumab,1,PS,Gastroenteritis,1,M,HO,84
175212751,2,Acute lymphocytic leukaemia,1,I,EXP,inotuzumab ozogamicin,2,SS,Multiple organ dysfunction syndrome,2,F,DE,62
175213491,16,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,16,SS,Hemiparesis,16,M,HO,95
175213491,16,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,16,SS,Hemiplegia,16,M,HO,95
175213491,16,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,16,SS,Speech disorder,16,M,HO,95
175213491,16,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,16,SS,Toxicity to various agents,16,M,HO,95
175213791,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood pressure increased,1,M,OT,141
175213791,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood pressure increased,1,M,HO,141
175213791,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Hypertensive crisis,1,M,OT,141
175213791,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Hypertensive crisis,1,M,HO,141
175215581,1,Product used for unknown indication,1,I,EXP,zoledronic acid,1,PS,Inappropriate antidiuretic hormone secretion,1,M,HO,2
175216361,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Invasive lobular breast carcinoma,1,F,LT,781
175216361,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Invasive lobular breast carcinoma,1,F,OT,781
175216361,2,Plasma cell myeloma,1,I,PER,lenalidomide,2,SS,Invasive lobular breast carcinoma,2,F,LT,781
175216361,2,Plasma cell myeloma,1,I,PER,lenalidomide,2,SS,Invasive lobular breast carcinoma,2,F,OT,781
175218122,1,Non-small cell lung cancer,2,F,EXP,lorlatinib,1,PS,Cholelithiasis,1,F,OT,6
175218122,1,Non-small cell lung cancer,2,F,EXP,lorlatinib,1,PS,Cholelithiasis,1,F,HO,6
175218122,1,Non-small cell lung cancer,2,F,EXP,lorlatinib,1,PS,Obstructive pancreatitis,1,F,OT,6
175218122,1,Non-small cell lung cancer,2,F,EXP,lorlatinib,1,PS,Obstructive pancreatitis,1,F,HO,6
175218143,1,Transitional cell cancer of renal pelvis and ureter metastatic,3,F,EXP,nivolumab,1,PS,Subdural haematoma,1,F,DE,130
175218143,1,Transitional cell cancer of renal pelvis and ureter metastatic,3,F,EXP,nivolumab,1,PS,Subdural haematoma,1,F,OT,130
175218143,1,Transitional cell cancer of renal pelvis and ureter metastatic,3,F,EXP,nivolumab,1,PS,Subdural haematoma,1,F,LT,130
175218143,1,Transitional cell cancer of renal pelvis and ureter metastatic,3,F,EXP,nivolumab,1,PS,Subdural haematoma,1,F,HO,130
175218143,1,Transitional cell cancer of renal pelvis and ureter metastatic,3,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,DE,130
175218143,1,Transitional cell cancer of renal pelvis and ureter metastatic,3,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,OT,130
175218143,1,Transitional cell cancer of renal pelvis and ureter metastatic,3,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,LT,130
175218143,1,Transitional cell cancer of renal pelvis and ureter metastatic,3,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,HO,130
175218371,2,Malignant melanoma,1,I,EXP,trametinib,2,SS,Non-cardiac chest pain,2,M,OT,64
175218371,2,Malignant melanoma,1,I,EXP,trametinib,2,SS,Pyrexia,2,M,OT,64
175218371,2,Malignant melanoma,1,I,EXP,trametinib,2,SS,Ventricular hypokinesia,2,M,OT,64
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Decreased appetite,9,M,OT,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Decreased appetite,9,M,HO,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Diarrhoea,9,M,OT,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Diarrhoea,9,M,HO,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Febrile neutropenia,9,M,OT,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Febrile neutropenia,9,M,HO,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Herpes simplex,9,M,OT,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Herpes simplex,9,M,HO,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Nausea,9,M,OT,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Nausea,9,M,HO,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Oral pain,9,M,OT,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Oral pain,9,M,HO,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Oropharyngeal pain,9,M,OT,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Oropharyngeal pain,9,M,HO,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Rhinorrhoea,9,M,OT,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Rhinorrhoea,9,M,HO,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Staphylococcal infection,9,M,OT,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Staphylococcal infection,9,M,HO,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Vomiting,9,M,OT,6
175218541,9,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,9,SS,Vomiting,9,M,HO,6
175218941,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Cellulitis,1,M,HO,64
175218941,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Overdose,1,M,HO,64
175221192,3,Chronic myeloid leukaemia,2,F,EXP,bosutinib,3,C,C-reactive protein increased,3,M,HO,775
175221192,3,Chronic myeloid leukaemia,2,F,EXP,bosutinib,3,C,Hepatic function abnormal,3,M,HO,775
175221192,3,Chronic myeloid leukaemia,2,F,EXP,bosutinib,3,C,Jaundice,3,M,HO,775
175221192,3,Chronic myeloid leukaemia,2,F,EXP,bosutinib,3,C,Pleural effusion,3,M,HO,775
175221192,3,Chronic myeloid leukaemia,2,F,EXP,bosutinib,3,C,Pneumocystis jirovecii pneumonia,3,M,HO,775
175221192,3,Chronic myeloid leukaemia,2,F,EXP,bosutinib,3,C,Pyrexia,3,M,HO,775
175221391,1,Breast cancer,1,I,EXP,alpelisib,1,PS,Colitis,1,F,HO,232
175221601,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Oesophageal candidiasis,1,F,HO,252
175221601,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Oesophageal candidiasis,1,F,OT,252
175221601,4,Plasma cell myeloma,1,I,PER,lenalidomide,4,SS,Oesophageal candidiasis,4,F,HO,252
175221601,4,Plasma cell myeloma,1,I,PER,lenalidomide,4,SS,Oesophageal candidiasis,4,F,OT,252
175224541,4,Neoplasm,1,I,EXP,avelumab,4,SS,Constipation,4,M,HO,2
175224752,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Cough,1,F,OT,7
175224752,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Dysaesthesia,1,F,OT,7
175224752,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Eczema,1,F,OT,7
175224752,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Hypoaesthesia,1,F,OT,7
175224752,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Hypokalaemia,1,F,OT,7
175224752,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Liver function test increased,1,F,OT,7
175224752,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Myalgia,1,F,OT,7
175224752,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Perioral dermatitis,1,F,OT,7
175224752,1,Non-small cell lung cancer metastatic,2,F,EXP,nivolumab,1,PS,Pyrexia,1,F,OT,7
175226803,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,10
175226803,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Decreased appetite,1,M,HO,10
175226803,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,10
175226803,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,10
175226803,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Renal failure,1,M,OT,10
175226803,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Renal failure,1,M,HO,10
175226803,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Vomiting,1,M,OT,10
175226803,1,Prostate cancer,3,F,EXP,nivolumab,1,PS,Vomiting,1,M,HO,10
175226803,2,Prostate cancer,3,F,EXP,ipilimumab,2,SS,Decreased appetite,2,M,OT,10
175226803,2,Prostate cancer,3,F,EXP,ipilimumab,2,SS,Decreased appetite,2,M,HO,10
175226803,2,Prostate cancer,3,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,OT,10
175226803,2,Prostate cancer,3,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,10
175226803,2,Prostate cancer,3,F,EXP,ipilimumab,2,SS,Renal failure,2,M,OT,10
175226803,2,Prostate cancer,3,F,EXP,ipilimumab,2,SS,Renal failure,2,M,HO,10
175226803,2,Prostate cancer,3,F,EXP,ipilimumab,2,SS,Vomiting,2,M,OT,10
175226803,2,Prostate cancer,3,F,EXP,ipilimumab,2,SS,Vomiting,2,M,HO,10
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Acute myocardial infarction,2,M,OT,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Acute myocardial infarction,2,M,HO,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Acute myocardial infarction,2,M,LT,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Atrioventricular block complete,2,M,OT,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Atrioventricular block complete,2,M,HO,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Atrioventricular block complete,2,M,LT,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Dysphagia,2,M,OT,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Dysphagia,2,M,HO,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Dysphagia,2,M,LT,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,General physical health deterioration,2,M,OT,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,General physical health deterioration,2,M,HO,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,General physical health deterioration,2,M,LT,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Hypertensive crisis,2,M,OT,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Hypertensive crisis,2,M,HO,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Hypertensive crisis,2,M,LT,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Myalgia,2,M,OT,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Myalgia,2,M,HO,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Myalgia,2,M,LT,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Off label use,2,M,OT,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Off label use,2,M,HO,14
175230131,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Off label use,2,M,LT,14
175230471,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Asthenia,1,M,OT,1
175230471,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Blood creatinine increased,1,M,OT,1
175230471,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Blood glucose increased,1,M,OT,1
175230471,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Blood urea increased,1,M,OT,1
175230471,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Constipation,1,M,OT,1
175230471,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Cough,1,M,OT,1
175230471,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Delirium,1,M,OT,1
175230471,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Hyperkalaemia,1,M,OT,1
175230471,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Hyponatraemia,1,M,OT,1
175232251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,29
175232251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Influenza like illness,1,M,OT,29
175232251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Melaena,1,M,OT,29
175232251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Oropharyngeal pain,1,M,OT,29
175232251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Osteoarthritis,1,M,OT,29
175232251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Otitis media,1,M,OT,29
175232251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Skin hyperpigmentation,1,M,OT,29
175234181,1,Chronic lymphocytic leukaemia,1,I,EXP,idelalisib,1,PS,Death,1,M,OT,232
175234181,1,Chronic lymphocytic leukaemia,1,I,EXP,idelalisib,1,PS,Death,1,M,DE,232
175234441,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Diabetes mellitus,1,M,OT,7
175234441,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Spinal stenosis,1,M,OT,7
175235781,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Acute respiratory failure,1,M,HO,719
175235781,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Acute respiratory failure,1,M,LT,719
175235781,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Pyrexia,1,M,HO,719
175235781,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Pyrexia,1,M,LT,719
175235781,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Acute respiratory failure,2,M,HO,708
175235781,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Acute respiratory failure,2,M,LT,708
175235781,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Pyrexia,2,M,HO,708
175235781,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Pyrexia,2,M,LT,708
175238021,13,Plasma cell myeloma,1,I,EXP,pomalidomide,13,SS,Neutropenia,13,M,OT,28
175238021,13,Plasma cell myeloma,1,I,EXP,pomalidomide,13,SS,Rash maculo-papular,13,M,OT,28
175238021,13,Plasma cell myeloma,1,I,EXP,pomalidomide,13,SS,Thrombocytopenia,13,M,OT,28
175238062,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Cytopenia,4,F,LT,327
175238062,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Cytopenia,4,F,HO,327
175238062,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Sepsis,4,F,LT,327
175238062,4,Plasma cell myeloma,2,F,EXP,lenalidomide,4,SS,Sepsis,4,F,HO,327
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Abdominal pain upper,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Abdominal pain upper,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Chest discomfort,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Chest discomfort,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Cough,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Cough,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Diarrhoea,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Diarrhoea,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Hypokalaemia,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Hypokalaemia,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Nasopharyngitis,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Nasopharyngitis,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Paraesthesia,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Paraesthesia,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pleural effusion,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pleural effusion,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Productive cough,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Productive cough,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pruritus,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pruritus,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pulmonary embolism,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pulmonary embolism,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pyrexia,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pyrexia,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Rhinorrhoea,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Rhinorrhoea,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Seizure,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Seizure,1,F,OT,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Vision blurred,1,F,HO,23
175239411,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Vision blurred,1,F,OT,23
175239673,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Colitis,1,M,HO,24
175239673,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Colitis,1,M,OT,24
175239673,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Colitis,1,M,DE,24
175239673,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Diverticulitis,1,M,HO,24
175239673,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Diverticulitis,1,M,OT,24
175239673,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Diverticulitis,1,M,DE,24
175239673,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,24
175239673,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,24
175239673,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,24
175239673,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Peritoneal abscess,1,M,HO,24
175239673,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Peritoneal abscess,1,M,OT,24
175239673,1,Malignant melanoma,3,F,EXP,nivolumab,1,PS,Peritoneal abscess,1,M,DE,24
175239673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Colitis,3,M,HO,24
175239673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Colitis,3,M,OT,24
175239673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Colitis,3,M,DE,24
175239673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Diverticulitis,3,M,HO,24
175239673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Diverticulitis,3,M,OT,24
175239673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Diverticulitis,3,M,DE,24
175239673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,HO,24
175239673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,OT,24
175239673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Malignant neoplasm progression,3,M,DE,24
175239673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Peritoneal abscess,3,M,HO,24
175239673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Peritoneal abscess,3,M,OT,24
175239673,3,Malignant melanoma,3,F,EXP,ipilimumab,3,SS,Peritoneal abscess,3,M,DE,24
175240741,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Pneumothorax,1,M,OT,8
175240741,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Rash,1,M,OT,8
175242303,1,Gastrooesophageal cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,329
175242341,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,M,OT,136
175246132,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Immune-mediated arthritis,1,F,HO,127
175246132,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Immune-mediated arthritis,1,F,OT,127
175247492,2,Plasma cell myeloma,2,F,PER,lenalidomide,2,SS,Toxic epidermal necrolysis,2,M,OT,97
175247492,2,Plasma cell myeloma,2,F,PER,lenalidomide,2,SS,Toxic epidermal necrolysis,2,M,DE,97
175253171,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Lipase increased,1,M,OT,223
175254391,4,Prostate cancer metastatic,1,I,EXP,enzalutamide,4,SS,Back pain,4,M,HO,1097
175254391,4,Prostate cancer metastatic,1,I,EXP,enzalutamide,4,SS,Chest pain,4,M,HO,1097
175254391,4,Prostate cancer metastatic,1,I,EXP,enzalutamide,4,SS,Myalgia,4,M,HO,1097
175254431,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Erysipelas,1,F,HO,178
175254431,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Erysipelas,1,F,OT,178
175257701,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Hypersensitivity,1,M,OT,46
175258882,1,Renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,64
175258882,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,64
175258901,12,Metastases to bone,1,I,EXP,denosumab,12,C,Pneumonia aspiration,12,M,HO,31
175262741,3,Breast cancer metastatic,1,I,EXP,palbociclib,3,SS,Arthritis,3,F,HO,63
175263911,1,Lung neoplasm malignant,1,I,EXP,entrectinib,1,PS,Cerebrovascular accident,1,M,OT,10
175263911,1,Lung neoplasm malignant,1,I,EXP,entrectinib,1,PS,Cerebrovascular accident,1,M,HO,10
175263911,1,Lung neoplasm malignant,1,I,EXP,entrectinib,1,PS,Pneumocentesis,1,M,OT,10
175263911,1,Lung neoplasm malignant,1,I,EXP,entrectinib,1,PS,Pneumocentesis,1,M,HO,10
175270251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Musculoskeletal pain,1,M,OT,29
175270251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Phlebitis infective,1,M,OT,29
175274121,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Cholangitis,1,F,OT,66
175274121,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Metastases to bone,1,F,OT,66
175276443,1,Uveal melanoma,3,F,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,113
175276443,2,Uveal melanoma,3,F,EXP,ipilimumab,2,SS,Diarrhoea,2,M,HO,113
175277181,1,Colorectal cancer metastatic,1,I,PER,panitumumab,1,PS,Neutropenia,1,F,HO,38
175278251,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Hypogammaglobulinaemia,1,M,LT,187
175278251,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Peritonitis,1,M,LT,187
175278251,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,C,Hypogammaglobulinaemia,2,M,LT,187
175278251,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,C,Peritonitis,2,M,LT,187
175278281,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Acute respiratory failure,1,F,HO,67
175278281,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Atrial fibrillation,1,F,HO,67
175278281,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Cardiac failure acute,1,F,HO,67
175278281,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Lower respiratory tract infection,1,F,HO,67
175278281,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Pneumonitis,1,F,HO,67
175278281,3,Plasma cell myeloma,1,I,EXP,carfilzomib,3,C,Acute respiratory failure,3,F,HO,67
175278281,3,Plasma cell myeloma,1,I,EXP,carfilzomib,3,C,Atrial fibrillation,3,F,HO,67
175278281,3,Plasma cell myeloma,1,I,EXP,carfilzomib,3,C,Cardiac failure acute,3,F,HO,67
175278281,3,Plasma cell myeloma,1,I,EXP,carfilzomib,3,C,Lower respiratory tract infection,3,F,HO,67
175278281,3,Plasma cell myeloma,1,I,EXP,carfilzomib,3,C,Pneumonitis,3,F,HO,67
175278471,1,Gastric cancer,1,I,EXP,ramucirumab,1,PS,Large intestinal haemorrhage,1,M,HO,64
175281451,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Supraventricular tachycardia,1,F,OT,62
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Alopecia,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Anaemia,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Constipation,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Diarrhoea,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Dizziness,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Dry skin,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Feeling cold,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Hot flush,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Hyperhidrosis,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Lacrimation increased,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Neutrophil count decreased,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Rash,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Rectal tenesmus,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Thrombocytopenia,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Vomiting,2,F,OT,2
175285161,2,Breast cancer metastatic,1,I,EXP,abemaciclib,2,SS,Weight decreased,2,F,OT,2
175285821,1,Plasma cell myeloma,1,I,EXP,thalidomide,1,PS,Progressive multifocal leukoencephalopathy,1,F,HO,288
175285821,1,Plasma cell myeloma,1,I,EXP,thalidomide,1,PS,Progressive multifocal leukoencephalopathy,1,F,OT,288
175289361,3,Malignant melanoma,1,I,EXP,encorafenib,3,SS,Hepatocellular injury,3,F,HO,60
175289361,4,Malignant melanoma,1,I,EXP,binimetinib,4,SS,Hepatocellular injury,4,F,HO,60
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,OT,1
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Back pain,1,F,OT,1
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Constipation,1,F,OT,1
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Diarrhoea,1,F,OT,1
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Dizziness,1,F,OT,1
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Ear pain,1,F,OT,1
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Erythema,1,F,OT,1
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Influenza like illness,1,F,OT,1
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Malaise,1,F,OT,1
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Ocular hyperaemia,1,F,OT,1
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Oral pain,1,F,OT,1
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,OT,1
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Paraesthesia,1,F,OT,1
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Pollakiuria,1,F,OT,1
175291991,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Pruritus,1,F,OT,1
175292293,2,Colorectal cancer metastatic,3,F,EXP,avelumab,2,SS,Acute kidney injury,2,F,HO,114
175292293,2,Colorectal cancer metastatic,3,F,EXP,avelumab,2,SS,Infusion related reaction,2,F,HO,114
175292621,2,Product used for unknown indication,1,I,EXP,palbociclib,2,SS,Lung neoplasm malignant,2,F,OT,437
175292621,2,Product used for unknown indication,1,I,EXP,palbociclib,2,SS,Second primary malignancy,2,F,OT,437
175292931,1,Transitional cell cancer of renal pelvis and ureter metastatic,1,I,EXP,nivolumab,1,PS,Arthritis,1,M,HO,89
175293321,4,Renal cell carcinoma,1,I,EXP,nivolumab,4,SS,Dermatitis,4,M,DE,563
175293321,4,Renal cell carcinoma,1,I,EXP,nivolumab,4,SS,Dermatitis,4,M,HO,563
175294441,17,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,17,C,Febrile neutropenia,17,F,HO,18
175294441,17,Prophylaxis of nausea and vomiting,1,I,EXP,granisetron,17,C,Staphylococcal infection,17,F,HO,18
175296931,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Febrile neutropenia,1,F,OT,55
175296931,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Febrile neutropenia,1,F,HO,55
175296931,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Influenza,1,F,OT,55
175296931,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Influenza,1,F,HO,55
175296941,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Blood sodium abnormal,1,F,HO,27
175296941,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Blood sodium abnormal,2,F,HO,55
175297211,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Appendicitis,1,M,HO,10
175297211,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Appendicitis,1,M,OT,10
175297211,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Epilepsy,1,M,HO,10
175297211,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Epilepsy,1,M,OT,10
175297211,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Pneumonia,1,M,HO,10
175297211,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Pneumonia,1,M,OT,10
175299151,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Myelitis transverse,1,F,OT,293
175299151,1,Non-small cell lung cancer metastatic,1,I,EXP,nivolumab,1,PS,Myelitis transverse,1,F,DS,293
175302641,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,64
175302641,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Asthenia,1,M,OT,64
175302641,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Bronchitis,1,M,OT,64
175302641,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,64
175302641,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Dehydration,1,M,OT,64
175302641,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Thyroiditis subacute,1,M,OT,64
175302641,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Adrenal insufficiency,2,M,OT,64
175302641,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Asthenia,2,M,OT,64
175302641,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Bronchitis,2,M,OT,64
175302641,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Decreased appetite,2,M,OT,64
175302641,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Dehydration,2,M,OT,64
175302641,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Thyroiditis subacute,2,M,OT,64
175305262,3,Plasma cell myeloma,2,F,EXP,nivolumab,3,C,Sudden death,3,M,OT,946
175305262,3,Plasma cell myeloma,2,F,EXP,nivolumab,3,C,Sudden death,3,M,DE,946
175315591,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Blood urine present,1,F,OT,10
175315591,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Urinary tract infection,1,F,OT,10
175315591,1,Multiple sclerosis,1,I,EXP,alemtuzumab,1,PS,Urinary tract infection bacterial,1,F,OT,10
175315932,23,White blood cell count increased,2,F,EXP,filgrastim,23,C,Alanine aminotransferase increased,23,M,HO,8
175315932,23,White blood cell count increased,2,F,EXP,filgrastim,23,C,Aspartate aminotransferase increased,23,M,HO,8
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,LT,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Emotional distress,1,M,HO,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Emotional distress,1,M,LT,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Emotional distress,1,M,OT,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Liver disorder,1,M,HO,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Liver disorder,1,M,LT,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Liver disorder,1,M,OT,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,LT,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Muscle disorder,1,M,HO,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Muscle disorder,1,M,LT,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Muscle disorder,1,M,OT,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Myocardial infarction,1,M,HO,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Myocardial infarction,1,M,LT,20
175317952,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Myocardial infarction,1,M,OT,20
175318302,1,Neuroendocrine carcinoma of the skin,2,F,EXP,avelumab,1,PS,Cellulitis,1,M,HO,100
175318302,1,Neuroendocrine carcinoma of the skin,2,F,EXP,avelumab,1,PS,Eczema,1,M,HO,100
175320931,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Cardiac failure acute,1,M,DE,276
175320931,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Congestive cardiomyopathy,1,M,DE,276
175321832,1,Oesophageal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Oesophageal fistula,1,F,LT,146
175321832,1,Oesophageal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Oesophageal fistula,1,F,HO,146
175321832,1,Oesophageal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Oesophageal fistula,1,F,DE,146
175321832,1,Oesophageal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Oesophageal fistula,1,F,OT,146
175321832,1,Oesophageal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Oesophageal haemorrhage,1,F,LT,146
175321832,1,Oesophageal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Oesophageal haemorrhage,1,F,HO,146
175321832,1,Oesophageal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Oesophageal haemorrhage,1,F,DE,146
175321832,1,Oesophageal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Oesophageal haemorrhage,1,F,OT,146
175321832,2,Oesophageal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Oesophageal fistula,2,F,LT,62
175321832,2,Oesophageal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Oesophageal fistula,2,F,HO,62
175321832,2,Oesophageal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Oesophageal fistula,2,F,DE,62
175321832,2,Oesophageal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Oesophageal fistula,2,F,OT,62
175321832,2,Oesophageal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Oesophageal haemorrhage,2,F,LT,62
175321832,2,Oesophageal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Oesophageal haemorrhage,2,F,HO,62
175321832,2,Oesophageal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Oesophageal haemorrhage,2,F,DE,62
175321832,2,Oesophageal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Oesophageal haemorrhage,2,F,OT,62
175326131,2,Plasma cell myeloma,1,I,EXP,carfilzomib,2,C,Toxic epidermal necrolysis,2,M,DE,117
175326141,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Pulpitis dental,1,M,HO,232
175326141,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Pulpitis dental,1,M,OT,232
175326141,3,Plasma cell myeloma,1,I,EXP,carfilzomib,3,SS,Pulpitis dental,3,M,HO,231
175326141,3,Plasma cell myeloma,1,I,EXP,carfilzomib,3,SS,Pulpitis dental,3,M,OT,231
175329421,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Pyrexia,1,M,HO,67
175333651,2,Oropharyngeal cancer,1,I,EXP,nivolumab,2,SS,Pain,2,M,HO,98
175333651,2,Oropharyngeal cancer,1,I,EXP,nivolumab,2,SS,Unevaluable event,2,M,HO,98
175338281,1,Chronic myeloid leukaemia,1,I,EXP,bosutinib,1,PS,Pleuropericarditis,1,F,HO,46
175338281,1,Chronic myeloid leukaemia,1,I,EXP,bosutinib,1,PS,Pleuropericarditis,1,F,LT,46
175339591,1,Breast cancer,1,I,EXP,palbociclib,1,PS,Colitis,1,F,HO,134
175339591,1,Breast cancer,1,I,EXP,palbociclib,1,PS,Hypotension,1,F,HO,134
175339801,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,C-reactive protein increased,1,M,OT,22
175339801,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,C-reactive protein increased,1,M,HO,22
175339801,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Diarrhoea haemorrhagic,1,M,OT,22
175339801,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Diarrhoea haemorrhagic,1,M,HO,22
175339801,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Immune-mediated enterocolitis,1,M,OT,22
175339801,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Immune-mediated enterocolitis,1,M,HO,22
175339801,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Intentional product use issue,1,M,OT,22
175339801,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Intentional product use issue,1,M,HO,22
175339801,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Prescribed overdose,1,M,OT,22
175339801,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Prescribed overdose,1,M,HO,22
175339801,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,C-reactive protein increased,2,M,OT,22
175339801,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,C-reactive protein increased,2,M,HO,22
175339801,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Diarrhoea haemorrhagic,2,M,OT,22
175339801,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Diarrhoea haemorrhagic,2,M,HO,22
175339801,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Immune-mediated enterocolitis,2,M,OT,22
175339801,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Immune-mediated enterocolitis,2,M,HO,22
175339801,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Intentional product use issue,2,M,OT,22
175339801,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Intentional product use issue,2,M,HO,22
175339801,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Prescribed overdose,2,M,OT,22
175339801,2,Malignant melanoma,1,I,EXP,nivolumab,2,SS,Prescribed overdose,2,M,HO,22
175344971,1,Leiomyosarcoma,1,I,PER,talimogene laherparepvec,1,PS,Dehydration,1,M,HO,23
175344971,3,Leiomyosarcoma,1,I,PER,nivolumab,3,SS,Dehydration,3,M,HO,30
175345161,2,Hormone-refractory prostate cancer,1,I,EXP,cabazitaxel,2,SS,Respiratory distress,2,M,DE,7
175346272,2,Mantle cell lymphoma,2,F,EXP,ibrutinib,2,SS,Pneumonia,2,M,HO,246
175349201,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Hypoxia,1,M,OT,377
175349201,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Hypoxia,1,M,HO,377
175349201,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,377
175349201,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,377
175349201,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Hypoxia,2,M,OT,233
175349201,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Hypoxia,2,M,HO,233
175349201,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Pneumonitis,2,M,OT,233
175349201,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Pneumonitis,2,M,HO,233
175349201,3,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Hypoxia,3,M,OT,377
175349201,3,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Hypoxia,3,M,HO,377
175349201,3,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Pneumonitis,3,M,OT,377
175349201,3,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Pneumonitis,3,M,HO,377
175349301,1,Hepatocellular carcinoma,1,I,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,114
175349301,1,Hepatocellular carcinoma,1,I,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,114
175349301,1,Hepatocellular carcinoma,1,I,EXP,nivolumab,1,PS,Infected dermal cyst,1,M,OT,114
175349301,1,Hepatocellular carcinoma,1,I,EXP,nivolumab,1,PS,Infected dermal cyst,1,M,HO,114
175349301,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Adrenal insufficiency,2,M,OT,2
175349301,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Adrenal insufficiency,2,M,HO,2
175349301,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Infected dermal cyst,2,M,OT,2
175349301,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Infected dermal cyst,2,M,HO,2
175350052,1,Chronic lymphocytic leukaemia,2,F,EXP,ibrutinib,1,PS,Hepatitis,1,M,HO,56
175351572,2,Plasma cell myeloma,2,F,EXP,carfilzomib,2,SS,Invasive breast carcinoma,2,F,OT,781
175354191,1,Non-small cell lung cancer stage IV,1,I,EXP,nivolumab,1,PS,Death,1,F,OT,129
175354191,1,Non-small cell lung cancer stage IV,1,I,EXP,nivolumab,1,PS,Death,1,F,HO,129
175354191,1,Non-small cell lung cancer stage IV,1,I,EXP,nivolumab,1,PS,Death,1,F,DE,129
175354191,1,Non-small cell lung cancer stage IV,1,I,EXP,nivolumab,1,PS,Fall,1,F,OT,129
175354191,1,Non-small cell lung cancer stage IV,1,I,EXP,nivolumab,1,PS,Fall,1,F,HO,129
175354191,1,Non-small cell lung cancer stage IV,1,I,EXP,nivolumab,1,PS,Fall,1,F,DE,129
175354191,1,Non-small cell lung cancer stage IV,1,I,EXP,nivolumab,1,PS,Weight decreased,1,F,OT,129
175354191,1,Non-small cell lung cancer stage IV,1,I,EXP,nivolumab,1,PS,Weight decreased,1,F,HO,129
175354191,1,Non-small cell lung cancer stage IV,1,I,EXP,nivolumab,1,PS,Weight decreased,1,F,DE,129
175354191,2,Non-small cell lung cancer stage IV,1,I,EXP,ipilimumab,2,SS,Death,2,F,OT,129
175354191,2,Non-small cell lung cancer stage IV,1,I,EXP,ipilimumab,2,SS,Death,2,F,HO,129
175354191,2,Non-small cell lung cancer stage IV,1,I,EXP,ipilimumab,2,SS,Death,2,F,DE,129
175354191,2,Non-small cell lung cancer stage IV,1,I,EXP,ipilimumab,2,SS,Fall,2,F,OT,129
175354191,2,Non-small cell lung cancer stage IV,1,I,EXP,ipilimumab,2,SS,Fall,2,F,HO,129
175354191,2,Non-small cell lung cancer stage IV,1,I,EXP,ipilimumab,2,SS,Fall,2,F,DE,129
175354191,2,Non-small cell lung cancer stage IV,1,I,EXP,ipilimumab,2,SS,Weight decreased,2,F,OT,129
175354191,2,Non-small cell lung cancer stage IV,1,I,EXP,ipilimumab,2,SS,Weight decreased,2,F,HO,129
175354191,2,Non-small cell lung cancer stage IV,1,I,EXP,ipilimumab,2,SS,Weight decreased,2,F,DE,129
175355952,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Anaemia,2,M,OT,870
175355952,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Anaemia,2,M,HO,870
175355952,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Rectal haemorrhage,2,M,OT,870
175355952,2,Plasma cell myeloma,2,F,EXP,pomalidomide,2,SS,Rectal haemorrhage,2,M,HO,870
175356961,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Diarrhoea,1,F,HO,134
175356961,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Diarrhoea,1,F,OT,134
175356961,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Hypokalaemia,1,F,HO,134
175356961,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Hypokalaemia,1,F,OT,134
175356961,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Pneumonitis,1,F,HO,134
175356961,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Pneumonitis,1,F,OT,134
175356961,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Pneumothorax,1,F,HO,134
175356961,1,Angiosarcoma,1,I,EXP,ipilimumab,1,PS,Pneumothorax,1,F,OT,134
175356961,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Diarrhoea,2,F,HO,134
175356961,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Diarrhoea,2,F,OT,134
175356961,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Hypokalaemia,2,F,HO,134
175356961,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Hypokalaemia,2,F,OT,134
175356961,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Pneumonitis,2,F,HO,134
175356961,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Pneumonitis,2,F,OT,134
175356961,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Pneumothorax,2,F,HO,134
175356961,2,Angiosarcoma,1,I,EXP,nivolumab,2,SS,Pneumothorax,2,F,OT,134
175357501,2,Ovarian cancer,1,I,EXP,trabectedin,2,SS,Anaemia,2,F,HO,14
175357501,2,Ovarian cancer,1,I,EXP,trabectedin,2,SS,Device related infection,2,F,HO,14
175357501,2,Ovarian cancer,1,I,EXP,trabectedin,2,SS,Febrile neutropenia,2,F,HO,14
175357501,2,Ovarian cancer,1,I,EXP,trabectedin,2,SS,Sepsis,2,F,HO,14
175357501,2,Ovarian cancer,1,I,EXP,trabectedin,2,SS,Thrombocytopenia,2,F,HO,14
175357741,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Infection,3,F,OT,236
175359632,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Pneumonia,1,F,HO,62
175359632,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Pneumonia,1,F,OT,62
175359632,3,Plasma cell myeloma,2,F,PER,lenalidomide,3,SS,Pneumonia,3,F,HO,62
175359632,3,Plasma cell myeloma,2,F,PER,lenalidomide,3,SS,Pneumonia,3,F,OT,62
175360161,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Atrial fibrillation,1,M,OT,135
175360701,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,General physical health deterioration,1,M,OT,47
175360701,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,47
175360701,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,OT,47
175360701,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Immune-mediated enterocolitis,1,M,HO,47
175360701,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Immune-mediated pancreatitis,1,M,OT,47
175360701,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Immune-mediated pancreatitis,1,M,HO,47
175360701,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Immune-mediated pneumonitis,1,M,OT,47
175360701,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Immune-mediated pneumonitis,1,M,HO,47
175360701,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,OT,47
175360701,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,General physical health deterioration,2,M,HO,47
175360701,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,M,OT,47
175360701,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Immune-mediated enterocolitis,2,M,HO,47
175360701,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Immune-mediated pancreatitis,2,M,OT,47
175360701,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Immune-mediated pancreatitis,2,M,HO,47
175360701,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Immune-mediated pneumonitis,2,M,OT,47
175360701,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Immune-mediated pneumonitis,2,M,HO,47
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Acute sinusitis,5,M,HO,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Acute sinusitis,5,M,OT,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Facial pain,5,M,HO,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Facial pain,5,M,OT,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Febrile neutropenia,5,M,HO,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Febrile neutropenia,5,M,OT,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Flushing,5,M,HO,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Flushing,5,M,OT,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Fungal infection,5,M,HO,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Fungal infection,5,M,OT,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Otitis externa,5,M,HO,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Otitis externa,5,M,OT,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Otitis media,5,M,HO,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Otitis media,5,M,OT,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Sluggishness,5,M,HO,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Sluggishness,5,M,OT,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Swelling face,5,M,HO,7
175360981,5,Acute lymphocytic leukaemia,1,I,EXP,thioguanine,5,SS,Swelling face,5,M,OT,7
175361171,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Renal failure,1,M,OT,63
175361171,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Renal failure,1,M,HO,63
175361171,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Renal failure,2,M,OT,63
175361171,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Renal failure,2,M,HO,63
175362371,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Altered state of consciousness,8,F,HO,5
175362371,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Altered state of consciousness,8,F,OT,5
175362371,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Cyanosis,8,F,HO,5
175362371,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Cyanosis,8,F,OT,5
175362371,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Drooling,8,F,HO,5
175362371,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Drooling,8,F,OT,5
175362371,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Irregular breathing,8,F,HO,5
175362371,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Irregular breathing,8,F,OT,5
175362371,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Seizure,8,F,HO,5
175362371,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Seizure,8,F,OT,5
175362371,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Somnolence,8,F,HO,5
175362371,8,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,8,SS,Somnolence,8,F,OT,5
175362662,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Sepsis,1,F,LT,171
175362662,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Sepsis,1,F,HO,171
175362662,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Sepsis,1,F,DE,171
175362662,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Septic shock,1,F,LT,171
175362662,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Septic shock,1,F,HO,171
175362662,1,Plasma cell myeloma,2,F,EXP,selinexor,1,PS,Septic shock,1,F,DE,171
175362683,1,Neuroblastoma,3,F,EXP,lorlatinib,1,PS,Febrile neutropenia,1,M,HO,12
175365251,1,Neoplasm,1,I,EXP,entrectinib,1,PS,Ejection fraction decreased,1,F,OT,93
175365462,1,Neoplasm,2,F,EXP,entrectinib,1,PS,Ventricular fibrillation,1,M,DE,3
175366782,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Infection,1,M,HO,8
175366782,3,Plasma cell myeloma,2,F,PER,lenalidomide,3,SS,Infection,3,M,HO,8
175367572,1,Neuroendocrine tumour,2,F,EXP,nivolumab,1,PS,Orthostatic hypotension,1,F,HO,47
175367572,2,Neuroendocrine carcinoma,2,F,EXP,ipilimumab,2,SS,Orthostatic hypotension,2,F,HO,47
175369372,1,Colorectal cancer metastatic,2,F,PER,panitumumab,1,PS,Electrolyte imbalance,1,F,HO,206
175369372,1,Colorectal cancer metastatic,2,F,PER,panitumumab,1,PS,Hypomagnesaemia,1,F,HO,206
175369372,1,Colorectal cancer metastatic,2,F,PER,panitumumab,1,PS,Skin toxicity,1,F,HO,206
175369473,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pericardial effusion,1,M,HO,11
175369473,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pericardial effusion,1,M,OT,11
175369473,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,11
175369473,1,Small cell lung cancer,3,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,11
175371221,2,Product used for unknown indication,1,I,EXP,lenalidomide,2,SS,Basal cell carcinoma,2,M,OT,1422
175371221,2,Product used for unknown indication,1,I,EXP,lenalidomide,2,SS,Metastasis,2,M,OT,1422
175371221,3,Product used for unknown indication,1,I,EXP,chlorambucil,3,SS,Basal cell carcinoma,3,M,OT,1450
175371221,3,Product used for unknown indication,1,I,EXP,chlorambucil,3,SS,Metastasis,3,M,OT,1450
175376701,1,Febrile neutropenia,1,I,EXP,pegfilgrastim,1,PS,Drug ineffective,1,M,LT,7
175376701,1,Febrile neutropenia,1,I,EXP,pegfilgrastim,1,PS,Drug ineffective,1,M,OT,7
175376701,1,Febrile neutropenia,1,I,EXP,pegfilgrastim,1,PS,Drug ineffective,1,M,HO,7
175376701,1,Febrile neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutropenia,1,M,LT,7
175376701,1,Febrile neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutropenia,1,M,OT,7
175376701,1,Febrile neutropenia,1,I,EXP,pegfilgrastim,1,PS,Neutropenia,1,M,HO,7
175376701,1,Febrile neutropenia,1,I,EXP,pegfilgrastim,1,PS,Pancytopenia,1,M,LT,7
175376701,1,Febrile neutropenia,1,I,EXP,pegfilgrastim,1,PS,Pancytopenia,1,M,OT,7
175376701,1,Febrile neutropenia,1,I,EXP,pegfilgrastim,1,PS,Pancytopenia,1,M,HO,7
175376701,1,Febrile neutropenia,1,I,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,M,LT,7
175376701,1,Febrile neutropenia,1,I,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,M,OT,7
175376701,1,Febrile neutropenia,1,I,EXP,pegfilgrastim,1,PS,Thrombocytopenia,1,M,HO,7
175379431,1,Oestrogen receptor positive breast cancer,1,I,EXP,palbociclib,1,PS,Acute interstitial pneumonitis,1,F,OT,75
175379431,1,Oestrogen receptor positive breast cancer,1,I,EXP,palbociclib,1,PS,Acute interstitial pneumonitis,1,F,DS,75
175379431,1,Oestrogen receptor positive breast cancer,1,I,EXP,palbociclib,1,PS,Cough,1,F,OT,75
175379431,1,Oestrogen receptor positive breast cancer,1,I,EXP,palbociclib,1,PS,Cough,1,F,DS,75
175379431,1,Oestrogen receptor positive breast cancer,1,I,EXP,palbociclib,1,PS,Dyspnoea exertional,1,F,OT,75
175379431,1,Oestrogen receptor positive breast cancer,1,I,EXP,palbociclib,1,PS,Dyspnoea exertional,1,F,DS,75
175379431,1,Oestrogen receptor positive breast cancer,1,I,EXP,palbociclib,1,PS,Lung infiltration,1,F,OT,75
175379431,1,Oestrogen receptor positive breast cancer,1,I,EXP,palbociclib,1,PS,Lung infiltration,1,F,DS,75
175380961,3,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,3,SS,Cerebral haemorrhage,3,M,OT,20
175380961,3,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,3,SS,Cerebral haemorrhage,3,M,HO,20
175380961,3,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,3,SS,Partial seizures,3,M,OT,20
175380961,3,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,3,SS,Partial seizures,3,M,HO,20
175380961,3,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,3,SS,Thrombosis,3,M,OT,20
175380961,3,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,3,SS,Thrombosis,3,M,HO,20
175381401,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Bronchitis,1,F,HO,52
175381401,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Dyspnoea,1,F,HO,52
175382271,5,Plasma cell myeloma,1,I,EXP,daratumumab,5,SS,Cytomegalovirus viraemia,5,M,OT,20
175382271,5,Plasma cell myeloma,1,I,EXP,daratumumab,5,SS,Infusion related reaction,5,M,OT,20
175382271,8,Plasma cell myeloma,1,I,EXP,lenalidomide,8,C,Cytomegalovirus viraemia,8,M,OT,6
175382271,8,Plasma cell myeloma,1,I,EXP,lenalidomide,8,C,Infusion related reaction,8,M,OT,6
175390281,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Cardiogenic shock,3,F,LT,22
175390281,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Cardiogenic shock,3,F,HO,22
175390281,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Cardiogenic shock,3,F,OT,22
175390281,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Myocarditis,3,F,LT,22
175390281,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Myocarditis,3,F,HO,22
175390281,3,Non-small cell lung cancer,1,I,EXP,pemetrexed disodium,3,SS,Myocarditis,3,F,OT,22
175392981,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Toxic epidermal necrolysis,1,M,DE,114
175399861,2,Product used for unknown indication,1,I,EXP,palbociclib,2,C,Abdominal pain,2,F,HO,135
175399861,2,Product used for unknown indication,1,I,EXP,palbociclib,2,C,Constipation,2,F,HO,135
175399861,2,Product used for unknown indication,1,I,EXP,palbociclib,2,C,Dysuria,2,F,HO,135
175399861,2,Product used for unknown indication,1,I,EXP,palbociclib,2,C,Flatulence,2,F,HO,135
175399861,2,Product used for unknown indication,1,I,EXP,palbociclib,2,C,Vomiting,2,F,HO,135
175403991,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Arthritis,1,M,OT,831
175403991,1,Lung neoplasm malignant,1,I,EXP,nivolumab,1,PS,Off label use,1,M,OT,831
175409041,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Acute sinusitis,2,F,HO,702
175409041,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Rash,2,F,HO,702
175409041,18,Plasma cell myeloma,1,I,EXP,zoledronic acid,18,C,Acute sinusitis,18,F,HO,681
175409041,18,Plasma cell myeloma,1,I,EXP,zoledronic acid,18,C,Rash,18,F,HO,681
175412892,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Toxic skin eruption,1,M,OT,2460
175416242,2,Plasma cell myeloma,2,F,EXP,carfilzomib,2,SS,Anaemia,2,F,HO,3
175416242,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Anaemia,3,F,HO,3
175420651,1,Soft tissue sarcoma,1,I,EXP,trabectedin,1,PS,Pyrexia,1,M,HO,20
175422131,2,Ovarian cancer,1,I,EXP,nivolumab,2,PS,Neutropenic sepsis,2,F,OT,41
175422131,2,Ovarian cancer,1,I,EXP,nivolumab,2,PS,Neutropenic sepsis,2,F,HO,41
175422472,1,Glioblastoma multiforme,2,F,EXP,nivolumab,1,SS,Systemic inflammatory response syndrome,1,F,LT,18
175422472,1,Glioblastoma multiforme,2,F,EXP,nivolumab,1,SS,Systemic inflammatory response syndrome,1,F,OT,18
175422472,2,Glioblastoma multiforme,2,F,EXP,ipilimumab,2,PS,Systemic inflammatory response syndrome,2,F,LT,18
175422472,2,Glioblastoma multiforme,2,F,EXP,ipilimumab,2,PS,Systemic inflammatory response syndrome,2,F,OT,18
175424871,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Syncope,1,M,HO,453
175424871,2,Plasma cell myeloma,1,I,PER,pomalidomide,2,SS,Syncope,2,M,HO,453
175425072,2,Plasma cell myeloma,2,F,EXP,lenalidomide,2,SS,Sarcomatoid carcinoma,2,F,OT,1733
175427201,1,Oropharyngeal cancer,1,I,EXP,nivolumab,1,PS,Pain,1,M,HO,98
175429532,1,Oesophageal adenocarcinoma,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,HO,57
175429532,1,Oesophageal adenocarcinoma,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,F,DE,57
175429532,2,Oesophageal adenocarcinoma,2,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,F,HO,57
175429532,2,Oesophageal adenocarcinoma,2,F,EXP,ipilimumab,2,SS,General physical health deterioration,2,F,DE,57
175430481,7,Plasma cell myeloma,1,I,PER,carfilzomib,7,SS,Cardiac failure congestive,7,F,HO,2077
175433941,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Death,1,F,OT,396
175433941,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Death,1,F,DE,396
175439212,7,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,7,SS,Decreased appetite,7,M,HO,12
175439212,7,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,7,SS,Nausea,7,M,HO,12
175439212,7,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,7,SS,Pancytopenia,7,M,HO,12
175439212,7,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,7,SS,Pyrexia,7,M,HO,12
175439212,7,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,7,SS,Red man syndrome,7,M,HO,12
175439212,7,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,7,SS,Somnolence,7,M,HO,12
175439212,7,Acute lymphocytic leukaemia,2,F,EXP,pegaspargase,7,SS,Vomiting,7,M,HO,12
175442471,2,Plasma cell myeloma,1,I,PER,daratumumab,2,PS,Acute sinusitis,2,F,HO,702
175442471,2,Plasma cell myeloma,1,I,PER,daratumumab,2,PS,Rash,2,F,HO,702
175442471,18,Plasma cell myeloma,1,I,PER,zoledronic acid,18,C,Acute sinusitis,18,F,HO,681
175442471,18,Plasma cell myeloma,1,I,PER,zoledronic acid,18,C,Rash,18,F,HO,681
175443302,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Acute kidney injury,1,M,HO,14
175443302,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Acute kidney injury,1,M,OT,14
175443302,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Hyponatraemia,1,M,HO,14
175443302,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Hyponatraemia,1,M,OT,14
175443302,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Hypotension,1,M,HO,14
175443302,1,Hormone-refractory prostate cancer,2,F,EXP,enzalutamide,1,PS,Hypotension,1,M,OT,14
175451581,4,Chronic graft versus host disease,1,I,EXP,ibrutinib,4,SS,Cough,4,M,HO,26
175451581,4,Chronic graft versus host disease,1,I,EXP,ibrutinib,4,SS,Cough,4,M,OT,26
175451581,4,Chronic graft versus host disease,1,I,EXP,ibrutinib,4,SS,Dyspnoea,4,M,HO,26
175451581,4,Chronic graft versus host disease,1,I,EXP,ibrutinib,4,SS,Dyspnoea,4,M,OT,26
175451581,4,Chronic graft versus host disease,1,I,EXP,ibrutinib,4,SS,Product dose omission,4,M,HO,26
175451581,4,Chronic graft versus host disease,1,I,EXP,ibrutinib,4,SS,Product dose omission,4,M,OT,26
175451852,3,Acute myeloid leukaemia,2,F,EXP,pegfilgrastim,3,SS,Acute myeloid leukaemia,3,F,OT,29
175451852,3,Acute myeloid leukaemia,2,F,EXP,pegfilgrastim,3,SS,Acute myeloid leukaemia,3,F,DE,29
175453951,2,B-cell lymphoma,1,I,EXP,pegfilgrastim,2,SS,Febrile neutropenia,2,F,HO,35
175453951,2,B-cell lymphoma,1,I,EXP,pegfilgrastim,2,SS,Febrile neutropenia,2,F,OT,35
175453951,2,B-cell lymphoma,1,I,EXP,pegfilgrastim,2,SS,Hypotension,2,F,HO,35
175453951,2,B-cell lymphoma,1,I,EXP,pegfilgrastim,2,SS,Hypotension,2,F,OT,35
175453951,2,B-cell lymphoma,1,I,EXP,pegfilgrastim,2,SS,Interstitial lung disease,2,F,HO,35
175453951,2,B-cell lymphoma,1,I,EXP,pegfilgrastim,2,SS,Interstitial lung disease,2,F,OT,35
175453951,2,B-cell lymphoma,1,I,EXP,pegfilgrastim,2,SS,Malaise,2,F,HO,35
175453951,2,B-cell lymphoma,1,I,EXP,pegfilgrastim,2,SS,Malaise,2,F,OT,35
175453951,2,B-cell lymphoma,1,I,EXP,pegfilgrastim,2,SS,Pneumonia aspiration,2,F,HO,35
175453951,2,B-cell lymphoma,1,I,EXP,pegfilgrastim,2,SS,Pneumonia aspiration,2,F,OT,35
175453951,2,B-cell lymphoma,1,I,EXP,pegfilgrastim,2,SS,Pyrexia,2,F,HO,35
175453951,2,B-cell lymphoma,1,I,EXP,pegfilgrastim,2,SS,Pyrexia,2,F,OT,35
175453951,2,B-cell lymphoma,1,I,EXP,pegfilgrastim,2,SS,Stomatitis,2,F,HO,35
175453951,2,B-cell lymphoma,1,I,EXP,pegfilgrastim,2,SS,Stomatitis,2,F,OT,35
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Anaemia,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Anaemia,1,M,HO,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Asthenia,1,M,HO,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood glucose decreased,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood glucose decreased,1,M,HO,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood glucose increased,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood glucose increased,1,M,HO,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood pressure decreased,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood pressure decreased,1,M,HO,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Chest discomfort,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Chest discomfort,1,M,HO,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Chronic obstructive pulmonary disease,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Chronic obstructive pulmonary disease,1,M,HO,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Decreased appetite,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Decreased appetite,1,M,HO,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Dizziness,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Dizziness,1,M,HO,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Dyspnoea,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Dyspnoea,1,M,HO,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Feeling cold,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Feeling cold,1,M,HO,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Pneumonia,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Pneumonia,1,M,HO,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Pulmonary oedema,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Pulmonary oedema,1,M,HO,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Pyrexia,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Pyrexia,1,M,HO,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Vomiting,1,M,OT,51
175454261,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Vomiting,1,M,HO,51
175456571,1,Chronic lymphocytic leukaemia,1,I,DIR,ibrutinib,1,PS,Brain injury,1,M,DE,212
175456571,1,Chronic lymphocytic leukaemia,1,I,DIR,ibrutinib,1,PS,Cardiac arrest,1,M,DE,212
175456571,1,Chronic lymphocytic leukaemia,1,I,DIR,ibrutinib,1,PS,Hypertension,1,M,DE,212
175456571,1,Chronic lymphocytic leukaemia,1,I,DIR,ibrutinib,1,PS,Ventricular fibrillation,1,M,DE,212
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Alopecia,21,F,HO,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Alopecia,21,F,OT,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Candida infection,21,F,HO,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Candida infection,21,F,OT,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Decreased appetite,21,F,HO,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Decreased appetite,21,F,OT,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Fatigue,21,F,HO,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Fatigue,21,F,OT,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Haematemesis,21,F,HO,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Haematemesis,21,F,OT,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Hypernatraemia,21,F,HO,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Hypernatraemia,21,F,OT,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Malaise,21,F,HO,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Malaise,21,F,OT,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Nausea,21,F,HO,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Nausea,21,F,OT,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Neutropenia,21,F,HO,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Neutropenia,21,F,OT,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Onychalgia,21,F,HO,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Onychalgia,21,F,OT,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Pain in jaw,21,F,HO,8
175459031,21,Premedication,1,I,EXP,granisetron,21,C,Pain in jaw,21,F,OT,8
175459152,1,Liposarcoma,2,F,EXP,palbociclib,1,PS,Death,1,M,DE,623
175465583,2,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,2,SS,Chills,2,M,HO,58
175465583,2,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,2,SS,Hyperphosphataemia,2,M,HO,58
175465583,2,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,2,SS,Pyrexia,2,M,HO,58
175465583,2,Chronic lymphocytic leukaemia,3,F,EXP,ibrutinib,2,SS,Tumour lysis syndrome,2,M,HO,58
175466181,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,PS,Abdominal pain,2,F,HO,23
175466181,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,PS,Abdominal pain,2,F,OT,23
175466181,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,PS,Rectal haemorrhage,2,F,HO,23
175466181,2,Renal cell carcinoma,1,I,EXP,nivolumab,2,PS,Rectal haemorrhage,2,F,OT,23
175471931,57,Plasma cell myeloma,1,I,PER,carfilzomib,57,SS,Pyrexia,57,M,HO,2242
175471931,63,Plasma cell myeloma,1,I,PER,daratumumab,63,SS,Pyrexia,63,M,HO,1616
175472191,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,SS,Blood glucose increased,1,M,HO,108
175472191,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,PS,Blood glucose increased,2,M,HO,108
175472582,1,Prostate cancer,2,F,EXP,apalutamide,1,PS,Ischaemic stroke,1,M,HO,485
175473601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,HO,159
175473601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Adrenal insufficiency,1,M,OT,159
175473601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,HO,159
175473601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,OT,159
175473601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,HO,159
175473601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,OT,159
175473601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Hypophysitis,1,M,HO,159
175473601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Hypophysitis,1,M,OT,159
175473601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Hypothyroidism,1,M,HO,159
175473601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Hypothyroidism,1,M,OT,159
175473601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Lipase increased,1,M,HO,159
175473601,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Lipase increased,1,M,OT,159
175474841,1,Hepatocellular carcinoma,1,I,EXP,nivolumab,1,PS,Microcytic anaemia,1,M,OT,202
175474841,1,Hepatocellular carcinoma,1,I,EXP,nivolumab,1,PS,Microcytic anaemia,1,M,HO,202
175474841,1,Hepatocellular carcinoma,1,I,EXP,nivolumab,1,PS,Renal failure,1,M,OT,202
175474841,1,Hepatocellular carcinoma,1,I,EXP,nivolumab,1,PS,Renal failure,1,M,HO,202
175475053,1,Angioimmunoblastic T-cell lymphoma,3,F,EXP,nivolumab,1,PS,Hypoxia,1,F,HO,6
175475053,1,Angioimmunoblastic T-cell lymphoma,3,F,EXP,nivolumab,1,PS,Hypoxia,1,F,OT,6
175475061,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Diarrhoea,1,M,HO,339
175475061,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Vomiting,1,M,HO,339
175475291,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,F,OT,72
175475291,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Acute kidney injury,1,F,HO,72
175476101,2,Plasma cell myeloma,1,I,EXP,thalidomide,2,SS,Disseminated varicella zoster vaccine virus infection,2,M,HO,9
175476961,3,Metastatic malignant melanoma,1,I,EXP,trametinib,3,SS,Abdominal pain,3,F,HO,314
175476961,3,Metastatic malignant melanoma,1,I,EXP,trametinib,3,SS,Abdominal pain,3,F,DE,314
175476961,3,Metastatic malignant melanoma,1,I,EXP,trametinib,3,SS,Constipation,3,F,HO,314
175476961,3,Metastatic malignant melanoma,1,I,EXP,trametinib,3,SS,Constipation,3,F,DE,314
175476961,3,Metastatic malignant melanoma,1,I,EXP,trametinib,3,SS,Intracranial pressure increased,3,F,HO,314
175476961,3,Metastatic malignant melanoma,1,I,EXP,trametinib,3,SS,Intracranial pressure increased,3,F,DE,314
175476961,3,Metastatic malignant melanoma,1,I,EXP,trametinib,3,SS,Malignant neoplasm progression,3,F,HO,314
175476961,3,Metastatic malignant melanoma,1,I,EXP,trametinib,3,SS,Malignant neoplasm progression,3,F,DE,314
175476961,3,Metastatic malignant melanoma,1,I,EXP,trametinib,3,SS,Metastatic malignant melanoma,3,F,HO,314
175476961,3,Metastatic malignant melanoma,1,I,EXP,trametinib,3,SS,Metastatic malignant melanoma,3,F,DE,314
175477341,1,Glioma,1,I,EXP,nivolumab,1,PS,Hyperthermia,1,F,OT,185
175477341,1,Glioma,1,I,EXP,nivolumab,1,PS,Loss of consciousness,1,F,OT,185
175477341,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Hyperthermia,2,F,OT,3
175477341,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Loss of consciousness,2,F,OT,3
175477481,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Lung neoplasm malignant,1,M,OT,379
175477481,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Lung neoplasm malignant,1,M,LT,379
175477822,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Mental disorder,1,M,HO,339
175478152,1,Metastatic malignant melanoma,2,F,EXP,nivolumab,1,SS,Gastritis,1,M,HO,20
175478152,2,Metastatic malignant melanoma,2,F,EXP,ipilimumab,2,PS,Gastritis,2,M,HO,20
175478152,3,Metastatic malignant melanoma,2,F,EXP,encorafenib,3,SS,Gastritis,3,M,HO,431
175478152,4,Metastatic malignant melanoma,2,F,EXP,binimetinib,4,SS,Gastritis,4,M,HO,431
175483631,2,Chronic lymphocytic leukaemia,1,I,EXP,lenalidomide,2,SS,Hyponatraemia,2,M,HO,403
175483631,2,Chronic lymphocytic leukaemia,1,I,EXP,lenalidomide,2,SS,Pneumonia,2,M,HO,403
175485021,6,Malignant melanoma,1,I,EXP,nivolumab,6,SS,Cerebral microangiopathy,6,F,OT,360
175485021,6,Malignant melanoma,1,I,EXP,nivolumab,6,SS,Leukoencephalopathy,6,F,OT,360
175485201,1,Chronic hepatitis C,1,I,EXP,peginterferon alfa-2b,1,SS,Syncope,1,M,HO,15
175488931,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Pulpitis dental,1,M,OT,231
175488931,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Pulpitis dental,3,M,OT,232
175488992,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,General physical health deterioration,1,M,HO,42
175488992,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Mucosal inflammation,1,M,HO,42
175488992,1,Squamous cell carcinoma of head and neck,2,F,EXP,nivolumab,1,PS,Staphylococcus test,1,M,HO,42
175489262,1,Dedifferentiated liposarcoma,2,F,EXP,selinexor,1,PS,Cachexia,1,M,HO,71
175491361,6,Malignant melanoma,1,I,EXP,nivolumab,6,SS,Cerebral microangiopathy,6,F,OT,360
175491361,6,Malignant melanoma,1,I,EXP,nivolumab,6,SS,Leukoencephalopathy,6,F,OT,360
175494071,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Pyrexia,1,M,HO,95
175494071,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Pyrexia,3,M,HO,95
175494101,1,Diffuse large B-cell lymphoma,1,I,EXP,selinexor,1,PS,Febrile neutropenia,1,F,HO,126
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Abdominal distension,1,F,OT,1
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Dizziness,1,F,OT,1
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Dyspepsia,1,F,OT,1
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Fall,1,F,OT,1
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Joint swelling,1,F,OT,1
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Nausea,1,F,OT,1
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Periorbital swelling,1,F,OT,1
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Peripheral swelling,1,F,OT,1
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Pruritus,1,F,OT,1
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Rash,1,F,OT,1
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Scratch,1,F,OT,1
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Seizure,1,F,OT,1
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Swelling face,1,F,OT,1
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Syncope,1,F,OT,1
175503521,1,Bone density abnormal,1,I,EXP,zoledronic acid,1,PS,Xanthelasma,1,F,OT,1
175504473,3,Plasma cell myeloma,3,F,EXP,daratumumab,3,C,Influenza,3,M,HO,328
175504473,3,Plasma cell myeloma,3,F,EXP,daratumumab,3,C,Respiratory syncytial virus infection,3,M,HO,328
175505151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Cardiac failure congestive,1,M,HO,50
175505151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Cardiac failure congestive,1,M,OT,50
175505151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Fatigue,1,M,HO,50
175505151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,50
175505151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Hot flush,1,M,HO,50
175505151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Hot flush,1,M,OT,50
175505151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Underdose,1,M,HO,50
175505151,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Underdose,1,M,OT,50
175511631,1,Prostate cancer,1,I,EXP,apalutamide,1,PS,Lymphocyte count decreased,1,M,OT,56
175511691,1,Soft tissue sarcoma,1,I,EXP,trabectedin,1,PS,Lymphopenia,1,F,OT,53
175511691,1,Soft tissue sarcoma,1,I,EXP,trabectedin,1,PS,Neutropenia,1,F,OT,53
175511751,1,Prostate cancer,1,I,EXP,apalutamide,1,PS,Radiation skin injury,1,M,OT,61
175511751,1,Prostate cancer,1,I,EXP,apalutamide,1,PS,Stomatitis,1,M,OT,61
175511781,1,Prostate cancer,1,I,EXP,apalutamide,1,PS,Constipation,1,M,OT,57
175511781,1,Prostate cancer,1,I,EXP,apalutamide,1,PS,Constipation,1,M,HO,57
175511781,1,Prostate cancer,1,I,EXP,apalutamide,1,PS,Hyponatraemia,1,M,OT,57
175511781,1,Prostate cancer,1,I,EXP,apalutamide,1,PS,Hyponatraemia,1,M,HO,57
175511781,5,Prostate cancer,1,I,EXP,degarelix,5,SS,Constipation,5,M,OT,57
175511781,5,Prostate cancer,1,I,EXP,degarelix,5,SS,Constipation,5,M,HO,57
175511781,5,Prostate cancer,1,I,EXP,degarelix,5,SS,Hyponatraemia,5,M,OT,57
175511781,5,Prostate cancer,1,I,EXP,degarelix,5,SS,Hyponatraemia,5,M,HO,57
175512061,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Neuropathy peripheral,3,M,HO,102
175512401,1,Acute lymphocytic leukaemia,1,I,EXP,inotuzumab ozogamicin,1,PS,Aphasia,1,M,HO,136
175513901,7,Nausea,1,I,EXP,granisetron,7,C,Epistaxis,7,M,DS,123
175514711,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Cerebral infarction,1,F,DE,1
175514711,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Cerebral infarction,1,F,HO,1
175514711,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Generalised tonic-clonic seizure,1,F,DE,1
175514711,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Generalised tonic-clonic seizure,1,F,HO,1
175514711,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hemiparesis,1,F,DE,1
175514711,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Hemiparesis,1,F,HO,1
175516801,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,185
175516801,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,185
175517031,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,C,Arrhythmia,2,F,OT,2
175517031,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,C,Epistaxis,2,F,OT,2
175520891,1,Renal cell carcinoma,1,I,EXP,axitinib,1,PS,Pancreatitis,1,F,HO,1442
175523272,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Haemolysis,1,F,HO,167
175523272,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Haemolysis,1,F,OT,167
175523272,4,Plasma cell myeloma,2,F,PER,lenalidomide,4,SS,Haemolysis,4,F,HO,167
175523272,4,Plasma cell myeloma,2,F,PER,lenalidomide,4,SS,Haemolysis,4,F,OT,167
175524561,2,Plasma cell myeloma,1,I,PER,carfilzomib,2,SS,Influenza,2,F,HO,380
175525452,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Abdominal pain,1,F,HO,173
175525452,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Chest pain,1,F,HO,173
175525931,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Death,1,M,HO,3
175525931,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Death,1,M,DE,3
175525931,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Pneumonia,1,M,HO,3
175525931,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Pneumonia,1,M,DE,3
175525931,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Renal failure,1,M,HO,3
175525931,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Renal failure,1,M,DE,3
175526931,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Atrioventricular block,1,M,DE,19
175526931,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Atrioventricular block,1,M,OT,19
175526931,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Myocarditis,1,M,DE,19
175526931,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Myocarditis,1,M,OT,19
175526931,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Atrioventricular block,2,M,DE,19
175526931,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Atrioventricular block,2,M,OT,19
175526931,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Myocarditis,2,M,DE,19
175526931,2,Metastatic renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Myocarditis,2,M,OT,19
175530102,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Immune-mediated hepatitis,2,M,OT,35
175530102,2,Renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Immune-mediated hepatitis,2,M,HO,35
175530102,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,SS,Immune-mediated hepatitis,3,M,OT,35
175530102,3,Renal cell carcinoma,2,F,EXP,nivolumab,3,SS,Immune-mediated hepatitis,3,M,HO,35
175530981,9,Product used for unknown indication,1,I,EXP,granisetron,9,C,Toxic leukoencephalopathy,9,F,DE,2
175530981,9,Product used for unknown indication,1,I,EXP,granisetron,9,C,Toxic leukoencephalopathy,9,F,LT,2
175533171,2,Plasma cell myeloma,1,I,EXP,pomalidomide,2,SS,Pneumonia,2,F,HO,46
175533171,3,Plasma cell myeloma,1,I,EXP,daratumumab,3,SS,Pneumonia,3,F,HO,46
175535471,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Confusional state,1,F,HO,8
175535471,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Hypoxia,1,F,HO,8
175535471,1,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Pyrexia,1,F,HO,8
175540171,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Leukopenia,1,F,HO,48
175540171,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Leukopenia,1,F,OT,48
175540461,6,Malignant melanoma,1,I,EXP,nivolumab,6,SS,Cerebral microangiopathy,6,F,OT,360
175540461,6,Malignant melanoma,1,I,EXP,nivolumab,6,SS,Leukoencephalopathy,6,F,OT,360
175545951,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,SS,Acute kidney injury,1,F,HO,8
175545951,5,Plasma cell myeloma,1,I,EXP,carfilzomib,5,SS,Acute kidney injury,5,F,HO,77
175546961,1,Peripheral T-cell lymphoma unspecified,1,I,EXP,nivolumab,1,PS,Acute respiratory failure,1,F,HO,12
175546961,1,Peripheral T-cell lymphoma unspecified,1,I,EXP,nivolumab,1,PS,Acute respiratory failure,1,F,LT,12
175546961,1,Peripheral T-cell lymphoma unspecified,1,I,EXP,nivolumab,1,PS,Acute respiratory failure,1,F,OT,12
175550091,1,Prostate cancer,1,I,DIR,enzalutamide,1,PS,Immune thrombocytopenic purpura,1,M,OT,16
175550091,1,Prostate cancer,1,I,DIR,enzalutamide,1,PS,Platelet count decreased,1,M,OT,16
175550091,1,Prostate cancer,1,I,DIR,enzalutamide,1,PS,Thrombocytopenia,1,M,OT,16
175550884,1,Neoplasm,4,F,EXP,trabectedin,1,PS,Haematotoxicity,1,M,HO,10
175550884,1,Neoplasm,4,F,EXP,trabectedin,1,PS,Haematotoxicity,1,M,OT,10
175550884,1,Neoplasm,4,F,EXP,trabectedin,1,PS,Pharyngitis,1,M,HO,10
175550884,1,Neoplasm,4,F,EXP,trabectedin,1,PS,Pharyngitis,1,M,OT,10
175554351,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Pancytopenia,1,F,HO,49
175554351,1,Breast cancer,1,I,PER,pegfilgrastim,1,PS,Pancytopenia,1,F,OT,49
175558801,2,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,2,SS,Acute kidney injury,2,F,HO,30
175558801,2,Lung adenocarcinoma,1,I,EXP,pemetrexed disodium,2,SS,Diarrhoea,2,F,HO,30
175559671,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Cytomegalovirus viraemia,1,M,OT,20
175559671,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Infusion related reaction,1,M,OT,20
175559671,8,Plasma cell myeloma,1,I,EXP,lenalidomide,8,C,Cytomegalovirus viraemia,8,M,OT,6
175559671,8,Plasma cell myeloma,1,I,EXP,lenalidomide,8,C,Infusion related reaction,8,M,OT,6
175562721,1,Thrombocytopenia,1,I,PER,romiplostim,1,PS,Anxiety,1,F,HO,883
175562721,1,Thrombocytopenia,1,I,PER,romiplostim,1,PS,Blood creatinine increased,1,F,HO,883
175562721,1,Thrombocytopenia,1,I,PER,romiplostim,1,PS,Blood fibrinogen decreased,1,F,HO,883
175562721,1,Thrombocytopenia,1,I,PER,romiplostim,1,PS,Cerebrovascular accident,1,F,HO,883
175562721,1,Thrombocytopenia,1,I,PER,romiplostim,1,PS,International normalised ratio increased,1,F,HO,883
175562721,1,Thrombocytopenia,1,I,PER,romiplostim,1,PS,Sinus tachycardia,1,F,HO,883
175562721,1,Thrombocytopenia,1,I,PER,romiplostim,1,PS,Troponin I increased,1,F,HO,883
175566421,1,Relapsing multiple sclerosis,1,I,EXP,ofatumumab,1,PS,Abdominal pain upper,1,F,HO,195
175566421,2,Relapsing multiple sclerosis,1,I,EXP,ofatumumab,2,SS,Abdominal pain upper,2,F,HO,204
175574812,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Asthenia,1,M,HO,133
175574812,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Orthostatic intolerance,1,M,HO,133
175575251,1,Plasma cell myeloma,1,I,EXP,pomalidomide,1,PS,Thrombosis,1,M,OT,10
175577801,1,Plasma cell myeloma,1,I,EXP,thalidomide,1,PS,Erythema,1,F,OT,35
175577801,1,Plasma cell myeloma,1,I,EXP,thalidomide,1,PS,Oedema peripheral,1,F,OT,35
175578251,5,Product used for unknown indication,1,I,EXP,filgrastim,5,C,Confusional state,5,M,HO,4
175578251,5,Product used for unknown indication,1,I,EXP,filgrastim,5,C,Confusional state,5,M,OT,4
175578251,5,Product used for unknown indication,1,I,EXP,filgrastim,5,C,Gastritis,5,M,HO,4
175578251,5,Product used for unknown indication,1,I,EXP,filgrastim,5,C,Gastritis,5,M,OT,4
175578251,5,Product used for unknown indication,1,I,EXP,filgrastim,5,C,Somnolence,5,M,HO,4
175578251,5,Product used for unknown indication,1,I,EXP,filgrastim,5,C,Somnolence,5,M,OT,4
175578332,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Brain neoplasm,1,F,OT,377
175578332,3,Plasma cell myeloma,2,F,PER,lenalidomide,3,SS,Brain neoplasm,3,F,OT,377
175581371,4,Colony stimulating factor therapy,1,I,EXP,filgrastim,4,SS,Gamma-glutamyltransferase increased,4,F,HO,4
175581371,4,Colony stimulating factor therapy,1,I,EXP,filgrastim,4,SS,Hepatocellular injury,4,F,HO,4
175584532,9,Neutropenia,2,F,EXP,filgrastim,9,C,Urinary tract infection,9,M,HO,477
175584532,9,Neutropenia,2,F,EXP,filgrastim,9,C,Urinary tract infection,9,M,DS,477
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Constipation,1,F,DS,105
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Constipation,1,F,OT,105
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Constipation,1,F,LT,105
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Constipation,1,F,HO,105
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Constipation,1,F,DE,105
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Sepsis,1,F,DS,105
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Sepsis,1,F,OT,105
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Sepsis,1,F,LT,105
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Sepsis,1,F,HO,105
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Sepsis,1,F,DE,105
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Syncope,1,F,DS,105
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Syncope,1,F,OT,105
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Syncope,1,F,LT,105
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Syncope,1,F,HO,105
175585881,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Syncope,1,F,DE,105
175586131,1,B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Brain oedema,1,M,DS,5
175586131,1,B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Brain oedema,1,M,OT,5
175586131,1,B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,DS,5
175586131,1,B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,5
175586131,1,B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,DS,5
175586131,1,B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,OT,5
175586452,1,Glioma,2,F,EXP,trametinib,1,PS,Viral myositis,1,F,HO,232
175587031,1,Bladder cancer,1,I,EXP,nivolumab,1,PS,Volvulus,1,M,OT,388
175587031,1,Bladder cancer,1,I,EXP,nivolumab,1,PS,Volvulus,1,M,HO,388
175588471,1,Neuroendocrine carcinoma of the skin,1,I,EXP,nivolumab,1,PS,Immune-mediated myositis,1,M,HO,25
175588471,1,Neuroendocrine carcinoma of the skin,1,I,EXP,nivolumab,1,PS,Immune-mediated myositis,1,M,OT,25
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Confusional state,1,F,HO,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Confusional state,1,F,OT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Confusional state,1,F,LT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diabetes insipidus,1,F,HO,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diabetes insipidus,1,F,OT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diabetes insipidus,1,F,LT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diabetes mellitus,1,F,HO,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diabetes mellitus,1,F,OT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Diabetes mellitus,1,F,LT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Eczema,1,F,HO,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Eczema,1,F,OT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Eczema,1,F,LT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,HO,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,OT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hyperglycaemia,1,F,LT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,F,HO,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,F,OT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hyperkalaemia,1,F,LT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Metabolic acidosis,1,F,HO,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Metabolic acidosis,1,F,OT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Metabolic acidosis,1,F,LT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Myoclonic epilepsy,1,F,HO,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Myoclonic epilepsy,1,F,OT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Myoclonic epilepsy,1,F,LT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Oropharyngeal pain,1,F,HO,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Oropharyngeal pain,1,F,OT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Oropharyngeal pain,1,F,LT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Polyuria,1,F,HO,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Polyuria,1,F,OT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Polyuria,1,F,LT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Renal colic,1,F,HO,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Renal colic,1,F,OT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Renal colic,1,F,LT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Somnolence,1,F,HO,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Somnolence,1,F,OT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Somnolence,1,F,LT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Thirst,1,F,HO,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Thirst,1,F,OT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Thirst,1,F,LT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Weight decreased,1,F,HO,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Weight decreased,1,F,OT,3
175589272,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Weight decreased,1,F,LT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Confusional state,2,F,HO,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Confusional state,2,F,OT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Confusional state,2,F,LT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Diabetes insipidus,2,F,HO,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Diabetes insipidus,2,F,OT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Diabetes insipidus,2,F,LT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Diabetes mellitus,2,F,HO,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Diabetes mellitus,2,F,OT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Diabetes mellitus,2,F,LT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Eczema,2,F,HO,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Eczema,2,F,OT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Eczema,2,F,LT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,F,HO,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,F,OT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hyperglycaemia,2,F,LT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hyperkalaemia,2,F,HO,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hyperkalaemia,2,F,OT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hyperkalaemia,2,F,LT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Metabolic acidosis,2,F,HO,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Metabolic acidosis,2,F,OT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Metabolic acidosis,2,F,LT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Myoclonic epilepsy,2,F,HO,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Myoclonic epilepsy,2,F,OT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Myoclonic epilepsy,2,F,LT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Oropharyngeal pain,2,F,HO,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Oropharyngeal pain,2,F,OT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Oropharyngeal pain,2,F,LT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Polyuria,2,F,HO,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Polyuria,2,F,OT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Polyuria,2,F,LT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Renal colic,2,F,HO,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Renal colic,2,F,OT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Renal colic,2,F,LT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Somnolence,2,F,HO,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Somnolence,2,F,OT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Somnolence,2,F,LT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Thirst,2,F,HO,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Thirst,2,F,OT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Thirst,2,F,LT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Weight decreased,2,F,HO,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Weight decreased,2,F,OT,3
175589272,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Weight decreased,2,F,LT,3
175590791,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Hepatitis fulminant,1,M,OT,13
175593322,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hepatic pain,1,M,HO,196
175593322,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hepatic pain,1,M,OT,196
175593322,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hepatic pain,1,M,DE,196
175593322,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hepatobiliary disease,1,M,HO,196
175593322,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hepatobiliary disease,1,M,OT,196
175593322,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Hepatobiliary disease,1,M,DE,196
175593322,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,HO,196
175593322,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,OT,196
175593322,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,M,DE,196
175593322,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hepatic pain,2,M,HO,383
175593322,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hepatic pain,2,M,OT,383
175593322,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hepatic pain,2,M,DE,383
175593322,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hepatobiliary disease,2,M,HO,383
175593322,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hepatobiliary disease,2,M,OT,383
175593322,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Hepatobiliary disease,2,M,DE,383
175593322,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,HO,383
175593322,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,OT,383
175593322,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Malignant neoplasm progression,2,M,DE,383
175593481,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Cholestasis,1,F,OT,188
175593481,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Cholestasis,1,F,HO,188
175593481,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Hepatocellular injury,1,F,OT,188
175593481,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Hepatocellular injury,1,F,HO,188
175593481,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Cholestasis,2,F,OT,188
175593481,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Cholestasis,2,F,HO,188
175593481,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Hepatocellular injury,2,F,OT,188
175593481,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Hepatocellular injury,2,F,HO,188
175600581,1,Plasma cell myeloma,1,I,DIR,carfilzomib,1,PS,Dyspnoea,1,F,HO,84
175600581,1,Plasma cell myeloma,1,I,DIR,carfilzomib,1,PS,Stem cell transplant,1,F,HO,84
175600581,2,Plasma cell myeloma,1,I,DIR,carfilzomib,2,SS,Dyspnoea,2,F,HO,77
175600581,2,Plasma cell myeloma,1,I,DIR,carfilzomib,2,SS,Stem cell transplant,2,F,HO,77
175601851,5,Ovarian cancer,1,I,EXP,nivolumab,5,SS,Acute kidney injury,5,F,HO,181
175601851,8,Neoplasm malignant,1,I,EXP,ipilimumab,8,SS,Acute kidney injury,8,F,HO,181
175604271,1,Non-small cell lung cancer,1,I,EXP,ceritinib,1,PS,Hepatic encephalopathy,1,M,HO,79
175604732,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Asthenia,1,M,OT,942
175604732,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Asthenia,1,M,HO,942
175604732,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,M,OT,942
175604732,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,M,HO,942
175604732,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pain,1,M,OT,942
175604732,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pain,1,M,HO,942
175604732,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,942
175604732,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,942
175604732,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Sepsis,1,M,OT,942
175604732,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Sepsis,1,M,HO,942
175604732,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Asthenia,2,M,OT,930
175604732,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Asthenia,2,M,HO,930
175604732,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Chronic obstructive pulmonary disease,2,M,OT,930
175604732,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Chronic obstructive pulmonary disease,2,M,HO,930
175604732,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Pain,2,M,OT,930
175604732,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Pain,2,M,HO,930
175604732,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Pneumonia,2,M,OT,930
175604732,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Pneumonia,2,M,HO,930
175604732,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Sepsis,2,M,OT,930
175604732,2,Lung neoplasm malignant,2,F,EXP,nivolumab,2,SS,Sepsis,2,M,HO,930
175604732,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Asthenia,3,M,OT,895
175604732,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Asthenia,3,M,HO,895
175604732,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Chronic obstructive pulmonary disease,3,M,OT,895
175604732,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Chronic obstructive pulmonary disease,3,M,HO,895
175604732,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pain,3,M,OT,895
175604732,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pain,3,M,HO,895
175604732,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pneumonia,3,M,OT,895
175604732,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Pneumonia,3,M,HO,895
175604732,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Sepsis,3,M,OT,895
175604732,3,Product used for unknown indication,2,F,EXP,nivolumab,3,SS,Sepsis,3,M,HO,895
175604732,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Asthenia,4,M,OT,867
175604732,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Asthenia,4,M,HO,867
175604732,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Chronic obstructive pulmonary disease,4,M,OT,867
175604732,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Chronic obstructive pulmonary disease,4,M,HO,867
175604732,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Pain,4,M,OT,867
175604732,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Pain,4,M,HO,867
175604732,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Pneumonia,4,M,OT,867
175604732,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Pneumonia,4,M,HO,867
175604732,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Sepsis,4,M,OT,867
175604732,4,Product used for unknown indication,2,F,EXP,nivolumab,4,SS,Sepsis,4,M,HO,867
175604732,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Asthenia,5,M,OT,839
175604732,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Asthenia,5,M,HO,839
175604732,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Chronic obstructive pulmonary disease,5,M,OT,839
175604732,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Chronic obstructive pulmonary disease,5,M,HO,839
175604732,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Pain,5,M,OT,839
175604732,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Pain,5,M,HO,839
175604732,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Pneumonia,5,M,OT,839
175604732,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Pneumonia,5,M,HO,839
175604732,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Sepsis,5,M,OT,839
175604732,5,Product used for unknown indication,2,F,EXP,nivolumab,5,SS,Sepsis,5,M,HO,839
175604732,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Asthenia,6,M,OT,825
175604732,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Asthenia,6,M,HO,825
175604732,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Chronic obstructive pulmonary disease,6,M,OT,825
175604732,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Chronic obstructive pulmonary disease,6,M,HO,825
175604732,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Pain,6,M,OT,825
175604732,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Pain,6,M,HO,825
175604732,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Pneumonia,6,M,OT,825
175604732,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Pneumonia,6,M,HO,825
175604732,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Sepsis,6,M,OT,825
175604732,6,Product used for unknown indication,2,F,EXP,nivolumab,6,SS,Sepsis,6,M,HO,825
175604732,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Asthenia,7,M,OT,783
175604732,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Asthenia,7,M,HO,783
175604732,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Chronic obstructive pulmonary disease,7,M,OT,783
175604732,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Chronic obstructive pulmonary disease,7,M,HO,783
175604732,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Pain,7,M,OT,783
175604732,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Pain,7,M,HO,783
175604732,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Pneumonia,7,M,OT,783
175604732,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Pneumonia,7,M,HO,783
175604732,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Sepsis,7,M,OT,783
175604732,7,Product used for unknown indication,2,F,EXP,nivolumab,7,SS,Sepsis,7,M,HO,783
175604732,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Asthenia,8,M,OT,769
175604732,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Asthenia,8,M,HO,769
175604732,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Chronic obstructive pulmonary disease,8,M,OT,769
175604732,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Chronic obstructive pulmonary disease,8,M,HO,769
175604732,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Pain,8,M,OT,769
175604732,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Pain,8,M,HO,769
175604732,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Pneumonia,8,M,OT,769
175604732,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Pneumonia,8,M,HO,769
175604732,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Sepsis,8,M,OT,769
175604732,8,Product used for unknown indication,2,F,EXP,nivolumab,8,SS,Sepsis,8,M,HO,769
175604732,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Asthenia,9,M,OT,754
175604732,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Asthenia,9,M,HO,754
175604732,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Chronic obstructive pulmonary disease,9,M,OT,754
175604732,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Chronic obstructive pulmonary disease,9,M,HO,754
175604732,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Pain,9,M,OT,754
175604732,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Pain,9,M,HO,754
175604732,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Pneumonia,9,M,OT,754
175604732,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Pneumonia,9,M,HO,754
175604732,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Sepsis,9,M,OT,754
175604732,9,Product used for unknown indication,2,F,EXP,nivolumab,9,SS,Sepsis,9,M,HO,754
175604732,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Asthenia,10,M,OT,741
175604732,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Asthenia,10,M,HO,741
175604732,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Chronic obstructive pulmonary disease,10,M,OT,741
175604732,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Chronic obstructive pulmonary disease,10,M,HO,741
175604732,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Pain,10,M,OT,741
175604732,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Pain,10,M,HO,741
175604732,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Pneumonia,10,M,OT,741
175604732,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Pneumonia,10,M,HO,741
175604732,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Sepsis,10,M,OT,741
175604732,10,Product used for unknown indication,2,F,EXP,nivolumab,10,SS,Sepsis,10,M,HO,741
175604732,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Asthenia,11,M,OT,727
175604732,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Asthenia,11,M,HO,727
175604732,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Chronic obstructive pulmonary disease,11,M,OT,727
175604732,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Chronic obstructive pulmonary disease,11,M,HO,727
175604732,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Pain,11,M,OT,727
175604732,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Pain,11,M,HO,727
175604732,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Pneumonia,11,M,OT,727
175604732,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Pneumonia,11,M,HO,727
175604732,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Sepsis,11,M,OT,727
175604732,11,Product used for unknown indication,2,F,EXP,nivolumab,11,SS,Sepsis,11,M,HO,727
175604732,12,Product used for unknown indication,2,F,EXP,nivolumab,12,SS,Asthenia,12,M,OT,699
175604732,12,Product used for unknown indication,2,F,EXP,nivolumab,12,SS,Asthenia,12,M,HO,699
175604732,12,Product used for unknown indication,2,F,EXP,nivolumab,12,SS,Chronic obstructive pulmonary disease,12,M,OT,699
175604732,12,Product used for unknown indication,2,F,EXP,nivolumab,12,SS,Chronic obstructive pulmonary disease,12,M,HO,699
175604732,12,Product used for unknown indication,2,F,EXP,nivolumab,12,SS,Pain,12,M,OT,699
175604732,12,Product used for unknown indication,2,F,EXP,nivolumab,12,SS,Pain,12,M,HO,699
175604732,12,Product used for unknown indication,2,F,EXP,nivolumab,12,SS,Pneumonia,12,M,OT,699
175604732,12,Product used for unknown indication,2,F,EXP,nivolumab,12,SS,Pneumonia,12,M,HO,699
175604732,12,Product used for unknown indication,2,F,EXP,nivolumab,12,SS,Sepsis,12,M,OT,699
175604732,12,Product used for unknown indication,2,F,EXP,nivolumab,12,SS,Sepsis,12,M,HO,699
175604732,13,Product used for unknown indication,2,F,EXP,nivolumab,13,SS,Asthenia,13,M,OT,678
175604732,13,Product used for unknown indication,2,F,EXP,nivolumab,13,SS,Asthenia,13,M,HO,678
175604732,13,Product used for unknown indication,2,F,EXP,nivolumab,13,SS,Chronic obstructive pulmonary disease,13,M,OT,678
175604732,13,Product used for unknown indication,2,F,EXP,nivolumab,13,SS,Chronic obstructive pulmonary disease,13,M,HO,678
175604732,13,Product used for unknown indication,2,F,EXP,nivolumab,13,SS,Pain,13,M,OT,678
175604732,13,Product used for unknown indication,2,F,EXP,nivolumab,13,SS,Pain,13,M,HO,678
175604732,13,Product used for unknown indication,2,F,EXP,nivolumab,13,SS,Pneumonia,13,M,OT,678
175604732,13,Product used for unknown indication,2,F,EXP,nivolumab,13,SS,Pneumonia,13,M,HO,678
175604732,13,Product used for unknown indication,2,F,EXP,nivolumab,13,SS,Sepsis,13,M,OT,678
175604732,13,Product used for unknown indication,2,F,EXP,nivolumab,13,SS,Sepsis,13,M,HO,678
175604732,14,Product used for unknown indication,2,F,EXP,nivolumab,14,SS,Asthenia,14,M,OT,664
175604732,14,Product used for unknown indication,2,F,EXP,nivolumab,14,SS,Asthenia,14,M,HO,664
175604732,14,Product used for unknown indication,2,F,EXP,nivolumab,14,SS,Chronic obstructive pulmonary disease,14,M,OT,664
175604732,14,Product used for unknown indication,2,F,EXP,nivolumab,14,SS,Chronic obstructive pulmonary disease,14,M,HO,664
175604732,14,Product used for unknown indication,2,F,EXP,nivolumab,14,SS,Pain,14,M,OT,664
175604732,14,Product used for unknown indication,2,F,EXP,nivolumab,14,SS,Pain,14,M,HO,664
175604732,14,Product used for unknown indication,2,F,EXP,nivolumab,14,SS,Pneumonia,14,M,OT,664
175604732,14,Product used for unknown indication,2,F,EXP,nivolumab,14,SS,Pneumonia,14,M,HO,664
175604732,14,Product used for unknown indication,2,F,EXP,nivolumab,14,SS,Sepsis,14,M,OT,664
175604732,14,Product used for unknown indication,2,F,EXP,nivolumab,14,SS,Sepsis,14,M,HO,664
175604732,15,Product used for unknown indication,2,F,EXP,nivolumab,15,SS,Asthenia,15,M,OT,650
175604732,15,Product used for unknown indication,2,F,EXP,nivolumab,15,SS,Asthenia,15,M,HO,650
175604732,15,Product used for unknown indication,2,F,EXP,nivolumab,15,SS,Chronic obstructive pulmonary disease,15,M,OT,650
175604732,15,Product used for unknown indication,2,F,EXP,nivolumab,15,SS,Chronic obstructive pulmonary disease,15,M,HO,650
175604732,15,Product used for unknown indication,2,F,EXP,nivolumab,15,SS,Pain,15,M,OT,650
175604732,15,Product used for unknown indication,2,F,EXP,nivolumab,15,SS,Pain,15,M,HO,650
175604732,15,Product used for unknown indication,2,F,EXP,nivolumab,15,SS,Pneumonia,15,M,OT,650
175604732,15,Product used for unknown indication,2,F,EXP,nivolumab,15,SS,Pneumonia,15,M,HO,650
175604732,15,Product used for unknown indication,2,F,EXP,nivolumab,15,SS,Sepsis,15,M,OT,650
175604732,15,Product used for unknown indication,2,F,EXP,nivolumab,15,SS,Sepsis,15,M,HO,650
175604732,16,Product used for unknown indication,2,F,EXP,nivolumab,16,SS,Asthenia,16,M,OT,622
175604732,16,Product used for unknown indication,2,F,EXP,nivolumab,16,SS,Asthenia,16,M,HO,622
175604732,16,Product used for unknown indication,2,F,EXP,nivolumab,16,SS,Chronic obstructive pulmonary disease,16,M,OT,622
175604732,16,Product used for unknown indication,2,F,EXP,nivolumab,16,SS,Chronic obstructive pulmonary disease,16,M,HO,622
175604732,16,Product used for unknown indication,2,F,EXP,nivolumab,16,SS,Pain,16,M,OT,622
175604732,16,Product used for unknown indication,2,F,EXP,nivolumab,16,SS,Pain,16,M,HO,622
175604732,16,Product used for unknown indication,2,F,EXP,nivolumab,16,SS,Pneumonia,16,M,OT,622
175604732,16,Product used for unknown indication,2,F,EXP,nivolumab,16,SS,Pneumonia,16,M,HO,622
175604732,16,Product used for unknown indication,2,F,EXP,nivolumab,16,SS,Sepsis,16,M,OT,622
175604732,16,Product used for unknown indication,2,F,EXP,nivolumab,16,SS,Sepsis,16,M,HO,622
175604732,17,Product used for unknown indication,2,F,EXP,nivolumab,17,SS,Asthenia,17,M,OT,580
175604732,17,Product used for unknown indication,2,F,EXP,nivolumab,17,SS,Asthenia,17,M,HO,580
175604732,17,Product used for unknown indication,2,F,EXP,nivolumab,17,SS,Chronic obstructive pulmonary disease,17,M,OT,580
175604732,17,Product used for unknown indication,2,F,EXP,nivolumab,17,SS,Chronic obstructive pulmonary disease,17,M,HO,580
175604732,17,Product used for unknown indication,2,F,EXP,nivolumab,17,SS,Pain,17,M,OT,580
175604732,17,Product used for unknown indication,2,F,EXP,nivolumab,17,SS,Pain,17,M,HO,580
175604732,17,Product used for unknown indication,2,F,EXP,nivolumab,17,SS,Pneumonia,17,M,OT,580
175604732,17,Product used for unknown indication,2,F,EXP,nivolumab,17,SS,Pneumonia,17,M,HO,580
175604732,17,Product used for unknown indication,2,F,EXP,nivolumab,17,SS,Sepsis,17,M,OT,580
175604732,17,Product used for unknown indication,2,F,EXP,nivolumab,17,SS,Sepsis,17,M,HO,580
175604732,18,Product used for unknown indication,2,F,EXP,nivolumab,18,SS,Asthenia,18,M,OT,566
175604732,18,Product used for unknown indication,2,F,EXP,nivolumab,18,SS,Asthenia,18,M,HO,566
175604732,18,Product used for unknown indication,2,F,EXP,nivolumab,18,SS,Chronic obstructive pulmonary disease,18,M,OT,566
175604732,18,Product used for unknown indication,2,F,EXP,nivolumab,18,SS,Chronic obstructive pulmonary disease,18,M,HO,566
175604732,18,Product used for unknown indication,2,F,EXP,nivolumab,18,SS,Pain,18,M,OT,566
175604732,18,Product used for unknown indication,2,F,EXP,nivolumab,18,SS,Pain,18,M,HO,566
175604732,18,Product used for unknown indication,2,F,EXP,nivolumab,18,SS,Pneumonia,18,M,OT,566
175604732,18,Product used for unknown indication,2,F,EXP,nivolumab,18,SS,Pneumonia,18,M,HO,566
175604732,18,Product used for unknown indication,2,F,EXP,nivolumab,18,SS,Sepsis,18,M,OT,566
175604732,18,Product used for unknown indication,2,F,EXP,nivolumab,18,SS,Sepsis,18,M,HO,566
175604732,19,Product used for unknown indication,2,F,EXP,nivolumab,19,SS,Asthenia,19,M,OT,549
175604732,19,Product used for unknown indication,2,F,EXP,nivolumab,19,SS,Asthenia,19,M,HO,549
175604732,19,Product used for unknown indication,2,F,EXP,nivolumab,19,SS,Chronic obstructive pulmonary disease,19,M,OT,549
175604732,19,Product used for unknown indication,2,F,EXP,nivolumab,19,SS,Chronic obstructive pulmonary disease,19,M,HO,549
175604732,19,Product used for unknown indication,2,F,EXP,nivolumab,19,SS,Pain,19,M,OT,549
175604732,19,Product used for unknown indication,2,F,EXP,nivolumab,19,SS,Pain,19,M,HO,549
175604732,19,Product used for unknown indication,2,F,EXP,nivolumab,19,SS,Pneumonia,19,M,OT,549
175604732,19,Product used for unknown indication,2,F,EXP,nivolumab,19,SS,Pneumonia,19,M,HO,549
175604732,19,Product used for unknown indication,2,F,EXP,nivolumab,19,SS,Sepsis,19,M,OT,549
175604732,19,Product used for unknown indication,2,F,EXP,nivolumab,19,SS,Sepsis,19,M,HO,549
175604732,20,Product used for unknown indication,2,F,EXP,nivolumab,20,SS,Asthenia,20,M,OT,531
175604732,20,Product used for unknown indication,2,F,EXP,nivolumab,20,SS,Asthenia,20,M,HO,531
175604732,20,Product used for unknown indication,2,F,EXP,nivolumab,20,SS,Chronic obstructive pulmonary disease,20,M,OT,531
175604732,20,Product used for unknown indication,2,F,EXP,nivolumab,20,SS,Chronic obstructive pulmonary disease,20,M,HO,531
175604732,20,Product used for unknown indication,2,F,EXP,nivolumab,20,SS,Pain,20,M,OT,531
175604732,20,Product used for unknown indication,2,F,EXP,nivolumab,20,SS,Pain,20,M,HO,531
175604732,20,Product used for unknown indication,2,F,EXP,nivolumab,20,SS,Pneumonia,20,M,OT,531
175604732,20,Product used for unknown indication,2,F,EXP,nivolumab,20,SS,Pneumonia,20,M,HO,531
175604732,20,Product used for unknown indication,2,F,EXP,nivolumab,20,SS,Sepsis,20,M,OT,531
175604732,20,Product used for unknown indication,2,F,EXP,nivolumab,20,SS,Sepsis,20,M,HO,531
175604732,21,Product used for unknown indication,2,F,EXP,nivolumab,21,SS,Asthenia,21,M,OT,517
175604732,21,Product used for unknown indication,2,F,EXP,nivolumab,21,SS,Asthenia,21,M,HO,517
175604732,21,Product used for unknown indication,2,F,EXP,nivolumab,21,SS,Chronic obstructive pulmonary disease,21,M,OT,517
175604732,21,Product used for unknown indication,2,F,EXP,nivolumab,21,SS,Chronic obstructive pulmonary disease,21,M,HO,517
175604732,21,Product used for unknown indication,2,F,EXP,nivolumab,21,SS,Pain,21,M,OT,517
175604732,21,Product used for unknown indication,2,F,EXP,nivolumab,21,SS,Pain,21,M,HO,517
175604732,21,Product used for unknown indication,2,F,EXP,nivolumab,21,SS,Pneumonia,21,M,OT,517
175604732,21,Product used for unknown indication,2,F,EXP,nivolumab,21,SS,Pneumonia,21,M,HO,517
175604732,21,Product used for unknown indication,2,F,EXP,nivolumab,21,SS,Sepsis,21,M,OT,517
175604732,21,Product used for unknown indication,2,F,EXP,nivolumab,21,SS,Sepsis,21,M,HO,517
175604732,22,Product used for unknown indication,2,F,EXP,nivolumab,22,SS,Asthenia,22,M,OT,503
175604732,22,Product used for unknown indication,2,F,EXP,nivolumab,22,SS,Asthenia,22,M,HO,503
175604732,22,Product used for unknown indication,2,F,EXP,nivolumab,22,SS,Chronic obstructive pulmonary disease,22,M,OT,503
175604732,22,Product used for unknown indication,2,F,EXP,nivolumab,22,SS,Chronic obstructive pulmonary disease,22,M,HO,503
175604732,22,Product used for unknown indication,2,F,EXP,nivolumab,22,SS,Pain,22,M,OT,503
175604732,22,Product used for unknown indication,2,F,EXP,nivolumab,22,SS,Pain,22,M,HO,503
175604732,22,Product used for unknown indication,2,F,EXP,nivolumab,22,SS,Pneumonia,22,M,OT,503
175604732,22,Product used for unknown indication,2,F,EXP,nivolumab,22,SS,Pneumonia,22,M,HO,503
175604732,22,Product used for unknown indication,2,F,EXP,nivolumab,22,SS,Sepsis,22,M,OT,503
175604732,22,Product used for unknown indication,2,F,EXP,nivolumab,22,SS,Sepsis,22,M,HO,503
175604732,23,Product used for unknown indication,2,F,EXP,nivolumab,23,SS,Asthenia,23,M,OT,475
175604732,23,Product used for unknown indication,2,F,EXP,nivolumab,23,SS,Asthenia,23,M,HO,475
175604732,23,Product used for unknown indication,2,F,EXP,nivolumab,23,SS,Chronic obstructive pulmonary disease,23,M,OT,475
175604732,23,Product used for unknown indication,2,F,EXP,nivolumab,23,SS,Chronic obstructive pulmonary disease,23,M,HO,475
175604732,23,Product used for unknown indication,2,F,EXP,nivolumab,23,SS,Pain,23,M,OT,475
175604732,23,Product used for unknown indication,2,F,EXP,nivolumab,23,SS,Pain,23,M,HO,475
175604732,23,Product used for unknown indication,2,F,EXP,nivolumab,23,SS,Pneumonia,23,M,OT,475
175604732,23,Product used for unknown indication,2,F,EXP,nivolumab,23,SS,Pneumonia,23,M,HO,475
175604732,23,Product used for unknown indication,2,F,EXP,nivolumab,23,SS,Sepsis,23,M,OT,475
175604732,23,Product used for unknown indication,2,F,EXP,nivolumab,23,SS,Sepsis,23,M,HO,475
175604732,24,Product used for unknown indication,2,F,EXP,nivolumab,24,SS,Asthenia,24,M,OT,461
175604732,24,Product used for unknown indication,2,F,EXP,nivolumab,24,SS,Asthenia,24,M,HO,461
175604732,24,Product used for unknown indication,2,F,EXP,nivolumab,24,SS,Chronic obstructive pulmonary disease,24,M,OT,461
175604732,24,Product used for unknown indication,2,F,EXP,nivolumab,24,SS,Chronic obstructive pulmonary disease,24,M,HO,461
175604732,24,Product used for unknown indication,2,F,EXP,nivolumab,24,SS,Pain,24,M,OT,461
175604732,24,Product used for unknown indication,2,F,EXP,nivolumab,24,SS,Pain,24,M,HO,461
175604732,24,Product used for unknown indication,2,F,EXP,nivolumab,24,SS,Pneumonia,24,M,OT,461
175604732,24,Product used for unknown indication,2,F,EXP,nivolumab,24,SS,Pneumonia,24,M,HO,461
175604732,24,Product used for unknown indication,2,F,EXP,nivolumab,24,SS,Sepsis,24,M,OT,461
175604732,24,Product used for unknown indication,2,F,EXP,nivolumab,24,SS,Sepsis,24,M,HO,461
175604732,25,Product used for unknown indication,2,F,EXP,nivolumab,25,SS,Asthenia,25,M,OT,447
175604732,25,Product used for unknown indication,2,F,EXP,nivolumab,25,SS,Asthenia,25,M,HO,447
175604732,25,Product used for unknown indication,2,F,EXP,nivolumab,25,SS,Chronic obstructive pulmonary disease,25,M,OT,447
175604732,25,Product used for unknown indication,2,F,EXP,nivolumab,25,SS,Chronic obstructive pulmonary disease,25,M,HO,447
175604732,25,Product used for unknown indication,2,F,EXP,nivolumab,25,SS,Pain,25,M,OT,447
175604732,25,Product used for unknown indication,2,F,EXP,nivolumab,25,SS,Pain,25,M,HO,447
175604732,25,Product used for unknown indication,2,F,EXP,nivolumab,25,SS,Pneumonia,25,M,OT,447
175604732,25,Product used for unknown indication,2,F,EXP,nivolumab,25,SS,Pneumonia,25,M,HO,447
175604732,25,Product used for unknown indication,2,F,EXP,nivolumab,25,SS,Sepsis,25,M,OT,447
175604732,25,Product used for unknown indication,2,F,EXP,nivolumab,25,SS,Sepsis,25,M,HO,447
175604732,26,Product used for unknown indication,2,F,EXP,nivolumab,26,SS,Asthenia,26,M,OT,433
175604732,26,Product used for unknown indication,2,F,EXP,nivolumab,26,SS,Asthenia,26,M,HO,433
175604732,26,Product used for unknown indication,2,F,EXP,nivolumab,26,SS,Chronic obstructive pulmonary disease,26,M,OT,433
175604732,26,Product used for unknown indication,2,F,EXP,nivolumab,26,SS,Chronic obstructive pulmonary disease,26,M,HO,433
175604732,26,Product used for unknown indication,2,F,EXP,nivolumab,26,SS,Pain,26,M,OT,433
175604732,26,Product used for unknown indication,2,F,EXP,nivolumab,26,SS,Pain,26,M,HO,433
175604732,26,Product used for unknown indication,2,F,EXP,nivolumab,26,SS,Pneumonia,26,M,OT,433
175604732,26,Product used for unknown indication,2,F,EXP,nivolumab,26,SS,Pneumonia,26,M,HO,433
175604732,26,Product used for unknown indication,2,F,EXP,nivolumab,26,SS,Sepsis,26,M,OT,433
175604732,26,Product used for unknown indication,2,F,EXP,nivolumab,26,SS,Sepsis,26,M,HO,433
175604732,27,Product used for unknown indication,2,F,EXP,nivolumab,27,SS,Asthenia,27,M,OT,419
175604732,27,Product used for unknown indication,2,F,EXP,nivolumab,27,SS,Asthenia,27,M,HO,419
175604732,27,Product used for unknown indication,2,F,EXP,nivolumab,27,SS,Chronic obstructive pulmonary disease,27,M,OT,419
175604732,27,Product used for unknown indication,2,F,EXP,nivolumab,27,SS,Chronic obstructive pulmonary disease,27,M,HO,419
175604732,27,Product used for unknown indication,2,F,EXP,nivolumab,27,SS,Pain,27,M,OT,419
175604732,27,Product used for unknown indication,2,F,EXP,nivolumab,27,SS,Pain,27,M,HO,419
175604732,27,Product used for unknown indication,2,F,EXP,nivolumab,27,SS,Pneumonia,27,M,OT,419
175604732,27,Product used for unknown indication,2,F,EXP,nivolumab,27,SS,Pneumonia,27,M,HO,419
175604732,27,Product used for unknown indication,2,F,EXP,nivolumab,27,SS,Sepsis,27,M,OT,419
175604732,27,Product used for unknown indication,2,F,EXP,nivolumab,27,SS,Sepsis,27,M,HO,419
175604732,28,Product used for unknown indication,2,F,EXP,nivolumab,28,SS,Asthenia,28,M,OT,405
175604732,28,Product used for unknown indication,2,F,EXP,nivolumab,28,SS,Asthenia,28,M,HO,405
175604732,28,Product used for unknown indication,2,F,EXP,nivolumab,28,SS,Chronic obstructive pulmonary disease,28,M,OT,405
175604732,28,Product used for unknown indication,2,F,EXP,nivolumab,28,SS,Chronic obstructive pulmonary disease,28,M,HO,405
175604732,28,Product used for unknown indication,2,F,EXP,nivolumab,28,SS,Pain,28,M,OT,405
175604732,28,Product used for unknown indication,2,F,EXP,nivolumab,28,SS,Pain,28,M,HO,405
175604732,28,Product used for unknown indication,2,F,EXP,nivolumab,28,SS,Pneumonia,28,M,OT,405
175604732,28,Product used for unknown indication,2,F,EXP,nivolumab,28,SS,Pneumonia,28,M,HO,405
175604732,28,Product used for unknown indication,2,F,EXP,nivolumab,28,SS,Sepsis,28,M,OT,405
175604732,28,Product used for unknown indication,2,F,EXP,nivolumab,28,SS,Sepsis,28,M,HO,405
175604732,29,Product used for unknown indication,2,F,EXP,nivolumab,29,SS,Asthenia,29,M,OT,370
175604732,29,Product used for unknown indication,2,F,EXP,nivolumab,29,SS,Asthenia,29,M,HO,370
175604732,29,Product used for unknown indication,2,F,EXP,nivolumab,29,SS,Chronic obstructive pulmonary disease,29,M,OT,370
175604732,29,Product used for unknown indication,2,F,EXP,nivolumab,29,SS,Chronic obstructive pulmonary disease,29,M,HO,370
175604732,29,Product used for unknown indication,2,F,EXP,nivolumab,29,SS,Pain,29,M,OT,370
175604732,29,Product used for unknown indication,2,F,EXP,nivolumab,29,SS,Pain,29,M,HO,370
175604732,29,Product used for unknown indication,2,F,EXP,nivolumab,29,SS,Pneumonia,29,M,OT,370
175604732,29,Product used for unknown indication,2,F,EXP,nivolumab,29,SS,Pneumonia,29,M,HO,370
175604732,29,Product used for unknown indication,2,F,EXP,nivolumab,29,SS,Sepsis,29,M,OT,370
175604732,29,Product used for unknown indication,2,F,EXP,nivolumab,29,SS,Sepsis,29,M,HO,370
175604732,30,Product used for unknown indication,2,F,EXP,nivolumab,30,SS,Asthenia,30,M,OT,356
175604732,30,Product used for unknown indication,2,F,EXP,nivolumab,30,SS,Asthenia,30,M,HO,356
175604732,30,Product used for unknown indication,2,F,EXP,nivolumab,30,SS,Chronic obstructive pulmonary disease,30,M,OT,356
175604732,30,Product used for unknown indication,2,F,EXP,nivolumab,30,SS,Chronic obstructive pulmonary disease,30,M,HO,356
175604732,30,Product used for unknown indication,2,F,EXP,nivolumab,30,SS,Pain,30,M,OT,356
175604732,30,Product used for unknown indication,2,F,EXP,nivolumab,30,SS,Pain,30,M,HO,356
175604732,30,Product used for unknown indication,2,F,EXP,nivolumab,30,SS,Pneumonia,30,M,OT,356
175604732,30,Product used for unknown indication,2,F,EXP,nivolumab,30,SS,Pneumonia,30,M,HO,356
175604732,30,Product used for unknown indication,2,F,EXP,nivolumab,30,SS,Sepsis,30,M,OT,356
175604732,30,Product used for unknown indication,2,F,EXP,nivolumab,30,SS,Sepsis,30,M,HO,356
175604732,31,Product used for unknown indication,2,F,EXP,nivolumab,31,SS,Asthenia,31,M,OT,342
175604732,31,Product used for unknown indication,2,F,EXP,nivolumab,31,SS,Asthenia,31,M,HO,342
175604732,31,Product used for unknown indication,2,F,EXP,nivolumab,31,SS,Chronic obstructive pulmonary disease,31,M,OT,342
175604732,31,Product used for unknown indication,2,F,EXP,nivolumab,31,SS,Chronic obstructive pulmonary disease,31,M,HO,342
175604732,31,Product used for unknown indication,2,F,EXP,nivolumab,31,SS,Pain,31,M,OT,342
175604732,31,Product used for unknown indication,2,F,EXP,nivolumab,31,SS,Pain,31,M,HO,342
175604732,31,Product used for unknown indication,2,F,EXP,nivolumab,31,SS,Pneumonia,31,M,OT,342
175604732,31,Product used for unknown indication,2,F,EXP,nivolumab,31,SS,Pneumonia,31,M,HO,342
175604732,31,Product used for unknown indication,2,F,EXP,nivolumab,31,SS,Sepsis,31,M,OT,342
175604732,31,Product used for unknown indication,2,F,EXP,nivolumab,31,SS,Sepsis,31,M,HO,342
175604732,32,Product used for unknown indication,2,F,EXP,nivolumab,32,SS,Asthenia,32,M,OT,314
175604732,32,Product used for unknown indication,2,F,EXP,nivolumab,32,SS,Asthenia,32,M,HO,314
175604732,32,Product used for unknown indication,2,F,EXP,nivolumab,32,SS,Chronic obstructive pulmonary disease,32,M,OT,314
175604732,32,Product used for unknown indication,2,F,EXP,nivolumab,32,SS,Chronic obstructive pulmonary disease,32,M,HO,314
175604732,32,Product used for unknown indication,2,F,EXP,nivolumab,32,SS,Pain,32,M,OT,314
175604732,32,Product used for unknown indication,2,F,EXP,nivolumab,32,SS,Pain,32,M,HO,314
175604732,32,Product used for unknown indication,2,F,EXP,nivolumab,32,SS,Pneumonia,32,M,OT,314
175604732,32,Product used for unknown indication,2,F,EXP,nivolumab,32,SS,Pneumonia,32,M,HO,314
175604732,32,Product used for unknown indication,2,F,EXP,nivolumab,32,SS,Sepsis,32,M,OT,314
175604732,32,Product used for unknown indication,2,F,EXP,nivolumab,32,SS,Sepsis,32,M,HO,314
175604732,33,Product used for unknown indication,2,F,EXP,nivolumab,33,SS,Asthenia,33,M,OT,300
175604732,33,Product used for unknown indication,2,F,EXP,nivolumab,33,SS,Asthenia,33,M,HO,300
175604732,33,Product used for unknown indication,2,F,EXP,nivolumab,33,SS,Chronic obstructive pulmonary disease,33,M,OT,300
175604732,33,Product used for unknown indication,2,F,EXP,nivolumab,33,SS,Chronic obstructive pulmonary disease,33,M,HO,300
175604732,33,Product used for unknown indication,2,F,EXP,nivolumab,33,SS,Pain,33,M,OT,300
175604732,33,Product used for unknown indication,2,F,EXP,nivolumab,33,SS,Pain,33,M,HO,300
175604732,33,Product used for unknown indication,2,F,EXP,nivolumab,33,SS,Pneumonia,33,M,OT,300
175604732,33,Product used for unknown indication,2,F,EXP,nivolumab,33,SS,Pneumonia,33,M,HO,300
175604732,33,Product used for unknown indication,2,F,EXP,nivolumab,33,SS,Sepsis,33,M,OT,300
175604732,33,Product used for unknown indication,2,F,EXP,nivolumab,33,SS,Sepsis,33,M,HO,300
175604732,34,Product used for unknown indication,2,F,EXP,nivolumab,34,SS,Asthenia,34,M,OT,286
175604732,34,Product used for unknown indication,2,F,EXP,nivolumab,34,SS,Asthenia,34,M,HO,286
175604732,34,Product used for unknown indication,2,F,EXP,nivolumab,34,SS,Chronic obstructive pulmonary disease,34,M,OT,286
175604732,34,Product used for unknown indication,2,F,EXP,nivolumab,34,SS,Chronic obstructive pulmonary disease,34,M,HO,286
175604732,34,Product used for unknown indication,2,F,EXP,nivolumab,34,SS,Pain,34,M,OT,286
175604732,34,Product used for unknown indication,2,F,EXP,nivolumab,34,SS,Pain,34,M,HO,286
175604732,34,Product used for unknown indication,2,F,EXP,nivolumab,34,SS,Pneumonia,34,M,OT,286
175604732,34,Product used for unknown indication,2,F,EXP,nivolumab,34,SS,Pneumonia,34,M,HO,286
175604732,34,Product used for unknown indication,2,F,EXP,nivolumab,34,SS,Sepsis,34,M,OT,286
175604732,34,Product used for unknown indication,2,F,EXP,nivolumab,34,SS,Sepsis,34,M,HO,286
175604732,35,Product used for unknown indication,2,F,EXP,nivolumab,35,SS,Asthenia,35,M,OT,272
175604732,35,Product used for unknown indication,2,F,EXP,nivolumab,35,SS,Asthenia,35,M,HO,272
175604732,35,Product used for unknown indication,2,F,EXP,nivolumab,35,SS,Chronic obstructive pulmonary disease,35,M,OT,272
175604732,35,Product used for unknown indication,2,F,EXP,nivolumab,35,SS,Chronic obstructive pulmonary disease,35,M,HO,272
175604732,35,Product used for unknown indication,2,F,EXP,nivolumab,35,SS,Pain,35,M,OT,272
175604732,35,Product used for unknown indication,2,F,EXP,nivolumab,35,SS,Pain,35,M,HO,272
175604732,35,Product used for unknown indication,2,F,EXP,nivolumab,35,SS,Pneumonia,35,M,OT,272
175604732,35,Product used for unknown indication,2,F,EXP,nivolumab,35,SS,Pneumonia,35,M,HO,272
175604732,35,Product used for unknown indication,2,F,EXP,nivolumab,35,SS,Sepsis,35,M,OT,272
175604732,35,Product used for unknown indication,2,F,EXP,nivolumab,35,SS,Sepsis,35,M,HO,272
175604732,36,Product used for unknown indication,2,F,EXP,nivolumab,36,SS,Asthenia,36,M,OT,229
175604732,36,Product used for unknown indication,2,F,EXP,nivolumab,36,SS,Asthenia,36,M,HO,229
175604732,36,Product used for unknown indication,2,F,EXP,nivolumab,36,SS,Chronic obstructive pulmonary disease,36,M,OT,229
175604732,36,Product used for unknown indication,2,F,EXP,nivolumab,36,SS,Chronic obstructive pulmonary disease,36,M,HO,229
175604732,36,Product used for unknown indication,2,F,EXP,nivolumab,36,SS,Pain,36,M,OT,229
175604732,36,Product used for unknown indication,2,F,EXP,nivolumab,36,SS,Pain,36,M,HO,229
175604732,36,Product used for unknown indication,2,F,EXP,nivolumab,36,SS,Pneumonia,36,M,OT,229
175604732,36,Product used for unknown indication,2,F,EXP,nivolumab,36,SS,Pneumonia,36,M,HO,229
175604732,36,Product used for unknown indication,2,F,EXP,nivolumab,36,SS,Sepsis,36,M,OT,229
175604732,36,Product used for unknown indication,2,F,EXP,nivolumab,36,SS,Sepsis,36,M,HO,229
175604732,37,Product used for unknown indication,2,F,EXP,nivolumab,37,SS,Asthenia,37,M,OT,202
175604732,37,Product used for unknown indication,2,F,EXP,nivolumab,37,SS,Asthenia,37,M,HO,202
175604732,37,Product used for unknown indication,2,F,EXP,nivolumab,37,SS,Chronic obstructive pulmonary disease,37,M,OT,202
175604732,37,Product used for unknown indication,2,F,EXP,nivolumab,37,SS,Chronic obstructive pulmonary disease,37,M,HO,202
175604732,37,Product used for unknown indication,2,F,EXP,nivolumab,37,SS,Pain,37,M,OT,202
175604732,37,Product used for unknown indication,2,F,EXP,nivolumab,37,SS,Pain,37,M,HO,202
175604732,37,Product used for unknown indication,2,F,EXP,nivolumab,37,SS,Pneumonia,37,M,OT,202
175604732,37,Product used for unknown indication,2,F,EXP,nivolumab,37,SS,Pneumonia,37,M,HO,202
175604732,37,Product used for unknown indication,2,F,EXP,nivolumab,37,SS,Sepsis,37,M,OT,202
175604732,37,Product used for unknown indication,2,F,EXP,nivolumab,37,SS,Sepsis,37,M,HO,202
175604732,38,Product used for unknown indication,2,F,EXP,nivolumab,38,SS,Asthenia,38,M,OT,180
175604732,38,Product used for unknown indication,2,F,EXP,nivolumab,38,SS,Asthenia,38,M,HO,180
175604732,38,Product used for unknown indication,2,F,EXP,nivolumab,38,SS,Chronic obstructive pulmonary disease,38,M,OT,180
175604732,38,Product used for unknown indication,2,F,EXP,nivolumab,38,SS,Chronic obstructive pulmonary disease,38,M,HO,180
175604732,38,Product used for unknown indication,2,F,EXP,nivolumab,38,SS,Pain,38,M,OT,180
175604732,38,Product used for unknown indication,2,F,EXP,nivolumab,38,SS,Pain,38,M,HO,180
175604732,38,Product used for unknown indication,2,F,EXP,nivolumab,38,SS,Pneumonia,38,M,OT,180
175604732,38,Product used for unknown indication,2,F,EXP,nivolumab,38,SS,Pneumonia,38,M,HO,180
175604732,38,Product used for unknown indication,2,F,EXP,nivolumab,38,SS,Sepsis,38,M,OT,180
175604732,38,Product used for unknown indication,2,F,EXP,nivolumab,38,SS,Sepsis,38,M,HO,180
175604732,39,Product used for unknown indication,2,F,EXP,nivolumab,39,SS,Asthenia,39,M,OT,146
175604732,39,Product used for unknown indication,2,F,EXP,nivolumab,39,SS,Asthenia,39,M,HO,146
175604732,39,Product used for unknown indication,2,F,EXP,nivolumab,39,SS,Chronic obstructive pulmonary disease,39,M,OT,146
175604732,39,Product used for unknown indication,2,F,EXP,nivolumab,39,SS,Chronic obstructive pulmonary disease,39,M,HO,146
175604732,39,Product used for unknown indication,2,F,EXP,nivolumab,39,SS,Pain,39,M,OT,146
175604732,39,Product used for unknown indication,2,F,EXP,nivolumab,39,SS,Pain,39,M,HO,146
175604732,39,Product used for unknown indication,2,F,EXP,nivolumab,39,SS,Pneumonia,39,M,OT,146
175604732,39,Product used for unknown indication,2,F,EXP,nivolumab,39,SS,Pneumonia,39,M,HO,146
175604732,39,Product used for unknown indication,2,F,EXP,nivolumab,39,SS,Sepsis,39,M,OT,146
175604732,39,Product used for unknown indication,2,F,EXP,nivolumab,39,SS,Sepsis,39,M,HO,146
175604732,40,Product used for unknown indication,2,F,EXP,nivolumab,40,SS,Asthenia,40,M,OT,118
175604732,40,Product used for unknown indication,2,F,EXP,nivolumab,40,SS,Asthenia,40,M,HO,118
175604732,40,Product used for unknown indication,2,F,EXP,nivolumab,40,SS,Chronic obstructive pulmonary disease,40,M,OT,118
175604732,40,Product used for unknown indication,2,F,EXP,nivolumab,40,SS,Chronic obstructive pulmonary disease,40,M,HO,118
175604732,40,Product used for unknown indication,2,F,EXP,nivolumab,40,SS,Pain,40,M,OT,118
175604732,40,Product used for unknown indication,2,F,EXP,nivolumab,40,SS,Pain,40,M,HO,118
175604732,40,Product used for unknown indication,2,F,EXP,nivolumab,40,SS,Pneumonia,40,M,OT,118
175604732,40,Product used for unknown indication,2,F,EXP,nivolumab,40,SS,Pneumonia,40,M,HO,118
175604732,40,Product used for unknown indication,2,F,EXP,nivolumab,40,SS,Sepsis,40,M,OT,118
175604732,40,Product used for unknown indication,2,F,EXP,nivolumab,40,SS,Sepsis,40,M,HO,118
175604732,41,Product used for unknown indication,2,F,EXP,nivolumab,41,SS,Asthenia,41,M,OT,104
175604732,41,Product used for unknown indication,2,F,EXP,nivolumab,41,SS,Asthenia,41,M,HO,104
175604732,41,Product used for unknown indication,2,F,EXP,nivolumab,41,SS,Chronic obstructive pulmonary disease,41,M,OT,104
175604732,41,Product used for unknown indication,2,F,EXP,nivolumab,41,SS,Chronic obstructive pulmonary disease,41,M,HO,104
175604732,41,Product used for unknown indication,2,F,EXP,nivolumab,41,SS,Pain,41,M,OT,104
175604732,41,Product used for unknown indication,2,F,EXP,nivolumab,41,SS,Pain,41,M,HO,104
175604732,41,Product used for unknown indication,2,F,EXP,nivolumab,41,SS,Pneumonia,41,M,OT,104
175604732,41,Product used for unknown indication,2,F,EXP,nivolumab,41,SS,Pneumonia,41,M,HO,104
175604732,41,Product used for unknown indication,2,F,EXP,nivolumab,41,SS,Sepsis,41,M,OT,104
175604732,41,Product used for unknown indication,2,F,EXP,nivolumab,41,SS,Sepsis,41,M,HO,104
175604732,42,Product used for unknown indication,2,F,EXP,nivolumab,42,SS,Asthenia,42,M,OT,90
175604732,42,Product used for unknown indication,2,F,EXP,nivolumab,42,SS,Asthenia,42,M,HO,90
175604732,42,Product used for unknown indication,2,F,EXP,nivolumab,42,SS,Chronic obstructive pulmonary disease,42,M,OT,90
175604732,42,Product used for unknown indication,2,F,EXP,nivolumab,42,SS,Chronic obstructive pulmonary disease,42,M,HO,90
175604732,42,Product used for unknown indication,2,F,EXP,nivolumab,42,SS,Pain,42,M,OT,90
175604732,42,Product used for unknown indication,2,F,EXP,nivolumab,42,SS,Pain,42,M,HO,90
175604732,42,Product used for unknown indication,2,F,EXP,nivolumab,42,SS,Pneumonia,42,M,OT,90
175604732,42,Product used for unknown indication,2,F,EXP,nivolumab,42,SS,Pneumonia,42,M,HO,90
175604732,42,Product used for unknown indication,2,F,EXP,nivolumab,42,SS,Sepsis,42,M,OT,90
175604732,42,Product used for unknown indication,2,F,EXP,nivolumab,42,SS,Sepsis,42,M,HO,90
175604732,43,Product used for unknown indication,2,F,EXP,nivolumab,43,SS,Asthenia,43,M,OT,76
175604732,43,Product used for unknown indication,2,F,EXP,nivolumab,43,SS,Asthenia,43,M,HO,76
175604732,43,Product used for unknown indication,2,F,EXP,nivolumab,43,SS,Chronic obstructive pulmonary disease,43,M,OT,76
175604732,43,Product used for unknown indication,2,F,EXP,nivolumab,43,SS,Chronic obstructive pulmonary disease,43,M,HO,76
175604732,43,Product used for unknown indication,2,F,EXP,nivolumab,43,SS,Pain,43,M,OT,76
175604732,43,Product used for unknown indication,2,F,EXP,nivolumab,43,SS,Pain,43,M,HO,76
175604732,43,Product used for unknown indication,2,F,EXP,nivolumab,43,SS,Pneumonia,43,M,OT,76
175604732,43,Product used for unknown indication,2,F,EXP,nivolumab,43,SS,Pneumonia,43,M,HO,76
175604732,43,Product used for unknown indication,2,F,EXP,nivolumab,43,SS,Sepsis,43,M,OT,76
175604732,43,Product used for unknown indication,2,F,EXP,nivolumab,43,SS,Sepsis,43,M,HO,76
175604732,44,Product used for unknown indication,2,F,EXP,nivolumab,44,SS,Asthenia,44,M,OT,48
175604732,44,Product used for unknown indication,2,F,EXP,nivolumab,44,SS,Asthenia,44,M,HO,48
175604732,44,Product used for unknown indication,2,F,EXP,nivolumab,44,SS,Chronic obstructive pulmonary disease,44,M,OT,48
175604732,44,Product used for unknown indication,2,F,EXP,nivolumab,44,SS,Chronic obstructive pulmonary disease,44,M,HO,48
175604732,44,Product used for unknown indication,2,F,EXP,nivolumab,44,SS,Pain,44,M,OT,48
175604732,44,Product used for unknown indication,2,F,EXP,nivolumab,44,SS,Pain,44,M,HO,48
175604732,44,Product used for unknown indication,2,F,EXP,nivolumab,44,SS,Pneumonia,44,M,OT,48
175604732,44,Product used for unknown indication,2,F,EXP,nivolumab,44,SS,Pneumonia,44,M,HO,48
175604732,44,Product used for unknown indication,2,F,EXP,nivolumab,44,SS,Sepsis,44,M,OT,48
175604732,44,Product used for unknown indication,2,F,EXP,nivolumab,44,SS,Sepsis,44,M,HO,48
175604732,45,Product used for unknown indication,2,F,EXP,nivolumab,45,SS,Asthenia,45,M,OT,34
175604732,45,Product used for unknown indication,2,F,EXP,nivolumab,45,SS,Asthenia,45,M,HO,34
175604732,45,Product used for unknown indication,2,F,EXP,nivolumab,45,SS,Chronic obstructive pulmonary disease,45,M,OT,34
175604732,45,Product used for unknown indication,2,F,EXP,nivolumab,45,SS,Chronic obstructive pulmonary disease,45,M,HO,34
175604732,45,Product used for unknown indication,2,F,EXP,nivolumab,45,SS,Pain,45,M,OT,34
175604732,45,Product used for unknown indication,2,F,EXP,nivolumab,45,SS,Pain,45,M,HO,34
175604732,45,Product used for unknown indication,2,F,EXP,nivolumab,45,SS,Pneumonia,45,M,OT,34
175604732,45,Product used for unknown indication,2,F,EXP,nivolumab,45,SS,Pneumonia,45,M,HO,34
175604732,45,Product used for unknown indication,2,F,EXP,nivolumab,45,SS,Sepsis,45,M,OT,34
175604732,45,Product used for unknown indication,2,F,EXP,nivolumab,45,SS,Sepsis,45,M,HO,34
175604732,46,Product used for unknown indication,2,F,EXP,nivolumab,46,SS,Asthenia,46,M,OT,20
175604732,46,Product used for unknown indication,2,F,EXP,nivolumab,46,SS,Asthenia,46,M,HO,20
175604732,46,Product used for unknown indication,2,F,EXP,nivolumab,46,SS,Chronic obstructive pulmonary disease,46,M,OT,20
175604732,46,Product used for unknown indication,2,F,EXP,nivolumab,46,SS,Chronic obstructive pulmonary disease,46,M,HO,20
175604732,46,Product used for unknown indication,2,F,EXP,nivolumab,46,SS,Pain,46,M,OT,20
175604732,46,Product used for unknown indication,2,F,EXP,nivolumab,46,SS,Pain,46,M,HO,20
175604732,46,Product used for unknown indication,2,F,EXP,nivolumab,46,SS,Pneumonia,46,M,OT,20
175604732,46,Product used for unknown indication,2,F,EXP,nivolumab,46,SS,Pneumonia,46,M,HO,20
175604732,46,Product used for unknown indication,2,F,EXP,nivolumab,46,SS,Sepsis,46,M,OT,20
175604732,46,Product used for unknown indication,2,F,EXP,nivolumab,46,SS,Sepsis,46,M,HO,20
175608011,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Respiratory tract infection,1,M,OT,127
175609152,1,Non-small cell lung cancer,2,F,EXP,lorlatinib,1,PS,Death,1,F,DE,211
175613631,1,Chronic leukaemia,1,I,EXP,nilotinib,1,PS,Keratosis pilaris,1,M,OT,198
175616521,9,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,9,SS,Non-cardiac chest pain,9,M,HO,280
175619802,1,Plasma cell myeloma,2,F,EXP,lenalidomide,1,PS,Sarcomatoid carcinoma,1,F,OT,1733
175621312,1,Acute myeloid leukaemia,2,F,EXP,midostaurin,1,PS,Periodontitis,1,M,HO,153
175621312,10,Prophylaxis,2,F,EXP,filgrastim,10,C,Periodontitis,10,M,HO,28
175622311,6,Malignant melanoma,1,I,EXP,nivolumab,6,SS,Cerebral microangiopathy,6,F,OT,360
175622311,6,Malignant melanoma,1,I,EXP,nivolumab,6,SS,Leukoencephalopathy,6,F,OT,360
175622781,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Iritis,1,F,OT,4
175622781,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Scleritis,1,F,OT,4
175624561,9,Plasma cell myeloma,1,I,EXP,daratumumab,9,SS,Neutropenia,9,F,OT,125
175624561,9,Plasma cell myeloma,1,I,EXP,daratumumab,9,SS,Neutropenia,9,F,LT,125
175624561,22,Product used for unknown indication,1,I,EXP,filgrastim,22,C,Neutropenia,22,F,OT,104
175624561,22,Product used for unknown indication,1,I,EXP,filgrastim,22,C,Neutropenia,22,F,LT,104
175625302,1,Diffuse large B-cell lymphoma,2,F,EXP,lenalidomide,1,PS,Adenocarcinoma gastric,1,M,HO,2280
175629751,6,Malignant melanoma,1,I,EXP,nivolumab,6,SS,Cerebral microangiopathy,6,F,OT,360
175629751,6,Malignant melanoma,1,I,EXP,nivolumab,6,SS,Leukoencephalopathy,6,F,OT,360
175629981,8,Plasma cell myeloma,1,I,PER,carfilzomib,8,SS,Febrile neutropenia,8,M,HO,1416
175629981,8,Plasma cell myeloma,1,I,PER,carfilzomib,8,SS,Pneumonia,8,M,HO,1416
175631151,6,Malignant melanoma,1,I,EXP,nivolumab,6,SS,Cerebral microangiopathy,6,F,OT,360
175631151,6,Malignant melanoma,1,I,EXP,nivolumab,6,SS,Leukoencephalopathy,6,F,OT,360
175631221,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Autoimmune anaemia,1,M,OT,239
175631291,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Anaemia,1,F,HO,742
175631291,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Anaemia,1,F,OT,742
175631291,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,False positive investigation result,1,F,HO,742
175631291,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,False positive investigation result,1,F,OT,742
175631291,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Hypophosphataemia,1,F,HO,742
175631291,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Hypophosphataemia,1,F,OT,742
175631291,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Large intestinal obstruction,1,F,HO,742
175631291,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Large intestinal obstruction,1,F,OT,742
175631291,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Lymphocyte count decreased,1,F,HO,742
175631291,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Lymphocyte count decreased,1,F,OT,742
175631291,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Sinus tachycardia,1,F,HO,742
175631291,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Sinus tachycardia,1,F,OT,742
175631291,2,Colorectal cancer,1,I,EXP,ipilimumab,2,SS,Anaemia,2,F,HO,742
175631291,2,Colorectal cancer,1,I,EXP,ipilimumab,2,SS,Anaemia,2,F,OT,742
175631291,2,Colorectal cancer,1,I,EXP,ipilimumab,2,SS,False positive investigation result,2,F,HO,742
175631291,2,Colorectal cancer,1,I,EXP,ipilimumab,2,SS,False positive investigation result,2,F,OT,742
175631291,2,Colorectal cancer,1,I,EXP,ipilimumab,2,SS,Hypophosphataemia,2,F,HO,742
175631291,2,Colorectal cancer,1,I,EXP,ipilimumab,2,SS,Hypophosphataemia,2,F,OT,742
175631291,2,Colorectal cancer,1,I,EXP,ipilimumab,2,SS,Large intestinal obstruction,2,F,HO,742
175631291,2,Colorectal cancer,1,I,EXP,ipilimumab,2,SS,Large intestinal obstruction,2,F,OT,742
175631291,2,Colorectal cancer,1,I,EXP,ipilimumab,2,SS,Lymphocyte count decreased,2,F,HO,742
175631291,2,Colorectal cancer,1,I,EXP,ipilimumab,2,SS,Lymphocyte count decreased,2,F,OT,742
175631291,2,Colorectal cancer,1,I,EXP,ipilimumab,2,SS,Sinus tachycardia,2,F,HO,742
175631291,2,Colorectal cancer,1,I,EXP,ipilimumab,2,SS,Sinus tachycardia,2,F,OT,742
175631291,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Anaemia,3,F,HO,21
175631291,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Anaemia,3,F,OT,21
175631291,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,False positive investigation result,3,F,HO,21
175631291,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,False positive investigation result,3,F,OT,21
175631291,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Hypophosphataemia,3,F,HO,21
175631291,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Hypophosphataemia,3,F,OT,21
175631291,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Large intestinal obstruction,3,F,HO,21
175631291,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Large intestinal obstruction,3,F,OT,21
175631291,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Lymphocyte count decreased,3,F,HO,21
175631291,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Lymphocyte count decreased,3,F,OT,21
175631291,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Sinus tachycardia,3,F,HO,21
175631291,3,Product used for unknown indication,1,I,EXP,ipilimumab,3,SS,Sinus tachycardia,3,F,OT,21
175631731,1,Atrial fibrillation,1,I,DIR,ibrutinib,1,PS,Atrial fibrillation,1,M,HO,22
175631731,1,Atrial fibrillation,1,I,DIR,ibrutinib,1,PS,Palpitations,1,M,HO,22
175631731,1,Atrial fibrillation,1,I,DIR,ibrutinib,1,PS,Tachycardia,1,M,HO,22
175633531,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Splenic abscess,1,F,OT,509
175633531,1,Metastatic renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Splenic abscess,1,F,HO,509
175634761,1,Non-Hodgkin's lymphoma unspecified histology aggressive refractory,1,I,EXP,axicabtagene ciloleucel,1,PS,Herpes zoster,1,M,OT,242
175639621,1,Osteogenesis imperfecta,1,I,PER,denosumab,1,PS,Femur fracture,1,F,OT,291
175643091,1,Prostate cancer stage IV,1,I,EXP,cabazitaxel,1,PS,Dyspnoea,1,M,DE,34
175643091,1,Prostate cancer stage IV,1,I,EXP,cabazitaxel,1,PS,Dyspnoea,1,M,HO,34
175644101,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Prescribed underdose,1,M,HO,18
175644101,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Rash maculo-papular,1,M,HO,18
175644101,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Prescribed underdose,2,M,HO,18
175644101,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Rash maculo-papular,2,M,HO,18
175650611,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Cerebrovascular accident,1,F,HO,124
175652361,4,Plasma cell myeloma,1,I,EXP,daratumumab,4,SS,Neutropenia,4,M,LT,49
175657051,1,Chronic myeloid leukaemia,1,I,EXP,nilotinib,1,PS,Dyspnoea,1,F,HO,16
175657051,1,Chronic myeloid leukaemia,1,I,EXP,nilotinib,1,PS,Dyspnoea,1,F,OT,16
175657051,1,Chronic myeloid leukaemia,1,I,EXP,nilotinib,1,PS,Hepatocellular injury,1,F,HO,16
175657051,1,Chronic myeloid leukaemia,1,I,EXP,nilotinib,1,PS,Hepatocellular injury,1,F,OT,16
175657051,1,Chronic myeloid leukaemia,1,I,EXP,nilotinib,1,PS,Pyrexia,1,F,HO,16
175657051,1,Chronic myeloid leukaemia,1,I,EXP,nilotinib,1,PS,Pyrexia,1,F,OT,16
175657051,1,Chronic myeloid leukaemia,1,I,EXP,nilotinib,1,PS,Subdural haematoma,1,F,HO,16
175657051,1,Chronic myeloid leukaemia,1,I,EXP,nilotinib,1,PS,Subdural haematoma,1,F,OT,16
175659991,2,Product used for unknown indication,1,I,EXP,pegfilgrastim,2,SS,Drug ineffective,2,F,HO,6
175659991,2,Product used for unknown indication,1,I,EXP,pegfilgrastim,2,SS,Drug ineffective,2,F,OT,6
175659991,2,Product used for unknown indication,1,I,EXP,pegfilgrastim,2,SS,Neutropenia,2,F,HO,6
175659991,2,Product used for unknown indication,1,I,EXP,pegfilgrastim,2,SS,Neutropenia,2,F,OT,6
175664031,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Arrhythmia,2,F,OT,2
175664031,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Epistaxis,2,F,OT,2
175664701,1,Plasma cell myeloma,1,I,EXP,pomalidomide,1,PS,Death,1,M,DE,805
175665801,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,103
175665801,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,103
175665801,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Immune-mediated hepatitis,1,M,DE,103
175665801,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Immune-mediated hepatitis,1,M,OT,103
175667701,1,Non-small cell lung cancer,1,I,EXP,selinexor,1,PS,Febrile neutropenia,1,F,HO,6
175670621,5,Prophylaxis,1,I,EXP,filgrastim,5,SS,Toxic skin eruption,5,M,OT,1
175671131,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Blood disorder,1,M,HO,16
175671131,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Blood disorder,1,M,LT,16
175671131,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Blood pressure increased,1,M,HO,16
175671131,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Blood pressure increased,1,M,LT,16
175671131,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Diarrhoea,1,M,HO,16
175671131,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Diarrhoea,1,M,LT,16
175671131,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Drug interaction,1,M,HO,16
175671131,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Drug interaction,1,M,LT,16
175671131,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Fatigue,1,M,HO,16
175671131,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Fatigue,1,M,LT,16
175671131,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Nausea,1,M,HO,16
175671131,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Nausea,1,M,LT,16
175671131,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Withdrawal syndrome,1,M,HO,16
175671131,1,Hormone-refractory prostate cancer,1,I,EXP,apalutamide,1,PS,Withdrawal syndrome,1,M,LT,16
175671403,1,Metastatic renal cell carcinoma,3,F,EXP,nivolumab,1,PS,Basal cell carcinoma,1,F,OT,980
175671681,1,Adenocarcinoma,1,I,PER,panitumumab,1,PS,Thrombosis,1,F,HO,45
175675121,1,Cholangiocarcinoma,1,I,EXP,nivolumab,1,PS,Arthritis,1,F,HO,10
175675121,2,Cholangiocarcinoma,1,I,EXP,ipilimumab,2,SS,Arthritis,2,F,HO,10
175676842,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pancreatitis,1,F,OT,94
175676842,1,Metastatic renal cell carcinoma,2,F,EXP,nivolumab,1,PS,Pancreatitis,1,F,HO,94
175676842,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Pancreatitis,2,F,OT,94
175676842,2,Metastatic renal cell carcinoma,2,F,EXP,ipilimumab,2,SS,Pancreatitis,2,F,HO,94
175679771,21,Premedication,1,I,EXP,granisetron,21,C,Hypertension,21,F,HO,2
175679771,21,Premedication,1,I,EXP,granisetron,21,C,Nausea,21,F,HO,2
175679771,21,Premedication,1,I,EXP,granisetron,21,C,Vomiting,21,F,HO,2
175680451,1,Ovarian cancer,1,I,EXP,trametinib,1,PS,Intestinal obstruction,1,F,HO,4
175680451,1,Ovarian cancer,1,I,EXP,trametinib,1,PS,Intestinal obstruction,1,F,OT,4
175680451,1,Ovarian cancer,1,I,EXP,trametinib,1,PS,Vomiting,1,F,HO,4
175680451,1,Ovarian cancer,1,I,EXP,trametinib,1,PS,Vomiting,1,F,OT,4
175683111,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Respiratory syncytial virus infection,2,F,HO,620
175683111,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Rhinovirus infection,2,F,HO,620
175683111,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Upper respiratory tract infection,2,F,HO,620
175683262,2,Plasma cell myeloma,2,F,EXP,thalidomide,2,C,Corona virus infection,2,M,HO,467
175683761,1,Bladder cancer,1,I,EXP,avelumab,1,SS,Retroperitoneal haemorrhage,1,M,HO,927
175683761,1,Bladder cancer,1,I,EXP,avelumab,1,SS,Retroperitoneal haemorrhage,1,M,DE,927
175683761,1,Bladder cancer,1,I,EXP,avelumab,1,SS,Shock haemorrhagic,1,M,HO,927
175683761,1,Bladder cancer,1,I,EXP,avelumab,1,SS,Shock haemorrhagic,1,M,DE,927
175683781,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,PS,Respiratory failure,3,F,OT,13
175683781,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,PS,Respiratory failure,3,F,HO,13
175683781,4,Renal cell carcinoma,1,I,EXP,nivolumab,4,SS,Respiratory failure,4,F,OT,13
175683781,4,Renal cell carcinoma,1,I,EXP,nivolumab,4,SS,Respiratory failure,4,F,HO,13
175684601,1,Hodgkin's disease stage III,1,I,EXP,brentuximab vedotin,1,PS,Neutrophil count decreased,1,F,OT,13
175685362,2,Plasma cell myeloma,2,F,EXP,carfilzomib,2,SS,Haemolysis,2,F,OT,167
175685362,2,Plasma cell myeloma,2,F,EXP,carfilzomib,2,SS,Haemolysis,2,F,HO,167
175685362,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Haemolysis,3,F,OT,167
175685362,3,Plasma cell myeloma,2,F,EXP,lenalidomide,3,SS,Haemolysis,3,F,HO,167
175686541,2,Plasma cell myeloma recurrent,1,I,EXP,daratumumab,2,SS,Plasma cell myeloma,2,F,OT,14
175687901,34,Prophylaxis,1,I,EXP,granisetron,34,C,Constipation,34,M,HO,20
175687901,34,Prophylaxis,1,I,EXP,granisetron,34,C,Constipation,34,M,OT,20
175687901,34,Prophylaxis,1,I,EXP,granisetron,34,C,Dyspnoea,34,M,HO,20
175687901,34,Prophylaxis,1,I,EXP,granisetron,34,C,Dyspnoea,34,M,OT,20
175687901,34,Prophylaxis,1,I,EXP,granisetron,34,C,Neutropenia,34,M,HO,20
175687901,34,Prophylaxis,1,I,EXP,granisetron,34,C,Neutropenia,34,M,OT,20
175687901,34,Prophylaxis,1,I,EXP,granisetron,34,C,Oedema,34,M,HO,20
175687901,34,Prophylaxis,1,I,EXP,granisetron,34,C,Oedema,34,M,OT,20
175687901,34,Prophylaxis,1,I,EXP,granisetron,34,C,Polyneuropathy,34,M,HO,20
175687901,34,Prophylaxis,1,I,EXP,granisetron,34,C,Polyneuropathy,34,M,OT,20
175687901,34,Prophylaxis,1,I,EXP,granisetron,34,C,Polyuria,34,M,HO,20
175687901,34,Prophylaxis,1,I,EXP,granisetron,34,C,Polyuria,34,M,OT,20
175687901,34,Prophylaxis,1,I,EXP,granisetron,34,C,Transient ischaemic attack,34,M,HO,20
175687901,34,Prophylaxis,1,I,EXP,granisetron,34,C,Transient ischaemic attack,34,M,OT,20
175688111,2,Prophylaxis,1,I,EXP,filgrastim,2,SS,Toxic skin eruption,2,M,OT,1
175688311,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Urinary retention,1,M,HO,4
175693331,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Chest pain,1,M,OT,1
175693331,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Cough,1,M,OT,1
175693331,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,1
175693331,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Dermatitis allergic,1,M,OT,1
175693331,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Diarrhoea,1,M,OT,1
175693331,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Fatigue,1,M,OT,1
175693331,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Folliculitis,1,M,OT,1
175693331,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Headache,1,M,OT,1
175693331,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Lymphadenopathy,1,M,OT,1
175693331,1,Renal cancer,1,I,EXP,nivolumab,1,PS,Myalgia,1,M,OT,1
175693631,1,Lung adenocarcinoma,1,I,EXP,nivolumab,1,PS,Chronic kidney disease,1,M,OT,2
175693631,1,Lung adenocarcinoma,1,I,EXP,nivolumab,1,PS,Condition aggravated,1,M,OT,2
175693631,1,Lung adenocarcinoma,1,I,EXP,nivolumab,1,PS,Hyponatraemia,1,M,OT,2
175694531,2,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,2,SS,Atrial fibrillation,2,F,HO,128
175696682,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Intestinal pseudo-obstruction,1,F,HO,35
175696682,1,Malignant melanoma,2,F,EXP,nivolumab,1,PS,Intestinal pseudo-obstruction,1,F,OT,35
175696682,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Intestinal pseudo-obstruction,2,F,HO,35
175696682,2,Malignant melanoma,2,F,EXP,ipilimumab,2,SS,Intestinal pseudo-obstruction,2,F,OT,35
175699011,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Anaemia,1,M,HO,23
175699011,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,23
175699011,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Ear infection,1,M,HO,23
175699011,1,Squamous cell carcinoma of head and neck,1,I,EXP,nivolumab,1,PS,Prescribed underdose,1,M,HO,23
175700891,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,190
175700891,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,190
175700891,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,190
175700891,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Vomiting,1,F,OT,190
175700891,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Vomiting,1,F,HO,190
175700891,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Vomiting,1,F,DE,190
175701051,1,Waldenstrom's macroglobulinaemia,1,I,EXP,ibrutinib,1,PS,Escherichia pyelonephritis,1,F,HO,1420
175704611,2,Metastatic malignant melanoma,1,I,EXP,nivolumab,2,PS,Bacteraemia,2,F,OT,9
175704611,2,Metastatic malignant melanoma,1,I,EXP,nivolumab,2,PS,Bacteraemia,2,F,HO,9
175704611,2,Metastatic malignant melanoma,1,I,EXP,nivolumab,2,PS,Bacteraemia,2,F,LT,9
175704611,2,Metastatic malignant melanoma,1,I,EXP,nivolumab,2,PS,Fistula,2,F,OT,9
175704611,2,Metastatic malignant melanoma,1,I,EXP,nivolumab,2,PS,Fistula,2,F,HO,9
175704611,2,Metastatic malignant melanoma,1,I,EXP,nivolumab,2,PS,Fistula,2,F,LT,9
175704611,2,Metastatic malignant melanoma,1,I,EXP,nivolumab,2,PS,Intestinal perforation,2,F,OT,9
175704611,2,Metastatic malignant melanoma,1,I,EXP,nivolumab,2,PS,Intestinal perforation,2,F,HO,9
175704611,2,Metastatic malignant melanoma,1,I,EXP,nivolumab,2,PS,Intestinal perforation,2,F,LT,9
175705301,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Pneumonia,1,M,OT,7
175705301,1,Malignant melanoma,1,I,EXP,ipilimumab,1,PS,Pneumonia,1,M,HO,7
175706781,5,Gastrooesophageal cancer,1,I,EXP,avelumab,5,SS,Splenic abscess,5,M,OT,180
175706781,5,Gastrooesophageal cancer,1,I,EXP,avelumab,5,SS,Splenic abscess,5,M,HO,180
175706951,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Abdominal discomfort,1,M,OT,36
175706951,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Anaemia,1,M,OT,36
175706951,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,36
175706951,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Back pain,1,M,OT,36
175706951,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Blood thyroid stimulating hormone decreased,1,M,OT,36
175706951,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Decreased appetite,1,M,OT,36
175706951,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Fatigue,1,M,OT,36
175706951,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Nephritis,1,M,OT,36
175706951,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Renal impairment,1,M,OT,36
175706951,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Seizure,1,M,OT,36
175706951,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Taste disorder,1,M,OT,36
175706951,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Thyroxine increased,1,M,OT,36
175706951,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Tremor,1,M,OT,36
175706951,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Tri-iodothyronine increased,1,M,OT,36
175707271,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Anaemia,1,M,HO,8
175707511,2,Breast cancer metastatic,1,I,EXP,alpelisib,2,SS,Hyperglycaemia,2,F,OT,10
175707511,2,Breast cancer metastatic,1,I,EXP,alpelisib,2,SS,Rash,2,F,OT,10
175707942,3,Neutropenia,2,F,EXP,filgrastim,3,C,Laryngitis,3,M,DS,188
175710811,1,Gastric cancer,1,I,EXP,nivolumab,1,SS,Dermatitis allergic,1,M,HO,4
175710811,2,Gastric cancer,1,I,EXP,ipilimumab,2,PS,Dermatitis allergic,2,M,HO,4
175712191,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Cytomegalovirus infection,2,F,HO,223
175712191,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Cytomegalovirus infection,2,F,LT,223
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Asthenia,2,F,OT,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Asthenia,2,F,LT,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Asthenia,2,F,HO,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Blood potassium decreased,2,F,OT,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Blood potassium decreased,2,F,LT,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Blood potassium decreased,2,F,HO,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Bone marrow failure,2,F,OT,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Bone marrow failure,2,F,LT,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Bone marrow failure,2,F,HO,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,C-reactive protein increased,2,F,OT,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,C-reactive protein increased,2,F,LT,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,C-reactive protein increased,2,F,HO,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Full blood count decreased,2,F,OT,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Full blood count decreased,2,F,LT,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Full blood count decreased,2,F,HO,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Haematochezia,2,F,OT,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Haematochezia,2,F,LT,7
175712311,2,Lymphocytic leukaemia,1,I,EXP,pegaspargase,2,SS,Haematochezia,2,F,HO,7
175712921,4,Plasma cell myeloma,1,I,EXP,pomalidomide,4,SS,Hypogammaglobulinaemia,4,F,OT,28
175712921,4,Plasma cell myeloma,1,I,EXP,pomalidomide,4,SS,Off label use,4,F,OT,28
175712921,4,Plasma cell myeloma,1,I,EXP,pomalidomide,4,SS,Peripheral sensory neuropathy,4,F,OT,28
175712921,4,Plasma cell myeloma,1,I,EXP,pomalidomide,4,SS,Respiratory tract infection,4,F,OT,28
175714281,1,Breast cancer male,1,I,EXP,palbociclib,1,PS,Anaemia,1,M,HO,30
175714281,1,Breast cancer male,1,I,EXP,palbociclib,1,PS,Anaemia,1,M,LT,30
175714281,1,Breast cancer male,1,I,EXP,palbociclib,1,PS,Anaemia,1,M,OT,30
175714281,1,Breast cancer male,1,I,EXP,palbociclib,1,PS,Leukopenia,1,M,HO,30
175714281,1,Breast cancer male,1,I,EXP,palbociclib,1,PS,Leukopenia,1,M,LT,30
175714281,1,Breast cancer male,1,I,EXP,palbociclib,1,PS,Leukopenia,1,M,OT,30
175714281,1,Breast cancer male,1,I,EXP,palbociclib,1,PS,Pancytopenia,1,M,HO,30
175714281,1,Breast cancer male,1,I,EXP,palbociclib,1,PS,Pancytopenia,1,M,LT,30
175714281,1,Breast cancer male,1,I,EXP,palbociclib,1,PS,Pancytopenia,1,M,OT,30
175714281,1,Breast cancer male,1,I,EXP,palbociclib,1,PS,Thrombocytopenia,1,M,HO,30
175714281,1,Breast cancer male,1,I,EXP,palbociclib,1,PS,Thrombocytopenia,1,M,LT,30
175714281,1,Breast cancer male,1,I,EXP,palbociclib,1,PS,Thrombocytopenia,1,M,OT,30
175714821,2,Gastrooesophageal cancer,1,I,EXP,avelumab,2,SS,Pneumonia,2,M,HO,50
175714821,2,Gastrooesophageal cancer,1,I,EXP,avelumab,2,SS,Splenic abscess,2,M,HO,50
175728231,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,C,Pneumonia,2,F,OT,40
175728231,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,C,Pneumonia,2,F,HO,40
175728301,6,Plasma cell myeloma,1,I,PER,carfilzomib,6,SS,Pneumonia,6,M,HO,1416
175728811,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Cerebral haemorrhage,1,M,DE,145
175728811,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Cerebral haemorrhage,1,M,LT,145
175728811,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Subdural haematoma,1,M,DE,145
175728811,1,Myelodysplastic syndrome,1,I,PER,darbepoetin alfa,1,PS,Subdural haematoma,1,M,LT,145
175732081,2,Gastric cancer,1,I,EXP,ramucirumab,2,SS,Pneumonitis,2,F,HO,64
175732081,2,Gastric cancer,1,I,EXP,ramucirumab,2,SS,Pulmonary embolism,2,F,HO,64
175741752,8,Tumour lysis syndrome,2,F,EXP,rasburicase,8,C,Death,8,M,DE,26
175743281,2,Product used for unknown indication,1,I,EXP,palbociclib,2,SS,Lung neoplasm malignant,2,F,OT,437
175743281,2,Product used for unknown indication,1,I,EXP,palbociclib,2,SS,Second primary malignancy,2,F,OT,437
175751531,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Cytomegalovirus gastroenteritis,2,F,HO,209
175751531,4,Plasma cell myeloma,1,I,EXP,daratumumab,4,SS,Cytomegalovirus gastroenteritis,4,F,HO,209
175752711,3,Plasma cell myeloma,1,I,EXP,pomalidomide,3,SS,Asthenia,3,F,HO,7
175752711,3,Plasma cell myeloma,1,I,EXP,pomalidomide,3,SS,Constipation,3,F,HO,7
175752711,3,Plasma cell myeloma,1,I,EXP,pomalidomide,3,SS,Fatigue,3,F,HO,7
175752711,3,Plasma cell myeloma,1,I,EXP,pomalidomide,3,SS,Pneumonia,3,F,HO,7
175755041,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Lung disorder,1,M,HO,243
175755041,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Lung disorder,1,M,OT,243
175755041,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Lung disorder,3,M,HO,243
175755041,3,Plasma cell myeloma,1,I,PER,lenalidomide,3,SS,Lung disorder,3,M,OT,243
175756061,3,Plasma cell myeloma,1,I,EXP,nivolumab,3,SS,Second primary malignancy,3,M,OT,648
175756061,5,Plasma cell myeloma,1,I,EXP,daratumumab,5,SS,Second primary malignancy,5,M,OT,662
175756882,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Blood bilirubin,1,F,HO,51
175756882,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Blood bilirubin,1,F,OT,51
175756882,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Blood bilirubin,1,F,DE,51
175756882,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Liver function test increased,1,F,HO,51
175756882,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Liver function test increased,1,F,OT,51
175756882,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Liver function test increased,1,F,DE,51
175756882,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,51
175756882,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,51
175756882,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,51
175756882,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,HO,51
175756882,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,OT,51
175756882,1,Breast cancer metastatic,2,F,EXP,nivolumab,1,PS,Thrombocytopenia,1,F,DE,51
175757911,5,Acute lymphocytic leukaemia,1,I,PER,inotuzumab ozogamicin,5,SS,Aphasia,5,M,HO,106
175759761,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Asthenia,1,M,OT,73
175759761,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Bone pain,1,M,OT,73
175759761,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Fatigue,1,M,OT,73
175759761,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Seizure,1,M,OT,73
175759761,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Vomiting,1,M,OT,73
175760551,28,Product used for unknown indication,1,I,EXP,denosumab,28,C,Pneumonia,28,F,OT,1410
175760551,28,Product used for unknown indication,1,I,EXP,denosumab,28,C,Pneumonitis,28,F,OT,1410
175760551,28,Product used for unknown indication,1,I,EXP,denosumab,28,C,Pulmonary embolism,28,F,OT,1410
175760962,1,Breast cancer,2,F,EXP,palbociclib,1,PS,Dizziness,1,F,HO,545
175760962,1,Breast cancer,2,F,EXP,palbociclib,1,PS,Headache,1,F,HO,545
175761841,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Joint swelling,1,F,HO,2
175762141,4,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,4,SS,Bacteraemia,4,F,HO,39
175762141,4,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,4,SS,Encephalitis fungal,4,F,HO,39
175762141,4,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,4,SS,Encephalopathy,4,F,HO,39
175762141,4,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,4,SS,Neutropenic colitis,4,F,HO,39
175762182,1,Prostate cancer,2,F,EXP,avelumab,1,PS,Acute kidney injury,1,M,LT,1
175762182,1,Prostate cancer,2,F,EXP,avelumab,1,PS,Acute kidney injury,1,M,DE,1
175762182,1,Prostate cancer,2,F,EXP,avelumab,1,PS,Acute kidney injury,1,M,HO,1
175762182,1,Prostate cancer,2,F,EXP,avelumab,1,PS,Dehydration,1,M,LT,1
175762182,1,Prostate cancer,2,F,EXP,avelumab,1,PS,Dehydration,1,M,DE,1
175762182,1,Prostate cancer,2,F,EXP,avelumab,1,PS,Dehydration,1,M,HO,1
175762182,1,Prostate cancer,2,F,EXP,avelumab,1,PS,Diarrhoea,1,M,LT,1
175762182,1,Prostate cancer,2,F,EXP,avelumab,1,PS,Diarrhoea,1,M,DE,1
175762182,1,Prostate cancer,2,F,EXP,avelumab,1,PS,Diarrhoea,1,M,HO,1
175762182,1,Prostate cancer,2,F,EXP,avelumab,1,PS,Pancytopenia,1,M,LT,1
175762182,1,Prostate cancer,2,F,EXP,avelumab,1,PS,Pancytopenia,1,M,DE,1
175762182,1,Prostate cancer,2,F,EXP,avelumab,1,PS,Pancytopenia,1,M,HO,1
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Acute myocardial infarction,2,M,OT,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Acute myocardial infarction,2,M,HO,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Acute myocardial infarction,2,M,LT,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Atrioventricular block complete,2,M,OT,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Atrioventricular block complete,2,M,HO,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Atrioventricular block complete,2,M,LT,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Dysphagia,2,M,OT,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Dysphagia,2,M,HO,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Dysphagia,2,M,LT,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,General physical health deterioration,2,M,OT,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,General physical health deterioration,2,M,HO,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,General physical health deterioration,2,M,LT,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Hypertensive crisis,2,M,OT,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Hypertensive crisis,2,M,HO,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Hypertensive crisis,2,M,LT,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Myalgia,2,M,OT,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Myalgia,2,M,HO,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Myalgia,2,M,LT,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Off label use,2,M,OT,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Off label use,2,M,HO,14
175769061,2,Uveal melanoma,1,I,EXP,nivolumab,2,SS,Off label use,2,M,LT,14
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Arthralgia,1,F,OT,1
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Back pain,1,F,OT,1
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Constipation,1,F,OT,1
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Diarrhoea,1,F,OT,1
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Dizziness,1,F,OT,1
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Ear pain,1,F,OT,1
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Erythema,1,F,OT,1
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Influenza like illness,1,F,OT,1
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Malaise,1,F,OT,1
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Ocular hyperaemia,1,F,OT,1
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Oral pain,1,F,OT,1
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,OT,1
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Paraesthesia,1,F,OT,1
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Pollakiuria,1,F,OT,1
175769681,1,Osteoporosis prophylaxis,1,I,EXP,zoledronic acid,1,PS,Pruritus,1,F,OT,1
175770891,6,Glioma,1,I,EXP,nilotinib,6,SS,Aspartate aminotransferase increased,6,F,OT,42
175770891,6,Glioma,1,I,EXP,nilotinib,6,SS,Astrocytoma,6,F,OT,42
175770891,6,Glioma,1,I,EXP,nilotinib,6,SS,Blood creatinine increased,6,F,OT,42
175770891,6,Glioma,1,I,EXP,nilotinib,6,SS,Blood lactate dehydrogenase increased,6,F,OT,42
175770891,6,Glioma,1,I,EXP,nilotinib,6,SS,Drug hypersensitivity,6,F,OT,42
175770891,6,Glioma,1,I,EXP,nilotinib,6,SS,Drug ineffective,6,F,OT,42
175770891,6,Glioma,1,I,EXP,nilotinib,6,SS,Malignant neoplasm progression,6,F,OT,42
175770891,6,Glioma,1,I,EXP,nilotinib,6,SS,Neoplasm progression,6,F,OT,42
175770891,6,Glioma,1,I,EXP,nilotinib,6,SS,Visual impairment,6,F,OT,42
175772941,5,Chronic myeloid leukaemia,1,I,EXP,bosutinib,5,C,Acute kidney injury,5,F,HO,553
175772941,5,Chronic myeloid leukaemia,1,I,EXP,bosutinib,5,C,Drug interaction,5,F,HO,553
175775831,7,Pelvic neoplasm,1,I,EXP,panitumumab,7,SS,Interstitial lung disease,7,M,DE,47
175778091,1,Colorectal cancer,1,I,EXP,nivolumab,1,SS,Bile duct stenosis,1,M,OT,54
175778091,1,Colorectal cancer,1,I,EXP,nivolumab,1,SS,Bile duct stenosis,1,M,HO,54
175778091,3,Colorectal cancer,1,I,EXP,ipilimumab,3,PS,Bile duct stenosis,3,M,OT,54
175778091,3,Colorectal cancer,1,I,EXP,ipilimumab,3,PS,Bile duct stenosis,3,M,HO,54
175779751,3,Neoplasm,1,I,EXP,avelumab,3,SS,Constipation,3,M,HO,2
175780821,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Anaemia,3,F,OT,13
175780821,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Diarrhoea,3,F,OT,13
175780821,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Fatigue,3,F,OT,13
175780821,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Gastrooesophageal reflux disease,3,F,OT,13
175780821,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Hypertension,3,F,OT,13
175780821,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Mucosal inflammation,3,F,OT,13
175780821,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Pain,3,F,OT,13
175780821,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Rash,3,F,OT,13
175780821,3,Product used for unknown indication,1,I,EXP,palbociclib,3,SS,Thrombocytopenia,3,F,OT,13
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Hyponatraemia,1,F,HO,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Hyponatraemia,1,F,OT,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Hyponatraemia,1,F,LT,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Hyponatraemia,1,F,DE,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Hypothalamo-pituitary disorder,1,F,HO,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Hypothalamo-pituitary disorder,1,F,OT,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Hypothalamo-pituitary disorder,1,F,LT,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Hypothalamo-pituitary disorder,1,F,DE,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,HO,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,OT,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,LT,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Malignant neoplasm progression,1,F,DE,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,F,HO,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,F,OT,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,F,LT,19
175780901,1,Hodgkin's disease,1,I,EXP,nivolumab,1,PS,Type 1 diabetes mellitus,1,F,DE,19
175781512,1,Plasma cell myeloma,2,F,EXP,thalidomide,1,PS,Conduction disorder,1,F,HO,2
175783441,8,Prophylaxis,1,I,EXP,filgrastim,8,SS,Toxic skin eruption,8,M,OT,1
175784161,4,Prophylaxis,1,I,EXP,filgrastim,4,SS,Toxic skin eruption,4,M,OT,1
175788271,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Death,2,F,DE,119
175788271,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Diarrhoea,2,F,DE,119
175788271,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Off label use,2,F,DE,119
175788271,2,Plasma cell myeloma,1,I,EXP,lenalidomide,2,SS,Skin lesion,2,F,DE,119
175789561,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Sjogren's syndrome,1,M,OT,102
175789561,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Sjogren's syndrome,1,M,HO,102
175789561,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Sjogren's syndrome,2,M,OT,102
175789561,2,Renal cell carcinoma,1,I,EXP,ipilimumab,2,SS,Sjogren's syndrome,2,M,HO,102
175789711,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Sepsis,1,F,OT,118
175789711,1,Uveal melanoma,1,I,EXP,nivolumab,1,PS,Sepsis,1,F,HO,118
175789711,2,Uveal melanoma,1,I,EXP,ipilimumab,2,SS,Sepsis,2,F,OT,118
175789711,2,Uveal melanoma,1,I,EXP,ipilimumab,2,SS,Sepsis,2,F,HO,118
175791651,1,Squamous cell carcinoma of the oral cavity,1,I,EXP,nivolumab,1,PS,Dry eye,1,M,OT,52
175791651,1,Squamous cell carcinoma of the oral cavity,1,I,EXP,nivolumab,1,PS,Off label use,1,M,OT,52
175791651,1,Squamous cell carcinoma of the oral cavity,1,I,EXP,nivolumab,1,PS,Vision blurred,1,M,OT,52
175795631,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Hyperpyrexia,1,F,HO,1
175795631,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,Platelet count decreased,1,F,HO,1
175795631,1,Breast cancer,1,I,EXP,zoledronic acid,1,PS,White blood cell count decreased,1,F,HO,1
175812182,2,Plasma cell myeloma,2,F,PER,daratumumab,2,SS,Neuropathy peripheral,2,F,OT,329
175813431,3,Acute lymphocytic leukaemia,1,I,EXP,inotuzumab ozogamicin,3,SS,Aphasia,3,M,HO,136
175813461,54,Neutropenia,1,I,EXP,filgrastim,54,C,Cardiac arrest,54,F,DE,9
175813461,54,Neutropenia,1,I,EXP,filgrastim,54,C,Cardiac arrest,54,F,HO,9
175813461,54,Neutropenia,1,I,EXP,filgrastim,54,C,Cardiac arrest,54,F,LT,9
175813461,54,Neutropenia,1,I,EXP,filgrastim,54,C,Encephalitis,54,F,DE,9
175813461,54,Neutropenia,1,I,EXP,filgrastim,54,C,Encephalitis,54,F,HO,9
175813461,54,Neutropenia,1,I,EXP,filgrastim,54,C,Encephalitis,54,F,LT,9
175813461,54,Neutropenia,1,I,EXP,filgrastim,54,C,Lethargy,54,F,DE,9
175813461,54,Neutropenia,1,I,EXP,filgrastim,54,C,Lethargy,54,F,HO,9
175813461,54,Neutropenia,1,I,EXP,filgrastim,54,C,Lethargy,54,F,LT,9
175813461,54,Neutropenia,1,I,EXP,filgrastim,54,C,Meningitis cryptococcal,54,F,DE,9
175813461,54,Neutropenia,1,I,EXP,filgrastim,54,C,Meningitis cryptococcal,54,F,HO,9
175813461,54,Neutropenia,1,I,EXP,filgrastim,54,C,Meningitis cryptococcal,54,F,LT,9
175815861,15,Prophylaxis,1,I,EXP,granisetron,15,C,Cellulitis,15,M,HO,10
175817841,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Atrial fibrillation,2,M,HO,291
175817841,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Atrial fibrillation,4,M,HO,199
175824701,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Cardiac failure,1,M,HO,1923
175824701,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Ejection fraction decreased,1,M,HO,1923
175824701,1,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,1,PS,Skin infection,1,M,HO,1923
175824711,1,Colorectal cancer,1,I,EXP,nivolumab,1,PS,Intestinal operation,1,M,HO,62
175824711,2,Colorectal cancer metastatic,1,I,EXP,ipilimumab,2,SS,Intestinal operation,2,M,HO,62
175827901,56,Neutropenia,1,I,EXP,filgrastim,56,C,Cardiac arrest,56,F,DE,374
175827901,56,Neutropenia,1,I,EXP,filgrastim,56,C,Cardiac arrest,56,F,LT,374
175827901,56,Neutropenia,1,I,EXP,filgrastim,56,C,Cardiac arrest,56,F,HO,374
175827901,56,Neutropenia,1,I,EXP,filgrastim,56,C,Lethargy,56,F,DE,374
175827901,56,Neutropenia,1,I,EXP,filgrastim,56,C,Lethargy,56,F,LT,374
175827901,56,Neutropenia,1,I,EXP,filgrastim,56,C,Lethargy,56,F,HO,374
175827901,56,Neutropenia,1,I,EXP,filgrastim,56,C,Meningitis cryptococcal,56,F,DE,374
175827901,56,Neutropenia,1,I,EXP,filgrastim,56,C,Meningitis cryptococcal,56,F,LT,374
175827901,56,Neutropenia,1,I,EXP,filgrastim,56,C,Meningitis cryptococcal,56,F,HO,374
175831442,1,Head and neck cancer,2,F,EXP,nivolumab,1,PS,Lymphadenitis,1,F,HO,258
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Ascites,1,M,OT,19
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Ascites,1,M,DE,19
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Ascites,1,M,HO,19
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,OT,19
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,DE,19
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Death,1,M,HO,19
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Mucosal inflammation,1,M,OT,19
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Mucosal inflammation,1,M,DE,19
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Mucosal inflammation,1,M,HO,19
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Pleural effusion,1,M,OT,19
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Pleural effusion,1,M,DE,19
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Pleural effusion,1,M,HO,19
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,OT,19
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,DE,19
175832751,1,Gastric cancer,1,I,EXP,nivolumab,1,PS,Pulmonary embolism,1,M,HO,19
175832782,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,General physical health deterioration,1,F,HO,13
175832782,2,Plasma cell myeloma,2,F,PER,lenalidomide,2,SS,General physical health deterioration,2,F,HO,13
175834321,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Myasthenia gravis,1,F,HO,411
175834321,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Myasthenia gravis,1,F,LT,411
175834321,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Myasthenia gravis,1,F,OT,411
175834321,1,Renal cell carcinoma,1,I,EXP,nivolumab,1,PS,Myasthenia gravis,1,F,DE,411
175834321,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Myasthenia gravis,2,F,HO,75
175834321,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Myasthenia gravis,2,F,LT,75
175834321,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Myasthenia gravis,2,F,OT,75
175834321,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Myasthenia gravis,2,F,DE,75
175834321,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Myasthenia gravis,3,F,HO,411
175834321,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Myasthenia gravis,3,F,LT,411
175834321,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Myasthenia gravis,3,F,OT,411
175834321,3,Renal cell carcinoma,1,I,EXP,ipilimumab,3,SS,Myasthenia gravis,3,F,DE,411
175834321,4,Product used for unknown indication,1,I,EXP,ipilimumab,4,SS,Myasthenia gravis,4,F,HO,75
175834321,4,Product used for unknown indication,1,I,EXP,ipilimumab,4,SS,Myasthenia gravis,4,F,LT,75
175834321,4,Product used for unknown indication,1,I,EXP,ipilimumab,4,SS,Myasthenia gravis,4,F,OT,75
175834321,4,Product used for unknown indication,1,I,EXP,ipilimumab,4,SS,Myasthenia gravis,4,F,DE,75
175834392,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Sialoadenitis,1,F,HO,3
175834392,1,Colorectal cancer,2,F,EXP,nivolumab,1,PS,Sialoadenitis,1,F,OT,3
175835872,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Dyspnoea,1,F,OT,183
175835872,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Dyspnoea,1,F,HO,183
175835872,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Hypoxia,1,F,OT,183
175835872,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Hypoxia,1,F,HO,183
175835872,4,Plasma cell myeloma,2,F,PER,pomalidomide,4,SS,Dyspnoea,4,F,OT,183
175835872,4,Plasma cell myeloma,2,F,PER,pomalidomide,4,SS,Dyspnoea,4,F,HO,183
175835872,4,Plasma cell myeloma,2,F,PER,pomalidomide,4,SS,Hypoxia,4,F,OT,183
175835872,4,Plasma cell myeloma,2,F,PER,pomalidomide,4,SS,Hypoxia,4,F,HO,183
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Biliary tract infection,1,M,HO,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Biliary tract infection,1,M,OT,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,HO,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,C-reactive protein increased,1,M,OT,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Cholangitis,1,M,HO,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Cholangitis,1,M,OT,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Fatigue,1,M,HO,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Fatigue,1,M,OT,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,HO,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Hepatic enzyme increased,1,M,OT,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,HO,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Hyperglycaemia,1,M,OT,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Infection,1,M,HO,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Infection,1,M,OT,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Pyrexia,1,M,HO,23
175836411,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Pyrexia,1,M,OT,23
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Biliary tract infection,2,M,HO,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Biliary tract infection,2,M,OT,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,C-reactive protein increased,2,M,HO,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,C-reactive protein increased,2,M,OT,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Cholangitis,2,M,HO,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Cholangitis,2,M,OT,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Fatigue,2,M,HO,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Fatigue,2,M,OT,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Hepatic enzyme increased,2,M,HO,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Hepatic enzyme increased,2,M,OT,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Hyperglycaemia,2,M,HO,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Hyperglycaemia,2,M,OT,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Infection,2,M,HO,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Infection,2,M,OT,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Pyrexia,2,M,HO,9
175836411,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Pyrexia,2,M,OT,9
175836461,6,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,6,SS,Liver injury,6,M,HO,11
175836461,6,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,6,SS,Purpura,6,M,HO,11
175836461,6,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,6,SS,Rash erythematous,6,M,HO,11
175836461,6,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,6,SS,Thrombocytopenia,6,M,HO,11
175837551,2,Mesothelioma,1,I,EXP,pemetrexed disodium,2,SS,Cardio-respiratory arrest,2,M,HO,42
175837551,2,Mesothelioma,1,I,EXP,pemetrexed disodium,2,SS,Cardio-respiratory arrest,2,M,OT,42
175841061,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Appetite disorder,1,M,OT,90
175841061,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,90
175841061,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Enteritis,1,M,OT,90
175841061,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Fatigue,1,M,OT,90
175841061,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Malaise,1,M,OT,90
175841061,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Pain,1,M,OT,90
175841061,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Somnolence,1,M,OT,90
175841061,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Appetite disorder,2,M,OT,118
175841061,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Dyspnoea,2,M,OT,118
175841061,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Enteritis,2,M,OT,118
175841061,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Fatigue,2,M,OT,118
175841061,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Malaise,2,M,OT,118
175841061,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Pain,2,M,OT,118
175841061,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Somnolence,2,M,OT,118
175841771,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Pneumonia,1,F,HO,329
175841771,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Pneumonia,1,F,DE,329
175841801,1,Plasma cell myeloma,1,I,EXP,selinexor,1,PS,Pneumonia,1,F,HO,24
175841801,3,Plasma cell myeloma,1,I,EXP,pomalidomide,3,SS,Pneumonia,3,F,HO,24
175847011,2,Mantle cell lymphoma,1,I,EXP,lenalidomide,2,C,Abdominal infection,2,M,HO,87
175848252,3,Breast cancer metastatic,2,F,EXP,denosumab,3,SS,Cellulitis,3,F,HO,36
175848252,3,Breast cancer metastatic,2,F,EXP,denosumab,3,SS,Cerebrovascular accident,3,F,HO,36
175848252,3,Breast cancer metastatic,2,F,EXP,denosumab,3,SS,Ejection fraction decreased,3,F,HO,36
175848252,3,Breast cancer metastatic,2,F,EXP,denosumab,3,SS,Hypertension,3,F,HO,36
175848252,4,Breast cancer metastatic,2,F,EXP,denosumab,4,SS,Cellulitis,4,F,HO,33
175848252,4,Breast cancer metastatic,2,F,EXP,denosumab,4,SS,Cerebrovascular accident,4,F,HO,33
175848252,4,Breast cancer metastatic,2,F,EXP,denosumab,4,SS,Ejection fraction decreased,4,F,HO,33
175848252,4,Breast cancer metastatic,2,F,EXP,denosumab,4,SS,Hypertension,4,F,HO,33
175848461,1,Breast cancer,1,I,EXP,palbociclib,1,PS,Bone marrow failure,1,F,HO,303
175852241,2,Breast cancer metastatic,1,I,EXP,palbociclib,2,SS,Pain,2,F,HO,68
175852431,5,Neutropenia,1,I,EXP,filgrastim,5,C,Neutrophil count decreased,5,M,HO,21
175852431,5,Neutropenia,1,I,EXP,filgrastim,5,C,White blood cell count decreased,5,M,HO,21
175852431,6,Prophylaxis,1,I,EXP,filgrastim,6,C,Neutrophil count decreased,6,M,HO,6
175852431,6,Prophylaxis,1,I,EXP,filgrastim,6,C,White blood cell count decreased,6,M,HO,6
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Abscess fungal,5,F,HO,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Abscess fungal,5,F,OT,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Aspergillus infection,5,F,HO,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Aspergillus infection,5,F,OT,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Clostridium test positive,5,F,HO,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Clostridium test positive,5,F,OT,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Colitis,5,F,HO,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Colitis,5,F,OT,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Encephalitis fungal,5,F,HO,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Encephalitis fungal,5,F,OT,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Encephalopathy,5,F,HO,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Encephalopathy,5,F,OT,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Escherichia bacteraemia,5,F,HO,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Escherichia bacteraemia,5,F,OT,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Febrile neutropenia,5,F,HO,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Febrile neutropenia,5,F,OT,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Movement disorder,5,F,HO,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Movement disorder,5,F,OT,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Neutropenic colitis,5,F,HO,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Neutropenic colitis,5,F,OT,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Toxicity to various agents,5,F,HO,39
175853291,5,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,5,SS,Toxicity to various agents,5,F,OT,39
175856941,6,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,6,SS,Hypotension,6,M,HO,31
175856941,6,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,6,SS,Hypotension,6,M,OT,31
175856941,6,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,6,SS,Pancreatitis,6,M,HO,31
175856941,6,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,6,SS,Pancreatitis,6,M,OT,31
175856941,6,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,6,SS,Sinus tachycardia,6,M,HO,31
175856941,6,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,6,SS,Sinus tachycardia,6,M,OT,31
175857901,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Fatigue,1,F,OT,44
175857901,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Myalgia,1,F,OT,44
175857901,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Rhabdomyolysis,1,F,OT,44
175858862,16,White blood cell count decreased,2,F,EXP,filgrastim,16,C,Liver disorder,16,M,HO,14
175859821,6,Plasma cell myeloma,1,I,EXP,pomalidomide,6,SS,Asthenia,6,M,OT,2046
175859821,6,Plasma cell myeloma,1,I,EXP,pomalidomide,6,SS,Asthenia,6,M,HO,2046
175859821,6,Plasma cell myeloma,1,I,EXP,pomalidomide,6,SS,Pyrexia,6,M,OT,2046
175859821,6,Plasma cell myeloma,1,I,EXP,pomalidomide,6,SS,Pyrexia,6,M,HO,2046
175859821,7,Product used for unknown indication,1,I,EXP,pomalidomide,7,SS,Asthenia,7,M,OT,1490
175859821,7,Product used for unknown indication,1,I,EXP,pomalidomide,7,SS,Asthenia,7,M,HO,1490
175859821,7,Product used for unknown indication,1,I,EXP,pomalidomide,7,SS,Pyrexia,7,M,OT,1490
175859821,7,Product used for unknown indication,1,I,EXP,pomalidomide,7,SS,Pyrexia,7,M,HO,1490
175859821,8,Product used for unknown indication,1,I,EXP,pomalidomide,8,SS,Asthenia,8,M,OT,1338
175859821,8,Product used for unknown indication,1,I,EXP,pomalidomide,8,SS,Asthenia,8,M,HO,1338
175859821,8,Product used for unknown indication,1,I,EXP,pomalidomide,8,SS,Pyrexia,8,M,OT,1338
175859821,8,Product used for unknown indication,1,I,EXP,pomalidomide,8,SS,Pyrexia,8,M,HO,1338
175859821,9,Product used for unknown indication,1,I,EXP,pomalidomide,9,SS,Asthenia,9,M,OT,1301
175859821,9,Product used for unknown indication,1,I,EXP,pomalidomide,9,SS,Asthenia,9,M,HO,1301
175859821,9,Product used for unknown indication,1,I,EXP,pomalidomide,9,SS,Pyrexia,9,M,OT,1301
175859821,9,Product used for unknown indication,1,I,EXP,pomalidomide,9,SS,Pyrexia,9,M,HO,1301
175859821,10,Product used for unknown indication,1,I,EXP,pomalidomide,10,SS,Asthenia,10,M,OT,404
175859821,10,Product used for unknown indication,1,I,EXP,pomalidomide,10,SS,Asthenia,10,M,HO,404
175859821,10,Product used for unknown indication,1,I,EXP,pomalidomide,10,SS,Pyrexia,10,M,OT,404
175859821,10,Product used for unknown indication,1,I,EXP,pomalidomide,10,SS,Pyrexia,10,M,HO,404
175859821,11,Product used for unknown indication,1,I,EXP,pomalidomide,11,SS,Asthenia,11,M,OT,404
175859821,11,Product used for unknown indication,1,I,EXP,pomalidomide,11,SS,Asthenia,11,M,HO,404
175859821,11,Product used for unknown indication,1,I,EXP,pomalidomide,11,SS,Pyrexia,11,M,OT,404
175859821,11,Product used for unknown indication,1,I,EXP,pomalidomide,11,SS,Pyrexia,11,M,HO,404
175859821,12,Product used for unknown indication,1,I,EXP,pomalidomide,12,SS,Asthenia,12,M,OT,370
175859821,12,Product used for unknown indication,1,I,EXP,pomalidomide,12,SS,Asthenia,12,M,HO,370
175859821,12,Product used for unknown indication,1,I,EXP,pomalidomide,12,SS,Pyrexia,12,M,OT,370
175859821,12,Product used for unknown indication,1,I,EXP,pomalidomide,12,SS,Pyrexia,12,M,HO,370
175859821,13,Product used for unknown indication,1,I,EXP,pomalidomide,13,SS,Asthenia,13,M,OT,327
175859821,13,Product used for unknown indication,1,I,EXP,pomalidomide,13,SS,Asthenia,13,M,HO,327
175859821,13,Product used for unknown indication,1,I,EXP,pomalidomide,13,SS,Pyrexia,13,M,OT,327
175859821,13,Product used for unknown indication,1,I,EXP,pomalidomide,13,SS,Pyrexia,13,M,HO,327
175859821,14,Product used for unknown indication,1,I,EXP,pomalidomide,14,SS,Asthenia,14,M,OT,310
175859821,14,Product used for unknown indication,1,I,EXP,pomalidomide,14,SS,Asthenia,14,M,HO,310
175859821,14,Product used for unknown indication,1,I,EXP,pomalidomide,14,SS,Pyrexia,14,M,OT,310
175859821,14,Product used for unknown indication,1,I,EXP,pomalidomide,14,SS,Pyrexia,14,M,HO,310
175859821,15,Product used for unknown indication,1,I,EXP,pomalidomide,15,SS,Asthenia,15,M,OT,198
175859821,15,Product used for unknown indication,1,I,EXP,pomalidomide,15,SS,Asthenia,15,M,HO,198
175859821,15,Product used for unknown indication,1,I,EXP,pomalidomide,15,SS,Pyrexia,15,M,OT,198
175859821,15,Product used for unknown indication,1,I,EXP,pomalidomide,15,SS,Pyrexia,15,M,HO,198
175859921,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Syncope,1,M,OT,305
175859921,1,Plasma cell myeloma,1,I,PER,carfilzomib,1,PS,Syncope,1,M,HO,305
175859921,2,Plasma cell myeloma,1,I,PER,lenalidomide,2,SS,Syncope,2,M,OT,305
175859921,2,Plasma cell myeloma,1,I,PER,lenalidomide,2,SS,Syncope,2,M,HO,305
175867632,2,Transitional cell carcinoma,2,F,EXP,ipilimumab,2,SS,Blood bilirubin increased,2,F,HO,44
175867632,3,Transitional cell carcinoma,2,F,EXP,nivolumab,3,SS,Blood bilirubin increased,3,F,HO,44
175870622,1,Oesophageal squamous cell carcinoma,2,F,EXP,nivolumab,1,PS,Hypophysitis,1,M,HO,142
175870622,2,Oesophageal squamous cell carcinoma,2,F,EXP,ipilimumab,2,SS,Hypophysitis,2,M,HO,142
175871111,18,Non-small cell lung cancer,1,I,EXP,denosumab,18,C,Dyspnoea,18,M,HO,29
175873641,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Febrile neutropenia,1,F,HO,1
175873641,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Infection susceptibility increased,1,F,HO,1
175873641,1,Product used for unknown indication,1,I,EXP,pegfilgrastim,1,PS,Leukopenia,1,F,HO,1
175874761,2,Malignant melanoma,1,I,EXP,nivolumab,2,PS,Hypoalbuminaemia,2,M,HO,176
175874971,5,Malignant melanoma,1,I,EXP,nivolumab,5,SS,Cerebral microangiopathy,5,F,OT,360
175874971,5,Malignant melanoma,1,I,EXP,nivolumab,5,SS,Leukoencephalopathy,5,F,OT,360
175875871,1,Lung adenocarcinoma,1,I,EXP,nivolumab,1,PS,Bronchitis viral,1,F,HO,249
175875871,1,Lung adenocarcinoma,1,I,EXP,nivolumab,1,PS,Coronavirus test positive,1,F,HO,249
175880751,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Adverse event,1,M,OT,52
175880751,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Adverse event,1,M,HO,52
175880751,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Pneumonitis,1,M,OT,52
175880751,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Pneumonitis,1,M,HO,52
175880751,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Pruritus,1,M,OT,52
175880751,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Pruritus,1,M,HO,52
175880751,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Weight decreased,1,M,OT,52
175880751,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Weight decreased,1,M,HO,52
175880751,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Adverse event,2,M,OT,52
175880751,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Adverse event,2,M,HO,52
175880751,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Pneumonitis,2,M,OT,52
175880751,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Pneumonitis,2,M,HO,52
175880751,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Pruritus,2,M,OT,52
175880751,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Pruritus,2,M,HO,52
175880751,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Weight decreased,2,M,OT,52
175880751,2,Malignant melanoma,1,I,EXP,ipilimumab,2,SS,Weight decreased,2,M,HO,52
175881141,2,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,2,SS,Liver injury,2,M,HO,11
175881141,2,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,2,SS,Purpura,2,M,HO,11
175881141,2,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,2,SS,Rash erythematous,2,M,HO,11
175881141,2,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,2,SS,Thrombocytopenia,2,M,HO,11
175881481,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Arthralgia,1,F,HO,86
175881481,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Myalgia,1,F,HO,86
175881481,1,Ovarian cancer,1,I,EXP,nivolumab,1,PS,Myositis,1,F,HO,86
175882201,6,Malignant melanoma,1,I,EXP,nivolumab,6,SS,Cerebral microangiopathy,6,F,OT,360
175882201,6,Malignant melanoma,1,I,EXP,nivolumab,6,SS,Leukoencephalopathy,6,F,OT,360
175887031,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Body temperature increased,1,F,OT,17
175887031,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Fatigue,1,F,OT,17
175887031,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Nasopharyngitis,1,F,OT,17
175887031,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Rash erythematous,1,F,OT,17
175887031,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Rash macular,1,F,OT,17
175887031,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Syncope,1,F,OT,17
175887031,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Body temperature increased,2,F,OT,1
175887031,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Fatigue,2,F,OT,1
175887031,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Nasopharyngitis,2,F,OT,1
175887031,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Rash erythematous,2,F,OT,1
175887031,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Rash macular,2,F,OT,1
175887031,2,Product used for unknown indication,1,I,EXP,nivolumab,2,SS,Syncope,2,F,OT,1
175887031,3,Malignant melanoma,1,I,EXP,ipilimumab,3,SS,Body temperature increased,3,F,OT,17
175887031,3,Malignant melanoma,1,I,EXP,ipilimumab,3,SS,Fatigue,3,F,OT,17
175887031,3,Malignant melanoma,1,I,EXP,ipilimumab,3,SS,Nasopharyngitis,3,F,OT,17
175887031,3,Malignant melanoma,1,I,EXP,ipilimumab,3,SS,Rash erythematous,3,F,OT,17
175887031,3,Malignant melanoma,1,I,EXP,ipilimumab,3,SS,Rash macular,3,F,OT,17
175887031,3,Malignant melanoma,1,I,EXP,ipilimumab,3,SS,Syncope,3,F,OT,17
175887031,4,Product used for unknown indication,1,I,EXP,ipilimumab,4,SS,Body temperature increased,4,F,OT,1
175887031,4,Product used for unknown indication,1,I,EXP,ipilimumab,4,SS,Fatigue,4,F,OT,1
175887031,4,Product used for unknown indication,1,I,EXP,ipilimumab,4,SS,Nasopharyngitis,4,F,OT,1
175887031,4,Product used for unknown indication,1,I,EXP,ipilimumab,4,SS,Rash erythematous,4,F,OT,1
175887031,4,Product used for unknown indication,1,I,EXP,ipilimumab,4,SS,Rash macular,4,F,OT,1
175887031,4,Product used for unknown indication,1,I,EXP,ipilimumab,4,SS,Syncope,4,F,OT,1
175900892,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Infection,1,M,HO,10
175900892,1,Plasma cell myeloma,2,F,PER,carfilzomib,1,PS,Pyrexia,1,M,HO,10
175900892,2,Plasma cell myeloma,2,F,PER,lenalidomide,2,SS,Infection,2,M,HO,10
175900892,2,Plasma cell myeloma,2,F,PER,lenalidomide,2,SS,Pyrexia,2,M,HO,10
175905631,2,Product used for unknown indication,1,I,EXP,pegfilgrastim,2,SS,Condition aggravated,2,F,HO,45
175905631,2,Product used for unknown indication,1,I,EXP,pegfilgrastim,2,SS,Mucosal inflammation,2,F,HO,45
175913751,2,Mesothelioma,1,I,EXP,pemetrexed disodium,2,SS,Cardio-respiratory arrest,2,M,OT,42
175913751,2,Mesothelioma,1,I,EXP,pemetrexed disodium,2,SS,Cardio-respiratory arrest,2,M,HO,42
175913751,2,Mesothelioma,1,I,EXP,pemetrexed disodium,2,SS,Off label use,2,M,OT,42
175913751,2,Mesothelioma,1,I,EXP,pemetrexed disodium,2,SS,Off label use,2,M,HO,42
175913751,2,Mesothelioma,1,I,EXP,pemetrexed disodium,2,SS,Product use in unapproved indication,2,M,OT,42
175913751,2,Mesothelioma,1,I,EXP,pemetrexed disodium,2,SS,Product use in unapproved indication,2,M,HO,42
175917001,1,Mesothelioma,1,I,EXP,pemetrexed disodium,1,SS,Cardio-respiratory arrest,1,M,HO,42
175918611,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Drug interaction,1,M,OT,290
175918611,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Osteonecrosis of jaw,1,M,OT,290
175919631,14,Prophylaxis,1,I,EXP,rasburicase,14,C,Febrile neutropenia,14,M,HO,59
175919631,14,Prophylaxis,1,I,EXP,rasburicase,14,C,Influenza,14,M,HO,59
175921131,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Eczema,2,M,HO,15
175921131,2,Plasma cell myeloma,1,I,EXP,daratumumab,2,SS,Rash maculo-papular,2,M,HO,15
175921131,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Eczema,4,M,HO,15
175921131,4,Plasma cell myeloma,1,I,EXP,lenalidomide,4,SS,Rash maculo-papular,4,M,HO,15
175929641,10,Acute lymphocytic leukaemia,1,I,EXP,pegaspargase,10,SS,Febrile neutropenia,10,M,HO,46
175930661,4,Plasma cell myeloma,1,I,EXP,daratumumab,4,SS,Cognitive disorder,4,F,HO,87
175930661,4,Plasma cell myeloma,1,I,EXP,daratumumab,4,SS,Cognitive disorder,4,F,DS,87
175930661,4,Plasma cell myeloma,1,I,EXP,daratumumab,4,SS,Confusional state,4,F,HO,87
175930661,4,Plasma cell myeloma,1,I,EXP,daratumumab,4,SS,Confusional state,4,F,DS,87
175930681,4,Product used for unknown indication,1,I,EXP,nivolumab,4,SS,Eyelid disorder,4,M,HO,10
175930681,4,Product used for unknown indication,1,I,EXP,nivolumab,4,SS,Urinary incontinence,4,M,HO,10
175930721,4,Product used for unknown indication,1,I,EXP,nivolumab,4,SS,Hyperbilirubinaemia,4,M,HO,14
175930721,4,Product used for unknown indication,1,I,EXP,nivolumab,4,SS,Hypotension,4,M,HO,14
175931191,1,Chemotherapy,1,I,EXP,crizotinib,1,PS,Neutrophil count decreased,1,F,HO,43
175931191,1,Chemotherapy,1,I,EXP,crizotinib,1,PS,White blood cell count decreased,1,F,HO,43
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Abnormal sensation in eye,17,F,DS,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Abnormal sensation in eye,17,F,HO,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Asthenia,17,F,DS,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Asthenia,17,F,HO,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Decreased appetite,17,F,DS,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Decreased appetite,17,F,HO,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Depression,17,F,DS,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Depression,17,F,HO,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Dyschezia,17,F,DS,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Dyschezia,17,F,HO,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Hypocalcaemia,17,F,DS,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Hypocalcaemia,17,F,HO,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Lethargy,17,F,DS,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Lethargy,17,F,HO,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Migraine,17,F,DS,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Migraine,17,F,HO,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Nasopharyngitis,17,F,DS,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Nasopharyngitis,17,F,HO,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Oropharyngeal pain,17,F,DS,19
175935481,17,Prophylaxis,1,I,EXP,filgrastim,17,C,Oropharyngeal pain,17,F,HO,19
175938631,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Arthralgia,1,M,OT,91
175938631,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Autoimmune disorder,1,M,OT,91
175940041,2,Ovarian cancer,1,I,EXP,trabectedin,2,SS,Anaemia,2,F,HO,14
175940041,2,Ovarian cancer,1,I,EXP,trabectedin,2,SS,Device related infection,2,F,HO,14
175940041,2,Ovarian cancer,1,I,EXP,trabectedin,2,SS,Febrile neutropenia,2,F,HO,14
175940041,2,Ovarian cancer,1,I,EXP,trabectedin,2,SS,Sepsis,2,F,HO,14
175940041,2,Ovarian cancer,1,I,EXP,trabectedin,2,SS,Thrombocytopenia,2,F,HO,14
175942281,3,Hormone-refractory prostate cancer,1,I,EXP,cabazitaxel,3,SS,Febrile neutropenia,3,M,DE,9
175942322,1,Acute lymphocytic leukaemia,2,F,EXP,inotuzumab ozogamicin,1,PS,Acute kidney injury,1,M,HO,7
175943051,1,Ovarian granulosa cell tumour,1,I,EXP,nivolumab,1,PS,Blood creatinine increased,1,F,OT,143
175943051,1,Ovarian granulosa cell tumour,1,I,EXP,nivolumab,1,PS,Immune-mediated nephritis,1,F,OT,143
175943051,1,Ovarian granulosa cell tumour,1,I,EXP,nivolumab,1,PS,Optic neuritis,1,F,OT,143
175943051,2,Ovarian granulosa cell tumour,1,I,EXP,ipilimumab,2,SS,Blood creatinine increased,2,F,OT,143
175943051,2,Ovarian granulosa cell tumour,1,I,EXP,ipilimumab,2,SS,Immune-mediated nephritis,2,F,OT,143
175943051,2,Ovarian granulosa cell tumour,1,I,EXP,ipilimumab,2,SS,Optic neuritis,2,F,OT,143
175950071,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Deep vein thrombosis,1,F,OT,371
175950071,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Pain in extremity,1,F,OT,371
175950071,1,Osteoporosis,1,I,EXP,zoledronic acid,1,PS,Peripheral swelling,1,F,OT,371
175959501,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Muscular weakness,1,M,LT,18
175959501,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Muscular weakness,1,M,DE,18
175959501,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Muscular weakness,1,M,HO,18
175959501,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Myositis,1,M,LT,18
175959501,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Myositis,1,M,DE,18
175959501,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Myositis,1,M,HO,18
175965251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,OT,46
175965251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Cardiac failure congestive,1,M,HO,46
175965251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,M,OT,46
175965251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Chronic obstructive pulmonary disease,1,M,HO,46
175965251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,OT,46
175965251,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Dyspnoea,1,M,HO,46
175965251,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Cardiac failure congestive,2,M,OT,46
175965251,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Cardiac failure congestive,2,M,HO,46
175965251,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Chronic obstructive pulmonary disease,2,M,OT,46
175965251,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Chronic obstructive pulmonary disease,2,M,HO,46
175965251,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Dyspnoea,2,M,OT,46
175965251,2,Non-small cell lung cancer,1,I,EXP,ipilimumab,2,SS,Dyspnoea,2,M,HO,46
175966251,2,Metastases to bone,1,I,EXP,zoledronic acid,2,SS,Joint swelling,2,F,HO,2
175966271,3,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,3,SS,Liver injury,3,M,HO,11
175966271,3,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,3,SS,Liver injury,3,M,OT,11
175966271,3,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,3,SS,Purpura,3,M,HO,11
175966271,3,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,3,SS,Purpura,3,M,OT,11
175966271,3,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,3,SS,Rash erythematous,3,M,HO,11
175966271,3,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,3,SS,Rash erythematous,3,M,OT,11
175966271,3,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,3,SS,Thrombocytopenia,3,M,HO,11
175966271,3,Plasma cell myeloma,1,I,EXP,brentuximab vedotin,3,SS,Thrombocytopenia,3,M,OT,11
175966331,3,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,3,SS,Body temperature increased,3,M,HO,3
175966331,3,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,3,SS,Body temperature increased,3,M,OT,3
175966331,3,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,3,SS,Cytokine release syndrome,3,M,HO,3
175966331,3,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,3,SS,Cytokine release syndrome,3,M,OT,3
175966331,3,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,3,SS,Feeling cold,3,M,HO,3
175966331,3,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,3,SS,Feeling cold,3,M,OT,3
175966331,3,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,3,SS,Malaise,3,M,HO,3
175966331,3,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,3,SS,Malaise,3,M,OT,3
175966331,3,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,3,SS,Rash maculo-papular,3,M,HO,3
175966331,3,Diffuse large B-cell lymphoma,1,I,EXP,axicabtagene ciloleucel,3,SS,Rash maculo-papular,3,M,OT,3
175969211,2,Plasma cell myeloma,1,I,PER,lenalidomide,2,SS,Respiratory syncytial virus infection,2,M,HO,8
175976231,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood pressure decreased,1,M,DE,20
175976231,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood pressure decreased,1,M,HO,20
175976231,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood pressure decreased,1,M,OT,20
175976231,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood pressure increased,1,M,DE,20
175976231,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood pressure increased,1,M,HO,20
175976231,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood pressure increased,1,M,OT,20
175976231,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Death,1,M,DE,20
175976231,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Death,1,M,HO,20
175976231,1,Prostate cancer,1,I,EXP,enzalutamide,1,PS,Death,1,M,OT,20
175978971,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Asthenia,1,F,HO,28
175978971,1,Malignant melanoma,1,I,EXP,nivolumab,1,PS,Gait disturbance,1,F,HO,28
175979471,2,Non-small cell lung cancer,1,I,DIR,bosutinib,2,SS,Clinical trial participant,2,M,HO,30
175979471,2,Non-small cell lung cancer,1,I,DIR,bosutinib,2,SS,Haematemesis,2,M,HO,30
175979471,2,Non-small cell lung cancer,1,I,DIR,bosutinib,2,SS,Haemoglobin decreased,2,M,HO,30
175981361,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood potassium increased,1,M,OT,63
175981361,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood potassium increased,1,M,HO,63
175981361,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood pressure increased,1,M,OT,63
175981361,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Blood pressure increased,1,M,HO,63
175981361,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Cardiac failure,1,M,OT,63
175981361,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Cardiac failure,1,M,HO,63
175981361,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Renal failure,1,M,OT,63
175981361,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Renal failure,1,M,HO,63
175981361,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Vomiting,1,M,OT,63
175981361,1,Hormone-refractory prostate cancer,1,I,EXP,enzalutamide,1,PS,Vomiting,1,M,HO,63
175987761,6,Chronic lymphocytic leukaemia,1,I,EXP,ibrutinib,6,SS,Neoplasm,6,M,HO,90
175989441,1,Metastases to bone,1,I,EXP,zoledronic acid,1,PS,Joint swelling,1,F,HO,2
175989991,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Coronavirus test positive,1,M,OT,85
175989991,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Coronavirus test positive,1,M,HO,85
175989991,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Coronavirus test positive,1,M,LT,85
175989991,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,OT,85
175989991,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,HO,85
175989991,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Pneumonia,1,M,LT,85
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Anxiety,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Anxiety,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Arthralgia,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Arthralgia,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Axillary pain,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Axillary pain,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Back pain,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Back pain,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Blood calcium decreased,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Blood calcium decreased,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Chest pain,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Chest pain,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Cough,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Cough,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Decreased appetite,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Decreased appetite,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Epistaxis,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Epistaxis,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Gingivitis,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Gingivitis,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Headache,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Headache,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Musculoskeletal discomfort,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Musculoskeletal discomfort,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Musculoskeletal pain,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Musculoskeletal pain,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Nausea,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Nausea,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Neck pain,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Neck pain,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Neuropathy peripheral,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Neuropathy peripheral,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Pain in extremity,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Pain in extremity,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Palpitations,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Palpitations,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Retching,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Retching,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Spinal pain,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Spinal pain,9,F,HO,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Tachycardia,9,F,OT,84
175997961,9,Vitamin D decreased,1,I,EXP,zoledronic acid,9,C,Tachycardia,9,F,HO,84
176004761,1,Plasma cell myeloma,1,I,PER,lenalidomide,1,PS,Neutrophil count decreased,1,M,OT,566
176005481,4,Plasma cell myeloma,1,I,PER,nivolumab,4,SS,Pneumonia,4,M,LT,950
176005481,4,Plasma cell myeloma,1,I,PER,nivolumab,4,SS,Pneumonia,4,M,HO,950
176009421,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Corona virus infection,1,M,HO,105
176009421,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Corona virus infection,1,M,LT,105
176027411,1,Myelodysplastic syndrome,1,I,PER,lenalidomide,1,PS,Cardiac failure congestive,1,F,HO,21
176028521,1,Lung adenocarcinoma,1,I,EXP,entrectinib,1,PS,Acute kidney injury,1,M,HO,14
176028521,1,Lung adenocarcinoma,1,I,EXP,entrectinib,1,PS,Hyperkalaemia,1,M,HO,14
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Acute kidney injury,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Blood osmolarity decreased,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Cellulitis,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Constipation,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Dehydration,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Ear swelling,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Headache,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Hyperglycaemia,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Hypomagnesaemia,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Hyponatraemia,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Lip swelling,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Nausea,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Pruritus,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Pyrexia,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Rash maculo-papular,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Sleep disorder,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Staphylococcus test positive,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Swelling face,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Swelling of eyelid,2,F,HO,8
176031671,2,Breast cancer metastatic,1,I,EXP,enzalutamide,2,SS,Vomiting,2,F,HO,8
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Anaemia,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Anal fissure,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Anal haemorrhage,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Angular cheilitis,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Blood lactic acid increased,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Diarrhoea,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Eczema,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Enterovirus infection,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Influenza,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Lethargy,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Lip swelling,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Malaise,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Oral disorder,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Proctalgia,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Productive cough,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Pyrexia,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Rash,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Rash maculo-papular,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Respiratory symptom,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,Rhinovirus infection,1,F,HO,14
176031781,1,"Astrocytoma, low grade",1,I,EXP,trametinib,1,PS,White blood cell count increased,1,F,HO,14
176032001,1,Prostate cancer,1,I,EXP,nivolumab,1,PS,Myocarditis,1,M,OT,18
176032001,1,Prostate cancer,1,I,EXP,nivolumab,1,PS,Myocarditis,1,M,HO,18
176032001,1,Prostate cancer,1,I,EXP,nivolumab,1,PS,Myocarditis,1,M,DE,18
176032001,2,Prostate cancer,1,I,EXP,ipilimumab,2,SS,Myocarditis,2,M,OT,18
176032001,2,Prostate cancer,1,I,EXP,ipilimumab,2,SS,Myocarditis,2,M,HO,18
176032001,2,Prostate cancer,1,I,EXP,ipilimumab,2,SS,Myocarditis,2,M,DE,18
176037571,1,Acute lymphocytic leukaemia,1,I,EXP,inotuzumab ozogamicin,1,SS,Aphasia,1,M,HO,136
176040091,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Respiratory tract infection,1,F,OT,2
176040091,1,Non-small cell lung cancer,1,I,EXP,nivolumab,1,PS,Respiratory tract infection,1,F,HO,2
176043021,1,Plasma cell myeloma,1,I,EXP,daratumumab,1,PS,Syncope,1,F,HO,1
176048091,1,Colorectal cancer metastatic,1,I,EXP,dacomitinib,1,PS,Alanine aminotransferase increased,1,M,OT,27
176048091,1,Colorectal cancer metastatic,1,I,EXP,dacomitinib,1,PS,Aspartate aminotransferase increased,1,M,OT,27
176050771,1,Diffuse large B-cell lymphoma,1,I,DIR,axicabtagene ciloleucel,1,PS,Confusional state,1,M,HO,1
176050771,1,Diffuse large B-cell lymphoma,1,I,DIR,axicabtagene ciloleucel,1,PS,Confusional state,1,M,OT,1
176050771,1,Diffuse large B-cell lymphoma,1,I,DIR,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,HO,1
176050771,1,Diffuse large B-cell lymphoma,1,I,DIR,axicabtagene ciloleucel,1,PS,Cytokine release syndrome,1,M,OT,1
176050771,1,Diffuse large B-cell lymphoma,1,I,DIR,axicabtagene ciloleucel,1,PS,Hyperglycaemia,1,M,HO,1
176050771,1,Diffuse large B-cell lymphoma,1,I,DIR,axicabtagene ciloleucel,1,PS,Hyperglycaemia,1,M,OT,1
176050771,1,Diffuse large B-cell lymphoma,1,I,DIR,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,HO,1
176050771,1,Diffuse large B-cell lymphoma,1,I,DIR,axicabtagene ciloleucel,1,PS,Neurotoxicity,1,M,OT,1
176050771,1,Diffuse large B-cell lymphoma,1,I,DIR,axicabtagene ciloleucel,1,PS,Neutrophil count decreased,1,M,HO,1
176050771,1,Diffuse large B-cell lymphoma,1,I,DIR,axicabtagene ciloleucel,1,PS,Neutrophil count decreased,1,M,OT,1
176052981,3,Renal cell carcinoma,1,I,EXP,avelumab,3,SS,Anaemia,3,F,HO,267
176052981,3,Renal cell carcinoma,1,I,EXP,avelumab,3,SS,Haematoma,3,F,HO,267
176052981,3,Renal cell carcinoma,1,I,EXP,avelumab,3,SS,Muscular weakness,3,F,HO,267
176052981,4,Renal cell carcinoma,1,I,EXP,axitinib,4,SS,Anaemia,4,F,HO,267
176052981,4,Renal cell carcinoma,1,I,EXP,axitinib,4,SS,Haematoma,4,F,HO,267
176052981,4,Renal cell carcinoma,1,I,EXP,axitinib,4,SS,Muscular weakness,4,F,HO,267
176055781,1,Plasma cell myeloma,1,I,EXP,thalidomide,1,PS,Mental disorder,1,M,OT,64
176055781,1,Plasma cell myeloma,1,I,EXP,thalidomide,1,PS,Plasma cell myeloma,1,M,OT,64
176055781,1,Plasma cell myeloma,1,I,EXP,thalidomide,1,PS,Suicidal ideation,1,M,OT,64
176059931,1,Acute lymphocytic leukaemia,1,I,EXP,nilotinib,1,PS,Basal cell carcinoma,1,F,OT,532
176065611,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Cardio-respiratory arrest,1,F,LT,38
176065611,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Cardio-respiratory arrest,1,F,HO,38
176065611,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Cardio-respiratory arrest,1,F,DS,38
176065611,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Cardio-respiratory arrest,1,F,DE,38
176065611,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Intestinal haemorrhage,1,F,LT,38
176065611,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Intestinal haemorrhage,1,F,HO,38
176065611,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Intestinal haemorrhage,1,F,DS,38
176065611,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Intestinal haemorrhage,1,F,DE,38
176065611,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Pneumonia,1,F,LT,38
176065611,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Pneumonia,1,F,HO,38
176065611,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Pneumonia,1,F,DS,38
176065611,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Pneumonia,1,F,DE,38
176066181,30,Prophylaxis,1,I,EXP,rasburicase,30,C,Scrotal abscess,30,M,HO,1786
176067381,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Death,1,F,DE,119
176067381,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Diarrhoea,1,F,DE,119
176067381,1,Plasma cell myeloma,1,I,EXP,lenalidomide,1,PS,Skin lesion,1,F,DE,119
176075401,3,Gastrooesophageal cancer,1,I,EXP,avelumab,3,SS,Splenic abscess,3,M,HO,180
176079731,2,Mantle cell lymphoma,1,I,EXP,ibrutinib,2,SS,Pneumonia,2,M,HO,613
176079731,2,Mantle cell lymphoma,1,I,EXP,ibrutinib,2,SS,Pneumonia,2,M,DE,613
176081551,1,Hepatocellular carcinoma,1,I,EXP,nivolumab,1,PS,Arthropathy,1,M,HO,11
176081551,1,Hepatocellular carcinoma,1,I,EXP,nivolumab,1,PS,Arthropathy,1,M,OT,11
176081551,2,Hepatocellular carcinoma,1,I,EXP,ipilimumab,2,SS,Arthropathy,2,M,HO,11
176081551,2,Hepatocellular carcinoma,1,I,EXP,ipilimumab,2,SS,Arthropathy,2,M,OT,11
176081831,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Anaemia,1,F,HO,2
176081831,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Anaemia,1,F,OT,2
176081831,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Dehydration,1,F,HO,2
176081831,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Dehydration,1,F,OT,2
176081831,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Dyspnoea,1,F,HO,2
176081831,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Dyspnoea,1,F,OT,2
176081831,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Fatigue,1,F,HO,2
176081831,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Fatigue,1,F,OT,2
176081831,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Pruritus,1,F,HO,2
176081831,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Pruritus,1,F,OT,2
176081831,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Rash maculo-papular,1,F,HO,2
176081831,1,Malignant melanoma,1,I,EXP,nivolumab,1,SS,Rash maculo-papular,1,F,OT,2
176081831,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Anaemia,2,F,HO,2
176081831,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Anaemia,2,F,OT,2
176081831,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Dehydration,2,F,HO,2
176081831,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Dehydration,2,F,OT,2
176081831,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Dyspnoea,2,F,HO,2
176081831,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Dyspnoea,2,F,OT,2
176081831,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Fatigue,2,F,HO,2
176081831,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Fatigue,2,F,OT,2
176081831,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Pruritus,2,F,HO,2
176081831,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Pruritus,2,F,OT,2
176081831,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Rash maculo-papular,2,F,HO,2
176081831,2,Malignant melanoma,1,I,EXP,ipilimumab,2,PS,Rash maculo-papular,2,F,OT,2
176082831,4,Renal cell carcinoma,1,I,EXP,ipilimumab,4,SS,Endocrine disorder,4,F,OT,77
176082831,4,Renal cell carcinoma,1,I,EXP,ipilimumab,4,SS,Endocrine disorder,4,F,HO,77
176082831,6,Renal cell carcinoma,1,I,EXP,nivolumab,6,SS,Endocrine disorder,6,F,OT,77
176082831,6,Renal cell carcinoma,1,I,EXP,nivolumab,6,SS,Endocrine disorder,6,F,HO,77
176084441,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Neutrophil count decreased,3,F,OT,42
176084441,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,Weight decreased,3,F,OT,42
176084441,3,Plasma cell myeloma,1,I,EXP,lenalidomide,3,SS,White blood cell count decreased,3,F,OT,42
176084881,2,Seminoma,1,I,EXP,bleomycin sulfate,2,SS,Pancytopenia,2,M,OT,4
176084881,2,Seminoma,1,I,EXP,bleomycin sulfate,2,SS,Pancytopenia,2,M,DE,4
176084881,2,Seminoma,1,I,EXP,bleomycin sulfate,2,SS,Pancytopenia,2,M,HO,4
176084881,2,Seminoma,1,I,EXP,bleomycin sulfate,2,SS,Septic shock,2,M,OT,4
176084881,2,Seminoma,1,I,EXP,bleomycin sulfate,2,SS,Septic shock,2,M,DE,4
176084881,2,Seminoma,1,I,EXP,bleomycin sulfate,2,SS,Septic shock,2,M,HO,4
81996483,5,Plasma cell myeloma,3,F,EXP,lenalidomide,5,SS,C-reactive protein increased,5,F,HO,80
81996483,5,Plasma cell myeloma,3,F,EXP,lenalidomide,5,SS,C-reactive protein increased,5,F,LT,80
81996483,5,Plasma cell myeloma,3,F,EXP,lenalidomide,5,SS,Hepatic function abnormal,5,F,HO,80
81996483,5,Plasma cell myeloma,3,F,EXP,lenalidomide,5,SS,Hepatic function abnormal,5,F,LT,80
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Anaemia,5,M,DS,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Anaemia,5,M,OT,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Anaemia,5,M,HO,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Atrial fibrillation,5,M,DS,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Atrial fibrillation,5,M,OT,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Atrial fibrillation,5,M,HO,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Dehydration,5,M,DS,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Dehydration,5,M,OT,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Dehydration,5,M,HO,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Diabetes mellitus,5,M,DS,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Diabetes mellitus,5,M,OT,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Diabetes mellitus,5,M,HO,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Diarrhoea,5,M,DS,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Diarrhoea,5,M,OT,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Diarrhoea,5,M,HO,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,General physical health deterioration,5,M,DS,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,General physical health deterioration,5,M,OT,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,General physical health deterioration,5,M,HO,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Hepatic function abnormal,5,M,DS,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Hepatic function abnormal,5,M,OT,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Hepatic function abnormal,5,M,HO,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Hypoxia,5,M,DS,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Hypoxia,5,M,OT,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Hypoxia,5,M,HO,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Melaena,5,M,DS,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Melaena,5,M,OT,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Melaena,5,M,HO,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Restlessness,5,M,DS,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Restlessness,5,M,OT,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Restlessness,5,M,HO,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Thrombocytopenia,5,M,DS,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Thrombocytopenia,5,M,OT,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Thrombocytopenia,5,M,HO,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Weight decreased,5,M,DS,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Weight decreased,5,M,OT,3
82731934,5,Plasma cell myeloma,4,F,EXP,lenalidomide,5,SS,Weight decreased,5,M,HO,3
92045146,6,Prophylaxis of nausea and vomiting,6,F,EXP,granisetron,6,C,Aortic dissection,6,M,LT,387
92045146,6,Prophylaxis of nausea and vomiting,6,F,EXP,granisetron,6,C,Aortic dissection,6,M,HO,387
92045146,6,Prophylaxis of nausea and vomiting,6,F,EXP,granisetron,6,C,Aortic dissection,6,M,DE,387
92045146,6,Prophylaxis of nausea and vomiting,6,F,EXP,granisetron,6,C,Non-small cell lung cancer metastatic,6,M,LT,387
92045146,6,Prophylaxis of nausea and vomiting,6,F,EXP,granisetron,6,C,Non-small cell lung cancer metastatic,6,M,HO,387
92045146,6,Prophylaxis of nausea and vomiting,6,F,EXP,granisetron,6,C,Non-small cell lung cancer metastatic,6,M,DE,387
99945954,1,Metastatic malignant melanoma,4,F,EXP,ipilimumab,1,PS,Cytomegalovirus colitis,1,F,OT,245
99945954,1,Metastatic malignant melanoma,4,F,EXP,ipilimumab,1,PS,Cytomegalovirus colitis,1,F,HO,245
